PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chung, KCC; Zamble, DB				Chung, Kim C. Chan; Zamble, Deborah B.			Protein Interactions and Localization of the Escherichia coli Accessory Protein HypA during Nickel Insertion to [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SUBUNIT; MATURATION; COMPLEX; SLYD; ZINC; CHAPERONE; SITE; IDENTIFICATION; BIOSYNTHESIS; RECOGNITION	Nickel delivery during maturation of Escherichia coli [NiFe] hydrogenase 3 includes the accessory proteins HypA, HypB, and SlyD. Although the isolated proteins have been characterized, little is known about how they interact with each other and the hydrogenase 3 large subunit, HycE. In this study the complexes of HypA and HycE were investigated after modification with the Strep-tag II. Multiprotein complexes containing HypA, HypB, SlyD, and HycE were observed, consistent with the assembly of a single nickel insertion cluster. An interaction between HypA and HycE did not require the other nickel insertion proteins, but HypB was not found with the large subunit in the absence of HypA. The HypA-HycE complex was not detected in the absence of the HypC or HypD proteins, involved in the preceding iron insertion step, and this interaction is enhanced by nickel brought into the cell by the NikABCDE membrane transporter. Furthermore, without the hydrogenase 1, 2, and 3 large subunits, complexes between HypA, HypB, and SlyD were observed. These results support the hypothesis that HypA acts as a scaffold for assembly of the nickel insertion proteins with the hydrogenase precursor protein after delivery of the iron center. At different stages of the hydrogenase maturation process, HypA was observed at or near the cell membrane by using fluorescence confocal microscopy, as was HycE, suggesting membrane localization of the nickel insertion event.	[Chung, Kim C. Chan; Zamble, Deborah B.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto	Zamble, DB (corresponding author), 80 St George St, Toronto, ON M5S 3H6, Canada.	dzamble@chem.utoronto.ca		Zamble, Deborah/0000-0002-8976-3375	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was funded in part by grants from Canadian Institutes of Health Research and the Canada Research Chairs Program.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J BACTERIOL, V186, P2603, DOI 10.1128/JB.186.9.2603-2611.2004; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Butland G, 2006, FEBS LETT, V580, P677, DOI 10.1016/j.febslet.2005.12.063; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Dubini A, 2003, FEBS LETT, V549, P141, DOI 10.1016/S0014-5793(03)00802-0; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Herbst RW, 2010, J AM CHEM SOC, V132, P10338, DOI 10.1021/ja1005724; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; Maeda T, 2007, APPL MICROBIOL BIOT, V77, P879, DOI 10.1007/s00253-007-1217-0; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; Mansure JJ, 2008, BIOTECHNOL LETT, V30, P1765, DOI 10.1007/s10529-008-9755-9; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; McGlynn SE, 2009, DALTON T, P4274, DOI 10.1039/b821432h; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; ROSSMANN R, 1994, EUR J BIOCHEM, V220, P377, DOI 10.1111/j.1432-1033.1994.tb18634.x; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; VARGA MER, 1995, BIOCHEM CELL BIOL, V73, P147, DOI 10.1139/o95-018; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Wu LF, 2000, ARCH MICROBIOL, V173, P319, DOI 10.1007/s002030000144; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	58	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43081	43090		10.1074/jbc.M111.290726	http://dx.doi.org/10.1074/jbc.M111.290726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016389	Green Published, hybrid			2022-12-25	WOS:000298351300029
J	Ichikawa, D; Mizuno, M; Yamamura, T; Miyake, S				Ichikawa, Daiju; Mizuno, Miho; Yamamura, Takashi; Miyake, Sachiko			GRAIL (Gene Related to Anergy in Lymphocytes) Regulates Cytoskeletal Reorganization through Ubiquitination and Degradation of Arp2/3 Subunit 5 and Coronin 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ANERGY; CBL-B; NEGATIVE REGULATION; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; TYROSINE KINASE; LIGASE; COMPLEX; BINDING; ACTIVATION	Anergy is an important mechanism for the maintenance of peripheral tolerance and avoidance of autoimmunity. The upregulation of E3 ubiqitin ligases, including GRAIL (gene related to anergy in lymphocytes), is a key event in the induction and preservation of anergy in T cells. However, the mechanisms of GRAIL-mediated anergy induction are still not completely understood. We examined which proteins serve as substrates for GRAIL in anergic T cells. Arp2/3-5 (actin-related protein 2/3 subunit 5) and coronin 1A were polyubiquitinated by GRAIL via Lys-48 and Lys-63 linkages. In anergic T cells and GRAIL-overexpressed T cells, the expression of Arp2/3-5 and coronin 1A was reduced. Furthermore, we demonstrated that GRAIL impaired lamellipodium formation and reduced the accumulation of F-actin at the immunological synapse. GRAIL functions via the ubiquitination and degradation of actin cytoskeleton-associated proteins, in particular Arp2/3-5 and coronin 1A. These data reveal that GRAIL regulates proteins involved in the actin cytoskeletal organization, thereby maintaining the unresponsive state of anergic T cells.	[Ichikawa, Daiju; Mizuno, Miho; Yamamura, Takashi; Miyake, Sachiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Miyake, S (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	miyake@ncnp.go.jp			Japan Society for the Promotion of Science [7210, 20790093]; Ministry of Health, Labor and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in-Aid for Scientific Research B: 7210 (to S. M.) and Grant-in-Aid for Young Scientists B: 20790093 (to D. I.) from the Japan Society for the Promotion of Science, and Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; QUILL H, 1987, J IMMUNOL, V138, P3704; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Schartner JM, 2009, J BIOL CHEM, V284, P34674, DOI 10.1074/jbc.M109.024497; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Su LL, 2009, J IMMUNOL, V183, P438, DOI 10.4049/jimmunol.0900204; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	37	18	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43465	43474		10.1074/jbc.M111.222711	http://dx.doi.org/10.1074/jbc.M111.222711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016387	Green Published, hybrid			2022-12-25	WOS:000298351300066
J	Kim, J; Eskiocak, U; Stadler, G; Lou, ZJ; Kuro-o, M; Shay, JW; Wright, WE				Kim, Jinyong; Eskiocak, Ugur; Stadler, Guido; Lou, Zhenjun; Kuro-o, Makoto; Shay, Jerry W.; Wright, Woodring E.			Short Hairpin RNA Screen Indicates That Klotho Beta/FGF19 Protein Overcomes Stasis in Human Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY ENSHEATHING CELLS; CANINE SCHWANN-CELLS; GROWTH-FACTOR; ENDOTHELIAL-CELLS; BETA-KLOTHO; LIFE-SPAN; IN-VITRO; TELOMERASE; IMMORTALIZATION; FGF19	Normal human colonic epithelial cells (HCECs) are not immortalized by telomerase alone but also require CDK4. Some human cell types growth-arrest due to stress-or aberrant signaling-induced senescence (stasis). Stasis represents the consequences of growth conditions culture that are inadequate to maintain long-term proliferation. Overexpressed CDK4 titers out p16 and allows cells to ignore the growth arrest signals produced by stasis. To identify factors contributing to the inadequate culture environment, we used a 62,000-member shRNA library to knock down factors cooperating with human telomerase reverse transcriptase (hTERT) in the immortalization of HCECs. Knockdown of Klotho gamma (KLG; also known as KLPH and LCTL) allowed hTERT to immortalize HCECs. KLG is one isoform of the Klotho family of factors that coordinate interaction between different FGF ligands and the FGF receptor. We also found that knockdown of KLG induced another member of the Klotho family, Klotho beta (KLB). Induction of KLB was maintained and could activate ERK1/2 in immortalized cells. Supplementation of the culture medium with the KLB ligand FGF19 had a similar effect on hTERT-expressing HCECs as knockdown of KLG regarding both immortalization and down-regulation of the tumor suppressor Klotho alpha. Together, these data suggest that KLB is an important regulator in the immortalization of HCECs by facilitating FGF19 growth factor signaling.	[Kim, Jinyong; Eskiocak, Ugur; Stadler, Guido; Lou, Zhenjun; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wright, WE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Eskiocak, Ugur/M-9903-2015		National Institutes of Health [AG01228, AG019712, DK091392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001228, R37AG001228, R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG01228 (to W. E. W.) and AG019712 and DK091392 (to M. K.).	Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; de Oliveira RM, 2006, FEBS LETT, V580, P5753, DOI 10.1016/j.febslet.2006.09.036; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurz DJ, 2003, ARTERIOSCL THROM VAS, V23, P748, DOI 10.1161/01.ATV.0000069624.55424.61; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; WANG H, 2011, J CLIN INVE IN PRESS; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645	27	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43294	43300		10.1074/jbc.M111.267641	http://dx.doi.org/10.1074/jbc.M111.267641			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020932	Green Published, hybrid			2022-12-25	WOS:000298351300049
J	Creaney, J; Dick, IM; Yeoman, D; Wong, S; Robinson, BWS				Creaney, Jenette; Dick, Ian M.; Yeoman, Deborah; Wong, Sarah; Robinson, Bruce W. S.			Auto-Antibodies to beta-F1-ATPase and Vimentin in Malignant Mesothelioma	PLOS ONE			English	Article							MEGAKARYOCYTE POTENTIATING FACTOR; ATP SYNTHASE; BIOENERGETIC SIGNATURE; SERUM MESOTHELIN; CANCER; DIAGNOSIS; PROGNOSIS; PROTEINS; WARBURG; OSTEOPONTIN	Patients with Malignant Mesothelioma (MM) develop unidentified auto-antibodies to MM tumour antigens. This study was conducted to identify the targets of MM patient auto-antibodies in order to try to understand more of the anti-tumour response and to determine if these antibodies might be helpful for diagnosis or prognostication. Using MM patient sera in a Western immunoblott screening strategy, no common immunoreactive proteins were identified. The sera from one long-term survivor recognised a protein band of 50-60 kDa present in cell lysates from four of five MM cell lines tested. The immunoreactive proteins in this band were identified by 2D electrophoretic separation of a MM cell line protein lysate, followed by analysis of excised immunoreactive proteins on a MALDI TOF mass spectrometer and peptide mass fingerprinting. The immunoreactive proteins identified were vimentin (accession gi55977767) and the ATP synthase (F1-ATPase) beta chain (accession gi114549 and gi47606749). ELISA assays were developed for antibodies to these proteins. Neither vimentin (median and 95% CI 0.346; 0.32-0.468 for MM patients, 0.327; 0.308-0.428 for controls) nor beta-F1-ATPase (0.257; 0.221-0.453 for MM patients, 0.263; 0.22-0.35 for controls) showed significant differences in autoantibody levels between a group of MM patients and controls. Using a dichotomized antibody level (high, low) for these targets we demonstrated that vimentin antibody levels were not associated with survival. In contrast, high beta-F1-ATPase antibody levels were significantly associated with increased median survival (18 months) compared to low beta F1 ATPase antibody levels (9 months; p = 0.049). Immunohistochemical analysis on a MM tissue microarray showed cytoplasmic staining in 28 of 33 samples for vimentin and strong cytoplasmic staining in 14 and weak in 16 samples for beta-F1-ATPase. Therefore antibodies to neither vimentin nor beta-F1-ATPase are useful for differential diagnosis of MM, however high antibody levels to beta-F1-ATPase may be associated with increased survival and this warrants further investigation.	[Creaney, Jenette; Dick, Ian M.; Yeoman, Deborah; Wong, Sarah; Robinson, Bruce W. S.] Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Creaney, Jenette; Robinson, Bruce W. S.] Sir Charles Gairdner Hosp, Australian Mesothelioma Tissue Bank, Nedlands, WA 6009, Australia; [Robinson, Bruce W. S.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Creaney, J (corresponding author), Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Nedlands, WA 6009, Australia.	creaneyj@cyllene.uwa.edu.au	Robinson, Bruce/N-1900-2014		National Health and Medical Research Council of Australia [PG 458532]; Insurance Commission of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia	This study was funded in part by research grants from the National Health and Medical Research Council of Australia PG 458532 (http://www.nhmrc.gov.au/) and the Insurance Commission of Western Australia (http://www.icwa.wa.gov.au/id/id_medical.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE P, 2010, ANN ONCOL; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Creaney J, 2008, BRIT J CANCER, V98, P1562, DOI 10.1038/sj.bjc.6604340; Creaney J, 2001, BRIT J CANCER, V84, P52, DOI 10.1054/bjoc.2000.1529; CREANEY J, 2010, CANC EPIDEMIOL BIOMA; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Creaney J, 2007, CHEST, V132, P1239, DOI 10.1378/chest.07-0013; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2007, J BIOENERG BIOMEMBR, V39, P259, DOI 10.1007/s10863-007-9087-9; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hollevoet K, 2010, AM J RESP CRIT CARE, V181, P620, DOI 10.1164/rccm.200907-1020OC; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Jones FG, 1999, AUTOIMMUNITY, V30, P157, DOI 10.3109/08916939908993850; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lock RA, 2001, PATHOLOGY, V33, P365; Mahesh B, 2007, AM J PATHOL, V170, P1415, DOI 10.2353/ajpath.2007.060728; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Robinson C, 1998, LUNG CANCER, V20, P175, DOI 10.1016/S0169-5002(98)00014-2; Robinson C, 2000, AM J RESP CELL MOL, V22, P550, DOI 10.1165/ajrcmb.22.5.3930; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; VACIRCA D, 2010, NEUROBIOL AGING; Vantourout P, 2008, MOL IMMUNOL, V45, P485, DOI 10.1016/j.molimm.2007.05.026; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754	36	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26515	10.1371/journal.pone.0026515	http://dx.doi.org/10.1371/journal.pone.0026515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022619	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400063
J	Pardanaud, L; Eichmann, A				Pardanaud, Luc; Eichmann, Anne			Extraembryonic Origin of Circulating Endothelial Cells	PLOS ONE			English	Article							BONE-MARROW; PROGENITOR CELLS; MICROGLIA DERIVE; CHICK-EMBRYO; YOLK-SAC; ANGIOGENESIS; VASCULOGENESIS; RECRUITMENT; NEOVASCULARIZATION; ERYTHROPOIESIS	Circulating endothelial cells (CEC) are contained in the bone marrow and peripheral blood of adult humans and participate to the revascularization of ischemic tissues. These cells represent attractive targets for cell or gene therapy aimed at improving ischemic revascularization or inhibition of tumor angiogenesis. The embryonic origin of CEC has not been addressed previously. Here we use quail-chick chimeras to study CEC origin and participation to the developing vasculature. CEC are traced with different markers, in particular the QH1 antibody recognizing only quail endothelial cells. Using yolk-sac chimeras, where quail embryos are grafted onto chick yolk sacs and vice-versa, we show that CEC are generated in the yolk sac. These cells are mobilized during wound healing, demonstrating their participation to angiogenic repair processes. Furthermore, we found that the allantois is also able to give rise to CEC in situ. In contrast to the yolk sac and allantois, the embryo proper does not produce CEC. Our results show that CEC exclusively originate from extra-embryonic territories made with splanchnopleural mesoderm and endoderm, while definitive hematopoietic stem cells and endothelial cells are of intra-embryonic origin.	[Pardanaud, Luc; Eichmann, Anne] Coll France, CIRB, F-75231 Paris, France; [Pardanaud, Luc; Eichmann, Anne] INSERM U1050, F-75005 Paris, France; [Pardanaud, Luc; Eichmann, Anne] CNRS UMR 7241, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pardanaud, L (corresponding author), Coll France, CIRB, F-75231 Paris, France.	luc.pardanaud@college-de-france.fr		Luc, Pardanaud/0000-0002-7358-6730	Inserm; Fondation pour la recherche medicale (FRM); Fondation Bettencourt-Schueller	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller	This work was supported by Inserm, Fondation pour la recherche medicale (FRM) and Fondation Bettencourt-Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; CUADROS MA, 1992, DEVELOPMENT, V115, P157; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dieterlen-Lievre F, 2010, INT J DEV BIOL, V54, P1079, DOI 10.1387/ijdb.093047fd; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; Dudek AZ, 2010, TRANSL RES, V156, P136, DOI 10.1016/j.trsl.2010.07.003; Dudley AC, 2010, BLOOD, V116, P3367, DOI 10.1182/blood-2010-02-271122; Erbs S, 2007, CIRCULATION, V116, P366, DOI 10.1161/CIRCULATIONAHA.106.671545; FLAMME I, 1989, ANAT EMBRYOL, V180, P259, DOI 10.1007/BF00315884; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; HALFTER W, 1993, J COMP NEUROL, V327, P442, DOI 10.1002/cne.903270309; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; KESSEL J, 1987, DEVELOPMENT, V101, P45; Le Douarin N. M., 1964, B BIOL FR BELG, V98, P544; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MARTIN C, 1972, CR SOC BIOL, V166, P283; MARTIN C, 1980, DEV BIOL, V75, P303, DOI 10.1016/0012-1606(80)90165-7; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; Navarro M, 2003, J ANAT, V202, P213, DOI 10.1046/j.1469-7580.2003.00156.x; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Pardanaud L, 2006, DEVELOPMENT, V133, DOI 10.1242/dev.02461; Pardanaud L, 2009, NATURE, V459, P1068, DOI 10.1038/4591068a; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; POURQUIE O, 1990, DEVELOPMENT, V109, P743; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; SABIN F, 1932, CONTR EMBRYOL, V9, P215; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; WILT FH, 1965, SCIENCE, V147, P1588, DOI 10.1126/science.147.3665.1588; ZACCHEI A M, 1961, Arch Ital Anat Embriol, V66, P36; Zambidis ET, 2007, ANN NY ACAD SCI, V1106, P223, DOI 10.1196/annals.1392.010; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215	50	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25889	10.1371/journal.pone.0025889	http://dx.doi.org/10.1371/journal.pone.0025889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022461	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600018
J	Lee, N; Wong, CK; Chan, PKS; Chan, MCW; Wong, RYK; Lun, SWM; Ngai, KLK; Lui, GCY; Wong, BCK; Lee, SKW; Choi, KW; Hui, DSC				Lee, Nelson; Wong, Chun Kwok; Chan, Paul K. S.; Chan, Martin C. W.; Wong, Rity Y. K.; Lun, Samantha W. M.; Ngai, Karry L. K.; Lui, Grace C. Y.; Wong, Bonnie C. K.; Lee, Sharon K. W.; Choi, Kin Wing; Hui, David S. C.			Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults	PLOS ONE			English	Article							CLINICAL-ASPECTS; HOST RESPONSES; WHOLE-BLOOD; VIRUS; CELLS; FERRETS; HYPERCYTOKINEMIA; INTERFERON; ACTIVATION; INFECTION	Background: Studying cytokine/chemokine responses in severe influenza infections caused by different virus subtypes may improve understanding on pathogenesis. Methods: Adults hospitalized for laboratory-confirmed seasonal and pandemic 2009 A/H1N1 (pH1N1) influenza were studied. Plasma concentrations of 13 cytokines/chemokines were measured at presentation and then serially, using cytometric-bead-array with flow-cytometry and ELISA. PBMCs from influenza patients were studied for cytokine/chemokine expression using ex-vivo culture (Whole Blood Assay,+/- PHA/LPS stimulation). Clinical variables were prospectively recorded and analyzed. Results: 63 pH1N1 and 53 seasonal influenza patients were studied. pH1N1 patients were younger (mean +/- S.D. 42.8 +/- 19.2 vs 70.5 +/- 16.7 years), and fewer had comorbidities. Respiratory/cardiovascular complications were common in both groups (71.4% vs 81.1%), although severe pneumonia with hypoxemia (54.0% vs 28.3%) and ICU admissions (25.4% vs 1.9%) were more frequent with pH1N1. Hyperactivation of the proinflammatory cytokines IL-6, CXCL8/IL-8, CCL2/MCP-1 and sTNFR-1 was found in pH1N1 pneumonia (2-15 times normal) and in complicated seasonal influenza, but not in milder pH1N1 infections. The adaptive-immunity (Th1/Th17)-related CXCL10/IP-10, CXCL9/MIG and IL-17A however, were markedly suppressed in severe pH1N1 pneumonia (2-27 times lower than seasonal influenza; P-values<0.01). This pattern was further confirmed with serial measurements. Hypercytokinemia tended to be sustained in pH1N1 pneumonia, associated with a slower viral clearance [PCR-negativity: day 3-4, 55% vs 85%; day 6-7, 67% vs 100%]. Elevated proinflammatory cytokines, particularly IL-6, predicted ICU admission (adjusted OR 12.6, 95% CI 2.6-61.5, per log(10)unit increase; P = 0.002), and correlated with fever, tachypnoea, deoxygenation, and length-of-stay (Spearman's rho, P-values<0.01) in influenza infections. PBMCs in seasonal influenza patients were activated and expressed cytokines ex vivo (e.g. IL-6, CXCL8/IL-8, CCL2/MCP-1, CXCL10/IP-10, CXCL9/MIG); their 'responsiveness' to stimuli was shown to change dynamically during the illness course. Conclusions: A hyperactivated proinflammatory, but suppressed adaptive-immunity (Th1/Th17)-related cytokine response pattern was found in severe pH1N1 pneumonia, different from seasonal influenza. Cytokine/immune-dysregulation may be important in its pathogenesis.	[Lee, Nelson; Chan, Martin C. W.; Wong, Rity Y. K.; Lui, Grace C. Y.; Wong, Bonnie C. K.; Lee, Sharon K. W.; Choi, Kin Wing; Hui, David S. C.] Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson; Chan, Paul K. S.; Hui, David S. C.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun Kwok; Lun, Samantha W. M.; Lee, Sharon K. W.] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Paul K. S.; Ngai, Karry L. K.] Chinese Univ Hong Kong, Dept Microbiol, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lee, N (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013; Lui, Grace/N-4498-2019; Lee, Nelson/B-6418-2008; Wong, CK/H-3256-2016; Hui, David Shu-Cheong/O-2754-2015; Lui, Chung Yan Grace/N-5178-2016	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608; Lee, Nelson/0000-0002-0783-6607; Wong, CK/0000-0002-5637-8331; Hui, David Shu-Cheong/0000-0003-4382-2445; Lui, Chung Yan Grace/0000-0001-5242-2967	Stanley Ho Centre for Emerging Infectious Diseases (The Chinese University of Hong Kong); Department of Medicine and Therapeutics, Faculty of Medicine (The Chinese University of Hong Kong); F. Hoffmann-La Roche Ltd.	Stanley Ho Centre for Emerging Infectious Diseases (The Chinese University of Hong Kong)(Chinese University of Hong Kong); Department of Medicine and Therapeutics, Faculty of Medicine (The Chinese University of Hong Kong)(Chinese University of Hong Kong); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This study was jointly supported by a research fund from the Stanley Ho Centre for Emerging Infectious Diseases and a research fund from the Department of Medicine and Therapeutics, Faculty of Medicine; both are internal funding sources (The Chinese University of Hong Kong). The third source was an unrestricted, educational grant from F. Hoffmann-La Roche Ltd for this principle investigator-initiated study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; [Anonymous], INFL; Arankalle V.A., 2010, PLOS ONE, V5; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Ison MG, 2010, CLEV CLIN J MED, V77, P812, DOI 10.3949/ccjm.77a.10135; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jiang TJ, 2010, CLIN IMMUNOL, V137, P303, DOI 10.1016/j.clim.2010.07.010; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; LEE N, 2011, LANCET IN PRESS; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Lit LCW, 2006, ANN RHEUM DIS, V65, P209, DOI 10.1136/ard.2005.038315; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Sato M, 2009, CYTOKINE, V47, P65, DOI 10.1016/j.cyto.2009.05.003; Simmons C, 2008, NEW ENGL J MED, V359, P1621, DOI 10.1056/NEJMcibr0805865; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016	44	103	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26050	10.1371/journal.pone.0026050	http://dx.doi.org/10.1371/journal.pone.0026050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022504	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600037
J	Siddiqui, RA; Krawczak, M; Platzer, M; Sauermann, U				Siddiqui, Roman A.; Krawczak, Michael; Platzer, Matthias; Sauermann, Ulrike			Association of TLR7 Variants with AIDS-Like Disease and AIDS Vaccine Efficacy in Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; RNA SECONDARY STRUCTURE; NONHUMAN-PRIMATES; IFN-ALPHA; INTERFERON-ALPHA; HIV-1 INFECTION; VECTOR VACCINE	In HIV infection, TLR7-triggered IFN-alpha production exerts a direct antiviral effect through the inhibition of viral replication, but may also be involved in immune pathogenesis leading to AIDS. TLR7 could also be an important mediator of vaccine efficacy. In this study, we analyzed polymorphisms in the X-linked TLR7 gene in the rhesus macaque model of AIDS. Upon resequencing of the TLR7 gene in 36 rhesus macaques of Indian origin, 12 polymorphic sites were detected. Next, we identified three tightly linked single nucleotide polymorphisms (SNP) as being associated with survival time. Genotyping of 119 untreated, simian immunodeficiency virus (SIV)-infected male rhesus macaques, including an 'MHC adjusted' subset, revealed that the three TLR7 SNPs are also significantly associated with set-point viral load. Surprisingly, this effect was not observed in 72 immunized SIV-infected male monkeys. We hypothesize (i) that SNP c.13G > A in the leader peptide is causative for the observed genotype-phenotype association and that (ii) the underlying mechanism is related to RNA secondary structure formation. Therefore, we investigated a fourth SNP (c.-17C > T), located 17 bp upstream of the ATG translation initiation codon, that is also potentially capable of influencing RNA structure. In c.13A carriers, neither set-point viral load nor survival time were related to the c.-17C > T genotype. In c.13G carriers, by contrast, the c.-17C allele was significantly associated with prolonged survival. Again, no such association was detected among immunized SIV-infected macaques. Our results highlight the dual role of TLR7 in immunodeficiency virus infection and vaccination and imply that it may be important to control human AIDS vaccine trials, not only for MHC genotype, but also for TLR7 genotype.	[Siddiqui, Roman A.; Sauermann, Ulrike] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Siddiqui, Roman A.; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	Deutsches Primatenzentrum (DPZ); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Kiel	Siddiqui, RA (corresponding author), TMF Technol Methods & Infrastruct Networked Med R, Berlin, Germany.	usauerm@dpz.eu	Krawczak, Michael/A-8964-2010	Krawczak, Michael/0000-0003-2603-1502	German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) [0313360]	German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) grant 0313360. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2008, J LEUKOCYTE BIOL, V83, P1060, DOI 10.1189/jlb.1007675; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jarjanazi H, 2008, PROTEINS, V70, P394, DOI 10.1002/prot.21548; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Ketloy C, 2008, VET IMMUNOL IMMUNOP, V125, P18, DOI 10.1016/j.vetimm.2008.05.001; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; MCMICHAEL A, 2010, NAT P; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mohren S, 2009, BIOCHEM BIOPH RES CO, V379, P1015, DOI 10.1016/j.bbrc.2009.01.011; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; Oh DY, 2009, AIDS, V23, P297, DOI 10.1097/QAD.0b013e32831fb540; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schlaepfer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001999; Schott E, 2008, J VIRAL HEPATITIS, V15, P71, DOI 10.1111/j.1365-2893.2007.00898.x; Schulte R, 2009, VIROLOGY, V383, P300, DOI 10.1016/j.virol.2008.10.012; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Siddiqui RA, 2009, AM J HUM GENET, V85, P228, DOI 10.1016/j.ajhg.2009.07.013; Stolte-Leeb N, 2008, VIRAL IMMUNOL, V21, P235, DOI 10.1089/vim.2007.0103; Suh YS, 2008, VACCINE, V26, P6690, DOI 10.1016/j.vaccine.2008.07.055; Suh YS, 2006, VACCINE, V24, P1811, DOI 10.1016/j.vaccine.2005.10.026; Tavel JA, 2010, J INTERF CYTOK RES, V30, P461, DOI 10.1089/jir.2009.0090; Ten Haaft P, 1998, J VIROL, V72, P10281, DOI 10.1128/JVI.72.12.10281-10285.1998; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; YAMADA O, 1988, AIDS RES HUM RETROV, V4, P287, DOI 10.1089/aid.1988.4.287; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25474	10.1371/journal.pone.0025474	http://dx.doi.org/10.1371/journal.pone.0025474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022401	gold, Green Published, Green Submitted			2022-12-25	WOS:000295978600016
J	Segaert, K; Menenti, L; Weber, K; Hagoort, P				Segaert, Katrien; Menenti, Laura; Weber, Kirsten; Hagoort, Peter			A Paradox of Syntactic Priming: Why Response Tendencies Show Priming for Passives, and Response Latencies Show Priming for Actives	PLOS ONE			English	Article							SPOKEN SENTENCE PRODUCTION; LANGUAGE PRODUCTION; PHRASE STRUCTURE; PERSISTENCE; MODEL; ACTIVATION	Speakers tend to repeat syntactic structures across sentences, a phenomenon called syntactic priming. Although it has been suggested that repeating syntactic structures should result in speeded responses, previous research has focused on effects in response tendencies. We investigated syntactic priming effects simultaneously in response tendencies and response latencies for active and passive transitive sentences in a picture description task. In Experiment 1, there were priming effects in response tendencies for passives and in response latencies for actives. However, when participants' pre-existing preference for actives was altered in Experiment 2, syntactic priming occurred for both actives and passives in response tendencies as well as in response latencies. This is the first investigation of the effects of structure frequency on both response tendencies and latencies in syntactic priming. We discuss the implications of these data for current theories of syntactic processing.	[Segaert, Katrien; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Segaert, Katrien; Menenti, Laura; Weber, Kirsten; Hagoort, Peter] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Menenti, Laura] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Max Planck Society; Radboud University Nijmegen; University of Glasgow	Segaert, K (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Katrien.Segaert@mpi.nl	Segaert, Katrien/AAT-9387-2021; Weber, Kirsten/U-5244-2018; Hagoort, Peter/B-7417-2012	Segaert, Katrien/0000-0002-3002-5837; Weber, Kirsten/0000-0001-8192-2207; 	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	KW was funded by an NWO Toptalent Grant (http://www.nwo.nl/nwohome.nsf/pages/NWOA_6SQDWG_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Anderson JR, 1996, AM PSYCHOL, V51, P355, DOI 10.1037/0003-066X.51.4.355; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bernolet S, 2010, COGNITION, V114, P455, DOI 10.1016/j.cognition.2009.11.005; Bernolet S, 2009, COGNITION, V112, P300, DOI 10.1016/j.cognition.2009.05.013; BOCK K, 1992, PSYCHOL REV, V99, P150, DOI 10.1037/0033-295X.99.1.150; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Bock K, 1986, COGNITIVE PSYCHOL, V18, P355, DOI [10.1016/0010-0285(86)90004-6, DOI 10.1016/0010-0285(86)90004-6]; Bock K, 2007, COGNITION, V104, P437, DOI 10.1016/j.cognition.2006.07.003; Boyland J, 1998, EVIDENCE SYNTACTIC P; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Corley M, 2002, PSYCHON B REV, V9, P126, DOI 10.3758/BF03196267; Cornelis L., 1996, LANG SCI, V18, P247, DOI [10.1016/0388-0001(96)00018-6, DOI 10.1016/0388-0001(96)00018-6]; Ferreira VS, 2006, LANG COGNITIVE PROC, V21, P1011, DOI 10.1080/016909600824609; Ferreira VS, 2003, J MEM LANG, V48, P379, DOI 10.1016/S0749-596X(02)00523-5; Gries S.T.h., 2005, ANN REV COGNITIVE LI, V3, P182, DOI 10.1075/arcl.3.10gri; Hartsuiker RJ, 1999, Q J EXP PSYCHOL-A, V52, P129, DOI 10.1080/027249899391250; Hartsuiker RJ, 1998, LANG SPEECH, V41, P143, DOI 10.1177/002383099804100202; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jaeger T.Florian., 2007, U ROCHESTER WORKING, V3, P26; Kaschak MP, 2007, MEM COGNITION, V35, P925, DOI 10.3758/BF03193466; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Menenti L, 2011, PSYCHOL SCI, V22, P1173, DOI 10.1177/0956797611418347; Miller J., 1998, SPONTANEOUS SPOKEN L; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2009, R FDN STAT COMP; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reitter D, 2011, COGNITIVE SCI, V35, P587, DOI 10.1111/j.1551-6709.2010.01165.x; Scheepers C, 2003, COGNITION, V89, P179, DOI 10.1016/S0010-0277(03)00119-7; Segaert K, 2009, CUNY C HUM SENT PROC; Smith M, 2001, COGNITION, V78, P123, DOI 10.1016/S0010-0277(00)00110-4; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; Wheeldon LR, 2003, LANG COGNITIVE PROC, V18, P431, DOI 10.1080/01690960244000063	39	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24209	10.1371/journal.pone.0024209	http://dx.doi.org/10.1371/journal.pone.0024209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022352	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200001
J	Hu, Y; Galkin, AV; Wu, CL; Reddy, V; Su, AI				Hu, Yue; Galkin, Anna V.; Wu, Chunlei; Reddy, Venkateshwar; Su, Andrew I.			CAFET Algorithm Reveals Wnt/PCP Signature in Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; PROMOTER HYPERMETHYLATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; MICROARRAY DATA; DIX DOMAIN; CANCER; WNT; ADENOCARCINOMA	We analyzed the gene expression patterns of 138 Non-Small Cell Lung Cancer (NSCLC) samples and developed a new algorithm called Coverage Analysis with Fisher's Exact Test (CAFET) to identify molecular pathways that are differentially activated in squamous cell carcinoma (SCC) and adenocarcinoma (AC) subtypes. Analysis of the lung cancer samples demonstrated hierarchical clustering according to the histological subtype and revealed a strong enrichment for the Wnt signaling pathway components in the cluster consisting predominantly of SCC samples. The specific gene expression pattern observed correlated with enhanced activation of the Wnt Planar Cell Polarity (PCP) pathway and inhibition of the canonical Wnt signaling branch. Further real time RT-PCR follow-up with additional primary tumor samples and lung cancer cell lines confirmed enrichment of Wnt/PCP pathway associated genes in the SCC subtype. Dysregulation of the canonical Wnt pathway, characterized by increased levels of beta-catenin and epigenetic silencing of negative regulators, has been reported in adenocarcinoma of the lung. Our results suggest that SCC and AC utilize different branches of the Wnt pathway during oncogenesis.	[Hu, Yue; Galkin, Anna V.; Wu, Chunlei; Reddy, Venkateshwar; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	Hu, Y (corresponding author), NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	asu@scripps.edu	Wu, Chunlei/ABF-4720-2020	Wu, Chunlei/0000-0002-2629-6124; Su, Andrew I./0000-0002-9859-4104				Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Borok Z, 2006, PEDIATR RES, V59, p84R, DOI 10.1203/01.pdr.0000203563.37626.77; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Kadoya T, 2002, MOL CELL BIOL, V22, P3803, DOI 10.1128/MCB.22.11.3803-3819.2002; Katoh M, 2005, ONCOL REP, V14, P1583; Koch A, 2005, CLIN CANCER RES, V11, P4295, DOI 10.1158/1078-0432.CCR-04-1162; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee JH, 2004, CANCER RES, V64, P4235, DOI 10.1158/0008-5472.CAN-04-0275; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Paul S, 2008, NEOPLASMA, V55, P165; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Tiseo M, 2009, EXPERT REV ANTICANC, V9, P425, DOI 10.1586/ERA.09.3; Wada H, 2009, ZEBRAFISH, V6, P3, DOI 10.1089/zeb.2008.0557; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	45	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25807	10.1371/journal.pone.0025807	http://dx.doi.org/10.1371/journal.pone.0025807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016777	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700019
J	Salyakina, D; Cukier, HN; Lee, JM; Sacharow, S; Nations, LD; Ma, DQ; Jaworski, JM; Konidari, I; Whitehead, PL; Wright, HH; Abramson, RK; Williams, SM; Menon, R; Haines, JL; Gilbert, JR; Cuccaro, ML; Pericak-Vance, MA				Salyakina, Daria; Cukier, Holly N.; Lee, Joycelyn M.; Sacharow, Stephanie; Nations, Laura D.; Ma, Deqiong; Jaworski, James M.; Konidari, Ioanna; Whitehead, Patrice L.; Wright, Harry H.; Abramson, Ruth K.; Williams, Scott M.; Menon, Ramkumar; Haines, Jonathan L.; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.			Copy Number Variants in Extended Autism Spectrum Disorder Families Reveal Candidates Potentially Involved in Autism Risk	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENOME; MICRODELETION; ASSOCIATION; EXPRESSION; IMPLICATE; 16P11.2; LOCI; MICRODUPLICATIONS; REARRANGEMENTS	Copy number variations (CNVs) are a major cause of genetic disruption in the human genome with far more nucleotides being altered by duplications and deletions than by single nucleotide polymorphisms (SNPs). In the multifaceted etiology of autism spectrum disorders (ASDs), CNVs appear to contribute significantly to our understanding of the pathogenesis of this complex disease. A unique resource of 42 extended ASD families was genotyped for over 1 million SNPs to detect CNVs that may contribute to ASD susceptibility. Each family has at least one avuncular or cousin pair with ASD. Families were then evaluated for co-segregation of CNVs in ASD patients. We identified a total of five deletions and seven duplications in eleven families that co-segregated with ASD. Two of the CNVs overlap with regions on 7p21.3 and 15q24.1 that have been previously reported in ASD individuals and two additional CNVs on 3p26.3 and 12q24.32 occur near regions associated with schizophrenia. These findings provide further evidence for the involvement of ICA1 and NXPH1 on 7p21.3 in ASD susceptibility and highlight novel ASD candidates, including CHL1, FGFBP3 and POUF41. These studies highlight the power of using extended families for gene discovery in traits with a complex etiology.	[Salyakina, Daria; Cukier, Holly N.; Lee, Joycelyn M.; Sacharow, Stephanie; Nations, Laura D.; Ma, Deqiong; Jaworski, James M.; Konidari, Ioanna; Whitehead, Patrice L.; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sacharow, Stephanie; Ma, Deqiong; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Wright, Harry H.; Abramson, Ruth K.] Univ S Carolina, Sch Med, Dept Neuropsychiat, Columbia, SC USA; [Williams, Scott M.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Menon, Ramkumar] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Menon, Ramkumar] Emory Univ, Rollins Sch Publ Hlth, Dept Obstet & Gynecol, Atlanta, GA 30322 USA	University of Miami; University of Miami; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Vanderbilt University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Salyakina, D (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mpericak@med.miami.edu	Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019; Haines, Jonathan/C-3374-2012	Williams, Scott/0000-0002-4835-9544; Haines, Jonathan/0000-0002-4351-4728; Cukier, Holly/0000-0003-3459-7792; Salyakina, Daria/0000-0003-3283-3691; Lee, Joycelyn/0000-0002-3811-8755	National Institutes of Health [R01MH080647]; National Institute of Neurological Disorders and Stroke [P01NS026630]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (R01MH080647), www.nih.gov; the National Institute of Neurological Disorders and Stroke (P01NS026630), www.ninds.nih.gov; and by a gift from the Hussman Foundation, www.hussmanfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Brouwers N, 2011, MOL PSYCHIAT; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Cukier HN, 2011, AM J MED GENET B, V156B, P493, DOI 10.1002/ajmg.b.31188; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gai X, 2011, MOL PSYCHIATR; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; Klejbor I, 2009, SCHIZOPHR RES, V113, P308, DOI 10.1016/j.schres.2009.06.006; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Lanier J, 2009, DEV DYNAM, V238, P3065, DOI 10.1002/dvdy.22145; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Liu SX, 2003, IMMUNOL LETT, V86, P169, DOI 10.1016/S0165-2478(03)00004-X; LORD C, RISI S AUTISM DIAGNO; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Missler M, 1998, J NEUROSCI, V18, P3630; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; RUTTER M, LORD C AUTISM DIAGNO; Rutter M., 2003, SOCIAL COMMUNICATION; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Shen YP, 2011, AM J MED GENET B, V156B, P225, DOI 10.1002/ajmg.b.31147; Sparrow S., 2016, VINELAND ADAPTIVE BE; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074	54	62	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26049	10.1371/journal.pone.0026049	http://dx.doi.org/10.1371/journal.pone.0026049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016809	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300053
J	Santoro, R; Marani, M; Blandino, G; Muti, P; Strano, S				Santoro, R.; Marani, M.; Blandino, G.; Muti, P.; Strano, S.			Melatonin triggers p53(Ser) phosphorylation and prevents DNA damage accumulation	ONCOGENE			English	Article						melatonin; p53; cancer; prevention; DNA; repair	BREAST-CANCER; P53 STABILITY; PML; RISK; APOPTOSIS; PROSTATE; PROTEIN; LIGHT; PREMENOPAUSAL; GAMMA-H2AX	Several epidemiological studies have shown that high levels of melatonin, an indolic hormone secreted mainly by the pineal gland, reduce the risks of developing cancer, thus suggesting that melatonin triggers the activation of tumor-suppressor pathways that lead to the prevention of malignant transformation. This paper illustrates that melatonin induces phosphorylation of p53 at Ser-15 inhibiting cell proliferation and preventing DNA damage accumulation of both normal and transformed cells. This activity requires p53 and promyelocytic leukemia (PML) expression and efficient phosphorylation of p53 at Ser-15 residue. Melatonin-induced p53 phosphorylation at Ser-15 residue does not require ataxia telangiectasia-mutated activity, whereas it is severely impaired upon chemical inhibition of p38 mitogen-activated protein kinase activity. By and large, these findings imply that the activation of the p53 tumor-suppressor pathway is a critical mediator of melatonin and its anticancer effects. Therefore, it provides molecular insights into increasing observational evidence for the role that melatonin has in cancer prevention.	[Santoro, R.; Marani, M.; Strano, S.] Italian Natl Canc Inst Regina Elena, Mol Chemoprevent Grp, Dept Mol Med, I-00144 Rome, Italy; [Blandino, G.] Italian Natl Canc Inst Regina Elena, Dept Mol Med, Translat Oncogenom Unit ROC, I-00144 Rome, Italy; [Muti, P.] Italian Natl Canc Inst Regina Elena, Sci Director Off, I-00144 Rome, Italy		Strano, S (corresponding author), Italian Natl Canc Inst Regina Elena, Mol Chemoprevent Grp, Dept Mol Med, Via Elio Chianesi 53, I-00144 Rome, Italy.	strano@ifo.it	Strano, Sabrina/K-9654-2016; Muti, Paola/AAD-9108-2020; Santoro, Raffaela/B-1152-2013; Blandino, Giovanni/B-1137-2013; strano, sabrina/B-6743-2013	Santoro, Raffaela/0000-0003-3218-2358; Blandino, Giovanni/0000-0002-6970-2241; strano, sabrina/0000-0002-6341-4230; Marani, Marina/0000-0003-1585-3586	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero della Salute; Fondazione Veronesi; FIRB; New Idea Award; Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Fondazione Veronesi(Fondazione Umberto Veronesi); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); New Idea Award; Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank Dr E O'Neill and Dr Y Shiloh for gift of reagents and cell lines. Moreover, we also thank T Merlino for kindly revising the English text. This study was supported by Associazione Italiana Ricerca sul Cancro (AIRC, to SS and GB), Ministero della Salute (GB and PM), Fondazione Veronesi (GB), FIRB (GB), New Idea Award (SS) and Fondazione Italiana Ricerca sul Cancro (FIRC, fellowship to RS).	Alpert M, 2009, MED HYPOTHESES, V73, P324, DOI 10.1016/j.mehy.2009.02.027; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Chiu SJ, 2008, TOXICOL LETT, V179, P63, DOI 10.1016/j.toxlet.2008.04.004; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Flynn-Evans EE, 2009, CANCER CAUSE CONTROL, V20, P1753, DOI 10.1007/s10552-009-9405-0; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Ji CX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-50; KANE MA, 1994, MELANOMA RES, V4, P59, DOI 10.1097/00008390-199402000-00009; Kim CH, 2010, KOREAN J PHYSIOL PHA, V14, P365, DOI 10.4196/kjpp.2010.14.6.365; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kliukiene J, 2001, BRIT J CANCER, V84, P397, DOI 10.1054/bjoc.2000.1617; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kloog I, 2008, CHRONOBIOL INT, V25, P65, DOI 10.1080/07420520801921572; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lipton J, 2009, NEUROLOGY, V73, P323, DOI 10.1212/WNL.0b013e3181af78a5; Lukas J, 2009, NATURE, V458, P581, DOI 10.1038/458581a; Markantonis SL, 2008, J CLIN PHARMACOL, V48, P240, DOI 10.1177/0091270007311112; Mediavilla MD, 1999, LIFE SCI, V65, P415, DOI 10.1016/S0024-3205(99)00262-3; Nur-E-Kamal A, 2003, J BIOL CHEM, V278, P12475, DOI 10.1074/jbc.M212915200; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pearson M, 2001, ONCOGENE, V20, P7250, DOI 10.1038/sj.onc.1204856; Roy D, 2001, ENDOCRINOLOGY, V142, P4711, DOI 10.1210/en.142.11.4711; Sainz RM, 2005, PROSTATE, V63, P29, DOI 10.1002/pros.20155; Schernhammer ES, 2008, JNCI-J NATL CANCER I, V100, P898, DOI 10.1093/jnci/djn171; Schernhammer ES, 2010, CANCER EPIDEM BIOMAR, V19, P729, DOI 10.1158/1055-9965.EPI-09-1229; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sliwinski T, 2007, MUTAT RES-GEN TOX EN, V634, P220, DOI 10.1016/j.mrgentox.2007.07.013; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; VAKKURI O, 1985, LIFE SCI, V37, P489, DOI 10.1016/0024-3205(85)90412-6; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Xi SC, 2000, J PINEAL RES, V29, P172, DOI 10.1034/j.1600-079X.2000.d01-64.x; Xian ZH, 2005, WORLD J GASTROENTERO, V11, P4102, DOI 10.3748/wjg.v11.i26.4102	43	63	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	24					2931	2942		10.1038/onc.2011.469	http://dx.doi.org/10.1038/onc.2011.469			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22002314	Green Published			2022-12-25	WOS:000305388400003
J	Liu, YC; Lin, MC; Chen, HC; Tam, MF; Lin, LY				Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Tam, Ming F.; Lin, Lih-Yuan			The Role of Small Ubiquitin-like Modifier-interacting Motif in the Assembly and Regulation of Metal-responsive Transcription Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEIN GENE-EXPRESSION; PROMYELOCYTIC LEUKEMIA PROTEIN; SIGNAL-TRANSDUCTION CASCADES; PLACENTA GROWTH-FACTOR; FACTOR MTF-1; FACTOR-I; FUNCTIONAL-CHARACTERIZATION; INDUCIBLE TRANSCRIPTION; NUCLEAR TRANSLOCATION; SUMO MODIFICATION	Metal-responsive transcription factor 1 (MTF-1) is an essential protein required for mouse embryonic development. We report here the occurrence of sumoylation on MTF-1. Mutational studies demonstrated that sumoylation occurs on the lysine residue at position 627 (Lys(627)) of mouse MTF-1. Small ubiquitin-like modifier (SUMO)-1 was fused to the C terminus of MTF-1 to mimic the sumoylated form of the protein and it suppressed the transcriptional activity of MTF-1. The nuclear translocation activity, DNA-binding activity, and protein stability of SUMO-fused MTF-1 are similar to that of wild type MTF-1. The level of sumoylation was reduced by metal in a dose-and time-dependent manner. The fact that zinc reduces MTF-1 sumoylation makes the suppressive role of sumoylated MTF-1 in transcription physiologically less significant because the SUMO moiety of MTF-1 is removed when MTF-1 translocates into nucleus. We further identified a SUMO-interacting motif (SIM) on MTF-1. Remarkably, MTF-1 binds sumoylated MTF-1 and/or other cellular factors in a SIM-dependent manner. This interaction was disrupted by treating cells with zinc. Gel permeation chromatography demonstrated that MTF-1 forms SIM-dependent complexes. This cross-interaction transpires in the cytoplasm and markedly reduces upon nuclear translocation. It can therefore be concluded that SUMO conjugation and the SIM on MTF-1 do not play a critical role in suppressing transcriptional activity. Instead, MTF-1 forms complexes with cellular factors through SIM and SUMO moiety in the cytoplasm. The result explores a new understanding for the mode of MTF-1 assembly and regulation in cells.	[Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Lin, Lih-Yuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Lin, Lih-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Tam, Ming F.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Lin, LY (corresponding author), 101,Sec 2,Kuang Fu Rd, Hsinchu, Taiwan.	lylin@life.nthu.edu.tw		Lin, Lih-Yuan/0000-0001-9827-3434	National Science Council, Taiwan, Republic of China [NSC98-2311-B-007-015-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC98-2311-B-007-015-MY3 from the National Science Council, Taiwan, Republic of China.	Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chang YJ, 2002, J BIOL CHEM, V277, P7118, DOI 10.1074/jbc.M109924200; Chen WY, 2002, BIOCHEM BIOPH RES CO, V291, P798, DOI 10.1006/bbrc.2002.6517; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Daniels PJ, 2003, NUCLEIC ACIDS RES, V31, P6710, DOI 10.1093/nar/gkg913; der Maur Adrian Auf, 1999, Biological Chemistry, V380, P175; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Green CJ, 2001, CANCER RES, V61, P2696; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jiang HM, 2004, BIOCHEM J, V382, P33, DOI 10.1042/BJ20040504; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin KA, 2005, J CELL PHYSIOL, V205, P428, DOI 10.1002/jcp.20417; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McNally BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002277; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Murphy BJ, 1999, CANCER RES, V59, P1315; Murphy BJ, 2008, MOL CANCER RES, V6, P483, DOI 10.1158/1541-7786.MCR-07-0341; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Quimby BB, 2006, ONCOGENE, V25, P2999, DOI 10.1038/sj.onc.1209335; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Stitt MS, 2006, VASC PHARMACOL, V44, P149, DOI 10.1016/j.vph.2005.10.004; Suico MA, 2006, BIOCHEM BIOPH RES CO, V348, P880, DOI 10.1016/j.bbrc.2006.07.151; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	61	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42818	42829		10.1074/jbc.M111.253203	http://dx.doi.org/10.1074/jbc.M111.253203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021037	Green Published, hybrid			2022-12-25	WOS:000298351300003
J	Chang, ML; Lin, SM; Yeh, CT				Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting			HURP Expression-Assisted Risk Scores Identify Prognosis Distinguishable Subgroups in Early Stage Liver Cancer	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; ALPHA-FETOPROTEIN; AURORA-A; DIAGNOSIS; GENE; CIRRHOSIS; CELLS; PREDICTORS	Background: Hepatoma up-regulated protein (HURP) is a component of the chromatin-dependent pathway for spindle assembly. We examined the prognostic predictive value of HURP in human hepatocellular carcinoma (HCC). Methods: HURP expression was evaluated by immunocytochemistry of fine needle aspirated hepatoma cells in 97 HCC patients with Barcelona Clinic Liver Cancer (BCLC) stage A. Subsequently, these patients underwent partial hepatectomy (n = 18) or radiofrequency ablation (n = 79) and were followed for 2 to 35 months. The clinicopathological parameters were submitted for survival analysis. Results: HURP expression in aspirated HCC cells was detected in 19.6% patients. Kaplan-Meier survival analysis showed that positive HURP expression (P = 0.023), cytological grading >= 3 (P = 0.008), AFP >= 35 ng/mL (P = 0.039), bilirubin >= 1.3 mg/dL (P = 0.010), AST >= 50 U/L (P = 0.003) and ALT >= 35 U/L (P = 0.005) were all associated with a shorter disease-free survival. A stepwise multivariate Cox proportional hazard model revealed that positive HURP expression (HR, 2.334; 95% CI, 1.165-4.679, P = 0.017), AST >= 50 U/L (HR, 3.697; 95% CI, 1.868-7.319, p<0.001), cytological grade >= 3 (HR, 4.249; 95% CI, 2.061-8.759, P<0.001) and tumor number >1 (HR, 2.633; 95% CI, 1.212-5.722, P = 0.014) were independent predictors for disease-free survival. By combining the 4 independent predictors, patients with different risk scores (RS) showed distinguishable disease-free survival (RS <= 1 vs. RS = 2, P = 0.001; RS = 2 vs. RS = 3, P<0.001). In contrast, the patients cannot be separated into prognosis distinguishable subgroups by using AJCC/UICC TNM staging system. Conclusion: HCC patients with BCLC stage A can be separated into three prognosis-distinguishable groups by use of a risk score that is based upon HURP expression in aspirated HCC cells, ALT, cytological grade and tumor number.	[Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting] Chang Gung Mem Hosp, Liver Res Ctr, Tao Yuan, Taiwan; [Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatol, Tao Yuan, Taiwan; [Chang, Ming-Ling; Yeh, Chau-Ting] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, ML (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Tao Yuan, Taiwan.	chauting@adm.cgmh.org.tw			Chang Gung Medical Research Program [CMRP-370693]	Chang Gung Medical Research Program	This project was supported by grant from Chang Gung Medical Research Program (CMRP-370693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Betz MJ, 2009, NAT REV ENDOCRINOL, V5, P297, DOI 10.1038/nrendo.2009.93; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chiu AW, 2002, UROLOGY, V60, P181, DOI 10.1016/S0090-4295(02)01672-2; Cho YK, 2010, HEPATOLOGY, V51, P1284, DOI 10.1002/hep.23466; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fernandes ML, 2009, BRIT J SURG, V96, P756, DOI 10.1002/bjs.6645; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Gudmundsson KO, 2007, STEM CELLS, V25, P1498, DOI 10.1634/stemcells.2005-0479; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Huang GT, 1996, J HEPATOL, V25, P334, DOI 10.1016/S0168-8278(96)80120-6; HUANG J, 2010, J GASTROINTEST  1030; Huang YL, 2003, ANTICANCER RES, V23, P2729; KOMATSU S, 2011, BR J SURG       0119; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin CC, 2008, J GASTROEN HEPATOL, V23, pE146, DOI 10.1111/j.1440-1746.2007.04924.x; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Liu Da-quan, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1149; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Murakata A, 2011, ANN SURG, V253, P94, DOI 10.1097/SLA.0b013e3181f9bc00; Nazir RT, 2010, JCPSP-J COLL PHYSICI, V20, P373, DOI 06.2010/JCPSP.373376; NOGUCHI S, 1986, CANCER, V58, P321, DOI 10.1002/1097-0142(19860715)58:2<321::AID-CNCR2820580219>3.0.CO;2-B; PORTELLA G, 2010, CURR MED CHEM   1214; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; RUSTGI VK, 1987, GASTROENTEROL CLIN N, V16, P545; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; SHAH SA, 2007, ANN SURG, V245, P51; Talwalkar JA, 2004, GASTROENTEROLOGY, V127, pS126, DOI 10.1053/j.gastro.2004.09.026; Tsai CY, 2008, J BIOL CHEM, V283, P26302, DOI 10.1074/jbc.C800117200; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Wang YC, 2006, BIOCHEM BIOPH RES CO, V340, P244, DOI 10.1016/j.bbrc.2005.12.005; Wilde A, 2006, J CELL BIOL, V173, P829, DOI 10.1083/jcb.200605150; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; YOSHITAKE K, 2011, ANN SURG ONCOL  0201; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zavaglia C, 2005, AM J GASTROENTEROL, V100, P2708, DOI 10.1111/j.1572-0241.2005.00289.x; Zhou YM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-78	50	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26323	10.1371/journal.pone.0026323	http://dx.doi.org/10.1371/journal.pone.0026323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022601	gold, Green Submitted, Green Published			2022-12-25	WOS:000295984400046
J	Raman, J; Mauff, K; Muianga, P; Mussa, A; Maharaj, R; Barnes, KI				Raman, Jaishree; Mauff, Katya; Muianga, Pedro; Mussa, Abdul; Maharaj, Rajendra; Barnes, Karen I.			Five Years of Antimalarial Resistance Marker Surveillance in Gaza Province, Mozambique, Following Artemisinin-Based Combination Therapy Roll Out	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; DRUG-RESISTANCE; SULFADOXINE-PYRIMETHAMINE; SOUTHERN MOZAMBIQUE; PFMDR1 GENE; DIHYDROFOLATE-REDUCTASE; ARTEMETHER-LUMEFANTRINE; MALARIA; AFRICA; IDENTIFICATION	Antimalarial drug resistance is a major obstacle to malaria control and eventual elimination. The routine surveillance for molecular marker of resistance is an efficient way to assess drug efficacy, which remains feasible in areas where malaria control interventions have succeeded in substantially reducing malaria transmission. Community based asexual parasite prevalence surveys were conducted annually in sentinel sites in Gaza Province, Mozambique from 2006 until 2010, before, during and after antimalarial policy changes to artesunate plus sulfadoxine-pyrimethamine in 2006 and to artemether-lumefantrine in 2008. Genetic analysis of dhfr, dhps, crt, and mdr1 resistant genes was conducted on 3 331 (14.4%) Plasmodium falciparum PCR positive samples collected over the study period from 23 229 children aged 2 to 15 years. The quintuple dhfr/dhps mutation associated with sulfadoxine-pyrimethamine resistance increased from 56.2% at baseline to 75.8% by 2010. At baseline the crt76T and mdr186Y mutants were approaching fixation, 96.1% and 74.7%, respectively. Following the deployment of artemisinin-based combination therapy, prevalence of both these chloroquine-resistance markers began declining, reaching 32.4% and 30.9%, respectively, by 2010. All samples analysed over the 5-year period possessed a single copy of the mdr1 gene. The high and increasing prevalence of the quintuple mutation supports the change in drug policy from artesunate plus sulfadoxine-pyrimethamine to artemether-lumefantrine in Mozambique. As chloroquine related drug pressure decreased in the region, so did the molecular markers associated with chloroquine resistance (crt76T and mdr186Y). However, this reversion to the wild-type mdr186N predisposes parasites towards developing lumefantrine resistance. Close monitoring of artemether-lumefantrine efficacy is therefore essential, particularly given the high drug pressure within the region where most countries now use artemether-lumefantrine as first line treatment.	[Raman, Jaishree; Maharaj, Rajendra] MRC, Malaria Res Programme, Durban, South Africa; [Mauff, Katya; Barnes, Karen I.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Mauff, Katya] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Muianga, Pedro] Gaza Prov Directorate Hlth, Xai Xai, Mozambique; [Mussa, Abdul] Natl Malaria Control Programme, Maputo City, Mozambique	University of Cape Town; University of Cape Town	Raman, J (corresponding author), MRC, Malaria Res Programme, Durban, South Africa.	jaishree.raman@mrc.ac.za	Raman, Jaishree/AAB-8960-2020	Raman, Jaishree/0000-0003-0728-3093	Global Fund to Fight AIDS, Tuberculosis and Malaria [MAF-202-GO2-M-00]	Global Fund to Fight AIDS, Tuberculosis and Malaria	This study was funded by a grant from The Global Fund to Fight AIDS, Tuberculosis and Malaria (MAF-202-GO2-M-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EN, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-141; [Anonymous], 2003, ASS MON ANT DRUG EFF; BARNES AJ, 1991, LANCET, V338, P1338, DOI 10.1016/0140-6736(91)92644-H; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Dlamini SV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-68; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Enosse S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-115; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Menard D, 2006, AM J TROP MED HYG, V75, P381, DOI 10.4269/ajtmh.2006.75.381; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raman J, 2008, AM J TROP MED HYG, V78, P256, DOI 10.4269/ajtmh.2008.78.256; Raman J, 2010, AM J TROP MED HYG, V82, P788, DOI 10.4269/ajtmh.2010.09-0401; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Spalding MD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-338; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; *WHO, 2010, MAL WORLD REP 2010; WHO, 2020, REP ANT DRUG EFF RES; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	33	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25992	10.1371/journal.pone.0025992	http://dx.doi.org/10.1371/journal.pone.0025992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022487	Green Submitted, gold, Green Published			2022-12-25	WOS:000295981600025
J	Barden, HE; Wogelius, RA; Li, DQ; Manning, PL; Edwards, NP; van Dongen, BE				Barden, Holly E.; Wogelius, Roy A.; Li, Daqing; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.			Morphological and Geochemical Evidence of Eumelanin Preservation in the Feathers of the Early Cretaceous Bird, Gansus yumenensis	PLOS ONE			English	Article							BACTERIAL-DEGRADATION; PLUMAGE COLORATION; ORGANIC-MATTER; COPPER SULFIDE; MELANIN; BLACK; EVOLUTION	Recent studies have shown evidence for the preservation of colour in fossilized soft tissues by imaging melanosomes, melanin pigment containing organelles. This study combines geochemical analyses with morphological observations to investigate the preservation of melanosomes and melanin within feathers of the Early Cretaceous bird, Gansus yumenensis. Scanning electron microscopy reveals structures concordant with those previously identified as eumelanosomes within visually dark areas of the feathers but not in lighter areas or sedimentary matrices. Fourier transform infrared analyses show different spectra for the feathers and their matrices; melanic functional groups appear in the feather including carboxylic acid and ketone groups that are not seen in the matrix. When mapped, the carboxylic acid group absorption faithfully replicates the visually dark areas of the feathers. Electron Paramagnetic Resonance spectroscopy of one specimen demonstrates the presence of organic signals but proved too insensitive to resolve melanin. Pyrolysis gas chromatography mass spectrometry shows a similar distribution of aliphatic material within both feathers that are different from those of their respective matrices. In combination, these techniques strongly suggest that not only do the feathers contain endogenous organic material, but that both geochemical and morphological evidence supports the preservation of original eumelanic pigment residue.	[Barden, Holly E.; Wogelius, Roy A.; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Barden, Holly E.; Wogelius, Roy A.; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester, Lancs, England; [Li, Daqing] Gansu Geol Museum, Lanzhou, Peoples R China; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Manchester; University of Manchester; University of Pennsylvania	Barden, HE (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England.	holly.barden@postgrad.manchester.ac.uk	Manning, Phillip/F-9966-2011; Wogelius, Roy/C-4917-2008	Manning, Phillip/0000-0002-7161-6246; van Dongen, Bart/0000-0003-1189-142X; Wogelius, Roy/0000-0002-5781-2152; Edwards, Nicholas/0000-0002-3760-4225	Natural Environment Research Council; National Natural Science Foundation of China [40672007, 41072019]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HEB is supported by a PhD studentship from the Natural Environment Research Council, additional funding for collection was provided by the National Natural Science Foundation of China (40672007 and 41072019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo IE, 1994, FUNDAMENTALS MICROBI; [Anonymous], 2006, BROCK BIOL MICROORGA; BLOIS MS, 1964, BIOPHYS J, V4, P471, DOI 10.1016/S0006-3495(64)86797-7; Bokony V, 2003, P ROY SOC B-BIOL SCI, V270, P2491, DOI 10.1098/rspb.2003.2506; Butler MJ, 2005, MYCOLOGIA, V97, P312, DOI 10.3852/mycologia.97.2.312; CAESARTONTHAT TC, 1995, APPL ENVIRON MICROB, V61, P1968, DOI 10.1128/AEM.61.5.1968-1975.1995; Centeno SA, 2008, J MOL STRUCT, V873, P149, DOI 10.1016/j.molstruc.2007.03.026; Cesarini JP, 1996, ADV SPACE RES, V18, P35, DOI 10.1016/0273-1177(96)00025-7; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Edwards NP, 2011, P ROY SOC B-BIOL SCI, V278, P3209, DOI 10.1098/rspb.2011.0135; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Filip Z, 2001, EUR J SOIL BIOL, V37, P137, DOI 10.1016/S1164-5563(01)01078-0; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Grande JM, 2004, ARDEOLA, V51, P375; Gunderson AR, 2008, J AVIAN BIOL, V39, P539, DOI 10.1111/j.0908-8857.2008.04413.x; Gupta NS, 2007, ORG GEOCHEM, V38, P28, DOI 10.1016/j.orggeochem.2006.09.014; Gupta NS, 2006, P R SOC B, V273, P2777, DOI 10.1098/rspb.2006.3646; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Latocha M, 2000, J ANAL APPL PYROL, V56, P89, DOI 10.1016/S0165-2370(00)00082-6; Latocha M., 2004, POLISH J MED PHYS EN, V10, P119; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lingham-Soliar T, 2010, NATURWISSENSCHAFTEN, V97, P479, DOI 10.1007/s00114-010-0661-3; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Marshall CP, 2011, NAT GEOSCI, V4, P240, DOI 10.1038/NGEO1084; McGraw KJ, 2003, OIKOS, V102, P402; Pacton M, 2006, TERRA NOVA, V18, P380, DOI 10.1111/j.1365-3121.2006.00702.x; Pacton M, 2007, GEOMICROBIOL J, V24, P571, DOI 10.1080/01490450701672042; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Russell J.D., 1987, HDB DETERMINATIVE ME, P133; Stepien K, 2009, J AM SOC MASS SPECTR, V20, P464, DOI 10.1016/j.jasms.2008.11.003; Suarez M, 2008, J VERTEBRATE PAL S28, V28, p149A; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zhang J, 2007, FRONT BIOL, V2, P26, DOI [10.1007/s11515-007-0004-8, DOI 10.1007/S11515-007-0004-8]	39	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25494	10.1371/journal.pone.0025494	http://dx.doi.org/10.1371/journal.pone.0025494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022404	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600019
J	Sondermeijer, BM; Bakker, A; Halliani, A; de Ronde, MWJ; Marquart, AA; Tijsen, AJ; Mulders, TA; Kok, MGM; Battjes, S; Maiwald, S; Sivapalaratnam, S; Trip, MD; Moerland, PD; Meijers, JCM; Creemers, EE; Pinto-Sietsma, SJ				Sondermeijer, Brigitte M.; Bakker, Annemieke; Halliani, Amalia; de Ronde, Maurice W. J.; Marquart, Arnoud A.; Tijsen, Anke J.; Mulders, Ties A.; Kok, Maayke G. M.; Battjes, Suzanne; Maiwald, Steffi; Sivapalaratnam, Suthesh; Trip, Mieke D.; Moerland, Perry D.; Meijers, Joost C. M.; Creemers, Esther E.; Pinto-Sietsma, Sara-Joan			Platelets in Patients with Premature Coronary Artery Disease Exhibit Upregulation of miRNA340*and miRNA624*	PLOS ONE			English	Article							RISK-FACTORS; MICRORNA EXPRESSION; CIRCULATING MICRORNAS; PERIPHERAL-BLOOD; BIOMARKER; SIGNATURES; PROFILES	Background: Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings: In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance: Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.	[Sondermeijer, Brigitte M.; Bakker, Annemieke; de Ronde, Maurice W. J.; Mulders, Ties A.; Kok, Maayke G. M.; Battjes, Suzanne; Maiwald, Steffi; Sivapalaratnam, Suthesh; Trip, Mieke D.; Meijers, Joost C. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Halliani, Amalia; Tijsen, Anke J.; Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Marquart, Arnoud A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sondermeijer, BM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.J.Pinto@amc.uva.nl	Meijers, J.C.M./S-5981-2019; SJ, Pinto-Sietsma/AAI-3207-2021; Moerland, Perry/AAG-1425-2020	Meijers, J.C.M./0000-0002-4198-6780; Moerland, Perry/0000-0002-2357-3659; Tijsen, Anke/0000-0002-8030-8894; Creemers, Esther/0000-0002-9001-3854	Academic Medical Center	Academic Medical Center	This research was supported by institutional funding of the Academic Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; AI J, 2009, BIOCH BIOPHYS RES CO; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY TP, ATHEROSCLER IN PRESS; RODRIGUES AC, MICRORNA EXPRESSION; Scheuner MT, 2001, CURR OPIN CARDIOL, V16, P251, DOI 10.1097/00001573-200107000-00006; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008	36	78	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25946	10.1371/journal.pone.0025946	http://dx.doi.org/10.1371/journal.pone.0025946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022480	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600032
J	Bie, L; Zhao, G; Cheng, P; Rondeau, G; Porwollik, S; Ju, Y; Xia, XQ; McClelland, M				Bie, Li; Zhao, Gang; Cheng, Pui; Rondeau, Gaelle; Porwollik, Steffen; Ju, Yan; Xia, Xiao-Qin; McClelland, Michael			The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; CELL-PROLIFERATION; CANCER-CELLS; ANEUPLOIDY; BUBR1; ASTROCYTOMAS; TUMORS; GRADE; CLASSIFICATION; GLIOBLASTOMA	Identification of gene expression changes that improve prediction of survival time across all glioma grades would be clinically useful. Four Affymetrix GeneChip datasets from the literature, containing data from 771 glioma samples representing all WHO grades and eight normal brain samples, were used in an ANOVA model to screen for transcript changes that correlated with grade. Observations were confirmed and extended using qPCR assays on RNA derived from 38 additional glioma samples and eight normal samples for which survival data were available. RNA levels of eight major mitotic spindle assembly checkpoint (SAC) genes (BUB1, BUB1B, BUB3, CENPE, MAD1L1, MAD2L1, CDC20, TTK) significantly correlated with glioma grade and six also significantly correlated with survival time. In particular, the level of BUB1B expression was highly correlated with survival time (p<0.0001), and significantly outperformed all other measured parameters, including two standards; WHO grade and MIB-1 (Ki-67) labeling index. Measurement of the expression levels of a small set of SAC genes may complement histological grade and other clinical parameters for predicting survival time.	[Bie, Li; Zhao, Gang; Ju, Yan] Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Bie, Li; Xia, Xiao-Qin; McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Cheng, Pui; Rondeau, Gaelle; Porwollik, Steffen; Xia, Xiao-Qin; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Xia, Xiao-Qin] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	Jilin University; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Bie, L (corresponding author), Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China.	xqxia@ihb.ac.cn; mmcclell@uci.edu		McClelland, Michael/0000-0003-1788-9347; xia, xiao qin/0000-0002-8034-1096	National Cancer Institute Early Detection Research Network [U01CA152738]; CDMRP BCRP [W81XWH-08-1-0720]; State Scholarship Fund from China [2009104187]; Jilin University; NATIONAL CANCER INSTITUTE [U01CA152738] Funding Source: NIH RePORTER	National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDMRP BCRP; State Scholarship Fund from China; Jilin University(Jilin University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MM was supported in part by a National Cancer Institute Early Detection Research Network grant U01CA152738 and by CDMRP BCRP W81XWH-08-1-0720. LB was supported by the State Scholarship Fund from China (no. 2009104187). YJ and GZ were supported by Jilin University. MM, XQ, PC and GR donated part of their time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2010, CANCER SCI, V101, P639, DOI 10.1111/j.1349-7006.2009.01457.x; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Burum-Auensen E, 2008, CELL PROLIFERAT, V41, P645, DOI 10.1111/j.1365-2184.2008.00539.x; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chang EF, 2009, J NEUROSURG, V111, P203, DOI 10.3171/2009.2.JNS081101; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Duchrow M, 2003, HISTOPATHOLOGY, V42, P566, DOI 10.1046/j.1365-2559.2003.01613.x; Faria MHG, 2006, NEUROPATHOLOGY, V26, P519, DOI 10.1111/j.1440-1789.2006.00724.x; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garside R, 2007, Health Technol Assess, V11, piii; Garside R, 2007, HEALTH TECHNOL ASSES, V11, P221; Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907; Gladhaug IP, 2010, HISTOPATHOLOGY, V56, P345, DOI 10.1111/j.1365-2559.2010.03489.x; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoyt MA, 2001, J CELL BIOL, V154, P909, DOI 10.1083/jcb.200108010; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihmann T, 2004, J CANCER RES CLIN, V130, P749, DOI 10.1007/s00432-004-0612-5; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; KAMIKUBO K, 1986, JPN J PHARMACOL, V40, P342, DOI 10.1254/jjp.40.342; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lausen B, 2004, BIOMETRICAL J, V46, P364, DOI 10.1002/bimj.200310030; Lee YK, 2009, BRIT J CANCER, V101, P504, DOI 10.1038/sj.bjc.6605161; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maes L, 2007, CELL PROLIFERAT, V40, P14; Marucci G, 2008, VIRCHOWS ARCH, V453, P599, DOI 10.1007/s00428-008-0685-7; Molinie V, 2003, ANN PATHOL, V23, P306; Olesen SH, 2001, CARCINOGENESIS, V22, P813, DOI 10.1093/carcin/22.5.813; Paulus W, 2009, ACTA NEUROPATHOL, V118, P603, DOI 10.1007/s00401-009-0600-6; Percy MJ, 2000, GENE CHROMOSOME CANC, V29, P356, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1044>3.0.CO;2-N; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pich A, 2004, ANN ONCOL, V15, P1319, DOI 10.1093/annonc/mdh299; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Reis RM, 2001, ACTA NEUROPATHOL, V101, P297; Rindi G, 2007, ENDOCR PATHOL, V18, P145, DOI 10.1007/s12022-007-0020-x; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shichiri M, 2002, CANCER RES, V62, P13; Shigeishi H, 2001, ONCOL REP, V8, P791; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Torp SH, 2002, PATHOL RES PRACT, V198, P261; Torp SH, 2002, CLIN NEUROPATHOL, V21, P252; Torp SH, 2001, APMIS, V109, P865, DOI 10.1034/j.1600-0463.2001.091209.x; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walker DG, 2003, J CLIN NEUROSCI, V10, P1, DOI 10.1016/S0967-5868(02)00261-8; Wang Yun-wei, 2005, Zhonghua Wei Chang Wai Ke Za Zhi, V8, P503; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Wong KK, 2005, CANCER RES, V65, P76; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Xiao Y, 2008, PROG NAT SCI, V18, P945, DOI 10.1016/j.pnsc.2008.03.003; Xu LJ, 2009, MOL IMMUNOL, V46, P569, DOI 10.1016/j.molimm.2008.07.035; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yoshida Y, 2010, J NEURO-ONCOL, V98, P41, DOI 10.1007/s11060-009-0064-5; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	73	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25631	10.1371/journal.pone.0025631	http://dx.doi.org/10.1371/journal.pone.0025631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022424	gold, Green Published			2022-12-25	WOS:000295976000026
J	Intskirveli, I; Metherate, R; Cramer, KS				Intskirveli, Irakli; Metherate, Raju; Cramer, Karina S.			Null Mutations in EphB Receptors Decrease Sharpness of Frequency Tuning in Primary Auditory Cortex	PLOS ONE			English	Article							EPHRIN-AS; THALAMOCORTICAL PROJECTIONS; IN-VIVO; FUNCTIONAL-ORGANIZATION; SPECTRAL INTEGRATION; RETINOTECTAL SYSTEM; INFERIOR COLLICULUS; STRUCTURED ACTIVITY; SYNAPSE FORMATION; MAPS	Primary auditory cortex (A1) exhibits a tonotopic representation of characteristic frequency (CF). The receptive field properties of A1 neurons emerge from a combination of thalamic inputs and intracortical connections. However, the mechanisms that guide growth of these inputs during development and shape receptive field properties remain largely unknown. We previously showed that Eph family proteins help establish tonotopy in the auditory brainstem. Moreover, other studies have shown that these proteins shape topography in visual and somatosensory cortices. Here, we examined the contribution of Eph proteins to cortical organization of CF, response thresholds and sharpness of frequency tuning. We examined mice with null mutations in EphB2 and EphB3, as these mice show significant changes in auditory brainstem connectivity. We mapped A1 using local field potential recordings in adult EphB2(-/-); EphB3(-/-) and EphB3(-/-) mice, and in a central A1 location inserted a 16-channel probe to measure tone-evoked current-source density (CSD) profiles. Based on the shortest-latency current sink in the middle layers, which reflects putative thalamocortical input, we determined frequency receptive fields and sharpness of tuning (Q(20)) for each recording site. While both mutant mouse lines demonstrated increasing CF values from posterior to anterior A1 similar to wild type mice, we found that the double mutant mice had significantly lower Q(20) values than either EphB3(-/-) mice or wild type mice, indicating broader tuning. In addition, we found that the double mutants had significantly higher CF thresholds and longer onset latency at threshold than mice with wild type EphB2. These results demonstrate that EphB receptors influence auditory cortical responses, and suggest that EphB signaling has multiple functions in auditory system development.	[Intskirveli, Irakli] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Intskirveli, I (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	cramerk@uci.edu		Cramer, Karina/0000-0003-3793-4862	NIH [R01 NIDCD 005771, NIH P30DC008369, NIH R01 DA12929]; NSF [IOS-0642346]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005771, P30DC008369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants NIH R01 NIDCD 005771, NIH P30DC008369, NIH R01 DA12929 and NSF IOS-0642346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chen ZY, 2004, J NEUROSCI, V24, P2366, DOI 10.1523/JNEUROSCI.4711-03.2004; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Flanagan JG, 1997, CELL, V90, P403; Gabriele ML, 2011, DEV NEUROBIOL, V71, P182, DOI 10.1002/dneu.20842; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hsieh CY, 2010, J NEUROSCI, V30, P9840, DOI 10.1523/JNEUROSCI.0386-10.2010; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kawai H, 2011, J NEUROSCI IN PRESS; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Miko IJ, 2007, J COMP NEUROL, V505, P669, DOI 10.1002/cne.21530; MULLERPREUSS P, 1984, HEARING RES, V16, P133, DOI 10.1016/0378-5955(84)90003-0; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhang YF, 2005, HEARING RES, V201, P145, DOI 10.1016/j.heares.2004.10.003	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26192	10.1371/journal.pone.0026192	http://dx.doi.org/10.1371/journal.pone.0026192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022561	Green Published, gold			2022-12-25	WOS:000295976000083
J	Piskun, CM; Muthuswamy, A; Huelsmeyer, MK; Thompson, V; Stein, TJ				Piskun, Caroline M.; Muthuswamy, Anantharaman; Huelsmeyer, Michael K.; Thompson, Victoria; Stein, Timothy J.			Wnt/beta-Catenin Expression Does Not Correlate with Serum Alkaline Phosphatase Concentration in Canine Osteosarcoma Patients	PLOS ONE			English	Article							APPENDICULAR OSTEOSARCOMA; BETA-CATENIN; PROGNOSTIC-FACTORS; DIFFERENTIATION; METASTASIS; AMPUTATION; DIAGNOSIS; DOGS	Osteosarcoma is an aggressive malignancy of the bone and an increase in serum alkaline phosphatase concentration has clinical prognostic value in both humans and canines. Increased serum alkaline phosphatase concentration at the time of diagnosis has been associated with poorer outcomes for osteosarcoma patients. The biology underlying this negative prognostic factor is poorly understood. Given that activation of the Wnt signaling pathway has been associated with alkaline phosphatase expression in osteoblasts, we hypothesized that the Wnt/beta-catenin signaling pathway would be differentially activated in osteosarcoma tissue based on serum ALP status. Archived canine osteosarcoma samples and primary canine osteosarcoma cell lines were used to evaluate the status of Wnt/beta-catenin signaling pathway activity through immunohistochemical staining, western immunoblot analyses, quantitative reverse-transcription polymerase chain reaction, and a Wnt-responsive promoter activity assay. We found no significant difference in beta-catenin expression or activation between OSA populations differing in serum ALP concentration. Pathway activity was mildly increased in the primary OSA cell line generated from a patient with increased serum ALP compared to the normal serum ALP OSA cell line. Further investigation into the mechanisms underlying differences in serum ALP concentration is necessary to improve our understanding of the biological implications of this negative prognostic indicator.	[Piskun, Caroline M.; Huelsmeyer, Michael K.; Thompson, Victoria; Stein, Timothy J.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Muthuswamy, Anantharaman] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Piskun, CM (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	tjstein@wisc.edu			National Institutes of Health [T32 RR17503]; CTSA/NCRR [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR017503, UL1RR025011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants T32 RR17503 (CMP) and CTSA/NCRR 1UL1RR025011 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; DERNELL W.S., 2007, WITHROW MACEWENS SMA, P540; Ehrhart N, 1998, J AM VET MED ASSOC, V213, P1002; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Garzotto CK, 2000, J VET INTERN MED, V14, P587, DOI 10.1892/0891-6640(2000)014&lt;0587:PSOSAP&gt;2.3.CO;2; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Henthorn PS, 1999, DYNAMICS BONE CARTIL, P130; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Iwaya K, CLIN EXP METASTASIS, V20, P525; Liptak JM, 2004, COMP CONT EDUC PRACT, V26, P172; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Morello E, 2011, VET J, V189, P268, DOI 10.1016/j.tvjl.2010.08.014; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Philips B, 2009, J AM ANIM HOSP ASSOC, V45, P33, DOI 10.5326/0450033; Polakis P, 2000, GENE DEV, V14, P1837; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Stein TJ, 2011, VET COMP ONCOL, V9, P65, DOI 10.1111/j.1476-5829.2010.00236.x; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904	36	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26106	10.1371/journal.pone.0026106	http://dx.doi.org/10.1371/journal.pone.0026106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022527	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200036
J	Bunt, J; Hasselt, NE; Zwijnenburg, DA; Koster, J; Versteeg, R; Kool, M				Bunt, Jens; Hasselt, Nancy E.; Zwijnenburg, Danny A.; Koster, Jan; Versteeg, Rogier; Kool, Marcel			Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma	PLOS ONE			English	Article							EMBRYONIC STEM; REGULATES EXPRESSION; TRANSCRIPTION; INDUCTION; PROFILES; NETWORK; IDENTIFICATION; AMPLIFICATION; METHYLATIONS; OCCUPANCY	Both OTX2 and MYC are important oncogenes in medulloblastoma, the most common malignant brain tumor in childhood. Much is known about MYC binding to promoter regions, but OTX2 binding is hardly investigated. We used ChIP-on-chip data to analyze the binding patterns of both transcription factors in D425 medulloblastoma cells. When combining the data for all promoter regions in the genome, OTX2 binding showed a remarkable bi-modal distribution pattern with peaks around 2250 bp upstream and +650 bp downstream of the transcription start sites (TSSs). Indeed, 40.2% of all OTX2-bound TSSs had more than one significant OTX2-binding peak. This OTX2-binding pattern was very different from the TSS-centered single peak binding pattern observed for MYC and other known transcription factors. However, in individual promoter regions, OTX2 and MYC have a strong tendency to bind in proximity of each other. OTX2-binding sequences are depleted near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding. This contrasts to the enrichment of E-box sequences at TSSs. Both OTX2 and MYC binding independently correlated with higher gene expression. Interestingly, genes of promoter regions with multiple OTX2 binding as well as MYC binding showed the highest expression levels in D425 cells and in primary medulloblastomas. Genes within this class of promoter regions were enriched for medulloblastoma and stem cell specific genes. Our data suggest an important functional interaction between OTX2 and MYC in regulating gene expression in medulloblastoma.	[Bunt, Jens; Hasselt, Nancy E.; Zwijnenburg, Danny A.; Koster, Jan; Versteeg, Rogier; Kool, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Bunt, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kool@dkfz-heidelberg.de	Kool, Marcel/H-2541-2013; Versteeg, Rogier/AAQ-1765-2020; Bunt, Jens/C-4775-2014; Koster, Jan/C-5934-2008	Bunt, Jens/0000-0003-0397-2019; Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Zwijnenburg, Danny/0000-0002-9353-8904				Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Bunt J, 2011, INT J CANC IN PRESS; Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di CH, 2005, CANCER RES, V65, P919; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morgan R, 1999, MECH DEVELOP, V85, P97, DOI 10.1016/S0925-4773(99)00091-X; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 2003, BIOCHEM BIOPH RES CO, V300, P908, DOI 10.1016/S0006-291X(02)02934-0; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	47	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26058	10.1371/journal.pone.0026058	http://dx.doi.org/10.1371/journal.pone.0026058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016811	gold, Green Published, Green Submitted			2022-12-25	WOS:000295971700036
J	Kawahara-Miki, R; Wada, K; Azuma, N; Chiba, S				Kawahara-Miki, Ryouka; Wada, Kenta; Azuma, Noriko; Chiba, Susumu			Expression Profiling without Genome Sequence Information in a Non-Model Species, Pandalid Shrimp (Pandalus latirostris), by Next-Generation Sequencing	PLOS ONE			English	Article							MESSENGER-RNA; DROSOPHILA-MELANOGASTER; ENVIRONMENT INTERACTION; ALLELE FREQUENCIES; MOUSE OOCYTES; EGG SIZE; TRANSCRIPTOME; POPULATION; EVOLUTION; MATURATION	While the study of phenotypic variation is a central theme in evolutionary biology, the genetic approaches available to understanding this variation are usually limited because of a lack of genomic information in non-model organisms. This study explored the utility of next-generation sequencing (NGS) technologies for studying phenotypic variations between 2 populations of a non-model species, the Hokkai shrimp (Pandalus latirostris; Decapoda, Pandalidae). Before we performed transcriptome analyses using NGS, we examined the genetic and phenotypic differentiation between the populations. Analyses using microsatellite DNA markers suggested that these populations genetically differed from one another and that gene flow is restricted between them. Moreover, the results of our 4-year field observations indicated that the egg traits varied genetically between the populations. Using mRNA extracted from the ovaries of 5 females in each population of Hokkai shrimp, we then performed a transcriptome analysis of the 2 populations. A total of 13.66 gigabases (Gb) of 75-bp reads was obtained. Further, 58,804 and 33,548 contigs for the first and second population, respectively, and 47,467 contigs for both populations were produced by de novo assembly. We detected 552 sequences with the former approach and 702 sequences with the later one; both sets of sequences showed greater than twofold differences in the expression levels between the 2 populations. Twenty-nine sequences were found in both approaches and were considered to be differentially expressed genes. Among them, 9 sequences showed significant similarity to functional genes. The present study showed a de novo assembly approach for the transcriptome of a non-model species using only short-read sequence data, and provides a strategy for identifying sequences showing significantly different expression levels between populations.	[Kawahara-Miki, Ryouka] Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan; [Wada, Kenta; Azuma, Noriko; Chiba, Susumu] Tokyo Univ Agr, Fac Bioind, Abashiri, Hokkaido, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture	Kawahara-Miki, R (corresponding author), Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan.	s2chiba@bioindustry.nodai.ac.jp	Chiba, Susumu/D-1697-2017; Miki, Ryoka/E-7857-2017	Chiba, Susumu/0000-0003-1545-1552; Miki, Ryoka/0000-0003-2072-8851	Ministry of Education, Culture, Sports, Science and Technology [S0801025, 21780184]; Tokyo University of Agriculture; Grants-in-Aid for Scientific Research [21780184] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Agriculture; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (S0801025, and 21780184) and by a Grant-in-Aid for Advanced Study Projects from the Tokyo University of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2001, HISTOCHEM CELL BIOL, V115, P95; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, R LANG ENV STAT COMP; Azuma N, 2011, CONSERV GENET RESOUR, V3, P529, DOI 10.1007/s12686-011-9396-5; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Chiba S, 2004, FISHERIES SCI, V70, P1174, DOI 10.1111/j.1444-2906.2004.00920.x; Chiba S, 2000, MAR ECOL PROG SER, V203, P215, DOI 10.3354/meps203215; Chiba S, 2003, AQUACULTURE SCI, V51, P375; Chittenden CM, 2010, PLOS ONE, V5; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Edeline E, 2007, P NATL ACAD SCI USA, V104, P15799, DOI 10.1073/pnas.0705908104; Ernsting G, 2000, AM NAT, V155, P804, DOI 10.1086/303361; Falconer D. S, 1996, INTRO QUANTITATIVE G; Falush D, 2003, GENETICS, V164, P1567; Fujii T, 2010, J GENETICS, V89; Gebauer F, 1996, P NATL ACAD SCI USA, V93, P14602, DOI 10.1073/pnas.93.25.14602; Geraci F, 2003, BIOCHEM BIOPH RES CO, V310, P748, DOI 10.1016/j.bbrc.2003.09.067; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Han D, 2009, J EXPT BIOL, V212; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Hokkaido Research Organization, 2011, MAR NET HOKK DAT BAS; Ibarra AM, 2009, AQUACULTURE, V297, P64, DOI 10.1016/j.aquaculture.2009.09.015; KAWAMURA N, 1990, GENETICA, V81, P205, DOI 10.1007/BF00360866; Kim EK, 2006, PHYSIOL RES, V55, P405, DOI 10.33549/physiolres.930773; KUBO ITSUO, 1951, BULL JAPANESE SOC SCI FISH, V16, P71; Leimar O, 2009, EVOL ECOL, V23, P125, DOI 10.1007/s10682-007-9194-4; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI [10.2307/2410382, 10.1111/j.1558-5646.1994.tb05309.x]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MIZUSHIMA T, 1987, Scientific Reports of Hokkaido Fisheries Experimental Station, P25; Mizushima T, 1980, MONTH J FISH EXP STN, V37, P87; Mizushima T, 1979, MONTHLY J FISHERIES, V36, P53; Mizushima T, 1986, MONTHLY J FISHERIES, V43, P77; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishihama Yuji, 1997, Scientific Reports of Hokkaido Fisheries Experimental Station, V50, P1; Oh B, 2000, DEVELOPMENT, V127, P3795; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Onishi Yuta, 2001, Benthos Research, V56, P9; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Roff Derek A., 1992; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambandan D, 2008, GENETICS, V179, P1079, DOI 10.1534/genetics.108.086769; Schneider S, 2000, ARLEQIN VER 2 000 SO; Sitonikov AV, 1997, RUSSIAN J GENETICS, V33, P1158; SLATKIN M, 1995, GENETICS, V139, P457; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Tartia AP, 2009, DEVELOPMENT, V136, P2247, DOI 10.1242/dev.036756; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wolf JBW, 2010, MOL ECOL, V19, P703; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	66	32	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26043	10.1371/journal.pone.0026043	http://dx.doi.org/10.1371/journal.pone.0026043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016807	gold, Green Published			2022-12-25	WOS:000295971700035
J	Pelletier, J; Dayan, F; Durivault, J; Ilc, K; Pecou, E; Pouyssegur, J; Mazure, NM				Pelletier, J.; Dayan, F.; Durivault, J.; Ilc, K.; Pecou, E.; Pouyssegur, J.; Mazure, N. M.			The asparaginyl hydroxylase factor-inhibiting HIF is essential for tumor growth through suppression of the p53-p21 axis	ONCOGENE			English	Article						FIH; HIF-1; hypoxia; p53; tumor growth	HYPOXIA-INDUCIBLE FACTOR; PAS DOMAIN PROTEIN-1; RENAL-CELL CARCINOMA; TRANSCRIPTIONAL ACTIVITY; FACTOR-I; TRANSACTIVATION DOMAIN; FIH; EXPRESSION; HIF-1-ALPHA; PATHWAY	We showed previously that factor-inhibiting hypoxia-inducible factor HIF (FIH) monitors the expression of a spectrum of genes that are dictated by the cell's partial oxygen pressure. This action is mediated by the C-TAD, one of two transactivation domains (TADs) of the hypoxia-inducible factor. Here, we questioned: (1) the function of FIH as a HIF-1 modulator of gene expression in the context of a physiological oxygen gradient occurring in three-dimensional cultures and in tumors and (2) the role of FIH as a modulator of the growth of human tumor cells. We first showed that the expression pattern of HIF target genes that depend on the C-TAD, such as carbonic anhydrase IX, was spacially displaced to more oxygenated areas when FIH was silenced, whereas overexpression of FIH restricted this pattern to more hypoxic areas. Second, we showed that silencing fih severely reduced in vitro cell proliferation and in vivo tumor growth of LS174 colon adenocarcinoma and A375 melanoma cells. Finally, silencing of fih significantly increased both the total and phosphorylated forms of the tumor suppressor p53, leading to an increase in its direct target, the cell cycle inhibitor p21. Moreover, p53-deficient or mutant cells were totally insensitive to FIH expression. Thus, FIH activity is essential for tumor growth through the suppression of the p53-p21 axis, the major barrier that prevents cancer progression.	[Mazure, N. M.] Univ Nice Sophia Antipolis, CNRS, Inst Dev Biol & Canc Res, Ctr Antoine Lacassagne,UMR 6543, F-06189 Nice, France; [Dayan, F.; Pecou, E.] Univ Nice Sophia Antipolis, CNRS, Lab JA Dieudonne, UMR 6632, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Mazure, NM (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Dev Biol & Canc Res, Ctr Antoine Lacassagne,UMR 6543, 33 Ave Valombrose, F-06189 Nice, France.	Nathalie.Mazure@unice.fr	pelletier, joffrey/K-8930-2014	pelletier, joffrey/0000-0001-9174-044X; Durivault, Jerome/0000-0002-8228-2915; Pecou Gambaudo, Elisabeth/0000-0002-1108-7282	Ligue Nationale Contre le Cancer (equipe labellisee); Association pour la Recherche contre le Cancer; Institut National du Cancer; Agence Nationale pour la Recherche; METOXIA (EU); Centre A Lacassagne; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; University of Nice	Ligue Nationale Contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); METOXIA (EU)(European Commission); Centre A Lacassagne; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice	The laboratory is funded by the Ligue Nationale Contre le Cancer (equipe labellisee), the Association pour la Recherche contre le Cancer, the Institut National du Cancer, the Agence Nationale pour la Recherche, METOXIA (EU program FP7), the Centre A Lacassagne, the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale and the University of Nice (http://www.unice.fr/isdbc/). We thank Dr Corinne Bertolotto and Dr Frederic Bost for their helpful advices. We also thank Dr M Christiane Brahimi-Horn for critical reading and editorial correction.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Dayan F, 2008, CANCER MICROENVIRON, V1, P53, DOI 10.1007/s12307-008-0006-3; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaluz S, 2008, BLOOD, V111, P5258, DOI 10.1182/blood-2008-02-140079; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kroeze SGC, 2010, EUR J CANCER, V46, P3375, DOI 10.1016/j.ejca.2010.07.018; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Morris MR, 2004, J CLIN PATHOL, V57, P706, DOI 10.1136/jcp.2003.011767; Newbold RF, 2002, MUTAGENESIS, V17, P539, DOI 10.1093/mutage/17.6.539; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Schodel J, 2010, KIDNEY INT, V78, P857, DOI 10.1038/ki.2010.284; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	40	29	29	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					2989	3001		10.1038/onc.2011.471	http://dx.doi.org/10.1038/onc.2011.471			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22002313				2022-12-25	WOS:000305388400008
J	Charan, RA; Hanson, R; Clemens, PR				Charan, Rakshita A.; Hanson, Ryan; Clemens, Paula R.			Deubiquitinating enzyme A20 negatively regulates NF-kappa B signaling in skeletal muscle in mdx mice	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; inflammation; regeneration; differentiation; TNFAIP3	DUCHENNE MUSCULAR-DYSTROPHY; ZINC-FINGER PROTEIN; CELL-DIFFERENTIATION; GENE-PRODUCTS; MOUSE MUSCLE; NECROSIS; ACTIVATION; EXPRESSION; FIBERS; DEATH	Duchenne muscular dystrophy (DMD) is caused by the lack of a functional dystrophin protein that results in muscle fiber membrane disruption and, ultimately, degeneration. Regeneration of muscle fibers fails progressively, and muscle tissue is replaced with connective tissue. As a result, DMD causes progressive limb muscle weakness and cardiac and respiratory failure. The absence of dystrophin from muscle fibers triggers the chronic activation of the nuclear factor of kappa B (NF-kappa B). Chronic activation of NF-kappa B in muscle leads to infiltration of macrophages, up-regulation of the ubiquitin-proteosome system, and down-regulation of the helix-loop-helix muscle regulatory factor, MyoD. These processes, triggered by NF-kappa B activation, promote muscle degeneration and failure of muscle regeneration. A20 (TNFAIP3) is a critical negative regulator of NF-kappa B. In this study, we characterize the role of A20 in regulating NF-kappa B activation in skeletal muscle, identifying a novel role in muscle regeneration. A20 is highly expressed in regenerating muscle fibers, and knockdown of A20 impairs muscle differentiation in vitro, which suggests that A20 expression is critically important for regeneration of dystrophic muscle tissue. Furthermore, down-regulation of the classic pathway of NF-kappa B activation is associated with up-regulation of the alternate pathway in regenerating muscle fibers, suggesting a mechanism by which A20 promotes muscle regeneration. These results demonstrate the important role of A20 in muscle fiber repair and suggest the potential of A20 as a therapeutic target to ameliorate the pathology and clinical symptoms of DMD.-Charan, R. A., Hanson, R., Clemens, P. R. Deubiquitinating enzyme A20 negatively regulates NF-kappa B signaling in skeletal muscle in mdx mice. FASEB J. 26, 587-595 (2012). www.fasebj.org	[Charan, Rakshita A.; Hanson, Ryan; Clemens, Paula R.] Univ Pittsburgh, Dept Neurol, Sch Med, Pittsburgh, PA 15213 USA; [Charan, Rakshita A.; Clemens, Paula R.] Dept Vet Affairs Med Ctr, Neurol Serv, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clemens, PR (corresponding author), Univ Pittsburgh, Dept Neurol, Sch Med, S520 Biomed Sci Tower,203 Lothrop St, Pittsburgh, PA 15213 USA.	pclemens@pitt.edu		Hanson, Ryan/0000-0002-2564-3710	VA Merit Review grant; University of Pittsburgh	VA Merit Review grant(US Department of Veterans Affairs); University of Pittsburgh(University of Pittsburgh)	The authors thank Daniel Reay and Gabriela Niizawa for technical assistance and advice. This work was supported by a VA Merit Review grant and University of Pittsburgh departmental funds. The authors take full responsibility for the contents of this paper, which do not represent the views of the Department of Veterans Affairs or the U.S. Government.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Canicio J, 2001, J BIOL CHEM, V276, P20228, DOI 10.1074/jbc.M100718200; Dahlman JM, 2010, J BIOL CHEM, V285, P5479, DOI 10.1074/jbc.M109.075606; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Kunter U, 2005, KIDNEY INT, V68, P1520, DOI 10.1111/j.1523-1755.2005.00564.x; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Nordquist J, 2007, MOL MED, V13, P461, DOI 10.2119/2006-00066.Nordquist; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Pan Y, 2008, MOL CELLS, V25, P531; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tran TM, 2009, APOPTOSIS, V14, P320, DOI 10.1007/s10495-009-0311-4; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	38	11	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					587	595		10.1096/fj.11-189829	http://dx.doi.org/10.1096/fj.11-189829			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22012122				2022-12-25	WOS:000300485700012
J	Chen, ZH; Gopalakrishnan, SM; Bui, MH; Soni, NB; Warrior, U; Johnson, EF; Donnelly, JB; Glaser, KB				Chen, Zehan; Gopalakrishnan, Sujatha M.; Bui, Mai-Ha; Soni, Niru B.; Warrior, Usha; Johnson, Eric F.; Donnelly, Jennifer B.; Glaser, Keith B.			1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2) A CAUTIONARY NOTE ON THE ANTICANCER MECHANISM OF AN eEF2 KINASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-II; IDENTIFICATION; CANCER; INHIBITORS; MECHANISM; CELLS; LEADS; SITE; EF-2	Eukaryotic elongation factor-2 kinase (eEF2K) relays growth and stress signals to protein synthesis through phosphorylation and inactivation of eukaryotic elongation factor 2 (eEF2). 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) is a widely accepted inhibitor of mammalian eEF2K and an efficacious anti-proliferation agent against different cancer cells. It implied that eEF2K could be an efficacious anticancer target. However, eEF2K siRNA was ineffective against cancer cells including those sensitive to NH125. To test if pharmacological intervention differs from siRNA interference, we identified a highly selective small molecule eEF2K inhibitor A-484954. Like siRNA, A-484954 had little effect on cancer cell growth. We carefully examined the effect of NH125 and A-484954 on phosphorylation of eEF2, the known cellular substrate of eEF2K. Surprisingly, NH125 increased eEF2 phosphorylation, whereas A-484954 inhibited the phosphorylation as expected for an eEF2K inhibitor. Both A-484954 and eEF2K siRNA inhibited eEF2K and reduced eEF2 phosphorylation with little effect on cancer cell growth. These data demonstrated clearly that the anticancer activity of NH125 was more correlated with induction of eEF2 phosphorylation than inhibition of eEF2K. Actually, induction of eEF2 phosphorylation was reported to correlate with inhibition of cancer cell growth. We compared several known inducers of eEF2 phosphorylation including AMPK-activators and an mTOR inhibitor. Interestingly, stronger induction of eEF2 phosphorylation correlated with more effective growth inhibition. We also explored signal transduction pathways leading to NH125-induced eEF2 phosphorylation. Preliminary data suggested that NH125-induced eEF2 phosphorylation was likely mediated through multiple pathways. These observations identified an opportunity for a new multipathway approach to anticancer therapies.	[Chen, Zehan] Abbott Labs, Global Pharmaceut Prod Res Div, Canc Res & Adv Technol, Abbott Pk, IL 60064 USA	Abbott Laboratories	Chen, ZH (corresponding author), Abbott Labs, Global Pharmaceut Prod Res Div, Canc Res & Adv Technol, AP9-2,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	aj.chen@sbcglobal.net						Anderson SN, 2004, J BIOMOL SCREEN, V9, P112, DOI 10.1177/1087057103260592; Arora S, 2004, MOL PHARMACOL, V66, P460; Arora S, 2003, CANCER RES, V63, P6894; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Burns DJ, 2001, DRUG DISCOV TODAY, V6, pS40; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Cho SI, 2000, BBA-GEN SUBJECTS, V1475, P207, DOI 10.1016/S0304-4165(00)00061-1; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; Hong-Brown LQ, 2008, J CELL BIOCHEM, V105, P814, DOI 10.1002/jcb.21882; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodriguez-Mora O, 2005, EXPERT OPIN THER TAR, V9, P791, DOI 10.1517/14728222.9.4.791; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yamamoto K, 2000, BIOSCI BIOTECH BIOCH, V64, P919, DOI 10.1271/bbb.64.919; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	32	72	75	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43951	43958		10.1074/jbc.M111.301291	http://dx.doi.org/10.1074/jbc.M111.301291			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020937	Green Published, hybrid			2022-12-25	WOS:000298402300036
J	Kang, H; Jang, SW; Ko, J				Kang, Hyereen; Jang, Sung-Wuk; Ko, Jesang			Human Leucine Zipper Protein sLZIP Induces Migration and Invasion of Cervical Cancer Cells via Expression of Matrix Metalloproteinase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; C-JUN; MMP-9; FIBROBLASTS; PROGRESSION; PATHWAY; VP16	Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to abnormal tumor growth, inflammation, tissue invasion, and metastasis. Matrix metalloproteinase-9 (MMP-9) represents one of the most prominent proteinases associated with inflammation and tumorigenesis. The recently identified human transcription factor sLZIP is a member of the leucine zipper transcription factor family. Although sLZIP is known to function in ligand-induced transactivation of the glucocorticoid receptor, its exact functions and target genes are not known. In this study, we investigated the role of sLZIP in MMP-9 expression and its involvement in cervical cancer development. Our results show that sLZIP increased the expression of MMP-9 at both the mRNA and protein levels and the proteolytic activity of MMP-9 in HeLa and SiHa cells. sLZIP also increased the transcriptional activity of MMP-9 by binding directly to the cAMP-responsive element of the MMP-9 promoter region. Involvement of sLZIP in MMP-9 expression was further supported by the fact that ME-180 cells expressing sLZIP siRNA were refractory to MMP-9 expression. Results from wound healing and invasion assays showed that sLZIP enhanced both the migration and invasion of cervical cancer cells. The increased migration and invasion of HeLa and SiHa cells that were induced by sLZIP were abrogated by inhibition of the proteolytic activity of MMP-9. These results indicate that sLZIP plays a critical role in MMP-9 expression and is probably involved in invasion and metastasis of cervical cancer.	[Kang, Hyereen; Jang, Sung-Wuk; Ko, Jesang] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			National Research Foundation of Korea (NRF) [2011-0017957, 2011-0001573, 2011-0027756]; Ministry of Education, Science, and Technology, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grant 2011-0017957, Basic Research Laboratory Program Grant 2011-0001573, and Disease Network Research Program Grant 2011-0027756 from the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Busti C, 2010, INTERN EMERG MED, V5, P13, DOI 10.1007/s11739-009-0283-y; CASTELLAZZI M, 1990, ONCOGENE, V5, P1541; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fic P, 2011, POSTEP HIG MED DOSW, V65, P16, DOI 10.5604/17322693.931536; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; Johansson N, 2000, CELL MOL LIFE SCI, V57, P5, DOI 10.1007/s000180050495; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kupferman ME, 2000, AM J PATHOL, V157, P1777, DOI 10.1016/S0002-9440(10)64815-8; Lee PPH, 2001, J CELL PHYSIOL, V188, P75, DOI 10.1002/jcp.1090; Libra M, 2009, INT J ONCOL, V34, P897, DOI 10.3892/ijo_00000215; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Maity G, 2011, J CANCER RES CLIN, V137, P347, DOI 10.1007/s00432-010-0892-x; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Rao JS, 1996, CLIN EXP METASTAS, V14, P12, DOI 10.1007/BF00157681; Sato T, 2002, CANCER RES, V62, P1025; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; SUZUKI T, 1991, JPN J CANCER RES, V82, P58, DOI 10.1111/j.1349-7006.1991.tb01746.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wittekindt C, 2011, ACTA OTO-LARYNGOL, V131, P101, DOI 10.3109/00016489.2010.506886; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225	42	21	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42072	42081		10.1074/jbc.M111.272302	http://dx.doi.org/10.1074/jbc.M111.272302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009750	hybrid, Green Published			2022-12-25	WOS:000298180900017
J	Nelson, ER; Levi, B; Sorkin, M; James, AW; Liu, KJ; Quarto, N; Longaker, MT				Nelson, Emily R.; Levi, Benjamin; Sorkin, Michael; James, Aaron W.; Liu, Karen J.; Quarto, Natalina; Longaker, Michael T.			Role of GSK-3 beta in the Osteogenic Differentiation of Palatal Mesenchyme	PLOS ONE			English	Article							CLEFT-PALATE; BONE-FORMATION; CELL FATE; WNT; ACTIVATION; MICE; PROLIFERATION; CHONDROCYTES; REQUIREMENT; MECHANISM	Introduction: The function of Glycogen Synthase Kinases 3 beta (GSK-3 beta) has previously been shown to be necessary for normal secondary palate development. Using GSK-3 beta null mouse embryos, we examine the potential coordinate roles of Wnt and Hedgehog signaling on palatal ossification. Methods: Palates were harvested from GSK-3 beta, embryonic days 15.0-18.5 (e15.0-e18.5), and e15.5 Indian Hedgehog (Ihh) null embryos, and their wild-type littermates. The phenotype of GSK-3 beta null embryos was analyzed with skeletal whole mount and pentachrome stains. Spatiotemporal regulation of osteogenic gene expression, in addition to Wnt and Hedgehog signaling activity, were examined in vivo on GSK-3 beta and Ihh +/+ and -/- e15.5 embryos using in situ hybridization and immunohistochemistry. To corroborate these results, expression of the same molecular targets were assessed by qRT-PCR of e15.5 palates, or e13.5 palate cultures treated with both Wnt and Hedgehog agonists and anatagonists. Results: GSK-3 beta null embryos displayed a 48 percent decrease (*p < 0.05) in palatine bone formation compared to wild-type littermates. GSK-3 beta null embryos also exhibited decreased osteogenic gene expression that was associated with increased Wnt and decreased Hedgehog signaling. e13.5 palate culture studies demonstrated that Wnt signaling negatively regulates both osteogenic gene expression and Hedgehog signaling activity, while inhibition of Wnt signaling augments both osteogenic gene expression and Hedgehog signaling activity. In addition, no differences in Wnt signaling activity were noted in Ihh null embryos, suggesting that canonical Wnt may be upstream of Hedgehog in secondary palate development. Lastly, we found that GSK-3 beta -/- palate cultures were "rescued" with the Wnt inhibitor, Dkk-1. Conclusions: Here, we identify a critical role for GSK-3 beta in palatogenesis through its direct regulation of canonical Wnt signaling. These findings shed light on critical developmental pathways involved in palatogenesis and may lead to novel molecular targets to prevent cleft palate formation.	[Nelson, Emily R.; Levi, Benjamin; Sorkin, Michael; James, Aaron W.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England; [Quarto, Natalina] Univ Naples Federico 2, Dipartimento Sci Chirurg Anestesiol Rianimatorie, Naples, Italy; [Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; University of London; King's College London; University of Naples Federico II; Stanford University	Nelson, ER (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA.	longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165	National Institutes of Health, National Institute of Dental and Craniofacial Research [1R21DE018727]; Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine; National Endowment for Plastic Surgery; National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases [1F32AR057302]; BBSRC [BB/E013872/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013872/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018727] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine; National Endowment for Plastic Surgery; National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health, National Institute of Dental and Craniofacial Research grant 1R21DE018727, the Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine, and the National Endowment for Plastic Surgery to Dr. Longaker. Dr. Levi was supported by the National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases grant 1F32AR057302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Jin YR, 2011, DEV BIOL, V352, P1, DOI 10.1016/j.ydbio.2011.01.004; Juriloff DM, 2006, BIRTH DEFECTS RES A, V76, P574, DOI 10.1002/bdra.20302; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Levi B, 2011, PLAST RECONSTR SURG, V127, P1182, DOI 10.1097/PRS.0b013e3182043a07; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Quarto N, 2010, TISSUE ENG PT A, V16, P3185, DOI 10.1089/ten.tea.2010.0133; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Taya Y, 1999, DEVELOPMENT, V126, P3869; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; YAVROPOULOU MP, 2007, GUT, V6, P279	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25847	10.1371/journal.pone.0025847	http://dx.doi.org/10.1371/journal.pone.0025847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022457	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600015
J	Baliki, MN; Schnitzer, TJ; Bauer, WR; Apkarian, AV				Baliki, Marwan N.; Schnitzer, Thomas J.; Bauer, William R.; Apkarian, A. Vania			Brain Morphological Signatures for Chronic Pain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER DECREASE; FIBROMYALGIA PATIENTS; CINGULATE CORTEX; AMYGDALA; OSTEOARTHRITIS; CONNECTIVITY; PERFORMANCE; PERCEPTION; MECHANISMS	Chronic pain can be understood not only as an altered functional state, but also as a consequence of neuronal plasticity. Here we use in vivo structural MRI to compare global, local, and architectural changes in gray matter properties in patients suffering from chronic back pain (CBP), complex regional pain syndrome (CRPS) and knee osteoarthritis (OA), relative to healthy controls. We find that different chronic pain types exhibit unique anatomical 'brain signatures'. Only the CBP group showed altered whole-brain gray matter volume, while regional gray matter density was distinct for each group. Voxel-wise comparison of gray matter density showed that the impact on the extent of chronicity of pain was localized to a common set of regions across all conditions. When gray matter density was examined for large regions approximating Brodmann areas, it exhibited unique large-scale distributed networks for each group. We derived a barcode, summarized by a single index of within-subject co-variation of gray matter density, which enabled classification of individual brains to their conditions with high accuracy. This index also enabled calculating time constants and asymptotic amplitudes for an exponential increase in brain re-organization with pain chronicity, and showed that brain reorganization with pain chronicity was 6 times slower and twice as large in CBP in comparison to CRPS. The results show an exuberance of brain anatomical reorganization peculiar to each condition and as such reflecting the unique maladaptive physiology of different types of chronic pain.	[Baliki, Marwan N.; Apkarian, A. Vania] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Schnitzer, Thomas J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bauer, William R.] Univ Toledo, Dept Neurosci, Toledo, OH 43606 USA; [Apkarian, A. Vania] Feinberg Sch Med, Dept Anesthesia, Chicago, IL USA; [Apkarian, A. Vania] Feinberg Sch Med, Dept Surg, Chicago, IL USA	Northwestern University; Northwestern University; University System of Ohio; University of Toledo; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Baliki, MN (corresponding author), Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu		Apkarian, A. Vania/0000-0002-9788-7458	National Institutes of Health National Institute of Neurological Disorders and Stroke [NS35115]; anonymous foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); anonymous foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health National Institute of Neurological Disorders and Stroke NS35115. MNB was funded by an anonymous foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Davis KD, 1995, NEUROREPORT, V7, P321, DOI 10.1097/00001756-199512290-00077; Fields H., 2006, P 11 WORLD C PAIN SE, P449; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Harden RN, 2005, J PAIN, V6, P364, DOI 10.1016/j.jpain.2005.01.350; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmidt-Wilcke Tobias, 2008, Curr Rheumatol Rep, V10, P467; SCHMIDTWILCKE T, 2006, PAIN; Schweinhardt P, 2008, PAIN, V140, P411, DOI 10.1016/j.pain.2008.09.014; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tu CH, 2010, PAIN, V150, P462, DOI 10.1016/j.pain.2010.05.026; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Wright IC, 1999, CEREB CORTEX, V9, P366, DOI 10.1093/cercor/9.4.366; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	247	254	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26010	10.1371/journal.pone.0026010	http://dx.doi.org/10.1371/journal.pone.0026010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022493	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600035
J	Silliman, BR; Bertness, MD; Altieri, AH; Griffin, JN; Bazterrica, MC; Hidalgo, FJ; Crain, CM; Reyna, MV				Silliman, Brian R.; Bertness, Mark D.; Altieri, Andrew H.; Griffin, John N.; Cielo Bazterrica, M.; Hidalgo, Fernando J.; Crain, Caitlin M.; Reyna, Maria V.			Whole-Community Facilitation Regulates Biodiversity on Patagonian Rocky Shores	PLOS ONE			English	Article							POSITIVE INTERACTIONS; SPECIES INTERACTIONS; SALT MARSHES; NEW-ZEALAND; DIVERSITY; NETWORKS; HABITAT; DISTURBANCE; PREDATION; PRODUCTIVITY	Background: Understanding the factors that generate and maintain biodiversity is a central goal in ecology. While positive species interactions (i.e., facilitation) have historically been underemphasized in ecological research, they are increasingly recognized as playing important roles in the evolution and maintenance of biodiversity. Dominant habitat-forming species (foundation species) buffer environmental conditions and can therefore facilitate myriad associated species. Theory predicts that facilitation will be the dominant community-structuring force under harsh environmental conditions, where organisms depend on shelter for survival and predation is diminished. Wind-swept, arid Patagonian rocky shores are one of the most desiccating intertidal rocky shores ever studied, providing an opportunity to test this theory and elucidate the context-dependency of facilitation. Methodology/Principal Findings: Surveys across 2100 km of southern Argentinean coastline and experimental manipulations both supported theoretical predictions, with 43 out of 46 species in the animal assemblage obligated to living within the matrices of mussels for protection from potentially lethal desiccation stress and predators having no detectable impact on diversity. Conclusions/Significance: These results provide the first experimental support of long-standing theoretical predictions and reveal that in extreme climates, maintenance of whole-community diversity can be maintained by positive interactions that ameliorate physical stress. These findings have important conservation implications and emphasize that preserving foundation species should be a priority in remediating the biodiversity consequences of global climate change.	[Silliman, Brian R.; Griffin, John N.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Bertness, Mark D.; Altieri, Andrew H.; Crain, Caitlin M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Cielo Bazterrica, M.; Hidalgo, Fernando J.; Reyna, Maria V.] Univ Patagonia, Dept Biol, Puerto Madryn, Chibut, Argentina; [Reyna, Maria V.] Natl Univ Mar del Plata, Dept Biol, Mar Del Plata, Buenos Aires, Argentina	State University System of Florida; University of Florida; Brown University; National University of Mar del Plata	Silliman, BR (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	brs@ufl.edu	Altieri, Andrew H/P-1738-2017; Hidalgo, Fernando/L-8046-2013	Altieri, Andrew/0000-0001-7439-8742; Silliman, Brian/0000-0001-6360-650X; Griffin, John/0000-0003-3295-6480	Mellon Foundation; NSF [0542822]; University of Florida	Mellon Foundation; NSF(National Science Foundation (NSF)); University of Florida(University of Florida)	A grant from the Mellon Foundation (www.mellon.org) to M. D. Bertness supported this work as well as an NSF award (#0542822) to M. D. Bertness and B. R. Silliman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Alberti J, 2007, MAR ECOL PROG SER, V349, P235, DOI 10.3354/meps07089; Altieri AH, 2007, AM NAT, V169, P195, DOI 10.1086/510603; Angelini C, BIO SCI IN PRESS; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bazterrica MC, 2007, J EXP MAR BIOL ECOL, V353, P22, DOI 10.1016/j.jembe.2007.08.018; Bertness MD, 2006, ECOL MONOGR, V76, P439, DOI 10.1890/0012-9615(2006)076[0439:TCSOWA]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brose U, 2005, ECOL LETT, V8, P1317, DOI 10.1111/j.1461-0248.2005.00838.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2000, ECOLOGY, V81, P1179, DOI 10.2307/177200; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dayton P. K., 1972, P C CONSERVATION PRO, P81, DOI DOI 10.1007/S00442-010-1685-2; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Gaines, 2007, ENCY TIDEPOOLS ROCKY; Halpern BS, 2007, FRONT ECOL ENVIRON, V5, P153, DOI 10.1890/1540-9295(2007)5[153:IPIIAR]2.0.CO;2; HART DD, 1992, OECOLOGIA, V91, P220, DOI 10.1007/BF00317787; Hidalgo FJ, 2007, ESTUAR COAST, V30, P886, DOI 10.1007/BF02841342; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; LUBCHENCO J, 1978, ECOL MONOGR, V48, P67, DOI 10.2307/2937360; McClain CR, 2010, ECOLOGY, V91, P964, DOI 10.1890/09-0087.1; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Naeem S., 2009, BIODIVERSITY ECOSYST; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1985, AM NAT, V125, P679, DOI 10.1086/284371; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2003, OIKOS, V101, P549, DOI 10.1034/j.1600-0706.2003.12070.x; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Suchanek TH, 1986, ECOLOGY ROCKY COASTS; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	44	90	91	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24502	10.1371/journal.pone.0024502	http://dx.doi.org/10.1371/journal.pone.0024502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022356	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600003
J	Mng'ong'o, FC; Sambali, JJ; Sabas, E; Rubanga, J; Magoma, J; Ntamatungiro, AJ; Turner, EL; Nyogea, D; Ensink, JHJ; Moore, SJ				Mng'ong'o, Frank C.; Sambali, Joseph J.; Sabas, Eustachkius; Rubanga, Justine; Magoma, Jaka; Ntamatungiro, Alex J.; Turner, Elizabeth L.; Nyogea, Daniel; Ensink, Jeroen H. J.; Moore, Sarah J.			Repellent Plants Provide Affordable Natural Screening to Prevent Mosquito House Entry in Tropical Rural Settings-Results from a Pilot Efficacy Study	PLOS ONE			English	Article							ANOPHELES-GAMBIAE DIPTERA; WESTERN KENYA; MALARIA VECTORS; FEEDING-BEHAVIOR; LANTANA-CAMARA; BODY-SIZE; SUGAR AVAILABILITY; FUNESTUS DIPTERA; FIELD-EVALUATION; CULICIDAE	Sustained malaria control is underway using a combination of vector control, prompt diagnosis and treatment of malaria cases. Progress is excellent, but for long-term control, low-cost, sustainable tools that supplement existing control programs are needed. Conventional vector control tools such as indoor residual spraying and house screening are highly effective, but difficult to deliver in rural areas. Therefore, an additional means of reducing mosquito house entry was evaluated: the screening of mosquito house entry points by planting the tall and densely foliated repellent plant Lantana camara L. around houses. A pilot efficacy study was performed in Kagera Region, Tanzania in an area of high seasonal malaria transmission, where consenting families within the study village planted L. camara (Lantana) around their homes and were responsible for maintaining the plants. Questionnaire data on house design, socioeconomic status, malaria prevention knowledge, attitude and practices was collected from 231 houses with Lantana planted around them 90 houses without repellent plants. Mosquitoes were collected using CDC Light Traps between September 2008 and July 2009. Data were analysed with generalised negative binomial regression, controlling for the effect of sampling period. Indoor catches of mosquitoes in houses with Lantana were compared using the Incidence Rate Ratio (IRR) relative to houses without plants in an adjusted analysis. There were 56% fewer Anopheles gambiae s.s. (IRR 0.44, 95% CI 0.28-0.68, p<0.0001); 83% fewer Anopheles funestus s.s. (IRR 0.17, 95% CI 0.09-0.32, p<0.0001), and 50% fewer mosquitoes of any kind (IRR 0.50, 95% CI 0.38-0.67, p<0.0001) in houses with Lantana relative to controls. House screening using Lantana reduced indoor densities of malaria vectors and nuisance mosquitoes with broad community acceptance. Providing sufficient plants for one home costs US $1.50 including maintenance and labour costs, (30 cents per person). L. camara mode of action and suitability for mosquito control is discussed.	[Mng'ong'o, Frank C.; Sabas, Eustachkius; Rubanga, Justine; Magoma, Jaka] Concern Worldwide Tanzania, Dar Es Salaam, Tanzania; [Mng'ong'o, Frank C.; Ensink, Jeroen H. J.; Moore, Sarah J.] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England; [Sambali, Joseph J.; Ntamatungiro, Alex J.; Nyogea, Daniel; Moore, Sarah J.] Ifakara Hlth Inst, Biomed & Environm Grp, Ifakara, Tanzania; [Sambali, Joseph J.] Univ Durham, Dept Geog, Durham, England; [Turner, Elizabeth L.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Durham University; University of London; London School of Hygiene & Tropical Medicine	Mng'ong'o, FC (corresponding author), Concern Worldwide Tanzania, Dar Es Salaam, Tanzania.	sarah.moore@lshtm.ac.uk	Moore, Sarah J/HGE-7143-2022	Moore, Sarah J/0000-0002-0938-6654	Xerox Foundation; Concern Worldwide Tanzania	Xerox Foundation; Concern Worldwide Tanzania	Funding was provided by the Xerox Foundation. http://www.xerox.com/corporate-citizenship-2010/our-communities/xerox-foundation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to express our appreciations to Manu Mwaipopo, Andrew Fitzgibon and James Davey (Country Director-Concern Worldwide Tanzania) for their untiring encouragement and support.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; [Anonymous], 2003, ACIAR MONOGRAPH; [Anonymous], WHO GLOB MAL PROGR P; BAEZ JE, J DEV EC, V96, P391; Beier JC, 1996, J MED ENTOMOL, V33, P613, DOI 10.1093/jmedent/33.4.613; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Broughton S, 2000, BIOL CONTROL, V17, P272, DOI 10.1006/bcon.1999.0793; BURKOT TR, 1988, PARASITOL TODAY, V4, P156, DOI 10.1016/0169-4758(88)90151-2; Carstairs SD, 2010, PEDIATRICS, V126, pE1585, DOI 10.1542/peds.2010-1669; DEWEERDT J, EC DEV INITIATIVES; Diallo DA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P377; Dua VK, 2010, INDIAN J MED RES, V131, P434; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; FOURIE N, 1987, Journal of the South African Veterinary Association, V58, P173; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gary RE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-19; Ghisalberti EL, 2000, FITOTERAPIA, V71, P467, DOI 10.1016/S0367-326X(00)00202-1; GILLIES MT, 1954, B ENTOMOL RES, V45, P375, DOI 10.1017/S000748530002719X; Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jones AE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-162; Kaufmann C, 2004, J VECTOR ECOL, V29, P140; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Llusia J, 2010, GLOBAL ECOL BIOGEOGR, V19, P863, DOI 10.1111/j.1466-8238.2010.00557.x; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Moore SJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-344; National Bureau of Statistics and Office of the Chief Government Statistician-Zanzibar, 2005, TANZ DEM HLTH SURV 2; Ogoma SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-221; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; OKOTH JO, 1986, ACTA TROP, V43, P283; Omolo MO, 2005, PHYTOMEDICINE, V12, P241, DOI 10.1016/j.phymed.2003.10.004; Padhy PK, 2005, CHEMOSPHERE, V59, P1643, DOI 10.1016/j.chemosphere.2005.01.046; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rabarison P, 1997, Sante, V7, P39; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; Seyoum A, 2003, TROP MED INT HEALTH, V8, P1005, DOI 10.1046/j.1360-2276.2003.01125.x; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Stone CM, 2011, ANIM BEHAV, V81, P765, DOI 10.1016/j.anbehav.2011.01.008; Straif SC, 1996, J MED ENTOMOL, V33, P608, DOI 10.1093/jmedent/33.4.608; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; *USDA, 1947, E733 USDA BUR ENT PL; Van den Broeck J, 2005, PLOS MED, V2, P966, DOI 10.1371/journal.pmed.0020267; Walker TW, 1996, J AM MOSQUITO CONTR, V12, P172; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	59	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25927	10.1371/journal.pone.0025927	http://dx.doi.org/10.1371/journal.pone.0025927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022471	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000046
J	Sheena, A; Mohan, SS; Haridas, NPA; Anilkumar, G				Sheena, Aswathy; Mohan, Suma S.; Haridas, Nidhina Pachakkil A.; Anilkumar, Gopalakrishnapillai			Elucidation of the Glucose Transport Pathway in Glucose Transporter 4 via Steered Molecular Dynamics Simulations	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; EXOFACIAL LIGAND-BINDING; SUGAR-TRANSPORT; HUMAN ERYTHROCYTE; C-TERMINI; GLUT1; ACCESSIBILITY; MECHANISM; HELIX; ATP	Background: GLUT4 is a predominant insulin regulated glucose transporter expressed in major glucose disposal tissues such as adipocytes and muscles. Under the unstimulated state, GLUT4 resides within intracellular vesicles. Various stimuli such as insulin translocate this protein to the plasma membrane for glucose transport. In the absence of a crystal structure for GLUT4, very little is known about the mechanism of glucose transport by this protein. Earlier we proposed a homology model for GLUT4 and performed a conventional molecular dynamics study revealing the conformational rearrangements during glucose and ATP binding. However, this study could not explain the transport of glucose through the permeation tunnel. Methodology/Principal Findings: To elucidate the molecular mechanism of glucose transport and its energetic, a steered molecular dynamics study (SMD) was used. Glucose was pulled from the extracellular end of GLUT4 to the cytoplasm along the pathway using constant velocity pulling method. We identified several key residues within the tunnel that interact directly with either the backbone ring or the hydroxyl groups of glucose. A rotation of glucose molecule was seen near the sugar binding site facilitating the sugar recognition process at the QLS binding site. Conclusions/Significance: This study proposes a possible glucose transport pathway and aids the identification of several residues that make direct interactions with glucose during glucose transport. Mutational studies are required to further validate the observation made in this study.	[Sheena, Aswathy; Mohan, Suma S.; Haridas, Nidhina Pachakkil A.; Anilkumar, Gopalakrishnapillai] Amrita Sch Biotechnol, Amrita Vishwa Vidyapeeth, Kollam, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Sheena, A (corresponding author), Amrita Sch Biotechnol, Amrita Vishwa Vidyapeeth, Kollam, India.	g.soanil@gmail.com	Mohan S, Suma/GNW-4180-2022; gopala, Anilkumar/AAG-2713-2021	Mohan S, Suma/0000-0001-7692-163X; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X; Nidhina Haridas, Pachakkil antharaparambath/0000-0003-3096-206X	Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India [BT/PR11427/BID/07/270/2008]	Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India	This work is supported by the Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India, grant no: BT/PR11427/BID/07/270/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani H, 2002, J CELL SCI, V115, P131; Alisio A, 2004, J BIOL CHEM, V279, P26540, DOI 10.1074/jbc.M402303200; Araki S, 1996, BIOCHEM J, V315, P153, DOI 10.1042/bj3150153; BARNETT JEG, 1973, BIOCHEM J, V135, P539, DOI 10.1042/bj1350539; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doege H, 1998, BIOCHEM J, V329, P289, DOI 10.1042/bj3290289; EZAKI O, 1982, J BIOL CHEM, V257, P4306; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; Mohan S, 2009, J BIOMOL STRUCT DYN, V26, P455, DOI 10.1080/07391102.2009.10507260; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Prasad CNV, 2009, BIOCHEM BIOPH RES CO, V380, P39, DOI 10.1016/j.bbrc.2009.01.008; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Tsigelny Igor F., 2008, Journal of Bioinformatics and Computational Biology, V6, P885, DOI 10.1142/S0219720008003801; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VERHEY KJ, 1993, J CELL BIOL, V123, P137, DOI 10.1083/jcb.123.1.137; Zou HJ, 2008, J PHYS CHEM B, V112, P13070, DOI 10.1021/jp710964x	49	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25747	10.1371/journal.pone.0025747	http://dx.doi.org/10.1371/journal.pone.0025747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022441	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000035
J	Walensky, RP; Morris, BL; Reichmann, WM; Paltiel, AD; Arbelaez, C; Donnell-Fink, L; Katz, JN; Losina, E				Walensky, Rochelle P.; Morris, Bethany L.; Reichmann, William M.; Paltiel, A. David; Arbelaez, Christian; Donnell-Fink, Laurel; Katz, Jeffrey N.; Losina, Elena			Resource Utilization and Cost-Effectiveness of Counselor-vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency Department	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; UNITED-STATES; OPPORTUNISTIC INFECTIONS; PREVENTION; LOPINAVIR/RITONAVIR; RECOMMENDATIONS; EMTRICITABINE; ADOLESCENTS	Background: Routine HIV screening in emergency department (ED) settings may require dedicated personnel. We evaluated the outcomes, costs and cost-effectiveness of HIV screening when offered by either a member of the ED staff or by an HIV counselor. Methods: We employed a mathematical model to extend data obtained from a randomized clinical trial of provider-vs. counselor-based HIV screening in the ED. We compared the downstream survival, costs, and cost-effectiveness of three HIV screening modalities: 1) no screening program; 2) an ED provider-based program; and 3) an HIV counselor-based program. Trial arm-specific data were used for test offer and acceptance rates (provider offer 36%, acceptance 75%; counselor offer 80%, acceptance 71%). Undiagnosed HIV prevalence (0.4%) and linkage to care rates (80%) were assumed to be equal between the screening modalities. Personnel costs were derived from trial-based resource utilization data. We examined the generalizability of results by conducting sensitivity analyses on offer and acceptance rates, undetected HIV prevalence, and costs. Results: Estimated HIV screening costs in the provider and counselor arms averaged $8.10 and $31.00 per result received. The Provider strategy (compared to no screening) had an incremental cost-effectiveness ratio of $58,700/quality-adjusted life year (QALY) and the Counselor strategy (compared to the Provider strategy) had an incremental cost-effectiveness ratio of $64,500/QALY. Results were sensitive to the relative offer and acceptance rates by strategy and the capacity of providers to target-screen, but were robust to changes in undiagnosed HIV prevalence and programmatic costs. Conclusions: The cost-effectiveness of provider-based HIV screening in an emergency department setting compares favorably to other US screening programs. Despite its additional cost, counselor-based screening delivers just as much return on investment as provider based-screening. Investment in dedicated HIV screening personnel is justified in situations where ED staff resources may be insufficient to provide comprehensive, sustainable screening services.	[Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.; Morris, Bethany L.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Reichmann, William M.; Donnell-Fink, Laurel; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Arbelaez, Christian] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Walensky, Rochelle P.; Losina, Elena] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Med, New Haven, CT USA; [Reichmann, William M.; Losina, Elena] Boston Univ Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Boston University	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.	rwalensky@partners.org	Morris, Bethany L./GNH-4419-2022	Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Mental Health [R01 MH073445, R01 MH65869]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869, R01MH073445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health (R01 MH073445, R01 MH65869), and the Doris Duke Charitable Foundation, Clinical Scientist Development Award to RPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accessed 2011 Jul 27, 2008, MED PHYS FEE SCHED; [Anonymous], 2009, 2009 RED BOOK; Arbelaez C, 2009, J EMERG MED IN PRESS; Arbelaez C, 2009, INT J EMERG MED, V2, P187, DOI 10.1007/s12245-009-0123-x; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Association of American Medical Colleges, 2008, FAC SAL SURV REP; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; [Bureau of HIV/STD Viral Hepatitis Prevention], 2008, ROUT OPT OUT HIV SCR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Department of Health and Human Services, 2011, GUID US ANT AG HIV I; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; George C, 2009, HOUSTON CHRONICLE; Gold MR, 1996, COST EFFECTIVENESS H; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Haley N, 2002, PREV MED, V34, P632, DOI 10.1006/pmed.2002.1030; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Hewitt P, 2011, ANN EMERG MED, V57, p16A, DOI 10.1016/j.annemergmed.2011.02.007; Irwin K, 2001, AIDS Alert, V16, P113; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; LALEZARI J, 2007, 14 C RETR OPP INF FE; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Martin EG, 2010, VALUE HEALTH, V13, P893, DOI 10.1111/j.1524-4733.2010.00763.x; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MERRILL JM, 1990, SOUTHERN MED J, V83, P613, DOI 10.1097/00007611-199006000-00004; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Parish SJ, 2007, J SEX MED, V4, P259, DOI 10.1111/j.1743-6109.2007.00430.x; Pinkerton SD, 2010, AIDS PATIENT CARE ST, V24, P409, DOI 10.1089/apc.2009.0348; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Texas Department of State Health Services, 2005, TEX VIT STAT LIF TAB; University HealthSystems Consortium, 2008, CDP ONL REP; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2011, ANN EMERG MED, V58, pS126, DOI 10.1016/j.annemergmed.2011.03.023; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; *WHO, 2009, CHOOSING INT AR COST	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25575	10.1371/journal.pone.0025575	http://dx.doi.org/10.1371/journal.pone.0025575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022415	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000022
J	Antonelou, MH; Kriebardis, AG; Stamoulis, KE; Trougakos, IP; Papassideri, IS				Antonelou, Marianna H.; Kriebardis, Anastasios G.; Stamoulis, Konstantinos E.; Trougakos, Ioannis P.; Papassideri, Issidora S.			Apolipoprotein J/Clusterin in Human Erythrocytes Is Involved in the Molecular Process of Defected Material Disposal during Vesiculation	PLOS ONE			English	Article							RED-CELLS; OXIDATIVE STRESS; IN-VIVO; CLUSTERIN; PROTEIN; STORAGE; MEMBRANE; TRANSFUSION; HEMOGLOBIN; APOPTOSIS	Background: We have showed that secretory Apolipoprotein J/Clusterin (sCLU) is down-regulated in senescent, stressed or diseased red blood cells (RBCs). It was hypothesized that sCLU loss relates to RBCs vesiculation, a mechanism that removes erythrocyte membrane patches containing defective or potentially harmful components. Methodology/Principal Findings: To investigate this issue we employed a combination of biochemical and microscopical approaches in freshly prepared RBCs or RBCs stored under standard blood bank conditions, an in vitro model system of cellular aging. We found that sCLU is effectively exocytosed in vivo during membrane vesiculation of freshly prepared RBCs. In support, the RBCs' sCLU content was progressively reduced during RBCs ex vivo maturation and senescence under cold storage due to its selective exocytosis in membrane vesicles. A range of typical vesicular components, also involved in RBCs senescence, like Band 3, CD59, hemoglobin and carbonylated membrane proteins were found to physically interact with sCLU. Conclusions/Significance: The maturation of RBCs is associated with a progressive loss of sCLU. We propose that sCLU is functionally involved in the disposal of oxidized/defected material through RBCs vesiculation. This process most probably takes place through sCLU interaction with RBCs membrane proteins that are implicit vesicular components. Therefore, sCLU represents a pro-survival factor acting for the postponement of the untimely clearance of RBCs.	[Antonelou, Marianna H.; Kriebardis, Anastasios G.; Trougakos, Ioannis P.; Papassideri, Issidora S.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece; [Kriebardis, Anastasios G.] Technol & Educ Inst Athens, Fac Hlth & Caring Profess, Dept Med Labs, Athens, Greece; [Stamoulis, Konstantinos E.] Ctr Blood Transfus, Nikea, Piraeus, Greece	National & Kapodistrian University of Athens; University of West Attica	Antonelou, MH (corresponding author), Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece.	itrougakos@biol.uoa.gr; ipapasid@biol.uoa.gr	Trougakos, Ioannis/R-6149-2018; Antonelou, Marianna H/C-1267-2011	Trougakos, Ioannis/0000-0002-6179-2772; Antonelou, Marianna H/0000-0003-3787-3596; Kriebardis, Anastasios/0000-0003-3915-1829	Hellenic General Secretariat for Research and Technology [2009 - 09FR-56]; University of Athens Special Account for Research	Hellenic General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); University of Athens Special Account for Research	This work was partially supported by a "Greece-France R and T Cooperation Grant, 2009 - 09FR-56" of the Hellenic General Secretariat for Research and Technology to IPT, as well as by a "Kapodistrias" Grant of the University of Athens Special Account for Research Grants to ISP. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bosman GJCGM, 2010, J PROTEOMICS, V73, P396, DOI 10.1016/j.jprot.2009.07.010; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; D'Amici GM, 2007, J PROTEOME RES, V6, P3242, DOI 10.1021/pr070179d; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kay M, 2005, ANN NY ACAD SCI, V1057, P85, DOI 10.1196/annals.1356.005; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Kriebardis AG, 2006, BLOOD CELL MOL DIS, V36, P279, DOI 10.1016/j.bcmd.2006.01.003; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; MERI S, 1990, IMMUNOLOGY, V71, P1; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Stahl AL, 2009, MOL IMMUNOL, V46, P2236, DOI 10.1016/j.molimm.2009.04.012; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; WAGNER GM, 1987, BLOOD, V69, P1777; WHITLOW M, 1993, BLOOD, V81, P510; Willekens FLA, 2003, BLOOD, V101, P747, DOI 10.1182/blood-2002-02-0500; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; WOLFE LC, 1985, TRANSFUSION, V25, P185, DOI 10.1046/j.1537-2995.1985.25385219897.x; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26033	10.1371/journal.pone.0026033	http://dx.doi.org/10.1371/journal.pone.0026033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016805	Green Submitted, gold, Green Published			2022-12-25	WOS:000295970300051
J	Li, L; Zhao, B; Du, J; Zhang, KZ; Ling, CX; Li, SSC				Li, Lei; Zhao, Bing; Du, Jun; Zhang, Kaizhong; Ling, Charles X.; Li, Shawn Shun-Cheng			DomPep-A General Method for Predicting Modular Domain-Mediated Protein-Protein Interactions	PLOS ONE			English	Article							PHOSPHORYLATION SITES; SH2 DOMAIN; BINDING PEPTIDE; PDZ-DOMAINS; SPECIFICITY; NETWORKS; SCRIBBLE; TOOL; IDENTIFICATION; RECOGNITION	Protein-protein interactions (PPIs) are frequently mediated by the binding of a modular domain in one protein to a short, linear peptide motif in its partner. The advent of proteomic methods such as peptide and protein arrays has led to the accumulation of a wealth of interaction data for modular interaction domains. Although several computational programs have been developed to predict modular domain-mediated PPI events, they are often restricted to a given domain type. We describe DomPep, a method that can potentially be used to predict PPIs mediated by any modular domains. DomPep combines proteomic data with sequence information to achieve high accuracy and high coverage in PPI prediction. Proteomic binding data were employed to determine a simple yet novel parameter Ligand-Binding Similarity which, in turn, is used to calibrate Domain Sequence Identity and Position-Weighted-Matrix distance, two parameters that are used in constructing prediction models. Moreover, DomPep can be used to predict PPIs for both domains with experimental binding data and those without. Using the PDZ and SH2 domain families as test cases, we show that DomPep can predict PPIs with accuracies superior to existing methods. To evaluate DomPep as a discovery tool, we deployed DomPep to identify interactions mediated by three human PDZ domains. Subsequent in-solution binding assays validated the high accuracy of DomPep in predicting authentic PPIs at the proteome scale. Because DomPep makes use of only interaction data and the primary sequence of a domain, it can be readily expanded to include other types of modular domains.	[Li, Lei; Zhao, Bing; Li, Shawn Shun-Cheng] Univ Western Ontario, Dept Biochem, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON, Canada; [Du, Jun; Zhang, Kaizhong; Ling, Charles X.] Univ Western Ontario, Dept Comp Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Li, L (corresponding author), Univ Western Ontario, Dept Biochem, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON, Canada.	sli@uwo.ca	Li, Lei/A-8647-2012; Li, Shawn/A-9007-2012		Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute	Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This work was supported by grants (to SSCL) from the Canadian Cancer Society and Genome Canada through the Ontario Genomics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Brannetti B, 2000, J MOL BIOL, V298, P313, DOI 10.1006/jmbi.2000.3670; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Joachims T., 1999, ADV KERNEL METHODS S; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; KANEKO T, 2011, TRENDS BIOCH SCI; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li TT, 2008, PROTEINS, V70, P404, DOI 10.1002/prot.21563; LINDING R, 2007, NUCL ACIDS RES; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Metais JY, 2005, FEBS LETT, V579, P3725, DOI 10.1016/j.febslet.2005.05.062; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Petit MM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-1; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takizawa S, 2006, GENES CELLS, V11, P453, DOI 10.1111/j.1365-2443.2006.00954.x; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YAFFE MB, 2006, SCI STKE, pPE28; Zhang L, 2006, MOL CELL PROTEOMICS, V5, P1224, DOI 10.1074/mcp.M500346-MCP200; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25528	10.1371/journal.pone.0025528	http://dx.doi.org/10.1371/journal.pone.0025528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003397	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300018
J	Li, WB; Zeng, TY				Li, Wenbing; Zeng, Tingying			Preparation of TiO2 Anatase Nanocrystals by TiCl4 Hydrolysis with Additive H2SO4	PLOS ONE			English	Article							SINGLET OXYGEN PRODUCTION; PHOTOCATALYTIC ACTIVITY; HYDROTHERMAL SYNTHESIS; SIZE QUANTIZATION; AMORPHOUS TITANIA; AQUEOUS-SOLUTION; RUTILE TIO2; NANOPARTICLES; HYDROPHILICITY; SEMICONDUCTOR	A new methodology was developed to synthesize uniform titania anatase nanocrystals by the hydrolysis of titanium chloride in sulfuric acid aqueous solutions at 0-90 degrees C. The samples were characterized by Raman spectroscopy, UV-visible spectroscopy, transmission electron microscopy (TEM), electron diffraction (ED), and an Energy dispersive X-ray spectroscopy (EDS). The effects of the reaction temperature, mole ratio of SO42- to Ti4+, and the calcinations temperature on the particle size and crystal phase were investigated. Depending on the acidity, the hydrolysis temperature, and the calcination temperature, rhombic anatase nanocrystals sizes in the range of 10 nm to 50 nm were obtained. In the additive of sulfuric acid, Raman spectra and electron diffraction confirmed that the nanoparticles are composed of anatase TiO2. No other titania phases, such as rutile or brookite, were detected.	[Li, Wenbing] Jackson State Univ, Dept Biol & Chem, Jackson, MS 39217 USA; [Zeng, Tingying] MIT, Ctr Exciton, Cambridge, MA 02139 USA	Jackson State University; Massachusetts Institute of Technology (MIT)	Li, WB (corresponding author), Jackson State Univ, Dept Biol & Chem, Jackson, MS 39217 USA.	wenbinglee@gmail.com			U.S. National Science Foundation [0520789]	U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation under contract #0520789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANPO M, 1987, J PHYS CHEM-US, V91, P4305, DOI 10.1021/j100300a021; Bessekhouad Y, 2004, J PHOTOCH PHOTOBIO A, V167, P49, DOI 10.1016/j.jphotochem.2003.12.001; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Ding WP, 2002, J CATAL, V206, P14, DOI 10.1006/jcat.2001.3457; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Henderson MA, 2003, J AM CHEM SOC, V125, P14974, DOI 10.1021/ja037764+; Hu SW, 2003, J CATAL, V220, P240, DOI 10.1016/S0021-9517(03)00294-X; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Innocenzi P, 2000, CHEM MATER, V12, P3726, DOI 10.1021/cm001139b; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Li WB, 2010, J PHYS CHEM C, V114, P7263, DOI 10.1021/jp908160m; Li WB, 2009, ACS APPL MATER INTER, V1, P1778, DOI 10.1021/am9003039; Li WB, 2009, CHEMPHYSCHEM, V10, P1789, DOI 10.1002/cphc.200900155; Li YZ, 2004, LANGMUIR, V20, P10838, DOI 10.1021/la0489716; Li YZ, 2002, J MATER CHEM, V12, P1387, DOI 10.1039/b200018k; Mandelbaum PA, 1999, J PHYS CHEM B, V103, P5505, DOI 10.1021/jp984812h; Moritz T, 1997, J PHYS CHEM B, V101, P8052, DOI 10.1021/jp9705131; Nagaveni K, 2004, APPL CATAL B-ENVIRON, V48, P83, DOI 10.1016/j.apcatb.2003.09.013; OLLIS D F, 1991, Environmental Science and Technology, V25, P1523; Parala H, 2002, J MATER CHEM, V12, P1625, DOI 10.1039/b202767d; Park HK, 1997, J AM CERAM SOC, V80, P743, DOI 10.1111/j.1151-2916.1997.tb02891.x; Park NG, 2000, J PHYS CHEM B, V104, P8989, DOI 10.1021/jp994365l; Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m; Roy S, 2000, MATER RES BULL, V35, P1195, DOI 10.1016/S0025-5408(00)00314-7; Seifert G, 2002, J PHYS CHEM B, V106, P2497, DOI 10.1021/jp0131323; Seo DS, 2001, J CRYST GROWTH, V229, P428, DOI 10.1016/S0022-0248(01)01196-4; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; Stathatos E, 1997, LANGMUIR, V13, P4295, DOI 10.1021/la9701642; Sun J, 2003, J AM CERAM SOC, V86, P1677, DOI 10.1111/j.1151-2916.2003.tb03539.x; Takeuchi M, 2003, J PHYS CHEM B, V107, P14278, DOI 10.1021/jp0308514; TOMPSETT GA, 1995, J RAMAN SPECTROSC, V26, P57, DOI 10.1002/jrs.1250260110; Vorontsov AV, 2001, J PHOTOCH PHOTOBIO A, V144, P193, DOI 10.1016/S1010-6030(01)00462-2; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; White JM, 2003, J PHYS CHEM B, V107, P9029, DOI 10.1021/jp0345046; Wu MM, 2002, CHEM MATER, V14, P1974, DOI 10.1021/cm0102739; Yanagisawa K, 1999, J PHYS CHEM B, V103, P7781, DOI 10.1021/jp990521c; Yin HB, 2001, J MATER CHEM, V11, P1694, DOI 10.1039/b008974p; Zeng TY, 1998, MATER CHEM PHYS, V56, P163, DOI 10.1016/S0254-0584(98)00170-9; Zhang HZ, 2001, NANO LETT, V1, P81, DOI 10.1021/nl0055198; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Zhang QH, 1999, NANOSTRUCT MATER, V11, P1293, DOI 10.1016/S0965-9773(99)00421-3; Zhang YH, 2001, CATAL TODAY, V68, P89, DOI 10.1016/S0920-5861(01)00295-4	42	25	26	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21082	10.1371/journal.pone.0021082	http://dx.doi.org/10.1371/journal.pone.0021082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	22022494	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000050
J	Helwig, M; Lee, SN; Hwang, JR; Ozawa, A; Medrano, JF; Lindberg, I				Helwig, Michael; Lee, Sang-Nam; Hwang, Jae Ryoung; Ozawa, Akihiko; Medrano, Juan F.; Lindberg, Iris			Dynamic Modulation of Prohormone Convertase 2 (PC2)-mediated Precursor Processing by 7B2 Protein PREFERENTIAL EFFECT ON GLUCAGON SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROOPIOMELANOCORTIN-DERIVED PEPTIDES; NULL MICE; NEUROENDOCRINE CELLS; ENZYMATIC-ACTIVITY; CT PEPTIDE; IN-VIVO; PC2; EXPRESSION; OVEREXPRESSION; BIOSYNTHESIS	The small neuroendocrine protein 7B2 is required for the production of active prohormone convertase 2 (PC2), an enzyme involved in the synthesis of peptide hormones, such as glucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone. However, whether 7B2 can dynamically modulate peptide production through regulation of PC2 activity remains unclear. Infection of the pancreatic alpha cell line alpha-TC6 with 7B2-encoding adenovirus efficiently increased production of glucagon, whereas siRNA-mediated knockdown of 7B2 significantly decreased stored glucagon. Furthermore, rescue of 7B2 expression in primary pituitary cultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiating the role of 7B2 as a regulatory factor in peptide biosynthesis. In anterior pituitary and pancreatic beta cell lines, however, overexpression of 7B2 affected neither production nor secretion of peptides despite increased release of active PC2. In direct contrast, 7B2 overexpression decreased the secretion and increased the activity of PC2 within alpha-TC6 cells; the increased intracellular concentration of active PC2 within these cells may therefore account for the enhanced production of glucagon. In line with these findings, we found elevated circulating glucagon levels in 7B2-overexpressing cast/cast mice in vivo. Surprisingly, when proopiomelanocortin and proglucagon were co-expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was preferentially decreased when 7B2 was knocked down. Taken together, these results suggest that proglucagon cleavage has a greater dependence on PC2 activity than other precursors and moreover that 7B2-dependent routing of PC2 to secretory granules is cell line-specific. The manipulation of 7B2 could therefore represent an effective way to selectively regulate synthesis of certain PC2-dependent peptides.	[Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Lee, Sang-Nam] Yonsei Univ, Res Ctr Nat Human Def Syst, Coll Med, Seoul 120752, South Korea; [Hwang, Jae Ryoung] Sungkyunkwan Univ, Mol Therapy Res Ctr, Seoul 135710, South Korea; [Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University System of Maryland; University of Maryland Baltimore; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); University of California System; University of California Davis	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Bldg HSF 2,Rm S251,20 Penn St, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Ozawa, Akihiko/U-4426-2019		National Institutes of Health [DK49703]; German Academy of Sciences Leopoldina Foundation [LPDS 2009-33]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academy of Sciences Leopoldina Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK49703 (to I. L.).; Supported by German Academy of Sciences Leopoldina Foundation Grant LPDS 2009-33.	Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; Bouatia-Naji N, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-44; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Dion LD, 1996, J VIROL METHODS, V56, P99, DOI 10.1016/0166-0934(95)01973-1; Farber CR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-34; Fortenberry Y, 1999, J NEUROCHEM, V73, P994, DOI 10.1046/j.1471-4159.1999.0730994.x; GUEST PC, 1992, J BIOL CHEM, V267, P22401; HSI KL, 1982, FEBS LETT, V147, P261, DOI 10.1016/0014-5793(82)81055-7; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Johanning K, 1996, J NEUROCHEM, V66, P898; Lanoue E, 2001, ENDOCRINOLOGY, V142, P4141, DOI 10.1210/en.142.9.4141; Laurent V, 2004, ENDOCRINOLOGY, V145, P519, DOI 10.1210/en.2003-0829; Laurent V, 2002, P NATL ACAD SCI USA, V99, P3087, DOI 10.1073/pnas.261715099; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lee SN, 2007, BIOCHEM BIOPH RES CO, V355, P825, DOI 10.1016/j.bbrc.2007.02.034; MAINS RE, 2000, HDB PHYSL 7, V4, P85; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Paquet L, 1996, MOL CELL ENDOCRINOL, V120, P161, DOI 10.1016/0303-7207(96)03834-8; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2314, DOI 10.1210/en.143.6.2314; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2324, DOI 10.1210/en.143.6.2324; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; Schmidt G, 2006, DIABETES, V55, P452, DOI 10.2337/diabetes.55.02.06.db05-0733; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P171; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; SHEN FS, 1993, J BIOL CHEM, V268, P24910; Wang J, 2001, DIABETES, V50, P534, DOI 10.2337/diabetes.50.3.534; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	37	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42504	42513		10.1074/jbc.M111.281980	http://dx.doi.org/10.1074/jbc.M111.281980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013069	Green Published, hybrid			2022-12-25	WOS:000298180900058
J	Jiang, XY; Sun, CF; Zhang, QG; Zou, SM				Jiang, Xia-Yun; Sun, Cheng-Fei; Zhang, Quan-Gen; Zou, Shu-Ming			ENU-Induced Mutagenesis in Grass Carp (Ctenopharyngodon idellus) by Treating Mature Sperm	PLOS ONE			English	Article							LYMPHOCYSTIS DISEASE; GENETIC SCREEN; ZEBRAFISH; MUTATIONS; IDENTIFICATION; CONSERVATION; DIVERGENCE; RESISTANCE; SYSTEM; FISH	N-ethyl-N-nitrosourea (ENU) mutagenesis is a useful approach for genetic improvement of plants, as well as for inducing functional mutants in animal models including mice and zebrafish. In the present study, mature sperm of grass carp (Ctenopharyngodon idellus) were treated with a range of ENU concentrations for 45 min, and then wild-type eggs were fertilized. The results indicated that the proportion of embryos with morphological abnormalities at segmentation stage or dead fry at hatching stage increased with increasing ENU dose up to 10 mM. Choosing a dose that was mutagenic, but provided adequate numbers of viable fry, an F1 population was generated from 1 mM ENU-treated sperm for screening purposes. The ENU-treated F1 population showed large variations in growth during the first year. A few bigger mutants with morphologically normal were generated, as compared to the controls. Analysis of DNA from 15 F1 ENU-treated individuals for mutations in partial coding regions of igf-2a, igf-2b, mstn-1, mstn-2, fst-1 and fst-2 loci revealed that most ENU-treated point mutations were GC to AT or AT to GC substitution, which led to nonsense, nonsynonymous and synonymous mutations. The average mutation rate at the examined loci was 0.41%. These results indicate that ENU treatment of mature sperm can efficiently induce point mutations in grass carp, which is a potentially useful approach for genetic improvement of these fish.	[Jiang, Xia-Yun; Sun, Cheng-Fei; Zhang, Quan-Gen; Zou, Shu-Ming] Shanghai Ocean Univ, Key Lab Aquat Genet Resources & Utilizat, Shanghai, Peoples R China	Shanghai Ocean University	Jiang, XY (corresponding author), Shanghai Ocean Univ, Key Lab Aquat Genet Resources & Utilizat, Shanghai, Peoples R China.	smzou@shou.edu.cn			Ministry of Agriculture of China [200903045]; China 863 project [2011AA100403, 2009AA10Z105]; Shanghai Educational Committee [08SG50]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); China 863 project(National High Technology Research and Development Program of China); Shanghai Educational Committee	This research was supported by grants from the Special Funding from the Ministry of Agriculture of China (200903045) to Zou, by China 863 project (2011AA100403,2009AA10Z105) to Zou, and by the Shu-Guang Project of Shanghai Educational Committee (08SG50) to Zou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; BONEY SE, 1984, T AM FISH SOC, V113, P348, DOI 10.1577/1548-8659(1984)113&lt;348:SRABOG&gt;2.0.CO;2; Driever W, 1996, DEVELOPMENT, V123, P37; *FEMA, 2008, CHIN FISH YB, P8; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Goda T, 2006, PLOS GENET, V2, P811, DOI 10.1371/journal.pgen.0020091; [韩启霞 Han Qixia], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P895; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Imai Y, 2000, GENETICS, V155, P261; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Jin P, 2004, CHINESE SCI BULL, V49, P2154, DOI 10.1360/982004-188; Khoo SK, 2004, FISH PATHOL, V39, P95, DOI 10.3147/jsfp.39.95; KIRPICHNIKOV VS, 1981, GENETIC BASES FISH S, P302; Knapik EW, 2000, MAMM GENOME, V11, P511, DOI 10.1007/s003350010098; Li M, 2001, CHINESE SCI BULL, V46, P1523, DOI 10.1007/BF02900572; Liu F, 2009, AQUACULTURE, V297, P51, DOI 10.1016/j.aquaculture.2009.09.008; Liu S., 1988, Journal of Fisheries of China, V12, P81; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; LOU Y, 1999, FISH BREEDING, P136; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozaki A, 2010, AQUACULTURE, V308, pS62, DOI 10.1016/j.aquaculture.2010.07.039; RILEY BB, 1995, P NATL ACAD SCI USA, V92, P5997, DOI 10.1073/pnas.92.13.5997; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHIBUYA T, 1993, MUTAT RES, V297, P3, DOI 10.1016/0165-1110(93)90005-8; SHIMA A, 1991, P NATL ACAD SCI USA, V88, P2545, DOI 10.1073/pnas.88.6.2545; van Eeden FJM, 1999, METHOD CELL BIOL, V60, P21; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Xu Zu-yuan, 2002, Yichuan, V24, P548; YU X, 2011, MOD FISH INFORM, V26, P29; Yuan XN, 2011, GENE, V470, P46, DOI 10.1016/j.gene.2010.10.003; Zhang H, 2011, MAR BIOTECHNOL, V13, P1017, DOI 10.1007/s10126-011-9365-8; Zhao JL, 2011, ENVIRON BIOL FISH, V90, P85, DOI 10.1007/s10641-010-9720-z; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	37	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26475	10.1371/journal.pone.0026475	http://dx.doi.org/10.1371/journal.pone.0026475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022617	Green Published, gold			2022-12-25	WOS:000295984400061
J	Francis, R; Xu, X; Park, H; Wei, CJ; Chang, S; Chatterjee, B; Lo, C				Francis, Richard; Xu, Xin; Park, Hyunsoo; Wei, Chin-Jen; Chang, Stephen; Chatterjee, Bishwanath; Lo, Cecilia			Connexin43 Modulates Cell Polarity and Directional Cell Migration by Regulating Microtubule Dynamics	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; NEURAL CREST CELLS; N-CADHERIN; FIBROBLAST MIGRATION; NEURONAL MIGRATION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TGF-BETA; MICE; EXPRESSION	Knockout mice deficient in the gap junction gene connexin43 exhibit developmental anomalies associated with abnormal neural crest, primordial germ cell, and proepicardial cell migration. These migration defects are due to a loss of directional cell movement, and are associated with abnormal actin stress fiber organization and a loss of polarized cell morphology. To elucidate the mechanism by which Cx43 regulates cell polarity, we used a wound closure assays with mouse embryonic fibroblasts (MEFs) to examine polarized cell morphology and directional cell movement. Studies using embryonic fibroblasts from Cx43 knockout (Cx43KO) mice showed Cx43 deficiency caused cell polarity defects as characterized by a failure of the Golgi apparatus and the microtubule organizing center to reorient with the direction of wound closure. Actin stress fibers at the wound edge also failed to appropriately align, and stabilized microtubule (Glu-tubulin) levels were markedly reduced. Forced expression of Cx43 with deletion of its tubulin-binding domain (Cx43dT) in both wildtype MEFs and neural crest cell explants recapitulated the cell migration defects seen in Cx43KO cells. However, forced expression of Cx43 with point mutation causing gap junction channel closure had no effect on cell motility. TIRF imaging revealed increased microtubule instability in Cx43KO cells, and microtubule targeting of membrane localized Cx43 was reduced with expression of Cx43dT construct in wildtype cells. Together, these findings suggest the essential role of Cx43 gap junctions in development is mediated by regulation of the tubulin cytoskeleton and cell polarity by Cx43 via a nonchannel function.	[Francis, Richard; Lo, Cecilia] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Xu, Xin; Park, Hyunsoo; Wei, Chin-Jen; Chang, Stephen; Chatterjee, Bishwanath] NHLBI, Genet & Dev Biol Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Francis, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA.	cel36@pitt.edu	Francis, Richard/P-2524-2015	Francis, Richard/0000-0002-4401-1946; Chang, Stephen/0000-0001-7385-075X	NHLBI [ZO1-HL005701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005701] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI grant ZO1-HL005701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Chaldoupi SM, 2009, CARDIOVASC RES, V84, P15, DOI 10.1093/cvr/cvp203; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Clauss SB, 2006, DEV DYNAM, V235, P2786, DOI 10.1002/dvdy.20887; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Ewart JL, 1997, DEVELOPMENT, V124, P1281; Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giessmann D, 2005, ANAT EMBRYOL, V209, P391, DOI 10.1007/s00429-005-0456-z; Gomes ER, 2006, METHOD ENZYMOL, V406, P579, DOI 10.1016/S0076-6879(06)06045-9; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Guo YH, 2003, AM J PHYSIOL-LUNG C, V285, pL1213, DOI 10.1152/ajplung.00066.2003; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li WEI, 2002, DEVELOPMENT, V129, P2031; LI Z, 2008, CLIN EXP METASTASIS; Liu YY, 2007, ACTA BIOCH BIOPH SIN, V39, P391, DOI 10.1111/j.1745-7270.2007.00296.x; Lo CW, 1997, DEV GENET, V20, P119, DOI 10.1002/(SICI)1520-6408(1997)20:2<119::AID-DVG5>3.0.CO;2-A; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Majoul I, 2007, HISTOCHEM CELL BIOL, V127, P355, DOI 10.1007/s00418-007-0273-y; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Olk S, 2010, GLIA, V58, P494, DOI 10.1002/glia.20942; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; Squecco R, 2006, MOL BIOL CELL, V17, P4896, DOI 10.1091/mbc.E06-03-0243; Sullivan R, 1998, DEV BIOL, V204, P224, DOI 10.1006/dbio.1998.9089; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Walker DL, 2005, DEV BIOL, V284, P479, DOI 10.1016/j.ydbio.2005.06.004; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Xu X, 2001, CELL COMMUN ADHES, V8, P321, DOI 10.3109/15419060109080746; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039	61	75	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26379	10.1371/journal.pone.0026379	http://dx.doi.org/10.1371/journal.pone.0026379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022608	Green Accepted, Green Published, gold			2022-12-25	WOS:000295981600056
J	Sullivan, R; Kinra, S; Ekelund, U; Bharathi, AV; Vaz, M; Kurpad, A; Collier, T; Reddy, KS; Prabhakaran, D; Ben-Shlomo, Y; Smith, GD; Ebrahim, S; Kuper, H				Sullivan, Ruth; Kinra, Sanjay; Ekelund, Ulf; Bharathi, A., V; Vaz, Mario; Kurpad, Anura; Collier, Tim; Reddy, Kolli Srinath; Prabhakaran, Dorairaj; Ben-Shlomo, Yoav; Smith, George Davey; Ebrahim, Shah; Kuper, Hannah			Socio-Demographic Patterning of Physical Activity across Migrant Groups in India: Results from the Indian Migration Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENERGY COSTS; RISK-FACTORS; URBAN; QUESTIONNAIRE; OBESITY; SEDENTARY; EPIDEMIC; EXERCISE	Objective: To investigate the relationship between rural to urban migration and physical activity (PA) in India. Methods: 6,447 (42% women) participants comprising 2077 rural, 2,094 migrants and 2,276 urban were recruited. Total activity (MET hr/day), activity intensity (min/day), PA Level (PAL) television viewing and sleeping (min/day) were estimated and associations with migrant status examined, adjusting for the sib-pair design, age, site, occupation, education, and socioeconomic position (SEP). Results: Total activity was highest in rural men whereas migrant and urban men had broadly similar activity levels (p < 0.001). Women showed similar patterns, but slightly lower levels of total activity. Sedentary behaviour and television viewing were lower in rural residents and similar in migrant and urban groups. Sleep duration was highest in the rural group and lowest in urban non-migrants. Migrant men had considerably lower odds of being in the highest quartile of total activity than rural men, a finding that persisted after adjustment for age, SEP and education (OR 0.53, 95% CI 0.37, 0.74). For women, odds ratios attenuated and associations were removed after adjusting for age, SEP and education. Conclusion: Our findings suggest that migrants have already acquired PA levels that closely resemble long-term urban residents. Effective public health interventions to increase PA are needed.	[Sullivan, Ruth; Kinra, Sanjay; Ebrahim, Shah; Kuper, Hannah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Ekelund, Ulf] MRC, Epidemiol Unit, Cambridge, England; [Bharathi, A., V] Indira Gandhi Natl Open Univ, Bangalore, Karnataka, India; [Vaz, Mario; Kurpad, Anura] St Johns Res Inst, Bangalore, Karnataka, India; [Collier, Tim] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Ben-Shlomo, Yoav; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, Med Res Council Ctr Causal Anal Translat Epidemio, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; St. John's National Academy of Health Sciences; St. John's Research Institute; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol; University of Bristol	Sullivan, R (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England.	ruth.sullivan@lshtm.ac.uk	Ekelund, Ulf/AAE-8471-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013; Prabhakaran, Dorairaj/B-4147-2011	Ekelund, Ulf/0000-0003-2115-9267; Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Prabhakaran, Dorairaj/0000-0002-3172-834X; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Reddy, K Srinath/0000-0003-3416-3548	Wellcome Trust [GR070797MF]; Economic and Social Research Council; MRC [MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Indian Migration Study was funded by the Wellcome Trust (grant no. GR070797MF). RS is funded by a 3-year PhD studentship from the Economic and Social Research Council. The funders had no role in study design, in data collection, analysis, or interpretation, in writing the report, or in the decision to submit the article for publication. The researchers are independent from the funding source.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; [Anonymous], 1985, WHO TECH REP SER, P1; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Bansal D., 2010, PUBLIC HEALTH NUTR, P1; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauman A, 2005, REV BEST PRACTICE IN; Bharathi AV, 2010, PUBLIC HEALTH NUTR, V13, P47, DOI 10.1017/S1368980009005850; Bharathi AV, 2000, INDIAN J MED RES, V111, P95; Bharathi AV, 2009, ASSESSMENT PHYS ACTI; Creber RMM, 2010, REV PANAM SALUD PUBL, V28, P1, DOI 10.1590/S1020-49892010000700001; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; FAO/WHO/UNU, 2005, JOINT FAO WHO UNU EX, P35; Gautam Yogesh, 2009, Indian J Community Med, V34, P346, DOI 10.4103/0970-0218.58397; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; James W. P. T., 1990, HUMAN ENERGY REQUIRE; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Kinra S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4974; Kuriyan R, 2006, BRIT J NUTR, V96, P71, DOI 10.1079/BJN20061672; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Margetts B, 2004, PUBLIC HEALTH NUTR, V7, P361, DOI 10.1079/PHN2004622; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Pucher J, 2005, TRANSP POLICY, V12, P185, DOI 10.1016/j.tranpol.2005.02.008; Rao S, 2008, PUBLIC HEALTH NUTR, V11, P142, DOI 10.1017/S1368980007000055; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; SACN Energy Requirements Working Group, 2010, SACN EN REQ IN PRESS; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shetty P, 2005, PUBLIC HEALTH NUTR, V8, P994, DOI 10.1079/PHN2005792; SHETTY PS, 1994, EUR J CLIN NUTR, V48, pS28; Soares MJ, 1998, BRIT J NUTR, V79, P333, DOI 10.1079/BJN19980057; Sobngwi E, 2001, INT J EPIDEMIOL, V30, P1361, DOI 10.1093/ije/30.6.1361; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Vaz M, 2004, J Assoc Physicians India, V52, P541; Vaz M, 2005, PUBLIC HEALTH NUTR, V8, P1153, DOI 10.1079/PHN2005802; Vaz M, 2004, OCCUP MED-OXFORD, V54, P369, DOI 10.1093/occmed/kqg100; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292; WHO, 2003, WHO TECHN REP SER, V916, P54; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Yajnik CS, 2004, P NUTR SOC, V63, P387, DOI 10.1079/PNS2004365; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205	49	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24898	10.1371/journal.pone.0024898	http://dx.doi.org/10.1371/journal.pone.0024898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022366	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295981600004
J	Idema, S; Caretti, V; Lamfers, MLM; van Beusechem, VW; Noske, DP; Vandertop, WP; Dirven, CMF				Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; van Beusechem, Victor W.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.			Anatomical Differences Determine Distribution of Adenovirus after Convection-Enhanced Delivery to the Rat Brain	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; CENTRAL-NERVOUS-SYSTEM; VIRUS-SIZED PARTICLES; IN-VIVO; MALIGNANT GLIOMAS; CANINE BRAIN; PHASE-I; EXTRACELLULAR-SPACE; INFUSION; VECTORS	Background: Convection-enhanced delivery (CED) of adenoviruses offers the potential of widespread virus distribution in the brain. In CED, the volume of distribution (Vd) should be related to the volume of infusion (Vi) and not to dose, but when using adenoviruses contrasting results have been reported. As the characteristics of the infused tissue can affect convective delivery, this study was performed to determine the effects of the gray and white matter on CED of adenoviruses and similar sized super paramagnetic iron oxide nanoparticles (SPIO). Methodology/Principal Findings: We convected AdGFP, an adenovirus vector expressing Green Fluorescent Protein, a virus sized SPIO or trypan blue in the gray and white matter of the striatum and external capsule of Wistar rats and towards orthotopic infiltrative brain tumors. The resulting Vds were compared to Vi and transgene expression to SPIO distribution. Results show that in the striatum Vd is not determined by the Vi but by the infused virus dose, suggesting diffusion, active transport or receptor saturation rather than convection. Distribution of virus and SPIO in the white matter is partly volume dependent, which is probably caused by preferential fluid pathways from the external capsule to the surrounding gray matter, as demonstrated by co-infusing trypan blue. Distant tumors were reached using the white matter tracts but tumor penetration was limited. Conclusions/Significance: CED of adenoviruses in the rat brain and towards infiltrative tumors is feasible when regional anatomical differences are taken into account while SPIO infusion could be considered to validate proper catheter positioning and predict adenoviral distribution.	[Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.] Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.] Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Canc Ctr Amsterdam, Amsterdam, Netherlands; [van Beusechem, Victor W.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Sect Oncogen, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Idema, S (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands.	s.idema@vumc.nl	Vandertop, William P./K-9288-2018; Lamfers, Martine/C-6246-2016	Vandertop, William/0000-0001-5417-0265; Noske, David/0000-0001-5992-4468; Lamfers, Martine/0000-0001-7745-9029	Dutch Cancer Society [VU2002-2594]; Hersenstichting Nederland [10F02.27]; Semmy foundation; Egbers foundation	Dutch Cancer Society(KWF Kankerbestrijding); Hersenstichting Nederland; Semmy foundation; Egbers foundation	This work was supported by the Dutch Cancer Society, grant VU2002-2594, the Hersenstichting Nederland, grant 10F02.27 and by the Semmy and Egbers foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; Betz AL, 1998, EXP NEUROL, V150, P136, DOI 10.1006/exnr.1997.6755; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Candolfi M, 2007, NEURO-ONCOLOGY, V9, P245, DOI 10.1215/15228517-2007-012; Candolfi M, 2007, NEUROSURGERY, V60, P167, DOI 10.1227/01.NEU.0000249210.89096.6C; Chen MY, 2005, J NEUROSURG, V103, P311, DOI 10.3171/jns.2005.103.2.0311; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grill J, 2002, MOL THER, V6, P609, DOI 10.1006/mthe.2002.0713; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Horellou P, 1997, EXP NEUROL, V144, P131, DOI 10.1006/exnr.1996.6399; Hosokawa M, 2002, J VIROL METHODS, V103, P191, DOI 10.1016/S0166-0934(02)00028-9; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; KARTHIKEYAN L, 1994, J CELL SCI, V107, P3213; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Krauze MT, 2005, EXP NEUROL, V196, P104, DOI 10.1016/j.expneurol.2005.07.009; Kroll RA, 1996, NEUROSURGERY, V38, P746, DOI 10.1227/00006123-199604000-00024; Kunwar Sandeep, 2006, Neurosurg Focus, V20, pE15; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Kuroiwa T, 1999, J NEUROSURG, V90, P499, DOI 10.3171/jns.1999.90.3.0499; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; LIEBERMAN DM, 1995, J NEUROSURG, V82, P1021, DOI 10.3171/jns.1995.82.6.1021; Lonser RR, 1999, J NEUROSURG, V91, P294, DOI 10.3171/jns.1999.91.2.0294; Lonser RR, 1998, J NEUROSURG, V89, P616, DOI 10.3171/jns.1998.89.4.0616; Lopez KA, 2006, NEUROL RES, V28, P542, DOI 10.1179/016164106X116836; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Oh S, 2007, J NEUROSURG, V107, P568, DOI 10.3171/JNS-07/09/0568; Oh S, 2007, J NEUROSURG, V107, P136, DOI 10.3171/JNS-07/07/0136; Parsa AT, 2000, NEUROSURGERY, V47, P993, DOI 10.1097/00006123-200010000-00050; Puumalainen AM, 1998, HUM GENE THER, V9, P1769, DOI 10.1089/hum.1998.9.12-1769; Sampson JH, 2003, J NEURO-ONCOL, V65, P27, DOI 10.1023/A:1026290315809; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, NEUROSURGERY, V60, P89, DOI 10.1227/01.NEU.0000249256.09289.5F; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; van Beusechem VW, 2000, GENE THER, V7, P1940, DOI 10.1038/sj.gt.3301323; van Beusechem VW, 2002, CANCER RES, V62, P6165; Vargova L, 2003, GLIA, V42, P77, DOI 10.1002/glia.10204; Vavra M, 2004, NEURO-ONCOLOGY, V6, P104, DOI 10.1215/S1152851703000449; WHITTLE IR, 1990, ACTA NEUROCHIR, V105, P158, DOI 10.1007/BF01670001; Zamecnik J, 2005, Cesk Patol, V41, P12; ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233, DOI 10.1007/BF00296784	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24396	10.1371/journal.pone.0024396	http://dx.doi.org/10.1371/journal.pone.0024396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022354	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600002
J	Bruintjes, R; Bonfils, D; Heg, D; Taborsky, M				Bruintjes, Rick; Bonfils, Danielle; Heg, Dik; Taborsky, Michael			Paternity of Subordinates Raises Cooperative Effort in Cichlids	PLOS ONE			English	Article							BROODCARE HELPERS; HELPING-BEHAVIOR; MULTIPLE PATERNITY; UNRELATED HELPERS; COMPUTER-PROGRAM; LAKE TANGANYIKA; BREEDING GROUPS; GROUP-SIZE; RELATEDNESS; EVOLUTION	Background: In cooperative breeders, subordinates generally help a dominant breeding pair to raise offspring. Parentage studies have shown that in several species subordinates can participate in reproduction. This suggests an important role of direct fitness benefits for cooperation, particularly where groups contain unrelated subordinates. In this situation parentage should influence levels of cooperation. Here we combine parentage analyses and detailed behavioural observations in the field to study whether in the highly social cichlid Neolamprologus pulcher subordinates participate in reproduction and if so, whether and how this affects their cooperative care, controlling for the effect of kinship. Methodology/Principal Findings: We show that: (i) male subordinates gained paternity in 27.8% of all clutches and (ii) if they participated in reproduction, they sired on average 11.8% of young. Subordinate males sharing in reproduction showed more defence against experimentally presented egg predators compared to subordinates not participating in reproduction, and they tended to stay closer to the breeding shelter. No effects of relatedness between subordinates and dominants (to mid-parent, dominant female or dominant male) were detected on parentage and on helping behaviour. Conclusions/Significance: This is the first evidence in a cooperatively breeding fish species that the helping effort of male subordinates may depend on obtained paternity, which stresses the need to consider direct fitness benefits in evolutionary studies of helping behaviour.	[Bruintjes, Rick; Bonfils, Danielle; Heg, Dik; Taborsky, Michael] Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland; [Bruintjes, Rick] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Heg, Dik] Univ Bern, ISPM, Bern, Switzerland	University of Bern; University of Bristol; University of Bern	Bruintjes, R (corresponding author), Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland.	rbruintjes@yahoo.com	Taborsky, Michael/F-8420-2013	Taborsky, Michael/0000-0002-1357-4316; Heg, Dik/0000-0002-8766-7945	Swiss National Science Foundation (SNSF) [30100A0-105626, 31003A_118464, 31003A_122511]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by the Swiss National Science Foundation (SNSF grants 30100A0-105626, 31003A_118464 and 31003A_122511 to Dr. Taborsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; AWATA S, 2006, BEHAV ECOLOGY, P1; Balshine S, 2001, BEHAV ECOL SOCIOBIOL, V50, P134, DOI 10.1007/s002650100343; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Bruintjes R, 2008, ANIM BEHAV, V75, P1843, DOI 10.1016/j.anbehav.2007.12.004; Bruintjes R, 2011, ANIM BEHAV, V81, P387, DOI 10.1016/j.anbehav.2010.10.004; Bruintjes R, 2010, FUNCT ECOL, V24, P1054, DOI 10.1111/j.1365-2435.2010.01715.x; Canestrari D, 2005, BEHAV ECOL SOCIOBIOL, V57, P422, DOI 10.1007/s00265-004-0879-1; Cant MA, 2003, J ZOOL, V259, P115, DOI 10.1017/S0952836902003011; Cochran GR, 2000, J MAMMAL, V81, P746, DOI 10.1644/1545-1542(2000)081<0746:EOFSOT>2.3.CO;2; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; Dickinson JL, 2004, BEHAV ECOL, V15, P233, DOI 10.1093/beheco/arh001; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dierkes P, 1999, BEHAV ECOL, V10, P510, DOI 10.1093/beheco/10.5.510; Duftner N, 2007, MOL PHYLOGENET EVOL, V45, P706, DOI 10.1016/j.ympev.2007.08.001; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Gashagaza M.M., 1986, AFR STUDY MONOGR, V6, P37; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Gilchrist JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1053, DOI 10.1007/s00265-006-0338-2; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARTLEY IR, 1995, ANIM BEHAV, V49, P789, DOI 10.1016/0003-3472(95)80210-X; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Heg D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010784; Heg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005458; Houston AI, 1997, P ROY SOC B-BIOL SCI, V264, P173, DOI 10.1098/rspb.1997.0025; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Kreiberg Henrik, 2000, P503, DOI 10.1016/B978-012529650-2/50038-X; Le Vin AL, 2010, ANIM BEHAV, V79, P1109, DOI 10.1016/j.anbehav.2010.02.006; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; LEVIN AL, 2011, ANIMAL BEHA IN PRESS; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; Mitchell JS, 2009, BEHAVIOUR, V146, P1665, DOI 10.1163/000579509X12459328580026; Mitchell JS, 2009, ETHOLOGY, V115, P1162, DOI 10.1111/j.1439-0310.2009.01705.x; Nam KB, 2010, P ROY SOC B-BIOL SCI, V277, P3299, DOI 10.1098/rspb.2010.0737; Norusis M. J., 2010, PASW STAT 18 ADV STA; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Schurch R, 2010, BEHAV ECOL, V21, P588, DOI 10.1093/beheco/arq024; Skubic E, 2004, J THEOR BIOL, V227, P487, DOI 10.1016/j.jtbi.2003.11.021; Stacey P.B., 1990, COOPERATIVE BREEDING; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Taborsky B, 2007, BEHAV ECOL, V18, P652, DOI 10.1093/beheco/arm026; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; Taborsky M, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P265, DOI 10.1017/CBO9780511641954.012; Whittingham LA, 1997, BEHAV ECOL SOCIOBIOL, V40, P261, DOI 10.1007/s002650050341; Whittingham LA, 1998, ANIM BEHAV, V55, P629, DOI 10.1006/anbe.1997.0751; WONG M, 2011, BIOL REV; Wright J, 2010, P ROY SOC B-BIOL SCI, V277, P437, DOI 10.1098/rspb.2009.1360; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	76	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25673	10.1371/journal.pone.0025673	http://dx.doi.org/10.1371/journal.pone.0025673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022428	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000029
J	Marion, RM; Schotta, G; Ortega, S; Blasco, MA				Marion, Rosa M.; Schotta, Gunnar; Ortega, Sagrario; Blasco, Maria A.			Suv4-20h Abrogation Enhances Telomere Elongation during Reprogramming and Confers a Higher Tumorigenic Potential to iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; H4 LYSINE-20 TRIMETHYLATION; MAMMALIAN TELOMERES; HUMAN FIBROBLASTS; HISTONE H4; DEFINED FACTORS; DNA-DAMAGE; CANCER; GENERATION; LENGTH	Reprogramming of adult differentiated cells to induced pluripotent stem cells (iPS) cells has been achieved by overexpression of specific transcription factors. Nuclear reprogramming induces a series of profound changes at the telomeres of the parental differentiated cells, including a telomerase-dependent telomere elongation and the remodeling of telomeric chromatin. In particular, iPS cells show a decreased density of H4K20me3 heterochromatic mark at telomeres compared to the parental cells. Suv4-20h1 and Suv4-20h2 histone methytransferases (HMTases) are responsible for the trimethylation of H4K20 at telomeres, as cells deficient for both HMTases show decreased levels of H4K20me3 at telomeric chromatin. Here, we set to address the role of the Suv4-20h enzymes in telomere reprogramming by generating bona-fide iPS cells from mouse embryonic fibroblasts (MEFs) double null for both HMTases (Suv4-20dn MEFs). We found that Suv4-20h deficiency enhances telomere elongation during reprogramming without altering their ability to protect the chromosome ends or the efficiency of reprogramming. Moreover, teratomas generated from Suv4-20dn iPS cells also have elongated telomeres and an increased growth rate when compared to wild-type controls. These results indicate that abrogation of Suv4-20h enzymes and loss of heterochromatic mark H4K20me3 at telomeric heterochromatin facilitates telomere reprogramming and provides an increased tumorigenic potential to the resulting iPS cells.	[Marion, Rosa M.; Blasco, Maria A.] Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain; [Schotta, Gunnar] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany; [Schotta, Gunnar] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Ortega, Sagrario] Spanish Natl Canc Ctr, Biotechnol Program, Transgen Mice Unit, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Munich; University of Munich; Centro Nacional de Investigaciones Oncologicas (CNIO)	Marion, RM (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Marión, Rosa/AAE-8657-2020; Marión, Rosa/L-1488-2015	Blasco, Maria A./0000-0002-4211-233X; Marión, Rosa/0000-0002-0374-3884; Marión, Rosa/0000-0002-0374-3884; Schotta, Gunnar/0000-0003-4940-6135	Spanish Ministry of Science and Innovation [SAF2008-05384, CSD2007-00017]; European Union [2007-A-201630, 2007-A-200950]; European Research Council [232854]; Korber Foundation; Fundacion Botin; Fundacion Lilly (Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Korber Foundation; Fundacion Botin; Fundacion Lilly (Spain)	MB's laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA#232854, Korber Foundation, Fundacion Botin and Fundacion Lilly (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollo-Jimenez F, 2010, SEMIN CANCER BIOL, V20, P98, DOI 10.1016/j.semcancer.2010.02.002; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; CHADENEAU C, 1995, ONCOGENE, V11, P893; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Lopez de Silanes I, 2010, NATURE COMMUNICATION; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2010, CURR OPIN GENET DEV, V20, P190, DOI 10.1016/j.gde.2010.01.005; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Martinez P, 2010, AGING CELL; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2010, SEMIN CELL DEV BIOL, V21, P186, DOI 10.1016/j.semcdb.2009.09.015; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	63	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25680	10.1371/journal.pone.0025680	http://dx.doi.org/10.1371/journal.pone.0025680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022429	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000030
J	Pedersen, L; Jensen, MH; Krishna, S				Pedersen, Lykke; Jensen, Mogens Hogh; Krishna, Sandeep			Dickkopf1-A New Player in Modelling the Wnt Pathway	PLOS ONE			English	Article							SEGMENTATION CLOCK; NEGATIVE REGULATOR; BETA-CATENIN/TCF; CELL FATE; MECHANISM; MOUSE; FRONT; GRADIENT; NOTCH; AXIN	The Wnt signaling pathway transducing the stabilization of beta-catenin is essential for metazoan embryo development and is misregulated in many diseases such as cancers. In recent years models have been proposed for the Wnt signaling pathway during the segmentation process in developing embryos. Many of these include negative feedback loops where Axin2 plays a key role. However, Axin2 null mice show no segmentation phenotype. We therefore propose a new model where the negative feedback involves Dkk1 rather than Axin2. We show that this model can exhibit the same type of oscillations as the previous models with Axin2 and as observed in experiments. We show that a spatial Wnt gradient can consistently convert this temporal periodicity into the spatial periodicity of somites, provided the oscillations in new cells arising in the presomitic mesoderm are synchronized with the oscillations of older cells. We further investigate the hypothesis that a change in the Wnt level in the tail bud during the later stages of somitogenesis can lengthen the time period of the oscillations and hence the size and separation of the later somites.	[Pedersen, Lykke; Jensen, Mogens Hogh] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Krishna, Sandeep] Natl Ctr Biol Sci, Bangalore, Karnataka, India	University of Copenhagen; Niels Bohr Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Pedersen, L (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	lykkep@nbi.dk	Pedersen, Lykke/AAM-2297-2020; Pedersen, Lykke/J-8049-2012; Jensen, Mogens H./U-5510-2017	Pedersen, Lykke/0000-0002-8935-415X; Pedersen, Lykke/0000-0002-8935-415X; Jensen, Mogens H./0000-0001-8104-4299; krishna, sandeep/0000-0002-0581-173X	Danish National Science Research Foundation	Danish National Science Research Foundation(Danmarks Grundforskningsfond)	This research is supported by the Danish National Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Baker RE, 2006, DEV BIOL, V293, P116, DOI 10.1016/j.ydbio.2006.01.018; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Campanelli M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000728; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Jensen PB, 2010, BIOPHYS J, V98, P943, DOI 10.1016/j.bpj.2009.11.039; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Naiche L, 2011, PNAS, V108, P4010; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Santillan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001561; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Wolpert L., 2011, PRINCIPLES DEV; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	46	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25550	10.1371/journal.pone.0025550	http://dx.doi.org/10.1371/journal.pone.0025550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022411	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000020
J	Azpiroz, MF; Bascuas, T; Lavina, M				Azpiroz, Maria F.; Bascuas, Thais; Lavina, Magela			Microcin H47 System: An Escherichia coli Small Genomic Island with Novel Features	PLOS ONE			English	Article							PATHOGENICITY ISLANDS; CHROMOSOME; DIRECTIONALITY; RECOMBINATION; INTEGRASE; EXCISION	Genomic islands are DNA regions containing variable genetic information related to secondary metabolism. Frequently, they have the ability to excise from and integrate into replicons through site-specific recombination. Thus, they are usually flanked by short direct repeats that act as attachment sites, and contain genes for an integrase and an excisionase which carry out the genetic exchange. These mobility events would be at the basis of the horizontal transfer of genomic islands among bacteria. Microcin H47 is a ribosomally-synthesized antibacterial peptide that belongs to the group of chromosome-encoded microcins. The 13 kb-genetic system responsible for its production resides in the chromosome of the Escherichia coli H47 strain and is flanked by extensive and imperfect direct repeats. In this work, both excision and integration of the microcin H47 system were experimentally detected. The analyses were mainly performed in E. coli K12 cells carrying the microcin system cloned in a multicopy plasmid. As expected of a site-specific recombination event, the genetic exchange also occurred in a context deficient for homologous recombination. The DNA sequence of the attachment sites resulting from excision were hybrid between the sequences of the direct repeats. Unexpectedly, different hybrid attachment sites appeared which resulted from recombination in four segments of identity between the direct repeats. Genes encoding the trans-acting proteins responsible for the site-specific recombination were shown to be absent in the microcin H47 system. Therefore, they should be provided by the remaining genetic context, not only in the H47 strain but also in E. coli K12 cells, where both excision and integration occurred. Moreover, a survey of the attachment sites in data banks revealed that they are widely spread among E. coli strains. It is concluded that the microcin system is a small island H47 genomic island-that would employ a parasitic strategy for its mobility.	[Azpiroz, Maria F.; Bascuas, Thais; Lavina, Magela] Fac Ciencias, Secc Fisiol & Genet Bacterianas, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Azpiroz, MF (corresponding author), Fac Ciencias, Secc Fisiol & Genet Bacterianas, Montevideo, Uruguay.	fernanda@fcien.edu.uy		Bascuas, Thais/0000-0002-3011-2201; Azpiroz, Fernando/0000-0002-7327-960X	Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay	Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay	This work was funded by Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azpiroz MF, 2009, MICROB PATHOGENESIS, V47, P274, DOI 10.1016/j.micpath.2009.09.003; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; GAGGERO C, 1993, J BACTERIOL, V175, P5420, DOI 10.1128/JB.175.17.5420-5427.1993; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; LAVINA M, 1990, J BACTERIOL, V172, P6585, DOI 10.1128/jb.172.11.6585-6588.1990; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santiviago CA, 2010, J BACTERIOL, V192, P2246, DOI 10.1128/JB.00270-09; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Waldor MK, 2010, MOL MICROBIOL, V78, P537, DOI 10.1111/j.1365-2958.2010.07365.x	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26179	10.1371/journal.pone.0026179	http://dx.doi.org/10.1371/journal.pone.0026179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022554	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200046
J	Seno, T; Hamaguchi, M; Ashihara, E; Kohno, M; Ishino, H; Yamamoto, A; Kadoya, M; Nakamura, K; Murakami, K; Matoba, S; Maekawa, T; Kawahito, Y				Seno, Takahiro; Hamaguchi, Masahide; Ashihara, Eishi; Kohno, Masataka; Ishino, Hidetaka; Yamamoto, Aihiro; Kadoya, Masatoshi; Nakamura, Kaoru; Murakami, Ken; Matoba, Satoaki; Maekawa, Taira; Kawahito, Yutaka			15-Deoxy-Delta(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; LOW-DENSITY-LIPOPROTEIN; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; PPAR-GAMMA; IN-VITRO; EXPRESSION; APOPTOSIS; CHOLESTEROL; MODULATION	Aim: 15-Deoxy-Delta(12,14) Prostaglandin J(2) (15d-PGJ(2)) is a ligand of peroxisome proliferator-activated receptor gamma (PPAR gamma) having diverse effects such as the differentiation of adipocytes and atherosclerotic lesion formation. 15d-PGJ(2) can also regulate the expression of inflammatory mediators on immune cells independent of PPAR gamma. We investigated the antiatherogenic effect of 15d-PGJ(2). Methods: We fed apolipoprotein (apo) E-deficient female mice a Western-type diet from 8 to 16 wk of age and administered 1 mg/kg/day 15d-PGJ(2) intraperitoneally. We measured atherosclerotic lesions at the aortic root, and examined the expression of macrophage and inflammatory atherosclerotic molecules by immunohistochemical and real-time PCR in the lesion. Results: Atherosclerotic lesion formation was reduced in apo E-null mice treated with 15d-PGJ(2), as compared to in the controls. Immunohistochemical and real-time PCR analyses showed that the expression of MCP-1, TNF-alpha, and MMP-9 in atherosclerotic lesions was significantly decreased in 15d-PGJ(2) treated mice. The 15d-PGJ(2) also reduced the expression of macrophages and RelA mRNA in atherosclerotic lesions. Conclusion: This is the first report 15d-PGJ(2), a natural PPARc agonist, can improve atherosclerotic lesions in vivo. 15d-PGJ(2) may be a beneficial therapeutic agent for atherosclerosis.	[Seno, Takahiro; Kohno, Masataka; Ishino, Hidetaka; Yamamoto, Aihiro; Kadoya, Masatoshi; Nakamura, Kaoru; Murakami, Ken; Kawahito, Yutaka] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Inflammat & Immunol, Kyoto, Japan; [Hamaguchi, Masahide] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Osaka, Japan; [Ashihara, Eishi] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Grad Sch Med Sci, Kyoto, Japan; [Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan; [Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Osaka University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto University	Seno, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Inflammat & Immunol, Kyoto, Japan.	kawahity@koto.kpu-m.ac.jp		Hamaguchi, Masahide/0000-0002-8651-4445; Kawahito, Yutaka/0000-0002-3860-0488				Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blanco M, 2005, STROKE, V36, P1189, DOI 10.1161/01.STR.0000166054.55993.e5; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Dong YG, 2004, ACTA PHARMACOL SIN, V25, P47; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hamaguchi M, 2010, J CLIN BIOCHEM NUTR, V47, P138, DOI 10.3164/jcbn.10-33; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Ide T, 2003, THROMB RES, V110, P311, DOI 10.1016/S0049-3848(03)00418-3; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; Libby P, 2006, J AM COLL CARDIOL, V48, pA33, DOI 10.1016/j.jacc.2006.08.011; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shinohara E, 1998, ATHEROSCLEROSIS, V136, P275, DOI 10.1016/S0021-9150(97)00220-7; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tanaka T, 2005, EUR J PHARMACOL, V508, P255, DOI 10.1016/j.ejphar.2004.10.056; Toriumi Y, 2003, FEBS LETT, V553, P419, DOI 10.1016/S0014-5793(03)01040-8; Usui S, 2002, J LIPID RES, V43, P805; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Yousefipour Z, 2009, AM J NEPHROL, V30, P201, DOI 10.1159/000218061; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687	29	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25541	10.1371/journal.pone.0025541	http://dx.doi.org/10.1371/journal.pone.0025541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003398	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300019
J	Chau, BNT; Nguyen, HT; Ha, TTP; Van Tran, N; Wills, B; Farrar, J; Santangelo, JD; Simmons, CP				Chau Bich Nguyen Tran; Hieu Trong Nguyen; Ha Thanh Thi Phan; Ngoc Van Tran; Wills, Bridget; Farrar, Jeremy; Santangelo, Joseph D.; Simmons, Cameron P.			The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; ENTERIC VIRUSES; MOUTH-DISEASE; TAIWAN; WATER; ANTIBODIES; SINGAPORE; HAND	Enterovirus 71 (EV71)-associated hand, foot and mouth disease has emerged as a serious public health problem in South East Asia over the last decade. To better understand the prevalence of EV71 infection, we determined EV71 seroprevalence and seroincidence amongst healthy infants and children in Ho Chi Minh City, Viet Nam. In a cohort of 200 newborns, 55% of cord blood samples contained EV71 neutralizing antibodies and these decayed to undetectable levels by 6 months of age in 98% of infants. The EV71 neutralizing antibody seroconversion rate was 5.6% in the first year and 14% in the second year of life. In children 5-15 yrs of age, seroprevalence of EV71 neutralizing antibodies was 84% and in cord blood it was 55%. Taken together, these data suggest EV71 force of infection is high and highlights the need for more research into its epidemiology and pathogenesis in high disease burden countries.	[Chau Bich Nguyen Tran; Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Ctr Trop Med, Oxford, England; [Hieu Trong Nguyen] Hung Vuong Hosp, Dept Neonatol, Ho Chi Minh City, Vietnam; [Ngoc Van Tran] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Santangelo, Joseph D.] Inviragen Pte Ltd, Singapore, Singapore; [Ha Thanh Thi Phan] Dist 8 Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Chau, BNT (corresponding author), Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.	chautnb@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Simmons, Cameron P/ABA-3896-2021; Huy, Nguyen Tien/B-2573-2010	Simmons, Cameron P/0000-0002-9039-7392; Huy, Nguyen Tien/0000-0002-9543-9440; Hirayama, Kenji/0000-0001-9467-1777; Ha Manh, Tuan/0000-0002-4998-2581	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Inviragen Ltd., made available laboratory resources for the conduct of the laboratory tests, but were not involved in the analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Ehlers MM, 2005, WATER RES, V39, P2253, DOI 10.1016/j.watres.2005.04.014; Gibson KE, 2011, AM J TROP MED HYG, V84, P20, DOI 10.4269/ajtmh.2011.10-0389; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lodder WJ, 2010, APPL ENVIRON MICROB, V76, P5965, DOI 10.1128/AEM.00245-10; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wang Shih-Min, 2008, Pediatrics and Neonatology, V49, P113, DOI 10.1016/S1875-9572(08)60024-8; Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123; *WHO WPR, 2009, WHO WARNS GROW THREA	20	28	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21116	10.1371/journal.pone.0021116	http://dx.doi.org/10.1371/journal.pone.0021116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22016795	Green Published, gold			2022-12-25	WOS:000292699000004
J	Zaynagetdinov, R; Stathopoulos, GT; Sherrill, TP; Cheng, DS; McLoed, AG; Ausborn, JA; Polosukhin, VV; Connelly, L; Zhou, W; Fingleton, B; Peebles, RS; Prince, LS; Yull, FE; Blackwell, TS				Zaynagetdinov, R.; Stathopoulos, G. T.; Sherrill, T. P.; Cheng, D-S; McLoed, A. G.; Ausborn, J. A.; Polosukhin, V. V.; Connelly, L.; Zhou, W.; Fingleton, B.; Peebles, R. S.; Prince, L. S.; Yull, F. E.; Blackwell, T. S.			Epithelial nuclear factor-kappa B signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes	ONCOGENE			English	Article						mouse; lung; cancer; Treg; inflammation; NF-kappa B	OBSTRUCTIVE PULMONARY-DISEASE; ANTI-CD25 MONOCLONAL-ANTIBODY; FUNCTIONAL INACTIVATION; CHRONIC INFLAMMATION; SMOKING-CESSATION; CUTTING EDGE; CANCER; CELLS; COPD; DEPLETION	The mechanisms by which chronic inflammatory lung diseases, particularly chronic obstructive pulmonary disease, confer enhanced risk for lung cancer are not well-defined. To investigate whether nuclear factor (NF)-kappa B, a key mediator of immune and inflammatory responses, provides an interface between persistent lung inflammation and carcinogenesis, we utilized tetracycline-inducible transgenic mice expressing constitutively active I kappa B kinase beta in airway epithelium (IKTA (IKK beta trans-activated) mice). Intraperitoneal injection of ethyl carbamate (urethane), or 3-methylcholanthrene (MCA) and butylated hydroxytoluene (BHT) was used to induce lung tumorigenesis. Doxycycline-treated IKTA mice developed chronic airway inflammation and markedly increased numbers of lung tumors in response to urethane, even when transgene expression (and therefore epithelial NF-kappa B activation) was begun after exposure to carcinogen. Studies using a separate tumor initiator/promoter model (MCA+BHT) indicated that NF-kappa B functions as an independent tumor promoter. Enhanced tumor formation in IKTA mice was preceded by increased proliferation and reduced apoptosis of alveolar epithelium, resulting in increased formation of premalignant lesions. Investigation of inflammatory cells in lungs of IKTA mice revealed a substantial increase in macrophages and lymphocytes, including functional CD4+/CD25+/FoxP3+ regulatory T lymphocytes (Tregs). Importantly, Treg depletion using repetitive injections of anti-CD25 antibodies limited excessive tumor formation in IKTA mice. At 6 weeks following urethane injection, antibody-mediated Treg depletion in IKTA mice reduced the number of premalignant lesions in the lungs in association with an increase in CD8 lymphocytes. Thus, persistent NF-kappa B signaling in airway epithelium facilitates carcinogenesis by sculpting the immune/inflammatory environment in the lungs. Oncogene (2012) 31, 3164-3176; doi:10.1038/onc.2011.480; published online 17 October 2011	[Blackwell, T. S.] Vanderbilt Univ, Sch Med, Ctr Lung Res, Dept Med,Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [McLoed, A. G.; Ausborn, J. A.; Connelly, L.; Fingleton, B.; Yull, F. E.; Blackwell, T. S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Prince, L. S.; Blackwell, T. S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Peebles, R. S.; Blackwell, T. S.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Prince, L. S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Blackwell, TS (corresponding author), Vanderbilt Univ, Sch Med, Ctr Lung Res, Dept Med,Div Allergy Pulm & Crit Care Med, 1161 21st Ave S,T-1218 MCN, Nashville, TN 37232 USA.	timothy.blackwell@vanderbilt.edu	Connelly, Linda/GVS-4612-2022; Stathopoulos, Georgios/D-6576-2013; Stathopoulos, Georgios/AAE-6884-2020	Stathopoulos, Georgios/0000-0002-9215-6461; 	Department of Veterans Affairs; Vanderbilt Cancer Center; National Institutes of Health [5T32HL094296-03, CA113734]; NATIONAL CANCER INSTITUTE [T32CA009592, R01CA113734] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086324, T32HL094296, R01HL097195] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Department of Veterans Affairs (TSB), Vanderbilt Cancer Center Support Grant 2010 (TSB), National Institutes of Health Grants (no.5T32HL094296-03, RZ and CA113734, FEY).	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes Peter J, 2008, Proc Am Thorac Soc, V5, P857, DOI 10.1513/pats.200807-069TH; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bonvallot V, 2001, AM J RESP CELL MOL, V25, P515, DOI 10.1165/ajrcmb.25.4.4515; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Degl'Innocenti E, 2008, CANCER RES, V68, P292, DOI 10.1158/0008-5472.CAN-07-2429; Gamble E, 2007, EUR RESPIR J, V30, P467, DOI 10.1183/09031936.00013006; Granville CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005061; Hashimoto K, 2005, J IMMUNOL, V174, P525, DOI 10.4049/jimmunol.174.1.525; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Malkinson AM, 2000, CHEST, V117, p228S, DOI 10.1378/chest.117.5_suppl_1.228S; Malkinson AM, 1997, CANCER RES, V57, P2832; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nummer D, 2007, J NATL CANCER I, V99, P1188, DOI 10.1093/jnci/djm064; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Plumb J, 2009, EUR RESPIR J, V34, P89, DOI 10.1183/09031936.00100708; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schneider T, 2011, J THORAC ONCOL, V6, P432, DOI 10.1097/JTO.0b013e31820b80ca; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Yull FE, 2003, J HISTOCHEM CYTOCHEM, V51, P741, DOI 10.1177/002215540305100605; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a	54	40	42	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	26					3164	3176		10.1038/onc.2011.480	http://dx.doi.org/10.1038/onc.2011.480			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22002309	Green Accepted			2022-12-25	WOS:000305934400005
J	Kozminsky-Atias, A; Zilberberg, N				Kozminsky-Atias, Adi; Zilberberg, Noam			Molding the business end of neurotoxins by diversifying evolution	FASEB JOURNAL			English	Article						active surface; ion channels; multigene families	ALPHA-LIKE TOXIN; SCORPION BETA-TOXINS; MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; CHANNEL SELECTIVITY; POSITIVE SELECTION; FUNCTIONAL SURFACE; RAPID EVOLUTION; SODIUM-CHANNELS	A diverse range of organisms utilize neurotoxins that target specific ion channels and modulate their activity. Typically, toxins are clustered into several multigene families, providing an organism with the upper hand in the never-ending predator-prey arms race. Several gene families, including those encoding certain neurotoxins, have been subject to diversifying selection forces, resulting in rapid gene evolution. Here we sought a spatial pattern in the distribution of both diversifying and purifying selection forces common to neurotoxin gene families. Utilizing the mechanistic empirical combination model, we analyzed various toxin families from different phyla affecting various receptors and relying on diverse modes of action. Through this approach, we were able to detect clear correlations between the pharmacological surface of a toxin and rapidly evolving domains, rich in positively selected residues. On the other hand, patches of negatively selected residues were restricted to the nontoxic face of the molecule and most likely help in stabilizing the tertiary structure of the toxin. We thus propose a mutual evolutionary strategy of venomous animals in which adaptive molecular evolution is directed toward the toxin active surface. Furthermore, we propose that the binding domains of unstudied toxins could be readily predicted using evolutionary considerations.-Kozminsky-Atias, A., Zilberberg, N. Molding the business end of neurotoxins by diversifying evolution. FASEB J. 26, 576-586 (2012). www.fasebj.org	[Kozminsky-Atias, Adi; Zilberberg, Noam] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Zilberberg, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	noamz@bgu.ac.il	Zilberberg, Noam/F-2005-2012	Zilberberg, Noam/0000-0002-7848-2391	Israel Science Foundation [1237/10]	Israel Science Foundation(Israel Science Foundation)	The authors are grateful to Ariel Novoplansky and Moran Gershoni for helpful discussions. This work was supported by a grant from the Israel Science Foundation (1237/10) to N.Z.	Alape-Giron A, 1999, EUR J BIOCHEM, V259, P225, DOI 10.1046/j.1432-1327.1999.00021.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2004, J BIOL CHEM, V279, P8206, DOI 10.1074/jbc.M307531200; Cohen L, 2008, J BIOL CHEM, V283, P15169, DOI 10.1074/jbc.M801229200; Cohen L, 2006, FASEB J, V20, P1933, DOI 10.1096/fj.05-5545fje; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Darbon H, 1999, J Soc Biol, V193, P445; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; FAINZILBER M, 1991, EUR J BIOCHEM, V202, P589, DOI 10.1111/j.1432-1033.1991.tb16412.x; Froy O, 1998, FASEB J, V12, P1793, DOI 10.1096/fasebj.12.15.1793; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Gruber J, 2007, ACTA CRYSTALLOGR D, V63, P50, DOI 10.1107/S0907444906046762; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HSEU TH, 1977, J MOL EVOL, V10, P167, DOI 10.1007/BF01751810; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; LEGOAS R, 1992, BIOCHEMISTRY-US, V31, P4867, DOI 10.1021/bi00135a018; Li M, 2005, MOL BIOL EVOL, V22, P934, DOI 10.1093/molbev/msi077; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; Mebs D, 2001, TOXICON, V39, P87, DOI 10.1016/S0041-0101(00)00155-0; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Petan T, 2002, BIOCHEM J, V363, P353, DOI 10.1042/0264-6021:3630353; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Prijatelj P, 2006, BIOCHIMIE, V88, P69, DOI 10.1016/j.biochi.2005.06.015; Prijatelj P, 2008, TOXICON, V51, P1520, DOI 10.1016/j.toxicon.2008.03.031; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; Servent D, 2000, EUR J PHARMACOL, V393, P197, DOI 10.1016/S0014-2999(00)00095-9; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sun YM, 2003, J BIOL CHEM, V278, P24125, DOI 10.1074/jbc.M211931200; Tamiya T, 2006, MOL DIVERS, V10, P529, DOI 10.1007/s11030-006-9049-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian CH, 2008, TOXICON, V51, P555, DOI 10.1016/j.toxicon.2007.11.010; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wang CG, 2003, BIOCHEMISTRY-US, V42, P4699, DOI 10.1021/bi0270438; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810; Zilberberg N, 1996, BIOCHEMISTRY-US, V35, P10215, DOI 10.1021/bi9528309	86	21	21	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					576	586		10.1096/fj.11-187179	http://dx.doi.org/10.1096/fj.11-187179			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22009937				2022-12-25	WOS:000300485700011
J	Higa, A; Mulot, A; Delom, F; Bouchecareilh, M; Nguyen, DT; Boismenu, D; Wise, MJ; Chevet, E				Higa, Arisa; Mulot, Audrey; Delom, Frederic; Bouchecareilh, Marion; Duc Thang Nguyen; Boismenu, Daniel; Wise, Michael J.; Chevet, Eric			Role of Pro-oncogenic Protein Disulfide Isomerase (PDI) Family Member Anterior Gradient 2 (AGR2) in the Control of Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; HUMAN HOMOLOG; EXPRESSION; CANCER; GENE; TRANSLOCATION; ER; IMMUNOGENICITY; SURVIVAL; ANTIGEN	The protein-disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) is reportedly overexpressed in numerous cancers and plays a role in cancer development. However, to date the molecular functions of AGR2 remain to be characterized. Herein we have identified AGR2 as bound to newly synthesized cargo proteins using a proteomics analysis of endoplasmic reticulum (ER) membrane-bound ribosomes. Nascent protein chains that translocate into the ER associate with specific ER luminal proteins, which in turn ensures proper folding and posttranslational modifications. Using both imaging and biochemical approaches, we confirmed that AGR2 localizes to the lumen of the ER and indirectly associates with ER membrane-bound ribosomes through nascent protein chains. We showed that AGR2 expression is controlled by the unfolded protein response and is in turn is involved in the maintenance of ER homeostasis. Remarkably, we have demonstrated that siRNA-mediated knockdown of AGR2 significantly alters the expression of components of the ER-associated degradation machinery and reduces the ability of cells to cope with acute ER stress, properties that might be relevant to the role of AGR2 in cancer development.	[Higa, Arisa; Mulot, Audrey; Bouchecareilh, Marion; Chevet, Eric] Univ Bordeaux Segalen, INSERM, U1053, F-33076 Bordeaux, France; [Delom, Frederic; Duc Thang Nguyen; Chevet, Eric] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Boismenu, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Wise, Michael J.] Univ Western Australia, Dept Biomol Biomed & Chem Sci, Perth, WA 6009, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; McGill University; University of Western Australia	Chevet, E (corresponding author), Univ Bordeaux Segalen, INSERM, U1053, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	eric.chevet@u-bordeaux2.fr	chevet, eric/E-4992-2016; Wise, Michael/B-5676-2012; Delom, Frederic/J-2782-2014	chevet, eric/0000-0001-5855-4522; Wise, Michael/0000-0001-6559-4303; Delom, Frederic/0000-0002-4600-7633	INSERM; Institut National du Cancer (INCa); Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale; Association de Recherche contre le Cancer; Conseil Regional d'Aquitaine; French government; Genome Quebec/Canada	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French government; Genome Quebec/Canada	This work was supported by grants from INSERM (Avenir) and Institut National du Cancer (INCa), Ligue Nationale contre le Cancer, Fondation pour la Recherche Medicale, Association de Recherche contre le Cancer, and Conseil Regional d'Aquitaine (to E. C.).; Supported by a Ph. D. scholarship from the French government.; Frederic Delom and mass spectrometry sequencing were supported in part by an operating grant from Genome Quebec/Canada to the Montreal Proteomics Network (Cell Map Project).	Bates PA, 2001, PROTEINS, P39; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 2001, COLD SPRING HARB SYM, V66, P543, DOI 10.1101/sqb.2001.66.543; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Dumartin L., 2011, CANC RES IN PRESS; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kovalyova LI, 2006, APPL BIOCHEM MICRO+, V42, P424, DOI 10.1134/S0003683806040156; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lepreux S, 2011, LIVER INT, V31, P322, DOI 10.1111/j.1478-3231.2010.02438.x; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Wise Michael J, 2002, Bioinformatics, V18 Suppl 1, pS38; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	51	80	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44855	44868		10.1074/jbc.M111.275529	http://dx.doi.org/10.1074/jbc.M111.275529			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22025610	Green Published, hybrid			2022-12-25	WOS:000298645500054
J	Gardsvoll, H; Kjaergaard, M; Jacobsen, B; Kriegbaum, MC; Huang, MD; Ploug, M				Gardsvoll, Henrik; Kjaergaard, Magnus; Jacobsen, Benedikte; Kriegbaum, Mette C.; Huang, Mingdong; Ploug, Michael			Mimicry of the Regulatory Role of Urokinase in Lamellipodia Formation by Introduction of a Non-native Interdomain Disulfide Bond in Its Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; BREAST-CANCER; MONOCLONAL-ANTIBODIES; CELLULAR RECEPTOR; ANTHRAX TOXIN; INVASIVE FOCI; STROMAL CELLS; BINDING-SITE; IN-VIVO; VITRONECTIN	The high-affinity interaction between the urokinase-type plasminogen activator (uPA) and its glycolipid-anchored receptor (uPAR) plays a regulatory role for both extravascular fibrinolysis and uPAR-mediated adhesion and migration on vitronectin-coated surfaces. We have recently proposed that the adhesive function of uPAR is allosterically regulated via a "tightening" of its three-domain structure elicited by uPA binding. To challenge this proposition, we redesigned the uPAR structure to limit its inherent conformational flexibility by covalently tethering domains DI and DIII via a non-natural interdomain disulfide bond (uPAR(H47C-N259C)). The corresponding soluble receptor has 1) a smaller hydrodynamic volume, 2) a higher content of secondary structure, and 3) unaltered binding kinetics towards uPA. Most importantly, the purified uPAR(H47C-N259C) also displays a gain in affinity for the somatomedin B domain of vitronectin compared with uPAR(wt), thus recapitulating the improved affinity that accompanies uPA-uPAR(wt) complex formation. This functional mimicry is, intriguingly, operational also in a cellular setting, where it controls lamellipodia formation in uPAR-transfected HEK293 cells adhering to vitronectin. In this respect, the engineered constraint in uPAR(H47C-N259C) thus bypasses the regulatory role of uPA binding, resulting in a constitutively active uPAR. In conclusion, our data argue for a biological relevance of the interdomain dynamics of the glycolipid-anchored uPAR on the cell surface.	[Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Ploug, Michael] Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark; [Gardsvoll, Henrik; Jacobsen, Benedikte; Huang, Mingdong; Ploug, Michael] Univ Copenhagen, Danish Chinese Ctr Proteases & Canc, DK-2200 Copenhagen N, Denmark; [Kjaergaard, Magnus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China	Rigshospitalet; University of Copenhagen; University of Copenhagen; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Ploug, M (corresponding author), Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, Rm 3-3-31,Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk	Huang, Mingdong/J-4278-2017; Kjaergaard, Magnus/A-6591-2012; Kjaergaard, Magnus/AAD-7717-2019	Huang, Mingdong/0000-0003-0085-9141; Kjaergaard, Magnus/0000-0002-7020-9366; Ploug, Michael/0000-0003-2215-4265	The Danish National Research Foundation (Centre for Proteases and Cancer); The Lundbeck Foundation	The Danish National Research Foundation (Centre for Proteases and Cancer); The Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Danish National Research Foundation (Centre for Proteases and Cancer) and The Lundbeck Foundation.	BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Foekens JA, 2000, CANCER RES, V60, P636; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; GRONDAHLHANSEN J, 1988, J LAB CLIN MED, V111, P42; Hildenbrand R, 2009, AM J PATHOL, V174, P2246, DOI 10.2353/ajpath.2009.080785; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jacobsen B, 2007, PROTEIN EXPRES PURIF, V52, P286, DOI 10.1016/j.pep.2006.08.011; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Kriegbaum MC, 2011, CURR DRUG TARGETS, V12, P1711; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Ngo JCK, 2011, CURR DRUG TARGETS, V12, P1729; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Nieves EC, 2010, J BIOL CHEM, V285, P12595, DOI 10.1074/jbc.M109.008581; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PLOUG M, 1994, BIOCHEMISTRY-US, V33, P8991, DOI 10.1021/bi00196a017; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PYKE C, 1991, AM J PATHOL, V138, P1059; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Seeds N, 2011, CELL MOL NEUROBIOL, V31, P961, DOI 10.1007/s10571-011-9701-6; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; STRATTONTHOMAS JR, 1995, PROTEIN ENG, V8, P463, DOI 10.1093/protein/8.5.463; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551	50	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43515	43526		10.1074/jbc.M111.300020	http://dx.doi.org/10.1074/jbc.M111.300020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025616	Green Published, hybrid			2022-12-25	WOS:000298351300071
J	Liu, XJ; Cheng, YH; Chen, XW; Yang, J; Xu, L; Zhang, CX				Liu, Xiaojun; Cheng, Yunhui; Chen, Xiuwei; Yang, Jian; Xu, Ling; Zhang, Chunxiang			MicroRNA-31 Regulated by the Extracellular Regulated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IN-VITRO; EXPRESSION; MIR-31; PROLIFERATION; CANCER; MIR-143; LATS2; METASTASIS; WARTS/LATS	Aberrant growth of vascular smooth muscle cells (VSMCs) is a major cellular event in the pathogenesis of many proliferative vascular diseases. Recently, microRNA-31 (miR-31) has been found to play a critical role in cancer cell proliferation. However, the biological role of miR-31 in VSMC growth and the mechanisms involved are currently unknown. In the present study, the expression of rat mature miR-31 (rno-miR-31) was determined in cultured VSMCs and in rat carotid arteries. We identified that rno-miR-31 is an abundant miRNA in VSMCs, and its expression was significantly increased in proliferative VSMCs and in vascular walls with neointimal growth. The up-regulation of rno-miR-31 in proliferative VSMCs was inhibited by the inhibitor of mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK). By both gain-of-function and loss-of-function approaches, we demonstrated that rno-miR-31 had a proproliferative effect on VSMCs. We further identified that LATS2 (large tumor suppressor homolog 2) is a downstream target gene product of rno-miR-31 that is involved in rno-miR-31-mediated effect on VSMC proliferation. The LATS2 as a target gene protein of rno-miR-31 is verified in vivo in balloon-injured rat carotid arteries. The results suggest that MAPK/ERK/miR-31/LATS2 may represent a novel signaling pathway in VSMC growth. miR-31 is able to enhance VSMC proliferation via its downstream target gene product, LATS2.	[Liu, Xiaojun; Cheng, Yunhui; Chen, Xiuwei; Yang, Jian; Xu, Ling; Zhang, Chunxiang] Univ Med & Dent New Jersey, RNA & Cardiovasc Res Lab, Dept Anesthesiol, New Jersey Med Sch, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, CX (corresponding author), Univ Med & Dent New Jersey, RNA & Cardiovasc Res Lab, Dept Anesthesiol, New Jersey Med Sch, 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	zhang, xiang chun/HCH-7063-2022; Chen, Xiuwei/AAH-6695-2021; Cheng, Yunhui/D-3922-2012	zhang, xiang chun/0000-0001-8303-6495; 	National Institutes of Health [HL080133, HL095707]; American Heart Association [09GRNT2250567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095707, R01HL080133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080133 and HL095707 (to C. Z.). This work was also supported by American Heart Association Grant 09GRNT2250567 (to C. Z.).	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Chen G, 2011, J ETHNOPHARMACOL, V135, P7, DOI 10.1016/j.jep.2011.02.011; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hori T, 2000, ONCOGENE, V19, P3101, DOI 10.1038/sj.onc.1203659; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Sakakibara K, 2005, J BIOL CHEM, V280, P25470, DOI 10.1074/jbc.M502320200; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008	50	80	91	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42371	42380		10.1074/jbc.M111.261065	http://dx.doi.org/10.1074/jbc.M111.261065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22020941	Green Published, hybrid			2022-12-25	WOS:000298180900046
J	Wang, X; Li, X; Zhang, YB; Zhang, F; Sun, LY; Lin, J; Wang, DM; Wang, LY				Wang, Xu; Li, Xin; Zhang, Yong-Biao; Zhang, Feng; Sun, Liyuan; Lin, Jie; Wang, Duen-Mei; Wang, Lu-Ya			Genome-Wide Linkage Scan of a Pedigree with Familial Hypercholesterolemia Suggests Susceptibility Loci on Chromosomes 3q25-26 and 21q22	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; COMBINED HYPERLIPIDEMIA; COMPLEX TRAIT; GENE; CHOLESTEROL; DISEASE; ABCG1; HETEROGENEITY; MUTATIONS; DISORDER	Background: Familial hypercholesterolemia (FH) is a heritable disorder that can increase the risk of premature coronary heart disease. Studies suggest there are substantial genetic heterogeneities for different populations. Here we tried to identify novel susceptibility loci for FH in a Chinese pedigree. Methodology/Principal Findings: We performed a SNP-based genome-wide linkage scan with the Chinese FH pedigree. Two suggestive linkage loci not previously reported were identified on chromosomes 3q25.1-26.1 (NPL = 9.01, nominal P < 0.00001, and simulated occurrence per genome scan = 1.08) and 21q22.3 (NPL = 8.95, nominal P < 0.00001, and simulated occurrence per genome scan = 1.26). In the interaction analysis with a trimmed version of the pedigree, we obtained a significantly increased joint LOD score (2.70) compared with that obtained when assuming the two loci uncorrelated, suggesting that more than one locus was involved in this pedigree. Exon screening of two candidate genes ABCG1 and LSS from one of the suggestive region 21q22 didn't report any causative mutations. Conclusions/Significances: These results confirm complex etiologies and suggest new genetic casual factors for the FH disorder. Further study of the two candidate regions is advocated.	[Wang, Xu; Sun, Liyuan; Lin, Jie; Wang, Lu-Ya] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ, Beijing, Peoples R China; [Wang, Xu; Sun, Liyuan; Lin, Jie; Wang, Lu-Ya] Capital Univ Med Sci, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China; [Li, Xin; Zhang, Yong-Biao; Zhang, Feng; Wang, Duen-Mei] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, X (corresponding author), Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ, Beijing, Peoples R China.	wangluya@126.com			National Natural Science Foundation of China [30771986]; Beijing Natural Science Foundation [7112022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (No. 30771986) and Beijing Natural Science Foundation (No. 7112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abou Jamra R, 2007, AM J HUM GENET, V81, P974, DOI 10.1086/521690; Al-Kateb H, 2002, CIRC RES, V90, P951, DOI 10.1161/01.RES.0000018002.43041.08; Berger M, 2005, BLOOD, V105, P638, DOI 10.1182/blood-2004-05-2018; Bhatnagar D, 2006, ANN CLIN BIOCHEM, V43, P441, DOI 10.1258/000456306778904641; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; Eden ER, 2001, AM J HUM GENET, V68, P653, DOI 10.1086/318795; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furuyama S, 2009, J ATHEROSCLER THROMB, V16, P194, DOI 10.5551/jat.E380; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Medeiros AM, 2010, ATHEROSCLEROSIS, V212, P553, DOI 10.1016/j.atherosclerosis.2010.07.012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Robles-Osorio L, 2006, ARCH MED RES, V37, P102, DOI 10.1016/j.arcmed.2005.04.018; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Strauch K, 2003, HUM HERED, V56, P200, DOI 10.1159/000076394; Strauch K, 2003, HUM HERED, V55, P202, DOI 10.1159/000073204; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	26	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24838	10.1371/journal.pone.0024838	http://dx.doi.org/10.1371/journal.pone.0024838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022364	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600003
J	Wei, CG; Wang, GQ; Chen, X; Huang, HL; Liu, B; Xu, Y; Li, F				Wei, Chengguo; Wang, Guoqing; Chen, Xin; Huang, Honglan; Liu, Bin; Xu, Ying; Li, Fan			Identification and Typing of Human Enterovirus: A Genomic Barcode Approach	PLOS ONE			English	Article							VP1; MECHANISMS; PHYLOGENY; EVOLUTION; OUTBREAKS; PROTEIN; REGION; AGENTS; PCR	Identification and typing of human enterovirus (HEVs) are important to pathogen detection and therapy. Previous phylogeny-based typing methods are mainly based on multiple sequence alignments of specific genes in the HEVs, but the results are not stable with respect to different choices of genes. Here we report a novel method for identification and typing of HEVs based on information derived from their whole genomes. Specifically, we calculate the k-mer based barcode image for each genome, HEV or other human viruses, for a fixed k, 1<k<7, where a genome barcode is defined in terms of the k-mer frequency distribution across the whole genome for all combinations of k-mers. A phylogenetic tree is constructed using a barcode-based distance and a neighbor-joining method among a set of 443 representative non-HEV human viruses and 395 HEV sequences. The tree shows a clear separation of the HEV viruses from all the non-HEV viruses with 100% accuracy and a separation of the HEVs into four distinct clads with 93.4% consistency with a multiple sequence alignment-based phylogeny. Our detailed analyses of the HEVs having different typing results by the two methods indicate that our results are in better agreement with known information about the HEVs.	[Wei, Chengguo; Wang, Guoqing; Huang, Honglan; Li, Fan] Jilin Univ, Norman Bethune Med Coll, Dept Pathogeny Biol, Changchun 130023, Jilin, Peoples R China; [Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Chen, Xin; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Liu, Bin] Jilin Univ, Bethune Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Wei, CG (corresponding author), Jilin Univ, Norman Bethune Med Coll, Dept Pathogeny Biol, Changchun 130023, Jilin, Peoples R China.	xyn@bmb.uga.edu; lifan@jlu.edu.cn	Huang, Honglan/GRR-2513-2022		National Basic Research Program of China (973 program) [2011CB512003]; National Natural Science Foundation of China [30872415, 81071424, 81101295]; China Postdoctoral Science Foundation [20110491311]; National Science Foundation [DEB-0830024]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Basic Research Program of China (973 program, 2011CB512003) and National Natural Science Foundation of China (30872415). It is also supported in part by National Natural Science Foundation of China (81071424 and 81101295), China Postdoctoral Science Foundation (20110491311) and National Science Foundation (DEB-0830024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang CH, 2003, GRAEF ARCH CLIN EXP, V241, P554, DOI 10.1007/s00417-003-0680-2; FAUQUET CM, 2005, 8 IUOMS VIR DIV INT; GRANDIEN M, 1989, DIAGNOSTIC PROCEDURE, P513; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; JUN EJ, 2010, INVEST OPHTH VIS SCI, V52, P58; KAPSENBERG JG, 1988, LABORATORY DIAGNOSIS, V2, P692; Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kim KS, 2001, REV MED VIROL, V11, P355, DOI 10.1002/rmv.326; Kottaridi C, 2006, ARCH VIROL, V151, P1117, DOI 10.1007/s00705-005-0697-4; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miyazawa I, 2008, JPN J INFECT DIS, V61, P247; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Pallansch M., 2007, FIELDS VIROLOGY, P839; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; Stadnick E, 2004, J VIROL, V78, P13987, DOI 10.1128/JVI.78.24.13987-14002.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Xiao XL, 2009, J VIROL METHODS, V159, P23, DOI 10.1016/j.jviromet.2009.02.022; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	34	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26296	10.1371/journal.pone.0026296	http://dx.doi.org/10.1371/journal.pone.0026296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022592	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600050
J	Aster, JC; Bodnar, N; Xu, LW; Karnell, F; Milholland, JM; Maillard, I; Histen, G; Nam, Y; Blacklow, SC; Pear, WS				Aster, Jon C.; Bodnar, Nick; Xu, Lanwei; Karnell, Fredrick; Milholland, John M.; Maillard, Ivan; Histen, Gavin; Nam, Yunsun; Blacklow, Stephen C.; Pear, Warren S.			Notch Ankyrin Repeat Domain Variation Influences Leukemogenesis and Myc Transactivation	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEIN SECONDARY STRUCTURE; T-CELL LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; C-MYC; CIRCULAR-DICHROISM; INTRACELLULAR DOMAINS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE AUTOREGULATION; CRYSTAL-STRUCTURE	Background: The functional interchangeability of mammalian Notch receptors (Notch1-4) in normal and pathophysiologic contexts such as cancer is unsettled. We used complementary in vivo, cell-based and structural analyses to compare the abilities of activated Notch1-4 to support T cell development, induce T cell acute lymphoblastic leukemia/lymphoma (T-ALL), and maintain T-ALL cell growth and survival. Principal Findings: We find that the activated intracellular domains of Notch1-4 (ICN1-4) all support T cell development in mice and thymic organ culture. However, unlike ICN1-3, ICN4 fails to induce T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and is unable to rescue the growth of Notch1-dependent T-ALL cell lines. The ICN4 phenotype is mimicked by weak gain-of-function forms of Notch1, suggesting that it stems from a failure to transactivate one or more critical target genes above a necessary threshold. Experiments with chimeric receptors demonstrate that the Notch ankyrin repeat domains differ in their leukemogenic potential, and that this difference correlates with activation of Myc, a direct Notch target that has an important role in Notch-associated T-ALL. Conclusions/Significance: We conclude that the leukemogenic potentials of Notch receptors vary, and that this functional difference stems in part from divergence among the highly conserved ankyrin repeats, which influence the transactivation of specific target genes involved in leukemogenesis.	[Aster, Jon C.; Histen, Gavin; Blacklow, Stephen C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Xu, Lanwei; Karnell, Fredrick; Milholland, John M.; Maillard, Ivan; Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Abramson Family Canc Res Inst,Inst Med & Engn, Philadelphia, PA 19104 USA; [Bodnar, Nick; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bodnar, Nick; Nam, Yunsun; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Aster, JC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu; wpear@mail.med.upenn.edu		Bodnar, Nicholas/0000-0003-2410-7542; Nam, Yunsun/0000-0002-7939-8626; Maillard, Ivan/0000-0003-1312-6748	National Institutes of Health [T32 CA09140]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA092433, T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (WSP, JCA, and SCB) and the Leukemia and Lymphoma Society SCOR Program (WSP, JCA, and SCB). JMM was supported by NIH training grant T32 CA09140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Beatus P, 2001, MECH DEVELOP, V104, P3, DOI 10.1016/S0925-4773(01)00373-2; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; CULLION K, 2009, BLOOD; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gallahan D, 1996, CANCER RES, V56, P1775; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kraman M, 2005, FASEB J, V19, P1311, DOI 10.1096/fj.04-3407fje; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Vercauteren SM, 2004, BLOOD, V104, P2315, DOI 10.1182/blood-2004-01-0204; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	57	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25645	10.1371/journal.pone.0025645	http://dx.doi.org/10.1371/journal.pone.0025645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022427	gold, Green Published, Green Submitted			2022-12-25	WOS:000295978600025
J	Lehtonen, S				Lehtonen, Samuli			Towards Resolving the Complete Fern Tree of Life	PLOS ONE			English	Article							NONCODING CHLOROPLAST DNA; RBCL NUCLEOTIDE-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; GENE-SEQUENCES; MISSING DATA; EXTANT FERNS; DATA SETS; PTERIDACEAE; ACCURACY; TAXA	In the past two decades, molecular systematic studies have revolutionized our understanding of the evolutionary history of ferns. The availability of large molecular data sets together with efficient computer algorithms, now enables us to reconstruct evolutionary histories with previously unseen completeness. Here, the most comprehensive fern phylogeny to date, representing over one-fifth of the extant global fern diversity, is inferred based on four plastid genes. Parsimony and maximum-likelihood analyses provided a mostly congruent results and in general supported the prevailing view on the higher-level fern systematics. At a deep phylogenetic level, the position of horsetails depended on the optimality criteria chosen, with horsetails positioned as the sister group either of Marattiopsida-Polypodiopsida clade or of the Polypodiopsida. The analyses demonstrate the power of using a 'supermatrix' approach to resolve large-scale phylogenies and reveal questionable taxonomies. These results provide a valuable background for future research on fern systematics, ecology, biogeography and other evolutionary studies.	Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Turku	Lehtonen, S (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	samile@utu.fi		Lehtonen, Samuli/0000-0001-6235-2026	Kone Foundation; Academy of Finland	Kone Foundation; Academy of Finland(Academy of Finland)	This study received funding from the Kone Foundation and the Academy of Finland grants to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Bouma WLM, 2010, AUST SYST BOT, V23, P143, DOI 10.1071/SB09047; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gatesy J, 2004, SYST BIOL, V53, P342, DOI 10.1080/10635150490423971; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Hauk WD, 2003, MOL PHYLOGENET EVOL, V28, P131, DOI 10.1016/S1055-7903(03)00032-0; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; HongMei L, 2007, SCI CHINA SER C, V50, P789, DOI 10.1007/s11427-007-0099-9; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lehtonen S, 2010, BOT J LINN SOC, V163, P305, DOI 10.1111/j.1095-8339.2010.01063.x; Maddison WP, 2017, MESQUITE MODULAR SYS; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Moran RC, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P367, DOI 10.1017/CBO9780511541827.015; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Ott M, 2007, P ACM IEEE SUP C; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Prado J, 2007, TAXON, V56, P355, DOI 10.1002/tax.562008; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Rambaut A, 2009, FIGTREE V1 3 1; Rothfels CJ, 2008, TAXON, V57, P712, DOI 10.1002/tax.573005; Rothwell GW, 2006, INT J PLANT SCI, V167, P737, DOI 10.1086/503298; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Shavit L, 2007, MOL BIOL EVOL, V24, P2400, DOI 10.1093/molbev/msm178; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Small RL, 2005, MOL PHYLOGENET EVOL, V36, P509, DOI 10.1016/j.ympev.2005.04.018; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wolf PG, 1997, AM J BOT, V84, P1429, DOI 10.2307/2446141; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; Wolf PG, 1999, PLANT SYST EVOL, V219, P263, DOI 10.1007/BF00985583; Wolf PG, 1995, AM FERN J, V85, P306, DOI 10.2307/1547812; Wolsan M, 2010, CLADISTICS, V26, P168, DOI 10.1111/j.1096-0031.2009.00281.x; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	61	98	105	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24851	10.1371/journal.pone.0024851	http://dx.doi.org/10.1371/journal.pone.0024851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022365	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600006
J	Mizuguchi, N; Sakamoto, M; Muraoka, T; Nakagawa, K; Kanazawa, S; Nakata, H; Moriyama, N; Kanosue, K				Mizuguchi, Nobuaki; Sakamoto, Masanori; Muraoka, Tetsuro; Nakagawa, Kento; Kanazawa, Shoichi; Nakata, Hiroki; Moriyama, Noriyoshi; Kanosue, Kazuyuki			The Modulation of Corticospinal Excitability during Motor Imagery of Actions with Objects	PLOS ONE			English	Article							EVOKED-POTENTIALS MEPS; REPRESENTATION; FACILITATION; RESPONSES; POSTURE; MUSCLE; TASKS	We investigated whether corticospinal excitability during motor imagery of actions (the power or the pincer grip) with objects was influenced by actually touching objects (tactile input) and by the congruency of posture with the imagined action (proprioceptive input). Corticospinal excitability was assessed by monitoring motor evoked potentials (MEPs) in the first dorsal interosseous following transcranial magnetic stimulation over the motor cortex. MEPs were recorded during imagery of the power grip of a larger-sized ball (7 cm) or the pincer grip of a smaller-sized ball (3 cm) with or without passively holding the larger-sized ball with the holding posture or the smaller-sized ball with the pinching posture. During imagery of the power grip, MEPs amplitude was increased only while the actual posture was the same as the imagined action (the holding posture). On the other hand, during imagery of the pincer grip while touching the ball, MEPs amplitude was enhanced in both postures. To examine the pure effect of touching (tactile input), we recorded MEPs during imagery of the power and pincer grip while touching various areas of an open palm with a flat foam pad. The MEPs amplitude was not affected by the palmer touching. These findings suggest that corticospinal excitability during imagery with an object is modulated by actually touching an object through the combination of tactile and proprioceptive inputs.	[Mizuguchi, Nobuaki; Nakagawa, Kento; Kanazawa, Shoichi] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Mizuguchi, Nobuaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Sakamoto, Masanori] Kumamoto Univ, Dept Phys Educ, Fac Educ, Kumamoto, Japan; [Muraoka, Tetsuro] Nihon Univ, Coll Econ, Chiyoda Ku, Tokyo, Japan; [Nakata, Hiroki; Moriyama, Noriyoshi; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University; Japan Society for the Promotion of Science; Kumamoto University; Nihon University; Waseda University	Mizuguchi, N (corresponding author), Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan.	mizuguchi@suou.waseda.jp		Muraoka, Tetsuro/0000-0002-2303-1139; Nakagawa, Kento/0000-0002-6203-6602	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant for the fellows of the Japan Society for the Promotion of Science awarded to NM and the Grant-in-Aid for the Global COE "Sport Sciences for the Promotion of Active Life,'' Waseda University, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Fluet MC, 2010, J NEUROSCI, V30, P15175, DOI 10.1523/JNEUROSCI.3343-10.2010; Fourkas AD, 2006, BEHAV BRAIN RES, V168, P190, DOI 10.1016/j.bbr.2005.10.015; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; HASEGAWA Y, FURTHER INSIGHT TASK; Hashimoto R, 1999, EXP BRAIN RES, V125, P75, DOI 10.1007/s002210050660; Isaac AR., 1992, SPORT PSYCHOL, V6, P192, DOI [10.1123/tsp.6.2.192, DOI 10.1123/TSP.6.2.192, DOI 10.1123/tsp.6.2.192]; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Li S, 2004, COGNITIVE BRAIN RES, V20, P273, DOI 10.1016/j.cogbrainres.2004.03.003; Liang N, 2007, NEUROREPORT, V18, P1241, DOI 10.1097/WNR.0b013e3282202707; McAvinue LP, 2008, EUR J COGN PSYCHOL, V20, P232, DOI 10.1080/09541440701394624; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Mizuguchi N, 2009, EXP BRAIN RES, V196, P529, DOI 10.1007/s00221-009-1875-5; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Sakamoto M, 2009, NEUROSCI RES, V65, P23, DOI 10.1016/j.neures.2009.05.003; Stevens JA, 2005, COGNITION, V95, P329, DOI 10.1016/j.cognition.2004.02.008; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tinazzi M, 2003, EXP BRAIN RES, V150, P222, DOI 10.1007/s00221-003-1448-y; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Villiger M, 2011, EXP BRAIN RES, V209, P85, DOI 10.1007/s00221-010-2522-x; Yahagi S, 1998, ELECTROMYOGR MOTOR C, V109, P409, DOI 10.1016/S0924-980X(98)00041-1	26	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26006	10.1371/journal.pone.0026006	http://dx.doi.org/10.1371/journal.pone.0026006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022491	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600034
J	Cook, DC; Fraser, RW; Paini, DR; Warden, AC; Lonsdale, WM; De Barro, PJ				Cook, David C.; Fraser, Rob W.; Paini, Dean R.; Warden, Andrew C.; Lonsdale, W. Mark; De Barro, Paul J.			Biosecurity and Yield Improvement Technologies Are Strategic Complements in the Fight against Food Insecurity	PLOS ONE			English	Article							MAJOR CROPS; WHEAT; SPREAD; INVASIONS; LOSSES	The delivery of food security via continued crop yield improvement alone is not an effective food security strategy, and must be supported by pre- and post-border biosecurity policies to guard against perverse outcomes. In the wake of the green revolution, yield gains have been in steady decline, while post-harvest crop losses have increased as a result of insufficiently resourced and uncoordinated efforts to control spoilage throughout global transport and storage networks. This paper focuses on the role that biosecurity is set to play in future food security by preventing both pre- and post-harvest losses, thereby protecting crop yield. We model biosecurity as a food security technology that may complement conventional yield improvement policies if the gains in global farm profits are sufficient to offset the costs of implementation and maintenance. Using phytosanitary measures that slow global spread of the Ug99 strain of wheat stem rust as an example of pre-border biosecurity risk mitigation and combining it with post-border surveillance and invasive alien species control efforts, we estimate global farm profitability may be improved by over US$4.5 billion per annum.	[Cook, David C.] Dept Agr & Food Western Australia, Bunbury, WA, Australia; [Cook, David C.; Paini, Dean R.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Fraser, Rob W.] Univ Kent, Dept Econ, Kent, OH USA; [Paini, Dean R.; Warden, Andrew C.; Lonsdale, W. Mark; De Barro, Paul J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cook, DC (corresponding author), Dept Agr & Food Western Australia, Bunbury, WA, Australia.	david.cook@agric.wa.gov.au	Paini, Dean R/C-2341-2009; Warden, Andrew C/C-1484-2008; Cook, David C/C-1064-2009; De Barro, Paul J/C-1724-2008; Lonsdale, Mark/C-1403-2008	Warden, Andrew C/0000-0003-2683-9798; Cook, David C/0000-0002-2954-7697; Lonsdale, Mark/0000-0002-6163-3691	Cooperative Research Centre for National Plant Biosecurity [CRC10162]; Australian Government's Cooperative Research Centres	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was supported by the Cooperative Research Centre for National Plant Biosecurity (Project No. CRC10162), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; Barrett C., 2002, HDB AGR EC, V2; Biosecurity Australia, 2001, GUID IMP RISK AN; Byerlee D., 1993, IMPACTS INT WHEAT BR; Cook DC, 2010, RISK ANAL, V30, P1303, DOI 10.1111/j.1539-6924.2010.01439.x; COOK DC, 2003, PRIORITISING EXOTIC, P185; Cribb J, 2010, COMING FAMINE: THE GLOBAL FOOD CRISIS AND WHAT WE CAN DO TO AVOID IT, P1; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; Edkins Jenny, 2000, WHOSE HUNGER CONCEPT; FAO, 2010, FAOSTAT DAT; *FAPRI, 2010, ELAST; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Food and Agriculture Organization (FAO), 2010, STATE FOOD INSECURIT; Hengeveld B., 1989, DYNAMICS BIOL INVASI; Hengeweld R., 1989, DYNAMICS BIOL INVASI; Hinchy M. D., 1991, COST BENEFIT ANAL QU; Hodson DP, 2007, J AGR SCI-CAMBRIDGE, V145, P115, DOI 10.1017/S0021859607006855; HOLMES EE, 1993, AM NAT, V142, P779, DOI 10.1086/285572; *INT MON FUND, 2010, PRIM COMM PRIC; KHETARPA RK, 2008, INT C WHEAT STEM RUS, P71; LAL D, 1992, POLITICAL EC INTERAC, P27; Lantican M.A., 2005, IMPACTS INT WHEAT BR; LANTICAN MA, 2002, CIM MYT WORLD WHEAT, P39; Leff B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002108; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; LUCIA MD, 1994, AGR ENG DEV POST HAR; Maxwell S, 1996, FOOD POLICY, V21, P155, DOI 10.1016/0306-9192(95)00074-7; McCann K, 2000, THEOR POPUL BIOL, V57, P97, DOI 10.1006/tpbi.1999.1444; MEERBURG BG, 2009, PEST MANAGEMENT SCI, V65; MOODY ME, 1988, J APPL ECOL, V25, P1009, DOI 10.2307/2403762; Neethirajan S, 2007, FOOD CONTROL, V18, P157, DOI 10.1016/j.foodcont.2005.09.008; Normile D, 2010, SCIENCE, V327, P806, DOI 10.1126/science.327.5967.806; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Okubo A., 2002, DIFFUSION ECOLOGICAL; PAINI DR, 2010, CRC10001 NAT PLANT B; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; PRABHU KV, 2008, INT C WHEAT STEM RUS, P67; Reynolds MP, 2006, J AGR SCI-CAMBRIDGE, V144, P3, DOI 10.1017/S0021859606005867; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; SEN AM, 1992, POLITICAL EC DEV UND, P5; Shigesada N, 1997, BIOL INVASIONS THEOR; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Stoeckel A., 2008, HIGH FOOD PRICES CAU; Stokstad E, 2007, SCIENCE, V315, P1786, DOI 10.1126/science.315.5820.1786; Trethowan RM, 2002, CROP SCI, V42, P1441, DOI 10.2135/cropsci2002.1441; TROSTLE R, 2008, WRS0801 USDA, P30; U.S. Department of State, 2008, COUNTR REP HUM RIGHT; *UN, 2002, WORLD POP PROSP 2000; Walker P., 1989, FAMINE EARLY WARNING; Wilby, 2005, NEW AGENDA BIOSECURI	53	21	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26084	10.1371/journal.pone.0026084	http://dx.doi.org/10.1371/journal.pone.0026084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022517	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000066
J	El Ayadi, A; Zigmond, MJ				El Ayadi, Amina; Zigmond, Michael J.			Low Concentrations of Methamphetamine Can Protect Dopaminergic Cells against a Larger Oxidative Stress Injury: Mechanistic Study	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; RAT-BRAIN; IN-VITRO; NEURODEGENERATIVE DISEASES; 6-HYDROXYDOPAMINE LESIONS; PRECONDITIONING PROTECTS; EXTRACELLULAR DOPAMINE; ACTIVATED RECEPTOR-1	Mild stress can protect against a larger insult, a phenomenon termed preconditioning or tolerance. To determine if a low intensity stressor could also protect cells against intense oxidative stress in a model of dopamine deficiency associated with Parkinson disease, we used methamphetamine to provide a mild, preconditioning stress, 6-hydroxydopamine (6-OHDA) as a source of potentially toxic oxidative stress, and MN9D cells as a model of dopamine neurons. We observed that prior exposure to subtoxic concentrations of methamphetamine protected these cells against 6-OHDA toxicity, whereas higher concentrations of methamphetamine exacerbated it. The protection by methamphetamine was accompanied by decreased uptake of both [H-3] dopamine and 6-OHDA into the cells, which may have accounted for some of the apparent protection. However, a number of other effects of methamphetamine exposure suggest that the drug also affected basic cellular survival mechanisms. First, although methamphetamine preconditioning decreased basal pERK1/2 and pAkt levels, it enhanced the 6-OHDA-induced increase in these phosphokinases. Second, the apparent increase in pERK1/2 activity was accompanied by increased pMEK1/2 levels and decreased activity of protein phosphatase 2. Third, methamphetamine upregulated the pro-survival protein Bcl-2. Our results suggest that exposure to low concentrations of methamphetamine cause a number of changes in dopamine cells, some of which result in a decrease in their vulnerability to subsequent oxidative stress. These observations may provide insights into the development of new therapies for prevention or treatment of PD.	[El Ayadi, Amina; Zigmond, Michael J.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [El Ayadi, Amina] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston	El Ayadi, A (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	amelayad@utmb.edu; zigmond@pitt.edu		El Ayadi, Amina/0000-0002-3657-0633	National Institute of Neurological Disorders and Stroke "NINDS'' [NS19608]; US Department of Army [DAMD 17-03-047]; Levi Montalcini/International Brain Research Organization (IBRO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019608, P01NS019608, R01NS070825] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke "NINDS''(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Army; Levi Montalcini/International Brain Research Organization (IBRO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke "NINDS'' (NS19608), the US Department of Army grant (DAMD 17-03-047) and the Levi Montalcini/International Brain Research Organization (IBRO) fellowship for AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa T, 1997, BRAIN RES, V767, P34, DOI 10.1016/S0006-8993(97)00542-8; Ajimaporn A, 2008, BRAIN RES BULL, V77, P361, DOI 10.1016/j.brainresbull.2008.09.006; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Begum N, 1996, J BIOL CHEM, V271, P31166, DOI 10.1074/jbc.271.49.31166; Behl C, 1999, PROG NEUROBIOL, V57, P301, DOI 10.1016/S0301-0082(98)00055-0; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Berman SB, 1996, J NEUROCHEM, V67, P593; Bezard E, 2003, J NEUROSCI, V23, P10999; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 1997, SYNAPSE, V25, P176; Cannon JR, 2006, BRAIN RES, V1116, P177, DOI 10.1016/j.brainres.2006.07.094; Cannon JR, 2005, NEUROSCI LETT, V373, P189, DOI 10.1016/j.neulet.2004.10.089; Carvalho F, 2001, ADDICT BIOL, V6, P213, DOI 10.1080/13556210120056544; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; De Miglio MR, 2002, CANCER RES, V62, P4459; Defazio G, 1996, BRAIN RES BULL, V40, P257, DOI 10.1016/0361-9230(96)00041-X; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dobrossy MD, 2003, EXP NEUROL, V184, P274, DOI 10.1016/S0014-4886(03)00028-1; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Ebert AD, 2005, EXP NEUROL, V191, pS80, DOI 10.1016/j.expneurol.2004.08.024; El Ayadi A, 2001, METAB BRAIN DIS, V16, P121; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Feng H, 2004, ONCOGENE, V23, P7310, DOI 10.1038/sj.onc.1208041; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Guilarte TR, 2001, NEUROTOXICOLOGY, V22, P725, DOI 10.1016/S0161-813X(01)00046-8; Hanson GR, 1998, ANN NY ACAD SCI, V844, P103, DOI 10.1111/j.1749-6632.1998.tb08225.x; Haq SEA, 1998, FEBS LETT, V434, P305, DOI 10.1016/S0014-5793(98)01000-X; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; Imam SZ, 2002, ANN NY ACAD SCI, V965, P204; Johnson-Davis KL, 2004, J PHARMACOL EXP THER, V309, P578, DOI 10.1124/jpet.103.062695; Johnson-Davis KL, 2003, EUR J PHARMACOL, V482, P151, DOI 10.1016/j.ejphar.2003.09.063; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kokoshka JM, 1998, BRAIN RES, V799, P78, DOI 10.1016/S0006-8993(98)00472-7; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Leak RK, 2006, J NEUROCHEM, V99, P1151, DOI 10.1111/j.1471-4159.2006.04149.x; Lebuffe G, 2003, AM J PHYSIOL-HEART C, V284, pH299, DOI 10.1152/ajpheart.00706.2002; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Li RCX, 2000, AM J PHYSIOL-HEART C, V279, pH1679, DOI 10.1152/ajpheart.2000.279.4.H1679; Lin AN, 2002, AGING CELL, V1, P112, DOI 10.1046/j.1474-9728.2002.00014.x; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Linsenbardt AJ, 2009, NEUROTOXICOLOGY, V30, P1030, DOI 10.1016/j.neuro.2009.07.006; Liu JW, 2006, BRAIN RES, V1098, P113, DOI 10.1016/j.brainres.2006.04.086; Lotharius J, 2001, ANN NEUROL, V49, P79, DOI 10.1002/1531-8249(200101)49:1<79::AID-ANA11>3.0.CO;2-D; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Marini M, 1996, INT J RADIAT BIOL, V70, P337, DOI 10.1080/095530096145076; Matsuzaki H, 2004, BIOL PSYCHIAT, V55, P52, DOI 10.1016/S0006-3223(03)00785-6; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Mocanu MM, 2002, J MOL CELL CARDIOL, V34, P661, DOI 10.1006/jmcc.2002.2006; Mockridge JW, 2000, AM J PHYSIOL-HEART C, V279, pH492, DOI 10.1152/ajpheart.2000.279.2.H492; Moroz IA, 2004, EXP NEUROL, V189, P78, DOI 10.1016/j.expneurol.2004.05.012; Oh YJ, 1995, NEUROBIOL DIS, V2, P157, DOI 10.1006/nbdi.1995.0017; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Park SU, 2002, J NEUROSCI, V22, P4399, DOI 10.1523/JNEUROSCI.22-11-04399.2002; Peng J, 2003, IUBMB LIFE, V55, P267, DOI 10.1080/1521654031000121666; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pike CJ, 1996, J NEUROCHEM, V66, P1374; Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Sato M, 2000, AM J PHYSIOL-HEART C, V279, pH901, DOI 10.1152/ajpheart.2000.279.3.H901; Shankaran M, 1998, PHARMACOL BIOCHEM BE, V61, P361, DOI 10.1016/S0091-3057(98)00103-8; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Smith AD, 2002, NEUROPSYCHOPHARMACOL, V26, P756, DOI 10.1016/S0893-133X(01)00420-1; Smith KJ, 2007, BRAIN RES, V1157, P74, DOI 10.1016/j.brainres.2007.04.056; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Sommer C, 2008, J NEUROPATH EXP NEUR, V67, P85, DOI 10.1097/nen.0b013e3181630ba6; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stowe DF, 2004, ANTIOXID REDOX SIGN, V6, P439, DOI 10.1089/152308604322899512; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Tai KK, 2002, J NEUROSCI RES, V69, P559, DOI 10.1002/jnr.10309; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; WALL SC, 1995, MOL PHARMACOL, V47, P544; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhang QG, 2009, NEUROSCI RES, V63, P205, DOI 10.1016/j.neures.2008.12.010; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; ZIGMOND MJ, 1997, 6 HYDROXYDOPAMINE TO, P75; Zuo ZY, 2006, EUR J PHARMACOL, V542, P84, DOI 10.1016/j.ejphar.2006.05.027	103	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24722	10.1371/journal.pone.0024722	http://dx.doi.org/10.1371/journal.pone.0024722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022363	Green Accepted, Green Published, gold			2022-12-25	WOS:000295976000005
J	Everman, S; Yi, ZP; Langlais, P; Mandarino, LJ; Luo, ML; Roberts, C; Katsanos, CS				Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.			Reproducibility of an HPLC-ESI-MS/MS Method for the Measurement of Stable-Isotope Enrichment of in Vivo-Labeled Muscle ATP Synthase Beta Subunit	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; MITOCHONDRIAL; INSULIN; BETA-F1-ATPASE; RATES; EXPRESSION; TURNOVER; DYNAMICS	We sought to evaluate the reproducibility of a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based approach to measure the stable-isotope enrichment of in vivo-labeled muscle ATP synthase beta subunit (beta-F1-ATPase), a protein most directly involved in ATP production, and whose abundance is reduced under a variety of circumstances. Muscle was obtained from a rat infused with stable-isotope-labeled leucine. The muscle was homogenized, beta-F1-ATPase immunoprecipitated, and the protein was resolved using 1D-SDS PAGE. Following trypsin digestion of the isolated protein, the resultant peptide mixtures were subjected to analysis by HPLC-ESI-MS/MS, which resulted in the detection of multiple beta-F1-ATPase peptides. There were three beta-F1-ATPase unique peptides with a leucine residue in the amino acid sequence, and which were detected with high intensity relative to other peptides and assigned with >95% probability to beta-F1-ATPase. These peptides were specifically targeted for fragmentation to access their stable-isotope enrichment based on MS/MS peak areas calculated from extracted ion chromatographs for selected labeled and unlabeled fragment ions. Results showed best linearity (R(2) = 0.99) in the detection of MS/MS peak areas for both labeled and unlabeled fragment ions, over a wide range of amounts of injected protein, specifically for the beta-F1-ATPase(134-143) peptide. Measured stable-isotope enrichment was highly reproducible for the beta-F1-ATPase(134-143) peptide (CV = 2.9%). Further, using mixtures of synthetic labeled and unlabeled peptides we determined that there is an excellent linear relationship (R(2) = 0.99) between measured and predicted enrichment for percent enrichments ranging between 0.009% and 8.185% for the beta-F1-ATPase(134-143) peptide. The described approach provides a reliable approach to measure the stable-isotope enrichment of in-vivo-labeled muscle beta-F1-ATPase based on the determination of the enrichment of the beta-F1-ATPase(134-143) peptide.	[Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.] Mayo Clin Arizona, Scottsdale, AZ USA; [Yi, Zhengping] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm Hlth Sci, Detroit, MI USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Wayne State University	Everman, S (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA.	christos.katsanos@asu.edu			Arizona State University; National Institutes of Health [R01DK47936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047936] Funding Source: NIH RePORTER	Arizona State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work conducted at the Center for Metabolic and Vascular Biology at Arizona State University and was partially supported by Arizona State University start-up funds (to CK) and by the National Institutes of Health grant R01DK47936 (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Burd Nicholas A, 2011, Nutr Metab (Lond), V8, P15, DOI 10.1186/1743-7075-8-15; Chinkes D, 1996, AM J PHYSIOL-ENDOC M, V270, pE67, DOI 10.1152/ajpendo.1996.270.1.E67; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; IZQUIERDO JM, 1995, EUR J BIOCHEM, V232, P344, DOI 10.1111/j.1432-1033.1995.tb20817.x; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lombardi A, 2009, J PROTEOMICS, V72, P708, DOI 10.1016/j.jprot.2009.02.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Newcomer B, 2001, INT J OBESITY, V25, P1309, DOI 10.1038/sj.ijo.0801673; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wolfe RR, 2004, ISOTOPE TRACERS META; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355	20	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26171	10.1371/journal.pone.0026171	http://dx.doi.org/10.1371/journal.pone.0026171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022551	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000079
J	Henderson, BR; Saeedi, BJ; Campagnola, G; Geiss, BJ				Henderson, Brittney R.; Saeedi, Bejan J.; Campagnola, Grace; Geiss, Brian J.			Analysis of RNA Binding by the Dengue Virus NS5 RNA Capping Enzyme	PLOS ONE			English	Article							TYPE-2 NONSTRUCTURAL PROTEIN-3; MESSENGER-RNA; NTPASE ACTIVITY; CAP STRUCTURE; METHYLTRANSFERASE; HELICASE; 5'-TRIPHOSPHATASE; IDENTIFICATION; METHYLATIONS; RECOGNITION	Flaviviruses are small, capped positive sense RNA viruses that replicate in the cytoplasm of infected cells. Dengue virus and other related flaviviruses have evolved RNA capping enzymes to form the viral RNA cap structure that protects the viral genome and directs efficient viral polyprotein translation. The N-terminal domain of NS5 possesses the methyltransferase and guanylyltransferase activities necessary for forming mature RNA cap structures. The mechanism for flavivirus guanylyltransferase activity is currently unknown, and how the capping enzyme binds its diphosphorylated RNA substrate is important for deciphering how the flavivirus guanylyltransferase functions. In this report we examine how flavivirus NS5 N-terminal capping enzymes bind to the 5' end of the viral RNA using a fluorescence polarization-based RNA binding assay. We observed that the K-D for RNA binding is approximately 200 nM Dengue, Yellow Fever, and West Nile virus capping enzymes. Removal of one or both of the 5' phosphates reduces binding affinity, indicating that the terminal phosphates contribute significantly to binding. RNA binding affinity is negatively affected by the presence of GTP or ATP and positively affected by S-adensyl methoninine (SAM). Structural superpositioning of the dengue virus capping enzyme with the Vaccinia virus VP39 protein bound to RNA suggests how the flavivirus capping enzyme may bind RNA, and mutagenesis analysis of residues in the putative RNA binding site demonstrate that several basic residues are critical for RNA binding. Several mutants show differential binding to 5' di-, mono-, and un-phosphorylated RNAs. The mode of RNA binding appears similar to that found with other methyltransferase enzymes, and a discussion of diphosphorylated RNA binding is presented.	[Henderson, Brittney R.; Saeedi, Bejan J.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Campagnola, Grace; Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Henderson, BR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Saeedi, Bejan/0000-0001-8356-5960	Rocky Mountain Regional Center for Excellence 10 [U54 AI-065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Center for Excellence 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a grant from the Rocky Mountain Regional Center for Excellence 10 (U54 AI-065357) to BJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; CONG PJ, 1995, MOL CELL BIOL, V15, P6222; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; MARTIN RL, 1991, ARCH BIOCHEM BIOPHYS, V284, P26, DOI 10.1016/0003-9861(91)90257-J; Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001; Ogino T, 2008, J VIROL, V82, P7729, DOI 10.1128/JVI.00326-08; PRITCHARD CE, 1994, NUCLEIC ACIDS RES, V22, P2592, DOI 10.1093/nar/22.13.2592; Qiu T, 2003, VIROLOGY, V316, P313, DOI 10.1016/j.virol.2003.08.027; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sippl MJ, 2008, BIOINFORMATICS, V24, P870, DOI 10.1093/bioinformatics/btn020; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	28	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25795	10.1371/journal.pone.0025795	http://dx.doi.org/10.1371/journal.pone.0025795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022449	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000039
J	Maragno, AL; Pironin, M; Alcalde, H; Cong, XL; Knobeloch, KP; Tangy, F; Zhang, DE; Ghysdael, J; Quang, CT				Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Cong, Xiuli; Knobeloch, Klaus-Peter; Tangy, Frederic; Zhang, Dong-Er; Ghysdael, Jacques; Christine Tran Quang			ISG15 Modulates Development of the Erythroid Lineage	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; BCL-X-L; FLI-1-TRANSFORMED ERYTHROBLASTS; RETICULOCYTE MATURATION; STRESS ERYTHROPOIESIS; CONJUGATION SYSTEM; CASPASE ACTIVATION; E2 ENZYME; IN-VIVO; DIFFERENTIATION	Activation of erythropoietin receptor allows erythroblasts to generate erythrocytes. In a search for genes that are up-regulated during this differentiation process, we have identified ISG15 as being induced during late erythroid differentiation. ISG15 belongs to the ubiquitin-like protein family and is covalently linked to target proteins by the enzymes of the ISGylation machinery. Using both in vivo and in vitro differentiating erythroblasts, we show that expression of ISG15 as well as the ISGylation process related enzymes Ube1L, UbcM8 and Herc6 are induced during erythroid differentiation. Loss of ISG15 in mice results in decreased number of BFU-E/CFU-E in bone marrow, concomitant with an increased number of these cells in the spleen of these animals. ISG15(-/-) bone marrow and spleen-derived erythroblasts show a less differentiated phenotype both in vivo and in vitro, and over-expression of ISG15 in erythroblasts is found to facilitate erythroid differentiation. Furthermore, we have shown that important players of erythroid development, such as STAT5, Globin, PLC gamma and ERK2 are ISGylated in erythroid cells. This establishes a new role for ISG15, besides its well-characterized anti-viral functions, during erythroid differentiation.	[Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] CNRS, UMR3306, F-91405 Orsay, France; [Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France; [Knobeloch, Klaus-Peter] Univ Clin Freiburg, Freiburg, Germany; [Tangy, Frederic] Inst Pasteur, CNRS, Unite Genom Virale & Vaccinat, URA 3015, Paris, France; [Cong, Xiuli; Zhang, Dong-Er] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Diego	Maragno, AL (corresponding author), CNRS, UMR3306, F-91405 Orsay, France.	Christine.Tran-Quang@curie.u-psud.fr	QUANG, christine TRAN/G-7508-2016; GHYSDAEL, Jacques/F-3377-2013		Institut Curie; Centre National de la Recherche Scientifique; Institut Nationale de la Sante et de la Recherche Medicale; Ligue Nationale Contre le Cancer; National Institutes of Health [GM066955]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	Institut Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Nationale de la Sante et de la Recherche Medicale; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ALM was supported by a predoctoral fellowship from the Institut Curie. This work was supported by funds from Centre National de la Recherche Scientifique, Institut Nationale de la Sante et de la Recherche Medicale, Ligue Nationale Contre le Cancer (JG, equipe labellisee) and National Institutes of Health grant GM066955 to D-EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Dolznig H, 2006, ONCOGENE, V25, P2890, DOI 10.1038/sj.onc.1209308; Dolznig H, 2002, CURR BIOL, V12, P1076, DOI 10.1016/S0960-9822(02)00930-2; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Fang J, 2008, BLOOD, V112, P886, DOI 10.1182/blood-2008-02-138909; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Lee TL, 2008, BIOCHEM BIOPH RES CO, V375, P326, DOI 10.1016/j.bbrc.2008.07.164; Lesault I, 2002, EMBO J, V21, P694, DOI 10.1093/emboj/21.4.694; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Quadrini KJ, 2006, FEBS LETT, V580, P2285, DOI 10.1016/j.febslet.2006.03.039; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; von Lindern M, 2004, CELL CYCLE, V3, P876; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; ZHANG X, 2010, J INTERFERO IN PRESS; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	47	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26068	10.1371/journal.pone.0026068	http://dx.doi.org/10.1371/journal.pone.0026068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022510	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000062
J	Muroi, A; Ramadan, A; Nishihara, M; Yamamoto, M; Ozawa, R; Takabayashi, J; Arimura, G				Muroi, Atsushi; Ramadan, Abdelaziz; Nishihara, Masahiro; Yamamoto, Masaki; Ozawa, Rika; Takabayashi, Junji; Arimura, Gen-ichiro			The Composite Effect of Transgenic Plant Volatiles for Acquired Immunity to Herbivory Caused by Inter-Plant Communications	PLOS ONE			English	Article							LIMA-BEAN LEAVES; AIRBORNE SIGNALS; INDUCED RESISTANCE; PREDATORY MITE; DEFENSE GENES; RESPONSES; DAMAGE; ARABIDOPSIS; SAGEBRUSH; EMISSION	A blend of volatile organic compounds (VOCs) emitted from plants induced by herbivory enables the priming of defensive responses in neighboring plants. These effects may provide insights useful for pest control achieved with transgenic-plant-emitted volatiles. We therefore investigated, under both laboratory and greenhouse conditions, the priming of defense responses in plants (lima bean and corn) by exposing them to transgenic-plant-volatiles (VOCos) including (E)-beta-ocimene, emitted from transgenic tobacco plants (NtOS2) that were constitutively overexpressing (E)-beta-ocimene synthase. When lima bean plants that had previously been placed downwind of NtOS2 in an open-flow tunnel were infested by spider mites, they were more defensive to spider mites and more attractive to predatory mites, in comparison to the infested plants that had been placed downwind of wild-type tobacco plants. This was similarly observed when the NtOS2-downwind maize plants were infested with Mythimna separata larvae, resulting in reduced larval growth and greater attraction of parasitic wasps (Cotesia kariyai). In a greenhouse experiment, we also found that lima bean plants (VOCos-receiver plants) placed near NtOS2 were more attractive when damaged by spider mites, in comparison to the infested plants that had been placed near the wild-type plants. More intriguingly, VOCs emitted from infested VOCos-receiver plants affected their conspecific neighboring plants to prime indirect defenses in response to herbivory. Altogether, these data suggest that transgenic-plant- emitted volatiles can enhance the ability to prime indirect defenses via both plant-plant and plant-plant-plant communications.	[Muroi, Atsushi; Ramadan, Abdelaziz; Arimura, Gen-ichiro] Kyoto Univ, Global COE Program Evolut & Biodivers, Grad Sch Sci, Kyoto, Japan; [Muroi, Atsushi; Ramadan, Abdelaziz; Yamamoto, Masaki; Ozawa, Rika; Takabayashi, Junji; Arimura, Gen-ichiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Ramadan, Abdelaziz] Ain Shams Univ, Fac Sci, Dept Bot, Cairo, Egypt; [Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan	Kyoto University; Kyoto University; Egyptian Knowledge Bank (EKB); Ain Shams University; Iwate Biotechnology Research Center	Muroi, A (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan.	garimura@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Nishihara, Masahiro/0000-0002-1454-8785; Ramadan, Abdelaziz/0000-0003-4794-5602	Global COE Program Kyoto University [A06]; Research Institute for Sustainable Humanosphere, Kyoto University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Global COE Program Kyoto University; Research Institute for Sustainable Humanosphere, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by the Global COE Program A06 of Kyoto University, and by a research grant for Exploratory Research on Sustainable Humanosphere Science from the Research Institute for Sustainable Humanosphere, Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; Asai N, 2009, PLANT SIGNAL BEHAV, V4, P294, DOI 10.4161/psb.4.4.8275; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Choh Y, 2006, J CHEM ECOL, V32, P2073, DOI 10.1007/s10886-006-9130-z; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; De Boer JG, 2004, J CHEM ECOL, V30, P255, DOI 10.1023/B:JOEC.0000017976.60630.8c; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Heil M, 2010, BIOL LETTERS, V6, P843, DOI 10.1098/rsbl.2010.0440; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Mishiba K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009670; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; TAKABAYASHI J, 1992, ENTOMOL EXP APPL, V64, P187, DOI 10.1111/j.1570-7458.1992.tb01608.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x	32	40	44	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24594	10.1371/journal.pone.0024594	http://dx.doi.org/10.1371/journal.pone.0024594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022359	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000003
J	Thang, ND; Yajima, I; Kumasaka, MY; Ohnuma, S; Yanagishita, T; Hayashi, R; Shekhar, HU; Watanabe, D; Kato, M				Nguyen Dinh Thang; Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Yanagishita, Takeshi; Hayashi, Rumiko; Shekhar, Hossain U.; Watanabe, Daisuke; Kato, Masashi			Barium Promotes Anchorage-Independent Growth and Invasion of Human HaCaT Keratinocytes via Activation of c-SRC Kinase	PLOS ONE			English	Article							TUBE-WELL WATER; MESENCHYMAL TRANSITION; DRINKING-WATER; TRACE-ELEMENTS; CANCER CELLS; EXPRESSION; MATRIX; RET; CONTAMINATION; BANGLADESH	Explosive increases in skin cancers have been reported in more than 36 million patients with arsenicosis caused by drinking arsenic-polluted well water. This study and previous studies showed high levels of barium as well as arsenic in the well water. However, there have been no reports showing a correlation between barium and cancer. In this study, we examined whether barium (BaCl(2)) may independently have cancer-related effects on human precancerous keratinocytes (HaCaT). Barium (5-50 mu M) biologically promoted anchorage-independent growth and invasion of HaCaT cells in vitro. Barium (5 mu M) biochemically enhanced activities of c-SRC, FAK, ERK and MT1-MMP molecules, which regulate anchorage-independent growth and/or invasion. A SRC kinase specific inhibitor, protein phosphatase 2 (PP2), blocked barium-mediated promotion of anchorage-independent growth and invasion with decreased c-SRC kinase activity. Barium (2.5-5 mu M) also promoted anchorage-independent growth and invasion of fibroblasts (NIH3T3) and immortalized nontumorigenic melanocytes (melan-a), but not transformed cutaneous squamous cell carcinoma (HSC5 and A431) and malignant melanoma (Mel-ret) cells, with activation of c-SRC kinase. Taken together, our biological and biochemical findings newly suggest that the levels of barium shown in drinking well water independently has the cancer-promoting effects on precancerous keratinocytes, fibroblast and melanocytes in vitro.	[Nguyen Dinh Thang; Yajima, Ichiro; Kumasaka, Mayuko Y.; Shekhar, Hossain U.; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Nguyen Dinh Thang; Yanagishita, Takeshi; Watanabe, Daisuke] Aichi Med Univ, Dept Dermatol, Sch Med, Nagakute, Aichi 48011, Japan; [Ohnuma, Shoko; Kato, Masashi] Chubu Univ, Voluntary Body Int Hlth Care, Kasugai, Aichi 487, Japan; [Hayashi, Rumiko] Aichi Prefectural Inst Publ Hlth, Nagoya, Aichi 462, Japan	Chubu University; Aichi Medical University; Chubu University	Thang, ND (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; Watanabe, Daisuke/AAG-2962-2021; YAJIMA, Ichiro/I-7467-2014	Shekhar, Hossain/0000-0002-8960-0840; Watanabe, Daisuke/0000-0001-6817-3993	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003, 23650241, S0801055]; Japan Society for the Promotion of Science (JSPS); Lydia O'Leary Memorial Foundation; Tokyo Biochemical Research Foundation (TBRF); Mitsui Co., Ltd. [R08-C097]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Lydia O'Leary Memorial Foundation; Tokyo Biochemical Research Foundation (TBRF); Mitsui Co., Ltd.(Mitsui & Co., LTD.)	This work was supported in part by Grants-in-Aid for Scientific Research (B)(No. 19390168, 20406003), Grant-in-Aid for Challenging Exploratory Research (No. 23650241) and COE Project for Private Universities (Health Science Hills) (S0801055) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science (JSPS) Asia Africa Science Platform Program, Lydia O'Leary Memorial Foundation, Research Grant from the Tokyo Biochemical Research Foundation (TBRF) and Mitsui & Co., Ltd. Environment Fund (R08-C097). The authors also declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusa T, 2006, ENVIRON POLLUT, V139, P95, DOI 10.1016/j.envpol.2005.04.033; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Biswas BK, 1998, CURR SCI INDIA, V74, P134; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Chanpiwat P, 2011, ENVIRON POLLUT, V159, P567, DOI 10.1016/j.envpol.2010.10.007; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; DIETZ DD, 1992, FUND APPL TOXICOL, V19, P527, DOI 10.1016/0272-0590(92)90091-U; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Frisbie SH, 2009, ENVIRON HEALTH PERSP, V117, P410, DOI 10.1289/ehp.11886; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Kang J, 2008, INT J MOL MED, V21, P777; Kato M, 2003, P NATL ACAD SCI USA, V100, P6398, DOI 10.1073/pnas.1132162100; Kato M., 2010, Toxicological and Environmental Chemistry, V92, P1609, DOI 10.1080/02772241003707454; Kato M, 2002, CANCER RES, V62, P2414; Kato M, 1999, ONCOGENE, V18, P837, DOI 10.1038/sj.onc.1202329; KATO M, 2011, CANC EPIDEM IN PRESS; Kato M, 2008, J TOXICOL ENV HEAL A, V71, P1053, DOI 10.1080/15287390802114998; Kato M, 2011, TOXICOL IN VITRO, V25, P623, DOI 10.1016/j.tiv.2010.12.012; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kurokawa M, 2001, ARCH DERMATOL, V137, P102; LAKSHMI SC, 2007, AM J PHYSIOL-CELL PH, V292, P1701; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P517, DOI 10.1089/15230860260196326; National Toxicology Program, 1994, Natl Toxicol Program Tech Rep Ser, V432, P1; NISHIOKA H, 1975, MUTAT RES, V31, P185, DOI 10.1016/0165-1161(75)90088-6; Ohshima Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/j.jdermsci.2009.11.004; PERRY HM, 1983, TRACE SUBST ENV HLTH, V16, P155; Pu MY, 1996, ONCOGENE, V13, P2615; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smola-Hess S, 2005, J GEN VIROL, V86, P1291, DOI 10.1099/vir.0.80551-0; Takino T, 2010, BIOCHEM BIOPH RES CO, V396, P1042, DOI 10.1016/j.bbrc.2010.05.059; TANIGUCHI M, 1992, ONCOGENE, V7, P1491; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yajima I, 2009, J DERMATOL SCI, V55, P68, DOI 10.1016/j.jdermsci.2009.02.010	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25636	10.1371/journal.pone.0025636	http://dx.doi.org/10.1371/journal.pone.0025636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022425	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000027
J	Sotoyama, H; Zheng, YJ; Iwakura, Y; Mizuno, M; Aizawa, M; Shcherbakova, K; Wang, R; Namba, H; Nawa, H				Sotoyama, Hidekazu; Zheng, Yingjun; Iwakura, Yuriko; Mizuno, Makoto; Aizawa, Miho; Shcherbakova, Ksenia; Wang, Ran; Namba, Hisaaki; Nawa, Hiroyuki			Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PRENATAL IMMUNE ACTIVATION; PREPULSE INHIBITION; BASAL GANGLIA; PREFRONTAL CORTEX; IN-VIVO; NEUROLEPTIC-NAIVE; GABAERGIC NEURONS; GENE-EXPRESSION; AMNIOTIC-FLUID	Epidermal growth factor (EGF) is one of the ErbB receptor ligands implicated in schizophrenia neuropathology as well as in dopaminergic development. Based on the immune inflammatory hypothesis for schizophrenia, neonatal rats are exposed to this cytokine and later develop neurobehavioral abnormality such as prepulse inhibition (PPI) deficit. Here we found that the EGF-treated rats exhibited persistent increases in tyrosine hydroxylase levels and dopamine content in the globus pallidus. Furthermore, pallidal dopamine release was elevated in EGF-treated rats, but normalized by subchronic treatment with risperidone concomitant with amelioration of their PPI deficits. To evaluate pathophysiologic roles of the dopamine abnormality, we administered reserpine bilaterally to the globus pallidus to reduce the local dopamine pool. Reserpine infusion ameliorated PPI deficits of EGF-treated rats without apparent aversive effects on locomotor activity in these rats. We also administered dopamine D1-like and D2-like receptor antagonists (SCH23390 and raclopride) and a D2-like receptor agonist (quinpirole) to the globus pallidus and measured PPI and bar-hang latencies. Raclopride (0.5 and 2.0 mu g/site) significantly elevated PPI levels of EGF-treated rats, but SCH23390 (0.5 and 2.0 mu g/site) had no effect. The higher dose of raclopride induced catalepsy-like changes in control animals but not in EGF-treated rats. Conversely, local quinpirole administration to EGF-untreated control rats induced PPI deficits and anti-cataleptic behaviors, confirming the pathophysiologic role of the pallidal hyperdopaminergic state. These findings suggest that the pallidal dopaminergic innervation is vulnerable to circulating EGF at perinatal and/or neonatal stages and has strong impact on the D2-like receptor-dependent behavioral deficits relevant to schizophrenia.	[Sotoyama, Hidekazu; Zheng, Yingjun; Iwakura, Yuriko; Mizuno, Makoto; Aizawa, Miho; Shcherbakova, Ksenia; Wang, Ran; Namba, Hisaaki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan	Niigata University	Sotoyama, H (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan.	hnawa@bri.niigata-u.ac.jp	Sotoyama, Hidekazu/AAD-4953-2019; Shcherbakova, Ksenia/GZK-5646-2022	Shcherbakova, Ksenia/0000-0001-5091-6795; Sotoyama, Hidekazu/0000-0002-7206-0454	JST Agency; Takeda Science Foundation	JST Agency; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by a Grant-in-Aid for Basic Scientific Research (B), Health and Labor Sciences Research Grants, Core Research for Evolutional Science and Technology from the JST Agency, Takeda Science Foundation, and grants for Promotion of Niigata University Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Anttila S, 2004, NEUROREPORT, V15, P1215, DOI 10.1097/00001756-200405190-00027; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Bouali-Benazzouz R, 2009, NEUROSCIENCE, V164, P588, DOI 10.1016/j.neuroscience.2009.07.034; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; EARLY TS, 1987, P NATL ACAD SCI USA, V84, P561, DOI 10.1073/pnas.84.2.561; Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39; ElKhodor BF, 1997, EXP NEUROL, V145, P118, DOI 10.1006/exnr.1997.6437; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fuchs H, 2004, NEUROCHEM INT, V45, P1029, DOI 10.1016/j.neuint.2004.05.008; Fuchs H, 2004, EXP BRAIN RES, V154, P66, DOI 10.1007/s00221-003-1638-7; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Goto Y, 2007, INT REV NEUROBIOL, V78, P41, DOI 10.1016/S0074-7742(06)78002-3; Gur RE, 1998, AM J PSYCHIAT, V155, P1711, DOI 10.1176/ajp.155.12.1711; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hashimoto R, 2009, WORLD J BIOL PSYCHIA, V10, P65, DOI 10.1080/15622970701762536; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hofmann GE, 1990, ACTA OBSTET GYN SCAN, V69, P217, DOI 10.3109/00016349009028683; Hokama H, 1995, PSYCHIAT RES-NEUROIM, V61, P209, DOI 10.1016/0925-4927(95)02729-H; IWAKURA Y, 2011, J NEUROCHEM IN PRESS; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Iwakura Y, 2011, J NEUROCHEM, V118, P45, DOI 10.1111/j.1471-4159.2011.07287.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; KODSI MH, 1995, BEHAV NEUROSCI, V109, P912, DOI 10.1037/0735-7044.109.5.912; KORNBLUM HI, 1995, NEUROSCIENCE, V69, P1025, DOI 10.1016/0306-4522(95)00392-V; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Marchese G, 2003, BRIT J PHARMACOL, V140, P520, DOI 10.1038/sj.bjp.0705478; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Menon V, 2001, AM J PSYCHIAT, V158, P646, DOI 10.1176/appi.ajp.158.4.646; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Mizuno M, 2004, ANN NY ACAD SCI, V1025, P612, DOI 10.1196/annals.1316.076; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Nagano T, 2007, EUR J NEUROSCI, V25, P380, DOI 10.1111/j.1460-9568.2007.05297.x; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; OGREN SO, 1988, NEUROSCI LETT, V85, P333, DOI 10.1016/0304-3940(88)90588-5; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Prensa L, 2009, J NEURAL TRANSM-SUPP, P49, DOI 10.1007/978-3-211-92660-4_4; Qu Y, 2008, PHARMACOL BIOCHEM BE, V90, P686, DOI 10.1016/j.pbb.2008.05.012; Qu Y, 2009, PSYCHOPHARMACOLOGY, V207, P271, DOI 10.1007/s00213-009-1654-9; Querejeta E, 2001, NEUROSCI LETT, V300, P79, DOI 10.1016/S0304-3940(01)01550-6; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Rommelfanger KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00139; Sano H, 2003, J NEUROSCI, V23, P9078; Shibuya M, 2010, J NEURAL TRANSM, V117, P887, DOI 10.1007/s00702-010-0418-3; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Smith Y, 1998, NEUROSCIENCE, V86, P353; SOLBRIG M, 2004, RAT NERVOUS SYSTEM; Sotoyama H, 2007, PSYCHOPHARMACOLOGY, V191, P783, DOI 10.1007/s00213-006-0595-9; Spinks R, 2005, SCHIZOPHR RES, V73, P229, DOI 10.1016/j.schres.2004.05.020; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Toda Mitsuru, 2007, Curr Psychiatry Rep, V9, P329, DOI 10.1007/s11920-007-0041-7; Tohmi M, 2005, BEHAV GENET, V35, P615, DOI 10.1007/s10519-005-5357-7; Tsuda N, 2008, BRAIN DEV-JPN, V30, P533, DOI 10.1016/j.braindev.2008.01.006; Varner MW, 1996, J SOC GYNECOL INVEST, V3, P17, DOI 10.1016/1071-5576(95)00044-5; Virgintino D, 1998, INT J DEV BIOL, V42, P1165; VONBOHLEN, 2009, DEV ENG DOPAMINE NEU, P73; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wakuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003648; Winter C, 2008, EUR NEUROPSYCHOPHARM, V18, P712, DOI 10.1016/j.euroneuro.2008.06.001; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518	76	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25831	10.1371/journal.pone.0025831	http://dx.doi.org/10.1371/journal.pone.0025831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022452	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000042
J	Stieler, K; Schindler, S; Schlomm, T; Hohn, O; Bannert, N; Simon, R; Minner, S; Schindler, M; Fischer, N				Stieler, Kristin; Schindler, Sarah; Schlomm, Thorsten; Hohn, Oliver; Bannert, Norbert; Simon, Ronald; Minner, Sarah; Schindler, Michael; Fischer, Nicole			No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; INFECTIOUS RETROVIRUS; PREVALENCE; EPITHELIUM; ABSENCE; PCR	Background: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). Methodology/Principal Findings: Peripheral bloodmononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissuemicroarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. Conclusion: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining.	[Stieler, Kristin; Schindler, Sarah; Fischer, Nicole] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol & Virol, Hamburg, Germany; [Schindler, Sarah; Schindler, Michael] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, Hamburg, Germany; [Hohn, Oliver; Bannert, Norbert] Ctr HIV & Retrovirol, Robert Koch Inst, Berlin, Germany; [Simon, Ronald; Minner, Sarah] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Robert Koch Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stieler, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol & Virol, Hamburg, Germany.	nfischer@uke.de	Schlomm, Thorsten/G-8046-2011; Schindler, Michael/C-1647-2015	Schindler, Michael/0000-0001-8989-5813; Simon, Ronald/0000-0003-0158-4258				Alberts B, 2011, SCIENCE, V333, P35, DOI 10.1126/science.333.6038.35-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Baraniuk JN, 2010, CURR ALLERGY ASTHM R, V10, P210, DOI 10.1007/s11882-010-0106-2; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Cohen J, 2011, SCIENCE, V331, P1253, DOI 10.1126/science.331.6022.1253; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Groom HC, 2010, P NATL ACAD SCI US; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Menendez-Arias L, 2011, REV MED VIROL, V21, P3, DOI 10.1002/rmv.673; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Sauter D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-103; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Shin CH, 2011, J VIROL; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler KSC, 2010, VIROLOGY; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Switzer WM, 2011, PLOS ONE, P6; Trottier G, 2010, EUR UROL, V57, P358, DOI 10.1016/j.eururo.2009.11.021; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	43	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25592	10.1371/journal.pone.0025592	http://dx.doi.org/10.1371/journal.pone.0025592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022417	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000023
J	Abou-Kheir, W; Hynes, PG; Martin, P; Yin, JJ; Liu, YN; Seng, V; Lake, R; Spurrier, J; Kelly, K				Abou-Kheir, Wassim; Hynes, Paul G.; Martin, Philip; Yin, Juan Juan; Liu, Yen-Nien; Seng, Victoria; Lake, Ross; Spurrier, Joshua; Kelly, Kathleen			Self-Renewing Pten(-/-)TP53(-/-) Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; PROSTATE-CANCER CELLS; STEM-CELLS; PTEN; BONE; TUMORIGENESIS; POPULATION; SURVIVAL; PATHWAY; ORIGIN	Prostate cancers of luminal adenocarcinoma histology display a range of clinical behaviors. Although most prostate cancers are slow-growing and indolent, a proportion is aggressive, developing metastasis and resistance to androgen deprivation treatment. One hypothesis is that a portion of aggressive cancers initiate from stem-like, androgen-independent tumor-propagating cells. Here we demonstrate the in vitro creation of a mouse cell line, selected for growth as self-renewing stem/progenitor cells, which manifests many in vivo properties of aggressive prostate cancer. Normal mouse prostate epithelium containing floxed Pten and TP53 alleles was subjected to CRE-mediated deletion in vitro followed by serial propagation as protospheres. A polyclonal cell line was established from dissociated protospheres and subsequently a clonal daughter line was derived. Both lines demonstrate a mature luminal phenotype in vitro. The established lines contain a stable minor population of progenitor cells with protosphere-forming ability and multi-lineage differentiation capacity. Both lines formed orthotopic adenocarcinoma tumors with metastatic potential to lung. Intracardiac inoculation resulted in brain and lung metastasis, while intra-tibial injection induced osteoblastic bone formation, recapitulating the bone metastatic phenotype of human prostate cancer. The cells showed androgen receptor dependent growth in vitro. Importantly, in vivo, the deprivation of androgens from established orthotopic tumors resulted in tumor regression and eventually castration-resistant growth. These data suggest that transformed prostate progenitor cells preferentially differentiate toward luminal cells and recapitulate many characteristics of the human disease.	[Abou-Kheir, Wassim; Hynes, Paul G.; Martin, Philip; Yin, Juan Juan; Liu, Yen-Nien; Seng, Victoria; Lake, Ross; Spurrier, Joshua; Kelly, Kathleen] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Abou-Kheir, Wassim] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American University of Beirut	Abou-Kheir, W (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov	Abou-Kheir, Wassim/AAP-2587-2020; Liu, Yen-Nien/AAW-4698-2021	Abou-Kheir, Wassim/0000-0001-9719-9324; Spurrier, Joshua/0000-0002-6267-7231	National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010802] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the support of the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; MARTIN PL, 2011, AM J PATHOLOGY; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530	29	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26112	10.1371/journal.pone.0026112	http://dx.doi.org/10.1371/journal.pone.0026112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022528	Green Submitted, gold, Green Published			2022-12-25	WOS:000295973200037
J	Huang, HJ; Angelo, LS; Rodon, J; Sun, M; Kuenkele, KP; Parsons, HA; Trent, JC; Kurzrock, R				Huang, Helen J.; Angelo, Laura S.; Rodon, Jordi; Sun, Michael; Kuenkele, Klaus-Peter; Parsons, Henrique A.; Trent, Jonathan C.; Kurzrock, Razelle			R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis	PLOS ONE			English	Article							NEUROECTODERMAL-TUMOR; SITU HYBRIDIZATION; LUNG-CANCER; CELL-LINE; INSULIN-LIKE-GROWTH-FACTOR-2; TRANSLOCATION; INHIBITORS; M6P/IGF2R; RATIONALE; EWS-FLI1	A subset of patients with Ewing's sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also be suppressed by small interfering (si) RNA against the EWS/FLI-1 fusion protein, the hallmark of Ewing's sarcoma. The growth of two Ewing's sarcoma cell lines (TC-32 and TC-71) was inhibited by the fully human anti-IGF-1R antibody, R1507 (clonogenic and MTT assays). TC-32 and TC-71 cells express high levels of IGF-2, while RD-ES and A4573 Ewing's cell lines, which were less responsive to R1507 in our assays, express low or undetectable IGF-2, respectively. TC-71 cells also expressed high levels of IGF-1R, and R1507 decreased steady-state levels of this receptor by internalization/degradation, an effect which was associated with a decrease in p-IGF-1R, p-IRS-1, and p-Akt. EWS/FLI-1 siRNA also decreased p-Akt, due to its ability to increase IGF-BP3 levels and subsequently decrease IGF-1 and IGF-2 levels, thus inhibiting signaling through p-IGF-1R. This inhibition correlated with growth suppression and apoptosis. The attenuation of Akt activation was confirmed in TC-71 and HEK-293 (human embryonic kidney) cells by transfecting them with IGF-1R siRNA. We conclude that antibodies and siRNA to IGF-1R, as well as siRNA to EWS/FLI-1, act via intersecting IGF/IGF-1R signals that suppress a common point in this pathway, namely the phosphorylation of Akt.	[Huang, Helen J.; Angelo, Laura S.; Rodon, Jordi; Sun, Michael; Parsons, Henrique A.; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Phase Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Rodon, Jordi] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain; [Kuenkele, Klaus-Peter] Roche Diagnost GmbH, Penzberg, Germany; [Trent, Jonathan C.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Div Canc Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Roche Holding; University of Texas System; UTMD Anderson Cancer Center	Huang, HJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Phase Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA.	rkurzroc@mdanderson.org	Trent, Jonathan/AAR-7113-2021; Kurzrock, Razelle/AAU-9782-2020	Trent, Jonathan/0000-0001-6169-5238; Afonseca Parsons, Henrique/0000-0002-0436-4368	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research [RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant number RR024148 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research (http://www.ncrr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran PJ, 2011, J PHARMACOL EXP THER, V337, P644, DOI 10.1124/jpet.110.178400; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Burchill SA, 2008, EXPERT REV ANTICANC, V8, P1675, DOI 10.1586/14737140.8.10.1675; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chapuis N, 2009, HAEMATOLOGICA, V95, P415; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Gong Y, 2009, PLOS ONE, V4, P1; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hailey J, 2002, MOL CANCER THER, V1, P1349; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hu CK, 2006, PROSTATE CANCER P D, V9, P62, DOI 10.1038/sj.pcan.4500842; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Hung G, 2002, INT J ONCOL, V20, P475; Jambhekar NA, 2006, ARCH PATHOL LAB MED, V130, P1813; Jamieson TA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-4; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kolb EA, 2010, PEDIATR BLOOD CANCER, V55, P67, DOI 10.1002/pbc.22479; Kong FM, 2000, ONCOGENE, V19, P1572, DOI 10.1038/sj.onc.1203437; Kotsinas A, 2008, CANCER LETT, V259, P177, DOI 10.1016/j.canlet.2007.10.013; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mateo-Lozano S, 2006, CLIN CANCER RES, V12, P6781, DOI 10.1158/1078-0432.CCR-06-0609; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Meric F, 2000, CLIN CANCER RES, V6, P3832; O'Sullivan MJ, 2001, HUM PATHOL, V32, P1109, DOI 10.1053/hupa.2001.28247; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Parija T, 2005, J BIOSCIENCES, V30, P371, DOI 10.1007/BF02703674; Pavelic J, 2005, AM J RESP CELL MOL, V32, P65, DOI 10.1165/rcmb.2004-0232OC; Pavelic J, 2007, GYNECOL ONCOL, V105, P727, DOI 10.1016/j.ygyno.2007.02.012; Pavelic K, 2003, J PATHOL, V201, P430, DOI 10.1002/path.1465; Pavelic K, 2002, MOL MED, V8, P771, DOI 10.1007/BF03402082; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Qian X, 2005, DIAGN MOL PATHOL, V14, P23, DOI 10.1097/01.pdm.0000140192.27878.97; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Savage SA, 2007, CANCER EPIDEM BIOMAR, V16, P1667, DOI 10.1158/1055-9965.EPI-07-0214; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Toretsky JA, 1999, CANCER RES, V59, P5745; van Doorninck JA, 2010, J CLIN ONCOL, V28, P1989, DOI 10.1200/JCO.2009.24.5845; Wang Q, 2008, J CLIN INVEST, V118, P2389, DOI 10.1172/JCI36260; Yeh J, 2008, LUNG CANCER, V60, P166, DOI 10.1016/j.lungcan.2007.09.023	49	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26060	10.1371/journal.pone.0026060	http://dx.doi.org/10.1371/journal.pone.0026060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022506	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200028
J	Liu, FC; Hwang, TL; Lau, YT; Yu, HP				Liu, Fu-Chao; Hwang, Tsong-Long; Lau, Ying-Tung; Yu, Huang-Ping			Mechanism of Salutary Effects of Astringinin on Rodent Hepatic Injury following Trauma-Hemorrhage: Akt-Dependent Hemeoxygenase-1 Signaling Pathways	PLOS ONE			English	Article							RECEPTOR-RELATED PATHWAY; UP-REGULATION; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION INJURY; MEDIATED ATTENUATION; DOWN-REGULATION; ORGAN FUNCTION; LUNG INJURY; ESTROGEN; RESVERATROL	Astringinin can attenuate organ injury following trauma-hemorrhage, the mechanism remains unknown. Protein kinase B/hemeoxygenase-1 (Akt/HO-1) pathway exerts potent anti-inflammatory effects in various tissues. The aim of this study is to elucidate whether Akt/HO-1 plays any role in astringinin-mediated attenuation of hepatic injury following trauma-hemorrhage. For study this, male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure 35-40 mmHg for 90 min) followed by fluid resuscitation. A single dose of astringinin (0.3 mg/kg body weight) with or without a PI3K inhibitor (wortmannin) or a HO antagonist (chromium-mesoporphyrin) was administered during resuscitation. Various parameters were measured at 24 h post-resuscitation. Results showed that trauma-hemorrhage increased plasma aspartate and alanine aminotransferases (AST and ALT) concentrations and hepatic myeloperoxidase activity, cytokine induced neutrophil chemoattractant (CINC)-1, CINC-3, intercellular adhesion molecule-1, and interleukin-6 levels. These parameters were significantly improved in the astringinin-treated rats subjected to trauma-hemorrhage. Astringinin treatment also increased hepatic Akt activation and HO-1 expression as compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of wortmannin or chromium-mesoporphyrin abolished the astringinin-induced beneficial effects on post-resuscitation pro-inflammatory responses and hepatic injury. These findings collectively suggest that the salutary effects of astringinin administration on attenuation of hepatic injury after trauma-hemorrhage are likely mediated via Akt dependent HO-1 up-regulation.	[Liu, Fu-Chao; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan; [Lau, Ying-Tung] Chang Gung Univ, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Lau, Ying-Tung] Chang Gung Inst Technol, Dept Cosmet Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology	Liu, FC (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021; Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council (NSC) [98-2314-B-182A-034-MY3, 99-2314-B-182A-057-MY2]; Chang Gung Memorial Hospital [CMRPG381072, CMRPG392121]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC 98-2314-B-182A-034-MY3) and Chang Gung Memorial Hospital (CMRPG381072) to H-PY and from the National Science Council (NSC 99-2314-B-182A-057-MY2) and Chang Gung Memorial Hospital (CMRPG392121) to F-CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bastianetto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012935; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Chen WP, 2009, BRIT J PHARMACOL, V157, P381, DOI 10.1111/j.1476-5381.2008.00106.x; Choi BM, 2008, EUR J PHARMACOL, V580, P12, DOI 10.1016/j.ejphar.2007.10.044; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dorman Robert B, 2004, Comp Hepatol, V3 Suppl 1, pS42, DOI 10.1186/1476-5926-2-S1-S42; Doucet D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009421; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Hing LM, 2001, FREE RADICAL BIO MED, V30, P877, DOI 10.1016/S0891-5849(01)00474-9; Huang YS, 2011, CHINESE J PHYSIOL, V54, P183, DOI 10.4077/CJP.2011.AMM024; Kim HJ, 2008, J NUTR BIOCHEM, V19, P459, DOI 10.1016/j.jnutbio.2007.06.001; Lee YM, 2009, CANCER LETT, V285, P166, DOI 10.1016/j.canlet.2009.05.011; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Salinas M, 2004, FEBS LETT, V578, P90, DOI 10.1016/j.febslet.2004.10.077; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Szalay L, 2006, AM J PHYSIOL-REG I, V290, pR812, DOI 10.1152/ajpregu.00658.2005; Szalay L, 2005, AM J PHYSIOL-HEART C, V289, pH92, DOI 10.1152/ajpheart.01247.2004; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Yang SL, 2009, J LEUKOCYTE BIOL, V85, P1015, DOI 10.1189/jlb.0508288; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2007, J LEUKOCYTE BIOL, V82, P774, DOI 10.1189/jlb.0307182; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	34	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25907	10.1371/journal.pone.0025907	http://dx.doi.org/10.1371/journal.pone.0025907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022464	gold, Green Submitted, Green Published			2022-12-25	WOS:000295973200019
J	Tyagi, A; Ahmed, F; Thakur, N; Sharma, A; Raghava, GPS; Kumar, M				Tyagi, Atul; Ahmed, Firoz; Thakur, Nishant; Sharma, Arun; Raghava, Gajendra P. S.; Kumar, Manoj			HIVsirDB: A Database of HIV Inhibiting siRNAs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA INTERFERENCE; DESIGN; ESCAPE; SHRNA; REPLICATION; EXPRESSION; INFECTION; SEQUENCES; COVERAGE	Background: Human immunodeficiency virus (HIV) is responsible for millions of deaths every year. The current treatment involves the use of multiple antiretroviral agents that may harm patients due to their toxic nature. RNA interference (RNAi) is a potent candidate for the future treatment of HIV, uses short interfering RNA (siRNA/shRNA) for silencing HIV genes. In this study, attempts have been made to create a database HIVsirDB of siRNAs responsible for silencing HIV genes. Descriptions: HIVsirDB is a manually curated database of HIV inhibiting siRNAs that provides comprehensive information about each siRNA or shRNA. Information was collected and compiled from literature and public resources. This database contains around 750 siRNAs that includes 75 partially complementary siRNAs differing by one or more bases with the target sites and over 100 escape mutant sequences. HIVsirDB structure contains sixteen fields including siRNA sequence, HIV strain, targeted genome region, efficacy and conservation of target sequences. In order to facilitate user, many tools have been integrated in this database that includes; i) siRNAmap for mapping siRNAs on target sequence, ii) HIVsirblast for BLAST search against database, iii) siRNAalign for aligning siRNAs. Conclusion: HIVsirDB is a freely accessible database of siRNAs which can silence or degrade HIV genes. It covers 26 types of HIV strains and 28 cell types. This database will be very useful for developing models for predicting efficacy of HIV inhibiting siRNAs. In summary this is a useful resource for researchers working in the field of siRNA based HIV therapy. HIVsirDB database is accessible at http://crdd.osdd.net/raghava/hivsir/.	[Tyagi, Atul; Ahmed, Firoz; Thakur, Nishant; Sharma, Arun; Raghava, Gajendra P. S.; Kumar, Manoj] Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Tyagi, A (corresponding author), Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India.	manojk@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Ahmed, Firoz/AAR-6971-2021; Kumar, Manoj/G-1274-2010; Tyagi, Atul/AAK-5620-2020; Thakur, Nishant/L-7590-2016	Raghava, Gajendra P.S./0000-0002-8902-2876; Ahmed, Firoz/0000-0003-4702-5144; Kumar, Manoj/0000-0003-3769-052X; Sharma, Arun/0000-0003-3854-7944; Tyagi, Atul/0000-0001-9569-3273	Council of Scientific and Industrial Research (CSIR) India	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research (CSIR) India has provided the financial support as Institute of Microbial Technology is an estiblishment of CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnor JS, 2009, ANTIVIR RES, V83, P156, DOI 10.1016/j.antiviral.2009.04.008; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chalk AM, 2005, NUCLEIC ACIDS RES, V33, pD131, DOI 10.1093/nar/gki136; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Hajeri PB, 2009, DRUG DISCOV TODAY, V14, P851, DOI 10.1016/j.drudis.2009.06.001; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Kanzaki LIB, 2008, REV MED VIROL, V18, P5, DOI 10.1002/rmv.553; Konstantinova P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-15; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Mcintyre GJ, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-1; Mcintyre GJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-55; McQuisten KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007522; Montagnier L, 2010, VIROLOGY, V397, P248, DOI 10.1016/j.virol.2009.10.045; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ren YL, 2009, NUCLEIC ACIDS RES, V37, pD146, DOI 10.1093/nar/gkn817; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Rossi JJ, 2006, BIOTECHNIQUES, V40, P25, DOI 10.2144/000112167; Sabariegos R, 2006, J VIROL, V80, P571, DOI 10.1128/JVI.80.2.571-577.2006; Singh SK, 2008, EXPERT OPIN BIOL TH, V8, P449, DOI [10.1517/14712598.8.4.449, 10.1517/14712598.8.4.449 ]; Tatt ID, 2001, AIDS, V15, pS59, DOI 10.1097/00002030-200100005-00009; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake Olivier, 2005, J RNAi Gene Silencing, V1, P56; Truss M, 2005, NUCLEIC ACIDS RES, V33, pD108, DOI 10.1093/nar/gkil131; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25917	10.1371/journal.pone.0025917	http://dx.doi.org/10.1371/journal.pone.0025917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022467	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200020
J	Xin, ZS; Han, W; Zhao, ZQ; Xia, Q; Yin, B; Yuan, JG; Peng, XZ				Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Xia, Qing; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong			PCBP2 Enhances the Antiviral Activity of IFN-alpha against HCV by Stabilizing the mRNA of STAT1 and STAT2	PLOS ONE			English	Article							3'-UNTRANSLATED REGION; COMPLEX; REPLICATION; PROTEIN; GENES	Interferon-alpha (IFN-alpha) is a natural choice for the treatment of hepatitis C, but half of the chronically infected individuals do not achieve sustained clearance of hepatitis C virus (HCV) during treatment with IFN-alpha alone. The virus can impair IFN-alpha signaling and cellular factors that have an effect on the viral life cycles. We found that the protein PCBP2 is down-regulated in HCV-replicon containing cells (R1b). However, the effects and mechanisms of PCBP2 on HCV are unclear. To determine the effect of PCBP2 on HCV, overexpression and knockdown of PCBP2 were performed in R1b cells. Interestingly, we found that PCBP2 can facilitate the antiviral activity of IFN-alpha against HCV, although the RNA level of HCV was unaffected by either the overexpression or absence of PCBP2 in R1b cells. RIP-qRT-PCR and RNA half-life further revealed that PCBP2 stabilizes the mRNA of STAT1 and STAT2 through binding the 3'Untranslated Region (UTR) of these two molecules, which are pivotal for the IFN-alpha anti-HCV effect. RNA pull-down assay confirmed that there were binding sites located in the C-rich tracts in the 3'UTR of their mRNAs. Stabilization of mRNA by PCBP2 leads to the increased protein expression of STAT1 and STAT2 and a consistent increase of phosphorylated STAT1 and STAT2. These effects, in turn, enhance the antiviral effect of IFN-alpha. These findings indicate that PCBP2 may play an important role in the IFN-alpha response against HCV and may benefit the HCV clinical therapy.	[Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xin, Zhongshuai] Natl Inst Food & Drug Control, Div Biochem & Gene Engn Med, Beijing, Peoples R China; [Xia, Qing] Natl Ctr Biomed Anal, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China	Xin, ZS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	yuanjiangang@pumc.edu.cn; pengxiaozhong@pumc.edu.cn			National 863 Program [2006AA020504]; National Natural Sciences Foundation of China [30825023, 30721063, 31071203]; 973 Program [2007CB946902, 2009CB825403, 2011CB504902]; National Project for Communicable Diseases Control [2008ZX10003-012]; Program for New Century Excellent Talents in University [NCET-07-0505]	National 863 Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Project for Communicable Diseases Control; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by funds from the National 863 Program 2006AA020504; National Natural Sciences Foundation of China, 30825023, 30721063 and 31071203; 973 Program 2007CB946902, 2009CB825403 and 2011CB504902; National Project for Communicable Diseases Control 2008ZX10003-012, and the Program for New Century Excellent Talents in University NCET-07-0505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLYN S, 2008, VIROLOGY, V374, P280; AMAR T, 2004, J BIOL CHEM, V279, P49680; AMY BR, 2005, J VIROL, V79, P10126; ANGELA MD, 2005, VIROLOGY, V335, P72; ANNA ME, 2010, CELL, V140, P652; ARTUR K, 2009, PLOS PATHOG, V5, P1; Bartenschlager R, 2007, VIRUS RES, V127, P127, DOI 10.1016/j.virusres.2007.07.003; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DEBJANI G, 2008, P NATL ACAD SCI USA, V105, P11673; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fontanes V, 2009, VIROLOGY, V394, P82, DOI 10.1016/j.virol.2009.08.012; Frese M, 2001, J GEN VIROL, V82, P723, DOI 10.1099/0022-1317-82-4-723; Fried Michael W., 2002, NEW ENGL J MED, V347, P975, DOI [10.1056/NEJMoa020047, DOI 10.1056/NEJMOA020047]; FUPING Y, 2009, NATURE IMMUNOL, V10, P1300; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale M, 2003, HEPATOLOGY, V37, P975, DOI 10.1053/jhep.2003.50201; HIDEKI A, 2006, J BIOMED SCI, V13, P469; JACK DK, 2006, NAT PROTOC, V1, P302; Ji S. C., 2007, BLOOD, V110, P994; Ji XJ, 2007, MOL CELL BIOL, V27, P3290, DOI 10.1128/MCB.02289-05; JIAN K, 2003, MOL CELL BIO, V23, P1125; JIAN K, 2006, MOL CELL BIO, V26, P5603; KAMRAN G, 2009, IMMUNOL REV, V228, P273; KARLA JH, 2008, ANTIVIR RES, V77, P169; KENG HL, 2007, J HEPATOL, V46, P759; KRLSTER M, 2000, J HEPATOL, V33, P764; KYUNG SC, 2006, VIRUS RES, V115, P1; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Miao RD, 2008, J BIOSCIENCES, V33, P723, DOI 10.1007/s12038-008-0092-x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; MORTIMER K, 2005, J HEPATOL, V43, P225; NOBUYUKI K, 2009, VIRUS RES, V146, P41; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; POLEN S, 2008, VIROLOGY, V378, P243; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; ROLAND Z, 2008, BIOCHEM BIOPH RES CO, V366, P917; SHELLY AW, 2009, J BIOL CHEM, V284, P9039; SHELLY AW, 2003, MOL CELL BIO, V23, P7055; SHERRI LC, 2009, J VIROL, V83, P6717; Shirasaki T, 2010, J INFECT DIS, V202, P75, DOI 10.1086/653081; SHUETSU F, 2001, VIRUS RES, V73, P67; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WENYU L, 2005, GASTROENTEROLOGY, V128, P1034; Wu Jin-ming, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P702; Xu L, 2009, MOL PHARMACOL, V76, P872, DOI 10.1124/mol.109.057596; YEVGENY B, 2003, J VIROL METHODS, V107, P245; ZHIHUA D, 2007, RNA, V13, P1043	51	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25419	10.1371/journal.pone.0025419	http://dx.doi.org/10.1371/journal.pone.0025419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022391	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200007
J	Cortes-Canteli, M; Aguilar-Morante, D; Sanz-SanCristobal, M; Megias, D; Santos, A; Perez-Castillo, A				Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Megias, Diego; Santos, Angel; Perez-Castillo, Ana			Role of C/EBP beta Transcription Factor in Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DENTATE GYRUS; PROLIFERATION; MEMORY; NEURONS; CONSOLIDATION; INJURY; BRAIN	Background: The dentate gyrus of the hippocampus is one of the regions in which neurogenesis takes place in the adult brain. We have previously demonstrated that CCAAT/enhancer binding protein beta (C/EBP beta) is expressed in the granular layer of the dentate gyrus of the adult mouse hippocampus. Taking into account the important role of C/EBP beta in the consolidation of long term memory, the fact that newborn neurons in the hippocampus contribute to learning and memory processes, and the role of this transcription factor, previously demonstrated by our group, in regulating neuronal differentiation, we speculated that this transcription factor could regulate stem/progenitor cells in this region of the brain. Methodology/Principal Findings: Here, we show, using C/EBP beta knockout mice, that C/EBP beta expression is observed in the subset of newborn cells that proliferate in the hippocampus of the adult brain. Mice lacking C/EBP beta present reduced survival of newborn cells in the hippocampus, a decrease in the number of these cells that differentiate into neurons and a diminished number of cells that are proliferating in the subgranular zone of the dentate gyrus. These results were further confirmed in vitro. Neurosphere cultures from adult mice deficient in C/EBP beta present less proliferation and neuronal differentiation than neurospheres derived from wild type mice. Conclusions/Significance: In summary, using in vivo and in vitro strategies, we have identified C/EBP beta as a key player in the proliferation and survival of the new neurons produced in the adult mouse hippocampus. Our results support a novel role of C/EBP beta in the processes of adult hippocampal neurogenesis, providing new insights into the mechanisms that control neurogenesis in this region of the brain.	[Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] CIBERNED, Madrid, Spain; [Megias, Diego] Ctr Nacl Invest Oncol, Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Complutense University of Madrid	Cortes-Canteli, M (corresponding author), Rockefeller Univ, Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA.	aperez@iib.uam.es	Santos, Angel/K-3744-2014; Cortes-Canteli, Marta/L-5449-2014; Megías, Diego/L-6008-2014; Aguilar-Morante, Diana/AAE-8572-2019; Perez-Castillo, Ana/A-9505-2015	Santos, Angel/0000-0002-7551-8483; Cortes-Canteli, Marta/0000-0001-8802-4338; Aguilar-Morante, Diana/0000-0001-9775-0841; Megias, Diego/0000-0003-0755-0518; Perez-Castillo, Ana/0000-0002-2632-5853	Consejo Superior de Investigaciones Cientificas; Ministerio de Investigacion y Ciencia [SAF2007-62811, SAF2010-16365]; Instituto de Salud Carlos III	Consejo Superior de Investigaciones Cientificas; Ministerio de Investigacion y Ciencia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a postdoctoral fellowship of the Consejo Superior de Investigaciones Cientificas (M.C.-C.) Grant Sponsor: Ministerio de Investigacion y Ciencia; Grant numbers: SAF2007-62811 and SAF2010-16365. CIBERNED is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Choi YS, 2003, MOL CELLS, V16, P232; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuentealba L, 2004, GLIA, V45, P238, DOI 10.1002/glia.10325; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gagliardi M, 2003, J BIOL CHEM, V278, P43846, DOI 10.1074/jbc.M304085200; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Yukawa K, 1998, J BIOL CHEM, V273, P31345, DOI 10.1074/jbc.273.47.31345	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24842	10.1371/journal.pone.0024842	http://dx.doi.org/10.1371/journal.pone.0024842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003384	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300005
J	Garza, AS; Khan, SH; Moure, CM; Edwards, DP; Kumar, R				Garza, Anna S.; Khan, Shagufta H.; Moure, Carmen M.; Edwards, Dean P.; Kumar, Raj			Binding-Folding Induced Regulation of AF1 Transactivation Domain of the Glucocorticoid Receptor by a Cofactor That Binds to Its DNA Binding Domain	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; JUN DIMERIZATION PROTEIN-2; NUCLEAR HORMONE-RECEPTORS; PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ANDROGEN RECEPTOR; GENE ACTIVATION; DISORDER; COMPLEX; REGION	Intrinsically disordered (ID) regions of proteins commonly exist within transcription factors, including the N-terminal domain (NTD) of steroid hormone receptors (SHRs) that possesses a powerful activation function, AF1 region. The mechanisms by which SHRs pass signals from a steroid hormone to control gene expression remain a central unresolved problem. The role of N-terminal activation function AF1, which exists in an intrinsically disordered (ID) conformation, in this process is of immense importance. It is hypothesized that under physiological conditions, ID AF1 undergoes disorder/order transition via inter- and intra-molecular communications, which allows AF1 surfaces to interact with specific co-regulatory proteins, critical for the final outcome of target gene expression regulated by SHRs. However, the means by which AF1 acquires functionally folded conformations is not well understood. In this study, we tested whether binding of jun dimerization protein 2 (JDP2) within the DNA binding domain (DBD) of the glucocorticoid receptor (GR) leads to acquisition of functionally active structure in its AF1/NTD. Our results show that signals mediated from GR DBD:JDP2 interactions in a two domain GR fragment, consisting of the entire NTD and little beyond DBD, significantly increased secondary/tertiary structure formation in the NTD/AF1. This increased structure formation facilitated AF1's interaction with specific co-regulatory proteins and subsequent glucocorticoid response element-mediated AF1 promoter:reporter activity. These results support the hypothesis that inter- and intra-molecular signals give a functionally active structure(s) to the GR AF1, which is important for its transcriptional activity.	[Khan, Shagufta H.; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Garza, Anna S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Moure, Carmen M.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol & Pathol, Houston, TX 77030 USA	Geisinger Commonwealth School of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Garza, AS (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	rkumar@tcmedc.org			NIH NIDDK [R01DK058829]; NIH NCI [CA046938, DK049030]; NATIONAL CANCER INSTITUTE [R01CA046938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829, R01DK049030] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH NIDDK Grant R01DK058829 (to RK), and NIH NCI CA046938 and DK049030 (to DPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DIEKEN ES, 1992, MOL CELL BIOL, V12, P589, DOI 10.1128/MCB.12.2.589; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engel KB, 2011, MOL CELL BIOL, V31, P3267, DOI 10.1128/MCB.05351-11; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019689; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, ESSAYS BIOCHEM, V40, P27, DOI 10.1042/bse0400027; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; NAZARETH LV, 1991, J BIOL CHEM, V266, P12976; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Thompson EB, 2003, BIOCHEM BIOPH RES CO, V306, P1, DOI 10.1016/S0006-291X(03)00877-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25875	10.1371/journal.pone.0025875	http://dx.doi.org/10.1371/journal.pone.0025875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003412	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300035
J	Isagawa, T; Nagae, G; Shiraki, N; Fujita, T; Sato, N; Ishikawa, S; Kume, S; Aburatani, H				Isagawa, Takayuki; Nagae, Genta; Shiraki, Nobuaki; Fujita, Takanori; Sato, Noriko; Ishikawa, Shumpei; Kume, Shoen; Aburatani, Hiroyuki			DNA Methylation Profiling of Embryonic Stem Cell Differentiation into the Three Germ Layers	PLOS ONE			English	Article							HOMEOBOX GENE-CLUSTER; MODEL-BASED ANALYSIS; HUMAN GENOME; HISTONE H3; DEVELOPMENTAL REGULATORS; CHIP-CHIP; POLYCOMB; EXPRESSION; WIDE; PLURIPOTENT	Embryogenesis is tightly regulated by multiple levels of epigenetic regulation such as DNA methylation, histone modification, and chromatin remodeling. DNA methylation patterns are erased in primordial germ cells and in the interval immediately following fertilization. Subsequent developmental reprogramming occurs by de novo methylation and demethylation. Variance in DNA methylation patterns between different cell types is not well understood. Here, using methylated DNA immunoprecipitation and tiling array technology, we have comprehensively analyzed DNA methylation patterns at proximal promoter regions in mouse embryonic stem (ES) cells, ES cell-derived early germ layers (ectoderm, endoderm and mesoderm) and four adult tissues (brain, liver, skeletal muscle and sperm). Most of the methylated regions are methylated across all three germ layers and in the three adult somatic tissues. This commonly methylated gene set is enriched in germ cell-associated genes that are generally transcriptionally inactive in somatic cells. We also compared DNA methylation patterns by global mapping of histone H3 lysine 4/27 trimethylation, and found that gain of DNA methylation correlates with loss of histone H3 lysine 4 trimethylation. Our combined findings indicate that differentiation of ES cells into the three germ layers is accompanied by an increased number of commonly methylated DNA regions and that these tissue-specific alterations in methylation occur for only a small number of genes. DNA methylation at the proximal promoter regions of commonly methylated genes thus appears to be an irreversible mark which functions to fix somatic lineage by repressing the transcription of germ cell-specific genes.	[Isagawa, Takayuki; Nagae, Genta; Fujita, Takanori; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Inst Mol Embryol & Genet, Div Stem Cell Biol, Kumamoto, Japan; [Sato, Noriko] Tokyo Metropolitan Inst Med Sci, Dept Allergy & Immunol, Tokyo 113, Japan; [Ishikawa, Shumpei] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Tokyo, Japan	University of Tokyo; Kumamoto University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo	Isagawa, T (corresponding author), Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan.	haburata-tky@umin.ac.jp	Nagae, Genta/H-6579-2019; Nagae, Genta/AAN-1167-2021; Sato, Noriko/Y-7693-2019	Nagae, Genta/0000-0002-2929-7990; shiraki, nobuaki/0000-0001-6708-9976	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20221009]; National Institute of Biomedical Innovation (NIBIO), Japan; Grants-in-Aid for Scientific Research [22659070] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by a Grant-in-Aid for Scientific Research (S) 20221009 (H.A.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Gottardo R, 2008, BIOMETRICS, V64, P468, DOI 10.1111/j.1541-0420.2007.00899.x; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; Kawaguchi M, 2008, J BIOL CHEM, V283, P12064, DOI 10.1074/jbc.M709648200; Korb M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-7; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LESKOWITZ S, 1968, NATURE, V218, P479, DOI 10.1038/218479a0; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modutlwa Nkaelang, 2009, Nucleic Acids Symp Ser (Oxf), P105, DOI 10.1093/nass/nrp053; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morishita H, 2004, EUR J NEUROSCI, V20, P2843, DOI 10.1111/j.1460-9568.2004.03803.x; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shiraki A, 2009, OPT EXPRESS, V17, P16038, DOI 10.1364/OE.17.016038; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; YAGI K, CLIN CANC RES, V16, P21; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26052	10.1371/journal.pone.0026052	http://dx.doi.org/10.1371/journal.pone.0026052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016810	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300054
J	Speed, JS; George, EM; Arany, M; Cockrell, K; Granger, JP				Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.			Role of 20-Hydroxyeicosatetraenoic Acid in Mediating Hypertension in Response to Chronic Renal Medullary Endothelin Type B Receptor Blockade	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; P-450 METABOLITES; ARACHIDONIC-ACID; RATS; 20-HETE; EXCRETION	Background: The renal medullary endothelin (ET-1) system plays an important role in the control of sodium excretion and arterial pressure (AP) through the activation of renal medullary ET-B receptors. We have previously shown that blockade of endothelin type B receptors (ET-B) leads to salt-sensitive hypertension through mechanisms that are not fully understood. One possible mechanism is through a reduction in renal medullary production of 20-hydroxyeicosatetraenoic acid (20-HETE). 20-HETE, a metabolite of arachidonic acid, has natriuretic properties similar to ET-B activation. While these findings suggest a possible interaction between ET-B receptor activation and 20-HETE production, it is unknown whether blockade of medullary ET-B receptors in rats maintained on a high sodium intake leads to reductions in 20-HETE production. Methodology/Principal Findings: The effect of increasing sodium intake from low (NS = .8%) to high (HS = 8%) on renal medullary production of 20-HETE in the presence and absence of renal medullary ET-B receptor antagonism was examined. Renal medullary blockade of ET-B receptors resulted in salt sensitive hypertension. In control rats, blood pressure rose from 112.8 +/- 2.4 mmHg (NS) to 120.7 +/- 9.3 mmHg (HS). In contrast, when treated with an ET-B receptor blocker, blood pressure was significantly elevated from 123.7 +/- 3.2 (NS) to 164.2 +/- 7.1 (HS). Furthermore, increasing sodium intake was associated with elevated medullary 20-HETE (5.6 +/-.8 in NS vs. 14.3 +/- 3.7 pg/mg in HS), an effect that was completely abolished by renal medullary ET-B receptor blockade (4.9 +/-.8 for NS and 4.5 +/-.6 pg/mg for HS). Finally, the hypertensive response to intramedullary ET-B receptor blockade was blunted in rats pretreated with a specific 20-HETE synthesis inhibitor. Conclusion: These data suggest that increases in renal medullary production of 20-HETE associated with elevating salt intake may be, in part, due to ET-B receptor activation within the renal medulla.	[Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Speed, JS (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	jgranger@umc.edu	George, Eric/ABE-2767-2020	George, Eric/0000-0002-6622-7369	National Institutes of Health (NIH) [HL51971]; American Heart Association (AHA) [09PRE2250470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grant HL51971 (www.nih.gov) and American Heart Association (AHA) grant 09PRE2250470 (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Elijovich F, 2002, J HUM HYPERTENS, V16, P459, DOI 10.1038/sj.jhh.1001419; Escalante BA, 2002, AM J PHYSIOL-RENAL, V282, pF144, DOI 10.1152/ajprenal.0064.2001; Gariepy CE, 2000, J CLIN INVEST, V105, P925, DOI 10.1172/JCI8609; Gurbanov K, 1996, AM J PHYSIOL-RENAL, V271, pF1166, DOI 10.1152/ajprenal.1996.271.6.F1166; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hoagland KM, 2003, HYPERTENSION, V42, P669, DOI 10.1161/01.HYP.0000084634.97353.1A; HOFFMAN A, 1994, KIDNEY INT, V45, P556, DOI 10.1038/ki.1994.72; Hsieh TJ, 2000, AM J PHYSIOL-RENAL, V279, pF112, DOI 10.1152/ajprenal.2000.279.1.F112; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; Maier KG, 2000, AM J PHYSIOL-HEART C, V279, pH863, DOI 10.1152/ajpheart.2000.279.2.H863; MORTENSEN LH, 1990, HYPERTENSION, V15, P729, DOI 10.1161/01.HYP.15.6.729; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Plato CF, 2000, AM J PHYSIOL-RENAL, V279, pF326, DOI 10.1152/ajprenal.2000.279.2.F326; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144, DOI 10.1152/ajprenal.2001.281.1.F144; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schneider MP, 2008, HYPERTENSION, V51, P1605, DOI 10.1161/HYPERTENSIONAHA.107.108126; Stec DE, 1997, HYPERTENSION, V29, P315, DOI 10.1161/01.HYP.29.1.315; Wessale JL, 2002, CLIN SCI, V103, p112S, DOI 10.1042/CS103S112S; Williams JM, 2005, HYPERTENSION, V46, P366, DOI 10.1161/01.HYP.0000172755.25382.fc; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yu M, 2007, AM J PHYSIOL-REG I, V292, pR2400, DOI 10.1152/ajpregu.00791.2006	23	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26063	10.1371/journal.pone.0026063	http://dx.doi.org/10.1371/journal.pone.0026063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016812	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300055
J	Teschke, M; Wendt, S; Kawaguchi, S; Kramer, A; Meyer, B				Teschke, Mathias; Wendt, Sabrina; Kawaguchi, So; Kramer, Achim; Meyer, Bettina			A Circadian Clock in Antarctic Krill: An Endogenous Timing System Governs Metabolic Output Rhythms in the Euphausid Species Euphausia superba	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; LIGHT; ENTRAINMENT; PACEMAKERS; ZEITGEBER; EYESTALK; RANGE; CRY	Antarctic krill, Euphausia superba, shapes the structure of the Southern Ocean ecosystem. Its central position in the food web, the ongoing environmental changes due to climatic warming, and increasing commercial interest on this species emphasize the urgency of understanding the adaptability of krill to its environment. Krill has evolved rhythmic physiological and behavioral functions which are synchronized with the daily and seasonal cycles of the complex Southern Ocean ecosystem. The mechanisms, however, leading to these rhythms are essentially unknown. Here, we show that krill possesses an endogenous circadian clock that governs metabolic and physiological output rhythms. We found that expression of the canonical clock gene cry2 was highly rhythmic both in a light-dark cycle and in constant darkness. We detected a remarkable short circadian period, which we interpret as a special feature of the krill's circadian clock that helps to entrain the circadian system to the extreme range of photoperiods krill is exposed to throughout the year. Furthermore, we found that important key metabolic enzymes of krill showed bimodal circadian oscillations (similar to 9-12 h period) in transcript abundance and enzymatic activity. Oxygen consumption of krill showed similar to 9-12 h oscillations that correlated with the temporal activity profile of key enzymes of aerobic energy metabolism. Our results demonstrate the first report of an endogenous circadian timing system in Antarctic krill and its likely link to metabolic key processes. Krill's circadian clock may not only be critical for synchronization to the solar day but also for the control of seasonal events. This study provides a powerful basis for the investigation into the mechanisms of temporal synchronization in this marine key species and will also lead to the first comprehensive analyses of the circadian clock of a polar marine organism through the entire photoperiodic cycle.	[Teschke, Mathias; Wendt, Sabrina; Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany; [Kawaguchi, So] Australian Antarctic Div, Dept Environm & Heritage, Kingston, Tas, Australia; [Kawaguchi, So] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Meyer, Bettina] Alfred Wegener Inst Polar & Marine Res, Sci Div Polar Biol Oceanog, D-2850 Bremerhaven, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Teschke, M (corresponding author), Charite, Lab Chronobiol, D-13353 Berlin, Germany.	mathias.teschke@charite.de; achim.kramer@charite.de	Meyer, Bettina/ABB-5311-2020	Meyer, Bettina/0000-0001-6804-9896; Kawaguchi, So/0000-0002-2042-5095; Kramer, Achim/0000-0001-9671-6078	German Ministry of Education and Research (BMBF) [03F0400A]; German Research Foundation (DFG) [TE 618/3-1]; EU	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This work was supported by the German Ministry of Education and Research (BMBF) through project Lazarev Sea Krill Study (LAKRIS, 03F0400A). MT was supported by funding of the German Research Foundation (DFG) through project Photoperiodic Time Measurement in Antarctic krill (TE 618/3-1). Research in A.K.'s laboratory is supported by the 6 th EU framework programme EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Aguzzi J, 2004, J CRUSTACEAN BIOL, V24, P282, DOI 10.1651/C-2458; Arechiga H, 1998, P ROY SOC B-BIOL SCI, V265, P1819, DOI 10.1098/rspb.1998.0507; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Fanjul-Moles ML, 2004, J EXP BIOL, V207, P1453, DOI 10.1242/jeb.00900; Folk GE, 2006, BIOL RHYTHM RES, V37, P455, DOI 10.1080/09291010600738551; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Gatti S, 2002, MAR BIOL, V140, P1075, DOI 10.1007/s00227-002-0786-9; Godlewska Malgorzata, 1996, Polskie Archiwum Hydrobiologii, V43, P9; jami Al-Ahmadi K, 2008, RES J MICROBIOL, V3, P395; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kawaguchi S, 2007, POLAR BIOL, V30, P689, DOI 10.1007/s00300-006-0226-2; Kawaguchi S, 2010, DEEP-SEA RES PT II, V57, P683, DOI 10.1016/j.dsr2.2009.10.017; King R, 2003, MAR FRESHW BEHAV PHY, V36, P271, DOI 10.1080/10236240310001614457; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WQ, 2010, CURR BIOL, V20, P533, DOI 10.1016/j.cub.2010.01.042; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; MAYZAUD P, 1978, LIMNOL OCEANOGR, V23, P1144, DOI 10.4319/lo.1978.23.6.1144; Mazzotta GM, 2010, CHRONOBIOL INT, V27, P425, DOI 10.3109/07420521003697494; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Meyer B, 2002, MAR BIOL, V141, P855, DOI 10.1007/s00227-002-0877-7; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; MEZYKOWSKI T, 1979, MEERESFORSCHUNG, V27, P124; MOLODTSOV NV, 1972, COMP BIOCHEM PHYSIOL, V41, P113, DOI 10.1016/0305-0491(72)90013-2; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Pohl H, 1999, PHYSIOL BEHAV, V67, P327, DOI 10.1016/S0031-9384(99)00070-0; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; Silverin B, 2009, HORM BEHAV, V56, P163, DOI 10.1016/j.yhbeh.2009.04.002; Stitt M.., 1984, METHODS ENZYMATIC AN, V4, P353; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Sullivan JM, 2009, CHRONOBIOL INT, V26, P1136, DOI 10.1080/07420520903217960; Teschke M, 2007, LIMNOL OCEANOGR, V52, P1046, DOI 10.4319/lo.2007.52.3.1046; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Yang JS, 2006, BRAIN RES, V1067, P13, DOI 10.1016/j.brainres.2005.10.003; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	47	43	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26090	10.1371/journal.pone.0026090	http://dx.doi.org/10.1371/journal.pone.0026090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22022521	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300058
J	Ding, Y; Ding, J; Wu, K; Wen, W; Liu, C; Yan, HX; Chen, C; Wang, S; Tang, H; Gao, CK; Guo, LN; Cao, D; Li, Z; Feng, GS; Wang, HY; Xu, ZF				Ding, Y.; Ding, J.; Wu, K.; Wen, W.; Liu, C.; Yan, H-X; Chen, C.; Wang, S.; Tang, H.; Gao, C-K; Guo, L-N; Cao, D.; Li, Z.; Feng, G-S; Wang, H-Y; Xu, Z-F			Cross-talk between endothelial cells and tumor via delta-like ligand4/Notch/PTEN signaling inhibits lung cancer growth	ONCOGENE			English	Article						lung cancer; vascular endothelial cells; delta-like ligand 4; Notch; PTEN	UP-REGULATION; THERAPEUTIC IMPLICATIONS; NOTCH; ANGIOGENESIS; DLL4; ACTIVATION; PATHWAY; PTEN; PROLIFERATION; EXPRESSION	Lung cancer is a leading cause of cancer death in many countries. Notch signaling has been demonstrated to frequently participate in the process of lung carcinogenesis. Delta-like ligand 4 (Dll4) is a vascular-specific ligand of Notch, and has a critical role in the angiogenesis of numerous cancers. However, the role of Dll4 in the crosstalk between endothelial cells (ECs) and tumor cells remains obscure. Herein, our study revealed that Dll4-expressing ECs (EC-Dll4) significantly suppressed the proliferation of neighboring non-small cell lung cancer (NSCLC) cells and attenuated the growth of NSCLC xenograft in nude mice. On the contrary, silencing endothelial Dll4 by its specific interference RNA reversed these effects of Dll4 on NSCLC cell proliferation and tumor formation. Furthermore, activation of Notch1, but not Notch2 or Notch3, was enhanced in NSCLC cells cultured with EC-Dll4, as well as in xenografts induced by a mixture of NSCLC cells and EC-Dll4. Interference of Notch1 significantly attenuated Dll4-mediated suppression of NSCLC cell proliferations, indicating that Dll4/Notch1 signaling negatively modulates the NSCLC growth. Moreover, PTEN expression in NSCLC cells was increased by EC-Dll4 or rhDll4 (recombinant human-Dll4 protein), and the induction was impaired by Notch1 interference suggesting that Dll4 could upregulate PTEN expression by Notch1. Taken together, we conclude that the cross-talk between ECs and NSCLC cells by Dll4/Notch1/PTEN signaling pathway inhibits the growth of NSCLC. Oncogene (2012) 31, 2899-2906; doi:10.1038/onc.2011.467; published online 17 October 2011	[Ding, Y.; Wang, S.; Tang, H.; Gao, C-K; Xu, Z-F] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, Shanghai 200003, Peoples R China; [Ding, J.; Wu, K.; Wen, W.; Liu, C.; Yan, H-X; Chen, C.; Guo, L-N; Cao, D.; Li, Z.; Wang, H-Y] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Feng, G-S] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, G-S] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Naval Medical University; Naval Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego	Xu, ZF (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac & Cardiovasc Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	hywangk@vip.sina.com; xu_zhi_fei@yahoo.com.cn	ding, jin/GVT-5062-2022		National Natural Science Foundation of China [30972965, 31071236, 30800576]; Shanghai Pujiang program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang program(Shanghai Pujiang Program)	This work was supported by grants from the National Natural Science Foundation of China (30972965, 31071236 and 30800576) and the Shanghai Pujiang program.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kunnimalaiyaan M, 2005, AM J PHYSIOL-GASTR L, V289, pG636, DOI 10.1152/ajpgi.00146.2005; Kunnimalaiyaan M, 2007, ONCOLOGIST, V12, P535, DOI 10.1634/theoncologist.12-5-535; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Nor JE, 2001, CANCER RES, V61, P2183; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Winer E, 2009, J CLIN ONCOL, V27, P812, DOI 10.1200/JCO.2008.21.2134; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	37	37	40	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	23					2899	2906		10.1038/onc.2011.467	http://dx.doi.org/10.1038/onc.2011.467			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	22002304				2022-12-25	WOS:000305277900009
J	Pichierri, P; Nicolai, S; Cignolo, L; Bignami, M; Franchitto, A				Pichierri, P.; Nicolai, S.; Cignolo, L.; Bignami, M.; Franchitto, A.			The RAD9-RAD1-HUS1 (9.1.1) complex interacts with WRN and is crucial to regulate its response to replication fork stalling	ONCOGENE			English	Article						RecQ helicases; replication checkpoint; genome instability; Werner syndrome	WERNER-SYNDROME PROTEIN; DNA-POLYMERASE-BETA; GENOMIC INSTABILITY; HELICASE ACTIVITY; CHK1 ACTIVATION; COMMON PATHWAY; MRE11 COMPLEX; MOUSE HUS1; CELL-CYCLE; S-PHASE	The WRN protein belongs to the RecQ family of DNA helicases and is implicated in replication fork restart, but how its function is regulated remains unknown. We show that WRN interacts with the 9.1.1 complex, one of the central factors of the replication checkpoint. This interaction is mediated by the binding of the RAD1 subunit to the N-terminal region of WRN and is instrumental for WRN relocalization in nuclear foci and its phosphorylation in response to replication arrest. We also find that ATR-dependent WRN phosphorylation depends on TopBP1, which is recruited by the 9.1.1 complex in response to replication arrest. Finally, we provide evidence for a cooperation between WRN and 9.1.1 complex in preventing accumulation of DNA breakage and maintaining genome integrity at naturally occurring replication fork stalling sites. Taken together, our data unveil a novel functional interplay between WRN helicase and the replication checkpoint, contributing to shed light into the molecular mechanism underlying the response to replication fork arrest. Oncogene (2012) 31, 2809-2823; doi:10.1038/onc.2011.468; published online 17 October 2011	[Pichierri, P.] Ist Super Sanita, Sect Expt & Computat Carcinogenesis, Dept Environm & Primary Prevent, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Pichierri, P (corresponding author), Ist Super Sanita, Sect Expt & Computat Carcinogenesis, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	pietro.pichierri@iss.it	Pichierri, Pietro/AAA-5476-2021; Franchitto, Annapaola/K-7564-2016	Pichierri, Pietro/0000-0002-2702-3523; Franchitto, Annapaola/0000-0003-4232-4727	Fondazione Telethon [GGP04094]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG9294, IG4400]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We are grateful to Drs L Comai and M Lalle for providing recombinant proteins and Drs D Toniolo and M Rocchi for providing BACs for FISH analysis. This work was supported by Fondazione Telethon to PP (Grant no. GGP04094) and, in part, by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) to PP (Grant no. IG9294) and AF (Grant no. IG4400).	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Cheng WH, 2007, EXP GERONTOL, V42, P871, DOI 10.1016/j.exger.2007.04.011; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Franchitto A, 2004, CELL CYCLE, V3, P1331, DOI 10.4161/cc.3.10.1185; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pichierri Pietro, 2007, Ital J Biochem, V56, P130; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Rodriguez-Lopez AM, 2003, MECH AGEING DEV, V124, P167, DOI 10.1016/S0047-6374(02)00131-8; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; SCAPPATICCI S, 1982, HUM GENET, V62, P16, DOI 10.1007/BF00295599; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; Weiss RS, 2000, GENE DEV, V14, P1886; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhu M, 2007, MOL BIOL CELL, V18, P1044, DOI 10.1091/mbc.E06-10-0957; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	48	18	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	23					2809	2823		10.1038/onc.2011.468	http://dx.doi.org/10.1038/onc.2011.468			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	22002307	Green Accepted			2022-12-25	WOS:000305277900002
J	Wang, Y; Keck, ZY; Saha, A; Xia, JM; Conrad, F; Lou, JL; Eckart, M; Marks, JD; Foung, SKH				Wang, Yong; Keck, Zhen-yong; Saha, Anasuya; Xia, Jinming; Conrad, Fraser; Lou, Jianlong; Eckart, Michael; Marks, James D.; Foung, Steven K. H.			Affinity Maturation to Improve Human Monoclonal Antibody Neutralization Potency and Breadth against Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE DISPLAY; B TYPE-I; LIVER-TRANSPLANTATION; SCAVENGER RECEPTOR; E2 GLYCOPROTEIN; CELL ENTRY; CONFORMATIONAL EPITOPES; MOLECULAR EVOLUTION; ROBUST PRODUCTION; GRAFT-SURVIVAL	A potent neutralizing antibody to a conserved hepatitis C virus (HCV) epitope might overcome its extreme variability, allowing immunotherapy. The human monoclonal antibody HC-1 recognizes a conformational epitope on the HCV E2 glycoprotein. Previous studies showed that HC-1 neutralizes most HCV genotypes but has modest potency. To improve neutralization, we affinity-matured HC-1 by constructing a library of yeast-displayed HC-1 single chain Fv (scFv) mutants, using for selection an E2 antigen from one of the poorly neutralized HCVpp. We developed an approach by parallel mutagenesis of the heavy chain variable (VH) and k-chain variable (Vk) genes separately, then combining the optimized VH and Vk mutants. This resulted in the generation of HC-1-related scFv variants exhibiting improved affinities. The best scFv variant had a 92-fold improved affinity. After conversion to IgG(1), some of the antibodies exhibited a 30-fold improvement in neutralization activity. Both surface plasmon resonance and solution kinetic exclusion analysis showed that the increase in affinity was largely due to a lowering of the dissociation rate constant, K-off. Neutralization against a panel of HCV pseudoparticles and infectious 2a HCV virus improved with the affinity-matured IgG1 antibodies. Interestingly, some of these antibodies neutralized a viral isolate that was not neutralized by wild-type HC-1. Moreover, propagating 2a HCVcc under the selective pressure of WT HC-1 or affinity-matured HC-1 antibodies yielded no viral escape mutants and, with the affinity-matured IgG1, needed 100-fold less antibody to achieve complete virus elimination. Taken together, these findings suggest that affinity-matured HC-1 antibodies are excellent candidates for therapeutic development.	[Foung, Steven K. H.] Stanford Univ, Sch Med, Dept Pathol, Stanford Blood Ctr, Palo Alto, CA 94304 USA; [Conrad, Fraser; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94110 USA; [Eckart, Michael] Stanford Univ, Sch Med, Prot & Nucle Acid Facil, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University	Foung, SKH (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford Blood Ctr, 3373 Hillview Ave, Palo Alto, CA 94304 USA.	sfoung@stanford.edu		Foung, Steven/0000-0001-7149-6160	USPHS [HL079381, AI081903]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081903] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by USPHS Grants HL079381 and AI081903 (to S. K. H. F.).	Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Biggins Scott W, 2005, Clin Liver Dis, V9, P505, DOI 10.1016/j.cld.2005.05.004; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Charlton M, 2004, LIVER TRANSPLANT, V10, P1120, DOI 10.1002/lt.20211; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; FOUNG S, 2011, 18 S HEP C VIR REL V; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Gustchina E, 2009, VIROLOGY, V393, P112, DOI 10.1016/j.virol.2009.07.019; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; MARTELL M, 1994, J VIROL, V68, P3425, DOI 10.1128/JVI.68.5.3425-3436.1994; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Miller Keith D, 2008, Curr Protoc Cytom, VChapter 4, DOI 10.1002/0471142956.cy0407s45; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pawlotsky Jean-Michel, 2011, Gastroenterology, V140, P746, DOI 10.1053/j.gastro.2011.01.028; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Samuel D, 2003, GASTROENTEROLOGY, V124, P642, DOI 10.1053/gast.2003.50095; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Tan YJ, 2003, VIROLOGY, V308, P250, DOI 10.1016/S0042-6822(02)00136-8; Veldt BJ, 2008, AM J TRANSPLANT, V8, P2426, DOI 10.1111/j.1600-6143.2008.02362.x; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	50	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44218	44233		10.1074/jbc.M111.290783	http://dx.doi.org/10.1074/jbc.M111.290783			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22002064	hybrid, Green Published			2022-12-25	WOS:000298402300062
J	Hensel, A; Beck, S; El Magraoui, F; Platta, HW; Girzalsky, W; Erdmann, R				Hensel, Astrid; Beck, Sabrina; El Magraoui, Fouzi; Platta, Harald W.; Girzalsky, Wolfgang; Erdmann, Ralf			Cysteine-dependent Ubiquitination of Pex18p Is Linked to Cargo Translocation across the Peroxisomal Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; MATRIX PROTEIN IMPORT; YEAST SACCHAROMYCES-CEREVISIAE; SIGNAL TYPE-1 RECEPTOR; PTS1 RECEPTOR; CONSERVED CYSTEINE; TRANSPORT; MACHINERY; MECHANISM; BIOGENESIS	The peroxisomal matrix protein import is facilitated by cycling receptor molecules that shuttle between the cytosol and the peroxisomal membrane. In the yeast Saccharomyces cerevisiae, the import of proteins harboring a peroxisomal targeting signal of type II (PTS2) is mediated by the receptor Pex7p and its co-receptor Pex18p. Here we demonstrate that Pex18p undergoes two kinds of ubiquitin modifications. One of these ubiquitination events depends on lysines 13 and 20 and forces rapid Pex18p turnover by proteasomal degradation. A cysteine residue near the extreme Pex18p amino-terminus is required for the second type of ubiquitination. It turned out that this cysteine residue at position 6 is essential for the function of Pex18p in peroxisomal protein import but does not contribute to receptor-cargo association and binding to the peroxisomal import apparatus. However, in contrast to the wild-type protein, cysteine 6-mutated Pex18p is arrested in a membrane-protected state, whereas Pex7p is accessible in a protease protection assay. This finding indicates that Pex18p export is linked to cargo translocation, which supports the idea of an export-driven import of proteins into peroxisomes.	[Hensel, Astrid; Beck, Sabrina; El Magraoui, Fouzi; Platta, Harald W.; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, Fak Med, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, Fak Med, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280; Astrid, Hensel/0000-0002-0793-0249	Deutsche Forschungsgemeinschaft [SFB642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB642.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Albertini M, 2001, EUR J CELL BIOL, V80, P257, DOI 10.1078/0171-9335-00164; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Girzalsky W, 2006, J BIOL CHEM, V281, P19417, DOI 10.1074/jbc.M603344200; Girzalsky W, 2009, BIOL CHEM, V390, P745, DOI 10.1515/BC.2009.104; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Halbach A, 2009, J BIOL CHEM, V284, P3906, DOI 10.1074/jbc.M806950200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Purdue PE, 1998, J CELL BIOL, V143, P1859; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith JJ, 2001, J BIOL CHEM, V276, P1618, DOI 10.1074/jbc.M005072200; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	63	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43495	43505		10.1074/jbc.M111.286104	http://dx.doi.org/10.1074/jbc.M111.286104			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021076	Green Published, hybrid			2022-12-25	WOS:000298351300069
J	Tsai, AL; Berka, V; Sharina, I; Martin, E				Tsai, Ah-Lim; Berka, Vladimir; Sharina, Iraida; Martin, Emil			Dynamic Ligand Exchange in Soluble Guanylyl Cyclase (sGC) IMPLICATIONS FOR sGC REGULATION AND DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE RECEPTOR; S-NITROSYLATION; CARBON-MONOXIDE; NITRATE TOLERANCE; NO ACTIVATION; HEME; CELLS; SENSOR; NITROGLYCERIN; DISSOCIATION	Accumulating evidence indicates that the functional properties of soluble guanylyl cyclase (sGC) are affected not only by the binding of NO but also by the NO:sGC ratio and a number of cellular factors, including GTP. In this study, we monitored the time-resolved transformations of sGC and sGC-NO complexes generated with stoichiometric or excess NO in the presence and absence of GTP. We demonstrate that the initial five-coordinate sGC-NO complex is highly activated by stoichiometric NO but is unstable and transforms into a five-coordinate sGC-2 state. This sGC-2 rebinds NO to form a low activity sGC-NO complex. The stability of the initial complex is greatly enhanced by GTP binding, binding of an additional NO molecule, or substitution of beta His-107. We propose that the transient nature of the sGC-NO complex, the formation of a desensitized sGC-2 state, and its transformation into a low activity sGC-NO adduct require beta His-107. We conclude that conformational changes leading to sGC desensitization may be prevented by GTP binding to the catalytic site or by binding of an additional NO molecule to the proximal side of the heme. The implications of these observations for cellular NO/cGMP signaling and the process of rapid desensitization of sGC are discussed in the context of the proposed model of sGC/NO interactions and dynamic transformations.	[Tsai, Ah-Lim; Berka, Vladimir] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; [Sharina, Iraida; Martin, Emil] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Tsai, AL (corresponding author), Univ Texas Med Sch Houston, Dept Internal Med, Div Hematol, Houston, TX 77030 USA.	ah-lim.tsai@uth.tmc.edu; emil.martin@uth.tmc.edu	Sharina, Iraida/C-9888-2014	Martin, Emil/0000-0002-9094-4165	National Institutes of Health [HL088128, HL088128S, HL095820]; American Heart Association, South Central Affiliate [09GRNT2060182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095820, F32HL008812, R01HL088128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, South Central Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088128 and HL088128S (to E. M.) and HL095820 (to A.-L. T.) from NHLBI. This work was also supported by Grant-in-aid 09GRNT2060182 from the American Heart Association, South Central Affiliate (to E. M.).	Baskaran P, 2011, BIOCHEMISTRY-US, V50, P4291, DOI 10.1021/bi2004087; Batchelor AM, 2010, P NATL ACAD SCI USA, V107, P22060, DOI 10.1073/pnas.1013147107; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Boon EM, 2005, CURR OPIN CHEM BIOL, V9, P441, DOI 10.1016/j.cbpa.2005.08.015; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009; Davis JP, 1997, BIOCHEM BIOPH RES CO, V238, P351, DOI 10.1006/bbrc.1997.7278; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Derbyshire ER, 2008, BIOCHEMISTRY-US, V47, P3892, DOI 10.1021/bi7022943; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halvey EJ, 2009, J BIOL CHEM, V284, P25630, DOI 10.1074/jbc.M109.030338; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; HATAKEYAMA K, 1992, J BIOL CHEM, V267, P20734; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ibrahim M, 2010, BIOCHEMISTRY-US, V49, P4864, DOI 10.1021/bi100506j; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; Makino R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177576; Marti MA, 2005, J AM CHEM SOC, V127, P7721, DOI 10.1021/ja042870c; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; Mayer B, 2009, MOL PHARMACOL, V75, P886, DOI 10.1124/mol.108.052142; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Moncada S., 2006, V176, P213; MULSCH A, 1988, EUR J PHARMACOL, V158, P191, DOI 10.1016/0014-2999(88)90066-0; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Russwurm M, 2002, J BIOL CHEM, V277, P24883, DOI 10.1074/jbc.M110570200; Sato M, 2006, ANAL CHEM, V78, P8175, DOI 10.1021/ac061791b; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Schmidt P, 2003, EUR J PHARMACOL, V468, P167, DOI 10.1016/S0014-2999(03)01674-1; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Vogel KM, 1999, J BIOL INORG CHEM, V4, P804, DOI 10.1007/s007750050354; WALDMAN SA, 1986, BIOCHEM PHARMACOL, V35, P3525, DOI 10.1016/0006-2952(86)90622-2; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhou ZM, 2008, ARTERIOSCL THROM VAS, V28, P1803, DOI 10.1161/ATVBAHA.108.165043	58	44	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43182	43192		10.1074/jbc.M111.290304	http://dx.doi.org/10.1074/jbc.M111.290304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009742	Green Published, hybrid			2022-12-25	WOS:000298351300039
J	Hu, G; Qiu, WY; Ceulemans, A				Hu, Guang; Qiu, Wen-Yuan; Ceulemans, Arnout			A New Euler's Formula for DNA Polyhedra	PLOS ONE			English	Article							MOLECULAR DESIGN; ARCHITECTURE; TOPOLOGY	DNA polyhedra are cage-like architectures based on interlocked and interlinked DNA strands. We propose a formula which unites the basic features of these entangled structures. It is based on the transformation of the DNA polyhedral links into Seifert surfaces, which removes all knots. The numbers of components mu, of crossings c, and of Seifert circles s are related by a simple and elegant formula: s+mu = c+2. This formula connects the topological aspects of the DNA cage to the Euler characteristic of the underlying polyhedron. It implies that Seifert circles can be used as effective topological indices to describe polyhedral links. Our study demonstrates that, the new Euler's formula provides a theoretical framework for the stereo-chemistry of DNA polyhedra, which can characterize enzymatic transformations of DNA and be used to characterize and design novel cages with higher genus.	[Hu, Guang] Lanzhou Univ, State Key Lab Appl Organ Chem, Dept Chem, Lanzhou 730000, Peoples R China; [Hu, Guang; Ceulemans, Arnout] Katholieke Univ Leuven, Dept Chem, Louvain, Belgium; [Hu, Guang; Ceulemans, Arnout] Katholieke Univ Leuven, INPAC Inst Nanoscale Phys & Chem, Louvain, Belgium	Lanzhou University; KU Leuven; KU Leuven	Hu, G (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Dept Chem, Lanzhou 730000, Peoples R China.	wyqiu@lzu.edu.cn	Hu, Guang/B-2909-2012	Hu, Guang/0000-0002-8754-1541	National Natural Science Foundation of China [20973085, 10831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090211110006]; Leuven INPAC institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Leuven INPAC institute	This work was supported by grants from the National Natural Science Foundation of China (Nos. 20973085 and 10831001) and Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20090211110006). Financial support from the Leuven INPAC institute is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124; [Anonymous], 2008, EULERS GEM POLYHEDRO; Castle T, 2009, NEW J CHEM, V33, P2107, DOI 10.1039/b907338h; CEULEMANS A, 1991, NATURE, V353, P52, DOI 10.1038/353052a0; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; CRONWELL PR, 2004, KNOTS LINKS; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; GRUNBAUM B, 1973, CONVEX POLYTOPES; He Y, 2009, ANGEW CHEM INT EDIT, V48, P128, DOI 10.1002/anie.200802230; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hu G, 2011, B MATH BIOL, V73, P3030, DOI 10.1007/s11538-011-9659-z; Hu GA, 2010, J MATH CHEM, V48, P401, DOI 10.1007/s10910-010-9682-6; Hu G, 2009, J MATH CHEM, V46, P592, DOI 10.1007/s10910-008-9487-z; Hyde ST, 2007, ACTA CRYSTALLOGR A, V63, P186, DOI 10.1107/S0108767306052421; Jablan S., POLYHEDRAL KNOTS LIN; Jonoska N, 2002, LNCS, V340, P70; JONOSKA N, 2008, J PHYS A, V14; Lijnen E, 2005, J CHEM INF MODEL, V45, P1719, DOI 10.1021/ci0502496; NEUWIRTH L, 1979, SCI AM, V240, P110, DOI 10.1038/scientificamerican0679-110; Oliveira CLP, 2010, ACS NANO, V4, P1367, DOI 10.1021/nn901510v; Qiu WY, 2010, DNA PROP MODIF FUNCT, P1; Qiu WY, 2008, SCI CHINA SER B, V51, P13, DOI 10.1007/s11426-008-0018-3; Qiu WY, 2000, MATH CHEM S, V6, P175; Qiu WY, 2005, J MOL STRUC-THEOCHEM, V756, P163, DOI 10.1016/j.theochem.2005.09.014; QIU WY, 2010, MATH CHEM CHEM RES A, P327; Seifert H, 1935, MATH ANN, V110, P571, DOI 10.1007/BF01448044; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang CA, 2009, FARADAY DISCUSS, V143, P221, DOI 10.1039/b905313c; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; [No title captured]	33	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26308	10.1371/journal.pone.0026308	http://dx.doi.org/10.1371/journal.pone.0026308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022596	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400045
J	Butala, NM; Desai, MM; Linnander, EL; Wong, YR; Mikhail, DG; Ott, LS; Spertus, JA; Bradley, EH; Aaty, AA; Abdelfattah, A; Gamal, A; Kholeif, H; El Baz, M; Allam, AH; Krumholz, HM				Butala, Neel M.; Desai, Mayur M.; Linnander, Erika L.; Wong, Y. Rex; Mikhail, Daoud G.; Ott, Lesli S.; Spertus, John A.; Bradley, Elizabeth H.; Aaty, Ahmed Abdel; Abdelfattah, Alia; Gamal, Ayman; Kholeif, Hatem; El Baz, Mohamed; Allam, A. H.; Krumholz, Harlan M.			Gender Differences in Presentation, Management, and In-Hospital Outcomes for Patients with AMI in a Lower-Middle Income Country: Evidence from Egypt	PLOS ONE			English	Article							ACUTE-CORONARY-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; WOMEN; MEN; SYMPTOMS; REGISTRY; IMPACT	Background: Many studies in high-income countries have investigated gender differences in the care and outcomes of patients hospitalized with acute myocardial infarction (AMI). However, little evidence exists on gender differences among patients with AMI in lower-middle-income countries, where the proportion deaths stemming from cardiovascular disease is projected to increase dramatically. This study examines gender differences in patients in the lower-middle-income country of Egypt to determine if female patients with AMI have a different presentation, management, or outcome compared with men. Methods and Findings: Using registry data collected over 18 months from 5 Egyptian hospitals, we considered 1204 patients (253 females, 951 males) with a confirmed diagnosis of AMI. We examined gender differences in initial presentation, clinical management, and in-hospital outcomes using t-tests and x(2) tests. Additionally, we explored gender differences in in-hospital death using multivariate logistic regression to adjust for age and other differences in initial presentation. We found that women were older than men, had higher BMI, and were more likely to have hypertension, diabetes mellitus, dyslipidemia, heart failure, and atrial fibrillation. Women were less likely to receive aspirin upon admission (p<0.01) or aspirin or statins at discharge (p = 0.001 and p<0.05, respectively), although the magnitude of these differences was small. While unadjusted in-hospital mortality was significantly higher for women (OR: 2.10; 95% CI: 1.54 to 2.87), this difference did not persist in the fully adjusted model (OR: 1.18; 95% CI: 0.55 to 2.55). Conclusions: We found that female patients had a different profile than men at the time of presentation. Clinical management of men and women with AMI was similar, though there are small but significant differences in some areas. These gender differences did not translate into differences in in-hospital outcome, but highlight differences in quality of care and represent important opportunities for improvement.	[Butala, Neel M.; Desai, Mayur M.; Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, Sch Med, New Haven, CT 06520 USA; [Desai, Mayur M.; Linnander, Erika L.; Wong, Y. Rex; Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Desai, Mayur M.; Mikhail, Daoud G.; Ott, Lesli S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Spertus, John A.] Univ Missouri, Kansas City Sch Med, Kansas City, MO 64110 USA; [Aaty, Ahmed Abdel] Univ Alexandria, Alexandria, Egypt; [Abdelfattah, Alia] Cairo Univ, Cairo, Egypt; [Gamal, Ayman] Medinat Nasr Hosp, Cairo, Egypt; [Kholeif, Hatem; El Baz, Mohamed; Allam, A. H.] Al Azhar Univ, Cairo, Egypt	Yale University; Yale University; Yale University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University	Butala, NM (corresponding author), Yale Univ, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, Sch Med, New Haven, CT 06520 USA.	neel.butala@yale.edu	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Desai, Mayur/0000-0001-6616-0945; Linnander, Erika/0000-0002-3417-1049	National Bank of Egypt; Wilbur Downs Fellowship	National Bank of Egypt; Wilbur Downs Fellowship	This research was supported by the National Bank of Egypt and the Wilbur Downs Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091; Arslanian-Engoren C, 2006, AM J CARDIOL, V98, P1177, DOI 10.1016/j.amjcard.2006.05.049; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bello N, 2004, PROG CARDIOVASC DIS, V46, P287, DOI 10.1016/j.pcad.2003.08.001; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Centers for Medicare & Medicaid Services The Joint Commission, 2011, SPEC MAN NAT HOSP IN; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; Hasdai D, 2003, AM J CARDIOL, V91, P1466, DOI 10.1016/S0002-9149(03)00400-4; Heer T, 2006, AM J CARDIOL, V98, P160, DOI 10.1016/j.amjcard.2006.01.072; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Meischke H, 1998, AM J EMERG MED, V16, P363, DOI 10.1016/S0735-6757(98)90128-0; Njolstad I, 1996, CIRCULATION, V93, P450; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Safavi K, 2010, ASIA-PAC J PUBLIC HE, V22, p90S, DOI 10.1177/1010539510373017; Shafey O, 2003, TOBACCO CONTROL COUN; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Song XT, 2007, CHINESE MED J-PEKING, V120, P1063, DOI 10.1097/00029330-200706020-00007; Srichaiveth Boonchu, 2007, Journal of the Medical Association of Thailand, V90, P65; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; World Bank Group, 2011, COUNTR LEND GROUPS; World Health Organization (WHO), 2006, HLTH SYST PROF EG; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; ZUBAID M, 2007, PRELIMINARY RESULTS	29	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25904	10.1371/journal.pone.0025904	http://dx.doi.org/10.1371/journal.pone.0025904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022463	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600031
J	Vuononvirta, J; Toivonen, L; Grondahl-Yli-Hannuksela, K; Barkoff, AM; Lindholm, L; Mertsola, J; Peltola, V; He, QS				Vuononvirta, Juho; Toivonen, Laura; Grondahl-Yli-Hannuksela, Kirsi; Barkoff, Alex-Mikael; Lindholm, Laura; Mertsola, Jussi; Peltola, Ville; He, Qiushui			Nasopharyngeal Bacterial Colonization and Gene Polymorphisms of Mannose-Binding Lectin and Toll-Like Receptors 2 and 4 in Infants	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; MICROBIAL INTERACTIONS; MORAXELLA-CATARRHALIS; STAPHYLOCOCCUS-AUREUS; OTITIS-MEDIA; ASSOCIATION; CHILDREN; SUSCEPTIBILITY	Background: Human nasopharynx is often colonized by potentially pathogenic bacteria. Gene polymorphisms in mannose-binding lectin (MBL), toll-like receptor (TLR) 2 and TLR4 have been reported. The present study aimed to investigate possible association between nasopharyngeal bacterial colonization and gene polymorphisms of MBL, TLR2 and TLR4 in healthy infants. Methodology/Principal Findings: From August 2008 to June 2010, 489 nasopharyngeal swabs and 412 blood samples were taken from 3-month-old healthy Finnish infants. Semi-quantitative culture was performed and pyrosequencing was used for detection of polymorphisms in MBL structural gene at codons 52, 54, and 57, TLR2 Arg753Gln and TLR4 Asp299Gly. Fifty-nine percent of subjects were culture positive for at least one of the four species: 11% for Streptococcus pneumoniae, 23% for Moraxella catarrhalis, 1% for Haemophilus influenzae and 25% for Staphylococcus aureus. Thirty-two percent of subjects had variant types in MBL, 5% had polymorphism of TLR2, and 18% had polymorphism of TLR4. Colonization rates of S. pneumoniae and S. aureus were significantly higher in infants with variant types of MBL than those with wild type (p = .011 and p = .024). Colonization rates of S. aureus and M. catarrhalis were significantly higher in infants with polymorphisms of TLR2 and of TLR4 than those without (p = .027 and p = .002). Conclusions: Our study suggests that there is an association between nasopharyngeal bacterial colonization and genetic variation of MBL, TLR2 and TLR4 in young infants. This finding supports a role for these genetic variations in susceptibility of children to respiratory infections.	[Vuononvirta, Juho; Grondahl-Yli-Hannuksela, Kirsi; Barkoff, Alex-Mikael; He, Qiushui] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Toivonen, Laura; Mertsola, Jussi; Peltola, Ville] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Toivonen, Laura; Peltola, Ville] Univ Turku, Turku Inst Child & Youth Res, Turku, Finland; [Lindholm, Laura] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Turku	Vuononvirta, J (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland.	qiushui.he@thl.fi	Mertsola, Jussi/AAE-3460-2021		Academy of Finland; Special Governmental Fund for University Hospitals (EVO)	Academy of Finland(Academy of Finland); Special Governmental Fund for University Hospitals (EVO)	This work was supported by the Academy of Finland and the Special Governmental Fund for University Hospitals (EVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad Parviz, 2009, V496, P73, DOI 10.1007/978-1-59745-553-4_7; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; El-Helou O, 2011, HUM IMMUNOL, V72, P47, DOI 10.1016/j.humimm.2010.10.001; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lebon A, 2011, CLIN VACCINE IMMUNOL, V18, P180, DOI 10.1128/CVI.00357-10; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, pS121, DOI 10.1097/INF.0b013e3181b6d7ec; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roos A, 2006, J IMMUNOL METHODS, V309, P108, DOI 10.1016/j.jim.2005.11.017; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Verhaegh SJC, 2010, CLIN MICROBIOL INFEC, V16, P992, DOI 10.1111/j.1469-0691.2009.03008.x; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weyrich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013980; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006	33	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26198	10.1371/journal.pone.0026198	http://dx.doi.org/10.1371/journal.pone.0026198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022564	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600044
J	Mayoral, RJ; Deho, L; Rusca, N; Bartonicek, N; Saini, HK; Enright, AJ; Monticelli, S				Mayoral, Ramon J.; Deho, Lorenzo; Rusca, Nicole; Bartonicek, Nenad; Saini, Harpreet Kaur; Enright, Anton J.; Monticelli, Silvia			MiR-221 Influences Effector Functions and Actin Cytoskeleton in Mast Cells	PLOS ONE			English	Article							SYSTEMIC MASTOCYTOSIS; MICRORNA CONTROL; IMMUNE-SYSTEM; KIT RECEPTOR; EXPRESSION; DIFFERENTIATION; ERYTHROPOIESIS; ACTIVATION; SEQUENCES; SURVIVAL	Mast cells have essential effector and immunoregulatory functions in IgE-associated allergic disorders and certain innate and adaptive immune responses, but the role of miRNAs in regulating mast cell functions is almost completely unexplored. To examine the role of the activation-induced miRNA miR-221 in mouse mast cells, we developed robust lentiviral systems for miRNA overexpression and depletion. While miR-221 favored mast cell adhesion and migration towards SCF or antigen in trans-well migration assays, as well as cytokine production and degranulation in response to IgE-antigen complexes, neither miR-221 overexpression, nor its ablation, interfered with mast cell differentiation. Transcriptional profiling of miR-221-overexpressing mast cells revealed modulation of many transcripts, including several associated with the cytoskeleton; indeed, miR-221 overexpression was associated with reproducible increases in cortical actin in mast cells, and with altered cellular shape and cell cycle in murine fibroblasts. Our bioinformatics analysis showed that this effect was likely mediated by the composite effect of miR-221 on many primary and secondary targets in resting cells. Indeed, miR-221-induced cellular alterations could not be recapitulated by knockdown of one of the major targets of miR-221. We propose a model in which miR-221 has two different roles in mast cells: in resting cells, basal levels of miR-221 contribute to the regulation of the cell cycle and cytoskeleton, a general mechanism probably common to other miR-221-expressing cell types, such as fibroblasts. Vice versa, upon induction in response to mast cell stimulation, miR-221 effects are mast cell-specific and activation-dependent, contributing to the regulation of degranulation, cytokine production and cell adherence. Our studies provide new insights into the roles of miR-221 in mast cell biology, and identify novel mechanisms that may contribute to mast cell-related pathological conditions, such as asthma, allergy and mastocytosis.	[Mayoral, Ramon J.; Deho, Lorenzo; Rusca, Nicole; Monticelli, Silvia] Inst Res Biomed, Bellinzona, Switzerland; [Bartonicek, Nenad; Saini, Harpreet Kaur; Enright, Anton J.] EMBL European Bioinformat Inst, Cambridge, England	Universita della Svizzera Italiana; European Molecular Biology Laboratory (EMBL)	Mayoral, RJ (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	silvia.monticelli@irb.unisi.ch	Bartonicek, Nenad/B-6675-2016; Enright, Anton/F-3094-2011; Monticelli, Silvia/ABE-7054-2020; Saini, Harpreet/F-3882-2011	Bartonicek, Nenad/0000-0003-2144-1887; Enright, Anton/0000-0002-6090-3100; Saini, Harpreet/0000-0002-3733-7657; Monticelli, Silvia/0000-0002-5909-8802	San Raffaele University (Italy); Swiss National Science Foundation [31003A_121991]	San Raffaele University (Italy); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	RJM was the recipient of a pre-doctoral fellowship from the San Raffaele University (Italy). This work was supported by the Swiss National Science Foundation grant 31003A_121991 to SM and by a contribution from the Ceresio Foundation (Switzerland) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartonicek N, 2010, BIOINFORMATICS; Bartonicek N, 2010, BIOINFORMAT IN PRESS; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Blank U, 2006, CURR PROTOC CELL BIO; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Deho' L, 2010, ARCH IMMUNOL THER EX, V58, P279, DOI 10.1007/s00005-010-0086-x; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hollmann TJ, 2008, AM J SURG PATHOL, V32, P139, DOI 10.1097/PAS.0b013e3180ca9a02; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu S, 2011, IMMUNOL CELL BIOL; Mayerhofer M, 2008, J IMMUNOL, V180, P5466, DOI 10.4049/jimmunol.180.8.5466; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; RAZIN E, 1984, J IMMUNOL, V132, P1479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x; Sotlar K, 2004, AM J SURG PATHOL, V28, P1319, DOI 10.1097/01.pas.0000138181.89743.7b; Spinello I, 2009, ONCOGENE, V28, P2276, DOI 10.1038/onc.2009.87; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807	43	69	75	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26133	10.1371/journal.pone.0026133	http://dx.doi.org/10.1371/journal.pone.0026133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022537	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000072
J	Sheridan, SD; Theriault, KM; Reis, SA; Zhou, F; Madison, JM; Daheron, L; Loring, JF; Haggarty, SJ				Sheridan, Steven D.; Theriault, Kraig M.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Daheron, Laurence; Loring, Jeanne F.; Haggarty, Stephen J.			Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome	PLOS ONE			English	Article							REPEAT EXPANSION; MESSENGER-RNA; METHYLATION; DIFFERENTIATION; PROTEIN; INVOLVEMENT; INSTABILITY; EXPRESSION; MECHANISM; ALLELES	Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability. In addition to cognitive deficits, FXS patients exhibit hyperactivity, attention deficits, social difficulties, anxiety, and other autistic-like behaviors. FXS is caused by an expanded CGG trinucleotide repeat in the 59 untranslated region of the Fragile X Mental Retardation (FMR1) gene leading to epigenetic silencing and loss of expression of the Fragile X Mental Retardation protein (FMRP). Despite the known relationship between FMR1 CGG repeat expansion and FMR1 silencing, the epigenetic modifications observed at the FMR1 locus, and the consequences of the loss of FMRP on human neurodevelopment and neuronal function remain poorly understood. To address these limitations, we report on the generation of induced pluripotent stem cell (iPSC) lines from multiple patients with FXS and the characterization of their differentiation into post-mitotic neurons and glia. We show that clones from reprogrammed FXS patient fibroblast lines exhibit variation with respect to the predominant CGG-repeat length in the FMR1 gene. In two cases, iPSC clones contained predominant CGG-repeat lengths shorter than measured in corresponding input population of fibroblasts. In another instance, reprogramming a mosaic patient having both normal and pre-mutation length CGG repeats resulted in genetically matched iPSC clonal lines differing in FMR1 promoter CpG methylation and FMRP expression. Using this panel of patient-specific, FXS iPSC models, we demonstrate aberrant neuronal differentiation from FXS iPSCs that is directly correlated with epigenetic modification of the FMR1 gene and a loss of FMRP expression. Overall, these findings provide evidence for a key role for FMRP early in human neurodevelopment prior to synaptogenesis and have implications for modeling of FXS using iPSC technology. By revealing disease-associated cellular phenotypes in human neurons, these iPSC models will aid in the discovery of novel therapeutics for FXS and other autism-spectrum disorders sharing common pathophysiology.	[Sheridan, Steven D.; Theriault, Kraig M.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA; [Sheridan, Steven D.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Haggarty, Stephen J.] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Daheron, Laurence] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Daheron, Laurence] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Scripps Research Institute	Sheridan, SD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA.	haggarty@chgr.mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Loring, Jeanne F/A-1620-2011	Haggarty, Stephen J/0000-0002-7872-168X; Loring, Jeanne F/0000-0001-6226-9767	FRAXA Research Foundation; Harvard Stem Cell Institute; Stanley Medical Research Institute; National Institute Of Mental Health [R33MH087896]; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087896, R21MH087896] Funding Source: NIH RePORTER	FRAXA Research Foundation; Harvard Stem Cell Institute; Stanley Medical Research Institute; National Institute Of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the FRAXA Research Foundation, a seed grant from the Harvard Stem Cell Institute, the Stanley Medical Research Institute, and a grant (#R33MH087896) from the National Institute Of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, BIOCHEM BIOPH RES CO, V393, P211, DOI 10.1016/j.bbrc.2010.01.101; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bhattacharyya A, 2008, STEM CELLS DEV, V17, P107, DOI 10.1089/scd.2007.0073; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Castren M, 2006, CELL CYCLE, V5, P1528, DOI 10.4161/cc.5.14.3096; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Datta S, 2011, CHROMOSOME RES, V19, P445, DOI 10.1007/s10577-011-9206-7; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kumari D, 2010, HUM MOL GENET, V19, P4634, DOI 10.1093/hmg/ddq394; Kumari D, 2009, J BIOL CHEM, V284, P7413, DOI 10.1074/jbc.R800026200; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Maddalena A., 2001, GENET MED, V3, P200, DOI DOI 10.1097/00125817-200105000-00010; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Sheridan SD, 2008, METHOD CELL BIOL, V86, P29, DOI 10.1016/S0091-679X(08)00003-4; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739	44	219	226	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26203	10.1371/journal.pone.0026203	http://dx.doi.org/10.1371/journal.pone.0026203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022567	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000085
J	Sivakumaran, TA; Igo, RP; Kidd, JM; Itsara, A; Kopplin, LJ; Chen, W; Hagstrom, SA; Peachey, NS; Francis, PJ; Klein, ML; Chew, EY; Ramprasad, VL; Tay, WT; Mitchell, P; Seielstad, M; Stambolian, DE; Edwards, AO; Lee, KE; Leontiev, DV; Jun, G; Wang, Y; Tian, LP; Qiu, FY; Henning, AK; LaFramboise, T; Sen, P; Aarthi, M; George, R; Raman, R; Das, MK; Vijaya, L; Kumaramanickavel, G; Wong, TY; Swaroop, A; Abecasis, GR; Klein, R; Klein, BEK; Nickerson, DA; Eichler, EE; Iyengar, SK				Sivakumaran, Theru A.; Igo, Robert P., Jr.; Kidd, Jeffrey M.; Itsara, Andy; Kopplin, Laura J.; Chen, Wei; Hagstrom, Stephanie A.; Peachey, Neal S.; Francis, Peter J.; Klein, Michael L.; Chew, Emily Y.; Ramprasad, Vedam L.; Tay, Wan-Ting; Mitchell, Paul; Seielstad, Mark; Stambolian, Dwight E.; Edwards, Albert O.; Lee, Kristine E.; Leontiev, Dmitry V.; Jun, Gyungah; Wang, Yang; Tian, Liping; Qiu, Feiyou; Henning, Alice K.; LaFramboise, Thomas; Sen, Parveen; Aarthi, Manoharan; George, Ronnie; Raman, Rajiv; Das, Manmath Kumar; Vijaya, Lingam; Kumaramanickavel, Govindasamy; Wong, Tien Y.; Swaroop, Anand; Abecasis, Goncalo R.; Klein, Ronald; Klein, Barbara E. K.; Nickerson, Deborah A.; Eichler, Evan E.; Iyengar, Sudha K.			A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; SEGMENTAL DUPLICATIONS; SUSCEPTIBILITY; HAPLOTYPE; VARIANT; GENOME; GENES; ASSOCIATION; MACULOPATHY; PROTEINS	Complement factor H shows very strong association with Age-related Macular Degeneration (AMD), and recent data suggest that multiple causal variants are associated with disease. To refine the location of the disease associated variants, we characterized in detail the structural variation at CFH and its paralogs, including two copy number polymorphisms (CNP), CNP147 and CNP148, and several rare deletions and duplications. Examination of 34 AMD-enriched extended families (N = 293) and AMD cases (White N = 4210 Indian = 134; Malay = 140) and controls (White N = 3229; Indian = 117; Malay = 2390) demonstrated that deletion CNP148 was protective against AMD, independent of SNPs at CFH. Regression analysis of seven common haplotypes showed three haplotypes, H1, H6 and H7, as conferring risk for AMD development. Being the most common haplotype H1 confers the greatest risk by increasing the odds of AMD by 2.75-fold (95% CI = [2.51, 3.01]; p = 8.31 x 10(-109)); Caucasian (H6) and Indian-specific (H7) recombinant haplotypes increase the odds of AMD by 1.85-fold (p = 3.52 x 10(-9)) and by 15.57-fold (P = 0.007), respectively. We identified a 32-kb region downstreamof Y402H (rs1061170), shared by all three risk haplotypes, suggesting that this region may be critical for AMD development. Further analysis showed that two SNPs within the 32 kb block, rs1329428 and rs203687, optimally explain disease association. rs1329428 resides in 20 kb unique sequence block, but rs203687 resides in a 12 kb block that is 89% similar to a noncoding region contained in Delta CNP148. We conclude that causal variation in this region potentially encompasses both regulatory effects at single markers and copy number.	[Sivakumaran, Theru A.; Igo, Robert P., Jr.; Leontiev, Dmitry V.; Jun, Gyungah; Wang, Yang; Tian, Liping; Qiu, Feiyou] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Sivakumaran, Theru A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Kopplin, Laura J.; LaFramboise, Thomas; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; [Kidd, Jeffrey M.; Itsara, Andy; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chen, Wei; Abecasis, Goncalo R.] Univ Michigan Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI USA; [Hagstrom, Stephanie A.; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Hagstrom, Stephanie A.; Peachey, Neal S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Peachey, Neal S.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH USA; [Francis, Peter J.; Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Chew, Emily Y.] NEI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Ramprasad, Vedam L.; Aarthi, Manoharan; Kumaramanickavel, Govindasamy] Sankara Nethralaya, Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Chennai, Tamil Nadu, India; [Tay, Wan-Ting; Wong, Tien Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117595, Singapore; [Mitchell, Paul] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia; [Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Stambolian, Dwight E.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Stambolian, Dwight E.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Edwards, Albert O.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Lee, Kristine E.; Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Jun, Gyungah] Boston Univ, Dept Med, Boston, MA 02215 USA; [Jun, Gyungah] Boston Univ, Dept Ophthalmol, Boston, MA 02215 USA; [Jun, Gyungah] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Henning, Alice K.] EMMES Corp, Rockville, MD USA; [Sen, Parveen; Raman, Rajiv; Das, Manmath Kumar; Vijaya, Lingam] Sankara Nethralaya, Vis Res Fdn, Dept Med Retina, Chennai, Tamil Nadu, India; [George, Ronnie] Sankara Nethralaya, Vis Res Fdn, Dept Glaucoma, Chennai, Tamil Nadu, India; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Australia; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; [Swaroop, Anand] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Case Western Reserve University; Cincinnati Children's Hospital Medical Center; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; Singapore National Eye Center; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Pennsylvania; University of Pennsylvania; University of Oregon; University of Wisconsin System; Boston University; Boston University; Boston University; Emmes Corporation; Centre for Eye Research Australia; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Sivakumaran, TA (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu	Peachey, Neal/G-5533-2010; Wong, Tien Yin/AAC-9724-2020; KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021; Sen, Parveen/W-4707-2019; Raman, Rajiv/A-7234-2009; Seielstad, Mark/T-7841-2019; Mitchell, Paul/P-1498-2014; /S-1190-2019; Chen, Wei/AAX-5994-2020; Igo, Rob/P-3438-2019	Peachey, Neal/0000-0002-4419-7226; Wong, Tien Yin/0000-0002-8448-1264; KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Raman, Rajiv/0000-0001-5842-0233; /0000-0001-7488-250X; Chen, Wei/0000-0001-7196-8703; Igo, Rob/0000-0002-0024-1993; Seielstad, Mark/0000-0001-5783-1401; Abecasis, Goncalo/0000-0003-1509-1825; george, ronnie/0000-0001-7368-0252; Manoharan, Aarthi/0000-0003-2318-2786; Jun, Gyungah/0000-0002-3230-8697; Kidd, Jeffrey/0000-0002-9631-1465; Swaroop, Anand/0000-0002-1975-1141; Klein, Ronald/0000-0002-4428-6237	National Eye Institute [EY015810, U10EY06594, EY015286, EY13438, EY10605, T32 EY007157]; Retina Research Foundation; Department of Biotechnology, Government of India, New Delhi, India [DBT/PR7788/MED/12/299/2006]; National Heart, Lung, and Blood Institute [HL07567]; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK057292]; National Institutes of Health [T32 GM07250]; Singapore's National Medical Research Council [0796/2003, 0863/2004, CSI/0002/2005]; Biomedical Research Council [501/1/25-5]; Singapore Tissue Network; U.S. Public Health Service Resource from National Center for Research Resources [RR03655]; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University; University Hospitals of Cleveland [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010605, T32EY007157, R03EY013438, R01EY015286, U10EY006594, ZIAEY000475, R01EY015810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007250] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore's National Medical Research Council(National Medical Research Council, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Tissue Network; U.S. Public Health Service Resource from National Center for Research Resources; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by EY015810, U10EY06594, EY015286, EY13438, EY10605 and T32 EY007157 from the National Eye Institute; the Retina Research Foundation; the Department of Biotechnology (DBT/PR7788/MED/12/299/2006), Government of India, New Delhi, India (GK); training grant HL07567, from the National Heart, Lung, and Blood Institute; U01DK057292 from the National Institute of Diabetes and Digestive and Kidney Diseases; and the Medical Sciences Training Program T32 GM07250 (LJK), National Institutes of Health; grants from Singapore's National Medical Research Council Grant (0796/2003, 0863/2004 and CSI/0002/2005), Biomedical Research Council (501/1/25-5) and Singapore Tissue Network. Some of the analyses were carried out using the software package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. This research was also supported by the Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University and University Hospitals of Cleveland (P30CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Dewan A, 2007, CURR OPIN GENET DEV, V17, P228, DOI 10.1016/j.gde.2007.04.004; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Patel N, 2008, EYE, V22, P768, DOI 10.1038/sj.eye.6702844; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson CL, 2007, HUM MOL GENET, V16, P2135, DOI 10.1093/hmg/ddm164; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	46	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25598	10.1371/journal.pone.0025598	http://dx.doi.org/10.1371/journal.pone.0025598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022419	Green Published, gold			2022-12-25	WOS:000295976000025
J	Nagaraja, SB; Satyanarayana, S; Chadha, SS; Kalemane, S; Jaju, J; Achanta, S; Reddy, K; Potharaju, V; Shamrao, SRM; Dewan, P; Rony, Z; Tetali, S; Anchala, R; Kannuri, NK; Harries, AD; Singh, SK				Nagaraja, Sharath Burugina; Satyanarayana, Srinath; Chadha, Sarabjit Singh; Kalemane, Santosha; Jaju, Jyoti; Achanta, Shanta; Reddy, Kishore; Potharaju, Vishnu; Shamrao, Srinivas Rao Motta; Dewan, Puneet; Rony, Zachariah; Tetali, Shailaja; Anchala, Raghupathi; Kannuri, Nanda Kishore; Harries, Anthony David; Singh, Sachdeva Kuldeep			How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?	PLOS ONE			English	Article							CHEMOTHERAPY; TUBERCULOSIS; OUTCOMES	Setting: Seven districts in Andhra Pradesh, South India Objectives: To a) determine treatment outcomes of patients who fail first line anti-TB treatment and are not placed on an multi-drug resistant TB (MDR-TB) regimen, and b) relate the treatment outcomes to culture and drug susceptibility patterns (C&DST). Design: Retrospective cohort study using routine programme data and Mycobacterium TB Culture C&DST between July 2008 and December 2009. Results: There were 202 individuals given a re-treatment regimen and included in the study. Overall treatment outcomes were: 68 (34%) with treatment success, 84 (42%) failed, 36 (18%) died, 13 (6.5%) defaulted and 1 transferred out. Treatment success for category I and II failures was low at 37%. In those with positive cultures, 81 had pan-sensitive strains with 31 (38%) showing treatment success, while 61 had drug-resistance strains with 9 (15%) showing treatment success. In 58 patients with negative cultures, 28 (48%) showed treatment success. Conclusion: Treatment outcomes of patients who fail a first-line anti-TB treatment and who are not placed on an MDR-TB regimen are unacceptably poor. The worst outcomes are seen among category II failures and those with negative cultures or drug-resistance. There are important programmatic implications which need to be addressed.	[Nagaraja, Sharath Burugina; Jaju, Jyoti; Achanta, Shanta; Dewan, Puneet] Off WHO Representat India, New Delhi, India; [Satyanarayana, Srinath; Chadha, Sarabjit Singh; Harries, Anthony David] Int Union Against TB & Lung Dis The Union, Paris, France; [Kalemane, Santosha] Impact Hlth Solut, Hyderabad, Andhra Pradesh, India; [Reddy, Kishore; Potharaju, Vishnu] State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Shamrao, Srinivas Rao Motta] State TB Cell, Directorate Hlth Serv, Hyderabad, Andhra Pradesh, India; [Rony, Zachariah] Med Sans Frontieres, Med Dept Operat Res, Brussels Operat Ctr, Luxembourg, Luxembourg; [Tetali, Shailaja; Anchala, Raghupathi; Kannuri, Nanda Kishore] Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, Andhra Pradesh, India; [Singh, Sachdeva Kuldeep] Govt India, Cent TB Div, Minist Hlth & Family Welf, New Delhi, India; [Harries, Anthony David] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	World Health Organization; Doctors Without Borders; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Nagaraja, SB (corresponding author), Off WHO Representat India, New Delhi, India.	sharathb@rntcp.org	Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Kannuri, Nanda Kishore/0000-0003-2352-6972; zachariah, rony/0000-0002-2915-9328; Satyanarayana, Srinath/0000-0002-5420-2551; Anchala, Raghupathy/0000-0003-4733-211X	Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India	Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India	The research was supported through an operational research course which was funded through a memorandum of understanding between the Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union) and the Public Health Foundation of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division, 2006, PROC MAN REV NAT TUB; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2010, DOTS PLUS GUID; Central Tuberculosis Division, 2010, TUB IND 2010; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2003, TREATM TUB GUID NAT	10	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25698	10.1371/journal.pone.0025698	http://dx.doi.org/10.1371/journal.pone.0025698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022433	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200012
J	Vogt, KE; Gerharz, S; Graham, J; Canepari, M				Vogt, Kaspar E.; Gerharz, Stephan; Graham, Jeremy; Canepari, Marco			Combining Membrane Potential Imaging with L-Glutamate or GABA Photorelease	PLOS ONE			English	Article							METABOTROPIC SLOW EPSC; CA1 PYRAMIDAL NEURONS; INOSITOL TRISPHOSPHATE; PURKINJE NEURONS; LASER PHOTOLYSIS; CAGED COMPOUNDS; RAT; VOLTAGE; RECEPTORS; RELEASE	Combining membrane potential imaging using voltage sensitive dyes with photolysis of L-glutamate or GABA allows the monitoring of electrical activity elicited by the neurotransmitter at different sub-cellular sites. Here we describe a simple system and some basic experimental protocols to achieve these measurements. We show how to apply the neurotransmitter and how to vary the dimension of the area of photolysis. We assess the localisation of photolysis and of the recorded membrane potential changes by depolarising the dendrites of cerebellar Purkinje neurons with L-glutamate photorelease using different experimental protocols. We further show in the apical dendrites of CA1 hippocampal pyramidal neurons how L-glutamate photorelease can be used to calibrate fluorescence changes from voltage sensitive dyes in terms of membrane potential changes (in mV) and how GABA photorelease can be used to investigate the phenomenon of shunting inhibition. We also show how GABA photorelease can be used to measure chloride-mediated changes of membrane potential under physiological conditions originating from different regions of a neuron, providing important information on the local intracellular chloride concentrations. The method and the proof of principle reported here open the gateway to a variety of important applications where the advantages of this approach are necessary.	[Vogt, Kaspar E.; Gerharz, Stephan; Canepari, Marco] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland; [Graham, Jeremy] CAIRN Res Ltd, Faversham, England; [Canepari, Marco] INSERM, U836, Team 3, Grenoble, France; [Canepari, Marco] Univ Grenoble 1, Inst Neurosci, Grenoble, France	University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Vogt, KE (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.	marco.canepari@ujf-grenoble.fr	Canepari, Marco/AAJ-6709-2021; Canepari, Marco/H-6772-2012	Canepari, Marco/0000-0001-9759-2388; Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X	Swiss National Science Foundation [3100A0_122000]; Agence nationale de la recherche [Voltimagmicro, Emergence-10]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence nationale de la recherche(French National Research Agency (ANR))	The experiments (new equipment and running costs) were purchased with the grant of the Swiss National Science Foundation (grant 3100A0_122000). The publication fee is covered by the grant of the Agence nationale de la recherche (grant: Voltimagmicro, Emergence-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004; Canepari M, 2003, J NEUROSCI, V23, P4066; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; M Canepari, MEMBRANE POTENTIAL I; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Sobie EA, 2007, PFLUG ARCH EUR J PHY, V454, P663, DOI 10.1007/s00424-007-0229-z; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Trigo FF, 2009, J NEUROSCI METH, V181, P159, DOI 10.1016/j.jneumeth.2009.04.022; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; Vogt KE, 2011, J PHYSIOL-LONDON, V589, P489, DOI 10.1113/jphysiol.2010.200220; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1	38	22	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24911	10.1371/journal.pone.0024911	http://dx.doi.org/10.1371/journal.pone.0024911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022367	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200003
J	Barzegar, A; Moosavi-Movahedi, AA				Barzegar, Abolfazl; Moosavi-Movahedi, Ali A.			Intracellular ROS Protection Efficiency and Free Radical-Scavenging Activity of Curcumin	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT MECHANISM; LIPID-PEROXIDATION; IN-VIVO; DISEASE; METABOLISM; THERAPY; DAMAGE; BRAIN; MODEL	Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activities of curcumin in polar solvents by a comparative study using ESR, reduction of ferric iron in aqueous medium and intracellular ROS/toxicity assays. ESR data indicated that the steric hindrance among adjacent big size groups within a galvinoxyl molecule limited the curcumin to scavenge galvinoxyl radicals effectively, while curcumin showed a powerful capacity for scavenging intracellular smaller oxidative molecules such as H(2)O(2), HO(center dot), ROO(center dot). Cell viability and ROS assays demonstrated that curcumin was able to penetrate into the polar medium inside the cells and to protect them against the highly toxic and lethal effects of cumene hydroperoxide. Curcumin also showed good electron-transfer capability, with greater activity than trolox in aqueous solution. Curcumin can readily transfer electron or easily donate H-atom from two phenolic sites to scavenge free radicals. The excellent electron transfer capability of curcumin is because of its unique structure and different functional groups, including a beta-diketone and several pi electrons that have the capacity to conjugate between two phenyl rings. Therfore, since curcumin is inherently a lipophilic compound, because of its superb intracellular ROS scavenging activity, it can be used as an effective antioxidant for ROS protection within the polar cytoplasm.	[Barzegar, Abolfazl] Univ Tabriz, Res Inst Fundamental Sci RIFS, Tabriz, Iran; [Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran	University of Tabriz; University of Tehran	Barzegar, A (corresponding author), Univ Tabriz, Res Inst Fundamental Sci RIFS, Tabriz, Iran.	barzegar@tabrizu.ac.ir	Moosavi-Movahedi, Ali A./K-7453-2013	Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Barzegar, Abolfazl/0000-0002-1237-0848	Iran National Science Foundation (INSF); Research Institute for Fundamental Sciences (RIFS)-University of Tabriz	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Research Institute for Fundamental Sciences (RIFS)-University of Tabriz	Financial support was provided by the Iran National Science Foundation (INSF) and the Research Institute for Fundamental Sciences (RIFS)-University of Tabriz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2008, FOOD RES INT, V41, P1, DOI 10.1016/j.foodres.2007.10.001; Angelopoulou R, 2009, REPROD TOXICOL, V28, P167, DOI 10.1016/j.reprotox.2009.04.003; Arun N, 2002, PLANT FOOD HUM NUTR, V57, P41, DOI 10.1023/A:1013106527829; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; BARZEGAR A, 2011, J IRANIAN C IN PRESS; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Di Matteo V, 2003, CNS NEUROL DISORD-DR, V2, P95, DOI 10.2174/1568007033482959; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gerber M, 2002, B CANCER, V89, P293; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; Jovanovic SV, 2001, J AM CHEM SOC, V123, P3064, DOI 10.1021/ja003823x; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lefer DJ, 2000, AM J MED, V109, P315, DOI 10.1016/S0002-9343(00)00467-8; Manikandan P, 2004, INT J BIOCHEM CELL B, V36, P1967, DOI 10.1016/j.biocel.2004.01.030; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rukkumani R, 2004, J PHARM PHARM SCI, V7, P274; Shi HL, 2001, METHOD ENZYMOL, V335, P157; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Steer P, 2002, LIPIDS, V37, P231, DOI 10.1007/s11745-002-0885-3; Sun YM, 2002, ORG LETT, V4, P2909, DOI 10.1021/ol0262789; Teruya K, 2002, CYTOTECHNOLOGY, V40, P107, DOI 10.1023/A:1023926407877; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Venkateswarlu S, 2005, BIOORGAN MED CHEM, V13, P6374, DOI 10.1016/j.bmc.2005.06.050	36	208	214	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26012	10.1371/journal.pone.0026012	http://dx.doi.org/10.1371/journal.pone.0026012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016801	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700032
J	Shen, CL; Craigo, J; Ding, M; Chen, Y; Gupta, P				Shen, Chengli; Craigo, Jodi; Ding, Ming; Chen, Yue; Gupta, Phalguni			Origin and Dynamics of HIV-1 Subtype C Infection in India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; SOUTH; STRAINS; HISTORY; IDENTIFICATION; SURVEILLANCE; PHYLOGENIES; PREVALENCE	Objective: To investigate the geographical origin and evolution dynamics of HIV-1 subtype C infection in India. Design: Ninety HIV-1 subtype C env gp120 subtype C sequences from India were compared with 312 env gp120 reference subtype C sequences from 27 different countries obtained from Los Alamos HIV database. All the HIV-1 subtype C env gp120 sequences from India were used for the geographical origin analysis and 61 subtype C env gp120 sequences with known sampling year (from 1991 to 2008) were employed to determine the origin of HIV infection in India. Methods: Phylogenetic analysis of HIV-1 env sequences was used to investigate the geographical origin and tMRCA of Indian HIV-1 subtype C. Evolutionary parameters including origin date and demographic growth patterns of Indian subtype C were estimated using a Bayesian coalescent-based approach under relaxed molecular clock models. Findings: The majority of the analyzed Indian and South African HIV-1 subtype C sequences formed a single monophyletic cluster. The most recent common ancestor date was calculated to be 1975.56 (95% HPD, 1968.78-1981.52). Reconstruction of the effective population size revealed three phases of epidemic growth: an initial slow growth, followed by exponential growth, and then a plateau phase approaching present time. Stabilization of the epidemic growth phase correlated with the foundation of National AIDS Control Organization in India. Interpretation: Indian subtype C originated from a single South African lineage in the middle of 1970s. The current study emphasizes not only the utility of HIV-1 sequence data for epidemiological studies but more notably highlights the effectiveness of community or government intervention strategies in controlling the trend of the epidemic.	[Shen, Chengli; Ding, Ming; Chen, Yue; Gupta, Phalguni] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Craigo, Jodi] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Craigo, Jodi] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Shen, Chengli] Capital Med Univ Beijing Youan Hosp, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Gupta, P (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	pgupta1@pitt.edu			National Institutes of Health [R01HD052436]; AIDS International Fogarty [TW001038-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052436] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS International Fogarty; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant R01HD052436 from National Institutes of Health. Dr. Chengli Shen was also partially supported by an AIDS International Fogarty grant TW001038-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022; Cassol S, 1996, AIDS RES HUM RETROV, V12, P1435, DOI 10.1089/aid.1996.12.1435; Castro E, 2005, J CLIN VIROL, V32, P257, DOI 10.1016/j.jcv.2004.11.004; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; DIETRICH U, 1993, AIDS, V7, P23, DOI 10.1097/00002030-199301000-00003; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; GREZ M, 1994, J VIROL, V68, P2161, DOI 10.1128/JVI.68.4.2161-2168.1994; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Liitsola K, 2000, SCAND J INFECT DIS, V32, P475, DOI 10.1080/003655400458721; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; Maitra A, 1999, AIDS RES HUM RETROV, V15, P941, DOI 10.1089/088922299310656; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Mandal D, 2000, INDIAN J MED RES, V112, P165; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tripathy S, 1996, AIDS RES HUM RETROV, V12, P1199, DOI 10.1089/aid.1996.12.1199; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395	34	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25956	10.1371/journal.pone.0025956	http://dx.doi.org/10.1371/journal.pone.0025956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016790	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000295971700029
J	Hale, LA; Fowler, DK; Eisen, JS				Hale, Laura A.; Fowler, Daniel K.; Eisen, Judith S.			Netrin Signaling Breaks the Equivalence between Two Identified Zebrafish Motoneurons Revealing a New Role of Intermediate Targets	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; EMBRYONIC ZEBRAFISH; AXON GUIDANCE; MOTOR AXONS; SPINAL-CORD; GENE-EXPRESSION; NERVOUS-SYSTEM; GROWTH CONES; RECEPTOR; NEURONS	Background: We previously showed that equivalence between two identified zebrafish motoneurons is broken by interactions with identified muscle fibers that act as an intermediate target for the axons of these motoneurons. Here we investigate the molecular basis of the signaling interaction between the intermediate target and the motoneurons. Principal Findings: We provide evidence that Netrin 1a is an intermediate target-derived signal that causes two equivalent motoneurons to adopt distinct fates. We show that although these two motoneurons express the same Netrin receptors, their axons respond differently to Netrin 1a encountered at the intermediate target. Furthermore, we demonstrate that when Netrin 1a is knocked down, more distal intermediate targets that express other Netrins can also function to break equivalence between these motoneurons. Significance: Our results suggest a new role for intermediate targets in breaking neuronal equivalence. The data we present reveal that signals encountered during axon pathfinding can cause equivalent neurons to adopt distinct fates. Such signals may be key in diversifying a neuronal population and leading to correct circuit formation.	[Hale, Laura A.; Fowler, Daniel K.; Eisen, Judith S.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Hale, LA (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eisen@uoneuro.uoregon.edu			NIH [NS23915, HD22486, GM07413]; American Heart Association [AHA 0610097Z]; University of Oregon Clarence; Lucille Dunbar Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS023915, R01NS023915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Oregon Clarence; Lucille Dunbar Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by NIH grants NS23915 and HD22486 to JSE. LAH was also supported by American Heart Association Predoctoral Fellowship AHA 0610097Z, NIH Training Grant GM07413, and a University of Oregon Clarence and Lucille Dunbar Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1995, DEVELOPMENT, V121, P4117; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Beattie CE, 2000, DEVELOPMENT, V127, P2653; Bradford D, 2009, INT J BIOCHEM CELL B, V41, P487, DOI 10.1016/j.biocel.2008.03.014; Bruses JL, 2011, J COMP NEUROL, V519, P1797, DOI 10.1002/cne.22602; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Chao DL, 2009, NAT REV NEUROSCI, V10, P262, DOI 10.1038/nrn2594; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1992, NEURON, V8, P231, DOI 10.1016/0896-6273(92)90290-T; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Eisen JS, 2001, NAT NEUROSCI, V4, P1065, DOI 10.1038/nn742; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fricke C, 2005, DEV DYNAM, V234, P732, DOI 10.1002/dvdy.20492; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Hilario JD, 2010, DEVELOPMENT, V137, P4261, DOI 10.1242/dev.051730; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KIMBLE J, 1979, CELL LINEAGE STEM CE, P59; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KUWADA JY, 1985, DEV BIOL, V110, P114, DOI 10.1016/0012-1606(85)90069-7; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lim AH, 2011, DEVELOPMENT, V138, P3847, DOI 10.1242/dev.068403; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; MYERS PZ, 1986, J NEUROSCI, V6, P2278; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Park KW, 2005, DEV DYNAM, V234, P726, DOI 10.1002/dvdy.20474; Pineda RH, 2006, DEVELOPMENT, V133, P3827, DOI 10.1242/dev.02559; RAIBLE DW, 1995, CURR OPIN GENET DEV, V5, P444, DOI 10.1016/0959-437X(95)90047-K; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Sato-Maeda M, 2008, DEVELOPMENT, V135, P323, DOI 10.1242/dev.007559; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; SULI A, 2007, THESIS U UTAH SALT L; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tallafuss A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-18; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Welten MCM, 2006, ZEBRAFISH, V3, P465, DOI 10.1089/zeb.2006.3.465; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Ziel JW, 2010, DEV DYNAM, V239, P1296, DOI 10.1002/dvdy.22225	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25841	10.1371/journal.pone.0025841	http://dx.doi.org/10.1371/journal.pone.0025841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003409	Green Submitted, gold, Green Published			2022-12-25	WOS:000295970300030
J	Mehta, MV; Gandal, MJ; Siegel, SJ				Mehta, Mili V.; Gandal, Michael J.; Siegel, Steven J.			mGluR5-Antagonist Mediated Reversal of Elevated Stereotyped, Repetitive Behaviors in the VPA Model of Autism	PLOS ONE			English	Article							MGLUR5 ANTAGONIST MPEP; CORE SYMPTOM DOMAINS; FRAGILE-X-SYNDROME; SPECTRUM DISORDERS; ANXIOLYTIC-LIKE; MOUSE MODEL; RECEPTOR ANTAGONIST; GROOMING BEHAVIOR; VALPROIC ACID; ANIMAL-MODEL	Autism spectrum disorders (ASD) are highly disabling developmental disorders with a population prevalence of 1-3%. Despite a strong genetic etiology, there are no current therapeutic options that target the core symptoms of ASD. Emerging evidence suggests that dysfunction of glutamatergic signaling, in particular through metabotropic glutamate receptor 5 (mGluR5) receptors, may contribute to phenotypic deficits and may be appropriate targets for pharmacologic intervention. This study assessed the therapeutic potential of 2-methyl-6-phenylethyl-pyrididine (MPEP), an mGluR5-receptor antagonist, on repetitive and anxiety-like behaviors in the valproic acid (VPA) mouse model of autism. Mice were exposed prenatally on day E13 to VPA and assessed for repetitive self-grooming and marble burying behaviors as adults. Anxiety-like behavior and locomotor activity were measured in an open-field. VPA-exposed mice displayed increased repetitive and anxiety-like behaviors, consistent with previously published results. Across both marble burying and self-grooming assays, MPEP significantly reduced repetitive behaviors in VPA-treated mice, but had no effect on locomotor activity. These results are consistent with emerging preclinical literature that mGluR5-antagonists may have therapeutic efficacy for core symptoms of autism.	[Mehta, Mili V.; Gandal, Michael J.; Siegel, Steven J.] Univ Penn, Dept Psychiat, Translat Neurosci Program, Philadelphia, PA 19104 USA	University of Pennsylvania	Mehta, MV (corresponding author), Univ Penn, Dept Psychiat, Translat Neurosci Program, Philadelphia, PA 19104 USA.	siegels@upenn.edu	Gandal, Michael/AAE-4282-2020	Gandal, Michael/0000-0001-5800-5128; Siegel, Steven/0000-0001-8058-9713	National Institutes of Health [R01-DA023210, T32-MH017168]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health Grants R01-DA023210 (SJS) and T32-MH017168 (MJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji B, 2006, AM J PSYCHIAT, V163, P551, DOI 10.1176/appi.ajp.163.3.551; Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; BANGASH MA, 2011, CELL; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; CARLSON GC, 2011, PHARM BIOCH BEHAV; Comer JS, 2004, CLIN PSYCHOL REV, V24, P663, DOI 10.1016/j.cpr.2004.04.004; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Guclu B, 2007, SOMATOSENS MOT RES, V24, P21, DOI 10.1080/08990220601179418; Homayoun H, 2010, EUR J PHARMACOL, V639, P33, DOI 10.1016/j.ejphar.2009.12.042; Jesner OS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005040.pub2; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; Kim Y, 2011, AM J PSYCHIAT; King BH, 2009, ARCH GEN PSYCHIAT, V66, P583, DOI 10.1001/archgenpsychiatry.2009.30; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McDougle CJ, 2005, AM J PSYCHIAT, V162, P1142, DOI 10.1176/appi.ajp.162.6.1142; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Montana MC, 2009, J PHARMACOL EXP THER, V330, P834, DOI 10.1124/jpet.109.154138; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pittenger Christopher, 2006, NeuroRx, V3, P69, DOI 10.1016/j.nurx.2005.12.006; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Richler J, 2007, J AUTISM DEV DISORD, V37, P73, DOI 10.1007/s10803-006-0332-6; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scahill L, 2007, J CHILD ADOL PS NURS, V20, P188, DOI 10.1111/j.1744-6171.2007.00112.x; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Spooren WPJM, 2000, J PHARMACOL EXP THER, V295, P1267; Tatarczynska E, 2001, BRIT J PHARMACOL, V132, P1423, DOI 10.1038/sj.bjp.0703923; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; West L, 2009, J PEDIATR HEALTH CAR, V23, P75, DOI 10.1016/j.pedhc.2008.12.001; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	49	114	119	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26077	10.1371/journal.pone.0026077	http://dx.doi.org/10.1371/journal.pone.0026077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016815	Green Submitted, gold, Green Published			2022-12-25	WOS:000295970300057
J	Pericacho, M; Alonso-Martin, S; Larrucea, S; Gonzalez-Manchon, C; Fernandez, D; Sanchez, I; Ayuso, MS; Parrilla, R				Pericacho, Miguel; Alonso-Martin, Sonia; Larrucea, Susana; Gonzalez-Manchon, Consuelo; Fernandez, Dario; Sanchez, Ines; Ayuso, Matilde S.; Parrilla, Roberto			Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EMBRYONIC STEM-CELLS; L-SELECTIN; INTEGRIN ACTIVATION; MAJOR SIALOPROTEIN; PODOCYTE BIOLOGY; IN-VIVO; PLATELETS; BINDING; TALIN	Podocalyxin (Podxl) is a type I membrane sialoprotein of the CD34 family, originally described in the epithelial glomerular cells of the kidney (podocytes) in which it plays an important function. Podxl can also be found in megakaryocytes and platelets among other extrarenal places. The surface exposure of Podxl upon platelet activation suggested it could play some physiological role. To elucidate the function of Podxl in platelets, we generated mice with restricted ablation of the podxl gene in megakaryocytes using the Cre-LoxP gene targeting methodology. Mice with Podxl-null megakaryocytes did not show any apparent phenotypical change and their rates of growth, life span and fertility did not differ from the floxed controls. However, Podxl-null mice showed prolonged bleeding time and decreased platelet aggregation in response to physiological agonists. The number, size- distribution and polyploidy of Podxl-null megakaryocytes were similar to the floxed controls. Podxl-null platelets showed normal content of surface receptors and normal activation by agonists. However, the mice bearing Podxl-null platelets showed a significant retardation in the ferric chloride-induced occlusion of the carotid artery. Moreover, acute thrombosis induced by the i.v. injection of sublethal doses of collagen and phenylephrine produced a smaller fall in the number of circulating platelets in Podxl-null mice than in control mice. In addition, perfusion of uncoagulated blood from Podxl-null mice in parallel flow chamber showed reduced adhesion of platelets and formation of aggregates under high shear stress. It is concluded that platelet Podxl is involved in the control of hemostasis acting as a platelet co-stimulator, likely due to its pro-adhesive properties.	[Alonso-Martin, Sonia; Gonzalez-Manchon, Consuelo; Sanchez, Ines; Ayuso, Matilde S.; Parrilla, Roberto] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain; [Pericacho, Miguel; Gonzalez-Manchon, Consuelo; Fernandez, Dario; Ayuso, Matilde S.; Parrilla, Roberto] CIBERER, Madrid, Spain; [Larrucea, Susana] Hosp Cruces, Lab Inmunol, Baracaldo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Cruces	Pericacho, M (corresponding author), CIBERER, Madrid, Spain.	rparrilla@cib.csic.es	Milagros Rodriguez, Biblioteca-CIB/H-7697-2015; Fernández, Darío/B-9516-2013; Fernández, Darío/K-2587-2019; Alonso-Martin, Sonia/F-3021-2013; Ayuso, Matilde Sánchez/B-2777-2008; Alonso-Martin, Sonia/L-2751-2019; Fernández, Darío/P-6505-2019; Larrucea, Susana/E-4743-2012; Pericacho, Miguel/H-1786-2016; Gonzalez-Manchon, Consuelo/H-9257-2015	Fernández, Darío/0000-0003-1481-6660; Fernández, Darío/0000-0002-9763-7328; Alonso-Martin, Sonia/0000-0002-3254-0365; Ayuso, Matilde Sánchez/0000-0003-2504-0925; Alonso-Martin, Sonia/0000-0002-3254-0365; Pericacho, Miguel/0000-0003-0226-482X; Gonzalez-Manchon, Consuelo/0000-0002-3081-0253; Larrucea, Susana/0000-0002-4019-2751	Spanish Ministry of Science and Innovation [SAF2007-61701, BFU2010-15237]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	present work was supported by a grant from the Spanish Ministry of Science and Innovation (SAF2007-61701 and BFU2010-15237) (http://www.micinn.es). The CIBER de Enfermedades Raras (CIBERER) (http://www.ciberer.es) is an initiative of the Spanish National Health Institute Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; ALONSOMARTIN S, THROMB RES, V125, pE300; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; EDDY A, 1998, SEMIN NEPHROL, V18, P12; Endlich K, 2001, CURR OPIN NEPHROL HY, V10, P331, DOI 10.1097/00041552-200105000-00006; GROTTUM KA, 1969, BRIT J HAEMATOL, V16, P277, DOI 10.1111/j.1365-2141.1969.tb00402.x; Hemmings L, 1996, J CELL SCI, V109, P2715; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; Larrucea S, 2007, CELL MOL LIFE SCI, V64, P2965, DOI 10.1007/s00018-007-7374-6; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Li J, 2001, DNA SEQUENCE, V12, P407, DOI 10.3109/10425170109084466; Liu SC, 2000, J CELL SCI, V113, P3563; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; MESTER L, 1972, NATURE-NEW BIOL, V236, P213, DOI 10.1038/newbio236213a0; Miettinen A, 1999, AM J PATHOL, V154, P813, DOI 10.1016/S0002-9440(10)65328-X; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; Rasband W., 2006, IMAGEJ; Rodriguez RB, 2006, TISSUE ANTIGENS, V68, P407, DOI 10.1111/j.1399-0039.2006.00692.x; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Torres M, 1998, CURR TOP DEV BIOL, V36, P99; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26025	10.1371/journal.pone.0026025	http://dx.doi.org/10.1371/journal.pone.0026025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016802	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300049
J	Diaz-Rodriguez, E; Garcia-Lavandeira, M; Perez-Romero, S; Senra, A; Canibano, C; Palmero, I; Borrello, MG; Dieguez, C; Alvarez, CV				Diaz-Rodriguez, E.; Garcia-Lavandeira, M.; Perez-Romero, S.; Senra, A.; Canibano, C.; Palmero, I.; Borrello, M. G.; Dieguez, C.; Alvarez, C. V.			Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells	ONCOGENE			English	Article						dependence receptor; apoptosis; p19Arf; p53; Pit-1; OIA	ARF TUMOR-SUPPRESSOR; REGULATES P53-DEPENDENT APOPTOSIS; RET-GENE-EXPRESSION; NONCODING RNA; CYCLE ARREST; P53 PATHWAY; DAP KINASE; RB+/-MICE; GROWTH; SENESCENCE	Somatotrophs produce growth hormone (GH) and are the most abundant secretory cells of the pituitary. Somatotrophs express the transcription factor Pit-1 and the dependence receptor RET, its co-receptor GFRa1 and ligand GDNF. Pit-1 is a transcription factor essential for somatotroph proliferation and differentiation and for GH expression. GDNF represses excess Pit-1 expression preventing excess GH. In the absence of GDNF, RET behaves as a dependence receptor, becomes intracellularly processed and induces strong Pit-1 expression leading to p53 accumulation and apoptosis. How accumulation of Pit-1 leads to p53 expression is unknown. We have unveiled the relationship of Pit-1 with the p19Arf gene. There is a parallel correlation of RET processing, Pit-1 increase and ARF protein and mRNA expression. Interfering the pathway with RET, Pit-1 or p19Arf siRNA blocked apoptosis. We have found a Pit-1 DNA-binding element within the ARF promoter. Pit-1 directly regulates the CDKN2A locus and binds to the p19Arft promoter inducing p19Arf gene expression. The Pit-1-binding element is conserved in rodents and humans. RET/Pit-1 induces p19Arf/p53 and apoptosis not only in a somatotroph cell line but also in primary cultures of pituitary somatotrophs, where ARF siRNA interference also blocks p53 and apoptosis. Analyses of the somatotrophs in whole pituitaries supported the above findings. Thus Pit-1, a differentiation factor, activates the oncogene-induced apoptosis (OIA) pathway as oncogenes exerting a tight control in somatotrophs to prevent the disease due to excess of GH (insulin-resistance, metabolic disease, acromegaly). Oncogene (2012) 31, 2824-2835; doi:10.1038/onc.2011.458; published online 24 October 2011	[Diaz-Rodriguez, E.; Garcia-Lavandeira, M.; Perez-Romero, S.; Senra, A.; Canibano, C.; Dieguez, C.; Alvarez, C. V.] Univ Santiago de Compostela, CIMUS, IDIS Neoplasia & Endocrine Differentiat, Dept Physiol,Sch Med, Santiago De Compostela, Spain; [Palmero, I.] Alberto Sols CSIC UAM, Inst Invest Biomed, Madrid, Spain; [Borrello, M. G.] IRCCS Ist Nazl Tumori Fdn, Dept Expt Oncol, Operat Unit Mol Mech Canc Growth & Progress, Milan, Italy	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Fondazione IRCCS Istituto Nazionale Tumori Milan	Alvarez, CV (corresponding author), Univ Santiago de Compostela, Dept Physiol, Sch Med, IDIS CIMUS, Santiago De Compostela 15782, Spain.	clara.alvarez@usc.es	Lavandeira, Montserrat García/R-4708-2019; Palmero, Ignacio/B-4346-2013; Borrello, Maria Grazia/C-3161-2017; Alvarez, Clara V/AAN-4173-2020	Lavandeira, Montserrat García/0000-0001-9208-2418; Borrello, Maria Grazia/0000-0002-6854-2848; Perez, Sihara/0000-0003-1744-0208; dieguez, carlos/0000-0002-0919-4337; Alvarez, Clara V/0000-0003-1500-4058	Xunta de Galicia-MICINN-FEDER [06PXIB208107PR, 09CSA011208PR, BFU2007-60571, BFU2010-16652]; European Community (Fondo Social Europeo)	Xunta de Galicia-MICINN-FEDER; European Community (Fondo Social Europeo)	We thank Susana Bravo and Maria Garcia-Rendueles for helpful methodological advice. This project has been supported by grants Xunta de Galicia-MICINN-FEDER, 06PXIB208107PR, 09CSA011208PR, BFU2007-60571 and BFU2010-16652 to CVA. E D-R has been an Anxeles Alvarino fellow and M G-L is a Lucas Labrada fellow (Xunta de Galicia). These programs are co-financed by the European Community (Fondo Social Europeo). The text has been reviewed by G Lockhart, a professional editor of biomedical English.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bravo SB, 2003, ONCOGENE, V22, P7819, DOI 10.1038/sj.onc.1207029; Bravo SB, 2010, ANAL BIOCHEM, V400, P219, DOI 10.1016/j.ab.2010.01.034; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Carneiro C, 1998, ONCOGENE, V16, P1455, DOI 10.1038/sj.onc.1201662; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2008, RES PERSPECT END INT, P83, DOI 10.1007/978-3-540-73855-8_8; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Colao A, 2010, FRONT HORM RES, V38, P94, DOI 10.1159/000318499; Coya R, 1999, J NEUROENDOCRINOL, V11, P351; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Garcia A, 2001, MOL ENDOCRINOL, V15, P1484, DOI 10.1210/me.15.9.1484; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; Garcia-Lavandeira M, 2010, FRONT HORM RES, V38, P127, DOI 10.1159/000318502; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HERMAN V, 1993, J CLIN ENDOCR METAB, V77, P50, DOI 10.1210/jc.77.1.50; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Japon MA, 2002, J CLIN ENDOCR METAB, V87, P1879, DOI 10.1210/jc.87.4.1879; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kirsch M, 2009, GENE CHROMOSOME CANC, V48, P143, DOI 10.1002/gcc.20621; Kovi RC, 2010, CELL DEATH DIFFER, V17, P513, DOI 10.1038/cdd.2009.140; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Serrano M, 2010, CELL CYCLE, V9, P4256, DOI 10.4161/cc.9.21.13785; Solloso A, 2008, J CELL PHYSIOL, V215, P140, DOI 10.1002/jcp.21295; Taneja P, 2010, CANCER RES, V70, P9084, DOI 10.1158/0008-5472.CAN-10-0159; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Tsai KY, 2002, P NATL ACAD SCI USA, V99, P16865, DOI 10.1073/pnas.262499599; Urbano AG, 2000, ENDOCRINOLOGY, V141, P1893, DOI 10.1210/en.141.5.1893; van Beek AP, 2010, J CLIN ENDOCR METAB, V95, P3664, DOI 10.1210/jc.2009-2506; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang H, 2008, BIOCHEM BIOPH RES CO, V370, P594, DOI 10.1016/j.bbrc.2008.03.152; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zhou ZX, 2005, CANCER RES, V65, P787; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	62	19	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	23					2824	2835		10.1038/onc.2011.458	http://dx.doi.org/10.1038/onc.2011.458			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	22020338				2022-12-25	WOS:000305277900003
J	Heinke, J; Kerber, M; Rahner, S; Mnich, L; Lassmann, S; Helbing, T; Werner, M; Patterson, C; Bode, C; Moser, M				Heinke, J.; Kerber, M.; Rahner, S.; Mnich, L.; Lassmann, S.; Helbing, T.; Werner, M.; Patterson, C.; Bode, C.; Moser, M.			Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior	ONCOGENE			English	Article						BMPER; BMPs; MMPs; tumor progression; tumor angiogenesis	BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; EXTRACELLULAR REGULATION; ID1 EXPRESSION; DIRECT BINDING; METASTASIS; GROWTH; ANGIOGENESIS; ANTAGONIST; PROSTATE	Bone morphogenetic proteins (BMPs) are growth factors that exert important functions in cell proliferation, migration and differentiation. Till date, multiple human tumors have been reported to display a dysregulation of several members of the BMP pathway that is associated with enhanced malignant tumor growth and metastasis. BMPER (BMP endothelial cell precursor-derived regulator) is a direct BMP modulator that is necessary for BMPs to exert their full-range signaling activity. Moreover, BMPER is expressed by endothelial cells and their progenitors, and has pro-angiogenic features in these cells. Here, we describe the expression of BMPER in human specimens of lung, colon and cervix carcinomas and cell lines derived from such carcinomas. In contrast to healthy tissues, BMPER is highly expressed upon malignant deterioration. Functionally, loss of BMPER in the lung tumor cell line A549 impairs proliferation, migration, invasion as well as tumor cell-induced endothelial cell sprout formation. In contrast, stimulation of A549 cells with exogenous BMPER had no further effect. We found that the BMPER effect may be transduced by regulation of the BMP target transcription factor inhibitor of DNA binding 1 (Id1) and matrix metalloproteinases (MMPs) 9 and 2. These facilitators of cell migration are down-regulated when BMPER is absent. To prove the relevance of our in vitro results in vivo, we generated Lewis lung carcinoma cells with impaired BMPER expression and implanted them into the lungs of C57BL/6 mice. In this model, the absence of BMPER resulted in severely reduced tumor growth and tumor angiogenesis. Taken together, these data unequivocally demonstrate that the BMP modulator BMPER is highly expressed in malignant tumors and tumor growth is dependent on the presence of BMPER.	[Heinke, J.; Kerber, M.; Rahner, S.; Mnich, L.; Helbing, T.; Bode, C.; Moser, M.] Univ Freiburg, Dept Med 3, D-79106 Freiburg, Germany; [Lassmann, S.; Werner, M.] Univ Freiburg, Univ Med Ctr, Inst Pathol, D-79106 Freiburg, Germany; [Patterson, C.] Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC USA	University of Freiburg; University of Freiburg; University of North Carolina; University of North Carolina Chapel Hill	Moser, M (corresponding author), Univ Freiburg, Dept Med 3, Hugstetter Str 55, D-79106 Freiburg, Germany.	Martin.Moser@uniklinik-freiburg.de		Esser, Jennifer/0000-0002-8494-2016	German Research Foundation (DFG) [SFB-TR23 (A1), Mo973/5-1, Mo973/6-1, SFB850, SFB850 TP C5, TP Z1]; LandesStiftung Baden-Wurttemberg; Mushett Family Foundation (Chester, NJ, USA); Robert-Bosch-Stiftung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061656] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); LandesStiftung Baden-Wurttemberg; Mushett Family Foundation (Chester, NJ, USA); Robert-Bosch-Stiftung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Bianca Engert, Anja Schopflin and Ute Wering for excellent technical assistance. Work in MM's laboratory is supported by German Research Foundation (DFG) SFB-TR23 (A1), DFG Mo973/5-1 and DFG Mo973/6-1. Work in the laboratory of SL and MW is supported by the German Research Foundation/DFG (SFB850 TP C5, TP Z1), the LandesStiftung Baden-Wurttemberg and the Mushett Family Foundation (Chester, NJ, USA) and the Robert-Bosch-Stiftung.	Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Arihiro K, 2001, PATHOL INT, V51, P100, DOI 10.1046/j.1440-1827.2001.01164.x; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blish KR, 2008, MOL BIOL CELL, V19, P457, DOI 10.1091/mbc.E07-05-0433; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Conley CA, 2000, DEVELOPMENT, V127, P3947; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Gordon KJ, 2009, CARCINOGENESIS, V30, P238, DOI 10.1093/carcin/bgn274; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Klose A, 2011, NEOPLASIA, V13, P276, DOI 10.1593/neo.101540; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lin KY, 2007, CANCER RES, V67, P1832, DOI 10.1158/0008-5472.CAN-06-3014; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Moll F, 2006, FASEB J, V20, P240, DOI 10.1096/fj.05-4126com; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Raida M, 2005, INT J ONCOL, V26, P1465; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rothhammer T, 2005, CANCER RES, V65, P448; Rothhammer T, 2008, EUR J CANCER, V44, P2526, DOI 10.1016/j.ejca.2008.07.029; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Sheu BC, 2009, FRONT BIOSCI-LANDMRK, V14, P1571, DOI 10.2741/3325; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Weiss KR, 2006, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01.blo.0000229333.98781.56; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu JB, 2011, CANCER GENE THER, V18, P20, DOI 10.1038/cgt.2010.55; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yu XY, 2008, DEV DYNAM, V237, P3613, DOI 10.1002/dvdy.21769; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	70	25	25	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	24					2919	2930		10.1038/onc.2011.473	http://dx.doi.org/10.1038/onc.2011.473			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22020334	Green Published, Green Accepted			2022-12-25	WOS:000305388400002
J	Seebohm, G; Strutz-Seebohm, N; Ursu, ON; Preisig-Muller, R; Zuzarte, M; Hill, EV; Kienitz, MC; Bendahhou, S; Fauler, M; Tapken, D; Decher, N; Collins, A; Jurkat-Rott, K; Steinmeyer, K; Lehmann-Horn, F; Daut, J; Tavare, JM; Pott, L; Bloch, W; Lang, F				Seebohm, Guiscard; Strutz-Seebohm, Nathalie; Ursu, Oana N.; Preisig-Mueller, Regina; Zuzarte, Marylou; Hill, Elaine V.; Kienitz, Marie-Cecile; Bendahhou, Said; Fauler, Michael; Tapken, Daniel; Decher, Niels; Collins, Anthony; Jurkat-Rott, Karin; Steinmeyer, Klaus; Lehmann-Horn, Frank; Daut, Juergen; Tavare, Jeremy M.; Pott, Lutz; Bloch, Wilhelm; Lang, Florian			Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome	FASEB JOURNAL			English	Article						oocytes; PIP2; trafficking; PIP5K3; Kir2	INDUCIBLE KINASE ISOFORMS; RECTIFYING K+ CHANNELS; VENTRICULAR MYOCYTES; HEART-FAILURE; DIFFERENTIAL SENSITIVITY; PERIODIC PARALYSIS; KIR2.1 CHANNELS; MUTATIONS; PROTEIN; I-K1	Inward rectifier potassium channels of the Kir2 subfamily are important determinants of the electrical activity of brain and muscle cells. Genetic mutations in Kir2.1 associate with Andersen-Tawil syndrome (ATS), a familial disorder leading to stress-triggered periodic paralysis and ventricular arrhythmia. To identify the molecular mechanisms of this stress trigger, we analyze Kir channel function and localization electrophysiologically and by time-resolved confocal microscopy. Furthermore, we employ a mathematical model of muscular membrane potential. We identify a novel corticoid signaling pathway that, when activated by glucocorticoids, leads to enrichment of Kir2 channels in the plasma membranes of mammalian cell lines and isolated cardiac and skeletal muscle cells. We further demonstrate that activation of this pathway can either partly restore (40% of cases) or further impair (20% of cases) the function of mutant ATS channels, depending on the particular Kir2.1 mutation. This means that glucocorticoid treatment might either alleviate or deteriorate symptoms of ATS depending on the patient's individual Kir2.1 genotype. Thus, our findings provide a possible explanation for the contradictory effects of glucocorticoid treatment on symptoms in patients with ATS and may open new pathways for the design of personalized medicines in ATS therapy.-Seebohm, G., Strutz-Seebohm, N., Ursu, O. N., Preisig-Muller, R., Zuzarte, M., Hill, E. V., Kienitz, M.-C., Bendahhou, S., Fauler, M., Tapken, D., Decher, N., Collins, A., Jurkat-Rott, K., Steinmeyer, K., Lehmann-Horn, F., Daut, J., Tavare, J. M., Pott, L., Bloch, W., Lang, F. Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome. FASEB J. 26, 513-522 (2012). www.fasebj.org	[Seebohm, Guiscard] Ruhr Univ Bochum, Dept Biochem 1, Cat Channel Grp, D-44780 Bochum, Germany; [Kienitz, Marie-Cecile; Pott, Lutz] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Ursu, Oana N.; Lang, Florian] Univ Tubingen, Inst Physiol 1, Tubingen, Germany; [Preisig-Mueller, Regina; Zuzarte, Marylou; Daut, Juergen] Univ Marburg, Inst Physiol, Marburg, Germany; [Hill, Elaine V.; Tavare, Jeremy M.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Bendahhou, Said] Univ Nice Sophia Antipolis, Unite Mixte Rech UMR 6097, Ctr Natl Rech Sci CNRS Transport Ion Aspects Norm, Nice, France; [Fauler, Michael; Jurkat-Rott, Karin; Lehmann-Horn, Frank] Univ Ulm, Div Neurophysiol, Ulm, Germany; [Tapken, Daniel] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Copenhagen, Denmark; [Collins, Anthony] Queens Univ Belfast, Ctr Vis & Vasc Sci, Inst Clin Sci, Belfast, Antrim, North Ireland; [Steinmeyer, Klaus] Sanofi Aventis, Therapeut Strateg Unit TSU Aging, Frankfurt, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Cologne, Germany	Ruhr University Bochum; Ruhr University Bochum; Eberhard Karls University of Tubingen; Philipps University Marburg; University of Bristol; UDICE-French Research Universities; Universite Cote d'Azur; Ulm University; University of Copenhagen; Queens University Belfast; Sanofi-Aventis; German Sport University Cologne	Seebohm, G (corresponding author), Ruhr Univ Bochum, Dept Biochem 1, Cat Channel Grp, Univ Str 150, D-44780 Bochum, Germany.	guiscard.seebohm@gmx.de	Decher, Niels/AAF-5002-2020	Pott, Lutz/0000-0002-4000-4132; Tapken, Daniel/0000-0002-0166-0751	Deutsche Forschungsgemeinschaft [SE1077/3, STR649/1-1, La315/4-5, DE1482/2-1, DE1482/3-2, TP A4, SFB593]; P. E. Kempkes Foundation [16/06]; Association Francaise contre les Myopathies; Medical Research Council [G7708269] Funding Source: researchfish; MRC [G7708269] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); P. E. Kempkes Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Deutsche Forschungsgemeinschaft (grants SE1077/3 to G.S., STR649/1-1 to N.S., La315/4-5 to F. L., DE1482/2-1 and DE1482/3-2 to N.D., and TP A4, SFB593 to J.D.), the P. E. Kempkes Foundation (grant 16/06 to R. P. M.), and the Association Francaise contre les Myopathies (grant to S. B.). F. L. H. is an endowed Senior Research Professor of the Gemeinnutzige Hertie-Stiftung. The authors declare no conflicts of interest.	ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; BECHEM M, 1983, EUR J CELL BIOL, V31, P366; Beckmann C, 2008, CELL PHYSIOL BIOCHEM, V21, P259, DOI 10.1159/000129381; Bendahhou S, 2007, HUM MOL GENET, V16, P900, DOI 10.1093/hmg/ddm034; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Collins A, 2005, MOL PHARMACOL, V67, P1214, DOI 10.1124/mol.104.008292; Collins A, 2002, J BIOL CHEM, V277, P35815, DOI 10.1074/jbc.M206032200; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Dunker N, 2002, MECH DEVELOP, V113, P111, DOI 10.1016/S0925-4773(02)00015-1; Han W, 2001, CIRCULATION, V104, P2095, DOI 10.1161/hc4201.097134; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jones SVP, 2003, MOL PHARMACOL, V64, P987, DOI 10.1124/mol.64.4.987; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; Liu Y, 2001, MOL PHARMACOL, V59, P1061, DOI 10.1124/mol.59.5.1061; Lodge NJ, 1997, J MOL CELL CARDIOL, V29, P3211, DOI 10.1006/jmcc.1997.0548; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Seebohm G, 2008, CIRC RES, V103, P1451, DOI 10.1161/CIRCRESAHA.108.177360; Seemann G, 2007, AM J PHYSIOL-HEART C, V292, pH549, DOI 10.1152/ajpheart.00701.2006; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P391, DOI 10.1113/jphysiol.2004.079624; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Vicente R, 2004, FEBS LETT, V572, P189, DOI 10.1016/j.febslet.2004.07.030; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zitron E, 2004, CARDIOVASC RES, V63, P520, DOI 10.1016/j.cardiores.2004.02.015	43	15	18	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					513	522		10.1096/fj.11-189126	http://dx.doi.org/10.1096/fj.11-189126			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22002906				2022-12-25	WOS:000300485700005
J	Chen, CC; Hardy, DB; Mendelson, CR				Chen, Chien-Cheng; Hardy, Daniel B.; Mendelson, Carole R.			Progesterone Receptor Inhibits Proliferation of Human Breast Cancer Cells via Induction of MAPK Phosphatase 1 (MKP-1/DUSP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; DUAL-SPECIFICITY PHOSPHATASE; ESTROGEN PLUS PROGESTIN; HER-2 NEU ONCOGENE; POSTMENOPAUSAL WOMEN; GROWTH-FACTOR; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN RESISTANCE; SYNTHETIC PROGESTIN	The roles of progesterone (P-4) and of progesterone receptor (PR) in development and pathogenesis of breast cancer remain unclear. In this study, we observed that treatment of T47D breast cancer cells with progestin antagonized effects of fetal bovine serum (FBS) to stimulate cell proliferation, whereas siRNA-mediated knockdown of endogenous PR abrogated progestin-mediated anti-proliferative effects. To begin to define mechanisms for the anti-proliferative action of P-4/PR, we considered the role of MAPK phosphatase 1 (MKP-1/DUSP1), which catalyzes dephosphorylation and inactivation of MAPKs. Progestin treatment of T47D cells rapidly induced MKP-1 expression in a PR-dependent manner. Importantly, P-4 induction of MKP-1 was associated with reduced levels of phosphorylated ERK1/2, whereas siRNA knockdown of MKP-1 blocked progestin-mediated ERK1/2 dephosphorylation and repression of FBS-induced cell proliferation. The importance of PR in MKP-1 expression was supported by findings that MKP-1 and PR mRNA levels were significantly correlated in 30 human breast cancer cell lines. By contrast, no correlation was observed with the glucocorticoid receptor, a known regulator of MKP-1 in other cell types. ChIP and luciferase reporter assay findings suggest that PR acts in a ligand-dependent manner through binding to two progesterone response elements downstream of the MKP-1 transcription start site to up-regulate MKP-1 promoter activity. PR also interacts with two Sp1 sites just downstream of the transcription start site to increase MKP-1 expression. Collectively, these findings suggest that MKP-1 is a critical mediator of antiproliferative and anti-inflammatory actions of PR in the breast.	Univ Texas SW Med Ctr Dallas, N Texas March Dimes Birth Defects Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, N Texas March Dimes Birth Defects Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Carole.Mendelson@UTSouthwestern.edu		Mendelson, Carole Ruth/0000-0003-1696-9791; Hardy, Daniel/0000-0001-5445-273X	National Institutes of Health [5-R01-DK031206, 2-R56-DK031206]; Susan G. Komen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK031206, R01DK031206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5-R01-DK031206 and 2-R56-DK031206 (to C. R. M.). This work was also supported by a postdoctoral fellowship from the Susan G. Komen Foundation (to C.-C. C. and D. B. H.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Buzdar A, 1996, J CLIN ONCOL, V14, P2000, DOI 10.1200/JCO.1996.14.7.2000; Byrne MJ, 1997, J CLIN ONCOL, V15, P3141, DOI 10.1200/JCO.1997.15.9.3141; Cerliani JP, 2011, CANCER RES, V71, P3720, DOI 10.1158/0008-5472.CAN-10-3074; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Coyle YM, 2007, CANCER LETT, V258, P253, DOI 10.1016/j.canlet.2007.09.011; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deroo BJ, 2002, J STEROID BIOCHEM, V81, P309, DOI 10.1016/S0960-0760(02)00072-9; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; GILL PG, 1991, BREAST CANCER RES TR, V20, P53, DOI 10.1007/BF01833357; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; Gizard F, 2005, FEBS LETT, V579, P5535, DOI 10.1016/j.febslet.2005.08.084; Gizard F, 2006, MOL CELL BIOL, V26, P7632, DOI 10.1128/MCB.00326-06; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hultborn R, 1996, ACTA ONCOL, V35, P75, DOI 10.3109/02841869609083975; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keith BD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-84; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kobayashi S, 2010, MOL ENDOCRINOL, V24, P2292, DOI 10.1210/me.2010-0289; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lebeau A, 2003, BREAST CANCER RES TR, V79, P187, DOI 10.1023/A:1023958324448; Lin VCL, 2001, CLIN CANCER RES, V7, P2880; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Musgrove EA, 1998, MOL CELL BIOL, V18, P1812, DOI 10.1128/MCB.18.4.1812; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PANNUTI F, 1988, EUR J CANCER CLIN ON, V24, P423, DOI 10.1016/S0277-5379(98)90012-8; PARAZZINI F, 1993, ONCOLOGY, V50, P483; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Quiles I, 2009, MOL ENDOCRINOL, V23, P809, DOI 10.1210/me.2008-0454; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Swarbrick A, 2000, MOL CELL BIOL, V20, P2581, DOI 10.1128/MCB.20.7.2581-2591.2000; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; VANDERBURG B, 1992, J STEROID BIOCHEM, V42, P457, DOI 10.1016/0960-0760(92)90257-J; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; VIGNON F, 1983, J CLIN ENDOCR METAB, V56, P1124, DOI 10.1210/jcem-56-6-1124; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YOUNG PCM, 1980, CANCER-AM CANCER SOC, V46, P2961, DOI 10.1002/1097-0142(19801215)46:12+<2961::AID-CNCR2820461444>3.0.CO;2-E; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	81	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43091	43102		10.1074/jbc.M111.295865	http://dx.doi.org/10.1074/jbc.M111.295865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020934	Green Published, hybrid			2022-12-25	WOS:000298351300030
J	Felder, TK; Soyal, SM; Oberkofler, H; Hahne, P; Auer, S; Weiss, R; Gadermaier, G; Miller, K; Krempler, F; Esterbauer, H; Patsch, W				Felder, Thomas K.; Soyal, Selma M.; Oberkofler, Hannes; Hahne, Penelope; Auer, Simon; Weiss, Richard; Gadermaier, Gabriele; Miller, Karl; Krempler, Franz; Esterbauer, Harald; Patsch, Wolfgang			Characterization of Novel Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha (PGC-1 alpha) Isoform in Human Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; HEPATIC GLUCONEOGENESIS; ENERGY-METABOLISM; SKELETAL-MUSCLE; GENE-EXPRESSION; MESSENGER-RNA; TRANSCRIPTIONAL COACTIVATORS; HUNTINGTONS-DISEASE; INSULIN-RESISTANCE; GENOME-WIDE	Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a transcriptional coactivator that contributes to the regulation of numerous transcriptional programs including the hepatic response to fasting. Mechanisms at transcriptional and post-transcriptional levels allow PGC-1 alpha to support distinct biological pathways. Here we describe a novel human liver-specific PGC-1 alpha transcript that results from alternative promoter usage and is induced by FOXO1 as well as glucocorticoids and cAMP-response element-binding protein signaling but is not present in other mammals. Hepatic tissue levels of novel and wild-type transcripts were similar but were only moderately associated (p< 0.003). Novel mRNA levels were associated with a polymorphism located in its promoter region, whereas wildtype transcript levels were not. Furthermore, hepatic PCK1 mRNA levels exhibited stronger associations with the novel than with the wild-type transcript levels. Except for a deletion of 127 amino acids at the N terminus, the protein, termed L-PGC1 alpha, is identical to PGC-1 alpha. L-PGC-1 alpha was localized in the nucleus and showed coactivation properties that overlap with those of PGC-1 alpha. Collectively, our data support a role of L-PGC-1 alpha in gluconeogenesis, but functional differences predicted from the altered structure suggest that L-PGC-1 alpha may have arisen to adapt PGC-1 alpha to more complex metabolic pathways in humans.	[Felder, Thomas K.; Soyal, Selma M.; Oberkofler, Hannes; Hahne, Penelope; Auer, Simon; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, A-5020 Salzburg, Austria; [Weiss, Richard; Gadermaier, Gabriele] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Miller, Karl] Krankenhaus Hallein, Dept Surg, A-5400 Hallein, Austria; [Krempler, Franz] Krankenhaus Hallein, Dept Internal Med, A-5400 Hallein, Austria; [Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria	Paracelsus Private Medical University; Salzburg University; Medical University of Vienna	Patsch, W (corresponding author), Paracelsus Med Univ, Dept Lab Med, Mullner Hauptstr 48, A-5020 Salzburg, Austria.	wolfgang.patsch@pmu.ac.at	Felder, Thomas K/A-8342-2017; Weiss, Richard/N-7279-2013; Gadermaier, Gabriele/L-5997-2015	Felder, Thomas K/0000-0001-8266-5513; Weiss, Richard/0000-0003-3185-7253; Gadermaier, Gabriele/0000-0002-4886-417X; Esterbauer, Harald/0000-0001-7343-7455	Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P19893-B05]; Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF) [L507-058]; Land Salzburg; Verein fur Medizinische Forschung Salzburg, Austria	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF); Land Salzburg; Verein fur Medizinische Forschung Salzburg, Austria	This study was supported by grants from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF Project P19893-B05), the Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF Project L507-058), the Land Salzburg, and the Verein fur Medizinische Forschung Salzburg, Austria.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Felder TK, 2010, INT J OBESITY, V34, P846, DOI 10.1038/ijo.2010.7; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iyemere VP, 1998, NUCLEIC ACIDS RES, V26, P2098, DOI 10.1093/nar/26.9.2098; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Leitner WW, 1997, J IMMUNOL, V159, P6112; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; MARUYAMA K, 1994, GENE, V138, P171; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Oberkofler H, 2002, J BIOL CHEM, V277, P16750, DOI 10.1074/jbc.M200475200; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rha GB, 2009, J BIOL CHEM, V284, P35165, DOI 10.1074/jbc.M109.052506; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42923	42936		10.1074/jbc.M111.227496	http://dx.doi.org/10.1074/jbc.M111.227496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009745	Green Published, hybrid			2022-12-25	WOS:000298351300014
J	Labasque, M; Devaux, JJ; Leveque, C; Faivre-Sarrailh, C				Labasque, Marilyne; Devaux, Jerome J.; Leveque, Christian; Faivre-Sarrailh, Catherine			Fibronectin Type III-like Domains of Neurofascin-186 Protein Mediate Gliomedin Binding and Its Clustering at the Developing Nodes of Ranvier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL SURFACE; ANKYRIN-G; NRCAM; DIFFERENTIATION; CONTACTIN; CHANNELS; COMPLEX; MATRIX; CAM; F11	The cell adhesion molecules (CAMs) of the immunoglobulin superfamily (Ig-CAMs) play a crucial role in the organization of the node of Ranvier in myelinated axons. In the peripheral nervous system, Gliomedin (Gldn) secreted by Schwann cell microvilli binds NgCAM-related CAM (NrCAM) and Neurofascin-186 (NF186) and direct the nodal clustering of voltage-gated sodium channels (Nav). NF186 is the single axonal Gldn partner to ensure Nav clustering at nodes, whereas NrCAM is only required in glial cells (Feinberg, K., Eshed-Eisenbach, Y., Frechter, S., Amor, V., Salomon, D., Sabanay, H., Dupree, J. L., Grumet, M., Brophy, P. J., Shrager, P., and Peles, E. (2010) Neuron 65, 490-502). The olfactomedin domain of Gldn is implicated in the interaction with nodal Ig-CAMs. However, the interacting modules of NrCAM or NF186 involved in Gldn association are unknown. Here, we report that fibronectin type III-like (FnIII) domains of both Ig-CAMs mediate their interaction with Gldn in pulldown and cell binding assays. Using surface plasmon resonance assays, we determined that NrCAM and NF186 display similar affinity constant for their association with Gldn (K-D of 0.9 and 5.7 nM, respectively). We characterized the FnIII domains 1 and 2 of NF186 as interacting modules that ensure association with Gldn. We found that the soluble FnIII domains of NF186 (FnIII-Fc) bind on Schwann cells and inhibit Gldn and Nav clustering at heminodes, the precursors of mature nodes in myelinating cultures. Our study reveals the unexpected importance of FnIII domains of Ig-CAMs in the organization of nodes of Ranvier in peripheral axons. Thus, NF186 utilizes distinct modules to organize the multimeric nodal complex.	[Labasque, Marilyne; Devaux, Jerome J.; Faivre-Sarrailh, Catherine] Aix Marseille Univ, Ctr Rech Neurobiol & Neurophysiol Marseille, F-13344 Marseille, France; [Labasque, Marilyne; Devaux, Jerome J.; Faivre-Sarrailh, Catherine] CNRS, UMR 6231, F-13344 Marseille, France; [Leveque, Christian] Ctr Anal Proteom Marseille, F-13344 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Faivre-Sarrailh, C (corresponding author), Fac Med Nord, UMR CRN2M 6231, Bd Pierre Dramard, F-13344 Marseille 15, France.	catherine.sarrailh@univmed.fr	Faivre-Sarrailh, Catherine/M-6738-2016; Labasque, Marilyne/AAE-2498-2022; leveque, christian/GVU-3567-2022; Devaux, jerome/X-8581-2019	leveque, christian/0000-0003-2583-2148; Devaux, jerome/0000-0001-6383-4334; Faivre-Sarrailh, Catherine/0000-0002-1718-0533; Labasque, Marilyne/0000-0002-1467-2866	Association pour la Recherche sur la Sclerose en Plaques; National Multiple Sclerosis Society	Association pour la Recherche sur la Sclerose en Plaques; National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by the Association pour la Recherche sur la Sclerose en Plaques (to C. F.-S.) and the National Multiple Sclerosis Society (to C. F.-S., fellowship for M. L.).	Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; Cervello M, 1996, J CELL SCI, V109, P699; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband Matthew N., 2006, V43, P129, DOI 10.1007/014; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Thaxton C, 2011, NEURON, V69, P244, DOI 10.1016/j.neuron.2010.12.016; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	35	31	32	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42426	42434		10.1074/jbc.M111.266353	http://dx.doi.org/10.1074/jbc.M111.266353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009740	hybrid, Green Published			2022-12-25	WOS:000298180900051
J	Anbazhagan, V; Sankhala, RS; Singh, BP; Swamy, MJ				Anbazhagan, V.; Sankhala, Rajeshwer S.; Singh, Bhanu Pratap; Swamy, Musti J.			Isothermal Titration Calorimetric Studies on the Interaction of the Major Bovine Seminal Plasma Protein, PDC-109 with Phospholipid Membranes	PLOS ONE			English	Article							OVIDUCTAL SPERM RESERVOIR; ELECTRON-SPIN-RESONANCE; AMINO-ACID-SEQUENCE; APOLIPOPROTEIN-A-I; BINDING PROTEINS; HEPARIN-BINDING; MODEL MEMBRANES; BULL SPERM; CHOLESTEROL; PHOSPHORYLCHOLINE	The interaction of the major bovine seminal plasma protein, PDC-109 with lipid membranes was investigated by isothermal titration calorimetry. Binding of the protein to model membranes made up of diacyl phospholipids was found to be endothermic, with positive values of binding enthalpy and entropy, and could be analyzed in terms of a single type of binding sites on the protein. Enthalpies and entropies for binding to diacylphosphatidylcholine membranes increased with increase in temperature, although a clear-cut linear dependence was not observed. The entropically driven binding process indicates that hydrophobic interactions play a major role in the overall binding process. Binding of PDC-109 with dimyristoylphosphatidylcholine membranes containing 25 mol% cholesterol showed an initial increase in the association constant as well as enthalpy and entropy of binding with increase in temperature, whereas the values decreased with further increase in temperature. The affinity of PDC-109 for phosphatidylcholine increased at higher pH, which is physiologically relevant in view of the basic nature of the seminal plasma. Binding of PDC-109 to Lyso-PC could be best analysed in terms of two types of binding interactions, a high affinity interaction with Lyso-PC micelles and a low-affinity interaction with the monomeric lipid. Enthalpy-entropy compensation was observed for the interaction of PDC-109 with phospholipid membranes, suggesting that water structure plays an important role in the binding process.	[Anbazhagan, V.; Sankhala, Rajeshwer S.; Singh, Bhanu Pratap; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Anbazhagan, V (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjssc@uohyd.ernet.in	Swamy, Musti/B-9418-2009	Swamy, Musti/0000-0002-3108-3633; Veerappan, Anbazhagan/0000-0002-0931-8192; Singh, Bhanu/0000-0003-3309-8772	Department of Science and Technology (India); Council of Scientific and Industrial Research (India); University Grants Commission (UGC) (India); UGC through UPE; UGC through CAS	Department of Science and Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC) (India)(University Grants Commission, India); UGC through UPE; UGC through CAS	This work was supported by a research grant from the Department of Science and Technology (India) to MJS. VA and RSS were supported by Senior Research Fellowships from Council of Scientific and Industrial Research (India), and BPS was supported by a Junior Research Fellowship from University Grants Commission (UGC) (India). We acknowledge the UGC for their support through the UPE and CAS programs, to the University of Hyderabad and School of Chemistry, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2005, BIOCHEMISTRY-US, V44, P2103, DOI 10.1021/bi048077d; Anbazhagan V, 2008, BBA-PROTEINS PROTEOM, V1784, P891, DOI 10.1016/j.bbapap.2008.03.002; Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; BAKER ME, 1985, BIOCHEM BIOPH RES CO, V130, P1010, DOI 10.1016/0006-291X(85)91715-2; Bergeron A, 2005, MOL REPROD DEV, V71, P461, DOI 10.1002/mrd.20310; Boisvert M, 2004, BIOL REPROD, V70, P656, DOI 10.1095/biolreprod.103.023069; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002; Calvete JJ, 1996, PROTEIN EXPRES PURIF, V8, P48, DOI 10.1006/prep.1996.0073; CALVETE JJ, 1994, FEBS LETT, V350, P203, DOI 10.1016/0014-5793(94)00768-3; CALVETE JJ, 1995, BIOCHEM J, V310, P615, DOI 10.1042/bj3100615; Calvete JJ, 1997, FEBS LETT, V407, P201, DOI 10.1016/S0014-5793(97)00344-X; CHANDONNET L, 1990, MOL REPROD DEV, V26, P313, DOI 10.1002/mrd.1080260404; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; ESCH FS, 1983, BIOCHEM BIOPH RES CO, V113, P861, DOI 10.1016/0006-291X(83)91078-1; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Harper Michael J. K., 1994, P123; Harrison RAP, 1996, REPROD FERT DEVELOP, V8, P581, DOI 10.1071/RD9960581; Ignotz GG, 2001, BIOL REPROD, V64, P1806, DOI 10.1095/biolreprod64.6.1806; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassiseraye D, 2008, BBA-BIOMEMBRANES, V1778, P502, DOI 10.1016/j.bbamem.2007.10.025; Liberda J, 2001, FOLIA BIOL-PRAGUE, V47, P113; Lin MS, 2007, COLLOID SURFACE B, V58, P231, DOI 10.1016/j.colsurfb.2007.03.014; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Marsh D., 1990, CRC HDB LIPID BILAYE; Moreau R, 1998, BIOCHEM BIOPH RES CO, V246, P148, DOI 10.1006/bbrc.1998.8513; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Revah I, 2000, BIOL REPROD, V62, P1010, DOI 10.1095/biolreprod62.4.1010; Sankhala RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017330; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; SCHEIT KH, 1988, BIOSCIENCE REP, V8, P589, DOI 10.1007/BF01117339; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; SEIDAH NG, 1987, BIOCHEM J, V243, P195, DOI 10.1042/bj2430195; SHIVAJI S, 1990, PROTEINS SEMINAL PLA, P526; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Sultan NAM, 2005, ARCH BIOCHEM BIOPHYS, V437, P115, DOI 10.1016/j.abb.2005.03.005; Swamy MJ, 2000, BIOCHEMISTRY-US, V39, P12476, DOI 10.1021/bi000699l; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Swamy MJ, 2002, FEBS LETT, V528, P230, DOI 10.1016/S0014-5793(02)03316-1; Therien I, 1998, BIOL REPROD, V59, P768, DOI 10.1095/biolreprod59.4.768; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Villemure Michele, 2003, Reprod Biol Endocrinol, V1, P39, DOI 10.1186/1477-7827-1-39; Visconti PE, 1998, J ANDROL, V19, P242; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yanagimachi R., 1994, P189; Zhang WM, 2006, ARCH BIOCHEM BIOPHYS, V445, P174, DOI 10.1016/j.abb.2005.10.022; 1998, ITC DATA ANAL ORIGIN	58	40	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25993	10.1371/journal.pone.0025993	http://dx.doi.org/10.1371/journal.pone.0025993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022488	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600026
J	Koutras, C; Levesque, G				Koutras, Carolina; Levesque, Georges			Identification of Novel NPRAP/delta-Catenin-Interacting Proteins and the Direct Association of NPRAP with Dynamin 2	PLOS ONE			English	Article							DELTA-CATENIN; BETA-CATENIN; EXPRESSION ANALYSIS; ALPHA-INTERNEXIN; E-CADHERIN; REGION; LOCALIZATION; SPECIFICITY; ADHESION; COMPLEX	Neural plakophilin-related armadillo protein (NPRAP or delta-catenin) is a neuronal-specific protein that is best known for its interaction with presenilin 1 (PS1). Interestingly, the hemizygous loss of NPRAP is associated with severe mental retardation in cri du chat syndrome (CDCS), and mutations in PS1 cause an aggressive, early-onset form of Alzheimer's disease. Until recently, studies on the function of NPRAP have focused on its ability to modulate dendritic protrusion elaboration through its binding to cell adhesion and scaffolding molecules. However, mounting evidence indicates that NPRAP participates in intracellular signaling and exists in the nucleus, where it modulates gene expression. This apparent bifunctional nature suggests an elaborate neuronal role, but how NPRAP came to participate in such distinct subcellular events remains a mystery. To gain insight into this pathway, we immunoprecipitated NPRAP from human SH SY5Y cells and identified several novel interacting proteins by mass spectrometry. These included neurofilament alpha-internexin, interferon regulatory protein 2 binding factors, and dynamins 1 and 2. We further validated dynamin 2/NPRAP colocalization and direct interaction in vivo, confirming their bona fide partnership. Interestingly, dynamin 2 has established roles in endocytosis and actin assembly, and both of these processes have the potential to interface with the cell adhesion and intracellular signaling processes that involve NPRAP. Our data provide new avenues for approaching NPRAP biology and suggest a broader role for this protein than previously thought.	[Koutras, Carolina; Levesque, Georges] Univ Laval, Fac Med, Dept Psychiat Neurosci, Quebec City, PQ G1K 7P4, Canada; [Koutras, Carolina; Levesque, Georges] CHUL, Neurosci Unit, Quebec City, PQ, Canada	Laval University; Laval University	Koutras, C (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	Georges.levesque@crchul.ulaval.ca		Koutras, Carolina/0000-0002-9854-8458	Canadian Institutes of Health Research [MOP-64309]; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca, MOP-64309) and the Fonds de Recherche en Sante du Quebec (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; [Anonymous], NIXON RAYA CYTOSKELE; [Anonymous], HGNC DAT HGNCH EMBL; BARRONCASELLA EA, 1995, J BIOL CHEM, V270, P21472, DOI 10.1074/jbc.270.37.21472; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Church DM, 1997, GENOME RES, V7, P787, DOI 10.1101/gr.7.8.787; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Mainardi PC, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-33; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	54	6	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25379	10.1371/journal.pone.0025379	http://dx.doi.org/10.1371/journal.pone.0025379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022388	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600007
J	Li, CC; Dabrowska, J; Hazra, R; Rainnie, DG				Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.			Synergistic Activation of Dopamine D1 and TrkB Receptors Mediate Gain Control of Synaptic Plasticity in the Basolateral Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ANTAGONIST SCH 23390; PROTEIN-KINASE-A; NEUROTROPHIC FACTOR; TYROSINE KINASE; LATE-PHASE; FREQUENCY STIMULATION; MEMORY CONSOLIDATION; SIGNALING PATHWAY; NMDA RECEPTOR	Fear memory formation is thought to require dopamine, brain-derived neurotrophic factor (BDNF) and zinc release in the basolateral amygdala (BLA), as well as the induction of long term potentiation (LTP) in BLA principal neurons. However, no study to date has shown any relationship between these processes in the BLA. Here, we have used in vitro whole-cell patch clamp recording from BLA principal neurons to investigate how dopamine, BDNF, and zinc release may interact to modulate the LTP induction in the BLA. LTP was induced by either theta burst stimulation (TBS) protocol or spaced 5 times high frequency stimulation (5xHFS). Significantly, both TBS and 5xHFS induced LTP was fully blocked by the dopamine D1 receptor antagonist, SCH23390. LTP induction was also blocked by the BDNF scavenger, TrkB-FC, the zinc chelator, DETC, as well as by an inhibitor of matrix metalloproteinases (MMPs), gallardin. Conversely, prior application of the dopamine reuptake inhibitor, GBR12783, or the D1 receptor agonist, SKF39393, induced robust and stable LTP in response to a sub-threshold HFS protocol (2xHFS), which does not normally induce LTP. Similarly, prior activation of TrkB receptors with either a TrkB receptor agonist, or BDNF, also reduced the threshold for LTP-induction, an effect that was blocked by the MEK inhibitor, but not by zinc chelation. Intriguingly, the TrkB receptor agonist-induced reduction of LTP threshold was fully blocked by prior application of SCH23390, and the reduction of LTP threshold induced by GBR12783 was blocked by prior application of TrkB-FC. Together, our results suggest a cellular mechanism whereby the threshold for LTP induction in BLA principal neurons is critically dependent on the level of dopamine in the extracellular milieu and the synergistic activation of postsynaptic D1 and TrkB receptors. Moreover, activation of TrkB receptors appears to be dependent on concurrent release of zinc and activation of MMPs.	[Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA	Emory University	Li, CC (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	drainni@emory.edu	Rainnie, Donald/L-3853-2016	Rainnie, Donald/0000-0003-0758-0530	National Institute of Mental Health [MH069852]; base center [RR-00165]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069852] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); base center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant (MH069852) to D. G. R. and the base center grant to the Yerkes National Primate Research Center #RR-00165, Animal Resource Program at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Braga AFM, 2004, MOL NEUROBIOL, V30, P127; Chen LY, 2010, P NATL ACAD SCI USA, V107, P7030, DOI 10.1073/pnas.0912973107; Christensen MK, 1998, J COMP NEUROL, V400, P375, DOI 10.1002/(SICI)1096-9861(19981026)400:3<375::AID-CNE7>3.0.CO;2-5; Conner JM, 1997, J NEUROSCI, V17, P2295; COWANSAGE KK, 2009, CURR MOL PHARM, V3, P12; Dabrowska J, 2010, NEUROSCIENCE, V171, P721, DOI 10.1016/j.neuroscience.2010.09.011; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Huber KM, 1998, NEUROPHARMACOLOGY, V37, P571, DOI 10.1016/S0028-3908(98)00050-1; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; MADSEN TE, 2009, NEUR M PLANN CHIC IL; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Monfils MH, 2007, MOL PHARMACOL, V72, P235, DOI 10.1124/mol.107.038232; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; Muly EC, 2009, BRAIN STRUCT FUNCT, V213, P375, DOI 10.1007/s00429-009-0214-8; Musumeci G, 2009, J NEUROSCI, V29, P10131, DOI 10.1523/JNEUROSCI.1707-09.2009; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Purcell AL, 2003, NEURON, V37, P473, DOI 10.1016/S0896-6273(03)00030-8; RAINNIE DG, 1992, J NEUROPHYSIOL, V67, P443, DOI 10.1152/jn.1992.67.2.443; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rattiner LM, 2005, NEUROSCIENTIST, V11, P323, DOI 10.1177/1073858404272255; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reznikov LR, 2008, J COMP NEUROL, V508, P458, DOI 10.1002/cne.21687; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 1999, LEARN MEMORY, V6, P97; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Takahashi H, 2010, J NEUROSCI, V30, P3043, DOI 10.1523/JNEUROSCI.5689-09.2010; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wright JW, 2007, NEURAL PLAST, V2007, P73813, DOI DOI 10.1155/2007/73813; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	68	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26065	10.1371/journal.pone.0026065	http://dx.doi.org/10.1371/journal.pone.0026065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022509	Green Published, gold			2022-12-25	WOS:000295981600029
J	Maati, HMO; Peyronnet, R; Devader, C; Veyssiere, J; Labbal, F; Gandin, C; Mazella, J; Heurteaux, C; Borsotto, M				Maati, Hamid Moha Ou; Peyronnet, Remi; Devader, Christelle; Veyssiere, Julie; Labbal, Fabien; Gandin, Carine; Mazella, Jean; Heurteaux, Catherine; Borsotto, Marc			A Human TREK-1/HEK Cell Line: A Highly Efficient Screening Tool for Drug Development in Neurological Diseases	PLOS ONE			English	Article							DOMAIN POTASSIUM CHANNELS; POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; K+ CHANNELS; GENERAL-ANESTHESIA; LINOLENIC ACID; K-2P CHANNELS; RILUZOLE; NEUROPROTECTION	TREK-1 potassium channels are involved in a number of physiopathological processes such as neuroprotection, pain and depression. Molecules able to open or to block these channels can be clinically important. Having a cell model for screening such molecules is of particular interest. Here, we describe the development of the first available cell line that constituvely expresses the TREK-1 channel. The TREK-1 channel expressed by the h-TREK-1/HEK cell line has conserved all its modulation properties. It is opened by stretch, pH, polyunsaturated fatty acids and by the neuroprotective molecule, riluzole and it is blocked by spadin or fluoxetine. We also demonstrate that the h-TREK-1/HEK cell line is protected against ischemia by using the oxygen-glucose deprivation model.	[Maati, Hamid Moha Ou; Peyronnet, Remi; Devader, Christelle; Veyssiere, Julie; Labbal, Fabien; Gandin, Carine; Mazella, Jean; Heurteaux, Catherine; Borsotto, Marc] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Maati, HMO (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Valbonne, France.	borsotto@ipmc.cnrs.fr	Mazella, Jean/A-6767-2012; Maati, Hamid Moha ou/M-2240-2019; HEURTEAUX, Catherine/M-4947-2016; BORSOTTO, Marc/M-5096-2016	Maati, Hamid Moha ou/0000-0002-8711-1760; HEURTEAUX, Catherine/0000-0002-9741-9777; BORSOTTO, Marc/0000-0002-1302-7419; Peyronnet, Remi/0000-0002-5708-6410	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche -Maladies NeuroPsychiatriques [ANR-2009-MNPS-026.01]; Fondation Coeur et arteres; CIFRE	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche -Maladies NeuroPsychiatriques(French National Research Agency (ANR)); Fondation Coeur et arteres; CIFRE	This work is supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche -Maladies NeuroPsychiatriques (ANR-2009-MNPS-026.01), and the Fondation Coeur et arteres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr A. Patel for careful reading of the manuscript. J. V. was supported by a CIFRE fellowship.	Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Buckler KJ, 2005, J PHYSIOL-LONDON, V562, P213, DOI 10.1113/jphysiol.2004.077503; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Ducroq J, 2010, BRIT J PHARMACOL, V159, P93, DOI 10.1111/j.1476-5381.2009.00371.x; Duprat F, 2000, MOL PHARMACOL, V57, P906; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Gardener MJ, 2004, BRIT J PHARMACOL, V142, P192, DOI 10.1038/sj.bjp.0705691; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Kang JS, 2010, J PHARMACOL EXP THER, V334, P619, DOI 10.1124/jpet.110.169391; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lang-Lazdunski L, 2003, J VASC SURG, V38, P564, DOI 10.1016/S0741-5214(03)00473-7; Lang-Lazdunski L, 1999, J THORAC CARDIOV SUR, V117, P881, DOI 10.1016/S0022-5223(99)70367-3; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Sandoz G, 2011, P NATL ACAD SCI USA, V108, P2605, DOI 10.1073/pnas.1015788108; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Terrenoire C, 2001, CIRC RES, V89, P336, DOI 10.1161/hh1601.094979; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q	50	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25602	10.1371/journal.pone.0025602	http://dx.doi.org/10.1371/journal.pone.0025602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022421	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600010
J	Aksu, Y; Miller, DJ; Kesidis, G; Bigler, DC; Yang, QX				Aksu, Yaman; Miller, David J.; Kesidis, George; Bigler, Don C.; Yang, Qing X.			An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN ATROPHY; PATTERN-CLASSIFICATION; CSF BIOMARKERS; DIAGNOSIS; RATES; SELECTION; HAMMER; IMAGES; ONSET	Alzheimer's disease (AD) and mild cognitive impairment (MCI) are of great current research interest. While there is no consensus on whether MCIs actually "convert'' to AD, this concept is widely applied. Thus, the more important question is not whether MCIs convert, but what is the best such definition. We focus on automatic prognostication, nominally using only a baseline brain image, of whether an MCI will convert within a multi-year period following the initial clinical visit. This is not a traditional supervised learning problem since, in ADNI, there are no definitive labeled conversion examples. It is not unsupervised, either, since there are (labeled) ADs and Controls, as well as cognitive scores for MCIs. Prior works have defined MCI subclasses based on whether or not clinical scores significantly change from baseline. There are concerns with these definitions, however, since, e.g., most MCIs (and ADs) do not change from a baseline CDR = 0.5 at any subsequent visit in ADNI, even while physiological changes may be occurring. These works ignore rich phenotypical information in an MCI patient's brain scan and labeled AD and Control examples, in defining conversion. We propose an innovative definition, wherein an MCI is a converter if any of the patient's brain scans are classified "AD'' by a Control-AD classifier. This definition bootstraps design of a second classifier, specifically trained to predict whether or not MCIs will convert. We thus predict whether an AD-Control classifier will predict that a patient has AD. Our results demonstrate that this definition leads not only to much higher prognostic accuracy than by-CDR conversion, but also to subpopulations more consistent with known AD biomarkers (including CSF markers). We also identify key prognostic brain region biomarkers.	[Aksu, Yaman; Yang, Qing X.] Penn State Univ Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA 17033 USA; [Miller, David J.; Kesidis, George] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Kesidis, George] Penn State Univ, Comp Sci & Engn Dept, University Pk, PA 16802 USA; [Bigler, Don C.] Penn State Univ Coll Med, Ctr Emerging Neurotechnol & Imaging, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Aksu, Y (corresponding author), Penn State Univ Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA 17033 USA.	djmiller@engr.psu.edu	Yang, Heroine/GRY-2630-2022		NIH [R01 AG02771, P30 AG010129, K01, AG030514]; Pennsylvania Department of Health; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [U19AG010483, P30AG010129, U01AG024904, K01AG030514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding supporting this work has been provided in part through NIH R01 AG02771 and the Pennsylvania Department of Health. The authors thank Dr. Michelle Shaffer for assistance with statistical testing and Jianli Wang and Zachary Herse for assistance with segmentation. This research was supported by NIH grants P30 AG010129, K01, AG030514, and the Dana Foundation. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Y, 2010, IEEE T NEURAL NETWOR, V21, P701, DOI 10.1109/TNN.2010.2041069; [Anonymous], STAT PARAMETRIC MAPP; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Chambers J. M., 1993, STAT MODELS S; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chetelat G, 2002, NEUROREPORT, V13, P1939; Chou YY, 2010, NEUROBIOL AGING, V31, P1386, DOI 10.1016/j.neurobiolaging.2010.05.001; CHOU YY, 2009, P SPIE, V7259; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Davatzikos C, 1998, HUM BRAIN MAPP, V6, P334; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; DAVATZIKOS C, 2011, NEUROBIOL AGING, V32, P2322, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023, DOI 10.1016/J.NEUROBIOLAGING.2010.05.023]; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; de Leon MJ, 2006, NEUROBIOL AGING, V27, P394, DOI 10.1016/j.neurobiolaging.2005.07.003; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DUDA RO, 2001, PATTERN CLASSIFICATI; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Frisoni GB, 2009, J NEUROL, V256, P916, DOI 10.1007/s00415-009-5040-7; Fung GM, 2004, COMPUT OPTIM APPL, V28, P185, DOI 10.1023/B:COAP.0000026884.66338.df; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Leow AD, 2009, NEUROIMAGE, V45, P645, DOI 10.1016/j.neuroimage.2009.01.004; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; PETERSEN RC, 2004, MILD COGNITIVE IMPAI; Rusinek H, 2004, NEUROLOGY, V63, P2354, DOI 10.1212/01.WNL.0000148602.30175.AC; Schott JM, 2005, NEUROLOGY, V65, P119, DOI 10.1212/01.wnl.0000167542.89697.0f; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; SCHUFF N, 2010, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROIOLAGING.2010.07.012; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shen DG, 2003, NEUROIMAGE, V18, P28, DOI 10.1006/nimg.2002.1301; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Thompson PM, 2003, J NEUROSCI, V23, P994; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25074	10.1371/journal.pone.0025074	http://dx.doi.org/10.1371/journal.pone.0025074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022375	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000008
J	Tabara, H; Naito, Y; Ito, A; Katsuma, A; Sakurai, MA; Ohno, S; Shimizu, H; Yabuta, N; Nojima, H				Tabara, Hiroe; Naito, Yoko; Ito, Akihiko; Katsuma, Asako; Sakurai, Minami A.; Ohno, Shouichi; Shimizu, Hiroyuki; Yabuta, Norikazu; Nojima, Hiroshi			Neonatal Lethality in Knockout Mice Expressing the Kinase-Dead Form of the Gefitinib Target GAK Is Caused by Pulmonary Dysfunction	PLOS ONE			English	Article							CELL LUNG-CANCER; CLATHRIN-MEDIATED ENDOCYTOSIS; EGFR; REGULATOR; PROTEIN; TRAFFICKING; INHIBITORS	Gefitinib (Iressa) is an inhibitor of the epidermal growth factor receptor (EGFR) that has shown promising activity in the treatment of patients with non-small cell lung cancer (NSCLC). However, adverse side effects of gefitinib treatment, such as respiratory dysfunction, have limited the therapeutic benefit of this targeting strategy. The present results show that this adverse effect can be attributed to the inhibition of the novel gefitinib target GAK (Cyclin G-associated kinase), which is as potently inhibited by the drug as the tyrosine kinase activity of EGFR. Knockout mice expressing the kinase-dead form of GAK (GAK-kd) died within 30 min after birth primarily due to respiratory dysfunction. Immunohistochemical analysis revealed that surfactant protein A (SP-A) was abundant within alveolar spaces in GAK-kd(+/+) mice but not in GAK-kd(-/-) pups. E-cadherin and phosphorylated EGFR signals were also abnormal, suggesting the presence of flat alveolar cells with thin junctions. These results suggest that inhibition of GAK by gefitinib may cause pulmonary alveolar dysfunction, and the present study may help prevent side effects associated with gefitinib therapy in NSCLC patients.	[Tabara, Hiroe; Naito, Yoko; Katsuma, Asako; Sakurai, Minami A.; Ohno, Shouichi; Shimizu, Hiroyuki; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan; [Ito, Akihiko] Kinki Univ, Dept Pathol, Fac Med, Osaka, Japan	Osaka University; Kindai University (Kinki University)	Tabara, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15101006, 20370081, 21651085]; Grants-in-Aid for Scientific Research [23370086] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081) and Exploratory Research (No. 21651085) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/) to Hiroshi Nojima. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehmer D, 2005, CANCER RES, V65, P379; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Ray MR, 2006, INT J CANCER, V118, P1108, DOI 10.1002/ijc.21469; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Sanford M, 2009, DRUGS, V69, P2303, DOI 10.2165/10489100-000000000-00000; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101	28	18	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26034	10.1371/journal.pone.0026034	http://dx.doi.org/10.1371/journal.pone.0026034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022498	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000056
J	Caruso, F; Mendoza, L; Castro, P; Cotoras, M; Aguirre, M; Matsuhiro, B; Isaacs, M; Rossi, M; Viglianti, A; Antonioletti, R				Caruso, Francesco; Mendoza, Leonora; Castro, Paulo; Cotoras, Milena; Aguirre, Maria; Matsuhiro, Betty; Isaacs, Mauricio; Rossi, Miriam; Viglianti, Angela; Antonioletti, Roberto			Antifungal Activity of Resveratrol against Botrytis cinerea Is Improved Using 2-Furyl Derivatives	PLOS ONE			English	Article							APOPTOSIS-INDUCING AGENTS; MOLECULAR-STRUCTURE; TRANS-RESVERATROL; STILBENE ANALOGS; METHYL ETHERS; PTEROSTILBENE; STYRYLHETEROCYCLES; PHYTOALEXINS; LACCASE; INHIBITION	The antifungal effect of three furyl compounds closely related to resveratrol, (E)-3,4,5-trimethoxy-beta-(2-furyl)-styrene (1), (E)-4-methoxy-beta-(2-furyl)-styrene (2) and (E)-3,5-dimethoxy-beta-(2-furyl)-styrene (3) against Botrytis cinerea was analyzed. The inhibitory effect, at 100 mu g ml(-1) 21 of compounds 1, 2, 3 and resveratrol on conidia germination, was determined to be about 70%, while at the same concentration pterostilbene (a dimethoxyl derivative of resveratrol) produced complete inhibition. The title compounds were more fungitoxic towards in vitro mycelial growth than resveratrol and pterostilbene. Compound 3 was the most active and a potential explanation of this feature is given using density functional theory (DFT) calculations on the demethoxylation/demethylation process. Compound 3 was further evaluated for its effects on laccase production, oxygen consumption and membrane integrity of B. cinerea. An increase of the laccase activity was observed in the presence of compound 3 and, using Sytox Green nucleic acid stain, it was demonstrated that this compound altered B. cinerea membrane. Finally, compound 3 partially affected conidia respiration.	[Caruso, Francesco; Antonioletti, Roberto] Univ Rome, Ist Chim Biomol, CNR, Ist Chim, Rome, Italy; [Mendoza, Leonora; Castro, Paulo; Cotoras, Milena; Aguirre, Maria; Matsuhiro, Betty] Univ Santiago Chile, Fac Quim & Biol, Santiago, Chile; [Isaacs, Mauricio] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Rossi, Miriam] Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Sapienza University Rome; Universidad de Santiago de Chile; Universidad de Chile; Vassar College	Caruso, F (corresponding author), Univ Rome, Ist Chim Biomol, CNR, Ist Chim, Rome, Italy.	caruso@vassar.edu; rossi@vassar.edu	Isaacs, Mauricio/N-3027-2013; Aguirre, Maria J/A-3935-2013	Aguirre, Maria/0000-0003-1134-4469; Isaacs Casanova, Mauricio/0000-0003-0503-0949; Rossi, Miriam/0000-0001-9609-474X	Consiglio Nazionale delle Ricerche, Rome, Italy; Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; International Foundation for Science [F/3115-1, C/2807-2]; FONDECYT [N 1090723]	Consiglio Nazionale delle Ricerche, Rome, Italy(Consiglio Nazionale delle Ricerche (CNR)); Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; International Foundation for Science(International Foundation for Science); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Consiglio Nazionale delle Ricerche, Rome, Italy; Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; the International Foundation for Science Grants No F/3115-1 (LM) and C/2807-2 (MC), and FONDECYT N 1090723 (LM, MC and FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Antonioletti R, 2008, TETRAHEDRON, V64, P4644, DOI 10.1016/j.tet.2008.02.091; AUN CE, 1990, J CHEM SOC PERK T 2, P645, DOI 10.1039/p29900000645; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caruso F, 2004, J AGR FOOD CHEM, V52, P7279, DOI 10.1021/jf048794e; Chefetz B, 1998, APPL ENVIRON MICROB, V64, P3175; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Chu LT, 2007, HETEROCYCLES, V71, P165; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; ELAD Y, 1995, PHYTOPATHOLOGY, V85, P637; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P253, DOI 10.1016/S0031-9422(00)00450-7; HART JH, 1981, ANNU REV PHYTOPATHOL, V19, P437, DOI 10.1146/annurev.py.19.090181.002253; Ho JH, 2001, ORG LETT, V3, P409, DOI 10.1021/ol006917k; Ho TI, 2000, J AM CHEM SOC, V122, P8575, DOI 10.1021/ja0011562; Katsuyama Yohei, 2007, Biotechnology Journal, V2, P1286, DOI 10.1002/biot.200700098; Kim S, 2003, CHEM PHARM BULL, V51, P516; Kim S, 2002, J MED CHEM, V45, P160, DOI 10.1021/jm010298j; LATORRE BA, 1994, PLANT DIS, V78, P990, DOI 10.1094/PD-78-0990; Lee SK, 2003, BIOORG MED CHEM LETT, V13, P3689, DOI 10.1016/j.bmcl.2003.08.013; Mendoza L, 2005, J AGR FOOD CHEM, V53, P10080, DOI 10.1021/jf0511749; Meng XL, 2008, CHEM-BIOL INTERACT, V174, P51, DOI 10.1016/j.cbi.2008.04.015; MEUNIER G, 1985, J AM CHEM SOC, V107, P2558, DOI 10.1021/ja00294a064; Mikstacka R, 2007, MOL NUTR FOOD RES, V51, P517, DOI 10.1002/mnfr.200600135; Munoz G, 2002, MYCOL RES, V106, P594, DOI 10.1017/S0953756202005981; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Niewiadomy A, 2006, J PESTIC SCI, V31, P14, DOI 10.1584/jpestics.31.14; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PEZET R, 1990, J PHYTOPATHOL, V129, P19, DOI 10.1111/j.1439-0434.1990.tb04286.x; PEZET R, 1991, PHYSIOL MOL PLANT P, V39, P441, DOI 10.1016/0885-5765(91)90010-F; Pezet Roger, 1995, P317; Roberti M, 2003, J MED CHEM, V46, P3546, DOI 10.1021/jm030785u; Rossi M, 2008, J AGR FOOD CHEM, V56, P10557, DOI 10.1021/jf801923j; Sang KL, 2004, BIOORG MED CHEM LETT, V14, P2105, DOI 10.1016/j.bmcl.2004.02.038; SANGHEE K, 2003, Patent No. 2003018013; Sbaghi M, 1996, PLANT PATHOL, V45, P139, DOI 10.1046/j.1365-3059.1996.d01-101.x; Schouten A, 2002, MOL MICROBIOL, V43, P883, DOI 10.1046/j.1365-2958.2002.02801.x; Sobarzo-Sanchez E, 2006, STRUCT CHEM, V17, P483, DOI 10.1007/s11224-006-9070-9; Tamura H, 1999, PESTIC SCI, V55, P681, DOI 10.1002/(SICI)1096-9063(199907)55:7&lt;681::AID-PS16&gt;3.0.CO;2-8; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Tofi M, 2005, ORG LETT, V7, P3347, DOI 10.1021/ol051205l; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; van Baarlen P, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P143; Voda K, 2004, J MOL MODEL, V10, P76, DOI 10.1007/s00894-003-0174-5; Wang ZY, 2009, ORG BIOMOL CHEM, V7, P863, DOI 10.1039/b821870f; Wu JY, 1999, ORG LETT, V1, P1039, DOI 10.1021/ol990828u; Yang GF, 2002, PEST MANAG SCI, V58, P1063, DOI 10.1002/ps.584	50	46	49	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25421	10.1371/journal.pone.0025421	http://dx.doi.org/10.1371/journal.pone.0025421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022392	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200008
J	Ponce, J; Calvet, X; Gallach, M; Ponce, M				Ponce, Julio; Calvet, Xavier; Gallach, Marta; Ponce, Marta		AEG	Esophagitis in a High H. pylori Prevalence Area: Severe Disease Is Rare but Concomitant Peptic Ulcer Is Frequent	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; LOS-ANGELES CLASSIFICATION; POPULATION-BASED COHORT; ENDOSCOPIC ASSESSMENT; EROSIVE ESOPHAGITIS; SYMPTOMS; INTEROBSERVER; DYSPEPSIA; HEARTBURN; INFECTION	Background: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. Objective: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of endoscopies in Spain. Design: Retrospective observational study. A multivariate analysis was performed to determine variables predicting severe esophagitis. Setting: Databases of 29 Spanish endoscopy units. Patients: Patients submitted to a diagnostic endoscopy during the year 2005. Interventions: Retrospective review of the databases. Main Outcome Measurements: Esophagitis severity (graded according to the Los Angeles classification) and associated endoscopic findings. Results: Esophagitis was observed in 8.7% of the 93,699 endoscopies reviewed. Severe esophagitis (LA grade C or D) accounted for 22.5% of cases of the disease and was found in 1.9% of all endoscopies. Incidences of esophagitis and those of severe esophagitis were 86.2 and 18.7 cases per 100,000 inhabitants per year respectively. Male sex (OR 1.89) and advanced age (OR 4.2 for patients in the fourth age quartile) were the only variables associated with severe esophagitis. Associated peptic ulcer was present in 8.8% of cases. Limitations: Retrospective study, no data on individual proton pump inhibitors use. Conclusions: Severe esophagitis is an infrequent finding in Spain. It occurs predominantly in males and in older individuals. Peptic ulcer disease is frequently associated with erosive esophagitis.	[Ponce, Julio; Ponce, Marta] Hosp Univ La Fe, Serv Aparato Digest, Valencia, Spain; [Ponce, Julio; Calvet, Xavier; Ponce, Marta] CIBEREHD Inst Salud Carlos III, Barcelona, Spain; [Calvet, Xavier; Gallach, Marta] Univ Autonoma Barcelona, Dept Med, Inst Univ Parc Tauli, E-08193 Barcelona, Spain; [Calvet, Xavier; Gallach, Marta] Hosp Sabadell, Unitat Malalties Digest, Sabadell, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Ponce, J (corresponding author), Hosp Univ La Fe, Serv Aparato Digest, Valencia, Spain.	xcalvet@cspt.es	Calvet, Xavier/H-3288-2019; Bujanda, Luis/AAB-2485-2021; Dolz Abadía, Carlos/I-1757-2017	Calvet, Xavier/0000-0002-6278-9663; Bujanda, Luis/0000-0002-4353-9968; Calvet, Xavier/0000-0002-4413-4209	Astra-Zeneca; Instituto de Salud Carlos III [C03/02, PI 05/1157, CIBEREHD]	Astra-Zeneca(AstraZeneca); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by a grant from Astra-Zeneca and by grants from the Instituto de Salud Carlos III (C03/02 and PI 05/1157 and CIBEREHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Carlsson R, 1998, EUR J GASTROEN HEPAT, V10, P119, DOI 10.1097/00042737-199802000-00004; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2002, SCAND J GASTROENTERO, V37, P899, DOI 10.1080/003655202760230847; FENNERTY B, 2004, GUT S6, V53, pA111; Haque M, 2000, NEW ZEAL MED J, V113, P178; Ho KY, 2005, AM J GASTROENTEROL, V100, P1923, DOI 10.1111/j.1572-0241.2005.50138.x; *I NAC EST, 2007, REV PADR MUN 2005 DA; JOHANSSON KE, 1986, SCAND J GASTROENTERO, V21, P837, DOI 10.3109/00365528609011128; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; KANG JY, 1993, J CLIN GASTROENTEROL, V16, P70, DOI 10.1097/00004836-199301000-00019; Kang JY, 1999, EUR J GASTROEN HEPAT, V11, P845, DOI 10.1097/00042737-199908000-00006; Kennedy T, 2000, ALIMENT PHARM THER, V14, P1589, DOI 10.1046/j.1365-2036.2000.00884.x; KNILLJONES RP, 1984, SCAND J GASTROENTERO, V19, P72; Kotzan J, 2001, PHARM RES-DORDR, V18, P1367, DOI 10.1023/A:1013010616496; Kusano M, 1999, GASTROINTEST ENDOSC, V49, P700, DOI 10.1016/S0016-5107(99)70285-3; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Lassen A, 2005, SCAND J GASTROENTERO, V40, P705, DOI 10.1080/00365520510015476; Louis E, 2002, EUR J GASTROEN HEPAT, V14, P279, DOI 10.1097/00042737-200203000-00012; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Martinez SD, 2003, ALIMENT PHARM THER, V17, P537, DOI 10.1046/j.1365-2036.2003.01423.x; Mishima I, 2005, SCAND J GASTROENTERO, V40, P1005, DOI 10.1080/00365520510023260; Moayyedi P, 2005, ALIMENT PHARM THER, V22, P11, DOI 10.1111/j.1365-2036.2005.02605.x; Navarro M., 1999, Clinical Microbiology and Infection, V5, P704, DOI 10.1111/j.1469-0691.1999.tb00518.x; Pandolfino JE, 2002, GASTROINTEST ENDOSC, V56, P639, DOI 10.1067/mge.2002.129220; Pilotto A, 2006, J AM GERIATR SOC, V54, P1537, DOI 10.1111/j.1532-5415.2006.00899.x; Ponce J, 2006, ALIMENT PHARM THER, V23, P175, DOI 10.1111/j.1365-2036.2006.02733.x; Rath HC, 2004, GASTROINTEST ENDOSC, V60, P44, DOI 10.1016/S0016-5107(04)01289-1; Ronkainen J, 2006, ALIMENT PHARM THER, V23, P1725, DOI 10.1111/j.1365-2036.2006.02952.x; Rosaida MS, 2004, EUR J GASTROEN HEPAT, V16, P495, DOI 10.1097/00042737-200405000-00010; Ruigomez A, 2004, ALIMENT PHARM THERAP, V20, P751, DOI 10.1111/j.1365-2036.2004.02169.x; Smith T, 2003, GASTROINTEST ENDOSC, V58, P9, DOI 10.1067/mge.2003.308; Wu JCY, 2002, GASTROINTEST ENDOSC, V55, P461, DOI 10.1067/mge.2002.122617; Yeh C, 1997, DIGEST DIS SCI, V42, P702, DOI 10.1023/A:1018835324210	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25051	10.1371/journal.pone.0025051	http://dx.doi.org/10.1371/journal.pone.0025051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022373	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200005
J	Karhunen, M				Karhunen, Markku			Dynamics of a Sex-Linked Deleterious Mutation in Populations Subject to Sex Reversal	PLOS ONE			English	Article							Y-CHROMOSOMES; RECOMBINATION; EVOLUTION; DEGENERATION; FEMALE	The heterogametic sex chromosomes (i.e. mammalian Y and avian W) do not usually recombine with the homogametic sex chromosomes which is known to lead into rapid degeneration of Y and W due to accumulation of deleterious mutations. On the other hand, some 96% of amphibian species have homomorphic, i.e. nondegenerate Y chromosomes. Nicolas Perrin's fountainofyouth hypothesis states that this is a result of recombination between X and Y chromosomes in sexreversed individuals. In this study, I model the consequences of such recombination for the dynamics of a deleterious mutation occurring in Y chromosomes. As expected, even relatively low levels of sex reversal help to purge deleterious mutations. However, the populationdynamic consequences of this depend on the type of selection that operates on the population undergoing sex reversal. Under fecundity selection, sex reversal can be beneficial for some parameter values, whereas under survival selection, it seems to be always harmful.	Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki	Karhunen, M (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	markku.karhunen@helsinki.fi		Karhunen, Markku/0000-0001-9086-8214	Academy of Finland [124242, 213457]; European Research Council (ERC) [205905]	Academy of Finland(Academy of Finland); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was supported by Academy of Finland (grants 124242 and 213457 to Otso Ovaskainen) and the European Research Council (ERC Starting Grant 205905 to Otso Ovaskainen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-King M, 2010, EVOL BIOL, V37, P234, DOI 10.1007/s11692-010-9101-8; Aida T, 1921, GENETICS, V6, P554; Alho JS, 2010, MOL ECOL, V19, P1763, DOI 10.1111/j.1365-294X.2010.04607.x; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bull J. J., 1983, EVOLUTION SEX DETERM; BURT A, 1991, J EVOLUTION BIOL, V4, P259, DOI 10.1046/j.1420-9101.1991.4020259.x; Charlesworth B, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-226; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Engelstadter J, 2008, GENETICS, V180, P957, DOI 10.1534/genetics.108.092379; Grossen C, 2011, EVOLUTION, V65, P64, DOI 10.1111/j.1558-5646.2010.01098.x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; KEENEY S, 2011, SCIENCE, V331, P916; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Lynn A, 2005, AM J HUM GENET, V77, P670, DOI 10.1086/491718; Marais GAB, 2010, GENOME BIOL EVOL, V2, P347, DOI 10.1093/gbe/evq026; Matsuba C, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-3; Matsuba C, 2010, EVOLUTION, V64, P3634, DOI 10.1111/j.1558-5646.2010.01076.x; Matsuba C, 2009, MOL ECOL RESOUR, V9, P555, DOI 10.1111/j.1755-0998.2008.02368.x; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; STEINEMANN M, 1993, P NATL ACAD SCI USA, V90, P5737, DOI 10.1073/pnas.90.12.5737; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Stelkens RB, 2010, MOL ECOL, V19, P627, DOI 10.1111/j.1365-294X.2010.04526.x; SWITONSKI M, 2010, CHROMOSOME RES, V18, P720; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Wallace H, 1997, CHROMOSOMA, V106, P526; Wedekind C, 2010, MOL ECOL, V19, P1760, DOI 10.1111/j.1365-294X.2010.04608.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x	36	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25362	10.1371/journal.pone.0025362	http://dx.doi.org/10.1371/journal.pone.0025362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016765	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700007
J	Odaka, K; Aoki, I; Moriya, J; Tateno, K; Tadokoro, H; Kershaw, J; Minamino, T; Irie, T; Fukumura, T; Komuro, I; Saga, T				Odaka, Kenichi; Aoki, Ichio; Moriya, Junji; Tateno, Kaoru; Tadokoro, Hiroyuki; Kershaw, Jeff; Minamino, Tohru; Irie, Toshiaki; Fukumura, Toshimitsu; Komuro, Issei; Saga, Tsuneo			In Vivo Tracking of Transplanted Mononuclear Cells Using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; MRI; NEOVASCULARIZATION; MUSCLE; BRAIN; IRON; ANGIOGENESIS; CHANNELS; NICKEL	Background: Transplantation of mononuclear cells (MNCs) has previously been tested as a method to induce therapeutic angiogenesis to treat limb ischemia in clinical trials. Non-invasive high resolution imaging is required to track the cells and evaluate clinical relevance after cell transplantation. The hypothesis that MRI can provide in vivo detection and long-term observation of MNCs labeled with manganese contrast-agent was investigated in ischemic rat legs. Methods and Findings: The Mn-labeled MNCs were evaluated using 7-tesla high-field magnetic resonance imaging (MRI). Intramuscular transplanted Mn-labeled MNCs were visualized with MRI for at least 7 and up to 21 days after transplantation in the ischemic leg. The distribution of Mn-labeled MNCs was similar to that of In-111-labeled MNCs measured with single-photon emission computed tomography (SPECT) and Dil-dyed MNCs with fluorescence microscopy. In addition, at 1-2 days after transplantation the volume of the site injected with intact Mn-labeled MNCs was significantly larger than that injected with dead MNCs, although the dead Mn-labeled MNCs were also found for approximately 2 weeks in the ischemic legs. The area covered by CD31-positive cells (as a marker of capillary endothelial cells) in the intact Mn-MNCs implanted site at 43 days was significantly larger than that at a site implanted with dead Mn-MNCs. Conclusions: The present Mn-enhanced MRI method enabled visualization of the transplanted area with a 150-175 mu m in-plane spatial resolution and allowed the migration of labeled-MNCs to be observed for long periods in the same subject. After further optimization, MRI-based Mn-enhanced cell-tracking could be a useful technique for evaluation of cell therapy both in research and clinical applications.	[Odaka, Kenichi; Aoki, Ichio; Kershaw, Jeff; Irie, Toshiaki; Fukumura, Toshimitsu; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Moriya, Junji; Tateno, Kaoru; Minamino, Tohru; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan; [Tadokoro, Hiroyuki] Tokai Univ, Dept Biomed Engn, Shizuoka, Japan	National Institutes for Quantum Science & Technology; Chiba University; Tokai University	Odaka, K (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	aoki@nirs.go.jp	Aoki, Ichio/G-2529-2011; Aoki, Ichio/ABF-7336-2020; Minamino, Tohru/P-8145-2018; Fukumura, Toshimitsu/E-2847-2012	Aoki, Ichio/0000-0002-4429-5053; Minamino, Tohru/0000-0003-1627-6151; 	Japan Society for the Promotion of Science (JSPS); Japan Cardiovascular Research Foundation; Grants-in-Aid for Scientific Research [21390237] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research Japan (Kakenhi) from the Japan Society for the Promotion of Science (JSPS) and a grant from the Japan Cardiovascular Research Foundation. The research was also partly supported by the JSPS through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2006, NMR BIOMED, V19, P50, DOI 10.1002/nbm.1000; Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; ARCHIBALD FS, 1987, ARCH BIOCHEM BIOPHYS, V256, P638, DOI 10.1016/0003-9861(87)90621-7; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Brurok H, 1999, NMR BIOMED, V12, P364, DOI 10.1002/(SICI)1099-1492(199910)12:6<364::AID-NBM585>3.3.CO;2-Q; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; BULTE JWM, 1993, MAGNET RESON MED, V29, P32, DOI 10.1002/mrm.1910290108; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; GIMI B, 2002, P 10 ANN M ISMRM 18; GRAHAM DG, 1984, NEUROTOXICOLOGY, V5, P83; HENDRICK RE, 1993, JMRI-J MAGN RESON IM, V3, P137, DOI 10.1002/jmri.1880030126; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hu TCC, 2005, MAGN RESON MED, V54, P196, DOI 10.1002/mrm.20516; Hu TCC, 2004, NMR BIOMED, V17, P620, DOI 10.1002/nbm.933; Hu TCC, 2001, MAGNET RESON MED, V46, P884, DOI 10.1002/mrm.1273; HUNTER DR, 1980, CIRC RES, V47, P721, DOI 10.1161/01.RES.47.5.721; Ikenaga S, 2001, J SURG RES, V96, P277, DOI 10.1006/jsre.2000.6080; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Leor J, 2006, CIRCULATION, V114, pI94, DOI 10.1161/CIRCULATIONAHA.105.000331; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Moriya J, 2009, CIRC-CARDIOVASC INTE, V2, P245, DOI 10.1161/CIRCINTERVENTIONS.108.799361; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Nowak B, 2007, EUR J NUCL MED MOL I, V34, P715, DOI 10.1007/s00259-006-0275-3; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Sotak CH, 2008, CONTRAST MEDIA MOL I, V3, P95, DOI 10.1002/cmmi.235; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tateno K, 2006, CIRC RES, V98, P1194, DOI 10.1161/01.RES.0000219901.13974.15; Tatsumi T, 2007, CIRC J, V71, P1199, DOI 10.1253/circj.71.1199; Toyoda KI, 2004, NEUROREPORT, V15, P589, DOI 10.1097/00001756-200403220-00004; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; *WHO, 1996, HLTH CRIT OTH SUPP I, P276; Winkler T, 2008, TISSUE ENG PT A, V14, P1149, DOI [10.1089/ten.tea.2007.0179, 10.1089/tea.2007.0179]; Yamada M, 2009, MAGN RESON MED, V62, P1047, DOI 10.1002/mrm.22071; Zelivyanskaya ML, 2003, J NEUROSCI RES, V73, P284, DOI 10.1002/jnr.10693; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	49	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25487	10.1371/journal.pone.0025487	http://dx.doi.org/10.1371/journal.pone.0025487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003393	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300014
J	Siemen, H; Colas, D; Heller, HC; Brustle, O; Pera, RAR				Siemen, Henrike; Colas, Damien; Heller, H. Craig; Bruestle, Oliver; Pera, Renee A. Reijo			Pumilio-2 Function in the Mouse Nervous System	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; SELF-RENEWAL; MICE; BEHAVIORS; STRESS; IDENTIFICATION; STEROIDS; HOMOLOG; SEIZURE	Coordinated mRNA translation at the synapse is increasingly recognized as a critical mechanism for neuronal regulation. Pumilio, a translational regulator, is known to be involved in neuronal homeostasis and memory formation in Drosophila. Most recently, the mammalian Pumilio homolog Pumilio-2 (Pum2) has been found to play a role in the mammalian nervous system, in particular in regulating morphology, arborization and excitability of neuronal dendrites, in vitro. However, the role of Pum2 in vivo remains unclear. Here, we report our investigation of the functional and molecular consequences of Pum2 disruption in vivo using an array of neurophysiology, behavioral and gene expression profiling techniques. We used Pum2-deficient mice to monitor in vivo brain activity using EEG and to study behavior traits, including memory, locomotor activity and nesting capacities. Because of the suspected role of Pum2 in neuronal excitability, we also examined the susceptibility to seizure induction. Finally, we used a quantitative gene expression profiling assay to identify key molecular partners of Pum2. We found that Pum2-deficient mice have abnormal behavioral strategies in spatial and object memory test. Additionally, Pum2 deficiency is associated with increased locomotor activity and decreased body weight. We also observed environmentally-induced impairment in nesting behavior. Most importantly, Pum2-deficient mice showed spontaneous EEG abnormalities and had lower seizure thresholds using a convulsing dosage of pentylenetetrazole. Finally, some genes, including neuronal ion channels, were differentially expressed in the hippocampus of Pum2-deficient mice. These findings demonstrate that Pum2 serves key functions in the adult mammalian central nervous system encompassing neuronal excitability and behavioral response to environmental challenges.	[Siemen, Henrike; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Siemen, Henrike; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-5300 Bonn, Germany; [Colas, Damien; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; University of Bonn; Stanford University	Siemen, H (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	reneer@stanford.edu		Heller, H Craig/0000-0003-4479-5880; Reijo Pera, Renee/0000-0002-6487-1329; Colas, Damien/0000-0002-7008-3257	"Stiftung der deutschen Wirtschaft'', Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047721] Funding Source: NIH RePORTER	"Stiftung der deutschen Wirtschaft'', Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an anonymous donor to the Stanford Institute for Stem Cell Biology and Regenerative Medicine. HS was supported by a fellowship from the "Stiftung der deutschen Wirtschaft'', Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Colas D, 2008, NEUROBIOL DIS, V30, P1, DOI 10.1016/j.nbd.2007.07.014; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Koh HY, 2008, GENES BRAIN BEHAV, V7, P120, DOI 10.1111/j.1601-183X.2007.00351.x; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Marshall KM, 2011, CURR TOP BEHAV NEURO, V8, P1, DOI 10.1007/7854_2011_136; McGinnis MY, 2007, PHYSIOL BEHAV, V92, P1010, DOI 10.1016/j.physbeh.2007.07.010; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Schweers BA, 2002, GENETICS, V161, P1177; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; VELISEK L, 1992, N-S ARCH PHARMACOL, V346, P588, DOI 10.1007/BF00169017; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Weston Andrew J., 2007, Invertebrate Neuroscience, V7, P75, DOI 10.1007/s10158-006-0037-8; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	42	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25932	10.1371/journal.pone.0025932	http://dx.doi.org/10.1371/journal.pone.0025932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016787	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300040
J	Kraemer, S; Vaught, JD; Bock, C; Gold, L; Katilius, E; Keeney, TR; Kim, N; Saccomano, NA; Wilcox, SK; Zichi, D; Sanders, GM				Kraemer, Stephan; Vaught, Jonathan D.; Bock, Christopher; Gold, Larry; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Saccomano, Nicholas A.; Wilcox, Sheri K.; Zichi, Dom; Sanders, Glenn M.			From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay	PLOS ONE			English	Article							DNA	Recently, we reported a SOMAmer-based, highly multiplexed assay for the purpose of biomarker identification. To enable seamless transition from highly multiplexed biomarker discovery assays to a format suitable and convenient for diagnostic and life-science applications, we developed a streamlined, plate-based version of the assay. The plate-based version of the assay is robust, sensitive (sub-picomolar), rapid, can be highly multiplexed (upwards of 60 analytes), and fully automated. We demonstrate that quantification by microarray-based hybridization, Luminex bead-based methods, and qPCR are each compatible with our platform, further expanding the breadth of proteomic applications for a wide user community.	[Kraemer, Stephan; Vaught, Jonathan D.; Bock, Christopher; Gold, Larry; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Saccomano, Nicholas A.; Wilcox, Sheri K.; Zichi, Dom; Sanders, Glenn M.] SomaLogic Inc, Boulder, CO USA; [Gold, Larry] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kraemer, S (corresponding author), SomaLogic Inc, Boulder, CO USA.	nsaccomano@somalogic.com; gsanders@somalogic.com			SomaLogic, Inc.	SomaLogic, Inc.	This work was funded by SomaLogic, Inc. Study design, data collection and analysis, decision to publish, and preparation of this manuscript were carried out by SomaLogic employees.	Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Keeney TR, 2009, JALA-J LAB AUTOM, V14, P360, DOI 10.1016/j.jala.2009.05.003; O'Farrell PH, 2008, PROTEOMICS, V8, P4842, DOI 10.1002/pmic.200800719; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	11	164	177	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26332	10.1371/journal.pone.0026332	http://dx.doi.org/10.1371/journal.pone.0026332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022604	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400048
J	Rea, M; Kullmann, S; Veit, R; Casile, A; Braun, C; Belardinelli, MO; Birbaumer, N; Caria, A				Rea, Massimiliano; Kullmann, Stephanie; Veit, Ralf; Casile, Antonino; Braun, Christoph; Belardinelli, Marta Olivetti; Birbaumer, Niels; Caria, Andrea			Effects of Aversive Stimuli on Prospective Memory. An Event-Related fMRI Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN-REGIONS; ATTENTION; EXPRESSION; THREAT; FACE; INVOLVEMENT; PERFORMANCE; MECHANISMS	Prospective memory (PM) describes the ability to execute a previously planned action at the appropriate point in time. Although behavioral studies clearly showed that prospective memory performance is affected by the emotional significance attributed to the intended action, no study so far investigated the brain mechanisms subserving the modulatory effect of emotional salience on PM performance. The general aim of the present study was to explore brain regions involved in prospective memory processes when PM cues are associated with emotional stimuli. In particular, based on the hypothesised critical role of the prefrontal cortex in prospective memory in the presence of emotionally salient stimuli, we expected a stronger involvement of aPFC when the retrieval and execution of the intended action is cued by an aversive stimulus. To this aim BOLD responses of PM trials cued by aversive facial expressions were compared to PM trials cued by neutral facial expressions. Whole brain analysis showed that PM task cued by aversive stimuli is differentially associated with activity in the right lateral prefrontal area (BA 10) and in the left caudate nucleus. Moreover a temporal shift between the response of the caudate nucleus that preceded that of aPFC was observed. These findings suggest that the caudate nucleus might provide an early analysis of the affective properties of the stimuli, whereas the anterior lateral prefrontal cortex (BA10) would be involved in a slower and more deliberative analysis to guide goal-directed behaviour.	[Rea, Massimiliano; Kullmann, Stephanie; Veit, Ralf; Braun, Christoph; Birbaumer, Niels; Caria, Andrea] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Casile, Antonino] Italian Inst Technol, Dept Neurobiol, Boston, MA USA; [Casile, Antonino] Harvard Univ, Sch Med, Boston, MA USA; [Casile, Antonino] Univ Trento, Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Trento, Italy; [Braun, Christoph] Univ Trento, Ctr Mind Brain Sci CiMEC, Trento, Italy; [Belardinelli, Marta Olivetti] Univ Roma La Sapienza, Dept Psychol 1, Rome, Italy; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard Medical School; Istituto Italiano di Tecnologia - IIT; University of Trento; University of Trento; Sapienza University Rome	Rea, M (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	massimiliano.rea@med.uni-tuebingen.de	Braun, Christoph/J-4160-2014; Olivetti, Marta/T-4540-2017; Veit, Ralf/F-8907-2012; Braun, Christoph/E-4561-2010; Kullmann, Stephanie/Q-3976-2018	Braun, Christoph/0000-0002-7836-4010; Olivetti, Marta/0000-0003-3169-3359; Veit, Ralf/0000-0001-9860-642X; Braun, Christoph/0000-0002-7836-4010; Kullmann, Stephanie/0000-0001-9951-923X; Birbaumer, Niels/0000-0002-6786-5127; Caria, Andrea/0000-0003-2017-7084	Deutsche Forschungsgemeinschaft (DFG) [SFB 437]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG SFB 437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; ALTGASSEN M, 2011, J CLIN EXPT NEUROPSY, P1; Altgassen M, 2010, Q J EXP PSYCHOL, V63, P1057, DOI 10.1080/17470211003770920; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bruce V., 1998, EYE BEHOLDER SCI FAC; Burgess P.W., 2005, MEASURING MIND SPEED, P215; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Buxton R., 2002, INTRO FUNCTIONAL MAG; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Clark-Foos A, 2009, AM J PSYCHOL, V122, P89; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cohen AL, 2008, MEM COGNITION, V36, P149, DOI 10.3758/MC.36.1.149; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ellis J, 1999, BRIT J PSYCHOL, V90, P9, DOI 10.1348/000712699161233; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harris LM, 1999, MEMORY, V7, P117, DOI 10.1080/741943717; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Kensinger EA, 2004, COGN AFFECT BEHAV NE, V4, P1, DOI 10.3758/CABN.4.1.1; Kliegel M, 2005, COGNITION EMOTION, V19, P1199, DOI 10.1080/02699930500233820; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; MARTIN LL, 2001, THEORIES MOOD COGNIT, V8; MEACHAM JA, 1980, J GEN PSYCHOL, V103, P203, DOI 10.1080/00221309.1980.9920999; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Muhlberger A, 2011, SOC COGN AFFECT NEUR, V6, P321, DOI 10.1093/scan/nsq039; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A., 2000, HDB PSYCHOPHYSIOLOGY, P533; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; RENDELL PG, 2010, PROSPECTIVE MEMORY E, P1; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rude SS, 1999, COGNITION EMOTION, V13, P267, DOI 10.1080/026999399379276; Schmidt SR, 2004, MEM COGNITION, V32, P443, DOI 10.3758/BF03195837; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk J, 2001, COGNITION EMOTION, V15, P279, DOI 10.1080/0269993004200222; Vrticka P, 2009, SOC NEUROSCI-UK, V4, P384, DOI 10.1080/17470910902941793; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; West R, 2005, PSYCHON B REV, V12, P502, DOI 10.3758/BF03193795; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	70	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26290	10.1371/journal.pone.0026290	http://dx.doi.org/10.1371/journal.pone.0026290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022589	gold, Green Published, Green Submitted			2022-12-25	WOS:000295984400043
J	Jornot, L; Cordey, S; Caruso, A; Gerber, C; Vukicevic, M; Tapparel, C; Kaiser, L; Burger, D; Roosnek, E; Lacroix, JS; Rochat, T				Jornot, Lan; Cordey, Samuel; Caruso, Assunta; Gerber, Christine; Vukicevic, Marija; Tapparel, Caroline; Kaiser, Laurent; Burger, Danielle; Roosnek, Eddy; Lacroix, Jean Silvain; Rochat, Thierry			T Lymphocytes Promote the Antiviral and Inflammatory Responses of Airway Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; NITRIC-OXIDE; RHINOVIRUS INFECTION; IN-VITRO; IFN-GAMMA; TNF-ALPHA; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; EXPRESSION	Hypothesis: T cells modulate the antiviral and inflammatory responses of airway epithelial cells to human rhinoviruses (HRV). Methods: Differentiated primary human nasal epithelial cells (HNEC) grown on collagen-coated filters were exposed apically to HRV14 for 6 h, washed thoroughly and co-cultured with anti-CD3/CD28 activated T cells added in the basolateral compartment for 40 h. Results: HRV14 did not induce IFN gamma, NOS2, CXCL8 and IL-6 in HNEC, but enhanced expression of the T cell attractant CXCL10. On the other hand, HNEC co-cultured with activated T cells produced CXCL10 at a level several orders of magnitude higher than that induced by HRV14. Albeit to a much lower degree, activated T cells also induced CXCL8, IL-6 and NOS2. Anti-IFN gamma antibodies and TNF soluble receptor completely blocked CXCL10 upregulation. Furthermore, a significant correlation was observed between epithelial CXCL10 mRNA expression and the amounts of IFN gamma and TNF secreted by T cells. Likewise, increasing numbers of T cells to a constant number of HNEC in co-cultures resulted in increasing epithelial CXCL10 production, attaining a plateau at high IFN gamma and TNF levels. Hence, HNEC activation by T cells is induced mainly by IFN gamma and/or TNF. Activated T cells also markedly inhibited viral replication in HNEC, partially through activation of the nitric oxide pathway. Conclusion: Cross-talk between T cells and HNEC results in activation of the latter and increases their contribution to airway inflammation and virus clearance.	[Jornot, Lan; Caruso, Assunta; Gerber, Christine; Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Cordey, Samuel; Tapparel, Caroline; Kaiser, Laurent] Univ Hosp Geneva, Div Infect Dis, Virol Lab, Geneva, Switzerland; [Vukicevic, Marija; Roosnek, Eddy] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Burger, Danielle] Univ Hosp Geneva, Div Immunol & Allergy, Geneva, Switzerland; [Lacroix, Jean Silvain] Univ Hosp Geneva, Rhinol Olfactol Unit, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Jornot, L (corresponding author), Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland.	Lan.H.Jornot@hcuge.ch	Cordey, Samuel/C-9240-2018	Cordey, Samuel/0000-0002-2684-5680; Tapparel Vu, Caroline/0000-0002-0411-6567; Kaiser, Laurent/0000-0002-0857-2252	Geneva University Hospitals; Swiss Society for Cystic Fibrosis	Geneva University Hospitals; Swiss Society for Cystic Fibrosis	This work was supported by a research grant from the Geneva University Hospitals and, in part, by a grant from the Swiss Society for Cystic Fibrosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Dreschers S, 2007, CELL MOL LIFE SCI, V64, P181, DOI 10.1007/s00018-006-6266-5; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; JOHNSTON SL, 1995, AM J RESP CRIT CARE, V152, pS46, DOI 10.1164/ajrccm/152.4_Pt_2.S46; Jornot L, 2008, EUR RESPIR J, V32, P769, DOI 10.1183/09031936.00051608; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Pizzichini MMM, 1998, AM J RESP CRIT CARE, V158, P1178, DOI 10.1164/ajrccm.158.4.9712082; Proud D, 2005, CURR OPIN ALLERGY CL, V5, P37, DOI 10.1097/00130832-200502000-00008; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Qi XF, 2009, J CELL PHYSIOL, V220, P690, DOI 10.1002/jcp.21815; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Sanders SP, 2004, J ALLERGY CLIN IMMUN, V113, P697, DOI 10.1016/j.jaci.2004.01.755; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Taima K, 2006, RESPIRATION, V73, P360, DOI 10.1159/000091646; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Xu WL, 2006, FREE RADICAL BIO MED, V41, P19, DOI 10.1016/j.freeradbiomed.2006.01.037; Yasuda H, 2006, EUR RESPIR J, V28, P51, DOI 10.1183/09031936.06.00058505	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26293	10.1371/journal.pone.0026293	http://dx.doi.org/10.1371/journal.pone.0026293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022590	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600048
J	McKeone, R; Vieira, H; Gregory-Evans, K; Gregory-Evans, CY; Denny, P				McKeone, Richard; Vieira, Helena; Gregory-Evans, Kevin; Gregory-Evans, Cheryl Y.; Denny, Paul			Foxf2: A Novel Locus for Anterior Segment Dysgenesis Adjacent to the Foxc1 Gene	PLOS ONE			English	Article							FORKHEAD/WINGED-HELIX GENE; TRANSCRIPTION FACTOR FOXF2; AXENFELD-RIEGER SYNDROME; CONGENITAL GLAUCOMA; IRIS HYPOPLASIA; MUTATIONS; EXPRESSION; SPECTRUM; CHAMBER; MOUSE	Anterior segment dysgenesis (ASD) is characterised by an abnormal migration of neural crest cells or an aberrant differentiation of the mesenchymal cells during the formation of the eye's anterior segment. These abnormalities result in multiple tissue defects affecting the iris, cornea and drainage structures of the iridocorneal angle including the ciliary body, trabecular meshwork and Schlemm's canal. In some cases, abnormal ASD development leads to glaucoma, which is usually associated with increased intraocular pressure. Haploinsufficiency through mutation or chromosomal deletion of the human FOXC1 transcription factor gene or duplications of the 6p25 region is associated with a spectrum of ocular abnormalities including ASD. However, mapping data and phenotype analysis of human deletions suggests that an additional locus for this condition may be present in the same chromosomal region as FOXC1. DHPLC screening of ENU mutagenised mouse archival tissue revealed five novel mouse Foxf2 mutations. Re-derivation of one of these (the Foxf2(W174R) mouse lineage) resulted in heterozygote mice that exhibited thinning of the iris stroma, hyperplasia of the trabecular meshwork, small or absent Schlemm's canal and a reduction in the iridocorneal angle. Homozygous E18.5 mice showed absence of ciliary body projections, demonstrating a critical role for Foxf2 in the developing eye. These data provide evidence that the Foxf2 gene, separated from Foxc1 by less than 70 kb of genomic sequence (250 kb in human DNA), may explain human abnormalities in some cases of ASD where FOXC1 has been excluded genetically.	[McKeone, Richard; Denny, Paul] MRC Mammalian Genet Unit, Oxford, England; [Vieira, Helena] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Cell & Mol Biol, London, England; [Gregory-Evans, Kevin; Gregory-Evans, Cheryl Y.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	Imperial College London; University of British Columbia	McKeone, R (corresponding author), Univ Western Australia, Lions Eye Inst, Dept Mol Ophthalmol, Perth, WA 6009, Australia.	paul.denny3@gmail.com	Gregory-Evans, Kevin/G-9551-2011; Vieira, Helena/M-1623-2017; Vieira, Helena/GWC-5973-2022; Gregory-Evans, Cheryl Y/G-9550-2011	Vieira, Helena/0000-0002-3663-289X; Denny, Paul/0000-0003-4659-6893; Gregory-Evans, Kevin/0000-0003-3572-3105; Gregory-Evans, Kevin/0000-0002-0104-7893	Medical Research Council; The Funding for Science and Technology; Birth Defects Foundation; Medical Research Council [MC_U142684174] Funding Source: researchfish; MRC [MC_U142684174] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Funding for Science and Technology; Birth Defects Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was provided by the Medical Research Council (RM & PD), The Funding for Science and Technology (HV) and Birth Defects Foundation (CYGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Beauchamp G R, 1984, J Pediatr Ophthalmol Strabismus, V21, P209; Chanda B, 2008, HUM MOL GENET, V17, P3446, DOI 10.1093/hmg/ddn238; Coca-Prados M, 1999, PROG RETIN EYE RES, V18, P403, DOI 10.1016/S1350-9462(98)00026-3; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Davies AF, 1999, J MED GENET, V36, P708; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DeScipio C, 2005, AM J MED GENET A, V134A, P3, DOI 10.1002/ajmg.a.30573; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Evans MJ, 1997, TRENDS GENET, V13, P370, DOI 10.1016/S0168-9525(97)01240-7; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Gouge A, 2001, MECH DEVELOP, V107, P203, DOI 10.1016/S0925-4773(01)00465-8; Gould Douglas B, 2004, BMC Med Genet, V5, P17, DOI 10.1186/1471-2350-5-17; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Hellqvist M, 1998, J BIOL CHEM, V273, P23335, DOI 10.1074/jbc.273.36.23335; Iseri SU, 2009, HUM MUTAT, V30, P1378, DOI 10.1002/humu.21079; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; JERNDAL T, 1983, AM J HUM GENET, V35, P645; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Koolen DA, 2005, EUR J HUM GENET, V13, P1169, DOI 10.1038/sj.ejhg.5201487; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Miura N, 1998, GENOMICS, V50, P346, DOI 10.1006/geno.1998.5288; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIELDS MB, 1985, SURV OPHTHALMOL, V29, P387, DOI 10.1016/0039-6257(85)90205-X; Skarie JM, 2009, INVEST OPHTH VIS SCI, V50, P5026, DOI 10.1167/iovs.09-3447; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0; ZURCHER VL, 1990, AM J MED GENET, V35, P261, DOI 10.1002/ajmg.1320350223	49	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25489	10.1371/journal.pone.0025489	http://dx.doi.org/10.1371/journal.pone.0025489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022403	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600018
J	Ausec, L; Zakrzewski, M; Goesmann, A; Schluter, A; Mandic-Mulec, I				Ausec, Luka; Zakrzewski, Martha; Goesmann, Alexander; Schlueter, Andreas; Mandic-Mulec, Ines			Bioinformatic Analysis Reveals High Diversity of Bacterial Genes for Laccase-Like Enzymes	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR; MICROBIAL COMMUNITY; POLYPHENOL OXIDASE; ALKALINE LACCASE; PURIFICATION; CLONING; FOREST; ALIGNMENT; SEQUENCE	Fungal laccases have been used in various fields ranging from processes in wood and paper industries to environmental applications. Although a few bacterial laccases have been characterized in recent years, prokaryotes have largely been neglected as a source of novel enzymes, in part due to the lack of knowledge about the diversity and distribution of laccases within Bacteria. In this work genes for laccase-like enzymes were searched for in over 2,200 complete and draft bacterial genomes and four metagenomic datasets, using the custom profile Hidden Markov Models for two-and three-domain laccases. More than 1,200 putative genes for laccase-like enzymes were retrieved from chromosomes and plasmids of diverse bacteria. In 76% of the genes, signal peptides were predicted, indicating that these bacterial laccases may be exported from the cytoplasm, which contrasts with the current belief. Moreover, several examples of putatively horizontally transferred bacterial laccase genes were described. Many metagenomic sequences encoding fragments of laccase-like enzymes could not be phylogenetically assigned, indicating considerable novelty. Laccase-like genes were also found in anaerobic bacteria, autotrophs and alkaliphiles, thus opening new hypotheses regarding their ecological functions. Bacteria identified as carrying laccase genes represent potential sources for future biotechnological applications.	[Ausec, Luka; Mandic-Mulec, Ines] Univ Ljubljana, Dept Food Sci, Ljubljana, Slovenia; [Ausec, Luka; Mandic-Mulec, Ines] Univ Ljubljana, Technol Biotech Fac, Ljubljana, Slovenia; [Zakrzewski, Martha; Goesmann, Alexander] Univ Bielefeld, Inst Bioinformat, Ctr Biotechnol CeBiTec, Bielefeld, Germany; [Zakrzewski, Martha; Schlueter, Andreas] Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol CeBiTec, Bielefeld, Germany	University of Ljubljana; University of Ljubljana; University of Bielefeld; University of Bielefeld	Ausec, L (corresponding author), Univ Ljubljana, Dept Food Sci, Ljubljana, Slovenia.	ines.mandic@bf.uni-lj.si		Schluter, Andreas/0000-0003-4830-310X; Goesmann, Alexander/0000-0002-7086-2568	European Commission [KBBE-222625]; CLIB Graduate Cluster Industrial Biotechnology	European Commission(European CommissionEuropean Commission Joint Research Centre); CLIB Graduate Cluster Industrial Biotechnology	This work was supported by the METAEXPLORE grant from the European Commission (KBBE-222625). MZ received a scholarship from the CLIB Graduate Cluster Industrial Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Alexandre G, 2000, TRENDS BIOTECHNOL, V18, P41, DOI 10.1016/S0167-7799(99)01406-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Auriol M, 2007, WATER RES, V41, P3281, DOI 10.1016/j.watres.2007.05.008; Ausec L, 2011, SOIL BIOL BIOCHEM, V43, P975, DOI 10.1016/j.soilbio.2011.01.013; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; GIVAUDAN A, 1993, FEMS MICROBIOL LETT, V108, P205, DOI 10.1111/j.1574-6968.1993.tb06100.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Komori H, 2009, FEBS LETT, V583, P1189, DOI 10.1016/j.febslet.2009.03.008; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Pereira L, 2009, J BIOTECHNOL, V139, P68, DOI 10.1016/j.jbiotec.2008.09.001; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Rodriguez-Rodriguez CE, 2011, BIORESOURCE TECHNOL, V102, P5602, DOI 10.1016/j.biortech.2011.02.029; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sanchez-Amat A, 2001, BBA-PROTEIN STRUCT M, V1547, P104, DOI 10.1016/S0167-4838(01)00174-1; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Singh G, 2009, BRAZ J MICROBIOL, V40, P26, DOI 10.1590/S1517-83822009000100004; Sirim Demet, 2011, Database (Oxford), V2011, pbar006, DOI 10.1093/database/bar006; Suzuki T, 2003, BIOSCI BIOTECH BIOCH, V67, P2167, DOI 10.1271/bbb.67.2167; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5	54	87	94	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25724	10.1371/journal.pone.0025724	http://dx.doi.org/10.1371/journal.pone.0025724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022440	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000034
J	Fielding, K; Koba, A; Grant, AD; Charalambous, S; Day, J; Spak, C; Wald, A; Huang, ML; Corey, L; Churchyard, GJ				Fielding, Katherine; Koba, Ai; Grant, Alison D.; Charalambous, Salome; Day, John; Spak, Cedric; Wald, Anna; Huang, Meei-Li; Corey, Lawrence; Churchyard, Gavin J.			Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS DISEASE; END-ORGAN-DISEASE; HIV-1-INFECTED WOMEN; AIDS PATIENTS; PROGRESSION; CMV; PLASMA; SURVIVAL; LOAD; DNA	Background: Cytomegalovirus (CMV) viremia has been shown to be an independent risk factor for increased mortality among HIV-infected individuals in the developing world. While CMV infection is nearly ubiquitous in resource-poor settings, few data are available on the role of subclinical CMV reactivation on HIV. Methods: Using a cohort of mineworkers with stored plasma samples, we investigated the association between CMV DNA concentration and mortality prior to antiretroviral therapy availability. Results: Among 1341 individuals (median CD4 count 345 cells/mu l, 70% WHO stage 1 or 2, median follow-up 0.9 years), 70 (5.2%) had CMV viremia at baseline; 71 deaths occurred. In univariable analysis CMV viremia at baseline was associated with a three-fold increase in mortality (hazard ratio [HR] 3.37; 95% confidence intervals [CI] 1.60, 7.10). After adjustment for CD4 count, WHO stage and HIV viral load (N = 429 with complete data), the association was attenuated (HR 2.27; 95% CI 0.88, 5.83). Mortality increased with higher CMV viremia (>= 1,000 copies/ml vs. no viremia, adjusted HR 3.65, 95% CI: 1.29, 10.41). Results were similar using time-updated CMV viremia. Conclusions: High copy number, subclinical CMV viremia was an independent risk factor for mortality among male HIV-infected adults in South Africa with relatively early HIV disease. Studies to determine whether anti-CMV therapy to mitigate high copy number viremia would increase lifespan are warranted.	[Fielding, Katherine; Churchyard, Gavin J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Koba, Ai; Grant, Alison D.; Day, John] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Charalambous, Salome; Day, John; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Spak, Cedric; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Wald, Anna; Huang, Meei-Li; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Fielding, K (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	Katherine.fielding@lshtm.ac.uk	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	Anglogold; National Institutes of Health (NIH) [AI-30731]; Fred Hutchinson ALC [CA018029]; UK Department of Health; AngloGold Health Services; Medical Research Council [G0700837] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER; MRC [G0700837] Funding Source: UKRI	Anglogold; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson ALC; UK Department of Health; AngloGold Health Services; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by financial support from Anglogold. Additional laboratory work was funded by National Institutes of Health (NIH) Grant AI-30731 and the Fred Hutchinson ALC award grant number CA018029. Alison Grant was supported by a Public Health Career Scientist Award from the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. 1. The parent study referred to in the manuscript was funded by Anglogold. 2. Aurum Health Research, which at the time was a wholly owned subsidiary company of AngloGold Health Services, provided salary support to KF, SC, JD and GJC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009; Burak KW, 2002, LIVER TRANSPLANT, V8, P362, DOI 10.1053/jlts.2002.32282; Charalambous S, 2004, AIDS CARE, V16, P47, DOI 10.1080/09540120310001633967; Day JH, 2004, J INFECT DIS, V190, P1677, DOI 10.1086/424851; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; DREW WL, 1992, CLIN INFECT DIS, V14, P608, DOI 10.1093/clinids/14.2.608-a; Erice A, 2003, CLIN INFECT DIS, V37, P567, DOI 10.1086/375843; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; George B, 2010, TRANSPL INFECT DIS, V12, P322, DOI 10.1111/j.1399-3062.2010.00504.x; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Kempen JH, 2003, CLIN INFECT DIS, V37, P1365, DOI 10.1086/379077; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Micol R, 2009, JAIDS-J ACQ IMM DEF, V51, P486, DOI 10.1097/QAI.0b013e3181a254c2; Robain M, 2001, AIDS, V15, P251, DOI 10.1097/00002030-200101260-00016; SABIN CA, 1995, EPIDEMIOL INFECT, V114, P361, DOI 10.1017/S095026880005799X; Slyker JA, 2009, AIDS, V23, P117, DOI 10.1097/QAD.0b013e32831c8abd; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; WEBSTER A, 1989, LANCET, V2, P681; Wohl DA, 2005, JAIDS-J ACQ IMM DEF, V38, P538, DOI 10.1097/01.qai.0000155204.96973.c3; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	23	31	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25571	10.1371/journal.pone.0025571	http://dx.doi.org/10.1371/journal.pone.0025571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022413	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000295976000021
J	Saleh, AD; Savage, JE; Cao, L; Soule, BP; Ly, D; DeGraff, W; Harris, CC; Mitchell, JB; Simone, NL				Saleh, Anthony D.; Savage, Jason E.; Cao, Liu; Soule, Benjamin P.; Ly, David; DeGraff, William; Harris, Curtis C.; Mitchell, James B.; Simone, Nicole L.			Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MESSENGER-RNA; CANCER; CELLS; GROWTH; PROLIFERATION; MODULATION; RESISTANCE; PROFILES; THERAPY	Genotoxic stressors, such as radiation, induce cellular damage that activates pre-programmed repair pathways, some of which involve microRNAs (miRNA) that alter gene expression. The let-7 family of miRNA regulates multiple cellular processes including cell division and DNA repair pathways. However, the role and mechanism underlying regulation of let-7 genes in response to stress have yet to be elucidated. In this study we demonstrate that let-7a and let-7b expression decreases significantly following exposure to agents that induce stress including ionizing radiation. This decrease in expression is dependent on p53 and ATM in vitro and is not observed in a p53(-/-) colon cancer cell line (HCT116) or ATM(-/-) human fibroblasts. Chromatin Immunoprecipitation (ChIP) analysis showed p53 binding to a region upstream of the let-7 gene following radiation exposure. Luciferase transient transfections demonstrated that this p53 binding site is necessary for radiation-induced decreases in let-7 expression. A radiation-induced decrease in let-7a and let-7b expression is also observed in radiation-sensitive tissues in vivo and correlates with altered expression of proteins in p53-regulated proapoptotic signaling pathways. In contrast, this decreased expression is not observed in p53 knock-out mice suggesting that p53 directly repress let-7 expression. Exogenous expression of let-7a and let-7b increased radiation-induced cytotoxicity in HCT116 p53(+/+) cells but not HCT116 p53(-/-) cells. These results are the first demonstration of a mechanistic connection between the radiation-induced stress response and the regulation of miRNA and radiation-induced cytotoxicity and suggest that this process may be a molecular target for anticancer agents.	[Saleh, Anthony D.; Savage, Jason E.; Ly, David; Simone, Nicole L.] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Soule, Benjamin P.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [DeGraff, William; Mitchell, James B.] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Saleh, AD (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	simonen@mail.nih.gov		Simone, Nicole/0000-0002-7662-7470	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC006321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P109; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Cuddihy AR, 2004, CANCER METAST REV, V23, P237, DOI 10.1023/B:CANC.0000031764.81141.e4; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saleh AD, 2011, NUCLEOS NUCLEOT NUCL, V30, P235, DOI 10.1080/15257770.2011.569810; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001	25	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24429	10.1371/journal.pone.0024429	http://dx.doi.org/10.1371/journal.pone.0024429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022355	Green Published, gold			2022-12-25	WOS:000295973200002
J	Aveic, S; Pigazzi, M; Basso, G				Aveic, Sanja; Pigazzi, Martina; Basso, Giuseppe			BAG1: The Guardian of Anti-Apoptotic Proteins in Acute Myeloid Leukemia	PLOS ONE			English	Article							BCL-2-BINDING PROTEIN; BCL-2 PROTEIN; EXPRESSION; CELLS; ISOFORMS; SURVIVAL; FAMILY; MCL-1; DEGRADATION; UBIQUITIN	BCL2 associated Athano-Gene 1 (BAG1) is a multifunctional protein that has been described to be involved in different cell processes linked to cell survival. It has been reported as deregulated in diverse cancer types. Here, BAG1 protein was found highly expressed in children with acute myeloid leukemia at diagnosis, and in a cohort of leukemic cell lines. A silencing approach was used for determining BAG1's role in AML, finding that its down-regulation decreased expression of BCL2, BCL-XL, MCL1, and phospho-ERK1/2, all proteins able to sustain leukemia, without affecting the pro-apoptotic protein BAX. BAG1 down-regulation was also found to increase expression of BAG3, whose similar activity was able to compensate the loss of function of BAG1. BAG1/BAG3 co-silencing caused an enhanced cell predisposition to death in cell lines and also in primary AML cultures, affecting the same proteins. Cell death was CASPASE-3 dependent, was accompanied by PARP cleavage and documented by an increased release of pro-apoptotic molecules Smac/DIABLO and Cytochrome c. BAG1 was found to directly maintain BCL2 and to protect MCL1 from proteasomal degradation by controlling USP9X expression, which appeared to be its novel target. Finally, BAG1 was found able to affect leukemia cell fate by influencing the expression of anti-apoptotic proteins crucial for AML maintenance.	[Aveic, Sanja; Pigazzi, Martina; Basso, Giuseppe] Univ Padua, Dept Pediat, Hematol Oncol Lab, Padua, Italy	University of Padua	Aveic, S (corresponding author), Univ Padua, Dept Pediat, Hematol Oncol Lab, Padua, Italy.	martina.pigazzi@unipd.it	Aveic, Sanja/J-9456-2014; Pigazzi, Martina/K-7997-2016	Aveic, Sanja/0000-0002-3886-4360; PIGAZZI, MARTINA/0000-0002-4793-5263; BASSO, GIUSEPPE/0000-0002-2634-9302	Universita di Padova; AIRC; PRIN/Programmi di ricerca di Rilevante Interesse Nazionale; Ministero della Salute	Universita di Padova; AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN/Programmi di ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy)	This study was supported by grants from the Fondazione CARIPARO, Fondazione Citta della Speranza, from Universita di Padova (SA, MP); from AIRC (Associazione Italiana Ricerca sul Cancro, to GB), from PRIN/Programmi di ricerca di Rilevante Interesse Nazionale (to GB), and from Ministero della Salute (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LR, 2010, ONCOGENE, V29, P527, DOI 10.1038/onc.2009.362; BENSI L, 1995, HAEMATOLOGICA, V80, P98; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; BRADBURY DA, 1995, BRIT J HAEMATOL, V91, P374, DOI 10.1111/j.1365-2141.1995.tb05306.x; Brimmell M, 1999, BRIT J CANCER, V81, P1042, DOI 10.1038/sj.bjc.6690805; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; CAMPOS L, 1993, BLOOD, V81, P3091; Chen J, 2002, ONCOGENE, V21, P7050, DOI 10.1038/sj.onc.1205845; Cutress RI, 2002, BRIT J CANCER, V87, P834, DOI 10.1038/sj.bjc.6600538; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Frascella E, 2004, LEUKEMIA, V18, P1427, DOI 10.1038/sj.leu.2403410; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Konopleva M, 2000, BLOOD, V95, P3929; Konopleva M, 2002, BRIT J HAEMATOL, V118, P521, DOI 10.1046/j.1365-2141.2002.03637.x; Kudoh M, 2002, CANCER RES, V62, P1904; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; MAUNG ZT, 1994, BRIT J HAEMATOL, V88, P105, DOI 10.1111/j.1365-2141.1994.tb04984.x; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pession A, 2005, LEUKEMIA, V19, P2043, DOI 10.1038/sj.leu.2403869; Pession A, 2009, BLOOD, V114, P13, DOI 10.1182/blood.V114.22.17.17; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Takayama S, 1998, CANCER RES, V58, P3116; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TAKAYAMA S, 1999, EMBO J, V21, P6135; TESTA U, 2007, HAEMATOLOGICA, V98, P81; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Townsend PA, 2003, BBA-REV CANCER, V1603, P83, DOI 10.1016/S0304-419X(03)00002-7; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	52	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26097	10.1371/journal.pone.0026097	http://dx.doi.org/10.1371/journal.pone.0026097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016818	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700039
J	Bardaji, L; Anorga, M; Jackson, RW; Martinez-Bilbao, A; Yanguas-Casas, N; Murillo, J				Bardaji, Leire; Anorga, Maite; Jackson, Robert W.; Martinez-Bilbao, Alejandro; Yanguas-Casas, Natalia; Murillo, Jesus			Miniature Transposable Sequences Are Frequently Mobilized in the Bacterial Plant Pathogen Pseudomonas syringae pv. phaseolicola	PLOS ONE			English	Article							ARTEMIS COMPARISON TOOL; FLANK AVIRULENCE GENES; INSERTION SEQUENCES; TOMATO DC3000; PATHOVAR PHASEOLICOLA; COMPARATIVE GENOMICS; PROKARYOTIC GENOMES; NUCLEOTIDE-SEQUENCE; VIRULENCE; ELEMENTS	Mobile genetic elements are widespread in Pseudomonas syringae, and often associate with virulence genes. Genome reannotation of the model bean pathogen P. syringae pv. phaseolicola 1448A identified seventeen types of insertion sequences and two miniature inverted-repeat transposable elements (MITEs) with a biased distribution, representing 2.8% of the chromosome, 25.8% of the 132-kb virulence plasmid and 2.7% of the 52-kb plasmid. Employing an entrapment vector containing sacB, we estimated that transposition frequency oscillated between 2.6 x 10(-5) and 1.1 x 10(-6), depending on the clone, although it was stable for each clone after consecutive transfers in culture media. Transposition frequency was similar for bacteria grown in rich or minimal media, and from cells recovered from compatible and incompatible plant hosts, indicating that growth conditions do not influence transposition in strain 1448A. Most of the entrapped insertions contained a full-length IS801 element, with the remaining insertions corresponding to sequences smaller than any transposable element identified in strain 1448A, and collectively identified as miniature sequences. From these, fragments of 229, 360 and 679-nt of the right end of IS801 ended in a consensus tetranucleotide and likely resulted from one-ended transposition of IS801. An average 0.7% of the insertions analyzed consisted of IS801 carrying a fragment of variable size from gene PSPPH_0008/PSPPH_0017, showing that IS801 can mobilize DNA in vivo. Retrospective analysis of complete plasmids and genomes of P. syringae suggests, however, that most fragments of IS801 are likely the result of reorganizations rather than one-ended transpositions, and that this element might preferentially contribute to genome flexibility by generating homologous regions of recombination. A further miniature sequence previously found to affect host range specificity and virulence, designated MITEPsy1 (100-nt), represented an average 2.4% of the total number of insertions entrapped in sacB, demonstrating for the first time the mobilization of a MITE in bacteria.	[Bardaji, Leire; Anorga, Maite; Martinez-Bilbao, Alejandro; Yanguas-Casas, Natalia; Murillo, Jesus] Univ Publ Navarra, Escuela Tecn Super Ingenieros Agronomos, Dept Agr Prod, Lab Patol Vegetal, Pamplona, Spain; [Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading, Berks, England	Universidad Publica de Navarra; University of Reading	Bardaji, L (corresponding author), Univ Publ Navarra, Escuela Tecn Super Ingenieros Agronomos, Dept Agr Prod, Lab Patol Vegetal, Pamplona, Spain.	jesus.murillo@unavarra.es	Casás, Natalia Yanguas/AAB-6704-2019; Murillo, Jesus/D-2901-2009; Jackson, Robert W/C-2973-2009	Casás, Natalia Yanguas/0000-0003-4368-0176; Murillo, Jesus/0000-0001-6585-2421; Jackson, Robert W/0000-0002-2042-4105; Anorga, Maite/0000-0002-5239-7615	Ministerio de Ciencia e Innovacion [AGL2008-55311-CO2-01]; FEDER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission)	This work was funded with the Spanish Plan Nacional I+D+I grant AGL2008-55311-CO2-01 (Ministerio de Ciencia e Innovacion; http://www.micinn.es/)co financed by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Arnold DL, 2001, MICROBIOL-SGM, V147, P1171, DOI 10.1099/00221287-147-5-1171; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025705; Bertels F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002132; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Burt A, 2006, GENES CONFLICT BIOL; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen Y, 2009, GENE, V436, P1, DOI 10.1016/j.gene.2009.01.019; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRAIG NL, 2002, MOBILE DNA, V2; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Drevinek P, 2010, J CLIN MICROBIOL, V48, P34, DOI 10.1128/JCM.01433-09; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fuhrer ME, 2008, PSEUDOMONAS SYRINGAE, P175; Garcillan-Barcia MP, 2002, FEMS MICROBIOL ECOL, V42, P303, DOI 10.1111/j.1574-6941.2002.tb01020.x; Garcillan-Barcia MP, 2002, MOBILE DNA, VII, P891; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Han Y, 2010, NUCLEIC ACIDS RES, V193, P4259; HARPER S, 1987, PHYSIOL MOL PLANT P, V31, P153, DOI 10.1016/0885-5765(87)90061-0; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kamiunten Hiroshi, 2002, Journal of General Plant Pathology, V68, P75, DOI 10.1007/PL00013057; KEANE PJ, 1970, AUST J BIOL SCI, V23, P585, DOI 10.1071/BI9700585; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; KING EO, 1954, J LAB CLIN MED, V44, P301; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; MENDIOLA MV, 1994, P NATL ACAD SCI USA, V91, P1922, DOI 10.1073/pnas.91.5.1922; Miche L, 2001, ENVIRON MICROBIOL, V3, P766, DOI 10.1046/j.1462-2920.2001.00251.x; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Oguiza JA, 2004, MICROBIOL-SGM, V150, P473, DOI 10.1099/mic.0.26635-0; Ohtsubo Y, 2005, APPL ENVIRON MICROB, V71, P1822, DOI 10.1128/AEM.71.4.1822-1828.2005; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P2492, DOI 10.1128/AAC.00033-09; Richter GY, 1998, MOL GEN GENET, V260, P381, DOI 10.1007/s004380050907; Rivas LA, 2005, APPL ENVIRON MICROB, V71, P3778, DOI 10.1128/AEM.71.7.3778-3785.2005; Robertson AE, 2004, MOL PLANT MICROBE IN, V17, P1376, DOI 10.1094/MPMI.2004.17.12.1376; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; ROMANTSCHUK M, 1991, MOL MICROBIOL, V5, P617, DOI 10.1111/j.1365-2958.1991.tb00732.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Sundin George W., 2009, P295; SZABO LJ, 1984, J BACTERIOL, V157, P821, DOI 10.1128/JB.157.3.821-827.1984; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Teverson DM, 1991, THESIS U BIRMINGHAM; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Valle J, 2007, J BACTERIOL, V189, P2886, DOI 10.1128/JB.01767-06; Vivian A, 2001, MICROBIOL-SGM, V147, P763, DOI 10.1099/00221287-147-4-763; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; YAMADA T, 1986, P NATL ACAD SCI USA, V83, P8263, DOI 10.1073/pnas.83.21.8263; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zhou F, 2008, BIOCHEM BIOPH RES CO, V365, P790, DOI 10.1016/j.bbrc.2007.11.038	71	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25773	10.1371/journal.pone.0025773	http://dx.doi.org/10.1371/journal.pone.0025773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016774	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295971700016
J	Li, X; Chu, JL; Wang, AJ; Zhu, YQ; Chu, WK; Yang, L; Li, S				Li, Xian; Chu, Julia; Wang, Aijun; Zhu, Yiqian; Chu, Wai Keung; Yang, Li; Li, Song			Uniaxial Mechanical Strain Modulates the Differentiation of Neural Crest Stem Cells into Smooth Muscle Lineage on Micropatterned Surfaces	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PROGENITOR CELLS; CYCLIC STRAIN; IN-VITRO; EXPRESSION; TISSUE; STIMULATION; DIVERSITY; PHENOTYPE	Neural crest stem cells (NCSCs) play an important role in the development and represent a valuable cell source for tissue engineering. However, how mechanical factors in vivo regulate NCSC differentiation is not understood. Here NCSCs were derived from induced pluripotent stem cells and used as a model to determine whether vascular mechanical strain modulates the differentiation of NCSCs into smooth muscle (SM) lineage. NCSCs were cultured on micropatterned membranes to mimic the organization of smooth muscle cells (SMCs), and subjected to cyclic uniaxial strain. Mechanical strain enhanced NCSC proliferation and ERK2 phosphorylation. In addition, mechanical strain induced contractile marker calponin-1 within 2 days and slightly induced SM myosin within 5 days. On the other hand, mechanical strain suppressed the differentiation of NCSCs into Schwann cells. The induction of calponin-1 by mechanical strain was inhibited by neural induction medium but further enhanced by TGF-beta. For NCSCs pre-treated with TGF-beta, mechanical strain induced the gene expression of both calponin-1 and SM myosin. Our results demonstrated that mechanical strain regulates the differentiation of NCSCs in a manner dependent on biochemical factors and the differentiation stage of NCSCs. Understanding the mechanical regulation of NCSC differentiation will shed light on the development and remodeling of vascular tissues, and how transplanted NCSCs respond to mechanical factors.	[Li, Xian; Yang, Li] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China; [Li, Xian; Chu, Julia; Wang, Aijun; Zhu, Yiqian; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chu, Wai Keung] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Chongqing University; University of California System; University of California Berkeley; University of California System; University of California San Diego	Li, X (corresponding author), Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China.	yanglicqu@gmail.com; song_li@berkeley.edu	Wang, Aijun/C-7559-2013	Wang, Aijun/0000-0002-2985-3627	National Institutes of Health [EB012240, HL083900]; College and University of China [B06023]; California Institute for Regenerative Medicine [TG2-01164]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College and University of China; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by grants from the National Institutes of Health (EB012240 and HL083900 to S.L.), Innovation and Attracting Talents Program for College and University of China ('111' Project) (B06023; to L.Y.), a postdoctoral training grant TG2-01164 from California Institute for Regenerative Medicine (to A.W.), and a Predoctoral Fellowship from the American Heart Association (to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; BIRUKOV KG, 1995, MOL CELL BIOCHEM, V144, P131, DOI 10.1007/BF00944392; Cevallos M, 2006, DIFFERENTIATION, V74, P552, DOI 10.1111/j.1432-0436.2006.00089.x; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 2004, ANAT REC PART A, V276A, P22, DOI 10.1002/ar.a.10128; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Kurpinski K, 2009, CELL MOL BIOENG, V2, P606, DOI 10.1007/s12195-009-0090-6; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; LIU Y, 2003, J BIOL CHEM; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Moustakas A, 2001, J CELL SCI, V114, P4359; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Topper JN, 2000, TRENDS CARDIOVAS MED, V10, P132, DOI 10.1016/S1050-1738(00)00061-X; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011	35	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26029	10.1371/journal.pone.0026029	http://dx.doi.org/10.1371/journal.pone.0026029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016804	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300050
J	Taube, W; Lundbye-Jensen, J; Schubert, M; Gollhofer, A; Leukel, C				Taube, Wolfgang; Lundbye-Jensen, Jesper; Schubert, Martin; Gollhofer, Albert; Leukel, Christian			Evidence That the Cortical Motor Command for the Initiation of Dynamic Plantarflexion Consists of Excitation followed by Inhibition	PLOS ONE			English	Article							MAGNETIC BRAIN-STIMULATION; CORTICOSPINAL PATHWAYS; SURROUND INHIBITION; LOWER-LIMB; MOTONEURONS; MOVEMENT; ADAPTATIONS; HUMANS; REFLEX; STANCE	At the onset of dynamic movements excitation of the motor cortex (M1) is spatially restricted to areas representing the involved muscles whereas adjacent areas are inhibited. The current study elucidates whether the cortical motor command for dynamic contractions is also restricted to a certain population of cortical neurons responsible for the fast corticospinal projections. Therefore, corticospinal transmission was assessed with high temporal resolution during dynamic contractions after both, magnetic stimulation over M1 and the brainstem. The high temporal resolution could be obtained by conditioning the soleus H-reflex with different interstimulus intervals by cervicomedullary stimulation (CMS-conditioning) and transcranial magnetic stimulation (TMS) of M1 (M1-conditioning). This technique provides a precise time course of facilitation and inhibition. CMS- and M1-conditioning produced an 'early facilitation' of the H-reflex, which occurred around 3 ms earlier with CMS-conditioning. The early facilitation is believed to be caused by activation of direct monosynaptic projections to the spinal motoneurons. CMS-conditioning resulted in a subsequent 'late facilitation', which is considered to reflect activity of slow-conducting and/or indirect corticospinal pathways. In contrast, M1-conditioning produced a 'late dis-facilitation' or even 'late inhibition'. As the late dis-facilitation was only seen following M1- but not CMS-conditioning, it is argued that cortical activation during dynamic tasks is restricted to fast, direct corticospinal projections whereas corticomotoneurons responsible for slow and/or indirectly projecting corticospinal pathways are inhibited. The functional significance of restricting the descending cortical drive to fast corticospinal pathways may be to ensure a temporally focused motor command during the execution of dynamic movements.	[Taube, Wolfgang; Leukel, Christian] Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland; [Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Schubert, Martin] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland; [Gollhofer, Albert; Leukel, Christian] Univ Freiburg, Dept Sport Sci, Freiburg, Germany	University of Fribourg; University of Copenhagen; University of Copenhagen; University of Zurich; University of Freiburg	Taube, W (corresponding author), Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland.	wolfgang.taube@unifr.ch	Lundbye-Jensen, Jesper/ABH-4025-2020; Taube, Wolfgang/E-4018-2012; Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Taube, Wolfgang/0000-0002-8802-2065; 				Beck S, 2008, J NEUROSCI, V28, P10363, DOI 10.1523/JNEUROSCI.3564-08.2008; Berg RW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003218; CRONE C, 1990, EXP BRAIN RES, V81, P35; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Morita H, 1998, EXP BRAIN RES, V120, P143, DOI 10.1007/s002210050388; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P777, DOI 10.1113/jphysiol.1995.sp020703; NIELSEN J, 1993, J PHYSIOL-LONDON, V471, P223, DOI 10.1113/jphysiol.1993.sp019899; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P791, DOI 10.1113/jphysiol.1995.sp020704; NIELSEN J, 1995, J PHYSIOL-LONDON, V486, P779, DOI 10.1113/jphysiol.1995.sp020853; Petersen N, 1998, J PHYSIOL-LONDON, V513, P599, DOI 10.1111/j.1469-7793.1998.599bb.x; Schubert M, 2008, EUR J NEUROSCI, V27, P2007, DOI 10.1111/j.1460-9568.2008.06186.x; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; UGAWA Y, 1994, ANN NEUROL, V36, P618, DOI 10.1002/ana.410360410; Wasaka T, 2005, EUR J NEUROSCI, V22, P1239, DOI 10.1111/j.1460-9568.2005.04289.x	18	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25657	10.1371/journal.pone.0025657	http://dx.doi.org/10.1371/journal.pone.0025657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003402	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300023
J	Seifert, EL; Caron, AZ; Morin, K; Coulombe, J; He, XH; Jardine, K; Dewar-Darch, D; Boekelheide, K; Harper, ME; McBurney, MW				Seifert, Erin L.; Caron, Annabelle Z.; Morin, Katy; Coulombe, Josee; He, Xiao Hong; Jardine, Karen; Dewar-Darch, Danielle; Boekelheide, Kim; Harper, Mary-Ellen; McBurney, Michael W.			SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice	FASEB JOURNAL			English	Article						sirtuin; knock-in; metabolism	LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; SIR2-ALPHA PROTEIN; DEACETYLASE SIRT1; CELL-SURVIVAL; GENE; AUTOPHAGY; MECHANISM; NAD; RESVERATROL	The protein encoded by the sirt1 gene is an enzyme, SirT1, that couples the hydrolysis of NAD(+) to the deacetylation of acetyl-lysine residues in substrate proteins. Mutations of the sirt1 gene that fail to encode protein have been introduced into the mouse germ line, and the animals homozygous for these null mutations have various physiological abnormalities. To determine which of the characteristics of these sirt1(-/-) mice are a consequence of the absence of the catalytic activity of the SirT1 protein, we created a mouse strain carrying a point mutation (H355Y) that ablates the catalytic activity but does not affect the amount of the SirT1 protein. Mice carrying point mutations in both sirt1 genes, sirt1(Y/Y), have a phenotype that is overlapping but not identical to that of the sirt1-null animals. The sirt1(Y/Y) phenotype is significantly milder than that seen in the sirt1(-/-) animals. For example, female sirt1(Y/Y) animals are fertile, while sirt1(-/-) females are sterile. On the other hand, both sirt1(-/-) and sirt1(Y/Y) male mice are sterile and hypermetabolic. We report that sirt1(Y/Y) mice respond aberrantly to caloric restriction, although the effects are more subtle than seen in sirt1(-/-) mice. Thus, the SirT1 protein has functions that can be attributed to the catalytic activity of the protein, as well as other functions that are conferred by the protein itself.-Seifert, E. L., Caron, A. Z., Morin, K., Coulombe, J., Hong He, X., Jardine, K., Dewar-Darch, D., Boekelheide, K., Harper, M.-E., McBurney, M. W. SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice. FASEB J. 26, 555-566 (2012). www.fasebj.org	[Seifert, Erin L.; Caron, Annabelle Z.; Morin, Katy; Coulombe, Josee; He, Xiao Hong; Jardine, Karen; Dewar-Darch, Danielle; McBurney, Michael W.] Univ Ottawa, Ottawa Hosp Res Inst, Program Canc Therapeut, Ottawa, ON K1H 8L6, Canada; [Seifert, Erin L.; Caron, Annabelle Z.; Morin, Katy; Coulombe, Josee; He, Xiao Hong; Jardine, Karen; Dewar-Darch, Danielle; McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada; [Morin, Katy; Harper, Mary-Ellen; McBurney, Michael W.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Sch Med, Warren Alpert Med Sch, Providence, RI 02912 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Brown University	McBurney, MW (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Program Canc Therapeut, 501 Smyth Rd,Box 926, Ottawa, ON K1H 8L6, Canada.	mmcburney@ohri.ca		Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research. The authors acknowledge the help of Ryan Tuen and Andrea Robinson, who worked on this project during their coop work terms; Dr. Ruth Slack and members of her laboratory, who helped establish cultures of cortical neurons; and Dr. Robert Screaton, in whose laboratory the enzyme assays were performed.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Armstrong CM, 2002, MOL BIOL CELL, V13, P1427, DOI 10.1091/mbc.01-10-0482; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Huber JL, 2010, FUTURE MED CHEM, V2, P1751, DOI 10.4155/FMC.10.257; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CANCER RES, V1, P402; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Powell MJ, 2011, CANCER RES, V71, P964, DOI 10.1158/0008-5472.CAN-10-3172; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wu CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002000; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073	54	47	51	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					555	566		10.1096/fj.11-193979	http://dx.doi.org/10.1096/fj.11-193979			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22006156				2022-12-25	WOS:000300485700009
J	Shi, Y; Huang, HS; Deng, XY; He, XB; Yang, JW; Yang, HP; Shi, LE; Mei, LJ; Gao, JM; Zhou, NM				Shi, Ying; Huang, Haishan; Deng, Xiaoyan; He, Xiaobai; Yang, Jingwen; Yang, Huipeng; Shi, Liangen; Mei, Lijuan; Gao, Jimin; Zhou, Naiming			Identification and Functional Characterization of Two Orphan G-protein-coupled Receptors for Adipokinetic Hormones from Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COCKROACH PERIPLANETA-AMERICANA; BEETLE TRIBOLIUM-CASTANEUM; CORPORA CARDIACA; CORPUS CARDIACUM; MANDUCA-SEXTA; FAT-BODY; NEUROPEPTIDE; PEPTIDE; FAMILY; LOCUST	Adipokinetic hormones (AKHs) are the best studied insect neuropeptides with the function of mobilizing lipids and carbohydrates during energy-expensive activities and modulating fundamental physiological processes, such as sugar homeostasis, lipid metabolism, and reproduction. Three distinct cDNAs encoding the prepro-Bombyx AKH1-3 have been cloned and confirmed by mass spectrometric methods. Our previous research suggested the Bombyx AKH receptor is activated by AKH1 and AKH2 with high affinity but by AKH3 with quite low affinity. In this study, using stable functional expression of the receptors in HEK293 cells, we have now identified AKH3 as a specific ligand for two orphan G-protein-coupled receptors, and we therefore named them AKHR2a and AKHR2b, respectively. We demonstrated that both AKHR2a and AKHR2b were activated by AKH3 at high affinity and by AKH1 and AKH2 at low affinity, leading to an increase of intracellular cAMP levels and activation of ERK1/2 and receptor internalization, but they were not activated by Bombyx corazonin. Conversely, the Bombyx corazonin receptor was activated by corazonin but not by AKH1-3. Quantitative RT-PCR revealed that AKHR2a and AKHR2b were both highly expressed in the testis but were also detected at low levels in other tissues. These results will lead to a better understanding of the AKH/AKHR system in the regulation of fundamental physiological processes.	[Huang, Haishan; Mei, Lijuan; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China; [Shi, Ying; Deng, Xiaoyan; He, Xiaobai; Yang, Huipeng; Mei, Lijuan; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Jingwen; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang University; Zhejiang University	Gao, JM (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China.	jimingao@yahoo.com; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		National Natural Science Foundation of China [31072090]; Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 31072090, Ministry of Science and Technology Grant 2008AA02Z138, and Zhejiang Natural Science Foundation Grant Z2080207.	Arrese EL, 1999, J LIPID RES, V40, P556; Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; BRADFIELD JY, 1989, J BIOL CHEM, V264, P12791; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Gade G, 2006, BIOCHEM J, V393, P705, DOI 10.1042/BJ20050735; GADE G, 1994, PEPTIDES, V15, P1, DOI 10.1016/0196-9781(94)90162-7; Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X; Gade G, 2008, PEPTIDES, V29, P1124, DOI 10.1016/j.peptides.2008.03.002; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hansen KK, 2006, BIOCHEM BIOPH RES CO, V343, P638, DOI 10.1016/j.bbrc.2006.03.012; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Holmgren S, 2001, BRAIN RES BULL, V55, P723, DOI 10.1016/S0361-9230(01)00556-1; Huang HS, 2011, CELL SIGNAL, V23, P1455, DOI 10.1016/j.cellsig.2011.04.006; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; ISHIBASHI J, 1992, BIOSCI BIOTECH BIOCH, V56, P66, DOI 10.1271/bbb.56.66; Kaufmann C, 2009, INSECT BIOCHEM MOLEC, V39, P770, DOI 10.1016/j.ibmb.2009.09.002; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Marco HG, 2011, PEPTIDES, V32, P454, DOI 10.1016/j.peptides.2010.10.015; Michitsch J, 2008, PEPTIDES, V29, P226, DOI 10.1016/j.peptides.2007.08.031; OUDEJANS RCHM, 1991, EUR J BIOCHEM, V195, P351, DOI 10.1111/j.1432-1033.1991.tb15713.x; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; SCHAFFER MH, 1990, BIOCHEM J, V269, P315, DOI 10.1042/bj2690315; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; STONE JV, 1976, NATURE, V263, P207, DOI 10.1038/263207a0; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; VROEMEN SF, 1995, MOL CELL ENDOCRINOL, V107, P165, DOI 10.1016/0303-7207(94)03438-Y; Vroemen SF, 1998, MOL CELL ENDOCRINOL, V141, P7, DOI 10.1016/S0303-7207(98)00079-3; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Zhu CG, 2009, FEBS LETT, V583, P1463, DOI 10.1016/j.febslet.2009.03.060	37	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42390	42402		10.1074/jbc.M111.275602	http://dx.doi.org/10.1074/jbc.M111.275602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009754	Green Published, hybrid			2022-12-25	WOS:000298180900048
J	Anrather, J; Gallo, EF; Kawano, T; Orio, M; Abe, T; Gooden, C; Zhou, P; Iadecola, C				Anrather, Josef; Gallo, Eduardo F.; Kawano, Takayuki; Orio, Marcello; Abe, Takato; Gooden, Camile; Zhou, Ping; Iadecola, Costantino			Purinergic Signaling Induces Cyclooxygenase-1-Dependent Prostanoid Synthesis in Microglia: Roles in the Outcome of Excitotoxic Brain Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTAGLANDIN E-2; IN-VIVO; NEUROLOGICAL DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; P2X(7) RECEPTORS; OXIDATIVE DAMAGE; MOUSE-BRAIN; ATP	Cyclooxygenases (COX) are prostanoid synthesizing enzymes constitutively expressed in the brain that contribute to excitotoxic neuronal cell death. While the neurotoxic role of COX-2 is well established and has been linked to prostaglandin E-2 synthesis, the role of COX-1 is not clearly understood. In a model of N-Methyl-D-aspartic acid (NMDA) induced excitotoxicity in the mouse cerebral cortex we found a distinctive temporal profile of COX-1 and COX-2 activation where COX-1, located in microglia, is responsible for the early phase of prostaglandin E-2 synthesis (10 minutes after NMDA), while both COX-1 and COX-2 contribute to the second phase (3-24 hours after NMDA). Microglial COX-1 is strongly activated by ATP but not excitatory neurotransmitters or the Toll-like receptor 4 ligand bacterial lipopolysaccharide. ATP induced microglial COX-1 dependent prostaglandin E-2 synthesis is dependent on P2X7 receptors, extracellular Ca2+ and cytoplasmic phospholipase A2. NMDA receptor activation induces ATP release from cultured neurons leading to microglial P2X7 receptor activation and COX-1 dependent prostaglandin E-2 synthesis in mixed microglial-neuronal cultures. Pharmacological inhibition of COX-1 has no effect on the cortical lesion produced by NMDA, but counteracts the neuroprotection exerted by inhibition of COX-2 or observed in mice lacking the prostaglandin E-2 receptor type 1. Similarly, the neuroprotection exerted by the prostaglandin E-2 receptor type 2 agonist butaprost is not observed after COX-1 inhibition. P2X7 receptors contribute to NMDA induced prostaglandin E-2 production in vivo and blockage of P2X7 receptors reverses the neuroprotection offered by COX-2 inhibition. These findings suggest that purinergic signaling in microglia triggered by neuronal ATP modulates excitotoxic cortical lesion by regulating COX-1 dependent prostanoid production and unveil a previously unrecognized protective role of microglial COX-1 in excitotoxic brain injury.	[Anrather, Josef; Gallo, Eduardo F.; Kawano, Takayuki; Orio, Marcello; Abe, Takato; Gooden, Camile; Zhou, Ping; Iadecola, Costantino] Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA	Cornell University	Anrather, J (corresponding author), Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA.	joa2006@med.cornell.edu	Gallo, Eduardo/GPP-1460-2022; Iadecola, c/ABB-8377-2020; Abe, Takato/L-8393-2013	Abe, Takato/0000-0002-4185-5254; Iadecola, Costantino/0000-0001-9797-073X; Gallo, Eduardo F./0000-0001-9906-1425	US National Institutes of Health (NIH) [NS035806]; NIH/National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035806] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by US National Institutes of Health (NIH) grant NS035806. C.I. is the recipient of a Javits award from NIH/National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Akanuma S, 2010, J PHARMACOL EXP THER, V333, P912, DOI 10.1124/jpet.109.165332; Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Andreasson K, 2010, PROSTAG OTH LIPID M, V91, P104, DOI 10.1016/j.prostaglandins.2009.04.003; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Brown P, 2002, J PHYSIOL-LONDON, V540, P851; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deininger MH, 1999, J NEUROIMMUNOL, V95, P202, DOI 10.1016/S0165-5728(98)00257-4; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; HASSAN NF, 1991, J LEUKOCYTE BIOL, V50, P86, DOI 10.1002/jlb.50.1.86; Hoozemans JJM, 2002, BRAIN RES, V951, P218, DOI 10.1016/S0006-8993(02)03164-5; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Iadecola C, 2001, J CEREBR BLOOD F MET, V21, P1436, DOI 10.1097/00004647-200112000-00008; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kwon KJ, 2005, J NEUROSCI RES, V81, P73, DOI 10.1002/jnr.20520; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; MARTINS JP, 2011, BRIT J PHARM; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Sasaki T, 2004, J CEREBR BLOOD F MET, V24, P107, DOI 10.1097/01.WCB.0000100065.36077.4A; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stock JL, 2001, J CLIN INVEST, V107, P325, DOI 10.1172/JCI6749; Taniguchi H, 2007, J NEUROSCI, V27, P4303, DOI 10.1523/JNEUROSCI.0321-07.2007; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Wang H, 2005, CEREB CORTEX, V15, P1250, DOI 10.1093/cercor/bhi008; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743	52	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25916	10.1371/journal.pone.0025916	http://dx.doi.org/10.1371/journal.pone.0025916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022466	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600019
J	Guillemot, V; Tenenhaus, A; Le Brusquet, L; Frouin, V				Guillemot, Vincent; Tenenhaus, Arthur; Le Brusquet, Laurent; Frouin, Vincent			Graph Constrained Discriminant Analysis: A New Method for the Integration of a Graph into a Classification Process	PLOS ONE			English	Article							GENE-EXPRESSION; NETWORKS; INFORMATION; PREDICTION; ALGORITHM; MODELS	Integrating gene regulatory networks (GRNs) into the classification process of DNA microarrays is an important issue in bioinformatics, both because this information has a true biological interest and because it helps in the interpretation of the final classifier. We present a method called graph-constrained discriminant analysis (gCDA), which aims to integrate the information contained in one or several GRNs into a classification procedure. We show that when the integrated graph includes erroneous information, gCDA's performance is only slightly worse, thus showing robustness to misspecifications in the given GRNs. The gCDA framework also allows the classification process to take into account as many a priori graphs as there are classes in the dataset. The gCDA procedure was applied to simulated data and to three publicly available microarray datasets. gCDA shows very interesting performance when compared to state-of-the-art classification methods. The software package gcda, along with the real datasets that were used in this study, are available online: http://biodev.cea.fr/gcda/.	[Guillemot, Vincent; Tenenhaus, Arthur; Frouin, Vincent] IRCM, DSV, Lab Funct Genom CEA, Evry, France; [Guillemot, Vincent; Tenenhaus, Arthur; Le Brusquet, Laurent] Dept Signals & Elect Syst Supelec, Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Guillemot, V (corresponding author), IRCM, DSV, Lab Funct Genom CEA, Evry, France.	Vincent.Guillemot@ibe.med.uni-muenchen.de; vincent.frouin@cea.fr	Guillemot, Vincent/E-1598-2011; Guillemot, Vincent/AAV-6018-2021	Guillemot, Vincent/0000-0002-7421-0655; 	CEA	CEA(French Atomic Energy Commission)	This work was funded by a CEA - Region Ile de France grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Binder H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-18; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dimitriadou E., 2010, E1071 MISC FUNCTIONS; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GUILLEMOT V, 2008, P IEEE INT C BIOINF, P207, DOI DOI 10.1109/BIBMW.2008.4686237; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Hand DJ, 2006, STAT SCI, V21, P1, DOI 10.1214/088342306000000060; Hastie Y., 2009, RDA SHRUNKEN CENTROI; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; KRAMER N, 2010, PARCOR REGULARIZED E; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Mansmann U, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P249, DOI 10.1007/978-3-7908-2413-1_14; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; MCLACHLAN GJ, 2004, ANAL MICROARRAY GENE; MEYER PE, 2010, MINET MUTUAL INFORM; Rapaport F, 2008, BIOINFORMATICS, V24, pI375, DOI 10.1093/bioinformatics/btn188; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schott JR, 2007, COMPUT STAT DATA AN, V51, P6535, DOI 10.1016/j.csda.2007.03.004; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Whittaker J., 1990, GRAPHICAL MODELS APP; Zhang J.D., 2010, KEGGGRAPH KEGGGRAPH; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	31	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26146	10.1371/journal.pone.0026146	http://dx.doi.org/10.1371/journal.pone.0026146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022543	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600031
J	Scarlett, CJ; Colvin, EK; Pinese, M; Chang, DK; Morey, AL; Musgrove, EA; Pajic, M; Apte, M; Henshall, SM; Sutherland, RL; Kench, JG; Biankin, AV				Scarlett, Christopher J.; Colvin, Emily K.; Pinese, Mark; Chang, David K.; Morey, Adrienne L.; Musgrove, Elizabeth A.; Pajic, Marina; Apte, Minoti; Henshall, Susan M.; Sutherland, Robert L.; Kench, James G.; Biankin, Andrew V.			Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; STEM-CELLS; BETA-CELL; IN-VIVO; TUBULAR COMPLEXES; ADULT STEM; REGENERATION; MICE; TRANSPLANTATION; EXPRESSION	Background and Aims: Chronic pancreatitis and pancreatic cancer are characterised by extensive stellate cell mediated fibrosis, and current therapeutic development includes targeting pancreatic cancer stroma and tumor-host interactions. Recent evidence has suggested that circulating bone marrow derived stem cells (BMDC) contribute to solid organs. We aimed to define the role of circulating haematopoietic cells in the normal and diseased pancreas. Methods: Whole bone marrow was harvested from male beta-actin-EGFP donor mice and transplanted into irradiated female recipient C57/BL6 mice. Chronic pancreatitis was induced with repeat injections of caerulein, while carcinogenesis was induced with an intrapancreatic injection of dimethylbenzanthracene (DMBA). Phenotype of engrafted donor-derived cells within the pancreas was assessed by immunohistochemistry, immunofluorescence and in situ hybridisation. Results: GFP positive cells were visible in the exocrine pancreatic epithelia from 3 months post transplantation. These exhibited acinar morphology and were positive for amylase and peanut agglutinin. Mice administered caerulein developed chronic pancreatitis while DMBA mice exhibited precursor lesions and pancreatic cancer. No acinar cells were identified to be donor-derived upon cessation of cerulein treatment, however rare occurrences of bone marrow-derived acinar cells were observed during pancreatic regeneration. Increased recruitment of BMDC was observed within the desmoplastic stroma, contributing to the activated pancreatic stellate cell (PaSC) population in both diseases. Expression of stellate cell markers CELSR3, PBX1 and GFAP was observed in BMD cancer-associated PaSCs, however cancer-associated, but not pancreatitis-associated BMD PaSCs, expressed the cancer PaSC specific marker CELSR3. Conclusions: This study demonstrates that BMDC can incorporate into the pancreas and adopt the differentiated state of the exocrine compartment. BMDC that contribute to the activated PaSC population in chronic pancreatitis and pancreatic cancer have different phenotypes, and may play important roles in these diseases. Further, bone marrow transplantation may provide a useful model for the study of tumor-host interactions in cancer and pancreatitis.	[Scarlett, Christopher J.; Colvin, Emily K.; Pinese, Mark; Chang, David K.; Musgrove, Elizabeth A.; Pajic, Marina; Henshall, Susan M.; Sutherland, Robert L.; Kench, James G.; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Div Surg, Sydney, NSW, Australia; [Morey, Adrienne L.] St Vincents Hosp, Dept Anat Pathol, Darlinghurst, NSW 2010, Australia; [Apte, Minoti] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney	Scarlett, CJ (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	a.biankin@garvan.org.au	Sutherland, Robert L/A-8378-2008; Apte, Minoti/X-2864-2019	Apte, Minoti/0000-0003-0194-8939; Biankin, Andrew/0000-0002-0362-5597; Scarlett, Christopher/0000-0002-4140-7785; Kench, James Geoffrey/0000-0001-8687-4988; Morey, Adrienne/0000-0002-7823-8276; Pinese, Mark/0000-0001-5078-6687; Chang, David/0000-0002-4821-3078; Colvin, Emily/0000-0002-5435-5902; Pajic, Marina/0000-0002-3871-3829	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council (NHMRC) of Australia; Cancer Council New South Wales; St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; R. T. Hall Trust	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; R. T. Hall Trust	This work was supported by the Cancer Institute New South Wales (CINSW), the National Health and Medical Research Council (NHMRC) of Australia, The Cancer Council New South Wales, the St. Vincent's Clinic Foundation, the Royal Australian College of Surgeons, the Australian Cancer Research Foundation, and the R. T. Hall Trust. AVB, CJS, DKC, EAM and EKC are supported by fellowships from the CINSW. RLS is a Senior Principal Fellow of the NHMRC and holds the Petre Chair of Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2006, EUR J CANCER, V42, P1247, DOI 10.1016/j.ejca.2006.01.034; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Apte MV, 2003, PANCREAS, V27, P316, DOI 10.1097/00006676-200311000-00008; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Biankin SA, 2007, PATHOLOGY, V39, P247, DOI 10.1080/00313020701230807; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; DELAPORTE PL, 1991, PANCREAS, V6, P298, DOI 10.1097/00006676-199105000-00007; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Diaz-Flores L, 2006, HISTOL HISTOPATHOL, V21, P995, DOI 10.14670/HH-21.995; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Gao XD, 2008, BIOCHEM BIOPH RES CO, V371, P132, DOI 10.1016/j.bbrc.2008.04.033; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kallifatidis G, 2008, CANCER GENE THER, V15, P231, DOI 10.1038/sj.cgt.7701097; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Pan JJ, 2009, ONCOL RES, V17, P339, DOI 10.3727/096504009788428424; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Schreiber H, 2010, SCIENCE, V330, P761, DOI 10.1126/science.1198345; Sparmann G, 2010, CELL RES, V20, P288, DOI 10.1038/cr.2010.10; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Swenson ES, 2009, BIOCHEM BIOPH RES CO, V379, P526, DOI 10.1016/j.bbrc.2008.12.104; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Toth ZE, 2007, EXP CELL RES, V313, P1943, DOI 10.1016/j.yexcr.2007.02.024; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wang XL, 2006, STEM CELLS, V24, P307, DOI 10.1634/stemcells.2005-0052; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; WILLEMER S, 1989, DIGEST DIS SCI, V34, P46, DOI 10.1007/BF01536153; Worthley DL, 2009, STEM CELLS, V27, P1463, DOI 10.1002/stem.63	52	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26088	10.1371/journal.pone.0026088	http://dx.doi.org/10.1371/journal.pone.0026088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022519	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000295981600030
J	Stanger-Hall, KF; Hall, DW				Stanger-Hall, Kathrin F.; Hall, David W.			Abstinence-Only Education and Teen Pregnancy Rates: Why We Need Comprehensive Sex Education in the U.S	PLOS ONE			English	Article							5 DEVELOPED-COUNTRIES; UNINTENDED PREGNANCY; UNITED-STATES; POLICIES	The United States ranks first among developed nations in rates of both teenage pregnancy and sexually transmitted diseases. In an effort to reduce these rates, the U.S. government has funded abstinence-only sex education programs for more than a decade. However, a public controversy remains over whether this investment has been successful and whether these programs should be continued. Using the most recent national data (2005) from all U. S. states with information on sex education laws or policies (N = 48), we show that increasing emphasis on abstinence education is positively correlated with teenage pregnancy and birth rates. This trend remains significant after accounting for socioeconomic status, teen educational attainment, ethnic composition of the teen population, and availability of Medicaid waivers for family planning services in each state. These data show clearly that abstinence-only education as a state policy is ineffective in preventing teenage pregnancy and may actually be contributing to the high teenage pregnancy rates in the U. S. In alignment with the new evidence-based Teen Pregnancy Prevention Initiative and the Precaution Adoption Process Model advocated by the National Institutes of Health, we propose the integration of comprehensive sex and STD education into the biology curriculum in middle and high school science classes and a parallel social studies curriculum that addresses risk-aversion behaviors and planning for the future.	[Stanger-Hall, Kathrin F.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Hall, David W.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Stanger-Hall, KF (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	ksh@uga.edu	Stanger-Hall, Kathrin/L-1695-2019	Stanger-Hall, Kathrin/0000-0002-6941-4178; Hall, David/0000-0001-7708-6656	University of Georgia Research Foundation	University of Georgia Research Foundation	This work was funded by the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADV YOUTH SEX ED, STAT PROF; Advocates for Youth, 2007, HIST FED ABST ONL FU; Alford S., 2009, ADOLESCENT SEXUAL HL; Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; *BZGA, 2006, BZGA WHO C YOUTH SEX; BZgA, 2006, COUNTR PAP YOUTH SEX; Callahan J., 2007, ABSTINENCE ED STATE; *CAN STAT CAN, 2005, PREGN OUTC AG GROUP; *CDC TASKF COMM PR, 2009, GUID COMM PREV SERV; Collins C., 2002, POLICY MONOGRAPH SER; *COUNC COMM EC RES, ACCRA COST LIV IND C; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Frost J. J., 2008, IMPROVING CONTRACEPT; GOLD RB, 2005, MEDICAID CRITCAL SOU; GOODSON P, 2004, ABSTINENCE ED EVALUA; Guttmacher Institute, 2011, STAT POL BRIEF SEX S; HOFFMANN SD, 2006, NUMBERS PUBLIC COSTS; Horn B, 1983, Nurse Pract, V8, P74; *INT COMP, 2006, NAT CAMP PREV TEEN U; Jemmott JB, 2010, ARCH PEDIAT ADOL MED, V164, P152, DOI 10.1001/archpediatrics.2009.267; Kaye K., 2009, FOG ZONE MISPERCEPTI; Kirby D.R., 2007, NATL CAMPAIGN PREVEN; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Kost K., 2010, US TEENAGE PREGNANCI; KREININ T, 2001, SEXUALLY HLTH AM; MARTIN JA, 2007, NAT VITAL STAT REPOR, V56; *NAT CTR ED STAT, 2007, SAT DAT TABL FIG TAB; National Institutes of Health, 2005, THEOR GLANC APPL HLT; National Research Council (NRC), 1996, NAT SCI ED STAND; Perper K, 2010, CHILD TRENDS PUBLICA; Richards, 2009, NEXT STEPS AM FAMILY; RODRIGUEZ M, 1995, SIECUS REPORT, V28, P1; Santelli J, 2006, J ADOLESCENT HEALTH, V38, P83, DOI 10.1016/j.jadohealth.2005.06.002; *SAS I INC, JMP STAT DISC SOFTW; SCHALET A, 2004, MED GEN MED, V44; *SIECUS, 2005, SIECUS STAT PROF FIS; *SIECUS, REST FAIL TITL 5 ABS; Singh S, 2001, FAM PLANN PERSPECT, V33, P251, DOI 10.2307/3030192; *SPSS INC, SPSS MAC VERS 17 0; Strayhorn Joseph M, 2009, Reprod Health, V6, P14, DOI 10.1186/1742-4755-6-14; Trenholm Christopher, 2007, MATH POLICY RES; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009; *UK DEP ED, 2011, UK DEP ED 2011 18 16; Underhill K, 2007, PLOS MED, V4, P1471, DOI 10.1371/journal.pmed.0040275; *US BUR CENS, 2006, R1901 MED HOUS INC 2; *US HR, CONT FED FUND ABST O; Yang Z, 2010, J ADOLESCENT HEALTH, V46, P517, DOI 10.1016/j.jadohealth.2010.03.021; ZINTH K, 2007, SEX ED LAWS STATES S	49	162	164	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24658	10.1371/journal.pone.0024658	http://dx.doi.org/10.1371/journal.pone.0024658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022362	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600002
J	Ashktorab, H; Nguza, B; Fatemi, M; Nouraie, M; Smoot, DT; Schaffer, AA; Kupfer, SS; Camargo, CA; Brim, H				Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Nouraie, Mehdi; Smoot, Duane T.; Schaeffer, Alejandro A.; Kupfer, Sonia S.; Camargo, Carlos A., Jr.; Brim, Hassan			Case-Control Study of Vitamin D, dickkopf homolog 1 (DKK1) Gene Methylation, VDR Gene Polymorphism and the Risk of Colon Adenoma in African Americans	PLOS ONE			English	Article							D-RECEPTOR GENE; BREAST-CANCER RISK; COLORECTAL-CANCER; RECTAL-CANCER; CIRCULATING 25-HYDROXYVITAMIN-D; D DEFICIENCY; PREVENTION; POPULATION; ASSOCIATIONS; METAANALYSIS	Background: There are sparse data on genetic, epigenetic and vitamin D exposure in African Americans (AA) with colon polyp. Consequently, we evaluated serum 25(OH) D levels, vitamin D receptor (VDR) polymorphisms and the methylation status of the tumor suppressor gene dickkopf homolog 1 (DKK1) as risk factors for colon polyp in this population. Methods: The case-control study consisted of 93 patients with colon polyp (cases) and 187 healthy individuals (controls) at Howard University Hospital. Serum levels of 25(OH)D (including D3, D2, and total) were measured by liquid chromatography-mass spectrometry. DNA analysis focused on 49 single nucleotide polymorphisms (SNPs) in the VDR gene. Promoter methylation analysis of DKK1 was also performed. The resulting data were processed in unadjusted and multivariable logistic regression analyses. Results: Cases and controls differed in vitamin D status (D-3 < 50 nmol/L: Median of 35.5 in cases vs. 36.8 in controls nmol/L; P = 0.05). Low levels of 25(OH)D-3 (< 50 nmol/L) were observed in 86% of cases and 68% of controls and it was associated with higher risks of colon polyp (odds ratio of 2.7, 95% confidence interval 1.3-3.4). The SNP analysis showed no association between 46 VDR polymorphisms and colon polyp. The promoter of the DKK1 gene was unmethylated in 96% of the samples. Conclusion: We found an inverse association between serum 25(OH)D-3 and colon polyp in AAs. VDR SNPs and DKK1 methylation were not associated with colon polyp. Vitamin D levels may in part explain the higher incidence of polyp in AAs.	[Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Smoot, Duane T.] Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA; [Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Smoot, Duane T.] Howard Univ, Ctr Canc, Coll Med, Washington, DC 20059 USA; [Nouraie, Mehdi] Howard Univ, Coll Med, Ctr Sickle Cell Dis, Washington, DC USA; [Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kupfer, Sonia S.] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA	Howard University; Howard University; Howard University; Howard University; National Institutes of Health (NIH) - USA; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ashktorab, H (corresponding author), Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA.	hashktorab@howard.edu	Kupfer, Sonia S/ABD-9416-2021; Camargo, Carlos A./C-2145-2008; Schaffer, Alejandro A/F-2902-2012; Ashktorab, hassan/AAJ-2908-2020; Schaffer, Alejandro/N-1222-2019; Nouraie, Seyed Mehdi/O-4071-2018	Camargo, Carlos A./0000-0002-5071-7654; Nouraie, Seyed Mehdi/0000-0001-7465-0581	National Institutes of Health [CA102681]; Massachusetts General Hospital Center for D-receptor Activation Research; NIH, NLM; NATIONAL CANCER INSTITUTE [R01CA102681, K08CA142892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Center for D-receptor Activation Research; NIH, NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by a PHS grant from the National Institutes of Health CA102681, (H.A) and by the Massachusetts General Hospital Center for D-receptor Activation Research (C.A.C). The Cancer Research Foundation (S.S.K.) and the Digestive Disease Research Core Center (P30 DK42086). This work was also supported by the Intramural Research Program of the NIH, NLM (A.A.S.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2011, NUTR CANCER, V63, P319, DOI 10.1080/01635581.2011.535960; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2009, DIGEST DIS SCI, V54, P1985, DOI 10.1007/s10620-009-0866-5; Barroso E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-385; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; Davis CD, 2008, AM J CLIN NUTR, V88, p565S, DOI 10.1093/ajcn/88.2.565S; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P2540, DOI 10.1158/1055-9965.EPI-09-0228; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fedirko V, 2010, AM J EPIDEMIOL, V172, P489, DOI 10.1093/aje/kwq157; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Jemal A, 2009, CANCER EPIDEM BIOMAR, V18, P3349, DOI 10.1158/1055-9965.EPI-09-0740; Jenab M, 2009, CANCER EPIDEM BIOMAR, V18, P2485, DOI 10.1158/1055-9965.EPI-09-0319; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Li C, 2009, DIGEST DIS SCI, V54, P634, DOI 10.1007/s10620-008-0375-y; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Lorente A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-61; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mohr SB, 2009, ANN EPIDEMIOL, V19, P79, DOI 10.1016/j.annepidem.2008.10.003; Murtaugh MA, 2006, NUTR CANCER, V55, P35, DOI 10.1207/s15327914nc5501_5; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Sharma N, 2004, J CLIN GASTROENTEROL, V38, P844, DOI 10.1097/00004836-200411000-00003; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Slattery ML, 2009, MUTAT RES-FUND MOL M, V660, P12, DOI 10.1016/j.mrfmmm.2008.10.001; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Tangpricha V, 2005, J NUTR, V135, P2350, DOI 10.1093/jn/135.10.2350; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Wei MY, 2008, CANCER EPIDEM BIOMAR, V17, P2958, DOI 10.1158/1055-9965.EPI-08-0402; Zhang CL, 2008, CLIN CHIM ACTA, V395, P111, DOI 10.1016/j.cca.2008.05.019	45	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25314	10.1371/journal.pone.0025314	http://dx.doi.org/10.1371/journal.pone.0025314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022386	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600012
J	Kunze, A; Valero, A; Zosso, D; Renaud, P				Kunze, Anja; Valero, Ana; Zosso, Dominique; Renaud, Philippe			Synergistic NGF/B27 Gradients Position Synapses Heterogeneously in 3D Micropatterned Neural Cultures	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMMOBILIZED CONCENTRATION GRADIENTS; ADULT SENSORY NEURONS; CORTICAL THICKNESS; NEURITE OUTGROWTH; FACTOR-I; HIPPOCAMPAL-NEURONS; INSULIN; RAT; NGF	Native functional brain circuits show different numbers of synapses (synaptic densities) in the cerebral cortex. Until now, different synaptic densities could not be studied in vitro using current cell culture methods for primary neurons. Herein, we present a novel microfluidic based cell culture method that combines 3D micropatterning of hydrogel layers with linear chemical gradient formation. Micropatterned hydrogels were used to encapsulate dissociated cortical neurons in laminar cell layers and neurotrophic factors NGF and B27 were added to influence the formation of synapses. Neurotrophic gradients allowed for the positioning of distinguishable synaptic densities throughout a 3D micropatterned neural culture. NGF and B27 gradients were maintained in the microfluidic device for over two weeks without perfusion pumps by utilizing a refilling procedure. Spatial distribution of synapses was examined with a pre-synaptic marker to determine synaptic densities. From our experiments, we observed that (1) cortical neurons responded only to synergistic NGF/B27 gradients, (2) synaptic density increased proportionally to synergistic NGF/B27 gradients; (3) homogeneous distribution of B27 disturbed cortical neurons in sensing NGF gradients and (4) the cell layer position significantly impacted spatial distribution of synapses.	[Kunze, Anja; Valero, Ana; Renaud, Philippe] Ecole Polytech Fed Lausanne, Microsyst Lab LMIS4, Inst Microengn, Lausanne, Switzerland; [Zosso, Dominique] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS 5, Inst Elect Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kunze, A (corresponding author), Ecole Polytech Fed Lausanne, Microsyst Lab LMIS4, Inst Microengn, Lausanne, Switzerland.	anja.kunze@epfl.ch	Zosso, Dominique/F-4783-2010; Kunze, Anja/F-8339-2013; Renaud, Philippe/AAQ-6205-2021; Renaud, P/A-6994-2011	Zosso, Dominique/0000-0001-5685-4273; Kunze, Anja/0000-0002-5220-0982; Renaud, Philippe/0000-0001-5199-1252; Renaud, P/0000-0001-5199-1252	Ecole Polytechnique Federale de Lausanne (EPFL)	Ecole Polytechnique Federale de Lausanne (EPFL)	The authors are funded by the Ecole Polytechnique Federale de Lausanne (EPFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADOWSKASZALEWS.E, 2011, BRAIN RES IN PRESS; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bekheet SH, 2010, TISSUE CELL, V42, P165, DOI 10.1016/j.tice.2010.03.005; BLESCH A, 2009, ENCY NEUROSCIENCE, P1093; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; CELINDA MK, 2009, J NEURAL ENG, V6, P16002; Chen J, 2010, ADV MED SCI-POLAND, V55, P32, DOI 10.2478/v10039-010-0020-9; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; FEDOROFF S, 2001, SERUM FREE MEDIA NEU, P255; FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F; Fu BM, 1995, AM J PHYSIOL-HEART C, V269, pH2124, DOI 10.1152/ajpheart.1995.269.6.H2124; Hoener MC, 1996, BRAIN RES, V728, P47; HWANG JJ, 1995, MOL CELLS, V5, P501; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168; Keenan TM, 2010, LAB CHIP, V10, P116, DOI 10.1039/b913494h; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI 10.1039/c01c00240b; KUNZE A, 2011, BIOTECHNOLOGY BIOENG; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; LEHMANN M, 2010, ALZHEIMERS DEMENT, V6, pS447; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Ma CHE, 2009, BRAIN RES, V1289, P1, DOI 10.1016/j.brainres.2009.06.093; Markham JA, 2003, NEUROSCIENCE, V116, P71, DOI 10.1016/S0306-4522(02)00554-7; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267; Norman LL, 2009, TISSUE ENG PART B-RE, V15, P291, DOI [10.1089/ten.teb.2009.0114, 10.1089/ten.TEB.2009.0114]; OHSAWA F, 1993, NEUROSCIENCE, V57, P67, DOI 10.1016/0306-4522(93)90112-S; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; RECIOPINTO E, 1988, NEUROCHEM INT, V12, P397, DOI 10.1016/0197-0186(88)90021-6; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Roy TS, 2002, J PHARMACOL EXP THER, V300, P124, DOI 10.1124/jpet.300.1.124; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; SHEN K, 2010, COLD SPRING HARBOR P, V2; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Stroh M, 2003, BIOPHYS J, V85, P581, DOI 10.1016/S0006-3495(03)74502-0; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Williams BJ, 2006, PROG NEUROBIOL, V80, P114, DOI 10.1016/j.pneurobio.2006.09.001; Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023; Yu LMY, 2010, BIOMATERIALS, V31, P6987, DOI 10.1016/j.biomaterials.2010.05.070	49	23	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26187	10.1371/journal.pone.0026187	http://dx.doi.org/10.1371/journal.pone.0026187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022558	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600043
J	Pinto, A; Halliday, C; Zahra, M; van Hal, S; Olma, T; Maszewska, K; Iredell, JR; Meyer, W; Chen, SCA				Pinto, Angie; Halliday, Catriona; Zahra, Melissa; van Hal, Sebastian; Olma, Tom; Maszewska, Krystyna; Iredell, Jonathan R.; Meyer, Wieland; Chen, Sharon C. -A.			Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identification of Yeasts Is Contingent on Robust Reference Spectra	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; CANDIDA-BRACARENSIS; MULTICENTER; SUSCEPTIBILITY; NIVARIENSIS; GATTII	Background: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for yeast identification is limited by the requirement for protein extraction and for robust reference spectra across yeast species in databases. We evaluated its ability to identify a range of yeasts in comparison with phenotypic methods. Methods: MALDI-TOF MS was performed on 30 reference and 167 clinical isolates followed by prospective examination of 67 clinical strains in parallel with biochemical testing (total n = 264). Discordant/unreliable identifications were resolved by sequencing of the internal transcribed spacer region of the rRNA gene cluster. Principal Findings: Twenty (67%; 16 species), and 24 (80%) of 30 reference strains were identified to species, (spectral score >= 2.0) and genus (score >= 1.70)-level, respectively. Of clinical isolates, 140/167 (84%) strains were correctly identified with scores of >= 2.0 and 160/167 (96%) with scores of >= 1.70; amongst Candida spp. (n = 148), correct species assignment at scores of >= 2.0, and >= 1.70 was obtained for 86% and 96% isolates, respectively (vs. 76.4% by biochemical methods). Prospectively, species-level identification was achieved for 79% of isolates, whilst 91% and 94% of strains yielded scores of >= 1.90 and >= 1.70, respectively (100% isolates identified by biochemical methods). All test scores of 1.70-1.90 provided correct species assignment despite being identified to "genus-level''. MALDI-TOF MS identified uncommon Candida spp., differentiated Candida parapsilosis from C. orthopsilosis and C. metapsilosis and distinguished between C. glabrata, C. nivariensis and C. bracarensis. Yeasts with scores of <1.70 were rare species such as C. nivariensis (3/10 strains) and C. bracarensis (n = 1) but included 4/12 Cryptococcus neoformans. There were no misidentifications. Four novel species-specific spectra were obtained. Protein extraction was essential for reliable results. Conclusions: MALDI-TOF MS enabled rapid, reliable identification of clinically-important yeasts. The addition of spectra to databases and reduction in identification scores required for species-level identification may improve its utility.	[Pinto, Angie; Halliday, Catriona; Olma, Tom; Iredell, Jonathan R.; Meyer, Wieland; Chen, Sharon C. -A.] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Sydney, NSW, Australia; [Zahra, Melissa; van Hal, Sebastian] Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Sydney, NSW, Australia; [Maszewska, Krystyna; Meyer, Wieland; Chen, Sharon C. -A.] Univ Sydney, Mol Mycol Res Lab, Westmead Millenium Inst, Sydney Med Sch,Westmead Hosp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research	Pinto, A (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Sydney, NSW, Australia.	Sharon.chen@swahs.health.nsw.gov.au	Halliday, Catriona/AAX-7689-2020; Meyer, Wieland/G-1204-2015	Meyer, Wieland/0000-0001-9933-8340; van Hal, Sebastiaan/0000-0001-5852-4155				Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Borman AM, 2008, J CLIN MICROBIOL, V46, P933, DOI 10.1128/JCM.02116-07; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen SCA, 2009, CLIN MICROBIOL INFEC, V15, P662, DOI 10.1111/j.1469-0691.2009.02821.x; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Correia A, 2006, INT J SYST EVOL MICR, V56, P313, DOI 10.1099/ijs.0.64076-0; Cuenca-Estrella M, 2011, MED MYCOL, V49, P525, DOI 10.3109/13693786.2010.546373; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Eigner U, 2009, CLIN LAB, V55, P289; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Hazen KC, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1762; Hsu DI, 2010, J ANTIMICROB CHEMOTH, V65, P1765, DOI 10.1093/jac/dkq216; Iranzo Tatay A, 2011, 21 ECCMID 27 ICC; James SA, 2001, INT J SYST EVOL MICR, V51, P1917, DOI 10.1099/00207713-51-5-1917; KURTZMAN CP, 1998, YEASTS TAXONOMIC STU, P77; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lartigue MF, 2009, J CLIN MICROBIOL, V47, P2284, DOI 10.1128/JCM.00175-09; Lau A, 2009, FUTURE MICROBIOL, V4, P1185, DOI [10.2217/fmb.09.70, 10.2217/FMB.09.70]; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; McTaggart LR, 2011, J CLIN MICROBIOL, V49, P3050, DOI 10.1128/JCM.00651-11; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Petti CA, 2008, MM18A CLIN LAB STAND, P54; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Quiles-Melero I, 2012, EUR J CLIN MICROBIOL, V31, P67, DOI 10.1007/s10096-011-1277-z; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Shepard JR, 2008, J CLIN MICROBIOL, V46, P50, DOI 10.1128/JCM.01385-07; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; van Asbeck E, 2008, DIAGN MICR INFEC DIS, V62, P106, DOI 10.1016/j.diagmicrobio.2008.04.019; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	39	112	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25712	10.1371/journal.pone.0025712	http://dx.doi.org/10.1371/journal.pone.0025712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022438	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600027
J	Denic, A; Macura, SI; Warrington, AE; Pirko, I; Grossardt, BR; Pease, LR; Rodriguez, M				Denic, Aleksandar; Macura, Slobodan I.; Warrington, Arthur E.; Pirko, Istvan; Grossardt, Brandon R.; Pease, Larry R.; Rodriguez, Moses			A Single Dose of Neuron-Binding Human Monoclonal Antibody Improves Spontaneous Activity in a Murine Model of Demyelination	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BEHAVIORAL-RESPONSES; DEFICITS; RATS; INJURY; METHYLPHENIDATE; ABSENCE; LESIONS; MYELIN; MICE	Our laboratory demonstrated that a natural human serum antibody, sHIgM12, binds to neurons in vitro and promotes neurite outgrowth. We generated a recombinant form, rHIgM12, with identical properties. Intracerebral infection with Theiler's Murine Encephalomyelitis Virus (TMEV) of susceptible mouse strains results in chronic demyelinating disease with progressive axonal loss and neurologic dysfunction similar to progressive forms of multiple sclerosis. To study the effects of rHIgM12 on the motor function of TMEV-infected mice, we monitored spontaneous nocturnal activity over many weeks. Nocturnal behavior is a sensitive measure of rodent neurologic function because maximal activity changes are expected to occur during the normally active night time monitoring period. Mice were placed in activity boxes eight days prior to treatment to collect baseline spontaneous activity. After treatment, activity in each group was continuously recorded over 8 weeks. We chose a long 8-week monitoring period for two reasons: (1) we previously demonstrated that IgM induced remyelination is present by 5 weeks post treatment, and (2) TMEV-induced demyelinating disease in this strain progresses very slowly. Due to the long observation periods and large data sets, differences among treatment groups may be difficult to appreciate studying the original unfiltered recordings. To clearly delineate changes in the highly fluctuating original data we applied three different methods: (1) binning, (2) application of Gaussian low-pass filters (GF) and (3) polynomial fitting. Using each of the three methods we showed that compared to control IgM and saline, early treatment with rHIgM12 induced improvement in both horizontal and vertical motor function, whereas later treatment improved only horizontal activity. rHIgM12 did not alter activity of normal, uninfected mice. This study supports the hypothesis that treatment with a neuron-binding IgM not only protects neurons in vitro, but also influences functional motor improvement.	[Denic, Aleksandar; Warrington, Arthur E.; Pirko, Istvan; Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Macura, Slobodan I.] Mayo Clin, Dept Biochem, Rochester, MN USA; [Grossardt, Brandon R.] Mayo Clin, Dept Biomed Stat, Rochester, MN USA; [Pease, Larry R.; Rodriguez, Moses] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Denic, A (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu	Grossardt, Brandon R/A-9554-2019	Grossardt, Brandon R/0000-0001-7112-9061; Denic, Aleksandar/0000-0001-9157-5405; Rodriguez, Moses/0000-0001-6328-6497	National Institutes of Health [R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357, R21 NS073684]; National Multiple Sclerosis Society [CA 1060A11]; Applebaum Foundation; Hilton Foundation; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129, R01NS024180, R01NS048357, R21NS073684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Applebaum Foundation; Hilton Foundation; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357 and R21 NS073684) and the National Multiple Sclerosis Society (CA 1060A11). The authors also acknowledge, with thanks, support from the Applebaum and Hilton Foundations and the Minnesota Partnership Award for Biotechnology and Medical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Denic A., 2010, PATHOPHYSIOLOGY, V18, P21; Hoch JC, 1996, NMR DATA PROCESSING; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; JACOBS L, 1986, ARCH NEUROL-CHICAGO, V43, P452, DOI 10.1001/archneur.1986.00520050032017; Jones MV, 2008, J NEUROIMMUNOL, V199, P83, DOI 10.1016/j.jneuroim.2008.05.013; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; McGavern DB, 1999, EXP NEUROL, V158, P171, DOI 10.1006/exnr.1999.7082; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; Melnick SM, 2001, PHARMACOL BIOCHEM BE, V69, P219, DOI 10.1016/S0091-3057(01)00545-7; Mikami Y, 2004, J NEUROSCI RES, V76, P453, DOI 10.1002/jnr.20086; Mikami Y, 2002, J NEUROSURG, V97, P142, DOI 10.3171/spi.2002.97.1.0142; Pohl D, 2006, J PEDIATR-US, V149, P125, DOI 10.1016/j.jpeds.2006.01.003; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Rodriguez M, 2003, BRAIN, V126, P751, DOI 10.1093/brain/awg070; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Torres-Reveron A, 2006, NEUROTOXICOL TERATOL, V28, P165, DOI 10.1016/j.ntt.2005.12.005; Warrington AE, 2004, J NEUROPATH EXP NEUR, V63, P461, DOI 10.1093/jnen/63.5.461; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820; Warrington AE, 2007, J NEUROSCI RES, V85, P967, DOI 10.1002/jnr.21217; Zhu N, 2007, BEHAV NEUROSCI, V121, P1272, DOI 10.1037/0735-7044.121.6.1272	21	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26001	10.1371/journal.pone.0026001	http://dx.doi.org/10.1371/journal.pone.0026001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022490	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000052
J	Reinhold, WC; Erliandri, I; Liu, HF; Zoppoli, G; Pommier, Y; Larionov, V				Reinhold, William C.; Erliandri, Indri; Liu, Hongfang; Zoppoli, Gabriele; Pommier, Yves; Larionov, Vladimir			Identification of a Predominant Co-Regulation among Kinetochore Genes, Prospective Regulatory Elements, and Association with Genomic Instability	PLOS ONE			English	Article							CELL-LINE PANEL; CENP-A; CHROMOSOME SEGREGATION; MICROTUBULE INTERFACE; EXPRESSION PROFILES; OUTER KINETOCHORE; COLORECTAL-CANCER; CENTROMERE; COMPLEX; ANEUPLOIDY	The NCI-60 cell line panel is the most extensively characterized set of cells in existence, and has been used extensively as a screening tool for drug discovery. Previously, the potential of this panel has not been applied to the fundamental cellular processes of chromosome segregation. In the current study, we used data from multiple microarray platforms accumulated for the NCI-60 to characterize an expression pattern of genes involved in kinetochore assembly. This analysis revealed that 17 genes encoding the constitutive centromere associated network of the kinetochore core (the CCAN complex) plus four additional genes with established importance in kinetochore maintenance (CENPE, CENPF, INCENP, and MIS12) exhibit similar patterns of expression in the NCI-60, suggesting a mechanism for co-regulated transcription of these genes which is maintained despite the multiple genetic and epigenetic rearrangements accumulated in these cells (such as variations in DNA copy number and karyotypic complexity). A complex group of potential regulatory influences are identified for these genes, including the transcription factors CREB1, E2F1, FOXE1, and FOXM1, DNA copy number variation, and microRNAs has-miR-200a, 23a, 23b, 30a, 30c, 27b, 374b, 365. Thus, our results provide a template for experimental studies on the regulation of genes encoding kinetochore proteins, the process that, when aberrant, leads to the aneuploidy that is a hallmark of many cancers. We propose that the comparison of expression profiles in the NCI-60 cell line panel could be a tool for the identification of other gene groups whose products are involved in the assembly of organelle protein complexes.	[Reinhold, William C.; Erliandri, Indri; Liu, Hongfang; Zoppoli, Gabriele; Pommier, Yves; Larionov, Vladimir] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Hongfang] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Zoppoli, Gabriele] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Genoa	Reinhold, WC (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	wcr@mail.nih.gov; larionov@mail.nih.gov	Zoppoli, Gabriele/B-6935-2016; Zoppoli, Gabriele/B-6935-2016; Reinhold, William/J-6704-2017	Zoppoli, Gabriele/0000-0003-3890-5588; Zoppoli, Gabriele/0000-0002-1619-1708; Reinhold, William/0000-0001-5513-9323	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010413] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009959] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding for this work is from the National Cancer Institute's intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 2001, CHROMOSOMA, V110, P65, DOI 10.1007/s004120100130; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; CARROLL CW, 2010, J CELL BIOL; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chiu SH, 2008, ARTIF INTELL MED, V44, P221, DOI 10.1016/j.artmed.2008.06.005; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Larsen R, 2000, INTRO MATH STAT ITS; LEUNG W, 2010, CANC EPIDEMIOL; LIU H, 2010, CANC BIOL THER, V9; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; ONKEN MD, 2010, J MOL DIAGN; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Roschke AV, 2003, CANCER RES, V63, P8634; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2003, CANCER RES, V63, P3511; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25991	10.1371/journal.pone.0025991	http://dx.doi.org/10.1371/journal.pone.0025991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016797	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700031
J	Gilson, M; Fukai, T				Gilson, Matthieu; Fukai, Tomoki			Stability versus Neuronal Specialization for STDP: Long-Tail Weight Distributions Solve the Dilemma	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; ASYMMETRIC HEBBIAN PLASTICITY; SYNAPTIC PLASTICITY; LEARNING RULE; MODELS; CONNECTIVITY; RETENTION; SYNAPSES; NETWORKS; DYNAMICS	Spike-timing-dependent plasticity (STDP) modifies the weight (or strength) of synaptic connections between neurons and is considered to be crucial for generating network structure. It has been observed in physiology that, in addition to spike timing, the weight update also depends on the current value of the weight. The functional implications of this feature are still largely unclear. Additive STDP gives rise to strong competition among synapses, but due to the absence of weight dependence, it requires hard boundaries to secure the stability of weight dynamics. Multiplicative STDP with linear weight dependence for depression ensures stability, but it lacks sufficiently strong competition required to obtain a clear synaptic specialization. A solution to this stability-versus-function dilemma can be found with an intermediate parametrization between additive and multiplicative STDP. Here we propose a novel solution to the dilemma, named log-STDP, whose key feature is a sublinear weight dependence for depression. Due to its specific weight dependence, this new model can produce significantly broad weight distributions with no hard upper bound, similar to those recently observed in experiments. Log-STDP induces graded competition between synapses, such that synapses receiving stronger input correlations are pushed further in the tail of (very) large weights. Strong weights are functionally important to enhance the neuronal response to synchronous spike volleys. Depending on the input configuration, multiple groups of correlated synaptic inputs exhibit either winner-share-all or winner-take-all behavior. When the configuration of input correlations changes, individual synapses quickly and robustly readapt to represent the new configuration. We also demonstrate the advantages of log-STDP for generating a stable structure of strong weights in a recurrently connected network. These properties of log-STDP are compared with those of previous models. Through long-tail weight distributions, log-STDP achieves both stable dynamics for and robust competition of synapses, which are crucial for spike-based information processing.	[Gilson, Matthieu; Fukai, Tomoki] Riken Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan; [Gilson, Matthieu; Fukai, Tomoki] Japan Sci & Technol Agcy, Tokyo, Japan; [Gilson, Matthieu; Fukai, Tomoki] RIKEN Computat Sci Res Program, Brain & Neural Syst Team, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN	Gilson, M (corresponding author), Riken Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan.	gilson@brain.riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638	Japan Science and Technology Agency; Core Research for Evolutional Science and Technology	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	The present research was supported by the Japan Science and Technology Agency and Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Buchanan Katherine A, 2010, Front Synaptic Neurosci, V2, P11, DOI 10.3389/fnsyn.2010.00011; Burkitt AN, 2004, NEURAL COMPUT, V16, P885, DOI 10.1162/089976604773135041; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P19, DOI 10.3389/fnsyn.2010.00019; Fukai T, 2001, BIOL CYBERN, V85, P107, DOI 10.1007/PL00007998; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021912; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Gutig R, 2003, J NEUROSCI, V23, P3697; Hennequin G, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00143; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Masquelier T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001377; Meffin H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041911; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama Makoto, 2010, Front Synaptic Neurosci, V2, P22, DOI 10.3389/fnsyn.2010.00022; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Savin C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000757; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; van Rossum MCW, 2001, NEUROCOMPUTING, V38, P409, DOI 10.1016/S0925-2312(01)00360-5; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zou Q, 2007, BIOL CYBERN, V97, P81, DOI [10.1007/s00422-007-0155-3, 10.1007/S00422-007-0155-3]	42	55	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25339	10.1371/journal.pone.0025339	http://dx.doi.org/10.1371/journal.pone.0025339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003389	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300010
J	Redondo, N; Sanz, MA; Welnowska, E; Carrasco, L				Redondo, Natalia; Angel Sanz, Miguel; Welnowska, Ewelina; Carrasco, Luis			Translation without eIF2 Promoted by Poliovirus 2A Protease	PLOS ONE			English	Article							INITIATION-FACTOR 4G; CAP-INDEPENDENT TRANSLATION; YEAST SACCHAROMYCES-CEREVISIAE; RIBOSOME ENTRY SITES; EUKARYOTIC TRANSLATION; MESSENGER-RNA; MAMMALIAN-CELLS; FACTOR-II; IN-VIVO; MEMBRANE PROLIFERATION	Poliovirus RNA utilizes eIF2 for the initiation of translation in cell free systems. Remarkably, we now describe that poliovirus translation takes place at late times of infection when eIF2 is inactivated by phosphorylation. By contrast, translation directed by poliovirus RNA is blocked when eIF2 is inactivated at earlier times. Thus, poliovirus RNA translation exhibits a dual mechanism for the initiation of protein synthesis as regards to the requirement for eIF2. Analysis of individual poliovirus non-structural proteins indicates that the presence of 2A(pro) alone is sufficient to provide eIF2 independence for IRES-driven translation. This effect is not observed with a 2A(pro) variant unable to cleave eIF4G. The level of 2A(pro) synthesized in culture cells is crucial for obtaining eIF2 independence. Expression of the N-or C-terminus fragments of eIF4G did not stimulate IRES-driven translation, nor provide eIF2 independence, consistent with the idea that the presence of 2A(pro) at high concentrations is necessary. The finding that 2A(pro) provides eIF2-independent translation opens a new and unsuspected area of research in the field of picornavirus protein synthesis.	[Redondo, Natalia; Angel Sanz, Miguel; Welnowska, Ewelina; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Redondo, N (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	nsevillano@cbm.uam.es	Carrasco, Luis/E-2435-2012; Carrasco, Luis/H-3001-2017; Sanz, Miguel A/H-1914-2015; sanz-gomez, miguel/Y-6244-2019	Carrasco, Luis/0000-0003-3833-8835; Sanz, Miguel A/0000-0001-6573-883X; sanz-gomez, miguel/0000-0002-5761-9010; REDONDO, NATALIA/0000-0001-9356-8102	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN) [BFU2009-07352]; FPI (Formacion de Personal Investigador); FPU (Formacion de Profesorado Universitario); Fundacion Ramon Areces	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI (Formacion de Personal Investigador)(Spanish Government); FPU (Formacion de Profesorado Universitario)(Spanish Government); Fundacion Ramon Areces	This study was supported by a DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN) grant (BFU2009-07352). NR and EW are holders of FPI (Formacion de Personal Investigador) and FPU (Formacion de Profesorado Universitario) fellowships, respectively. The Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa'' by the Fundacion Ramon Areces is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; Aldabe R, 1996, J BIOL CHEM, V271, P23134, DOI 10.1074/jbc.271.38.23134; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; Sanz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004772; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Barco A, 1997, J BIOL CHEM, V272, P12683, DOI 10.1074/jbc.272.19.12683; BARCO A, 1995, EMBO J, V14, P3349, DOI 10.1002/j.1460-2075.1995.tb07341.x; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; BLACK TL, 1993, J VIROL, V67, P791, DOI 10.1128/JVI.67.2.791-800.1993; BLACK TL, 1989, J VIROL, V63, P2244, DOI 10.1128/JVI.63.5.2244-2251.1989; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Foeger N, 2002, J BIOL CHEM, V277, P44300, DOI 10.1074/jbc.M208006200; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; HAMBIDGE SJ, 1992, P NATL ACAD SCI USA, V89, P10272, DOI 10.1073/pnas.89.21.10272; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; MACADAM AJ, 1994, EMBO J, V13, P924, DOI 10.1002/j.1460-2075.1994.tb06336.x; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; MOLLA A, 1993, J VIROL, V67, P4688, DOI 10.1128/JVI.67.8.4688-4695.1993; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; ONEILL RE, 1989, J VIROL, V63, P5069, DOI 10.1128/JVI.63.12.5069-5075.1989; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; RANSONE LJ, 1987, J VIROL, V61, P1781, DOI 10.1128/JVI.61.6.1781-1787.1987; RANSONE LJ, 1988, J VIROL, V62, P3551, DOI 10.1128/JVI.62.10.3551-3557.1988; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; Welnowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022230; WHETTER LE, 1994, J VIROL, V68, P5253, DOI 10.1128/JVI.68.8.5253-5263.1994; White JP, 2011, J VIROL, V85, P8884, DOI 10.1128/JVI.00792-11; Willcocks MM, 2004, J GEN VIROL, V85, P1125, DOI 10.1099/vir.0.19564-0; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Xi QR, 2004, GENE DEV, V18, P1997, DOI 10.1101/gad.1212504; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25699	10.1371/journal.pone.0025699	http://dx.doi.org/10.1371/journal.pone.0025699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003403	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300024
J	Lin, TY; Cheng, YC; Yang, HC; Lin, WC; Wang, CC; Lai, PL; Shieh, SY				Lin, T-Y; Cheng, Y-C; Yang, H-C; Lin, W-C; Wang, C-C; Lai, P-L; Shieh, S-Y			Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis	ONCOGENE			English	Article						BTG3; ERK; JMJD3/KDM6B; cellular senescence	DEMETHYLASE JMJD3 CONTRIBUTES; ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; INK4A-ARF LOCUS; FAMILY; PROTEINS; BARRIER; STRESS; TARGET; RB	The B-cell translocation gene 3 (BTG3) is a member of the antiproliferative BTG gene family and a downstream target of p53. BTG3 also binds and inhibits E2F1. Although it connects functionally two major growth-regulatory pathways, the physiological role of BTG3 remains largely uncharacterized. Here, we present evidence that loss of BTG3 in normal cells induced cellular senescence, which was correlated with enhanced ERK-AP1 signaling and elevated expression of the histone H3K27me3 demethylase JMJD3/KDM6B, leading to acute induction of p16(INK4a). Importantly, we also found that BTG3 expression is specifically downregulated in prostate cancer, thus providing a physiological link with human cancers. Our data suggest that BTG3 may have a fail-safe role against tumorigenic progression. Oncogene (2012) 31, 3287-3297; doi:10.1038/onc.2011.491; published online 24 October 2011	[Lin, T-Y; Cheng, Y-C; Yang, H-C; Shieh, S-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Cheng, Y-C] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, W-C; Wang, C-C; Lai, P-L] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	National Science Council of Taiwan; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants from the National Science Council of Taiwan and Academia Sinica to S-Y Shieh.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Rahmani Z, 2006, J CELL SCI, V119, P646, DOI 10.1242/jcs.02778; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	26	40	42	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	27					3287	3297		10.1038/onc.2011.491	http://dx.doi.org/10.1038/onc.2011.491			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22020331				2022-12-25	WOS:000306113400008
J	Zhang, X; Chen, X; Lin, J; Lwin, T; Wright, G; Moscinski, LC; Dalton, WS; Seto, E; Wright, K; Sotomayor, E; Tao, J				Zhang, X.; Chen, X.; Lin, J.; Lwin, T.; Wright, G.; Moscinski, L. C.; Dalton, W. S.; Seto, E.; Wright, K.; Sotomayor, E.; Tao, J.			Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas	ONCOGENE			English	Article						Myc; miR15a/miR-16-1; lymphoma	C-MYC; HISTONE DEACETYLASE; MICRORNA EXPRESSION; BURKITT-LYMPHOMA; DOWN-REGULATION; LUNG-CANCER; MIR-15A; OVEREXPRESSION; MALIGNANCIES; ACTIVATION	Our recent study demonstrated miR-15a/16-1 down-regulation in mantle cell lymphoma (MCL). Here, we investigated mechanisms of miR-15a/16-1 transcriptional repression and its epigenetic regulation by c-Myc and histone deacetylase (HDAC) in MCL. c-Myc expression was detected in MCL cell lines and in the primary MCL samples, and pri-miR-15a/16-1 mRNAs were significantly upregulated in Mino and Jeko-1 cells with c-Myc knockdown by small interfering RNAs (siRNAs). Our co-immunoprecipitation analysis showed that c-Myc interacted with HDAC3. Moreover, using chromatin immunoprecipitation, we demonstrated that both c-Myc and HDAC3 co-localized to the two promoters of the miR-15a/16-1 cluster gene, DLEU2, and inhibition of HDAC3 increased histone acetylation of the DLEU2 promoters. Luciferase reporter assay confirmed the dependence of Myc-mediated DLEU2 transcriptional repression on HDAC3. Treatment with the pan-HDAC inhibitor, suberoylanilide hydroxamic acid and HDAC3 siRNA resulted in increased miR-15a/16-1 expression. The regulatory mechanism of miR-15a/16-1 was further demonstrated in Burkitt lymphoma and Myc over-expressing cell lines. These findings highlight the role of HDAC3 in Myc-induced miR-15a/16-1 changes and reveal novel mechanisms for c-Myc-driven microRNA suppression and malignant transformation in aggressive B-cell malignancies.	[Zhang, X.; Chen, X.; Lin, J.; Lwin, T.; Wright, G.; Moscinski, L. C.; Dalton, W. S.; Seto, E.; Wright, K.; Sotomayor, E.; Tao, J.] Univ S Florida, Dept Malignant Hematol, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol & Expt Therapeut Program, Tampa, FL 33613 USA; [Zhang, X.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Tianjin Medical University	Tao, J (corresponding author), Univ S Florida, Dept Malignant Hematol, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol & Expt Therapeut Program, MCC LAB 2071,12902 Magnolia Dr, Tampa, FL 33613 USA.	Jianguo.Tao@moffitt.org	Wright, George W/M-1660-2017		National Cancer Institutes [R01 CA137123]; Maher Fund; Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA137123, R01CA134807] Funding Source: NIH RePORTER	National Cancer Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maher Fund; Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Tissue Procurement, Molecular Core Laboratory and Flow Cytometry Core Facilities at H Lee Moffitt Cancer Center for providing specimens and molecular analysis. We thank Rasa Hamilton for editorial assistance. This work was supported by grants from the National Cancer Institutes (R01 CA137123, to JT), Maher Fund (to JT) and Moffitt Cancer Center Foundation (to JT).	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han L, 2007, CANCER BIOL THER, V6, P1284; Hartmann E, 2008, J CLIN ONCOL, V26, P4966, DOI 10.1200/JCO.2007.12.0410; Hernandez L, 1999, LEUKEMIA, V13, P2087, DOI 10.1038/sj.leu.2401599; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Lee EM, 2009, INT J MOL MED, V24, P45, DOI 10.3892/ijmm_00000204; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Robertus JL, 2010, BRIT J HAEMATOL, V149, P896, DOI 10.1111/j.1365-2141.2010.08111.x; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147	29	128	132	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					3002	3008		10.1038/onc.2011.470	http://dx.doi.org/10.1038/onc.2011.470			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22002311	Green Accepted			2022-12-25	WOS:000305388400009
J	Khanna, M; Chen, CH; Kimble-Hill, A; Parajuli, B; Perez-Miller, S; Baskaran, S; Kim, J; Dria, K; Vasiliou, V; Mochly-Rosen, D; Hurley, TD				Khanna, May; Chen, Che-Hong; Kimble-Hill, Ann; Parajuli, Bibek; Perez-Miller, Samantha; Baskaran, Sulochanadevi; Kim, Jeewon; Dria, Karl; Vasiliou, Vasilis; Mochly-Rosen, Daria; Hurley, Thomas D.			Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYACETOPHENONE-SEPHAROSE; ACTIVITY-BASED PROBES; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; ACTIVATION; GENE; CYCLOPHOSPHAMIDE; IDENTIFICATION; DETOXIFICATION; PURIFICATION	Human aldehyde dehydrogenases (ALDHs) comprise a family of 17 homologous enzymes that metabolize different biogenic and exogenic aldehydes. To date, there are relatively few general ALDH inhibitors that can be used to probe the contribution of this class of enzymes to particular metabolic pathways. Here, we report the discovery of a general class of ALDH inhibitors with a common mechanism of action. The combined data from kinetic studies, mass spectrometric measurements, and crystallographic analyses demonstrate that these inhibitors undergo an enzyme-mediated beta-elimination reaction generating a vinyl ketone intermediate that covalently modifies the active site cysteine residue present in these enzymes. The studies described here can provide the basis for rational approach to design ALDH isoenzyme-specific inhibitors as research tools and perhaps as drugs, to address diseases such as cancer where increased ALDH activity is associated with a cellular phenotype.	[Khanna, May; Kimble-Hill, Ann; Parajuli, Bibek; Perez-Miller, Samantha; Baskaran, Sulochanadevi; Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Che-Hong; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Ctr Comprehens Canc, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Transgen Mouse Res Ctr, Stanford, CA 94305 USA; [Dria, Karl] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Vasiliou, Vasilis] Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Stanford University; Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hurley, TD (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	thurley@iupui.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; Kimble-Hill, Ann/0000-0001-9575-5454; Kim, Jeewon/0000-0002-1063-0239; Khanna, May/0000-0002-9989-6374; vasiliou, vasilis/0000-0003-2552-3118; HURLEY, THOMAS/0000-0002-5942-1163; Perez-Miller, Samantha/0000-0002-9034-3693	National Institutes of Health [R01-AA018123, R21-AA019746, R01-AA018123-S1, R01-AA11147, EY11490]; National Science Foundation [0821661]; NCI [Y1-CO-1020]; NIGMS, National Institutes of Health [Y1-GM-1104]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011490, R29EY011490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018123, R37AA011147, R01AA011147, R21AA019746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AA018123 and R21-AA019746 (to T. D. H.), R01-AA018123-S1 (to A. K.-H.), R01-AA11147 (to D. M.-R.) and EY11490 (V. V.). The mass spectrometry work was supported by National Science Foundation MRI Grant 0821661. General Medical/CAncer Collaborative Access Team was supported in whole or in part by NCI Grant Y1-CO-1020 and NIGMS Grant Y1-GM-1104, National Institutes of Health, at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. Daria Mochly-Rosen is the founder and a shareholder of KAI Pharmaceuticals. However, none of the work described in this study is based on or supported by the company. Che-Hong Chen and Daria Mochly-Rosen are listed as inventors in pending patents filed by Stanford University that are related to this work.	ALDRIDGE WN, 1972, ENZYME INHIBITORS SU, P1; Allali-Hassani A, 2001, CHEM-BIOL INTERACT, V130, P125, DOI 10.1016/S0009-2797(00)00228-3; Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Ascenzi P, 2001, CURR PROTEIN PEPT SC, V2, P137, DOI 10.2174/1389203013381170; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Black William, 2009, Human Genomics, V4, P136; BOSRON WF, 1986, BIOCHEMISTRY-US, V25, P1876, DOI 10.1021/bi00356a006; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Cheriyan J, 2009, BRIT J CLIN PHARMACO, V68, P518, DOI 10.1111/j.1365-2125.2009.03475.x; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; Harada S, 1999, ALCOHOL CLIN EXP RES, V23, P958, DOI 10.1111/j.1530-0277.1999.tb04212.x; HILTON J, 1984, CANCER RES, V44, P5156; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; Kumar S, 2004, P NATL ACAD SCI USA, V101, P7943, DOI 10.1073/pnas.0402323101; MANTHEY CL, 1990, CANCER RES, V50, P4991; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Negoro M, 2005, ALCOHOL CLIN EXP RES, V29, p304S, DOI 10.1097/01.alc.0000191811.06936.04; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Overstreet DH, 2009, PHARMACOL BIOCHEM BE, V94, P255, DOI 10.1016/j.pbb.2009.09.004; Parajuli B, 2011, CHEM-BIOL INTERACT, V191, P153, DOI 10.1016/j.cbi.2011.02.018; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1997, CLIN CANCER RES, V3, P1901; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; VONEITZEN U, 1994, CANCER LETT, V76, P45, DOI 10.1016/0304-3835(94)90132-5; Yao LN, 2010, NAT MED, V16, P1024, DOI 10.1038/nm.2200	35	53	56	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43486	43494		10.1074/jbc.M111.293597	http://dx.doi.org/10.1074/jbc.M111.293597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021038	Green Published, hybrid			2022-12-25	WOS:000298351300068
J	Yang, A; Shi, GL; Zhou, CL; Lu, R; Li, H; Sun, L; Jin, Y				Yang, Acong; Shi, Guilai; Zhou, Chenlin; Lu, Rui; Li, Hui; Sun, Lei; Jin, Ying			Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERING-RNA VECTOR; GENE-EXPRESSION; CLEAVING ACTIVITY; CANCER-CELLS; PLURIPOTENCY; CYCLE; DIFFERENTIATION; PROLIFERATION; NANOG; OCT4	Embryonic stem cells (ESCs) can undergo unlimited self-renewal and retain pluripotent developmental potential. The unique characteristics of ESCs, including a distinct transcriptional network, a poised epigenetic state, and a specific cell cycle profile, distinguish them from somatic cells. However, the molecular mechanisms underlying these special properties of ESCs are not fully understood. Here, we report that nucleolin, a nucleolar protein highly expressed in undifferentiated ESCs, plays an essential role for the maintenance of ESC self-renewal. When nucleolin is knocked down by specific short hairpin RNA (shRNA), ESCs display dramatically reduced cell proliferation rate, increased cell apoptosis, and G(1) phase accumulation. Down-regulation of nucleolin also leads to evident ESC differentiation as well as decreased self-renewal ability. Interestingly, expression of pluripotency markers (Oct4 and Nanog) is unaltered in these differentiated cells. Mechanistically, depletion of nucleolin up-regulates the p53 protein level and activates the p53-dependent pathway, at least in part, via increasing p53 protein stability. Silencing of p53 rescues G(1) phase accumulation and apoptosis caused by nucleolin deficiency entirely, although it partially blocks abnormal differentiation in nucleolin-depleted ESCs. It is noteworthy that knocking down nucleolin in NIH3T3 cells affected cell survival and proliferation in a much milder way, despite the comparable silencing efficiency obtained in ESCs and NIH3T3 cells. Collectively, our data demonstrate that nucleolin is a critical regulator of ESC self-renewal and that suppression of the p53-dependent pathway is the major molecular mechanism underlying functions of nucleolin in ESCs.	[Yang, Acong; Li, Hui; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Inst Med Sci, Shanghai 200025, Peoples R China; [Yang, Acong; Shi, Guilai; Zhou, Chenlin; Lu, Rui; Li, Hui; Sun, Lei; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Chinese Acad Sci,Inst Hlth, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Inst Med Sci, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Sun, Lei/J-9943-2015; Yang, Acong/B-2929-2012	, jin ying/0000-0003-0070-2048; li, hui/0000-0002-7409-7787; Yang, Acong/0000-0002-1279-566X; Lu, Rui/0000-0003-1593-2612	National Natural Science Foundation [91019023, 30730051, 30911130361, 31100990]; National High Technology Research and Development Program of China [2010CB945201, 2011CB965101, 2009CB941103, 2007CB947904, 2007CB948004, 2011DFB30010]; Chinese Academy of Science [XDA01010102]; China Postdoctoral Science Foundation [20090460626]; Shanghai Postdoctoral Research Plan; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Science(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Research Plan; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation Grants 91019023, 30730051, 30911130361, and 31100990, National High Technology Research and Development Program of China Grants 2010CB945201, 2011CB965101, 2009CB941103, 2007CB947904, 2007CB948004, and 2011DFB30010, Chinese Academy of Science Grant XDA01010102, China Postdoctoral Science Foundation Grant 20090460626, Shanghai Postdoctoral Research Plan, and Shanghai Leading Academic Discipline Project Grant S30201.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boheler KR, 2009, J CELL PHYSIOL, V221, P10, DOI 10.1002/jcp.21866; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; DERENZINI M, 1995, LAB INVEST, V73, P497; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Ginisty H, 1999, J CELL SCI, V112, P761; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; ORRICK LR, 1973, P NATL ACAD SCI USA, V70, P1316, DOI 10.1073/pnas.70.5.1316; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang BB, 2006, BIOCHEM BIOPH RES CO, V347, P1129, DOI 10.1016/j.bbrc.2006.07.020	39	40	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43370	43382		10.1074/jbc.M111.225185	http://dx.doi.org/10.1074/jbc.M111.225185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013067	Green Published, hybrid			2022-12-25	WOS:000298351300057
J	Bando, SY; Alegro, MC; Amaro, E; Silva, AV; Castro, LHM; Wen, HT; Lima, LD; Brentani, H; Moreira, CA				Bando, Silvia Y.; Alegro, Maryana C.; Amaro, Edson, Jr.; Silva, Alexandre V.; Castro, Luiz H. M.; Wen, Hung-Tzu; Lima, Leandro de A.; Brentani, Helena; Moreira-Filho, Carlos Alberto			Hippocampal CA3 Transcriptome Signature Correlates with Initial Precipitating Injury in Refractory Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							FEBRILE SEIZURES; GENE-EXPRESSION; ENDOSOMAL PROTEIN; SOMATOSTATIN; BRAIN; NEUROGENESIS; MODULATION; TEXTURE; TRANSMISSION; RELEASE	Background: Prolonged febrile seizures constitute an initial precipitating injury (IPI) commonly associated with refractory mesial temporal lobe epilepsy (RMTLE). In order to investigate IPI influence on the transcriptional phenotype underlying RMTLE we comparatively analyzed the transcriptomic signatures of CA3 explants surgically obtained from RMTLE patients with (FS) or without (NFS) febrile seizure history. Texture analyses on MRI images of dentate gyrus were conducted in a subset of surgically removed sclerotic hippocampi for identifying IPI-associated histo-radiological alterations. Methodology/Principal Findings: DNA microarray analysis revealed that CA3 global gene expression differed significantly between FS and NFS subgroups. An integrative functional genomics methodology was used for characterizing the relations between GO biological processes themes and constructing transcriptional interaction networks defining the FS and NFS transcriptomic signatures and its major gene-gene links (hubs). Co-expression network analysis showed that: i) CA3 transcriptomic profiles differ according to the IPI; ii) FS distinctive hubs are mostly linked to glutamatergic signalization while NFS hubs predominantly involve GABAergic pathways and neurotransmission modulation. Both networks have relevant hubs related to nervous system development, what is consistent with cell genesis activity in the hippocampus of RMTLE patients. Moreover, two candidate genes for therapeutic targeting came out from this analysis: SSTR1, a relevant common hub in febrile and afebrile transcriptomes, and CHRM3, due to its putative role in epilepsy susceptibility development. MRI texture analysis allowed an overall accuracy of 90% for pixels correctly classified as belonging to FS or NFS groups. Histological examination revealed that granule cell loss was significantly higher in FS hippocampi. Conclusions/Significance: CA3 transcriptional signatures and dentate gyrus morphology fairly correlate with IPI in RMTLE, indicating that FS-RMTLE represents a distinct phenotype. These findings may shed light on the molecular mechanisms underlying refractory epilepsy phenotypes and contribute to the discovery of novel specific drug targets for therapeutic interventions.	[Bando, Silvia Y.; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Alegro, Maryana C.] Univ Sao Paulo, Escola Politecn, Integrated Syst Lab, Sao Paulo, Brazil; [Amaro, Edson, Jr.] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [Silva, Alexandre V.] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Castro, Luiz H. M.] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Neurol Div, Sao Paulo, Brazil; [Wen, Hung-Tzu] Univ Sao Paulo, Fac Med, Hosp Clin, Epilepsy Surg Grp, Sao Paulo, Brazil; [Lima, Leandro de A.] Hosp Canc AC Camargo, Biotechnol Lab, Sao Paulo, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Dept Psychiat, Inst Nacl Psiquiatria Desenvolvimento, Sao Paulo, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Lab Invest Med 23, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo	Bando, SY (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	carlos.moreira@icr.usp.br	Castro, Luiz H M/H-9427-2012; moreira-filho, carlos alberto/J-2551-2014; Amaro, Edson/B-6653-2009; Brentani, Helena/G-6839-2011; Silva, Alexandre V/A-2634-2011; Lima, Leandro/F-4132-2012; amaro, edson/GLR-7735-2022	Castro, Luiz H M/0000-0003-1878-8548; moreira-filho, carlos alberto/0000-0003-3433-4714; Amaro, Edson/0000-0002-5889-1382; Brentani, Helena/0000-0001-5192-4682; Silva, Alexandre V/0000-0001-7107-0864; Lima, Leandro/0000-0001-5313-9485; amaro, edson/0000-0002-5889-1382; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56.446-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) [475051/2009-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant no. 2005/56.446-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) grant no. 475051/2009-2 to CAM-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil B, 2007, EPILEPSY RES, V73, P104, DOI 10.1016/j.eplepsyres.2006.08.005; Alberi S, 2005, MOL CELL NEUROSCI, V29, P313, DOI 10.1016/j.mcn.2005.03.011; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bae EK, 2010, J CLIN NEUROL, V6, P73, DOI 10.3988/jcn.2010.6.2.73; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Berg AT, 1999, NEUROLOGY, V53, P1742, DOI 10.1212/WNL.53.8.1742; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/00019052-200404000-00013; Cendes F, 2003, ARQ NEURO-PSIQUIAT, V61, P1; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Cho EY, 2009, GENE, V429, P44, DOI 10.1016/j.gene.2008.10.008; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Corradini I, 2009, ANN NY ACAD SCI, V1152, P93, DOI 10.1111/j.1749-6632.2008.03995.x; Csaba Z, 2005, J NEUROPATH EXP NEUR, V64, P956, DOI 10.1097/01.jnen.0000186923.50215.50; Diaz E, 2010, EUR J NEUROSCI, V32, P261, DOI 10.1111/j.1460-9568.2010.07357.x; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; Duvernoy H. M., 1988, HUMAN HIPPOCAMPUS AT; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Ermolinsky B, 2008, NEUROREPORT, V19, P1291, DOI 10.1097/WNR.0b013e3283094bb6; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Goodyer CG, 2004, NEUROSCIENCE, V125, P441, DOI 10.1016/j.neuroscience.2004.02.001; Grigorescu SE, 2002, IEEE T IMAGE PROCESS, V11, P1160, DOI 10.1109/TIP.2002.804262; Hahn A, 2009, BRAIN DEV-JPN, V31, P515, DOI 10.1016/j.braindev.2009.04.012; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Heuser K, 2011, SEIZURE-EUR J EPILEP, V20, P163, DOI 10.1016/j.seizure.2010.11.015; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hudson LD, 2011, TRANSGENIC RES, V20, P951, DOI 10.1007/s11248-010-9470-x; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kerr N, 2010, MOL CELL NEUROSCI, V44, P165, DOI 10.1016/j.mcn.2010.03.005; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Lee SH, 2011, J PHYSIOL-LONDON, V589, P891, DOI 10.1113/jphysiol.2010.198499; Lee TS, 2007, MOL MED, V13, P1, DOI 10.2119/2006-00079.Lee; Ma XM, 2003, J NEUROSCI, V23, P10593; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maeda K, 2001, NEUROL MED-CHIR, V41, P582, DOI 10.2176/nmc.41.582; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; MANJUNATH BS, 1991, IEEE T PATTERN ANAL, V13, P478, DOI 10.1109/34.134046; Mathern GW, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.43.s.5.28.x; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Morales-Corraliza J, 2010, EPILEPSIA, V51, P1910, DOI 10.1111/j.1528-1167.2010.02680.x; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; O'Dell C, 2005, PEDIATR NEUROL, V33, P166, DOI 10.1016/j.pediatrneurol.2005.03.005; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Potier S, 2005, EUR J NEUROSCI, V21, P1828, DOI 10.1111/j.1460-9568.2005.04026.x; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasikala M., 2008, Journal of Medical Engineering & Technology, V32, P198, DOI 10.1080/03091900701455524; Scantlebury MH, 2010, EPILEPSY RES, V89, P27, DOI 10.1016/j.eplepsyres.2009.11.002; Siebzehnrubl FA, 2008, EPILEPSIA, V49, P55, DOI 10.1111/j.1528-1167.2008.01638.x; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Tallent MK, 2008, MOL CELL ENDOCRINOL, V286, P96, DOI 10.1016/j.mce.2007.12.004; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004; Zook JM, 2005, MAGN RESON IMAGING, V23, P671, DOI 10.1016/j.mri.2005.04.002	90	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26268	10.1371/journal.pone.0026268	http://dx.doi.org/10.1371/journal.pone.0026268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022585	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600044
J	Blattler, F; Hahnloser, RHR				Blaettler, Florian; Hahnloser, Richard H. R.			An Efficient Coding Hypothesis Links Sparsity and Selectivity of Neural Responses	PLOS ONE			English	Article							SONG SYSTEM; FOREBRAIN CIRCUIT; AUDITORY NEURONS; NATURAL SOUNDS; REPRESENTATIONS; INHIBITION; EXCITATION; CONNECTIONS; ADAPTATION; ALGORITHMS	To what extent are sensory responses in the brain compatible with first-order principles? The efficient coding hypothesis projects that neurons use as few spikes as possible to faithfully represent natural stimuli. However, many sparsely firing neurons in higher brain areas seem to violate this hypothesis in that they respond more to familiar stimuli than to nonfamiliar stimuli. We reconcile this discrepancy by showing that efficient sensory responses give rise to stimulus selectivity that depends on the stimulus-independent firing threshold and the balance between excitatory and inhibitory inputs. We construct a cost function that enforces minimal firing rates in model neurons by linearly punishing suprathreshold synaptic currents. By contrast, subthreshold currents are punished quadratically, which allows us to optimally reconstruct sensory inputs from elicited responses. We train synaptic currents on many renditions of a particular bird's own song (BOS) and few renditions of conspecific birds' songs (CONs). During training, model neurons develop a response selectivity with complex dependence on the firing threshold. At low thresholds, they fire densely and prefer CON and the reverse BOS (REV) over BOS. However, at high thresholds or when hyperpolarized, they fire sparsely and prefer BOS over REV and over CON. Based on this selectivity reversal, our model suggests that preference for a highly familiar stimulus corresponds to a high-threshold or strong-inhibition regime of an efficient coding strategy. Our findings apply to songbird mirror neurons, and in general, they suggest that the brain may be endowed with simple mechanisms to rapidly change selectivity of neural responses to focus sensory processing on either familiar or nonfamiliar stimuli. In summary, we find support for the efficient coding hypothesis and provide new insights into the interplay between the sparsity and selectivity of neural responses.	[Blaettler, Florian; Hahnloser, Richard H. R.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Blattler, F (corresponding author), Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland.	rich@ini.phys.ethz.ch		Hahnloser, Richard/0000-0002-4039-7773	ETH Zurich [TH-03 06-1]; Swiss National Science Foundation (SNF)	ETH Zurich(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	F.B. was supported by a TH grant of the ETH Zurich (TH-03 06-1), and R.H. was supported by the Swiss National Science Foundation (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; Amin N, 2010, J NEUROPHYSIOL, V104, P784, DOI 10.1152/jn.00128.2010; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; BELL AJ, 1995, INT CONF ACOUST SPEE, P3415, DOI 10.1109/ICASSP.1995.479719; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Green DM, 1966, SIGNAL DETECTION THE; Greene G, 2009, NETWORK-COMP NEURAL, V20, P162, DOI 10.1080/09548980903108267; GRIFFIN DW, 1984, IEEE T ACOUST SPEECH, V32, P236, DOI 10.1109/TASSP.1984.1164317; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hoyer PO, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P557, DOI 10.1109/NNSP.2002.1030067; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lewicki MS, 1996, J NEUROSCI, V16, P6987; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nick TA, 2005, J NEUROBIOL, V62, P469, DOI 10.1002/neu.20115; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Plumbley MD, 2003, IEEE T NEURAL NETWOR, V14, P534, DOI 10.1109/TNN.2003.810616; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Sharpee T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000646; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Woolley SMN, 2010, DEV NEUROBIOL, V70, P235, DOI 10.1002/dneu.20783; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009	57	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25506	10.1371/journal.pone.0025506	http://dx.doi.org/10.1371/journal.pone.0025506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022405	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000295978600020
J	Lodi, A; Ronen, SM				Lodi, Alessia; Ronen, Sabrina M.			Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; DECISION-SUPPORT-SYSTEM; PROTON MR SPECTROSCOPY; HUMAN BREAST-LESIONS; IN-VIVO; CELL-METABOLISM; CHOLINE KINASE; BRAIN-TUMORS; INHIBITION; PHOSPHOCHOLINE	Targeted therapeutic approaches are increasingly being implemented in the clinic, but early detection of response frequently presents a challenge as many new therapies lead to inhibition of tumor growth rather than tumor shrinkage. Development of novel non-invasive methods to monitor response to treatment is therefore needed. Magnetic resonance spectroscopy (MRS) and magnetic resonance spectroscopic imaging are non-invasive imaging methods that can be employed to monitor metabolism, and previous studies indicate that these methods can be useful for monitoring the metabolic consequences of treatment that are associated with early drug target modulation. However, single-metabolite biomarkers are often not specific to a particular therapy. Here we used an unbiased 1H MRS-based metabolomics approach to investigate the overall metabolic consequences of treatment with the phosphoinositide 3-kinase inhibitor LY294002 and the heat shock protein 90 inhibitor 17AAG in prostate and breast cancer cell lines. LY294002 treatment resulted in decreased intracellular lactate, alanine fumarate, phosphocholine and glutathione. Following 17AAG treatment, decreased intracellular lactate, alanine, fumarate and glutamine were also observed but phosphocholine accumulated in every case. Furthermore, citrate, which is typically observed in normal prostate tissue but not in tumors, increased following 17AAG treatment in prostate cells. This approach is likely to provide further information about the complex interactions between signaling and metabolic pathways. It also highlights the potential of MRS-based metabolomics to identify metabolic signatures that can specifically inform on molecular drug action.	[Lodi, Alessia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lodi, A (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	sabrina.ronen@ucsf.edu			National Institutes of Health (NIH) [RO1 CA130819]; NATIONAL CANCER INSTITUTE [R01CA130819] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH; www.nih.gov) grant RO1 CA130819. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2009, MOL CANCER THER, V8, P1305, DOI 10.1158/1535-7163.MCT-09-0039; Brandes AH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2729; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Glunde K, 2006, MOL PHARMACEUT, V3, P496, DOI 10.1021/mp060067e; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jacobs MA, 2004, J MAGN RESON IMAGING, V19, P68, DOI 10.1002/jmri.10427; Jagannathan NR, 1998, NMR BIOMED, V11, P414, DOI 10.1002/(SICI)1099-1492(199812)11:8<414::AID-NBM537>3.0.CO;2-W; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jordan NF, 2005, NMR BIOMED, V18, P430, DOI 10.1002/nbm.977; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Koul D, 2010, NEURO-ONCOLOGY, V12, P559, DOI 10.1093/neuonc/nop058; Kurhanewicz J, 1996, RADIOLOGY, V198, P795, DOI 10.1148/radiology.198.3.8628874; Le HC, 2009, MAGN RESON MED, V62, P1112, DOI 10.1002/mrm.22137; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Mori N, 2004, MOL IMAGING, V3, P319, DOI 10.1162/1535350042973517; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Peet AC, 2007, NMR BIOMED, V20, P692, DOI 10.1002/nbm.1181; Perez-Ruiz A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-581; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Romanska HM, 2009, NEOPLASIA, V11, P1301, DOI 10.1593/neo.09850; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; ROSS B, 1994, MAGN RESON QUART, V10, P191; Sankaranarayanapillai M, 2008, MOL IMAGING, V7, P92, DOI 10.2310/7290.2008.0011; Schnackenberg LK, 2009, METABOLOME ANAL STRA, P159; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Sitter B, 2004, MAGN RESON MATER PHY, V16, P174, DOI 10.1007/s10334-003-0025-5; Solit DB, 2007, CLIN CANCER RES, V13, P1775, DOI 10.1158/1078-0432.CCR-06-1863; Stroobants S, 2003, EUR J CANCER, V39, P2012, DOI 10.1016/S0959-8049(03)00073-X; SU JS, 2011, NMR BIOMED; Tate AR, 2006, NMR BIOMED, V19, P411, DOI 10.1002/nbm.1016; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; Van den Abbeele AD, 2008, PET CLIN, V3, P77, DOI 10.1016/j.cpet.2008.08.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yeung DKW, 2001, RADIOLOGY, V220, P40, DOI 10.1148/radiology.220.1.r01jl0240	60	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26155	10.1371/journal.pone.0026155	http://dx.doi.org/10.1371/journal.pone.0026155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022547	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000077
J	Na, B; Huang, ZM; Wang, Q; Qi, ZX; Tian, YJ; Lu, CC; Yu, JW; Hanes, MA; Kakar, S; Huang, EJ; Ou, JHJ; Liu, LM; Yen, TSB				Na, Bing; Huang, Zhiming; Wang, Qian; Qi, Zhongxia; Tian, Yongjun; Lu, Cheng-Chan; Yu, Jingwei; Hanes, Martha A.; Kakar, Sanjay; Huang, Eric J.; Ou, J. -H. James; Liu, Limin; Yen, T. S. Benedict			Transgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; LARGE SURFACE PROTEIN; HEPATOCELLULAR-CARCINOMA; ENDOPLASMIC-RETICULUM; X-PROTEIN; ER STRESS; TRANSCRIPTION FACTOR; TUMOR-GROWTH; S-PROMOTER; CYCLIN D1	Hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, is most commonly caused by chronic hepatitis B virus (HBV) infection. However, whether HBV plays any direct role in carcinogenesis, other than indirectly causing chronic liver injury by inciting the host immune response, remains unclear. We have established two independent transgenic mouse lines expressing the complete genome of a mutant HBV ("preS2 mutant") that is found at much higher frequencies in people with HCC than those without. The transgenic mice show evidence of stress in the endoplasmic reticulum (ER) and overexpression of cyclin D1 in hepatocytes. These mice do not show any evidence of chronic liver injury, but by 2 years of age a majority of the male mice develop hepatocellular neoplasms, including HCC. Unexpectedly, we also found a significant increase in hepatocarcinogenesis independent of necroinflammation in a transgenic line expressing the entire wildtype HBV. As in the mutant HBV mice, HCC was found only in aged-2-year-old-mice of the wildtype HBV line. The karyotype in all the three transgenic lines appears normal and none of the integration sites of the HBV transgene in the mice is near an oncogene or tumor suppressor gene. The significant increase of HCC incidence in all the three transgenic lines-expressing either mutant or wildtype HBV-therefore argues strongly that in absence of chronic necroinflammation, HBV can contribute directly to the development of HCC.	[Na, Bing; Huang, Zhiming; Wang, Qian; Kakar, Sanjay; Huang, Eric J.; Yen, T. S. Benedict] Vet Adm Med Ctr, Pathol Serv, San Francisco, CA 94121 USA; [Na, Bing; Liu, Limin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Qi, Zhongxia; Yu, Jingwei] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Tian, Yongjun; Ou, J. -H. James] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Lu, Cheng-Chan] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan; [Hanes, Martha A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Lab Anim Resources, San Antonio, TX 78229 USA; [Kakar, Sanjay; Huang, Eric J.; Yen, T. S. Benedict] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; National Cheng Kung University; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Francisco	Na, B (corresponding author), Vet Adm Med Ctr, Pathol Serv, San Francisco, CA 94121 USA.	Limin.Liu@ucsf.edu	Huang, Eric J./AAH-7997-2019; Tian, Yongjun/F-8007-2011	Huang, Eric J./0000-0002-5381-3801; 	US National Institutes of Health [R01CA55578, R01AI060559, R01CA122359, P30DK26743, P01CA123328]; Taiwan National Science Council [NSC88-2314-B-006-053, NSC89-2314-B-006-026]; NATIONAL CANCER INSTITUTE [P01CA123328, R01CA122359, R01CA055578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the US National Institutes of Health (R01CA55578 to TSBY, R01AI060559 to JHJO, R01CA122359 to LL, P30DK26743 to the University of California, San Francisco Liver Center, and P01CA123328 to TSBY, JHJO, and LL) and from the Taiwan National Science Council (NSC88-2314-B-006-053 and NSC89-2314-B-006-026 to CCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; [Anonymous], 1972, J Hered, V63, P69; ARAKI K, 1991, JPN J CANCER RES, V82, P235, DOI 10.1111/j.1349-7006.1991.tb01834.x; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Deane NG, 2001, CANCER RES, V61, P5389; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fan YF, 2000, J GASTROEN HEPATOL, V15, P519, DOI 10.1046/j.1440-1746.2000.02187.x; FERNHOLZ D, 1993, VIROLOGY, V194, P137, DOI 10.1006/viro.1993.1243; Foo NC, 2002, HEPATOLOGY, V36, P1400, DOI 10.1053/jhep.2002.36819; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Huang ZM, 2005, MOL CELL BIOL, V25, P7522, DOI 10.1128/MCB.25.17.7522-7533.2005; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Nagy Andras, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4706; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Raimondo G, 2004, J HEPATOL, V40, P515, DOI 10.1016/j.jhep.2003.11.025; Reifenberg K, 1997, J HEPATOL, V26, P119, DOI 10.1016/S0168-8278(97)80018-9; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Tai PC, 2002, VIROLOGY, V292, P44, DOI 10.1006/viro.2001.1239; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Xu ZC, 1996, J VIROL, V70, P133, DOI 10.1128/JVI.70.1.133-140.1996; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yergeau DA, 2007, NAT PROTOC, V2, P2975, DOI 10.1038/nprot.2007.428; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445; ZHOU DX, 1991, MOL CELL BIOL, V11, P1353, DOI 10.1128/MCB.11.3.1353; ZHOU DX, 1990, J BIOL CHEM, V265, P20731	49	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26240	10.1371/journal.pone.0026240	http://dx.doi.org/10.1371/journal.pone.0026240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022578	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000091
J	Batut, J; Duboe, C; Vandel, L				Batut, Julie; Duboe, Carine; Vandel, Laurence			The Methyltransferases PRMT4/CARM1 and PRMT5 Control Differentially Myogenesis in Zebrafish	PLOS ONE			English	Article							PROTEIN ARGININE METHYLATION; REGULATORY FACTORS; TAIL MESODERM; NO-TAIL; MUSCLE; CARM1; SLOW; SPADETAIL; IDENTIFICATION; TRANSCRIPTION	In vertebrates, skeletal myogenesis involves the sequential activation of myogenic factors to lead ultimately to the differentiation into slow and fast muscle fibers. How transcriptional co-regulators such as arginine methyltransferases PRMT4/CARM1 and PRMT5 control myogenesis in vivo remains poorly understood. Loss-of-function experiments using morpholinos against PRMT4/CARM1 and PRMT5 combined with in situ hybridization, quantitative polymerase chain reaction, as well as immunohistochemistry indicate a positive, but differential, role of these enzymes during myogenesis in vivo. While PRMT5 regulates myod, myf5 and myogenin expression and thereby slow and fast fiber formation, PRMT4/CARM1 regulates myogenin expression, fast fiber formation and does not affect slow fiber formation. However, our results show that PRMT4/CARM1 is required for proper slow myosin heavy chain localization. Altogether, our results reveal a combinatorial role of PRMT4/CARM1 and PRMT5 for proper myogenesis in zebrafish.	[Batut, Julie; Duboe, Carine; Vandel, Laurence] Univ Toulouse Paul Sabatier, Ctr Dev Biol, Toulouse, France; [Batut, Julie; Duboe, Carine; Vandel, Laurence] CNRS, Ctr Dev Biol, UMR 5547, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batut, J (corresponding author), Univ Toulouse Paul Sabatier, Ctr Dev Biol, Toulouse, France.	vandel@cict.fr	Batut, Julie/ABC-1505-2021	Batut, Julie/0000-0002-1984-2094; Vandel, Laurence/0000-0002-3692-2942	Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer; Association Francaise contre les Myopathies	Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique (http://www.cnrs.fr/), Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/), and Association Francaise contre les Myopathies (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher SL, 2002, DEVELOPMENT, V129, P3311; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Ceschin DG, 2011, GENE DEV, V25, P1132, DOI 10.1101/gad.619211; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; Cortes F, 2003, DEV CELL, V5, P865, DOI 10.1016/S1534-5807(03)00362-9; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Devoto SH, 1996, DEVELOPMENT, V122, P3371; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fauquier L, 2008, FASEB J, V22, P3337, DOI 10.1096/fj.07-104604; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Mallappa C, 2011, NUCLEIC ACIDS RES, V39, P1243, DOI 10.1093/nar/gkq896; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xu YF, 1999, DNA CELL BIOL, V18, P85, DOI 10.1089/104454999315655; Yahi H, 2006, EXPERT OPIN THER TAR, V10, P923, DOI 10.1517/14728222.10.6.923	35	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25427	10.1371/journal.pone.0025427	http://dx.doi.org/10.1371/journal.pone.0025427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016767	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700009
J	Lai, Y; Yi, GH; Chen, A; Bhardwaj, K; Tragesser, BJ; Valverde, RA; Zlotnick, A; Mukhopadhyay, S; Ranjith-Kumar, CT; Kao, CC				Lai, Yvonne; Yi, Guanghui; Chen, Alice; Bhardwaj, Kanchan; Tragesser, Brady J.; Valverde, Rodrigo A.; Zlotnick, Adam; Mukhopadhyay, Suchetana; Ranjith-Kumar, C. T.; Kao, C. Cheng			Viral Double-Strand RNA-Binding Proteins Can Enhance Innate Immune Signaling by Toll-Like Receptor 3	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; DE-NOVO INITIATION; FUNCTIONAL ANALYSES; EPITHELIAL-CELLS; COAT PROTEIN; RIG-I; LUPUS-ERYTHEMATOSUS; POLYMERASE; NS5B; INFECTION	Toll-like Receptor 3 (TLR3) detects double-stranded (ds) RNAs to activate innate immune responses. While poly(I:C) is an excellent agonist for TLR3 in several cell lines and in human peripheral blood mononuclear cells, viral dsRNAs tend to be poor agonists, leading to the hypothesis that additional factor(s) are likely required to allow TLR3 to respond to viral dsRNAs. TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. The polymerase from the genotype 2a JFH-1 HCV was a poor enhancer of TLR3 signaling until it was mutated to favor a conformation that could bind better to a partially duplexed RNA. The 1b polymerase also co-localizes with TLR3 in endosomes. RNA-binding capsid proteins (CPs) from two positive-strand RNA viruses and the hepadenavirus hepatitis B virus (HBV) were also potent enhancers of TLR3 signaling by poly(I:C) or viral dsRNAs. A truncated version of the HBV CP that lacked an arginine-rich RNA-binding domain was unable to enhance TLR3 signaling. These results demonstrate that several viral RNA-binding proteins can enhance the dsRNA-dependent innate immune response initiated by TLR3.	[Lai, Yvonne; Yi, Guanghui; Chen, Alice; Bhardwaj, Kanchan; Tragesser, Brady J.; Zlotnick, Adam; Ranjith-Kumar, C. T.; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Valverde, Rodrigo A.] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA; [Mukhopadhyay, Suchetana] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Louisiana State University System; Louisiana State University; Indiana University System; Indiana University Bloomington	Lai, Y (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	Mackie, Ken/E-3384-2013; Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016	Bhardwaj, Kanchan/0000-0002-7331-7717; Zlotnick, Adam/0000-0001-9945-6267	National Institute of Allergy and Infectious Diseases [RAI075015A, 1RO1AI073335, 1RO1090280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090280, R01AI067417, R01AI073335, R21AI075015] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CCK acknowledges funding from National Institute of Allergy and Infectious Diseases grants RAI075015A, 1RO1AI073335 and 1RO1090280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dragnea B, 2003, J AM CHEM SOC, V125, P6374, DOI 10.1021/ja0343609; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; Fox JM, 1998, VIROLOGY, V244, P212, DOI 10.1006/viro.1998.9107; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gauzzi MC, 2010, IMMUNOBIOLOGY, V215, P713, DOI 10.1016/j.imbio.2010.05.008; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GUIALIS A, 1994, CLIN EXP IMMUNOL, V95, P385; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Kao CC, 2011, MOL PLANT PATHOL, V12, P403, DOI 10.1111/j.1364-3703.2010.00678.x; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Lai Y, 2011, LL37 CATIONIC UNPUB; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Leonard Joshua N., 2009, V517, P55, DOI 10.1007/978-1-59745-541-1_4; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mukhopadhyay S, 2002, J VIROL, V76, P11128, DOI 10.1128/JVI.76.21.11128-11132.2002; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nahum A, 2011, J ALLERGY CLIN IMMUN, V127, P528, DOI 10.1016/j.jaci.2010.09.031; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Qi XP, 2011, MOL PLANT MICROBE IN, V24, P25, DOI 10.1094/MPMI-07-10-0147; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Ranjith-Kumar CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012878; Ranjith-Kumar CT, 2004, J VIROL, V78, P12207, DOI 10.1128/JVI.78.22.12207-12217.2004; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; RAO ALN, 1995, VIROLOGY, V211, P42, DOI 10.1006/viro.1995.1377; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; SACHER R, 1989, J VIROL, V63, P4545, DOI 10.1128/JVI.63.11.4545-4552.1989; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Seeger CZF, 2007, HEPADNAVIRUSES FIELD, P2977; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Valverde RA, 2007, VIRUS GENES, V35, P399, DOI 10.1007/s11262-007-0092-1; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Watkins WJ, 2010, CURR OPIN DRUG DISC, V13, P441; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zlotnick A, 2011, TRENDS MICROBIOL, V19, P14, DOI 10.1016/j.tim.2010.11.003	73	26	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25837	10.1371/journal.pone.0025837	http://dx.doi.org/10.1371/journal.pone.0025837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016778	gold, Green Published, Green Submitted			2022-12-25	WOS:000295971700020
J	Lauterbach, L; Idris, Z; Vincent, KA; Lenz, O				Lauterbach, Lars; Idris, Zulkifli; Vincent, Kylie A.; Lenz, Oliver			Catalytic Properties of the Isolated Diaphorase Fragment of the NAD(+)-Reducing [NiFe]-Hydrogenase from Ralstonia eutropha	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; NOCARDIA-OPACA 1B; BOVINE HEART-MITOCHONDRIA; ALCALIGENES-EUTROPHUS; ESCHERICHIA-COLI; REDUCING HYDROGENASE; SOLUBLE HYDROGENASE; ACTIVE-SITE; THERMUS-THERMOPHILUS	The NAD(+)-reducing soluble hydrogenase (SH) from Ralstonia eutropha H16 catalyzes the H-2-driven reduction of NAD(+), as well as reverse electron transfer from NADH to H+, in the presence of O-2. It comprises six subunits, HoxHYFUI(2), and incorporates a [NiFe] H+/H-2 cycling catalytic centre, two non-covalently bound flavin mononucleotide (FMN) groups and an iron-sulfur cluster relay for electron transfer. This study provides the first characterization of the diaphorase sub-complex made up of HoxF and HoxU. Sequence comparisons with the closely related peripheral subunits of Complex I in combination with UV/Vis spectroscopy and the quantification of the metal and FMN content revealed that HoxFU accommodates a [2Fe2S] cluster, FMN and a series of [4Fe4S] clusters. Protein film electrochemistry (PFE) experiments show clear electrocatalytic activity for both NAD(+) reduction and NADH oxidation with minimal overpotential relative to the potential of the NAD(+)/NADH couple. Michaelis-Menten constants of 56 mu M and 197 mu M were determined for NADH and NAD(+), respectively. Catalysis in both directions is product inhibited with K-I values of around 0.2 mM. In PFE experiments, the electrocatalytic current was unaffected by O-2, however in aerobic solution assays, a moderate superoxide production rate of 54 nmol per mg of protein was observed, meaning that the formation of reactive oxygen species (ROS) observed for the native SH can be attributed mainly to HoxFU. The results are discussed in terms of their implications for aerobic functioning of the SH and possible control mechanism for the direction of catalysis.	[Lauterbach, Lars; Lenz, Oliver] Humboldt Univ, Dept Microbiol, Inst Biol, Berlin, Germany; [Idris, Zulkifli; Vincent, Kylie A.] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford, England	Humboldt University of Berlin; University of Oxford	Lauterbach, L (corresponding author), Humboldt Univ, Dept Microbiol, Inst Biol, Berlin, Germany.	kylie.vincent@chem.ox.ac.uk; oliver.lenz@cms.hu-berlin.de	Lenz, Oliver/N-5130-2019; Lauterbach, Lars/L-6671-2014; Vincent, Kylie/H-1224-2011; Lenz, Oliver/C-1582-2019; Lauterbach, Lars/P-6741-2019	Lenz, Oliver/0000-0003-4550-5128; Lauterbach, Lars/0000-0002-6601-6473; Lenz, Oliver/0000-0003-4550-5128; Lauterbach, Lars/0000-0002-6601-6473; Vincent, Kylie/0000-0001-6444-9382	Royal Society for an International Joint Project; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG)	Royal Society for an International Joint Project; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors are grateful to the Royal Society for an International Joint Project Grant. The work of OL and LL was supported by the Cluster of Excellence "Unifying Concepts in Catalysis" funded by the Deutsche Forschungsgemeinschaft (DFG). KAV is a Royal Society Research Fellow and a Research Councils United Kingdom Academic Fellow and has received support from the Oxford University Press John Fell Fund and the European Research Council (ERC Starting Grant 258600). ZI is grateful for a scholarship from the Malaysian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Albracht SPJ, 2003, BBA-BIOENERGETICS, V1557, P41, DOI 10.1016/S0005-2728(02)00393-6; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Barker CD, 2007, BIOCHEMISTRY-US, V46, P3454, DOI 10.1021/bi061988y; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Bleijlevens B, 2004, J BIOL CHEM, V279, P46686, DOI 10.1074/jbc.M406942200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GAVRIKOVA EV, 1995, BBA-BIOENERGETICS, V1230, P23, DOI 10.1016/0005-2728(95)00015-B; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Grivennikova VG, 2003, BBA-BIOENERGETICS, V1607, P79, DOI 10.1016/j.bbabio.2003.09.001; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Horch M, 2010, ANGEW CHEM INT EDIT, V49, P8026, DOI 10.1002/anie.201002197; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Jackson JB, 2003, FEBS LETT, V555, P176, DOI 10.1016/S0014-5793(03)01123-2; JOHANNSSEN W, 1991, ARCH MICROBIOL, V155, P303, DOI 10.1007/BF00252217; Kohlstadt M, 2008, BIOCHEMISTRY-US, V47, P13036, DOI 10.1021/bi801307n; KUHN M, 1984, J BACTERIOL, V159, P633, DOI 10.1128/JB.159.2.633-639.1984; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauterbach L, 2011, EUR J INORG CHEM, P1067, DOI 10.1002/ejic.201001053; Lippard S. J., 1994, PRINCIPLES BIOINORGA; LOOMIS AG, 1928, INT CRIT TABLES, V3, P255; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Massanz C, 1998, J BACTERIOL, V180, P1023, DOI 10.1128/JB.180.5.1023-1029.1998; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Noll G, 2008, J PHOTOCH PHOTOBIO A, V200, P34, DOI 10.1016/j.jphotochem.2008.06.019; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; RAGAN CI, 1982, BIOCHEMISTRY-US, V21, P590, DOI 10.1021/bi00532a027; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHNEIDER K, 1981, BIOCHEM J, V193, P99, DOI 10.1042/bj1930099; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; SCHNEIDER K, 1984, EUR J BIOCHEM, V138, P533, DOI 10.1111/j.1432-1033.1984.tb07948.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; SCHNEIDER K, 1978, BIOCHEM BIOPH RES CO, V84, P564, DOI 10.1016/0006-291X(78)90743-X; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1143, P199, DOI 10.1016/0005-2728(93)90143-4; Spiegelhauer O, 2009, BIOCHEMISTRY-US, V48, P11412, DOI 10.1021/bi901370u; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Linden E, 2006, J BIOL INORG CHEM, V11, P247, DOI 10.1007/s00775-005-0075-4; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Zhao T, 2001, J BACTERIOL, V183, P6225, DOI 10.1128/JB.183.21.6225-6233.2001	60	39	39	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25939	10.1371/journal.pone.0025939	http://dx.doi.org/10.1371/journal.pone.0025939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016788	Green Published, Green Submitted, gold			2022-12-25	WOS:000295971700026
J	Stitz, M; Baldwin, IT; Gaquerel, E				Stitz, Michael; Baldwin, Ian T.; Gaquerel, Emmanuel			Diverting the Flux of the JA Pathway in Nicotiana attenuata Compromises the Plant's Defense Metabolism and Fitness in Nature and Glasshouse	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; PREDATOR-PREY INTERACTIONS; JASMONIC ACID; METHYL JASMONATE; MOLECULAR-INTERACTIONS; HERBIVORE RESISTANCE; RESPONSES; SIGNAL; GROWTH; ROLES	A plant's inducible defenses against herbivores as well as certain developmental processes are known to be controlled by the jasmonic acid (JA) pathway. We have previously shown that ectopically expressing Arabidopsis thaliana JA O-methyltransferase in Nicotiana attenuata (35S-jmt) strongly reduces the herbivory-elicited jasmonate bursts by acting as metabolic sink that redirects free JA towards methylation; here we examine the consequences of this metabolic sink on N. attenuata's secondary metabolism and performance in nature. In the glasshouse, 35S-jmt plants produced fewer seed capsules due to shorter floral styles, which could be restored to wild type (WT) levels after hand-pollination, and were more susceptible to Manduca sexta larvae attack. When transplanted into the Great Basin Desert in Utah, 35S-jmt plants grew as well as WT empty vector, but were highly attacked by native herbivores of different feeding guilds: leaf chewers, miners, and single cell feeders. This greater susceptibility was strongly associated with reduced emissions of volatile organic compounds (hexenylesters, monoterpenes and sesquiterpenes) and profound alterations in the production of direct defenses (trypsin proteinase inhibitors [TPI], nicotine, diterpene glycosides [DTGs] and phenylpropanoid-polyamine conjugates) as revealed by a combination of targeted and metabolomics analyses of field collected samples. Complementation experiments with JA-Ile, whose formation is outcompeted in 35S-jmt plants by the methylation reaction, restored the local TPI activation to WT levels and partially complemented nicotine and DTG levels in elicited but not systemic leaves. These findings demonstrate that MeJA, the major JA metabolite in 35S-jmt plants, is not an active signal in defense activation and highlights the value of creating JA sinks to disrupt JA signaling, without interrupting the complete octadecanoid pathway, in order to investigate the regulation of plants' defense metabolism in nature.	[Stitz, Michael; Baldwin, Ian T.; Gaquerel, Emmanuel] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Stitz, M (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	egaquerel@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Gaquerel, Emmanuel/I-2503-2014; Gaquerel, Emmanuel/ABE-6313-2020	Gaquerel, Emmanuel/0000-0003-0796-6417; Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Max Planck Society was the only funder of this work. The Max Planck Society had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, PLANT CELL ENVIRON, V33, P2028, DOI 10.1111/j.1365-3040.2010.02203.x; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; Cipollini D, 2007, NEW PHYTOL, V173, P146, DOI 10.1111/j.1469-8137.2006.01882.x; Cipollini D, 2010, EVOL ECOL, V24, P59, DOI 10.1007/s10682-008-9290-0; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DEMOLE E, 1962, HELV CHIM ACTA, V45, P1951, DOI 10.1002/hlca.19620450629; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1988, EXP APPL ACAROL, V5, P225, DOI 10.1007/BF02366096; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jung Choonkyun, 2003, Journal of Applied Biological Chemistry, V46, P52; Kallenbach M, 2010, PLANT PHYSIOL, V152, P1760, DOI 10.1104/pp.110.900317; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MEYER A, 1984, J PLANT GROWTH REGUL, V3, P1, DOI 10.1007/BF02041987; Pandey SP, 2008, PLANT J, V54, P845, DOI 10.1111/j.1365-313X.2008.03450.x; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Roda A, 2004, MOL ECOL, V13, P2421, DOI 10.1111/j.1365-294X.2004.02260.x; SABELIS MW, 1983, ENTOMOL EXP APPL, V33, P303, DOI 10.1111/j.1570-7458.1983.tb03273.x; Schittko U, 2001, PLANT PHYSIOL, V125, P701, DOI 10.1104/pp.125.2.701; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Song JT, 2000, PLANT MOL BIOL, V42, P647, DOI 10.1023/A:1006381625421; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Tautenhahn R., 2008, BMC BIOINFORMATICS, V9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu JS, 2008, PLANTA, V227, P1161, DOI 10.1007/s00425-008-0690-8; Xue Rengao, 2007, Journal of Genetics and Genomics, V34, P339, DOI 10.1016/S1673-8527(07)60036-8; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; YAO KN, 1995, PLANT CELL, V7, P1787, DOI 10.1105/tpc.7.11.1787; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x	61	29	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25925	10.1371/journal.pone.0025925	http://dx.doi.org/10.1371/journal.pone.0025925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22022469	Green Submitted, gold, Green Published			2022-12-25	WOS:000295971700025
J	Siebers, B; Zaparty, M; Raddatz, G; Tjaden, B; Albers, SV; Bell, SD; Blombach, F; Kletzin, A; Kyrpides, N; Lanz, C; Plagens, A; Rampp, M; Rosinus, A; von Jan, M; Makarova, KS; Klenk, HP; Schuster, SC; Hensel, R				Siebers, Bettina; Zaparty, Melanie; Raddatz, Guenter; Tjaden, Britta; Albers, Sonja-Verena; Bell, Steve D.; Blombach, Fabian; Kletzin, Arnulf; Kyrpides, Nikos; Lanz, Christa; Plagens, Andre; Rampp, Markus; Rosinus, Andrea; von Jan, Mathias; Makarova, Kira S.; Klenk, Hans-Peter; Schuster, Stephan C.; Hensel, Reinhard			The Complete Genome Sequence of Thermoproteus tenax: A Physiologically Versatile Member of the Crenarchaeota	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; TRANSFER-RNA GENES; SULFOLOBUS-SOLFATARICUS; DNA-REPLICATION; FACTOR B; PROTEIN; TRANSCRIPTION; IDENTIFICATION; ARCHAEA; BINDING	Here, we report on the complete genome sequence of the hyperthermophilic Crenarchaeum Thermoproteus tenax (strain Kra 1, DSM 2078(T)) a type strain of the crenarchaeotal order Thermoproteales. Its circular 1.84-megabase genome harbors no extrachromosomal elements and 2,051 open reading frames are identified, covering 90.6% of the complete sequence, which represents a high coding density. Derived from the gene content, T. tenax is a representative member of the Crenarchaeota. The organism is strictly anaerobic and sulfur-dependent with optimal growth at 86 degrees C and pH 5.6. One particular feature is the great metabolic versatility, which is not accompanied by a distinct increase of genome size or information density as compared to other Crenarchaeota. T. tenax is able to grow chemolithoautotrophically (CO2/H-2) as well as chemoorganoheterotrophically in presence of various organic substrates. All pathways for synthesizing the 20 proteinogenic amino acids are present. In addition, two presumably complete gene sets for NADH:quinone oxidoreductase (complex I) were identified in the genome and there is evidence that either NADH or reduced ferredoxin might serve as electron donor. Beside the typical archaeal A(0)A(1)-ATP synthase, a membrane-bound pyrophosphatase is found, which might contribute to energy conservation. Surprisingly, all genes required for dissimilatory sulfate reduction are present, which is confirmed by growth experiments. Mentionable is furthermore, the presence of two proteins (ParA family ATPase, actin-like protein) that might be involved in cell division in Thermoproteales, where the ESCRT system is absent, and of genes involved in genetic competence (DprA, ComF) that is so far unique within Archaea.	[Siebers, Bettina] Univ Duisburg Essen, Biofilm Ctr, Fac Chem, Essen, Germany; [Zaparty, Melanie] Univ Regensburg, Inst Mol & Cellular Anat, Regensburg, Germany; [Raddatz, Guenter] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Tjaden, Britta; Albers, Sonja-Verena; Plagens, Andre; Hensel, Reinhard] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Bell, Steve D.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Blombach, Fabian] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kletzin, Arnulf] Tech Univ Darmstadt, Inst Microbiol & Genet, Darmstadt, Germany; [Kyrpides, Nikos] DOE Joint Genome Inst, Walnut Creek, CA USA; [Lanz, Christa; Rosinus, Andrea] Max Planck Inst Dev Biol, Genome Ctr, Tubingen, Germany; [Rampp, Markus] Max Planck Inst Plasma Phys, Comp Ctr Garching, Max Planck Soc RZG, Munich, Germany; [von Jan, Mathias; Klenk, Hans-Peter] German Collect Microorganisms & Cell Cultures, DSMZ, Braunschweig, Germany; [Makarova, Kira S.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	University of Duisburg Essen; University of Regensburg; Max Planck Society; Max Planck Society; University of Oxford; Wageningen University & Research; Technical University of Darmstadt; United States Department of Energy (DOE); Max Planck Society; Max Planck Society; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Siebers, B (corresponding author), Univ Duisburg Essen, Biofilm Ctr, Fac Chem, Essen, Germany.	bettina.siebers@uni-due.de; melanie.zaparty@vkl.uni-regensburg.de	Kyrpides, Nikos C./A-6305-2014; Albers, Sonja-Verena/H-8689-2019; Blombach, Fabian/AAT-9241-2020; Albers, Sonja-Verena/H-1213-2012; Kletzin, Arnulf/AAO-7366-2020	Kyrpides, Nikos C./0000-0002-6131-0462; Albers, Sonja-Verena/0000-0003-2459-2226; Blombach, Fabian/0000-0001-5337-8662; Rampp, Markus/0000-0001-8177-8698; Kletzin, Arnulf/0000-0002-4500-2232; Siebers, Bettina/0000-0002-9905-541X	University of Duisburg-Essen (Germany); Deutsche Forschungsgemeinschaft (DFG) [SPP1112, He1238/16-2]; Dutch Science Organization (NWO); Max Planck society	University of Duisburg-Essen (Germany); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Max Planck society(Max Planck Society)	This work was supported by the University of Duisburg-Essen (Germany) and the Deutsche Forschungsgemeinschaft (DFG; SPP1112) by grant He1238/16-2, 3 (Dr. Hensel). Dr. Albers was supported by a VIDI grant of the Dutch Science Organization (NWO) and intramural funds of the Max Planck society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DG, 2006, VIROLOGY, V351, P280, DOI 10.1016/j.virol.2006.03.039; Albers SV, 2006, NAT REV MICROBIOL, V4, P537, DOI 10.1038/nrmicro1440; Albers SV, 1999, J BACTERIOL, V181, P4285, DOI 10.1128/JB.181.14.4285-4291.1999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2008, J BACTERIOL, V190, P2957, DOI 10.1128/JB.01949-07; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baliga NS, 2000, MOL MICROBIOL, V36, P1184, DOI 10.1046/j.1365-2958.2000.01916.x; Bandeiras TM, 2009, BBA-BIOENERGETICS, V1787, P37, DOI 10.1016/j.bbabio.2008.09.009; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; BAUMEISTER W, 1992, J BIOENERG BIOMEMBR, V24, P567, DOI 10.1007/BF00762349; Bell SD, 2000, J BIOL CHEM, V275, P12934, DOI 10.1074/jbc.275.17.12934; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Born TL, 1999, CURR OPIN CHEM BIOL, V3, P607, DOI 10.1016/S1367-5931(99)00016-2; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Coenye T, 2005, FEMS MICROBIOL LETT, V242, P117, DOI 10.1016/j.femsle.2004.10.050; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Csuros M, 2009, MOL BIOL EVOL, V26, P2087, DOI 10.1093/molbev/msp123; Dirmeier R, 1998, EUR J BIOCHEM, V252, P486, DOI 10.1046/j.1432-1327.1998.2520486.x; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; EIKMANNS B, 1983, ARCH MICROBIOL, V136, P111, DOI 10.1007/BF00404783; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; Elkins J.G., 2008, P NATL ACAD SCI USA, V105, P8805; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; FISCHER F, 1983, NATURE, V301, P511, DOI 10.1038/301511a0; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Graupner M, 2001, J BACTERIOL, V183, P5203, DOI 10.1128/JB.183.17.5203-5205.2001; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Haring M, 2004, VIROLOGY, V323, P233, DOI 10.1016/j.virol.2004.03.002; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Higuchi S, 1999, P JPN ACAD B-PHYS, V75, P241, DOI 10.2183/pjab.75.241; Hiller A, 2003, J BIOENERG BIOMEMBR, V35, P121, DOI 10.1023/A:1023742002493; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-38; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Linke Burkhard, 2006, Appl Bioinformatics, V5, P193, DOI 10.2165/00822942-200605030-00008; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo X, 2007, J BACTERIOL, V189, P403, DOI 10.1128/JB.01246-06; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 1999, GENOME RES, V9, P608; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mogi T, 2009, J BIOCHEM, V145, P763, DOI 10.1093/jb/mvp033; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Nather DJ, 2004, BIOCHEM SOC T, V32, P199, DOI 10.1042/BST0320199; NEUMANN H, 1990, MOL GEN GENET, V222, P435, DOI 10.1007/BF00633851; Orita I, 2005, J BACTERIOL, V187, P3636, DOI 10.1128/JB.187.11.3636-3642.2005; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Paytubi S, 2009, MOL MICROBIOL, V72, P1487, DOI 10.1111/j.1365-2958.2009.06737.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; Ramos-Vera WH, 2009, J BACTERIOL, V191, P4286, DOI 10.1128/JB.00145-09; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; SANGER F, 1973, P NATL ACAD SCI USA, V70, P1209, DOI 10.1073/pnas.70.4.1209; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAFER S, 1989, EUR J BIOCHEM, V186, P695, DOI 10.1111/j.1432-1033.1989.tb15262.x; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; SELIG M, 1994, ARCH MICROBIOL, V162, P286, DOI 10.1007/BF00301853; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Swiatek A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-17; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tsoka S, 2003, ARCHAEA, V1, P223; Tsubaki M, 2000, J INORG BIOCHEM, V82, P19, DOI 10.1016/S0162-0134(00)00140-9; van der Oost J, 2007, ARCHAEA EVOLUTION PH, V22, P247; Vaupel M, 1996, EUR J BIOCHEM, V236, P294, DOI 10.1111/j.1432-1033.1996.00294.x; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Verhees CH, 2001, J BIOL CHEM, V276, P40926, DOI 10.1074/jbc.M104603200; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; WILDHABER I, 1987, EMBO J, V6, P1475, DOI 10.1002/j.1460-2075.1987.tb02389.x; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; Zaparty M, 2008, ARCH MICROBIOL, V190, P231, DOI 10.1007/s00203-008-0375-5; Zaparty M, 2008, J BACTERIOL, V190, P2231, DOI 10.1128/JB.01524-07; ZILLIG W, 1981, ZBL BAKT MIK HYG I C, V2, P205, DOI 10.1016/S0721-9571(81)80001-4	119	40	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24222	10.1371/journal.pone.0024222	http://dx.doi.org/10.1371/journal.pone.0024222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003381	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300002
J	Wu, J; Park, JP; Dooley, K; Cropek, DM; West, AC; Banta, S				Wu, Jun; Park, Jong Pil; Dooley, Kevin; Cropek, Donald M.; West, Alan C.; Banta, Scott			Rapid Development of New Protein Biosensors Utilizing Peptides Obtained via Phage Display	PLOS ONE			English	Article							QUARTZ-CRYSTAL MICROBALANCE; MODIFIED GOLD ELECTRODES; ALANINE AMINOTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; IMPEDANCE SPECTROSCOPY; CYTOCHROME-C; RECOGNITION; SERUM; IMMUNOSENSOR; TRANSAMINASE	There is a consistent demand for new biosensors for the detection of protein targets, and a systematic method for the rapid development of new sensors is needed. Here we present a platform where short unstructured peptides that bind to a desired target are selected using M13 phage display. The selected peptides are then chemically synthesized and immobilized on gold, allowing for detection of the target using electrochemical techniques such as electrochemical impedance spectroscopy (EIS). A quartz crystal microbalance (QCM) is also used as a diagnostic tool during biosensor development. We demonstrate the utility of this approach by creating a novel peptide-based electrochemical biosensor for the enzyme alanine aminotransferase (ALT), a well-known biomarker of hepatotoxicity. Biopanning of the M13 phage display library over immobilized ALT, led to the rapid identification of a new peptide (ALT5-8) with an amino acid sequence of WHWRNPDFWYLK. Phage particles expressing this peptide exhibited nanomolar affinity for immobilized ALT (K(d,app)= 85 +/- 20 nM). The newly identified ALT5-8 peptide was then chemically synthesized with a C-terminal cysteine for gold immobilization. The performance of the gold-immobilized peptides was studied with cyclic voltammetry (CV), QCM, and EIS. Using QCM, the sensitivity for ALT detection was 8.9 +/- 0.9 Hz/(mu g/mL) and the limit of detection (LOD) was 60 ng/mL. Using EIS measurements, the sensitivity was 142 +/- 12 impedance percentage change %/(mu g/mL) and the LOD was 92 ng/mL. In both cases, the LOD was below the typical concentration of ALT in human blood. Although both QCM and EIS produced similar LODs, EIS is preferable due to a larger linear dynamic range. Using QCM, the immobilized peptide exhibited a nanomolar dissociation constant for ALT (K(d) = 20.1 +/- 0.6 nM). These results demonstrate a simple and rapid platform for developing and assessing the performance of sensitive, peptide-based biosensors for new protein targets.	[Wu, Jun; Park, Jong Pil; Dooley, Kevin; West, Alan C.; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY USA; [Cropek, Donald M.] USA, Engineer Res & Dev Ctr, CERL, Champaign, IL USA	Columbia University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Construction Engineering Research Laboratory (CERL); Geospatial Research Laboratory (GRL)	Wu, J (corresponding author), Atotech USA Inc, Albany, NY USA.	sbanta@columbia.edu			United States Army Corps of Engineers Applied Research program	United States Army Corps of Engineers Applied Research program	This study was funded by the United States Army Corps of Engineers Applied Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Amacher DE, 2002, HUM EXP TOXICOL, V21, P253, DOI 10.1191/0960327102ht247oa; Archer MJ, 2009, SENSORS-BASEL, V9, P6298, DOI 10.3390/s90806298; BARKER PD, 1990, EUR J BIOCHEM, V190, P171, DOI 10.1111/j.1432-1033.1990.tb15561.x; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Casero E, 2010, ANALYST, V135, P1878, DOI 10.1039/c0an00120a; Ceriotti L, 2007, BIOSENS BIOELECTRON, V22, P3057, DOI 10.1016/j.bios.2007.01.004; Chang KS, 2007, BIOSENS BIOELECTRON, V22, P2914, DOI 10.1016/j.bios.2006.12.001; Chen XJJ, 2008, ANAL CHEM, V80, P9622, DOI 10.1021/ac800796b; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Curtis TM, 2009, LAB CHIP, V9, P2176, DOI [10.1039/b901314h, 10.1039/b901314b]; DIGLERIA K, 1986, J ELECTROANAL CHEM, V213, P333, DOI 10.1016/0022-0728(86)80216-9; Dover JE, 2009, J MICROBIOL METH, V78, P10, DOI 10.1016/j.mimet.2009.04.008; GRUBER W, 1977, J CLIN CHEM CLIN BIO, V15, P565; HAFKENSCHEID JCM, 1979, CLIN CHEM, V25, P55; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756; Inamori K, 2008, ANAL CHEM, V80, P643, DOI 10.1021/ac701667g; Iqbal SS, 2000, BIOSENS BIOELECTRON, V15, P549, DOI 10.1016/S0956-5663(00)00108-1; JUNG K, 1977, CLIN CHIM ACTA, V79, P515, DOI 10.1016/0009-8981(77)90171-1; Kaplan MM, 2002, ANN INTERN MED, V137, P49, DOI 10.7326/0003-4819-137-1-200207020-00012; Kara P, 2010, BIOSENS BIOELECTRON, V26, P1715, DOI 10.1016/j.bios.2010.07.090; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Laricchia-Robbio L, 2004, BIOSENS BIOELECTRON, V19, P1753, DOI 10.1016/j.bios.2003.11.026; Lisdat F, 2008, ANAL BIOANAL CHEM, V391, P1555, DOI 10.1007/s00216-008-1970-7; Liu FF, 2009, SENSOR ACTUAT B-CHEM, V136, P133, DOI 10.1016/j.snb.2008.11.031; Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007; Luppa PB, 2001, CLIN CHIM ACTA, V314, P1, DOI 10.1016/S0009-8981(01)00629-5; Mantzila AG, 2007, BIOSENS BIOELECTRON, V23, P362, DOI 10.1016/j.bios.2007.04.017; Marx KA, 2007, SPRINGER SER CHEM SE, V5, P371, DOI 10.1007/5346_033; Nanduri V, 2007, BIOSENS BIOELECTRON, V22, P986, DOI 10.1016/j.bios.2006.03.025; Newman JD, 2006, MOL BIOTECHNOL, V32, P249, DOI 10.1385/MB:32:3:249; Nilsson F, 2000, ADV DRUG DELIVER REV, V43, P165, DOI 10.1016/S0169-409X(00)00068-5; Ohgami N, 2007, BIOSENS BIOELECTRON, V22, P1330, DOI 10.1016/j.bios.2006.06.007; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park JP, 2010, BIOTECHNOL BIOENG, V105, P678, DOI 10.1002/bit.22597; Privett BJ, 2008, ANAL CHEM, V80, P4499, DOI 10.1021/ac8007219; Ronkainen NJ, 2010, CHEM SOC REV, V39, P1747, DOI 10.1039/b714449k; Sadik OA, 2009, BIOSENS BIOELECTRON, V24, P2749, DOI 10.1016/j.bios.2008.10.003; Shen Z, 2005, ANAL CHEM, V77, P797, DOI 10.1021/ac048655w; Wang J, 2001, ELECTROANAL, V13, P13, DOI 10.1002/1521-4109(200101)13:1<13::AID-ELAN13>3.0.CO;2-F; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wu J, 2010, ANAL CHEM, V82, P8235, DOI 10.1021/ac101657h; Xuan GS, 2003, BIOSENS BIOELECTRON, V19, P365, DOI 10.1016/S0956-5663(03)00194-5	46	46	47	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24948	10.1371/journal.pone.0024948	http://dx.doi.org/10.1371/journal.pone.0024948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003385	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300006
J	Yamamoto, M; Kato, T; Hotta, C; Nishiyama, A; Kurotaki, D; Yoshinari, M; Takami, M; Ichino, M; Nakazawa, M; Matsuyama, T; Kamijo, R; Kitagawa, S; Ozato, K; Tamura, T				Yamamoto, Michio; Kato, Takayuki; Hotta, Chie; Nishiyama, Akira; Kurotaki, Daisuke; Yoshinari, Masahiro; Takami, Masamichi; Ichino, Motohide; Nakazawa, Masatoshi; Matsuyama, Toshifumi; Kamijo, Ryutaro; Kitagawa, Seiichi; Ozato, Keiko; Tamura, Tomohiko			Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; INTERFERON-REGULATORY FACTOR-4; PROGENITOR CELLS; STEM-CELLS; LEUKEMIA; MACROPHAGES; EXPRESSION; DIFFERENTIATION; ICSBP; RESPONSES	Interferon regulatory factor (IRF) 8 and IRF4 are structurally-related, hematopoietic cell-specific transcription factors that cooperatively regulate the differentiation of dendritic cells and B cells. Whilst in myeloid cells IRF8 is known to modulate growth and differentiation, the role of IRF4 is poorly understood. In this study, we show that IRF4 has activities similar to IRF8 in regulating myeloid cell development. The ectopic expression of IRF4 in myeloid progenitor cells in vitro inhibits cell growth, promotes macrophages, but hinders granulocytic cell differentiation. We also show that IRF4 binds to and activates transcription through the IRF-Ets composite sequence (IECS). Furthermore, we demonstrate that Irf8(-/-)Irf4(-/-) mice exhibit a more severe chronic myeloid leukemia (CML)-like disease than Irf8(-/-) mice, involving a disproportionate expansion of granulocytes at the expense of monocytes/macrophages. Irf4(-/-) mice, however, display no obvious abnormality in myeloid cell development, presumably because IRF4 is expressed at a much lower level than IRF8 in granulocyte-macrophage progenitors. Our results also suggest that IRF8 and IRF4 have not only common but also specific activities in myeloid cells. Since the expression of both the IRF8 and IRF4 genes is downregulated in CML patients, these results may add to our understanding of CML pathogenesis.	[Yamamoto, Michio; Hotta, Chie; Nishiyama, Akira; Kurotaki, Daisuke; Yoshinari, Masahiro; Ichino, Motohide; Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Kato, Takayuki; Kitagawa, Seiichi; Tamura, Tomohiko] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 558, Japan; [Takami, Masamichi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan; [Nakazawa, Masatoshi] Yokohama City Univ, Dept Expt Anim Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Matsuyama, Toshifumi] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Ozato, Keiko; Tamura, Tomohiko] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	Yokohama City University; Osaka Metropolitan University; Showa University; Yokohama City University; Nagasaki University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yamamoto, M (corresponding author), Yokohama City Univ, Dept Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	tamurat@yokohama-cu.ac.jp		Kurotaki, Daisuke/0000-0002-4728-0113; Takami, Masamichi/0000-0002-4506-3975	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Yokohama City University; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Yokohama Foundation for Advancement of Medical Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23659492] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama City University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; Yokohama Foundation for Advancement of Medical Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B), the Grant-in-Aid for Exploratory Research, and the research grant for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Grant for Strategic Research Promotion from Yokohama City University, and research grants from the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation, and the Yokohama Foundation for Advancement of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; CHEN W, 1992, P NATL ACAD SCI USA, V89, P1468, DOI 10.1073/pnas.89.4.1468; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Marecki S, 1999, J IMMUNOL, V163, P2713; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	39	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25812	10.1371/journal.pone.0025812	http://dx.doi.org/10.1371/journal.pone.0025812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003407	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300028
J	Chen, BB; Glasser, JR; Coon, TA; Mallampalli, RK				Chen, B. B.; Glasser, J. R.; Coon, T. A.; Mallampalli, R. K.			F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest	ONCOGENE			English	Article						ubiquitin; camodulin; lung	CALCIUM-CONCENTRATION; REGULATORY ENZYME; D1 DEGRADATION; CALMODULIN; CANCER; PHOSPHORYLATION; EXPRESSION; KINASE; IDENTIFICATION; ALPHA	Dysregulated behavior of cell cycle proteins and their control by ubiquitin E3 ligases is an emerging theme in human lung cancer. Here, we identified and characterized the activity of a novel F-box protein, termed FBXL2, belonging to the SCF (Skip-Cullin1-F-box protein) E3 ligase family. Ectopically expressed FBXL2 triggered G2/M-phase arrest, induced chromosomal anomalies and increased apoptosis of transformed lung epithelia by mediating polyubiquitination and degradation of the mitotic regulator, cyclin D3. Unlike other F-box proteins that target phosphodegrons within substrates, FBXL2 uniquely recognizes a canonical calmodulin (CaM)-binding motif within cyclin D3 to facilitate its polyubiquitination. CaM bound and protected cyclin D3 from FBXL2 by direct intermolecular competition with the F-box protein for access within this motif. The chemotherapeutic agent vinorelbine increased apoptosis of human lung carcinoma cells by inducing FBXL2 expression and cyclin D3 degradation, an effect accentuated by CaM knockdown. Depletion of endogenous FBXL2 stabilized cyclin D3 levels, accelerated cancer cell growth and increased cell viability after vinorelbine treatment. Last, ectopic expression of FBXL2 significantly inhibited the growth and migration of tumorogenic cells and tumor formation in athymic nude mice. These observations implicate SCFFBXL2 as an indispensible regulator of mitosis that serves as a tumor suppressor. Oncogene (2012) 31, 2566-2579; doi:10.1038/onc.2011.432; published online 24 October 2011	[Mallampalli, R. K.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, UPMC Montefiore,Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, R. K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, R. K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, UPMC Montefiore,Acute Lung Injury Ctr Excellence, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; US Department of Veterans Affairs; National Institutes of Health [HL096376, HL097376, HL098174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096376, R01HL097376, R01HL098174] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); US Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	We thank AF Stewart for critical review of the manuscript and helpful suggestions. This material is based upon work supported, in part, by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported by a Merit Review Award from the US Department of Veterans Affairs and National Institutes of Health R01 grants HL096376, HL097376 and HL098174 (to RKM). The contents presented do not represent the views of the Department of Veterans Affairs or the United States Government.	Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Brown E M, 1984, Prog Clin Biol Res, V168, P139; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen BB, 2011, MOL CELL BIOL, V22, P22; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Duan YN, 2010, INFLAMMATION, V33, P189, DOI 10.1007/s10753-009-9173-8; Fang MZ, 2002, J VET MED SCI, V64, P201, DOI 10.1292/jvms.64.201; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Ilyin GP, 1999, FEBS LETT, V459, P75, DOI 10.1016/S0014-5793(99)01211-9; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Korkotian E, 1996, J PHYSIOL-LONDON, V496, P39, DOI 10.1113/jphysiol.1996.sp021663; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; LU KP, 1992, MOL ENDOCRINOL, V6, P365, DOI 10.1210/me.6.3.365; Malard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-147; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Papay J, 2007, APPL IMMUNOHISTO M M, V15, P19, DOI 10.1097/01.pai.0000213143.32030.f5; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pszczolkowski MA, 1999, MOL CELL ENDOCRINOL, V158, P163, DOI 10.1016/S0303-7207(99)00167-7; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Sterlacci W, 2010, J THORAC ONCOL, V5, P1325, DOI 10.1097/JTO.0b013e3181e77efc; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tanguay DA, 2001, J IMMUNOL, V166, P4273, DOI 10.4049/jimmunol.166.7.4273; Taules M, 1998, J BIOL CHEM, V273, P33279, DOI 10.1074/jbc.273.50.33279; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Weiderpass Elisabete, 2010, J Prev Med Public Health, V43, P459, DOI 10.3961/jpmph.2010.43.6.459; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012; Zhang SW, 2002, J BIOL CHEM, V277, P35314, DOI 10.1074/jbc.M202179200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	56	59	62	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2566	2579		10.1038/onc.2011.432	http://dx.doi.org/10.1038/onc.2011.432			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	22020328	Green Accepted			2022-12-25	WOS:000304191800007
J	Schreiber, G; Barberis, M; Scolari, S; Klaus, C; Herrmann, A; Klipp, E				Schreiber, Gabriele; Barberis, Matteo; Scolari, Silvia; Klaus, Christine; Herrmann, Andreas; Klipp, Edda			Unraveling interactions of cell cycle-regulating proteins Sic1 and B-type cyclins in living yeast cells: a FLIM-FRET approach	FASEB JOURNAL			English	Article						Saccharomyces cerevisiae; Forster resonance energy transfer; fluorescence lifetime imaging microscopy; Cdk1-Clb complexes; Cdk inhibitor	INFLUENZA-VIRUS HEMAGGLUTININ; KINASE INHIBITOR SIC1; S-PHASE; CDK INHIBITOR; DNA-REPLICATION; IN-VITRO; PHOSPHORYLATION; PROTEOLYSIS; DEGRADATION; TRANSITION	Sic1, cyclin-dependent kinase inhibitor of budding yeast, is synthesized in anaphase and largely degraded at the S-phase onset to regulate timing of DNA synthesis. Sic1 interacts with phase-specific B-type cyclin (Clb)-kinase (Cdk1) complexes, central regulators in cell cycle control. Its appearance is timed to mediate reduction in kinase activities at appropriate stages. Clbs are unstable proteins with extremely short half-lives. Interactions of Sic1 with Clbs have been detected both in vitro and in vivo by high-throughput genome-wide screenings. Furthermore, we have recently shown that Sic1 regulates waves of Clbs, acting as a timer in their appearance, thus controlling Cdk1-Clbs activation. The molecular mechanism is not yet fully understood but is hypothesized to occur via stoichiometric binding of Sic1 to Cdk1-Clb complexes. Using Forster resonance energy transfer (FRET) via fluorescence lifetime imaging microscopy (FLIM), we showed association of Sic1 to Clb cyclins in living yeast cells. This finding is consistent with the notion that inhibition of kinase activity can occur over the whole cell cycle progression despite variable Sic1 levels. Specifically, Sic1/Clb3 interaction was observed for the first time, and Sic1/Clb2 and Sic1/Clb5 pairs were confirmed, but no Sic1/Clb4 interaction was found, which suggests that, despite high functional homology between Clbs, only some of them can target Sic1 function in vivo.-Schreiber, G., Barberis, M., Scolari, S., Klaus, C., Herrmann, A., Klipp, E. Unraveling interactions of cell cycle-regulating proteins Sic1 and B-type cyclins in living yeast cells: a FLIM-FRET approach. FASEB J. 26, 546-554 (2012). www.fasebj.org	[Schreiber, Gabriele; Barberis, Matteo; Scolari, Silvia; Klaus, Christine; Herrmann, Andreas; Klipp, Edda] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Barberis, M (corresponding author), Humboldt Univ, Dept Biol, Invalidenstr 42, D-10115 Berlin, Germany.	matteo.barberis@biologie.hu-berlin.de; edda.klipp@rz.hu-berlin.de		Barberis, Matteo/0000-0001-5640-7422	European Commission, Experimental Network for Functional Integration (ENFIN) [LSHG-CT-2005-518254]; UNICELLSYS [HEALTH-2007-201142]; Deutsche Forschungsgemeinschaft [GRK-1121, Sonderforschungsbereich 740]	European Commission, Experimental Network for Functional Integration (ENFIN); UNICELLSYS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Rodrigo F. de Almeida for fruitful discussions on the data. This work was supported by grants from the European Commission, Experimental Network for Functional Integration (ENFIN; contract LSHG-CT-2005-518254) and UNICELLSYS (contract HEALTH-2007-201142), to E. K., from Deutsche Forschungsgemeinschaft (GRK-1121) to A. H., and from Sonderforschungsbereich 740 to A.H. and E.K.	AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bailly E, 1999, MOL CELL BIOL, V19, P6872; Barberis M, 2005, BIOCHEM BIOPH RES CO, V336, P1040, DOI 10.1016/j.bbrc.2005.08.224; Barberis M, 2005, BIOCHEM J, V387, P639, DOI 10.1042/BJ20041299; Barberis M., 2012, ADV SYSTEMS BIOL ADV, V736; Barberis M, 2012, BIOTECHNOL ADV, V30, P108, DOI 10.1016/j.biotechadv.2011.09.004; BASCO RD, 1995, MOL CELL BIOL, V15, P5030; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Engel S, 2010, BIOCHEM J, V425, P567, DOI 10.1042/BJ20091388; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Futcher B, 1996, YEAST, V12, P1635; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Honey S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e24; Kishi T, 2008, P NATL ACAD SCI USA, V105, P14497, DOI 10.1073/pnas.0806253105; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Komakhin R A, 2008, Mol Biol (Mosk), V42, P494; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; MENDENHALL MD, 1987, CELL, V50, P927, DOI 10.1016/0092-8674(87)90519-8; MENDENHALL MD, 1993, SCIENCE, V259, P216, DOI 10.1126/science.8421781; Miller A, 2010, J BIOL CHEM, V285, P35142, DOI 10.1074/jbc.M110.166918; Morgan D. O., 2007, PRIMERS BIOL SERIES; Morgan DO, 2002, NATURE, V418, P495, DOI 10.1038/418495a; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nair DK, 2006, OPT EXPRESS, V14, P12217, DOI 10.1364/OE.14.012217; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossi RL, 2005, CELL CYCLE, V4, P1798, DOI 10.4161/cc.4.12.2189; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Toone WM, 1997, ANNU REV MICROBIOL, V51, P125, DOI 10.1146/annurev.micro.51.1.125; Toyn JH, 1997, GENETICS, V145, P85; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	62	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					546	554		10.1096/fj.11-192518	http://dx.doi.org/10.1096/fj.11-192518			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22002907				2022-12-25	WOS:000300485700008
J	Collen, PN; Sassi, JF; Rogniaux, H; Marfaing, H; Helbert, W				Collen, Pi Nyvall; Sassi, Jean-Francois; Rogniaux, Helene; Marfaing, Helene; Helbert, William			Ulvan Lyases Isolated from the Flavobacteria Persicivirga ulvanivorans Are the First Members of a New Polysaccharide Lyase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDES; CHEMICAL-STRUCTURE; RHEOLOGICAL PROPERTIES; ALGINATE LYASES; CHLOROPHYTA; COMPLEX	Ulvans are complex sulfated polysaccharides found in the cell walls of green algae belonging to the genus Ulva. These polysaccharides are composed of disaccharide repetition moieties made up of sulfated rhamnose linked to either glucuronic acid, iduronic acid, or xylose. Two ulvan lyases of 30 and 46 kDa were purified from the culture supernatant of Persicivirga ulvanivorans. Based on peptide sequencing, the gene encoding the 46-kDa ulvan lyase was cloned. Sequence analysis revealed that the protein is modular and possesses a catalytic module similar to that of the 30-kDa ulvan lyase along with a module of unknown function. The ulvan-degrading function of the gene was confirmed by expression of the catalytic module in a heterologous system. The gene encoding the catalytic module has no sequence homolog in sequence databases and is likely to be the first member of a novel polysaccharide lyase family. Analysis of degradation products showed that both the 30- and 46-kDa ulvan lyases are endolytic and cleave the glycosidic bond between the sulfated rhamnose and a glucuronic or iduronic acid.	[Collen, Pi Nyvall; Helbert, William] Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France; [Sassi, Jean-Francois; Marfaing, Helene] Ctr Etud & Valorisat Algues, F-22610 Pleubian, France; [Rogniaux, Helene] INRA, Biopolymeres Interact Assemblages UR1268, F-44316 Nantes, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; INRAE	Helbert, W (corresponding author), Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France.	helbert@sb-roscoff.fr	SASSI, Jean Francois/D-4076-2013	MARFAING, Helene/0000-0003-0894-5538	French National Research Agency (ANR) [ANR-07-RIB-019]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR) by Grant ANR-07-RIB-019.	Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; BOUTACHFAITI R, 2010, Patent No. 261894; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; PERCIVAL E, 1967, CHEM ENZYMOLOGY MARI, P176; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; Quemener B, 2000, FOOD HYDROCOLLOID, V14, P9, DOI 10.1016/S0268-005X(99)00042-9; RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3; Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020; Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023; Robic A, 2009, J PHYCOL, V45, P962, DOI 10.1111/j.1529-8817.2009.00699.x; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Tabatabai M. A., 1974, Sulphur Institute Journal, V10, P11; Tondervik A, 2010, J BIOL CHEM, V285, P35284, DOI 10.1074/jbc.M110.162800; Zobell CE, 1941, J MAR RES, V4, P42	25	63	67	5	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42063	42071		10.1074/jbc.M111.271825	http://dx.doi.org/10.1074/jbc.M111.271825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009751	Green Published, hybrid			2022-12-25	WOS:000298180900016
J	Maric, HM; Mukherjee, J; Tretter, V; Moss, SJ; Schindelin, H				Maric, Hans-Michael; Mukherjee, Jayanta; Tretter, Verena; Moss, Stephen J.; Schindelin, Hermann			Gephyrin-mediated gamma-Aminobutyric Acid Type A and Glycine Receptor Clustering Relies on a Common Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN-STEM MOTONEURONS; GABA(A) RECEPTOR; GABAERGIC SYNAPSES; INHIBITORY SYNAPSES; PROTEIN GEPHYRIN; KNOCKOUT MICE; BETA-SUBUNIT; SUBTYPES; PHOSPHORYLATION; COLOCALIZATION	Gephyrin is the major protein determinant for the clustering of inhibitory neurotransmitter receptors. Earlier analyses revealed that gephyrin tightly binds to residues 398-410 of the glycine receptor beta subunit (GlyR beta) and, as demonstrated only recently, also interacts with GABA(A) receptors (GABA(A)Rs) containing the alpha 1, alpha 2, and alpha 3 subunits. Here, we dissect the molecular basis underlying the interactions between gephyrin and GABA(A)Rs containing these alpha-subunits and compare them to the crystal structure of the gephyrin-GlyR beta complex. Biophysical and biochemical assays revealed that, in contrast to its tight interaction with GlyR beta, gephyrin only loosely interacts with GABAAR alpha 2, whereas it has an intermediate affinity for the GABAAR alpha 1 and alpha 3 subunits. Despite the wide variation in affinities and the low overall sequence homology among the identified receptor subunits, competition assays confirmed the receptor-gephyrin interaction to be a mutually exclusive process. Selected gephyrin point mutants that critically weaken complex formation with GlyR beta also abolished the GABA(A)R alpha 1 and alpha 3 interactions. Additionally, we identified a common binding motif with two conserved aromatic residues that are central for gephyrin binding. Consistent with the biochemical data, mutations of the corresponding residues within the cytoplasmic domain of alpha 2 subunit-containing GABA(A)Rs attenuated clustering of these receptors at postsynaptic sites in hippocampal neurons. Taken together, our experiments provide key insights regarding similarities and differences in the complex formation between gephyrin and GABA(A)Rs compared with GlyRs and, hence, the accumulation of these receptors at postsynaptic sites.	[Maric, Hans-Michael; Schindelin, Hermann] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Tretter, Verena] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Mukherjee, Jayanta; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA	University of Wurzburg; Medical University of Vienna; Tufts University	Schindelin, H (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de	Maric, Hans Michael/AAQ-8205-2020; Schindelin, Hermann/Q-2697-2019	Maric, Hans Michael/0000-0002-2719-4752; 	Deutsche Forschungsgemeinschaft [RVZ FZ 82, Schi 425/2-1, SFB487 C7]; European Community [HEALTH-F4-2008-202088]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, R01NS051195] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (RVZ FZ 82, Schi 425/2-1, and SFB487 C7; to H. S.) and the European Community (EC-FP7 integrated project "Neurocypres"; HEALTH-F4-2008-202088; to V. T.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Geiman EJ, 2002, J COMP NEUROL, V444, P275, DOI 10.1002/cne.10148; Giesemann T, 2003, J NEUROSCI, V23, P8330; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; O'Brien JA, 1999, J NEUROPHYSIOL, V82, P1638, DOI 10.1152/jn.1999.82.3.1638; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	35	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42105	42114		10.1074/jbc.M111.303412	http://dx.doi.org/10.1074/jbc.M111.303412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006921	Green Published, hybrid			2022-12-25	WOS:000298180900021
J	Regala, RP; Justilien, V; Walsh, MP; Weems, C; Khoor, A; Murray, NR; Fields, AP				Regala, Roderick P.; Justilien, Verline; Walsh, Michael P.; Weems, Capella; Khoor, Andras; Murray, Nicole R.; Fields, Alan P.			Matrix Metalloproteinase-10 Promotes Kras-Mediated Bronchio-Alveolar Stem Cell Expansion and Lung Cancer Formation	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-INITIATING CELLS; BREAST-TUMORS; MOUSE MODEL; IN-SITU; IDENTIFICATION; PROGRESSION; ADENOCARCINOMA; MICRODISSECTION; PROLIFERATION	Matrix metalloproteinase 10 (MMP-10; stromelysin 2) is a member of a large family of structurally related matrix metalloproteinases, many of which have been implicated in tumor progression, invasion and metastasis. We recently identified Mmp10 as a gene that is highly induced in tumor-initiating lung bronchioalveolar stem cells (BASCs) upon activation of oncogenic Kras in a mouse model of lung adenocarcinoma. However, the potential role of Mmp10 in lung tumorigenesis has not been addressed. Here, we demonstrate that Mmp10 is overexpressed in lung tumors induced by either the smoke carcinogen urethane or oncogenic Kras. In addition, we report a significant reduction in lung tumor number and size after urethane exposure or genetic activation of oncogenic Kras in Mmp10 null (Mmp10(-/-)) mice. This inhibitory effect is reflected in a defect in the ability of Mmp10-deficient BASCs to expand and undergo transformation in response to urethane or oncogenic Kras in vivo and in vitro, demonstrating a role for Mmp10 in the tumor-initiating activity of Kras-transformed lung stem cells. To determine the potential relevance of MMP10 in human cancer we analyzed Mmp10 expression in publicly-available gene expression profiles of human cancers. Our analysis reveals that MMP10 is highly overexpressed in human lung tumors. Gene set enhancement analysis (GSEA) demonstrates that elevated MMP10 expression correlates with both cancer stem cell and tumor metastasis genomic signatures in human lung cancer. Finally, Mmp10 is elevated in many human tumor types suggesting a widespread role for Mmp10 in human malignancy. We conclude that Mmp10 plays an important role in lung tumor initiation via maintenance of a highly tumorigenic, cancer-initiating, stem-like cell population, and that Mmp10 expression is associated with stem-like, highly metastatic genotypes in human lung cancers. These results indicate that Mmp10 may represent a novel therapeutic approach to target lung cancer stem cells.	[Regala, Roderick P.; Justilien, Verline; Walsh, Michael P.; Weems, Capella; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Khoor, Andras] Mayo Clin, Coll Med, Dept Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Regala, RP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Pillay, Nischalan/F-9536-2012		National Cancer Institute [R01 CA081436-13, R21 CA151250-01, CA115160]; V Foundation for Cancer Research; James and Esther King Biomedical Research Program [1KG-05-33971]; NIH from the NCI; NATIONAL CANCER INSTITUTE [R21CA151250, R01CA081436, F32CA115160] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research; James and Esther King Biomedical Research Program; NIH from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute (R01 CA081436-13 and R21 CA151250-01), the V Foundation for Cancer Research, and the James and Esther King Biomedical Research Program (1KG-05-33971) to APF; a Ruth A. Kirschstein Postdoctoral Fellowship Award CA115160 from the NCI (RPR); and a NIH Research Supplement to Promote Diversity in Health-related Research Award from the NCI (VJ). Alan P. Fields is the Monica Flynn Jacoby Professor of Cancer Research, an endowment that provides partial support for his research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Becker M, 2005, MOL CANCER THER, V4, P151; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BOLSTAD BM, PREPROCESSCORE COLLE; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Cho NH, 2004, ONCOGENE, V23, P845, DOI 10.1038/sj.onc.1207140; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giangreco A, 2007, AM J RESP CRIT CARE, V175, P547, DOI 10.1164/rccm.200607-984PP; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kelly-Spratt KS, 2009, ONCOGENE, V28, P3652, DOI 10.1038/onc.2009.226; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; MALKINSON AM, 1985, J NATL CANCER I, V75, P971, DOI 10.1093/jnci/75.5.971; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; R Core Team, 2021, R LANG ENV STAT COMP; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sawey ET, 2008, CELL CYCLE, V7, P566, DOI 10.4161/cc.7.5.5531; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	85	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26439	10.1371/journal.pone.0026439	http://dx.doi.org/10.1371/journal.pone.0026439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022614	gold, Green Published, Green Submitted			2022-12-25	WOS:000295984400058
J	Abel, U; Deichmann, A; Nowrouzi, A; Gabriel, R; Bartholomae, CC; Glimm, H; von Kalle, C; Schmidt, M				Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred			Analyzing the Number of Common Integration Sites of Viral Vectors - New Methods and Computer Programs	PLOS ONE			English	Article							CELL GENE-THERAPY; SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; LENTIVIRAL VECTOR; IDENTIFIES GENES; SCID-X1; ACTIVATION; CANCER	Vectors based on gamma-retroviruses or lentiviruses have been shown to stably express therapeutical transgenes and effectively cure different hematological diseases. Molecular follow up of the insertional repertoire of gene corrected cells in patients and preclinical animal models revealed different integration preferences in the host genome including clusters of integrations in small genomic areas (CIS; common integrations sites). In the majority, these CIS were found in or near genes, with the potential to influence the clonal fate of the affected cell. To determine whether the observed degree of clustering is statistically compatible with an assumed standard model of spatial distribution of integrants, we have developed various methods and computer programs for gamma-retroviral and lentiviral integration site distribution. In particular, we have devised and implemented mathematical and statistical approaches for comparing two experimental samples with different numbers of integration sites with respect to the propensity to form CIS as well as for the analysis of coincidences of integration sites obtained from different blood compartments. The programs and statistical tools described here are available as workspaces in R code and allow the fast detection of excessive clustering of integration sites from any retrovirally transduced sample and thus contribute to the assessment of potential treatment-related risks in preclinical and clinical retroviral gene therapy studies.	[Abel, Ulrich] Heidelberg Univ, Dept Med Biometry, Heidelberg, Germany; [Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Abel, U (corresponding author), Heidelberg Univ, Dept Med Biometry, Heidelberg, Germany.	abel@imbi.uni-heidelberg.de; manfred.schmidt@nct-heidelberg.de			Deutsche Forschungsgemeinschaft DFG [SCHM 2134/1-1, SCHM 2134/1-2, SFB873-A7]; Bundesministerium fur Bildung und Forschung BMBF [01GU0809 (iGene)]; European Commission [LSHB-CT-2004-005242-CONSERT, LSHB-CT-2006-018933-CLINIGENE, HEALTH-F5-2009-222878-PERSIST]; Helmholtz-Alliance (HAIT)	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz-Alliance (HAIT)	This work was supported by the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de) grant (SCHM 2134/1-1, SCHM 2134/1-2 and SFB873-A7), by the Bundesministerium fur Bildung und Forschung BMBF (www.bmbf.de) grant (01GU0809 (iGene)), by the European Commission's 6th and 7th Framework Programs (http://ec.europa.eu/research) contracts (LSHB-CT-2004-005242-CONSERT, LSHB-CT-2006-018933-CLINIGENE and HEALTH-F5-2009-222878-PERSIST) and by the Helmholtz-Alliance (HAIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000570; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Bartholomae CC, 2011, MOL THER, V19, P703, DOI 10.1038/mt.2011.19; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Heuser H., 1980, LEHRBUCH ANAL 1; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hsu J., 1996, MULTIPLE COMP THEORY; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Li JL, 2009, J NONPARAMETR STAT, V21, P649, DOI 10.1080/10485250902770035; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Ott MG, 2007, CURR GENE THER, V7, P155, DOI 10.2174/156652307780859044; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047	36	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24247	10.1371/journal.pone.0024247	http://dx.doi.org/10.1371/journal.pone.0024247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022353	Green Submitted, gold, Green Published			2022-12-25	WOS:000295981600001
J	Banerjee, S; Paik, R; Mino, RE; Blauth, K; Fisher, ES; Madden, VJ; Fanning, AS; Bhat, MA				Banerjee, Swati; Paik, Raehum; Mino, Rosa E.; Blauth, Kevin; Fisher, Elizabeth S.; Madden, Victoria J.; Fanning, Alan S.; Bhat, Manzoor A.			A Laminin G-EGF-Laminin G Module in Neurexin IV Is Essential for the Apico-Lateral Localization of Contactin and Organization of Septate Junctions	PLOS ONE			English	Article							BLOOD-NERVE BARRIER; TUBE SIZE CONTROL; DROSOPHILA-VARICOSE; MYELINATED AXONS; EPITHELIAL-CELLS; PROTEIN; DOMAINS; COMPLEX; GLIA; REQUIRES	Septate junctions (SJs) display a unique ultrastructural morphology with ladder-like electron densities that are conserved through evolution. Genetic and molecular analyses have identified a highly conserved core complex of SJ proteins consisting of three cell adhesion molecules Neurexin IV, Contactin, and Neuroglian, which interact with the cytoskeletal FERM domain protein Coracle. How these individual proteins interact to form the septal arrays that create the paracellular barrier is poorly understood. Here, we show that point mutations that map to specific domains of neurexin IV lead to formation of fewer septae and disorganization of SJs. Consistent with these observations, our in vivo domain deletion analyses identified the first Laminin G-EGF-Laminin G module in the extracellular region of Neurexin IV as necessary for the localization of and association with Contactin. Neurexin IV protein that is devoid of its cytoplasmic region is able to create septae, but fails to form a full complement of SJs. These data provide the first in vivo evidence that specific domains in Neurexin IV are required for protein-protein interactions and organization of SJs. Given the molecular conservation of SJ proteins across species, our studies may provide insights into how vertebrate axo-glial SJs are organized in myelinated axons.	[Banerjee, Swati; Paik, Raehum; Mino, Rosa E.; Fisher, Elizabeth S.; Fanning, Alan S.; Bhat, Manzoor A.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Mino, Rosa E.; Blauth, Kevin; Fisher, Elizabeth S.; Bhat, Manzoor A.] Univ N Carolina, Sch Med, Curriculum Neurobiol, Chapel Hill, NC USA; [Madden, Victoria J.] Univ N Carolina, Sch Med, Microscopy Serv Lab, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, Neurodev Disorders Res Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Banerjee, S (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	Manzoor_Bhat@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Ariel, Pablo/AGJ-4118-2022; BHAT, MANZOOR/S-9273-2018	BHAT, MANZOOR/0000-0003-0989-1498; Fisher, Elizabeth/0000-0003-3430-2974; Mino, Rosa Eliana/0000-0001-6992-4744	National Institute of Neurological Disorders and Stroke [NS030356]; National Institute of General Medical Sciences [GM63074]; State of North Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063074] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); State of North Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by the following: National Institute of Neurological Disorders and Stroke (NS030356); National Institute of General Medical Sciences (GM63074), URL www.nih.gov; funds from the State of North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bachmann A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-55; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Banerjee S, 2008, DEV BIOL, V317, P585, DOI 10.1016/j.ydbio.2008.03.007; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Banerjee S, 2010, J NEUROSCI, V30, P5653, DOI 10.1523/JNEUROSCI.6187-09.2010; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blauth K, 2010, INT REV CEL MOL BIO, V283, P93, DOI 10.1016/S1937-6448(10)83003-5; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulgakova NA, 2008, J CELL SCI, V121, P2018, DOI 10.1242/jcs.031088; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; DEUTZMANN R, 1988, EUR J BIOCHEM, V177, P35, DOI 10.1111/j.1432-1033.1988.tb14342.x; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Hortsch M, 2003, TRENDS CELL BIOL, V13, P557, DOI 10.1016/j.tcb.2003.09.004; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Pillai AM, 2007, J NEUROSCI RES, V85, P2318, DOI 10.1002/jnr.21374; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25926	10.1371/journal.pone.0025926	http://dx.doi.org/10.1371/journal.pone.0025926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022470	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600020
J	Zou, JF; Hong, GN; Guo, XW; Zhang, L; Yao, C; Wang, J; Guo, Z				Zou, Jinfeng; Hong, Guini; Guo, Xinwu; Zhang, Lin; Yao, Chen; Wang, Jing; Guo, Zheng			Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MASS-SPECTROMETRY DATA; BREAST-CANCER; PROTEIN PROFILES; MICROARRAY DATA; SAMPLE-SIZE; SERUM; PROTEOMICS; NORMALIZATION; POWER	Background: There has been much interest in differentiating diseased and normal samples using biomarkers derived from mass spectrometry (MS) studies. However, biomarker identification for specific diseases has been hindered by irreproducibility. Specifically, a peak profile extracted from a dataset for biomarker identification depends on a data preprocessing algorithm. Until now, no widely accepted agreement has been reached. Results: In this paper, we investigated the consistency of biomarker identification using differentially expressed (DE) peaks from peak profiles produced by three widely used average spectrum-dependent pre-processing algorithms based on SELDI-TOF MS data for prostate and breast cancers. Our results revealed two important factors that affect the consistency of DE peak identification using different algorithms. One factor is that some DE peaks selected from one peak profile were not detected as peaks in other profiles, and the second factor is that the statistical power of identifying DE peaks in large peak profiles with many peaks may be low due to the large scale of the tests and small number of samples. Furthermore, we demonstrated that the DE peak detection power in large profiles could be improved by the stratified false discovery rate (FDR) control approach and that the reproducibility of DE peak detection could thereby be increased. Conclusions: Comparing and evaluating pre-processing algorithms in terms of reproducibility can elucidate the relationship among different algorithms and also help in selecting a pre-processing algorithm. The DE peaks selected from small peak profiles with few peaks for a dataset tend to be reproducibly detected in large peak profiles, which suggests that a suitable pre-processing algorithm should be able to produce peaks sufficient for identifying useful and reproducible biomarkers.	[Zou, Jinfeng; Hong, Guini; Zhang, Lin; Yao, Chen; Wang, Jing; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Guo, Xinwu; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; Harbin Medical University	Zou, JF (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Wang, Jing/B-5420-2014	Wang, Jing/0000-0002-8128-9920	National Natural Science Foundation of China [30970668, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]; Natural Science Foundation of Heilongjiang Province of China [QC2010012]; Heilongjiang Provincial Education Department [11541156]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Heilongjiang Provincial Education Department	This work was supported by the National Natural Science Foundation of China (30970668, 81071646, 91029717) (http://www.nsfc.gov.cn/Portal0/default106.htm), Excellent Youth Foundation of Heilongjiang Province (JC200808)(http://jj.hljkj.cn/qn/), Natural Science Foundation of Heilongjiang Province of China (QC2010012) (http://jj.hljkj.cn/zr/index.htm), and the Scientific Research Fund of Heilongjiang Provincial Education Department (11541156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caffrey RE, 2010, METHODS MOL BIOL, V641, P167, DOI 10.1007/978-1-60761-711-2_10; Callesen AK, 2008, J PROTEOME RES, V7, P1395, DOI 10.1021/pr800115f; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Cho William Chi-shing, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P871; Coombes K. R., 2007, PREPROCESSING MASS S; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; De Bock M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/906082; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Diao L, 2011, CANCER INFORM, V10, P45, DOI 10.4137/CIN.S6438; Dijkstra M, 2009, PROTEOMICS, V9, P3869, DOI 10.1002/pmic.200701064; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Emanuele VA, 2009, PROTEOMICS, V9, P1754, DOI 10.1002/pmic.200701171; Esteva FJ, 2005, BREAST CANCER RES, V7, pR436, DOI 10.1186/bcr1020; Fortin T, 2009, MOL CELL PROTEOMICS, V8, P1006, DOI 10.1074/mcp.M800238-MCP200; Froebel Julia, 2010, Archives of Physiology and Biochemistry, V116, P174, DOI 10.3109/13813455.2010.501082; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hogan JM, 2006, OMICS, V10, P152, DOI 10.1089/omi.2006.10.152; Huang Baisong, 2007, BMC Proc, V1 Suppl 1, pS142; Klebanov L, 2006, STAT APPL GENET MOL, V5; Kristina G, 2009, LAB CHIP, V9, P1014, DOI 10.1039/b815503h; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Li JN, 2005, CLIN CANCER RES, V11, P8312, DOI 10.1158/1078-0432.CCR-05-1538; Li X, 2005, STAT BIOL HEALTH, P91; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Mathelin C, 2006, BREAST CANCER RES TR, V96, P83, DOI 10.1007/s10549-005-9046-2; Mead JA, 2009, PROTEOMICS, V9, P861, DOI 10.1002/pmic.200800553; Meuleman W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-88; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Pusztai L, 2004, CANCER, V100, P1814, DOI 10.1002/cncr.20203; Qiu X, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-120; Ransohoff DF, 2005, J NATL CANCER I, V97, P315, DOI 10.1093/jnci/dji054; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanders ME, 2008, J PROTEOME RES, V7, P1500, DOI 10.1021/pr7008109; SAUVE AC, 2004, 2004 P GEN SIGN PROC; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Song HJ, 2009, ACTA PHARMACOL SIN, V30, P1550, DOI 10.1038/aps.2009.140; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Timms JF, 2007, CLIN CHEM, V53, P645, DOI 10.1373/clinchem.2006.080101; Truntzer C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-434; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wang J, 2011, MOL BIOSYST, V7, P1158, DOI 10.1039/c0mb00211a; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu ST, 2009, BIOINFORMATICS: TOOLS AND APPLICATIONS, P225, DOI 10.1007/978-0-387-92738-1_11; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365	61	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26294	10.1371/journal.pone.0026294	http://dx.doi.org/10.1371/journal.pone.0026294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022591	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600049
J	Herges, K; Millward, JM; Hentschel, N; Infante-Duarte, C; Aktas, O; Zipp, F				Herges, Katja; Millward, Jason M.; Hentschel, Nicole; Infante-Duarte, Carmen; Aktas, Orhan; Zipp, Frauke			Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; AXONAL GROWTH; IN-VITRO; CELLS; DEMYELINATION; BRAIN; DEATH; MICE	Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. However, studies of MS and the animal model, experimental autoimmune encephalomyelitis (EAE), indicate that neuronal pathology is the principle cause of clinical disability. Thus, there is need to develop new therapeutic strategies that not only address immunomodulation but also neuroprotection. Here we show that the combination therapy of Glatiramer acetate (GA), an immunomodulatory MS therapeutic, and the neuroprotectant epigallocatechin-3-gallate (EGCG), the main phenol in green tea, have synergistic protective effects in vitro and in the EAE model. EGCG and GA together led to increased protection from glutamate- and TRAIL-induced neuronal cell death in vitro. EGCG combined with GA induced regeneration of hippocampal axons in an outgrowth assay. The combined application of EGCG and GA did not result in unexpected adverse events in vivo. Neuroprotective and neuroregenerative effects could be translated in the in vivo model, where combination treatment with EGCG and GA significantly delayed disease onset, strongly reduced clinical severity, even after onset of symptoms and reduced inflammatory infiltrates. These results illustrate the promise of combining neuroprotective and anti-inflammatory treatments and strengthen the prospects of EGCG as an adjunct therapy for neuroinflammatory and neurodegenerative diseases.	[Herges, Katja; Zipp, Frauke] Univ Med Mainz, Dept Neurol, Mainz, Germany; [Herges, Katja] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Herges, Katja; Millward, Jason M.; Hentschel, Nicole; Infante-Duarte, Carmen] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Aktas, Orhan] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf	Herges, K (corresponding author), Univ Med Mainz, Dept Neurol, Mainz, Germany.	frauke.zipp@unimedizin-mainz.de	Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015	Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Infante Duarte, Carmen/0000-0003-3005-351X; Millward, Jason/0000-0003-4484-2798	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR 43]; Will Foundation; DAAD	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Will Foundation; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with SFB-TRR 43 to F.Z. and by the Will Foundation. K.H. received a fellowship from the German academic exchange program (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Aktas O, 2007, FRONT BIOSCI-LANDMRK, V12, P2912, DOI 10.2741/2281; Aktas O, 2006, NEUROSCIENTIST, V12, P305, DOI 10.1177/1073858405285208; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353; Costello F, 2007, CURR OPIN NEUROL, V20, P281, DOI 10.1097/WCO.0b013e328122de1b; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Hechler D, 2006, BRAIN RES REV, V52, P160, DOI 10.1016/j.brainresrev.2006.01.005; Holtje M, 2009, FASEB J, V23, P1115, DOI 10.1096/fj.08-116855; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011951; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Liu J, 2007, EUR J IMMUNOL, V37, P3143, DOI 10.1002/eji.200737398; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KR, 2009, BRAIN PATHOL; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; Schroeder EK, 2008, ANTIOXID REDOX SIGNA; Siffrin V, 2007, ADV IMMUNOL, V96, P1, DOI 10.1016/S0065-2776(07)96001-0; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Wang CH, 2006, J NEUROCHEM, V98, P1817, DOI 10.1111/j.1471-4159.2006.04081.x; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	37	60	63	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25456	10.1371/journal.pone.0025456	http://dx.doi.org/10.1371/journal.pone.0025456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022398	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295978600015
J	Santucci, N; D'Attilio, L; Kovalevski, L; Bozza, V; Besedovsky, H; del Rey, A; Bay, ML; Bottasso, O				Santucci, Natalia; D'Attilio, Luciano; Kovalevski, Leandro; Bozza, Veronica; Besedovsky, Hugo; del Rey, Adriana; Luisa Bay, Maria; Bottasso, Oscar			A Multifaceted Analysis of Immune-Endocrine-Metabolic Alterations in Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LEPTIN CONCENTRATIONS; INFLAMMATORY MARKERS; GAMMA PRODUCTION; NERVOUS-SYSTEM; PLASMA LEPTIN; FAT MASS; WEIGHT; NEUROENDOCRINE; RESPONSES	Our study investigated the circulating levels of factors involved in immune-inflammatory-endocrine-metabolic responses in patients with tuberculosis with the aim of uncovering a relation between certain immune and hormonal patterns, their clinical status and in vitro immune response. The concentration of leptin, adiponectin, IL-6, IL-1 beta, ghrelin, C-reactive protein (CRP), cortisol and dehydroepiandrosterone (DHEA), and the in vitro immune response (lymphoproliferation and IFN-gamma production) was evaluated in 53 patients with active untreated tuberculosis, 27 household contacts and 25 healthy controls, without significant age-or sex-related differences. Patients had a lower body mass index (BMI), reduced levels of leptin and DHEA, and increased concentrations of CRP, IL-6, cortisol, IL-1 beta and nearly significant adiponectin values than household contacts and controls. Within tuberculosis patients the BMI and leptin levels were positively correlated and decreased with increasing disease severity, whereas higher concentrations of IL-6, CRP, IL-1 beta, cortisol, and ghrelin were seen in cases with moderate to severe tuberculosis. Household contacts had lower DHEA and higher IL-6 levels than controls. Group classification by means of discriminant analysis and the k-nearest neighbor method showed that tuberculosis patients were clearly different from the other groups, having higher levels of CRP and lower DHEA concentration and BMI. Furthermore, plasma leptin levels were positively associated with the basal in vitro IFN-gamma production and the ConA-driven proliferation of cells from tuberculosis patients. Present alterations in the communication between the neuro-endocrine and immune systems in tuberculosis may contribute to disease worsening.	[Santucci, Natalia; D'Attilio, Luciano; Bozza, Veronica; Luisa Bay, Maria; Bottasso, Oscar] Univ Nacl Rosario, Inst Inmunol, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina; [Kovalevski, Leandro] Univ Nacl Rosario, Inst Invest Teor & Aplicadas, Escuela Estadist, Fac Ciencias Econ & Estadist, RA-2000 Rosario, Santa Fe, Argentina; [Besedovsky, Hugo; del Rey, Adriana] Inst Physiol & Pathophysiol, Marburg, Germany	National University of Rosario; National University of Rosario	Santucci, N (corresponding author), Univ Nacl Rosario, Inst Inmunol, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina.	bottasso@uolsinectis.com.ar	Santucci, Natalia Estefanía/AAE-2602-2022	Santucci, Natalia Estefanía/0000-0002-2440-2296	FONCYT [BID 1728/OC-AR PID 160]; Fundacion Florencio Fiorini	FONCYT(FONCyT); Fundacion Florencio Fiorini	This work was supported by grants from FONCYT (BID 1728/OC-AR PID 160) and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T.W, 2003, INTRO MULTIVARIATE S; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Baccan GC, 2011, BRAIN BEHAV IMMUN, V25, P548, DOI 10.1016/j.bbi.2010.12.009; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; BOTTASSO O, 2000, NEUROIMMUNOMODULAT, V16, P68; Bottasso Oscar, 2010, Current Immunology Reviews, V6, P314; Bozza VV, 2007, SCAND J IMMUNOL, V66, P97, DOI 10.1111/j.1365-3083.2007.01952.x; Bozza V, 2009, ANN NY ACAD SCI, V1153, P247, DOI 10.1111/j.1749-6632.2008.03976.x; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Choi CM, 2007, INT J TUBERC LUNG D, V11, P233; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Dannenberg Arthur M. Jr., 1994, P459; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Dillon Joseph S., 2005, Current Drug Targets - Inflammation and Allergy, V4, P377, DOI 10.2174/1568010054022079; FAREBEE SH, 1970, ADV TUBER RES, V7, P29; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Grange JM, 2011, TUBERCULOSIS, V91, P179, DOI 10.1016/j.tube.2010.12.004; Hernandez-Pando R, 2005, J INFECT DIS, V191, P299, DOI 10.1086/426453; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kellendonk C, 2002, ENDOCRINOLOGY, V143, P2333, DOI 10.1210/en.143.6.2333; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Langhans W, 2000, NUTRITION, V16, P996, DOI 10.1016/S0899-9007(00)00421-4; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lorenzi T, 2009, CYTOKINE GROWTH F R, V20, P137, DOI 10.1016/j.cytogfr.2009.02.003; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mahuad C, 2007, NEUROIMMUNOMODULAT, V14, P193, DOI 10.1159/000110646; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Ota K, 2009, ANN NY ACAD SCI, V1153, P82, DOI 10.1111/j.1749-6632.2008.03981.x; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Ribeiro F, 2007, BIOGERONTOLOGY, V8, P209, DOI 10.1007/s10522-006-9069-z; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Santucci N, 2010, NEUROIMMUNOMODULAT, V17, P184, DOI 10.1159/000258719; Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Stenlof K, 2003, J CLIN ENDOCR METAB, V88, P4379, DOI 10.1210/jc.2002-021733; Straub RH, 2011, BRAIN BEHAV IMMUN, V25, P1, DOI 10.1016/j.bbi.2010.08.002; Straub RH, 2003, FASEB J, V17, P2176, DOI 10.1096/fj.03-0433hyp; Taub DD, 2008, VITAM HORM, V77, P325, DOI 10.1016/S0083-6729(06)77014-5; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Yuksel I, 2003, ENDOCR RES, V29, P257, DOI 10.1081/ERC-120025033	52	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26363	10.1371/journal.pone.0026363	http://dx.doi.org/10.1371/journal.pone.0026363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022605	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600050
J	Egan, K; Crowley, D; Smyth, P; O'Toole, S; Spillane, C; Martin, C; Gallagher, M; Canney, A; Norris, L; Conlon, N; McEvoy, L; Ffrench, B; Stordal, B; Keegan, H; Finn, S; McEneaney, V; Laios, A; Ducree, J; Dunne, E; Smith, L; Berndt, M; Sheils, O; Kenny, D; O'Leary, J				Egan, Karl; Crowley, Darragh; Smyth, Paul; O'Toole, Sharon; Spillane, Cathy; Martin, Cara; Gallagher, Michael; Canney, Aoife; Norris, Lucy; Conlon, Niamh; McEvoy, Lynda; Ffrench, Brendan; Stordal, Britta; Keegan, Helen; Finn, Stephen; McEneaney, Victoria; Laios, Alex; Ducree, Jens; Dunne, Eimear; Smith, Leila; Berndt, Michael; Sheils, Orla; Kenny, Dermot; O'Leary, John			Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells	PLOS ONE			English	Article							GLYCOPROTEIN IB-ALPHA; EXPERIMENTAL LUNG METASTASIS; TUMOR-CELLS; DIMERIC BETA(2)-GLYCOPROTEIN-I; KALLIKREIN GENES; GROWTH-FACTOR; ACTIVATION; RECEPTORS; B7-H1; OVEREXPRESSION	Thrombosis is common in ovarian cancer. However, the interaction of platelets with ovarian cancer cells has not been critically examined. To address this, we investigated platelet interactions in a range of ovarian cancer cell lines with different metastatic potentials [HIO-80, 59M, SK-OV-3, A2780, A2780cis]. Platelets adhered to ovarian cancer cells with the most significant adhesion to the 59M cell line. Ovarian cancer cells induced platelet activation [P-selectin expression] in a dose dependent manner, with the most significant activation seen in response to the 59M cell line. The platelet antagonists [cangrelor, MRS2179, and apyrase] inhibited 59M cell induced activation suggesting a P2Y12 and P2Y1 receptor mediated mechanism of platelet activation dependent on the release of ADP by 59M cells. A2780 and 59M cells potentiated PAR-1, PAR-4, and TxA2 receptor mediated platelet activation, but had no effect on ADP, epinephrine, or collagen induced activation. Analysis of gene expression changes in ovarian cancer cells following treatment with washed platelets or platelet releasate showed a subtle but valid upregulation of anti-apoptotic, anti-autophagy pro-angiogenic, pro-cell cycle and metabolic genes. Thus, ovarian cancer cells with different metastatic potential adhere and activate platelets differentially while both platelets and platelet releasate mediate pro-survival and pro-angiogenic signals in ovarian cancer cells.	[Egan, Karl; Dunne, Eimear; Berndt, Michael; Kenny, Dermot] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Crowley, Darragh; Smyth, Paul; O'Toole, Sharon; Spillane, Cathy; Martin, Cara; Gallagher, Michael; Canney, Aoife; Conlon, Niamh; McEvoy, Lynda; Ffrench, Brendan; Stordal, Britta; Keegan, Helen; Finn, Stephen; McEneaney, Victoria; Laios, Alex; Sheils, Orla; O'Leary, John] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [O'Toole, Sharon; Norris, Lucy; Laios, Alex] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland; [Ducree, Jens; Berndt, Michael; Kenny, Dermot] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland; [Smith, Leila] Fluidigm Corp Europe, Amsterdam, Netherlands	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Dublin City University	Egan, K (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	olearyjj@tcd.ie	Laios, Alexandros/AAN-9433-2020; Norris, Lucy/B-8904-2009; Sheils, Orla Sheils M/B-8461-2015; Ducrée, Jens/M-4264-2014; Ducrée, Jens/AAL-4994-2021; Dunne, Eimear/AGX-1949-2022; Kenny, Dermot/C-3898-2012; Norris, Lucy/AAJ-2747-2020; Finn, Stephen/V-3236-2019; Berndt, Michael C/D-5580-2012; Dunne, Eimear/C-6785-2012; Ducrée, Jens/P-3756-2019; Laios, Alex/AAD-7618-2020	Laios, Alexandros/0000-0002-4870-7393; Norris, Lucy/0000-0001-7862-3230; Sheils, Orla Sheils M/0000-0002-4493-9496; Ducrée, Jens/0000-0002-0366-1897; Dunne, Eimear/0000-0001-9862-1398; Kenny, Dermot/0000-0001-5548-3263; Norris, Lucy/0000-0001-7862-3230; Finn, Stephen/0000-0002-8628-5814; Dunne, Eimear/0000-0001-9862-1398; Ducrée, Jens/0000-0002-0366-1897; Martin, Cara/0000-0001-8411-8564; Gallagher, Michael/0000-0003-1636-2404; Egan, Karl/0000-0001-5828-0365; Ffrench, Brendan/0000-0002-5647-3734; o toole, sharon/0000-0002-9260-3225; O'Leary, John/0000-0001-7311-9326	Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)]; National Biophotonics and Imaging Platform, Ireland; Irish Government; Health Research Board (Ireland); Emer Casey Foundation, Ireland	Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)](Science Foundation Ireland); National Biophotonics and Imaging Platform, Ireland; Irish Government; Health Research Board (Ireland); Emer Casey Foundation, Ireland	This research was supported by a grant from Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)]. KE is supported through the National Biophotonics and Imaging Platform, Ireland, and funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013. DC is supported by the Health Research Board (Ireland) Scholars Programme: Molecular Medicine - From Genes to Function. BF and LMcE are supported by the Emer Casey Foundation, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITOKALLIOTALLBERG AM, 1988, CANCER RES, V48, P2396; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Bambace NM, 2010, PLATELETS, V21, P85, DOI 10.3109/09537100903470298; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Braun S, 2001, J CLIN ONCOL, V19, P368, DOI 10.1200/JCO.2001.19.2.368; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Chandler LA, 1998, INT J CANCER, V78, P106, DOI 10.1002/(SICI)1097-0215(19980925)78:1<106::AID-IJC17>3.0.CO;2-9; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DVORETSKY PM, 1988, HUM PATHOL, V19, P57, DOI 10.1016/S0046-8177(88)80316-2; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gungor T, 2009, ARCH GYNECOL OBSTET, V279, P53, DOI 10.1007/s00404-008-0673-9; Holmes CE, 2009, CLIN EXP METASTAS, V26, P653, DOI 10.1007/s10585-009-9264-9; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Iodice S, 2008, J THROMB HAEMOST, V6, P781, DOI 10.1111/j.1538-7836.2008.02928.x; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Maloney JP, 1998, AM J PHYSIOL-HEART C, V275, pH1054, DOI 10.1152/ajpheart.1998.275.3.H1054; Medina C, 2006, J PHARMACOL EXP THER, V317, P739, DOI 10.1124/jpet.105.098384; Miesbach W, 2009, CLIN REV ALLERG IMMU, V36, P91, DOI 10.1007/s12016-008-8101-2; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Mullenders J, 2010, MOL CANCER RES, V8, P592, DOI 10.1158/1541-7786.MCR-09-0386; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nieswandt B, 1999, CANCER RES, V59, P1295; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; Pennings MTT, 2007, J THROMB HAEMOST, V5, P369, DOI 10.1111/j.1538-7836.2007.02310.x; PHILIPPE C, 1993, AM J PATHOL, V143, P1713; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Stevens Joanne M, 2004, Methods Mol Biol, V272, P145; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Uluckan O, 2008, J CELL BIOCHEM, V104, P1311, DOI 10.1002/jcb.21709; Urbanus RT, 2008, J THROMB HAEMOST, V6, P1405, DOI 10.1111/j.1538-7836.2008.03021.x; White TC, 2008, J THROMB HAEMOST, V6, P995, DOI 10.1111/j.1538-7836.2008.02979.x; White-Adams TC, 2009, ARTERIOSCL THROM VAS, V29, P1602, DOI 10.1161/ATVBAHA.109.187393; Yanagie Hironobu, 2010, Gan To Kagaku Ryoho, V37, P2052; Yang WL, 2004, CANCER RES, V64, P1534, DOI 10.1158/0008-5472.CAN-03-2928; Yousef GM, 2003, CANCER RES, V63, P2223; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4; Zhang LQ, 2011, MOL BIOL CELL, V22, P128, DOI 10.1091/mbc.E10-06-0556; Zhang T, 2010, CANCER IMMUNOL IMMUN, V59, P1097, DOI 10.1007/s00262-010-0836-y	52	120	126	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26125	10.1371/journal.pone.0026125	http://dx.doi.org/10.1371/journal.pone.0026125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022533	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000071
J	Girardet, C; Bonnet, MS; Jdir, R; Sadoud, M; Thirion, S; Tardivel, C; Roux, J; Lebrun, B; Wanaverbecq, N; Mounien, L; Trouslard, J; Jean, A; Dallaporta, M; Troadec, JD				Girardet, Clemence; Bonnet, Marion S.; Jdir, Rajae; Sadoud, Medhi; Thirion, Sylvie; Tardivel, Catherine; Roux, Julien; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis			The Food-Contaminant Deoxynivalenol Modifies Eating by Targeting Anorexigenic Neurocircuitry	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; TISSUE DISTRIBUTION; ORAL-EXPOSURE; VAGUS NERVE; BODY-WEIGHT; MEAL SIZE; MICE; RAT; NESFATIN-1; MYCOTOXINS	Physiological regulations of energy balance and body weight imply highly adaptive mechanisms which match caloric intake to caloric expenditure. In the central nervous system, the regulation of appetite relies on complex neurocircuitry which disturbance may alter energy balance and result in anorexia or obesity. Deoxynivalenol (DON), a trichothecene, is one of the most abundant mycotoxins found on contaminated cereals and its stability during processing and cooking explains its widespread presence in human food. DON has been implicated in acute and chronic illnesses in both humans and farm animals including weight loss. Here, we provide the first demonstration that DON reduced feeding behavior and modified satiation and satiety by interfering with central neuronal networks dedicated to food intake regulation. Moreover, our results strongly suggest that during intoxication, DON reaches the brain where it modifies anorexigenic balance. In view of the widespread human exposure to DON, the present results may lead to reconsider the potential consequences of chronic DON consumption on human eating disorders.	[Girardet, Clemence; Bonnet, Marion S.; Jdir, Rajae; Sadoud, Medhi; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] Univ Paul Cezanne, Marseille, France; [Girardet, Clemence; Bonnet, Marion S.; Tardivel, Catherine; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] INRA USC 2027, Marseille, France; [Girardet, Clemence; Bonnet, Marion S.; Thirion, Sylvie; Tardivel, Catherine; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] CNRS UMR 6231, Ctr Rech Neurobiol Neurophysiol Marseille, Dept Physiol Neurovegetat, Marseille, France; [Thirion, Sylvie] Univ Aix Marseille 2, Marseille, France; [Roux, Julien] Biomeostasis, Contract Res Org, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Girardet, C (corresponding author), Univ Paul Cezanne, Marseille, France.	j-d.troadec@univ-cezanne.fr	Girardet, Clemence/GQQ-0627-2022; troadec, jean denis/V-1412-2017	Thirion, Sylvie/0000-0001-5361-8275; Girardet, Clemence/0000-0002-0302-3350; Mounien, Lourdes/0000-0002-9221-5783; Wanaverbecq, Nicolas/0000-0001-5486-2771; Troadec, jean denis/0000-0003-0346-6247	Aix-Marseille University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Recherche Agronomique (INRA)	Aix-Marseille University; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA)	This work was supported by the Aix-Marseille University, the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD DL, 1986, FOOD CHEM TOXICOL, V24, P935, DOI 10.1016/0278-6915(86)90321-2; Benoit S, 2000, HORM BEHAV, V37, P299, DOI 10.1006/hbeh.2000.1588; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Bonnet MS, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-27; Bretz M, 2006, J AGR FOOD CHEM, V54, P6445, DOI 10.1021/jf061008g; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flannery BM, 2011, FOOD CHEM TOXICOL, V49, P1863, DOI 10.1016/j.fct.2011.05.004; Flynn MC, 1998, AM J PHYSIOL-REG I, V275, pR174, DOI 10.1152/ajpregu.1998.275.1.R174; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Girardet C, 2011, TOX SCI IN PRESS; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Hermann GE, 2001, AM J PHYSIOL-REG I, V280, pR289, DOI 10.1152/ajpregu.2001.280.1.R289; HSIAO S, 1983, PEPTIDES, V4, P15, DOI 10.1016/0196-9781(83)90158-4; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Kurokawa M, 2000, PHYSIOL BEHAV, V70, P105, DOI 10.1016/S0031-9384(00)00226-2; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lombaert GA, 2003, FOOD ADDIT CONTAM A, V20, P494, DOI 10.1080/0265203031000094645; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pecchi E, 2006, PHYSIOL GENOMICS, V25, P485, DOI 10.1152/physiolgenomics.00306.2005; Pecchi E, 2008, J NEUROIMMUNOL, V199, P104, DOI 10.1016/j.jneuroim.2008.05.012; Pecchi E, 2007, J COMP NEUROL, V501, P353, DOI 10.1002/cne.21259; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2008, TOXICOL LETT, V178, P83, DOI 10.1016/j.toxlet.2008.02.005; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Porter MH, 1998, PHYSIOL BEHAV, V64, P581, DOI 10.1016/S0031-9384(98)00082-1; Prelusky Dan B., 1993, Natural Toxins, V1, P296, DOI 10.1002/nt.2620010508; ROTTER BA, 1992, J TOXICOL ENV HEALTH, V37, P329, DOI 10.1080/15287399209531673; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Timofeeva E, 2005, EUR J NEUROSCI, V22, P1489, DOI 10.1111/j.1460-9568.2005.04330.x; van Kol SWM, 2011, TOXICOL APPL PHARM, V250, P299, DOI 10.1016/j.taap.2010.11.001; VANDERWEELE DA, 1994, PHYSIOL BEHAV, V56, P619, DOI 10.1016/0031-9384(94)90310-7; WEST DB, 1987, APPETITE, V8, P221, DOI 10.1016/0195-6663(87)90021-3; Wolf-Hall CE, 1999, J FOOD PROTECT, V62, P962, DOI 10.4315/0362-028X-62.8.962; Yamamoto K, 2002, METHOD FIND EXP CLIN, V24, P135, DOI 10.1358/mf.2002.24.3.802297; Zheng HY, 2005, AM J PHYSIOL-REG I, V289, pR247, DOI 10.1152/ajpregu.00869.2004	41	63	64	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26134	10.1371/journal.pone.0026134	http://dx.doi.org/10.1371/journal.pone.0026134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022538	Green Published, gold			2022-12-25	WOS:000295976000073
J	Torres-Benito, L; Neher, MF; Cano, R; Ruiz, R; Tabares, L				Torres-Benito, Laura; Neher, Margret Feodora; Cano, Raquel; Ruiz, Rocio; Tabares, Lucia			SMN Requirement for Synaptic Vesicle, Active Zone and Microtubule Postnatal Organization in Motor Nerve Terminals	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOUSE MODELS; NEUROMUSCULAR-JUNCTION; NEURON PROTEIN; RIBONUCLEOPROTEIN BIOGENESIS; MITOCHONDRIAL DYSFUNCTION; SINGLE NUCLEOTIDE; DETERMINING GENE; MESSENGER-RNA; GROWTH CONES	Low levels of the Survival Motor Neuron (SMN) protein produce Spinal Muscular Atrophy (SMA), a severe monogenetic disease in infants characterized by muscle weakness and impaired synaptic transmission. We report here severe structural and functional alterations in the organization of the organelles and the cytoskeleton of motor nerve terminals in a mouse model of SMA. The decrease in SMN levels resulted in the clustering of synaptic vesicles (SVs) and Active Zones (AZs), reduction in the size of the readily releasable pool (RRP), and the recycling pool (RP) of synaptic vesicles, a decrease in active mitochondria and limiting of neurofilament and microtubule maturation. We propose that SMN is essential for the normal postnatal maturation of motor nerve terminals and that SMN deficiency disrupts the presynaptic organization leading to neurodegeneration.	[Torres-Benito, Laura; Neher, Margret Feodora; Cano, Raquel; Ruiz, Rocio; Tabares, Lucia] Univ Seville, Sch Med, Dept Physiol & Med Biophys, Seville, Spain	University of Sevilla	Torres-Benito, L (corresponding author), Univ Seville, Sch Med, Dept Physiol & Med Biophys, Seville, Spain.	ltabares@us.es	Ruiz, Rocio/B-9306-2013; Torres-Benito, Laura/X-5491-2019; Tabares, Lucia/K-8768-2015	Ruiz, Rocio/0000-0001-5142-9972; Tabares, Lucia/0000-0002-4027-4044; Cano, Raquel/0000-0002-5927-5725	Spanish Ministry of Science and Innovation [BFU2010-21648]; Junta de Andalucia [P09-CVI-4862]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	The financial support of the following research grants is gratefully acknowledged: FUNDAME (Gename Project), Spanish Ministry of Science and Innovation BFU2010-21648, and Junta de Andalucia P09-CVI-4862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Glinka M, 2010, HUM MOL GENET, V19, P1951, DOI 10.1093/hmg/ddq073; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hao LT, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-24; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2009, NEUROSCI LETT, V449, P246, DOI 10.1016/j.neulet.2008.10.107; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Nguyen DM, 2006, CANCER J, V12, P257, DOI 10.1097/00130404-200607000-00004; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Peter CJ, 2011, HUM MOL GENET; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Ruiz R, 2011, J NEUROSCI, V31, P2000, DOI 10.1523/JNEUROSCI.4663-10.2011; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Torres-Benito L, 2011, DEV NEUROBIOL; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Wimmer VC, 2006, J NEUROSCI, V26, P109, DOI 10.1523/JNEUROSCI.3268-05.2006; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	72	59	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26164	10.1371/journal.pone.0026164	http://dx.doi.org/10.1371/journal.pone.0026164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022549	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000078
J	Echeverria, PC; Bernthaler, A; Dupuis, P; Mayer, B; Picard, D				Echeverria, Pablo C.; Bernthaler, Andreas; Dupuis, Pierre; Mayer, Bernd; Picard, Didier			An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; BIOLOGICAL NETWORKS; NUCLEAR IMPORT; GENE ONTOLOGY; COMPLEX; UPDATE; CANCER; CYTOSCAPE; SNAPSHOT; RECEPTOR	Understanding the functions of proteins requires information about their protein-protein interactions (PPI). The collective effort of the scientific community generates far more data on any given protein than individual experimental approaches. The latter are often too limited to reveal an interactome comprehensively. We developed a workflow for parallel mining of all major PPI databases, containing data from several model organisms, and to integrate data from the literature for a protein of interest. We applied this novel approach to build the PPI network of the human Hsp90 molecular chaperone machine (Hsp90Int) for which previous efforts have yielded limited and poorly overlapping sets of interactors. We demonstrate the power of the Hsp90Int database as a discovery tool by validating the prediction that the Hsp90 cochaperone Aha1 is involved in nucleocytoplasmic transport. Thus, we both describe how to build a custom database and introduce a powerful new resource for the scientific community.	[Echeverria, Pablo C.; Dupuis, Pierre; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland; [Bernthaler, Andreas; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria	University of Geneva; Emergentec Biodevelopment GmbH	Echeverria, PC (corresponding author), Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland.	didier.picard@unige.ch	Echeverria, Pablo Christian/A-9098-2010	Echeverria, Pablo Christian/0000-0003-1367-9692	Canton de Geneve; Swiss National Science Foundation	Canton de Geneve; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Canton de Geneve and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; DeZwaan DC, 2010, TRENDS BIOCHEM SCI, V35, P384, DOI 10.1016/j.tibs.2010.02.005; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hartson SD, 2011, BIOCH BIOPH IN PRESS; He F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-519; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Lehne Benjamin, 2009, Human Genomics, V3, P291; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Platzer A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-224; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shin CJ, 2009, PROTEOMICS, V9, P5256, DOI 10.1002/pmic.200900262; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang TY, 2011, MOL BIOSYST, V7, P2278, DOI 10.1039/c1mb05028a; Wang X, 2010, CANCER INVEST, V28, P635, DOI 10.3109/07357901003630983; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	62	152	158	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26044	10.1371/journal.pone.0026044	http://dx.doi.org/10.1371/journal.pone.0026044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022502	Green Submitted, Green Published, gold			2022-12-25	WOS:000295973200027
J	Shabrova, EV; Tarnopolsky, O; Singh, AP; Plutzky, J; Vorsa, N; Quadro, L				Shabrova, Elena V.; Tarnopolsky, Olga; Singh, Ajay P.; Plutzky, Jorge; Vorsa, Nicholi; Quadro, Loredana			Insights into the Molecular Mechanisms of the Anti-Atherogenic Actions of Flavonoids in Normal and Obese Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; ACID OXIDATION; PLASMA ADIPONECTIN; GENE-EXPRESSION; RECEPTOR-ALPHA; POTENTIAL ROLE; PPAR-ALPHA	Obesity is a major and independent risk factor for cardiovascular disease and it is strongly associated with the development of dyslipidemia, insulin resistance and type 2 diabetes. Flavonoids, a diverse group of polyphenol compounds of plant origin widely distributed in human diet, have been reported to have numerous health benefits, although the mechanisms underlying these effects have remained obscure. We analyzed the effects of chronic dietary supplementation with flavonoids extracted from cranberry (FLS) in normal and obese C57/BL6 mice compared to mice maintained on the same diets lacking FLS. Obese mice supplemented with flavonoids showed an amelioration of insulin resistance and plasma lipid profile, and a reduction of visceral fat mass. We provide evidence that the adiponectin-AMPK pathway is the main mediator of the improvement of these metabolic disorders. In contrast, the reduced plasma atherogenic cholesterol observed in normal mice under FLS seems to be due to a downregulation of the hepatic cholesterol synthesis pathway. Overall, we demonstrate for the first time that the molecular mechanisms underlying the beneficial effects of flavonoids are determined by the metabolic state.	[Shabrova, Elena V.; Tarnopolsky, Olga; Singh, Ajay P.; Vorsa, Nicholi] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Plutzky, Jorge] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA USA; [Plutzky, Jorge] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Vorsa, Nicholi] Rutgers State Univ, PE Marucci Ctr, Chatsworth, NJ USA; [Shabrova, Elena V.; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA; [Shabrova, Elena V.; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Harvard University; Brigham & Women's Hospital; Harvard University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shabrova, EV (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	vorsa@aesop.rutgers.edu; quadro@aesop.rutgers.edu	Plutzky, Jorge/V-3410-2019		PE Marucci Center for Blueberry and Cranberry Research; Extension Program Enhancement Grants (BCPEG) Program; USDA [2009-34155-19957]	PE Marucci Center for Blueberry and Cranberry Research; Extension Program Enhancement Grants (BCPEG) Program; USDA(United States Department of Agriculture (USDA))	This work was supported by a grant from the PE Marucci Center for Blueberry and Cranberry Research and Extension Program Enhancement Grants (BCPEG) Program to LQ, and by the National Research Initiative Grant no. 2009-34155-19957 from the USDA Cooperative State Research, Education, and Extension Service to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Barnes S, 2005, CURR OPIN PLANT BIOL, V8, P324, DOI 10.1016/j.pbi.2005.03.010; Bhagwat SA, 2006, USDA DATABASE FLAVON; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Bursill CA, 2007, ATHEROSCLEROSIS, V193, P86, DOI 10.1016/j.atherosclerosis.2006.08.033; Chan DC, 2009, J CLIN ENDOCR METAB, V94, P989, DOI 10.1210/jc.2008-1457; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Council N, 1996, GUID CAR US LAB AN; Decorde K, 2009, MOL NUTR FOOD RES, V53, P659, DOI 10.1002/mnfr.200800165; Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P51, DOI 10.1097/HPC.0b013e318057d4c9; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Guerre-Millo M, 2008, DIABETES METAB, V34, P12, DOI 10.1016/j.diabet.2007.08.002; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hayashida K, 2004, AM J PHYSIOL-REG I, V286, pR359, DOI 10.1152/ajpregu.00214.2003; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Liburt NR, 2009, COMP EXERC PHYSIOL, V6, P157, DOI 10.1017/S175525401000005X; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moskaug JO, 2005, AM J CLIN NUTR, V81, p277S, DOI 10.1093/ajcn/81.1.277S; Naderali EK, 2003, CLIN SCI, V105, P403, DOI 10.1042/CS20030094; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Nagasako-Akazome Yoko, 2007, J Oleo Sci, V56, P417; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Ortiz B, 2009, J LIPID RES, V50, P2278, DOI 10.1194/jlr.M900054-JLR200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rao TP, 2005, J MED FOOD, V8, P362, DOI 10.1089/jmf.2005.8.362; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Ruel G, 2006, BRIT J NUTR, V96, P357, DOI 10.1079/BJN20061814; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; SPADY DK, 1983, J LIPID RES, V24, P303; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Unger RH, 2000, REGUL PEPTIDES, V92, P87, DOI 10.1016/S0167-0115(00)00154-3; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Verges B, 2006, ARTERIOSCL THROM VAS, V26, P1364, DOI 10.1161/01.ATV.0000219611.50066.bd; Wang CY, 2004, J CLIN ENDOCR METAB, V89, P4762, DOI 10.1210/jc.2004-0820; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Yamamoto Y, 2006, BIOSCI BIOTECH BIOCH, V70, P933, DOI 10.1271/bbb.70.933; Yang DJ, 2010, J AGR FOOD CHEM, V58, P2020, DOI 10.1021/jf903355q; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	86	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24634	10.1371/journal.pone.0024634	http://dx.doi.org/10.1371/journal.pone.0024634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016761	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700002
J	Brand, MT; Carter, MQ; Parker, CT; Chapman, MR; Huynh, S; Zhou, YG				Brand, Maria T.; Carter, Michelle Q.; Parker, Craig T.; Chapman, Matthew R.; Huynh, Steven; Zhou, Yaguang			Salmonella Biofilm Formation on Aspergillus niger Involves Cellulose - Chitin Interactions	PLOS ONE			English	Article							ENTERICA SEROVAR THOMPSON; ESCHERICHIA-COLI K-12; CURLI FIBERS; TYPHIMURIUM; EXPRESSION; FAMILY; BIOSYNTHESIS; COLONIZATION; ENDOBACTERIA; ATTACHMENT	Salmonella cycles between host and nonhost environments, where it can become an active member of complex microbial communities. The role of fungi in the environmental adaptation of enteric pathogens remains relatively unexplored. We have discovered that S. enterica Typhimurium rapidly attaches to and forms biofilms on the hyphae of the common fungus, Aspergillus niger. Several Salmonella enterica serovars displayed a similar interaction, whereas other bacterial species were unable to bind to the fungus. Bacterial attachment to chitin, a major constituent of fungal cell walls, mirrored this specificity. Pre-incubation of S. Typhimurium with N-acetylglucosamine, the monomeric component of chitin, reduced binding to chitin beads by as much as 727-fold and inhibited attachment to A. niger hyphae considerably. A cellulose-deficient mutant of S. Typhimurium failed to attach to chitin beads and to the fungus. Complementation of this mutant with the cellulose operon restored binding to chitin beads to 79% of that of the parental strain and allowed for attachment and biofilm formation on A. niger, indicating that cellulose is involved in bacterial attachment to the fungus via the chitin component of its cell wall. In contrast to cellulose, S. Typhimurium curli fimbriae were not required for attachment and biofilm development on the hyphae but were critical for its stability. Our results suggest that cellulose-chitin interactions are required for the production of mixed Salmonella-A. niger biofilms, and support the hypothesis that encounters with chitinaceous alternate hosts may contribute to the ecological success of human pathogens.	[Brand, Maria T.; Carter, Michelle Q.; Parker, Craig T.; Huynh, Steven; Zhou, Yaguang] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	United States Department of Agriculture (USDA); University of Michigan System; University of Michigan	Brand, MT (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	maria.brandl@ars.usda.gov		Chapman, Matthew/0000-0002-2645-1294; Parker, Craig/0000-0002-7719-8882; Carter, Michelle Qiu/0000-0002-0710-7420	USDA National Research Initiative [2002-51110-01986]; USDA Agricultural Research Service [5325-42000-044-00D, 5325-42000-045-00D]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847] Funding Source: NIH RePORTER	USDA National Research Initiative(United States Department of Agriculture (USDA)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by USDA National Research Initiative Competitive Grant no. 2002-51110-01986 and by USDA Agricultural Research Service CRIS projects 5325-42000-044-00D and 5325-42000-045-00D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREA DH, 2003, MOL MICROBIOL, V48, P1357; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bertaux J, 2005, ENVIRON MICROBIOL, V7, P1786, DOI 10.1111/j.1462-2920.2005.00867.x; Bianciotto V, 2004, APPL ENVIRON MICROB, V70, P3600, DOI 10.1128/aem.70.6.3600-3608.2004; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P2653, DOI 10.1128/AEM.71.5.2653-2662.2005; Brandl MT, 2002, APPL ENVIRON MICROB, V68, P3614, DOI 10.1128/AEM.68.7.3614-3621.2002; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; CHAUDHURI S, 2010, APPL ENV MICROBIOL; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Frases S, 2006, APPL ENVIRON MICROB, V72, P1542, DOI 10.1128/AEM.72.2.1542-1550.2006; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kobayashi D. Y, 2005, FUNGAL COMMUNITY ITS, P399; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Kondo T, 2004, CELLULOSE, V11, P463, DOI 10.1023/B:CELL.0000046413.91309.55; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; Maeyama R, 2004, J BIOMED MATER RES A, V70A, P274, DOI 10.1002/jbm.a.30077; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; PEL R, 1990, J GEN MICROBIOL, V136, P695, DOI 10.1099/00221287-136-4-695; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SANDHU GS, 1995, J CLIN MICROBIOL, V33, P2913, DOI 10.1128/JCM.33.11.2913-2919.1995; SHAUN MB, 2006, BIOESSAYS, V28, P799, DOI DOI 10.1002/BIES.20441; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; Uesugi AR, 2007, J FOOD PROTECT, V70, P1784, DOI 10.4315/0362-028X-70.8.1784; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	54	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25553	10.1371/journal.pone.0025553	http://dx.doi.org/10.1371/journal.pone.0025553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003399	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300020
J	Canino, C; Mori, F; Cambria, A; Diamantini, A; Germoni, S; Alessandrini, G; Borsellino, G; Galati, R; Battistini, L; Blandino, R; Facciolo, F; Citro, G; Strano, S; Muti, P; Blandino, G; Cioce, M				Canino, C.; Mori, F.; Cambria, A.; Diamantini, A.; Germoni, S.; Alessandrini, G.; Borsellino, G.; Galati, R.; Battistini, L.; Blandino, R.; Facciolo, F.; Citro, G.; Strano, S.; Muti, P.; Blandino, G.; Cioce, M.			SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells	ONCOGENE			English	Article						EMT; chemoresistance; SASP; mesothelioma	MALIGNANT PLEURAL MESOTHELIOMA; CANCER STEM-CELLS; AUTOCRINE GROWTH-FACTOR; IN-VITRO; BREAST-CANCER; MESENCHYMAL TRANSITION; TUBERCULOUS PLEURISY; CELLULAR SENESCENCE; SIGNAL TRANSDUCER; EXPRESSION	Here we show that pemetrexed-treated mesothelioma cells undergo accelerated senescence. This is characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype). Conditioned media from senescent MPM (malignant pleural mesothelioma) cells trigger the emergence of EMT (epithelial-to-mesenchymal)-like, clonogenic and chemoresistant cell subpopulations, expressing high levels of ALDH (aldehyde dehydrogenase) activity (ALDH(bright) cells). We show by fluorescence-activated cell sorting of purified ALDH(bright) and ALDH(low) cells, that both cell-autonomous and cell-non-autonomous mechanisms converge to maintain the SASP-induced, EMT-like cell subpopulations. Chemoresistant ALDH(bright) cells exist within primary MPM specimens and enrichment for ALDH(bright) cells correlates with an earlier tumor onset into NOD/SCID mice. We show that RAS(v12) expression induces SASP-like changes in untransformed human mesothelial cells, and that p53 ablation increases the effect of RASv12 expression. We identify STAT3 activation as a crucial event downstream to SASP signaling. In fact, small hairpin RNA-mediated ablation of STAT3 deeply attenuates the induction of EMT genes and the increase of ALDH(bright) cells induced by SASP-cytokines. This strongly affects the chemoresistance of MPM cells in vitro and leads to anticancer effects in vivo. Oncogene (2012) 31, 3148-3163; doi:10.1038/onc.2011.485; published online 24 October 2011	[Canino, C.; Blandino, G.; Cioce, M.] Italian Natl Canc Inst Regina Elena, Translat Oncogenom Unit, Rome, Italy; [Mori, F.; Galati, R.; Strano, S.] Italian Natl Canc Inst Regina Elena, Mol Chemoprevent Grp, Rome, Italy; [Cambria, A.; Blandino, R.] S Vincenzo Hosp, Taormina, Italy; [Diamantini, A.; Borsellino, G.; Battistini, L.] IRCCS Santa Lucia Fdn, Neuroimmunol Unit, Rome, Italy; [Germoni, S.; Citro, G.] Italian Natl Canc Inst Regina Elena, SAFU Dept, Rome, Italy; [Alessandrini, G.; Facciolo, F.] Italian Natl Canc Inst, Unit Thorac Surg, Rome, Italy; [Muti, P.] Italian Natl Canc Inst Regina Elena, Sci Directors Off, Rome, Italy	IRCCS Santa Lucia	Blandino, G (corresponding author), Regina Elena Inst Canc Res, Translat Oncogen Unit, Via Elio Chianesi 53, I-00144 Rome, Italy.	blandino@ifo.it; mcioce@ifo.it	Cioce, Mario/R-9734-2017; Galati, Rossella/ABH-6437-2020; Muti, Paola/AAD-9108-2020; Galati, Rossella Maria/H-8867-2017; Blandino, Giovanni/B-1137-2013; Strano, Sabrina/K-9654-2016; Battistini, Luca/D-6920-2014; Battistini, luca/ABE-1882-2021; strano, sabrina/B-6743-2013; Borsellino, Giovanna/K-3074-2016	Cioce, Mario/0000-0001-8129-6664; Galati, Rossella/0000-0003-2646-8384; Galati, Rossella Maria/0000-0003-2646-8384; Blandino, Giovanni/0000-0002-6970-2241; Battistini, Luca/0000-0002-6488-4891; strano, sabrina/0000-0002-6341-4230; Borsellino, Giovanna/0000-0002-4227-6481; Alessandrini, Gabriele/0000-0002-4380-7627; Facciolo, Francesco/0000-0002-7137-8946	INAIL (Italian Workers' Compensation Authority)	INAIL (Italian Workers' Compensation Authority)	We thank Ms Tania Merlino (Regina Elena Cancer Institute, Rome) for revising and proofreading the manuscript and Dr Frank Sinicrope (Rochester, MN) for the ShSTAT3 vectors available at ADDGENE (UK). We acknowledge INAIL (Italian Workers' Compensation Authority) for grant support to GB.	Achcar RDD, 2007, ARCH PATHOL LAB MED, V131, P1350; Adhikari AS, 2011, FRONT BIOSCI-LANDMRK, V16, P1927, DOI 10.2741/3831; Albonici L, 2009, INT J IMMUNOPATH PH, V22, P389, DOI 10.1177/039463200902200216; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Casarsa C, 2011, CANCER LETT, V302, P136, DOI 10.1016/j.canlet.2011.01.009; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fujino S, 1996, AM J RESP CELL MOL, V14, P508, DOI 10.1165/ajrcmb.14.6.8652179; Galffy G, 1999, CANCER RES, V59, P367; Hazarika M, 2005, CLIN CANCER RES, V11, P982; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Huang C, 2011, INT J ONCOL, V38, P1637, DOI 10.3892/ijo.2011.1000; Kim C, 2011, YONSEI MED J, V52, P51, DOI 10.3349/ymj.2011.52.1.51; KRYCZEK I, 2011, INT J CANC; Kubo T, 2011, CLIN CANCER RES, V17, P4965, DOI 10.1158/1078-0432.CCR-10-3040; Laberge RM, 2011, CANC MICROENVIRON; Li Q, 2007, CLIN CANCER RES, V13, P5918, DOI 10.1158/1078-0432.CCR-07-0501; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; METCALF RA, 1992, CANCER RES, V52, P2610; Mor O, 1997, AM J RESP CELL MOL, V16, P9, DOI 10.1165/ajrcmb.16.1.8998073; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Oka M, 2010, EXP DERMATOL, V19, pE50, DOI 10.1111/j.1600-0625.2009.00972.x; Park JS, 2003, SCAND J IMMUNOL, V57, P463, DOI 10.1046/j.1365-3083.2003.01201.x; Pompeo E, 2009, ANN THORAC SURG, V88, P426, DOI 10.1016/j.athoracsur.2009.04.038; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Ruco LP, 1996, J PATHOL, V179, P266; Scarpa S, 2002, ONCOL REP, V9, P205; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schramm A, 2010, EUR J CARDIO-THORAC, V37, P566, DOI 10.1016/j.ejcts.2009.08.027; Sidi R, 2011, EUR J CANCER, V47, P326, DOI 10.1016/j.ejca.2010.09.044; Sivertsen S, 2006, LUNG CANCER, V54, P309, DOI 10.1016/j.lungcan.2006.08.010; Suzuki Y, 2010, INT J CANCER, V127, P1948, DOI 10.1002/ijc.25197; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Tolnay E, 1998, J CANCER RES CLIN, V124, P291, DOI 10.1007/s004320050171; Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	49	119	123	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	26					3148	3163		10.1038/onc.2011.485	http://dx.doi.org/10.1038/onc.2011.485			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22020330	Green Published			2022-12-25	WOS:000305934400004
J	Feierler, J; Wirth, M; Welte, B; Schussler, S; Jochum, M; Faussner, A				Feierler, Jens; Wirth, Markus; Welte, Benjamin; Schuessler, Steffen; Jochum, Marianne; Faussner, Alexander			Helix 8 Plays a Crucial Role in Bradykinin B-2 Receptor Trafficking and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ANGIOTENSIN-II RECEPTOR; LIGHT-DEPENDENT CHANGES; B2 KININ RECEPTORS; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; CYTOPLASMIC END; DOWN-REGULATION; SMALL-MOLECULE; TERMINAL TAIL	Upon activation the human bradykinin B-2 receptor (B2R) acts as guanine nucleotide exchange factor for the G proteins G(q/11) and G(i). Thereafter, it gets phosphorylated by G protein-coupled receptor kinases (GRKs) and recruits beta-arrestins, which block further G protein activation and promote B2R internalization via clathrin-coated pits. As for most G protein-coupled receptors of family A, an intracellular helix 8 after transmembrane domain 7 is also predicted for the B2R. We show here that disruption of helix 8 in the B2R by either C-terminal truncation or just by mutation of a central amino acid (Lys-315) to a helix-breaking proline resulted in strong reduction of surface expression. Interestingly, this malfunction could be overcome by the addition of the membrane-permeable B2R antagonist JSM10292, suggesting that helix 8 has a general role for conformational stabilization that can be accounted for by an appropriate antagonist. Intriguingly, an intact helix 8, but not the C terminus with its phosphorylation sites, was indispensable for receptor sequestration and for interaction of the B2R with GRK2/3 and beta-arrestin2 as shown by co-immunoprecipitation. Recruitment of beta-arrestin1, however, required the presence of the C terminus. Taken together, our results demonstrate that helix 8 of the B2R plays a crucial role not only in efficient trafficking to the plasma membrane or the activation of G proteins but also for the interaction of the B2R with GRK2/3 and beta-arrestins. Additional data obtained with chimera of B2R with other G protein-coupled receptors of family A suggest that helix 8 might have similar functions in other GPCRs as well.	[Feierler, Jens; Wirth, Markus; Welte, Benjamin; Schuessler, Steffen; Jochum, Marianne; Faussner, Alexander] Univ Munich, Abt Klin Chem & Klin Biochem, D-80336 Munich, Germany	University of Munich	Faussner, A (corresponding author), Univ Munich, Abt Klin Chem & Klin Biochem, Nussbaumstr 20, D-80336 Munich, Germany.	alexander.faussner@med.uni-muenchen.de	Wirth, Markus/ABW-6155-2022					Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blaukat A, 2003, AM J PHYSIOL-HEART C, V284, pH1909, DOI 10.1152/ajpheart.00034.2003; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Faussner A, 2005, FEBS J, V272, P129, DOI 10.1111/j.1432-1033.2004.04390.x; Faussner A, 1998, J BIOL CHEM, V273, P2617, DOI 10.1074/jbc.273.5.2617; Faussner A, 2003, AM J PHYSIOL-HEART C, V284, pH1892, DOI 10.1152/ajpheart.01147.2002; Faussner A, 1999, IMMUNOPHARMACOLOGY, V45, P13, DOI 10.1016/S0162-3109(99)00052-1; Faussner A, 2009, FEBS J, V276, P3491, DOI 10.1111/j.1742-4658.2009.07071.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Gibson C, 2009, J MED CHEM, V52, P4370, DOI 10.1021/jm9002445; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; Kai H, 1998, BIOCHEM J, V332, P781, DOI 10.1042/bj3320781; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kalatskaya I, 2006, BIOL CHEM, V387, P603, DOI 10.1515/BC.2006.077; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tebben AJ, 2011, METHODS MOL BIOL, V672, P359, DOI 10.1007/978-1-60761-839-3_15; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x; Zhang XQ, 2008, J NEUROCHEM, V106, P781, DOI 10.1111/j.1471-4159.2008.05431.x	49	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43282	43293		10.1074/jbc.M111.256909	http://dx.doi.org/10.1074/jbc.M111.256909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016392	Green Published, hybrid			2022-12-25	WOS:000298351300048
J	Fong, YH; Wong, HC; Chuck, CP; Chen, YW; Sun, HZ; Wong, KB				Fong, Yu Hang; Wong, Ho Chun; Chuck, Chi Pang; Chen, Yu Wai; Sun, Hongzhe; Wong, Kam-Bo			Assembly of Preactivation Complex for Urease Maturation in Helicobacter pylori CRYSTAL STRUCTURE OF UreF-UreH PROTEIN COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN; NICKEL-BINDING; ACTIVATION; APOPROTEIN; IDENTIFICATION; MUTAGENESIS; FUSION; SITE	Colonization of Helicobacter pylori in the acidic environment of the human stomach depends on the neutralizing activity of urease. Activation of apo-urease involves carboxylation of lysine 219 and insertion of two nickel ions. In H. pylori, this maturation process involves four urease accessory proteins as follows: UreE, UreF, UreG, and UreH. It is postulated that the apo-urease interacts with UreF, UreG, and UreH to form a pre-activation complex that undergoes GTP-dependent activation of urease. The crystal structure of the UreF-UreH complex reveals conformational changes in two distinct regions of UreF upon complex formation. First, the flexible C-terminal residues of UreF become ordered, forming an extra helix alpha 10 and a loop structure stabilized by hydrogen bonds involving Arg-250. Second, the first turn of helix alpha 2 uncoils to expose a conserved residue, Tyr-48. Substitution of R250A or Y48A in UreF abolishes the formation of the heterotrimeric complex of UreG-UreF-UreH and abolishes urease maturation. Our results suggest that the C-terminal residues and helix alpha 2 of UreF are essential for the recruitment of UreG for the formation of the pre-activation complex. The molecular mass of the UreF-UreH complex determined by static light scattering was 116 +/- 2.3 kDa, which is consistent with the quaternary structure of a dimer of heterodimers observed in the crystal structure. Taking advantage of the unique 2-fold symmetry observed in both the crystal structures of H. pylori urease and the UreF-UreH complex, we proposed a topology model of the pre-activation complex for urease maturation.	Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu Wai] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of London; King's College London; University of Hong Kong	Wong, KB (corresponding author), Chinese Univ Hong Kong, Rm Sci Ctr 289, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Chen, Yu Wai/AAJ-8037-2020; Wong, Kam-Bo/AAU-9364-2021; /D-3123-2009	Wong, Kam-Bo/0000-0002-6984-5373; Chen, Yu Wai/0000-0001-7833-7533; Wong, Kam-Bo/0000-0002-6984-5373; /0000-0001-6697-6899	Research Grants Council of Hong Kong [HKU 1/07C]; University Grants Council of Hong Kong [SEG CUHK08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Council of Hong Kong	This work was supported by the Collaborative Research Fund of the Research Grants Council of Hong Kong Grant HKU 1/07C.; We thank Carmen Lau for help with cloning, Ka Ming Lee for help with figure preparation, and Chi Kong Lau, Kwok Ho Chan, and Martin Rees for many helpful discussions. We also thank staff members of the Diamond Light Source beamline I-04, in particular, Michael Mrosek, for assistance with data collection and analysis. The equipment used in this study was supported in part by University Grants Council of Hong Kong One-Off Special Equipment Grant SEG CUHK08.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balasubramanian A, 2010, J MOL BIOL, V400, P274, DOI 10.1016/j.jmb.2010.05.009; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Benini S, 1999, STRUCTURE, V7, P205, DOI 10.1016/S0969-2126(99)80026-4; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Carter EL, 2010, J BACTERIOL, V192, P2294, DOI 10.1128/JB.01426-09; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Chang ZZ, 2004, J BIOL CHEM, V279, P15305, DOI 10.1074/jbc.M312979200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Heimer SR, 2001, J BACTERIOL, V183, P1423, DOI 10.1128/JB.183.4.1423-1433.2001; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JK, 2006, J BACTERIOL, V188, P8413, DOI 10.1128/JB.01265-06; Lam R, 2010, PROTEINS, V78, P2839, DOI 10.1002/prot.22802; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moncrief MBC, 1996, J BACTERIOL, V178, P5417, DOI 10.1128/jb.178.18.5417-5421.1996; Moncrief MBC, 1997, J BACTERIOL, V179, P4081, DOI 10.1128/jb.179.13.4081-4086.1997; PARK IS, 1994, P NATL ACAD SCI USA, V91, P3233, DOI 10.1073/pnas.91.8.3233; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; PARK IS, 1995, SCIENCE, V267, P1156, DOI 10.1126/science.7855593; Quiroz-Valenzuela S, 2008, ARCH BIOCHEM BIOPHYS, V480, P51, DOI 10.1016/j.abb.2008.09.004; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Salomone-Stagni M, 2007, PROTEINS, V68, P749, DOI 10.1002/prot.21472; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Soriano A, 2000, BIOCHEMISTRY-US, V39, P12435, DOI 10.1021/bi001296o; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Voland P, 2003, AM J PHYSIOL-GASTR L, V284, pG96, DOI 10.1152/ajpgi.00160.2002; WARREN JR, 1983, LANCET, V1, P1273; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045	42	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43241	43249		10.1074/jbc.M111.296830	http://dx.doi.org/10.1074/jbc.M111.296830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013070	hybrid, Green Published			2022-12-25	WOS:000298351300044
J	Linster, CL; Noel, G; Stroobant, V; Vertommen, D; Vincent, MF; Bommer, GT; Veiga-da-Cunha, M; Van Schaftingen, E				Linster, Carole L.; Noel, Gaetane; Stroobant, Vincent; Vertommen, Didier; Vincent, Marie-Francoise; Bommer, Guido T.; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			Ethylmalonyl-CoA Decarboxylase, a New Enzyme Involved in Metabolite Proofreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED DIPHOSPHOPYRIDINE NUCLEOTIDE; L-2-HYDROXYGLUTARIC ACIDURIA; SHORT-CHAIN; METHYLMALONYL COENZYME; CROTONASE SUPERFAMILY; ESCHERICHIA-COLI; UROPYGIAL GLAND; ANIMAL TISSUES; PROPIONIC ACID; R-PATHWAY	Background: Acetyl-CoA and propionyl-CoA carboxylases slowly form ethylmalonyl-CoA as a side activity. Results: Anew enzyme, ethylmalonyl-CoA decarboxylase, was identified in mammalian tissues and shown to be encoded by the ECHDC1 gene. Knocking down this gene increased the formation of ethylmalonate from butyrate in cultured cells. Conclusion: Ethylmalonyl-CoA decarboxylase may be a new "metabolite proofreading" enzyme. Significance: Its deficiency may cause ethylmalonic aciduria.	[Linster, Carole L.; Noel, Gaetane; Bommer, Guido T.; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Duve Inst, Welbio & Lab Physiol Chem, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Duve Inst, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; [Vincent, Marie-Francoise] Clin Univ St Luc, Lab Metab Dis, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, Welbio & Lab Physiol Chem, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Bommer, Guido/A-8425-2011	Van Schaftingen, Emile/0000-0002-6199-7647; Bommer, Guido/0000-0001-6898-4884; Vertommen, Didier/0000-0001-7648-8282; Linster, Carole/0000-0001-7143-0719	Fonds de la Recherche Scientifique (FRS-FNRS); European Union [276814]; Welbio (Walloon region)	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); Welbio (Walloon region)(WELBIO)	This work was supported by the Fonds de la Recherche Scientifique (FRS-FNRS), by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 276814, and by Welbio (Walloon region).	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; BARETZ BH, 1979, J BIOL CHEM, V254, P3468; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; BETTEY M, 1992, J PLANT PHYSIOL, V140, P513, DOI 10.1016/S0176-1617(11)80780-7; BUCKNER JS, 1978, ARCH BIOCHEM BIOPHYS, V186, P152, DOI 10.1016/0003-9861(78)90474-5; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Coleman TM, 2002, CHEM BIOL, V9, P1227, DOI 10.1016/S1074-5521(02)00264-8; Deutsch J, 2002, NEUROCHEM RES, V27, P1577, DOI 10.1023/A:1021614422668; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FONG JC, 1977, J BIOL CHEM, V252, P542; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HILLBRICK GC, 1995, AUST J AGR RES, V46, P1259, DOI 10.1071/AR9951259; JACOB J, 1978, J LIPID RES, V19, P148; KAZIRO Y, 1961, J BIOL CHEM, V236, P1917; KOLATTUKUDY PE, 1987, ARCH BIOCHEM BIOPHYS, V256, P446, DOI 10.1016/0003-9861(87)90601-1; Korman SH, 2005, CLIN CHEM, V51, P610, DOI 10.1373/clinchem.2004.043265; Loupatty FJ, 2006, MOL GENET METAB, V87, P243, DOI 10.1016/j.ymgme.2005.09.019; MAMER OA, 1976, BIOCHEM J, V160, P417, DOI 10.1042/bj1600417a; Mamer OA, 2001, J CHROMATOGR B, V758, P49, DOI 10.1016/S0378-4347(01)00111-6; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MAZUMDER R, 1962, J BIOL CHEM, V237, P3065; MEINHART JO, 1956, J BIOL CHEM, V220, P821; Miller A L, 1975, Methods Enzymol, V35, P11, DOI 10.1016/0076-6879(75)35132-X; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Pedersen CB, 2008, HUM GENET, V124, P43, DOI 10.1007/s00439-008-0521-9; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SPRECHER M, 1966, J BIOL CHEM, V241, P872; Steenweg ME, 2010, HUM MUTAT, V31, P380, DOI 10.1002/humu.21197; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; WAITE M, 1962, J BIOL CHEM, V237, P2750	43	36	41	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42992	43003		10.1074/jbc.M111.281527	http://dx.doi.org/10.1074/jbc.M111.281527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016388	Green Published, hybrid			2022-12-25	WOS:000298351300020
J	Wood, KC; Batchelor, AM; Bartus, K; Harris, KL; Garthwaite, G; Vernon, J; Garthwaite, J				Wood, Katherine C.; Batchelor, Andrew M.; Bartus, Katalin; Harris, Kathryn L.; Garthwaite, Giti; Vernon, Jeffrey; Garthwaite, John			Picomolar Nitric Oxide Signals from Central Neurons Recorded Using Ultrasensitive Detector Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLYL CYCLASE; LONG-TERM POTENTIATION; IN-VIVO; CONCENTRATION DYNAMICS; RAT CEREBELLUM; CHEMICAL BIOLOGY; LIVING CELLS; BRAIN-TISSUE; SYNTHASE; ACTIVATION	Nitric oxide (NO) is a widespread signaling molecule with potentially multifarious actions of relevance to health and disease. A fundamental determinant of how it acts is its concentration, but there remains a lack of coherent information on the patterns of NO release from its sources, such as neurons or endothelial cells, in either normal or pathological conditions. We have used detector cells having the highest recorded NO sensitivity to monitor NO release from brain tissue quantitatively and in real time. Stimulation of NMDA receptors, which are coupled to activation of neuronal NO synthase, routinely generated NO signals from neurons in cerebellar slices. The average computed peak NO concentrations varied across the anatomical layers of the cerebellum, from 12 to 130 pM. The mean value found in the hippocampus was 200 pM. Much variation in the amplitudes recorded by individual detector cells was observed, this being attributable to their location at variable distances from the NO sources. From fits to the data, the NO concentrations at the source surfaces were 120 pM to 1.4 nM, and the underlying rates of NO generation were 36-350 nM/s, depending on area. Our measurements are 4-5 orders of magnitude lower than reported by some electrode recordings in cerebellum or hippocampus. In return, they establish coherence between the NO concentrations able to elicit physiological responses in target cells through guanylyl cyclase-linked NO receptors, the concentrations that neuronal NO synthase is predicted to generate locally, and the concentrations that neurons actually produce.	[Wood, Katherine C.; Batchelor, Andrew M.; Bartus, Katalin; Harris, Kathryn L.; Garthwaite, Giti; Vernon, Jeffrey; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	john.garthwaite@ucl.ac.uk	Wood, Katherine/K-6728-2019; Batchelor, Andrew/C-1174-2008	Wood, Katherine/0000-0002-5520-5025; Batchelor, Andrew/0000-0002-5984-7842; Hampden-Smith, Kathryn/0000-0002-8053-5114	Wellcome Trust [081512]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Programme Grant 081512 from The Wellcome Trust.	Amatore C, 2006, CHEMPHYSCHEM, V7, P181, DOI 10.1002/cphc.200500202; Batchelor AM, 2010, P NATL ACAD SCI USA, V107, P22060, DOI 10.1073/pnas.1013147107; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Burette A, 2002, J NEUROSCI, V22, P8961; De Visscher G, 2002, J CEREBR BLOOD F MET, V22, P515, DOI 10.1097/00004647-200205000-00002; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Frade JG, 2009, HIPPOCAMPUS, V19, P603, DOI 10.1002/hipo.20536; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Glitsch M, 1999, J NEUROSCI, V19, P511; Griffiths C, 2003, MOL PHARMACOL, V64, P1349, DOI 10.1124/mol.64.6.1349; Griffiths C, 2002, EUR J NEUROSCI, V15, P962, DOI 10.1046/j.1460-9568.2002.01930.x; Hall CN, 2006, J PHYSIOL-LONDON, V577, P549, DOI 10.1113/jphysiol.2006.118380; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halvey EJ, 2009, J BIOL CHEM, V284, P25630, DOI 10.1074/jbc.M109.030338; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; Keynes RG, 2004, EUR J NEUROSCI, V19, P1163, DOI 10.1111/j.1460-9568.2004.03217.x; Kimura S, 1998, J NEUROSCI, V18, P8551; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Ledo A, 2005, P NATL ACAD SCI USA, V102, P17483, DOI 10.1073/pnas.0503624102; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Liu XP, 2010, FREE RADICAL BIO MED, V48, P554, DOI 10.1016/j.freeradbiomed.2009.11.024; Lizasoain I, 1996, PEDIATR RES, V39, P779, DOI 10.1203/00006450-199605000-00006; Lourenco CF, 2011, HIPPOCAMPUS, V21, P622, DOI 10.1002/hipo.20774; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; MURAD F, 1994, RECENT PROG HORM RES, V49, P239; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Salerno JC, 2008, FEBS LETT, V582, P1395, DOI 10.1016/j.febslet.2008.03.051; SALTER M, 1995, NEUROPHARMACOLOGY, V34, P639, DOI 10.1016/0028-3908(95)00036-6; Salter M, 1996, J NEUROCHEM, V66, P1683; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Sato M, 2005, P NATL ACAD SCI USA, V102, P14515, DOI 10.1073/pnas.0505136102; Sato M, 2006, ANAL CHEM, V78, P8175, DOI 10.1021/ac061791b; SOUTHAM E, 1991, J NEUROCHEM, V56, P2072, DOI 10.1111/j.1471-4159.1991.tb03468.x; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wakatsuki H, 1998, J PHYSIOL-LONDON, V513, P71, DOI 10.1111/j.1469-7793.1998.071by.x; Wang W, 1998, DEV BRAIN RES, V111, P65, DOI 10.1016/S0165-3806(98)00123-0; WARREN MA, 1990, J ANAT, V170, P173; Zeng SY, 2010, J NEUROPHYSIOL, V103, P1798, DOI 10.1152/jn.91235.2008; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	51	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43172	43181		10.1074/jbc.M111.289777	http://dx.doi.org/10.1074/jbc.M111.289777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016390	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000298351300038
J	Morioka, M; Parameswaran, H; Naruse, K; Kondo, M; Sokabe, M; Hasegawa, Y; Suki, B; Ito, S				Morioka, Masataka; Parameswaran, Harikrishnan; Naruse, Keiji; Kondo, Masashi; Sokabe, Masahiro; Hasegawa, Yoshinori; Suki, Bela; Ito, Satoru			Microtubule Dynamics Regulate Cyclic Stretch-Induced Cell Alignment in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							CULTURED ENDOTHELIAL-CELLS; EXTERNALLY APPLIED STRAIN; MECHANICAL STRETCH; LIVING CELLS; ACTIN-FILAMENTS; FOCAL ADHESIONS; STRESS FIBERS; REORIENTATION; ORIENTATION; MODEL	Microtubules are structural components of the cytoskeleton that determine cell shape, polarity, and motility in cooperation with the actin filaments. In order to determine the role of microtubules in cell alignment, human airway smooth muscle cells were exposed to cyclic uniaxial stretch. Human airway smooth muscle cells, cultured on type I collagen-coated elastic silicone membranes, were stretched uniaxially (20% in strain, 30 cycles/min) for 2 h. The population of airway smooth muscle cells which were originally oriented randomly aligned near perpendicular to the stretch axis in a time-dependent manner. However, when the cells treated with microtubule disruptors, nocodazole and colchicine, were subjected to the same cyclic uniaxial stretch, the cells failed to align. Lack of alignment was also observed for airway smooth muscle cells treated with a microtubule stabilizer, paclitaxel. To understand the intracellular mechanisms involved, we developed a computational model in which microtubule polymerization and attachment to focal adhesions were regulated by the preexisting tensile stress, pre-stress, on actin stress fibers. We demonstrate that microtubules play a central role in cell reorientation when cells experience cyclic uniaxial stretching. Our findings further suggest that cell alignment and cytoskeletal reorganization in response to cyclic stretch results from the ability of the microtubule-stress fiber assembly to maintain a homeostatic strain on the stress fiber at focal adhesions. The mechanism of stretch-induced alignment we uncovered is likely involved in various airway functions as well as in the pathophysiology of airway remodeling in asthma.	[Morioka, Masataka; Kondo, Masashi; Hasegawa, Yoshinori; Ito, Satoru] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4648601, Japan; [Naruse, Keiji] Okayama Univ, Grad Sch Med, Dept Cardiovasc Physiol, Okayama 7008530, Japan; [Parameswaran, Harikrishnan; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Nagoya University; Nagoya University; Okayama University; Boston University	Morioka, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan.	itori@med.nagoya-u.ac.jp	Sokabe, Masahiro/I-1565-2012; Parameswaran, Harikrishnan/D-9839-2012; Ito, Satoru/AAT-5219-2020; Kondo, Masashi/I-7378-2014; NARUSE, Keiji/B-1620-2011; Hasegawa, Yoshinori/I-1277-2012	Ito, Satoru/0000-0001-7885-4653; Parameswaran, Harikrishnan/0000-0002-5324-5517; naruse, keiji/0000-0003-4100-6444	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19689017, 22890837]; National Heart, Lung, and Blood Institute [HL098976]; MENICON; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MENICON; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant-in-Aid for Young Scientists A #19689017 and for Scientific Research C #22890837 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. I.) and by National Heart, Lung, and Blood Institute Grant HL098976 (to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; K.N. has served on the STREX Advisory Board for up to $ 1,000. He has received a grant from MENICON for $1,001-$5,000, and a sponsored grant from the National Institutes of Health for $5,001-$10,000. He has a patent pending with STREX for a stretch machine, and owns stock in the amount of $10,001-$50,000. None of the other authors have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; BATES JHT, 1990, J APPL PHYSIOL, V69, P995, DOI 10.1152/jappl.1990.69.3.995; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Fung Y. C., 1977, 1 COURSE CONTINUUM M; Gierke S, 2010, METHOD CELL BIOL, V97, P15, DOI 10.1016/S0091-679X(10)97002-7; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; Hayakawa K, 2000, ZOOL SCI, V17, P617, DOI 10.2108/zsj.15.617; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Ito S, 2006, AM J PHYSIOL-LUNG C, V290, pL1227, DOI 10.1152/ajplung.00299.2005; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kadi A, 1998, BIOCHEM BIOPH RES CO, V246, P690, DOI 10.1006/bbrc.1998.8536; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2002, J CELL SCI, V115, P2283; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200; Lei M, 1997, J APPL PHYSIOL, V82, P70, DOI 10.1152/jappl.1997.82.1.70; Malek AM, 1996, J CELL SCI, V109, P713; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; OAKLEY C, 1993, J CELL SCI, V106, P343; Paul RJ, 2000, AM J PHYSIOL-HEART C, V279, pH2493, DOI 10.1152/ajpheart.2000.279.5.H2493; Pirentis AP, 2011, CELL MOL BIOENG, V4, P67, DOI 10.1007/s12195-010-0152-9; Putnam AJ, 1998, J CELL SCI, V111, P3379; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Smiley-Jewell SM, 2002, J APPL PHYSIOL, V93, P1506, DOI 10.1152/japplphysiol.01109.2001; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Smith PG, 2003, AM J PHYSIOL-LUNG C, V285, pL456, DOI 10.1152/ajplung.00329.2002; Smith PG, 1997, EXP CELL RES, V232, P127, DOI 10.1006/excr.1997.3492; Stamenovic D, 2005, ACTA BIOMATER, V1, P255, DOI 10.1016/j.actbio.2005.01.004; Stamenovic D, 2005, J BIOMECH, V38, P1728, DOI 10.1016/j.jbiomech.2004.07.016; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Stamenovic D, 2008, RESP PHYSIOL NEUROBI, V163, P25, DOI 10.1016/j.resp.2008.02.009; Stamenovic D, 2009, CELL MOL BIOENG, V2, P475, DOI 10.1007/s12195-009-0093-3; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598	60	53	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26384	10.1371/journal.pone.0026384	http://dx.doi.org/10.1371/journal.pone.0026384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022610	gold, Green Published, Green Submitted			2022-12-25	WOS:000295984400052
J	Tkachuk, A; Kim, M; Kravchuk, O; Savitsky, M				Tkachuk, Artem; Kim, Maria; Kravchuk, Oksana; Savitsky, Mikhail			A New Powerful Method for Site-Specific Transgene Stabilization Based on Chromosomal Double-Strand Break Repair	PLOS ONE			English	Article							POST-INTEGRATION BEHAVIOR; ZINC-FINGER NUCLEASES; MEXICAN FRUIT-FLY; HOMOLOGOUS RECOMBINATION; DROSOPHILA-MELANOGASTER; GENOMIC INTEGRATION; PHI-C31 INTEGRASE; MAMMALIAN-CELLS; PHAGE PHI-C31; AEDES-AEGYPTI	Transgenic insects are a promising tool in sterile insect techniques and population replacement strategies. Such transgenic insects can be created using nonautonomous transposons, which cannot be transferred without a transposase source. In biocontrol procedures where large numbers of insects are released, there is increased risk of transgene remobilization caused by external transposase sources that can alter the characteristics of the transgenic organisms lead horizontal transgene transfer to other species. Here we describe a novel, effective method for transgene stabilization based on the introduction of directed double-strand breaks (DSB) into a genome-integrated sequence and their subsequent repair by the single-strand annealing (SSA) pathway. Due to the construct's organization, the repair pathway is predictable, such that all transposon and marker sequences can be deleted, while preserving integration of exogenous DNA in the genome. The exceptional conservation of DNA repair pathways makes this method suitable for a broad range of organisms.	[Tkachuk, Artem; Kim, Maria; Kravchuk, Oksana; Savitsky, Mikhail] Russian Acad Sci, Inst Gene Biol, Grp Telomere Biol, Moscow, Russia; [Savitsky, Mikhail] Univ Oslo, Ctr Med Studies, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Tkachuk, A (corresponding author), Russian Acad Sci, Inst Gene Biol, Grp Telomere Biol, Moscow, Russia.	msavitsky@gmail.com	Tkachuk, Artem/AAU-1208-2021; Savitsky, Mikhail/AAC-7631-2022; Kravchuk, Oksana/B-9624-2014	Kravchuk, Oksana/0000-0002-8363-6666; Savitsky, Mikhail/0000-0002-4735-5517; Tkachuk, Artem/0000-0003-3262-4873	Russian Academy of Sciences; Center for Medical Studies, Oslo University; Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia [P597, P274]	Russian Academy of Sciences(Russian Academy of Sciences); Center for Medical Studies, Oslo University; Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia	This work was supported by the Molecular and Cellular Biology Program of the Russian Academy of Sciences, the Young Scientists Support Program of the Russian Academy of Sciences (to M. K.), a stipend from the Center for Medical Studies, Oslo University (to M. S.) and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013" (state contracts P597 and P274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Atkinson PW, 2008, ADV EXP MED BIOL, V627, P60; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Condon KC, 2007, INSECT MOL BIOL, V16, P573, DOI 10.1111/j.1365-2583.2007.00752.x; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Handler AM, 2004, INSECT BIOCHEM MOLEC, V34, P121, DOI 10.1016/j.ibmb.2003.08.005; Hay BA, 2010, J INSECT PHYSIOL, V56, P1402, DOI 10.1016/j.jinsphys.2010.05.022; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Kappeler M, 2008, NUCLEIC ACIDS RES, V36, P6907, DOI 10.1093/nar/gkn793; Lozovsky ER, 2002, GENETICS, V160, P527; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; O'Brochta DA, 2008, ADV EXP MED BIOL, V627, P1, DOI 10.1007/978-0-387-78225-6_1; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Preston CR, 2002, GENETICS, V161, P711; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2003, GENETICS, V165, P1831; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Meza JS, 2011, GENETICA, V139, P53, DOI 10.1007/s10709-010-9484-6; Scali C, 2007, MOL GENET GENOMICS, V278, P575, DOI 10.1007/s00438-007-0274-5; Schetelig MF, 2011, GENETICA, V139, P71, DOI 10.1007/s10709-010-9494-4; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Sigrist CJA, 1997, GENETICS, V147, P209; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; THOMPSON AJ, 1992, GENE, V119, P247, DOI 10.1016/0378-1119(92)90278-W; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wilson R, 2003, INSECT BIOCHEM MOLEC, V33, P853, DOI 10.1016/S0965-1748(03)00044-4; Wimmer EA, 2003, NAT REV GENET, V4, P225, DOI 10.1038/nrg1021	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26422	10.1371/journal.pone.0026422	http://dx.doi.org/10.1371/journal.pone.0026422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022613	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400057
J	Butler, RJ; Brusatte, SL; Reich, M; Nesbitt, SJ; Schoch, RR; Hornung, JJ				Butler, Richard J.; Brusatte, Stephen L.; Reich, Mike; Nesbitt, Sterling J.; Schoch, Rainer R.; Hornung, Jahn J.			The Sail-Backed Reptile Ctenosauriscus from the Latest Early Triassic of Germany and the Timing and Biogeography of the Early Archosaur Radiation	PLOS ONE			English	Article							POPOSAURUS-GRACILIS; EVOLUTIONARY RADIATION; MIDDLE; BUNTSANDSTEIN; TIMESCALE; DIVERSIFICATION; BIOSTRATIGRAPHY; REDESCRIPTION; RAUISUCHIA; FOOTPRINTS	Background: Archosaurs (birds, crocodilians and their extinct relatives including dinosaurs) dominated Mesozoic continental ecosystems from the Late Triassic onwards, and still form a major component of modern ecosystems (> 10,000 species). The earliest diverse archosaur faunal assemblages are known from the Middle Triassic (c. 244 Ma), implying that the archosaur radiation began in the Early Triassic (252.3-247.2 Ma). Understanding of this radiation is currently limited by the poor early fossil record of the group in terms of skeletal remains. Methodology/Principal Findings: We redescribe the anatomy and stratigraphic position of the type specimen of Ctenosauriscus koeneni (Huene), a sail-backed reptile from the Early Triassic (late Olenekian) Solling Formation of northern Germany that potentially represents the oldest known archosaur. We critically discuss previous biomechanical work on the 'sail' of Ctenosauriscus, which is formed by a series of elongated neural spines. In addition, we describe Ctenosauriscus-like postcranial material from the earliest Middle Triassic (early Anisian) Rot Formation of Waldhaus, southwestern Germany. Finally, we review the spatial and temporal distribution of the earliest archosaur fossils and their implications for understanding the dynamics of the archosaur radiation. Conclusions/Significance: Comprehensive numerical phylogenetic analyses demonstrate that both Ctenosauriscus and the Waldhaus taxon are members of a monophyletic grouping of poposauroid archosaurs, Ctenosauriscidae, characterised by greatly elongated neural spines in the posterior cervical to anterior caudal vertebrae. The earliest archosaurs, including Ctenosauriscus, appear in the body fossil record just prior to the Olenekian/Anisian boundary (c. 248 Ma), less than 5 million years after the Permian-Triassic mass extinction. These earliest archosaur assemblages are dominated by ctenosauriscids, which were broadly distributed across northern Pangea and which appear to have been the first global radiation of archosaurs.	[Butler, Richard J.] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA; [Reich, Mike; Hornung, Jahn J.] Univ Gottingen, Geowissenschaftliches Zentrum, Gottingen, Germany; [Nesbitt, Sterling J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Schoch, Rainer R.] Staatliches Museum Nat Kunde, Stuttgart, Germany	University of Munich; American Museum of Natural History (AMNH); Columbia University; University of Gottingen; University of Washington; University of Washington Seattle	Butler, RJ (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	r.butler@lrz.uni-muenchen.de	Reich, Mike/A-3745-2012; Butler, Richard J./A-5239-2011; Brusatte, Stephen/O-9663-2014	Butler, Richard J./0000-0003-2136-7541; Hornung, Jahn/0000-0002-4929-5490; Nesbitt, Sterling/0000-0002-7017-1652; Reich, Mike/0000-0003-3837-3497; Brusatte, Stephen/0000-0001-7525-7319	personal Alexander von Humboldt Research Fellowship; National Science Foundation [DEB 1110357]	personal Alexander von Humboldt Research Fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by a personal Alexander von Humboldt Research Fellowship to the lead author (RJB). The participation of the second author (SLB) was funded by a National Science Foundation Graduate Research Fellowship and Doctoral Dissertation Improvement Grant (DEB 1110357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL O, 1939, REICH TIERE ERGANZUN; Alcober O, 1997, J VERTEBR PALEONTOL, V17, P548, DOI 10.1080/02724634.1997.10011001; ARP G, 2004, GEOBIOLOGIE, V2, P147; ATTRIDGE J, 1964, NATURE, V201, P445, DOI 10.1038/201445a0; Benton M.J., 1995, FOSSIL REPTILES GREA; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2011, P GEOLOGIST ASSOC, V122, P25, DOI 10.1016/j.pgeola.2010.08.004; BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; Benton MJ, 1997, J VERTEBR PALEONTOL, V17, P74, DOI 10.1080/02724634.1997.10010955; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH ENV SCI T R SO, V101, P367, DOI 10.1017/S1755691011020056; Brusatte SL, 2011, P ROY SOC B-BIOL SCI, V278, P1107, DOI 10.1098/rspb.2010.1746; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Buffetaut Eric, 1993, Paleontologia Lombarda, V2, P39; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; CARROLL RL, 1988, VERTEBRATE PALEONTOL; CASE EC, 1907, PUBLICATIONS CARNEGI, V55, P1; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Cheng ZW, 1980, MESOZOIC STRATIGRAPH, P114; Cisneros JC, 2008, J SYST PALAEONTOL, V6, P345, DOI 10.1017/S1477201907002350; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Ebel Klaus, 1998, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V261, P1; EBERT T, 1894, ERLAUTERUNGEN GEOLOG; FALKENSTEIN F, 2001, AUFSCHLUSS, V52, P227; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Fraas O, 1877, WURTTEMBERGISCHE NAT, V33, P1; Franca MAG, 2011, NATURWISSENSCHAFTEN, V98, P389, DOI 10.1007/s00114-011-0782-3; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Galton Peter M., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V201, P303; Galton PM, STUTTGARTER BEITRAGE, V116, P1; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gauthier JA, 2011, B PEABODY MUS NAT HI, V52, P107, DOI 10.3374/014.052.0102; Gebauer EVI, 2004, NEUES JAHRB GEOL P-A, V231, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gower David J., 2000, P140; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 2000, NEUES JAHRB GEOL P-A, V218, P447, DOI 10.1127/njgpa/218/2000/447; Grauvogel-Stamm L., 1999, TRIAS GANZ ANDERE WE, P271; GRAUVOGELSTAMM L, 1993, REV PALAEOBOT PALYNO, V77, P185, DOI 10.1016/0034-6667(93)90004-E; Hounslow MW, 2010, GEOL SOC SPEC PUBL, V334, P61, DOI 10.1144/SP334.4; Huene F. von, 1902, GEOLOGISCHE PALAONTO, V6, P1; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; Huxley T.H., 1877, GEOL SOC AM MEM, VIII, P1; Kallies H.-B., 1963, GEOLOGISCHES JB, V80, P367; KAMPHAUSEN D, 1993, VEREINS, V75, P217; Kozur H., 2005, ALBERTIANA, V32, P21; KOZUR H.W., 2008, BER GEOL B A, V76, P53; Kozur HW, 2010, GEOL SOC SPEC PUBL, V334, P315, DOI 10.1144/SP334.13; Krebs B., 1969, Eclogae Geologicae Helvetiae, V62, P697; KREBS B, 1976, GUSTAV, V13, P40; Krebs B. E., 1965, Schweizerische Palaeontologische Abhandlungen, V81, P1; Kubo T, 2007, PALAEONTOLOGY, V50, P1519, DOI 10.1111/j.1475-4983.2007.00723.x; Kuhn O., 1964, Jahresheft des Vereins fuer Vaterlaendische Naturkunde in Wuerttemberg, V118-119, P293; KUHN O, 1968, DTSCH SAURIER; Kuhn O., 1971, SAURIER DTSCH TRIAS; Kuhn O, 1966, REPTILIEN; KUMM A, 1941, GEOLOGIE LAGERSTATTE, P5; Kurschner WM, 2010, GEOL SOC SPEC PUBL, V334, P263, DOI 10.1144/SP334.11; Lange W., 1922, Zeitschrift der Deutschen Geologischen Gesellschaft Berlin Abhandl, V74, P162; Laurenti JN, 1768, SPECIMEN MED EXHIBEN; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Li C, 2006, NATURWISSENSCHAFTEN, V93, P200, DOI 10.1007/s00114-006-0097-y; Linnaeus C., 1758, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Lucas SG, 2002, LETHAIA, V35, P97, DOI 10.1080/002411602320183962; LUCAS SG, 1993, NM MUS NAT HIST SCI, V3, P301; Lucas SG, 2010, GEOL SOC SPEC PUBL, V334, P447, DOI 10.1144/SP334.15; MADER D, 1984, NATURWISSENSCHAFTEN, V71, P137, DOI 10.1007/BF01137774; MADER D, 1982, NATURWISSENSCHAFTEN, V69, P311, DOI 10.1007/BF00480451; Mehl MG, 1915, J GEOL, V23, P516, DOI 10.1086/622268; MEISCHNER KD, 1962, PALAEONTOL Z, V70, P185; MILNER AR, 1990, PALAEONTOLOGY, V33, P873; MULLER AH, 1968, LEHRBUCH PALAOZOOLOG, V3; MULLER AH, 1985, LEHRBUCH PALAOZOOLOG, V3; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; NAGEL U, 1968, GEOL JB, V86, P5; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; NESBITT SJ, 2005, NEUES JB GEOL PAL, V332, P332; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; PEABODY FRANK E., 1948, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P295; Peyer K, 2008, J VERTEBR PALEONTOL, V28, P363, DOI 10.1671/0272-4634(2008)28[363:ANSAFT]2.0.CO;2; Ptaszynski T, 2000, ACTA PALAEONTOL POL, V45, P151; Rettig B, 1996, MITT GEOL I U HANNOV, V35, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; SCHACHNER ER, J MORPH IN PRESS, DOI DOI 10.1002/JMOR.10997); SCHLUTER HEINR, 1927, NEUES JAHRB MINERAL GEOL U PALAONT ABHANDL ABT B BEILAGE, V57, P12; Schmidt M., 1938, LEBEWELT UNSERER TRI; Schmidt M., 1928, LEBEWELT UNSERER TRI; Schoch RR, 2011, NEUES JAHRB GEOL P-A, V261, P49, DOI 10.1127/0077-7749/2011/0147; Schoch RR, 2010, NEUES JAHRB GEOL P-A, V255, P345, DOI 10.1127/0077-7749/2009/0030; Sen K, 2005, PALAEONTOLOGY, V48, P185, DOI 10.1111/j.1475-4983.2004.00438.x; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Sereno PC, 2005, STEM ARCHOSAURIA; Shishkin Mikhail A., 2000, P120; SHU OY, 1988, REV PALAEOBOT PALYNO, V54, P187, DOI 10.1016/0034-6667(88)90015-2; Spielmann Justin A., 2009, Palaeodiversity, P283; Stille H., 1933, HOCHSCHULEXKURSIONSK, V3; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szurlies M, 2007, EARTH PLANET SC LETT, V261, P602, DOI 10.1016/j.epsl.2007.07.018; von Huene F, 1956, PALAONTOLOGIE PHYLOG; von Zittel KA., 1911, GRUNDZUGE PALAONTOLO; von Zittel KA, 1887, HDB PALAEONTOLOGIE; VONHUENE F, 1938, NEUES JB MINERALOG B, V80, P264; VONHUENE F, 1932, PALAEONTOL Z, V14, P200; VONHUENE F, 1940, NEUES JB MINERALOG B, V83, P246; VONHUENE F, 1942, ZENTRALBLATT MINER B, V220, P220; VONHUENE F, 1917, CENTRALBLATT MINER G, V89, P89; VONHUENE F, 1914, CENTRALBLATT MINER G, V496, P496; VONNOPCSA F, 1928, PALAEOBIOLOGICA, V1, P163; VONZITTEL KA, 1923, GRUNDZUGE PALAONTOLO; VONZITTEL KA, 1927, TXB PALAEONTOLOGY, V2; VUSKOV BP, 1964, OSNOVY PALEONTOLOGII, V12, P235; Warrington G., 1980, GEOLOGICAL SOC LONDO, V13, P1; Weber J, 2002, GEOL SOC SPEC PUBL, V205, P103, DOI 10.1144/GSL.SP.2002.205.01.09; WEBER J, 2000, KOLNER FORUM GEOL PA, V7, P1; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Weinbaum JC, 2007, PALAEONTOL Z, V81, P131, DOI 10.1007/BF02988388; WELLES S. P., 1947, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P241; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wu X, 2008, CHINESE FOSSIL REPTI, P167; WU XC, 1981, VERTEBRAT PALASIATIC, V19, P122; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P40, DOI 10.1671/0272-4634(2001)021[0040:ROTDAA]2.0.CO;2; YOUNG CC, 1964, PALAEONTOL SINICA, V151, P1; Zhang Fa-kui, 1975, Vertebrata Palasiatica, V13, P144	135	98	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25693	10.1371/journal.pone.0025693	http://dx.doi.org/10.1371/journal.pone.0025693			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022431	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600012
J	Uyeda, TQP; Iwadate, Y; Umeki, N; Nagasaki, A; Yumura, S				Uyeda, Taro Q. P.; Iwadate, Yoshiaki; Umeki, Nobuhisa; Nagasaki, Akira; Yumura, Shigehiko			Stretching Actin Filaments within Cells Enhances their Affinity for the Myosin II Motor Domain	PLOS ONE			English	Article							HEAVY-CHAIN GENE; LABELED F-ACTIN; DEPOLYMERIZING FACTOR; KINETIC-ANALYSIS; DIFFERENTIAL REGULATION; CONFORMATIONAL-CHANGE; CORTICAL FLOW; DICTYOSTELIUM; DYNAMICS; LOCALIZATION	To test the hypothesis that the myosin II motor domain (S1) preferentially binds to specific subsets of actin filaments in vivo, we expressed GFP-fused S1 with mutations that enhanced its affinity for actin in Dictyostelium cells. Consistent with the hypothesis, the GFP-S1 mutants were localized along specific portions of the cell cortex. Comparison with rhodamine-phalloidin staining in fixed cells demonstrated that the GFP-S1 probes preferentially bound to actin filaments in the rear cortex and cleavage furrows, where actin filaments are stretched by interaction with endogenous myosin II filaments. The GFP-S1 probes were similarly enriched in the cortex stretched passively by traction forces in the absence of myosin II or by external forces using a microcapillary. The preferential binding of GFP-S1 mutants to stretched actin filaments did not depend on cortexillin I or PTEN, two proteins previously implicated in the recruitment of myosin II filaments to stretched cortex. These results suggested that it is the stretching of the actin filaments itself that increases their affinity for the myosin II motor domain. In contrast, the GFP-fused myosin I motor domain did not localize to stretched actin filaments, which suggests different preferences of the motor domains for different structures of actin filaments play a role in distinct intracellular localizations of myosin I and II. We propose a scheme in which the stretching of actin filaments, the preferential binding of myosin II filaments to stretched actin filaments, and myosin II-dependent contraction form a positive feedback loop that contributes to the stabilization of cell polarity and to the responsiveness of the cells to external mechanical stimuli.	[Uyeda, Taro Q. P.; Umeki, Nobuhisa; Nagasaki, Akira] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Iwadate, Yoshiaki; Yumura, Shigehiko] Yamaguchi Univ, Dept Funct Mol Biol, Grad Sch Med, Yamaguchi, Japan; [Iwadate, Yoshiaki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Yamaguchi University; Japan Science & Technology Agency (JST)	Uyeda, TQP (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-uyeda@aist.go.jp	yumura, shigehiko/E-8672-2013; Nagasaki, Akira/M-4892-2018	yumura, shigehiko/0000-0001-8249-0100; Nagasaki, Akira/0000-0002-1468-4592; Iwadate, Yoshiaki/0000-0002-5300-4393	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid to Y.I. and T.U. from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aizawa H, 1997, J CELL SCI, V110, P2333; ANDO T, 1985, J BIOL CHEM, V260, P2321; Asano Y, 2004, CELL MOTIL CYTOSKEL, V59, P17, DOI 10.1002/cm.20015; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; FUJIME S, 1971, J MOL BIOL, V62, P251, DOI 10.1016/0022-2836(71)90144-6; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Galkin VE, 2005, J MOL BIOL, V346, P565, DOI 10.1016/j.jmb.2004.11.078; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P614, DOI 10.1038/nsmb.1789; HAMMER JA, 1994, J CELL BIOL, V127, P1779, DOI 10.1083/jcb.127.6.1779; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYAKAWA K, 2011, J CELL BIOL IN PRESS; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hodgkinson JL, 1997, J MOL BIOL, V273, P150, DOI 10.1006/jmbi.1997.1307; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kee YS, 2008, CURR BIOL, V18, pR860, DOI 10.1016/j.cub.2008.07.071; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kuhn TB, 2008, ADV EXP MED BIOL, V644, P232; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Lord M, 2005, MOL BIOL CELL, V16, P5346, DOI 10.1091/mbc.E05-07-0601; LOSCALZO J, 1975, P NATL ACAD SCI USA, V72, P3412, DOI 10.1073/pnas.72.9.3412; LYMN RW, 1979, ANNU REV BIOPHYS BIO, V8, P145, DOI 10.1146/annurev.bb.08.060179.001045; Marshall TW, 2009, J CELL SCI, V122, P3061, DOI 10.1242/jcs.051482; Martin C, 2008, ADV EXP MED BIOL, V644, P187; Matsushita S, 2011, J BIOMECH, V44, P1776, DOI 10.1016/j.jbiomech.2011.04.012; McGough A, 1998, CURR OPIN STRUC BIOL, V8, P166, DOI 10.1016/S0959-440X(98)80034-1; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; OOSAWA F, 1973, COLD SPRING HARB SYM, V37, P277, DOI 10.1101/SQB.1973.037.01.038; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; Ostap EM, 2008, ADV EXP MED BIOL, V644, P273; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; SCHROEDER TE, 1988, ZOOL SCI, V5, P713; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; Shimozawa T, 2009, BIOPHYS J, V96, P1036, DOI 10.1016/j.bpj.2008.09.056; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; SUSSMAN M, 1987, DICTYOSTELIUM DISCOI, P9; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; TAWADA K, 1969, BIOCHIM BIOPHYS ACTA, V172, P311, DOI 10.1016/0005-2728(69)90073-5; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; Tsaturyan AK, 2005, BIOPHYS J, V88, P1902, DOI 10.1529/biophysj.104.050047; Tsujioka M, 2004, EMBO J, V23, P2216, DOI 10.1038/sj.emboj.7600238; Uehara R, 2010, CURR BIOL, V20, P1080, DOI 10.1016/j.cub.2010.04.058; Uyeda TQP, 2002, J MUSCLE RES CELL M, V23, P685, DOI 10.1023/A:1024463325335; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Washington RW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-10; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Yumura S, 2008, TRAFFIC, V9, P2089, DOI 10.1111/j.1600-0854.2008.00837.x; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652	94	111	113	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26200	10.1371/journal.pone.0026200	http://dx.doi.org/10.1371/journal.pone.0026200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022566	Green Published, gold			2022-12-25	WOS:000295978600045
J	Stevens, JR; O'Donnell, AF; Perry, TE; Benjamin, JJR; Barnes, CA; Johnston, GC; Singer, RA				Stevens, Jennifer R.; O'Donnell, Allyson F.; Perry, Troy E.; Benjamin, Jeremy J. R.; Barnes, Christine A.; Johnston, Gerald C.; Singer, Richard A.			FACT, the Bur Kinase Pathway, and the Histone Co-Repressor HirC Have Overlapping Nucleosome-Related Roles in Yeast Transcription Elongation	PLOS ONE			English	Article							RNA-POLYMERASE-II; N-TERMINAL DOMAIN; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA-REPLICATION; CHROMATIN TRANSCRIPTION; SPURIOUS TRANSCRIPTION; SYNTHETIC LETHAL; GENE-EXPRESSION	Gene transcription is constrained by the nucleosomal nature of chromosomal DNA. This nucleosomal barrier is modulated by FACT, a conserved histone-binding heterodimer. FACT mediates transcription-linked nucleosome disassembly and also nucleosome reassembly in the wake of the RNA polymerase II transcription complex, and in this way maintains the repression of 'cryptic' promoters found within some genes. Here we focus on a novel mutant version of the yeast FACT subunit Spt16 that supplies essential Spt16 activities but impairs transcription-linked nucleosome reassembly in dominant fashion. This Spt16 mutant protein also has genetic effects that are recessive, which we used to show that certain Spt16 activities collaborate with histone acetylation and the activities of a Bur-kinase/Spt4-Spt5/Paf1C pathway that facilitate transcription elongation. These collaborating activities were opposed by the actions of Rpd3S, a histone deacetylase that restores a repressive chromatin environment in a transcription-linked manner. Spt16 activity paralleling that of HirC, a corepressor of histone gene expression, was also found to be opposed by Rpd3S. Our findings suggest that Spt16, the Bur/Spt4-Spt5/Paf1C pathway, and normal histone abundance and/or stoichiometry, in mutually cooperative fashion, facilitate nucleosome disassembly during transcription elongation. The recessive nature of these effects of the mutant Spt16 protein on transcription-linked nucleosome disassembly, contrasted to its dominant negative effect on transcription-linked nucleosome reassembly, indicate that mutant FACT harbouring the mutant Spt16 protein competes poorly with normal FACT at the stage of transcription-linked nucleosome disassembly, but effectively with normal FACT for transcription-linked nucleosome reassembly. This functional difference is consistent with the idea that FACT association with the transcription elongation complex depends on nucleosome disassembly, and that the same FACT molecule that associates with an elongation complex through nucleosome disassembly is retained for reassembly of the same nucleosome.	[Stevens, Jennifer R.; O'Donnell, Allyson F.; Perry, Troy E.; Singer, Richard A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Benjamin, Jeremy J. R.; Barnes, Christine A.; Johnston, Gerald C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Stevens, JR (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	richard.singer@dal.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canada Graduate Scholarships; Killam Foundation; Nova Scotia Health Research Foundation; Cancer Nova Scotia; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation at CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Graduate Scholarships; Killam Foundation; Nova Scotia Health Research Foundation; Cancer Nova Scotia; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation at CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to RAS and GCJ from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC), and to CAB from NSERC. JRS was supported by NSERC and Canada Graduate Scholarships; AFO by studentships from CIHR, NSERC, the Killam Foundation, and the Nova Scotia Health Research Foundation; TEF by a Norah Stephen Oncology Summer Scholarship from Cancer Nova Scotia; and JJRB by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Barbour L, 2000, GENOME, V43, P910, DOI 10.1139/gen-43-5-910; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DeSilva H, 1998, GENETICS, V148, P657; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Duina AA, 2007, GENETICS, V177, P101, DOI 10.1534/genetics.106.067140; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Freiberg G, 2000, CURR GENET, V37, P221, DOI 10.1007/s002940050523; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; John S, 2000, GENE DEV, V14, P1196; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kihara T, 2008, EXP CELL RES, V314, P629, DOI 10.1016/j.yexcr.2007.10.004; Kim HJ, 2007, EMBO J, V26, P4467, DOI 10.1038/sj.emboj.7601870; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; LIU Y, 2009, MOL CELL BIOL; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; LORCH Y, 1994, P NATL ACAD SCI USA, V91, P11032, DOI 10.1073/pnas.91.23.11032; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; MCCULLOUGH L, 2011, GENETICS IN PRESS; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Myers CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020847; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; O'Donnell AF, 2009, MOL GENET GENOMICS, V282, P487, DOI 10.1007/s00438-009-0480-4; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schlesinger MB, 2000, GENETICS, V155, P1593; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	104	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25644	10.1371/journal.pone.0025644	http://dx.doi.org/10.1371/journal.pone.0025644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022426	Green Submitted, gold, Green Published			2022-12-25	WOS:000295976000028
J	Nogueira, NPD; de Souza, CF; Saraiva, FMD; Sultano, PE; Dalmau, SR; Bruno, RE; Goncalves, RDS; Laranja, GAT; Leal, LHM; Coelho, MGP; Masuda, CA; Oliveira, MF; Paes, MC				de Almeida Nogueira, Natalia Pereira; de Souza, Cintia Fernandes; de Souza Saraiva, Francis Monique; Sultano, Pedro Elias; Dalmau, Sergio Ranto; Bruno, Roberta Eitler; Sales Goncalves, Renata de Lima; Travassos Laranja, Gustavo Augusto; Monteiro Leal, Luis Henrique; Pinto Coelho, Marsen Garcia; Masuda, Claudio A.; Oliveira, Marcus F.; Paes, Marcia Cristina			Heme-Induced ROS in Trypanosoma Cruzi Activates CaMKII-Like That Triggers Epimastigote Proliferation. One Helpful Effect of ROS	PLOS ONE			English	Article							REDOX REGULATION; HYDROGEN-PEROXIDE; FREE-RADICALS; BLOODSUCKING INSECT; CELL-DEATH; KINASES; HEMATIN; MIDGUT; DEGRADATION; SEQUENCE	Heme is a ubiquitous molecule that has a number of physiological roles. The toxic effects of this molecule have been demonstrated in various models, based on both its pro-oxidant nature and through a detergent mechanism. It is estimated that about 10 mM of heme is released during blood digestion in the blood-sucking bug's midgut. The parasite Trypanosoma cruzi, the agent of Chagas' disease, proliferates in the midgut of the insect vector; however, heme metabolism in trypanosomatids remains to be elucidated. Here we provide a mechanistic explanation for the proliferative effects of heme on trypanosomatids. Heme, but not other porphyrins, induced T. cruzi proliferation, and this phenomenon was accompanied by a marked increase in reactive oxygen species (ROS) formation in epimastigotes when monitored by ROS-sensitive fluorescent probes. Heme-induced ROS production was time-and concentration-dependent. In addition, lipid peroxidation and the formation of 4-hydroxy-2-nonenal (4-HNE) adducts with parasite proteins were increased in epimastigotes in the presence of heme. Conversely, the antioxidants urate and GSH reversed the heme-induced ROS. Urate also decreased parasite proliferation. Among several protein kinase inhibitors tested only specific inhibitors of CaMKII, KN93 and Myr-AIP, were able to abolish heme-induced ROS formation in epimastigotes leading to parasite growth impairment. Taken together, these data provide new insight into T. cruzi-insect vector interactions: heme, a molecule from the blood digestion, triggers epimastigote proliferation through a redox-sensitive signalling mechanism.	[de Souza, Cintia Fernandes; de Souza Saraiva, Francis Monique; Sultano, Pedro Elias; Dalmau, Sergio Ranto; Bruno, Roberta Eitler; Travassos Laranja, Gustavo Augusto; Pinto Coelho, Marsen Garcia; Paes, Marcia Cristina] Univ Estado Rio De Janeiro, Lab Interacao Tripanossomatideos & Vetores, Dept Bioquim, IBRAG, Rio De Janeiro, Brazil; [de Almeida Nogueira, Natalia Pereira] Univ Fed Rio de Janeiro, Lab Artropodos Hematofagos, Inst Bioquim Med, Rio de Janeiro, Brazil; [Monteiro Leal, Luis Henrique] Univ Estado Rio De Janeiro, Lab Microscopia & Proc Imagens, Rio De Janeiro, Brazil; [Sales Goncalves, Renata de Lima; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Redox, Inst Bioquim Med, Rio de Janeiro, Brazil; [Masuda, Claudio A.] Univ Fed Rio de Janeiro, Lab Biol Mol Leveduras, Programa Biol Mol & Biotecnol, Inst Bioquim Med, Rio de Janeiro, Brazil; [Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Inflamacao & Metab, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio de Janeiro, Brazil; [Paes, Marcia Cristina] Univ Fed Rio de Janeiro, INCT EM, Rio de Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Nogueira, NPD (corresponding author), Univ Fed Rio de Janeiro, Lab Artropodos Hematofagos, Inst Bioquim Med, Rio de Janeiro, Brazil.	mcpaes@uerj.br	Masuda, Claudio A/F-7214-2014; Coelho, M.G.P./AAR-8546-2021; PAES, MARCIA CRISTINA/AAL-9530-2021; Nogueira, Natalia Pereira Almeida/A-2043-2015; Oliveira, Marcus/G-3158-2011	Masuda, Claudio A/0000-0002-0310-7108; Coelho, M.G.P./0000-0002-8945-7415; Oliveira, Marcus/0000-0002-9890-8425; Pereira de Almeida Nogueira, Natalia/0000-0003-3258-607X; Souza, Cintia/0000-0001-6068-5097; Saraiva, Francis/0000-0002-6744-3549	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PIBIC/UERJ; FAPERJ Jovens Cientistas do Nosso Estado	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC/UERJ; FAPERJ Jovens Cientistas do Nosso Estado(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and PIBIC/UERJ. MFO is a research scholar from CNPq and is a recipient of the FAPERJ Jovens Cientistas do Nosso Estado scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrera G, 2004, FREE RADICAL BIO MED, V37, P597, DOI 10.1016/j.freeradbiomed.2004.05.023; Bonizzi G, 2000, BIOCHEM PHARMACOL, V59, P7, DOI 10.1016/S0006-2952(99)00290-7; Bouallegue A, 2009, FREE RADICAL BIO MED, V47, P858, DOI 10.1016/j.freeradbiomed.2009.06.022; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOCAMPO R, 1981, J BIOL CHEM, V256, P930; Dreher D, 1996, EUR J CANCER, V32A, P30, DOI 10.1016/0959-8049(95)00531-5; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Franklin RA, 2006, ANTIOXID REDOX SIGN, V8, P1807, DOI 10.1089/ars.2006.8.1807; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Gough NR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281eg10; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Halliwell B., 2007, FREE RADICALS BIOL M; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; KALYANARAMAN B, 1983, J BIOL CHEM, V258, P3855; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lombardo ME, 2003, INT J BIOCHEM CELL B, V35, P1263, DOI 10.1016/S1357-2725(03)00033-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1745, DOI 10.1089/ars.2006.8.1745; Menezes D, 2006, PARASITOL RES, V98, P99, DOI 10.1007/s00436-005-0010-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Singal P K, 2000, Curr Cardiol Rep, V2, P206, DOI 10.1007/s11886-000-0070-x; Souza CF, 2009, BIOCHEM BIOPH RES CO, V390, P541, DOI 10.1016/j.bbrc.2009.09.135; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; VanderZee J, 1996, FREE RADICAL BIO MED, V20, P199, DOI 10.1016/0891-5849(95)02031-4; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d	59	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25935	10.1371/journal.pone.0025935	http://dx.doi.org/10.1371/journal.pone.0025935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022475	Green Submitted, Green Published, gold			2022-12-25	WOS:000295973200023
J	Kanno, T; Kamba, T; Yamasaki, T; Shibasaki, N; Saito, R; Terada, N; Toda, Y; Mikami, Y; Inoue, T; Kanematsu, A; Nishiyama, H; Ogawa, O; Nakamura, E				Kanno, T.; Kamba, T.; Yamasaki, T.; Shibasaki, N.; Saito, R.; Terada, N.; Toda, Y.; Mikami, Y.; Inoue, T.; Kanematsu, A.; Nishiyama, H.; Ogawa, O.; Nakamura, E.			JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma	ONCOGENE			English	Article						renal-cell carcinoma; VHL gene; JunB invasion; angiogenesis	TUMOR-SUPPRESSOR PROTEIN; NF-KAPPA-B; MATRIX METALLOPROTEINASES-2; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; IDENTIFICATION; CANCER; PVHL; PHEOCHROMOCYTOMA; LYMPHOMA	Inactivation of the von Hippel-Lindau (VHL) tumor-suppressor gene causes both hereditary and sporadic clear-cell renal-cell carcinoma (ccRCC). Although the best-characterized function of the VHL protein (pVHL) is regulation of hypoxia-inducible factor-alpha (HIF alpha), pVHL also controls the development of pheochromocytoma through HIF-independent pathways by regulating JunB. However, it is largely unknown how these pathways contribute to the development and progression of ccRCC. In the present study, we confirmed that JunB was upregulated in VHL-defective ccRCC specimens by immunostaining. Short-hairpin RNA (shRNA)-mediated knockdown of JunB in 786-O and A498 VHL null ccRCC cells suppressed their invasiveness. In addition, JunB knockdown significantly repressed tumor growth and microvessel density in xenograft tumor assays. Conversely, forced expression of wild-type, but not dimerization-defective, JunB in a VHL-restored 786-O subclone promoted invasion in vitro and tumor growth and vessel formation in vivo. Quantitative PCR array analysis revealed that JunB regulated multiple genes relating to tumor invasion and angiogenesis such as matrix metalloproteinase-2 (MMP-2), MMP-9 and chemokine (C-C motif) ligand-2 (CCL2) in 786-O cells. JunB knockdown in these cells reduced the proteolytic activity of both MMPs in gelatin zymography and the amount of CCL2 in the culture supernatant. Moreover, shRNA-mediated knockdown of MMP-2 or inhibition of CCL2 activity with a neutralizing antibody repressed xenograft tumor growth and angiogenesis. Collectively, these results suggest that JunB promotes tumor invasiveness and enhances angiogenesis in VHL-defective ccRCCs. Oncogene (2012) 31, 3098-3110; doi: 10.1038/onc.2011.475; published online 24 October 2011	[Nakamura, E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nakamura, E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kanno, T.; Kamba, T.; Yamasaki, T.; Shibasaki, N.; Saito, R.; Terada, N.; Inoue, T.; Kanematsu, A.; Nishiyama, H.; Ogawa, O.] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Toda, Y.] Kyoto Univ, Grad Sch Med, Anat Ctr, Kyoto, Japan; [Mikami, Y.] Kyoto Univ, Grad Sch Med, Anat Pathol Lab, Kyoto, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Kyoto University; Kyoto University; Kyoto University	Nakamura, E (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St,Mayer 457, Boston, MA 02115 USA.	Nakamura_Eijiro@dfci.harvard.edu	Terada, Naoki/ABD-2387-2020		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr William G Kaelin, Jr, for critical comments and for providing us with the different RCC cell lines. We appreciate all members of Cancer Research Courses for Integrated Research Training at Kyoto University Graduate School of Medicine for helpful advice and discussion. We also thank Tomoko Matsushita, Megumi Kuraguchi and Yuko Fujieda for technical assistance. Grant support: Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Calzada MJ, 2010, CLIN TRANSL ONCOL, V12, P160, DOI 10.1007/s12094-010-0485-9; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kallakury BVS, 2001, CLIN CANCER RES, V7, P3113; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Linehan WM, 2007, CLIN CANCER RES, V13, p671S, DOI 10.1158/1078-0432.CCR-06-1870; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Nakamura E, 2006, ENDOCR PATHOL, V17, P97, DOI 10.1385/EP:17:2:97; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Perez-Gracia JL, 2009, BRIT J CANCER, V101, P1876, DOI 10.1038/sj.bjc.6605409; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Struckmann K, 2008, J PATHOL, V214, P464, DOI 10.1002/path.2310; Takahashi M, 2002, INT J UROL, V9, P531, DOI 10.1046/j.1442-2042.2002.00516.x; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; WEIDNER N, 1995, AM J PATHOL, V147, P9; Woodward ER, 2006, ENDOCR-RELAT CANCER, V13, P415, DOI 10.1677/erc.1.00683; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131	48	38	41	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	25					3098	3110		10.1038/onc.2011.475	http://dx.doi.org/10.1038/onc.2011.475			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22020339	Green Submitted			2022-12-25	WOS:000305705900008
J	Ribeiro, LF; Furtado, GP; Lourenzoni, MR; Costa, AJ; Santos, CR; Nogueira, SCP; Betini, JA; Polizeli, MDTM; Murakami, MT; Ward, RJ				Ribeiro, Lucas F.; Furtado, Gilvan P.; Lourenzoni, Marcos R.; Costa-Filho, Antonio J.; Santos, Camila R.; Peixoto Nogueira, Simone C.; Betini, Jorge A.; Polizeli, Maria de Lourdes T. M.; Murakami, Mario T.; Ward, Richard J.			Engineering Bifunctional Laccase-Xylanase Chimeras for Improved Catalytic Performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; COTA LACCASE; ENHANCED THERMOSTABILITY; DIOXYGEN REDUCTION; DIRECTED EVOLUTION; FUSION PROTEINS; ENDOSPORE COAT; COPPER SITE; ENZYME; CONSTRUCTION	Background: Rational design methods can be used to create chimeric enzymes with novel catalytic combinations. Results: Bifunctional enzymes combining xylanase and laccase activities showed enhanced catalytic activity and stability. Conclusion: Formation of an inter-domain interface alters enzyme conformation that enhances catalytic performance of the chimera. Significance: Deeper understanding of structural principles of protein fusion can improve the design of novel catalysts.	[Lourenzoni, Marcos R.; Ward, Richard J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Ribeirao Preto, SP, Brazil; [Ribeiro, Lucas F.; Furtado, Gilvan P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049901 Ribeirao Preto, SP, Brazil; [Lourenzoni, Marcos R.] Verdartis Desenvolvimento Biotecnol Ltda ME, BR-14049901 Ribeirao Preto, SP, Brazil; [Costa-Filho, Antonio J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, BR-14049901 Ribeirao Preto, SP, Brazil; [Costa-Filho, Antonio J.] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, BR-13560970 Sao Carlos, SP, Brazil; [Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisas Energia & Mat, BR-13083970 Campinas, SP, Brazil; [Peixoto Nogueira, Simone C.; Betini, Jorge A.; Polizeli, Maria de Lourdes T. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049901 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Ward, RJ (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Ribeirao Preto, SP, Brazil.	rjward@ffclrp.usp.br	Santos, Camila/F-7095-2013; Ward, Richard John/C-2460-2012; Murakami, Mario T/F-5640-2016; Ribeiro, Lucas/C-1979-2012; Costa-Filho, Antonio José/AAZ-1808-2020; Murakami, Mario T/C-2087-2012; de Lourdes T.M. Polizeli, Maria/C-5350-2013; Fapesp, Biota/F-8655-2017; Costa-Filho, Antonio J/D-3153-2012	Santos, Camila/0000-0003-0652-4211; Ward, Richard John/0000-0003-1136-5737; Murakami, Mario T/0000-0002-0405-8010; Ribeiro, Lucas/0000-0003-4640-8629; de Lourdes T.M. Polizeli, Maria/0000-0002-5026-6363; Fapesp, Biota/0000-0002-9887-8449; Costa-Filho, Antonio J/0000-0001-6730-8737; Pessoa Furtado, Gilvan/0000-0002-8797-7783	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Allen MP., 1989, COMPUTER SIMULATION; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Andersson R, 2003, J SCI FOOD AGR, V83, P617, DOI 10.1002/jsfa.1321; ARNOLD FH, 2003, METHOD MOL BIOL, V230, P193; Ay J, 1998, P NATL ACAD SCI USA, V95, P6613, DOI 10.1073/pnas.95.12.6613; Bajpai P, 2004, CRIT REV BIOTECHNOL, V24, P1, DOI 10.1080/07388550490465817; Bento I, 2005, DALTON T, P3507, DOI 10.1039/b504806k; Bento I, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-28; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Blum DL, 2000, J BACTERIOL, V182, P1346, DOI 10.1128/JB.182.5.1346-1351.2000; BULOW L, 1987, EUR J BIOCHEM, V163, P443, DOI 10.1111/j.1432-1033.1987.tb10889.x; Chakar FS, 2000, HOLZFORSCHUNG, V54, P647, DOI 10.1515/HF.2000.109; Ciccotti Giovanni., 1987, SIMULATION LIQUIDS S; Claus H, 2004, MICRON, V35, P93, DOI 10.1016/j.micron.2003.10.029; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Crasto CJ, 2000, PROTEIN ENG, V13, P309, DOI 10.1093/protein/13.5.309; Dan WB, 2008, BIOTECHNOL LETT, V30, P221, DOI 10.1007/s10529-007-9543-y; Danson MJ, 1996, PROTEIN ENG, V9, P629, DOI 10.1093/protein/9.8.629; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Durao P, 2008, BIOCHEM J, V412, P339, DOI 10.1042/BJ20080166; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Fan ZM, 2009, APPL ENVIRON MICROB, V75, P1754, DOI 10.1128/AEM.02181-08; Fan ZM, 2009, BIOTECHNOL BIOENG, V102, P684, DOI 10.1002/bit.22112; Flander L, 2008, J AGR FOOD CHEM, V56, P5732, DOI 10.1021/jf800264a; Gianfreda L., 1999, BIOREMEDIAT J, V3, P1, DOI DOI 10.1080/10889869991219163; Gilbert M, 1998, NAT BIOTECHNOL, V16, P769, DOI 10.1038/nbt0898-769; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Guan ZB, 2007, APPL MICROBIOL BIOT, V73, P1114, DOI 10.1007/s00253-006-0591-3; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong SY, 2007, BIOTECHNOL LETT, V29, P931, DOI 10.1007/s10529-007-9334-5; Hua YW, 2004, J IND MICROBIOL BIOT, V31, P273, DOI 10.1007/s10295-004-0146-5; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Mandai T, 2009, BIOCHEM BIOPH RES CO, V384, P61, DOI 10.1016/j.bbrc.2009.04.064; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murakami MT, 2005, FEBS LETT, V579, P6505, DOI 10.1016/j.febslet.2005.10.039; Nixon AE, 1998, TRENDS BIOTECHNOL, V16, P258, DOI 10.1016/S0167-7799(98)01204-9; Paes G, 2007, PROTEIN ENG DES SEL, V20, P15, DOI 10.1093/protein/gzl049; Pandey A, 2000, J SCI IND RES INDIA, V59, P12; PATEL RN, 1993, APPL MICROBIOL BIOT, V39, P405, DOI 10.1007/BF00192102; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stoj C.S., 2006, ENCYCL INORG CHEM, DOI [10.1002/0470862106.ia055, DOI 10.1002/0470862106.IA055]; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sun JY, 2005, PROTEIN EXPRES PURIF, V42, P122, DOI 10.1016/j.pep.2005.03.009; Svergun DI, 1999, BIOPHYS J, V77, P2896; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; *TAPPI TECHN ASS P, 1996, TAPPI TEST METH; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Valls C, 2009, BIORESOURCE TECHNOL, V100, P2032, DOI 10.1016/j.biortech.2008.10.009; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Q, 2008, APPL BIOCHEM BIOTECH, V144, P273, DOI 10.1007/s12010-007-8016-z; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang PH, 2007, PROTEIN ENG DES SEL, V20, P497, DOI 10.1093/protein/gzm049	72	41	47	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43026	43038		10.1074/jbc.M111.253419	http://dx.doi.org/10.1074/jbc.M111.253419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006920	Green Published, hybrid			2022-12-25	WOS:000298351300023
J	Leyton, DL; Sevastsyanovich, YR; Browning, DF; Rossiter, AE; Wells, TJ; Fitzpatrick, RE; Overduin, M; Cunningham, AF; Henderson, IR				Leyton, Denisse L.; Sevastsyanovich, Yanina R.; Browning, Douglas F.; Rossiter, Amanda E.; Wells, Timothy J.; Fitzpatrick, Rebecca E.; Overduin, Michael; Cunningham, Adam F.; Henderson, Ian R.			Size and Conformation Limits to Secretion of Disulfide-bonded Loops in Autotransporter Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE TRANSLOCATION; TOXIN-B-SUBUNIT; ESCHERICHIA-COLI; PASSENGER DOMAIN; CRYSTAL-STRUCTURE; BACTERIAL AUTOTRANSPORTER; SHIGELLA-FLEXNERI; VIRULENCE FACTOR; SERINE-PROTEASE; IGA PROTEASE	Autotransporters are a superfamily of virulence factors typified by a channel-forming C terminus that facilitates translocation of the functional N-terminal passenger domain across the outer membrane of Gram-negative bacteria. This final step in the secretion of autotransporters requires a translocation-competent conformation for the passenger domain that differs markedly from the structure of the fully folded secreted protein. The nature of the translocation-competent conformation remains controversial, in particular whether the passenger domain can adopt secondary structural motifs, such as disulfide-bonded segments, while maintaining a secretion-competent state. Here, we used the endogenous and closely spaced cysteine residues of the plasmid-encoded toxin (Pet) from enteroaggregative Escherichia coli to investigate the effect of disulfide bond-induced folding on translocation of an autotransporter passenger domain. We reveal that rigid structural elements within disulfide-bonded segments are resistant to autotransporter-mediated secretion. We define the size limit of disulfide-bonded segments tolerated by the autotransporter system demonstrating that, when present, cysteine pairs are intrinsically closely spaced to prevent congestion of the translocator pore by large disulfide-bonded regions. These latter data strongly support the hairpin mode of autotransporter biogenesis.	[Leyton, Denisse L.; Sevastsyanovich, Yanina R.; Browning, Douglas F.; Rossiter, Amanda E.; Wells, Timothy J.; Fitzpatrick, Rebecca E.; Cunningham, Adam F.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Henderson, IR (corresponding author), Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England.	i.r.henderson@bham.ac.uk	Leyton, Denisse L/A-6915-2015; Henderson, Ian/AAD-5369-2019; Wells, Timothy/AAG-3311-2021; Overduin, Michael/AAG-3632-2020; Wells, Timothy/M-2025-2016	Leyton, Denisse L/0000-0003-4808-9289; Overduin, Michael/0000-0002-3114-6585; Browning, Douglas/0000-0003-4672-3514; Wells, Timothy/0000-0001-7766-5404; Henderson, Ian/0000-0002-9954-4977; Cunningham, Adam/0000-0003-0248-964X	Biotechnology and Biological Sciences Research Council; BBSRC [BB/G022054/1] Funding Source: UKRI; MRC [G0700151] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022054/1] Funding Source: researchfish; Medical Research Council [G0700151, G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (to M. O. and I. R. H.)	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; KLAUSER T, 1990, EMBO J, V9, P1991, DOI 10.1002/j.1460-2075.1990.tb08327.x; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Letley DP, 2006, MICROBIOL-SGM, V152, P1319, DOI 10.1099/mic.0.28548-0; Leyton DL, 2010, FEMS MICROBIOL LETT, V311, P133, DOI 10.1111/j.1574-6968.2010.02081.x; Loveless BJ, 1997, MOL MEMBR BIOL, V14, P113, DOI 10.3109/09687689709048171; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; MIYAZAKI H, 1989, J BACTERIOL, V171, P6566, DOI 10.1128/jb.171.12.6566-6572.1989; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2011, METHOD ENZYMOL, V492, P233, DOI 10.1016/B978-0-12-381268-1.00030-6; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Rutherford N, 2006, J BACTERIOL, V188, P4111, DOI 10.1128/JB.01949-05; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; St Geme JW, 2000, J BACTERIOL, V182, P6005, DOI 10.1128/JB.182.21.6005-6013.2000; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Zhai YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548	54	59	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42283	42291		10.1074/jbc.M111.306118	http://dx.doi.org/10.1074/jbc.M111.306118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006918	Green Published, hybrid			2022-12-25	WOS:000298180900038
J	Dong, YW; Yu, SS; Wang, QL; Dong, SL				Dong, Yun-wei; Yu, Shan-shan; Wang, Qing-lin; Dong, Shuang-lin			Physiological Responses in a Variable Environment: Relationships between Metabolism, Hsp and Thermotolerance in an Intertidal-Subtidal Species	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS SELENKA; SEA-CUCUMBER; OXYGEN-CONSUMPTION; CLIMATE-CHANGE; GROWTH; ADAPTATION; PERFORMANCE; STRESS	Physiological responses to temperature reflect the evolutionary adaptations of organisms to their thermal environment and the capability of animals to tolerate thermal stress. Contrary to conventional metabolism theory, increasing environmental temperatures have been shown to reduce metabolic rate in rocky-eulittoral-fringe species inhabiting highly variable environments, possibly as a strategy for energy conservation. To study the physiological adaptations of an intertidal-subtidal species to the extreme and unpredictable heat stress of the intertidal zone, oxygen consumption rate and heat shock protein expression were quantified in the sea cucumber Apostichopus japonicus. Using simulate natural temperatures, the relationship between temperature, physiological performance (oxygen consumption and heat shock proteins) and thermotolerance were assessed. Depression of oxygen consumption rate and upregulation of heat shock protein genes (hsps) occurred in sequence when ambient temperature was increased from 24 to 30 degrees C. Large-scale mortality of the sea cucumber occurred when temperatures rose beyond 30 degrees C, suggesting that the upregulation of heat shock proteins and mortality are closely related to the depression of aerobic metabolism, a phenomenon that is in line with the concept of oxygen-and capacity-limited thermal tolerance (OCLTT). The physiologically-related thermotolerance of this sea cucumber should be an adaptation to its local environment.	[Dong, Yun-wei] Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian Province, Peoples R China; [Yu, Shan-shan; Wang, Qing-lin; Dong, Shuang-lin] Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao, Shandong, Peoples R China	Xiamen University; Ocean University of China	Dong, YW (corresponding author), Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian Province, Peoples R China.	dongyw@xmu.edu.cn	HUANG, Shuiying/C-3117-2014; Dong, Yunwei/C-4617-2011; han, guodong/H-3404-2011	Dong, Yunwei/0000-0003-4550-2322; 	Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China [2011J06017]; Chinese National Science Foundation [30400333]; National Key Technologies R&D Program of China [2006BAD09A01]; Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China [BS2009NY019]	Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China (2011J06017), Chinese National Science Foundation (30400333), National Key Technologies R&D Program of China (2006BAD09A01), Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China (BS2009NY019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FAUNA CASINI PHYLUM; Dong YW, 2011, MAR BIOL, V158, P1223, DOI 10.1007/s00227-011-1642-6; Dong YW, 2008, FISHERIES SCI, V74, P573, DOI 10.1111/j.1444-2906.2008.01560.x; Dong YW, 2008, AQUACULTURE, V276, P179, DOI 10.1016/j.aquaculture.2008.01.028; Dong Yunwei, 2007, Journal of Ocean University of China, V6, P275, DOI 10.1007/s11802-007-0275-3; Dong YW, 2008, AQUACULTURE, V275, P329, DOI 10.1016/j.aquaculture.2007.12.006; Dong YW, 2006, AQUAC RES, V37, P1327, DOI 10.1111/j.1365-2109.2006.01570.x; Dong YW, 2006, AQUACULTURE, V255, P514, DOI 10.1016/j.aquaculture.2005.12.013; DONG YW, 2005, FISH SCI CHINA, V1, P33; Hamano T., 1989, Suisan Zoshoku, V37, P179; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Li Bao-Quan, 2002, Oceanologia et Limnologia Sinica, V33, P182; Marshall DJ, 2011, P ROY SOC B-BIOL SCI, V278, P281, DOI 10.1098/rspb.2010.1414; MARSHALL DJ, 2011, J EXP BIOL IN PRESS, DOI DOI 10.1242/JEB.059899.; Meng XL, 2009, AQUACULTURE, V294, P314, DOI 10.1016/j.aquaculture.2009.06.015; OMORI M, 1984, METHODS MARINE ZOOPL, P173; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Portner HO, 1998, COLD OCEAN PHYSL, P88, DOI DOI 10.1017/CBO9780511661723.005; Portner HO, 2000, ANTARCTIC ECOSYSTEMS, P109; Seebacher F, 2003, P ROY SOC B-BIOL SCI, V270, pS50, DOI 10.1098/rsbl.2003.0007; Sloan N. A., 1984, ECHINODERMATA, P109, DOI 10.1201/9781003079224-14; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; SOMERO GN, 2011, AM PHYSL SOC REGULAT, DOI DOI 10.1152/AJPREGU.00719.2010; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Yamana Y, 2009, FISHERIES SCI, V75, P585, DOI 10.1007/s12562-009-0076-2; Yang HS, 2006, J EXP MAR BIOL ECOL, V330, P505, DOI 10.1016/j.jembe.2005.09.010; YUSUKE Y, 2006, J NATL FISH U, V54, P111	31	28	29	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26446	10.1371/journal.pone.0026446	http://dx.doi.org/10.1371/journal.pone.0026446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022615	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400059
J	Papes, S; Ladich, F				Papes, Sandra; Ladich, Friedrich			Effects of Temperature on Sound Production and Auditory Abilities in the Striped Raphael Catfish Platydoras armatulus (Family Doradidae)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; NERVE-FIBER RESPONSE; TEMPORAL RESOLUTION; SONIC MUSCLE; INNER-EAR; DEPENDENCE; HEARING; BEHAVIOR; GOLDFISH; FROG	Background: Sound production and hearing sensitivity of ectothermic animals are affected by the ambient temperature. This is the first study investigating the influence of temperature on both sound production and on hearing abilities in a fish species, namely the neotropical Striped Raphael catfish Platydoras armatulus. Methodology/Principal Findings: Doradid catfishes produce stridulation sounds by rubbing the pectoral spines in the shoulder girdle and drumming sounds by an elastic spring mechanism which vibrates the swimbladder. Eight fish were acclimated for at least three weeks to 22 degrees, then to 30 degrees and again to 22 degrees C. Sounds were recorded in distress situations when fish were hand-held. The stridulation sounds became shorter at the higher temperature, whereas pulse number, maximum pulse period and sound pressure level did not change with temperature. The dominant frequency increased when the temperature was raised to 30 degrees C and the minimum pulse period became longer when the temperature decreased again. The fundamental frequency of drumming sounds increased at the higher temperature. Using the auditory evoked potential (AEP) recording technique, the hearing thresholds were tested at six different frequencies from 0.1 to 4 kHz. The temporal resolution was determined by analyzing the minimum resolvable click period (0.3-5 ms). The hearing sensitivity was higher at the higher temperature and differences were more pronounced at higher frequencies. In general, latencies of AEPs in response to single clicks became shorter at the higher temperature, whereas temporal resolution in response to double-clicks did not change. Conclusions/Significance: These data indicate that sound characteristics as well as hearing abilities are affected by temperatures in fishes. Constraints imposed on hearing sensitivity at different temperatures cannot be compensated even by longer acclimation periods. These changes in sound production and detection suggest that acoustic orientation and communication are affected by temperature changes in the neotropical catfish P. armatulus.	[Papes, Sandra; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Papes, S (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Austrian Science Fund (FWF) [P22319-B17]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF; grant P22319-B17 to Friedrich Ladich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2006, J FISH BIOL, V69, P1892, DOI 10.1111/j.1095-8649.2006.01247.x; Amorim M. Clara P., 2005, Acta Zoologica Sinica, V51, P1013; Amoser S., 2006, J ACOUST SOC AM, V120, P3056; Andersson E, 2003, FISH PHYSIOL BIOCHEM, V28, P411, DOI 10.1023/B:FISH.0000030608.76252.22; Bellgraph BJ, 2010, J THERM BIOL, V35, P6, DOI 10.1016/j.jtherbio.2009.10.001; BENNETT AF, 1985, J EXP BIOL, V115, P333; BRAWN VM, 1960, BEHAVIOUR, V18, P239; BRENOWITZ EA, 1985, BRAIN RES, V359, P364, DOI 10.1016/0006-8993(85)91452-0; Connaughton MA, 2000, J EXP BIOL, V203, P1503; Connaughton MA, 2004, J EXP BIOL, V207, P1643, DOI 10.1242/jeb.00928; COSSINS AR, 1977, J COMP PHYSIOL, V120, P109, DOI 10.1007/BF00619309; Domingues PM, 2002, AQUACULT INT, V10, P207, DOI 10.1023/A:1022148802078; EATOCK RA, 1981, J COMP PHYSIOL, V142, P219, DOI 10.1007/BF00605740; EGERT D, 1995, HEARING RES, V84, P72, DOI 10.1016/0378-5955(95)00019-Z; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; FAY RR, 1992, HEARING RES, V58, P9, DOI 10.1016/0378-5955(92)90003-6; Feher JJ, 1998, J MUSCLE RES CELL M, V19, P661, DOI 10.1023/A:1005333215172; Fine ML, 2003, CATFISHES, VOLS 1-2, P249; Fine ML, 1997, COPEIA, P777, DOI 10.2307/1447295; Fonseca PJ, 2007, J EXP BIOL, V210, P1834, DOI 10.1242/jeb.001495; Franz A, 2002, J COMP PHYSIOL A, V188, P261, DOI 10.1007/s00359-002-0298-6; Heyd A, 2000, REV SUISSE ZOOL, V107, P165, DOI 10.5962/bhl.part.80125; HUBL L, 1977, BEHAV PROCESS, V2, P305, DOI 10.1016/0376-6357(77)90001-8; Itoi S, 2003, FISH PHYSIOL BIOCHEM, V29, P237, DOI 10.1023/B:FISH.0000045721.26261.a4; JOHANSEN PH, 1985, CAN J ZOOL, V63, P1211, DOI 10.1139/z85-181; Jones EA, 2008, J EXP BIOL, V211, P1386, DOI 10.1242/jeb.014688; Kaatz I.M., 1999, BEHAV MORPHOLOGICAL; Kaatz IM, 2010, CURR ZOOL, V56, P73, DOI 10.1093/czoolo/56.1.73; KASTBERGER G, 1981, ZOOL JAHRB ALLG ZOOL, V85, P393; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P321; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2001, ANAT REC, V263, P297, DOI 10.1002/ar.1105; Ladich F., 1992, Bioacoustics, V4, P131; Ladich Friedrich, 2006, P3; Ladich Friedrich, 2003, P173, DOI 10.1007/978-0-387-22628-6_9; Ladich F, 2009, COMP BIOCHEM PHYS A, V154, P341, DOI 10.1016/j.cbpa.2009.07.004; Ladich Friedrich, 1997, Bioacoustics, V8, P185; Long GR, 1996, HEARING RES, V98, P22, DOI 10.1016/0378-5955(96)00057-3; Lugli M, 1996, J FISH BIOL, V49, P648; Mann DA, 2009, T AM FISH SOC, V138, P1000, DOI 10.1577/T08-052.1; Maruska KP, 2009, ENVIRON BIOL FISH, V84, P325, DOI 10.1007/s10641-009-9446-y; Muller J., 1842, ARCH ANATOMIE PHYSL, V1842, P307; Myrberg A.A. Jr, 1978, P137; Navarro I, 2002, FISH PHYSIOL BIOCHEM, V27, P205, DOI 10.1023/B:FISH.0000032726.78074.04; OLDFIELD BP, 1988, HEARING RES, V35, P151, DOI 10.1016/0378-5955(88)90114-1; Parmentier E, 2010, J EXP BIOL, V213, P1107, DOI 10.1242/jeb.039461; Pfeiffer W., 1965, Zeitschrift fuer Morphologie und Oekologie der Tiere, V54, P669, DOI 10.1007/BF00429936; PIORSKI NM, 1999, COMMUN MUS CIENE TEC, P19; Pruzsinszky I, 1998, ENVIRON BIOL FISH, V53, P183, DOI 10.1023/A:1007413108550; RATNASABAPATHI D, 1992, AGGRESSIVE BEHAV, V18, P365, DOI 10.1002/1098-2337(1992)18:5<365::AID-AB2480180506>3.0.CO;2-E; Salem MA, 1998, ARCH HISTOL CYTOL, V61, P179, DOI 10.1679/aohc.61.179; SIEGMUND R, 1977, EXPERIENTIA, V33, P1607, DOI 10.1007/BF01934025; SMOLDERS JWT, 1984, J COMP PHYSIOL, V155, P19, DOI 10.1007/BF00610927; Tavolga WN, 1960, ANIMAL SOUNDS COMMUN, P93; TORRICELLI P, 1990, Bioacoustics, V2, P261; vanDijk P, 1997, HEARING RES, V114, P243, DOI 10.1016/S0378-5955(97)00169-X; VANHEEL WHD, 1956, EXPERIENTIA, V12, P75; WALKOWIAK W, 1980, BEHAV PROCESS, V5, P363, DOI 10.1016/0376-6357(80)90019-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; WYSOCKI LE, 2006, J ACOUST SOC AM, V120, P3056; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274	65	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26479	10.1371/journal.pone.0026479	http://dx.doi.org/10.1371/journal.pone.0026479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022618	Green Published, gold			2022-12-25	WOS:000295984400062
J	Wang, CH; Eng, HL; Lin, KH; Chang, CH; Hsieh, CA; Lin, YL; Lin, TM				Wang, Chiou-Huey; Eng, Hock-Liew; Lin, Kuei-Hsiang; Chang, Cheng-Hsien; Hsieh, Chi-An; Lin, Yen-Li; Lin, Tsun-Mei			TLR7 and TLR8 Gene Variations and Susceptibility to Hepatitis C Virus Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; HCV-INFECTION; IMMUNE-RESPONSES; ALPHA PRODUCTION; EXPRESSION; AGONISTS; POLYMORPHISM	Toll-like receptors (TLRs) play pivotal roles in the innate immune system and control inflammatory responses and adaptive immunity. We previously evaluated associations between TLR7 and TLR8 gene SNPs and susceptibility to hepatitis C virus (HCV) infection. Our results suggested that TLR7IVS2-151G and TLR8-129G alleles were present at higher frequency in males of an HCV-infected group as compared to a control group (24.1% vs. 14.4%, p = 0.028; 17.6% vs. 6.8%, p = 0.004, respectively). Based upon their recognition of single stranded viral RNA, this suggested that TLR7 and TLR8 played a significant role in anti-HCV immune responses. Here, we studied the functional effects of these polymorphisms by analyzing the mRNA expressions of TLR7 and TLR8 and cytokine production induced ex vivo by TLR7- and TLR8-specific agonists using whole blood of subjects with different genotypes. The percentage of CD14+ cells from those with an AG haplotype that expressed TLR7 and TLR8 was significantly lower, but higher in intensity compared to cells from those with GG and AC haplotypes. Cells from those with an AG haplotype produced more IFN-alpha and less amounts of pro-inflammatory cytokines upon stimulation. This suggests that variations in TLR7 and TLR8 genes might impair immune responses during HCV infection.	[Wang, Chiou-Huey] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Lin, Kuei-Hsiang] Kaohsiung Med Univ, Dept Clin Lab, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chang, Cheng-Hsien] Kaohsiung Med Univ, Dept Ophthalmol, Kaohsiung, Taiwan; [Wang, Chiou-Huey; Lin, Yen-Li; Lin, Tsun-Mei] I SHOU Univ, Dept Lab Med, E Da Hosp, Kaohsiung, Taiwan; [Lin, Tsun-Mei] I SHOU Univ, Dept Med Res, E Da Hosp, Kaohsiung, Taiwan; [Eng, Hock-Liew] Chang Gung Univ, Dept Pathol, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Hsieh, Chi-An; Lin, Tsun-Mei] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University	Wang, CH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	ltmei@mail.ncku.edu.tw			National Science Council [NSC 96-2320-B-650-001-MY3]; E-DA Hospital [EDAHT-98002]	National Science Council(Ministry of Science and Technology, Taiwan); E-DA Hospital	This work was supported by the National Science Council [NSC 96-2320-B-650-001-MY3], E-DA Hospital [EDAHT-98002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Askar E, 2010, J MED VIROL, V82, P1859, DOI 10.1002/jmv.21893; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cheng PL, 2007, TRANSL RES, V150, P311, DOI 10.1016/j.trsl.2007.03.010; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Eng HL, 2004, GENES IMMUN, V5, P426, DOI 10.1038/sj.gene.6364100; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Huang WS, 2005, HEPATO-GASTROENTEROL, V52, P893; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kontorinis Nickolas, 2004, Rev Gastroenterol Disord, V4 Suppl 1, pS39; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Libri NA, 2009, J VIRAL HEPATITIS, V16, P315, DOI 10.1111/j.1365-2893.2008.01011.x; Lu SN, 2004, J VIRAL HEPATITIS, V11, P563, DOI 10.1111/j.1365-2893.2004.00533.x; Marotta F, 2007, J GASTROEN HEPATOL, V22, P697, DOI 10.1111/j.1440-1746.2007.04937.x; Mozer-Lisewska I, 2010, ARCH IMMUNOL THER EX, V58, P295, DOI 10.1007/s00005-010-0087-9; O'Neill LAJ, 2004, SCIENCE, V303, P1481, DOI 10.1126/science.1096113; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sato K, 2007, J GASTROEN HEPATOL, V22, P1627, DOI 10.1111/j.1440-1746.2006.04783.x; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005	34	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26235	10.1371/journal.pone.0026235	http://dx.doi.org/10.1371/journal.pone.0026235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022576	gold, Green Submitted, Green Published			2022-12-25	WOS:000295978600046
J	Elfaitouri, A; Shao, XW; Ulfstedt, JM; Muradrasoli, S; Wiener, AB; Golbob, S; Ohrmalm, C; Matousek, M; Zachrisson, O; Gottfries, CG; Blomberg, J				Elfaitouri, Amal; Shao, Xingwu; Ulfstedt, Johan Mattsson; Muradrasoli, Shaman; Wiener, Agnes Bolin; Golbob, Sultan; Ohrmalm, Christina; Matousek, Michael; Zachrisson, Olof; Gottfries, Carl-Gerhard; Blomberg, Jonas			Murine Gammaretrovirus Group G3 Was Not Found in Swedish Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ENDOGENOUS RETROVIRAL SEQUENCES; LEUKEMIA-VIRUS; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; BLOOD-CELLS; XMRV; CONTAMINATION; PCR; DNA	Background: The recent report of gammaretroviruses of probable murine origin in humans, called xenotropic murine retrovirus related virus (XMRV) and human murine leukemia virus related virus (HMRV), necessitated a bioinformatic search for this virus in genomes of the mouse and other vertebrates, and by PCR in humans. Results: Three major groups of murine endogenous gammaretroviruses were identified. The third group encompassed both exogenous and endogenous Murine Leukemia Viruses (MLVs), and most XMRV/HMRV sequences reported from patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Two sensitive real-time PCRs for this group were developed. The predicted and observed amplification range for these and three published XMRV/HMRV PCRs demonstrated conspicuous differences between some of them, partly explainable by a recombinatorial origin of XMRV. Three reverse transcription real-time PCRs (RTQPCRs), directed against conserved and not overlapping stretches of env, gag and integrase (INT) sequences of XMRV/HMRV were used on human samples. White blood cells from 78 patients suffering from ME/CFS, of which 30 patients also fulfilled the diagnostic criteria for fibromyalgia (ME/CFS/FM) and in 7 patients with fibromyalgia (FM) only, all from the Gothenburg area of Sweden. As controls we analyzed 168 sera from Uppsala blood donors. We controlled for presence and amplifiability of nucleic acid and for mouse DNA contamination. To score as positive, a sample had to react with several of the XMRV/HMRV PCRs. None of the samples gave PCR reactions which fulfilled the positivity criteria. Conclusions: XMRV/HMRV like proviruses occur in the third murine gammaretrovirus group, characterized here. PCRs developed by us, and others, approximately cover this group, except for the INT RTQPCR, which is rather strictly XMRV specific. Using such PCRs, XMRV/HMRV could not be detected in PBMC and plasma samples from Swedish patients suffering from ME/CFS/FM, and in sera from Swedish blood donors.	[Elfaitouri, Amal; Shao, Xingwu; Ulfstedt, Johan Mattsson; Muradrasoli, Shaman; Wiener, Agnes Bolin; Golbob, Sultan; Ohrmalm, Christina; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden; [Matousek, Michael; Zachrisson, Olof; Gottfries, Carl-Gerhard] Univ Gothenburg, Gottfries Clin AB, Inst Neurosci & Physiol, Gothenburg, Sweden	Uppsala University; University of Gothenburg	Elfaitouri, A (corresponding author), Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden.	Jonas.Blomberg@medsci.uu.se	Elfaitouri, Amal/GRO-7027-2022	Elfaitouri, Amal/0000-0002-0704-3252; Blomberg, Jonas/0000-0001-6492-2491; Ohrmalm, Christina/0000-0002-3287-3549	ME Research UK [SC 036942]; Irish ME Trust; stiftelsen Lars Hiertas minne [FO2010-0672]	ME Research UK; Irish ME Trust; stiftelsen Lars Hiertas minne	This work was supported by ME Research UK (Charity number SC 036942), and the Irish ME Trust and stiftelsen Lars Hiertas minne (FO2010-0672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Andersson AC, 2005, J VIROL, V79, P9270, DOI 10.1128/JVI.79.14.9270-9284.2005; BLOMBERG J, 2011, ADV VIROLOG IN PRESS; BLOMBERG J, 2010, APR 29 MAY 4 PRAG ME, P19; Bromham L, 2001, J VIROL, V75, P3053, DOI 10.1128/JVI.75.6.3053-3057.2001; BUCHWALD D, 1995, ANN INTERN MED, V123, P81, DOI 10.7326/0003-4819-123-2-199507150-00001; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forsman A, 2003, J VIROL METHODS, V111, P1, DOI 10.1016/S0166-0934(03)00127-7; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; HALTMEIER M, 1995, VIROLOGY, V209, P550, DOI 10.1006/viro.1995.1287; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Jason LA, 2010, BEHAV MED, V36, P24, DOI 10.1080/08964280903521370; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Kaiser J, 2011, SCIENCE, V331, P17, DOI 10.1126/science.331.6013.17; KAWAKAMI TG, 1978, J NATL CANCER I, V61, P1113; KAWAKAMI TG, 1980, INT J CANCER, V25, P641, DOI 10.1002/ijc.2910250514; KEWALRAMANI VN, 1992, J VIROL, V66, P3026, DOI 10.1128/JVI.66.5.3026-3031.1992; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Mikovits JA, 2010, AIDS REV, V12, P149; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; OHRMALM C, 2010, NUCLEIC ACIDS RES, P1; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Ribet D, 2008, J VIROL, V82, P4413, DOI 10.1128/JVI.02141-07; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Sauter D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-103; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Sperber G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S4; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tamura K, 2011, MOL BIOL EVOLUTION; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipper CH, 2005, J VIROL, V79, P8316, DOI 10.1128/JVI.79.13.8316-8329.2005; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	48	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24602	10.1371/journal.pone.0024602	http://dx.doi.org/10.1371/journal.pone.0024602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022360	Green Submitted, gold, Green Published			2022-12-25	WOS:000295976000004
J	Faggioli, F; Vezzoni, P; Montagna, C				Faggioli, Francesca; Vezzoni, Paolo; Montagna, Cristina			Single-Cell Analysis of Ploidy and Centrosomes Underscores the Peculiarity of Normal Hepatocytes	PLOS ONE			English	Article							MOUSE-LIVER; TETRAPLOIDY; POLYPLOIDY; ANEUPLOIDY; ABNORMALITIES; CYTOKINESIS; CENTRIOLES; DISEASE; CANCER; FUSION	Polyploidization is the most well recognized feature of the liver. Yet, a quantitative and behavioral analysis of centrosomes and DNA content in normal hepatocytes has been limited by the technical challenges of methods available. By using a novel approach employing FISH for chromosomes 18, X and Y we provide, for the first time, a detailed analysis of DNA copies during physiological development in the liver at single cell level. We demonstrate that aneuploidy and unbalanced DNA content in binucleated hepatocytes are common features in normal adult liver. Despite the common belief that hepatocytes contain 1, 2 or no more than 4 centrosomes, our double staining for centrosome associated proteins reveals extranumerary centrosomes in a high percentage of cells as early as 15 days of age. We show that in murine liver the period between 15 days and 1.5 months marks the transition from a prevalence of mononucleated cells to up to 75% of binucleated cells. Our data demonstrate that this timing correlates with a switch in centrosomes number. At 15 days the expected 1 or 2 centrosomes converge with several hepatocytes that contain 3 centrosomes; at 1.5 months the percentage of cells with 3 centrosomes decreases concomitantly with the increase of cells with more than 4 centrosomes. Our analysis shows that the extranumerary centrosomes emerge in concomitance with the process of binucleation and polyploidization and maintain alpha-tubulin nucleation activity. Finally, by integrating interphase FISH and immunofluorescent approaches, we detected an imbalance between centrosome number and DNA content in liver cells that deviates from the equilibrium expected in normal cells. We speculate that these unique features are relevant to the peculiar biological function of liver cells which are continuously challenged by stress, a condition that could predispose to genomic instability.	[Faggioli, Francesca; Vezzoni, Paolo] CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy; [Faggioli, Francesca; Vezzoni, Paolo] Ist Clin Humanitas, Med Biotechnol Unit, Milan, Italy; [Montagna, Cristina] Albert Einstein Coll Med, Dept Genet, New York, NY USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; Yeshiva University	Faggioli, F (corresponding author), CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy.	paolo.vezzoni@itb.cnr.it	Vezzoni, Paolo/R-3416-2019; Vezzoni, Paolo/K-3197-2018; Faggioli, Francesca/K-1592-2016	Faggioli, Francesca/0000-0001-8030-3674; Vezzoni, Paolo/0000-0002-6382-3923	Associazione Italiana per la Ricerca sul Cancro; Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base" [RBAP11H2R9-04]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base"	This work was partially funded by Associazione Italiana per la Ricerca sul Cancro, Project "A straightforward approach to the study of the role of cell fusion in cancer" to PV and by Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base" RBAP11H2R9-04 to PV. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Difilippantonio MJ, 2009, ENVIRON MOL MUTAGEN, V50, P672, DOI 10.1002/em.20532; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; FAGGIOLI F, MECH AGEING IN PRESS; Faggioli F, 2008, HEPATOLOGY, V48, P1655, DOI 10.1002/hep.22488; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	26	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26080	10.1371/journal.pone.0026080	http://dx.doi.org/10.1371/journal.pone.0026080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022514	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000064
J	McCormick, KE; Gaertner, BE; Sottile, M; Phillips, PC; Lockery, SR				McCormick, Kathryn E.; Gaertner, Bryn E.; Sottile, Matthew; Phillips, Patrick C.; Lockery, Shawn R.			Microfluidic Devices for Analysis of Spatial Orientation Behaviors in Semi-Restrained Caenorhabditis elegans	PLOS ONE			English	Article							C.-ELEGANS; NEURAL CIRCUITS; THERMOTAXIS; CHEMOTAXIS; NEURONS; MECHANISMS; GRADIENTS; OXYGEN	This article describes the fabrication and use of microfluidic devices for investigating spatial orientation behaviors in nematode worms (Caenorhabditis elegans). Until now, spatial orientation has been studied in freely moving nematodes in which the frequency and nature of encounters with the gradient are uncontrolled experimental variables. In the new devices, the nematode is held in place by a restraint that aligns the longitudinal axis of the body with the border between two laminar fluid streams, leaving the animal's head and tail free to move. The content of the fluid streams can be manipulated to deliver step gradients in space or time. We demonstrate the utility of the device by identifying previously uncharacterized aspects of the behavioral mechanisms underlying chemotaxis, osmotic avoidance, and thermotaxis in this organism. The new devices are readily adaptable to behavioral and imaging studies involving fluid borne stimuli in a wide range of sensory modalities.	[McCormick, Kathryn E.; Gaertner, Bryn E.; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Gaertner, Bryn E.; Phillips, Patrick C.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Sottile, Matthew] Galois Inc, Res & Dev, Portland, OR USA	University of Oregon; University of Oregon	McCormick, KE (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	shawn@chinook.uoregon.edu	Sottile, Matthew/J-1386-2019	Sottile, Matthew/0000-0001-7436-5246	National Institutes of Health [MH051383, NS069491]; National Science Foundation [IOS-0909816]; John Simon Guggenheim Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH112105, R29MH051383, R01MH051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS069491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); John Simon Guggenheim Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (MH051383 and NS069491), the National Science Foundation (IOS-0909816), and the John Simon Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; ALBRECHT DR, 2011, NAT METHODS; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; CULOTTI JG, 1978, GENETICS, V90, P243; DUSENBERY DB, 1975, GENETICS, V80, P297; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; FRAENKEL GS, 1940, ORIENTATION ANIMALS; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Giuffre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015274; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Ito H, 2006, J NEUROSCI METH, V154, P45, DOI 10.1016/j.jneumeth.2005.11.011; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jurado P, 2010, GENES BRAIN BEHAV, V9, P120, DOI 10.1111/j.1601-183X.2009.00549.x; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Koyama S, 2006, ANAL CHEM, V78, P3354, DOI 10.1021/ac052087i; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; LOCKERY SR, 2011, CURR OPIN N IN PRESS; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Zariwala HA, 2003, J NEUROSCI, V23, P4369	43	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25710	10.1371/journal.pone.0025710	http://dx.doi.org/10.1371/journal.pone.0025710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022437	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000032
J	Poisot, T; Verneau, O; Desdevises, Y				Poisot, Timothee; Verneau, Olivier; Desdevises, Yves			Morphological and Molecular Evolution Are Not Linked in Lamellodiscus (Plathyhelminthes, Monogenea)	PLOS ONE			English	Article							GYRODACTYLUS-SALARIS MALMBERG; OPISTHAPTORAL HARD PARTS; N. SP MONOGENEA; HOST-SPECIFICITY; DIPLODUS-SARGUS; BODY-SIZE; DIPLECTANIDAE; TELEOSTEI; PARASITES; PHYLOGENY	Lamellodiscus Johnston & Tiegs 1922 (Monogenea, Diplectanidae) is a genus of common parasites on the gills of sparid fishes. Here we show that this genus is probably undergoing a fast molecular diversification, as reflected by the important genetic variability observed within three molecular markers (partial nuclear 18S rDNA, Internal Transcribed Spacer 1, and mitonchondrial Cytochrome Oxidase I). Using an updated phylogeny of this genus, we show that molecular and morphological evolution are weakly correlated, and that most of the morphologically defined taxonomical units are not consistent with the molecular data. We suggest that Lamellodiscus morphology is probably constrained by strong environmental (host-induced) pressure, and discuss why this result can apply to other taxa. Genetic variability within nuclear 18S and mitochondrial COI genes are compared for several monogenean genera, as this measure may reflect the level of diversification within a genus. Overall our results suggest that cryptic speciation events may occur within Lamellodiscus, and discuss the links between morphological and molecular evolution.	[Poisot, Timothee; Desdevises, Yves] Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Poisot, Timothee; Desdevises, Yves] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Verneau, Olivier] Univ Perpignan Via Domitia, Ctr Format & Rech Environm Mediterraneens, CNRS, UPVD,UMR 5110, Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Poisot, T (corresponding author), Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France.	tpoisot@um2.fr	Desdevises, Yves/H-5334-2019; Desdevises, Yves/D-5528-2011; Desdevises, Yves/AAH-2097-2019	Desdevises, Yves/0000-0001-9774-0336; Desdevises, Yves/0000-0001-9774-0336; Poisot, Timothee/0000-0002-0735-5184				Amine F, 2007, PARASITE, V14, P281, DOI 10.1051/parasite/2007144281; Amine F, 2006, SYST PARASITOL, V64, P37, DOI 10.1007/s11230-005-9016-4; Amine F, 2006, PARASITE, V13, P45, DOI 10.1051/parasite/2006131045; Amine F, 2005, SYST PARASITOL, V1922, P187; Amine F, 2007, ACTA PARASITOL, V52, P305, DOI 10.2478/s11686-007-0052-x; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; BROWN JM, 1994, MOL BIOL EVOL, V11, P128; Bueno-Silva M, 2011, INT J PARASITOL, V41, P657, DOI 10.1016/j.ijpara.2011.01.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Davidova M, 2005, PARASITOL RES, V95, P398, DOI 10.1007/s00436-005-1311-0; DEQUEIROZ K, 1988, CLADISTICS, V4, P317, DOI 10.1111/j.1096-0031.1988.tb00518.x; Desdevises Y, 2002, EVOLUTION, V56, P2459, DOI 10.1111/j.0014-3820.2002.tb00171.x; Desdevises Y, 2000, INT J PARASITOL, V30, P741, DOI 10.1016/S0020-7519(00)00051-5; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Desdevises Y, 2001, INT J PARASITOL, V31, P205, DOI 10.1016/S0020-7519(00)00163-6; Diamanka A, 2011, FOLIA PARASIT, V58, P17, DOI 10.14411/fp.2011.002; Donoghue Michael J., 1994, P393; Ellis JT, 1999, PARASITOLOGY, V118, P357, DOI 10.1017/S0031182098003801; ERGENS R, 1985, FOLIA PARASIT, V32, P377; Euzet L, 1993, 2 INT S MON MONTP SE; FENCHEL T, 1993, OIKOS, V68, P375, DOI 10.2307/3544855; Garcia-Robledo C, 2011, J ANIM ECOL, V80, P976, DOI 10.1111/j.1365-2656.2011.01843.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Hansen H, 2007, PARASITOL RES, V100, P1389, DOI 10.1007/s00436-006-0423-5; Harrison G, 1992, ENDLESS FORMS SPECIE, P19; Havermans C, 2010, MOL PHYLOGENET EVOL, V55, P202, DOI 10.1016/j.ympev.2009.10.025; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Justine JL, 2010, SYST PARASITOL, V75, P159, DOI 10.1007/s11230-009-9224-4; Kaci-Chaouchi T, 2008, PARASITOLOGY, V135, P607, DOI 10.1017/S003118200800437X; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Libby E, 2011, P ROY SOC B-BIOL SCI, V278, P3574, DOI 10.1098/rspb.2011.0146; Littlewood DTJ, 1997, INT J PARASITOL, V27, P1289, DOI 10.1016/S0020-7519(97)00086-6; LUCKOW M, 1995, SYST BOT, V20, P589, DOI 10.2307/2419812; Lymbery AJ, 1996, PARASITOL TODAY, V12, P486, DOI 10.1016/S0169-4758(96)10071-5; MARZLUFF JM, 1991, ECOLOGY, V72, P428, DOI 10.2307/2937185; Matejusova I, 2002, SYST PARASITOL, V53, P39, DOI 10.1023/A:1019945921143; Matsubayashi KW, 2011, J EVOLUTION BIOL, V24, P1421, DOI 10.1111/j.1420-9101.2011.02274.x; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; MO TA, 1993, SYST PARASITOL, V26, P225, DOI 10.1007/BF00009730; MO TA, 1991, SYST PARASITOL, V20, P11, DOI 10.1007/BF00009707; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Neifar L, 2004, ZOOSYSTEMA, V26, P365; Olstad K, 2006, PARASITOLOGY, V133, P33, DOI 10.1017/S0031182006009966; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.2307/2411190, 10.1111/j.1558-5646.1997.tb01461.x]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-11; Perkins EM, 2009, MOL PHYLOGENET EVOL, V52, P705, DOI 10.1016/j.ympev.2009.05.008; Pleijel F, 2000, P ROY SOC B-BIOL SCI, V267, P627, DOI 10.1098/rspb.2000.1048; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Poisot T, 2010, BIOL J LINN SOC, V99, P559, DOI 10.1111/j.1095-8312.2009.01381.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulin R, 1996, CAN J ZOOL, V74, P726, DOI 10.1139/z96-082; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; R Core Team, 2021, R LANG ENV STAT COMP; Rambault A, 2007, TRACER V1 4; Rohde K, 2005, MARINE PARASITOLOGY, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shinn AP, 2001, J FISH DIS, V24, P83, DOI 10.1046/j.1365-2761.2001.00272.x; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Soller R, 2000, MAR BIOL, V136, P29, DOI 10.1007/s002270050004; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verneau O, 2011, PARASITOLOGY, V138, P1778, DOI 10.1017/S0031182011000333; Verneau O, 2002, P ROY SOC B-BIOL SCI, V269, P535, DOI 10.1098/rspb.2001.1899; Verneau O, 1997, MOL BIOL EVOL, V14, P630, DOI 10.1093/oxfordjournals.molbev.a025802; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554	75	23	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26252	10.1371/journal.pone.0026252	http://dx.doi.org/10.1371/journal.pone.0026252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022582	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000093
J	Liu, ZJ; Chen, LJ; Chen, SC; Cai, J; Tsai, WC; Hsiao, YY; Rao, WH; Ma, XY; Zhang, GQ				Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang			Paraholcoglossum and Tsiorchis, Two New Orchid Genera Established by Molecular and Morphological Analyses of the Holcoglossum Alliance	PLOS ONE			English	Article								Background: Holcoglossum is a small orchid genus of 12 species ranging from SW China to Thailand and NE India. Although molecular and morphological analyses have been performed to establish the phylogenetic relationships within this genus, the interspecific relations and its relations with allied genera, such as Rhynchostylis, Aerides and Vanda, remain unclear. Methodology/Principal Findings: In addition to morphological analysis, maximum parsimony, maximum likelihood, and Bayesian inference analyses were performed based on fragments of the nuclear ITS and chloroplast trnL-F and matK genes of 31 taxa (15 Holcoglossum, 14 Aeridinae, 2 outgroups) representing all major clades of the Holcoglossum alliance. The results suggest that Holcoglossum is triphyletic, comprising three clades: the Holcoglossum clade, its sister clade, and a distant clade more closely related to Rhynchostylis, Aerides, and Vanda than to the Holcoglossum clade. The Holcoglossum clade is further divided into three subclades; the genetic distances between these three subclades also support this delimitation. The molecular conclusion is consistent with their distinct morphological characters. Conclusions: We propose that the latter two clades comprise two new genera, Paraholcoglossum and Tsiorchis, and Holcoglossum clade divides into three sections. In addition, a new section, Holcoglossum sect. Nujiangensia, and a new species, Holcoglossum linearifolium, are proposed. Some new combinations are made, and a new scheme is provided for the classification of all species of Holcoglossum, Paraholcoglossum, and Tsiorchis.	[Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Chen, Sing-Chi] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; South China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Liu, ZJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	liuzj@sinicaorchid.org; zhang2384539@163.com	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Cai, Jing/0000-0002-2496-4731; Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, People's Republic of China [2005-122]; Science and Technology Project of Shenzhen, China [SYF200646408, SY200806270123A]	State Forestry Administration, People's Republic of China; Science and Technology Project of Shenzhen, China	This work is supported by the State Forestry Administration, People's Republic of China, (grant no. 2005-122) and the Science and Technology Project of Shenzhen, China (grant no. SYF200646408, SY200806270123A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Chase M. W, 1994, P 14 WORLD ORCH C, P61; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson Eric A., 1998, Lindleyana, V13, P121; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2009, FLORA CHINA, V25, P499; MARCIN G, 2010, MOL PHYLOGENET EVOL, V56, P784; McNeill J., 2006, V146, P1; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiv M, 1999, PLANT SYST EVOL, V218, P299, DOI 10.1007/BF01089233; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439	26	23	25	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24864	10.1371/journal.pone.0024864	http://dx.doi.org/10.1371/journal.pone.0024864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016762	gold, Green Published, Green Submitted			2022-12-25	WOS:000295971700003
J	Ma, Q; Zhou, J; Zhang, WW; Meng, XX; Sun, JW; Yuan, YJ				Ma, Qian; Zhou, Jian; Zhang, Weiwen; Meng, Xinxin; Sun, Junwei; Yuan, Ying-jin			Integrated Proteomic and Metabolomic Analysis of an Artificial Microbial Community for Two-Step Production of Vitamin C	PLOS ONE			English	Article							MOTHER-CELL; BACILLUS-SUBTILIS; COG DATABASE; SPORULATION; BIOLOGY; GROWTH; MICROORGANISMS; TRANSCRIPTOME; ADAPTATION	An artificial microbial community consisted of Ketogulonicigenium vulgare and Bacillus megaterium has been used in industry to produce 2-keto-gulonic acid (2-KGA), the precursor of vitamin C. During the mix culture fermentation process, sporulation and cell lysis of B. megaterium can be observed. In order to investigate how these phenomena correlate with 2-KGA production, and to explore how two species interact with each other during the fermentation process, an integrated time-series proteomic and metabolomic analysis was applied to the system. The study quantitatively identified approximate 100 metabolites and 258 proteins. Principal Component Analysis of all the metabolites identified showed that glutamic acid, 5-oxo-proline, L-sorbose, 2-KGA, 2, 6-dipicolinic acid and tyrosine were potential biomarkers to distinguish the different time-series samples. Interestingly, most of these metabolites were closely correlated with the sporulation process of B. megaterium. Together with several sporulation-relevant proteins identified, the results pointed to the possibility that Bacillus sporulation process might be important part of the microbial interaction. After sporulation, cell lysis of B. megaterium was observed in the co-culture system. The proteomic results showed that proteins combating against intracellular reactive oxygen stress (ROS), and proteins involved in pentose phosphate pathway, L-sorbose pathway, tricarboxylic acid cycle and amino acids metabolism were up-regulated when the cell lysis of B. megaterium occurred. The cell lysis might supply purine substrates needed for K. vulgare growth. These discoveries showed B. megaterium provided key elements necessary for K. vulgare to grow better and produce more 2-KGA. The study represents the first attempt to decipher 2-KGA-producing microbial communities using quantitative systems biology analysis.	[Ma, Qian; Zhou, Jian; Zhang, Weiwen; Yuan, Ying-jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Ma, Qian; Zhou, Jian; Zhang, Weiwen; Yuan, Ying-jin] Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Meng, Xinxin; Sun, Junwei] Welcome Pharmaceut Co Ltd, N China Pharmaceut Grp, Shijiazhuang, Hebei, Peoples R China	Tianjin University; Tianjin University	Ma, Q (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn		Sun, Junwei/0000-0001-8518-5064; Zhang, Weiwen/0000-0001-8305-5653	National Basic Research Program of China ("973" Program) [2007CB714301, 2011CBA00802]; National Natural Science Foundation of China [20736006, 21020102040]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support from the National Basic Research Program of China ("973" Program: 2007CB714301, 2011CBA00802), the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; BUONO F, 1966, J BACTERIOL, V91, P2291, DOI 10.1128/JB.91.6.2291-2299.1966; Cheng JS, 2009, APPL MICROBIOL BIOT, V83, P909, DOI 10.1007/s00253-009-2037-1; Ding MZ, 2010, METABOLOMICS, V6, P42, DOI 10.1007/s11306-009-0173-3; EATON MW, 1974, BIOCHEM J, V144, P327, DOI 10.1042/bj1440327; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hancock Robert D, 2009, Recent Pat Food Nutr Agric, V1, P39; Hosoya S, 2007, J BACTERIOL, V189, P2561, DOI 10.1128/JB.01738-06; Jackson CR, 2008, APPL ENVIRON MICROB, V74, P5237, DOI 10.1128/AEM.00923-08; Knaysi G, 1934, J BACTERIOL, V27, P109, DOI 10.1128/JB.27.2.109-119.1934; Kromer JO, 2004, J BACTERIOL, V186, P1769, DOI 10.1128/JB.186.6.1769-1784.2004; Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v; Leduc S, 2004, APPL MICROBIOL BIOT, V65, P163, DOI 10.1007/s00253-004-1562-1; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; SEDDON AP, 1986, J BIOL CHEM, V261, P1538; SPUDICH JA, 1968, J BIOL CHEM, V243, P4600; STEINKRAUS KH, 1957, J BACTERIOL, V74, P621, DOI 10.1128/JB.74.5.621-624.1957; Takagi Y, 2010, APPL MICROBIOL BIOT, V86, P469, DOI 10.1007/s00253-009-2312-1; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trauger SA, 2008, J PROTEOME RES, V7, P1027, DOI 10.1021/pr700609j; VANDERWERF P, 1971, P NATL ACAD SCI USA, V68, P2982; Wang LJ, 2007, J BACTERIOL, V189, P8467, DOI 10.1128/JB.01285-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Yin GL, 1997, IND MICROBIOL, V27, P1; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11	41	68	84	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26108	10.1371/journal.pone.0026108	http://dx.doi.org/10.1371/journal.pone.0026108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016820	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300061
J	Steinsbekk, A; Rise, MB; Bishop, F; Lewith, G				Steinsbekk, Aslak; Rise, Marit By; Bishop, Felicity; Lewith, George			Predictors for Adolescent Visits to Practitioners of Complementary and Alternative Medicine in a Total Population (the Young-HUNT Studies)	PLOS ONE			English	Article							CHILDREN; CAM; PREVALENCE; PROVIDERS; CARE	Aim: To investigate the factors predicting adolescent visits to practitioners of complementary and alternative medicine (CAM). Methods: A longitudinal cohort study conducted in an adolescent total population in Central Norway (The Nord-Trondelag Health Studies (HUNT)). In Young-HUNT 1, all inhabitants aged 13 to 19 years (N = 8944, 89% response rate) were invited to participate, and the youngest group (13 to 15 year olds) was surveyed again 4 years later (Young-HUNT 2, N = 2429, 82% response rate). The participants completed a comprehensive questionnaire on health and life style which included a question regarding visits to a CAM practitioner in the last 12 months. Results: One in eleven (8.7%, 95% CI 7.6-9.8%) had visited a CAM practitioner, an increase of 26% in 4 years (1.8% points). The final multivariable analysis predicted increased odds of an adolescent becoming a CAM visitor four years later (p<0.05) if she or he had previously visited a CAM practitioner (adjOR 3.4), had musculoskeletal pain (adjOR 1.5), had migraine (adjOR 2.3), used asthma medicines (adjOR 1.8) or suffered from another disease lasting more than three months (adjOR 2.1). Being male predicted reduced odds of visiting a CAM practitioner in the future (adjOR 0.6). Conclusion: We can conclude from this study that future visits to a CAM practitioner are predicted by both predisposing factors (being female, having visited a CAM practitioner previously) and medical need factors (having had musculoskeletal pain, migraine, used asthma medicines or experienced another disease lasting more than three months). None of the specific variables associated with CAM visits were predictive for CAM visits four years later.	[Steinsbekk, Aslak; Rise, Marit By] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Bishop, Felicity; Lewith, George] Univ Southampton, Complementary & Integrated Med Res Unit, Southampton, Hants, England	Norwegian University of Science & Technology (NTNU); University of Southampton	Steinsbekk, A (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	aslak.steinsbekk@ntnu.no	Steinsbekk, Aslak/E-9223-2012	Steinsbekk, Aslak/0000-0001-9090-0739; Lewith, George/0000-0002-2364-3960; Bishop, Felicity/0000-0002-8737-6662				ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; April KT, 2009, COMPLEMENT THER MED, V17, P208, DOI 10.1016/j.ctim.2009.03.003; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Birdee GS, 2010, PEDIATRICS, V125, P249, DOI 10.1542/peds.2009-1406; Bishop Felicity L, 2009, Complement Ther Clin Pract, V15, P8, DOI 10.1016/j.ctcp.2008.09.005; Bishop FL, 2010, PEDIATRICS, V125, P768, DOI 10.1542/peds.2009-1775; Braun C A, 2000, J Holist Nurs, V18, P176, DOI 10.1177/089801010001800208; Breuner CC, 1998, ARCH PEDIAT ADOL MED, V152, P1071; FOULADBAKHSH JM, 2007, J COMPLEMENTARY INTE, V4, P1, DOI DOI 10.2202/1553-3840.1035; Gross-Tsur V, 2003, PEDIATR NEUROL, V29, P53, DOI 10.1016/s0887-8994(03)00027-4; Harris P, 2000, COMPLEMENT THER MED, V8, P88, DOI 10.1054/ctim.2000.0353; Heuschkel R, 2002, AM J GASTROENTEROL, V97, P382, DOI 10.1111/j.1572-0241.2002.05474.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hughes SC, 2006, AMBUL PEDIATR, V6, P293, DOI 10.1016/j.ambp.2005.11.007; Little P, 2001, BRIT J GEN PRACT, V51, P977; Lorenc A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-9; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Steinsbekk A, 2008, FORSCH KOMPLEMENTMED, V15, P146, DOI 10.1159/000134904; Steinsbekk A, 2006, FORSCH KOMP KLAS NAT, V13, P88, DOI 10.1159/000092004; Yussman SM, 2004, AMBUL PEDIATR, V4, P429, DOI 10.1367/A03-091R1.1; Zwaanswijk M, 2003, EUR CHILD ADOLES PSY, V12, P153, DOI 10.1007/S00787-003-0322-6	22	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25719	10.1371/journal.pone.0025719	http://dx.doi.org/10.1371/journal.pone.0025719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003404	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295970300025
J	Lamour, NF; Wijesinghe, DS; Mietla, JA; Ward, KE; Stahelin, RV; Chalfant, CE				Lamour, Nadia F.; Wijesinghe, Dayanjan S.; Mietla, Jennifer A.; Ward, Katherine E.; Stahelin, Robert V.; Chalfant, Charles E.			Ceramide Kinase Regulates the Production of Tumor Necrosis Factor alpha (TNF alpha) via Inhibition of TNF alpha-converting Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CYTOSOLIC PHOSPHOLIPASE A(2); HIGHLY POTENT INHIBITIONS; SEPTIC SHOCK; BCL-X; ACID SPHINGOMYELINASE; SHEDDING ACTIVITY; SEVERE SEPSIS; DOUBLE-BLIND; CASPASE 9	Background: Pro-TNF alpha is transformed into the active/soluble form through proteolysis by TNF alpha-converting enzyme (TACE). Results: Genetic ablation of ceramide kinase induces an increase in TACE activity and secreted TNF alpha. Conclusion: Ceramide 1-phosphate (C1P) negatively regulates the activity of TACE. Significance: The TACE/C1P interaction is a viable drug target for the treatment of heart disease and sepsis.	[Lamour, Nadia F.; Wijesinghe, Dayanjan S.; Mietla, Jennifer A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Ward, Katherine E.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Virginia Commonwealth University	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, 1101 E Marshall St,POB 980614, Richmond, VA 23298 USA.	cechalfant@vcu.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [HL072925, CA117950, T32 GM008695, T31 HL094290, T32GM075762, NH1C06-RR17393]; ONO Pharmaceutical Co., Ltd.; American Heart Association [SDG0735350N]; NATIONAL CANCER INSTITUTE [R01CA154314, R01CA117950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290, R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008695, T32GM075762] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONO Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL072925 and CA117950 (to C. E. C.). This work was also supported by a research grant supplied by ONO Pharmaceutical Co., Ltd. (to C. E. C.) and by American Heart Association Grant SDG0735350N (to R. V. S.).; Recipient of National Institutes of Health NRSA Post-doctoral Fellowship (in Wound Healing) Grant T32 GM008695.; Recipient of National Institutes of Health NRSA Pre-doctoral Fellowship (in Functional Lipidomics in Cardiovascular and Respiratory Diseases) Grant T31 HL094290.; Recipient of National Institutes of Health Training Fellowship CBBI Grant T32GM075762 and an American Heart Association pre-doctoral fellowship.; We thank Dr. Frederick Bornancin of Novartis Pharma for providing breeding pairs of the CERK<SUP>-/-</SUP> mouse along with wild-type counterparts. Virginia Commonwealth University was recipient of National Institutes of Health Grant NH1C06-RR17393 (for renovation).	Abraham E, 1998, LANCET, V351, P929; Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Avni D, 2009, IMMUNOL LETT, V123, P1, DOI 10.1016/j.imlet.2008.12.011; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bhola M, 2000, BIOL NEONATE, V78, P207, DOI 10.1159/000014272; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DasGupta S, 2009, BIOORGAN MED CHEM, V17, P444, DOI 10.1016/j.bmc.2008.11.067; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Eske K, 2009, J IMMUNOL METHODS, V342, P13, DOI 10.1016/j.jim.2008.11.011; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Goldsmith M, 2009, IMMUNOLOGY, V127, P103, DOI 10.1111/j.1365-2567.2008.02928.x; Graf C, 2008, J IMMUNOL, V180, P3457, DOI 10.4049/jimmunol.180.5.3457; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; HINSHAW LB, 1990, CIRC SHOCK, V30, P279; Hoareau L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-1; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Le GT, 2005, CURR MED CHEM, V12, P2963, DOI 10.2174/092986705774462851; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Matsui T, 2002, BIOORG MED CHEM LETT, V12, P907, DOI 10.1016/S0960-894X(02)00037-9; Matsui T, 2002, BIOORG MED CHEM LETT, V12, P903, DOI 10.1016/S0960-894X(02)00036-7; Mitsutake S, 2004, J BIOL CHEM, V279, P17570, DOI 10.1074/jbc.M312885200; Newton RC, 2001, ANN RHEUM DIS, V60, pIII25; Ogata T, 2008, SURGERY, V143, P545, DOI 10.1016/j.surg.2007.11.010; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tsuji K, 2008, FEBS J, V275, P3815, DOI 10.1111/j.1742-4658.2008.06527.x; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; WATSON RWG, 1994, J LEUKOCYTE BIOL, V56, P95, DOI 10.1002/jlb.56.1.95; Wijesinghe DS, 2007, METHOD ENZYMOL, V434, P265, DOI 10.1016/S0076-6879(07)34015-9; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wijesinghe DS, 2009, J LIPID RES, V50, P1986, DOI 10.1194/jlr.M800367-JLR200; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179	65	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42808	42817		10.1074/jbc.M111.310169	http://dx.doi.org/10.1074/jbc.M111.310169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009748	Green Published, hybrid			2022-12-25	WOS:000298351300002
J	Cascio, S; Zhang, LX; Finn, OJ				Cascio, Sandra; Zhang, Lixin; Finn, Olivera J.			MUC1 Protein Expression in Tumor Cells Regulates Transcription of Proinflammatory Cytokines by Forming a Complex with Nuclear Factor-kappa B p65 and Binding to Cytokine Promoters IMPORTANCE OF EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; COLON-CANCER; PROGRESSION; ANTIGEN; MUCINS; GLYCOSYLATION; THERAPY	MUC1 is a transmembrane glycoprotein abnormally expressed in all stages of development of human adenocarcinomas. Overexpression and hypoglycosylation of MUC1 in cancer cells compared with normal epithelial cells are likely to alter its function and affect the behavior of cancer cells. The extracellular domain, specifically the highly O-glycosylated VNTR (variable number of tandem repeats) region, plays an important role in cell-cell communication; however, we show here that it also participates intracellularly in activation of the NF-kappa B pathway. Transfection of MUC1(-) tumor cells with cDNA encoding MUC1 with 22 tandem repeats (MUC1/22TR) or two tandem repeats (MUC1/2TR) or two isoforms that lack the VNTR region (MUC1/Z and MUC1/Y) showed that the highest expression levels of NF-kappa B family members correlated with the presence of VNTR and the highest number of tandem repeats. Because expression of MUC1 with VNTR on tumors was previously associated with chemotactic activity for cells of the innate immune system, we investigated the influence of MUC1 expression on the NF-kappa B-dependent transcriptional regulation of proinflammatory cytokines. ChIP and real-time PCR experiments revealed that MUC1/22TR up-regulated IL-6 and TNF-alpha expression by binding to their promoter regions in a NF-kappa B p65-dependent manner in both MUC1-transfected and human breast cancer cells that express endogenous MUC1. This newly detected complex of MUC1 and p65 is a novel mechanism that tumors can use to promote inflammation and cancer development.	[Cascio, Sandra; Zhang, Lixin; Finn, Olivera J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Cascio, Sandra] Fdn Ri MED, I-90134 Palermo, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cascio, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, E1046 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	sac131@pitt.edu	Zhang, Li/GWM-7501-2022	Cascio, Sandra/0000-0003-4234-0508	National Institutes of Health from NCI [CA56103]; Fondazione Ri.Med; NATIONAL CANCER INSTITUTE [R01CA056103] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Ri.Med; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA56103 (to O. J. F.) from NCI. This work was also supported by the Fondazione Ri.Med (to S. C.).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Beatty PL, 2010, CANCER PREV RES, V3, P438, DOI 10.1158/1940-6207.CAPR-09-0194; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Carlos CA, 2005, J IMMUNOL, V175, P1628, DOI 10.4049/jimmunol.175.3.1628; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; FONTENOT JD, 1995, J BIOMOL STRUCT DYN, V13, P245, DOI 10.1080/07391102.1995.10508837; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MERLIN J, 2011, ONCOGENE IN PRESS; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Taylor-Papadimitriou J, 2002, J MAMMARY GLAND BIOL, V7, P209, DOI 10.1023/A:1020360121451; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030	24	63	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42248	42256		10.1074/jbc.M111.297630	http://dx.doi.org/10.1074/jbc.M111.297630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22021035	Green Published, hybrid			2022-12-25	WOS:000298180900034
J	Groulx, N; McGuire, H; Laprade, R; Schwartz, JL; Blunck, R				Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Schwartz, Jean-Louis; Blunck, Rikard			Single Molecule Fluorescence Study of the Bacillus thuringiensis Toxin Cry1Aa Reveals Tetramerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID-BILAYERS; BRUSH-BORDER-MEMBRANE; DELTA-ENDOTOXIN; PORE FORMATION; ION-CHANNEL; INSECTICIDAL TOXINS; SELECTIVE CHANNELS; CRYSTAL PROTEINS; MIDGUT RECEPTORS; CRY4BA TOXIN	Pore-forming toxins constitute a class of potent virulence factors that attack their host membrane in a two- or three-step mechanism. After binding to the membrane, often aided by specific receptors, they form pores in the membrane. Pore formation either unfolds a cytolytic activity in itself or provides a pathway to introduce enzymes into the cells that act upon intracellular proteins. The elucidation of the pore-forming mechanism of many of these toxins represents a major research challenge. As the toxins often refold after entering the membrane, their structure in the membrane is unknown, and key questions such as the stoichiometry of individual pores and their mechanism of oligomerization remain unanswered. In this study, we used single subunit counting based on fluorescence spectroscopy to explore the oligomerization process of the Cry1Aa toxin of Bacillus thuringiensis. Purified Cry1Aa toxin molecules labeled at different positions in the pore-forming domain were inserted into supported lipid bilayers, and the photobleaching steps of single fluorophores in the fluorescence time traces were counted to determine the number of subunits of each oligomer. We found that toxin oligomerization is a highly dynamic process that occurs in the membrane and that tetramers represent the final form of the toxins in a lipid bilayer environment.	[Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Schwartz, Jean-Louis; Blunck, Rikard] Univ Montreal, Grp Etud Prote Membranaires GEPROM, Montreal, PQ H3C 3J7, Canada; [Schwartz, Jean-Louis] Univ Montreal, Ctr SEVE, Montreal, PQ H3C 3J7, Canada; [Schwartz, Jean-Louis; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	schwartz, jean-louis/D-9938-2011; Blunck, Rikard/AAM-3078-2020; Blunck, Rikard/L-4226-2013	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Natural Sciences and Engineering Research Council [327201DG, 171373DG]; Canada Research Chair [202965]; Canadian Foundation for Innovation [202965]; Groupe d'Etude des Proteines Membranaires (GEPROM); Fonds de Recherche de Quebec-Nature et Technologie; FRSQ; FQRNT	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Groupe d'Etude des Proteines Membranaires (GEPROM); Fonds de Recherche de Quebec-Nature et Technologie; FRSQ(Fonds de la Recherche en Sante du Quebec); FQRNT(FQRNT)	The work was supported in part by Natural Sciences and Engineering Research Council Grants 327201DG (to R. B.) and 171373DG (to J.-L. S. and R. L.), Canada Research Chair Grant 202965 and Canadian Foundation for Innovation Grant 202965 (to R. B.), the Groupe d'Etude des Proteines Membranaires (GEPROM), and student fellowships from Fonds de Recherche de Quebec-Nature et Technologie (to N. G. and H. M.). Work performed at GEPROM and Center SEVE was supported by FRSQ and FQRNT, respectively.	Alouf J., 2006, COMPREHENSIVE SOURCE; Alzate O, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-25; Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; ARONSON AI, 1995, J BACTERIOL, V177, P4059, DOI 10.1128/jb.177.14.4059-4065.1995; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carroll J, 1997, EUR J BIOCHEM, V245, P797, DOI 10.1111/j.1432-1033.1997.00797.x; CARROLL J, 1993, EUR J BIOCHEM, V214, P771, DOI 10.1111/j.1432-1033.1993.tb17979.x; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; ENGLISH L, 1994, INSECT BIOCHEM MOLEC, V24, P1025, DOI 10.1016/0965-1748(94)90140-6; FENG Q, 1994, BIOCHEMISTRY-US, V33, P8521, DOI 10.1021/bi00194a017; Garcia HG, 2011, BIOPHYS J, V101, P535, DOI 10.1016/j.bpj.2011.06.026; GAZIT E, 1995, J BIOL CHEM, V270, P2571, DOI 10.1074/jbc.270.6.2571; Girard F, 2009, BBA-BIOMEMBRANES, V1788, P575, DOI 10.1016/j.bbamem.2008.11.001; Girard F, 2009, APPL ENVIRON MICROB, V75, P359, DOI 10.1128/AEM.01930-08; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Groulx N, 2010, J GEN PHYSIOL, V136, P497, DOI 10.1085/jgp.200910347; Guereca L, 1999, BBA-PROTEIN STRUCT M, V1429, P342, DOI 10.1016/S0167-4838(98)00241-6; HAIDER MZ, 1989, BIOCHIM BIOPHYS ACTA, V978, P216, DOI 10.1016/0005-2736(89)90118-1; HOFTE H, 1989, MICROBIOL REV, V53, P242; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; Laflamme E, 2008, J MEMBRANE BIOL, V222, P127, DOI 10.1007/s00232-008-9106-8; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LEE MK, 1995, BIOCHEM BIOPH RES CO, V216, P306, DOI 10.1006/bbrc.1995.2625; Lenn T, 2011, CHEM COMMUN, V47, P400, DOI 10.1039/c0cc01707h; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; LORENCE A, 1995, FEBS LETT, V360, P217, DOI 10.1016/0014-5793(95)00092-N; MARTIN FG, 1995, J EXP BIOL, V198, P91; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; MASSON L, 1990, BIOCHEM J, V269, P507, DOI 10.1042/bj2690507; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Ounjai P, 2007, BIOCHEM BIOPH RES CO, V361, P890, DOI 10.1016/j.bbrc.2007.07.086; Peyronnet O, 2002, BBA-BIOMEMBRANES, V1567, P113, DOI 10.1016/S0005-2736(02)00605-3; Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Puntheeranurak T, 2005, ULTRAMICROSCOPY, V105, P115, DOI 10.1016/j.ultramic.2005.06.026; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 1997, FEBS LETT, V410, P397, DOI 10.1016/S0014-5793(97)00626-1; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Schwartz JL, 1997, FEBS LETT, V412, P270, DOI 10.1016/S0014-5793(97)00801-6; SCHWARTZ JL, 2000, ENTOMOPATHOGENIC BAC, P199; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; SLATIN SL, 1990, BIOCHEM BIOPH RES CO, V169, P765, DOI 10.1016/0006-291X(90)90397-6; Smedley DP, 1997, MOL MEMBR BIOL, V14, P13, DOI 10.3109/09687689709048164; Tigue NJ, 2001, APPL ENVIRON MICROB, V67, P5715, DOI 10.1128/AEM.67.12.5715-5720.2001; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tomimoto K, 2006, COMP BIOCHEM PHYS B, V144, P413, DOI 10.1016/j.cbpb.2006.04.013; Torres J, 2008, BBA-BIOMEMBRANES, V1778, P392, DOI 10.1016/j.bbamem.2007.10.028; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; VANFRANKENHUYZEN K, 1991, APPL ENVIRON MICROB, V57, P1650, DOI 10.1128/AEM.57.6.1650-1655.1991; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Villalon M, 1998, BBA-BIOMEMBRANES, V1368, P27, DOI 10.1016/S0005-2736(97)00184-3; WALTERS FS, 1994, INSECT BIOCHEM MOLEC, V24, P963, DOI 10.1016/0965-1748(94)90133-3; WALTERS FS, 1993, BIOCHEM BIOPH RES CO, V196, P921, DOI 10.1006/bbrc.1993.2337	59	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42274	42282		10.1074/jbc.M111.296103	http://dx.doi.org/10.1074/jbc.M111.296103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006922	Green Published, hybrid			2022-12-25	WOS:000298180900037
J	Hill, J; Chan, SA; Kuri, B; Smith, C				Hill, Jacqueline; Chan, Shyue-An; Kuri, Barbara; Smith, Corey			Pituitary Adenylate Cyclase-activating Peptide (PACAP) Recruits Low Voltage-activated T-type Calcium Influx under Acute Sympathetic Stimulation in Mouse Adrenal Chromaffin Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; VASOACTIVE INTESTINAL POLYPEPTIDE; RAT VENTRICULAR MYOCYTES; LOW-THRESHOLD EXOCYTOSIS; PANCREATIC BETA-CELLS; CATECHOLAMINE SECRETION; CA2+ CHANNELS; DIFFERENTIAL SECRETION; GENE-TRANSCRIPTION; SIGNALING PATHWAY	Low voltage-activated T-type Ca(v)3.2 calcium channels are expressed in neurosecretory chromaffin cells of the adrenal medulla. Previous studies have shown that naive adrenal chromaffin cells express a nominal Ca(v)3.2-dependent conductance. However, Ca(v)3.2 conductance is up-regulated following chronic hypoxia or long term exposure to cAMP analogs. Thus, although a link between chronic stressors and up-regulation of Ca(v)3.2 exists, there are no reports testing the specific role of Ca(v)3.2 channels in the acute sympathoadrenal stress response. In this study, we examined the effects of acute sympathetic stress on T-type Ca(v)3.2 calcium influx in mouse chromaffin cells in situ. Pituitary adenylate cyclase-activating peptide (PACAP) is an excitatory neuroactive peptide transmitter released by the splanchnic nerve under elevated sympathetic activity to stimulate the adrenal medulla. PACAP stimulation did not evoke action potential firing in chromaffin cells but did cause a persistent subthreshold membrane depolarization that resulted in an immediate and robust Ca2+-dependent catecholamine secretion. Moreover, PACAP-evoked secretion was sensitive to block by nickel chloride and was acutely inhibited by protein kinase C blockers. We utilized perforated patch electrophysiological recordings conducted in adrenal tissue slices to investigate the mechanism of PACAP-evoked calcium entry. We provide evidence that stimulation with exogenous PACAP and native neuronal stress stimulation both lead to a protein kinase C-mediated phosphodependent recruitment of a T-type Ca(v)3.2 Ca2+ influx. This in turn evokes catecholamine release during the acute sympathetic stress response.	[Smith, Corey] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Smith, C (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	Corey.Smith@Case.Edu		Chan, Shyue-An/0000-0001-9668-2103	National Institutes of Health [T32 HL 07887]; American Heart Association [10PRE4100002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 HL 07887. This work was also supported by American Heart Association Grant 10PRE4100002.	Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; Aunis D, 1998, INT REV CYTOL, V181, P213, DOI 10.1016/S0074-7696(08)60419-2; BEVINGTON A, 1985, BIOCHEM PHARMACOL, V34, P1497, DOI 10.1016/0006-2952(85)90690-2; BOKSA P, 1984, J NEUROCHEM, V42, P618, DOI 10.1111/j.1471-4159.1984.tb02727.x; BRAAS KM, 1994, ENDOCRINOLOGY, V134, P186, DOI 10.1210/en.134.1.186; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; Carabelli V, 2007, EUR BIOPHYS J BIOPHY, V36, P753, DOI 10.1007/s00249-007-0138-2; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; Chan SA, 2005, ARCH BIOCHEM BIOPHYS, V435, P65, DOI 10.1016/j.abb.2004.12.005; Chan SA, 2003, J PHYSIOL-LONDON, V553, P707, DOI 10.1113/jphysiol.2003.053918; Currie KPM, 1997, J NEUROSCI, V17, P4570; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FLOREY CD, 1993, BRIT MED J, V306, P1181, DOI 10.1136/bmj.306.6886.1181; FURUKAWA T, 1992, CIRC RES, V71, P1242, DOI 10.1161/01.RES.71.5.1242; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Geng GJ, 1997, AM J PHYSIOL-REG I, V273, pR1339, DOI 10.1152/ajpregu.1997.273.4.R1339; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GUO X, 1994, J PHYSIOL-LONDON, V475, P539, DOI 10.1113/jphysiol.1994.sp020092; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC375, DOI 10.1152/ajpcell.00495.2005; Hamelink C, 2002, J NEUROSCI, V22, P5310; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hayashi Kentarou, 2002, Bull Tokyo Dent Coll, V43, P31, DOI 10.2209/tdcpublication.43.31; HENRY J P, 1992, Integrative Physiological and Behavioral Science, V27, P66, DOI 10.1007/BF02691093; HOLMAN ME, 1994, J PHYSIOL-LONDON, V478, P115, DOI 10.1113/jphysiol.1994.sp020235; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; HOSHINO M, 1993, NEUROSCI LETT, V159, P35, DOI 10.1016/0304-3940(93)90792-J; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Joksovic PM, 2010, MOL PHARMACOL, V77, P87, DOI 10.1124/mol.109.059931; Jorgensen MS, 2002, REGUL PEPTIDES, V103, P59, DOI 10.1016/S0167-0115(01)00327-5; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; KIDOKORO Y, 1980, J PHYSIOL-LONDON, V307, P199, DOI 10.1113/jphysiol.1980.sp013431; KLEVANS LR, 1970, J PHARMACOL EXP THER, V172, P69; Kuri BA, 2009, J NEUROCHEM, V110, P1214, DOI 10.1111/j.1471-4159.2009.06206.x; Levitsky KL, 2009, J PHYSIOL-LONDON, V587, P1917, DOI 10.1113/jphysiol.2009.168989; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Marcantoni A, 2008, ACTA PHYSIOL, V192, P233, DOI 10.1111/j.1748-1716.2007.01815.x; MARLEY PD, 1988, TRENDS PHARMACOL SCI, V9, P102, DOI 10.1016/0165-6147(88)90177-0; Maturana A, 2009, ENDOCRINOLOGY, V150, P3726, DOI 10.1210/en.2008-1727; MCFADDEN PN, 1990, P NATL ACAD SCI USA, V87, P2031, DOI 10.1073/pnas.87.5.2031; Montero-Hadjadje M, 2006, ANN NY ACAD SCI, V1070, P431, DOI 10.1196/annals.1317.057; Morita K, 2002, J PHARMACOL EXP THER, V302, P972, DOI 10.1124/jpet.102.033456; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; PARK JY, 2006, MOON, V577, P513; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, J BIOENERG BIOMEMBR, V30, P313, DOI 10.1023/A:1021981420839; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Smith C, 1999, J NEUROSCI, V19, P589; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Souvannakitti D, 2010, J NEUROSCI, V30, P10763, DOI 10.1523/JNEUROSCI.2307-10.2010; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Tanaka K, 1996, ENDOCRINOLOGY, V137, P956, DOI 10.1210/en.137.3.956; Tanaka K, 1997, ENDOCRINOLOGY, V138, P4086, DOI 10.1210/en.138.10.4086; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; TISCHLER AS, 1995, NEUROSCI LETT, V189, P135, DOI 10.1016/0304-3940(95)11472-9; Turquier V, 2001, MOL PHARMACOL, V60, P42, DOI 10.1124/mol.60.1.42; Wakade A R, 1998, Adv Pharmacol, V42, P595; WALZ W, 2002, PATCH CLAMP ANAL ADV, V35, P163; WATANABE T, 1992, BIOCHEM BIOPH RES CO, V182, P403, DOI 10.1016/S0006-291X(05)80159-7; WATANABE T, 1995, AM J PHYSIOL-ENDOC M, V269, pE903, DOI 10.1152/ajpendo.1995.269.5.E903; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	73	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42459	42469		10.1074/jbc.M111.289389	http://dx.doi.org/10.1074/jbc.M111.289389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009744	hybrid, Green Published			2022-12-25	WOS:000298180900054
J	Wilczek, C; Chitta, R; Woo, E; Shabanowitz, J; Chait, BT; Hunt, DF; Shechter, D				Wilczek, Carola; Chitta, Raghu; Woo, Eileen; Shabanowitz, Jeffrey; Chait, Brian T.; Hunt, Donald F.; Shechter, David			Protein Arginine Methyltransferase Prmt5-Mep50 Methylates Histones H2A and H4 and the Histone Chaperone Nucleoplasmin in Xenopus laevis Eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN DECONDENSATION; MASS-SPECTROMETRY; SM PROTEINS; PRMT5; EXPRESSION; PHOSPHORYLATION; ACTIVATION; CHECKPOINT; BINDS; TRANSCRIPTION	Histone proteins carry information contained in post-translational modifications. Eukaryotic cells utilize this histone code to regulate the usage of the underlying DNA. In the maturing oocytes and eggs of the frog Xenopus laevis, histones are synthesized in bulk in preparation for deposition during the rapid early developmental cell cycles. During this key developmental time frame, embryonic pluripotent chromatin is established. In the egg, non-chromatin-bound histones are complexed with storage chaperone proteins, including nucleoplasmin. Here we describe the identification and characterization of a complex of the protein arginine methyltransferase 5 (Prmt5) and the methylosome protein 50 (Mep50) isolated from Xenopus eggs that specifically methylates predeposition histones H2A/H2A.X-F and H4 and the histone chaperone nucleoplasmin on a conserved motif(GRGXK). We demonstrate that nucleoplasmin (Npm), an exceedingly abundant maternally deposited protein, is a potent substrate for Prmt5-Mep50 and is monomethylated and symmetrically dimethylated at Arg-187. Furthermore, Npm modulates Prmt5-Mep50 activity directed toward histones, consistent with a regulatory role for Npm in vivo. We show that H2A and nucleoplasmin methylation appears late in oogenesis and is most abundant in the laid egg. We hypothesize that these very abundant arginine methylations are constrained to premid blastula transition events in the embryo and therefore may be involved in the global transcriptional repression found in this developmental time frame.	[Wilczek, Carola; Shechter, David] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Chitta, Raghu; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Woo, Eileen; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; University of Virginia; Rockefeller University	Shechter, D (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.shechter@einstein.yu.edu	Shechter, David/B-4660-2008; Hunt, Donald F/I-6936-2012	Shechter, David/0000-0001-9388-6004; Hunt, Donald F/0000-0003-2815-6368	National Institutes of Health [GM075486, RR00862, GM037537]; Albert Einstein College of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, F32GM075486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, Grants GM075486 (to D. S.), RR00862 (to B. T. C.), and GM037537 (to D. F. H.). This work was also supported by startup funds from the Albert Einstein College of Medicine.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; ANIZET MP, 1981, IN VITRO CELL DEV B, V17, P267; Arnan C, 2003, J BIOL CHEM, V278, P31319, DOI 10.1074/jbc.M305560200; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Banaszynski LA, 2010, METHODS, V51, P3, DOI 10.1016/j.ymeth.2009.12.014; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BURGLIN TR, 1987, GENE DEV, V1, P97, DOI 10.1101/gad.1.1.97; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Faber J, 1994, NORMAL TABLE XENOPUS; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; KALINICH JF, 1994, PROTEIN EXPRES PURIF, V5, P324, DOI 10.1006/prep.1994.1048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Leno GH, 1996, J BIOL CHEM, V271, P7253, DOI 10.1074/jbc.271.13.7253; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Ramos I, 2010, J BIOL CHEM, V285, P33771, DOI 10.1074/jbc.M110.150664; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; SEALY L, 1989, METHOD ENZYMOL, V170, P612; SEALY L, 1986, BIOCHEMISTRY-US, V25, P3064, DOI 10.1021/bi00358a049; Shafa M, 2010, BIOESSAYS, V32, P791, DOI 10.1002/bies.201000033; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; SHECHTER D, 2007, NAT REV GENET, V8, pS23; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Sible JC, 1998, CURR BIOL, V8, P347, DOI 10.1016/S0960-9822(98)70136-8; SIMEONI I, 2011, STEM CELLS IN PRESS; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yamada A, 2004, J CELL BIOL, V167, P841, DOI 10.1083/jcb.200406048; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015	57	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42221	42231		10.1074/jbc.M111.303677	http://dx.doi.org/10.1074/jbc.M111.303677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009756	Green Published, hybrid			2022-12-25	WOS:000298180900032
J	Shah, S; Henriksen, MA				Shah, Shaili; Henriksen, Melissa A.			A Novel Disrupter of Telomere Silencing 1-like (DOT1L) Interaction Is Required for Signal Transducer and Activator of Transcription 1 (STAT1)-activated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; INTERFERON-ALPHA; LYSINE METHYLATION; H3K79 METHYLATION; GAMMA-INTERFERON; MAMMALIAN-CELLS; SET DOMAIN; METHYLTRANSFERASE; YEAST; STAT1	JAK-STAT-activated gene expression is both rapid and transient and requires dynamic post-translational modification of the chromatin template. Previously, we showed that following IFN-gamma treatment, trimethylation of histone H3 at lysine 79 (H3K79me3) is rapidly and highly induced in the 5'-end of the STAT1-dependent gene interferon regulatory factor 1 (IRF1), but the role of this histone modification was unexplored. Here we report that DOT1L, the non-SET domain containing methyltransferase that modifies Lys-79, is localized across IRF1 in the uninduced state and is not further recruited by IFN-gamma induction. RNAi-mediated depletion of DOT1L, prevents the induction of H3K79me3 and lowers the transcription of IRF1 2-fold, as expected. Surprisingly, STAT1 binding to its DNA recognition element near the IRF1 promoter is diminished 2-fold in the DOT1L-depleted cell line. In vivo and in vitro protein interaction assays reveal a DOT1L-STAT1 interaction. Domain mapping identifies the middle region of DOT1L. (amino acids 580-1183) as the STAT1 interaction domain. Overexpression of the DOT1L, STAT 1 interaction domain represses IRF1 transcription (2-fold) and interferes with STAT1 DNA binding at IRF1 and endogenous DOT1L, histone methyltransferase activity. Collectively, our findings reveal a novel STAT1-DOT1L, interaction that is required for the regulation JAK-STAT-inducible gene expression.	[Shah, Shaili; Henriksen, Melissa A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Henriksen, MA (corresponding author), Univ Virginia, Dept Biol, POB 400328, Charlottesville, VA 22904 USA.	mah2hx@virginia.edu						Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Buro Lauren J, 2010, J Vis Exp, DOI 10.3791/2053; Buro LJ, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-16; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chipumuro E., 2011, FASEB J IN PRESS; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; FitzGerald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014714; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shuai K, 1996, MOL CELL BIOL, V16, P4932; Singh P, 2010, MOL CELL BIOL, V30, P2693, DOI 10.1128/MCB.01537-09; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Yu ZY, 2010, AM J PHYSIOL-RENAL, V298, pF617, DOI 10.1152/ajprenal.00636.2009; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	55	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41195	41204		10.1074/jbc.M111.284190	http://dx.doi.org/10.1074/jbc.M111.284190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	22002246	Green Published, hybrid			2022-12-25	WOS:000298057500008
J	Bainbridge, JM; Potts, T; O'Higgins, TG				Bainbridge, John Michael; Potts, Tavis; O'Higgins, Tim Gerard			Rapid Policy Network Mapping: A New Method for Understanding Governance Structures for Implementation of Marine Environmental Policy	PLOS ONE			English	Article							MANAGEMENT	Understanding the relationships and dependencies in the development and implementation of environmental policy is essential to the effective management of the marine environment. A new method of policy network analysis called 'Rapid Policy Network Mapping' was developed that delivers an insight for both technical and non-technical users into the lifecycle, relationships and dependencies of policy development. The method was applied to the Marine Strategy Framework Directive and the Water Framework Directive in the UK. These case studies highlight the environmental policy challenges to protect the UK's marine coastal environment and they identify differences in the styles of policy implementation between the devolved authorities of the UK. Rapid Policy Network Mapping provides an opportunity to create a collaborative policy data environment with a relatively small investment. As a tool for civil society it should assist in their ability to understand and influence policy making and implementation.	[Bainbridge, John Michael; Potts, Tavis; O'Higgins, Tim Gerard] Scottish Assoc Marine Sci, Ctr Coastal & Oceans Governance, Oban, Argyll, Scotland	UHI Millennium Institute	Bainbridge, JM (corresponding author), Scottish Assoc Marine Sci, Ctr Coastal & Oceans Governance, Oban, Argyll, Scotland.	john.bainbridge@sams.ac.uk	O'Higgins, Tim/G-6717-2015	O'Higgins, Tim/0000-0003-1274-4480; Potts, Tavis/0000-0001-7652-8854	European Community [226675]; Natural Environment Research Council [dml010007] Funding Source: researchfish; NERC [dml010007] Funding Source: UKRI	European Community(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement number 226675. The KnowSeas project is affiliated with LOICZ and LWEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Atkinson R., 2001, ACCESSING HIDDEN HAR; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Bots P. W. G., 1999, P 32 HAW INT C SYST; Bryman A., 2004, HDB DATA ANAL, DOI DOI 10.4135/9781848608184.N22; Cairney P., 2009, PUBLIC POLICY ADMIN, V24, P355, DOI DOI 10.1177/0952076709340508; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; *DEP ENV FOOD RUR, 2007, SEA CHANG; *DIR GEN MAR AFF F, 2009, SOC STUD FIELD INT M; Douvere F, 2007, MAR POLICY, V31, P182, DOI 10.1016/j.marpol.2006.07.003; *ENV AG, 2007, 2 CONS DOC WAT LIF L; *EUR COMM, 2009, SEC20091343 EUR COMM; European Commission, 2007, INT MAR POL EUR UN; Farquharson K., 2005, INT J SOC RES METHOD, V8, P345, DOI [10.1080/1364557042000203116, DOI 10.1080/1364557042000203116]; Fowler JH, 2009, P NATL ACAD SCI USA, V106, P1720, DOI 10.1073/pnas.0806746106; Friedman B. L., 2006, OXFORD HDB PUBLIC PO, P482; Garcia S., 2003, 443 FAO; Gilliland PM, 2008, MAR POLICY, V32, P787, DOI 10.1016/j.marpol.2008.03.022; Greenaway J, 2007, PUBLIC ADMIN, V85, P717, DOI 10.1111/j.1467-9299.2007.00661.x; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Lawton JH, 2007, J APPL ECOL, V44, P465, DOI 10.1111/j.1365-2664.2007.01315.x; Leifeld P., 2010, PREPRINTS M PLANCK I; LEIFELD P, 2008, M PLANCK I LECT; Leith MS, 2010, PARLIAMENT AFF, V63, P286, DOI 10.1093/pa/gsp032; Lipsky Michael, 1980, STREET LEVEL DEMOCRA; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; McArther S., 2008, ASIAN J PUBLIC AFFAI, V2, P55; Mikkelsen M., 2006, POLICY STUD-UK, V27, P17, DOI [10.1080/01442870500499868, DOI 10.1080/01442870500499868]; Monge P. R., 2003, THEORIES COMMUNICATI, P141; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; PETERSON J, 2003, POLITICAL SCI SERIES; Rhodes RAW, 2007, ORGAN STUD, V28, P1243, DOI 10.1177/0170840607076586; ROTH E, 2010, P LITT C 20 IN PRESS; *SCOTT GOV, 2008, SCOTT GOV STAK SURV; Smith H, 2011, J COAST CONSERV, V15, P291, DOI 10.1007/s11852-010-0098-z; Steunenberg B, 2009, J EUR PUBLIC POLICY, V16, P951, DOI 10.1080/13501760903226625; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Wasserman S., 1994, SOCIAL NETWORK ANAL	39	20	20	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26149	10.1371/journal.pone.0026149	http://dx.doi.org/10.1371/journal.pone.0026149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022545	gold, Green Submitted, Green Published			2022-12-25	WOS:000295981600032
J	Hornoy, B; Tarayre, M; Herve, M; Gigord, L; Atlan, A				Hornoy, Benjamin; Tarayre, Michele; Herve, Maxime; Gigord, Luc; Atlan, Anne			Invasive Plants and Enemy Release: Evolution of Trait Means and Trait Correlations in Ulex europaeus	PLOS ONE			English	Article							INCREASED COMPETITIVE ABILITY; APION-ULICIS FORST; INTRODUCED POPULATIONS; FLOWERING PHENOLOGY; SEED PREDATION; BIOTIC INTERACTIONS; NEW-ZEALAND; HYPOTHESIS; SELECTION; GORSE	Several hypotheses that attempt to explain invasive processes are based on the fact that plants have been introduced without their natural enemies. Among them, the EICA (Evolution of Increased Competitive Ability) hypothesis is the most influential. It states that, due to enemy release, exotic plants evolve a shift in resource allocation from defence to reproduction or growth. In the native range of the invasive species Ulex europaeus, traits involved in reproduction and growth have been shown to be highly variable and genetically correlated. Thus, in order to explore the joint evolution of life history traits and susceptibility to seed predation in this species, we investigated changes in both trait means and trait correlations. To do so, we compared plants from native and invaded regions grown in a common garden. According to the expectations of the EICA hypothesis, we observed an increase in seedling height. However, there was little change in other trait means. By contrast, correlations exhibited a clear pattern: the correlations between life history traits and infestation rate by seed predators were always weaker in the invaded range than in the native range. In U. europaeus, the role of enemy release in shaping life history traits thus appeared to imply trait correlations rather than trait means. In the invaded regions studied, the correlations involving infestation rates and key life history traits such as flowering phenology, growth and pod density were reduced, enabling more independent evolution of these key traits and potentially facilitating local adaptation to a wide range of environments. These results led us to hypothesise that a relaxation of genetic correlations may be implied in the expansion of invasive species.	[Hornoy, Benjamin; Tarayre, Michele; Atlan, Anne] Univ Rennes 1, CNRS, Rennes, France; [Herve, Maxime] Univ Rennes 1, BIO3P, Inst Natl Rech Agron Agrocampus Ouest, Rennes, France; [Gigord, Luc] Conservatoire Bot Natl Mascarin, St Leu, Reunion, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes	Hornoy, B (corresponding author), Univ Rennes 1, CNRS, Rennes, France.	anne.atlan@univ-rennes1.fr			CNRS (Centre National de la Recherche Scientifique); CNRS (Centre National de la Recherche Scientifique)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by an ATIP (Action Thematique et Incitative sur Programme) grant of the CNRS (Centre National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; [Anonymous], 2010, R LANG ENV STAT COMP; Atlan A, 2010, J EVOLUTION BIOL, V23, P362, DOI 10.1111/j.1420-9101.2009.01908.x; Barat M, 2008, ECOL ENTOMOL, V33, P328, DOI 10.1111/j.1365-2311.2007.00968.x; Barat M, 2007, ENTOMOL EXP APPL, V124, P167, DOI 10.1111/j.1570-7458.2007.00565.x; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.1111/j.1558-5646.1996.tb02350.x, 10.2307/2410650]; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Blumenthal DM, 2007, ECOLOGY, V88, P2758, DOI 10.1890/06-2115.1; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bowman G, 2008, PLANT ECOL, V197, P197, DOI 10.1007/s11258-007-9370-1; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; CHATER E. H., 1931, BULL ENT RES, V22, P225, DOI 10.1017/S0007485300035197; Davies WM, 1928, ANN APPL BIOL, V15, P263, DOI 10.1111/j.1744-7348.1928.tb07051.x; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Falconer D. S, 1996, INTRO QUANTITATIVE G; Futuyma D. J., 2005, EVOLUTION; Gilchrist GW, 2007, GENETICA, V129, P127, DOI 10.1007/s10709-006-9009-5; Herrera J, 1999, INT J PLANT SCI, V160, P887, DOI 10.1086/314183; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Hill RL, 2002, BIOL CONTROL, V25, P173, DOI 10.1016/S1049-9644(02)00057-9; HILL RL, 1991, NEW ZEAL J ZOOL, V18, P37, DOI 10.1080/03014223.1991.10757946; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Leimu R, 2002, OIKOS, V98, P229, DOI 10.1034/j.1600-0706.2002.980205.x; Levin DA, 2004, NEW PHYTOL, V161, P91, DOI 10.1046/j.1469-8137.2003.00921.x; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lowe S., 2000, ENCY BIOL INVASIONS; Lynch M., 1998, GENETICS ANAL QUANTI; Markin G.P., 1996, NEWSLETTER HAWAIIAN, V35, P45; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Metcalf CJE, 2009, EVOL ECOL, V23, P893, DOI 10.1007/s10682-008-9279-8; MILLENER L. H., 1962, NEW PHYTOL, V61, P119, DOI 10.1111/j.1469-8137.1962.tb06280.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Muller-Scharer H, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P137, DOI 10.1079/9780851997353.0137; Norghauer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018790; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Roff Derek, 2002, pi; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Tarayre M, 2007, EVOL ECOL, V21, P395, DOI 10.1007/s10682-006-9109-9; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Wolfe LM, 2004, ECOL LETT, V7, P813, DOI 10.1111/j.1461-0248.2004.00649.x; Zou JW, 2008, BIOL INVASIONS, V10, P291, DOI 10.1007/s10530-007-9130-0; [No title captured]; [No title captured]	65	35	35	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26275	10.1371/journal.pone.0026275	http://dx.doi.org/10.1371/journal.pone.0026275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022588	gold, Green Published			2022-12-25	WOS:000295981600046
J	Dzialak, MR; Olson, CV; Harju, SM; Webb, SL; Mudd, JP; Winstead, JB; Hayden-Wing, LD				Dzialak, Matthew R.; Olson, Chad V.; Harju, Seth M.; Webb, Stephen L.; Mudd, James P.; Winstead, Jeffrey B.; Hayden-Wing, L. D.			Identifying and Prioritizing Greater Sage-Grouse Nesting and Brood-Rearing Habitat for Conservation in Human-Modified Landscapes	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; FEMALE SPRUCE GROUSE; ENERGY DEVELOPMENT; CENTROCERCUS-UROPHASIANUS; SPATIAL-PATTERN; MONO COUNTY; PREDATION; SURVIVAL; MOVEMENTS; FIDELITY	Background: Balancing animal conservation and human use of the landscape is an ongoing scientific and practical challenge throughout the world. We investigated reproductive success in female greater sage-grouse (Centrocercus urophasianus) relative to seasonal patterns of resource selection, with the larger goal of developing a spatially-explicit framework for managing human activity and sage-grouse conservation at the landscape level. Methodology/Principal Findings: We integrated field-observation, Global Positioning Systems telemetry, and statistical modeling to quantify the spatial pattern of occurrence and risk during nesting and brood-rearing. We linked occurrence and risk models to provide spatially-explicit indices of habitat-performance relationships. As part of the analysis, we offer novel biological information on resource selection during egg-laying, incubation, and night. The spatial pattern of occurrence during all reproductive phases was driven largely by selection or avoidance of terrain features and vegetation, with little variation explained by anthropogenic features. Specifically, sage-grouse consistently avoided rough terrain, selected for moderate shrub cover at the patch level (within 90 m(2)), and selected for mesic habitat in mid and late brood-rearing phases. In contrast, risk of nest and brood failure was structured by proximity to anthropogenic features including natural gas wells and human-created mesic areas, as well as vegetation features such as shrub cover. Conclusions/Significance: Risk in this and perhaps other human-modified landscapes is a top-down (i.e., human-mediated) process that would most effectively be minimized by developing a better understanding of specific mechanisms (e.g., predator subsidization) driving observed patterns, and using habitat-performance indices such as those developed herein for spatially-explicit guidance of conservation intervention. Working under the hypothesis that industrial activity structures risk by enhancing predator abundance or effectiveness, we offer specific recommendations for maintaining high-performance habitat and reducing low-performance habitat, particularly relative to the nesting phase, by managing key high-risk anthropogenic features such as industrial infrastructure and water developments.	[Dzialak, Matthew R.; Olson, Chad V.; Harju, Seth M.; Webb, Stephen L.; Mudd, James P.; Winstead, Jeffrey B.; Hayden-Wing, L. D.] Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA		Dzialak, MR (corresponding author), Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA.	matt@haydenwing.com	Webb, Stephen L./B-6473-2009	Webb, Stephen L./0000-0001-6034-5164	ConocoPhillips Company; Encana Corporation; Noble Energy	ConocoPhillips Company; Encana Corporation; Noble Energy	This study was funded by ConocoPhillips Company, Encana Corporation and Noble Energy. Hayden-Wing Associates LLC provided in-kind contributions to support travel costs associated with dissemination of this work and the materials associated with data collection and analysis including: Radio-telemetry equipment, GPS devices and statistical analysis software. The authors are employed by Hayden-Wing Associates LLC and, therefore, played a role in the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Allison P. D., 1995, SURVIVAL ANAL USING; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; BERRY JD, 1985, J WILDLIFE MANAGE, V49, P237, DOI 10.2307/3801877; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Bui TVD, 2010, CONDOR, V112, P65, DOI 10.1525/cond.2010.090132; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Conway CJ, 2000, EVOLUTION, V54, P670; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; COX DR, 1972, J R STAT SOC B, V34, P187; Crunden C. W., 1963, Journal of Wildlife Management, V27, P846, DOI 10.2307/3798498; Darlington R. B., 1990, REGRESSION LINEAR MO; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; DRUT MS, 1994, GREAT BASIN NAT, V54, P170; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; DUNN PO, 1986, J WILDLIFE MANAGE, V50, P228, DOI 10.2307/3801903; Dzialak MR, 2011, LANDSCAPE ECOL, V26, P775, DOI 10.1007/s10980-011-9607-1; FISCHER RA, 1993, CONDOR, V95, P1038, DOI 10.2307/1369442; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gompper ME, 2008, ANIM CONSERV, V11, P13, DOI 10.1111/j.1469-1795.2008.00160.x; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; Hamilton L. C., 1992, REGRESSION GRAPHICS; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; HERZOG PW, 1978, J WILDLIFE MANAGE, V42, P632, DOI 10.2307/3800829; Hjermann DO, 2000, ECOLOGY, V81, P1462, DOI 10.1890/0012-9658(2000)081[1462:AHSIAW]2.0.CO;2; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; HOMER CG, 2010, PROVISIONAL REMOTE S; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jimenez JE, 2001, WILDLIFE SOC B, V29, P62; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSTON G, 2003, P 28 ANN SAS US GROU; Jones R. E., 1963, Journal of Wildlife Management, V27, P757, DOI 10.2307/3798492; KENNEDY B, 1989, CAN J ECON, V22, P383, DOI 10.2307/135675; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; KLEBENOW DA, 1969, J WILDLIFE MANAGE, V33, P649, DOI 10.2307/3799390; KLOTT JH, 1990, J WILDLIFE MANAGE, V54, P84, DOI 10.2307/3808905; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1341, DOI 10.2193/2008-339; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Kristan WB, 2003, ECOLOGY, V84, P2432, DOI 10.1890/02-0448; KUHFELD WF, 2000, TS621 SAS I; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Manzer DL, 2005, J WILDLIFE MANAGE, V69, P110, DOI 10.2193/0022-541X(2005)069&lt;0110:RGNSAC&gt;2.0.CO;2; MCCOURT KH, 1973, AUK, V90, P619, DOI 10.2307/4084160; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; McLoughlin PD, 2005, J ANIM ECOL, V74, P701, DOI 10.1111/j.1365-2656.2005.00967.x; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Moynahan BJ, 2007, J WILDLIFE MANAGE, V71, P1773, DOI 10.2193/2005-386; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; Patten MA, 2010, ECOL APPL, V20, P2148, DOI 10.1890/09-2370.1; Patterson R.L., 1952, SAGE GROUSE WYOMING; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Sargeant AB, 1998, INTERPRETING EVIDENC; SAS Institute, 2009, SAS STAT 9 2 US GUID; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; SCHLADWEILER P, 1968, J WILDLIFE MANAGE, V32, P426, DOI 10.2307/3798993; Schroeder M.A., 1999, Birds of North America, V425, P1; Schroeder MA, 2003, WILDLIFE BIOL, V9, P291, DOI 10.2981/wlb.2003.017; Schroeder MA, 2001, WILDLIFE SOC B, V29, P24; SMITH T, 2003, P 28 ANN SAS US GROU, P254; *STAT WY, 2008, STAT WYOM EX DEP EX; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; Thompson KM, 2006, WEST N AM NATURALIST, V66, P332, DOI 10.3398/1527-0904(2006)66[332:EBHUAP]2.0.CO;2; *US DEP INT, 2008, VERN FIELD OFF REC D; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; *VIS LEARN SYST IN, 2008, FEAT AN 4 2 ARCGIS; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; WALLESTAD RO, 1971, J WILDLIFE MANAGE, V35, P129, DOI 10.2307/3799881; Wegge P, 2007, WILDLIFE BIOL, V13, P87, DOI 10.2981/0909-6396(2007)13[87:GSTPNI]2.0.CO;2; *WY GAM FISH DEP, 2003, WYOM GREAT SAG GROUS; Zar J. H., 1996, BIOSTATISTICAL ANAL; 2010, FED REG, V75, P13910	90	54	55	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26273	10.1371/journal.pone.0026273	http://dx.doi.org/10.1371/journal.pone.0026273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022587	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600048
J	Plaisance, L; Caley, MJ; Brainard, RE; Knowlton, N				Plaisance, Laetitia; Caley, M. Julian; Brainard, Russell E.; Knowlton, Nancy			The Diversity of Coral Reefs: What Are We Missing?	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; BIODIVERSITY HOTSPOTS; MARINE BIODIVERSITY; SPECIES RICHNESS; EXTINCTION RISK; CLIMATE-CHANGE; CONSERVATION	Tropical reefs shelter one quarter to one third of all marine species but one third of the coral species that construct reefs are now at risk of extinction. Because traditional methods for assessing reef diversity are extremely time consuming, taxonomic expertise for many groups is lacking, and marine organisms are thought to be less vulnerable to extinction, most discussions of reef conservation focus on maintenance of ecosystem services rather than biodiversity loss. In this study involving the three major oceans with reef growth, we provide new biodiversity estimates based on quantitative sampling and DNA barcoding. We focus on crustaceans, which are the second most diverse group of marine metazoans. We show exceptionally high numbers of crustacean species associated with coral reefs relative to sampling effort (525 species from a combined, globally distributed sample area of 6.3 m(2)). The high prevalence of rare species (38% encountered only once), the low level of spatial overlap (81% found in only one locality) and the biogeographic patterns of diversity detected (Indo-West Pacific > Central Pacific > Caribbean) are consistent with results from traditional survey methods, making this approach a reliable and efficient method for assessing and monitoring biodiversity. The finding of such large numbers of species in a small total area suggests that coral reef diversity is seriously under-detected using traditional survey methods, and by implication, underestimated.	[Plaisance, Laetitia; Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Plaisance, Laetitia; Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Brainard, Russell E.] Natl Ocean & Atmospher Adm Fisheries, Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego; Scripps Institution of Oceanography; Australian Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA	Plaisance, L (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	plaisancel@si.edu	Caley, Julian/A-4042-2008	Caley, Julian/0000-0001-5739-749X	Alfred P. Sloan Foundation; Census of Marine Life; Census of Coral Reefs; BHP Billiton (Australia)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Census of Marine Life; Census of Coral Reefs; BHP Billiton (Australia)	This work was supported by the Alfred P. Sloan Foundation, Census of Marine Life, Census of Coral Reefs, and BHP Billiton (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; Bouchet Philippe, 2006, P31; Bouchet P, 2009, RAFFLES B ZOOL, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guilhaumon F, 2008, P NATL ACAD SCI USA, V105, P15458, DOI 10.1073/pnas.0803610105; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Idjadi JA, 2006, MAR ECOL PROG SER, V319, P117, DOI 10.3354/meps319117; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Plaisance L, 2009, CORAL REEFS, V28, P977, DOI 10.1007/s00338-009-0543-3; Reaka-Kudla Marjorie L., 1997, P83; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schloss PD, 2009, INTRO MOTHUR COMPUTA; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	30	129	134	17	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25026	10.1371/journal.pone.0025026	http://dx.doi.org/10.1371/journal.pone.0025026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022371	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600008
J	Buhling, F; Kouadio, M; Chwieralski, CE; Kern, U; Hohlfeld, JM; Klemm, N; Friedrichs, N; Roth, W; Deussing, JM; Peters, C; Reinheckel, T				Buehling, Frank; Kouadio, Martin; Chwieralski, Caroline E.; Kern, Ursula; Hohlfeld, Jens M.; Klemm, Nicole; Friedrichs, Nicole; Roth, Wera; Deussing, Jan M.; Peters, Christoph; Reinheckel, Thomas			Gene Targeting of the Cysteine Peptidase Cathepsin H Impairs Lung Surfactant in Mice	PLOS ONE			English	Article							PULMONARY SURFACTANT; MINI-CHAIN; PROTEIN-B; SUBSTRATE-SPECIFICITY; ENDOPEPTIDASE; CELLS; AMINOPEPTIDASE; DISEASE; DYSFUNCTION; DEFICIENT	Background: The 11 human cysteine cathepsins are proteases mainly located in the endolysosomal compartment of all cells and within the exocytosis pathways of some secretory cell types. Cathepsin H (Ctsh) has amino-and endopeptidase activities. In vitro studies have demonstrated Ctsh involvement in the processing and secretion of the pulmonary surfactant protein B (SP-B). Furthermore, Ctsh is highly expressed in the secretory organelles of alveolar type II pneumocytes where the surfactant proteins are processed. Methodology/Principal Findings: Hence, we generated Ctsh null mice by gene targeting in embryonic stem cells to investigate the role of this protease in surfactant processing in vivo. The targeting construct contains a beta-galactosidase (lacZ) reporter enabling the visualisation of Ctsh expression sites. Ctsh-deficiency was verified by northern blot, western blot, and measurement of the Ctsh aminopeptidase activity. Ctsh(-/-) mice show no gross phenotype and their development is normal without growth retardation. Broncho-alveolar lavage (BAL) from Ctsh(-/-) mice contained lower levels of SP-B indicating reduced SP-B secretion. The BAL phospholipid concentration was not different in Ctsh(+/+) and Ctsh(-/-) mice, but measurement of surface tension by pulsating bubble surfactometry revealed an impairment of the tension reducing function of lung surfactant of Ctsh(-/-) mice. Conclusions/Significance: We conclude that cathepsin H is involved in the SP-B production and reduced SP-B levels impair the physical properties of the lung surfactant. However, Ctsh defiency does not reproduce the severe phenotype of SP-B deficient mice. Hence, other proteases of the secretory pathway of type II pneumocytes, i.e. cathepsins C or E, are still able to produce surfactant of sufficient quality in absence of Ctsh.	[Buehling, Frank] Carl Thiem Klinikum, Inst Lab Med, Cottbus, Germany; [Kouadio, Martin; Kern, Ursula; Klemm, Nicole; Friedrichs, Nicole; Roth, Wera; Deussing, Jan M.; Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; [Chwieralski, Caroline E.] Otto Von Guericke Univ, Magdeburg, Germany; [Kern, Ursula] Univ Freiburg, Fac Biol, Freiburg, Germany; [Kern, Ursula] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med, Div Immunol Allergol & Airway Res, Hannover, Germany; [Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; Otto von Guericke University; University of Freiburg; University of Freiburg; Fraunhofer Gesellschaft; University of Freiburg	Buhling, F (corresponding author), Carl Thiem Klinikum, Inst Lab Med, Cottbus, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Deussing, Jan M/ABB-5993-2021; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Hohlfeld, Jens/0000-0003-2646-6186; Deussing, Jan/0000-0002-9329-5252	Deutsche Forschungsgemeinschaft (DFG) [RE 1584/3-1, BU 1152/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants RE 1584/3-1 and BU 1152/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2010, CELL PHYSIOL BIOCHEM, V25, P81, DOI 10.1159/000272053; BAUDYS M, 1991, BIOMED BIOCHIM ACTA, V50, P569; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Dodt J, 2003, BIOL CHEM, V384, P1327, DOI 10.1515/BC.2003.149; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; Gocheva V, 2010, BIOL CHEM, V391, P937, DOI 10.1515/BC.2010.080; Guncar G, 1998, STRUCTURE, V6, P51; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Hohlfeld JM, 1999, AM J RESP CRIT CARE, V159, P1803, DOI 10.1164/ajrccm.159.6.9806145; KIRSCHKE H, 1977, ACTA BIOL MED GER, V36, P185; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Lu JI, 2007, J BIOL CHEM, V282, P22176, DOI 10.1074/jbc.M700063200; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Vasiljeva O, 2003, BIOCHEMISTRY-US, V42, P13522, DOI 10.1021/bi035355k; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WASANO K, 1994, HISTOCHEMISTRY, V102, P329, DOI 10.1007/BF00268903; WEAVER TE, 1992, AM J PHYSIOL, V263, pL95, DOI 10.1152/ajplung.1992.263.1.L95	28	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26247	10.1371/journal.pone.0026247	http://dx.doi.org/10.1371/journal.pone.0026247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022579	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000092
J	Chen, WS; Li, ZY; Hu, JY; Zhang, ZH; Chen, LL; Chen, YX; Liu, ZG				Chen, Wensheng; Li, Zhiyuan; Hu, Jiaoyue; Zhang, Zhenhao; Chen, Lelei; Chen, Yongxiong; Liu, Zuguo			Corneal Alternations Induced by Topical Application of Benzalkonium Chloride in Rabbit	PLOS ONE			English	Article							LIMBAL BASAL EPITHELIUM; BARRIER FUNCTION; TIGHT JUNCTIONS; LANGERHANS CELLS; OCULAR SURFACE; CUTTING EDGE; IN-VIVO; DRY EYE; ENDOTHELIUM; GATIFLOXACIN	Benzalkonium chloride (BAC) is the most common preservative in ophthalmic preparations. Here, we investigated the corneal alternations in rabbits following exposure to BAC. Twenty-four adult male New Zealand albino rabbits were randomly divided into three groups. BAC at 0.01%, 0.05%, or 0.1% was applied twice daily to one eye each of rabbits for 4 days. The contralateral untreated eyes were used as control. Aqueous tear production and fluorescein staining scores of BAC-treated eyes were compared with those of controls. The structure of the central cornea was examined by in vivo confocal microscopy. Expression of mucin-5 subtype AC (MUC5AC) in conjunctiva was detected by immunostainig on cryosections. Corneal barrier function was assessed in terms of permeability to carboxy fluorescein (CF). The distribution and expression of ZO-1, a known marker of tight junction, and reorganization of the perijunctional actomyosin ring (PAMR) were examined by immunofluorescence analysis. Although there were no significant differences between control and BAC-treated eyes in Schirmer scores, corneal fluorescein scores and the number of conjunctival MUC5AC staining cells, in vivo confocal microscopy revealed significant epithelial and stromal defects in all BAC-treated corneas. Moreover, BAC at 0.1% resulted in significant increases in central corneal thickness and endothelial CF permeability, compared with those in control eyes, and endothelial cell damage with dislocation of ZO-1 and disruption of PAMR. Topical application of BAC can quickly impair the whole cornea without occurrence of dry eye. A high concentration of BAC breaks down the barrier integrity of corneal endothelium, concomitant with the disruption of PAMR and remodeling of apical junctional complex in vivo.	[Chen, Wensheng] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, WS (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	cwensheng@hotmail.com; zuguoliu@xmu.edu.cn	li, zhiyuan/HGD-9581-2022		National Basic Research Program of China (Project 973) [2011CB504606]; National Natural Science Foundation of China, Beijing, China [30973249, 81100638]; Natural Science Foundation of Fujian Province, China [2009J01201]; Technological innovation platform program of Fujian Province, China [2009J1013]	National Basic Research Program of China (Project 973)(National Basic Research Program of China); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Technological innovation platform program of Fujian Province, China	This work was supported by the National Basic Research Program of China (Project 973) Grant 2011CB504606; National Natural Science Foundation of China, Beijing, China (grant no: 30973249; 81100638); and Natural Science Foundation of Fujian Province, China (grant no: 2009J01201); Technological innovation platform program of Fujian Province, China (grant no: 2009J1013). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Chen WS, 2007, CORNEA, V26, P1101, DOI 10.1097/ICO.0b013e318123771e; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; Chen WS, 2010, CORNEA, V29, P73, DOI 10.1097/ICO.0b013e3181ac9f92; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P565, DOI 10.1167/iovs.07-0419; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; Labbe A, 2006, J OCUL PHARMACOL TH, V22, P267, DOI 10.1089/jop.2006.22.267; Lemp Michael A., 1995, CLAO Journal, V21, P221; Liang H, 2008, BRIT J OPHTHALMOL, V92, P1275, DOI 10.1136/bjo.2008.138768; Lin H, 2010, INVEST OPHTH VIS SCI, V51, P122, DOI 10.1167/iovs.09-3629; Mandell KJ, 2006, INVEST OPHTH VIS SCI, V47, P2408, DOI 10.1167/iovs.05-0745; Nakamura T, 2010, BIOL PHARM BULL, V33, P107, DOI 10.1248/bpb.33.107; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579; Ramachandran C, 2010, INVEST OPHTH VIS SCI, V51, P2139, DOI 10.1167/iovs.09-4421; Rathore MS, 2006, AAPS PHARMSCITECH, V7; Riley MV, 1998, INVEST OPHTH VIS SCI, V39, P2076; Romanowski EG, 2008, J OCUL PHARMACOL TH, V24, P380, DOI 10.1089/jop.2008.0017; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; SRINIVAS SP, 2010, OPTOMETRY VISION SCI, V84, pE239; Swan K. C., 1944, AM J OPHTHALMOL, V27, P1118; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093	34	43	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26103	10.1371/journal.pone.0026103	http://dx.doi.org/10.1371/journal.pone.0026103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022526	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000068
J	Rahn, E; Petermann, P; Hsu, MJ; Rixon, FJ; Knebel-Morsdorf, D				Rahn, Elena; Petermann, Philipp; Hsu, Mei-Ju; Rixon, Frazer J.; Knebel-Morsdorf, Dagmar			Entry Pathways of Herpes Simplex Virus Type 1 into Human Keratinocytes Are Dynamin- and Cholesterol-Dependent	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; COATED VESICLE FORMATION; LIPID RAFTS; MEDIATED ENDOCYTOSIS; LOW-PH; INHIBITION; ENDOSOMES; RECEPTOR; PROTEIN; ACTIN	Herpes simplex virus type 1 (HSV-1) can enter cells via endocytic pathways or direct fusion at the plasma membrane depending on the cell line and receptor(s). Most studies into virus entry have used cultured fibroblasts but since keratinocytes represent the primary entry site for HSV-1 infection in its human host, we initiated studies to characterize the entry pathway of HSV-1 into human keratinocytes. Electron microscopy studies visualized free capsids in the cytoplasm and enveloped virus particles in vesicles suggesting viral uptake both by direct fusion at the plasma membrane and by endocytic vesicles. The ratio of the two entry modes differed in primary human keratinocytes and in the keratinocyte cell line HaCaT. Inhibitor studies further support a role for endocytosis during HSV-1 entry. Infection was inhibited by the cholesterol-sequestering drug methyl-beta-cyclodextrin, which demonstrates the requirement for host cholesterol during virus entry. Since the dynamin-specific inhibitor dynasore and overexpression of a dominant-negative dynamin mutant blocked infection, we conclude that the entry pathways into keratinocytes are dynamin-mediated. Electron microscopy studies confirmed that virus uptake is completely blocked when the GTPase activity of dynamin is inhibited. Ex vivo infection of murine epidermis that was treated with dynasore further supports the essential role of dynamin during entry into the epithelium. Thus, we conclude that HSV-1 can enter human keratinocytes by alternative entry pathways that require dynamin and host cholesterol.	[Rahn, Elena; Petermann, Philipp; Hsu, Mei-Ju; Knebel-Morsdorf, Dagmar] Univ Cologne, Ctr Biochem, Cologne, Germany; [Knebel-Morsdorf, Dagmar] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany; [Rixon, Frazer J.] MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [Hsu, Mei-Ju] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan	University of Cologne; University of Cologne; University of Glasgow; National Yang Ming Chiao Tung University	Rahn, E (corresponding author), Univ Cologne, Ctr Biochem, Cologne, Germany.	dagmar.moersdorf@uni-koeln.de			Deutsche Forschungsgemeinschaft [KN536/16-1]; Faculty of Medicine, University of Cologne; Boehringer Ingelheim Fonds; National Science Council (Taiwan); Deutscher Akademischer Austausch Dienst (Germany); Sandwich scholarship; UK Medical Research Council; Medical Research Council [MC_U130115834] Funding Source: researchfish; MRC [MC_U130115834] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, University of Cologne; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Deutscher Akademischer Austausch Dienst (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Sandwich scholarship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by grant KN536/16-1 from the Deutsche Forschungsgemeinschaft, the Koln Fortune Program/Faculty of Medicine, University of Cologne, and the Boehringer Ingelheim Fonds. MJH is supported by the National Science Council (Taiwan) and the Deutscher Akademischer Austausch Dienst (Germany) by a Sandwich scholarship. FR is funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Christian AE, 1997, J LIPID RES, V38, P2264; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; Fretz M, 2006, J CONTROL RELEASE, V116, P247, DOI 10.1016/j.jconrel.2006.07.009; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Gianni T, 2010, P NATL ACAD SCI USA, V107, P22260, DOI 10.1073/pnas.1014923108; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Harris C, 1999, INT J MOL MED, V3, P315; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Huber MT, 2001, J VIROL, V75, P10309, DOI 10.1128/JVI.75.21.10309-10318.2001; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jaiswal JK, 2009, CELL, V137, P1308, DOI 10.1016/j.cell.2009.04.064; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lee DA, 1998, BIOPHYS J, V74, P2747, DOI 10.1016/S0006-3495(98)77983-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McCLelland DA, 2002, J VIROL, V76, P7407, DOI 10.1128/JVI.76.15.7407-7417.2002; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Ren XF, 2011, CURR MICROBIOL, V62, P261, DOI 10.1007/s00284-010-9700-8; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Schelhaas M, 2003, J GEN VIROL, V84, P2473, DOI 10.1099/vir.0.19226-0; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Torgersen ML, 2001, J CELL SCI, V114, P3737; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	50	59	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25464	10.1371/journal.pone.0025464	http://dx.doi.org/10.1371/journal.pone.0025464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022400	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000295976000018
J	Sharma, D; Smits, BMG; Eichelberg, MR; Meilahn, AL; Muelbl, MJ; Haag, JD; Gould, MN				Sharma, Deepak; Smits, Bart M. G.; Eichelberg, Mark R.; Meilahn, Amanda L.; Muelbl, Matthew J.; Haag, Jill D.; Gould, Michael N.			Quantification of Epithelial Cell Differentiation in Mammary Glands and Carcinomas from DMBA- and MNU-Exposed Rats	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SEXUALLY IMMATURE RATS; NITROSO-N-METHYLUREA; STEM-CELLS; BREAST-CANCER; SIGNAL-TRANSDUCTION; IN-VIVO; CARCINOGENESIS; TUMORIGENESIS; 1-METHYL-1-NITROSOUREA	Rat mammary carcinogenesis models have been used extensively to study breast cancer initiation, progression, prevention, and intervention. Nevertheless, quantitative molecular data on epithelial cell differentiation in mammary glands of untreated and carcinogen-exposed rats is limited. Here, we describe the characterization of rat mammary epithelial cells (RMECs) by multicolor flow cytometry using antibodies against cell surface proteins CD24, CD29, CD31, CD45, CD49f, CD61, Peanut Lectin, and Thy-1, intracellular proteins CK14, CK19, and FAK, along with phalloidin and Hoechst staining. We identified the luminal and basal/myoepithelial populations and actively dividing RMECs. In inbred rats susceptible to mammary carcinoma development, we quantified the changes in differentiation of the RMEC populations at 1, 2, and 4 weeks after exposure to mammary carcinogens DMBA and MNU. DMBA exposure did not alter the percentage of basal or luminal cells, but upregulated CD49f (Integrin alpha 6) expression and increased cell cycle activity. MNU exposure resulted in a temporary disruption of the luminal/basal ratio and no CD49f upregulation. When comparing DMBA-or MNU-induced mammary carcinomas, the RMEC differentiation profiles are indistinguishable. The carcinomas compared with mammary glands from untreated rats, showed upregulation of CD29 (Integrin beta 1) and CD49f expression, increased FAK (focal adhesion kinase) activation especially in the CD29hi population, and decreased CD61 (Integrin beta 3) expression. This study provides quantitative insight into the protein expression phenotypes underlying RMEC differentiation. The results highlight distinct RMEC differentiation etiologies of DMBA and MNU exposure, while the resulting carcinomas have similar RMEC differentiation profiles. The methodology and data will enhance rat mammary carcinogenesis models in the study of the role of epithelial cell differentiation in breast cancer.	[Sharma, Deepak; Smits, Bart M. G.; Eichelberg, Mark R.; Meilahn, Amanda L.; Muelbl, Matthew J.; Haag, Jill D.; Gould, Michael N.] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sharma, D (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	bsmits@wisc.edu	Gould, Michael N/C-7414-2014	Sharma, Deepak/0000-0002-7529-5574	National Institutes of Health [CA123272, CA077494]; National Institute of Environmental Health Sciences [ES019466]; NATIONAL CANCER INSTITUTE [R01CA123272, R01CA077494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants [CA123272] and [CA077494], and National Institute of Environmental Health Sciences grant [ES019466]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi JL, 2005, MOL CARCINOGEN, V43, P155, DOI 10.1002/mc.20104; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; CLIFTON KH, 1986, CANCER RES, V46, P2390; DUNDAS SR, 1991, J CELL SCI, V100, P459; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; GUGLIOTTA P, 1988, J HISTOCHEM CYTOCHEM, V36, P659, DOI 10.1177/36.6.3367051; GULLINO PM, 1975, J NATL CANCER I, V54, P401; HUGGINS C, 1961, NATURE, V189, P204, DOI 10.1038/189204a0; KIM ND, 1993, EXP CELL RES, V207, P74, DOI 10.1006/excr.1993.1165; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; MILLER JA, 1970, CANCER RES, V30, P559; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Papaconstantinou AD, 2006, INT J CANCER, V118, P17, DOI 10.1002/ijc.21247; RUDLAND PS, 1982, J NATL CANCER I, V68, P799; RUDLAND PS, 1991, J HISTOCHEM CYTOCHEM, V39, P1257, DOI 10.1177/39.9.1918944; RUDLAND PS, 1988, J CELL SCI, P95; RUSSO IH, 1978, J NATL CANCER I, V61, P1439; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; RUSSO J, 1990, LAB INVEST, V62, P244; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shan L, 2005, CARCINOGENESIS, V26, P503, DOI 10.1093/carcin/bgh330; Singh M, 2000, LAB INVEST, V80, P221, DOI 10.1038/labinvest.3780025; Smits BMG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2933; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; THOMPSON HJ, 1995, CARCINOGENESIS, V16, P2407, DOI 10.1093/carcin/16.10.2407; Thompson HJ, 1998, CARCINOGENESIS, V19, P383, DOI 10.1093/carcin/19.3.383; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	36	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26145	10.1371/journal.pone.0026145	http://dx.doi.org/10.1371/journal.pone.0026145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022542	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000075
J	Oztokatli, H; Hornberg, M; Berghard, A; Bohm, S				Oztokatli, Hande; Hornberg, Maria; Berghard, Anna; Bohm, Staffan			Retinoic acid receptor and CNGA2 channel signaling are part of a regulatory feedback loop controlling axonal convergence and survival of olfactory sensory neurons	FASEB JOURNAL			English	Article						retinoids; neuronal activity; caspase-3; Kirrel-2; Neuropilin-1	VOMERONASAL NEURONS; ODORANT RECEPTORS; ADULT MICE; SYSTEM; BULB; EXPRESSION; MAP; PROJECTIONS; MOUSE; DIFFERENTIATION	Little is known about the identities and functions of extracellular signaling molecules that work in concert with neuronal activity to regulate refinement and maintenance of the mouse olfactory sensory map. We show that expression of a dominant negative retinoic acid receptor (RAR) in olfactory sensory neurons (OSNs) increased the number of glomeruli that incorrectly contained OSN axons expressing different odorant receptors. This phenotype became apparent postnatally, coincided with increased cell death, and was preceded by increased Neuropilin-1 and reduced Kirrel-2 expressions. Kirrel-2-mediated cell adhesion influences odorant receptor-specific axonal convergence and is regulated by odorant receptor signaling via the olfactory cyclic nucleotide-gated (CNG) ion channel. Accordingly, we found that inhibited RAR function correlated with reduced CNG channel expression. Naris occlusion experiments and analysis of CNG channel-deficient mice further indicated that RAR-regulated CNG channel levels influenced the intrinsic neuronal activity required for cell survival in the absence of odor stimulation. Finally, we showed that CNG channel activity regulated expression of the retinoic acid-degrading enzyme Cyp26B1. Combined, these results identify a novel homeostatic feedback mechanism involving retinoic acid metabolism and CNG channel activity, which influences glomerular homogeneity and maintenance of precisely connected OSNs.-Oztokatli, H., Hornberg, M., Berghard, A., Bohm, S. Retinoic acid receptor and CNGA2 channel signaling are part of a regulatory feedback loop controlling axonal convergence and survival of olfactory sensory neurons. FASEB J. 26, 617-627 (2012). www.fasebj.org	[Oztokatli, Hande; Hornberg, Maria; Berghard, Anna; Bohm, Staffan] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Umea University	Bohm, S (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	staffan.bohm@molbiol.umu.se			Swedish Medical Science Research Council [K2008-63X-20726-01-3]; Swedish Research Council FORMAS [221-2006-419]	Swedish Medical Science Research Council; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	The authors thank Dr. Viktoria Vedin for expert advice on immunohistochemistry; Dr. Jorg Strotmann (University of Hohenheim, Stuttgart, Germany) for allowing the authors to use MOL2.3-IRES-GFP-IRES-tauLacZ mice and for the gift of the anti-MOR256-17 antibody; and Dr. Peter Mombaerts (Max-Planck-Institut fur Biophysik, Frankfurt, Germany) for the P2-IRES-tauLacZ, OMP-tauLacZ, and OCNC1 mutant strains. This work was supported by the Swedish Medical Science Research Council (K2008-63X-20726-01-3) and Swedish Research Council FORMAS (221-2006-419 to A.B.).	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Baker H, 1999, J NEUROSCI, V19, P9313; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Berghard A, 1996, J NEUROSCI, V16, P909; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Di Schiavi E, 2005, EUR J NEUROSCI, V21, P3291, DOI 10.1111/j.1460-9568.2005.04164.x; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hagglund M, 2006, J NEUROSCI, V26, P3281, DOI 10.1523/JNEUROSCI.4955-05.2006; Henion TR, 2011, J NEUROSCI, V31, P6576, DOI 10.1523/JNEUROSCI.0224-11.2011; Hornberg M, 2009, J NEUROCHEM, V110, P1263, DOI 10.1111/j.1471-4159.2009.06216.x; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kerr MA, 2006, NAT NEUROSCI, V9, P484, DOI 10.1038/nn1673; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maritan M, 2009, P NATL ACAD SCI USA, V106, P3537, DOI 10.1073/pnas.0813224106; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Pun RYK, 2003, BIOPHYS J, V84, P3425, DOI 10.1016/S0006-3495(03)70064-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666	47	16	17	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					617	627		10.1096/fj.11-192450	http://dx.doi.org/10.1096/fj.11-192450			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22009938	Green Published			2022-12-25	WOS:000300485700015
J	Ishihara, T; Inoue, J; Kozaki, K; Imoto, I; Inazawa, J				Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji			HECT-type Ubiquitin Ligase ITCH Targets Lysosomal-associated Protein Multispanning Transmembrane 5 (LAPTM5) and Prevents LAPTM5-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; DEGRADATION; NEUROBLASTOMA; CANCER	LAPTM5 (lysosomal-associated protein multispanning transmembrane 5) is a membrane protein on the intracellular vesicles. We have previously demonstrated that the accumulation of LAPTM5-positive vesicles was closely associated with the programmed cell death occurring during the spontaneous regression of neuroblastomas. Although the accumulation of LAPTM5 protein might occur at the post-translational level, the molecular mechanism has been unclear. Here, we found that the level of LAPTM5 protein is regulated negatively by the degradation through ubiquitination by ITCH, an E3 ubiquitin ligase. ITCH directly binds to the PPxY motif of LAPTM5 via its WW domains and promotes ubiquitination through a HECT-type ligase domain. Overexpression of ITCH led to the degradation of LAPTM5 protein, and conversely, knockdown of ITCH by siRNA resulted in the stabilization of LAPTM5 protein. In addition, the inhibition of ITCH enhanced the cell death occurred by accumulation of LAPTM5 in neuroblastoma cells. These findings suggest that LAPTM5 is a novel substrate in terms of degradation by the ubiquitin ligase ITCH, and this system might act as a negative regulator in the spontaneous regression of neuroblastomas by preventing LAPTM5-mediated cell death.	[Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Bunkyo Ku, Tokyo 1138510, Japan; [Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Genome Med, Hard Tissue Genome Res Ctr, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp	imoto, Issei/D-8065-2012; Imoto, Issei/AAD-5799-2020; Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X	Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation; New Energy and Industrial Technology Development Organization; Foundation for Promotion of Cancer Research (Japan); Grants-in-Aid for Scientific Research [23390077] Funding Source: KAKEN	Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Foundation for Promotion of Cancer Research (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by a grant-in-aid for Scientific Research on Priority Areas and Innovative Areas, Young Scientists (B), Scientific Research (A) and (C), and a Global Center of Excellence Program from the Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, and New Energy and Industrial Technology Development Organization.; Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-year Strategy for Cancer Control, 5-1-1 Tsukiji Chuou-ku, Tokyo 104-0045, Japan.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; David R, 2011, NAT REV MOL CELL BIO, V12, P135, DOI 10.1038/nrm3063; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Ishihara T, 2008, CANCER SCI, V99, P1940, DOI 10.1111/j.1349-7006.2008.00900.x; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	24	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44086	44094		10.1074/jbc.M111.251694	http://dx.doi.org/10.1074/jbc.M111.251694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22009753	Green Published, hybrid			2022-12-25	WOS:000298402300049
J	Noda, C; Murata, T; Kanda, T; Yoshiyama, H; Sugimoto, A; Kawashima, D; Saito, S; Isomura, H; Tsurumi, T				Noda, Chieko; Murata, Takayuki; Kanda, Teru; Yoshiyama, Hironori; Sugimoto, Atsuko; Kawashima, Daisuke; Saito, Shinichi; Isomura, Hiroki; Tsurumi, Tatsuya			Identification and Characterization of CCAAT Enhancer-binding Protein (C/EBP) as a Transcriptional Activator for Epstein-Barr Virus Oncogene Latent Membrane Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPITHELIAL-CELLS; GENE-EXPRESSION; J-KAPPA; REGULATES EXPRESSION; BZLF1 PROTEIN; B-CELLS; PROMOTER; LMP1; MEMBRANE-PROTEIN-1; LYMPHOMA	Epstein-Barr virus LMP1, a major oncoprotein expressed in latent infection, is critical for primary B cell transformation, functioning as a TNFR family member by aggregation in the plasma membrane resulting in constitutive activation of cellular signals, such as NF-kappa B, MAPK, JAK/STAT, and AKT. Although transcription of LMP1 in latent type III cells is generally under the control of the viral coactivator EBNA2, little is known about EBNA2-independent LMP1 expression in type II latency. We thus screened a cDNA library for factors that can activate the LMP1 promoter in an EBNA2-independent manner, using a reporter assay system. So far, we have screened >20,000 clones, and here identified C/EBP epsilon as a new transcriptional activator. Exogenous expression of C/EBP alpha, -beta, or -epsilon efficiently augmented LMP1 mRNA and protein levels in EBV-positive cell lines, whereas other members of the C/EBP family exhibited modest or little activity. It has been demonstrated that LMP1 gene transcription depends on two promoter regions: proximal (ED-L1) and distal (TR-L1). Interestingly, although we first used the proximal promoter for screening, we found that C/EBP increased transcription from both promoters in latent EBV-positive cells. Mutagenesis in reporter assays and EMSA identified only one functional C/EBP binding site, through which activation of both proximal and distal promoters is mediated. Introduction of point mutations into the identified C/EBP site in EBV-BAC caused reduced LMP1 transcription from both LMP1 promoters in epithelial cells. In conclusion, C/EBP is a newly identified transcriptional activator of the LMP1 gene, independent of the EBNA2 coactivator.	[Noda, Chieko; Murata, Takayuki; Kanda, Teru; Sugimoto, Atsuko; Kawashima, Daisuke; Saito, Shinichi; Isomura, Hiroki; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Noda, Chieko; Tsurumi, Tatsuya] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Nagoya, Aichi 4678603, Japan; [Yoshiyama, Hironori] Hokkaido Univ, Inst Med Genet, Res Ctr Infection Associated Canc, Kita Ku, Sapporo, Hokkaido 0600815, Japan	Aichi Cancer Center; Nagoya City University; Hokkaido University	Tsurumi, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013; Yoshiyama, Hironori/H-5674-2019; Yoshiyama, Hironori/D-7902-2012	Murata, Takayuki/0000-0001-7228-0839; Yoshiyama, Hironori/0000-0001-7588-278X; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology [20390137, 21022055]; Ministry of Health, Labor and Welfare; Uehara Memorial Research Fund; Yasuda Medical Foundation; Institute for Genetic Medicine, Hokkaido University	Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Research Fund(Uehara Memorial Foundation); Yasuda Medical Foundation; Institute for Genetic Medicine, Hokkaido University	This work was supported by from the Ministry of Education, Science, Sports, Culture and Technology Scientific Research Grants-in-aid 20390137 and 21022055 (to T. T.), the Ministry of Health, Labor and Welfare (to T. T.), the Uehara Memorial Research Fund (to T. T.), the Yasuda Medical Foundation (to T. M.), and the Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University.	Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Harada S, 1997, J VIROL, V71, P6611, DOI 10.1128/JVI.71.9.6611-6618.1997; Hsiao JR, 2009, CANCER RES, V69, P4461, DOI 10.1158/0008-5472.CAN-09-0277; JOHANNSEN E, 1995, J VIROL, V69, P253, DOI 10.1128/JVI.69.1.253-262.1995; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.13.7004-7015.2004; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kis LL, 2006, IMMUNOL LETT, V104, P83, DOI 10.1016/j.imlet.2005.11.003; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; Konforte D, 2008, VIROLOGY, V374, P100, DOI 10.1016/j.virol.2007.12.027; Kordula T, 1996, BIOCHEM J, V313, P1019, DOI 10.1042/bj3131019; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; LAUX G, 1994, EMBO J, V13, P5624, DOI 10.1002/j.1460-2075.1994.tb06900.x; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Murata T, 2011, J BIOL CHEM, V286, P22007, DOI 10.1074/jbc.M110.199836; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Osada S, 1996, J BIOL CHEM, V271, P3891; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Robb BW, 2002, SURGERY, V132, P226, DOI 10.1067/msy.2002.125354; SADLER RH, 1995, J VIROL, V69, P4577, DOI 10.1128/JVI.69.7.4577-4581.1995; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Sjoblom A, 1998, J VIROL, V72, P1365; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Sugiyama T, 2001, FEBS LETT, V508, P16, DOI 10.1016/S0014-5793(01)03010-1; Tsai CN, 1999, VIROLOGY, V261, P288, DOI 10.1006/viro.1999.9851; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Yoshiyama H, 1997, J VIROL, V71, P5688, DOI 10.1128/JVI.71.7.5688-5691.1997	40	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42524	42533		10.1074/jbc.M111.271734	http://dx.doi.org/10.1074/jbc.M111.271734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013073	Green Published, hybrid			2022-12-25	WOS:000298180900060
J	Nieto, PS; Valdez, DJ; Acosta-Rodriguez, VA; Guido, ME				Nieto, Paula S.; Valdez, Diego J.; Acosta-Rodriguez, Victoria A.; Guido, Mario E.			Expression of Novel Opsins and Intrinsic Light Responses in the Mammalian Retinal Ganglion Cell Line RGC-5. Presence of OPN5 in the Rat Retina	PLOS ONE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; COUPLED RECEPTOR OPSIN; EARLY GENE-EXPRESSION; C-FOS-GENE; G-PROTEIN; PIGMENT-EPITHELIUM; CIRCADIAN REGULATION; PHOTOTRANSDUCTION CASCADE; AMPHIBIAN MELANOPHORES; SIGNALING PATHWAY	The vertebrate retina is known to contain three classes of photoreceptor cells: cones and rods responsible for vision, and intrinsically photoresponsive retinal ganglion cells (RGCs) involved in diverse non-visual functions such as photic entrainment of daily rhythms and pupillary light responses. In this paper we investigated the potential intrinsic photoresponsiveness of the rat RGC line, RGC-5, by testing for the presence of visual and non-visual opsins and assessing expression of the immediate-early gene protein c-Fos and changes in intracellular Ca2+ mobilization in response to brief light pulses. Cultured RGC-5 cells express a number of photopigment mRNAs such as retinal G protein coupled receptor (RGR), encephalopsin/panopsin (Opn3), neuropsin (Opn5) and cone opsin (Opn1mw) but not melanopsin (Opn4) or rhodopsin. Opn5 immunoreactivity was observed in RGC-5 cells and in the inner retina of rat, mainly localized in the ganglion cell layer (GCL). Furthermore, white light pulses of different intensities and durations elicited changes both in intracellular Ca2+ levels and in the induction of c-Fos protein in RGC-5 cell cultures. The results demonstrate that RGC-5 cells expressing diverse putative functional photopigments display intrinsic photosensitivity which accounts for the photic induction of c-Fos protein and changes in intracellular Ca2+ mobilization. The presence of Opn5 in the GCL of the rat retina suggests the existence of a novel type of photoreceptor cell.	[Nieto, Paula S.; Valdez, Diego J.; Acosta-Rodriguez, Victoria A.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Nieto, PS (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina.	mguido@fcq.unc.edu.ar		Acosta-Rodriguez, Victoria/0000-0002-4818-0667; Valdez, Diego Javier/0000-0002-4467-6761	Agencia Nacional de Promocion Cientifica y Tecnica [967, 898]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC); Fundacion Florencio Fiorini; Ministry of Sciences and Technology of Cordoba	Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Fundacion Florencio Fiorini; Ministry of Sciences and Technology of Cordoba	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT, PICT 2004 No 967 and PICT 2006 No 898), Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET), Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC), Fundacion Florencio Fiorini and Ministry of Sciences and Technology of Cordoba. MEG is a fellow of the John Simon Guggenheim Memorial Foundation, 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, MOL VIS, V13, P1311; AGRAWAL DK, CURR ALLERGY ASTHMA, V10, P39; Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Arendt D, 2003, INT J DEV BIOL, V47, P563; Bailey MJ, 2004, INVEST OPHTH VIS SCI, V45, P769, DOI 10.1167/iovs.03-1125; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Blackshaw S, 1999, J NEUROSCI, V19, P3681; BUSCHER M, 1988, ONCOGENE, V3, P301; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen P, 2001, J BIOL CHEM, V276, P21098, DOI 10.1074/jbc.M010441200; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; Contin MA, 2010, INVEST OPHTH VIS SCI, V51, P5491, DOI 10.1167/iovs.10-5643; DAVIES WL, 2010, EXP EYE RES; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; FOSTER RG, 2003, NOVART FDN SYMP, V253, P102; FOSTER RG, 2003, NOVART FDN SYMP, V253, P23; Foster RG, 2007, CURR BIOL, V17, pR746, DOI 10.1016/j.cub.2007.07.007; Foster Russell G., 2003, Novartis Foundation Symposium, V253, P3; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guido ME, 2010, PROG NEUROBIOL, V92, P484, DOI 10.1016/j.pneurobio.2010.08.005; Guido ME, 1999, NEUROSCIENCE, V90, P555, DOI 10.1016/S0306-4522(98)00467-9; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Halford S, 2001, CYTOGENET CELL GENET, V95, P234, DOI 10.1159/000059351; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hazlerigg DG, 2006, TRENDS ENDOCRIN MET, V17, P83, DOI 10.1016/j.tem.2006.02.004; IMAKI J, 1995, MOL BRAIN RES, V30, P48, DOI 10.1016/0169-328X(94)00270-O; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; KACZMAREK L, 2002, IMMEDIATE EARLY GENE; Kasper G, 2002, GENE, V295, P27, DOI 10.1016/S0378-1119(02)00799-0; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Li ZZ, 1999, PHOTOCHEM PHOTOBIOL, V69, P500, DOI 10.1562/0031-8655(1999)069<0500:DORTPF>2.3.CO;2; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Moorhouse AJ, 2004, BRAIN RES, V1003, P205, DOI 10.1016/j.brainres.2004.01.027; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; Nieto PS, 2010, NEUROCHEM INT, V57, P216, DOI 10.1016/j.neuint.2010.05.013; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; ROLLAG MD, 1996, J EXPT ZOOLOGY, P20; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; RUSAK B, 2002, IMMEDIATE EARLY GENE; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Semo M, 2007, EUR J NEUROSCI, V25, P2296, DOI 10.1111/j.1460-9568.2007.05461.x; Sernagor E, 2005, CURR BIOL, V15, pR556, DOI 10.1016/j.cub.2005.07.004; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC; Tosini G, 2000, P NATL ACAD SCI USA, V97, P11540, DOI 10.1073/pnas.210248297; Uchida K, 1999, MOL VIS, V5, pU1; Valdez DJ, 2009, FASEB J, V23, P1186, DOI 10.1096/fj.08-117085; VICENTE NBD, 2007, J PHISICS, V90; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Wood JPM, 2008, MOL VIS, V14, P334; WOOD JP, 2010, INVEST OPHTHALMOL VI; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T	93	26	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26417	10.1371/journal.pone.0026417	http://dx.doi.org/10.1371/journal.pone.0026417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022612	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400056
J	Ringler, M; Ringler, E; Mendoza, DM; Hodl, W				Ringler, Max; Ringler, Eva; Mendoza, Daniela Magana; Hoedl, Walter			Intrusion Experiments to Measure Territory Size: Development of the Method, Tests through Simulations, and Application in the Frog Allobates femoralis	PLOS ONE			English	Article							DART-POISON FROG; EPIPEDOBATES-FEMORALIS; HOME; BEHAVIOR; SHAPE; COMPETITION; PATTERN; KERNEL; MODELS	Territoriality is a widespread behaviour in animals and its analysis is crucial in several areas of behavioural, ecological and evolutionary research. Commonly, territory size is assessed through territory mapping and the application of simple area estimators such as minimum convex polygons. In the present study we demonstrate that territory size can be determined adequately with an active approach through intrusion experiments, a technique that is commonly used in behavioural research in other contexts. Tests with simulated data indicate that a minimum of twelve trials needs to be performed to establish reliable orders of relative territory size. To estimate absolute territory size, detailed hull techniques are most appropriate when analyzing point patterns of intrusion experiments, while the local convex hull estimator enables the construction of internal utilization distributions based on such point patterns. Additionally we suggest a 'stretch the centre' approach to emphasize the actual process of intrusion experiments in the construction of internal utilization distributions. To demonstrate the utility of the method, we apply all findings from the simulations to data from fieldwork with the model species Allobates femoralis, a territorial aromobatid frog from the lowland rainforest of French Guiana.	[Ringler, Max; Ringler, Eva; Mendoza, Daniela Magana; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria	University of Vienna	Ringler, M (corresponding author), Univ Vienna, Dept Evolutionary Biol, Vienna, Austria.	max.ringler@univie.ac.at	, Eva/F-9064-2014; Ringler, Max/J-4821-2012	, Eva/0000-0003-3273-6568; Ringler, Max/0000-0002-4530-4919	French Centre National de la Recherche Scientifique (CNRS); Austrian Science Fund (FWF) [18811]; University of Vienna; Austrian Academy of Sciences	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Vienna; Austrian Academy of Sciences	Field work was funded by the Nouragues Grant from the French Centre National de la Recherche Scientifique (CNRS, http://www.guyane.cnrs.fr) to Max Ringler and supported through the Austrian Science Fund (FWF, Project: 18811, PI Walter Hodl, http://www.fwf.ac.at). Max Ringler and Eva Ursprung were supported by a Forschungsstipendium of the University of Vienna (http://www.univie.ac.at) and Eva Ursprung was funded by a DOC-fFORTE scholarship from the Austrian Academy of Sciences (http://www.oeaw.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2010, ANIM BEHAV, V80, P1041, DOI 10.1016/j.anbehav.2010.09.009; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anich NM, 2009, AUK, V126, P626, DOI 10.1525/auk.2009.08219; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; BART J, 1995, ECOL APPL, V5, P411, DOI 10.2307/1942032; Beyer H. L, 2007, HAWTHS ANAL TOOLS AR; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; BOULANGER JG, 1990, J WILDLIFE MANAGE, V54, P310, DOI 10.2307/3809048; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Clark DJ, 2001, J ECON, V73, P167, DOI 10.1007/BF02340174; Dalke P. D., 1942, Bulletin Connecticut State Geological and Natural History Survey, Vno. 65, P1; *DAT E LLC, 2003, XTOOLS PRO ARCGIS DE; Desiardins JK, 2008, ANIM BEHAV, V75, P595, DOI 10.1016/j.anbehav.2007.05.025; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Downs JA, 2009, T GIS, V13, P527, DOI 10.1111/j.1467-9671.2009.01177.x; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; ENEMAR A, 1978, ORNIS SCAND, V9, P31, DOI 10.2307/3676136; Environmental Systems Research Institute (ESRI), 2009, ARCGIS DESKT 9 3 HEL; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; GALTON A, 2006, GEOGRAPHIC INFORM SC; Galton A, 2008, LECT NOTES ARTIF INT, V5248, P409, DOI 10.1007/978-3-540-87601-4_29; GETTY T, 1981, ECOLOGY, V62, P907, DOI 10.2307/1936988; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GIRALDEAU LA, 1987, AUK, V104, P535, DOI 10.2307/4087559; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; GIVEN MF, 1987, HERPETOLOGICA, V43, P467; Haines A. M, 2006, GAMEBIRD, P489; Harvey M. J., 1965, Journal of Mammalogy, V46, P398, DOI 10.2307/1377624; HODL W, 1983, VERH DTSCH ZOOL GES, V172; HODL W, 1983, PHYLLOBATES FEMORALI; HOOGE PN, 2000, ANIMAL MOVEMENT VER; HUFF DL, 1977, J MARKETING RES, V14, P581, DOI 10.2307/3151205; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Korsten P, 2007, BEHAVIOUR, V144, P447, DOI 10.1163/156853907780756030; Kraaijeveld K, 2003, OSTRICH, V74, P117, DOI 10.2989/00306520309485377; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; LAVER PN, 2005, ABODE USER MANUAL BE; LAVER PN, 2006, ABODE BETA V 5 KERNE; Lawson EJ, 1997, WILDLIFE SOC B, V25, P721; Lichti NI, 2011, J WILDLIFE MANAGE, V75, P413, DOI 10.1002/jwmg.48; LYONS A, 2004, LOCOH  LOCAL CONVEX; MENDOZA DM, 2008, THESIS DEP EVOLUTION; MITCHELL BR, 2006, REMOTELY WILD WILDLI, V21; Montanarin A, 2011, ETHOL ECOL EVOL, V23, P141, DOI 10.1080/03949370.2011.554884; Mu L, 2011, APPL GEOGR, V31, P621, DOI 10.1016/j.apgeog.2010.11.012; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; ODUM E. P., 1955, AUK, V72, P128; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; RODGERS AR, 2007, HRT HOME RANGE TOOLS; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; ROITHMAIR ME, 1992, ETHOLOGY, V92, P331, DOI 10.1111/j.1439-0310.1992.tb00970.x; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; SIEGEL S, 1957, AM STAT, V11, P13, DOI 10.2307/2685679; Sogge MK, 2007, CONDOR, V109, P475, DOI 10.1650/0010-5422(2007)109[475:WFNTDB]2.0.CO;2; STAMPS J, 1994, ADV STUD BEHAV, V23, P173, DOI 10.1016/S0065-3454(08)60354-X; SUTHERLAND WJ, 2009, ECOLOGICAL CENSUS TE; SVENSSON SE, 1979, J APPL ECOL, V16, P61, DOI 10.2307/2402728; Tinbergen N., 1957, Bird Study, V4, P14; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Ursprung E, 2009, BEHAVIOUR, V146, P153, DOI 10.1163/156853909X410711; van Dongen WFD, 2008, BEHAV ECOL, V19, P1025, DOI 10.1093/beheco/arn061; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; WHITE MS, 1985, AM CARTOGRAPHER, V12, P123, DOI 10.1559/152304085783915135; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	74	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25844	10.1371/journal.pone.0025844	http://dx.doi.org/10.1371/journal.pone.0025844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022456	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600014
J	Carpi, G; Cagnacci, F; Wittekindt, NE; Zhao, FQ; Qi, J; Tomsho, LP; Drautz, DI; Rizzoli, A; Schuster, SC				Carpi, Giovanna; Cagnacci, Francesca; Wittekindt, Nicola E.; Zhao, Fangqing; Qi, Ji; Tomsho, Lynn P.; Drautz, Daniela I.; Rizzoli, Annapaola; Schuster, Stephan C.			Metagenomic Profile of the Bacterial Communities Associated with Ixodes ricinus Ticks	PLOS ONE			English	Article							CANDIDATUS NEOEHRLICHIA-MIKURENSIS; CANONICAL CORRESPONDENCE-ANALYSIS; BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; MICROBIAL COMMUNITIES; AMBLYOMMA-AMERICANUM; PATHOGEN DNA; ROE DEER; DIVERSITY; IXODIDAE	Assessment of the microbial diversity residing in arthropod vectors of medical importance is crucial for monitoring endemic infections, for surveillance of newly emerging zoonotic pathogens, and for unraveling the associated bacteria within its host. The tick Ixodes ricinus is recognized as the primary European vector of disease-causing bacteria in humans. Despite I. ricinus being of great public health relevance, its microbial communities remain largely unexplored to date. Here we evaluate the pathogen-load and the microbiome in single adult I. ricinus by using 454- and Illumina-based metagenomic approaches. Genomic DNA-derived sequences were taxonomically profiled using a computational approach based on the BWA algorithm, allowing for the identification of known tick-borne pathogens at the strain level and the putative tick core microbiome. Additionally, we assessed and compared the bacterial taxonomic profile in nymphal and adult I. ricinus pools collected from two distinct geographic regions in Northern Italy by means of V6-16S rRNA amplicon pyrosequencing and community based ecological analysis. A total of 108 genera belonging to representatives of all bacterial phyla were detected and a rapid qualitative assessment for pathogenic bacteria, such as Borrelia, Rickettsia and Candidatus Neoehrlichia, and for other bacteria with mutualistic relationship or undetermined function, such as Wolbachia and Rickettsiella, was possible. Interestingly, the ecological analysis revealed that the bacterial community structure differed between the examined geographic regions and tick life stages. This finding suggests that the environmental context (abiotic and biotic factors) and host-selection behaviors affect their microbiome. Our data provide the most complete picture to date of the bacterial communities present within I. ricinus under natural conditions by using high-throughput sequencing technologies. This study further demonstrates a novel detection strategy for the microbiomes of arthropod vectors in the context of epidemiological and ecological studies.	[Carpi, Giovanna; Cagnacci, Francesca; Rizzoli, Annapaola] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Carpi, Giovanna; Wittekindt, Nicola E.; Zhao, Fangqing; Qi, Ji; Tomsho, Lynn P.; Drautz, Daniela I.; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Fondazione Edmund Mach; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carpi, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy.	guc12@psu.edu	QI, JI/E-2797-2016; Carpi, Giovanna/HHM-5942-2022; Rizzoli, Annapaola/B-8583-2011; Wittekindt, Nicola/G-3469-2013; Zhao, Fangqing/P-6309-2019; Cagnacci, Francesca/L-7377-2013; Rizzoli, Annapaola/J-2439-2012; Cagnacci, Francesca/B-9397-2011	Wittekindt, Nicola/0000-0002-3310-0919; Cagnacci, Francesca/0000-0002-4954-9980; Rizzoli, Annapaola/0000-0003-3997-6783; Cagnacci, Francesca/0000-0002-4954-9980; Zhao, Fangqing/0000-0002-6216-1235	European Union [GOCE-2003-010284 EDEN]; Fondazione Edmund Mach; The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" - "People" specific programme - Marie Curie actions	European Union(European Commission); Fondazione Edmund Mach; The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" - "People" specific programme - Marie Curie actions	This research was partially funded by European Union grant GOCE-2003-010284 EDEN and by additional research funds provided by the Fondazione Edmund Mach. The paper is cataloged by the Emerging Diseases in a changing European eNvironment (EDEN) Steering Committee as EDEN0261 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. This research was also partially funded by The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" project, within the context of the 7th research framework programme for the period 2007-2013 - "People" specific programme - Marie Curie actions - COFUND. Post-doctoral project GENOTICK, Principal investigator: GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Carpi G, 2009, VECTOR-BORNE ZOONOT, V9, P179, DOI 10.1089/vbz.2008.0068; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de la Fuente J, 2003, CLIN DIAGN LAB IMMUN, V10, P182, DOI 10.1128/CDLI.10.1.182-184.2003; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; Fehr JS, 2010, EMERG INFECT DIS, V16, P1127, DOI 10.3201/eid1607.091907; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Goodman J., 2005, TICK BORNE DIS HUMAN; Halos LG, 2006, VET RES, V37, P245, DOI 10.1051/vetres:2005055; Heise SR, 2010, J MED ENTOMOL, V47, P258, DOI 10.1603/ME09197; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jensen K, 2007, TRENDS PARASITOL, V23, P439, DOI 10.1016/j.pt.2007.07.006; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Manilla, 1998, FAUNA ITALIA ACARI I; Mannelli A, 2005, J MED ENTOMOL, V42, P168, DOI 10.1603/0022-2585(2005)042[0168:BBSLII]2.0.CO;2; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Piccolin G, 2006, VECTOR-BORNE ZOONOT, V6, P24, DOI 10.1089/vbz.2006.6.24; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schabereiter-Gurtner C, 2003, J MICROBIOL METH, V52, P251, DOI 10.1016/S0167-7012(02)00186-0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sparagano OAE, 1999, EXP APPL ACAROL, V23, P929, DOI 10.1023/A:1006313803979; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Ter Braak C. J. F., 1995, P91; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; von Loewenich FD, 2010, J CLIN MICROBIOL, V48, P2630, DOI 10.1128/JCM.00588-10; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432	53	187	192	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25604	10.1371/journal.pone.0025604	http://dx.doi.org/10.1371/journal.pone.0025604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022422	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600024
J	Hyams, C; Opel, S; Hanage, W; Yuste, J; Bax, K; Henriques-Normark, B; Spratt, BG; Brown, JS				Hyams, Catherine; Opel, Sophia; Hanage, William; Yuste, Jose; Bax, Katie; Henriques-Normark, Birgitta; Spratt, Brian G.; Brown, Jeremy S.			Effects of Streptococcus pneumoniae Strain Background on Complement Resistance	PLOS ONE			English	Article							HISTIDINE TRIAD PROTEINS; CAPSULAR SEROTYPE; MEDIATED IMMUNITY; INNATE IMMUNITY; PHASE VARIATION; MOSAIC GENES; DEPOSITION; INFECTION; PHAGOCYTOSIS; ACTIVATION	Background: Immunity to infections caused by Streptococcus pneumoniae is dependent on complement. There are wide variations in sensitivity to complement between S. pneumoniae strains that could affect their ability to cause invasive infections. Although capsular serotype is one important factor causing differences in complement resistance between strains, there is also considerable other genetic variation between S. pneumoniae strains that may affect complement-mediated immunity. We have therefore investigated whether genetically distinct S. pneumoniae strains with the same capsular serotype vary in their sensitivity to complement mediated immunity. Methodology and Principal Findings: C3b/iC3b deposition and neutrophil association were measured using flow cytometry assays for S. pneumoniae strains with different genetic backgrounds for each of eight capsular serotypes. For some capsular serotypes there was marked variation in C3b/iC3b deposition between different strains that was independent of capsule thickness and correlated closely to susceptibility to neutrophil association. C3b/iC3b deposition results also correlated weakly with the degree of IgG binding to each strain. However, the binding of C1q (the first component of the classical pathway) correlated more closely with C3b/iC3b deposition, and large differences remained in complement sensitivity between strains with the same capsular serotype in sera in which IgG had been cleaved with IdeS. Conclusions: These data demonstrate that bacterial factors independent of the capsule and recognition by IgG have strong effects on the susceptibility of S. pneumoniae to complement, and could therefore potentially account for some of the differences in virulence between strains.	[Hyams, Catherine; Opel, Sophia; Brown, Jeremy S.] Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Resp Res, London, England; [Hanage, William] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yuste, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Spanish Pneumococcal Reference Lab, Madrid, Spain; [Bax, Katie] UCL, Dept Anat, London, England; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of London; King's College London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of London; University College London; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Imperial College London	Hyams, C (corresponding author), Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Resp Res, London, England.	jeremy.brown@ucl.ac.uk	Hyams, Catherine/AAH-1721-2019; YUSTE, JOSE/ABG-9851-2020; Hanage, Bill/CAF-1813-2022	Hyams, Catherine/0000-0003-3923-1773; YUSTE, JOSE/0000-0001-7996-0837; Brown, Jeremy/0000-0002-5650-5361	Department of Health's NIHR Biomedical Research Centre; Astor Foundation; Glaxo Smith Kline through the University College London; British Lung Foundation [P05/3]; Ragnar and Torsten Soderberg foundation; Swedish Research Council; GlaxoSmithKline	Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Astor Foundation; Glaxo Smith Kline through the University College London; British Lung Foundation; Ragnar and Torsten Soderberg foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); GlaxoSmithKline(GlaxoSmithKline)	This work was undertaken at University College London, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. CH was supported by the Astor Foundation and Glaxo Smith Kline through the University College London MB PhD programme. JY was supported by the British Lung Foundation (P05/3). BHN is supported by the Ragnar and Torsten Soderberg foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JSB has received unrestricted travel funds to attend conferences from pharmaceutical companies (GlaxoSmithKline). CH was partially funded by an unrestricted grant from a pharmaceutical company (GlaxoSmithKline) to University College London to support the MD PhD programme. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; ANGEL CS, 1994, J INFECT DIS, V170, P600, DOI 10.1093/infdis/170.3.600; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Dave S, 2004, INDIAN J MED RES, V119, P66; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; HOSTETTER MK, 1986, J INFECT DIS, V153, P682, DOI 10.1093/infdis/153.4.682; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kerr AR, 2005, INFECT IMMUN, V73, P4245, DOI 10.1128/IAI.73.7.4245-4252.2005; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Melin M, 2010, INFECT IMMUN, V78, P5252, DOI 10.1128/IAI.00739-10; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Ren B, 2004, J IMMUNOL, V173, P7506, DOI 10.4049/jimmunol.173.12.7506; Sabharwal V, 2009, INFECT IMMUN, V77, P1121, DOI 10.1128/IAI.01148-08; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; SEGAL AW, 1980, FEBS LETT, V110, P111, DOI 10.1016/0014-5793(80)80035-4; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 1998, MICROB DRUG RESIST, V4, P129, DOI 10.1089/mdr.1998.4.129; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	48	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24581	10.1371/journal.pone.0024581	http://dx.doi.org/10.1371/journal.pone.0024581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022358	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600004
J	Alhadeff, R; Ganoth, A; Krugliak, M; Arkin, IT				Alhadeff, Raphael; Ganoth, Assaf; Krugliak, Miriam; Arkin, Isaiah T.			Promiscuous Binding in a Selective Protein: The Bacterial Na+/H+ Antiporter	PLOS ONE			English	Article							GATED ION CHANNELS; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; POTASSIUM CHANNELS; MEMBRANE-VESICLES; CALCIUM-PUMP; NHAA; SODIUM; PROTON; FAMILY	The ability to discriminate between highly similar substrates is one of the remarkable properties of enzymes. For example, transporters and channels that selectively distinguish between various solutes enable living organisms to maintain and control their internal environment in the face of a constantly changing surrounding. Herein, we examine in detail the selectivity properties of one of the most important salt transporters: the bacterial Na+/H+ antiporter. Selectivity can be achieved at either the substrate binding step or in subsequent antiporting. Surprisingly, using both computational and experimental analyses synergistically, we show that binding per se is not a sufficient determinant of selectively. All alkali ions from Li+ to Cs+ were able to competitively bind the antiporter's binding site, whether the protein was capable of pumping them or not. Hence, we propose that NhaA's binding site is relatively promiscuous and that the selectivity is determined at a later stage of the transport cycle.	[Alhadeff, Raphael; Ganoth, Assaf; Krugliak, Miriam; Arkin, Isaiah T.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Alhadeff, R (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	arkin@huji.ac.il	Arkin, Isaiah/GQA-4328-2022	Arkin, Isaiah/0000-0002-7659-1746	Rudin Fellowship Trust; Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israeli Science Foundation [784/01, 1249/05, 1581/08]	Rudin Fellowship Trust; Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israeli Science Foundation(Israel Science Foundation)	This work was supported in part by grants from The Rudin Fellowship Trust (to RA), The Lady Davis Fellowship Trust and The Valazzi-Pikovsky Fellowship Fund (to AG), and the Israeli Science Foundation (784/01, 1249/05, 1581/08 to ITA). ITA is the Arthur Lejwa Professor of Structural Biochemistry at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 1996, J MEMBRANE BIOL, V152, P195, DOI 10.1007/s002329900097; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickson A, 2010, ANNU REV PHYS CHEM, V61, P441, DOI 10.1146/annurev.physchem.012809.103433; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IMPEY RW, 1987, J AM CHEM SOC, V109, P5900, DOI 10.1021/ja00254a002; INABA K, 1994, BIOL PHARM BULL, V17, P573; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miloshevsky GV, 2004, TRENDS NEUROSCI, V27, P308, DOI 10.1016/j.tins.2004.03.013; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MULLINS LJ, 1959, J GEN PHYSIOL, V42, P817, DOI 10.1085/jgp.42.4.817; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; Ohgaki R, 2005, BBA-BIOMEMBRANES, V1712, P185, DOI 10.1016/j.bbamem.2005.03.011; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TSUCHIYA T, 1975, J BIOL CHEM, V250, P7687; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Yamaoka K, 2006, CURR PHARM DESIGN, V12, P429, DOI 10.2174/138161206775474468; Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25182	10.1371/journal.pone.0025182	http://dx.doi.org/10.1371/journal.pone.0025182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022382	Green Submitted, gold, Green Published			2022-12-25	WOS:000295976000012
J	Kamiyama, H; Kakoki, K; Yoshii, H; Iwao, M; Igawa, T; Sakai, H; Hayashi, H; Matsuyama, T; Yamamoto, N; Kubo, Y				Kamiyama, Haruka; Kakoki, Katsura; Yoshii, Hiroaki; Iwao, Masatomo; Igawa, Tsukasa; Sakai, Hideki; Hayashi, Hideki; Matsuyama, Toshifumi; Yamamoto, Naoki; Kubo, Yoshinao			Infection of XC Cells by MLVs and Ebola Virus Is Endosome-Dependent but Acidification-Independent	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; R-PEPTIDE; SYNCYTIUM FORMATION; RETROVIRUS RECEPTOR; TYPE-1 INFECTION; ENVELOPE PROTEIN; SURFACE RECEPTOR; MEMBRANE-FUSION; VIRAL ENTRY	Inhibitors of endosome acidification or cathepsin proteases attenuated infections mediated by envelope proteins of xenotropic murine leukemia virus-related virus (XMRV) and Ebola virus, as well as ecotropic, amphotropic, polytropic, and xenotropic murine leukemia viruses (MLVs), indicating that infections by these viruses occur through acidic endosomes and require cathepsin proteases in the susceptible cells such as TE671 cells. However, as previously shown, the endosome acidification inhibitors did not inhibit these viral infections in XC cells. It is generally accepted that the ecotropic MLV infection in XC cells occurs at the plasma membrane. Because cathepsin proteases are activated by low pH in acidic endosomes, the acidification inhibitors may inhibit the viral infections by suppressing cathepsin protease activation. The acidification inhibitors attenuated the activities of cathepsin proteases B and L in TE671 cells, but not in XC cells. Processing of cathepsin protease L was suppressed by the acidification inhibitor in NIH3T3 cells, but again not in XC cells. These results indicate that cathepsin proteases are activated without endosome acidification in XC cells. Treatment with an endocytosis inhibitor or knockdown of dynamin 2 expression by siRNAs suppressed MLV infections in all examined cells including XC cells. Furthermore, endosomal cathepsin proteases were required for these viral infections in XC cells as other susceptible cells. These results suggest that infections of XC cells by the MLVs and Ebola virus occur through endosomes and pH-independent cathepsin activation induces pH-independent infection in XC cells.	[Kamiyama, Haruka; Kakoki, Katsura; Yoshii, Hiroaki; Yamamoto, Naoki; Kubo, Yoshinao] Nagasaki Univ, Global COE Program, Inst Trop Med, Dept AIDS Res, Nagasaki 852, Japan; [Kamiyama, Haruka; Iwao, Masatomo] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 852, Japan; [Kakoki, Katsura; Igawa, Tsukasa; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 852, Japan; [Hayashi, Hideki; Matsuyama, Toshifumi; Kubo, Yoshinao] Nagasaki Univ, Grad Sch Biomed Sci, Div Cytokine Signaling, Nagasaki 852, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; National University of Singapore	Kamiyama, H (corresponding author), Nagasaki Univ, Global COE Program, Inst Trop Med, Dept AIDS Res, Nagasaki 852, Japan.	yoshinao@nagasaki-u.ac.jp	Hideki, Hayashi/AAW-9081-2021	Hayashi, Hideki/0000-0003-4585-6542	NEKKEN Research Found of Nagasaki University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22590416, 09J07637] Funding Source: KAKEN	NEKKEN Research Found of Nagasaki University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the NEKKEN Research Found 2008 of Nagasaki University, and by the Japan Society for the Promotion of Science. H. Kamiyama is a special research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1984, J VIROL, V50, P813, DOI 10.1128/JVI.50.3.813-821.1984; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; ANDERSEN KB, 1994, J VIROL, V68, P3175, DOI 10.1128/JVI.68.5.3175-3182.1994; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; HARTLEY JW, 1976, J VIROL, V19, P19, DOI 10.1128/JVI.19.1.19-25.1976; Iwakuma T, 1999, VIROLOGY, V261, P120, DOI 10.1006/viro.1999.9850; JONES JS, 1993, J VIROL, V67, P67, DOI 10.1128/JVI.67.1.67-74.1993; Kanbe K, 1999, VIROLOGY, V265, P264, DOI 10.1006/viro.1999.0036; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kizhatil K, 1997, J VIROL, V71, P7145, DOI 10.1128/JVI.71.10.7145-7156.1997; Kubo Y, 2007, ARCH VIROL, V152, P2169, DOI 10.1007/s00705-007-1054-6; Kubo Y, 2003, J GEN VIROL, V84, P2253, DOI 10.1099/vir.0.19126-0; Kubo Y, 2003, J VIROL, V77, P7510, DOI 10.1128/JVI.77.13.7510-7516.2003; Kubo Y, 2008, VIROLOGY, V375, P130, DOI 10.1016/j.virol.2008.01.047; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; Lavillette D, 2001, J VIROL, V75, P3685, DOI 10.1128/JVI.75.8.3685-3695.2001; LEIBOVITCH SA, 1984, BIOCHEM BIOPH RES CO, V119, P630, DOI 10.1016/S0006-291X(84)80296-X; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RAGHEB JA, 1994, J VIROL, V68, P3220, DOI 10.1128/JVI.68.5.3220-3231.1994; REIN A, 1994, J VIROL, V68, P1773, DOI 10.1128/JVI.68.3.1773-1781.1994; ROMMERSKIRCH W, 1988, NUCLEIC ACIDS RES, V16, P941, DOI 10.1093/nar/16.3.941; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; SVOBODA J, 1960, NATURE, V186, P980, DOI 10.1038/186980b0; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; WILSON CA, 1992, J VIROL, V66, P7262, DOI 10.1128/JVI.66.12.7262-7269.1992; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005; Yoshii H, 2008, J GEN VIROL, V89, P297, DOI 10.1099/vir.0.83430-0; Yoshii H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019352; Yoshii H, 2009, VIROLOGY, V394, P227, DOI 10.1016/j.virol.2009.08.045	47	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26180	10.1371/journal.pone.0026180	http://dx.doi.org/10.1371/journal.pone.0026180			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022555	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000081
J	Li, J; Li, ZH; Ruan, JB; Xu, C; Tong, YF; Pan, PW; Tempel, W; Crombet, L; Min, JR; Zang, JY				Li, Jing; Li, Zhihong; Ruan, Jianbin; Xu, Chao; Tong, Yufeng; Pan, Patricia W.; Tempel, Wolfram; Crombet, Lissete; Min, Jinrong; Zang, Jianye			Structural Basis for Specific Binding of Human MPP8 Chromodomain to Histone H3 Methylated at Lysine 9	PLOS ONE			English	Article							STATE-SPECIFIC RECOGNITION; MOLECULE E-CADHERIN; PHD FINGER; PROTEIN; COMPLEX; DOMAIN; MECHANISM; REPEATS; H3K4ME3; MODULES	Background: M-phase phosphoprotein 8 (MPP8) was initially identified to be a component of the RanBPM-containing large protein complex, and has recently been shown to bind to methylated H3K9 both in vivo and in vitro. MPP8 binding to methylated H3K9 is suggested to recruit the H3K9 methyltransferases GLP and ESET, and DNA methyltransferase 3A to the promoter of the E-cadherin gene, mediating the E-cadherin gene silencing and promote tumor cell motility and invasion. MPP8 contains a chromodomain in its N-terminus, which is used to bind the methylated H3K9. Methodology/Principal Findings: Here, we reported the crystal structures of human MPP8 chromodomain alone and in complex with the trimethylated histone H3K9 peptide (residue 1-15). The complex structure unveils that the human MPP8 chromodomain binds methylated H3K9 through a conserved recognition mechanism, which was also observed in Drosophila HP1, a chromodomain containing protein that binds to methylated H3K9 as well. The structure also reveals that the human MPP8 chromodomain forms homodimer, which is mediated via an unexpected domain swapping interaction through two beta strands from the two protomer subunits. Conclusions/Significance: Our findings reveal the molecular mechanism of selective binding of human MPP8 chromodomain to methylated histone H3K9. The observation of human MPP8 chromodomain in both solution and crystal lattice may provide clues to study MPP8-mediated gene regulation furthermore.	[Li, Jing; Ruan, Jianbin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China; [Li, Jing; Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Li, Zhihong; Xu, Chao; Tong, Yufeng; Pan, Patricia W.; Tempel, Wolfram; Crombet, Lissete; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toronto; Structural Genomics Consortium; University of Toronto	Li, J (corresponding author), Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China.	jr.min@utoronto.ca; zangjy@ustc.edu.cn	Xu, Chao/G-3885-2010; Min, Jinrong/G-3449-2011; Zang, Jianye/E-5228-2013; Tong, Yufeng/D-2785-2011	Xu, Chao/0000-0003-0444-7080; Min, Jinrong/0000-0001-5210-3130; Tong, Yufeng/0000-0001-7740-1812; Ruan, Jianbin/0000-0001-5843-8273	Chinese Ministry of Science and Technology [2009CB825502, 2006CB806501]; Chinese Academy of Sciences; National Natural Science Foundation of China [30970576]; Canadian Institutes for Health Research [1097737]; Structural Genomics Consortium; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Structural Genomics Consortium(University of Toronto); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by the grants from the Chinese Ministry of Science and Technology (Nos. 2009CB825502, 2006CB806501), "100 talents program'' of the Chinese Academy of Sciences, and the grant from National Natural Science Foundation of China (No 30970576) to JZ. This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; CHANG Y, 2011, J MOL BIOL; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; YAP KL, 2011, BIOCHEMISTRY	50	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25104	10.1371/journal.pone.0025104	http://dx.doi.org/10.1371/journal.pone.0025104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022377	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000009
J	Schroepfer, KK; Rosati, AG; Chartrand, T; Hare, B				Schroepfer, Kara K.; Rosati, Alexandra G.; Chartrand, Tanya; Hare, Brian			Use of "Entertainment" Chimpanzees in Commercials Distorts Public Perception Regarding Their Conservation Status	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ATTITUDES; KNOWLEDGE; WILDLIFE	Chimpanzees (Pan troglodytes) are often used in movies, commercials and print advertisements with the intention of eliciting a humorous response from audiences. The portrayal of chimpanzees in unnatural, human-like situations may have a negative effect on the public's understanding of their endangered status in the wild while making them appear as suitable pets. Alternatively, media content that elicits a positive emotional response toward chimpanzees may increase the public's commitment to chimpanzee conservation. To test these competing hypotheses, participants (n = 165) watched a series of commercials in an experiment framed as a marketing study. Imbedded within the same series of commercials was one of three chimpanzee videos. Participants either watched 1) a chimpanzee conservation commercial, 2) commercials containing "entertainment" chimpanzees or 3) control footage of the natural behavior of wild chimpanzees. Results from a post-viewing questionnaire reveal that participants who watched the conservation message understood that chimpanzees were endangered and unsuitable as pets at higher levels than those viewing the control footage. Meanwhile participants watching commercials with entertainment chimpanzees showed a decrease in understanding relative to those watching the control footage. In addition, when participants were given the opportunity to donate part of their earnings from the experiment to a conservation charity, donations were least frequent in the group watching commercials with entertainment chimpanzees. Control questions show that participants did not detect the purpose of the study. These results firmly support the hypothesis that use of entertainment chimpanzees in the popular media negatively distorts the public's perception and hinders chimpanzee conservation efforts.	[Schroepfer, Kara K.; Rosati, Alexandra G.; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA; [Rosati, Alexandra G.; Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Chartrand, Tanya] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Chartrand, Tanya] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Schroepfer, KK (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA.	k.schroepfer@duke.edu		Rosati, Alexandra/0000-0002-6906-7807	European Research Commission [233297]; National Science Foundation [NSF-BCS-27552, NSF-BCS-25172]	European Research Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by European Research Commission Advanced Grant Agreement 233297 and by National Science Foundation grant NSF-BCS-27552 and NSF-BCS-25172 to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Brent Linda, 2001, Special Topics in Primatology, V2, P1; CARTER J, 2003, STATUS SURVEY CONSER, P157; *CHIMP COLL, 2000, SERV LIF SENT YOUR V; Farmer KH, 2002, AM J PRIMATOL, V58, P117, DOI 10.1002/ajp.10054; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Kabasawa Asami, 2009, African Study Monographs, V30, P37; Kellert S.R., 1986, P50; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Liska J, 1999, ANTHROZOOS, V12, P88, DOI 10.2752/089279399787000372; Lukas KE., 2005, J ENVIRON EDUC, V36, P33; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Oates JF, 2008, PAN TROGLODYTES IUCN; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; PALMER C, 2010, SHOOTING WILD; PLOUS S, 1993, J SOC ISSUES, V49, P11, DOI 10.1111/j.1540-4560.1993.tb00907.x; ROSS S, 2010, CHIMPCARE; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Soulsbury CD, 2009, J APPL ANIM WELF SCI, V12, P1, DOI 10.1080/10888700802536483; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Taylor N, 2009, ANTHROZOOS, V22, P129, DOI 10.2752/175303709X434158; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Tisdell C, 2007, ECOL ECON, V60, P627, DOI 10.1016/j.ecolecon.2006.01.007; Tisdell C, 2006, ECOL MODEL, V198, P515, DOI 10.1016/j.ecolmodel.2006.04.021; VANNORMAN J, 2011, FED REGISTER, V76, P54423; Yen ST, 1997, J AGR RESOUR ECON, V22, P246	31	39	39	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26048	10.1371/journal.pone.0026048	http://dx.doi.org/10.1371/journal.pone.0026048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022503	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000060
J	Leontieva, OV; Demidenko, ZN; Gudkov, AV; Blagosklonny, MV				Leontieva, Olga V.; Demidenko, Zoya N.; Gudkov, Andrei V.; Blagosklonny, Mikhail V.			Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin	PLOS ONE			English	Article							GROWTH ARREST; TUMOR-CELLS; CYCLE; P53; MTOR; LEADS	Background: Depending on cellular context, p53-inducing agents (such as nutlin-3a) cause different outcomes including reversible quiescence and irreversible senescence. Inhibition of mTOR shifts the balance from senescence to quiescence. In cell lines with incomplete responses to p53, this shift may be difficult to document because of a high proportion of proliferating cells contaminating arrested (quiescent and senescent) cells. This problem also complicates the study of senescence caused by minimal levels of p21 that are capable to arrest a few cells. Methodology: During induction of senescence by low levels of endogenous p53 and ectopic p21, cells were co-treated with nocodazole, which eliminated proliferating cells. As a result, only senescent and quiescent cells remained. Results and Discussion: This approach revealed that rapamycin efficiently converted nutlin-induced-senescence into quiescence. In the presence of rapamycin, nutlin-arrested MCF-7 cells retained the proliferative potential and small/lean morphology. Using this approach, we also unmasked senescence in cells arrested by low levels of ectopic p21, capable to arrest only a small proportion of HT1080-p21-9 cells. When p21 did cause arrest, mTOR caused senescent phenotype. Rapamycin and high concentrations of nutlin-3a, which inhibit the mTOR pathway in these particular cells, suppressed senescence, ensuring quiescence instead. Thus, p21 causes senescence passively, just by causing arrest, while still active mTOR drives senescent phenotype.	[Leontieva, Olga V.; Demidenko, Zoya N.; Gudkov, Andrei V.; Blagosklonny, Mikhail V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Leontieva, OV (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	blagosklonny@oncotarget.com		Gudkov, Andrei/0000-0003-2548-0154				Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Blagosklonny MV, 2011, CELL CYCLE, V10, P2295, DOI 10.4161/cc.10.14.16819; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Pani G, 2011, CELL CYCLE, V10, P2450, DOI 10.4161/cc.10.15.16886; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909	17	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26126	10.1371/journal.pone.0026126	http://dx.doi.org/10.1371/journal.pone.0026126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022534	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200040
J	Parsons, CE; Young, KS; Parsons, E; Dean, A; Murray, L; Goodacre, T; Dalton, L; Stein, A; Kringelbach, ML				Parsons, Christine E.; Young, Katherine S.; Parsons, Emma; Dean, Annika; Murray, Lynne; Goodacre, Tim; Dalton, Louise; Stein, Alan; Kringelbach, Morten L.			The Effect of Cleft Lip on Adults' Responses to Faces: Cross-Species Findings	PLOS ONE			English	Article							INFANT; PALATE; ATTRACTIVENESS; APPEARANCE; BEHAVIOR; REPAIR; GENDER; YOUNG	Cleft lip and palate is the most common of the congenital conditions affecting the face and cranial bones and is associated with a raised risk of difficulties in infant- caregiver interaction; the reasons for such difficulties are not fully understood. Here, we report two experiments designed to explore how adults respond to infant faces with and without cleft lip, using behavioural measures of attractiveness appraisal ('liking') and willingness to work to view or remove the images ('wanting'). We found that infants with cleft lip were rated as less attractive and were viewed for shorter durations than healthy infants, an effect that was particularly apparent where the cleft lip was severe. Women rated the infant faces as more attractive than men did, but there were no differences in men and women's viewing times of these faces. In a second experiment, we found that the presence of a cleft lip in domestic animals affected adults' 'liking' and 'wanting' responses in a comparable way to that seen for human infants. Adults' responses were also remarkably similar for images of infants and animals with cleft lip, although no gender difference in attractiveness ratings or viewing times emerged for animals. We suggest that the presence of a cleft lip can substantially change the way in which adults respond to human and animal faces. Furthermore, women may respond in different ways to men when asked to appraise infant attractiveness, despite the fact that men and women 'want' to view images of infants for similar durations.	[Parsons, Christine E.; Young, Katherine S.; Parsons, Emma; Dean, Annika; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford, England; [Parsons, Christine E.; Young, Katherine S.; Kringelbach, Morten L.] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Parsons, Emma; Dean, Annika] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Murray, Lynne] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Goodacre, Tim; Dalton, Louise] John Radcliffe Hosp, Spires Cleft Ctr, Oxford OX3 9DU, England	University of Oxford; Aarhus University; University of Bath; University of Reading; University of Oxford	Parsons, CE (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	Morten.Kringelbach@queens.ox.ac.uk	Parsons, Christine/V-3571-2019; Kringelbach, Morten/AAW-5847-2021; Kringelbach, Morten L/AAF-5508-2020; Goodacre, Timothy/AAY-7888-2020; Parsons, Christine/G-9286-2016; Young, Katherine/O-9198-2017	Parsons, Christine/0000-0003-2856-6308; Kringelbach, Morten/0000-0002-3908-6898; Goodacre, Timothy/0000-0001-6812-2934; Parsons, Christine/0000-0003-2856-6308; Young, Katherine/0000-0002-1378-6415; Stein, Alan/0000-0001-8207-2822; Dalton, Louise/0000-0003-1923-5769	Wellcome Trust UK [017571]; TrygFonden Charitable Foundation; Medical Research Council	Wellcome Trust UK(Wellcome Trust); TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by funding from the Wellcome Trust, UK (017571), the TrygFonden Charitable Foundation, and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; BERMAN PW, 1980, PSYCHOL BULL, V88, P668, DOI 10.1037/0033-2909.88.3.668; BOUKYDIS CFZ, 1982, CHILD DEV, V53, P1291, DOI 10.2307/1129019; Dai XC, 2010, EMOTION, V10, P324, DOI 10.1037/a0017987; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; FIELD TM, 1984, INFANT BEHAV DEV, V7, P527, DOI 10.1016/S0163-6383(84)80012-0; Goodacre T, 2008, PAEDIAT CHILD HLTH, V18, P283, DOI DOI 10.1016/J.PAED.2008.03.008; Goodacre TEE, 2004, CLEFT PALATE-CRAN J, V41, P603, DOI 10.1597/03-028.1; HUTT C, 1972, HUM DEV, V15, P153, DOI 10.1159/000271239; KOOMEN HMY, 1993, J CHILD PSYCHOL PSYC, V34, P917, DOI 10.1111/j.1469-7610.1993.tb01098.x; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Marcusson A, 2002, SCAND J PLAST RECONS, V36, P16, DOI 10.1080/028443102753478327; Murray L, 2008, J CHILD PSYCHOL PSYC, V49, P115, DOI 10.1111/j.1469-7610.2007.01833.x; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Parsons CE, 2011, PLOS ONE, V6; RICHMAN LC, 1985, CLEFT PALATE J, V22, P93; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; SPELTZ ML, 1994, INFANT BEHAV DEV, V17, P131, DOI 10.1016/0163-6383(94)90048-5; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; STARR P, 1982, PSYCHOL REP, V50, P467, DOI 10.2466/pr0.1982.50.2.467; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	24	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25897	10.1371/journal.pone.0025897	http://dx.doi.org/10.1371/journal.pone.0025897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OO	22016785	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295971700023
J	Bucardo, F; Lindgren, PE; Svensson, L; Nordgren, J				Bucardo, Filemon; Lindgren, Per-Eric; Svensson, Lennart; Nordgren, Johan			Low Prevalence of Rotavirus and High Prevalence of Norovirus in Hospital and Community Wastewater after Introduction of Rotavirus Vaccine in Nicaragua	PLOS ONE			English	Article							ENTERIC VIRUSES; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; SURFACE WATERS; SEWAGE SAMPLES; GENOGROUP-I; RT-PCR; GENOTYPES; CHILDREN; POPULATION	Rotavirus (RV) and norovirus (NoV) are major causes of pediatric diarrhea and are altogether associated with approximately 800,000 deaths in young children every year. In Nicaragua, national RV vaccination program using the pentavalent RV5 vaccine from Merck was implemented in October 2006. To determine whether RV vaccination decreased the overall number of RV infections, we investigated the occurrence of RV and NoV in wastewater in the city of Leon from July 2007 to July 2008 and compared these data with pre-vaccination data. The major finding was the low prevalence of RV compared to NoV in all sampling points (11% vs 44%, p<0.05), and that RV concentration was lower as compared to NoV. RV was observed mainly during the rainy season (July-September), and the majority of all RV detected (6/9) belonged to subgroup (SG) I. The partial VP7-gene obtained from one RV positive sample was similar (99% nt identity) to a G6 VP7-gene of bovine origin and similar to the corresponding gene of the vaccine strain (98%). Furthermore RV G-types 2 and 4 were found in the incoming wastewater. NoV strains were detected throughout the year, of which a majority (20/21) were of genotype GII.4. We conclude that the introduction of RV vaccination reduced the transmission of RV in the community in Nicaragua. However, the burden of diarrhea in the country remains high, and the high prevalence of NoVs in hospital and municipal wastewater is noteworthy. This study highlights the need for further assessment of NoV following RV vaccine introduction.	[Bucardo, Filemon] Univ Leon, Dept Microbiol, Leon, Nicaragua; [Bucardo, Filemon; Svensson, Lennart; Nordgren, Johan] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden; [Lindgren, Per-Eric] Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University	Bucardo, F (corresponding author), Univ Leon, Dept Microbiol, Leon, Nicaragua.	johan.nordgren@liu.se	Bucardo, Filemon/AFK-4817-2022; svensson, lennart/K-6163-2019	Bucardo, Filemon/0000-0002-9819-870X; 	Swedish International Development Cooperation Agency [0.75007109]; Swedish Research Council [10392]; NETROPICA	Swedish International Development Cooperation Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); NETROPICA	The study was supported by grants from the Swedish International Development Cooperation Agency (http://www.sida.se/English/) (grant 0.75007109) and by the Swedish Research Council (http://www.vr.se/) (grant 10392). Dr. Bucardo received a travel grant from NETROPICA (http://www.netropica.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Arraj A, 2008, J WATER HEALTH, V6, P351, DOI 10.2166/wh.2008.053; Aw TG, 2009, APPL ENVIRON MICROB, V75, P4984, DOI 10.1128/AEM.00489-09; Banyai K, 2009, J CLIN VIROL, V46, P391, DOI 10.1016/j.jcv.2009.08.005; Barril PA, 2010, J MED VIROL, V82, P1277, DOI 10.1002/jmv.21800; Becker-Dreps S, 2011, PEDIATR INFECT DIS J, V30, P243, DOI 10.1097/INF.0b013e3181f87ffe; Boccia D, 2002, EMERG INFECT DIS, V8, P563, DOI 10.3201/eid0806.010371; Bohm S. R., 2007, Morbidity and Mortality Weekly Report, V56, P1212; Bourdett-Stanziola L, 2010, INTERVIROLOGY, V53, P390, DOI 10.1159/000317288; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2007, J CLIN MICROBIOL, V45, P990, DOI 10.1128/JCM.01992-06; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Cashman O, 2010, VET MICROBIOL, V146, P238, DOI 10.1016/j.vetmic.2010.05.012; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Duclos P, 2011, EXPERT REV VACCINES, V10, P163, DOI [10.1586/erv.10.171, 10.1586/ERV.10.171]; Espinoza F, 2006, PEDIATR INFECT DIS J, V25, P1078, DOI 10.1097/01.inf.0000242739.44424.0e; Fumian TM, 2010, J VIROL METHODS, V170, P42, DOI 10.1016/j.jviromet.2010.08.017; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002; Hamza IA, 2009, WATER RES, V43, P2657, DOI 10.1016/j.watres.2009.03.020; He XQ, 2011, WATER SCI TECHNOL, V63, P191, DOI 10.2166/wst.2011.032; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iwai M, 2009, APPL ENVIRON MICROB, V75, P1264, DOI 10.1128/AEM.01166-08; Kamel AH, 2010, J APPL MICROBIOL, V108, P1620, DOI 10.1111/j.1365-2672.2009.04562.x; Kitajima M, 2010, ENVIRON SCI TECHNOL, V44, P7116, DOI 10.1021/es100346a; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kremer JR, 2011, CLIN MICROBIOL INFEC, V17, P1173, DOI 10.1111/j.1469-0691.2010.03407.x; Laverick MA, 2004, LETT APPL MICROBIOL, V39, P127, DOI 10.1111/j.1472-765X.2004.01534.x; Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005; Lysen M, 2009, J CLIN MICROBIOL, V47, P2411, DOI 10.1128/JCM.02168-08; Mast TC, 2011, PEDIAT INFECT DIS J, V30; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Myrmel M., 2006, Journal of Water and Health, V4, P197, DOI 10.2166/wh.2006.0016; Nordgren J, 2008, J CLIN MICROBIOL, V46, P164, DOI 10.1128/JCM.01316-07; Nordgren J, 2010, J CLIN MICROBIOL, V48, P1859, DOI 10.1128/JCM.02288-09; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Nordgren J, 2009, WATER RES, V43, P1117, DOI 10.1016/j.watres.2008.11.053; Orozco Maribel, 2009, J Infect Dis, V200 Suppl 1, pS125, DOI 10.1086/605053; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2010, PEDIATRICS, V125, pE438, DOI 10.1542/peds.2009-1901; Prado T, 2011, WATER RES, V45, P1287, DOI 10.1016/j.watres.2010.10.012; Ramani S, 2010, J MED VIROL, V82, P1803, DOI 10.1002/jmv.21872; Sdiri-Loulizi K, 2010, J APPL MICROBIOL, V109, P1093, DOI 10.1111/j.1365-2672.2010.04772.x; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Swedish Environmental Protection Agency, 2008, GUID SWED ENV PROT A; Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Yen C, 2011, VACCINE, V29, P4151, DOI 10.1016/j.vaccine.2011.03.074	54	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25962	10.1371/journal.pone.0025962	http://dx.doi.org/10.1371/journal.pone.0025962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016794	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300043
J	Cohen, JM; Khandavilli, S; Camberlein, E; Hyams, C; Baxendale, HE; Brown, JS				Cohen, Jonathan M.; Khandavilli, Suneeta; Camberlein, Emilie; Hyams, Catherine; Baxendale, Helen E.; Brown, Jeremy S.			Protective Contributions against Invasive Streptococcus pneumoniae Pneumonia of Antibody and Th17-Cell Responses to Nasopharyngeal Colonisation	PLOS ONE			English	Article							INDEPENDENT ACQUIRED-IMMUNITY; ABC TRANSPORTER; DISEASE; CELLS; PNEUMOCOCCI; ESTABLISHMENT; PHAGOCYTOSIS; VACCINATION; BURDEN; INNATE	The nasopharyngeal commensal bacteria Streptococcus pneumoniae is also a frequent cause of serious infections. Nasopharyngeal colonisation with S. pneumoniae inhibits subsequent re-colonisation by inducing Th17-cell adaptive responses, whereas vaccination prevents invasive infections by inducing antibodies to S. pneumoniae capsular polysaccharides. In contrast, protection against invasive infection after nasopharyngeal colonisation with mutant S. pneumoniae strains was associated with antibody responses to protein antigens. The role of colonisation-induced Th17-cell responses during subsequent invasive infections is unknown. Using mouse models, we show that previous colonisation with S. pneumoniae protects against subsequent lethal pneumonia mainly by preventing bacteraemia with a more modest effect on local control of infection within the lung. Previous colonisation resulted in CD4-dependent increased levels of Th17-cell cytokines during subsequent infectious challenge. However, mice depleted of CD4 cells prior to challenge remained protected against bacteraemia, whereas no protection was seen in antibody deficient mice and similar protection could be achieved through passive transfer of serum. Serum from colonised mice but not antibody deficient mice promoted phagocytosis of S. pneumoniae, and previously colonised mice were able to rapidly clear S. pneumoniae from the blood after intravenous inoculation. Thus, despite priming for a Th17-cell response during subsequent infection, the protective effects of prior colonisation in this model was not dependent on CD4 cells but on rapid clearance of bacteria from the blood by antibody-mediated phagocytosis. These data suggest that whilst nasopharyngeal colonisation induces a range of immune responses, the effective protective responses depend upon the site of subsequent infection.	[Cohen, Jonathan M.; Khandavilli, Suneeta; Camberlein, Emilie; Hyams, Catherine; Brown, Jeremy S.] UCL, Dept Med, Ctr Resp Res, London, England; [Cohen, Jonathan M.; Baxendale, Helen E.] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Baxendale, Helen E.] UCL, Dept Immunol, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Cohen, JM (corresponding author), UCL, Dept Med, Ctr Resp Res, London, England.	jeremy.brown@ucl.ac.uk	Cohen, Jonathan/C-4588-2008; Hyams, Catherine/AAH-1721-2019	Cohen, Jonathan/0000-0002-3966-3640; Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361; Cohen, Jonathan/0000-0003-1004-5598	Department of Health's National Institute for Health Research Biomedical Research Centre; Medical Research Council [G0700829, G0600410]; Astor Foundation; GlaxoSmithKline; MRC [G0600410, G0700829] Funding Source: UKRI	Department of Health's National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Astor Foundation; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at University College London Hospitals and University College London (UCL) which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme. JMC was supported by a Clinical Research Training Fellowship from the Medical Research Council (G0700829). EC was supported by the Medical Research Council (grant G0600410). CH was supported by the Astor Foundation and with an unrestricted educational grant from GlaxoSmithKline towards the UCL MBPhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HOLDSWORTH RJ, 1989, BRIT J EXP PATHOL, V70, P669; Hussell T, 2009, BIOCHEM SOC T, V37, P811, DOI 10.1042/BST0370811; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirby AC, 2007, EUR J IMMUNOL, V37, P3404, DOI 10.1002/eji.200737216; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; MUSHER DM, 1993, CLIN INFECT DIS, V17, P66, DOI 10.1093/clinids/17.1.66; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Roche AM, 2007, INFECT IMMUN, V75, P2469, DOI 10.1128/IAI.01972-06; Roche AM, 2010, INFECT IMMUN, V78, P2231, DOI 10.1128/IAI.01058-09; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	33	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25558	10.1371/journal.pone.0025558	http://dx.doi.org/10.1371/journal.pone.0025558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003400	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300021
J	Deol, YS; Nasser, MW; Yu, LB; Zou, XH; Ganju, RK				Deol, Yadwinder S.; Nasser, Mohd W.; Yu, Lianbo; Zou, Xianghong; Ganju, Ramesh K.			Tumor-suppressive Effects of Psoriasin (S100A7) Are Mediated through the beta-Catenin/T Cell Factor 4 Protein Pathway in Estrogen Receptor-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; MAMMARY EPITHELIAL-CELLS; CARCINOMA IN-SITU; ONCOSTATIN-M; WNT PATHWAY; EXPRESSION; PROGRESSION; BINDING; GENES; APC	Psoriasin (S100A7) is expressed in several epithelial malignancies including breast cancer. Although S100A7 is associated with the worst prognosis in estrogen receptor alpha-negative (ER alpha(-)) invasive breast cancers, its role in ER alpha-positive (ER alpha(+)) breast cancers is relatively unknown. We investigated the significance of S100A7 in ER alpha(+) breast cancer cells and observed that S100A7 overexpression in ER alpha(+) breast cancer cells, MCF7 and T47D, exhibited decreased migration, proliferation, and wound healing. These results were confirmed in vivo in nude mouse model system. Mice injected with S100A7-overexpressing MCF7 cells showed significant reduction in tumor size compared with mice injected with vector control cells. Further mechanistic studies revealed that S100A7 mediates the tumor-suppressive effects via a coordinated regulation of the beta-catenin/TCF4 pathway and an enhanced interaction of beta-catenin and E-cadherin in S100A7-overexpressing ER alpha(+) breast cancer cells. We observed down-regulation of beta-catenin, p-GSK3 beta, TCF4, cyclin D1, and c-myc in S100A7-overexpressing ER alpha(+) breast cancer cells. In addition, we observed increased expression of GSK3 beta. Treatment with GSK3 beta inhibitor CHIR 99021 increased the expression of beta-catenin and its downstream target c-myc in S100A7-overexpressing cells. Tumors derived from mice injected with S100A7-overexpressing MCF7 cells also showed reduced activation of the beta-catenin/TCF4 pathway. Therefore, our studies reveal for the first time that S100A7-overexpressing ER alpha(+) breast cancer cells exhibit tumor suppressor capabilities through down-modulation of the beta-catenin/TCF4 pathway both in vitro and in vivo. Because S100A7 has been shown to enhance tumorigenicity in ER alpha(-) cells, our studies suggest that S100A7 may possess differential activities in ER alpha(+) compared with ER alpha(-) cells.	[Deol, Yadwinder S.; Nasser, Mohd W.; Zou, Xianghong; Ganju, Ramesh K.] Ohio State Univ, Dept Pathol, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA; [Deol, Yadwinder S.; Ganju, Ramesh K.] Ohio State Univ, Mol Cellular & Dev Biol Program, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ganju, RK (corresponding author), Ohio State Univ, Dept Pathol, Med & Comprehens Canc Ctr, 1645 Neil Ave,185D Hamilton Hall, Columbus, OH 43210 USA.	ramesh.ganju@osumc.edu	zou, Xianghong/E-4374-2011; Nasser, Mohd/Y-3355-2019; yu, lianbo/B-3472-2010		National Institutes of Health [R01CA109527, R01CA153490]; Department of Defense [W81XWH-11-1-0279, W8XWH-11-1-0275]; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109527, R01CA153490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA109527 and R01CA153490 and Department of Defense Grants W81XWH-11-1-0279 and W8XWH-11-1-0275 (to R. K. G.).; Supported by a Pelotonia fellowship from The Ohio State University Comprehensive Cancer Center.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; GILLETT C, 1994, CANCER RES, V54, P1812; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Leygue E, 1996, CANCER RES, V56, P4606; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; MOOGLUTZ C, 1995, INT J CANCER, V63, P297, DOI 10.1002/ijc.2910630225; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin Patrice J, 2003, Cancer Treat Res, V115, P169; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Ravindranath A, 2008, CURR MOL MED, V8, P38; Ray G, 2005, ONCOL REP, V13, P445; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; South AP, 1999, J INVEST DERMATOL, V112, P910, DOI 10.1046/j.1523-1747.1999.00613.x; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wolf R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001108; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	44	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44845	44854		10.1074/jbc.M111.225466	http://dx.doi.org/10.1074/jbc.M111.225466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22016394	hybrid, Green Published			2022-12-25	WOS:000298645500053
J	Bernert, B; Porsch, H; Heldin, P				Bernert, Berit; Porsch, Helena; Heldin, Paraskevi			Hyaluronan Synthase 2 (HAS2) Promotes Breast Cancer Cell Invasion by Suppression of Tissue Metalloproteinase Inhibitor 1 (TIMP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BB; MATRIX METALLOPROTEINASES; DERMAL FIBROBLASTS; EPITHELIAL-CELLS; EXPRESSION; CD44; RECEPTOR; ACTIVATION; MIGRATION; TUMORIGENESIS	Invasion and metastasis are the primary causes of breast cancer mortality, and increased knowledge about the molecular mechanisms involved in these processes is highly desirable. High levels of hyaluronan in breast tumors have been correlated with poor patient survival. The involvement of hyaluronan in the early invasive phase of a clone of breast cancer cell line MDA-MB-231 that forms bone metastases was studied using an in vivo-like basement membrane model. The metastatic to bone tumor cells exhibited a 7-fold higher hyaluronan-synthesizing capacity compared with MDA-MB-231 cells predominately due to an increased expression of hyaluronan synthase 2 (HAS2). We found that knockdown of HAS2 completely suppressed the invasive capability of these cells by the induction of tissue metalloproteinase inhibitor 1 (TIMP-1) and dephosphorylation of focal adhesion kinase. HAS2 knockdown-mediated inhibition of basement membrane remodeling was rescued by HAS2 overexpression, transfection with TIMP-1 siRNA, or addition of TIMP-1-blocking antibodies. Moreover, knockdown of HAS2 suppressed the EGF-mediated induction of the focal adhesion kinase/PI3K/Akt signaling pathway. Thus, this study provides new insights into a possible mechanism whereby HAS2 enhances breast cancer invasion.	[Bernert, Berit; Porsch, Helena; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595, SE-75124 Uppsala, Sweden.	evi.heldin@licr.uu.se			Swedish Cancer Society; Mizutani Foundation for Glycoscience; Agnes and Mac Rudbergs Foundation (Uppsala University)	Swedish Cancer Society(Swedish Cancer Society); Mizutani Foundation for Glycoscience; Agnes and Mac Rudbergs Foundation (Uppsala University)	The work was supported by grants from the Swedish Cancer Society, the Mizutani Foundation for Glycoscience, and the Agnes and Mac Rudbergs Foundation (Uppsala University).	Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; BIRKEDALHANSEN H, 1982, BIOCHEM BIOPH RES CO, V107, P1173, DOI 10.1016/S0006-291X(82)80120-4; Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Corte MD, 2010, J CANCER RES CLIN, V136, P745, DOI 10.1007/s00432-009-0713-2; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DelaTorre M, 1995, ANTICANCER RES, V15, P2791; DELATORRE M, 1993, HUM PATHOL, V24, P1294, DOI 10.1016/0046-8177(93)90262-F; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Heldin P, 1996, ONCOL REP, V3, P1011; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Hibbard MK, 2000, CANCER RES, V60, P4869; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jacobson A, 2002, INT J CANCER, V102, P212, DOI 10.1002/ijc.10683; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Persson U, 1997, J BIOL CHEM, V272, P21187, DOI 10.1074/jbc.272.34.21187; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Schraufstatter Ingrid, 2009, J Stem Cells, V4, P191, DOI jsc.2010.4.4.191; Schrohl AS, 2004, CLIN CANCER RES, V10, P2289, DOI 10.1158/1078-0432.CCR-03-0360; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Unger K, 2010, ENDOCR-RELAT CANCER, V17, P87, DOI 10.1677/ERC-09-0065; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	68	81	85	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42349	42359		10.1074/jbc.M111.278598	http://dx.doi.org/10.1074/jbc.M111.278598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22016393	Green Published, hybrid			2022-12-25	WOS:000298180900044
J	Burdina, AO; Klosterman, SM; Shtessel, L; Ahmed, S; Richmond, JE				Burdina, Anna O.; Klosterman, Susan M.; Shtessel, Ludmila; Ahmed, Shawn; Richmond, Janet E.			In Vivo Analysis of Conserved C. elegans Tomosyn Domains	PLOS ONE			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; REGULATES EXOCYTOSIS; FUSION; IDENTIFICATION; MEMBRANE; PROTEINS; UNC-13; CELLS; FORMS	Neurosecretion is critically dependent on the assembly of a macromolecular complex between the SNARE proteins syntaxin, SNAP-25 and synaptobrevin. Evidence indicates that the binding of tomosyn to syntaxin and SNAP-25 interferes with this assembly, thereby negatively regulating both synaptic transmission and peptide release. Tomosyn has two conserved domains: an N-terminal encompassing multiple WD40 repeats predicted to form two beta-propeller structures and a C-terminal SNARE-binding motif. To assess the function of each domain, we performed an in vivo analysis of the N- and C-terminal domains of C. elegans tomosyn (TOM-1) in a tom-1 mutant background. We verified that both truncated TOM-1 constructs were transcribed at levels comparable to rescuing full-length TOM-1, were of the predicted size, and localized to synapses. Unlike full-length TOM-1, expression of the N- or C-terminal domains alone was unable to restore inhibitory control of synaptic transmission in tom-1 mutants. Similarly, co-expression of both domains failed to restore TOM-1 function. In addition, neither the N-nor C-terminal domain inhibited release when expressed in a wild-type background. Based on these results, we conclude that the ability of tomosyn to regulate neurotransmitter release in vivo depends on the physical integrity of the protein, indicating that both N- and C-terminal domains are necessary but not sufficient for effective inhibition of release in vivo.	[Burdina, Anna O.; Klosterman, Susan M.; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Shtessel, Ludmila; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Burdina, AO (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jer@uic.edu			National Institutes of Health [RO1 MH073156]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant RO1 MH073156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HORZ HP, MONITORING MICROBIAL; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; YAMAMOTO Y, J BIOL CHEM, V285, P40943; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zheng Q, 2011, DEVELOPMENT, V138, P87, DOI 10.1242/dev.055350	27	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26185	10.1371/journal.pone.0026185	http://dx.doi.org/10.1371/journal.pone.0026185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022557	gold, Green Submitted, Green Published			2022-12-25	WOS:000295981600034
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification of Intracellular and Plasma Membrane Calcium Channel Homologues in Pathogenic Parasites	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; BLOOD FLUKE SCHISTOSOMA; OPERATED CA2+ ENTRY; MUSCLE RYANODINE RECEPTOR; SURFACE ANION CHANNEL; VOLTAGE-GATED SODIUM; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; LEISHMANIA-DONOVANI; GENOME SEQUENCE	Ca2+ channels regulate many crucial processes within cells and their abnormal activity can be damaging to cell survival, suggesting that they might represent attractive therapeutic targets in pathogenic organisms. Parasitic diseases such as malaria, leishmaniasis, trypanosomiasis and schistosomiasis are responsible for millions of deaths each year worldwide. The genomes of many pathogenic parasites have recently been sequenced, opening the way for rational design of targeted therapies. We analyzed genomes of pathogenic protozoan parasites as well as the genome of Schistosoma mansoni, and show the existence within them of genes encoding homologues of mammalian intracellular Ca2+ release channels: inositol 1,4,5-trisphosphate receptors (IP(3)Rs), ryanodine receptors (RyRs), two-pore Ca2+ channels (TPCs) and intracellular transient receptor potential (Trp) channels. The genomes of Trypanosoma, Leishmania and S. mansoni parasites encode IP3R/RyR and Trp channel homologues, and that of S. mansoni additionally encodes a TPC homologue. In contrast, apicomplexan parasites lack genes encoding IP3R/RyR homologues and possess only genes encoding TPC and Trp channel homologues (Toxoplasma gondii) or Trp channel homologues alone. The genomes of parasites also encode homologues of mammalian Ca2+ influx channels, including voltage-gated Ca2+ channels and plasma membrane Trp channels. The genome of S. mansoni also encodes Orai Ca2+ channel and STIM Ca2+ sensor homologues, suggesting that store-operated Ca2+ entry may occur in this parasite. Many anti-parasitic agents alter parasite Ca2+ homeostasis and some are known modulators of mammalian Ca2+ channels, suggesting that parasite Ca2+ channel homologues might be the targets of some current anti-parasitic drugs. Differences between human and parasite Ca2+ channels suggest that pathogen-specific targeting of these channels may be an attractive therapeutic prospect.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665	St. John's College, Cambridge; Wellcome Trust	St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres Senior Research Associateship from St. John's College, Cambridge (to DLP) and by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439, DOI 10.1093/nar/gkl777; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Bentley GN, 2007, PARASITOLOGY, V134, P833, DOI 10.1017/S0031182006002162; Bentley GN, 2004, GENE, V329, P27, DOI 10.1016/j.gene.2003.12.009; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biel M, 1996, TRENDS CARDIOVAS MED, V6, P274, DOI 10.1016/S1050-1738(96)00105-3; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CASEMORE D. P., 1997, CRYPTOSPORIDIUM CRYP, P65; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chenik M, 2005, PARASITOL RES, V98, P5, DOI 10.1007/s00436-005-0012-z; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; CLARKSON AB, 1982, SCIENCE, V216, P1321, DOI 10.1126/science.6805075; Cudmore Sarah L, 2010, J Infect Public Health, V3, P47, DOI 10.1016/j.jiph.2010.01.003; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Day TA, 2000, PARASITOLOGY, V120, P417, DOI 10.1017/S0031182099005594; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; DOCAMPO R, 1993, MOL BIOCHEM PARASIT, V59, P305, DOI 10.1016/0166-6851(93)90228-P; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2007, MEM I OSWALDO CRUZ, V102, P329, DOI 10.1590/S0074-02762007000300012; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Greenberg RM, 2005, PARASITOLOGY, V131, pS97, DOI 10.1017/S0031182005008346; Greenberg RM, 2005, INT J PARASITOL, V35, P1, DOI 10.1016/j.ijpara.2004.09.004; Gupta S, 2006, EXP PARASITOL, V113, P161, DOI 10.1016/j.exppara.2005.12.020; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hohenegger M, 1996, MOL PHARMACOL, V50, P1443; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; Jones ML, 2009, MOL BIOCHEM PARASIT, V168, P55, DOI 10.1016/j.molbiopara.2009.06.007; Kang MS, 2005, MOL PHARMACOL, V68, P34, DOI 10.1124/mol.104.010553; Klauke N, 2000, J MEMBRANE BIOL, V174, P141, DOI 10.1007/s002320001039; Kohn AB, 2001, PARASITOLOGY, V123, P489, DOI 10.1017/S0031182001008691; Kohn AB, 2001, J BIOL CHEM, V276, P36873, DOI 10.1074/jbc.C100273200; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lalle Marco, 2010, Infectious Disorders - Drug Targets, V10, P283; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; LEY V, 1988, J EXP MED, V168, P649, DOI 10.1084/jem.168.2.649; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lisk G, 2006, EUKARYOT CELL, V5, P1882, DOI 10.1128/EC.00212-06; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi H, 2008, ANNOTATION TOXOPLASM; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Martins VD, 2010, J BIOL CHEM, V285, P30906, DOI 10.1074/jbc.M110.142190; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; Mendonca-Silva DL, 2006, PARASITOLOGY, V133, P67, DOI 10.1017/S0031182006000023; Mendoza M, 2008, PARASITOLOGY, V135, P1303, DOI 10.1017/S0031182008004903; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moreno SNJ, 2009, J EUKARYOT MICROBIOL, V56, P208, DOI 10.1111/j.1550-7408.2009.00404.x; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; MORENO SNJ, 1992, MOL BIOCHEM PARASIT, V52, P251, DOI 10.1016/0166-6851(92)90057-Q; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; Nagamune Kisaburo, 2008, V47, P70; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; PHILOSOPH H, 1989, J BIOL CHEM, V264, P10420; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prasad A, 2001, MOL CELL BIOCHEM, V224, P39, DOI 10.1023/A:1011965109446; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; RAHA S, 1994, MOL BIOCHEM PARASIT, V65, P63, DOI 10.1016/0166-6851(94)90115-5; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Reimao JQ, 2010, BIOORGAN MED CHEM, V18, P8044, DOI 10.1016/j.bmc.2010.09.015; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; SARKAR D, 1995, FEBS LETT, V375, P83, DOI 10.1016/0014-5793(95)01161-7; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; Serrano-Martin X, 2009, ANTIMICROB AGENTS CH, V53, P1403, DOI 10.1128/AAC.01215-08; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Sitsapesan R, 1996, J MEMBRANE BIOL, V153, P93, DOI 10.1007/s002329900113; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; Tempone AG, 2009, PARASITOL RES, V105, P499, DOI 10.1007/s00436-009-1427-8; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; Valderramos SG, 2010, ANTIMICROB AGENTS CH, V54, P3842, DOI 10.1128/AAC.00121-10; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wolstenholme AJ, 2011, ADV EXP MED BIOL, V704, P359, DOI 10.1007/978-94-007-0265-3_20; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; YU FH, 2004, SCI STKE; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	148	84	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26218	10.1371/journal.pone.0026218	http://dx.doi.org/10.1371/journal.pone.0026218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022573	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600040
J	Naish, S; Hu, WB; Mengersen, K; Tong, SL				Naish, Suchithra; Hu, Wenbiao; Mengersen, Kerrie; Tong, Shilu			Spatio-Temporal Patterns of Barmah Forest Virus Disease in Queensland, Australia	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; NEW-SOUTH-WALES; GEOGRAPHIC INFORMATION-SYSTEMS; CLIMATE-CHANGE; ENVIRONMENTAL-FACTORS; SPATIAL AUTOCORRELATION; ARBOVIRUS DISEASES; MURRAY VALLEY; HEALTH; TRANSMISSION	Background: Barmah Forest virus (BFV) disease is a common and wide-spread mosquito-borne disease in Australia. This study investigated the spatio-temporal patterns of BFV disease in Queensland, Australia using geographical information system (GIS) tools and geostatistical analysis. Methods/Principal Findings: We calculated the incidence rates and standardised incidence rates of BFV disease. Moran's I statistic was used to assess the spatial autocorrelation of BFV incidences. Spatial dynamics of BFV disease was examined using semi-variogram analysis. Interpolation techniques were applied to visualise and display the spatial distribution of BFV disease in statistical local areas (SLAs) throughout Queensland. Mapping of BFV disease by SLAs reveals the presence of substantial spatio-temporal variation over time. Statistically significant differences in BFV incidence rates were identified among age groups (x(2) = 7587, df = 7327, p<0.01). There was a significant positive spatial autocorrelation of BFV incidence for all four periods, with the Moran's I statistic ranging from 0.1506 to 0.2901 (p<0.01). Semi-variogram analysis and smoothed maps created from interpolation techniques indicate that the pattern of spatial autocorrelation was not homogeneous across the state. Conclusions/Significance: This is the first study to examine spatial and temporal variation in the incidence rates of BFV disease across Queensland using GIS and geostatistics. The BFV transmission varied with age and gender, which may be due to exposure rates or behavioural risk factors. There are differences in the spatio-temporal patterns of BFV disease which may be related to local socio-ecological and environmental factors. These research findings may have implications in the BFV disease control and prevention programs in Queensland.	[Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	Naish, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	s.naish@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Hu, Wenbiao/0000-0001-6422-9240	QUT; NHMRC [553043, 519788]	QUT; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	SN is supported by a QUT Scholarship. ST is supported by an NHMRC Research Fellowship (#553043) and WH is funded an NHMRC Postdoctoral Research Training Fellowship (#519788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, MAPINFO PROF SOFTW M; [Anonymous], 2011, MAPINFO PROF SOFTW V; [Anonymous], 2007, KEY CONCEPTS TECHNIQ; Anselin L., 2019, GEODA WORKBOOK; Australian Bureau of Statistics, 2006, CENS POP HOUS BAS CO; Australian Bureau of Statistics, 2008, AUSTR DEM STAT SEPT; Australian Bureau of Statistics, 2009, CENS POP HOUS BAS CO; Bell N, 2008, INJURY PREV, V14, P346, DOI 10.1136/ip.2008.018903; Bi P, 2000, J EPIDEMIOL COMMUN H, V54, P69, DOI 10.1136/jech.54.1.69; Bonet M, 2007, INT J OCCUP ENV HEAL, V13, P188, DOI 10.1179/oeh.2007.13.2.188; BOUGHTON CR, 1984, MED J AUSTRALIA, V141, P700, DOI 10.5694/j.1326-5377.1984.tb113225.x; Boyd AM, 2002, AUST VET J, V80, P83, DOI 10.1111/j.1751-0813.2002.tb12057.x; Boyd AM, 2001, AM J TROP MED HYG, V65, P777, DOI 10.4269/ajtmh.2001.65.777; Breslow NE, 1987, STAT METHODS CANC RE, VII, P59; Carl G, 2007, ECOL MODEL, V207, P159, DOI 10.1016/j.ecolmodel.2007.04.024; Cleveland WS, VISUALISING DATA; Dale PER, 1998, J VECTOR ECOL, V23, P54; Dalgarno L, 1999, ENCY VIROLOGY, P1570; Department of Health and Ageing, 2009, NAT NOT DIS SURV SYS; Dhileepan K, 1996, MED VET ENTOMOL, V10, P375, DOI 10.1111/j.1365-2915.1996.tb00760.x; Doggett SL, 1999, J MED ENTOMOL, V36, P861, DOI 10.1093/jmedent/36.6.861; DOHERTY RL, 1979, AUST J EXP BIOL MED, V57, P509, DOI 10.1038/icb.1979.52; DOHERTY RL, 1972, AUST VET J, V48, P172, DOI 10.1111/j.1751-0813.1972.tb09267.x; EH Isaaks, 1989, INTRO APPL GEOSTATIS, P249; Fisher N. I., 1987, STAT ANAL SPHERICAL; Fitzsimmons GJ, 2009, COMMUN DIS INTELL, V33, P155; Flexman JP, 1998, MED J AUSTRALIA, V169, P159, DOI 10.5694/j.1326-5377.1998.tb116019.x; Gatton ML, 2004, AM J TROP MED HYG, V71, P629, DOI 10.4269/ajtmh.2004.71.629; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Hills SL, 1997, ARBOVIRUS RES AUST, V7, P95; Hu WB, 2007, AM J TROP MED HYG, V76, P814, DOI 10.4269/ajtmh.2007.76.814; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jacups SP, 2008, VECTOR-BORNE ZOONOT, V8, P283, DOI 10.1089/vbz.2007.0152; Kelly-Hope LA, 2002, AUST NZ J PUBL HEAL, V26, P69, DOI 10.1111/j.1467-842X.2002.tb00274.x; LaBeaud AD, 2008, GEOSPATIAL HEALTH, V2, P215, DOI 10.4081/gh.2008.245; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Liu C, 2008, COMMUN DIS INTELL, V32, P31; Mackenzie J S, 1998, Commun Dis Intell, V22, P93; MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P457, DOI 10.1038/icb.1982.51; Merianos A, 1992, COMMUN DIS INTELL, V16, P110; Miller M, 2005, COMMUN DIS INTELL, V29, P1; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Naish S, 2006, ENVIRON HEALTH PERSP, V114, P678, DOI 10.1289/ehp.8568; Naish S, 2009, TROP MED INT HEALTH, V14, P247, DOI 10.1111/j.1365-3156.2008.02217.x; Olano JP, 2009, AGENTS EMERGING INFE, P1; OLIVER MA, 1992, J PUBLIC HEALTH MED, V14, P280; Poidinger M, 1997, AM J TROP MED HYG, V57, P230, DOI 10.4269/ajtmh.1997.57.230; Queensland Department of Health, 2009, NAT NOT DIS SURV SYS; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Rezaeian M, 2007, J EPIDEMIOL COMMUN H, V61, P98, DOI 10.1136/jech.2005.043117; RN Parker, 2008, GIS SPATIAL ANAL SOC; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell R. C., 1994, Bulletin of the Society for Vector Ecology, V19, P73; Russell RC, 1998, J VECTOR ECOL, V23, P1; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100; Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; Selvin S., 1996, STAT ANAL EPIDEMIOLO; SIMPSON DIH, 1972, BRIT MED BULL, V28, P10, DOI 10.1093/oxfordjournals.bmb.a070876; Sipe NG, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-36; Smith DW, 2008, TOGAVIRUSES CAUSING, P83; Sweeny A, 2009, QUEENSLAND HLTH NOTI; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Tong S, 2005, INT J ENVIRON HEAL R, V15, P89, DOI 10.1080/09603120500062060; Tong S, 2004, INTERN MED J, V34, P58, DOI 10.1111/j.1444-0903.2004.00520.x; Tran A, 2004, EMERG INFECT DIS, V10, P615, DOI 10.3201/eid1004.030186; VALE TG, 1991, AUST J ZOOL, V39, P1, DOI 10.1071/ZO9910001; Waller L.A., 2004, APPL SPATIAL STAT PU; Weinstein P, 1997, ENVIRON HEALTH PERSP, V105, P364, DOI 10.2307/3433322; Woodruff RE, 2006, EPIDEMIOLOGY, V17, P569, DOI 10.1097/01.ede.0000229467.92742.7b; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034	73	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25688	10.1371/journal.pone.0025688	http://dx.doi.org/10.1371/journal.pone.0025688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022430	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600026
J	Passacquale, G; Vamadevan, P; Pereira, L; Hamid, C; Corrigall, V; Ferro, A				Passacquale, Gabriella; Vamadevan, Padman; Pereira, Luis; Hamid, Colleen; Corrigall, Valerie; Ferro, Albert			Monocyte-Platelet Interaction Induces a Pro-Inflammatory Phenotype in Circulating Monocytes	PLOS ONE			English	Article							PROSTAGLANDIN E-2; EXPRESSION; ACTIVATION; ADHESION	Background: Activated platelets exert a pro-inflammatory action that can be largely ascribed to their ability to interact with leukocytes and modulate their activity. We hypothesized that platelet activation and consequent formation of monocyte-platelet aggregates (MPA) induces a pro-inflammatory phenotype in circulating monocytes. Methodology/Principal Findings: CD62P(+) platelets and MPA were measured, and monocytes characterized, by whole blood flow cytometry in healthy subjects, before and two days after receiving influenza immunization. Three monocytic subsets were identified: CD14(+) CD16(-), CD14(high) CD16(+) and CD14(low) CD16(+). The increase in high sensitivity C-reactive protein post-immunization was accompanied by increased platelet activation and MPA formation (25.02 +/- 12.57 vs 41.48 +/- 16.81; p = 0.01), along with enhancement of circulating CD14(high) CD16(+) cells (4.7 +/- 3.6 vs 10.4 +/- 4.8; p = 0.003), their percentage being linearly related to levels of CD62P(+)-platelets (r(2) = 0.4347; p = 0.0008). In separate in vitro experiments, co-incubation of CD14(+)CD16(-) cells, isolated from healthy donor subjects, with autologous platelets gave rise to up-regulation of CD16 on monocytes as compared with those maintained in medium alone (% change in CD14(+) CD16(+) cells following 48 h co-incubation of monocytes with platelets was +106 +/- 51% vs monocytes in medium alone; p<0.001). This effect correlated directly with degree of MPA formation (r(2) = 0.7731; p<0.0001) and was associated with increased monocyte adhesion to endothelial cells. P-selectin glycoprotein ligand-1 (PSGL-1) blocking antibody, which abrogates MPA formation, abolished these effects, as did the cyclooxygenase (COX)-2 selective inhibitor NS-398, aspirin and the EP1/EP2-selective antagonist AH6809. Conclusions/Significance: These data suggest that MPA formation, as occurs in the blood under pro-inflammatory conditions, expands the pool of circulating CD14(high) CD16(+) monocytes in a COX-2 dependent manner, and these monocytes exhibit increased adhesion to endothelium. Our findings delineate a novel mechanism underlying the pro-inflammatory effect of platelet activation.	[Passacquale, Gabriella; Vamadevan, Padman; Pereira, Luis; Hamid, Colleen; Ferro, Albert] Kings Coll London, Cardiovasc Div, Dept Clin Pharmacol, London WC2R 2LS, England; [Corrigall, Valerie] Kings Coll London, Acad Dept Rheumatol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Passacquale, G (corresponding author), Kings Coll London, Cardiovasc Div, Dept Clin Pharmacol, London WC2R 2LS, England.	albert.ferro@kcl.ac.uk		Ferro, Albert/0000-0002-5486-9145	Guy's and St Thomas' Charity	Guy's and St Thomas' Charity	The study was funded by an Advanced Training fellowship to Dr. Passacquale from the Guy's and St Thomas' Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon C, 1998, J LEUKOCYTE BIOL, V63, P469, DOI 10.1002/jlb.63.4.469; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P246, DOI 10.1161/01.ATV.0000104005.92603.f2; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Gkaliagkousi E, 2009, EUR HEART J, V30, P3048, DOI 10.1093/eurheartj/ehp330; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Htun P, 2006, STROKE, V37, P2283, DOI 10.1161/01.STR.0000236638.75591.61; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Joseph JE, 2001, BRIT J HAEMATOL, V115, P451, DOI 10.1046/j.1365-2141.2001.03101.x; Kato M, 2001, J PHARM PHARMACOL, V53, P1679, DOI 10.1211/0022357011778070; Kubo N, 2000, J LIPID RES, V41, P1060; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Meja KK, 1997, BRIT J PHARMACOL, V122, P149, DOI 10.1038/sj.bjp.0701360; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; Posthouwer D, 2004, VACCINE, V23, P362, DOI 10.1016/j.vaccine.2004.05.035; Smout J, 2009, ANGIOLOGY, V60, P362, DOI 10.1177/0003319709332959; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	25	138	148	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25595	10.1371/journal.pone.0025595	http://dx.doi.org/10.1371/journal.pone.0025595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022418	Green Published, Green Submitted			2022-12-25	WOS:000295976000024
J	Wang, XY; Fan, J; Liu, D; Fu, SQ; Ingvarsson, S; Chen, HP				Wang, Xiyin; Fan, Jing; Liu, Dong; Fu, Siqing; Ingvarsson, Sigurdur; Chen, Huiping			Spreading of Alu Methylation to the Promoter of the MLH1 Gene in Gastrointestinal Cancer	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DE-NOVO METHYLATION; HMLH1 PROMOTER; CELL-LINES; SITES; HYPOMETHYLATION; EXPRESSION; UPSTREAM; PATTERNS; ELEMENTS	The highly repetitive Alu retroelements are regarded as methylation centres in the genome. Methylation in the gene promoters could be spreading from them. Promoter methylation of MLH1 is frequently detected in cancers, but the underlying mechanism is unclear. The aim of this study is to understand whether the methylation in the Alu elements is associated with promoter methylation in the MLH1 gene. Bisulfite genomic sequencing was used to analyse the CpG sites of the 59 end (promoter, exon 1 and Alu-containing intron 1) of the MLH1 gene in colorectal cancer cells and tissues, and gastric cancer tissues. Hypomethylation in the Alu elements and hypermethylation in the promoters and the regions between the promoters and the Alu elements were detected in two cancer cell lines and seven cancer tissues. However, demethylation or hypomethylation of the MLH1 promoter and regions between promoter and the Alu elements, and hypermethylation in the Alu elements, were identified in the normal tissues. MLH1 promoter methylation may spread from Alu elements that are located in intron 1 of the MLH1 gene. The trans-acting elements binding to the mutation sites could play a role in the methylation spreading.	[Wang, Xiyin; Fan, Jing; Liu, Dong; Fu, Siqing; Chen, Huiping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan 430074, Hubei, Peoples R China; [Ingvarsson, Sigurdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland, Fac Med, Reykjavik, Iceland	Huazhong University of Science & Technology; University of Iceland; University of Iceland	Wang, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan 430074, Hubei, Peoples R China.	huiping@mail.hust.edu.cn	Wang, Xiyin/AAF-4747-2019; Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714; Wang, Xiyin/0000-0002-3642-9373	Huazhong University of Science and Technology [2010MS034]	Huazhong University of Science and Technology	This project was supported by the Huazhong University of Science and Technology (2010MS034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Deng GR, 1999, CANCER RES, V59, P2029; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kang GH, 2002, PATHOL INT, V52, P764, DOI 10.1046/j.1440-1827.2002.01423.x; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Mei MX, 2010, CANCER EPIDEMIOL, V34, P93, DOI 10.1016/j.canep.2009.12.009; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Turker MS, 1997, MUTAT RES-REV MUTAT, V386, P119, DOI 10.1016/S1383-5742(96)00048-8; Xiang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-44	15	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25913	10.1371/journal.pone.0025913	http://dx.doi.org/10.1371/journal.pone.0025913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022465	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000045
J	Yuan, QX; Chen, L; Liu, CP; Xu, KF; Mao, XD; Liu, C				Yuan, Qingxin; Chen, Lu; Liu, Cuiping; Xu, Kuanfeng; Mao, Xiaodong; Liu, Chao			Postnatal Pancreatic Islet beta Cell Function and Insulin Sensitivity at Different Stages of Lifetime in Rats Born with Intrauterine Growth Retardation	PLOS ONE			English	Article							THRIFTY PHENOTYPE HYPOTHESIS; LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; ENDOCRINE PANCREAS; CHILDHOOD GROWTH; ADIPOSE-TISSUE; FETAL; RESTRICTION; OBESITY; ORIGINS	Epidemiological studies have linked intrauterine growth retardation (IUGR) to the metabolic diseases, consisting of insulin resistance, type 2 diabetes, obesity and coronary artery disease, during adult life. To determine the internal relationship between IUGR and islet beta cell function and insulin sensitivity, we established the IUGR model by maternal nutrition restriction during mid- to late-gestation. Glucose tolerance test and insulin tolerance test(ITT) in vivo and glucose stimulated insulin secretion(GSIS) test in vitro were performed at different stages in IUGR and normal groups. Body weight, pancreas weight and pancreas/body weight of IUGR rats were much lower than those in normal group before 3 weeks of age. While the growth of IUGR rats accelerated after 3 weeks, pancreas weight and pancreas/body weight remained lower till 15 weeks of age. In the newborns, the fasting glucose and insulin levels of IUGR rats were both lower than those of controls, whereas glucose levels at 120 and 180 min after glucose load were significantly higher in IUGR group. Between 3 and 15 weeks of age, both the fasting glucose and insulin levels were elevated and the glucose tolerance was impaired with time in IUGR rats. At age 15 weeks, the area under curve of insulin(AUCi) after glucose load in IUGR rats elevated markedly. Meanwhile, the stimulating index of islets in IUGR group during GSIS test at age 15 weeks was significantly lower than that of controls. ITT showed no significant difference in two groups before 7 weeks of age. However, in 15-week-old IUGR rats, there was a markedly blunted glycemic response to insulin load compared with normal group. These findings demonstrate that IUGR rats had both impaired pancreatic development and deteriorated glucose tolerance and insulin sensitivity, which would be the internal causes why they were prone to develop type 2 diabetes.	[Yuan, Qingxin; Chen, Lu; Liu, Cuiping; Xu, Kuanfeng; Mao, Xiaodong; Liu, Chao] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yuan, QX (corresponding author), Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	drliuchaonj@126.com			Chinese Jiangsu province major subject grant [SK200214]	Chinese Jiangsu province major subject grant	This research was supported by a Chinese Jiangsu province major subject grant SK200214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOKAS RA, 1986, J NUTR, V116, P412, DOI 10.1093/jn/116.3.412; Anazawa S, 2003, DIABETES CARE, V26, P2210, DOI 10.2337/diacare.26.7.2210; Beringue F, 2002, DIABETES, V51, P385, DOI 10.2337/diabetes.51.2.385; Bispham J, 2005, ENDOCRINOLOGY, V146, P3943, DOI 10.1210/en.2005-0246; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Green AS, 2010, J ENDOCRINOL, V205, P211, DOI 10.1677/JOE-09-0399; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Iliadou A, 2004, INT J EPIDEMIOL, V33, P948, DOI 10.1093/ije/dyh117; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Lane RH, 2001, BRAIN RES, V895, P186, DOI 10.1016/S0006-8993(01)02074-1; LangleyEvans SC, 1997, J HYPERTENS, V15, P537, DOI 10.1097/00004872-199715050-00010; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; [刘翠萍 LIU Cuiping], 2007, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V27, P242; Liu XM, 2006, PANCREAS, V32, P9, DOI 10.1097/01.mpa.0000191647.40044.58; Muhlhausler BS, 2005, J PHYSIOL-LONDON, V565, P185, DOI 10.1113/jphysiol.2004.079079; NICOLINI U, 1990, HORM METAB RES, V22, P426, DOI 10.1055/s-2007-1004939; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Sadiq HF, 1998, PEDIATR RES, V43, P91, DOI 10.1203/00006450-199801000-00014; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Shen QA, 2011, NUTRITION, V27, P364, DOI 10.1016/j.nut.2010.03.003; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Styrud J, 2005, BIOL NEONATE, V88, P122, DOI 10.1159/000086136; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Yuan QX, 2010, HORM METAB RES, V42, P491, DOI 10.1055/s-0030-1249058	39	22	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25167	10.1371/journal.pone.0025167	http://dx.doi.org/10.1371/journal.pone.0025167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022381	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000011
J	Cook, D; Sanchez-Carbente, MD; Lachance, C; Radzioch, D; Tremblay, S; Khandjian, EW; DesGroseillers, L; Murai, KK				Cook, Denise; Sanchez-Carbente, Maria del Rayo; Lachance, Claude; Radzioch, Danuta; Tremblay, Sandra; Khandjian, Edouard W.; DesGroseillers, Luc; Murai, Keith K.			Fragile X Related Protein 1 Clusters with Ribosomes and Messenger RNAs at a Subset of Dendritic Spines in the Mouse Hippocampus	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; ACTIVITY-DEPENDENT TRAFFICKING; MAMMALIAN STRESS GRANULES; SYNAPTIC PLASTICITY; BINDING PROTEINS; NEURONS; FXR1; FMRP; TRANSLATION; LOCALIZATION	The formation and storage of memories in neuronal networks relies on new protein synthesis, which can occur locally at synapses using translational machinery present in dendrites and at spines. These new proteins support long-lasting changes in synapse strength and size in response to high levels of synaptic activity. To ensure that proteins are made at the appropriate time and location to enable these synaptic changes, messenger RNA (mRNA) translation is tightly controlled by dendritic RNA-binding proteins. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein with high homology to Fragile X Mental Retardation Protein (FMRP) and is known to repress and activate mRNA translation in non-neuronal cells. However, unlike FMRP, very little is known about the role of FXR1P in the central nervous system. To understand if FXR1P is positioned to regulate local mRNA translation in dendrites and at synapses, we investigated the expression and targeting of FXR1P in developing hippocampal neurons in vivo and in vitro. We found that FXR1P was highly expressed during hippocampal development and co-localized with ribosomes and mRNAs in the dendrite and at a subset of spines in mouse hippocampal neurons. Our data indicate that FXR1P is properly positioned to control local protein synthesis in the dendrite and at synapses in the central nervous system.	[Cook, Denise; Murai, Keith K.] McGill Univ, Ctr Res Neurosci, Montreal Gen Hosp, Dept Neurol & Neurosurg,Res Inst,Hlth Ctr, Montreal, PQ H3A 2T5, Canada; [Sanchez-Carbente, Maria del Rayo; DesGroseillers, Luc] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Lachance, Claude; Radzioch, Danuta] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 2T5, Canada; [Tremblay, Sandra; Khandjian, Edouard W.] Univ Laval, Ctr Rech Robert Giffard, Quebec City, PQ, Canada	McGill University; Universite de Montreal; McGill University; Laval University	Cook, D (corresponding author), McGill Univ, Ctr Res Neurosci, Montreal Gen Hosp, Dept Neurol & Neurosurg,Res Inst,Hlth Ctr, Montreal, PQ H3A 2T5, Canada.	keith.murai@mcgill.ca	Lachance, Claude/A-4214-2012; del Rayo Sánchez, Maria/AAG-3615-2020	Lachance, Claude/0000-0002-1974-1787; del Rayo Sánchez, Maria/0000-0001-9586-3033; Radzioch, Danuta/0000-0002-1601-2757; Cook, Denise/0000-0002-8837-1492	Canadian Institutes of Health Research, Canadian Foundation for Innovation; National Institutes of Health (USA) [1R21DA026053-01]; Frederick Banting and Charles Best CIHR; FRSQ; Canadian Institutes of Health Research; NSERC; Consejo Nacional de Ciencia y Tecnologia (CONACYT); NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026053] Funding Source: NIH RePORTER	Canadian Institutes of Health Research, Canadian Foundation for Innovation(Canada Foundation for InnovationCanadian Institutes of Health Research (CIHR)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick Banting and Charles Best CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Canadian Institutes of Health Research, Canada Research Chairs Program, Canadian Foundation for Innovation and the National Institutes of Health grant 1R21DA026053-01 (USA) (K.K.M.). D.C. was supported through a Frederick Banting and Charles Best CIHR Doctoral Research Award and an FRSQ Doctoral Award. L.D.G. was funded by the Canadian Institutes of Health Research, E.W. K. by the NSERC, and M.d.R.S-C. received a postdoctoral fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; HARRELL FE, 2003, HMISC S FUNCTION LIB; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Huot ME, 2001, HUM MOL GENET, V10, P2803, DOI 10.1093/hmg/10.24.2803; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1998, HUM MOL GENET, V7, P2121, DOI 10.1093/hmg/7.13.2121; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Knowles RB, 1996, J NEUROSCI, V16, P7812; KOSIK KS, 2002, SCI STKE, pPE16; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Levenga J, 2009, NEUROBIOL DIS, V35, P241, DOI 10.1016/j.nbd.2009.05.004; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LO DC, 2001, CURR PROTOC NEUROSCI, V15, pCH3; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Say E, 2010, MOL CELL, V38, P236, DOI 10.1016/j.molcel.2010.04.004; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; STEWARD O, 1985, J NEUROSCI RES, V13, P75, DOI 10.1002/jnr.490130106; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Team R. D. C, 2011, R LANG ENV STAT COMP; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; TORRE ER, 1992, J NEUROSCI, V12, P762; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZINCHUK V, 2008, CURR PROTOC CELL BIO, V19, pCH4; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	67	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26120	10.1371/journal.pone.0026120	http://dx.doi.org/10.1371/journal.pone.0026120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022532	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200039
J	Ayrapetov, MK; Xu, C; Sun, YL; Zhu, KY; Parmar, K; D'Andrea, AD; Price, BD				Ayrapetov, Marina K.; Xu, Chang; Sun, Yingli; Zhu, Kaya; Parmar, Kalindi; D'Andrea, Alan D.; Price, Brendan D.			Activation of Hif1 alpha by the Prolylhydroxylase Inhibitor Dimethyoxalyglycine Decreases Radiosensitivity	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLASE INHIBITORS; GENE-EXPRESSION; DNA-DAMAGE; PROLINE HYDROXYLATION; HISTONE DEMETHYLASES; HUMAN CANCERS; JMJD2 FAMILY; TUMOR-GROWTH; GAMMA-RAYS	Hypoxia inducible factor 1 alpha (Hif1 alpha) is a stress responsive transcription factor, which regulates the expression of genes required for adaption to hypoxia. Hif1 alpha is normally hydroxylated by an oxygen-dependent prolylhydroxylase, leading to degradation and clearance of Hif1 alpha from the cell. Under hypoxic conditions, the activity of the prolylhydroxylase is reduced and Hif1 alpha accumulates. Hif1 alpha is also constitutively expressed in tumor cells, where it is associated with resistance to ionizing radiation. Activation of the Hif1 alpha transcriptional regulatory pathway may therefore function to protect normal cells from DNA damage caused by ionizing radiation. Here, we utilized the prolylhydroxylase inhibitor dimethyloxalylglycine (DMOG) to elevate Hif1 alpha levels in mouse embryonic fibroblasts (MEFs) to determine if DMOG could function as a radioprotector. The results demonstrate that DMOG increased Hif1 alpha protein levels and decreased the sensitivity of MEFs to ionizing radiation. Further, the ability of DMOG to function as a radioprotector required Hif1 alpha, indicating a key role for Hif1 alpha's transcriptional activity. DMOG also induced the Hif1 alpha-dependent accumulation of several DNA damage response proteins, including CHD4 and MTA3 (sub-units of the NuRD deacetylase complex) and the Suv39h1 histone H3 methyltransferase. Depletion of Suv39h1, but not CHD4 or MTA3, reduced the ability of DMOG to protect cells from radiation damage, implicating increased histone H3 methylation in the radioprotection of cells. Finally, treatment of mice with DMOG prior to total body irradiation resulted in significant radioprotection of the mice, demonstrating the utility of DMOG and related prolylhydroxylase inhibitors to protect whole organisms from ionizing radiation. Activation of Hif1a through prolylhydroxylase inhibition therefore identifies a new pathway for the development of novel radiation protectors.	[Ayrapetov, Marina K.; Xu, Chang; Zhu, Kaya; Parmar, Kalindi; D'Andrea, Alan D.; Price, Brendan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, Boston, MA 02115 USA; [Sun, Yingli] Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Key Lab, Beijing, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Ayrapetov, MK (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	sunyl@big.ac.cn; kalindi_parmar@dfci.harvard.edu; brendan_price@dfci.harvard.edu			National Cancer Institute (NCI) [CA64585, CA93602]; Associates of the Joint Center for Radiation Therapy (AJCRT) foundation; National Institute of Allergy and Infectious Diseases (NIAID) [U19 A1067751]; NATIONAL CANCER INSTITUTE [R01CA064585, R01CA093602] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associates of the Joint Center for Radiation Therapy (AJCRT) foundation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (NCI) (CA64585 and CA93602), the Associates of the Joint Center for Radiation Therapy (AJCRT) foundation and by National Institute of Allergy and Infectious Diseases (NIAID) U19 A1067751 center grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; HALL EJ, 1988, AM J CLIN ONCOL-CANC, V11, P220, DOI 10.1097/00000421-198806000-00003; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2007.01676.x; Kim SH, 2007, ONCOL REP, V17, P647; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Liu XB, 2009, J CELL BIOCHEM, V106, P903, DOI 10.1002/jcb.22064; Lomb DJ, 2007, J NEUROCHEM, V103, P1897, DOI 10.1111/j.1471-4159.2007.04873.x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; NETA R, 1986, J IMMUNOL, V136, P2483; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; RASEY JS, 1984, RADIAT RES, V97, P598, DOI 10.2307/3576151; Ryan HE, 2000, CANCER RES, V60, P4010; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Schwartz DL, 2010, MOL CANCER THER, V9, P2057, DOI 10.1158/1535-7163.MCT-09-0768; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; TALMADGE JE, 1989, BLOOD, V73, P2093; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; vanOs R, 1997, EXP HEMATOL, V25, P205; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Williams KJ, 2005, RADIOTHER ONCOL, V75, P89, DOI 10.1016/j.radonc.2005.01.009; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhang XW, 2004, CANCER RES, V64, P8139, DOI 10.1158/0008-5472.CAN-03-2301; Zhong H, 1999, CANCER RES, V59, P5830	59	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26064	10.1371/journal.pone.0026064	http://dx.doi.org/10.1371/journal.pone.0026064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016813	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300056
J	Borovjagin, AV; Dong, J; Passineau, MJ; Ren, CC; Lamani, E; Mamaeva, OA; Wu, HJ; Keyser, E; Murakami, M; Chen, S; MacDougall, M				Borovjagin, Anton V.; Dong, Juan; Passineau, Michael J.; Ren, Changchun; Lamani, Ejvis; Mamaeva, Olga A.; Wu, Hongju; Keyser, Enid; Murakami, Miho; Chen, Shuo; MacDougall, Mary			Adenovirus Gene Transfer to Amelogenesis Imperfecta Ameloblast-Like Cells	PLOS ONE			English	Article							CELLULAR ATTACHMENT RECEPTORS; FIBER-MODIFIED ADENOVIRUSES; OVARIAN-CANCER CELLS; ENAMEL MATRIX; TRANSFER EFFICIENCY; EXPRESSION; VECTORS; PROTEIN; ADHESION; COXSACKIEVIRUS	To explore gene therapy strategies for amelogenesis imperfecta (AI), a human ameloblast-like cell population was established from third molars of an AI-affected patient. These cells were characterized by expression of cytokeratin 14, major enamel proteins and alkaline phosphatase staining. Suboptimal transduction of the ameloblast-like cells by an adenovirus type 5 (Ad5) vector was consistent with lower levels of the coxsackie-and-adenovirus receptor (CAR) on those cells relative to CAR-positive A549 cells. To overcome CAR -deficiency, we evaluated capsid-modified Ad5 vectors with various genetic capsid modifications including "pK7'' and/or "RGD'' motif-containing short peptides incorporated in the capsid protein fiber as well as fiber chimera with the Ad serotype 3 (Ad3) fiber "knob'' domain. All fiber modifications provided an augmented transduction of AI-ameloblasts, revealed following vector dose normalization in A549 cells with a superior effect (up to 404-fold) of pK7/RGD double modification. This robust infectivity enhancement occurred through vector binding to both alpha(v)3/alpha(v)beta 5 integrins and heparan sulfate proteoglycans (HSPGs) highly expressed by AI-ameloblasts as revealed by gene transfer blocking experiments. This work thus not only pioneers establishment of human AI ameloblast-like cell population as a model for in vitro studies but also reveals an optimal infectivity-enhancement strategy for a potential Ad5 vector-mediated gene therapy for AI.	[Borovjagin, Anton V.] Univ Alabama Birmingham, Sch Dent, Dept Periodont, Birmingham, AL 35294 USA; [Dong, Juan] Univ Alabama Birmingham, Sch Dent, Dept Orthodont, Birmingham, AL 35294 USA; [Ren, Changchun; Lamani, Ejvis; MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA; [Borovjagin, Anton V.; Dong, Juan; Ren, Changchun; Lamani, Ejvis; Mamaeva, Olga A.; MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Wu, Hongju; Keyser, Enid] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Wu, Hongju; Murakami, Miho] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Passineau, Michael J.] W Penn Allegheny Hlth Syst, Div Cardiovasc Med, Pittsburgh, PA USA; [Passineau, Michael J.] W Penn Allegheny Hlth Syst, Allegheny Singer Res Inst, Pittsburgh, PA USA; [Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Pediat Dent, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Borovjagin, AV (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Periodont, Birmingham, AL 35294 USA.	macdougall@uab.edu	MacDougall, Mary/ABG-8212-2021		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE019802-03, R01 DE019802] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bartlett JD, 1998, CONNECT TISSUE RES, V39, P101, DOI 10.3109/03008209809023916; BELIN MT, 1993, J GEN VIROL, V74, P1485, DOI 10.1099/0022-1317-74-8-1485; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Borovjagin AV, 2005, CANCER GENE THER, V12, P475, DOI 10.1038/sj.cgt.7700806; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Ciuffi A, 2008, CURR GENE THER, V8, P419, DOI 10.2174/156652308786848021; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dhar D, 2009, J VIROL, V83, P2130, DOI 10.1128/JVI.02127-08; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hemminki A, 2003, CANCER RES, V63, P847; Hemminki A, 2001, MOL THER, V4, P223, DOI 10.1006/mthe.2001.0446; Hidaka C, 1999, J CLIN INVEST, V103, P579, DOI 10.1172/JCI5309; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kanerva A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002917; Kasono K, 1999, CLIN CANCER RES, V5, P2571; Kawakami Y, 2003, CANCER RES, V63, P1262; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kochanek S, 2001, CURR OPIN MOL THER, V3, P454; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDougall M, 1998, CONNECT TISSUE RES, V39, P25, DOI 10.3109/03008209809023909; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; Majhen D, 2009, VIRUS RES, V139, P64, DOI 10.1016/j.virusres.2008.10.004; McDonald D, 1999, GENE THER, V6, P1512, DOI 10.1038/sj.gt.3301006; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Murakami M, 2010, PROSTATE, V70, P362, DOI 10.1002/pros.21070; Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1; Muto Taro, 2007, J Med Invest, V54, P331, DOI 10.2152/jmi.54.331; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nettelbeck DM, 2003, ANTI-CANCER DRUG, V14, P577, DOI 10.1097/00001813-200309000-00001; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Reddy PS, 2002, MOL THER, V5, P63, DOI 10.1006/mthe.2001.0510; Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; Stoff-Khalili MA, 2005, CANCER BIOL THER, V4, P1203, DOI 10.4161/cbt.4.11.2084; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Wickham TJ, 1996, NAT BIOTECHNOL, V14, P1570, DOI 10.1038/nbt1196-1570; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; Zalzal SF, 2008, MATRIX BIOL, V27, P352, DOI 10.1016/j.matbio.2008.01.003; Zhen Z, 2004, HUM GENE THER, V15, P709, DOI 10.1089/1043034041361262; ZSENGELLER ZK, 1995, HUM GENE THER, V6, P457, DOI 10.1089/hum.1995.6.4-457	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24281	10.1371/journal.pone.0024281	http://dx.doi.org/10.1371/journal.pone.0024281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003382	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300003
J	Jeanblanc, M; Ragu, S; Gey, C; Contrepois, K; Courbeyrette, R; Thuret, JY; Mann, C				Jeanblanc, M.; Ragu, S.; Gey, C.; Contrepois, K.; Courbeyrette, R.; Thuret, J-Y; Mann, C.			Parallel pathways in RAF-induced senescence and conditions for its reversion	ONCOGENE			English	Article						senescence; DNA damage; oxidative stress; RAF kinase; CKI	ONCOGENE-INDUCED SENESCENCE; NORMAL HUMAN FIBROBLASTS; CELL-CYCLE ARREST; PREMATURE SENESCENCE; HETEROCHROMATIN FORMATION; SIGNALING PATHWAY; IN-VITRO; S-PHASE; KINASE; P53	We developed a clonal WI-38hTERT/GFP-RAF1-ER immortal cell line to study RAF-induced senescence of human fibroblasts. Activation of the GFP-RAF1-ER kinase by addition of 4-hydroxy-tamoxifen led to a robust induction of senescence within one population doubling, accompanied by the assembly of heterochromatic foci. At least two pathways contribute in parallel to this senescence leading to the accumulation of p15, p16, p21 and p27 inhibitors of cyclin-dependent kinases (CKIs). Cells that traversed S phase after RAF1 kinase activation experienced a replicative stress manifested by phosphorylation of H2AX and Chk2 and synthesis of p21. However, about half the cells in the population were blocked without passing through S phase and did not show activation of DNA-damage checkpoints. When the cells were cultivated in 5% oxygen, RAF1 activation generated minimal reactive oxygen species, but RAF-induced senescence occurred efficiently in these conditions even in the presence of anti-oxidants or inhibitors of DNA checkpoint pathways. Despite the presence of heterochromatic foci, simultaneous knockdown of p16 and p21 with inactivation of the GFP-RAF1-ER kinase led to rapid reversion of the senescent state with the majority of cells becoming competent for long-term proliferation. These results demonstrate that replicative and oxidative stresses are not required for RAF-induced senescence, and this senescence is readily reversed upon loss of CKIs. Oncogene (2012) 31, 3072-3085; doi: 10.1038/onc.2011.481; published online 24 October 2011	[Jeanblanc, M.; Ragu, S.; Gey, C.; Contrepois, K.; Courbeyrette, R.; Thuret, J-Y; Mann, C.] CEA Saclay, CEA, Serv Biol Integrat & Genet Mol, iBiTec S, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Mann, C (corresponding author), CEA Saclay, CEA, Serv Biol Integrat & Genet Mol, iBiTec S, Bat 142, F-91191 Gif Sur Yvette, France.	carl.mann@cea.fr		Mann, Carl/0000-0001-7212-1512; Thuret, Jean-Yves/0000-0001-5385-7620	French National Research Agency [ANR-07-BLAN-0098-CSD8]; French Association for Cancer Research [ARC 4917]; French Association for Cancer Research; CEA Irtelis doctoral fellowship through the CEA Plasticity and Instability of the Genome Intramural Program	French National Research Agency(French National Research Agency (ANR)); French Association for Cancer Research; French Association for Cancer Research; CEA Irtelis doctoral fellowship through the CEA Plasticity and Instability of the Genome Intramural Program	We thank Chiara Castelli (Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy) for pLXSN-hTERT, Marco Crescenzi (Istituto Superiore di Sanita, Rome, Italy) for GST-CKI plasmids, and Martin McMahon (University of California San Francisco, USA) for the RAF1-ER plasmids, the IMR90/GFP-RAF1-ER cells and for invaluable advice. JYT thanks Masashi Narita for fruitful discussions and we also thank Michel Toledano for comments on the manuscript. This work was supported by grants from the French National Research Agency (ANR-07-BLAN-0098-CSD8) and the French Association for Cancer Research (ARC 4917), and benefited from discussions within the CEA/Curie network on Replication, Chromosomal Instability, and Cancer. SR is the recipient of a postdoctoral fellowship from the French Association for Cancer Research, and KC received a CEA Irtelis doctoral fellowship through the CEA Plasticity and Instability of the Genome Intramural Program.	[Anonymous], 2010, R LANG ENV STAT COMP; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Contrepois K, 2010, J PROTEOME RES, V9, P5501, DOI 10.1021/pr100497a; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dalerba P, 2005, CANCER RES, V65, P2321, DOI 10.1158/0008-5472.CAN-04-3678; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Robles SJ, 1999, BIOCHEM PHARMACOL, V58, P675, DOI 10.1016/S0006-2952(99)00127-6; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Terry NHA, 2006, NAT PROTOC, V1, P859, DOI 10.1038/nprot.2006.113; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wei S, 1999, CANCER RES, V59, P1539; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yu Q, 2002, CANCER RES, V62, P5743; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	52	42	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	25					3072	3085		10.1038/onc.2011.481	http://dx.doi.org/10.1038/onc.2011.481			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22020327				2022-12-25	WOS:000305705900006
J	Huang, JS; Jia, YZ; Fu, T; Viswakarma, N; Bai, L; Rao, MS; Zhu, YJ; Borensztajn, J; Reddy, JK				Huang, Jiansheng; Jia, Yuzhi; Fu, Tao; Viswakarma, Navin; Bai, Liang; Rao, M. Sambasiva; Zhu, Yijun; Borensztajn, Jayme; Reddy, Janardan K.			Sustained activation of PPAR alpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice	FASEB JOURNAL			English	Article						fatty acyl-CoA oxidase-1; Acox1 deficiency; endoplasmic reticulum stress; liver tumors	ACYL-COA OXIDASE; LEPTIN-DEFICIENT MICE; RECEPTOR-ALPHA; PEROXISOME PROLIFERATORS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; GLUCOSE-TOLERANCE; BODY-WEIGHT; LIVER; GAMMA	Obesity, a major health concern, results from an imbalance between energy intake and expenditure. Leptin-deficient ob/ob mice are paradigmatic of obesity, resulting from excess energy intake and storage. Mice lacking acyl-CoA oxidase 1 (Acox1), the first enzyme of the peroxisomal fatty acid beta-oxidation system, are characterized by increased energy expenditure and a lean body phenotype caused by sustained activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) by endogenous ligands in liver that remain unmetabolized in the absence of Acox1. We generated ob/ob mice deficient in Acox1 (Acox1(-/-)) to determine how the activation of PPAR alpha by endogenous ligands might affect the obesity of ob/ob mice. In contrast to Acox1(-/-) (14.3 +/- 1.2 g at 6 mo) and the Acox1-deficient (ob/ob) double-mutant mice (23.8 +/- 4.6 g at 6 mo), the ob/ob mice are severely obese (54.3 +/- 3.2 g at 6 mo) and had significantly more (P<0.01) epididymal fat content. The resistance of Acox1(-/-)/ob/ob mice to obesity is due to increased PPAR alpha-mediated up-regulation of genes involved in fatty acid oxidation in liver. Activation of PPAR alpha in Acox1-deficient ob/ob mice also reduces serum glucose and insulin (P<0.05) and improves glucose tolerance and insulin sensitivity. Further, PPAR alpha activation reduces hepatic steatosis and increases hepatocellular regenerative response in Acox1(-/-)/ob/ob mice at a more accelerated pace than in mice lacking only Acox1. However, Acox1(-/-)/ob/ob mice manifest hepatic endoplasmic reticulum (ER) stress and also develop hepatocellular carcinomas (8 of 8 mice) similar to those observed in Acox1(-/-) mice (10 of 10 mice), but unlike in ob/ob (0 of 14 mice) and OB/OB (0 of 6 mice) mice, suggesting that superimposed ER stress and PPAR alpha activation contribute to carcinogenesis in a fatty liver. Finally, absence of Acox1 in ob/ob mice can impart resistance to high-fat diet (60% fat)-induced obesity, and their liver had significantly (P<0.01) more cell proliferation. These studies with Acox1(-/-)/ob/ob mice indicate that sustained activation of lipid-sensing nuclear receptor PPAR alpha attenuates obesity and restores glucose homeostasis by ameliorating insulin resistance but increases the risk for liver cancer development, in part related to excess energy combustion.-Huang, J., Jia, Y., Fu, T., Viswakarma, N., Bai, L., Sambasiva Rao, M., Zhu, Y., Borensztajn, J., Reddy, J. K. Sustained activation of PPAR alpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 26, 628-638 (2012). www.fasebj.org	[Huang, Jiansheng; Jia, Yuzhi; Fu, Tao; Viswakarma, Navin; Bai, Liang; Rao, M. Sambasiva; Zhu, Yijun; Borensztajn, Jayme; Reddy, Janardan K.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu			U.S. National Institutes of Health [GM23750, DK083163]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083163, R56DK083163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in part, by U.S. National Institutes of Health grants GM23750 and DK083163 to J.K.R. The authors thank Dr. Aurore Vluggens for her gracious and generous assistance in the analysis of liver tumors.	Abdelkarim M, 2010, J BIOL CHEM, V285, P36759, DOI 10.1074/jbc.M110.166231; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Chen H, 2010, ENDOCRINOLOGY, V151, P3115, DOI 10.1210/en.2009-1366; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fu T, 2006, BIOCHEM BIOPH RES CO, V341, P1172, DOI 10.1016/j.bbrc.2006.01.071; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2011, AM J PATHOL, V179, P703, DOI 10.1016/j.ajpath.2011.04.030; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ohnishi M, 2011, FASEB J, V25, P2031, DOI 10.1096/fj.10-167056; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rao MS, 2002, IN VIVO, V16, P145; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vluggens A, 2010, LAB INVEST, V90, P696, DOI 10.1038/labinvest.2010.46; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	55	69	71	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					628	638		10.1096/fj.11-194019	http://dx.doi.org/10.1096/fj.11-194019			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22009939	Green Published			2022-12-25	WOS:000300485700016
J	Purushotham, A; Xu, Q; Li, XL				Purushotham, Aparna; Xu, Qing; Li, Xiaoling			Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding	FASEB JOURNAL			English	Article						sirtuin; oxidative stress; GL/FFA cycle; phospholipid/lysolipid; testosterone	ACTIVATED PROTEIN-KINASE; HEPATIC GENE-EXPRESSION; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; MAMMALIAN SIRTUINS; CIRCADIAN CONTROL; LIPID-METABOLISM; SKELETAL-MUSCLE; DISEASE	SIRT1 is a highly-conserved NAD(+)-dependent protein deacetylase that plays essential roles in the regulation of energy metabolism, genomic stability, and stress response. Although the functions of SIRT1 in many organs have been extensively studied in tissue-specific knockout mouse models, the systemic role of SIRT1 is still largely unknown as a result of severe developmental defects that result from whole-body knockout in mice. Here, we investigated the systemic functions of SIRT1 in metabolic homeostasis by utilizing a whole-body SIRT1 heterozygous mouse model. These mice are phenotypically normal under standard feeding conditions. However, when chronically challenged with a 40% fat diet, they become obese and insulin resistant, display increased serum cytokine levels, and develop hepatomegaly. Hepatic metabolomic analyses revealed that SIRT1 heterozygous mice have elevated gluconeogenesis and oxidative stress. Surprisingly, they are depleted of glycerolipid metabolites and free fatty acids, yet accumulate lysolipids. Moreover, high-fat feeding induces elevation of serum testosterone levels and enlargement of seminal vesicles in SIRT1 heterozygous males. Microarray analysis of liver mRNA indicates that they have altered expression of genes involved in steroid metabolism and glycerolipid metabolism. Taken together, our findings indicate that SIRT1 plays a vital role in the regulation of systemic energy and steroid hormone homeostasis.-Purushotham, A., Xu, Q., Li, X. Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J. 26, 656-667 (2012). www.fasebj.org	[Purushotham, Aparna; Xu, Qing; Li, Xiaoling] Natl Inst Environm Hlth Sci, Lab Signal Transduct, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Li, XL (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	lix3@niehs.nih.gov	Li, Xiaoling/A-2994-2015	Li, Xiaoling/0000-0001-5920-7784	U.S. National Institutes of Health, NIEHS [Z01 ES102205]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES102205] Funding Source: NIH RePORTER	U.S. National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. Anton Jetten, Stephen Shears, John Cidlowski, and members of the X. L. laboratory for critical reading of the manuscript, and Dr. Michael W. McBurney (University of Ottawa, Ottawa, ON, Canada) for providing the SIRT1-null allele. The authors also thank the National Institute of Environmental Health Sciences (NIEHS) Laboratory of Experimental Pathology for histological staining and serum hormone ELISA; the NIEHS microarray facility for performing the microarray experiments, and Liwen Liu for analyzing the microarray data. This research was supported by the Intramural Research Program of the U.S. National Institutes of Health, NIEHS to X. L. (Z01 ES102205).	ABBASZADE IG, 1995, MOL ENDOCRINOL, V9, P1214, DOI 10.1210/me.9.9.1214; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baptiste CG, 2010, J STEROID BIOCHEM, V122, P42, DOI 10.1016/j.jsbmb.2009.12.010; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng H. L., 2003, P NATL ACAD SCI US; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; DANNO H, 1992, J NUTR SCI VITAMINOL, V38, P517, DOI 10.3177/jnsv.38.517; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Delic D, 2010, J MOL ENDOCRINOL, V45, P379, DOI 10.1677/JME-10-0026; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park CHJ, 1996, MOL CELL ENDOCRINOL, V116, P157, DOI 10.1016/0303-7207(95)03707-1; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	65	43	45	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					656	667		10.1096/fj.11-195172	http://dx.doi.org/10.1096/fj.11-195172			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22006157	Green Published			2022-12-25	WOS:000300485700018
J	Palacios, L; Dickinson, RJ; Sacristan-Reviriego, A; Didmon, MP; Marin, MJ; Martin, H; Keyse, SM; Molina, M				Palacios, Lorena; Dickinson, Robin J.; Sacristan-Reviriego, Almudena; Didmon, Mark P.; Jose Marin, Maria; Martin, Humberto; Keyse, Stephen M.; Molina, Maria			Distinct Docking Mechanisms Mediate Interactions between the Msg5 Phosphatase and Mating or Cell Integrity Mitogen-activated Protein Kinases (MAPKs) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; TYROSINE PHOSPHATASES; INTERACTION MOTIF; PTP-SL; DIFFERENTIAL REGULATION; CATALYTIC ACTIVATION; STE5 SCAFFOLD; YEAST; PATHWAY; SITES	MAPK phosphatases (MKPs) are negative regulators of signaling pathways with distinct MAPK substrate specificities. For example, the yeast dual specificity phosphatase Msg5 dephosphorylates the Fus3 and Slt2 MAPKs operating in the mating and cell wall integrity pathways, respectively. Like other MAPK-interacting proteins, most MKPs bind MAPKs through specific docking domains. These include D-motifs, which contain basic residues that interact with acidic residues in the common docking (CD) domain of MAPKs. Here we show that Msg5 interacts not only with Fus3, Kss1, and Slt2 but also with the pseudokinase Slt2 paralog Mlp1. Using yeast two-hybrid and in vitro interaction assays, we have identified distinct regions within the N-terminal domain of Msg5 that differentially bind either the MAPKs Fus3 and Kss1 or Slt2 and Mlp1. Whereas a canonical D-site within Msg5 mediates interaction with the CD domains of Fus3 and Kss1, a novel motif ((IYT104)-I-102) within Msg5 is involved in binding to Slt2 and Mlp1. Furthermore, mutation of this site prevents the phosphorylation of Msg5 by Slt2. This motif is conserved in Sdp1, another MKP that dephosphorylates Slt2, as well as in Msg5 orthologs from other yeast species. A region spanning amino acids 274-373 within Slt2 and Mlp1 mediates binding to this Msg5 motif in a CD domain-independent manner. In contrast, Slt2 uses its CD domain to bind to its upstream activator Mkk1. This binding flexibility may allow MAPK pathways to exploit additional regulatory controls in order to provide fine modulation of both pathway activity and specificity.	[Dickinson, Robin J.; Didmon, Mark P.; Keyse, Stephen M.] Univ Dundee, Ninewells Hosp & Med Sch, CR UK Stress Response Lab, Med Res Inst, Dundee DD1 9SY, Scotland; [Palacios, Lorena; Sacristan-Reviriego, Almudena; Jose Marin, Maria; Martin, Humberto; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Palacios, Lorena; Sacristan-Reviriego, Almudena; Jose Marin, Maria; Martin, Humberto; Molina, Maria] Inst Ramon & Cajal Invest Sanitarias, Madrid 28040, Spain	University of Dundee; Complutense University of Madrid	Keyse, SM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, CR UK Stress Response Lab, Med Res Inst, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk; molmifa@farm.ucm.es	Brieva, Humberto Martin/E-9254-2016; Martín, Humberto/Z-3423-2019; Molina, Maria/ABE-7186-2021; Keyse, Stephen M./B-9575-2009	Brieva, Humberto Martin/0000-0002-6736-3602; Martín, Humberto/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Keyse, Stephen M./0000-0002-5150-8221	Ministerio de Ciencia e Innovacion (Spain) [BIO2007-67299, BIO2010-22369-C02-01]; BSCH-UCM [920628]; Cancer Research UK [C8227/A12053]; Cancer Research UK [12053] Funding Source: researchfish	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); BSCH-UCM; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Ministerio de Ciencia e Innovacion (Spain) Grants BIO2007-67299 and BIO2010-22369-C02-01 and Program for UCM Research Groups Grant 920628 from BSCH-UCM (to M. M.). Research in the CR-UK Stress Response Laboratory (to R. J. D., M. P. D., and S. M. K.) is supported by Cancer Research UK Program Grant C8227/A12053 (to S. M. K.).	Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jimenez-Sanchez M, 2007, J BIOL CHEM, V282, P31174, DOI 10.1074/jbc.M706270200; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kim KY, 2007, YEAST, V24, P335, DOI 10.1002/yea.1475; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Limardo RGR, 2011, BIOCHEMISTRY-US, V50, P1384, DOI 10.1021/bi1007518; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	53	13	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42037	42050		10.1074/jbc.M111.286948	http://dx.doi.org/10.1074/jbc.M111.286948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006927	hybrid, Green Published			2022-12-25	WOS:000298180900014
J	Geier, J; Hudak, M				Geier, Janos; Hudak, Mariann			Changing the Chevreul Illusion by a Background Luminance Ramp: Lateral Inhibition Fails at Its Traditional Stronghold - A Psychophysical Refutation	PLOS ONE			English	Article							HERMANN GRID ILLUSION; BRIGHTNESS PERCEPTION; NEURAL DYNAMICS; LIGHTNESS; INDUCTION; CONTRAST; MODEL; ORGANIZATION; EYE	The Chevreul illusion is a well-known 19(th) century brightness illusion, comprising adjacent homogeneous grey bands of different luminance, which are perceived as inhomogeneous. It is generally explained by lateral inhibition, according to which brighter areas projected to the retina inhibit the sensitivity of neighbouring retinal areas. Lateral inhibition has been considered the foundation-stone of early vision for a century, upon which several computational models of brightness perception are built. One of the last strongholds of lateral inhibition is the Chevreul illusion, which is often illustrated even in current textbooks. Here we prove that lateral inhibition is insufficient to explain the Chevreul illusion. For this aim, we placed the Chevreul staircase in a luminance ramp background, which noticeably changed the illusion. In our psychophysical experiments, all 23 observers reported a strong illusion, when the direction of the ramp was identical to that of the staircase, and all reported homogeneous steps (no illusion) when its direction was the opposite. When the background of the staircase was uniform, 14 saw the illusion, and 9 saw no illusion. To see whether the change of the entire background area or that of the staircase boundary edges were more important, we placed another ramp around the staircase, whose direction was opposite to that of the original, larger ramp. The result is that though the inner ramp is rather narrow (mean = 0.51 deg, SD = 0.48 deg, N = 23), it still dominates perception. Since all conditions of the lateral inhibition account were untouched within the staircase, lateral inhibition fails to model these perceptual changes. Area ratios seem insignificant; the role of boundary edges seems crucial. We suggest that long range interactions between boundary edges and areas enclosed by them, such that diffusion-based models describe, provide a much more plausible account for these brightness phenomena, and local models are insufficient.	[Geier, Janos] Stereo Vis Ltd, Budapest, Hungary; [Hudak, Mariann] Budapest Univ Technol & Econ, Fac Nat Sci, Dept Cognit Sci, H-1117 Budapest, Hungary; [Hudak, Mariann] Budapest Univ Technol & Econ, Hungarian Acad Sci, Res Grp Cognit Sci, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics; Hungarian Academy of Sciences	Geier, J (corresponding author), Stereo Vis Ltd, Budapest, Hungary.	janos@geier.hu			Stereo Vision Ltd.	Stereo Vision Ltd.	This study was funded by Stereo Vision Ltd. through the directorship and 50% ownership of Janos Geier, who designed the experiments, contributed to the analysis and wrote the paper.	Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Blake  R., 2006, PERCEPTION; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; COHEN MA, 1984, PERCEPT PSYCHOPHYS, V36, P428, DOI 10.3758/BF03207497; Geier J, 2008, PERCEPTION, V37, P651, DOI 10.1068/p5622; Gilchrist A., 2006, SEEING BLACK WHITE; Goldstein E B, 2009, SENSATION PERCEPTION; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; HARTLINE HK, 1949, FED PROC, V8, P69; JAMESON D, 1975, LEONARDO, V8, P125, DOI 10.2307/1572954; KINGDOM F, 1992, VISION RES, V32, P1565, DOI 10.1016/0042-6989(92)90212-2; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P57; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; McArthur JA, 1999, VISION RES, V39, P1199, DOI 10.1016/S0042-6989(98)00216-8; Otazu X, 2008, VISION RES, V48, P733, DOI 10.1016/j.visres.2007.12.008; PESSOA L, 1995, VISION RES, V35, P2201, DOI 10.1016/0042-6989(94)00313-0; Ratliff F., 1965, MACH BANDS QUANTITAT; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SPILLMANN L, 1994, PERCEPTION, V23, P691, DOI 10.1068/p230691; von Bekesy G, 1967, SENSORY INHIBITION; von Bezold W., 1874, FARBENLEHRER HINBLIC; Watt J., 1985, VISION RES, V25, P1661; WHITE M, 1979, PERCEPTION, V8, P413, DOI 10.1068/p080413	27	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26062	10.1371/journal.pone.0026062	http://dx.doi.org/10.1371/journal.pone.0026062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022508	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600038
J	Baba-Moussa, L; Sina, H; Scheftel, JM; Moreau, B; Sainte-Marie, D; Kotchoni, SO; Prevost, G; Couppie, P				Baba-Moussa, Lamine; Sina, Haziz; Scheftel, Jean-Michel; Moreau, Brigitte; Sainte-Marie, Dominique; Kotchoni, Simeon O.; Prevost, Gilles; Couppie, Pierre			Staphylococcal Panton-Valentine Leucocidin as a Major Virulence Factor Associated to Furuncles	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; LEUKOCIDIN GENES; NASAL CARRIAGE; S-COMPONENT; LUKE-LUKD; AUREUS; STRAINS; PNEUMONIA; FAMILY; SKIN	Panton-Valentine Leucocidin (PVL), one of the beta-barrel pore-forming staphylococcal leucotoxins, is known to be associated to furuncles and some severe community pneumonia. However, it is still uncertain how many other virulence factors are also associated to furuncles and what the risk factors of furuncles are in immuno-compromised status of patients, especially the HIV (+) patients. In this paper, we use antigen immunoprecipitation and multiplex PCR approach to determine the presence of 19 toxins, 8 adhesion factors and the PFGE profiles associated to furuncles in three independent patient study groups of S. aureus (SA) isolates collected from the Cayenne General Hospital (French Guiana). The patient groups were made of: 16 isolates from HIV (-) patients, 9 from HIV (+) patients suffering from furuncles, and 30 control isolates from patients with diverse secondary infected dermatitis. Our data reveals that the majority (96%) of SA strains isolated from HIV patient-derived furuncles significantly produced PVL (p<10(-7)), whereas only 10% of SA strains produced this toxin in secondary infected dermatosis. A high prevalence of LukE-LukD-producing isolates (56 to 78%) was recorded in patient groups. Genes encoding clumping factor B, collagen-and laminin-binding proteins (clfB, cna, lbp, respectively) were markedly frequent (30 to 55%), without being associated to a specific group. Pulse field gel electrophoresis evidenced 24 overall pulsotypes, whereas the 25 PVL-producing isolates were distributed into 15 non clonal fingerprints. These pulsotypes were not specific PVL-producing isolates. PVL appears to be the major virulence factor associated to furuncles in Europe and in South America regardless of the immune status of the HIV patients.	[Baba-Moussa, Lamine; Sina, Haziz] Univ Abomey Calavi, Dept Biochim & Biol Cellulaire, Cotonou, Benin; [Scheftel, Jean-Michel; Prevost, Gilles] Inst Bacteriol, Unite EA Physiopathol & Med 4438, Strasbourg, France; [Moreau, Brigitte] Ctr Hosp Cayenne, Serv Biol Polyvalente, Cayenne, French Guiana; [Sainte-Marie, Dominique; Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol, Cayenne, French Guiana; [Sainte-Marie, Dominique; Couppie, Pierre] Inst Guyanais Dermatol Trop, Cayenne, French Guiana; [Kotchoni, Simeon O.] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA	University of Abomey Calavi; Rutgers State University Camden; Rutgers State University New Brunswick	Baba-Moussa, L (corresponding author), Univ Abomey Calavi, Dept Biochim & Biol Cellulaire, Cotonou, Benin.	laminesaid@yahoo.fr		SINA, Haziz/0000-0001-8630-3798; Couppie, Pierre/0000-0002-4213-2867				Baba-Moussa L, 2008, J HOSP INFECT, V68, P32, DOI 10.1016/j.jhin.2007.10.010; Baba-Moussa L, 2010, AFR J BIOTECHNOL, V9, P604; BABAMOUSSA L, 1999, MED MALADIES INFECT, V29, P689; Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Bronner S, 2000, APPL ENVIRON MICROB, V66, P3931, DOI 10.1128/AEM.66.9.3931-3938.2000; CARRE N, 2011, MED MALADIES INFECT, V10, P1016; COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Del Giudice P, 2011, DERMATOLOGY, V222, P167, DOI 10.1159/000324044; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Gravet A, 1999, J CLIN MICROBIOL, V37, P4012, DOI 10.1128/JCM.37.12.4012-4019.1999; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Liassine N, 2004, J CLIN MICROBIOL, V42, P825, DOI 10.1128/JCM.42.2.825-828.2004; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; MITHOE D, 2011, EUR J CLIN MICROBIOL, DOI DOI 10.1007/S10096-011-1316-9O; Naas T, 2005, J HOSP INFECT, V61, P321, DOI 10.1016/j.jhin.2005.01.027; *NAT COMM CLIN LAB, 2010, M100S12 NCCLS; Nguyen MH, 1999, ANN INTERN MED, V130, P221, DOI 10.7326/0003-4819-130-3-199902020-00026; Panton PN, 1932, LANCET, V1, P506; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Pitche P, 1995, Sante, V5, P349; PREVOST G, 1991, J HOSP INFECT, V17, P255, DOI 10.1016/0195-6701(91)90270-I; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Prevost Gilles, 2005, P243; RAVIGLIONE MC, 1990, AM J INFECT CONTROL, V18, P64, DOI 10.1016/0196-6553(90)90083-5; Seiberling KA, 2005, LARYNGOSCOPE, V115, P1580, DOI 10.1097/01.mlg.0000168111.11802.9c; SMITH KJ, 1994, ARCH DERMATOL, V130, P521, DOI 10.1001/archderm.130.4.521; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; WARD PD, 1980, INFECT IMMUN, V28, P393; Yamasaki O, 2005, CLIN INFECT DIS, V40, P381, DOI 10.1086/427290	39	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25716	10.1371/journal.pone.0025716	http://dx.doi.org/10.1371/journal.pone.0025716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022439	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000033
J	Bardaji, L; Perez-Martinez, I; Rodriguez-Moreno, L; Rodriguez-Palenzuela, P; Sundin, GW; Ramos, C; Murillo, J				Bardaji, Leire; Perez-Martinez, Isabel; Rodriguez-Moreno, Luis; Rodriguez-Palenzuela, Pablo; Sundin, George W.; Ramos, Cayo; Murillo, Jesus			Sequence and Role in Virulence of the Three Plasmid Complement of the Model Tumor-Inducing Bacterium Pseudomonas savastanoi pv. savastanoi NCPPB 3335	PLOS ONE			English	Article							SYRINGAE SUBSP SAVASTANOI; ARTEMIS COMPARISON TOOL; MESORHIZOBIUM-LOTI; REPLICATION REGIONS; PHASEOLICOLA 1448A; EFFECTOR PROTEINS; SECRETION SYSTEM; GENOMIC ANALYSIS; OLIVE KNOTS; DNA	Pseudomonas savastanoi pv. savastanoi NCPPB 3335 is a model for the study of the molecular basis of disease production and tumor formation in woody hosts, and its draft genome sequence has been recently obtained. Here we closed the sequence of the plasmid complement of this strain, composed of three circular molecules of 78,357 nt (pPsv48A), 45,220 nt (pPsv48B), and 42,103 nt (pPsv48C), all belonging to the pPT23A-like family of plasmids widely distributed in the P. syringae complex. A total of 152 coding sequences were predicted in the plasmid complement, of which 38 are hypothetical proteins and seven correspond to putative virulence genes. Plasmid pPsv48A contains an incomplete Type IVB secretion system, the type III secretion system (T3SS) effector gene hopAF1, gene ptz, involved in cytokinin biosynthesis, and three copies of a gene highly conserved in plant-associated proteobacteria, which is preceded by a hrp box motif. A complete Type IVA secretion system, a well conserved origin of transfer (oriT), and a homolog of the T3SS effector gene hopAO1 are present in pPsv48B, while pPsv48C contains a gene with significant homology to isopentenyl-diphosphate delta-isomerase, type 1. Several potential mobile elements were found on the three plasmids, including three types of MITE, a derivative of IS801, and a new transposon effector, ISPsy30. Although the replication regions of these three plasmids are phylogenetically closely related, their structure is diverse, suggesting that the plasmid architecture results from an active exchange of sequences. Artificial inoculations of olive plants with mutants cured of plasmids pPsv48A and pPsv48B showed that pPsv48A is necessary for full virulence and for the development of mature xylem vessels within the knots; we were unable to obtain mutants cured of pPsv48C, which contains five putative toxin-antitoxin genes.	[Bardaji, Leire; Murillo, Jesus] Univ Publ Navarra, Dept Agr Prod, Escuela Tecn Super Ingn Agronomos, Pamplona, Spain; [Perez-Martinez, Isabel; Rodriguez-Moreno, Luis; Ramos, Cayo] Univ Malaga, Fac Ciencias, Area Genet, Inst Hort Subtrop & Mediterranea La Mayora, E-29071 Malaga, Spain; [Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Escuela Tecn Super Ingn Agronomos, Madrid, Spain; [Sundin, George W.] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Universidad Politecnica de Madrid; Michigan State University; Michigan State University	Bardaji, L (corresponding author), Univ Publ Navarra, Dept Agr Prod, Escuela Tecn Super Ingn Agronomos, Pamplona, Spain.	jesus.murillo@unavarra.es	RAMOS, CAYO/G-3818-2011; RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; Moreno, Luis Rodriguez/U-8457-2017; Rodriguez-Moreno, Luis/AAU-4085-2020; Murillo, Jesus/D-2901-2009	RAMOS, CAYO/0000-0002-2362-5041; RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; Moreno, Luis Rodriguez/0000-0003-2385-8782; Rodriguez-Moreno, Luis/0000-0003-2385-8782; Murillo, Jesus/0000-0001-6585-2421	Ministerio de Ciencia e Innovacion [AGL2008-55311-CO2-01, AGL2008-55311-CO2-02]; FEDER; Departamento de Educacion y Cultura, Gobierno de Navarra, Spain [57/2007]; Junta de Andalucia, Spain [P08-CVI-03475]; Spanish Ministry of Education and Science [AP2002-3800]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission); Departamento de Educacion y Cultura, Gobierno de Navarra, Spain; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Ministry of Education and Science(Spanish Government)	This research has been supported by the Spanish Plan Nacional I+D+I grants AGL2008-55311-CO2-01 and AGL2008-55311-CO2-02 (Ministerio de Ciencia e Innovacion; http://www.micinn.es/), co-financed by FEDER, and by grants ref. 57/2007 from the Departamento de Educacion y Cultura, Gobierno de Navarra, Spain (http://www.educacion.navarra.es/portal/) and ref. P08-CVI-03475 from the Junta de Andalucia, Spain (http://www.juntadeandalucia.es). IP-M was awarded a Spanish Ministry of Education and Science fellowship (AP2002-3800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025773; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BROM S, 1992, J BACTERIOL, V174, P5183, DOI 10.1128/JB.174.16.5183-5189.1992; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; DRIVER JA, 1984, HORTSCIENCE, V19, P507; FLORES M, 1993, P NATL ACAD SCI USA, V90, P4932, DOI 10.1073/pnas.90.11.4932; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gibbon MJ, 1999, MICROBIOL-SGM, V145, P325, DOI 10.1099/13500872-145-2-325; GLASS NL, 1988, J BACTERIOL, V170, P2367, DOI 10.1128/jb.170.5.2367-2373.1988; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; IACOBELLIS NS, 1994, J PHYTOPATHOL, V140, P238, DOI 10.1111/j.1439-0434.1994.tb04813.x; Iacobellis NS, 2001, ENCY PLANT PATHOLOGY, P714; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Krid S, 2009, J APPL MICROBIOL, V106, P886, DOI 10.1111/j.1365-2672.2008.04058.x; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Ma ZH, 2007, APPL ENVIRON MICROB, V73, P1287, DOI 10.1128/AEM.01923-06; MACDONALD EMS, 1986, PLANT PHYSIOL, V82, P742, DOI 10.1104/pp.82.3.742; MURILLO J, 1994, MOL MICROBIOL, V12, P941, DOI 10.1111/j.1365-2958.1994.tb01082.x; MURILLO J, 1994, PLASMID, V31, P275, DOI 10.1006/plas.1994.1029; Murillo J, 2003, PSEUDOMONAS SYRINGAE AND RELATED PATHOGENS: BIOLOGY AND GENETICS, P127; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Okazaki S, 2010, MOL PLANT MICROBE IN, V23, P223, DOI 10.1094/MPMI-23-2-0223; Penyalver R, 2006, PHYTOPATHOLOGY, V96, P313, DOI 10.1094/PHYTO-96-0313; Perez-Martinez I, 2008, J BACTERIOL, V190, P625, DOI 10.1128/JB.01067-07; Perez-Martinez I, 2007, RES MICROBIOL, V158, P60, DOI 10.1016/j.resmic.2006.09.008; Perez-Martinez I, 2010, APPL ENVIRON MICROB, V76, P3611, DOI 10.1128/AEM.00133-10; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Quesada JM, 2010, PLANT PATHOL, V59, P262, DOI 10.1111/j.1365-3059.2009.02200.x; Rodriguez-Moreno L, 2008, PHYTOPATHOLOGY, V98, P815, DOI 10.1094/PHYTO-98-7-0815; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez C, 2009, MOL PLANT MICROBE IN, V22, P519, DOI 10.1094/MPMI-22-5-0519; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schluter A, 2007, APPL ENVIRON MICROB, V73, P6345, DOI 10.1128/AEM.01177-07; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Sesma A, 2000, MICROBIOL-SGM, V146, P2375, DOI 10.1099/00221287-146-10-2375; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; SILVERSTONE SE, 1993, CAN J MICROBIOL, V39, P659, DOI 10.1139/m93-095; Smith I.M., 1988, Q REV BIOL, DOI [DOI 10.1002/9781444314199, 10.1002/9781444314199]; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Sundin George W., 2009, P295; Sundin GW, 1999, MICROBIAL ECOL, V38, P27, DOI 10.1007/s002489900152; Surico G, 1992, MOL SIGNALS PLANT MI, P209; Tamura K, 2011, MOL BIOL EV IN PRESS; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Vivian A, 2001, MICROBIOL-SGM, V147, P763, DOI 10.1099/00221287-147-4-763; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005; ZHOU C, 1990, BIOTECHNIQUES, V8, P172	71	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25705	10.1371/journal.pone.0025705	http://dx.doi.org/10.1371/journal.pone.0025705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022435	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200013
J	Lammers, B; Zhao, Y; Hoekstra, M; Hildebrand, RB; Ye, D; Meurs, I; Van Berkel, TJC; Van Eck, M				Lammers, Bart; Zhao, Ying; Hoekstra, Menno; Hildebrand, Reeni B.; Ye, Dan; Meurs, Illiana; Van Berkel, Theo J. C.; Van Eck, Miranda			Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoE	PLOS ONE			English	Article							ATP-BINDING CASSETTE; ATHEROSCLEROTIC LESION DEVELOPMENT; HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-E; CHOLESTEROL EFFLUX; LIPID-ACCUMULATION; ABCG1; EXPRESSION; EXTRACTION; SECRETION	Aim: ABCA1 protects against atherosclerosis by facilitating cholesterol efflux from macrophage foam cells in the arterial wall to extracellular apolipoprotein (apo) A-I. In contrast to apoA-I, apoE is secreted by macrophages and can, like apoA-I, induce ABCA1-mediated cholesterol efflux. Yet, the combined effect of macrophage ABCA1 and apoE on lesion development is unexplored. Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow from ABCA1/apoE double KO (dKO) mice, their respective single KO's, and wild-type (WT) controls and were challenged with a high-fat/high-cholesterol diet for 9 weeks. In vitro cholesterol efflux experiments showed no differences between ABCA1 KO and dKO macrophages. The serum non-HDL/HDL ratio in dKO transplanted mice was 1.7-fold and 2.4-fold (p<0.01) increased compared to WT and ABCA1 KO transplanted mice, respectively. The atherosclerotic lesion area in dKO transplanted animals (650 +/- 94x10(3) mu m(2)), however, was 1.9-fold (p<0.01) and 1.6-fold (p<0.01) increased compared to single knockouts (ABCA1 KO: 341 +/- 20x10(3) mu m(2); apoE KO: 402 +/- 78x10(3) mu m(2), respectively) and 3.1-fold increased (p<0.001) compared to WT (211 +/- 20x10(3) mu m(2)). When normalized for serum cholesterol exposure, macrophage ABCA1 and apoE independently protected against atherosclerotic lesion development (p<0.001). Moreover, hepatic expression levels of TNF alpha and IL-6 were highly induced in dKO transplanted animals (3.0-fold; p<0.05, and 4.3-fold; p<0.001, respectively). In agreement, serum IL-6 levels were also enhanced in ABCA1 KO transplanted mice (p<0.05) and even further enhanced in dKO transplanted animals (3.1-fold as compared to ABCA1 KO transplanted animals; p<0.05). Conclusions: Combined deletion of macrophage ABCA1 and apoE results in a defect in cholesterol efflux and, compared to ABCA1 KO transplanted mice, elevated serum total cholesterol levels. Importantly, these mice also suffer from enhanced systemic and hepatic inflammation, together resulting in the observed augmented atherosclerotic lesion development.	[Lammers, Bart; Zhao, Ying; Hoekstra, Menno; Hildebrand, Reeni B.; Ye, Dan; Meurs, Illiana; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Univ, Gorlaeus Labs, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Lammers, B (corresponding author), Leiden Univ, Gorlaeus Labs, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands.	b.lammers@lacdr.leidenuniv.nl	Van Berkel, Theo/ABD-7677-2021; Zhao, Ying/C-3916-2011; Zhao, Ying/AAS-7970-2021	Hoekstra, Menno/0000-0001-7463-2893; van Eck, Miranda/0000-0003-3936-3194	Netherlands Heart Foundation [2005B002, 2008T070, 2007T056]; Netherlands Organization for Scientific Research [917.66.301]; Top Institute Pharma [T2-110]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Top Institute Pharma	This work was supported by The Netherlands Heart Foundation, Grant numbers 2005B002 (B. L.), and 2008T070 (M. H.); The Netherlands Organization for Scientific Research (VIDI Grant number 917.66.301 (I.M., M.V.E.)), and Top Institute Pharma (TIPharma grant number T2-110; M.H., T.V.B.). M.V.E. is an Established Investigator of the Netherlands Heart Foundation (Grant number 2007T056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisvert WA, 1999, J LIPID RES, V40, P806; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Holewijn S, 2010, J INTERN MED, V268, P567, DOI 10.1111/j.1365-2796.2010.02277.x; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Lammers B, 2009, ATHEROSCLEROSIS, V205, P420, DOI 10.1016/j.atherosclerosis.2009.01.017; Lin CY, 2001, J LIPID RES, V42, P1125; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Shi WB, 2004, BIOCHEM BIOPH RES CO, V317, P223, DOI 10.1016/j.bbrc.2004.03.037; SWEETNAM PM, 1994, CIRCULATION, V90, P769, DOI 10.1161/01.CIR.90.2.769; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; Van Eck M, 2000, ATHEROSCLEROSIS, V150, P71, DOI 10.1016/S0021-9150(99)00372-X; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; ZANOTTI I, ARTERIOSCLER THROMB, V31, P74	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26095	10.1371/journal.pone.0026095	http://dx.doi.org/10.1371/journal.pone.0026095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022523	Green Published, gold			2022-12-25	WOS:000295973200035
J	Romano, G; Costantini, M; Buttino, I; Ianora, A; Palumbo, A				Romano, Giovanna; Costantini, Maria; Buttino, Isabella; Ianora, Adrianna; Palumbo, Anna			Nitric Oxide Mediates the Stress Response Induced by Diatom Aldehydes in the Sea Urchin Paracentrotus lividus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE REGULATORY NETWORK; OXIDATIVE STRESS; MARINE DIATOMS; CHEMICAL DEFENSE; 2 ECOTYPES; EMBRYOS; SYNTHASE; FERTILIZATION; INHIBITION	Diatoms are ubiquitous and abundant primary producers that have been traditionally considered as a beneficial food source for grazers and for the transfer of carbon through marine food webs. However, many diatom species produce polyunsaturated aldehydes that disrupt development in the offspring of grazers that feed on these unicellular algae. Here we provide evidence that production of the physiological messenger nitric oxide increases after treatment with the polyunsaturated aldehyde decadienal in embryos of the sea urchin Paracentrotus lividus. At high decadienal concentrations, nitric oxide mediates initial apoptotic events leading to loss of mitochondrial functionality through the generation of peroxynitrite. At low decadienal concentrations, nitric oxide contributes to the activation of hsp70 gene expression thereby protecting embryos against the toxic effects of this aldehyde. When nitric oxide levels were lowered by inhibiting nitric oxide synthase activity, the expression of hsp70 in swimming blastula decreased and the proportion of abnormal plutei increased. However, in later pluteus stages nitric oxide was no longer able to exert this protective function: hsp70 and nitric oxide synthase expression decreased with a consequent increase in the expression of caspase-8. Our findings that nitric oxide production increases rapidly in response to a toxic exogenous stimulus opens new perspectives on the possible role of this gas as an important messenger to environmental stress in sea urchins and for understanding the cellular mechanisms underlying toxicity during diatom blooms.	[Romano, Giovanna; Buttino, Isabella; Ianora, Adrianna] Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy; [Costantini, Maria; Palumbo, Anna] Stn Zool Anton Dohrn, Cellular & Dev Biol Lab, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Romano, G (corresponding author), Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy.	palumbo@szn.it	Costantini, Maria/AGH-4080-2022; Romano, Giovanna/F-4561-2015; Ianora, Adrianna/O-3408-2019; Buttino, Isabella/AAI-3264-2020	Romano, Giovanna/0000-0002-4898-7153; Palumbo, Anna/0000-0002-5972-5589				Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2007, DEV DYNAM, V236, P1535, DOI 10.1002/dvdy.21161; Bonaventura R, 2011, CELL STRESS CHA 0701; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2004, MAR ECOL PROG SER, V273, P97, DOI 10.3354/meps273097; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; Cole AG, 2009, DEVELOPMENT, V136, P541, DOI 10.1242/dev.029959; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Giovine M, 2001, NITRIC OXIDE-BIOL CH, V5, P427, DOI 10.1006/niox.2001.0366; Giudice G, 1999, DEV GROWTH DIFFER, V41, P375; Hansen E, 2004, TOXICOL SCI, V81, P190, DOI 10.1093/toxsci/kfh192; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Kroncke KD, 2001, INT IMMUNOPHARMACOL, V1, P1407, DOI 10.1016/S1567-5769(01)00087-X; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Malysheva IY, 1996, FEBS LETT, V391, P21, DOI 10.1016/0014-5793(96)00691-6; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Matranga V, 2002, CELL MOL BIOL, V48, P345; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Mattiello T, 2010, J BIOL CHEM, V285, P24154, DOI 10.1074/jbc.M109.083428; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Mohri T, 2008, DEV BIOL, V322, P251, DOI 10.1016/j.ydbio.2008.07.023; NEMER M, 1991, DEV BIOL, V145, P255, DOI 10.1016/0012-1606(91)90124-L; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Pagano G, 1986, COMMUNITY TOXICITY T, P67; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Roccheri Maria C., 2000, Molecular Cell Biology Research Communications, V3, P306, DOI 10.1006/mcbr.2000.0230; ROCCHERI MC, 1993, J SUBMICR CYTOL PATH, V25, P173; ROCCHERI MC, 1988, CELL DIFFER DEV, V24, P209, DOI 10.1016/0045-6039(88)90052-8; ROCCHERI MC, 1981, DEV BIOL, V83, P173, DOI 10.1016/S0012-1606(81)80020-6; Roccheri MC, 2004, BIOCHEM BIOPH RES CO, V321, P80, DOI 10.1016/j.bbrc.2004.06.108; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; SCONZO G, 1992, GENE, V121, P353, DOI 10.1016/0378-1119(92)90143-D; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Sluder G, 1999, METHOD CELL BIOL, V61, P439; Smith KL, 2000, SCI TOTAL ENVIRON, V262, P185, DOI 10.1016/S0048-9697(00)00599-4; SNYDER SH, 1993, NATURE, V364, P577, DOI 10.1038/364577a0; Song LL, 2006, PLANT SCI, V171, P449, DOI 10.1016/j.plantsci.2006.05.002; Trapido-Rosenthal H, 2005, BIOL BULL-US, V208, P3, DOI 10.2307/3593094; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vital SA, 2008, ENVIRON EXP BOT, V62, P60, DOI 10.1016/j.envexpbot.2007.07.006; Willmott N, 1996, J BIOL CHEM, V271, P3699; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Zhang YM, 2009, PLANT CELL ENVIRON, V32, P509, DOI 10.1111/j.1365-3040.2009.01945.x; Zhang ZB, 2006, MED SCI MONITOR, V12, pBR75; Zhao L, 2008, J PLANT PHYSIOL, V165, P182, DOI 10.1016/j.jplph.2007.03.002	67	47	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25980	10.1371/journal.pone.0025980	http://dx.doi.org/10.1371/journal.pone.0025980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022485	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200025
J	Strengell, M; Ikonen, N; Ziegler, T; Julkunen, I				Strengell, Mari; Ikonen, Niina; Ziegler, Thedi; Julkunen, Ilkka			Minor Changes in the Hemagglutinin of Influenza A(H1N1) 2009 Virus Alter Its Antigenic Properties	PLOS ONE			English	Article							A H1N1; ASSOCIATION; RESPONSES; SEQUENCE; D222G; GENE	Background: The influenza A(H1N1) 2009 virus has been the dominant type of influenza A virus in Finland during the 20092010 and 2010-2011 epidemic seasons. We analyzed the antigenic characteristics of several influenza A(H1N1) 2009 viruses isolated during the two influenza seasons by analyzing the amino acid sequences of the hemagglutinin (HA), modeling the amino acid changes in the HA structure and measuring antibody responses induced by natural infection or influenza vaccination. Methods/Results: Based on the HA sequences of influenza A(H1N1) 2009 viruses we selected 13 different strains for antigenic characterization. The analysis included the vaccine virus, A/California/07/2009 and multiple California-like isolates from 2009-2010 and 2010-2011 epidemic seasons. These viruses had two to five amino acid changes in their HA1 molecule. The mutation(s) were located in antigenic sites Sa, Ca1, Ca2 and Cb region. Analysis of the antibody levels by hemagglutination inhibition test (HI) indicated that vaccinated individuals and people who had experienced a natural influenza A(H1N1) 2009 virus infection showed good immune responses against the vaccine virus and most of the wild-type viruses. However, one to two amino acid changes in the antigenic site Sa dramatically affected the ability of antibodies to recognize these viruses. In contrast, the tested viruses were indistinguishable in regard to antibody recognition by the sera from elderly individuals who had been exposed to the Spanish influenza or its descendant viruses during the early 20(th) century. Conclusions: According to our results, one to two amino acid changes (N125D and/or N156K) in the major antigenic sites of the hemagglutinin of influenza A(H1N1) 2009 virus may lead to significant reduction in the ability of patient and vaccine sera to recognize A(H1N1) 2009 viruses.	[Strengell, Mari; Ikonen, Niina; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Hlth & Welf, Viral Infect Unit, Dept Vaccines & Immune Protect, Helsinki, Finland	Finland National Institute for Health & Welfare	Strengell, M (corresponding author), Natl Inst Hlth & Welf, Viral Infect Unit, Dept Vaccines & Immune Protect, Helsinki, Finland.	mari.strengell@thl.fi		Julkunen, Ilkka/0000-0003-0165-2564; Ikonen, Niina/0000-0003-0724-8888	National Institute for Health and Welfare; Ministry of Health and Social Affairs (Finland); European Commission Directorate-General Research [201169]	National Institute for Health and Welfare; Ministry of Health and Social Affairs (Finland); European Commission Directorate-General Research(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the funds of the National Institute for Health and Welfare, the Ministry of Health and Social Affairs (Finland) and the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project (grant no 201169) supported by the European Commission Directorate-General Research and the participating member states. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aho M, 2010, EUROSURVEILLANCE, V15, P14; Barr IG, 2010, EUROSURVEILLANCE, V15, P6; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; European Medicines Agency, PAND SUMM PROD CHAR; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HILLIS DM, 1993, METHOD ENZYMOL, V224, P456, DOI 10.1016/0076-6879(93)24035-S; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kendal AP, CONCEPTS PROCEDURES; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; McCauley J, 2011, REPORT PREPARED WHO; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Suphaphiphat P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-157; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; WINTER G, 1981, NATURE, V292, P72, DOI 10.1038/292072a0; Xu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018016; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145	32	55	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25848	10.1371/journal.pone.0025848	http://dx.doi.org/10.1371/journal.pone.0025848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022458	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200017
J	Ruiss, R; Jochum, S; Mocikat, R; Hammerschmidt, W; Zeidler, R				Ruiss, Romana; Jochum, Simon; Mocikat, Ralph; Hammerschmidt, Wolfgang; Zeidler, Reinhard			EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells-A New Option for the Treatment of B-CLL	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; CD154 GENE-THERAPY; CD4(+) T-CELLS; CD40 LIGAND; IMMUNE RECOGNITION; IN-VIVO; RESPONSES; VACCINE; IDENTIFICATION	gp350, the major envelope protein of Epstein-Barr-Virus, confers B-cell tropism to the virus by interacting with the B lineage marker CD21. Here we utilize gp350 to generate tailored exosomes with an identical tropism. These exosomes can be used for the targeted co-transfer of functional proteins to normal and malignant human B cells. We demonstrate here the co-transfer of functional CD154 protein on tailored gp350+ exosomes to malignant B blasts from patients with B chronic lymphocytic leukemia (B-CLL), rendering B blasts immunogenic to tumor-reactive autologous T cells. Intriguingly, engulfment of gp350+ exosomes by B-CLL cells and presentation of gp350-derived peptides also re-stimulated EBV-specific T cells and redirected the strong antiviral cellular immune response in patients to leukemic B cells. In essence, we show that gp350 alone confers B-cell tropism to exosomes and that these exosomes can be further engineered to simultaneously trigger virus- and tumor-specific immune responses. The simultaneous exploitation of gp350 as a tropism molecule for tailored exosomes and as a neo-antigen in malignant B cells provides a novel attractive strategy for immunotherapy of B-CLL and other B-cell malignancies.	[Ruiss, Romana; Jochum, Simon; Hammerschmidt, Wolfgang] Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany; [Mocikat, Ralph] Helmholtz Zentrum, Inst Mol Immunol, Munich, Germany; [Zeidler, Reinhard] Univ Munich, Dept Otorhinolaryngol, Munich, Germany	Helmholtz Association; Helmholtz Association; University of Munich	Ruiss, R (corresponding author), Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany.	Reinhard.Zeidler@med.lmu.de	Hammerschmidt, Wolfgang/ABG-3921-2021; Zeidler, Reinhard/M-9837-2014	Hammerschmidt, Wolfgang/0000-0002-4659-0427; Zeidler, Reinhard/0000-0002-3357-4954; Multhoff, Gabriele/0000-0002-2616-3137	Deutsche Krebshilfe [107793]; Deutsche Jose Carreras Leukamie-Stiftung [DJCLS R09/17]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung	This project was supported by grant 107793 from the Deutsche Krebshilfe (www.krebshilfe.de) and grant DJCLS R09/17 from the Deutsche Jose Carreras Leukamie-Stiftung (www.carreras-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000583; Adhikary D, 2008, J VIROL, V82, P3903, DOI 10.1128/JVI.02227-07; AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1; AvilaCarino J, 1996, IMMUNOL LETT, V54, P45, DOI 10.1016/S0165-2478(96)02643-0; Battle TE, 2003, CLIN CANCER RES, V9, P2166; Beauvillain C, 2009, VACCINE, V27, P1750, DOI 10.1016/j.vaccine.2009.01.022; Biagi E, 2005, CLIN CANCER RES, V11, P6916, DOI 10.1158/1078-0432.CCR-05-0484; Biagi E, 2003, HUM GENE THER, V14, P545, DOI 10.1089/104303403764539332; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Cantwell M, 1997, NAT MED, V3, P984, DOI 10.1038/nm0997-984; Dilloo D, 1997, BLOOD, V90, P1927, DOI 10.1182/blood.V90.5.1927; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Kater AP, 2004, BRIT J HAEMATOL, V126, P512, DOI 10.1111/j.1365-2141.2004.05070.x; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kronenberger K, 2008, J IMMUNOTHER, V31, P723, DOI 10.1097/CJI.0b013e318183af26; Kuate S, 2007, VIROLOGY, V362, P26, DOI 10.1016/j.virol.2006.12.011; Mackus WJM, 2003, BLOOD, V102, P1057, DOI 10.1182/blood-2003-01-0182; Mautner J, 2004, EUR J IMMUNOL, V34, P2500, DOI 10.1002/eji.200324794; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; Steininger C, 2009, EUR J CLIN INVEST, V39, P497, DOI 10.1111/j.1365-2362.2009.02131.x; Takahashi S, 2001, HUM GENE THER, V12, P659, DOI 10.1089/104303401300057360; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tomita Y, 1998, IMMUNOL LETT, V60, P73, DOI 10.1016/S0165-2478(97)00142-9; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; WALLACE LE, 1991, J VIROL, V65, P3821, DOI 10.1128/JVI.65.7.3821-3828.1991; WATANABE T, 1994, BLOOD, V84, P3158; Wendtner CM, 2002, BLOOD, V100, P1655, DOI 10.1182/blood.V100.5.1655.h81702001655_1655_1661; Wierda WG, 2000, BLOOD, V96, P2917; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464	36	44	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25294	10.1371/journal.pone.0025294	http://dx.doi.org/10.1371/journal.pone.0025294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22022385	Green Published, Green Submitted, gold			2022-12-25	WOS:000295971700005
J	Huang, BY; Takahashi, K; Sakata, T; Kiso, H; Sugai, M; Fujimura, K; Shimizu, A; Kosugi, S; Sato, T; Bessho, K				Huang, Boyen; Takahashi, Katsu; Sakata, Tomoko; Kiso, Honoka; Sugai, Manabu; Fujimura, Kazuma; Shimizu, Akira; Kosugi, Shinji; Sato, Tosiya; Bessho, Kazuhisa			Increased Risk of Temporomandibular Joint Closed Lock: A Case-Control Study of ANKH Polymorphisms	PLOS ONE			English	Article							ANTERIOR DISC DISPLACEMENT; INTERNAL DERANGEMENT; ANKYLOSING-SPONDYLITIS; CRANIOMETAPHYSEAL DYSPLASIA; INTRAARTICULAR ADHESIONS; MOUSE MODEL; OSTEOARTHRITIS; REDUCTION; PYROPHOSPHATE; ARTHROSCOPY	Objectives: This study aimed to carry out a histological examination of the temporomandibular joint (TMJ) in ank mutant mice and to identify polymorphisms of the human ANKH gene in order to establish the relationship between the type of temporomandibular disorders (TMD) and ANKH polymorphisms. Materials and Methods: Specimens from the TMJ of ank mutant and wild-type mice were inspected with a haematoxylin and eosin staining method. A sample of 55 TMD patients were selected. Each was examined with standard clinical procedures and genotyping techniques. Results: The major histological finding in ank mutant mice was joint space narrowing. Within TMD patients, closed lock was more prevalent among ANKH-OR homozygotes (p = 0.011, OR = 7.7, 95% CI 1.6-36.5) and the elder (p = 0.005, OR = 2.4, 95% CI 1.3-4.3). Conclusions: Fibrous ankylosis was identified in the TMJ of ank mutant mice. In the human sample, ANKH-OR polymorphism was found to be a genetic marker associated with TMJ closed lock. Future investigations correlating genetic polymorphism to TMD are indicated.	[Huang, Boyen; Takahashi, Katsu; Sakata, Tomoko; Kiso, Honoka; Fujimura, Kazuma; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Med, Dept Biomed Eth, Kyoto, Japan; [Sugai, Manabu; Shimizu, Akira] Kyoto Univ, Kyoto Univ Hosp, Translat Res Ctr, Kyoto, Japan; [Sato, Tosiya] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Huang, BY (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan.	takahask@kuhp.kyoto-u.ac.jp	Huang, Boyen/AAR-3348-2020; KOSUGI, Shinji/GYR-2946-2022; Sato, Tosiya Shun/GXV-4060-2022; Huang, Boyen/I-7768-2014; Huang, Boyen/GRE-5912-2022; KOSUGI, Shinji/HCH-0631-2022; SATO, Toshiya/GYR-2957-2022	Huang, Boyen/0000-0002-1246-7447; Sato, Tosiya Shun/0000-0001-9830-013X; Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Sugai, Manabu/0000-0003-1668-7647	Japanese Society for the Promotion of Science [P09741]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a JSPS (official website: http://www.jsps.go.jp/english/) Postdoctoral Fellowship for Foreign Researchers (P09741) and a Grant-in-Aid for Scientific Research (B) from Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1990, PRACTICAL STAT MED R, P325; Bertram S, 2001, J AM DENT ASSOC, V132, P753, DOI 10.14219/jada.archive.2001.0272; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; Cevidanes LHS, 2010, ORAL SURG ORAL MED O, V110, P110, DOI 10.1016/j.tripleo.2010.01.008; Chen IP, 2009, J BONE MINER RES, V24, P1206, DOI [10.1359/JBMR.090218, 10.1359/jbmr.090218]; Chen J, 2009, ARCH ORAL BIOL, V54, P1091, DOI 10.1016/j.archoralbio.2009.10.001; D'Anto Vincenzo, 2010, Prog Orthod, V11, P174, DOI 10.1016/j.pio.2010.09.007; DEBONT LGM, 1986, J ORAL MAXIL SURG, V44, P634, DOI 10.1016/S0278-2391(86)80075-1; Dijkgraaf LC, 1998, INT J ORAL MAX SURG, V27, P268, DOI 10.1016/S0901-5027(05)80509-0; Dimitroulis G, 2002, J ORAL MAXIL SURG, V60, P519, DOI 10.1053/joms.2002.31848; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Emshoff R, 2002, J ORAL REHABIL, V29, P516, DOI 10.1046/j.1365-2842.2002.00883.x; Fox N, 1997, FAM PRACT, V14, P324, DOI 10.1093/fampra/14.4.324; Gesch D, 2004, QUINTESSENCE INT, V35, P143; Gonzalez-Garcia R, 2010, J ORAL MAXIL SURG, V68, P35, DOI 10.1016/j.joms.2009.04.127; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; HOLMLUND AB, 1992, ORAL SURG ORAL MED O, V73, P9, DOI 10.1016/0030-4220(92)90145-G; ISACSSON G, 1986, J ORAL MAXIL SURG, V44, P771, DOI 10.1016/0278-2391(86)90151-5; Kalaykova S, 2010, J OROFAC PAIN, V24, P373; Kalaykova SI, 2011, J OROFAC PAIN, V25, P153; Kiernan JA., 2008, HISTOLOGICAL HISTOCH, P141; Kiga N, 2010, Eur J Histochem, V54, pe34; Kohler AA, 2009, EUR ARCH PAEDIATR DE, V10, P16; Kononen M, 1996, LANCET, V347, P1080, DOI 10.1016/S0140-6736(96)90280-9; Leonardi R, 2010, ORAL SURG ORAL MED O, V109, P244, DOI 10.1016/j.tripleo.2009.09.028; Major P, 1999, J RHEUMATOL, V26, P616; Miyamoto H, 1999, ORAL SURG ORAL MED O, V88, P151, DOI 10.1016/S1079-2104(99)70109-5; MURAKAMI KI, 1992, J ORAL MAXIL SURG, V50, P705, DOI 10.1016/0278-2391(92)90102-6; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nitzan DW, 1997, J ORAL MAXIL SURG, V55, P151, DOI 10.1016/S0278-2391(97)90233-0; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Ogura N, 2002, J ORAL PATHOL MED, V31, P353, DOI 10.1034/j.1600-0714.2002.310606.x; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Paegle DI, 2003, INT J ORAL MAX SURG, V32, P397, DOI 10.1054/ijom.2003.0375; PAESANI D, 1992, AM J ORTHOD DENTOFAC, V101, P41, DOI 10.1016/0889-5406(92)70080-T; Peach CA, 2007, CLIN ORTHOP RELAT R, P67, DOI 10.1097/BLO.0b013e31811f39de; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; ROHLIN M, 1985, J ORAL MAXIL SURG, V43, P194, DOI 10.1016/0278-2391(85)90159-4; SAWHNEY CP, 1986, PLAST RECONSTR SURG, V77, P29, DOI 10.1097/00006534-198601000-00006; Tominaga K, 2002, BRIT J ORAL MAX SURG, V40, P232, DOI 10.1054/bjom.2001.0746; Tsui FWL, 2003, ARTHRITIS RHEUM-US, V48, P791, DOI 10.1002/art.10844; Wenghoefer M, 2008, J CRANIOFAC SURG, V19, P1114, DOI 10.1097/SCS.0b013e318176ac3b; Zhang SY, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-70	44	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25503	10.1371/journal.pone.0025503	http://dx.doi.org/10.1371/journal.pone.0025503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003394	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300015
J	Stienen, BMC; Tanaka, A; de Gelder, B				Stienen, Bernard M. C.; Tanaka, Akihiro; de Gelder, Beatrice			Emotional Voice and Emotional Body Postures Influence Each Other Independently of Visual Awareness	PLOS ONE			English	Article							FACIAL EXPRESSIONS; INFLUENCE RECOGNITION; BODILY EXPRESSIONS; PERCEPTION; AMYGDALA; FACE; ATTENTION; MASKING; THREAT; FEAR	Multisensory integration may occur independently of visual attention as previously shown with compound face-voice stimuli. We investigated in two experiments whether the perception of whole body expressions and the perception of voices influence each other when observers are not aware of seeing the bodily expression. In the first experiment participants categorized masked happy and angry bodily expressions while ignoring congruent or incongruent emotional voices. The onset between target and mask varied from -50 to +133 ms. Results show that the congruency between the emotion in the voice and the bodily expressions influences audiovisual perception independently of the visibility of the stimuli. In the second experiment participants categorized the emotional voices combined with masked bodily expressions as fearful or happy. This experiment showed that bodily expressions presented outside visual awareness still influence prosody perception. Our experiments show that audiovisual integration between bodily expressions and affective prosody can take place outside and independent of visual awareness.	[Stienen, Bernard M. C.; de Gelder, Beatrice] Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands; [Tanaka, Akihiro] Waseda Inst Adv Study, Tokyo, Japan; [de Gelder, Beatrice] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [de Gelder, Beatrice] Harvard Univ, Sch Med, Charlestown, MA USA	Tilburg University; Waseda University; Harvard University; Massachusetts General Hospital; Harvard University	Stienen, BMC (corresponding author), Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands.	B.deGelder@uvt.nl			Dutch Association of Scientific Research (NWO), Tango; EU [FDP6-NEST-043403]; MEXT [19001004]; European Commission, under FET-Open [249858]	Dutch Association of Scientific Research (NWO), Tango(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission, under FET-Open(European CommissionEuropean Commission Joint Research Centre)	This project was funded by the Dutch Association of Scientific Research (NWO), Tango, the EU project COBOL (FDP6-NEST-043403) and by Grant-in-Aid of MEXT for Specially Promoted Research (no. 19001004). The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open (grant number 249858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; de Gelder B, 2002, P NATL ACAD SCI USA, V99, P4121, DOI 10.1073/pnas.062018499; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Duncan S, 2007, TRENDS COGN SCI, V11, P190, DOI 10.1016/j.tics.2007.01.007; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; STIENEN BMC, EMOTION IN PRESS; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; VANDENSTOCK J, SOC NEUROSC IN PRESS; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Whalen PJ, 1998, J NEUROSCI, V18, P411	30	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25517	10.1371/journal.pone.0025517	http://dx.doi.org/10.1371/journal.pone.0025517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OC	22003396	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300017
J	Lorenzon, E; Colladel, R; Andreuzzi, E; Marastoni, S; Todaro, F; Schiappacassi, M; Ligresti, G; Colombatti, A; Mongiat, M				Lorenzon, E.; Colladel, R.; Andreuzzi, E.; Marastoni, S.; Todaro, F.; Schiappacassi, M.; Ligresti, G.; Colombatti, A.; Mongiat, M.			MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway	ONCOGENE			English	Article						angiogenesis; extracellular matrix; VEGF	AORTIC RING MODEL; ENDOTHELIAL-CELLS; MICROENVIRONMENTAL REGULATION; THERAPEUTIC IMPLICATIONS; TYROSINE KINASE; RECEPTOR; VEGF; THROMBOSPONDIN-1; IDENTIFICATION; GLYCOPROTEIN	MULTIMERIN2 (MMRN2), also known as Endoglyx-1, is an extracellular matrix glycoprotein whose function has so far remained elusive. Given its specific localization in tight association with the endothelium we hypothesized that this protein could modulate neo-angiogenesis. By multiple assays we showed that MMRN2 significantly impaired endothelial cell (EC) migration and organization of a functional vessel network. The interaction of ECs with MMRN2 induced a striking impairment of VEGFR1 and VEGFR2 activation. We focused our attention on VEGFR2, a chief regulator of angiogenesis, and clarified that MMRN2 interfered with the VEGF/VEGFR2 axis through a direct binding with VEGF-A. This novel interaction was assessed in several assays and the affinity was estimated (Kd similar to 50 nM). We next questioned whether the anti-angiogenic properties of MMRN2 could impair tumor growth. Although overexpression of MMRN2 by HT1080 cells did not affect their growth and apoptotic rate in vitro, it remarkably affected their growth in vivo. In fact, MMRN2-positive cells failed to efficiently grow and form well-vascularized tumors; a similar outcome was observed following treatment of established tumors with a MMRN2 adenoviral construct. Tumor-section immunostaining revealed a strong co-localization of VEGF-A with the ectopically expressed MMRN2. These novel findings suggest that VEGF may be sequestered by MMRN2 and be less available for the engagement to the receptors. Taken together these results highlight MMRN2 as a crucial player in the regulation of EC function, neo-angiogenesis and hence tumor growth. We hypothesize that secreted and deposited MMRN2 may function as a homeostatic barrier halting the sprouting of novel vessels, and suggest that these studies may embody the potential for the development of novel tools for cancer treatment. Oncogene (2012) 31, 3136-3147; doi:10.1038/onc.2011.487; published online 24 October 2011	[Colombatti, A.; Mongiat, M.] CRO IRCCS, Dept Mol Oncol & Translat Res, Expt Oncol Div 2, Aviano, PN, Italy; [Andreuzzi, E.; Colombatti, A.] Univ Udine, MATI Ctr Excellence, I-33100 Udine, Italy; [Ligresti, G.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	IRCCS Aviano (CRO); University of Udine; University of Washington; University of Washington Seattle	Mongiat, M (corresponding author), CRO IRCCS, Dept Mol Oncol & Translat Res, Expt Oncol Div 2, Via Franco Gallini 2, Aviano, PN, Italy.	acolombatti@cro.it; mmongiat@cro.it	Andreuzzi, Eva/AAX-5692-2020; Mongiat, Maurizio/H-8297-2018; Ligresti, Giovanni/AAB-9881-2019; Schiappacassi, Monica/AAX-5505-2020	Andreuzzi, Eva/0000-0002-5925-5230; Mongiat, Maurizio/0000-0001-6509-0068; Schiappacassi, Monica/0000-0003-4804-4291; colombatti, alfonso/0000-0002-3676-2379	ISS-ACC; AIRC; MIUR [RBRN07BMCT]	ISS-ACC; AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR))	We thank Dr Philip Thorpe and Dr Rolf Brekken for the generous gift of the Gv39M antibody. We thank the ISS-ACC Program 2, AIRC and MIUR (grant no.RBRN07BMCT) for supporting this work.	Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Brekken RA, 1998, CANCER RES, V58, P1952; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Hirama M, 2003, CANCER LETT, V198, P107, DOI 10.1016/S0304-3835(03)00286-6; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hotz B, 2010, NEOPLASIA, V12, P797, DOI 10.1593/neo.10418; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huber MA, 2006, J CUTAN PATHOL, V33, P145, DOI 10.1111/j.0303-6987.2006.00446.x; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Koperek O, 2007, INT J ONCOL, V31, P59; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2010, NEOPLASIA, V12, P294, DOI 10.1593/neo.91930; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; SANZMONCASI MP, 1994, LAB INVEST, V71, P366; Spessotto P, 2000, METH MOL B, V139, P321; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Ventura E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009145; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	43	54	57	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	26					3136	3147		10.1038/onc.2011.487	http://dx.doi.org/10.1038/onc.2011.487			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22020326	Bronze			2022-12-25	WOS:000305934400003
J	Francois, KO; Balzarini, J				Francois, Katrien O.; Balzarini, Jan			The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; CARBOHYDRATE-BINDING AGENTS; LINKED GLYCOSYLATION SITES; CYANOVIRIN-N; ANTIBODY 2G12; TYPE-1; RESISTANCE; DELETIONS; PROTEIN	Carbohydrate-binding agents bind to the N-glycans of HIV-1 envelope gp120 and prevent viral entry. Carbohydrate-binding agents can select for mutant viruses with deleted envelope glycans. Not all glycosylation motifs are mutated to the same extent. Site-directed mutagenesis revealed that deletions destroying the highly conserved (260)NGS(262) glycosylation motif resulted in non-infectious virus particles. We observed a significant lower CD4 binding in the case of the N260Q mutant gp120 virus strains, caused by a strikingly lower expression of gp120 and gp41 in the virus particle. In addition, the mutant N260Q HIV-1 envelope expressed in 293T cells was unable to form syncytia in co-cultures with U87.CD4.CXCR4.CCR5 cells, due to the lower expression of envelope protein on the surface of the transfected 293T cells. The detrimental consequence of this N-glycan deletion on virus infectivity could not be compensated for by the creation of novel glycosylation sites near this amino acid, leaving this uncovered envelope epitope susceptible to neutralizing antibody binding. Thus, the Asn-260 glycan in the gp120 envelope of HIV-1 represents a hot spot for targeting suicidal drugs or antibodies in a therapeutic effort to efficiently neutralize a broad array of virus strains.	[Francois, Katrien O.; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium	KU Leuven	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be			Katholieke Universiteit Leuven Centers of Excellence [EF-05/15]; Geconcerteerde Onderzoeksactie [10/014]; Fonds voor Wetenschappelijk Onderzoek [G.485.08]; European Commission;  [PF/10/018]	Katholieke Universiteit Leuven Centers of Excellence; Geconcerteerde Onderzoeksactie; Fonds voor Wetenschappelijk Onderzoek(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); 	This work was supported by Katholieke Universiteit Leuven Centers of Excellence Grant EF-05/15 and Program Financing Grant PF/10/018, Geconcerteerde Onderzoeksactie Grant 10/014, Fonds voor Wetenschappelijk Onderzoek Grant G.485.08, and the CHAARM Network Project of the European Commission.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082; Balzarini J, 2004, J VIROL, V78, P10617, DOI 10.1128/JVI.78.19.10617-10627.2004; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, J VIROL, V81, P362, DOI 10.1128/JVI.01404-06; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Fikkert V, 2002, ANTIMICROB AGENTS CH, V46, P3954, DOI 10.1128/AAC.46.12.3954-3962.2002; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; LEE WR, 1992, P NATL ACAD SCI USA, V89, P2213, DOI 10.1073/pnas.89.6.2213; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Pikora C, 2005, J VIROL, V79, P12575, DOI 10.1128/JVI.79.19.12575-12583.2005; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Van Damme EJM, 1998, HDB PLANT LECTINS PR; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; VANDAMME EJM, 1988, PLANT PHYSIOL, V86, P598, DOI 10.1104/pp.86.2.598; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	46	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42900	42910		10.1074/jbc.M111.274456	http://dx.doi.org/10.1074/jbc.M111.274456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006924	Green Published, hybrid			2022-12-25	WOS:000298351300012
J	Haque, I; Banerjee, S; Mehta, S; De, A; Majumder, M; Mayo, MS; Kambhampati, S; Campbell, DR; Banerjee, SK				Haque, Inamul; Banerjee, Snigdha; Mehta, Smita; De, Archana; Majumder, Monami; Mayo, Matthew S.; Kambhampati, Suman; Campbell, Donald R.; Banerjee, Sushanta K.			Cysteine-rich 61-Connective Tissue Growth Factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced Signaling Protein-2 (WISP-2) Regulates MicroRNA-10b via Hypoxia-inducible Factor-1 alpha-TWIST Signaling Networks in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; MOLECULAR CROSS-TALKS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; INVASIVE PHENOTYPES; UP-REGULATION; REAL-TIME; METASTASIS; P53; PROLIFERATION	MicroRNAs (miRNAs) are naturally occurring single-stranded RNA molecules that post-transcriptionally regulate the expression of target mRNA transcripts. Many of these target mRNA transcripts are involved in regulating processes commonly altered during tumorigenesis and metastatic growth. These include cell proliferation, differentiation, apoptosis, migration, and invasion. Among the several miRNAs, miRNA-10b (miR-10b) expression is increased in metastatic breast cancer cells and positively regulates cell migration and invasion through the suppression of the homeobox D10 (HOXD10) tumor suppressor signaling pathway. In breast metastatic cells, miR-10b expression is enhanced by a transcription factor TWIST1. We find that miR-10b expression in breast cancer cells can be suppressed by CCN5, and this CCN5 effect is mediated through the inhibition of TWIST1 expression. Moreover, CCN5-induced inhibition of TWIST1 expression is mediated through the translational inhibition/modification of hypoxia-inducible factor-1 alpha via impeding JNK signaling pathway. Collectively, these studies suggest a novel regulatory pathway exists through which CCN5 exerts its anti-invasive function. On the basis of these findings, it is plausible that reactivation of CCN5 in miR-10b-positive invasive/metastatic breast cancers alone or in combination with current therapeutic regimens could provide a unique, alternative strategy to existing breast cancer therapy.	[Banerjee, Sushanta K.] Vet Affairs Med Ctr, Canc Res Unit, Res Div 151, Kansas City, MO 64128 USA; [Haque, Inamul; Banerjee, Snigdha; Mehta, Smita; De, Archana; Majumder, Monami; Kambhampati, Suman] Univ Kansas, Med Ctr, Div Hematol & Oncol, Kansas City, KS 66205 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66205 USA; [Mayo, Matthew S.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66205 USA; [Banerjee, Sushanta K.] St Lukes Hosp, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64112 USA; [Campbell, Donald R.] St Lukes Hosp, Dept Med, Kansas City, MO 64112 USA; Univ Missouri, Kansas City, MO 64112 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Saint Luke's Hospital - Missouri; Saint Luke's Hospital - Missouri; University of Missouri System; University of Missouri Kansas City	Banerjee, SK (corresponding author), Vet Affairs Med Ctr, Canc Res Unit, Res Div 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee2@kumc.edu	Haque, Inamul/I-2482-2019; Mayo, Matthew S/E-3774-2015	Banerjee, Sushanta/0000-0002-7698-0717; Haque, Inamul/0000-0002-1307-9446				Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee S, 2003, NEOPLASIA, V5, P63, DOI 10.1016/S1476-5586(03)80018-0; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dhar K, 2007, CANCER RES, V67, P1520, DOI 10.1158/0008-5472.CAN-06-3753; Espinosa C. E. Stahlhut, 2006, YALE J BIOL MED, V79, P131; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Parkin DM, 1998, SEMIN CANCER BIOL, V8, P219, DOI 10.1006/scbi.1998.0080; Petroff BK, 2006, ANAL QUANT CYTOL, V28, P297; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Saxena N, 2001, MOL CELL BIOCHEM, V228, P99, DOI 10.1023/A:1013338912642; Sengupta K, 2006, BIOCHEMISTRY-US, V45, P10698, DOI 10.1021/bi060888p; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Slack Frank J, 2006, Genome Biol, V7, P328, DOI 10.1186/gb-2006-7-9-328; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Steeg PS, 2007, NATURE, V449, P671, DOI 10.1038/449671a; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Xiang J, 2010, CURR GENOMICS, V11, P129, DOI 10.2174/138920210790886853; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051	54	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43475	43485		10.1074/jbc.M111.284158	http://dx.doi.org/10.1074/jbc.M111.284158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020939	hybrid, Green Published			2022-12-25	WOS:000298351300067
J	Abu Jawdeh, BG; Khan, S; Deschenes, I; Hoshi, M; Goel, M; Lock, JT; Shinlapawittayatorn, K; Babcock, G; Lakhe-Reddy, S; DeCaro, G; Yadav, SP; Mohan, ML; Prasad, SVN; Schilling, WP; Ficker, E; Schelling, JR				Abu Jawdeh, Bassam G.; Khan, Shenaz; Deschenes, Isabelle; Hoshi, Malcolm; Goel, Monu; Lock, Jeffrey T.; Shinlapawittayatorn, Krekwit; Babcock, Gerald; Lakhe-Reddy, Sujata; DeCaro, Garren; Yadav, Satya P.; Mohan, Maradumane L.; Prasad, Sathyamangla V. Naga; Schilling, William P.; Ficker, Eckhard; Schelling, Jeffrey R.			Phosphoinositide Binding Differentially Regulates NHE1 Na+/H+ Exchanger-dependent Proximal Tubule Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C ACTIVATION; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RENAL-FUNCTION; APOPTOSIS; PROTEIN; PH; ISOFORMS; DOMAIN; PIP2	Tubular atrophy predicts chronic kidney disease progression, and is caused by proximal tubular epithelial cell (PTC) apoptosis. The normally quiescent Na+/H+ exchanger-1 (NHE1) defends against PTC apoptosis, and is regulated by PI(4,5)P-2 binding. Because of the vast array of plasma membrane lipids, we hypothesized that NHE1-mediated cell survival is dynamically regulated by multiple anionic inner leaflet phospholipids. In membrane overlay and surface plasmon resonance assays, the NHE1 C terminus bound phospholipids with low affinity and according to valence (PIP3 > PIP2> PIP = PA > PS). NHE1-phosphoinositide binding was enhanced by acidic pH, and abolished by NHE1 Arg/Lys to Ala mutations within two juxtamembrane domains, consistent with electrostatic interactions. PI(4,5)P-2-incorporated vesicles were distributed to apical and lateral PTC domains, increased NHE1-regulated Na+/H+ exchange, and blunted apoptosis, whereas NHE1 activity was decreased in cells enriched with PI(3,4,5)P-3, which localized to basolateral membranes. Divergent PI(4,5)P-2 and PI(3,4,5)P-3 effects on NHE1-dependent Na+/H+ exchange and apoptosis were confirmed by selective phosphoinositide sequestration with pleckstrin homology domain-containing phospholipase C delta and Akt peptides, PI 3-kinase, and Akt inhibition in wild-type and NHE1-null PTCs. The results reveal an on-off switch model, whereby NHE1 toggles between weak interactions with PI(4,5)P-2 and PI(3,4,5)P-3. In response to apoptotic stress, NHE1 is stimulated by PI(4,5)P-2, which leads to PI 3-kinase activation, and PI(4,5)P-2 phosphorylation. The resulting PI(3,4,5)P-3 dually stimulates sustained, downstream Akt survival signaling, and dampens NHE1 activity through competitive inhibition and depletion of PI(4,5)P-2.	[Schelling, Jeffrey R.] Case Western Reserve Univ, Rammelkamp Ctr Res, Dept Med, Cleveland, OH 44109 USA; [Deschenes, Isabelle; Hoshi, Malcolm; Goel, Monu; Lock, Jeffrey T.; Shinlapawittayatorn, Krekwit; Babcock, Gerald; Schilling, William P.] Case Western Reserve Univ, Dept Physiol & Biophys, Lerner Res Inst, Cleveland, OH 44109 USA; [Yadav, Satya P.; Mohan, Maradumane L.; Prasad, Sathyamangla V. Naga] Case Western Reserve Univ, Cleveland Clin Fdn, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Schelling, JR (corresponding author), Case Western Reserve Univ, Rammelkamp Ctr Res, Dept Med, 2500 MetroHlth Dr,R415, Cleveland, OH 44109 USA.	jeffrey.schelling@case.edu	Shinlapawittayatorn, Krekwit/AAW-2698-2021	Shinlapawittayatorn, Krekwit/0000-0003-1114-0087; Lock, Jeffrey T./0000-0003-1522-3189	National Institutes of Health [R01 DK067528, R01 DK072348, R01 HL097355]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067528, R01DK072348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK067528 and R01 DK072348 (to J. R. S.) and R01 HL097355 (to W. P. S.) and an American Heart Association fellowship grant (to B. G. A. J.).	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Bachmann O, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-70; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BARBER DL, 1991, CELL SIGNAL, V3, P387, DOI 10.1016/0898-6568(91)90069-7; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Bohle A, 1996, KIDNEY INT, V49, pS2; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cooke FT, 2010, METHODS MOL BIOL, V645, P179, DOI 10.1007/978-1-60327-175-2_12; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dibrov P, 2000, BIOSCIENCE REP, V20, P185, DOI 10.1023/A:1005567519792; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Khan S, 2006, CELL MOL BIOL, V52, P115, DOI 10.1170/T769; Khan S, 1999, LAB INVEST, V79, P1089; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE, P443; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lagana A, 2000, J CELL SCI, V113, P3649; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; MIAO B, 2010, P NATL ACAD SCI US; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Nath SK, 1996, AM J PHYSIOL-GASTR L, V270, pG431, DOI 10.1152/ajpgi.1996.270.3.G431; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; RISDON RA, 1968, LANCET, V2, P363; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; Schelling JR, 1999, KIDNEY INT, V56, P1313, DOI 10.1046/j.1523-1755.1999.00684.x; SCHELLING JR, 1992, J CLIN INVEST, V90, P2472, DOI 10.1172/JCI116139; SCHELLING JR, 1994, KIDNEY INT, V46, P675, DOI 10.1038/ki.1994.320; Schelling JR, 1998, LAB INVEST, V78, P813; Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196, DOI 10.1152/ajpcell.2001.281.4.C1196; SHINLAPAWITTAYA.K, 2011, CIRC CARDIO IN PRESS; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Soleimani M, 1998, KIDNEY INT, V53, P423, DOI 10.1046/j.1523-1755.1998.00771.x; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	76	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42435	42445		10.1074/jbc.M110.212845	http://dx.doi.org/10.1074/jbc.M110.212845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22020933	Green Published, hybrid			2022-12-25	WOS:000298180900052
J	Britton, JR; Pegg, J; Williams, CF				Britton, J. Robert; Pegg, Josephine; Williams, Chris F.			Pathological and Ecological Host Consequences of Infection by an Introduced Fish Parasite	PLOS ONE			English	Article							BOTHRIOCEPHALUS-ACHEILOGNATHI YAMAGUTI; LIFE-HISTORY TRAITS; CYPRINUS-CARPIO; CLIMATE-CHANGE; GROWTH; RESPONSES; TAPEWORM; DISEASES; RIVER	The infection consequences of the introduced cestode fish parasite Bothriocephalus acheilognathi were studied in a cohort of wild, young-of-the-year common carp Cyprinus carpio that lacked co-evolution with the parasite. Within the cohort, parasite prevalence was 42% and parasite burdens were up to 12% body weight. Pathological changes within the intestinal tract of parasitized carp included distension of the gut wall, epithelial compression and degeneration, pressure necrosis and varied inflammatory changes. These were most pronounced in regions containing the largest proportion of mature proglottids. Although the body lengths of parasitized and non-parasitized fish were not significantly different, parasitized fish were of lower body condition and reduced weight compared to non-parasitized conspecifics. Stable isotope analysis (delta N-15 and delta C-13) revealed trophic impacts associated with infection, particularly for delta N-15 where values for parasitized fish were significantly reduced as their parasite burden increased. In a controlled aquarium environment where the fish were fed ad libitum on an identical food source, there was no significant difference in values of delta N-15 and delta N-13 between parasitized and non-parasitized fish. The growth consequences remained, however, with parasitized fish growing significantly slower than non-parasitized fish, with their feeding rate (items s(-1)) also significantly lower. Thus, infection by an introduced parasite had multiple pathological, ecological and trophic impacts on a host with no experience of the parasite.	[Britton, J. Robert; Pegg, Josephine] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Williams, Chris F.] Environm Agcy, Brampton, Cambs, England	Bournemouth University	Britton, JR (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	rbritton@bournemouth.ac.uk	Britton, Robert/B-5040-2009; Britton, Robert/AAO-6673-2020	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; Pegg, Josephine/0000-0001-6364-4741	Fisheries Society of the British Isles; Bournemouth University; Environment Agency of England and Wales	Fisheries Society of the British Isles; Bournemouth University; Environment Agency of England and Wales	Funding for the study was received through a grant from the Fisheries Society of the British Isles (www.fsbi.co.uk), with support from Bournemouth University and the Environment Agency of England and Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANDREWS C, 1981, J FISH DIS, V4, P89, DOI 10.1111/j.1365-2761.1981.tb01113.x; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; Bauer O. N., 1973, Diseases of pond fishes.; Blanchet S, 2010, EVOL ECOL, V24, P1129, DOI 10.1007/s10682-010-9353-x; Blanchet S, 2009, TRENDS PARASITOL, V25, P364, DOI 10.1016/j.pt.2009.05.005; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; DUBININA MN, 1964, KEY PARASITES FRESHW, P480; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; FERNANDEZDELGADO C, 1990, HYDROBIOLOGIA, V206, P19, DOI 10.1007/BF00018966; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2006, MICROBES INFECT, V8, P1358, DOI 10.1016/j.micinf.2005.12.010; Grey J, 2006, POL J ECOL, V54, P563; HECKMANN RA, 1987, J PARASITOL, V73, P226, DOI 10.2307/3282373; Heckmann Richard A., 2000, Proceedings of Parasitology, V29, P1; Hoffman G.L., 1984, P233; HOOLE D, 1994, J FISH DIS, V17, P623, DOI 10.1111/j.1365-2761.1994.tb00260.x; Hoole D., 1994, P119; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; Khan TA, 2003, HYDROBIOLOGIA, V506, P465, DOI 10.1023/B:HYDR.0000008558.48008.63; Koop JAH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019706; MICHALAKIS Y, 1994, PARASITE, V1, P291, DOI 10.1051/parasite/1994014291; MINCHELLA DJ, 1991, TRENDS ECOL EVOL, V6, P250, DOI 10.1016/0169-5347(91)90071-5; MINERVINI R, 1985, RIV IT PISCIC ITTIOP, V20, P27; Murray AG, 2005, PREV VET MED, V67, P223, DOI 10.1016/j.prevetmed.2004.10.012; Norton J, 2005, PARASITOLOGY, V130, P679, DOI 10.1017/S0031182004007139; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Peeler EJ, 2011, BIOL INVASIONS, V13, P1291, DOI 10.1007/s10530-010-9890-9; Pegg J, 2011, ECOL FRESHW FISH, V20, P598, DOI 10.1111/j.1600-0633.2011.00509.x; Penczykowski RM, 2011, FRESHWATER BIOL, V56, P689, DOI 10.1111/j.1365-2427.2010.02499.x; Perrin N, 1996, OIKOS, V75, P317, DOI 10.2307/3546256; Phares K, 1996, INT J PARASITOL, V26, P575, DOI 10.1016/0020-7519(96)00025-2; Poulin R, 1998, J PARASITOL, V84, P1050, DOI 10.2307/3284645; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; SALGADOMALDONAD.G, 1993, ANALES I BIOL U NACL, V57, P213; Scholz T., 1992, Parassitologia (Rome), V34, P155; Sorci G, 1997, P ROY SOC B-BIOL SCI, V264, P285, DOI 10.1098/rspb.1997.0040; Sorensen RE, 1998, OECOLOGIA, V115, P188, DOI 10.1007/s004420050507; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; XIANGHUA L, 2007, CURRENT ZOOLOGY, V53, P470; FISHERIES AGR DEP 20	47	33	38	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26365	10.1371/journal.pone.0026365	http://dx.doi.org/10.1371/journal.pone.0026365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022606	Green Published, gold, Green Accepted			2022-12-25	WOS:000295984400051
J	Assassi, S; Leyva, AL; Mayes, MD; Sharif, R; Nair, DK; Fischbach, M; Nguyen, N; Reveille, JD; Gonzalez, EB; McNearney, TA				Assassi, Shervin; Leyva, Astrud L.; Mayes, Maureen D.; Sharif, Roozbeh; Nair, Deepthi K.; Fischbach, Michael; Ngan Nguyen; Reveille, John D.; Gonzalez, Emilio B.; McNearney, Terry A.		GENISOS Study Grp	Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; DISEASE SEVERITY; DISABILITY; AUTOANTIBODIES; INVOLVEMENT; SYMPTOMS	Objectives: Longitudinal studies examining the baseline predictors of fatigue in SSc have not been reported. Our objectives were to examine the course of fatigue severity over time and to identify baseline clinical, demographic, and psychosocial predictors of sequentially obtained fatigue scores in early SSc. We also examined baseline predictors of change in fatigue severity over time. Methods: We analyzed 1090 longitudinal Fatigue Severity Scale (FSS) scores belonging to 256 patients who were enrolled in the Genetics versus Environment in Scleroderma Outcomes Study (GENISOS). Predictive significance of baseline variables for sequentially obtained FSS scores was examined with generalized linear mixed models. Predictors of change in FSS over time were examined by adding an interaction term between the baseline variable and time-in-study to the model. Results: The patients' mean age was 48.6 years, 47% were Caucasians, and 59% had diffuse cutaneous involvement. The mean disease duration at enrollment was 2.5 years. The FSS was obtained at enrollment and follow-up visits (mean follow-up time = 3.8 years). Average baseline FSS score was 4.7(+/- 0.96). The FSS was relatively stable and did not show a consistent trend for change over time (p = 0.221). In a multivariable model of objective clinical variables, higher Medsger Gastrointestinal (p = 0.006) and Joint (p = 0.024) Severity Indices, and anti-U1-RNP antibodies (p = 0.024) were independent predictors of higher FSS. In the final model, ineffective coping skills captured by higher Illness Behavior Questionnaire scores (p<0.001), higher self-reported pain (p = 0.006), and higher Medsger Gastrointestinal Severity Index (p = 0.009) at enrollment were independent predictors of higher longitudinal FSS scores. Baseline DLco % predicted was the only independent variable that significantly predicted a change in FSS scores over time (p = 0.013), with lower DLco levels predicting an increase in FSS over time. Conclusions: This study identified potentially modifiable clinical and psychological factors that predict longitudinal fatigue severity in early SSc.	[Assassi, Shervin; Mayes, Maureen D.; Sharif, Roozbeh; Nair, Deepthi K.; Ngan Nguyen; Reveille, John D.] Univ Texas Hlth Sci Ctr, Div Rheumatol, Dept Med, Houston, TX 77225 USA; [Leyva, Astrud L.; Sharif, Roozbeh; Gonzalez, Emilio B.; McNearney, Terry A.] Univ Texas Med Branch, Dept Med, Galveston, TX USA; [Fischbach, Michael] Univ Texas Hlth Sci Ctr San Antonio, Div Rheumatol, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Assassi, S (corresponding author), Univ Texas Hlth Sci Ctr, Div Rheumatol, Dept Med, Houston, TX 77225 USA.	shervin.assassi@uth.tmc.edu	Sharif, Roozbeh/AAE-7492-2020; Leyva, Laura/B-5574-2019; Leyva, Laura/R-2187-2019	Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625	National Institutes of Health (NIH) Center for Research Translation [P50AR054144]; NIH [UL1-RR024148]; University Clinic Research Center [M01-RR00073, M01-RR01346]; National Center for Research Resources [TL1 RR024147];  [NIH-KL2RR024149-04];  [NIH -5T32-AR052283-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, KL2RR024149, M01RR000073, TL1RR024147, M01RR001346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, T32AR052283] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Center for Research Translation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Clinic Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIH) Center for Research Translation P50AR054144 (Arnett and MDM); NIH-KL2RR024149-04 (SA); NIH -5T32-AR052283-03(JDR); University Clinic Research Center Grants: M01-RR00073 (UTMB) and M01-RR01346 (UT-HSC-SA); the NIH Clinical and Translational Sciences Award UL1-RR024148; and TL1 RR024147 from the National Center for Research Resources. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Terry A McNearney is an employee of Eli Lilly and Company and contributed to the design and analysis of the study, the performing of experiments and writing of the manuscript.	Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Bassel M, 2011, RHEUMATOLOGY, V50, P762, DOI 10.1093/rheumatology/keq310; Bodukam V, 2011, RHEUMATOLOGY, V50, P330, DOI 10.1093/rheumatology/keq296; Burgos PI, 2009, ARTHRIT RHEUM-ARTHR, V61, P1179, DOI 10.1002/art.24649; Burnet RB, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-32; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Danieli E, 2005, CLIN RHEUMATOL, V24, P48, DOI 10.1007/s10067-004-0970-z; DEL RA, 2004, ARTHRITIS RHEUM, V51, P475, DOI DOI 10.1002/ART.20389; Gossec L, 2009, ANN RHEUM DIS, V68, P1680, DOI 10.1136/ard.2008.100271; Hewlett S, 2011, ANN RHEUM DIS, V70, P1060, DOI 10.1136/ard.2010.144691; Khanna D, 2005, J RHEUMATOL, V32, P832; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lambova S, 2010, AUTOIMMUN REV, V9, P761, DOI 10.1016/j.autrev.2010.06.006; LEROY EC, 1988, J RHEUMATOL, V15, P202; Loftus EV, 2008, AM J GASTROENTEROL, V103, P3132, DOI 10.1111/j.1572-0241.2008.02175.x; Maltais F, 2008, ANN INTERN MED, V149, P869, DOI 10.7326/0003-4819-149-12-200812160-00006; Mancuso CA, 2006, J RHEUMATOL, V33, P1496; McNearney TA, 2009, J RHEUMATOL, V36, P2724, DOI 10.3899/jrheum.090295; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Neill J, 2006, J ADV NURS, V56, P617, DOI 10.1111/j.1365-2648.2006.04054.x; PILOWSKY I, 1984, GEN HOSP PSYCHIAT, V6, P123, DOI 10.1016/0163-8343(84)90070-7; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Sanchez ML, 2009, CLIN EXP RHEUMATOL, V27, P64; Sandqvist G, 2008, RHEUMATOLOGY, V47, P1708, DOI 10.1093/rheumatology/ken359; Sandusky SB, 2009, RHEUMATOLOGY, V48, P165, DOI 10.1093/rheumatology/ken455; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Sharif R, 2011, SEMIN ARTHRITIS RHEU, V41, P38, DOI 10.1016/j.semarthrit.2011.01.002; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Thombs BD, 2008, RHEUMATOLOGY, V47, P1559, DOI 10.1093/rheumatology/ken331; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; Thombs BD, 2009, ARTHRIT RHEUM-ARTHR, V61, P966, DOI 10.1002/art.24614; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008; Wagner LI, 2004, BRIT J CANCER, V91, P822, DOI 10.1038/sj.bjc.6602012; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Yount S, 2007, CLIN EXP RHEUMATOL, V25, P838	40	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26061	10.1371/journal.pone.0026061	http://dx.doi.org/10.1371/journal.pone.0026061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022507	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600028
J	Kaer, K; Branovets, J; Hallikma, A; Nigumann, P; Speek, M				Kaer, Kristel; Branovets, Jelena; Hallikma, Anni; Nigumann, Pilvi; Speek, Mart			Intronic L1 Retrotransposons and Nested Genes Cause Transcriptional Interference by Inducing Intron Retention, Exonization and Cryptic Polyadenylation	PLOS ONE			English	Article							NONCODING RNAS; ANTISENSE PROMOTER; MESSENGER-RNA; EXPRESSION; ELONGATION; PATTERNS; BINDING; LONG; CIS; IDENTIFICATION	Background: Transcriptional interference has been recently recognized as an unexpectedly complex and mostly negative regulation of genes. Despite a relatively few studies that emerged in recent years, it has been demonstrated that a readthrough transcription derived from one gene can influence the transcription of another overlapping or nested gene. However, the molecular effects resulting from this interaction are largely unknown. Methodology/Principal Findings: Using in silico chromosome walking, we searched for prematurely terminated transcripts bearing signatures of intron retention or exonization of intronic sequence at their 3' ends upstream to human L1 retrotransposons, protein-coding and noncoding nested genes. We demonstrate that transcriptional interference induced by intronic L1s (or other repeated DNAs) and nested genes could be characterized by intron retention, forced exonization and cryptic polyadenylation. These molecular effects were revealed from the analysis of endogenous transcripts derived from different cell lines and tissues and confirmed by the expression of three minigenes in cell culture. While intron retention and exonization were comparably observed in introns upstream to L1s, forced exonization was preferentially detected in nested genes. Transcriptional interference induced by L1 or nested genes was dependent on the presence or absence of cryptic splice sites, affected the inclusion or exclusion of the upstream exon and the use of cryptic polyadenylation signals. Conclusions/Significance: Our results suggest that transcriptional interference induced by intronic L1s and nested genes could influence the transcription of the large number of genes in normal as well as in tumor tissues. Therefore, this type of interference could have a major impact on the regulation of the host gene expression.	[Kaer, Kristel; Branovets, Jelena; Hallikma, Anni; Nigumann, Pilvi; Speek, Mart] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia	Tallinn University of Technology	Kaer, K (corresponding author), Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia.	mart.speek@ttu.ee	Branovets, Jelena/AAF-7977-2020	Branovets, Jelena/0000-0001-7970-8543	Estonian Science Foundation [ETF8381]; Estonian Ministry of Education and Research [SF0140143s08]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by grants from the Estonian Science Foundation (ETF8381) and the Estonian Ministry of Education and Research (SF0140143s08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis R, 2008, TRENDS GENET, V24, P475, DOI 10.1016/j.tig.2008.08.003; BECKER KG, 1993, HUM MOL GENET, V2, P1697, DOI 10.1093/hmg/2.10.1697; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Crampton N, 2006, NUCLEIC ACIDS RES, V34, P5416, DOI 10.1093/nar/gkl668; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Dodd IB, 2002, MOL MICROBIOL, V45, P697, DOI 10.1046/j.1365-2958.2002.03038.x; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gal-Mark N, 2008, NUCLEIC ACIDS RES, V36, P2012, DOI 10.1093/nar/gkn024; Gibson CW, 2005, GENE, V350, P15, DOI 10.1016/j.gene.2004.12.045; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Naville M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r97; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Padidam M, 2001, BIOTECHNIQUES, V31, P328, DOI 10.2144/01312st04; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Petrakis TG, 2005, J BIOL CHEM, V280, P19454, DOI 10.1074/jbc.M413373200; Petruk S, 2007, RNA BIOL, V4, P1; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Piehler A, 2002, BIOCHEM BIOPH RES CO, V295, P408, DOI 10.1016/S0006-291X(02)00659-9; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sambrook J, 2001, MOL CLONING LAB MANU; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Steinhoff C, 2004, MOL GENET GENOMICS, V270, P394, DOI 10.1007/s00438-003-0931-2; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	74	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26099	10.1371/journal.pone.0026099	http://dx.doi.org/10.1371/journal.pone.0026099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022525	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600040
J	Smee, DF; Wong, MH; Russell, A; Ennis, J; Turner, JD				Smee, Donald F.; Wong, Min-Hui; Russell, Andrew; Ennis, Jane; Turner, Jeffrey D.			Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; CONSENSUS INTERFERON; SMALLPOX VACCINEE; RHESUS-MONKEYS; ANIMAL-MODELS; PATHOGENESIS; PREVENTION	An adenovirus 5 vector encoding for mouse interferon alpha, subtype 5 (mDEF201) was evaluated for efficacy against lethal vaccinia virus (WR strain) respiratory infections in mice. mDEF201 was administered as a single intranasal treatment either prophylactically or therapeutically at doses of 10(6) to 10(8) plaque forming units/mouse. When the prophylactic treatment was given at 56 days prior to infection, it protected 90% of animals from death (100% protection for treatments given between 1-49 days pre-infection), with minimal weight loss occurring during infection. Surviving animals re-challenged with virus 22 days after the primary infection were protected from death, indicating that mDEF201 did not compromise the immune response against the initial infection. Post-exposure therapy was given between 6-24 h after vaccinia virus exposure and protection was afforded by a 10(8) dose of mDEF201 given at 24 h, whereas a 10(7) dose was effective up to 12 h. Comparisons were made of the ability of mDEF201, given either 28 or 1 day prior to infection, to inhibit tissue virus titers and lung infection parameters. Lung, liver, and spleen virus titers were inhibited to nearly the same extent by either treatment, as were lung weights and lung hemorrhage scores (indicators of pneumonitis). Lung virus titers were significantly (>100-fold) lower than in the placebo group, and the other infection parameters in mDEF201 treated mice were nearly at baseline. In contrast, viral titers and lung infection parameters were high in the placebo group on day 5 of the infection. These results demonstrate the long-acting prophylactic and treatment capacity of mDEF201 to combat vaccinia virus infections.	[Smee, Donald F.; Wong, Min-Hui; Russell, Andrew] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA; [Ennis, Jane; Turner, Jeffrey D.] Defyrus Inc, Toronto, ON, Canada	Utah System of Higher Education; Utah State University	Smee, DF (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	don.smee@usu.edu			Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [N01-AI-30063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract N01-AI-30063 (awarded to Southern Research Institute, Birmingham, Alabama, USA) from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray M, 2003, ANTIVIR RES, V58, P101, DOI 10.1016/S0166-3542(03)00008-1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Du Y, 2008, BIOPHARM DRUG DISPOS, V29, P481, DOI 10.1002/bdd.630; Hutson TE, 2003, CLIN CANCER RES, V9, P1354; Jahrling PB, 2005, CURR MOL MED, V5, P817, DOI 10.2174/156652405774962326; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10; Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007; Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; NEWMANNHAEFELIN D, 1975, INFECT IMMUN, V12, P148; O'Brien L, 2009, J GEN VIROL, V90, P874, DOI 10.1099/vir.0.006833-0; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; RADWANSKI E, 1987, J CLIN PHARMACOL, V27, P432, DOI 10.1002/j.1552-4604.1987.tb03044.x; Smee DF, 2003, ANTIVIR RES, V57, P41, DOI 10.1016/S0166-3542(02)00199-7; Smee DF, 2001, ANTIVIR RES, V52, P55, DOI 10.1016/S0166-3542(01)00159-0; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; WEIMAR W, 1980, J GEN VIROL, V48, P25, DOI 10.1099/0022-1317-48-1-25; Wu JQH, 2007, VIROLOGY, V369, P206, DOI 10.1016/j.virol.2007.07.024	21	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26330	10.1371/journal.pone.0026330	http://dx.doi.org/10.1371/journal.pone.0026330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022603	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600049
J	Allin, MPG; Kontis, D; Walshe, M; Wyatt, J; Barker, GJ; Kanaan, RAA; McGuire, P; Rifkin, L; Murray, RM; Nosarti, C				Allin, Matthew P. G.; Kontis, Dimitris; Walshe, Muriel; Wyatt, John; Barker, Gareth J.; Kanaan, Richard A. A.; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			White Matter and Cognition in Adults Who Were Born Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DIFFUSION TENSOR MRI; CORPUS-CALLOSUM; YOUNG-ADULTS; BRAIN-DEVELOPMENT; ADOLESCENTS; VOXEL; CHILDREN; INJURY; AGE	Background and Purpose: Individuals born very preterm (before 33 weeks of gestation, VPT) are at risk of damage to developing white matter, which may affect later cognition and behaviour. Methods: We used diffusion tensor MRI (DT-MRI) to assess white matter microstructure (fractional anisotropy; FA) in 80 VPT and 41 term-born individuals (mean age 19.1 years, range 17-22, and 18.5 years, range17-22 years, respectively). VPT individuals were part of a 1982-1984 birth cohort which had been followed up since birth; term individuals were recruited by local press advertisement. General intellectual function, executive function and memory were assessed. Results: The VPT group had reduced FA in four clusters, and increased FA in four clusters relative to the Term group, involving several association tracts of both hemispheres. Clusters of increased FA were associated with more severe neonatal brain injury in the VPT group. Clusters of reduced FA were associated with lower birth weight and perinatal hypoxia, and with reduced adult cognitive performance in the VPT group only. Conclusions: Alterations of white matter microstructure persist into adulthood in VPT individuals and are associated with cognitive function.	[Allin, Matthew P. G.; Kontis, Dimitris; Walshe, Muriel; Barker, Gareth J.; Kanaan, Richard A. A.; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Wyatt, John] Royal Free & Univ Coll Med Sch, Dept Neonatal Paediat, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	Allin, MPG (corresponding author), Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England.	matthew.allin@kcl.ac.uk	Kontis, Dimitrios/B-3007-2009; Murray, Robin M/F-8658-2012; Walshe, Muriel/E-5214-2010; Nosarti, Chiara/G-5638-2010; Barker, Gareth J/C-9616-2009; Walshe, Margaret/M-9102-2016	Kontis, Dimitrios/0000-0002-7626-8324; Murray, Robin M/0000-0003-0829-0519; Walshe, Muriel/0000-0001-6829-1105; Nosarti, Chiara/0000-0001-6305-9710; Barker, Gareth J/0000-0002-5214-7421; McGuire, Philip/0000-0003-4381-0532; Kanaan, Richard/0000-0003-0992-1917; Rifkin, Larry/0000-0003-2590-9010; Walshe, Margaret/0000-0003-3924-8073	Wellcome Trust [065699/Z/01/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by a Wellcome Trust Project Grant (Ref: 065699/Z/01/Z). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Andrews JS, 2010, DEV MED CHILD NEUROL, V52, pE94, DOI 10.1111/j.1469-8749.2009.03456.x; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Basser P., 2006, CLIN MAGNETIC RESONA, P320; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Constable RT, 2008, PEDIATRICS, V121, P306, DOI 10.1542/peds.2007-0414; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Frangou S, 1997, BRIT J PSYCHIAT, V170, P328, DOI 10.1192/bjp.170.4.328; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gimenez M, 2006, NEUROIMAGE, V32, P1485, DOI 10.1016/j.neuroimage.2006.05.013; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2006, SEMIN FETAL NEONAT M, V11, P127, DOI 10.1016/j.siny.2005.11.007; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Her Majesty's Stationary Office (HMSO), 1991, OFFICE POPULATION CE; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Kontis D, 2009, NEUROREPORT, V20, P424, DOI 10.1097/WNR.0b013e328325a8f9; Lawrence EJ, 2010, J PEDIATR-US, V156, P889, DOI 10.1016/j.jpeds.2010.01.017; Lezak DH, 2004, NEUROPSYCHOLOGICAL A, V4; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mullen KM, 2011, NEUROIMAGE, V54, P2563, DOI 10.1016/j.neuroimage.2010.11.019; Myers EH, 2010, NEUROIMAGE, V51, P1445, DOI 10.1016/j.neuroimage.2010.03.049; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2009, NEUROIMAGE, V47, P1884, DOI 10.1016/j.neuroimage.2009.04.036; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2009, NEUROIMAGE, V47, P1904, DOI 10.1016/j.neuroimage.2009.04.041; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Perlman JM, 1998, EARLY HUM DEV, V53, P99, DOI 10.1016/S0378-3782(98)00037-1; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; STEWART AL, 1987, DEV MED CHILD NEUROL, V29, P3; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1999, WECHSLER ABBREVIATED; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Yung A, 2007, PEDIATR RES, V61, P732, DOI 10.1203/pdr.0b013e31805365db	73	101	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24525	10.1371/journal.pone.0024525	http://dx.doi.org/10.1371/journal.pone.0024525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022357	Green Published, gold			2022-12-25	WOS:000295976000002
J	Schrider, DR; Gout, JF; Hahn, MW				Schrider, Daniel R.; Gout, Jean-Francois; Hahn, Matthew W.			Very Few RNA and DNA Sequence Differences in the Human Transcriptome	PLOS ONE			English	Article							UNWINDING ACTIVITY; MESSENGER-RNA; PARALLEL DNA; COPY NUMBER; ADENOSINE; ALIGNMENT	RNA editing is an important cellular process by which the nucleotides in a mature RNA transcript are altered to cause them to differ from the corresponding DNA sequence. While this process yields essential transcripts in humans and other organisms, it is believed to occur at a relatively small number of loci. The rarity of RNA editing has been challenged by a recent comparison of human RNA and DNA sequence data from 27 individuals, which revealed that over 10,000 human exonic sites appear to exhibit RNA-DNA differences (RDDs). Many of these differences could not have been caused by either of the two previously known human RNA editing mechanisms-ADAR-mediated A -> G substitutions or APOBEC1-mediated C -> U switches-suggesting that a previously unknown mechanism of RNA editing may be active in humans. Here, we reanalyze these data and demonstrate that genomic sequences exist in these same individuals or in the human genome that match the majority of RDDs. Our results suggest that the majority of these RDD events were observed due to accurate transcription of sequences paralogous to the apparently edited gene but differing at the edited site. In light of our results it seems prudent to conclude that if indeed an unknown mechanism is causing RDD events in humans, such events occur at a much lower frequency than originally proposed.	[Schrider, Daniel R.; Gout, Jean-Francois; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Schrider, Daniel R.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Schrider, DR (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dschride@indiana.edu		Gout, Jean-Francois/0000-0002-4549-5647; Hahn, Matthew/0000-0002-5731-8808	National Institutes of Health [GM007757]; National Science Foundation [EF-0827411]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.R.S. is supported by National Institutes of Health Genetics, Cellular & Molecular Sciences Training Grant GM007757. J.F.G. is supported by National Science Foundation Grant EF-0827411. M. W. H. is supported by a fellowship from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas Stefan, 2006, RNA Biol, V3, P1; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; PRING D, 1993, PLANT MOL BIOL, V21, P1163, DOI 10.1007/BF00023611; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; ZHENG HQ, 1992, J VIROL, V66, P4693, DOI 10.1128/JVI.66.8.4693-4697.1992	21	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25842	10.1371/journal.pone.0025842	http://dx.doi.org/10.1371/journal.pone.0025842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022455	Green Submitted, gold, Green Published			2022-12-25	WOS:000295976000044
J	Vaughn, MP; Shinohara, DB; Castagna, N; Hicks, JL; Netto, G; De Marzo, AM; Speed, TJ; Reichert, ZR; Kwabi-Addo, B; Henderson, CJ; Wolf, CR; Yegnasubramanian, S; Nelson, WG				Vaughn, Matthew P.; Shinohara, Debika Biswal; Castagna, Nicole; Hicks, Jessica L.; Netto, George; De Marzo, Angelo M.; Speed, Traci J.; Reichert, Zachery R.; Kwabi-Addo, Bernard; Henderson, Colin J.; Wolf, C. Roland; Yegnasubramanian, Srinivasan; Nelson, William G.			Humanizing pi-Class Glutathione S-Transferase Regulation in a Mouse Model Alters Liver Toxicity in Response to Acetaminophen Overdose	PLOS ONE			English	Article							RAT CHEMICAL HEPATOCARCINOGENESIS; ISLAND DNA HYPERMETHYLATION; GSTP1 CPG ISLAND; HEPATOCELLULAR-CARCINOMA; TERMINAL KINASE; TRANSCRIPTIONAL ACTIVATION; PROMOTER HYPERMETHYLATION; GENE; MICE; JUN	Background: Glutathione S-transferases (GSTs) metabolize drugs and xenobiotics. Yet despite high protein sequence homology, expression of p-class GSTs, the most abundant of the enzymes, varies significantly between species. In mouse liver, hepatocytes exhibit high mGstp expression, while in human liver, hepatocytes contain little or no hGSTP1 mRNA or hGSTP1 protein. pi-class GSTs are known to be critical determinants of liver responses to drugs and toxins: when treated with high doses of acetaminophen, mGstp1/2+/+ mice suffer marked liver damage, while mGstp1/2-/- mice escape liver injury. Methodology/Principal Findings: To more faithfully model the contribution of p-class GSTs to human liver toxicology, we introduced hGSTP1, with its exons, introns, and flanking sequences, into the germline of mice carrying disrupted mGstp genes. In the resultant hGSTP1+ mGstp1/2-/- strain, pi-class GSTs were regulated differently than in wild-type mice. In the liver, enzyme expression was restricted to bile duct cells, Kupffer cells, macrophages, and endothelial cells, reminiscent of human liver, while in the prostate, enzyme production was limited to basal epithelial cells, reminiscent of human prostate. The human patterns of hGSTP1 transgene regulation were accompanied by human patterns of DNA methylation, with bisulfite genomic sequencing revealing establishment of an unmethylated CpG island sequence encompassing the gene promoter. Unlike wild-type or mGstp1/2-/- mice, when hGSTP1+ mGstp1/2-/- mice were overdosed with acetaminophen, liver tissues showed limited centrilobular necrosis, suggesting that pi-class GSTs may be critical determinants of toxin-induced hepatocyte injury even when not expressed by hepatocytes. Conclusions: By recapitulating human p-class GST expression, hGSTP1+ mGstp1/2-/- mice may better model human drug and xenobiotic toxicology.	[Vaughn, Matthew P.; Shinohara, Debika Biswal; Castagna, Nicole; Hicks, Jessica L.; Netto, George; De Marzo, Angelo M.; Speed, Traci J.; Reichert, Zachery R.; Yegnasubramanian, Srinivasan; Nelson, William G.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Shinohara, Debika Biswal] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Kwabi-Addo, Bernard] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Canc Res United Kingdom Mol Pharmacol Unit, Biomed Res Inst, Dundee DD1 9SY, Scotland	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard University; University of Dundee	Vaughn, MP (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	syegnasu@jhmi.edu; bnelson@jhmi.edu	Henderson, Colin/AAE-7141-2019; Kwabi-Addo, Bernard/A-6993-2016	Henderson, Colin/0000-0002-4764-639X; Kwabi-Addo, Bernard/0000-0003-3692-6350; Wolf, Charles Roland/0000-0002-6969-0113; Netto, George/0000-0003-3915-9134	National Institutes of Health/National Cancer Institute [CA91409, CA70196, CA58236]; Cancer Research UK [10822] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA070196, P50CA058236, P30CA006973, U54CA091409] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported by National Institutes of Health/National Cancer Institute grants CA91409, CA70196, and CA58236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Bakker J, 2002, J BIOL CHEM, V277, P22573, DOI 10.1074/jbc.M203009200; Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Cheung C, 2008, J PHARMACOL EXP THER, V327, P288, DOI 10.1124/jpet.108.141242; COLES B, 1988, ARCH BIOCHEM BIOPHYS, V264, P253, DOI 10.1016/0003-9861(88)90592-9; Dai GL, 2006, TOXICOL SCI, V92, P33, DOI 10.1093/toxsci/kfj192; DRAGAN YP, 1994, CARCINOGENESIS, V15, P2587, DOI 10.1093/carcin/15.11.2587; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Elsby R, 2003, J BIOL CHEM, V278, P22243, DOI 10.1074/jbc.M301211200; Esteller M, 1998, CANCER RES, V58, P4515; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; HOWIE AF, 1990, CARCINOGENESIS, V11, P451, DOI 10.1093/carcin/11.3.451; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; KITAHARA A, 1984, CANCER RES, V44, P2698; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; McGlynn KA, 2003, CANCER RES, V63, P4594; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; MOFFAT GJ, 1994, J BIOL CHEM, V269, P16397; Moffat GJ, 1996, J BIOL CHEM, V271, P1054, DOI 10.1074/jbc.271.2.1054; MOREL F, 1993, CANCER RES, V53, P231; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Ritchie KJ, 2007, CANCER RES, V67, P9248, DOI 10.1158/0008-5472.CAN-07-1764; RITCHIE KJ, 2009, P NATL ACAD SCI US; SATO K, 1984, GANN, V75, P199; SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964; Tchou JC, 2000, INT J ONCOL, V16, P663; TERRIER P, 1990, AM J PATHOL, V137, P845; VOLM M, 1991, BRIT J CANCER, V64, P700, DOI 10.1038/bjc.1991.384; Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028; Zhong S, 2002, CLIN CANCER RES, V8, P1087	38	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25707	10.1371/journal.pone.0025707	http://dx.doi.org/10.1371/journal.pone.0025707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022436	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200014
J	Balla-Jhagjhoorsingh, SS; Willems, B; Heyndrickx, L; Heyndrickx, L; Vereecken, K; Janssens, W; Seaman, MS; Corti, D; Lanzavecchia, A; Davis, D; Vanham, G				Balla-Jhagjhoorsingh, Sunita S.; Willems, Betty; Heyndrickx, Liesbeth; Heyndrickx, Leo; Vereecken, Katleen; Janssens, Wouter; Seaman, Michael S.; Corti, Davide; Lanzavecchia, Antonio; Davis, David; Vanham, Guido			Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HIV-1/SIV CHIMERIC VIRUS; MEMORY B-CELLS; POTENT NEUTRALIZATION; MUCOSAL CHALLENGE; PASSIVE TRANSFER; PROTECTION; MACAQUES; ASSAYS	Several new human monoclonal antibodies ( mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical Medicine (ITM). Our aim was to generate immunization antibodies equivalent to those seen in plasma. Here, we describe the selection and characterization of patient plasma and their mAbs, using a range of neutralization assays, including several peripheral blood mononuclear cell (PBMC) based assays and replicating primary viruses as well as cell line based assays and pseudoviruses (PV). The principal criterion for selection of patient plasma was the activity in an 'extended incubation phase' PBMC assay. Neutralizing Abs, derived from their memory B cells, were then selected by ELISA with envelope proteins as solid phase. MAbs were subsequently tested in a high-throughput HOS-PV assay to assess functional neutralization. The present study indicates that the strong profiles in the patients' plasma were not solely due to antibodies represented by the newly isolated mAbs. Although results from the various assays were divergent, they by and large indicate that neutralizing Abs to other epitopes of the HIV-1 envelope are present in the plasma and synergy between Abs may be important. Thus, the spectrum of the obtained mAbs does not cover the range of cross-reactivity seen in plasma in these carefully selected patients irrespective of which neutralization assay is used. Nevertheless, these mAbs are relevant for immunogen discovery because they bind to the recombinant glycoproteins to which the immune response needs to be targeted in vivo. Our observations illustrate the remaining challenges required for successful immunogen design and development.	[Balla-Jhagjhoorsingh, Sunita S.; Willems, Betty; Heyndrickx, Liesbeth; Heyndrickx, Leo; Vereecken, Katleen; Janssens, Wouter; Vanham, Guido] Inst Trop Med, B-2000 Antwerp, Belgium; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Corti, Davide; Lanzavecchia, Antonio] Inst Res Biomed, Bellinzona, Switzerland; [Davis, David] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Vanham, Guido] Free Univ Brussels, Fac Med & Pharmaceut Sci, B-1050 Brussels, Belgium	Institute of Tropical Medicine (ITM); Harvard University; Beth Israel Deaconess Medical Center; Universita della Svizzera Italiana; University of Antwerp; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Balla-Jhagjhoorsingh, SS (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	sballa@itg.be			Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery	Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery	Part of this research was supported by the Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery and no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis D, 2006, J MED VIROL, V78, P864, DOI 10.1002/jmv.20635; Davis D, 2004, VACCINE, V22, P747, DOI 10.1016/j.vaccine.2003.08.031; Davis D, 2003, J MED VIROL, V71, P332, DOI 10.1002/jmv.10490; Donners H, 2003, VACCINE, V22, P104, DOI 10.1016/S0264-410X(03)00530-9; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Haynes BF, 2010, CURR OPIN HIV AIDS, V5, P362, DOI 10.1097/COH.0b013e32833d2e90; Heeney JL, 1998, P NATL ACAD SCI USA, V95, P10803, DOI 10.1073/pnas.95.18.10803; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rusert P, 2009, AIDS, V23, P1319, DOI 10.1097/QAD.0b013e32832d92c2; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	50	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25488	10.1371/journal.pone.0025488	http://dx.doi.org/10.1371/journal.pone.0025488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016769	gold, Green Submitted, Green Published			2022-12-25	WOS:000295971700011
J	Mazak, JH; Christiansen, P; Kitchener, AC				Mazak, Ji H.; Christiansen, Per; Kitchener, Andrew C.			Oldest Known Pantherine Skull and Evolution of the Tiger	PLOS ONE			English	Article							PHYLOGENETIC RECONSTRUCTION; FELIDAE; CATS; PLIOPLEISTOCENE; PHYLOGEOGRAPHY; CARNIVORES; SOFTWARE; TIGRIS; MEGA	The tiger is one of the most iconic extant animals, and its origin and evolution have been intensely debated. Fossils attributable to extant pantherine species-lineages are less than 2 MYA and the earliest tiger fossils are from the Calabrian, Lower Pleistocene. Molecular studies predict a much younger age for the divergence of modern tiger subspecies at < 100 KYA, although their cranial morphology is readily distinguishable, indicating that early Pleistocene tigers would likely have differed markedly anatomically from extant tigers. Such inferences are hampered by the fact that well-known fossil tiger material is middle to late Pleistocene in age. Here we describe a new species of pantherine cat from Longdan, Gansu Province, China, Panthera zdanskyi sp. nov. With an estimated age of 2.55-2.16 MYA it represents the oldest complete skull of a pantherine cat hitherto found. Although smaller, it appears morphologically to be surprisingly similar to modern tigers considering its age. Morphological, morphometric, and cladistic analyses are congruent in confirming its very close affinity to the tiger, and it may be regarded as the most primitive species of the tiger lineage, demonstrating the first unequivocal presence of a modern pantherine species-lineage in the basal stage of the Pleistocene (Gelasian; traditionally considered to be Late Pliocene). This find supports a north-central Chinese origin of the tiger lineage, and demonstrates that various parts of the cranium, mandible, and dentition evolved at different rates. An increase in size and a reduction in the relative size of parts of the dentition appear to have been prominent features of tiger evolution, whereas the distinctive cranial morphology of modern tigers was established very early in their evolutionary history. The evolutionary trend of increasing size in the tiger lineage is likely coupled to the evolution of its primary prey species.	[Mazak, Ji H.] Shanghai Sci & Technol Museum, Shanghai, Peoples R China; [Christiansen, Per] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Kitchener, Andrew C.] Natl Museums Scotland, Edinburgh, Midlothian, Scotland	Aalborg University	Mazak, JH (corresponding author), Shanghai Sci & Technol Museum, Shanghai, Peoples R China.	jimazak@gmail.com		Kitchener, Andrew/0000-0003-2594-0827				Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Barry J.C., 1987, P235; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brongersma L. D., 1935, Zoologische Mededeelingen Leiden, V18, P1; Christiansen P, 2009, J VERTEBR PALEONTOL, V29, P934, DOI 10.1671/039.029.0314; Christiansen P, 2009, P NATL ACAD SCI USA, V106, P512, DOI 10.1073/pnas.0810435106; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Christiansen P, 2008, MAMM BIOL, V73, P451, DOI 10.1016/j.mambio.2007.08.001; Cole Theodore M. III, 2002, Systematics Association Special Volume Series, V64, P194; Cracraft J, 1998, ANIM CONSERV, V1, P139, DOI 10.1111/j.1469-1795.1998.tb00021.x; Davis BW, 2010, MOL PHYLOGENET EVOL, V56, P64, DOI 10.1016/j.ympev.2010.01.036; Driscoll CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004125; Geist V., 1983, ASB Bulletin, V30, P109; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guggisberg CAW, 1975, WILD CATS WORLD; Hemmer H., 1987, P28; Hemmer H., 1967, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V129, P83; HEMMER H, 1981, Palaeontologische Zeitschrift, V55, P109; Hemmer H, 1971, K NED AKAD WET B, V74, P35; Herrington S.J., 1987, P51; Hoogewerf A, 1970, UDJUNG KULON LAND LA; Hooijer D. A., 1947, AMER MUS NOVITATES, V1346, P1; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Karanth KU, 2008, J ZOOL 2, V250, P255; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Kitchener AC, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P53, DOI 10.1016/B978-0-8155-1570-8.00004-9; Kitchener Andrew C., 1999, P19; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURTEN B, 1971, AGE MAMMALS; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-177; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; Mattern MY, 2000, CLADISTICS, V16, P232, DOI 10.1111/j.1096-0031.2000.tb00354.x; Mazak JH, 2006, MAMM BIOL, V71, P268, DOI 10.1016/j.mambio.2006.02.007; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak JH, 2010, MAMMAL REV, V40, P90, DOI 10.1111/j.1365-2907.2009.00151.x; Mazak JH, 2010, MAMM BIOL, V75, P45, DOI 10.1016/j.mambio.2008.06.003; MAZAK V, 1968, Mammalia, V32, P104, DOI 10.1515/mamm.1968.32.1.104; Mazak V, 1983, MAMM SPEC, V152, P1; Mazak V, 1983, NEUE BREHM BUCHEREI; O'Brien S.J., 1987, P10; PEI WEN-CHUNG, 1934, PALAEONT SINICA [NATION GEOL SURY CHINA], VC8, P7; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Qiu Z.X., 2004, PALAEONTOL SIN NEW C, P1; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; ROHLF FJ, 2004, TPSRELW VER 1 39 DEP; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Schwarz E., 1912, Annals & Magazine of Natural History Series 8, V10; Schwarz E, 1913, BER SENCKENBERG NATU, V44, P70; Seidensticker J., 1987, P1; Shu-jin Luo, 2006, Zoological Research, V27, P441; Sody H. J. V., 1932, Journal of the Bombay Natural History Society, V36, P233; Sunquist Mel, 1999, P5; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TURNER A, 1990, GEOBIOS-LYON, V23, P349, DOI 10.1016/0016-6995(90)80006-2; Turner A., 1997, BIG CATS THEIR FOSSI; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Werdelin Lars, 2010, P59; Yu L, 2005, MOL PHYLOGENET EVOL, V35, P483, DOI 10.1016/j.ympev.2005.01.017; Zdansky O., 1924, Palaeontologia Sinica Series C, V2, P1; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	64	20	26	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25483	10.1371/journal.pone.0025483	http://dx.doi.org/10.1371/journal.pone.0025483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016768	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700010
J	Mourani, PM; Harris, JK; Sontag, MK; Robertson, CE; Abman, SH				Mourani, Peter M.; Harris, J. Kirk; Sontag, Marci K.; Robertson, Charles E.; Abman, Steven H.			Molecular Identification of Bacteria in Tracheal Aspirate Fluid from Mechanically Ventilated Preterm Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; UREAPLASMA-UREALYTICUM COLONIZATION; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; CHLAMYDIA-TRACHOMATIS; CHILDHOOD ASTHMA; BARCODED PRIMERS; GUT MICROBIOTA; INFLAMMATION; INFECTION	Background: Despite strong evidence linking infections to the pathogenesis of bronchopulmonary dysplasia (BPD), limitations of bacterial culture methods have precluded systematic studies of airway organisms relative to disease outcomes. Application of molecular bacterial identification strategies may provide new insight into the role of bacterial acquisition in the airways of preterm infants at risk for BPD. Methods: Serial (within 72 hours, 7, 14, and 21 days of life) tracheal aspirate samples were collected from 10 preterm infants with gestational age <= 34 weeks at birth, and birth weight of 500-1250 g who required mechanical ventilation for at least 21 days. Samples were analyzed by quantitative real time PCR assays for total bacterial load and by pyrosequencing for bacterial identification. Results: Subjects were diagnosed with mild (1), moderate (3), or severe (5) BPD. One patient died prior to determination of disease severity. 107,487 sequences were analyzed, with mean of 3,359 (range 1,724-4,915) per sample. 2 of 10 samples collected <72 hours of life contained adequate bacterial DNA for successful sequence analysis, one of which was from a subject exposed to chorioamnionitis. All other samples exhibited bacterial loads >70copies/reaction. 72 organisms were observed in total. Seven organisms represented the dominant organism (>50% of total sequences) in 31/32 samples with positive sequences. A dominant organism represented>90% of total sequences in 13 samples. Staphylococcus, Ureaplasmaparvum, and Ureaplasmaurealyticum were the most frequently identified dominant organisms, but Pseudomonas, Enterococcus, and Escherichia were also identified. Conclusions: Early bacterial colonization with diverse species occursafter the first 3 days of life in the airways of intubated preterm infants, and can be characterized by bacterial load and marked species diversity. Molecular identification of bacteria in the lower airways of preterm infants has the potential to yield further insight into the pathogenesis of BPD.	[Mourani, Peter M.; Harris, J. Kirk; Abman, Steven H.] Univ Colorado Denver, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO USA; [Sontag, Marci K.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Mourani, PM (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO USA.	Peter.Mourani@UCDenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121; Sontag, Marci/0000-0003-2501-652X; Harris, Jonathan/0000-0002-2378-4202	National Institutes of Health, National Center for Research Resources [K23 RR021021]; Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; National Heart Lung Blood Institute [R01 HL085703]; Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021021, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085703] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Colorado Clinical and Translational Sciences Institute; National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health, National Center for Research Resources K23 RR021021, http://www.ncrr.nih.gov/ and Colorado Clinical and Translational Sciences Institute UL1 RR025780, http://cctsi.ucdenver.edu/Pages/index.aspx; National Heart Lung Blood Institute R01 HL085703, http://www.nhlbi.nih.gov/; Thrasher Research Fund, http://www.thrasherresearch.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier R John, 2003, BMC Pediatr, V3, P10, DOI 10.1186/1471-2431-3-10; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cayabyab R G, 2003, J Matern Fetal Neonatal Med, V14, P205, DOI 10.1080/713606608; DaSilva O, 1997, PEDIATR INFECT DIS J, V16, P364, DOI 10.1097/00006454-199704000-00006; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2010, XPLORSEQ TOOL KIT TO; Garland SM, 1996, PATHOLOGY, V28, P266, DOI 10.1080/00313029600169134; GRONECK P, 1995, ARCH DIS CHILD-FETAL, V73, pF1, DOI 10.1136/fn.73.1.F1; Groneck P, 2001, PEDIATR PULM, V31, P331, DOI 10.1002/ppul.1055; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, APPL ENV MICROBIOL, V3863-3868; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Iles R, 1996, ACTA PAEDIATR, V85, P482, DOI 10.1111/j.1651-2227.1996.tb14067.x; JONSSON B, 1994, ACTA PAEDIATR, V83, P927, DOI 10.1111/j.1651-2227.1994.tb13174.x; Jonsson B, 1997, ARCH DIS CHILD-FETAL, V77, pF198, DOI 10.1136/fn.77.3.F198; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kotecha S, 1996, PEDIATR RES, V40, P250, DOI 10.1203/00006450-199608000-00010; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Lyon AJ, 1998, ARCH DIS CHILD-FETAL, V78, pF10, DOI 10.1136/fn.78.1.F10; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Speer CP, 2010, BRONCHOPULMONARY DYS, Vxvii; Stressmann FA, 2010, J PERINAT MED, V38, P333, DOI 10.1515/jpm.2010.026; Suerbaum S, 2009, GASTROENTEROLOGY, V137, P419, DOI 10.1053/j.gastro.2009.06.017; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; vanWaarde WM, 1997, EUR RESPIR J, V10, P886; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; WAITES KB, 1994, PEDIATR INFECT DIS J, V13, P287, DOI 10.1097/00006454-199404000-00008; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101	48	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25959	10.1371/journal.pone.0025959	http://dx.doi.org/10.1371/journal.pone.0025959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016793	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700030
J	Hollmann, M; Rieger, JW; Baecke, S; Lutzkendorf, R; Muller, C; Adolf, D; Bernarding, J				Hollmann, Maurice; Rieger, Jochem W.; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Adolf, Daniela; Bernarding, Johannes			Predicting Decisions in Human Social Interactions Using Real-Time fMRI and Pattern Classification	PLOS ONE			English	Article							NEURAL BASIS; BRAIN ACTIVITY; GAME-THEORY; PUNISHMENT; FAIRNESS; ATTENTION; MACHINE; CORTEX; STATES	Negotiation and trade typically require a mutual interaction while simultaneously resting in uncertainty which decision the partner ultimately will make at the end of the process. Assessing already during the negotiation in which direction one's counterpart tends would provide a tremendous advantage. Recently, neuroimaging techniques combined with multivariate pattern classification of the acquired data have made it possible to discriminate subjective states of mind on the basis of their neuronal activation signature. However, to enable an online-assessment of the participant's mind state both approaches need to be extended to a real-time technique. By combining real-time functional magnetic resonance imaging (fMRI) and online pattern classification techniques, we show that it is possible to predict human behavior during social interaction before the interacting partner communicates a specific decision. Average accuracy reached approximately 70% when we predicted online the decisions of volunteers playing the ultimatum game, a well-known paradigm in economic game theory. Our results demonstrate the successful online analysis of complex emotional and cognitive states using real-time fMRI, which will enable a major breakthrough for social fMRI by providing information about mental states of partners already during the mutual interaction. Interestingly, an additional whole brain classification across subjects confirmed the online results: anterior insula, ventral striatum, and lateral orbitofrontal cortex, known to act in emotional self-regulation and reward processing for adjustment of behavior, appeared to be strong determinants of later overt behavior in the ultimatum game. Using whole brain classification we were also able to discriminate between brain processes related to subjective emotional and motivational states and brain processes related to the evaluation of objective financial incentives.	[Hollmann, Maurice; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Adolf, Daniela; Bernarding, Johannes] Univ Magdeburg, Inst Biometry & Med Comp Sci, Fac Med, D-39106 Magdeburg, Germany; [Rieger, Jochem W.] Univ Magdeburg, Dept Neurol, Fac Med, D-39106 Magdeburg, Germany; [Hollmann, Maurice] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Otto von Guericke University; Otto von Guericke University; Max Planck Society	Hollmann, M (corresponding author), Univ Magdeburg, Inst Biometry & Med Comp Sci, Fac Med, D-39106 Magdeburg, Germany.	mhollmann@cbs.mpg.de		Rieger, Jochem/0000-0003-0955-2306				Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; AUMANN R, 2002, HDB GAME THEORY EC A, V11; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Camerer CF, 2007, ECON J, V117, pC26, DOI 10.1111/j.1468-0297.2007.02033.x; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Chang C., 2008, LIBSVM LIB SUPPORT V; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Darcet D, 2008, J ECON INTERACT COOR, V3, P137, DOI 10.1007/s11403-007-0027-x; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Eckel CC, 1996, J ECON BEHAV ORGAN, V30, P143, DOI 10.1016/S0167-2681(96)00854-2; ECKEL CC, 1999, ESA M; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FREY BS, 1995, J INST THEOR ECON, V151, P286; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Good P, 2005, PERMUTATION PARAMETR; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Henrich J., 2005, FDN HUMAN SOCIALITY; Hollmann M, 2008, J NEUROSCI METH, V175, P154, DOI 10.1016/j.jneumeth.2008.08.013; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; POSSE S, 2009, P 15 ANN M OHBM, V47, P78; Rieger JW, 2008, NEUROIMAGE, V42, P1056, DOI 10.1016/j.neuroimage.2008.06.014; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Scholkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SINGER T, 2008, AM ECON REV, V95, P340; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; SLEMBECK T, 1999, 9904 U ST GALLEN; Thoenissen D, 2002, J NEUROSCI, V22, P9024; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tootell RBH, 2000, NAT NEUROSCI, V3, P206, DOI 10.1038/72904; Valley K, 2002, GAME ECON BEHAV, V38, P127, DOI 10.1006/game.2001.0855; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	62	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25304	10.1371/journal.pone.0025304	http://dx.doi.org/10.1371/journal.pone.0025304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003388	Green Published, gold			2022-12-25	WOS:000295970300009
J	Park, EJ; Roh, J; Kim, SN; Kang, MS; Lee, BS; Kim, Y; Choi, S				Park, Eun-Jung; Roh, Jinkyu; Kim, Soo Nam; Kang, Min-Sung; Lee, Byoung-Seok; Kim, Younghun; Choi, Sangdun			Biological Toxicity and Inflammatory Response of Semi-Single-Walled Carbon Nanotubes	PLOS ONE			English	Article							C57BL/6 MICE; HISTAMINE; LUNG; EXPOSURE; FIBROSIS	The toxicological studies on carbon nanotubes (CNTs) have been urgently needed from the emerging diverse applications of CNTs. Physicochemical properties such as shape, diameter, conductance, surface charge and surface chemistry of CNTs gained during manufacturing processes play a key role in the toxicity. In this study, we separated the semi-conductive components of SWCNTs (semi-SWCNTs) and evaluated the toxicity on days 1, 7, 14 and 28 after intratracheal instillation in order to determine the role of conductance. Exposure to semi-SWCNTs significantly increased the growth of mice and significantly decreased the relative ratio of brain weight to body weight. Recruitment of monocytes into the bloodstream increased in a time-dependent manner, and significant hematological changes were observed 28 days after exposure. In the bronchoalveolar lavage (BAL) fluid, secretion of Th2-type cytokines, particularly IL-10, was more predominant than Th1-type cytokines, and expression of regulated on activation normal T cell expressed and secreted (RANTES), p53, transforming growth factor (TGF)-beta, and inducible nitric oxide synthase (iNOS) increased in a time-dependent manner. Fibrotic histopathological changes peaked on day 7 and decreased 14 days after exposure. Expression of cyclooxygenase-2 (COX-2), mesothelin, and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) also peaked on day 7, while that of TGF-beta peaked on days 7 and 14. Secretion of histamine in BAL fluid decreased in a time-dependent manner. Consequently, we suggest that the brain is the target organ of semi-SWCNTs brought into the lung, and conductance as well as length may be critical factors affecting the intensity and duration of the inflammatory response following SWCNT exposure.	[Park, Eun-Jung; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Roh, Jinkyu; Kim, Younghun] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kim, Soo Nam; Kang, Min-Sung; Lee, Byoung-Seok] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup, South Korea	Ajou University; Kwangwoon University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Park, Eun-Jung/Y-4427-2019		National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0016256]; Korea Food and Drug Administration [10182KFDA992-2302]; Priority Research Centers [NRF 2010-0028294]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Priority Research Centers	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0016256). This work was also partly supported by a grant from the Korea Food and Drug Administration (10182KFDA992-2302) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Maria I., 2010, Inflammation & Allergy Drug Targets, V9, P73; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Hakim-Rad K, 2009, CURR OPIN ALLERGY CL, V9, P427, DOI 10.1097/ACI.0b013e32832e9af1; Hellstrand K, 2000, CANCER INVEST, V18, P347, DOI 10.3109/07357900009012178; Janeway C, 2005, IMMUNOBIOLOGY IMMUNE, Vxxiii; Kim JE, 2010, J TOXICOL ENV HEAL A, V73, P1530, DOI 10.1080/15287394.2010.511578; Kim UJ, 2005, J AM CHEM SOC, V127, P15437, DOI 10.1021/ja052951o; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Miyata Y, 2006, J PHYS CHEM B, V110, P25, DOI 10.1021/jp055692y; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Okamoto T, 2009, CLIN EXP IMMUNOL, V157, P27, DOI 10.1111/j.1365-2249.2009.03958.x; Packard KA, 2003, INT IMMUNOPHARMACOL, V3, P909, DOI 10.1016/S1567-5769(02)00235-7; Park EJ, 2011, ARCH TOXICOL; Park EJ, 2010, TOXICOL APPL PHARM, V244, P226, DOI 10.1016/j.taap.2009.12.036; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Shvedova AA, 2008, TOXICOL APPL PHARM, V231, P235, DOI 10.1016/j.taap.2008.04.018; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2007, TOXICOL APPL PHARM, V221, P339, DOI 10.1016/j.taap.2007.03.018; Song Y, 2009, EUR RESPIR J, V34, P559, DOI 10.1183/09031936.00178308; Stoker Emily, 2008, Int J Toxicol, V27, P441, DOI 10.1080/10915810802552138; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; Wang LY, 2010, J TOXICOL ENV HEAL A, V73, P410, DOI 10.1080/15287390903486550; Yang CM, 2005, J PHYS CHEM B, V109, P19242, DOI 10.1021/jp053245c	29	29	31	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25892	10.1371/journal.pone.0025892	http://dx.doi.org/10.1371/journal.pone.0025892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016783	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300038
J	Wozniak, MA; Frost, AL; Preston, CM; Itzhaki, RF				Wozniak, Matthew A.; Frost, Alison L.; Preston, Chris M.; Itzhaki, Ruth F.			Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1	PLOS ONE			English	Article							GENE-EXPRESSION; APOLIPOPROTEIN E4; VIRAL GENOMES; BRAIN; LATENCY; HSV-1; DNA; VALACYCLOVIR; REACTIVATION; ASSOCIATION	Alzheimer's disease (AD) afflicts around 20 million people worldwide and so there is an urgent need for effective treatment. Our research showing that herpes simplex virus type 1 (HSV1) is a risk factor for AD for the brains of people who possess a specific genetic factor and that the virus causes accumulation of key AD proteins (beta-amyloid (A beta) and abnormally phosphorylated tau (P-tau)), suggests that anti-HSV1 antiviral agents might slow AD progression. However, currently available antiviral agents target HSV1 DNA replication and so might be successful in AD only if A beta and P-tau accumulation depend on viral DNA replication. Therefore, we investigated firstly the stage(s) of the virus replication cycle required for A beta and P-tau accumulation, and secondly whether antiviral agents prevent these changes using recombinant strains of HSV1 that progress only partly through the replication cycle and antiviral agents that inhibit HSV1 DNA replication. By quantitative immunocytochemistry we demonstrated that entry, fusion and uncoating of HSV1, are insufficient to induce A beta and P-tau production. We showed also that none of the "immediate early'' viral proteins is directly responsible, and that A beta and P-tau are produced at a subsequent stage of the HSV1 replication cycle. Importantly, the anti-HSV1 antiviral agents acyclovir, penciclovir and foscarnet reduced A beta and P-tau accumulation, as well as HSV1, with foscarnet being less effective in each case. P-tau accumulation was found to depend on HSV1 DNA replication, whereas A beta accumulation was not. The antiviral-induced decrease in A beta is attributable to the reduced number of new viruses, and hence the reduction in viral spread. Since antiviral agents reduce greatly A beta and P-tau accumulation in HSV1-infected cells, they would be suitable for treating AD with great advantage unlike current AD therapies, only the virus, not the host cell, would be targeted.	[Wozniak, Matthew A.; Frost, Alison L.; Itzhaki, Ruth F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Preston, Chris M.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland	University of Manchester; University of Glasgow	Wozniak, MA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ruth.itzhaki@manchester.ac.uk			Henry Smith Charity; Olympus Foundation; Visual Sciences Fund; MRC [MC_U130169964] Funding Source: UKRI; Medical Research Council [MC_U130169964] Funding Source: researchfish	Henry Smith Charity; Olympus Foundation; Visual Sciences Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Henry Smith Charity, an award from the Olympus Foundation, donations from the estate of Mrs. Louise de Launay and from the Visual Sciences Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1989, J VIROL, V63, P2260, DOI 10.1128/JVI.63.5.2260-2269.1989; BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Beffert U, 1998, LANCET, V351, P1330, DOI 10.1016/S0140-6736(05)79057-7; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; EARNSHAW DL, 1992, ANTIMICROB AGENTS CH, V36, P2747, DOI 10.1128/AAC.36.12.2747; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; GODOWSKI PJ, 1985, J VIROL, V55, P357, DOI 10.1128/JVI.55.2.357-365.1985; Hemling N, 2003, ANN NEUROL, V54, P267, DOI 10.1002/ana.10662; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Itabashi S, 1997, LANCET, V349, P1102, DOI 10.1016/S0140-6736(05)62325-2; Itzhaki RF, 2004, ANN NEUROL, V55, P299, DOI 10.1002/ana.10852; Itzhaki RF, 2001, J NEUROVIROL, V7, P570; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; JAMIESON DRS, 1995, J GEN VIROL, V76, P1417, DOI 10.1099/0022-1317-76-6-1417; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; JAMIESON GA, 1992, J PATHOL, V167, P365, DOI 10.1002/path.1711670403; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; JOHNSON PA, 1991, J VIROL, V65, P700, DOI 10.1128/JVI.65.2.700-710.1991; Koelle DM, 2010, SEX TRANSM INFECT, V86, P202, DOI 10.1136/sti.2009.039735; Leary JJ, 2002, ANTIMICROB AGENTS CH, V46, P762, DOI 10.1128/AAC.46.3.762-768.2002; Lerchundi R, 2011, J ALZHEIMERS DIS, V23, P513, DOI 10.3233/JAD-2010-101386; Lin WR, 1998, ALZHEIMERS REP, V1, P173; Lukiw WJ, 2010, NEUROREPORT, V21, P922, DOI 10.1097/WNR.0b013e32833da51a; Lycke J, 2003, ANTIMICROB AGENTS CH, V47, P2438, DOI 10.1128/AAC.47.8.2438-2441.2003; Marques AR, 2001, J NEUROVIROL, V7, P82; MCQUAID S, 1994, NEUROPATH APPL NEURO, V20, P103, DOI 10.1111/j.1365-2990.1994.tb01168.x; OHARE P, 1993, SEMIN VIROL, V4, P145, DOI 10.1006/smvy.1993.1010; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Pouplin T, 2011, ANTIMICROB AGENTS CH, V55, P3624, DOI 10.1128/AAC.01023-10; Preston CM, 2005, J VIROL, V79, P525, DOI 10.1128/JVI.79.1.525-535.2005; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Santana S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.010; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Thackray AM, 1996, J INFECT DIS, V173, P291, DOI 10.1093/infdis/173.2.291; Thackray AM, 2000, J INFECT DIS, V181, P1517, DOI 10.1086/315408; Thackray AM, 1998, ANTIMICROB AGENTS CH, V42, P1555, DOI 10.1128/AAC.42.7.1555; Thompson RL, 2010, FUTURE MED CHEM, V2, P1099, DOI 10.4155/FMC.10.197; WAGSTAFF AJ, 1994, DRUGS, V48, P199, DOI 10.2165/00003495-199448020-00007; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak Matthew A, 2010, Ther Adv Neurol Disord, V3, P141, DOI 10.1177/1756285610370069; Wozniak MA, 2009, J ALZHEIMERS DIS, V16, P341, DOI 10.3233/JAD-2009-0963; Zambrano A, 2008, J ALZHEIMERS DIS, V14, P259	52	96	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25152	10.1371/journal.pone.0025152	http://dx.doi.org/10.1371/journal.pone.0025152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003387	gold, Green Submitted, Green Published			2022-12-25	WOS:000295970300008
J	Ahn, SM; Cha, JY; Kim, J; Kim, D; Trang, HTH; Kim, YM; Cho, YH; Park, D; Hong, S				Ahn, S-M; Cha, J-Y; Kim, J.; Kim, D.; Trang, H. T. H.; Kim, Y-M; Cho, Y-H; Park, D.; Hong, S.			Smad3 regulates E-cadherin via miRNA-200 pathway	ONCOGENE			English	Article						Smad3; miRNA-200; E-cadherin; ZEB1/2; gastric cancer	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN GASTRIC-CANCER; II RECEPTOR GENE; TGF-BETA; MIR-200 FAMILY; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; REPRESSORS ZEB1; TUMOR INVASION	To identify potential microRNA (miRNA) links between Smad3, a mediator of TGF-beta (transforming growth factor-beta) signaling, and E-cadherin, we characterized the miRNA profiles of two gastric cancer cell lines: SNU484-LPCX, which does not express Smad3, and SNU484-Smad3, in which Smad3 is overexpressed. We found that among differentially expressed miRNAs, miR-200 family members are overexpressed in SNU484-Smad3 cells. Subsequent studies, including analysis of the effects of silencing Smad3 in SNU484-Smad3 cells and a luciferase reporter assay, revealed that Smad3 directly binds to a Smad-binding element located in the promoter region of miR-200b/a, where it functions as a transcriptional activator. TGF-beta did not affect the regulatory role of Smad3 in transcription of miR-200 and expression of epithelial-mesenchymal transition markers. We conclude that Smad3 regulates, at the transcriptional level, miR-200 family members, which themselves regulate ZEB1 and ZEB2, known transcriptional repressors of E-cadherin, at the posttranscriptional level in a TGF-beta-independent manner. This represents a novel link between Smad3 and posttranscriptional regulation by miRNAs in epithelial-mesenchymal transition in gastric cancer cells. Oncogene (2012) 31, 3051-3059; doi: 10.1038/onc.2011.484; published online 24 October 2011	[Park, D.] Gachon Univ Gil Hosp, Dept Gastroenterol, Inchon, South Korea; [Ahn, S-M; Cha, J-Y; Kim, J.; Kim, D.; Trang, H. T. H.; Kim, Y-M; Cho, Y-H; Hong, S.] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Canc Cell Biol Lab, Dept Mol Med, Yeonsu 406840, Incheon, South Korea; [Ahn, S-M] Gachon Univ Gil Hosp, Dept Translat Med, Inchon, South Korea	Gachon University; Gachon University; Gachon University	Park, D (corresponding author), Gachon Univ Gil Hosp, Dept Gastroenterol, Inchon, South Korea.	pdk66@gilhospital.com; sthong@gachon.ac.kr		Ahn, Sung-Min/0000-0002-5031-1929; Cha, JI-Young/0000-0002-8557-6214	National Research Foundation; Korea government (MEST) [KRF-2008-313-C00676, 2009-0081756, 2009-0081789]; department of gastroenterology, Gachon University Gil Hospital	National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); department of gastroenterology, Gachon University Gil Hospital	We thank Dr GJ Goodall for kindly providing the DNA constructs. This work was supported by the National Research Foundation grant funded by the Korea government (MEST) to S Hong (KRF-2008-313-C00676 and no. 2009-0081756), JY Cha and SM Ahn (no. 2009-0081789) and by the generous funding from the department of gastroenterology, Gachon University Gil Hospital to D Park.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fink SP, 2001, CANCER RES, V61, P256; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Humar B, 2009, CANCER RES, V69, P2050, DOI 10.1158/0008-5472.CAN-08-2457; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, GENE DEV, V14, P627; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PARSONS R, 1995, CANCER RES, V55, P5548; Pohl M, 2010, ANTICANCER RES, V30, P2603; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Takagi Y, 1998, BRIT J CANCER, V78, P1152, DOI 10.1038/bjc.1998.645; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yanagisawa K, 2000, ONCOGENE, V19, P2305, DOI 10.1038/sj.onc.1203591; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393	46	81	83	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	25					3051	3059		10.1038/onc.2011.484	http://dx.doi.org/10.1038/onc.2011.484			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22020340				2022-12-25	WOS:000305705900004
J	Grubb, DR; Luo, JT; Yu, YL; Woodcock, EA				Grubb, David R.; Luo, Jieting; Yu, Yen Lin; Woodcock, Elizabeth A.			Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes	FASEB JOURNAL			English	Article						Shank3; alpha(1)-adrenergic receptor; phospholipase C beta 1b	CARDIAC-HYPERTROPHY; MYOCARDIAL HYPERTROPHY; PRESSURE-OVERLOAD; SHANK FAMILY; HEART; CA2+; ACTIVATION; SKELETAL; CHANNELS; BRAIN	Activation of the heterotrimeric G protein, Gq, causes cardiomyocyte hypertrophy in vivo and in cell models. Responses to activated Gq in cardiomyocytes are mediated exclusively by phospholipase C beta 1b (PLC beta 1b), because it localizes at the sarcolemma by binding to Shank3, a high-molecular-weight (MW) scaffolding protein. Shank3 can bind to the Homer family of low-MW scaffolding proteins that fine tune Ca2+ signaling by facilitating crosstalk between Ca2+ channels at the cell surface with those on intracellular Ca2+ stores. Activation of alpha(1)-adrenergic receptors, expression of constitutively active G alpha q (G alpha qQL), or PLC beta 1b initiated cardiomyocyte hypertrophy and increased Homer 1c mRNA expression, by 1.6 +/- 0.18-, 1.9 +/- 0.17-, and 1.5 +/- 0.07-fold, respectively (means +/- SE, 6 independent experiments, P<0.05). Expression of Homer 1c induced an increase in cardiomyocyte area from 853 +/- 27 to 1146 +/- 31 mu m(2) (P<0.05); furthermore, expression of dominant-negative Homer (Homer 1a) reversed the increase in cell size caused by alpha(1)-adrenergic agonist or PLC beta 1b treatment (1503 +/- 48 to 996 +/- 28 and 1626 +/- 48 to 828 +/- 31 mu m(2), respectively, P<0.05). Homer proteins were localized near the sarcolemma, associated with Shank3 and phospholipase C beta 1b. We conclude that Gq-mediated hypertrophy involves activation of PLC beta 1b scaffolded onto a Shank3/Homer complex. Signaling downstream of Homer 1c is necessary and sufficient for Gq-initiated hypertrophy.-Grubb, D. R., Luo, J., Yu, Y. L., Woodcock, E. A. Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes. FASEB J. 26, 596-603 (2012). www.fasebj.org	[Grubb, David R.; Luo, Jieting; Yu, Yen Lin; Woodcock, Elizabeth A.] Baker IDI Heart & Diabet Inst, Mol Cardiol Lab, Melbourne, Vic 8008, Australia	Baker Heart and Diabetes Institute	Woodcock, EA (corresponding author), Baker IDI Heart & Diabet Inst, Mol Cardiol Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	liz.woodcock@bakeridi.edu.au			National Health and Medical Research Council (NHMRC) of Australia [526621, 526623]; Australian National Heart Foundation [GM08-3695]; Victorian government	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian National Heart Foundation(National Heart Foundation of Australia); Victorian government	This work was supported by grants in aid from the National Health and Medical Research Council (NHMRC) of Australia (526621 and 526623), as well as the Australian National Heart Foundation (GM08-3695). E. A. W. is a Principal Research Fellow of the NHMRC (586621). This work was supported, in part, by the Victorian government's Operational Infrastructure Support Program. The authors thank Monash Medical Imaging (Monash University, Melbourne, VIC, Australia) for confocal microscopy.	Abe H, 2003, MOL CELL NEUROSCI, V23, P157, DOI 10.1016/S1044-7431(03)00052-6; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Dorn GW, 2004, ANN NY ACAD SCI, V1015, P225, DOI 10.1196/annals.1302.019; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Ehrengruber MU, 2004, MOL NEUROBIOL, V29, P213, DOI 10.1385/MN:29:3:213; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Gasperini R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-29; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Grubb DR, 2011, FASEB J, V25, P1040, DOI 10.1096/fj.10-171470; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Minakami R, 2000, BIOCHEM BIOPH RES CO, V272, P466, DOI 10.1006/bbrc.2000.2777; Molkentin JD, 2006, J CLIN INVEST, V116, P623, DOI 10.1172/JCI27824; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sandona D, 2000, BIOCHEM BIOPH RES CO, V279, P348, DOI 10.1006/bbrc.2000.3948; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Sheng M, 2000, J CELL SCI, V113, P1851; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; Soloviev MM, 2000, EUR J BIOCHEM, V267, P634, DOI 10.1046/j.1432-1327.2000.01078.x; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Volpe P, 2004, BIOCHEM BIOPH RES CO, V316, P884, DOI 10.1016/j.bbrc.2004.02.132; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	37	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					596	603		10.1096/fj.11-190330	http://dx.doi.org/10.1096/fj.11-190330			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22012123				2022-12-25	WOS:000300485700013
J	Balamatsias, D; Kong, AM; Waters, JE; Sriratana, A; Gurung, R; Bailey, CG; Rasko, JEJ; Tiganis, T; Macaulay, SL; Mitchell, CA				Balamatsias, Demis; Kong, Anne M.; Waters, Joanne E.; Sriratana, Absorn; Gurung, Rajendra; Bailey, Charles G.; Rasko, John E. J.; Tiganis, Tony; Macaulay, S. Lance; Mitchell, Christina A.			Identification of P-Rex1 as a Novel Rac1-Guanine Nucleotide Exchange Factor (GEF) That Promotes Actin Remodeling and GLUT4 Protein Trafficking in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; GREEN-FLUORESCENT PROTEIN; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAY; SKELETAL-MUSCLE; RAT ADIPOCYTES; CELL-MIGRATION; MYOSIN MYO1C	Phosphoinositide 3-kinase (PI3K) signaling promotes the translocation of the glucose transporter, GLUT4, to the plasma membrane in insulin-sensitive tissues to facilitate glucose uptake. In adipocytes, insulin-stimulated reorganization of the actin cytoskeleton has been proposed to play a role in promoting GLUT4 translocation and glucose uptake, in a PI3K-dependent manner. However, the PI3K effectors that promote GLUT4 translocation via regulation of the actin cytoskeleton in adipocytes remain to be fully elucidated. Here we demonstrate that the PI3K-dependent Rac exchange factor, P-Rex1, enhances membrane ruffling in 3T3-L1 adipocytes and promotes GLUT4 trafficking to the plasma membrane at submaximal insulin concentrations. P-Rex1-facilitated GLUT4 trafficking requires a functional actin network and membrane ruffle formation and occurs in a PI3K- and Rac1-dependent manner. In contrast, expression of other Rho GTPases, such as Cdc42 or Rho, did not affect insulin-stimulated P-Rex1-mediated GLUT4 trafficking. P-Rex1 siRNA knockdown or expression of a P-Rex1 dominant negative mutant reduced but did not completely inhibit glucose uptake in response to insulin. Collectively, these studies identify a novel RacGEF in adipocytes as P-Rex1 that, at physiological insulin concentrations, functions as an insulin-dependent regulator of the actin cytoskeleton that contributes to GLUT4 trafficking to the plasma membrane.	[Balamatsias, Demis; Kong, Anne M.; Waters, Joanne E.; Sriratana, Absorn; Gurung, Rajendra; Tiganis, Tony; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bailey, Charles G.; Rasko, John E. J.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Macaulay, S. Lance] CSIRO Mat Sci & Engn CMSE, Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Parkville, Vic 3052, Australia	Monash University; University of Sydney; Centenary Institute; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tiganis, Tony/AAV-3495-2020; Macaulay, Stuart Lance/A-6086-2008; Rasko, John EJ/F-5754-2013	Tiganis, Tony/0000-0002-8065-9942; Macaulay, Stuart Lance/0000-0001-5069-9516; rasko, John/0000-0003-2975-807X; Mitchell, Christina A/0000-0001-9372-3192; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council, Australia [491029]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council, Australia, Grant 491029.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bento JL, 2008, GENOMICS, V92, P226, DOI 10.1016/j.ygeno.2008.06.004; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dobson SP, 1996, FEBS LETT, V393, P179, DOI 10.1016/0014-5793(96)00879-4; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Dorrestijn J, 1997, EXP CLIN ENDOCR DIAB, V105, P254, DOI 10.1055/s-0029-1211762; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Fossey SC, 2001, GENOMICS, V76, P45, DOI 10.1006/geno.2001.6584; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hou JC, 2006, J BIOL CHEM, V281, P23307, DOI 10.1074/jbc.M603127200; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Khayat ZA, 2000, J CELL SCI, V113, P279; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Lewis JP, 2010, GENOMICS, V96, P211, DOI 10.1016/j.ygeno.2010.07.006; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Oatey PB, 1997, BIOCHEM J, V327, P637; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Sweeney G, 2004, J BIOL CHEM, V279, P32233, DOI 10.1074/jbc.M402897200; SYLOW L, 2010, 70 SCI SESS ORL FL J; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Usui I, 2003, J BIOL CHEM, V278, P13765, DOI 10.1074/jbc.M208904200; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	69	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43229	43240		10.1074/jbc.M111.306621	http://dx.doi.org/10.1074/jbc.M111.306621			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002247	hybrid, Green Published			2022-12-25	WOS:000298351300043
J	Klein, G; Lindner, B; Brade, H; Raina, S				Klein, Gracjana; Lindner, Buko; Brade, Helmut; Raina, Satish			Molecular Basis of Lipopolysaccharide Heterogeneity in Escherichia coli ENVELOPE STRESS-RESPONSIVE REGULATORS CONTROL THE INCORPORATION OF GLYCOFORMS WITH A THIRD 3-DEOXY-alpha-D-MANNO-OCT-2-ULOSONIC ACID AND RHAMNOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; EXTRACYTOPLASMIC STRESS; CHROMOSOMAL GENES; ASSEMBLY SYSTEM; SIGMA-FACTOR; CORE REGION; CELL-LYSIS; RPOE GENE; K-12; SALMONELLA	Background: LPS is essential for viability, although it is highly heterogeneous. Results: Synthesis of different glycoforms is regulated by differential expression of WaaZ (KdoIII transferase) and WaaR (glycosyltransferase). RpoE-transcribed rybB sRNA represses WaaR synthesis, and ppGpp is required for KdoIII incorporation in RpoE-inducing conditions. Conclusion: RpoE induction causes truncation of outer core and rhamnose addition to KdoIII. Significance: LPS alterations are crucial for outer membrane function.	[Klein, Gracjana; Raina, Satish] Gdansk Univ Technol, Dept Microbiol, PL-80233 Gdansk, Poland; [Klein, Gracjana; Lindner, Buko; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Dept Microbiol, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065				Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Heinrichs DE, 1998, J BIOL CHEM, V273, P8849, DOI 10.1074/jbc.273.15.8849; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; JANSSON PE, 1981, EUR J BIOCHEM, V115, P571; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Leipold MD, 2007, J BIOL CHEM, V282, P26786, DOI 10.1074/jbc.M704131200; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Noor R, 2009, GENES CELLS, V14, P885, DOI 10.1111/j.1365-2443.2009.01318.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Reynolds CM, 2009, BIOCHEMISTRY-US, V48, P9627, DOI 10.1021/bi901391g; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; WOLLIN R, 1983, J BIOL CHEM, V258, P3769	40	36	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42787	42807		10.1074/jbc.M111.291799	http://dx.doi.org/10.1074/jbc.M111.291799			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021036	hybrid, Green Published			2022-12-25	WOS:000298351300001
J	Ali, BR; Ben-Rebeh, I; John, A; Akawi, NA; Milhem, RM; Al-Shehhi, NA; Al-Ameri, MM; Al-Shamisi, SA; Al-Gazali, L				Ali, Bassam R.; Ben-Rebeh, Imen; John, Anne; Akawi, Nadia A.; Milhem, Reham M.; Al-Shehhi, Nouf A.; Al-Ameri, Mouza M.; Al-Shamisi, Shamma A.; Al-Gazali, Lihadh			Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-MISFOLDING DISEASES; BETA-BINDING-PROTEIN; TGF-BETA; INTRACELLULAR-TRANSPORT; ENDOTHELIAL-CELLS; ROBINOW-SYNDROME; TRAFFIC JAMS; MUTATIONS; ER	Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant genetic condition affecting the vascular system and is characterised by epistaxis, arteriovenous malformations and mucocutaneous and gastrointestinal telangiectases. This disorder affects approximately 1 in 8,000 people worldwide. Significant morbidity is associated with this condition in affected individuals, and anaemia can be a consequence of repeated haemorrhages from telangiectasia in the gut and nose. In the majority of the cases reported, the condition is caused by mutations in either ACVRL1 or endoglin genes, which encode components of the TGF-beta signalling pathway. Numerous missense mutations in endoglin have been reported as causative defects for HHT but the exact underlying cellular mechanisms caused by these mutations have not been fully established despite data supporting a role for the endoplasmic reticulum (ER) quality control machinery. For this reason, we examined the subcellular trafficking of twenty-five endoglin disease-causing missense mutations. The mutant proteins were expressed in HeLa and HEK293 cell lines, and their subcellular localizations were established by confocal fluorescence microscopy alongside the analysis of their N-glycosylation profiles. ER quality control was found to be responsible in eight (L32R, V49F, C53R, V125D, A160D, P165L, I271N and A308D) out of eleven mutants located on the orphan extracellular domain in addition to two (C363Y and C382W) out of thirteen mutants in the Zona Pellucida (ZP) domain. In addition, a single intracellular domain missense mutant was examined and found to traffic predominantly to the plasma membrane. These findings support the notion of the involvement of the ER's quality control in the mechanism of a significant number, but not all, missense endoglin mutants found in HHT type 1 patients. Other mechanisms including loss of interactions with signalling partners as well as adverse effects on functional residues are likely to be the cause of the mutant proteins' loss of function.	[Ali, Bassam R.; Ben-Rebeh, Imen; John, Anne; Akawi, Nadia A.; Milhem, Reham M.; Al-Shehhi, Nouf A.; Al-Ameri, Mouza M.; Al-Shamisi, Shamma A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Ali, BR (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates.	bassam.ali@uaeu.ac.ae	Akawi, Nadia/AAX-2650-2020; Ali, Bassam/J-7014-2012	Akawi, Nadia/0000-0001-6311-7028; Ali, Bassam R/0000-0003-1306-6618; Milhem, Reham/0000-0002-1587-6502	United Arab Emirates University [NRF-RSA-1108-00439]	United Arab Emirates University	This project has been funded by the United Arab Emirates University NRF-RSA-1108-00439 grant to B. R. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; ABDULLA SA, 2005, HUM MUTAT, V25, P320; Ali BR, 2007, HUM GENET, V122, P389, DOI 10.1007/s00439-007-0409-0; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Assar O, 1991, LARYNGOSCOPE, V101, P977; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; BIDEAU A, 1992, ANN HUM BIOL, V19, P233, DOI 10.1080/03014469200002112; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dupuis-Girod S, 2010, J THROMB HAEMOST, V8, P1447, DOI 10.1111/j.1538-7836.2010.03860.x; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fernandez-L Africa, 2006, Hum Mutat, V27, P295; Fontalba A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-75; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hume AN, 2009, HUM MOL GENET, V18, P267, DOI 10.1093/hmg/ddn354; Karabegovic A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022079; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; LASTRES P, 1994, BIOCHEM J, V301, P765, DOI 10.1042/bj3010765; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McDonald J, 2011, CLIN GENET, V79, P335, DOI 10.1111/j.1399-0004.2010.01596.x; Paquet ME, 2001, HUM MOL GENET, V10, P1347, DOI 10.1093/hmg/10.13.1347; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Romisch K, 2004, TRAFFIC, V5, P815, DOI 10.1111/j.1600-0854.2004.00231.x; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26206	10.1371/journal.pone.0026206	http://dx.doi.org/10.1371/journal.pone.0026206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022569	Green Submitted, gold, Green Published			2022-12-25	WOS:000295981600039
J	Choi, YH; Jit, M; Gay, N; Andrews, N; Waight, PA; Melegaro, A; George, R; Miller, E				Choi, Yoon Hong; Jit, Mark; Gay, Nigel; Andrews, Nick; Waight, Pauline A.; Melegaro, Alessia; George, Robert; Miller, Elizabeth			7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TRANSMISSION PARAMETERS; COST-EFFECTIVENESS; CARRIAGE; VACCINES; MODELS	Background: The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to the US experience with PCV7. However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US. Methods and Findings: A previous model of pneumococcal vaccination was re-parameterised using data on vaccine coverage and IPD from England and Wales between 2006 and 2009. Disease incidence was adjusted for the increasing trend in reported IPD cases prior to vaccination. Using this data we estimated that individuals carrying PCV7 serotypes have much higher protection (96%; 95% CI 72%-100%) against acquisition of NVT carriage than the 15% previously estimated from US data, which leads to greater replacement. However, even with this level of replacement, the annual number of IPD cases may be 560 (95% CI, -100 to 1230) lower ten years after vaccine introduction compared to what it may have been without vaccination. A particularly marked fall of 39% in children under 15 years by 2015/6 is predicted. Conclusion: Our model suggests that PCV7 vaccination could result in a decrease in overall invasive pneumococcal disease, particularly in children, even in an environment of rapid replacement with non-PCV7 serotypes within 5 years of vaccine introduction at high coverage.	[Choi, Yoon Hong; Waight, Pauline A.; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Choi, Yoon Hong; Jit, Mark] Hlth Protect Agcy, Modelling & Econ Unit, London, England; [Gay, Nigel] Fu Consulting, Hungerford, Berks, England; [Andrews, Nick] Hlth Protect Agcy, Stat Unit, London, England; [Melegaro, Alessia] Bocconi Univ, DONDENA Ctr Res Social Dynam, Milan, Italy; [George, Robert] Hlth Protect Agcy, Resp & Syst Infect Lab, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Bocconi University; Health Protection Agency	Choi, YH (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	yoon.choi@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255; Melegaro, Alessia/0000-0003-2221-8898	Pfizer Vaccines	Pfizer Vaccines	The authors have read the journal's policy and have the following conflicts: RG has declared that he has received funding from Wyeth (now Pfizer Vaccines) to support conference attendance which was not for the purpose of this study. RG, EM and NA have declared that they have been a member of the Department of Health's Joint Committee on Vaccines and Immunisations Committee Sub-committee on pneumococcal vaccines. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Black S, 2010, PEDIATR INFECT DIS J, V29, P301, DOI 10.1097/INF.0b013e3181c391fb; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Weinbergera D.M., 2011, LANCET, V378, P1962, DOI [10.1016/S0140-6736(10)62225-8, DOI 10.1016/S0140-6736(10)62225-8]; *WHO, 2011, M STRAT ADV GROUP EX, V86, P1	26	48	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26190	10.1371/journal.pone.0026190	http://dx.doi.org/10.1371/journal.pone.0026190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022559	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000295981600035
J	Mar, JC; Matigian, NA; Quackenbush, J; Wells, CA				Mar, Jessica C.; Matigian, Nicholas A.; Quackenbush, John; Wells, Christine A.			attract: A Method for Identifying Core Pathways That Define Cellular Phenotypes	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; GENE	attract is a knowledge-driven analytical approach for identifying and annotating the gene-sets that best discriminate between cell phenotypes. attract finds distinguishing patterns within pathways, decomposes pathways into meta-genes representative of these patterns, and then generates synexpression groups of highly correlated genes from the entire transcriptome dataset. attract can be applied to a wide range of biological systems and is freely available as a Bioconductor package and has been incorporated into the MeV software system.	[Mar, Jessica C.; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Mar, Jessica C.; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Matigian, Nicholas A.; Quackenbush, John; Wells, Christine A.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Griffith University; Harvard University; Dana-Farber Cancer Institute; University of Queensland	Mar, JC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	jess@jimmy.harvard.edu; johnq@jimmy.harvard.edu; c.wells@uq.edu.au	Wells, Christine A/A-5071-2010; Matigian, Nicholas A/A-4935-2009; Matigian, Nicholas/AAF-9390-2020	Wells, Christine A/0000-0003-3133-3628; Matigian, Nicholas A/0000-0001-7735-9415; Matigian, Nicholas/0000-0001-7735-9415; Quackenbush, John/0000-0002-2702-5879; Mar, Jessica/0000-0002-5147-9299	US National Human Genome Research Institute [P50-HG004233]; Griffith University; Harvard Club of Australia Foundation; US National Library of Medicine [R01-LM010129]; Australian Research Council [LX0882502]; Australian Stem Cell Centre; National Health and Medical Research Council Australia [481945]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010129] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Griffith University(Griffith University); Harvard Club of Australia Foundation; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Australian Research Council(Australian Research Council); Australian Stem Cell Centre; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JQ and JCM are supported by a grant from the US National Human Genome Research Institute (P50-HG004233). JQ is also supported, in part, by a Jackson Memorial Visiting Fellowship from Griffith University (www.griffith.edu.au) and a Harvard Club of Australia Foundation Fellowship (http://hcag.org.au/), and from the US National Library of Medicine (R01-LM010129). CAW is supported by the Australian Research Council (www.arc.gov.au) International linkage scheme (LX0882502), The Australian Stem Cell Centre and the National Health and Medical Research Council Australia (www.nhmrc.gov.au) CDA fellowship (481945). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oron AP, 2008, BIOINFORMATICS, V24, P2586, DOI 10.1093/bioinformatics/btn465; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	16	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25445	10.1371/journal.pone.0025445	http://dx.doi.org/10.1371/journal.pone.0025445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022396	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295981600008
J	Chouhan, B; Denesyuk, A; Heino, J; Johnson, MS; Denessiouk, K				Chouhan, Bhanupratap; Denesyuk, Alexander; Heino, Jyrki; Johnson, Mark S.; Denessiouk, Konstantin			Conservation of the Human Integrin-Type Beta-Propeller Domain in Bacteria	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; MEDIATED ADHESION; CALCIUM-BINDING; ALPHA-SUBUNIT; I-DOMAIN; PROTEIN; EVOLUTION; RECOGNITION	Integrins are heterodimeric cell-surface receptors with key functions in cell-cell and cell-matrix adhesion. Integrin alpha and beta subunits are present throughout the metazoans, but it is unclear whether the subunits predate the origin of multicellular organisms. Several component domains have been detected in bacteria, one of which, a specific 7-bladed beta-propeller domain, is a unique feature of the integrin alpha subunits. Here, we describe a structure-derived motif, which incorporates key features of each blade from the X-ray structures of human alpha IIb beta 3 and alpha V beta 3, includes elements of the FG-GAP/Cage and Ca2+-binding motifs, and is specific only for the metazoan integrin domains. Separately, we searched for the metazoan integrin type beta-propeller domains among all available sequences from bacteria and unicellular eukaryotic organisms, which must incorporate seven repeats, corresponding to the seven blades of the beta-propeller domain, and so that the newly found structure-derived motif would exist in every repeat. As the result, among 47 available genomes of unicellular eukaryotes we could not find a single instance of seven repeats with the motif. Several sequences contained three repeats, a predicted transmembrane segment, and a short cytoplasmic motif associated with some integrins, but otherwise differ from the metazoan integrin alpha subunits. Among the available bacterial sequences, we found five examples containing seven sequential metazoan integrin-specific motifs within the seven repeats. The motifs differ in having one Ca2+-binding site per repeat, whereas metazoan integrins have three or four sites. The bacterial sequences are more conserved in terms of motif conservation and loop length, suggesting that the structure is more regular and compact than those example structures from human integrins. Although the bacterial examples are not full-length integrins, the full-length metazoan-type 7-bladed b-propeller domains are present, and sometimes two tandem copies are found.	[Chouhan, Bhanupratap; Denesyuk, Alexander; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Chouhan, Bhanupratap; Denessiouk, Konstantin] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	Abo Akademi University; University of Turku; University of Turku	Chouhan, B (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	kdenessi@btk.fi		Chouhan, Bhanupratap Singh/0000-0002-3918-5925	Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland; National Doctoral Program in Informational and Structural Biology	Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland(Academy of Finland); National Doctoral Program in Informational and Structural Biology	This work was supported in part by grants from Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging, the Sigrid Juselius Foundation, the Joe, Pentti and Tor Borg Memorial Fund, and by the Academy of Finland (Bioinformatics Infrastructure Program of Biocenter Finland and FIRI program). Bhanupratap Chouhan is supported by the National Doctoral Program in Informational and Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2007, INT J BIOL MACROMOL, V41, P454, DOI 10.1016/j.ijbiomac.2007.06.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUSTODIO MR, 1995, J EUKARYOT MICROBIOL, V42, P721, DOI 10.1111/j.1550-7408.1995.tb01623.x; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Herbaud ML, 1998, BBA-MOL CELL RES, V1448, P212, DOI 10.1016/S0167-4889(98)00145-1; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jenkins C, 2002, GENOME BIOL, V3; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; May AP, 1999, TRENDS BIOCHEM SCI, V24, P12, DOI 10.1016/S0968-0004(98)01310-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; TISA LS, 1993, J BACTERIOL, V175, P1235, DOI 10.1128/JB.175.5.1235-1238.1993; Tulla M, 2007, FEBS LETT, V581, P2434, DOI 10.1016/j.febslet.2007.04.054; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	50	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25069	10.1371/journal.pone.0025069	http://dx.doi.org/10.1371/journal.pone.0025069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022374	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600009
J	Gori, M; Sciutti, A; Burr, D; Sandini, G				Gori, Monica; Sciutti, Alessandra; Burr, David; Sandini, Giulio			Direct and Indirect Haptic Calibration of Visual Size Judgments	PLOS ONE			English	Article							REACH DISTANCE; PERCEPTION; EXPERIENCE; CONSTANCY; CHILDREN; GRASP; RECALIBRATION; RECOGNITION; DISTORTIONS; ILLUSIONS	It has long been suspected that touch plays a fundamental role in the calibration of visual perception, and much recent evidence supports this idea. However, as the haptic exploration workspace is limited by the kinematics of the body, the contribution of haptic information to the calibration process should occur only within the region of the haptic workspace reachable by a limb (peripersonal space). To test this hypothesis we evaluated visual size perception and showed that it is indeed more accurate inside the peripersonal space. We then show that allowing subjects to touch the (unseen) stimulus after observation restores accurate size perception; the accuracy persists for some time, implying that calibration has occurred. Finally, we show that observing an actor grasp the object also produces accurate (and lasting) size perception, suggesting that the calibration can also occur indirectly by observing goal-directed actions, implicating the involvement of the "mirror system''.	[Gori, Monica; Sciutti, Alessandra; Sandini, Giulio] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy; [Burr, David] Univ Florence, Dept Psychol, Florence, Italy; [Burr, David] CNR, Ist Neurosci, I-56100 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Gori, M (corresponding author), Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy.	monica.gori@iit.it	Gori, Monica/AAS-9963-2021; Gori, Monica/A-1238-2014; Sciutti, Alessandra/E-4291-2017	Gori, Monica/0000-0002-5616-865X; Sciutti, Alessandra/0000-0002-1056-3398; Sandini, Giulio/0000-0003-3324-985X; Burr, David/0000-0003-1541-8832	EC [229445]; Italian Ministry for Universities and Research [PRIN2009]	EC(European CommissionEuropean Commission Joint Research Centre); Italian Ministry for Universities and Research(Ministry of Education, Universities and Research (MIUR))	This study was partially supported by the EC project STANIB (FP7-ERC, n. 229445), and the PRIN2009 grant from the Italian Ministry for Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, J NEUROSCI, V30, P14745, DOI 10.1523/JNEUROSCI.2749-10.2010; Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Atkins JE, 2003, VISION RES, V43, P2603, DOI 10.1016/S0042-6989(03)00470-X; Atkins JE, 2001, VISION RES, V41, P449, DOI 10.1016/S0042-6989(00)00254-6; Berkeley, 1709, ESSAY NEW THEORY VIS; Bingham GP, 2000, J EXP PSYCHOL HUMAN, V26, P1436, DOI 10.1037//0096-1523.26.4.1436; CARLSON VR, 1962, J EXP PSYCHOL, V63, P68, DOI 10.1037/h0045909; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Coats R, 2008, EXP BRAIN RES, V189, P211, DOI 10.1007/s00221-008-1418-5; Efron B., 1994, INTRO BOOTSTRAP; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1995, EXP BRAIN RES, V105, P291; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Granrud CE, 2006, PERCEPT PSYCHOPHYS, V68, P1372, DOI 10.3758/BF03193736; Granrud CE, 2009, ATTEN PERCEPT PSYCHO, V71, P644, DOI 10.3758/APP.71.3.644; Gregory RL, 1999, Q J EXP PSYCHOL-A, V52, P801, DOI 10.1080/027249899390800; Ho YX, 2009, J NEUROPHYSIOL, V101, P2789, DOI 10.1152/jn.91129.2008; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mon-Williams M, 2007, J EXP PSYCHOL HUMAN, V33, P645, DOI 10.1037/0096-1523.33.3.645; Norman JF, 1996, J EXP PSYCHOL HUMAN, V22, P173, DOI 10.1037/0096-1523.22.1.173; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Van Doorn GH, 2010, ATTEN PERCEPT PSYCHO, V72, P813, DOI 10.3758/APP.72.3.813; Wallace, 1963, EXP PSYCHOL SOC MONO, V2; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wijntjes MWA, 2009, EXP BRAIN RES, V193, P639, DOI 10.1007/s00221-009-1713-9	34	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25599	10.1371/journal.pone.0025599	http://dx.doi.org/10.1371/journal.pone.0025599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022420	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600023
J	Georges, A; Benayoun, BA; Marongiu, M; Dipietromaria, A; L'Hote, D; Todeschini, AL; Auer, J; Crisponi, L; Veitia, RA				Georges, Adrien; Benayoun, Berenice A.; Marongiu, Mara; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Auer, Jana; Crisponi, Laura; Veitia, Reiner A.			SUMOylation of the Forkhead Transcription Factor FOXL2 Promotes Its Stabilization/Activation through Transient Recruitment to PML Bodies	PLOS ONE			English	Article							CELL LINE; NUCLEAR; ACTIVATION; PROTEINS; SUMO; LOCALIZATION; EXPRESSION; STRESS; OVARY; IDENTIFICATION	Background: FOXL2 is a transcription factor essential for ovarian development and maintenance. It is mutated in the genetic condition called Blepharophimosis Ptosis Epicantus inversus Syndrome (BPES) and in cases of isolated premature ovarian failure. We and others have previously shown that FOXL2 undergoes several post-translational modifications. Methods and Principal Findings: Here, using cells in culture, we show that interference with FOXL2 SUMOylation leads to a robust inhibition of its transactivation ability, which correlates with a decreased stability. Interestingly, FOXL2 SUMOylation promotes its transient recruitment to subnuclear structures that we demonstrate to be PML (Promyelocytic Leukemia) Nuclear Bodies. Since PML bodies are known to be sites where post-translational modifications of nuclear factors take place, we used tandem mass spectrometry to identify new post-translational modifications of FOXL2. Specifically, we detected four phosphorylated, one sulfated and three acetylated sites. Conclusions: By analogy with other transcription factors, we propose that PML Nuclear Bodies might transiently recruit FOXL2 to the vicinity of locally concentrated enzymes that could be involved in the post-translational maturation of FOXL2. FOXL2 acetylation, sulfation, phosphorylation as well as other modifications yet to be discovered might alter the transactivation capacity of FOXL2 and/or its stability, thus modulating its global intracellular activity.	[Georges, Adrien; Benayoun, Berenice A.; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] UMR 7592 CNRS Univ Paris Diderot, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France; [Georges, Adrien; Benayoun, Berenice A.; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris 07, Paris, France; [Georges, Adrien] Ecole Normale Super, F-75231 Paris, France; [Marongiu, Mara; Crisponi, Laura] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Dipietromaria, Aurelie] Univ Paris 11, Orsay, France; [Auer, Jana] Univ Paris 05, Fac Med Cochin Port Royal, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Georges, A (corresponding author), UMR 7592 CNRS Univ Paris Diderot, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Crisponi, Laura/AAC-2642-2019; LHOTE, David/AAD-5390-2020; Benayoun, Bérénice A./K-7048-2012; Georges, Adrien/ABD-6348-2021; Marongiu, Mara/H-9437-2019; L'Hote, David/L-2653-2017	Crisponi, Laura/0000-0001-9128-8537; Benayoun, Bérénice A./0000-0002-7401-4777; Marongiu, Mara/0000-0002-7321-2384; Georges, Adrien/0000-0003-4208-2393; L'Hote, David/0000-0001-5658-5018	AMN/Universite Paris VII; Fondation pour la Recherche Medicale; Universite Paris VII; Consiglio Nationale de la Richerca; Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS); Universite Paris V; Institut Universitaire de France; Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; CNRS	AMN/Universite Paris VII; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Universite Paris VII; Consiglio Nationale de la Richerca; Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris V; Institut Universitaire de France; Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; CNRS(Centre National de la Recherche Scientifique (CNRS))	AG and BB are supported by an AMN/Universite Paris VII fellowship; AD is supported by the Fondation pour la Recherche Medicale; DL and A-LT are funded by Universite Paris VII; MM and LC are funded by Consiglio Nationale de la Richerca; JA is funded by Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS) and Universite Paris V; RV is funded by Institut Universitaire de France, Fondation pour la Recherche Medicale, Ligue Nationale Contre le Cancer (Comite de Paris), Groupement d'Entreprises Francaises dans la Lutte contre le Cancer, CNRS and Universite Paris VII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Batty E, 2009, FRONT BIOSCI-LANDMRK, V14, P1182, DOI 10.2741/3302; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Bundgaard Jens R., 2008, V446, P47, DOI 10.1007/978-1-60327-084-7_4; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dave KA, 2009, MOL CELL PROTEOMICS, V8, P706, DOI 10.1074/mcp.M800459-MCP200; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Garcia-Dominguez M, GENE REGULATORY MECH, V1789, P451; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kumar A, 2004, MOL VIS, V10, P445; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Marongiu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009477; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P429, DOI 10.1074/mcp.M300140-MCP200; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	65	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25463	10.1371/journal.pone.0025463	http://dx.doi.org/10.1371/journal.pone.0025463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022399	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000017
J	Pidasheva, S; Trifari, S; Phillips, A; Hackney, JA; Ma, Y; Smith, A; Sohn, SJ; Spits, H; Little, RD; Behrens, TW; Honigberg, L; Ghilardi, N; Clark, HF				Pidasheva, Svetlana; Trifari, Sara; Phillips, Anne; Hackney, Jason A.; Ma, Yan; Smith, Ashley; Sohn, Sue J.; Spits, Hergen; Little, Randall D.; Behrens, Timothy W.; Honigberg, Lee; Ghilardi, Nico; Clark, Hilary F.			Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; ACTIVE CROHNS-DISEASE; ULCERATIVE-COLITIS; SEQUENCE VARIANTS; T-CELLS; CYTOKINE; POPULATION; DISTINCT; POLYMORPHISM	Genome-wide association studies (GWAS) in several populations have demonstrated significant association of the IL23R gene with IBD (Crohn's disease (CD) and ulcerative colitis (UC)) and psoriasis, suggesting that perturbation of the IL-23 signaling pathway is relevant to the pathophysiology of these diseases. One particular variant, R381Q (rs11209026), confers strong protection against development of CD. We investigated the effects of this variant in primary T cells from healthy donors carrying IL23R(R381) and IL23R(Q381) haplotypes. Using a proprietary anti-IL23R antibody, ELISA, flow cytometry, phosphoflow and real-time RT-PCR methods, we examined IL23R expression and STAT3 phosphorylation and activation in response to IL-23. IL23R(Q381) was associated with reduced STAT3 phosphorylation upon stimulation with IL-23 and decreased number of IL-23 responsive T-cells. We also observed slightly reduced levels of proinflammatory cytokine secretion in IL23R(Q381) positive donors. Our study shows conclusively that IL23R(Q381) is a loss-of-function allele, further strengthening the implication from GWAS results that the IL-23 pathway is pathogenic in human disease. This data provides an explanation for the protective role of R381Q in CD and may lead to the development of improved therapeutics for autoimmune disorders like CD.	[Pidasheva, Svetlana; Phillips, Anne; Hackney, Jason A.; Ma, Yan; Clark, Hilary F.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Pidasheva, Svetlana; Trifari, Sara; Sohn, Sue J.; Spits, Hergen; Ghilardi, Nico; Clark, Hilary F.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Behrens, Timothy W.] Genentech Inc, ITGR Biomarker Discovery Grp, San Francisco, CA 94080 USA; [Smith, Ashley; Honigberg, Lee] Genentech Inc, ITGR Early Dev, San Francisco, CA 94080 USA; [Ghilardi, Nico] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Little, Randall D.] Genizon BioSci Inc, St Laurent, PQ, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Pidasheva, S (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.	svetlana.pidasheva@gmail.com; clark.hilary@gene.com	Spits, Hergen/N-2581-2019; Little, Randall/O-7172-2014	Spits, Hergen/0000-0003-3269-8338; Ghilardi, Nico/0000-0003-4945-3097; Hackney, Jason/0000-0002-5922-563X; Miller, Allison/0000-0003-3816-2251	Genentech; Genizon	Genentech(Roche HoldingGenentech); Genizon	The funders (Genentech and Genizon) did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, since the authors are employees of these companies.	Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Crellin NK, 2007, J IMMUNOL METHODS, V324, P92, DOI 10.1016/j.jim.2007.05.008; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; MALEFYT RDW, 2008, EXPERT REV DERMATOL, V3, pS13; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Newman WG, 2009, J CLIN GASTROENTEROL, V43, P444, DOI 10.1097/MCG.0b013e318168bdf0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schulz KR, 2007, CURR PROTOC IMMUNOL; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Thompson NP, 1996, BRIT MED J, V312, P95; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yssel Hans, 2002, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0719s47	45	80	86	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25038	10.1371/journal.pone.0025038	http://dx.doi.org/10.1371/journal.pone.0025038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022372	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000007
J	Tu, JG; Guo, J; Zhang, AD; Zhang, WT; Zhao, ZZ; Zhou, HB; Liu, C; Chen, HC; Jin, ML				Tu, Jiagang; Guo, Jing; Zhang, Anding; Zhang, Wenting; Zhao, Zongzheng; Zhou, Hongbo; Liu, Cheng; Chen, Huanchun; Jin, Meilin			Effects of the C-Terminal Truncation in NS1 Protein of the 2009 Pandemic H1N1 Influenza Virus on Host Gene Expression	PLOS ONE			English	Article							A-VIRUS; INFECTED-CELLS; ACTIVATION; BINDING; VIRULENCE; P85-BETA; MOTIF	The 2009 pandemic H1N1 influenza virus encodes an NS1 protein with 11 amino acids (aa) truncation at the C-terminus. The C-terminal tail of influenza virus NS1 protein constitutes a nucleolar localization signal (NoLS) and is the binding domain of the cellular pre-mRNA processing protein, poly(A)-binding protein II (PABII). Here, our studies showed that the C-terminal-truncated NS1 of the 2009 pandemic virus was inefficient at blocking host gene expression, extension of the truncated NS1 to its full length increased the inhibition of host gene expression. Mechanistically, this increased inhibition of host gene expression by the full-length NS1 was not associated with nucleolar localization, but was due to the restoration of NS1's binding capacity to PABII. Furthermore, in vitro and in vivo characterization of two recombinant viruses encoding either the C-terminal 11-aa truncated or full-length NS1 of the 2009 pandemic virus showed that the C-terminal 11-aa truncation in NS1 did not significantly alter virus replication, but increased virus pathogenicity in mice.	[Tu, Jiagang; Guo, Jing; Zhang, Anding; Zhang, Wenting; Zhao, Zongzheng; Zhou, Hongbo; Liu, Cheng; Chen, Huanchun; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Peoples R China	Huazhong Agricultural University	Tu, JG (corresponding author), Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Peoples R China.	jml8328@126.com			National Basic Research Program of China (program 973) [2011CB505004 1/4 CE2010CB534002]; National Transgenic Major Program [2009ZX08009-141B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	National Basic Research Program of China (program 973)(National Basic Research Program of China); National Transgenic Major Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Basic Research Program of China (program 973, grant 2011CB5050041/4CE2010CB534002), the National Transgenic Major Program (2009ZX08009-141B), and Program for Changjiang Scholars and Innovative Research Team in University (IRT0726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dundon WG, 2009, VIRUSES-BASEL, V1, P1057, DOI 10.3390/v1031057; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, J GEN VIROL, V91, P1737, DOI 10.1099/vir.0.020925-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Han H, 2010, J GEN VIROL, V91, P2907, DOI 10.1099/vir.0.024943-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zhou HB, 2010, J INFECT DIS, V202, P1338, DOI 10.1086/656536; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	30	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26175	10.1371/journal.pone.0026175	http://dx.doi.org/10.1371/journal.pone.0026175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022552	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000080
J	Catry, P; Dias, MP; Phillips, RA; Granadeiro, JP				Catry, Paulo; Dias, Maria P.; Phillips, Richard A.; Granadeiro, Jose P.			Different Means to the Same End: Long-Distance Migrant Seabirds from Two Colonies Differ in Behaviour, Despite Common Wintering Grounds	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; CORYS SHEARWATER; PELAGIC SEABIRD; MIGRATION; ALBATROSSES; ISOTOPES; TRACKING; ECOLOGY; SUMMER; OCEAN	Although seabirds that are trans-equatorial migrants show apparently broad overlap among populations in the non-breeding season, such large-scale pattern may conceal subtle but nevertheless key differences in migratory behaviour. These specializations could reflect adaptation to different environments during the breeding season, carry-over effects from the breeding to the nonbreeding period, or asymmetries in competitive ability of birds of different origin. We compared the migratory and wintering behaviour of Cory's shearwaters Calonectris diomedea nesting in Berlengas and in the Selvagens, two colonies in contrasting oceanographic environments, separated by ca. 1200 km. Although no differences were found in winter distribution, there was a marked divergence in timing, route and the use of staging areas during the postbreeding (autumn) migration. Birds from Berlengas typically travelled to oceanic waters in the North Atlantic for an extended stopover, whereas those from Selvagens rarely did so. In the South Atlantic, birds from Selvagens spent more time in flight, perhaps because they had higher energy and nutrient requirements for feather replacement compared to birds from Berlengas, which moult more flight feathers during breeding. Stable isotope analyses of feathers suggested that this variation in activity patterns was unrelated to trophic ecology. Differences in migration routes and stopovers may expose populations to distinct threats, and should be taken into consideration when defining units for conservation purposes and developing appropriate management strategies.	[Catry, Paulo; Dias, Maria P.] ISPA, Ecoethol Res Unit, Lisbon, Portugal; [Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Granadeiro, Jose P.] Univ Lisbon, CESAM, Museu Nacl Hist Nat, P-1699 Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Universidade de Lisboa	Catry, P (corresponding author), ISPA, Ecoethol Res Unit, Lisbon, Portugal.	paulo.catry@gmail.com	Dias, Maria/D-1331-2012; Catry, Paulo/I-5408-2013; Granadeiro, José Pedro/E-8060-2011; Dias, Maria/AAK-1171-2021	Catry, Paulo/0000-0003-3000-0522; Granadeiro, José Pedro/0000-0002-7207-3474; Dias, Maria/0000-0002-7281-4391	Fundacao para a Ciencia e a Tecnologia [PTDC/MAR/71927/2006, UID 331/94]; FCT [BPD/46827/08]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by Fundacao para a Ciencia e a Tecnologia (www.fct.mctes.pt, Portugal) through Project PTDC/MAR/71927/2006 and as part of the Programa Plurianual (UI&D 331/94). MD benefited from a fellowship from FCT (BPD/46827/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2009, J ORNITHOL, V150, P329, DOI 10.1007/s10336-008-0354-2; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Catry P, 2011, J ORNITHOL, V152, P549, DOI 10.1007/s10336-010-0616-7; Catry P, 2009, J ORNITHOL, V150, P103, DOI 10.1007/s10336-008-0322-x; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Granadeiro JP, 2006, WATERBIRDS, V29, P56, DOI 10.1675/1524-4695(2006)29[56:NAPTOC]2.0.CO;2; Granadeiro JP, 1998, ANIM BEHAV, V56, P1169, DOI 10.1006/anbe.1998.0827; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Lecoq Miguel, 2010, Airo, V20, P36; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Rayner MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1330; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Young LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007623	28	46	49	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26079	10.1371/journal.pone.0026079	http://dx.doi.org/10.1371/journal.pone.0026079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022513	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000295973200031
J	Larsen, L; Rosenstierne, MW; Gaarn, LW; Bagge, A; Pedersen, L; Dahmcke, CM; Nielsen, JH; Dalgaard, LT				Larsen, Louise; Rosenstierne, Maiken W.; Gaarn, Louise W.; Bagge, Annika; Pedersen, Lykke; Dahmcke, Christina M.; Nielsen, Jens H.; Dalgaard, Louise T.			Expression and Localization of microRNAs in Perinatal Rat Pancreas: Role of miR-21 in Regulation of Cholesterol Metabolism	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-CELLS; INSULIN; ALPHA; FETAL; ACTIVATION; SECRETION; GENECODIS; REVEALS; BINDING	Objective: To investigate the expression of pancreatic microRNAs (miRNAs) during the period of perinatal beta-cell expansion and maturation in rats, determine the localization of these miRNAs and perform a pathway analysis with predicted target mRNAs expressed in perinatal pancreas. Research Design and Methods: RNA was extracted from whole pancreas at embryonic day 20 (E20), on the day of birth (P0) and two days after birth (P2) and hybridized to miRNA microarrays. Differentially expressed miRNAs were verified by northern blotting and their pancreatic localization determined by in situ hybridization. Pathway analysis was done using regulated sets of mRNAs predicted as targets of the miRNAs. Possible target genes were tested using reporter-gene analysis in INS-1E cells. Results: Nine miRNAs were differentially expressed perinatally, seven were confirmed to be regulated at the level of the mature miRNA. The localization studies showed endocrine localization of six of these miRNAs (miR-21, -23a, -29a, -125b-5p, -376b-3p and -451), and all were expressed in exocrine cells at one time point at least. Pathways involving metabolic processes, terpenoid and sterol metabolism were selectively affected by concomitant regulation by miRNAs and mRNAs, and Srebf1 was validated as a target of miR-21. Conclusions: The findings suggest that miRNAs are involved in the functional maturation of pancreatic exocrine and endocrine tissue following birth. Pathway analysis of target genes identify changes in sterol metabolism around birth as being selectively affected by differential miRNA expression during this period.	[Larsen, Louise; Rosenstierne, Maiken W.; Gaarn, Louise W.; Nielsen, Jens H.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Pedersen, Lykke] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Rosenstierne, Maiken W.; Bagge, Annika; Dahmcke, Christina M.; Dalgaard, Louise T.] Roskilde Univ, Dept Sci, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Roskilde University	Larsen, L (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	jenshn@sund.ku.dk; ltd@ruc.dk	Bagge, Annika/A-4151-2015; Pedersen, Lykke/AAM-2297-2020; Pedersen, Lykke/J-8049-2012; Dalgaard, Louise/O-3788-2015	Bagge, Annika/0000-0002-3897-9512; Pedersen, Lykke/0000-0002-8935-415X; Pedersen, Lykke/0000-0002-8935-415X; Dalgaard, Louise/0000-0002-3598-2775; Nielsen, Jens Hoiriis/0000-0001-8252-3048	Danish Research Council for Technology and Production; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Danish microRNA Consortium	Danish Research Council for Technology and Production; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Danish microRNA Consortium	These studies were supported by the Danish Research Council for Technology and Production, The Novo Nordisk Foundation, the European Foundation for the Study of Diabetes and the Danish microRNA Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haave NC, 2001, METABOLISM, V50, P12, DOI 10.1053/meta.2001.19498; He A, 2007, MOL ENDOCRINOL; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V378, P545, DOI 10.1016/j.bbrc.2008.11.105; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jorgensen MC, 2007, ENDOCR REV; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KAUNG HLC, 1994, DEV DYNAM, V200, P163, DOI 10.1002/aja.1002000208; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros JC, 2007, VENNY INTERACTIVE TO; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; SODOYEZGOFFAUX F, 1979, DIABETOLOGIA, V16, P121, DOI 10.1007/BF01225461; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Yamashita T, 2004, ENDOCRINOLOGY	49	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25997	10.1371/journal.pone.0025997	http://dx.doi.org/10.1371/journal.pone.0025997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022489	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200026
J	Palmieri, G; Bergamo, P; Luini, A; Ruvo, M; Gogliettino, M; Langella, E; Saviano, M; Hegde, RN; Sandomenico, A; Rossi, M				Palmieri, Gianna; Bergamo, Paolo; Luini, Alberto; Ruvo, Menotti; Gogliettino, Marta; Langella, Emma; Saviano, Michele; Hegde, Ramanath N.; Sandomenico, Annamaria; Rossi, Mose			Acylpeptide Hydrolase Inhibition as Targeted Strategy to Induce Proteasomal Down-Regulation	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; CELL LUNG-CARCINOMA; NF-KAPPA-B; SULFOLOBUS-SOLFATARICUS; THERAPEUTIC TARGET; UBIQUITIN SYSTEM; FATTY-ACIDS; DEGRADATION; APOPTOSIS; PATHWAY	Acylpeptide hydrolase (APEH), one of the four members of the prolyl oligopeptidase class, catalyses the removal of N-acylated amino acids from acetylated peptides and it has been postulated to play a key role in protein degradation machinery. Disruption of protein turnover has been established as an effective strategy to down-regulate the ubiquitin-proteasome system (UPS) and as a promising approach in anticancer therapy. Here, we illustrate a new pathway modulating UPS and proteasome activity through inhibition of APEH. To find novel molecules able to down-regulate APEH activity, we screened a set of synthetic peptides, reproducing the reactive-site loop of a known archaeal inhibitor of APEH (SsCEI), and the conjugated linoleic acid (CLA) isomers. A 12-mer SsCEI peptide and the trans10-cis12 isomer of CLA, were identified as specific APEH inhibitors and their effects on cell-based assays were paralleled by a dose-dependent reduction of proteasome activity and the activation of the pro-apoptotic caspase cascade. Moreover, cell treatment with the individual compounds increased the cytoplasm levels of several classic hallmarks of proteasome inhibition, such as NFkappaB, p21, and misfolded or polyubiquitinylated proteins, and additive effects were observed in cells exposed to a combination of both inhibitors without any cytotoxicity. Remarkably, transfection of human bronchial epithelial cells with APEH siRNA, promoted a marked accumulation of a mutant of the cystic fibrosis transmembrane conductance regulator (CFTR), herein used as a model of misfolded protein typically degraded by UPS. Finally, molecular modeling studies, to gain insights into the APEH inhibition by the trans10-cis12 CLA isomer, were performed. Our study supports a previously unrecognized role of APEH as a negative effector of proteasome activity by an unknown mechanism and opens new perspectives for the development of strategies aimed at modulation of cancer progression.	[Palmieri, Gianna; Gogliettino, Marta; Rossi, Mose] Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy; [Bergamo, Paolo] Natl Res Council CNR ISA, Inst Food Sci, Avellino, Italy; [Ruvo, Menotti; Langella, Emma; Sandomenico, Annamaria] Natl Res Council CNR IBB, Inst Biostruct & Bioimaging, Naples, Italy; [Saviano, Michele] Natl Council Res Italy CNR IC, Inst Crystallog, Bari, Italy; [Luini, Alberto; Hegde, Ramanath N.] Telethon Inst Genet & Med TIGEM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Palmieri, G (corresponding author), Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy.	g.palmieri@ibp.cnr.it	Bergamo, Paolo/F-7835-2013; Palmieri, Gianna/AAW-6176-2020; Saviano, Michele/R-1693-2016; Langella, Emma/ABE-6901-2020; Palmieri, Gianna/S-4872-2017; Sandomenico, Annamaria/AAS-4957-2020; Luini, Alberto/L-1372-2013	Bergamo, Paolo/0000-0002-1726-7911; Palmieri, Gianna/0000-0002-9007-4075; Saviano, Michele/0000-0001-5086-2459; Luini, Alberto/0000-0002-8729-2549; Sandomenico, Annamaria/0000-0001-5255-3668; Hegde, Ramanath Narayana/0000-0001-7224-3544; LANGELLA, EMMA/0000-0002-9033-1975	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	fundings for this study were from the project MoMa n. 1/014/06/0 of the Agenzia Spaziale Italiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hamel FG, 2009, METABOLISM, V58, P1047, DOI 10.1016/j.metabol.2009.04.005; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Landis-Piwowar KR, 2006, DRUG RESIST UPDATE, V9, P263, DOI 10.1016/j.drup.2006.11.001; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naujokat C, 2000, EUR J HAEMATOL, V65, P221, DOI 10.1034/j.1600-0609.2000.065004221.x; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Palmieri G, 2010, MOL BIOSYST, V6, P2498, DOI 10.1039/c005293k; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park Y, 2009, J FOOD COMPOS ANAL, V22, pS4, DOI 10.1016/j.jfca.2008.12.002; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Shah Imtiaz M., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P250, DOI 10.2174/187152907782793572; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Vlahakis SR, 2006, CURR OPIN CLIN NUTR, V9, P42, DOI 10.1097/01.mco.0000196144.11104.69; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350	48	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25888	10.1371/journal.pone.0025888	http://dx.doi.org/10.1371/journal.pone.0025888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016782	gold, Green Submitted, Green Published			2022-12-25	WOS:000295971700021
J	Lee, YJ; Mou, Y; Maric, D; Klimanis, D; Auh, S; Hallenbeck, JM				Lee, Yang-Ja; Mou, Yongshan; Maric, Dragan; Klimanis, Dace; Auh, Sungyoung; Hallenbeck, John M.			Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage	PLOS ONE			English	Article							IN-VITRO; MAMMALIAN HIBERNATION; ACTIVATING ENZYME; SUMO; STROKE; TOLERANCE; PATHOPHYSIOLOGY; INHIBITION; MECHANISM; CELLS	We have previously shown that a massive increase in global SUMOylation occurs during torpor in ground squirrels, and that overexpression of Ubc9 and/or SUMO-1 in cell lines and cortical neurons protects against oxygen and glucose deprivation. To examine whether increased global SUMOylation protects against ischemic brain damage, we have generated transgenic mice in which Ubc9 is expressed strongly in all tissues under the chicken beta-actin promoter. Ubc9 expression levels in 10 founder lines ranged from 2 to 30 times the endogenous level, and lines that expressed Ubc9 at modestly increased levels showed robust resistance to brain ischemia compared to wild type mice. The infarction size was inversely correlated with the Ubc9 expression levels for up to five times the endogenous level. Although further increases showed no additional benefit, the Ubc9 expression level was highly correlated with global SUMO-1 conjugation levels (and SUMO-2,3 levels to a lesser extent) up to a five-fold Ubc9 increase. Most importantly, there were striking reciprocal relationships between SUMO-1 (and SUMO-2,3) conjugation levels and cerebral infarction volumes among all tested animals, suggesting that the limit in cytoprotection by global SUMOylation remains undefined. These results support efforts to further augment global protein SUMOylation in brain ischemia.	[Lee, Yang-Ja; Mou, Yongshan; Klimanis, Dace; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, Neurophysiol Lab, NIH, Bethesda, MD 20892 USA; [Auh, Sungyoung] NINDS, Clin Neurosci Program HNQ22, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Lee, YJ (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov			National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2008, NEUROSCIENTIST, V14, P626, DOI 10.1177/1073858408322677; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HALLENBECK JM, 1993, ARCH NEUROL-CHICAGO, V50, P768, DOI 10.1001/archneur.1993.00540070080020; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Loftus LT, 2009, BRAIN RES, V1272, P71, DOI 10.1016/j.brainres.2009.03.034; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Storey KB, 2003, ADV EXP MED BIOL, V543, P21; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tomoiu A, 2006, J VIROL, V80, P10218, DOI 10.1128/JVI.00375-06; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450; Xu J, 2009, INT J ONCOL, V34, P939, DOI 10.3892/ijo_00000220; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	40	82	86	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25852	10.1371/journal.pone.0025852	http://dx.doi.org/10.1371/journal.pone.0025852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016779	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300031
J	Martins, M; Rosa, A; Guedes, LC; Fonseca, BV; Gotovac, K; Violante, S; Mestre, T; Coelho, M; Rosa, MM; Martin, ER; Vance, JM; Outeiro, TF; Wang, LY; Borovecki, F; Ferreira, JJ; Oliveira, SA				Martins, Madalena; Rosa, Alexandra; Guedes, Leonor C.; Fonseca, Benedita V.; Gotovac, Kristina; Violante, Sara; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Martin, Eden R.; Vance, Jeffery M.; Outeiro, Tiago F.; Wang, Liyong; Borovecki, Fran; Ferreira, Joaquim J.; Oliveira, Sofia A.			Convergence of miRNA Expression Profiling, alpha-Synuclein Interacton and GWAS in Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOCEREBROSIDASE MUTATIONS; GENE-EXPRESSION; RISK-FACTORS; PREDICTION; TOXICITY; PATHWAYS; SEMA5A; SITE; SNCA	miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological disorders such as Parkinson's disease (PD). miRNAs are abundant in the nervous system, essential for efficient brain function and play important roles in neuronal patterning and cell specification. To further investigate their involvement in the etiology of PD, we conducted miRNA expression profiling in peripheral blood mononuclear cells (PBMCs) of 19 patients and 13 controls using microarrays. We found 18 miRNAs differentially expressed, and pathway analysis of 662 predicted target genes of 11 of these miRNAs revealed an over-representation in pathways previously linked to PD as well as novel pathways. To narrow down the genes for further investigations, we undertook a parallel approach using chromatin immunoprecipitation-sequencing (ChIP-seq) analysis to uncover genome-wide interactions of alpha-synuclein, a molecule with a central role in both monogenic and idiopathic PD. Convergence of ChIP-seq and miRNomics data highlighted the glycosphingolipid biosynthesis and the ubiquitin proteasome system as key players in PD. We then tested the association of target genes belonging to these pathways with PD risk, and identified nine SNPs in USP37 consistently associated with PD susceptibility in three genome-wide association studies (GWAS) datasets (0.46 <= OR <= 0.63) and highly significant in the meta-dataset (3.36x10(-4)< p < 1.94x10(-3)). A SNP in ST8SIA4 was also highly associated with PD (p = 6.15x10(-3)) in the meta-dataset. These findings suggest that several miRNAs may act as regulators of both known and novel biological processes leading to idiopathic PD.	[Martins, Madalena; Guedes, Leonor C.; Fonseca, Benedita V.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Ferreira, Joaquim J.; Oliveira, Sofia A.] Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal; [Martins, Madalena; Rosa, Alexandra; Fonseca, Benedita V.; Violante, Sara; Oliveira, Sofia A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Rosa, Alexandra] Univ Madeira, Ctr Competencias Ciencias Vida, Unidade Ciencias Med, Funchal, Portugal; [Guedes, Leonor C.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Ferreira, Joaquim J.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Serv Neurol, Lisbon, Portugal; [Gotovac, Kristina; Borovecki, Fran] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Funct Genom,Ctr Translat & Clin Res, Zagreb 41001, Croatia; [Martin, Eden R.; Vance, Jeffery M.; Wang, Liyong] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Outeiro, Tiago F.] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, Lisbon, Portugal; [Outeiro, Tiago F.] Univ Med Gottingen, Ctr Mol Physiol Brain, Dept Neurodegenerat & Restaurat Res, Gottingen, Germany	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade da Madeira; Universidade de Lisboa; Hospital Santa Maria; University of Zagreb; University of Miami; Universidade de Lisboa; Universidade de Lisboa; University of Gottingen	Martins, M (corresponding author), Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal.	aaoliveira@fm.ul.pt	Rosa, Alexandra/AAA-3224-2022; Ferreira, Joaquim/AAA-1837-2020; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019	Rosa, Alexandra/0000-0002-1827-6828; Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Correia Guedes, Leonor/0000-0002-8422-0494; Martins, Madalena/0000-0001-8360-6806; Vance, Jeffery/0000-0003-3815-8199; Oliveira, Sofia A/0000-0001-7919-4191; Coelho, Miguel/0000-0002-4008-8110; Ferreira, Joaquim J/0000-0003-3950-5113	Fundacao para a Ciencia e a Tecnologia (FCT) [FCT/SAU/GMG/64428/2006, SFRH/BPD/29354/2006]; Center for Human Genetics at Duke University Medical Center (USA); NINDS [NS39764]; Portuguese Instituto do Emprego e Formacao Profissional; World Bank/Ministry of Science of the Republic of Croatia [24/08]; European Molecular Biology Organization (EMBO); Marie Curie International Reintegration Grant (Neurofold); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Center for Human Genetics at Duke University Medical Center (USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Portuguese Instituto do Emprego e Formacao Profissional; World Bank/Ministry of Science of the Republic of Croatia; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie International Reintegration Grant (Neurofold)(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) (FCT/SAU/GMG/64428/2006 to S.A.O., SFRH/BPD/29354/2006 to M.M.); the Center for Human Genetics at Duke University Medical Center (USA) for the grant awarded to S.A.O.; the NINDS grant NS39764 (HIHG); the fellowships from the Portuguese Instituto do Emprego e Formacao Profissional (B.V.F. and S.V.); and the Unity through Knowledge Fund (World Bank/Ministry of Science of the Republic of Croatia) grant 24/08 (F.B.). T.F.O. is supported by a European Molecular Biology Organization (EMBO) Installation Grant and a Marie Curie International Reintegration Grant (Neurofold). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bialecka M, 2006, NEUROSCI LETT, V399, P121, DOI 10.1016/j.neulet.2006.01.038; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Devine MJ, 2008, FEBS J, V275, P5748, DOI 10.1111/j.1742-4658.2008.06707.x; Ding HX, 2008, BRAIN RES, V1245, P126, DOI 10.1016/j.brainres.2008.09.080; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Haugarvoll K, 2009, EUR J HUM GENET, V17, P336, DOI 10.1038/ejhg.2008.187; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Outeiro TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006906; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Outeiro TF, 2008, PERSPECT MED CHEM, V2, P41; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Satterlee JS, 2007, J NEUROSCI, V27, P11856, DOI 10.1523/JNEUROSCI.3624-07.2007; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schwab R.S., 1969, 3 S PARK DIS, P152; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xie WL, 2010, BBA-MOL BASIS DIS, V1802, P935, DOI 10.1016/j.bbadis.2010.07.014; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	62	185	196	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25443	10.1371/journal.pone.0025443	http://dx.doi.org/10.1371/journal.pone.0025443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003392	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300013
J	Golini, L; Chouabe, C; Berthier, C; Cusimano, V; Fornaro, M; Bonvallet, R; Formoso, L; Giacomello, E; Jacquemond, V; Sorrentino, V				Golini, Lucia; Chouabe, Christophe; Berthier, Christine; Cusimano, Vincenza; Fornaro, Mara; Bonvallet, Robert; Formoso, Luca; Giacomello, Emiliana; Jacquemond, Vincent; Sorrentino, Vincenzo			Junctophilin 1 and 2 Proteins Interact with the L-type Ca2+ Channel Dihydropyridine Receptors (DHPRs) in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; CHARGE MOVEMENT; CALCIUM-CHANNELS; TRIADIC PROTEINS; CONTRACTION; RELEASE; COMPLEX; FIBERS; ENTRY	Junctophilins (JPs) anchor the endo/sarcoplasmic reticulum to the plasma membrane, thus contributing to the assembly of junctional membrane complexes in striated muscles and neurons. Recent studies have shown that JPs may be also involved in regulating Ca2+ homeostasis. Here, we report that in skeletal muscle, JP1 and JP2 are part of a complex that, in addition to ryanodine receptor 1 (RyR1), includes caveolin 3 and the dihydropyridine receptor (DHPR). The interaction between JPs and DHPR was mediated by a region encompassing amino acids 230-369 and amino acids 216-399 in JP1 and JP2, respectively. Immunofluorescence studies revealed that the pattern of DHPR and RyR signals in C2C12 cells knocked down for JP1 and JP2 was rather diffused and characterized by smaller puncta in contrast to that observed in control cells. Functional experiments revealed that down-regulation of JPs in differentiated C2C12 cells resulted in a reduction of intramembrane charge movement and the L-type Ca2+ current accompanied by a reduced number of DHPRs at the plasma membrane, whereas there was no substantial alteration in Ca2+ release from the sterol regulatory element-binding protein. Altogether, these results suggest that JP1 and JP2 can facilitate the assembly of DHPR with other proteins of the excitation-contraction coupling machinery.	[Golini, Lucia; Cusimano, Vincenza; Fornaro, Mara; Formoso, Luca; Giacomello, Emiliana; Sorrentino, Vincenzo] Univ Siena, Mol Med Sect, Dept Neurosci, I-53100 Siena, Italy; [Chouabe, Christophe; Berthier, Christine; Bonvallet, Robert; Jacquemond, Vincent] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Golini, Lucia; Cusimano, Vincenza; Fornaro, Mara; Formoso, Luca; Giacomello, Emiliana; Sorrentino, Vincenzo] Univ Siena, Interuniv Inst Myol, I-53100 Siena, Italy	University of Siena; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Siena	Sorrentino, V (corresponding author), Univ Siena, Mol Med Sect, Dept Neurosci, Via A Moro, I-53100 Siena, Italy.	vincenzo.sorrentino@unisi.it	berthier, christine/AAO-1247-2021; Sorrentino, Vincenzo/A-4793-2014; Giacomello, Emiliana/E-3080-2018	Sorrentino, Vincenzo/0000-0002-8573-8631; Giacomello, Emiliana/0000-0003-3329-6269; BERTHIER, Christine/0000-0002-9608-643X; Jacquemond, Vincent/0000-0003-4944-270X	Telethon [GGP08153]	Telethon(Fondazione Telethon)	This work was supported in part by a grant from Telethon (GGP08153).	Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; FRANZINIARMSTRO.C, 2004, MYOLOGY, P232; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Kakizawa S, 2008, CEREBELLUM, V7, P385, DOI 10.1007/s12311-008-0040-1; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Murray BE, 1997, BIOCHEM J, V324, P689, DOI 10.1042/bj3240689; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Phimister AJ, 2007, J BIOL CHEM, V282, P8667, DOI 10.1074/jbc.M609936200; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Serysheva II, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1226, DOI 10.1007/s10541-005-0068-5; Sorrentino V, 2011, INT J BIOCHEM CELL B, V43, P1075, DOI 10.1016/j.biocel.2011.04.004; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Vassilopoulos S, 2010, BIOCHEMISTRY-US, V49, P6130, DOI 10.1021/bi100796v; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang ZM, 2000, BIOPHYS J, V78, P1947, DOI 10.1016/S0006-3495(00)76742-7; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	42	60	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43717	43725		10.1074/jbc.M111.292755	http://dx.doi.org/10.1074/jbc.M111.292755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020936	Green Published, hybrid			2022-12-25	WOS:000298402300015
J	Nacev, BA; Grassi, P; Dell, A; Haslam, SM; Liu, JO				Nacev, Benjamin A.; Grassi, Paola; Dell, Anne; Haslam, Stuart M.; Liu, Jun O.			The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; LANOSTEROL 14-ALPHA-DEMETHYLASE; TUMOR ANGIOGENESIS; MASS-SPECTROMETRY; CANDIDA-ALBICANS; PLC-GAMMA; GOLGI; BEVACIZUMAB; CHOLESTEROL; ACTIVATION	Itraconazole is a safe and widely used antifungal drug that was recently found to possess potent antiangiogenic activity. Currently, there are four active clinical trials evaluating itraconazole as a cancer therapeutic. Tumor growth is dependent on angiogenesis, which is driven by the secretion of growth factors from the tumor itself. We report here that itraconazole significantly inhibited the binding of vascular endothelial growth factor (VEGF) to VEGF receptor 2 (VEGFR2) and that both VEGFR2 and an immediate downstream substrate, phospholipase C gamma 1, failed to become activated after VEGF stimulation. These effects were due to a defect in VEGFR2 trafficking, leading to a decrease in cell surface expression, and were associated with the accumulation of immature N-glycans on VEGFR2. Small molecule inducers of lysosomal cholesterol accumulation and mammalian target of rapamycin (mTOR) inhibition, two previously reported itraconazole activities, failed to recapitulate itraconazole's effects on VEGFR2 glycosylation and signaling. Likewise, glycosylation inhibitors did not alter cholesterol trafficking or inhibit mTOR. Repletion of cellular cholesterol levels, which was known to rescue the effects of itraconazole onmTOR and cholesterol trafficking, was also able to restore VEGFR2 glycosylation and signaling. This suggests that the new effects of itraconazole occur in parallel to those previously reported but are downstream of a common target. We also demonstrated that itraconazole globally reduced poly-N-acetyllactosamine and tetra-antennary complex N-glycans in endothelial cells and induced hypoglycosylation of the epidermal growth factor receptor in a renal cell carcinoma line, suggesting that itraconazole's effects extend beyond VEGFR2.	[Nacev, Benjamin A.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Grassi, Paola; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Imperial College London	Liu, JO (corresponding author), 725 N Wolfe St,Hunterian 516, Baltimore, MD 21205 USA.	joliu@jhu.edu		Dell, Anne/0000-0003-1380-2347	National Institutes of Health (NIH) [T32GM07309]; NIH, NCI [CA122814]; National Center for Research Resources (NCRR), NIH [UL1 RR 025005]; Flight Attendant Medical Research Institute; Commonwealth Foundation; Biotechnology and Biological Sciences Research Council [BBF0083091]; Marie Curie Initial Training Network; NATIONAL CANCER INSTITUTE [R01CA122814] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Flight Attendant Medical Research Institute; Commonwealth Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Initial Training Network(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Medical Scientist Training Program Grant T32GM07309 (to B. A. N.); by NIH, NCI Grant CA122814 (to J. O. L.); National Center for Research Resources (NCRR), NIH, Grant UL1 RR 025005; and the NIH Roadmap for Medical Research. This work was also supported by the Flight Attendant Medical Research Institute and the Commonwealth Foundation (to J. O. L.). Additional support was provided by Biotechnology and Biological Sciences Research Council Grant BBF0083091 and the Marie Curie Initial Training Network, Euro-glycoArrays Project, part of the FP7 People Programme.	Aftab BT, 2011, CANCER RES, V71, P6764, DOI 10.1158/0008-5472.CAN-11-0691; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Christian AE, 1997, J LIPID RES, V38, P2264; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V240, P635, DOI 10.1006/bbrc.1997.7719; DELL A, 1994, METHOD ENZYMOL, V230, P108; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frey T, 2009, J BIOL CHEM, V284, P16882, DOI 10.1074/jbc.M109.007609; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Hayes DF, 2011, JAMA-J AM MED ASSOC, V305, P506, DOI 10.1001/jama.2011.57; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schweitzer JK, 2009, CURR DRUG TARGETS, V10, P653, DOI 10.2174/138945009788680437; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shi W, 2010, ACS MED CHEM LETT, V1, P155, DOI 10.1021/ml1000068; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P4702, DOI 10.1021/bi00181a030; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J	46	82	92	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44045	44056		10.1074/jbc.M111.278754	http://dx.doi.org/10.1074/jbc.M111.278754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22025615	hybrid, Green Published			2022-12-25	WOS:000298402300045
J	Anderson, K; Nordquist, KA; Gao, XL; Hicks, KC; Zhai, B; Gygi, SP; Patel, TB				Anderson, Kimberly; Nordquist, Kyle A.; Gao, Xianlong; Hicks, Kristin C.; Zhai, Bo; Gygi, Steven P.; Patel, Tarun B.			Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; TYROSINE PHOSPHORYLATION; PROSTATE-CANCER; DOWN-REGULATION; GENE-PRODUCT; C-TERMINUS; GROWTH; ACTIVATION; PATHWAY	Sprouty (Spry) proteins modulate the actions of receptor tyrosine kinases during development and tumorigenesis. Decreases in cellular levels of Spry, especially Sprouty2 (Spry2), have been implicated in the growth and progression of tumors of the breast, prostate, lung, and liver. During development and tumor growth, cells experience hypoxia. Therefore, we investigated how hypoxia modulates the levels of Spry proteins. Hypoxia elevated the levels of all four expressed Spry isoforms in HeLa cells. Amounts of endogenous Spry2 in LS147T and HEP3B cells were also elevated by hypoxia. Using Spry2 as a prototype, we demonstrate that silencing and expression of prolyl hydroxylase domain proteins (PHD1-3) increase and decrease, respectively, the cellular content of Spry2. Spry2 also preferentially interacted with PHD1-3 and von Hippel-Lindau protein (pVHL) during normoxia but not in hypoxia. Additionally, Spry2 is hydroxylated on Pro residues 18, 144, and 160, and substitution of these residues with Ala enhanced stability of Spry2 and abrogated its interactions with pVHL. Silencing of pVHL increased levels of Spry2 by decreasing its ubiquitylation and degradation and thereby augmented the ability of Spry2 to inhibit FGF-elicited activation of ERK1/2. Thus, prolyl hydroxylase mediated hydroxylation and subsequent pVHL-elicited ubiquitylation of Spry2 target it for degradation and, consequently, provide a novel mechanism of regulating growth factor signaling.	[Anderson, Kimberly; Nordquist, Kyle A.; Gao, Xianlong; Hicks, Kristin C.; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Nordquist, Kyle A.; Gao, Xianlong; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Inst Signal Transduct, Maywood, IL 60153 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Loyola University Chicago; Loyola University Chicago; Harvard University; Harvard Medical School	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu		Hicks, Kristin/0000-0001-9192-875X	National Institutes of Health [073181, HG3456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants 073181 (to T. B. P.) and HG3456 (to S. P. G.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Brady SC, 2009, CANCER RES, V69, P6773, DOI 10.1158/0008-5472.CAN-08-4447; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Feng YH, 2011, CANCER BIOL THER, V11, P111, DOI 10.4161/cbt.11.1.13965; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; GLENN GM, 1991, HUM GENET, V87, P207, DOI 10.1007/BF00204184; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Haigl B, 2010, BIOL CHEM, V391, P813, DOI 10.1515/BC.2010.082; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Lin F, 2008, AM J CLIN PATHOL, V129, P592, DOI 10.1309/Q0FLUXFJ4FTTW1XR; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minowada G, 1999, DEVELOPMENT, V126, P4465; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Paltoglou S, 2007, ONCOGENE, V26, P604, DOI 10.1038/sj.onc.1209818; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Reich A, 1999, DEVELOPMENT, V126, P4139; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	59	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42027	42036		10.1074/jbc.M111.303222	http://dx.doi.org/10.1074/jbc.M111.303222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006925	Green Published, hybrid			2022-12-25	WOS:000298180900013
J	Yao, S; Sucheston, LE; Smiley, SL; Davis, W; Conroy, JM; Nowak, NJ; Ambrosone, CB; McCarthy, PL; Hahn, T				Yao, Song; Sucheston, Lara E.; Smiley, Shannon L.; Davis, Warren; Conroy, Jeffrey M.; Nowak, Norma J.; Ambrosone, Christine B.; McCarthy, Philip L., Jr.; Hahn, Theresa			Common Genetic Variants Are Associated with Accelerated Bone Mineral Density Loss after Hematopoietic Cell Transplantation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MARROW STROMAL CELLS; OSTEOPOROSIS; FRACTURES; CANCER	Background: Bone mineral density (BMD) loss commonly occurs after hematopoietic cell transplantation (HCT). Hypothesizing that genetic variants may influence post-HCT BMD loss, we conducted a prospective study to examine the associations of single nucleotide polymorphisms (SNP) in bone metabolism pathways and acute BMD loss after HCT. Methods and Findings: We genotyped 122 SNPs in 45 genes in bone metabolism pathways among 121 autologous and allogeneic HCT patients. BMD changes from pre-HCT to day + 100 post-HCT were analyzed in relation to these SNPs in linear regression models. After controlling for clinical risk factors, we identified 16 SNPs associated with spinal or femoral BMD loss following HCT, three of which have been previously implicated in genome-wide association studies of bone phenotypes, including rs2075555 in COL1A1, rs9594738 in RANKL, and rs4870044 in ESR1. When multiple SNPs were considered simultaneously, they explained 5-35% of the variance in post-HCT BMD loss. There was a significant trend between the number of risk alleles and the magnitude of BMD loss, with patients carrying the most risk alleles having the greatest loss. Conclusion: Our data provide the first evidence that common genetic variants play an important role in BMD loss among HCT patients similar to age-related BMD loss in the general population. This infers that the mechanism for post-HCT bone loss is a normal aging process that is accelerated during HCT. A limitation of our study comes from its small patient population; hence future larger studies are warranted to validate our findings.	[Yao, Song; Sucheston, Lara E.; Davis, Warren; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Smiley, Shannon L.; McCarthy, Philip L., Jr.; Hahn, Theresa] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Conroy, Jeffrey M.; Nowak, Norma J.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	Theresa.hahn@roswellpark.org	Yao, Song/A-2534-2012; McCarthy, Philip/ABA-5329-2020	Yao, Song/0000-0001-9442-1313	Cancer and Leukemia Group B (CALGB); NIH [5P30CA016056-34]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Cancer and Leukemia Group B (CALGB); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by a Cancer and Leukemia Group B (CALGB) Investigator Award for junior oncology faculty (S.L.S). The DataBank and BioRepository and the Genomics Shared Resource at Roswell Park Cancer Institute are Cancer Center Support Grant (CCSG) Shared Resources (NIH 5P30CA016056-34). The funding organizations played no roles during the conduct of the study or the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Amling M, 1996, J BONE MINER RES, V11, P36, DOI 10.1002/jbmr.5650110107; Benjamin RM, 2010, J AM DIET ASSOC, V110, P498, DOI 10.1016/j.jada.2010.02.018; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eisman JA, 1999, ENDOCR REV, V20, P788, DOI 10.1210/er.20.6.788; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; KELLY PJ, 1990, TRANSPLANTATION, V50, P881; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Lee WY, 2002, J CLIN ENDOCR METAB, V87, P329, DOI 10.1210/jc.87.1.329; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; McClune BL, 2011, BONE MARROW TRANSPL, V46, P1, DOI 10.1038/bmt.2010.198; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; PERRONE M, 2010, FDA CLEARS AMGENS BO; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schulte CMS, 2004, BLOOD, V103, P3635, DOI 10.1182/blood-2003-09-3081; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P5058, DOI 10.1210/jc.2002-020800; Yao S, 2008, BONE MARROW TRANSPL, V41, P393, DOI 10.1038/sj.bmt.1705918; Yao S, 2010, BIOL BLOOD MARROW TR, V16, P1130, DOI 10.1016/j.bbmt.2010.02.017	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25940	10.1371/journal.pone.0025940	http://dx.doi.org/10.1371/journal.pone.0025940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022476	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600021
J	Dodds, TJ; Mohler, BJ; Bulthoff, HH				Dodds, Trevor J.; Mohler, Betty J.; Buelthoff, Heinrich H.			Talk to the Virtual Hands: Self-Animated Avatars Improve Communication in Head-Mounted Display Virtual Environments	PLOS ONE			English	Article							TASK-PERFORMANCE; GESTURE; REPRESENTATION; ONLINE	Background: When we talk to one another face-to-face, body gestures accompany our speech. Motion tracking technology enables us to include body gestures in avatar-mediated communication, by mapping one's movements onto one's own 3D avatar in real time, so the avatar is self-animated. We conducted two experiments to investigate (a) whether head-mounted display virtual reality is useful for researching the influence of body gestures in communication; and (b) whether body gestures are used to help in communicating the meaning of a word. Participants worked in pairs and played a communication game, where one person had to describe the meanings of words to the other. Principal Findings: In experiment 1, participants used significantly more hand gestures and successfully described significantly more words when nonverbal communication was available to both participants (i.e. both describing and guessing avatars were self-animated, compared with both avatars in a static neutral pose). Participants 'passed' (gave up describing) significantly more words when they were talking to a static avatar (no nonverbal feedback available). In experiment 2, participants' performance was significantly worse when they were talking to an avatar with a prerecorded listening animation, compared with an avatar animated by their partners' real movements. In both experiments participants used significantly more hand gestures when they played the game in the real world. Conclusions: Taken together, the studies show how (a) virtual reality can be used to systematically study the influence of body gestures; (b) it is important that nonverbal communication is bidirectional (real nonverbal feedback in addition to nonverbal communication from the describing participant); and (c) there are differences in the amount of body gestures that participants use with and without the head-mounted display, and we discuss possible explanations for this and ideas for future investigation.	[Dodds, Trevor J.; Mohler, Betty J.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Korea University	Dodds, TJ (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	trevor.dodds@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; 	Max Planck Society; WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	Max Planck Society(Max Planck SocietyFoundation CELLEX); WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by a post doctoral grant from the Max Planck Society, and by the WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICROSOFT KINECT; Ashenfelter KT, 2009, J EXP PSYCHOL HUMAN, V35, P1072, DOI 10.1037/a0015017; Bailenson JN, 2002, J VISUAL COMP ANIMAT, V13, P313, DOI 10.1002/vis.297; Bailenson JN, 2008, MEDIATED INTERPERSON, V6, P77, DOI 10.4324/9780203926864; BARONI M, 2006, P EUR CHAP ASS COMP; CHARTRAND TL, 2005, NEW UNCONSCIOUS, P334, DOI DOI 10.1093/ACPROF:OSO/9780195307696.003; Choi YS., 2005, NEW UNCONSCIOUS, P309; Di Luca M, 2010, PRESENCE-TELEOP VIRT, V19, P569, DOI 10.1162/pres_a_00023; Dodds TJ, 2009, COMPUT GRAPH-UK, V33, P130, DOI 10.1016/j.cag.2009.01.001; Ennis C, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778828; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kendon A, 1990, CONDUCTING INTERACTI; KNOPF M, 1992, ANN NY ACAD SCI, V673, P172, DOI 10.1111/j.1749-6632.1992.tb27450.x; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lindeman RW, 2009, IEEE COMPUT GRAPH, V29, P80, DOI 10.1109/MCG.2009.28; Lok B, 2003, PRESENCE-VIRTUAL AUG, V12, P615, DOI 10.1162/105474603322955914; McDonnell R, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1609967.1609969; Mcneill David, 2007, GESTURE THOUGHT; Mehrabian A., 1972, NONVERBAL COMMUNICAT; Mohler BJ, 2010, PRESENCE-TELEOP VIRT, V19, P230, DOI 10.1162/pres.19.3.230; Morsella E, 2004, AM J PSYCHOL, V117, P411, DOI 10.2307/4149008; OMalley J.M, 1990, LEARNING STRATEGIES; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Rowe ML, 2009, SCIENCE, V323, P951, DOI 10.1126/science.1167025; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schroeder R, 2006, PRESENCE-VIRTUAL AUG, V15, P655, DOI 10.1162/pres.15.6.655; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; STEPTOE W, 2010, P 28 ACM SIGCHI C HU; *U STUTTG, TREETAGGER LANG IND; VINAYAGAMOORTHY V, 2006, EUR C STAT OF THE AR, P21; Whittaker S., 2003, HDB DISCOURSE PROCES, P253; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x; Yee N, 2006, PRESENCE-VIRTUAL AUG, V15, P309, DOI 10.1162/pres.15.3.309; Yee N, 2009, COMMUN RES, V36, P285, DOI 10.1177/0093650208330254; Zanbaka Catherine, 2006, P SIGCHI C HUM FACT, pD01, DOI [10.1145/1124772.1124945, DOI 10.1145/1124772.1124945]	40	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25759	10.1371/journal.pone.0025759	http://dx.doi.org/10.1371/journal.pone.0025759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022442	Green Submitted, gold, Green Published			2022-12-25	WOS:000295976000036
J	Furtbauer, I; Mundry, R; Heistermann, M; Schulke, O; Ostner, J				Fuertbauer, Ines; Mundry, Roger; Heistermann, Michael; Schuelke, Oliver; Ostner, Julia			You Mate, I Mate: Macaque Females Synchronize Sex not Cycles	PLOS ONE			English	Article							ESTROUS SYNCHRONY; REPRODUCTIVE SYNCHRONY; OVARIAN SYNCHRONY; SOCIAL-GROUPS; ASYNCHRONY; EVOLUTION; PRIMATES; MALES; DOMINANCE; PATERNITY	Extended female sexuality in species living in multimale-multifemale groups appears to enhance benefits from multiple males. Mating with many males, however, requires a low female monopolizability, which is affected by the spatiotemporal distribution of receptive females. Ovarian cycle synchrony potentially promotes overlapping receptivity if fertile and receptive periods are tightly linked. In primates, however, mating is often decoupled from hormonal control, hence reducing the need for synchronizing ovarian events. Here, we test the alternative hypothesis that females behaviorally coordinate their receptivity while simultaneously investigating ovarian cycle synchrony in wild, seasonal Assamese macaques (Macaca assamensis), a promiscuous species with extremely extended female sexuality. Using fecal hormone analysis to assess ovarian activity we show that fertile phases are randomly distributed, and that dyadic spatial proximity does not affect their distribution. We present evidence for mating synchrony, i.e., the occurrence of the females' receptivity was significantly associated with the proportion of other females mating on a given day. Our results suggest social facilitation of mating synchrony, which explains (i) the high number of simultaneously receptive females, and (ii) the low male mating skew in this species. Active mating synchronization may serve to enhance the benefits of extended female sexuality, and may proximately explain its patterning and maintenance.	[Fuertbauer, Ines; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany; [Fuertbauer, Ines; Schuelke, Oliver; Ostner, Julia] Max Planck Inst Evolutionary Anthropol, Integrat Primate Socioecol Grp, Leipzig, Germany; [Fuertbauer, Ines; Heistermann, Michael] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany	University of Gottingen; Max Planck Society; Deutsches Primatenzentrum (DPZ)	Furtbauer, I (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany.	ifuertb@uni-goettingen.de		Furtbauer, Ines/0000-0003-1404-6280	National Geographic Society; Max-Planck Society; German Initiative of Excellence	National Geographic Society(National Geographic Society); Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Initiative of Excellence	The project was supported with funds from the National Geographic Society, Max-Planck Society and the German Initiative of Excellence to the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SA, 1962, ANN NY ACAD SCI, V102, P338, DOI 10.1111/j.1749-6632.1962.tb13650.x; ANDELMAN SJ, 1985, J ZOOL, V205, P467; ANDELMAN SJ, 1987, AM NAT, V129, P785, DOI 10.1086/284675; [Anonymous], 2010, R LANG ENV STAT COMP; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D. M., 2010, LME4 MIXED EFFECTS M; BERCOVITCH FB, 1987, AM J PRIMATOL, V12, P189, DOI 10.1002/ajp.1350120206; Birkhead TR, 1992, SPERM COMPETITION BI; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clarke Parry, 2009, P42; CORDS M, 1986, ETHOLOGY, V72, P214; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Doran-Sheeny DM, 2009, AM J PRIMATOL, V71, P1011, DOI 10.1002/ajp.20743; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FRENCH JA, 1987, AM J PRIMATOL, V12, P469, DOI 10.1002/ajp.1350120403; Furtbauer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023105; Furtbauer I, 2010, INT J PRIMATOL, V31, P501, DOI 10.1007/s10764-010-9409-3; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gattermann R, 2002, HORM BEHAV, V42, P70, DOI 10.1006/hbeh.2002.1800; HANDELMANN G, 1980, HORM BEHAV, V14, P107, DOI 10.1016/0018-506X(80)90002-1; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hrdy SB, 2000, ANN NY ACAD SCI, V907, P75, DOI 10.1111/j.1749-6632.2000.tb06617.x; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Knobil E., 2006, PHYSL REPROD, V3rd ed; KNOWLTON N, 1979, ANIM BEHAV, V27, P1022, DOI 10.1016/0003-3472(79)90049-6; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Li Jin-Hua, 2005, Acta Zoologica Sinica, V51, P365; Maninger N, 2000, AM J PRIMATOL, V52, P81, DOI 10.1002/1098-2345(200010)52:2<81::AID-AJP2>3.0.CO;2-L; Matsumoto-Oda A, 2005, AM J PRIMATOL, V66, P159, DOI 10.1002/ajp.20135; Matsumoto-Oda A, 2007, BEHAV ECOL SOCIOBIOL, V61, P661, DOI 10.1007/s00265-006-0287-9; MCCLINTOCK MK, 1984, PHYSIOL BEHAV, V32, P701, DOI 10.1016/0031-9384(84)90181-1; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Monfort SL, 1996, BIOL REPROD, V55, P875, DOI 10.1095/biolreprod55.4.875; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Ostner J, 2011, HORM BEHAV, V59, P105, DOI 10.1016/j.yhbeh.2010.10.017; PEREIRA ME, 1991, PHYSIOL BEHAV, V49, P47, DOI 10.1016/0031-9384(91)90228-G; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Radespiel U, 2001, INT J PRIMATOL, V22, P71, DOI 10.1023/A:1026466015443; RIDLEY M, 1986, ANIM BEHAV, V34, P1848, DOI 10.1016/S0003-3472(86)80271-8; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P695, DOI 10.1006/anbe.2000.1630; ROWELL TE, 1978, BEHAV BIOL, V24, P141, DOI 10.1016/S0091-6773(78)93032-8; RUSSELL MJ, 1980, PHARMACOL BIOCHEM BE, V13, P737, DOI 10.1016/0091-3057(80)90020-9; Schank JC, 2001, BEHAV PROCESS, V56, P131, DOI 10.1016/S0376-6357(01)00194-2; Schank JC, 2001, J COMP PSYCHOL, V115, P3, DOI 10.1037//0735-7036.115.1.3; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Setchell JM, 2010, J EVOLUTION BIOL, V23, P136, DOI 10.1111/j.1420-9101.2009.01880.x; Setchell JM, 2011, PSYCHONEUROENDOCRINO, V36, P51, DOI 10.1016/j.psyneuen.2010.06.004; Sokal R. R., 2012, BIOMETRY; Soltis J, 2002, EVOL ANTHROPOL, V11, P187, DOI 10.1002/evan.10025; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stoinski TS, 2009, AM J PRIMATOL, V71, P587, DOI 10.1002/ajp.20692; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Tobler R, 2010, ANIM BEHAV, V80, P829, DOI 10.1016/j.anbehav.2010.07.018; VAN HOOF J. A. R. A. M., 1967, P7; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 1999, Cambridge Studies in Biological Anthropology, V22, P204; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; VANDENBERGH JG, 1974, PHYSIOL BEHAV, V13, P373, DOI 10.1016/0031-9384(74)90090-0; WALLEN K, 1990, NEUROSCI BIOBEHAV R, V14, P233, DOI 10.1016/S0149-7634(05)80223-4; WALLIS J, 1985, INT J PRIMATOL, V6, P335, DOI 10.1007/BF02745505; ZINNER D, 1994, BEHAV ECOL SOCIOBIOL, V35, P175, DOI 10.1007/BF00167957	79	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26144	10.1371/journal.pone.0026144	http://dx.doi.org/10.1371/journal.pone.0026144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022541	Green Published, gold			2022-12-25	WOS:000295976000074
J	Hutchinson, JR; Bates, KT; Molnar, J; Allen, V; Makovicky, PJ				Hutchinson, John R.; Bates, Karl T.; Molnar, Julia; Allen, Vivian; Makovicky, Peter J.			A Computational Analysis of Limb and Body Dimensions in Tyrannosaurus rex with Implications for Locomotion, Ontogeny, and Growth	PLOS ONE			English	Article							MUSCLE MOMENT ARMS; ELITE SPRINTING ATHLETE; BIPEDAL RUNNING ABILITY; FUNCTIONAL SPECIALIZATION; PELVIC LIMB; ALLOMETRIC EQUATIONS; SENSITIVITY-ANALYSIS; INERTIAL PROPERTIES; HINDLIMB MUSCULATURE; POSTNATAL ONTOGENY	The large theropod dinosaur Tyrannosaurus rex underwent remarkable changes during its growth from <10 kg hatchlings to >6000 kg adults in <20 years. These changes raise fascinating questions about the morphological transformations involved, peak growth rates, and scaling of limb muscle sizes as well as the body's centre of mass that could have influenced ontogenetic changes of locomotion in T. rex. Here we address these questions using three-dimensionally scanned computer models of four large, well-preserved fossil specimens as well as a putative juvenile individual. Furthermore we quantify the variations of estimated body mass, centre of mass and segment dimensions, to characterize inaccuracies in our reconstructions. These inaccuracies include not only subjectivity but also incomplete preservation and inconsistent articulations of museum skeletons. Although those problems cause ambiguity, we conclude that adult T. rex had body masses around 6000-8000 kg, with the largest known specimen ("Sue") perhaps similar to 9500 kg. Our results show that during T. rex ontogeny, the torso became longer and heavier whereas the limbs became proportionately shorter and lighter. Our estimates of peak growth rates are about twice as rapid as previous ones but generally support previous methods, despite biases caused by the usage of scale models and equations that underestimate body masses. We tentatively infer that the hindlimb extensor muscles masses, including the large tail muscle M. caudofemoralis longus, may have decreased in their relative size as the centre of mass shifted craniodorsally during T. rex ontogeny. Such ontogenetic changes would have worsened any relative or absolute decline of maximal locomotor performance. Regardless, T. rex probably had hip and thigh muscles relatively larger than any extant animal's. Overall, the limb "antigravity" muscles may have been as large as or even larger than those of ratite birds, which themselves have the most muscular limbs of any living animal.	[Hutchinson, John R.; Molnar, Julia; Allen, Vivian] Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield, Herts, England; [Bates, Karl T.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Makovicky, Peter J.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of London; University of London Royal Veterinary College; University of Liverpool; Field Museum of Natural History (Chicago)	Hutchinson, JR (corresponding author), Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield, Herts, England.	jrhutch@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038; Molnar, Julia/0000-0003-1455-0487	Natural Environment Research Council [NE/G00711X/1]; NERC [NE/G005877/1, NE/G00711X/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005877/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JH and JM were funded by Natural Environment Research Council (www.nerc.ac.uk) grant number NE/G00711X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; Alexander RM., 2003, PRINCIPLES ANIMAL LO; ALEXANDER RMN, 1977, J ZOOL, V183, P125, DOI 10.1111/j.1469-7998.1977.tb04177.x; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], 2009, SKELETAL MUSCLE STRU; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bates KT, 2010, J VERTEBR PALEONTOL, V30, P458, DOI 10.1080/02724630903409329; Bates KT, 2009, PALAEONTOL ELECTRON, V12; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bates KT, 2008, J VERTEBRATE PALEO S, V28; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA., 2003, ANIMAL LOCOMOTION; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Buchner HHF, 1997, J BIOMECH, V30, P653, DOI 10.1016/S0021-9290(97)00005-5; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carlson KJ, 2006, PRIMATES, V47, P218, DOI 10.1007/s10329-005-0166-4; Carpenter K., 1990, P141, DOI 10.1017/CBO9780511608377.013; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; CARRIER DR, 1983, J ZOOL, V201, P27; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; CLARK J, 1975, J ZOOL, V176, P87; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; DODSON P, 1975, J ZOOL, V175, P315; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; FEDAK MA, 1982, J EXP BIOL, V97, P23; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Hand S, 2004, J VERTEBRATE PALEO S, V24; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Henderson MD, 2008, TYRANNOSAURUS REX TY, P83; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; Herzog W., 2000, SKELETAL MUSCLE MECH; HILDEBRAND M, 1985, J MORPHOL, V184, P23, DOI 10.1002/jmor.1051840103; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Hutchinson JR, 2011, ANAT REC, V294, P756, DOI 10.1002/ar.21356; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Irschick DJ, 2000, J EXP BIOL, V203, P2133; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Larson Neal L., 2008, P1; Larson Peter L., 1994, Paleontological Society Special Publication, V7, P139; Larson PL, 1998, DIN INT S 3; Lipkin C, 2007, J PALEONTOL, V81, P1523, DOI 10.1666/06-024.1; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; Molnar R.E., 1990, P71, DOI 10.1017/CBO9780511608377.008; Newman B. H., 1970, Biol. J. Linn. Soc., V2, P119, DOI 10.1111/j.1095-8312.1970.tb01707.x; Osborn HF, 1906, B AM MUS NAT HIST, V22, P281; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Packard GC, 2010, J ZOOL, V282, P221, DOI 10.1111/j.1469-7998.2010.00737.x; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; PAGEL M, 1991, NATURE, V351, P532, DOI 10.1038/351532a0; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 2000, Gaia (Lisboa), V15, P257; Paul Gregory S., 2008, P306; Paxton H, 2010, J ANAT, V217, P153, DOI 10.1111/j.1469-7580.2010.01251.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2004, J ANAT, V206, P557; Persons W, 2009, J VERTEBRATE PALE S3, V29; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Peterson JE, 2009, PALAIOS, V24, P780, DOI 10.2110/palo.2009.p09-056r; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Reilly SA, 2005, J EXP BIOL, V208, P993, DOI 10.1242/jeb.01473; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Ricklefs RE, 2007, BIOL LETTERS, V3, P214, DOI 10.1098/rsbl.2006.0597; Romer AS, 1923, B AM MUS NAT HIST, V48, P605; Rubenson J, 2006, J EXP BIOL, V209, P2395, DOI 10.1242/jeb.02310; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Schauder W., 1924, Zeitschrift Ges Anat Munchen Abt 1, V71, P559, DOI 10.1007/BF02117347; Schoonaert K, 2007, J ANAT, V210, P518, DOI 10.1111/j.1469-7580.2007.00720.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Smith NC, 2010, J EXP BIOL, V213, P1347, DOI 10.1242/jeb.020271; Snively E, 2003, J MORPHOL, V255, P215, DOI 10.1002/jmor.10059; Snively E, 2007, PALEOBIOLOGY, V33, P610, DOI 10.1666/06059.1; Snively Eric, 2002, Senckenbergiana Lethaea, V82, P35; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Verstappen M, 1998, ZOOMORPHOLOGY, V118, P207, DOI 10.1007/s004350050070; Walker A.D., 1977, Linnean Soc Symp Ser, VNo. 4, P319; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Weyand PG, 2005, J EXP BIOL, V208, P2625, DOI 10.1242/jeb.01609; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P472, DOI 10.1111/j.1469-7580.2007.00704.x; Williams SB, 2007, J ANAT, V210, P491, DOI 10.1111/j.1469-7580.2007.00703.x; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077	116	76	80	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26037	10.1371/journal.pone.0026037	http://dx.doi.org/10.1371/journal.pone.0026037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022500	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000058
J	Robles, MTS; Case, A; Chong, JL; Leone, G; Pipas, JM				Robles, Maria Teresa Saenz; Case, Ashley; Chong, Jean-Leon; Leone, Gustavo; Pipas, James M.			The Retinoblastoma Tumor Suppressor Regulates a Xenobiotic Detoxification Pathway	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; LARGE T-ANTIGEN; RB/E2F PATHWAY; RB; CANCER; TUMORIGENESIS; DEFICIENT; ROLES; MOUSE; MICE	The retinoblastoma tumor suppressor (pRb) regulates cell cycle entry, progression and exit by controlling the activity of the E2F-family of transcription factors. During cell cycle exit pRb acts as a transcriptional repressor by associating with E2F proteins and thereby inhibiting their ability to stimulate the expression of genes required for S phase. Indeed, many tumors harbor mutations in the RB gene and the pRb-E2F pathway is compromised in nearly all types of cancers. In this report we show that both pRb and its interacting partners, the transcriptional factors E2F1-2-3, act as positive modulators of detoxification pathways important for metabolizing and clearing xenobiotics-such as toxins and drugs-from the body. Using a combination of conventional molecular biology techniques and microarray analysis of specific cell populations, we have analyzed the detoxification pathway in murine samples in the presence or absence of pRb and/or E2F1-2-3. In this report, we show that both pRb and E2F1-2-3 act as positive modulators of detoxification pathways in mice, challenging the conventional view of E2F1-2-3 as transcriptional repressors negatively regulated by pRb. These results suggest that mutations altering the pRb-E2F axis may have consequences beyond loss of cell cycle control by altering the ability of tissues to remove toxins and to properly metabolize anticancer drugs, and might help to understand the formation and progression rates of different types of cancer, as well as to better design appropriate therapies based on the particular genetic composition of the tumors.	[Robles, Maria Teresa Saenz; Case, Ashley; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Robles, MTS (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	pipas@pitt.edu			NIH [CA098956]; NATIONAL CANCER INSTITUTE [R01CA098956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an NIH grant to J. M. P. (CA098956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; Gu XS, 2010, DRUG METAB REV, V42, P482, DOI 10.3109/03602531003654915; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Markovics JA, 2005, J VIROL, V79, P7492, DOI 10.1128/JVI.79.12.7492-7502.2005; Nassar AF, 2009, DRUG METABOLISM HDB; Nelson David R., 2009, Human Genomics, V4, P59; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Saenz-Robles MT, 2007, ONCOGENE, V26, P5124, DOI 10.1038/sj.onc.1210310; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; Scripture CD, 2005, LANCET ONCOL, V6, P780, DOI 10.1016/S1470-2045(05)70388-0; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26019	10.1371/journal.pone.0026019	http://dx.doi.org/10.1371/journal.pone.0026019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022495	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000055
J	Kawakubo, Y; Suga, M; Tochigi, M; Yumoto, M; Itoh, K; Sasaki, T; Kano, Y; Kasai, K				Kawakubo, Yuki; Suga, Motomu; Tochigi, Mamoru; Yumoto, Masato; Itoh, Kenji; Sasaki, Tsukasa; Kano, Yukiko; Kasai, Kiyoto			Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; TYPE-3 GENE GRM3; SPEECH SOUNDS; AUDITORY MISMATCH; SCHIZOPHRENIA; ASSOCIATION; GLUTAMATE-RECEPTOR-3; POPULATION; MATTER; CORTEX	Background: The genetic and molecular basis of glutamatergic dysfunction is one key to understand schizophrenia, with the identification of an intermediate phenotype being an essential step. Mismatch negativity (MMN) or its magnetic counterpart, magnetic mismatch field (MMF) is an index of preattentive change detection processes in the auditory cortex and is generated through glutamatergic neurotransmission. We have previously shown that MMN/MMF in response to phoneme change is markedly reduced in schizophrenia. Variations in metabotropic glutamate receptor (GRM3) may be associated with schizophrenia, and has been shown to affect cortical function. Here we investigated the effect of GRM3 genotypes on phonetic MMF in healthy men. Methods: MMF in response to phoneme change was recorded using magnetoencephalography in 41 right-handed healthy Japanese men. Based on previous genetic association studies in schizophrenia, 4 candidate SNPs (rs6465084, rs2299225, rs1468412, rs274622) were genotyped. Results: GRM3 rs274622 genotype variations significantly predicted MMF strengths (p = 0.009), with C carriers exhibiting significantly larger MMF strengths in both hemispheres compared to the TT subjects. Conclusions: These results suggest that variations in GRM3 genotype modulate the auditory cortical response to phoneme change in humans. MMN/MMF, particularly those in response to speech sounds, may be a promising and sensitive intermediate phenotype for clarifying glutamatergic dysfunction in schizophrenia.	[Kawakubo, Yuki; Kano, Yukiko] Univ Tokyo, Dept Child Neuropsychiat, Tokyo, Japan; [Suga, Motomu; Tochigi, Mamoru; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Tokyo, Japan; [Yumoto, Masato] Univ Tokyo, Dept Lab Med, Tokyo, Japan; [Itoh, Kenji] Univ Tokyo, Dept Cognit & Speech Sci, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Hlth Serv Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Kawakubo, Y (corresponding author), Univ Tokyo, Dept Child Neuropsychiat, Tokyo, Japan.	yukik-tky@umin.ac.jp		Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Health, Labour, and Welfare [H19-kokoro-ippan-012, H20-kokoro-ippan-001, H20-3]; JSPS/MEXT, Japan [20023009, 21249064]	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS/MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Ministry of Health, Labour, and Welfare (Health and Labour Sciences Research Grants, Research on Psychiatric and Neurological Diseases and Mental Health, H19-kokoro-ippan-012, H20-kokoro-ippan-001, and H20-3 to KK), and from the JSPS/MEXT (No. 20023009 and 21249064 to KK), Japan. A part of this study was also the result of "Development of biomarker candidates for social behavior", carried out under the Strategic Research Program for Brain Sciences by the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JR, 2005, SCHIZOPHR RES, V77, P253, DOI 10.1016/j.schres.2005.04.001; Chen Q, 2005, SCHIZOPHR RES, V73, P21, DOI 10.1016/j.schres.2004.07.002; Corti C, 2007, BIOL PSYCHIAT, V62, P747, DOI 10.1016/j.biopsych.2006.12.005; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kasai K, 2003, SCHIZOPHR RES, V59, P159, DOI 10.1016/S0920-9964(01)00382-6; Kasai K, 2002, AM J PSYCHIAT, V159, P546, DOI 10.1176/appi.ajp.159.4.546; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Marenco S, 2006, AM J PSYCHIAT, V163, P740, DOI 10.1176/appi.ajp.163.4.740; Matsubayashi J, 2008, BRAIN RES, V1236, P159, DOI 10.1016/j.brainres.2008.07.120; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Norton N, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-23; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Takei Y, 2009, PSYCHOPHYSIOLOGY, V46, P52, DOI 10.1111/j.1469-8986.2008.00748.x; Tochigi M, 2006, SCHIZOPHR RES, V88, P260, DOI 10.1016/j.schres.2006.07.008; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Yamasue H, 2004, NEUROIMAGE, V22, P720, DOI 10.1016/j.neuroimage.2004.01.042	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24929	10.1371/journal.pone.0024929	http://dx.doi.org/10.1371/journal.pone.0024929			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022368	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200004
J	Meier, C; Anastasiadou, S; Knoll, B				Meier, Christin; Anastasiadou, Sofia; Knoell, Bernd			Ephrin-A5 Suppresses Neurotrophin Evoked Neuronal Motility, ERK Activation and Gene Expression	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; RECEPTOR TYROSINE KINASE; AXON GUIDANCE; GROWTH CONE; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; HIPPOCAMPAL AXONS; NERVOUS-SYSTEM; CELL REPULSION	During brain development, growth cones respond to attractive and repulsive axon guidance cues. How growth cones integrate guidance instructions is poorly understood. Here, we demonstrate a link between BDNF (brain derived neurotrophic factor), promoting axonal branching and ephrin-A5, mediating axonal repulsion via Eph receptor tyrosine kinase activation. BDNF enhanced growth cone filopodial dynamics and neurite branching of primary neurons. We show that ephrin-A5 antagonized this BDNF-evoked neuronal motility. BDNF increased ERK phosphorylation (P-ERK) and nuclear ERK entry. Ephrin-A5 suppressed BDNF-induced ERK activity and might sequester P-ERK in the cytoplasm. Neurotrophins are well established stimulators of a neuronal immediate early gene (IEG) response. This is confirmed in this study by e.g. c-fos, Egr1 and Arc upregulation upon BDNF application. This BDNF-evoked IEG response required the transcription factor SRF (serum response factor). Notably, ephrin-A5 suppressed a BDNF-evoked neuronal IEG response, suggesting a role of Eph receptors in modulating gene expression. In opposite to IEGs, long-term ephrin-A5 application induced cytoskeletal gene expression of tropomyosin and actinin. To uncover specific Eph receptors mediating ephrin-As impact on neurotrophin signaling, EphA7 deficient mice were analyzed. In EphA7 deficient neurons alterations in growth cone morphology were observed. However, ephrin-A5 still counteracted neurotrophin signaling suggesting that EphA7 is not required for ephrin and BDNF crosstalk. In sum, our data suggest an interaction of ephrin-As and neurotrophin signaling pathways converging at ERK signaling and nuclear gene activity. As ephrins are involved in development and function of many organs, such modulation of receptor tyrosine kinase signaling and gene expression by Ephs might not be limited to the nervous system.	[Meier, Christin; Anastasiadou, Sofia; Knoell, Bernd] Univ Tubingen, Neuronal Gene Express Lab, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany	Eberhard Karls University of Tubingen	Meier, C (corresponding author), Univ Tubingen, Neuronal Gene Express Lab, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany.	bernd.knoell@uni-ulm.de		Meyer zu Reckendorf, Sofia/0000-0001-6978-1915; Meier, Christin/0000-0002-1586-9206	DFG [KN543/2-1, SFB 446 (Tp B19)]; Schram Foundation; Hertie Foundation; Tubingen University	DFG(German Research Foundation (DFG)); Schram Foundation; Hertie Foundation; Tubingen University	B.K. is supported by the DFG through the Emmy Noether Program (KN543/2-1; www.dfg.de) and SFB 446 (Tp B19), the Schram Foundation (www.stifterverband.de), the Hertie Foundation (www.ghst.de), and by Young Investigator Grants of Tubingen University (www.uni-tuebingen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; BI C, 2011, J NEUROPHYSIOL; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Danzer SC, 2002, J NEUROSCI, V22, P9754; Drescher U, 2011, CURR BIOL, V21, pR30, DOI 10.1016/j.cub.2010.11.064; Dudanova I, 2010, CURR BIOL, V20, P2150, DOI 10.1016/j.cub.2010.11.021; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Faulkner RL, 2007, DEV NEUROSCI-BASEL, V29, P6, DOI 10.1159/000096207; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fitzgerald M, 2008, BIOCHEM BIOPH RES CO, V374, P625, DOI 10.1016/j.bbrc.2008.07.110; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Knoll B, 2001, DEVELOPMENT, V128, P895; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Martinez A, 2005, NEUROSCIENCE, V135, P451, DOI 10.1016/j.neuroscience.2005.06.052; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Olschlager V, 2004, ONCOGENE, V23, P6639, DOI 10.1038/sj.onc.1207883; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Poopalasundaram S, 2011, MOL CELL NEUROSCI, V47, P131, DOI 10.1016/j.mcn.2011.03.008; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Tong JF, 2003, J BIOL CHEM, V278, P6111, DOI 10.1074/jbc.M208972200; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yue X, 2008, DEV NEUROBIOL, V68, P1269, DOI 10.1002/dneu.20657; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	66	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26089	10.1371/journal.pone.0026089	http://dx.doi.org/10.1371/journal.pone.0026089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022520	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200033
J	Belgrano, A; Rakicevic, L; Mittempergher, L; Campanaro, S; Martinelli, VC; Mouly, V; Valle, G; Kojic, S; Faulkner, G				Belgrano, Anna; Rakicevic, Ljiljana; Mittempergher, Lorenza; Campanaro, Stefano; Martinelli, Valentina C.; Mouly, Vincent; Valle, Giorgio; Kojic, Snezana; Faulkner, Georgine			Multi-Tasking Role of the Mechanosensing Protein Ankrd2 in the Signaling Network of Striated Muscle	PLOS ONE			English	Article							ANKYRIN-REPEAT PROTEIN; SKELETAL-MUSCLE; NUCLEAR-PROTEIN; GENE-EXPRESSION; TIGHT JUNCTION; PDZ DOMAINS; CELL; BINDING; FAMILY; CARP	Background: Ankrd2 (also known as Arpp) together with Ankrd1/CARP and DARP are members of the MARP mechanosensing proteins that form a complex with titin (N2A)/calpain 3 protease/myopalladin. In muscle, Ankrd2 is located in the I-band of the sarcomere and moves to the nucleus of adjacent myofibers on muscle injury. In myoblasts it is predominantly in the nucleus and on differentiation shifts from the nucleus to the cytoplasm. In agreement with its role as a sensor it interacts both with sarcomeric proteins and transcription factors. Methodology/Principal Findings: Expression profiling of endogenous Ankrd2 silenced in human myotubes was undertaken to elucidate its role as an intermediary in cell signaling pathways. Silencing Ankrd2 expression altered the expression of genes involved in both intercellular communication (cytokine-cytokine receptor interaction, endocytosis, focal adhesion, tight junction, gap junction and regulation of the actin cytoskeleton) and intracellular communication (calcium, insulin, MAPK, p53, TGF-beta and Wnt signaling). The significance of Ankrd2 in cell signaling was strengthened by the fact that we were able to show for the first time that Nkx2.5 and p53 are upstream effectors of the Ankrd2 gene and that Ankrd1/CARP, another MARP member, can modulate the transcriptional ability of MyoD on the Ankrd2 promoter. Another novel finding was the interaction between Ankrd2 and proteins with PDZ and SH3 domains, further supporting its role in signaling. It is noteworthy that we demonstrated that transcription factors PAX6, LHX2, NFIL3 and MECP2, were able to bind both the Ankrd2 protein and its promoter indicating the presence of a regulatory feedback loop mechanism. Conclusions/Significance: In conclusion we demonstrate that Ankrd2 is a potent regulator in muscle cells affecting a multitude of pathways and processes.	[Belgrano, Anna; Martinelli, Valentina C.; Faulkner, Georgine] Int Ctr Genet Engn & Biotechnol, Muscle Mol Biol Grp, I-34012 Trieste, Italy; [Rakicevic, Ljiljana; Kojic, Snezana] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Mittempergher, Lorenza; Campanaro, Stefano; Valle, Giorgio; Faulkner, Georgine] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; [Mouly, Vincent] Univ Paris 06, Inst Myol, UM76, Paris, France	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Belgrade; University of Padua; UDICE-French Research Universities; Sorbonne Universite	Belgrano, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Muscle Mol Biol Grp, Padriciano 99, I-34012 Trieste, Italy.	snezanakojic@imgge.bg.ac.rs; faulkner@cribi.unipd.it	Campanaro, Stefano/I-5657-2019; Kojic, Snezana/AAF-4873-2019	CAMPANARO, STEFANO/0000-0002-9431-1648; Kojic, Snezana/0000-0001-5090-1278; Mittempergher, Lorenza/0000-0003-3425-3965; Mouly, Vincent/0000-0003-3809-4033; VALLE, GIORGIO/0000-0003-4377-5685	Telethon Foundation of Italy [GGP04088, GSP042894B]; Fondazione Cariparo, Italy; ICGEB, Italy [CRP/YUG-05-01]; Ministry of Education and Science of Serbia [173008]	Telethon Foundation of Italy(Fondazione Telethon); Fondazione Cariparo, Italy(Fondazione Cariparo); ICGEB, Italy; Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by grants from the Telethon Foundation of Italy (grant GGP04088 to GF and grant GSP042894B to GV), the Fondazione Cariparo, Italy (Progetto Eccellenza 2010 CHROMUS to GV), the Collaborative Research Programme, ICGEB, Italy (grant CRP/YUG-05-01 to SK) and the Ministry of Education and Science of Serbia (Project No. 173008). (http://www. telethon. it/en, http://www.fondazionecariparo. it/index.php, http://www.mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Band M, 2010, J MOL EVOL, V70, P1, DOI 10.1007/s00239-009-9306-6; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Baumeister A, 1997, J CELL BIOL, V139, P1231, DOI 10.1083/jcb.139.5.1231; Bean C, 2005, J MOL BIOL, V349, P349, DOI 10.1016/j.jmb.2005.03.063; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Cenni V, 2011, MOL BIOL CELL   0707, V7; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Faulkner G, 1999, J BIOL CHEM, V275, P41234; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Galvao TC, 2005, NUCLEIC ACIDS RES, V33, P6603, DOI 10.1093/nar/gki971; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Ishiguro N, 2005, HUM PATHOL, V36, P620, DOI 10.1016/j.humpath.2005.04.014; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Laure L, 2010, FEBS J, V277, P4322, DOI 10.1111/j.1742-4658.2010.07820.x; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meacci E, 2010, CELL MOL LIFE SCI, V67, P4269, DOI 10.1007/s00018-010-0442-3; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Moriyama M, 2001, BIOCHEM BIOPH RES CO, V285, P715, DOI 10.1006/bbrc.2001.5216; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Shimada T, 2004, ANAT REC PART A, V280A, P940, DOI 10.1002/ar.a.20109; Singh S, 2010, AM J PATHOL, V177, P2055, DOI 10.2353/ajpath.2010.091195; Siu PM, 2005, J APPL PHYSIOL, V99, P1897, DOI 10.1152/japplphysiol.00374.2005; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Takebayashi-Suzuki K, 2001, DEV BIOL, V234, P390, DOI 10.1006/dbio.2001.0270; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zou YM, 1997, DEVELOPMENT, V124, P793	72	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25519	10.1371/journal.pone.0025519	http://dx.doi.org/10.1371/journal.pone.0025519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016770	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700012
J	Bergouignan, L; Lefranc, JP; Chupin, M; Morel, N; Spano, JP; Fossati, P				Bergouignan, Loretxu; Lefranc, Jean Pierre; Chupin, Marie; Morel, Nastassja; Spano, Jean Philippe; Fossati, Philippe			Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; TEMPORAL-LOBE EPILEPSY; AUTONOETIC CONSCIOUSNESS; ALZHEIMERS-DISEASE; AUTOMATED SEGMENTATION; DEPRESSION; METAANALYSIS; SURVIVORS; PERSPECTIVE	Background: Neuroimaging studies show the hippocampus is a crucial node in the neural network supporting episodic autobiographical memory retrieval. Stress-related psychiatric disorders, namely Major Depression and Post Traumatic Stress Disorder (PTSD), are related to reduced hippocampus volume. However, this is not the case for remitted breast cancer patients with co-morbid stress-related psychiatric disorders. This exception may be due to the fact that, consequently to the cancer experience as such, this population might already be characterized by a reduced hippocampus with an episodic autobiographical memory deficit. Methodology: We scanned, with a 3T Siemens TRIO, 16 patients who had lived through a "standard experience of breast cancer'' (breast cancer and a standard treatment in remission since 18 month) in the absence of any associated stress-related psychiatric or neurological disorder and 21 matched controls. We then assessed their episodic autobiographical memory retrieval ability. Principal Findings: Remitted breast cancer patients had both a significantly smaller hippocampus and a significant deficit in episodic autobiographical memory retrieval. The hippocampus atrophy was characterized by a smaller posterior hippocampus. The posterior hippocampus volume was intimately related to the ability to retrieve negative memories and to the past experience of breast cancer or not. Conclusions/Significance: These results provide two main findings: (1) we identify a new population with a specific reduction in posterior hippocampus volume that is independent of any psychiatric or neurological pathology; (2) we show the intimate relation of the posterior hippocampus to the ability to retrieve episodic autobiographical memories. These are significant findings as it is the first demonstration that indicates considerable long-term effects of living through the experience of breast cancer and shows very specific hippocampal atrophy with a functional deficit without any presence of psychiatric pathology.	[Bergouignan, Loretxu; Morel, Nastassja; Fossati, Philippe] Hop La Pitie Salpetriere, CNRS, USR 3246, CR ICM, Paris, France; [Bergouignan, Loretxu] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden; [Bergouignan, Loretxu] Hop La Pitie Salpetriere, Ctr NeuroImaging Res, Paris, France; [Lefranc, Jean Pierre] Hop La Pitie Salpetriere, AP HP, Dept Gynecol Surg, Paris, France; [Chupin, Marie] Univ Paris 06, CNRS 7225, Inst Brain & Spinal Cord, INSERM,Ctr Res,UMR S875,U975, Paris, France; [Morel, Nastassja] Caen Basse Normandie Univ, INSERM, UMR S 923, EPHE,INSERM, Caen, France; [Spano, Jean Philippe] Hop La Pitie Salpetriere, AP HP, Dept Med Oncol, Paris, France; [Fossati, Philippe] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Dept Psychiat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bergouignan, L (corresponding author), Hop La Pitie Salpetriere, CNRS, USR 3246, CR ICM, Paris, France.	loretxu@alternatiba.org	Bergouignan, Loretxu/I-6465-2015	Bergouignan, Loretxu/0000-0002-4521-6206	National Institute of Cancer (France); Wenner-Gren Foundation (Sweden); League Against Cancer (France)	National Institute of Cancer (France); Wenner-Gren Foundation (Sweden); League Against Cancer (France)	This work was supported by the National Institute of Cancer (France) and Wenner-Gren Foundation (Sweden) fellowships to LB. This work was also supported by League Against Cancer (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Bergouignan L, 2008, BEHAV RES THER, V46, P322, DOI 10.1016/j.brat.2007.12.007; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; BUKBERG J, 1984, PSYCHOSOM MED, V46, P199, DOI 10.1097/00006842-198405000-00002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Carver CS, 2005, HEALTH PSYCHOL, V24, P508, DOI 10.1037/0278-6133.24.5.508; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Conrad CD, 2007, J NEUROSCI, V27, P8278, DOI 10.1523/JNEUROSCI.2121-07.2007; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236; de Geus EJC, 2007, BIOL PSYCHIAT, V61, P1062, DOI 10.1016/j.biopsych.2006.07.026; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gardiner JM, 2001, PHILOS T R SOC B, V356, P1351, DOI 10.1098/rstb.2001.0955; GERLACH JL, 1972, SCIENCE, V175, P1133, DOI 10.1126/science.175.4026.1133; Hakamata Y, 2007, NEUROSCI RES, V59, P383, DOI 10.1016/j.neures.2007.08.012; Hara E, 2008, J NEUROPSYCH CLIN N, V20, P302, DOI 10.1176/appi.neuropsych.20.3.302; Inagaki M, 2004, AM J PSYCHIAT, V161, P2263, DOI 10.1176/appi.ajp.161.12.2263; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; Libby LK, 2002, J PERS SOC PSYCHOL, V82, P167, DOI 10.1037//0022-3514.82.2.167; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Matsuoka Y, 2003, BIOL PSYCHIAT, V54, P736, DOI 10.1016/S0006-3223(02)01907-8; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Murray CA, 1998, J NEUROSCI, V18, P2974; Nilsson-Ihrfelt E, 2004, J PSYCHOSOM RES, V57, P363, DOI 10.1016/j.jpsychores.2004.01.009; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Schonfeld S, 2007, MEMORY, V15, P339, DOI 10.1080/09658210701256571; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; VINOKUR AD, 1990, CANCER-AM CANCER SOC, V65, P1242, DOI 10.1002/1097-0142(19900301)65:5<1242::AID-CNCR2820650535>3.0.CO;2-1; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144; Yoshikawa E, 2005, BREAST CANCER RES TR, V92, P81, DOI 10.1007/s10549-005-1412-6	54	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25349	10.1371/journal.pone.0025349	http://dx.doi.org/10.1371/journal.pone.0025349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OO	22016764	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700006
J	Jeong, SY; Crooks, DR; Wilson-Ollivierre, H; Ghosh, MC; Sougrat, R; Lee, J; Cooperman, S; Mitchell, JB; Beaumont, C; Rouault, TA				Jeong, Suh Young; Crooks, Daniel R.; Wilson-Ollivierre, Hayden; Ghosh, Manik C.; Sougrat, Rachid; Lee, Jaekwon; Cooperman, Sharon; Mitchell, James B.; Beaumont, Carole; Rouault, Tracey A.			Iron Insufficiency Compromises Motor Neurons and Their Mitochondrial Function in Irp2-Null Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; REGULATORY PROTEIN-2; NEURODEGENERATIVE DISEASE; TRANSFERRIN RECEPTOR; TARGETED DELETION; KNOCKOUT MICE; H-FERRITIN; HOMEOSTASIS; DEFICIENT; TDP-43	Genetic ablation of Iron Regulatory Protein 2 (Irp2, Ireb2), which post-transcriptionally regulates iron metabolism genes, causes a gait disorder in mice that progresses to hind-limb paralysis. Here we have demonstrated that misregulation of iron metabolism from loss of Irp2 causes lower motor neuronal degeneration with significant spinal cord axonopathy. Mitochondria in the lumbar spinal cord showed significantly decreased Complex I and II activities, and abnormal morphology. Lower motor neurons appeared to be the most adversely affected neurons, and we show that functional iron starvation due to misregulation of iron import and storage proteins, including transferrin receptor 1 and ferritin, may have a causal role in disease. We demonstrated that two therapeutic approaches were beneficial for motor neuron survival. First, we activated a homologous protein, IRP1, by oral Tempol treatment and found that axons were partially spared from degeneration. Secondly, we genetically decreased expression of the iron storage protein, ferritin, to diminish functional iron starvation. These data suggest that functional iron deficiency may constitute a previously unrecognized molecular basis for degeneration of motor neurons in mice.	[Jeong, Suh Young; Crooks, Daniel R.; Wilson-Ollivierre, Hayden; Ghosh, Manik C.; Cooperman, Sharon; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, NIH, Bethesda, MD 20892 USA; [Sougrat, Rachid] KAUST, Nanobiol Lab, Thuwal, Saudi Arabia; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Mitchell, James B.] NCI, NIH, Bethesda, MD 20892 USA; [Beaumont, Carole] Univ Paris Diderot, INSERM, U773, Ctr Rech Biomed Bichat Beaujon, Paris, France	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); King Abdullah University of Science & Technology; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jeong, SY (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, NIH, Bethesda, MD 20892 USA.	rouault@mail.nih.gov		Jeong, Suh Young/0000-0002-6376-7001; Sougrat, Rachid/0000-0001-6476-1886	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC006387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural program of Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Blasco H, 2011, J NEUROL SCI, V303, P124, DOI 10.1016/j.jns.2010.12.018; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Danzeisen R, 2006, J BIOL INORG CHEM, V11, P489, DOI 10.1007/s00775-006-0099-4; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; DYCK PJ, 1975, NEUROLOGY, V25, P781, DOI 10.1212/WNL.25.8.781; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kaur D, 2009, BRAIN RES, V1297, P17, DOI 10.1016/j.brainres.2009.08.043; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; ZHELEV Z, 2009, MOL PHARM	42	49	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25404	10.1371/journal.pone.0025404	http://dx.doi.org/10.1371/journal.pone.0025404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003390	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300011
J	Morse, M; Tran, E; Sun, HY; Levenson, R; Fang, Y				Morse, Megan; Tran, Elizabeth; Sun, Haiyan; Levenson, Robert; Fang, Ye			Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target	PLOS ONE			English	Article							DYNAMIC MASS REDISTRIBUTION; 7 TRANSMEMBRANE RECEPTORS; FREE OPTICAL BIOSENSOR; SIGNAL INTEGRATION; MORPHINE-TOLERANCE; ADENYLYL-CYCLASE; AGONIST; KINASE; TRAFFICKING; OPIATE	Development of new opioid drugs that provide analgesia without producing dependence is important for pain treatment. Opioid agonist drugs exert their analgesia effects primarily by acting at the mu opioid receptor (MOR) sites. High-resolution differentiation of opioid ligands is crucial for the development of new lead drug candidates with better tolerance profiles. Here, we use a label-free integrative pharmacology on-target (iPOT) approach to characterize the functional selectivity of a library of known opioid ligands for the MOR. This approach is based on the ability to detect dynamic mass redistribution (DMR) arising from the activation of the MOR in living cells. DMR assays were performed in HEK-MOR cells with and without preconditioning with probe molecules using label-free resonant waveguide grating biosensors, wherein the probe molecules were used to modify the activity of specific signaling proteins downstream the MOR. DMR signals obtained were then translated into high resolution heat maps using similarity analysis based on a numerical matrix of DMR parameters. Our data indicate that the iPOT approach clearly differentiates functional selectivity for distinct MOR signaling pathways among different opioid ligands, thus opening new avenues to discover and quantify the functional selectivity of currently used and novel opioid receptor drugs.	[Morse, Megan; Levenson, Robert] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Tran, Elizabeth; Sun, Haiyan; Fang, Ye] Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Morse, M (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	rlevenson@hmc.psu.edu; fangy2@corning.com		Fang, Ye/0000-0002-1322-7365; Levenson, Robert/0000-0002-0936-8421	Corning Inc.	Corning Inc.	Corning Inc. funded this study through the employment of Elizabeth Tran, Haiyan Sun and Ye Fang, who conceived, designed and performed the experiments, and analyzed the data for this study.	AMICHE M, 1989, MOL PHARMACOL, V35, P774; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; CHANG AC, 1994, J MED CHEM, V37, P1547, DOI 10.1021/jm00037a001; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y, 2005, FEBS LETT, V579, P6365, DOI 10.1016/j.febslet.2005.10.019; Fang Y, 2008, FEBS LETT, V582, P558, DOI 10.1016/j.febslet.2008.01.021; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.05.001; Fang Y, 2010, EXPERT OPIN DRUG DIS, V5, P1237, DOI 10.1517/17460441.2010.533652; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrie AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00033; Fichna J, 2008, BIOORG MED CHEM LETT, V18, P1350, DOI 10.1016/j.bmcl.2008.01.009; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gaveriaux-Ruff C, 2001, J PHARMACOL EXP THER, V298, P1193; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Giraldo J, 2008, BRIT J PHARMACOL, V155, P17, DOI 10.1038/bjp.2008.234; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Goral V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019282; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; JAMES MK, 1991, J PHARMACOL EXP THER, V259, P712; Jiang JX, 2010, P NATL ACAD SCI USA, V107, P2307, DOI 10.1073/pnas.0909310107; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kebig A, 2009, J RECEPT SIG TRANSD, V29, P140, DOI 10.1080/10799890903047437; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Liu AMF, 2005, NEUROSIGNALS, V14, P136, DOI 10.1159/000086296; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minneman K P, 2001, Mol Interv, V1, P108; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Neve Kim A., 2009, P87, DOI 10.1007/978-1-60327-335-0_6; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REISINE T, 1995, NEUROPHARMACOLOGY, V34, P463, DOI 10.1016/0028-3908(95)00025-2; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Stanasila L, 2000, J NEUROCHEM, V75, P1190, DOI 10.1046/j.1471-4159.2000.0751190.x; TAKEMORI AE, 1984, EUR J PHARMACOL, V104, P101, DOI 10.1016/0014-2999(84)90374-1; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; Tran E, 2009, J RECEPT SIG TRANSD, V29, P154, DOI 10.1080/10799890903052544; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WALDENBERG MLG, 2003, CNS DRUG REV, V9, P187; WARD SJ, 1982, J PHARMACOL EXP THER, V220, P494; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; YOUNG AM, 1984, J PHARMACOL EXP THER, V229, P118; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	69	40	41	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25643	10.1371/journal.pone.0025643	http://dx.doi.org/10.1371/journal.pone.0025643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003401	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300022
J	Mosher, RA; Tan, EH; Shin, J; Fischer, RL; Pikaard, CS; Baulcombe, DC				Mosher, Rebecca A.; Tan, Ek Han; Shin, Juhyun; Fischer, Robert L.; Pikaard, Craig S.; Baulcombe, David C.			An Atypical Epigenetic Mechanism Affects Uniparental Expression of Pol IV-Dependent siRNAs	PLOS ONE			English	Article							DIRECTED DNA-METHYLATION; SEED DEVELOPMENT; POLYCOMB GENE; ARABIDOPSIS; MAINTENANCE; CHROMOSOME; ENDOSPERM; DEMETER; METHYLTRANSFERASE; DEMETHYLATION	Background: Small RNAs generated by RNA polymerase IV (Pol IV) are the most abundant class of small RNAs in flowering plants. In Arabidopsis thaliana Pol IV-dependent short interfering (p4-si) RNAs are imprinted and accumulate specifically from maternal chromosomes in the developing seeds. Imprinted expression of protein-coding genes is controlled by differential DNA or histone methylation placed in gametes. To identify epigenetic factors required for maternal-specific expression of p4-siRNAs we analyzed the effect of a series of candidate mutations, including those required for genomic imprinting of protein-coding genes, on uniparental expression of a representative p4-siRNA locus. Results: Paternal alleles of imprinted genes are marked by DNA or histone methylation placed by DNA METHYLTRANSFERASE 1 or the Polycomb Repressive Complex 2. Here we demonstrate that repression of paternal p4-siRNA expression at locus 08002 is not controlled by either of these mechanisms. Similarly, loss of several chromatin modification enzymes, including a histone acetyltransferase, a histone methyltransferase, and two nucleosome remodeling proteins, does not affect maternal expression of locus 08002. Maternal alleles of imprinted genes are hypomethylated by DEMETER DNA glycosylase, yet expression of p4-siRNAs occurs irrespective of demethylation by DEMETER or related glycosylases. Conclusions: Differential DNA methylation and other chromatin modifications associated with epigenetic silencing are not required for maternal-specific expression of p4-siRNAs at locus 08002. These data indicate that there is an as yet unknown epigenetic mechanism causing maternal-specific p4-siRNA expression that is distinct from the well-characterized mechanisms associated with DNA methylation or the Polycomb Repressive Complex 2.	[Mosher, Rebecca A.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Mosher, Rebecca A.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Tan, Ek Han; Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Shin, Juhyun; Fischer, Robert L.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Cambridge; University of Arizona; Indiana University System; Indiana University Bloomington; University of California System; University of California Berkeley	Mosher, RA (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	rmosher@cals.arizona.edu	Mosher, Rebecca/F-4800-2010; Pikaard, Craig S/K-8772-2012; Shin, Juhyun/ABA-5432-2020	Mosher, Rebecca/0000-0003-2195-0825; Pikaard, Craig S/0000-0001-8204-7459; Baulcombe, David/0000-0003-0780-6878; Tan, Ek Han/0000-0001-8872-7404	Gatsby Charitable Foundation; EU [LSHG-CT-2006-037900]; National Science Foundation [OISE 0502199, MCB 0918821]; NIH [R01-GM069415]; Royal Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415, R01GM077590] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; EU(European Commission); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gatsby Charitable Foundation and the EU Sixth Framework Programme Integrated Project SIROCCO (LSHG-CT-2006-037900). RAM was supported in part by a National Science Foundation International Research Fellowship (OISE 0502199); JS was supported by NSF (MCB 0918821) and NIH (R01-GM069415) grants to RLF; DCB was supported as a Royal Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bongiorni S, 2003, GENETICA, V117, P271, DOI 10.1023/A:1022964700446; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; CROUSE HV, 1960, GENETICS, V45, P1429; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Earley KW, 2010, GENE DEV, V24, P1119, DOI 10.1101/gad.1914110; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Garnier O, 2008, EPIGENETICS-US, V3, P14, DOI 10.4161/epi.3.1.5554; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hsieh T-F, 2011, P NATL ACAD SCI US; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lloyd VK, 1999, GENETICS, V151, P1503; Maggert KA, 2002, GENETICS, V162, P1245; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; MARTIN CC, 1995, DEV GENET, V17, P233, DOI 10.1002/dvg.1020170308; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929; Vaillant I, 2006, EMBO REP IN PRESS; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25756	10.1371/journal.pone.0025756	http://dx.doi.org/10.1371/journal.pone.0025756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003406	Green Published, gold			2022-12-25	WOS:000295970300027
J	Kojima, Y; Nakayama, M; Nishina, T; Nakano, H; Koyanagi, M; Takeda, K; Okumura, K; Yagita, H				Kojima, Yuko; Nakayama, Masafumi; Nishina, Takashi; Nakano, Hiroyasu; Koyanagi, Makoto; Takeda, Kazuyoshi; Okumura, Ko; Yagita, Hideo			Importin beta 1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; DECOY RECEPTORS; CANCER-THERAPY; PERMEABILIZATION; APO2L/TRAIL; GLYCOSYLATION; ENDOCYTOSIS; MECHANISMS; RESISTANCE; EXPRESSION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/death receptor 5 (DR5)-mediated cell death plays an important role in the elimination of tumor cells and transformed cells. Recently, recombinant TRAIL and agonistic anti-DR5 monoclonal antibodies have been developed and applied to cancer therapy. However, depending on the type of cancer, the sensitivity to TRAIL has been reportedly different, and some tumor cells are resistant to TRAIL-mediated apoptosis. Using confocal microscopy, we found that large amounts of DR5 were localized in the nucleus in HeLa and HepG2 cells. Moreover, these tumor cells were resistant to TRAIL, whereas DU145 cells, which do not have nuclear DR5, were highly sensitive to TRAIL. By means of immunoprecipitation and Western blot analysis, we found that DR5 and importin beta 1 were physically associated, suggesting that the nuclear DR5 was transported through the nuclear import pathway mediated by importin beta 1. Two functional nuclear localization signals were identified in DR5, the mutation of which abrogated the nuclear localization of DR5 in HeLa cells. Moreover, the nuclear transport of DR5 was also prevented by the knockdown of importin beta 1 using siRNA, resulting in the up-regulation of DR5 expression on the cell surface and an increased sensitivity of HeLa and HepG2 cells to TRAIL. Taken together, our findings suggest that the importin beta 1-mediated nuclear localization of DR5 limits the DR5/TRAIL-induced cell death of human tumor cells and thus can be a novel target to improve cancer therapy with recombinant TRAIL and anti-DR5 antibodies.	[Kojima, Yuko] Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Biomed Imaging Res,Bunkyo Ku, Tokyo 1138421, Japan; [Nakayama, Masafumi; Nishina, Takashi; Nakano, Hiroyasu; Koyanagi, Makoto; Takeda, Kazuyoshi; Okumura, Ko; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Nishina, Takashi; Okumura, Ko] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Nakano, Hiroyasu] Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Mol & Biochem Res,Bunkyo Ku, Tokyo 1138421, Japan; [Nakayama, Masafumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Aoba Ku, Sendai, Miyagi 9805875, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Tohoku University	Kojima, Y (corresponding author), Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Biomed Imaging Res,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kojima-y@juntendo.ac.jp	Nishina, Takashi/AAQ-3942-2021	Nishina, Takashi/0000-0003-2301-9874; Nakayama, Masafumi/0000-0002-9839-7143; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science and Technology, Japan [19590257, 22240089]; Grants-in-Aid for Scientific Research [23659404, 23300355] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 19590257 and 22240089 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Bridgham JT, 2003, CELL DEATH DIFFER, V10, P19, DOI 10.1038/sj.cdd.4401174; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hintersteiner M, 2010, ACS CHEM BIOL, V5, P967, DOI 10.1021/cb100094k; Jazirehi AR, 2001, CLIN CANCER RES, V7, P3874; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kanazawa T, 2008, J CELL PHYSIOL, V215, P517, DOI 10.1002/jcp.21328; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Lanza F, 1997, CYTOMETRY, V30, P134; Leithner K, 2009, LUNG CANCER, V65, P98, DOI 10.1016/j.lungcan.2008.10.015; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; Miyakawa K, 1999, J BIOL CHEM, V274, P29352, DOI 10.1074/jbc.274.41.29352; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Petrocca F, 2011, J CLIN ONCOL, V29, P747, DOI 10.1200/JCO.2009.27.6287; SANDERS SL, 1992, J BIOL CHEM, V267, P13791; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; VONHEIJNE G, 1981, EUR J BIOCHEM, V116, P419; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; West CM, 2002, GLYCOBIOLOGY, V12, p17R, DOI 10.1093/glycob/12.2.17R; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961	44	49	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43383	43393		10.1074/jbc.M111.309377	http://dx.doi.org/10.1074/jbc.M111.309377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020938	hybrid, Green Published			2022-12-25	WOS:000298351300058
J	Wang, F; Song, WS; Brancati, G; Segatori, L				Wang, Fan; Song, Wensi; Brancati, Giovanna; Segatori, Laura			Inhibition of Endoplasmic Reticulum-associated Degradation Rescues Native Folding in Loss of Function Protein Misfolding Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISORDERS; ENZYME REPLACEMENT THERAPY; ER MANNOSIDASE-I; GAUCHER-DISEASE; GLUCOCEREBROSIDASE; RETROTRANSLOCATION; ENHANCEMENT; FIBROBLASTS; CHAPERONES; MUTATION	Lysosomal storage disorders are often caused by mutations that destabilize native folding and impair trafficking of secretory proteins. We demonstrate that endoplasmic reticulum (ER)-associated degradation (ERAD) prevents native folding of mutated lysosomal enzymes in patient-derived fibroblasts from two clinically distinct lysosomal storage disorders, namely Gaucher and Tay-Sachs disease. Prolonging ER retention via ERAD inhibition enhanced folding, trafficking, and activity of these unstable enzyme variants. Furthermore, combining ERAD inhibition with enhancement of the cellular folding capacity via proteostasis modulation resulted in synergistic rescue of mutated enzymes. ERAD inhibition was achieved by cell treatment with small molecules that interfere with recognition (kifunensine) or retrotranslocation (eeyarestatin I) of misfolded substrates. These different mechanisms of ERAD inhibition were shown to enhance ER retention of mutated proteins but were associated with dramatically different levels of ER stress, unfolded protein response activation, and unfolded protein response-induced apoptosis.	[Wang, Fan; Song, Wensi; Brancati, Giovanna; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA	Rice University	Segatori, L (corresponding author), CHBE-MS 362,6100 Main St, Houston, TX 77005 USA.	segatori@rice.edu		Brancati, Giovanna/0000-0002-8589-3463				Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Ishii S, 2007, BIOCHEM J, V406, P285, DOI 10.1042/BJ20070479; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lim-Melia ER, 2009, PEDIATR ANN, V38, P448, DOI 10.3928/00904481-20090723-09; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MICHELAKAKIS H, 1995, J INHERIT METAB DIS, V18, P609, DOI 10.1007/BF02436006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Sidransky E, 2007, MOL GENET METAB, V90, P122, DOI 10.1016/j.ymgme.2006.09.007; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Wang F, 2011, ACS CHEM BIOL, V6, P158, DOI 10.1021/cb100321m; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479	37	70	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43454	43464		10.1074/jbc.M111.274332	http://dx.doi.org/10.1074/jbc.M111.274332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006919	Green Published, hybrid			2022-12-25	WOS:000298351300065
J	Bai, YP; Luo, Y; Liu, SJ; Zhang, LJ; Shen, K; Dong, YS; Walls, CD; Quilliam, LA; Wells, CD; Cao, YJ; Zhang, ZY				Bai, Yunpeng; Luo, Yong; Liu, Sijiu; Zhang, Lujuan; Shen, Kui; Dong, Yuanshu; Walls, Chad D.; Quilliam, Lawrence A.; Wells, Clark D.; Cao, Youjia; Zhang, Zhong-Yin			PRL-1 Protein Promotes ERK1/2 and RhoA Protein Activation through a Non-canonical Interaction with the Src Homology 3 Domain of p115 Rho GTPase-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES; CELL-GROWTH; INVASION; MIGRATION; CANCER; FAMILY; PRENYLATION; PROGRESSION; METASTASIS; MOTILITY	Phosphatases of the regenerating liver (PRL) play oncogenic roles in cancer development and metastasis. Although previous studies indicate that PRL-1 promotes cell growth and migration by activating both the ERK1/2 and RhoA pathways, the mechanism by which it activates these signaling events remains unclear. We have identified a PRL-1-binding peptide (Peptide 1) that shares high sequence identity with a conserved motif in the Src homology 3 (SH3) domain of p115 Rho GTPase-activating protein (GAP). p115 RhoGAP directly binds PRL-1 in vitro and in cells via its SH3 domain. Structural analyses of the PRL-1 . Peptide 1 complex revealed a novel protein-protein interaction whereby a sequence motif within the PxxP ligand-binding site of the p115 RhoGAP SH3 domain occupies a folded groove within PRL-1. This prevents the canonical interaction between the SH3 domain of p115 RhoGAP and MEKK1 and results in activation of ERK1/2. Furthermore, PRL-1 binding activates RhoA signaling by inhibiting the catalytic activity of p115 RhoGAP. The results demonstrate that PRL-1 binding to p115 RhoGAP provides a coordinated mechanism underlying ERK1/2 and RhoA activation.	[Bai, Yunpeng; Luo, Yong; Liu, Sijiu; Zhang, Lujuan; Dong, Yuanshu; Walls, Chad D.; Quilliam, Lawrence A.; Wells, Clark D.; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Shen, Kui] No Illinois Univ, Dept Chem & Biochem, De Kalb, IL 60115 USA; [Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Indiana University System; Indiana University Bloomington; Northern Illinois University; Nankai University	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019; Bai, Yunpeng/M-8396-2014		National Institutes of Health [CA69202, CA126937]; NATIONAL CANCER INSTITUTE [R01CA151765, R01CA126937, R01CA069202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 and CA126937.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Christerson LB, 2002, J CELL PHYSIOL, V192, P200, DOI 10.1002/jcp.10125; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Li XF, 2006, J BIOL CHEM, V281, P28430, DOI 10.1074/jbc.M604135200; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Nakashima Masanao, 2010, J Pharmacol Exp Ther, V334, P627, DOI 10.1124/jpet.110.167809; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quilliam LA, 2001, METHOD ENZYMOL, V333, P187; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tribioli C, 1996, P NATL ACAD SCI USA, V93, P695, DOI 10.1073/pnas.93.2.695; Vogt DL, 2007, MOL CELL NEUROSCI, V36, P332, DOI 10.1016/j.mcn.2007.07.004; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716	33	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42316	42324		10.1074/jbc.M111.286302	http://dx.doi.org/10.1074/jbc.M111.286302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009749	Green Published, hybrid			2022-12-25	WOS:000298180900041
J	Ponnala, S; Veeravalli, KK; Chetty, C; Dinh, DH; Rao, JS				Ponnala, Shivani; Veeravalli, Krishna Kumar; Chetty, Chandramu; Dinh, Dzung H.; Rao, Jasti S.			Regulation of DNA Repair Mechanism in Human Glioma Xenograft Cells both In Vitro and In Vivo in Nude Mice	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PLASMINOGEN-ACTIVATOR RECEPTOR; GROWTH-FACTOR RECEPTOR; DEPENDENT PROTEIN-KINASE; UROKINASE RECEPTOR; IV COLLAGENASE; BRAIN-TUMORS; GENE-EXPRESSION; CATHEPSIN-B; LIPID RAFTS	Background: Glioblastoma Multiforme (GBM) is the most lethal form of brain tumor. Efficient DNA repair and anti-apoptotic mechanisms are making glioma treatment difficult. Proteases such as MMP9, cathepsin B and urokinase plasminogen activator receptor (uPAR) are over expressed in gliomas and contribute to enhanced cancer cell proliferation. Non-homologous end joining (NHEJ) repair mechanism plays a major role in double strand break (DSB) repair in mammalian cells. Methodology/Principal Findings: Here we show that silencing MMP9 in combination with uPAR/cathepsin B effects NHEJ repair machinery. Expression of DNA PKcs and Ku70/80 at both mRNA and protein levels in MMP9-uPAR (pMU) and MMP9-cathepsin B (pMC) shRNA-treated glioma xenograft cells were reduced. FACS analysis showed an increase in apoptotic peak and proliferation assays revealed a significant reduction in the cell population in pMU- and pMC-treated cells compared to untreated cells. We hypothesized that reduced NHEJ repair led to DSBs accumulation in pMU-and pMC-treated cells, thereby initiating cell death. This hypothesis was confirmed by reduced Ku70/Ku80 protein binding to DSB, increased comet tail length and elevated gamma H2AX expression in treated cells compared to control. Immunoprecipitation analysis showed that EGFR-mediated lowered DNA PK activity in treated cells compared to controls. Treatment with pMU and pMC shRNA reduced the expression of DNA PKcs and ATM, and elevated gamma H2AX levels in xenograft implanted nude mice. Glioma cells exposed to hypoxia and irradiation showed DSB accumulation and apoptosis after pMU and pMC treatments compared to respective controls. Conclusion/Significance: Our results suggest that pMU and pMC shRNA reduce glioma proliferation by DSB accumulation and increase apoptosis under normoxia, hypoxia and in combination with irradiation. Considering the radio- and chemo-resistant cancers favored by hypoxia, our study provides important therapeutic potential of MMP9, uPAR and cathepsin B shRNA in the treatment of glioma from clinical stand point.	[Ponnala, Shivani; Veeravalli, Krishna Kumar; Chetty, Chandramu; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Ponnala, S (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu		Veeravalli, Krishna Kumar/0000-0002-2243-004X	National Institute of Neurological Disorders and Stroke (N.I.N.D.S) [NS047699]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (N.I.N.D.S)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from National Institute of Neurological Disorders and Stroke (N.I.N.D.S), NS047699 (to JSR). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; Chetty C, 2010, MOL CANCER THER, V9, P2605, DOI 10.1158/1535-7163.MCT-10-0245; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Gopinath S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011668; GRAU C, 1988, RADIOTHER ONCOL, V13, P301, DOI 10.1016/0167-8140(88)90225-3; HALL EJ, 1994, INT J RADIAT ONCOL, V30, P241, DOI 10.1016/0360-3016(94)90542-8; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; James C. David, 1996, Current Opinion in Oncology, V8, P188; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; LEROMANCER M, 1994, J BIOL CHEM, V269, P17464; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; RAO JS, 1994, J NEURO-ONCOL, V18, P129, DOI 10.1007/BF01050419; RAO JS, 1993, CANCER RES, V53, P2208; REMPEL SA, 1994, CANCER RES, V54, P6027; RODRIGUEZ R, 1994, INT J RADIAT ONCOL, V29, P105, DOI 10.1016/0360-3016(94)90232-1; Rooprai HK, 1998, INT J ONCOL, V13, P1153; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; te Poele RH, 2002, CANCER RES, V62, P1876; TEICHER BA, 1990, CANCER RES, V50, P3339; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tovari J, 1998, CELL SIGNAL, V10, P277, DOI 10.1016/S0898-6568(97)00128-9; Veeravalli KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011583; von Pawel J, 2000, J CLIN ONCOL, V18, P1351, DOI 10.1200/JCO.2000.18.6.1351; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wanner G, 2008, RADIOTHER ONCOL, V86, P383, DOI 10.1016/j.radonc.2007.10.041; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	56	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26191	10.1371/journal.pone.0026191	http://dx.doi.org/10.1371/journal.pone.0026191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022560	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600036
J	Lee, CY; Jeffery, R; Hutchinson, G; Alison, MR; Poulsom, R; Wright, NA; Otto, WR				Lee, Chung-Yin; Jeffery, Rosemary; Hutchinson, Gillian; Alison, Malcolm R.; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.			Bone Marrow Cells in Murine Colitis: Multi-Signal Analysis Confirms Pericryptal Myofibroblast Engraftment without Epithelial Involvement	PLOS ONE			English	Article							MOUSE AGGREGATION CHIMERAS; STEM-CELLS; INTESTINAL EPITHELIUM; HOST-CELLS; FUSION; MICE; TRANSPLANTATION; TISSUE; INFLAMMATION; REGENERATION	Background: The contribution of bone marrow-derived cells to epithelial tissues in the inflamed gut remains controversial. Recent reports have suggested that cell fusion between bone marrow-derived cells and the intestinal epithelium takes place in inflammatory conditions. Methods: In attempts to confirm this, we have undertaken gender mis-matched bone marrow (BM) transplants from male Swiss Webster (SWR) mice to B and T cell-deficient female Rag2 KO mice which, 4 weeks later, were given 5% dextran sodium sulphate in drinking water to induce acute colitis. A further BM-treated group of animals with a graft versus host-like condition was also studied. We developed a new method to combine up to three brightfield or fluorescent lectin-or immuno-histochemical signals with fluorescent in situ hybridisation for the Y and X chromosomes to enable us unequivocally to identify BM-derived male cells which presented as different cell types in the gastrointestinal tract. Principal Findings: In rolled preparations of whole intestines we scanned around 1.5 million crypts at many tissue levels. In no instance did we see a Y chromosome-positive cell in the epithelial compartment, which was not also CD45-positive. We saw no evidence of cell fusion, based on combined X and Y chromosome analysis. Levels of CD45-positive stromal and lymphoid cells and pericryptal myfibroblasts (positive for alpha-smooth muscle actin) increased with time up to a plateau, which resembled the level seen in untreated control grafted animals. We saw very few Y chromosome-positive endothelial cells in intestinal stromal vessels. Conclusions: We conclude that whole BM transplantation does not result in intestinal epithelial engraftment in this model. Our new methods can usefully assist in multi-signal analyses of cell phenotypes following BM transplant and in models of chimaerism and regenerative medicine.	[Lee, Chung-Yin; Jeffery, Rosemary; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.] London Res Inst, Histopathol Lab, Canc Res UK, London, England; [Hutchinson, Gillian] London Res Inst, Biol Resources Unit, Canc Res UK, London, England; [Alison, Malcolm R.; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.] Barts & London Queen Marys Sch Med & Dent, Ctr Digest Dis, Blizard Inst, London, England	Cancer Research UK; Cancer Research UK; University of London; Queen Mary University London	Lee, CY (corresponding author), London Res Inst, Histopathol Lab, Canc Res UK, London, England.	w.r.otto@qmul.ac.uk	Alison, Malcolm/H-6961-2019; Wright, Nicholas/HHY-7227-2022	Wright, Nicholas/0000-0002-5525-3457	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	This work was funded by Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; Brittan M, 2005, GASTROENTEROLOGY, V128, P1984, DOI 10.1053/j.gastro.2005.03.028; Brittan M, 2005, J PATHOL, V205, P1, DOI 10.1002/path.1682; Brittan M, 2002, GUT, V50, P752, DOI 10.1136/gut.50.6.752; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Campbell TD, 2008, ETHNIC DIS, V18, P14; COOPER HS, 1993, LAB INVEST, V69, P238; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Fang BJ, 2003, J HEMATOTH STEM CELL, V12, P603, DOI 10.1089/15258160360732632; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hyun E, 2010, INFLAMM RES, V59, P699, DOI 10.1007/s00011-010-0181-9; Jeffery R, 2006, METH MOLEC MED, V120, P323; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Matsumoto T, 2005, GASTROENTEROLOGY, V128, P1851, DOI 10.1053/j.gastro.2005.03.085; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Naper C, 2010, INT IMMUNOL, V22, P973, DOI 10.1093/intimm/dxq452; Novelli MR, 1999, P NATL ACAD SCI USA, V96, P12553, DOI 10.1073/pnas.96.22.12553; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PONDER BAJ, 1986, HISTOCHEM J, V18, P217, DOI 10.1007/BF01676230; RANA R, 1990, RADIAT RES, V124, P96, DOI 10.2307/3577701; Reca R, 2007, STEM CELLS, V25, P3093, DOI 10.1634/stemcells.2007-0525; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Rosenberg DW, 1995, CANCER LETT, V98, P33, DOI 10.1016/0304-3835(95)03997-B; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SCHMIDT GH, 1985, J EMBRYOL EXP MORPH, V88, P219; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Tolar J, 2006, BLOOD, V107, P4182, DOI 10.1182/blood-2005-08-3289; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Wei YM, 2009, TRANSPLANTATION, V88, P42, DOI 10.1097/TP.0b013e3181a9f0a7; WILSON TJG, 1985, CELL TISSUE KINET, V18, P333, DOI 10.1111/j.1365-2184.1985.tb00662.x; Winton D J, 1992, Epithelial Cell Biol, V1, P59; WINTON DJ, 1989, MUTAGENESIS, V4, P404, DOI 10.1093/mutage/4.5.404; WRIGHT NA, 1984, BIOL EPITHELIAL CELL, P599; YABANA T, 2009, J PATHOL	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26082	10.1371/journal.pone.0026082	http://dx.doi.org/10.1371/journal.pone.0026082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022515	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600039
J	Teng, F; Zhou, YB; Jin, R; Chen, Y; Pei, XY; Liu, YF; Dong, JE; Wang, W; Pang, XW; Qian, XP; Chen, WF; Zhang, Y; Ge, Q				Teng, Fei; Zhou, Yubin; Jin, Rong; Chen, Yu; Pei, Xiaoyan; Liu, Yuanfeng; Dong, Jie; Wang, Wei; Pang, Xuewen; Qian, Xiaoping; Chen, Wei-Feng; Zhang, Yu; Ge, Qing			The Molecular Signature Underlying the Thymic Migration and Maturation of TCR alpha beta(+) CD4(+) CD8(-) Thymocytes	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; POSITIVELY SELECTED THYMOCYTES; MACROPHAGE-DERIVED CHEMOKINE; MEDULLARY EPITHELIAL-CELLS; T-CELLS; NEGATIVE SELECTION; CENTRAL TOLERANCE; GENE-EXPRESSION; LYMPHOKINE SECRETION; LYMPHOCYTE EGRESS	Background: After positive selection, the newly generated single positive (SP) thymocytes migrate to the thymic medulla, where they undergo negative selection to eliminate autoreactive T cells and functional maturation to acquire immune competence and egress capability. Methodology/Principal Findings: To elucidate the genetic program underlying this process, we analyzed changes in gene expression in four subsets of mouse TCR alpha beta(+) CD4(+) CD8-thymocytes (SP1 to SP4) representative of sequential stages in a previously defined differentiation program. A genetic signature of the migration of thymocytes was thus revealed. CCR7 and PlexinD1 are believed to be important for the medullary positioning of SP thymocytes. Intriguingly, their expression remains at low levels in the newly generated thymocytes, suggesting that the cortex-medulla migration may not occur until the SP2 stage. SP2 and SP3 cells gradually up-regulate transcripts involved in T cell functions and the Foxo1-KLF2-S1P(1) axis, but a number of immune function-associated genes are not highly expressed until cells reach the SP4 stage. Consistent with their critical role in thymic emigration, the expression of S1P(1) and CD62L are much enhanced in SP4 cells. Conclusions: These results support at the molecular level that single positive thymocytes undergo a differentiation program and further demonstrate that SP4 is the stage at which thymocytes acquire the immunocompetence and the capability of emigration from the thymus.	[Teng, Fei; Zhou, Yubin; Jin, Rong; Chen, Yu; Pei, Xiaoyan; Liu, Yuanfeng; Dong, Jie; Wang, Wei; Pang, Xuewen; Qian, Xiaoping; Chen, Wei-Feng; Zhang, Yu; Ge, Qing] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China	Peking University	Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China.	zhangyu007@bjmu.edu.cn; qingge@bjmu.edu.cn	Ge, Qing/A-6551-2012; Chen, Wei/GZK-7348-2022		Natural Basic Research Program of China [2010CB945300, 2011CB711000, 2011CB946100]; National Natural Sciences Foundation of China [31070787, 30830091]; Program for New Century Excellent Talents in University [NCET-10-0175/BMU20100005]; Research Fund for the Doctoral Program of Higher Education [20100001110049]; Key Laboratory of Medical Immunology, Ministry of Health	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Key Laboratory of Medical Immunology, Ministry of Health	This work was supported by grants from the Natural Basic Research Program of China (2010CB945300, Dr. Ge, 2011CB711000, Dr. Ge and 2011CB946100, Dr. Zhang), the National Natural Sciences Foundation of China (31070787, Dr. Ge, 30830091, Dr. Zhang), Program for New Century Excellent Talents in University (NCET-10-0175/BMU20100005), the Research Fund for the Doctoral Program of Higher Education (20100001110049), and Key Laboratory of Medical Immunology, Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bosco N, 2009, IMMUNOL CELL BIOL, V87, P50, DOI 10.1038/icb.2008.83; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bunting MD, 2010, IMMUNOL CELL BIOL; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chantry D, 1999, BLOOD, V94, P1890; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Davalos-Misslitz ACM, 2007, BLOOD, V110, P4351, DOI 10.1182/blood-2007-01-070284; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; DeRyckere D, 2003, J IMMUNOL, V171, P802, DOI 10.4049/jimmunol.171.2.802; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gopinathan R, 2001, TRANSPLANTATION, V72, P1533, DOI 10.1097/00007890-200111150-00011; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hoffmann R, 2003, J IMMUNOL, V170, P1339, DOI 10.4049/jimmunol.170.3.1339; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jin R, 2008, J IMMUNOL, V180, P2256, DOI 10.4049/jimmunol.180.4.2256; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; LUCAS B, 1994, J IMMUNOL, V153, P53; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Schmitz I, 2003, INT IMMUNOL, V15, P1237, DOI 10.1093/intimm/dxg125; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Scollay R, 1995, IMMUNOL TODAY; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzuki G, 1999, J IMMUNOL, V162, P5981; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tanzola MB, 2006, MOL IMMUNOL, V43, P754, DOI 10.1016/j.molimm.2005.03.006; Tian CR, 2004, J IMMUNOL, V173, P7217, DOI 10.4049/jimmunol.173.12.7217; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VICARI A, 1994, J IMMUNOL, V152, P2207; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Zachariah Marcus A, 2009, F1000 Biol Rep, V1, P60, DOI 10.3410/B1-60; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	76	21	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25567	10.1371/journal.pone.0025567	http://dx.doi.org/10.1371/journal.pone.0025567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022412	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600022
J	Christopher, DJ; James, P; Daley, P; Armstrong, L; Isaac, BTJ; Thangakunam, B; Premkumar, B; Zwerling, A; Pai, M				Christopher, Devasahayam J.; James, Prince; Daley, Peter; Armstrong, Lois; Isaac, Barney T. J.; Thangakunam, Balamugesh; Premkumar, Beulah; Zwerling, Alice; Pai, Madhukar			High Annual Risk of Tuberculosis Infection among Nursing Students in South India: A Cohort Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GAMMA; ASSAYS; IMMUNODIAGNOSIS; TESTS	Background: Nurses in developing countries are frequently exposed to infectious tuberculosis (TB) patients, and have a high prevalence of TB infection. To estimate the incidence of new TB infection, we recruited a cohort of young nursing trainees at the Christian Medical College in Southern India. Annual tuberculin skin testing (TST) was conducted to assess the annual risk of TB infection (ARTI) in this cohort. Methodology/Principal Findings: 436 nursing students completed baseline two-step TST testing in 2007 and 217 were TST-negative and therefore eligible for repeat testing in 2008. 181 subjects completed a detailed questionnaire on exposure to tuberculosis from workplace and social contacts. A physician verified the questionnaire and clinical log book and screened the subjects for symptoms of active TB. The majority of nursing students (96.7%) were females, almost 84% were under 22 years of age, and 80% had BCG scars. Among those students who underwent repeat testing in 2008, 14 had TST conversions using the ATS/CDC/IDSA conversion definition of 10 mm or greater increase over baseline. The ARTI was therefore estimated as 7.8% (95%CI: 4.3-12.8%). This was significantly higher than the national average ARTI of 1.5%. Sputum collection and caring for pulmonary TB patients were both high risk activities that were associated with TST conversions in this young nursing cohort. Conclusions: Our study showed a high ARTI among young nursing trainees, substantially higher than that seen in the general Indian population. Indian healthcare providers and the Indian Revised National TB Control Programme will need to implement internationally recommended TB infection control interventions to protect its health care workforce.	[Christopher, Devasahayam J.; James, Prince; Armstrong, Lois; Isaac, Barney T. J.; Thangakunam, Balamugesh; Premkumar, Beulah] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Daley, Peter] Mem Univ, St John, NF, Canada; [Zwerling, Alice; Pai, Madhukar] McGill Univ, Montreal, PQ, Canada	Christian Medical College & Hospital (CMCH) Vellore; Memorial University Newfoundland; McGill University	Christopher, DJ (corresponding author), Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Daley, Peter/J-8908-2017; Thangakunam, Balamugesh/H-4931-2019; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Daley, Peter/0000-0001-7068-8056; Thangakunam, Balamugesh/0000-0001-6799-065X; Pai, Madhukar/0000-0003-3667-4536	Canadian Institutes of Health Research (CIHR) [MOP-81362]; European Commission (EU); European and Developing Countries Clinical Trials Partnership [EDCTP]; Fonds de la recherche en sante du Quebec (FRSQ); College of Nursing, CMC, Vellore	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); European and Developing Countries Clinical Trials Partnership [EDCTP]; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); College of Nursing, CMC, Vellore	This study was funded in part by the Canadian Institutes of Health Research (CIHR) operating grants [MOP-81362], European Commission (EU-FP7; TBSusgent grant), and European and Developing Countries Clinical Trials Partnership [EDCTP (TB-NEAT grant)]. MP is a recipient of a CIHR New Investigator award and a Fonds de la recherche en sante du Quebec (FRSQ) establishment grant. AZ is a recipient of a CIHR doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We are grateful to all the student nurses at the Christian Medical College, Vellore, for their participation in our study. We also appreciate the support of College of Nursing, CMC, Vellore.	[Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; CTDTI, 2009, RNTCP STAT REP, P1; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Ling D, 2011, LANCET INFECT DIS; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Organization WH, 2009, WHO POL TB INF CONTR, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2011, NATL MED J INDIA, V24, P198; Raj R, 2011, NATL MED J INDIA, V24, P201; RNTCP I, 2010, GUID AIRB INF CONTR; Swindells JE, 2009, J HOSP INFECT, V73, P101, DOI 10.1016/j.jhin.2009.05.005; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; *WHO, 2010, WHO GLOB TUB CONTR W; Zwerling A, 2011, THORAX; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	25	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26199	10.1371/journal.pone.0026199	http://dx.doi.org/10.1371/journal.pone.0026199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022565	Green Published, Green Accepted, gold			2022-12-25	WOS:000295976000084
J	Niskanen, E; Kononen, M; Maatta, S; Hallikainen, M; Kivipelto, M; Casarotto, S; Massimini, M; Vanninen, R; Mervaala, E; Karhu, J; Soininen, H				Niskanen, Eini; Kononen, Mervi; Maatta, Sara; Hallikainen, Merja; Kivipelto, Miia; Casarotto, Silvia; Massimini, Marcello; Vanninen, Ritva; Mervaala, Esa; Karhu, Jari; Soininen, Hilkka			New Insights into Alzheimer's Disease Progression: A Combined TMS and Structural MRI Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MILD COGNITIVE IMPAIRMENT; CORTICAL THICKNESS ANALYSIS; MOTOR CORTEX EXCITABILITY; AUTOMATED 3-D EXTRACTION; WHITE-MATTER; HUMAN BRAIN; HAND AREA; THRESHOLD; INHIBITION	Background: Combination of structural and functional data of the human brain can provide detailed information of neurodegenerative diseases and the influence of the disease on various local cortical areas. Methodology and Principal Findings: To examine the relationship between structure and function of the brain the cortical thickness based on structural magnetic resonance images and motor cortex excitability assessed with transcranial magnetic stimulation were correlated in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients as well as in age-matched healthy controls. Motor cortex excitability correlated negatively with cortical thickness on the sensorimotor cortex, the precuneus and the cuneus but the strength of the correlation varied between the study groups. On the sensorimotor cortex the correlation was significant only in MCI subjects. On the precuneus and cuneus the correlation was significant both in AD and MCI subjects. In healthy controls the motor cortex excitability did not correlate with the cortical thickness. Conclusions: In healthy subjects the motor cortex excitability is not dependent on the cortical thickness, whereas in neurodegenerative diseases the cortical thinning is related to weaker cortical excitability, especially on the precuneus and cuneus. However, in AD subjects there seems to be a protective mechanism of hyperexcitability on the sensorimotor cortex counteracting the prominent loss of cortical volume since the motor cortex excitability did not correlate with the cortical thickness. Such protective mechanism was not found on the precuneus or cuneus nor in the MCI subjects. Therefore, our results indicate that the progression of the disease proceeds with different dynamics in the structure and function of neuronal circuits from normal conditions via MCI to AD.	[Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Niskanen, Eini; Kononen, Mervi; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Kononen, Mervi; Maatta, Sara; Mervaala, Esa] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland; [Hallikainen, Merja; Kivipelto, Miia; Vanninen, Ritva; Mervaala, Esa; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Casarotto, Silvia; Massimini, Marcello] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy; [Karhu, Jari] Nexstim Ltd, Helsinki, Finland; [Karhu, Jari] Univ Eastern Finland, Dept Physiol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Karolinska Institutet; University of Milan; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Niskanen, E (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	Eini.Niskanen@uef.fi	Kivipelto, Miia/AAS-3557-2021; Casarotto, Silvia/F-1251-2015; Casarotto, Silvia/Q-9402-2019; Massimini, Marcello/T-8115-2017	Casarotto, Silvia/0000-0002-7548-7664; Casarotto, Silvia/0000-0002-7548-7664; Kononen, Mervi/0000-0002-9622-2796; Kivipelto, Miia/0000-0003-0992-3875; Massimini, Marcello/0000-0003-2271-957X	European Union [224328]; Academy of Finland [123579, 121038, 120676]; Kuopio University Hospital EVO [5772709]	European Union(European Commission); Academy of Finland(Academy of Finland); Kuopio University Hospital EVO	This study was partly funded by the European Union 7th Framework Program, PredictAD, from Patient Data to Personalised Healthcare in Alzheimer's Disease (grant agreement no. 224328), Academy of Finland (grants no. 123579, no. 121038 and no. 120676), and Kuopio University Hospital EVO funding (grant no. 5772709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Akgun Y, 2009, SEIZURE-EUR J EPILEP, V18, P387, DOI 10.1016/j.seizure.2009.02.002; Alagona G, 2001, NEUROSCI LETT, V314, P57, DOI 10.1016/S0304-3940(01)02288-1; Alberici A, 2008, ACTA NEUROL SCAND, V118, P275, DOI 10.1111/j.1600-0404.2008.01017.x; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Bedard P, 2009, J NEUROPHYSIOL, V101, P834, DOI 10.1152/jn.90683.2008; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Danner N, 2008, J NEUROSCI METH, V174, P116, DOI 10.1016/j.jneumeth.2008.06.032; Danner N, 2011, SEIZURE-EUR J EPILEP, V20, P65, DOI 10.1016/j.seizure.2010.10.010; deCarvalho M, 1997, J NEUROL, V244, P304, DOI 10.1007/s004150050091; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Ferreri F, 2011, NEUROSCI LETT, V492, P94, DOI 10.1016/j.neulet.2011.01.064; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Haldane M, 2008, J PSYCHOPHARMACOL, V22, P138, DOI 10.1177/0269881107082955; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Julkunen V, 2010, J ALZHEIMERS DIS, V21, P1141, DOI 10.3233/JAD-2010-100114; Julkunen V, 2009, DEMENT GERIATR COGN, V28, P404, DOI 10.1159/000256274; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kimiskidis VK, 2004, NEUROPHYSIOL CLIN, V34, P259, DOI 10.1016/j.neucli.2004.10.002; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morita Y, 2008, ACTA NEUROL SCAND, V118, P159, DOI 10.1111/j.1600-0404.2007.00988.x; Oishi K, 2005, NEUROSCI RES, V52, P37, DOI 10.1016/j.neures.2005.01.008; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; Pennisi G, 2011, ARCH GERONTOL GERIAT, V53, pE111, DOI 10.1016/j.archger.2010.07.004; Pennisi G, 2011, J NEURAL TRANSM, V118, P587, DOI 10.1007/s00702-010-0554-9; Pepin JL, 1999, J NEUROL SCI, V170, P119, DOI 10.1016/S0022-510X(99)00206-3; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; RUOHONEN J, 1999, CLIN NEUROPHYSIOL, V51, P30; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Sakuma K, 2007, CLIN NEUROPHYSIOL, V118, P1460, DOI 10.1016/j.clinph.2007.03.018; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Silbert LC, 2006, CLIN NEUROPHYSIOL, V117, P1029, DOI 10.1016/j.clinph.2006.02.003; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Tian Y, 2008, BIOL PSYCHOL, V79, P171, DOI 10.1016/j.biopsycho.2008.04.006; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	63	34	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26113	10.1371/journal.pone.0026113	http://dx.doi.org/10.1371/journal.pone.0026113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022529	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000069
J	Lau, FH; Deo, RC; Mowrer, G; Caplin, J; Ahfeldt, T; Kaplan, A; Ptaszek, L; Walker, JD; Rosengard, BR; Cowan, CA				Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Caplin, Joshua; Ahfeldt, Tim; Kaplan, Adam; Ptaszek, Leon; Walker, Jennifer D.; Rosengard, Bruce R.; Cowan, Chad A.			Pattern Specification and Immune Response Transcriptional Signatures of Pericardial and Subcutaneous Adipose Tissue	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; RISK-FACTORS; BODY-FAT; ATHEROSCLEROSIS; EXPRESSION; OBESITY; GENES; INTERLEUKIN-6	Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States. Recent studies suggest that pericardial adipose tissue (PCAT) secretes inflammatory factors that contribute to the development of CVD. To better characterize the role of PCAT in the pathogenesis of disease, we performed a large-scale unbiased analysis of the transcriptional differences between PCAT and subcutaneous adipose tissue, analysing 53 microarrays across 19 individuals. As it was unknown whether PCAT-secreted factors are produced by adipocytes or cells in the supporting stromal fraction, we also sought to identify differentially expressed genes in isolated pericardial adipocytes vs. isolated subcutaneous adipocytes. Using microarray analysis, we found that: 1) pericardial adipose tissue and isolated pericardial adipocytes both overexpress atherosclerosis-promoting chemokines and 2) pericardial and subcutaneous fat depots, as well as isolated pericardial adipocytes and subcutaneous adipocytes, express specific patterns of homeobox genes. In contrast, a core set of lipid processing genes showed no significant overlap with differentially expressed transcripts. These depot-specific homeobox signatures and transcriptional profiles strongly suggest different functional roles for the pericardial and subcutaneous adipose depots. Further characterization of these inter-depot differences should be a research priority.	[Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Ahfeldt, Tim; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Ahfeldt, Tim; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ahfeldt, Tim; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Caplin, Joshua; Ptaszek, Leon] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA 02114 USA; [Walker, Jennifer D.; Rosengard, Bruce R.] Massachusetts Gen Hosp, Div Cardiac Surg, Dept Surg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lau, FH (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	ccowan@fas.harvard.edu	Ahfeldt, Tim/E-2935-2017	Ahfeldt, Tim/0000-0001-6377-7376	GlaxoSmithKline; Stowers Institute for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361, R01HL110733] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Stowers Institute for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from GlaxoSmithKline (http://www.gsk.com/) and by the Stowers Institute for Medical Research (http://www.stowers-institute.org/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LEAD CAUS DEATH; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bechara C, 2007, AM J PHYSIOL-HEART C, V293, pH3088, DOI 10.1152/ajpheart.00473.2007; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bosy-Westphal A, 2010, OBESITY, V18, P2111, DOI 10.1038/oby.2010.49; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Chang HY, 2009, SCIENCE, V326, P1206, DOI 10.1126/science.1175686; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Dutour A, 2010, J CLIN ENDOCR METAB, V95, P963, DOI 10.1210/jc.2009-1222; Fisher FM, 2002, HORM METAB RES, V34, P650, DOI 10.1055/s-2002-38246; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Holland PW, BMC BIOL, V5, P47; Iacobellis G, 2009, OBESITY, V17, P625, DOI 10.1038/oby.2008.575; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim TH, 2010, PERICARDIAL FAT AMOU; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Liu JK, 2010, DIABETES CARE, V33, P1635, DOI 10.2337/dc10-0245; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schecter AD, 2000, J BIOL CHEM, V275, P5466, DOI 10.1074/jbc.275.8.5466; STOPECK AT, 1993, J BIOL CHEM, V268, P17489; Tadros TM, 2010, OBESITY, V18, P1039, DOI 10.1038/oby.2009.343; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YU XH, 1992, P NATL ACAD SCI USA, V89, P6953, DOI 10.1073/pnas.89.15.6953; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26092	10.1371/journal.pone.0026092	http://dx.doi.org/10.1371/journal.pone.0026092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022522	Green Submitted, gold, Green Published			2022-12-25	WOS:000295973200034
J	Lee, SH; Lee, ST; Kim, BJ; Park, HK; Kim, CK; Jung, KH; Roh, JK				Lee, Seung-Hoon; Lee, Soon-Tae; Kim, Beom Joon; Park, Hee-Kwon; Kim, Chi-Kyung; Jung, Keun-Hwa; Roh, Jae-Kyu			Dynamic Temporal Change of Cerebral Microbleeds: Long-Term Follow-Up MRI Study	PLOS ONE			English	Article							SERUM TOTAL CHOLESTEROL; RISK-FACTOR; INTRACEREBRAL HEMORRHAGE; BLOOD-PRESSURE; SIGNAL LOSS; STROKE; MORTALITY; LESIONS; PROGRESS; MEN	Background: Cerebral microbleeds (MBs) are understood as an important radiologic marker of intracerebral hemorrhage. We sought to investigate the temporal changes of MBs and clinical factors associated with the changes using long-term follow-up MRI. Methods/Principal Findings: From October 2002 to July 2006, we prospectively enrolled patients with stroke or transient ischemic attack, and followed-up their brain MRIs with an interval >12 mo. We compared demographic factors, vascular risk factors, laboratory findings, and radiologic factors according to the presence or changes of MBs. A total of 224 patients successfully completed the follow-up examinations (mean, 27 months). Newly developed MBs were noted in 10 patients (6.8%) among those without MBs at baseline (n = 148), and in those with MBs at baseline (n = 76), the MB count had decreased in 11 patients (14.5%), and increased in 41 patients (53.9%). The estimated annual rate of change of MB numbers was 0.80 lesions per year in all patients, a value which became greater in those patients who exhibited MBs at baseline (MBs >= 5, 5.43 lesions per year). Strokes due to small vessel occlusion and intracerebral hemorrhage, as well as white matter lesions were independently associated with an increased MB count, whereas the highest quartile of low-density lipoprotein (LDL) cholesterol was associated with a decreased MB count. Conclusion: During the follow-up period, most of MBs showed dynamic temporal change. Symptomatic or asymptomatic small vessel diseases appear to act as risk factors while in contrast, a high level of LDL cholesterol may act as a protective factor against MB increase.	[Lee, Seung-Hoon; Lee, Soon-Tae; Kim, Beom Joon; Kim, Chi-Kyung; Jung, Keun-Hwa; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Seung-Hoon; Kim, Beom Joon; Kim, Chi-Kyung] Seoul Natl Univ Hosp, Clin Res Ctr Stroke, Seoul 110744, South Korea; [Park, Hee-Kwon] Inha Univ Hosp, Dept Neurol, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Inha University; Inha University Hospital	Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	rohjk@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Roh, Jae Kyu/J-5459-2012; Kim, Beom Joon/C-2904-2011; Lee, Soon-Tae/C-4663-2013	Kim, Beom Joon/0000-0002-2719-3012; Lee, Soon-Tae/0000-0003-4767-7564	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0026315]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0026315). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, STROKE; Henneman WJP, 2009, STROKE, V40, P492, DOI 10.1161/STROKEAHA.108.516286; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kim BJ, 2008, J NEUROL, V255, P1176, DOI 10.1007/s00415-008-0864-0; KONISHI M, 1993, STROKE, V24, P954, DOI 10.1161/01.STR.24.7.954; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Lee SH, 2004, NEUROLOGY, V63, P16, DOI 10.1212/01.WNL.0000132525.36804.A1; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Lee SH, 2004, NEUROLOGY, V62, P72, DOI 10.1212/01.WNL.0000101463.50798.0D; Lee SH, 2002, STROKE, V33, P2845, DOI 10.1161/01.STR.0000036092.23649.2E; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Roob G, 2000, CURR OPIN NEUROL, V13, P69, DOI 10.1097/00019052-200002000-00013; Rothwell Peter M, 2005, Cerebrovasc Dis, V20 Suppl 1, P24, DOI 10.1159/000088234; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; UEDA K, 1988, STROKE, V19, P48, DOI 10.1161/01.STR.19.1.48; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wong KS, 2003, NEUROLOGY, V60, P511, DOI 10.1212/01.WNL.0000046583.40125.20; YAMORI Y, 1976, JPN HEART J, V17, P390; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25930	10.1371/journal.pone.0025930	http://dx.doi.org/10.1371/journal.pone.0025930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022473	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200022
J	Mordant, P; Loriot, Y; Lahon, B; Castier, Y; Leseche, G; Soria, JC; Vozenin, MC; Decraene, C; Deutsch, E				Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Castier, Yves; Leseche, Guy; Soria, Jean-Charles; Vozenin, Marie-Catherine; Decraene, Charles; Deutsch, Eric			Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells	PLOS ONE			English	Article							PHASE-III TRIAL; GROWTH-FACTOR RECEPTOR; ATHYMIC NUDE-MICE; PERIPHERAL-BLOOD; METASTATIC MODEL; INHIBITS GROWTH; IMAGING-SYSTEM; PLEURAL CAVITY; BREAST-CANCER; INTACT TISSUE	Background: Preclinical models of non-small cell lung cancer (NSCLC) require better clinical relevance to study disease mechanisms and innovative therapeutics. We sought to compare and refine bioluminescent orthotopic mouse models of human localized NSCLC. Methods: Athymic nude mice underwent subcutaneous injection (group 1-SC, n = 15, control), percutaneous orthotopic injection (group 2-POI, n = 30), surgical orthotopic implantation of subcutaneously grown tumours (group 3-SOI, n = 25), or transpleural orthotopic injection (group 4-TOI, n = 30) of A549-luciferase cells. Bioluminescent in vivo imaging was then performed weekly. Circulating tumour cells (CTCs) were searched using Cellsearch (R) system in SC and TOI models. Results: Group 2-POI was associated with unexpected direct pleural spreading of the cellular solution in 53% of the cases, forbidding further evaluation of any localized lung tumour. Group 3-SOI was characterized by high perioperative mortality, initially localized lung tumours, and local evolution. Group 4-TOI was associated with low perioperative mortality, initially localized lung tumours, loco regional extension, and distant metastasis. CTCs were detected in 83% of nude mice bearing subcutaneous or orthotopic NSCLC tumours. Conclusions: Transpleural orthotopic injection of A549-luc cells in nude mouse lung induces localized tumour, followed by lymphatic extension and specific mortality, and allowed the first time identification of CTCs in a NSCLC mice model.	[Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Vozenin, Marie-Catherine; Deutsch, Eric] INSERM, U1030, Villejuif, France; [Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Soria, Jean-Charles; Vozenin, Marie-Catherine; Deutsch, Eric] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Mordant, Pierre; Castier, Yves; Leseche, Guy] Univ Paris 07, Hop Bichat, AP HP, Paris, France; [Mordant, Pierre; Castier, Yves; Leseche, Guy] Serv Chirurg Thorac, Paris, France; [Loriot, Yohann; Soria, Jean-Charles] SITEP, Dept Med, Villejuif, France; [Decraene, Charles] Inst Curie, Dept Rech Translat, Paris, France; [Decraene, Charles] CNRS, UMR144, Paris, France; [Deutsch, Eric] Dept Radiotherapie, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Mordant, P (corresponding author), INSERM, U1030, Villejuif, France.	eric.deutsch@igr.fr	Soria, Jean-Charles/F-3619-2014; Loriot, Yohann/W-5572-2019; Vozenin, Marie-Catherine/AAR-2268-2021; Mordant, Pierre/J-3603-2017	Vozenin, Marie-Catherine/0000-0002-2109-8073; deutsch, eric/0000-0002-8223-3697	French Society of Thoracic Surgery (SFCTCV); French Medical Research Foundation (FRM); Generation Thorax; French Cancer Research Association; Gustave Roussy Foundation (Fondation Gustave Roussy)	French Society of Thoracic Surgery (SFCTCV); French Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); Generation Thorax; French Cancer Research Association(Fondation ARC pour la Recherche sur le Cancer); Gustave Roussy Foundation (Fondation Gustave Roussy)	PM has been supported by the French Society of Thoracic Surgery (SFCTCV). BL has been supported by the French Medical Research Foundation (FRM) and Generation Thorax. This project has been supported by the French Cancer Research Association (ARC to MCV and ED) and the Gustave Roussy Foundation (Fondation Gustave Roussy to MCV and ED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Boehle AS, 2001, ANN THORAC SURG, V71, P1657, DOI 10.1016/S0003-4975(01)02408-0; Boehle AS, 2001, INT J CANCER, V94, P420, DOI 10.1002/ijc.1471; Buckle T, 2010, LAB ANIM-UK, V44, P40, DOI 10.1258/la.2009.009030; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Dolgin E, 2010, NAT MED, V16, P1348, DOI 10.1038/nm1210-1348; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fujino H, 2003, ONCOL REP, V10, P1709; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kang Y, 2006, CANCER SCI, V97, P996, DOI 10.1111/j.1349-7006.2006.00276.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kraus-Berthier L, 2000, CLIN CANCER RES, V6, P297; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; KUO TH, 1993, ANTICANCER RES, V13, P627; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li DN, 2007, J CLIN INVEST, V117, P346, DOI 10.1172/JCI30446; March TH, 2001, VET PATHOL, V38, P483, DOI 10.1354/vp.38-5-483; Matsumoto S, 2009, LUNG CANCER, V66, P75, DOI 10.1016/j.lungcan.2008.12.010; MCLEMORE TL, 1988, CANCER RES, V48, P2880; MCLEMORE TL, 1987, CANCER RES, V47, P5132; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nagamachi Y, 1998, CANCER LETT, V127, P203, DOI 10.1016/S0304-3835(98)00039-1; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Onn A, 2003, CLIN CANCER RES, V9, P5532; Pantel K, 1999, JNCI-J NATL CANCER I, V91, P1113, DOI 10.1093/jnci/91.13.1113; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pinzani P, 2006, HUM PATHOL, V37, P711, DOI 10.1016/j.humpath.2006.01.026; Pritchard C, 2007, BIOCHEM SOC T, V35, P1329, DOI 10.1042/BST0351329; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; REDDY S, 1987, CANCER RES, V47, P2456; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Soria JC, 2011, ANN ONCOL, V22, P1703, DOI 10.1093/annonc/mdq675; TEICHER BA, 1992, HIGH DOSE CANCER THE, P14; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang HY, 1997, ANN THORAC SURG, V64, P216, DOI 10.1016/S0003-4975(97)00343-3; WANG XE, 1992, ANTICANCER RES, V12, P1403; WANG XE, 1992, ANTICANCER RES, V12, P1399; WANG XO, 1992, INT J CANCER, V51, P992; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wittenburg LA, 2011, CHEM-BIOL INTERACT, V190, P73, DOI 10.1016/j.cbi.2011.01.029; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	63	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26073	10.1371/journal.pone.0026073	http://dx.doi.org/10.1371/journal.pone.0026073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022511	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200029
J	Pan, XQ; Suzuki, N; Hirano, I; Yamazaki, S; Minegishi, N; Yamamoto, M				Pan, Xiaoqing; Suzuki, Norio; Hirano, Ikuo; Yamazaki, Shun; Minegishi, Naoko; Yamamoto, Masayuki			Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; GENE-EXPRESSION; TRANSGENIC MICE; MESSENGER-RNA; RAT-KIDNEY; HYPOXIA; FIBROBLASTS; ENHANCER; HIF-1; HYDROXYLATION	Understanding the nature of renal erythropoietin-producing cells (REPs) remains a central challenge for elucidating the mechanisms involved in hypoxia and/or anemia-induced erythropoietin (Epo) production in adult mammals. Previous studies have shown that REPs are renal peritubular cells, but further details are lacking. Here, we describe an approach to isolate and characterize REPs. We bred mice bearing an Epo gene allele to which green fluorescent protein (GFP) reporter cDNA was knocked-in (Epo(GFP)) with mice bearing an Epo gene allele lacking the 3' enhancer (Epo Delta(3'E)). Mice harboring the mutant Epo(GFP/Delta 3'E) gene exhibited anemia (average Hematocrit 18% at 4 to 6 days after birth), and this perinatal anemia enabled us to identify and purify REPs based on GFP expression from the kidney. Light and confocal microscopy revealed that GFP immunostaining was confined to fibroblastic cells that reside in the peritubular interstitial space, confirming our previous observation in Epo-GFP transgenic reporter assays. Flow cytometry analyses revealed that the GFP fraction constitutes approximately 0.2% of the whole kidney cells and 63% of GFP-positive cells co-express CD73 (a marker for cortical fibroblasts and Epo-expressing cells in the kidney). Quantitative RT-PCR analyses confirmed that Epo expression was increased by approximately 100-fold in the purified population of REPs compared with that of the unsorted cells or CD73-positive fraction. Gene expression analyses showed enrichment of Hif2 alpha and Hif3 alpha mRNA in the purified population of REPs. The genetic approach described here provides a means to isolate a pure population of REPs, allowing the analysis of gene expression of a defined population of cells essential for Epo production in the kidney. This has provided evidence that positive regulation by HIF2 alpha and negative regulation by HIF3 alpha might be necessary for correct renal Epo induction. (282 words)	[Pan, Xiaoqing; Suzuki, Norio; Hirano, Ikuo; Yamazaki, Shun; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Minegishi, Naoko] Miyagi Univ, Sch Nursing, Sendai, Miyagi, Japan	Tohoku University; Miyagi University	Pan, XQ (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan.	masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Norio/F-3456-2010; Suzuki, Norio/AAZ-9458-2021	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Norio/0000-0001-6100-3350; Hirano, Ikuo/0000-0003-2304-3583	Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science; Tohoku University; Global COE for Conquest of Signal Transduction Diseases with Network Medicine; Grants-in-Aid for Scientific Research [10J06108] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science; Tohoku University; Global COE for Conquest of Signal Transduction Diseases with Network Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Creative Scientific Research, Scientific Research on Priority Areas and Scientific Research from the Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science, Tohoku University, Global COE for Conquest of Signal Transduction Diseases with Network Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN S, 1993, J HISTOCHEM CYTOCHEM, V41, P335, DOI 10.1177/41.3.8429197; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; ECKARDT KU, 1993, KIDNEY INT, V43, P815, DOI 10.1038/ki.1993.115; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fisher TS, 2009, BIOCHEM BIOPH RES CO, V388, P683, DOI 10.1016/j.bbrc.2009.08.058; Frede S, 2011, BLOOD, V117, P4905, DOI 10.1182/blood-2010-07-298083; Fried W, 2009, EXP HEMATOL, V37, P1007, DOI 10.1016/j.exphem.2009.05.010; Grenz A, 2007, AM J PHYSIOL-RENAL, V293, pF1501, DOI 10.1152/ajprenal.00243.2007; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; KOURY MJ, 1988, J CLIN INVEST, V82, P154, DOI 10.1172/JCI113564; KOURY ST, 1993, MICROSC RES TECHNIQ, V25, P29, DOI 10.1002/jemt.1070250106; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; MADAN A, 1995, BLOOD, V85, P2735; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Marxer-Meier A, 1998, ANAT EMBRYOL, V197, P143, DOI 10.1007/s004290050126; Maxwell PH, 1997, KIDNEY INT, V51, P393, DOI 10.1038/ki.1997.52; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; MULLER GA, 1995, KIDNEY INT, V48, pS33; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; SUNDELIN B, 1990, ANAT EMBRYOL, V182, P307, DOI 10.1007/BF02433491; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki N, 2007, METHOD ENZYMOL, V435, P157, DOI 10.1016/S0076-6879(07)35009-X; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07	53	72	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25839	10.1371/journal.pone.0025839	http://dx.doi.org/10.1371/journal.pone.0025839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022454	Green Submitted, gold, Green Published			2022-12-25	WOS:000295973200016
J	Muller, J; Stadler, J; Jarzabek-Muller, A; Hacker, H; ter Braak, C; Brandl, R				Mueller, Joerg; Stadler, Jutta; Jarzabek-Mueller, Andrea; Hacker, Hermann; ter Braak, Cajo; Brandl, Roland			The Predictability of Phytophagous Insect Communities: Host Specialists as Habitat Specialists	PLOS ONE			English	Article							ARTHROPOD ASSEMBLAGES; HERBIVOROUS INSECTS; PIERID BUTTERFLIES; SPECIES RICHNESS; BETA-DIVERSITY; NICHE BREADTH; DIET BREADTH; DISPERSAL; CONSERVATION; LEPIDOPTERA	The difficulties specialized phytophagous insects face in finding habitats with an appropriate host should constrain their dispersal. Within the concept of metacommunities, this leads to the prediction that host-plant specialists should sort into local assemblages according to the local environmental conditions, i.e. habitat conditions, whereas assemblages of host-plant generalists should depend also on regional processes. Our study aimed at ranking the importance of local environmental factors and species composition of the vegetation for predicting the species composition of phytophagous moth assemblages with either a narrow or a broad host range. Our database consists of 351,506 specimens representing 820 species of nocturnal Macrolepidoptera sampled between 1980 and 2006 using light traps in 96 strict forest reserves in southern Germany. Species were grouped as specialists or generalists according to the food plants of the larvae; specialists use host plants belonging to one genus. We used predictive canonical correspondence and co-correspondence analyses to rank the importance of local environmental factors, the species composition of the vegetation and the role of host plants for predicting the species composition of host-plant specialists and generalists. The cross-validatory fit for predicting the species composition of phytophagous moths was higher for host-plant specialists than for host-plant generalists using environmental factors as well as the composition of the vegetation. As expected for host-plant specialists, the species composition of the vegetation was a better predictor of the composition of these assemblages than the environmental variables. But surprisingly, this difference for specialized insects was not due to the occurrence of their host plants. Overall, our study supports the idea that owing to evolutionary constraints in finding a host, host-plant specialists and host-plant generalists follow two different models of metacommunities: the species-sorting and the mass-effect model.	[Mueller, Joerg; Jarzabek-Mueller, Andrea] Bavarian Forest Natl Pk, Grafenau, Germany; [Mueller, Joerg] Tech Univ Munich, Chair Terr Ecol, Res Dept Ecol & Ecosyst Management, D-8050 Freising Weihenstephan, Germany; [Stadler, Jutta] UFZ Leipzig Halle Ltd, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Hacker, Hermann] Bavarian State Collect Zool, Munich, Germany; [ter Braak, Cajo] WUR, Wageningen, Netherlands; [Brandl, Roland] Univ Marburg, Dept Ecol, Fac Biol, Marburg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Wageningen University & Research; Philipps University Marburg	Muller, J (corresponding author), Bavarian Forest Natl Pk, Grafenau, Germany.	joerg.mueller@npv-bw.bayern.de	Braak, Cajo J. F. ter/G-7006-2011; Stadler, Jutta/ABC-2494-2021	Braak, Cajo J. F. ter/0000-0002-0414-8745; Muller, Jorg/0000-0002-1409-1586	Bavarian State Institute of Forestry	Bavarian State Institute of Forestry	The study was financially supported by the Bavarian State Institute of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2005, AUSTRAL ECOL, V30, P281, DOI 10.1111/j.1442-9993.2005.01464.x; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Beck J, 2002, J TROP ECOL, V18, P33, DOI 10.1017/S026646740200202X; Bonte D, 2009, P ROYAL SOC B, V270, P1601; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; COURTNEY SP, 1987, OECOLOGIA, V71, P210, DOI 10.1007/BF00377286; COURTNEY SP, 1982, OECOLOGIA, V54, P101, DOI 10.1007/BF00541116; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Ellenberg H., 1991, SCR GEOBOT, DOI DOI 10.1002/FEDR.19931040323; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Franklin J, 2009, DIVERS DISTRIB, V15, P167, DOI 10.1111/j.1472-4642.2008.00536.x; Frenzel M, 2000, GLOBAL ECOL BIOGEOGR, V9, P293, DOI 10.1046/j.1365-2699.2000.00195.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gossner MM, 2011, LANDSCAPE ECOL, V26, P411, DOI 10.1007/s10980-010-9568-9; Guichard F, 2008, J THEOR BIOL, V250, P113, DOI 10.1016/j.jtbi.2007.09.018; Hacker H, BEITRAGE BAYERISCHEN, V1; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2003, THEOR POPUL BIOL, V64, P281, DOI 10.1016/S0040-5809(03)00093-5; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howeth JG, 2010, J ANIM ECOL, V79, P1000, DOI 10.1111/j.1365-2656.2010.01715.x; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Intachat J., 1997, Journal of Tropical Forest Science, V9, P411; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; Keil P, 2005, DIVERS DISTRIB, V11, P417, DOI 10.1111/j.1366-9516.2005.00172.x; Kisdi E, 2002, AM NAT, V159, P579, DOI 10.1086/339989; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Komonen A, 2004, OIKOS, V105, P41, DOI 10.1111/j.0030-1299.2004.12958.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marten A, 2006, MOL ECOL, V15, P2643, DOI 10.1111/j.1365-294X.2006.02940.x; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muller J, 2010, BIOL CONSERV, V143, P625, DOI 10.1016/j.biocon.2009.11.027; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Ostermann OP, 1998, J APPL ECOL, V35, P968, DOI 10.1111/j.1365-2664.1998.tb00016.x; Parvinen K, 2004, THEOR POPUL BIOL, V66, P233, DOI 10.1016/j.tpb.2004.06.002; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Quinn RM, 1998, ECOGRAPHY, V21, P279, DOI 10.1111/j.1600-0587.1998.tb00565.x; Quinn RM, 1997, ECOL ENTOMOL, V22, P197, DOI 10.1046/j.1365-2311.1997.00050.x; Rova E, 2010, J EVOLUTION BIOL, V23, P1657, DOI 10.1111/j.1420-9101.2010.02031.x; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177, DOI 10.1146/annurev.en.31.010186.001141; Schulze CH, 2003, ARTHROPODS OF TROPICAL FORESTS, P69; Segurado P, 2004, J BIOGEOGR, V43, P433; Shreeve T.G., 1992, P120; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SPITZER K, 1988, OIKOS, V53, P31, DOI 10.2307/3565659; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stork N. E., 1997, P551; STRONG DR, 1984, INSECTS PLANTS; Summerville KS, 2008, CAN ENTOMOL, V140, P475, DOI 10.4039/N07-Ls06; Summerville KS, 2002, ECOL APPL, V12, P820, DOI 10.2307/3060992; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	79	17	17	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25986	10.1371/journal.pone.0025986	http://dx.doi.org/10.1371/journal.pone.0025986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016796	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300045
J	Shehadeh, LA; Webster, KA; Hare, JM; Vazquez-Padron, RI				Shehadeh, Lina A.; Webster, Keith A.; Hare, Joshua M.; Vazquez-Padron, Roberto I.			Dynamic Regulation of Vascular Myosin Light Chain (MYL9) with Injury and Aging	PLOS ONE			English	Article							SMOOTH-MUSCLE; ATHEROSCLEROSIS; ARTERY; AGE; PHOSPHORYLATION; DISEASE; AORTA; RELAXATION; ISOFORMS; CELLS	Background: Aging-associated changes in the cardiovascular system increase the risk for disease development and lead to profound alterations in vascular reactivity and stiffness. Elucidating the molecular response of arteries to injury and age will help understand the exaggerated remodeling of aging vessels. Methodology/Principal Findings: We studied the gene expression profile in a model of mechanical vascular injury in the iliac artery of aging (22 months old) and young rats (4 months old). We investigated aging-related variations in gene expression at 30 min, 3 d and 7 d post injury. We found that the Myosin Light Chain gene (MYL9) was the only gene differentially expressed in the aged versus young injured arteries at all time points studied, peaking at day 3 after injury (4.6 fold upregulation (p<0.05) in the smooth muscle cell layers. We confirmed this finding on an aging aortic microarray experiment available through NCBI's GEO database. We found that Myl9 was consistently upregulated with age in healthy rat aortas. To determine the arterial localization of Myl9 with age and injury, we performed immunohistochemistry for Myl9 in rat iliac arteries and found that in healthy and injured (30 days post injury) arteries, Myl9 expression increased with age in the endothelial layers. Conclusions/Significance: The consistent upregulation of the myosin light chain protein (Myl9) with age and injury in arterial tissue draws attention to the increased vascular permeability and to the age-caused predisposition to arterial constriction after balloon angioplasty.	[Shehadeh, Lina A.; Hare, Joshua M.] Univ Miami, Dept Med, Div Cardiol, Leonard M Miller Sch Med, Miami, FL USA; [Shehadeh, Lina A.; Webster, Keith A.; Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Vasc Biol Inst, Miami, FL USA; [Shehadeh, Lina A.; Webster, Keith A.; Hare, Joshua M.; Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL USA; [Webster, Keith A.] Univ Miami, Leonard M Miller Sch Med, Dept Pharmacol, Miami, FL USA; [Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Shehadeh, LA (corresponding author), Univ Miami, Dept Med, Div Cardiol, Leonard M Miller Sch Med, Miami, FL USA.	lshehadeh@med.miami.edu; RVazquez@med.miami.edu		Webster, Keith A/0000-0002-6431-3642	American Heart Association [0930169N, 0535167B]; American Federation for Aging Research [M1001096]; NIH-NHLBI [1K01HL096413-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098511] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Federation for Aging Research; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the American Heart Association (Scientist Development Grant 0930169N) and American Federation for Aging Research (M1001096) to LAS; and by the American Heart Association (Scientist Development Award 0535167B) and NIH-NHLBI [1K01HL096413-01] to RIVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHOUR TT, 1990, CLIN CARDIOL, V13, P267, DOI 10.1002/clc.4960130407; BELMIN J, 1993, AM J PHYSIOL, V264, pH679, DOI 10.1152/ajpheart.1993.264.3.H679; Gabeler Edward E E, 2002, BMC Cardiovasc Disord, V2, P16, DOI 10.1186/1471-2261-2-16; HASEGAWA Y, 1992, J BIOCHEM-TOKYO, V111, P804, DOI 10.1093/oxfordjournals.jbchem.a123840; HATAKE K, 1990, STROKE, V21, P1039, DOI 10.1161/01.STR.21.7.1039; KRENDEL M, 2005, MYOSINS TAILS HEADS, P239; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Levy B. I., 2001, DIALOG CARDIOVASC ME, V6, P104; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Loukianov E, 1997, COMP BIOCHEM PHYS B, V117, P13, DOI 10.1016/S0305-0491(96)00309-4; Luo HA, 1996, ARTERIOSCL THROM VAS, V16, P1393, DOI 10.1161/01.ATV.16.11.1393; Miller SJ, 2007, AM J PHYSIOL-HEART C, V293, pH2634, DOI 10.1152/ajpheart.00397.2007; MIZUNO K, 1992, NEW ENGL J MED, V326, P287, DOI 10.1056/NEJM199201303260502; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; Steinberg D, 1997, ATHEROSCLEROSIS, V131, pS5, DOI 10.1016/S0021-9150(97)06115-7; STEMERMAN MB, 1982, P NATL ACAD SCI-BIOL, V79, P3863, DOI 10.1073/pnas.79.12.3863; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TOKUNAGA O, 1989, AM J PATHOL, V135, P967; Torella D, 2004, AM J PHYSIOL-HEART C, V287, pH2850, DOI 10.1152/ajpheart.01119.2003; Vazquez-Padron RI, 2004, J VASC SURG, V40, P1199, DOI 10.1016/j.jvs.2004.08.034; WEINGAND KW, 1986, ATHEROSCLEROSIS, V62, P137, DOI 10.1016/0021-9150(86)90059-6; WONG MKK, 1990, ARTERIOSCLEROSIS, V10, P76, DOI 10.1161/01.ATV.10.1.76; WYSOLMERSKI RB, 1991, AM J PHYSIOL, V261, pC32, DOI 10.1152/ajpcell.1991.261.1.C32; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	29	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25855	10.1371/journal.pone.0025855	http://dx.doi.org/10.1371/journal.pone.0025855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003410	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300032
J	Wehling-Henricks, M; Tidball, JG				Wehling-Henricks, Michelle; Tidball, James G.			Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane	PLOS ONE			English	Article							DEFICIENT SKELETAL-MUSCLE; HYDROXY-L-ARGININE; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; RESIDENT MACROPHAGES; LIFE-SPAN; MDX; EXPRESSION; UTROPHIN; TRANSGENE	Survival of dystrophin/utrophin double-knockout (dko) mice was increased by muscle-specific expression of a neuronal nitric oxide synthase (nNOS) transgene. Dko mice expressing the transgene (nNOS TG+/dko) experienced delayed onset of mortality and increased life-span. The nNOS TG+/dko mice demonstrated a significant decrease in the concentration of CD163+, M2c macrophages that can express arginase and promote fibrosis. The decrease in M2c macrophages was associated with a significant reduction in fibrosis of heart, diaphragm and hindlimb muscles of nNOS TG+/dko mice. The nNOS transgene had no effect on the concentration of cytolytic, CD68+, M1 macrophages. Accordingly, we did not observe any change in the extent of muscle fiber lysis in the nNOS TG+/dko mice. These findings show that nNOS/NO (nitric oxide)mediated decreases in M2c macrophages lead to a reduction in the muscle fibrosis that is associated with increased mortality in mice lacking dystrophin and utrophin. Interestingly, the dramatic and beneficial effects of the nNOS transgene were not attributable to localization of nNOS protein at the cell membrane. We did not detect any nNOS protein at the sarcolemma in nNOS TG+/dko muscles. This important observation shows that sarcolemmal localization is not necessary for nNOS to have beneficial effects in dystrophic tissue and the presence of nNOS in the cytosol of dystrophic muscle fibers can ameliorate the pathology and most importantly, significantly increase life-span.	[Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wehling-Henricks, M (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	jtidball@physci.ucla.edu	Tidball, James/H-7970-2012	Tidball, James/0000-0003-1202-8038	Muscular Dystrophy Association [3068, 157881, 4006]; National Institutes of Health [RO1 AR40343, RO1 AR47721]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047721, R01AR040343] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (3068 and 157881 to JGT; 4006 to Dr. Wehling-Henricks) and the National Institutes of Health (RO1 AR40343, RO1 AR47721 to Dr. Tidball). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deng B, 2009, J PHYSIOL-LONDON, V587, P1769, DOI 10.1113/jphysiol.2008.166256; EMERY AEH, 1993, GENETICS DUCHENNE MU; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HECKER M, 1995, P NATL ACAD SCI USA, V92, P4671, DOI 10.1073/pnas.92.10.4671; Heydemann A, 2004, J MOL CELL CARDIOL, V36, P213, DOI 10.1016/j.yjmcc.2003.09.020; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HONDA H, 1990, IMMUNOLOGY, V70, P272; Hrabak A, 1996, FEBS LETT, V390, P203, DOI 10.1016/0014-5793(96)00659-X; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kawano R, 2008, MOL THER, V16, P825, DOI 10.1038/mt.2008.23; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; McLennan IS, 1996, J ANAT, V188, P17; MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586; MENDELL JR, 1995, J CHILD NEUROL, V10, P150, DOI 10.1177/088307389501000219; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; MIYOSHI K, 1991, BRIT HEART J, V66, P452; Moriuchi T, 1993, Tokushima J Exp Med, V40, P83; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; SAKELLARIOU GK, 2011, AGING CELL, DOI DOI 10.1111/J.1474-9726.2011.00709.X/ABSTRACT; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290, DOI 10.1152/jappl.1994.77.1.290; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Thomazzi SM, 2001, BIOCHEM PHARMACOL, V62, P1417, DOI 10.1016/S0006-2952(01)00782-1; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Toussaint M, 2007, Chron Respir Dis, V4, P167, DOI 10.1177/1479972307080697; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Warner LE, 2002, HUM MOL GENET, V11, P1095, DOI 10.1093/hmg/11.9.1095; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wehling-Henricks M, 2008, HUM MOL GENET, V17, P2280, DOI 10.1093/hmg/ddn129; Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763; Wehling-Henricks M, 2009, HUM MOL GENET, V18, P3439, DOI 10.1093/hmg/ddp288; Wink DA, 1995, TOXICOL LETT, V82-3, P221, DOI 10.1016/0378-4274(95)03557-5; Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x; Witte MB, 2003, J GASTROINTEST SURG, V7, P378, DOI 10.1016/S1091-255X(02)00431-6; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	76	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25071	10.1371/journal.pone.0025071	http://dx.doi.org/10.1371/journal.pone.0025071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003386	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300007
J	Jun, HJ; Acquaviva, J; Chi, D; Lessard, J; Zhu, H; Woolfenden, S; Bronson, RT; Pfannl, R; White, F; Housman, DE; Iyer, L; Whittaker, CA; Boskovitz, A; Raval, A; Charest, A				Jun, H. J.; Acquaviva, J.; Chi, D.; Lessard, J.; Zhu, H.; Woolfenden, S.; Bronson, R. T.; Pfannl, R.; White, F.; Housman, D. E.; Iyer, L.; Whittaker, C. A.; Boskovitz, A.; Raval, A.; Charest, A.			Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme	ONCOGENE			English	Article						glioblastoma; genetically engineered mouse model; EGFR; PTEN; c-MET	GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; FACTOR-ALPHA CDNA; HUMAN GLIOMAS; KINASE INHIBITORS; TGF-ALPHA; IN-VIVO; NUCLEAR TRANSLOCATION; LENTIVIRAL VECTORS; MALIGNANT GLIOMAS	Glioblastoma multiforme (GBM) is an aggressive brain tumor for which there is no cure. Overexpression of wild-type epidermal growth factor receptor (EGFR) and loss of the tumor suppressor genes Ink4a/Arf and PTEN are salient features of this deadly cancer. Surprisingly, targeted inhibition of EGFR has been clinically disappointing, demonstrating an innate ability for GBM to develop resistance. Efforts at modeling GBM in mice using wild-type EGFR have proven unsuccessful to date, hampering endeavors at understanding molecular mechanisms of therapeutic resistance. Here, we describe a unique genetically engineered mouse model of EGFR-driven gliomagenesis that uses a somatic conditional overexpression and chronic activation of wild-type EGFR in cooperation with deletions in the Ink4a/Arf and PTEN genes in adult brains. Using this model, we establish that chronic activation of wild-type EGFR with a ligand is necessary for generating tumors with histopathological and molecular characteristics of GBMs. We show that these GBMs are resistant to EGFR kinase inhibition and we define this resistance molecularly. Inhibition of EGFR kinase activity using tyrosine kinase inhibitors in GBM tumor cells generates a cytostatic response characterized by a cell cycle arrest, which is accompanied by a substantial change in global gene expression levels. We demonstrate that an important component of this pattern is the transcriptional activation of the MET receptor tyrosine kinase and that pharmacological inhibition of MET overcomes the resistance to EGFR inhibition in these cells. These findings provide important new insights into mechanisms of resistance to EGFR inhibition and suggest that inhibition of multiple targets will be necessary to provide therapeutic benefit for GBM patients. Oncogene (2012) 31, 3039-3050; doi: 10.1038/onc.2011.474; published online 24 October 2011	[Jun, H. J.; Acquaviva, J.; Chi, D.; Lessard, J.; Zhu, H.; Woolfenden, S.; Charest, A.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Bronson, R. T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pfannl, R.; Boskovitz, A.; Raval, A.; Charest, A.] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA; [White, F.; Housman, D. E.; Whittaker, C. A.; Charest, A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [White, F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Housman, D. E.; Charest, A.] MIT, Dept Biol, Cambridge, MA USA; [Iyer, L.] Tufts Univ, Sch Med, Tufts Ctr Neurosci Res, Boston, MA 02111 USA	Tufts Medical Center; Harvard University; Harvard Medical School; Tufts University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University	Charest, A (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St,Box 5609, Boston, MA 02111 USA.	alain.charest@tufts.edu		Whittaker, Charles/0000-0002-2400-0094; Iyer, Lakshmanan/0000-0001-9167-6396; White, Forest/0000-0002-1545-1651	NIH Grant [NCI U01 CA141556, U54 CA119349]; American Cancer Society Research Scholar Award [117409]; NINDS [P30 NS047243]; NCI [T32 CA009429]; NATIONAL CANCER INSTITUTE [T32CA009429, U54CA119349, U01CA141556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Award(American Cancer Society); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs Bill Chiu and Ken Hung for helpful comments and Dr Robert R Langley (MD Anderson Cancer Center, Houston, TX, USA) for human TGF alpha cDNA. Dr Jason Coleman (MIT, Cambridge, MA, USA) for the pTyf vector and iCre cDNA. Dr John Alberta (DFCI, Boston, MA, USA) for the Olig2 antibody. This work was supported by NIH Grant NCI U01 CA141556 (AC and FW), American Cancer Society Research Scholar Award 117409 (AC), NIH Grant U54 CA119349 (DH and AC), NINDS P30 NS047243 (LI) and NCI T32 CA009429 (DC).	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Cheng J, 2002, CANCER RES, V62, P4157; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CIARDIELLO F, 1990, CELL GROWTH DIFFER, V1, P407; Coleman JE, 2003, PHYSIOL GENOMICS, V12, P221, DOI 10.1152/physiolgenomics.00135.2002; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIMARCO E, 1990, NAT IMMUN CELL GROW, V9, P209; DIMARCO E, 1989, ONCOGENE, V4, P831; Ding H, 2003, CANCER RES, V63, P1106; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Friedman HS, 2005, NEW ENGL J MED, V353, P1997, DOI 10.1056/NEJMp058186; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Huang PH, 2007, CELL CYCLE, V6, P2750, DOI 10.4161/cc.6.22.4922; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liang HY, 2004, INT J ONCOL, V24, P1057; Ling YH, 2007, MOL PHARMACOL, V72, P248, DOI 10.1124/mol.107.034827; MARUNO M, 1991, J NEUROSURG, V75, P97, DOI 10.3171/jns.1991.75.1.0097; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mellinghoff IK, 2007, CLIN CANCER RES, V13, P378, DOI 10.1158/1078-0432.CCR-06-1992; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; Mueller Kelly L, 2010, J Mol Signal, V5, P8, DOI 10.1186/1750-2187-5-8; Peng D, 1996, CANCER RES, V56, P3666; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SAMUELS V, 1989, AM J PATHOL, V134, P895; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; SCHLEGEL U, 1990, ONCOGENE, V5, P1839; Seol DW, 1998, BBA-GENE STRUCT EXPR, V1395, P252, DOI 10.1016/S0167-4781(97)00202-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHANKAR V, 1989, MOL CARCINOGEN, V2, P1, DOI 10.1002/mc.2940020102; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WATANABE S, 1987, P NATL ACAD SCI USA, V84, P1258, DOI 10.1073/pnas.84.5.1258; Woolfenden S, 2009, GENESIS, V47, P659, DOI 10.1002/dvg.20545; YUNG WKA, 1990, CANCER COMMUN, V2, P201, DOI 10.3727/095535490820874416; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	55	60	62	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	25					3039	3050		10.1038/onc.2011.474	http://dx.doi.org/10.1038/onc.2011.474			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22020333	Bronze, Green Submitted, Green Accepted			2022-12-25	WOS:000305705900003
J	Liao, YC; Ruan, JW; Lua, I; Li, MH; Chen, WL; Wang, JRY; Kao, RH; Chen, JH				Liao, Y. C.; Ruan, J. W.; Lua, I.; Li, M. H.; Chen, W. L.; Wang, J. R. Y.; Kao, R. H.; Chen, J. H.			Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling	ONCOGENE			English	Article						hPTTG1; GEF-H1; RhoA; tumour metastasis; cytoskeleton regulation	TUMOR-TRANSFORMING GENE; TRANSCRIPTIONAL ACTIVATION FUNCTION; SISTER-CHROMATID SEPARATION; NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; HUMAN SECURIN; ACTIN CYTOSKELETON; BINDING-FACTOR; PTTG; EXPRESSION	Human pituitary tumour-transforming gene 1 (hPTTG1) is an oncogenic transcription factor that is overexpressed in many tumour types, especially tumours with metastatic abilities. However, how hPTTG1 overexpression drives metastasis is not yet clear. As a transcription factor, hPTTG1 may promote metastasis by activating target genes that are involved in the metastatic process. Here, we showed that Rho guanine nucleotide exchange factor-H1 (GEF-H1) was transcriptionally activated by hPTTG1, thereby promoting breast cancer metastasis. Luciferase reporter analyses and chromatin immunoprecipitation (ChIP) assays showed that hPTTG1 directly bound and activated the GEF-H1 gene promoter. In this study, RNA interference-mediated knockdown of hPTTG1 in highly metastatic breast tumour cells decreased GEF-H1 expression and RhoA activation, thereby reducing cell motility and invasion, and interfering with cytoskeletal remodelling in vitro, and impairing the tumour metastasis in vivo. The restoration of GEF-H1 expression in hPTTG1-knockdown cells rescued the hPTTG1-knockdown effects on cytoskeletal changes in vitro and tumour metastasis in vivo. Conversely, ectopic expression of hPTTG1 in non-metastatic breast tumour cells induced cytoskeletal rearrangements, and allowed these cells to metastasise in a mouse model by orthotopic implantation. In human tumour samples, hPTTG1 expression was also correlated to GEF-H1 expression in aggressive breast carcinoma. Altogether, these findings definitively establish a role for hPTTG1 in activating the GEF-H1/RhoA pathway as a newly identified mechanism in breast cancer metastasis. Oncogene (2012) 31, 3086-3097; doi: 10.1038/onc.2011.476; published online 17 October 2011	[Lua, I.; Chen, J. H.] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien 97004, Hualien County, Taiwan; [Liao, Y. C.; Ruan, J. W.; Chen, J. H.] Tzu Chi Univ, Inst Med Sci, Hualien 97004, Hualien County, Taiwan; [Li, M. H.] Buddhist Tzu Chi Gen Hosp, Dept Pathol, Hualien, Taiwan; [Chen, W. L.] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Wang, J. R. Y.; Kao, R. H.] Buddhist Tzu Chi Gen Hosp, Dept Hematol Oncol, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; National Defense Medical Center; Buddhist Tzu Chi General Hospital	Chen, JH (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Rm D416,701,Sec 3,Zhongyang Rd, Hualien 97004, Hualien County, Taiwan.	noli401029@gmail.com	Ruan, Jhen-Wei/N-2624-2017; Ruan, Jhen-Wei/G-6647-2014	Ruan, Jhen-Wei/0000-0002-0636-1937; 	National Science Council of Taiwan [NSC96-2320-B-320-013-MY3]; National Health Research Institutes of Taiwan [NHRI-EX99-9928BI]; Tzu-Chi Foundation	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Tzu-Chi Foundation	Ms Lily Chen, Ms Vicky Chang and Ms Shi-Rong Lin provided expert technical assistance. We thank Dr Lu-Hai Wang's suggestions during the preparation of this manuscript. This study was supported by grants from the National Science Council of Taiwan (NSC96-2320-B-320-013-MY3), the National Health Research Institutes of Taiwan (NHRI-EX99-9928BI) and also partially by the Tzu-Chi Foundation.	Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2010, MOL CELL ENDOCRINOL, V326, P55, DOI 10.1016/j.mce.2010.02.012; Chien WW, 2000, J BIOL CHEM, V275, P19422, DOI 10.1074/jbc.M910105199; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; del Peso L, 1997, ONCOGENE, V15, P3047; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Ito T, 2008, CANCER RES, V68, P3214, DOI 10.1158/0008-5472.CAN-07-3043; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Libermann TA, 2006, CURR GENE THER, V6, P17, DOI 10.2174/156652306775515501; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Ridley AJ, 2001, J CELL SCI, V114, P2713; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Smith VE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001699; Solbach C, 2004, BREAST, V13, P80, DOI 10.1016/j.breast.2003.09.008; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang ZY, 2000, J BIOL CHEM, V275, P7459, DOI 10.1074/jbc.275.11.7459; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wittmann T, 2001, J CELL SCI, V114, P3795; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	46	50	52	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	25					3086	3097		10.1038/onc.2011.476	http://dx.doi.org/10.1038/onc.2011.476			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22002306	Green Published, hybrid			2022-12-25	WOS:000305705900007
J	Jeong, BR; Lin, Y; Joe, A; Guo, M; Korneli, C; Yang, HR; Wang, P; Yu, M; Cerny, RL; Staiger, D; Alfano, JR; Xu, YH				Jeong, Byeong-ryool; Lin, Yan; Joe, Anna; Guo, Ming; Korneli, Christin; Yang, Huirong; Wang, Ping; Yu, Min; Cerny, Ronald L.; Staiger, Dorothee; Alfano, James R.; Xu, Yanhui			Structure Function Analysis of an ADP-ribosyltransferase Type III Effector and Its RNA-binding Target in Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; SECRETION SYSTEM; INNATE IMMUNITY; RIBOSYLATING TOXINS; BACTERIAL EFFECTORS; RECOGNITION MOTIF; CRYSTAL-STRUCTURE; PROTEIN ATGRP7; VIRULENCE; DISCOVERY	The Pseudomonas syringae type III effector HopU1 is a mono-ADP-ribosyltransferase that is injected into plant cells by the type III protein secretion system. Inside the plant cell it suppresses immunity by modifying RNA-binding proteins including the glycine-rich RNA-binding protein GRP7. The crystal structure of HopU1 at 2.7-angstrom resolution reveals two unique protruding loops, L1 and L4, not found in other mono-ADP-ribosyltransferases. Site-directed mutagenesis demonstrates that these loops are essential for substrate recognition and enzymatic activity. HopU1 ADP-ribosylates the conserved arginine 49 of GRP7, and this reduces the ability of GRP7 to bind RNA in vitro. In vivo, expression of GRP7 with Arg-49 replaced with lysine does not complement the reduced immune responses of the Arabidopsis thaliana grp7-1 mutant demonstrating the importance of this residue for GRP7 function. These data provide mechanistic details how HopU1 recognizes this novel type of substrate and highlights the role of GRP7 in plant immunity.	[Jeong, Byeong-ryool; Joe, Anna; Guo, Ming; Alfano, James R.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Jeong, Byeong-ryool; Guo, Ming; Alfano, James R.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; [Lin, Yan; Yang, Huirong; Wang, Ping; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lin, Yan; Yang, Huirong; Wang, Ping; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Lin, Yan; Yu, Min; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Joe, Anna] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Korneli, Christin; Staiger, Dorothee] Univ Bielefeld, Dept Mol Cell Physiol, D-33501 Bielefeld, Germany; [Cerny, Ronald L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Fudan University; Fudan University; Fudan University; University of Nebraska System; University of Nebraska Lincoln; University of Bielefeld; University of Nebraska System; University of Nebraska Lincoln	Alfano, JR (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	jalfano2@unl.edu; xuyh@fudan.edu.cn	Jeong, Byeong-ryool/N-1661-2019; Xu, Yanhui/D-5119-2019; Wang, Ping/GZB-2001-2022	Jeong, Byeong-ryool/0000-0003-0642-1650; Staiger, Dorothee/0000-0002-1341-1381; Wang, Ping/0000-0002-2710-7188	National Institutes of Health [1R01AI069146-01A2]; Center for Plant Science Innovation at the University of Nebraska; German Research Foundation [STA 653/2, STA 653/3]; National Basic Research Program of China [2009CB918600]; Science and Technology Commission of Shanghai Municipality [10430709300]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Plant Science Innovation at the University of Nebraska; German Research Foundation(German Research Foundation (DFG)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI069146-01A2 (to J. R. A.). This work was also supported by Center for Plant Science Innovation at the University of Nebraska (to J. R. A.), German Research Foundation Grants STA 653/2 and STA 653/3 (to D. S.), and National Basic Research Program of China Grant 2009CB918600 and the International Collaboration Program from Science and Technology Commission of Shanghai Municipality Grant 10430709300 (to Y. X.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; BARBIERI JT, 2003, BACTERIAL PROTEIN TO, P215; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Block A, 2010, CELL MICROBIOL, V12, P318, DOI 10.1111/j.1462-5822.2009.01396.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Han S, 2002, INT J MED MICROBIOL, V291, P523; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kayser J P, 2004, J Biomol Tech, V15, P285; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; KING EO, 1954, J LAB CLIN MED, V44, P301; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee AL, 1997, BIOCHEMISTRY-US, V36, P14306, DOI 10.1021/bi970830y; Lin Y, 2010, ACTA CRYSTALLOGR F, V66, P932, DOI 10.1107/S1744309110022463; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; LUDDEN PW, 1989, CURR TOP CELL REGUL, V30, P23; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Mueller-Dieckmann C, 2002, J MOL BIOL, V322, P687, DOI 10.1016/S0022-2836(02)00818-5; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Okazaki IJ, 1996, REV PHYSIOL BIOCH P, V129, P51; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt F, 2010, MOL BIOL REP, V37, P839, DOI 10.1007/s11033-009-9636-x; Schoning JC, 2007, PLANT J, V52, P1119, DOI 10.1111/j.1365-313X.2007.03302.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Streitner C, 2008, PLANT J, V56, P239, DOI 10.1111/j.1365-313X.2008.03591.x; Streitner C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-221; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006	64	75	79	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43272	43281		10.1074/jbc.M111.290122	http://dx.doi.org/10.1074/jbc.M111.290122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013065	hybrid, Green Published			2022-12-25	WOS:000298351300047
J	Pan, XO; Kane, LA; Van Eyk, JE; Coulombe, PA				Pan, Xiaoou; Kane, Lesley A.; Van Eyk, Jennifer E.; Coulombe, Pierre A.			Type I Keratin 17 Protein Is Phosphorylated on Serine 44 by p90 Ribosomal Protein S6 Kinase 1 (RSK1) in a Growth- and Stress-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT PHOSPHORYLATION; BASAL-CELL CARCINOMAS; EPITHELIAL-CELLS; OKADAIC ACID; PACHYONYCHIA-CONGENITA; MUTATIONS CAUSE; CULTURED-CELLS; SKIN; REORGANIZATION; EXPRESSION	Keratin 17 (K17) is a type I intermediate filament protein that is constitutively expressed in ectoderm-derived epithelial appendages and robustly induced in epidermis following injury, during inflammation, and in chronic diseases such as psoriasis and cancer. Mutations within K17 are responsible for two rare diseases related to ectodermal dysplasias. Studies in K17-null mice uncovered several roles for K17, including structural support, resistance to TNF alpha-induced apoptosis, regulation of protein synthesis, and modulation of cytokine expression. Yet, little is known about the regulation of K17 protein via post-translational modification. Here, we report that serine 44 in the N-terminal head domain of K17 (K17-Ser(44)) is phosphorylated in response to extracellular stimuli (serum, EGF, and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate) that alter skin keratinocyte growth, and to cellular stresses (sorbitol-induced hyperosmotic shock, UV irradiation, and hydrogen peroxide-induced oxidative stress). It also occurs in basaloid skin tumors in situ. Upon its stimulation in skin keratinocytes, K17-Ser(44) phosphorylation is induced rapidly but stays on transiently. The majority of the phosphorylated K17-Ser(44) pool is polymer-bound and is not obviously related to a change in filament organization. The amino acid sequence surrounding K17-Ser(44) matches the consensus for the AGC family of basophilic kinases. We show that p90 RSK1, an AGC kinase involved in the regulation of cell survival and proliferation, phosphorylates K17-Ser(44) in skin keratinocytes. These findings confirm and expand the tight link that has emerged between K17 up-regulation and growth and stress responses in the skin epithelium.	[Pan, Xiaoou; Coulombe, Pierre A.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Kane, Lesley A.; Van Eyk, Jennifer E.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kane, Lesley A.; Van Eyk, Jennifer E.] Johns Hopkins Univ, Johns Hopkins Bayview Prote Ctr, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Dept Dermatol, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,Rm W8041, Baltimore, MD 21205 USA.	coulombe@jhsph.edu			National Institutes of Health through NIAMS [AR44232, CA160255]; NATIONAL CANCER INSTITUTE [R01CA160255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR44232 and CA160255 (to P. A. C.) through NIAMS.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BODE AM, 2003, SCI STKE, pRE2; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; COULOMBE PA, 1991, J CELL BIOL, V115, P1661, DOI 10.1083/jcb.115.6.1661; Covello SP, 1998, BRIT J DERMATOL, V139, P475; DEJONG EMGJ, 1991, ARCH DERMATOL RES, V283, P480, DOI 10.1007/BF00371788; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Komine M, 1996, J INVEST DERMATOL, V107, P569, DOI 10.1111/1523-1747.ep12582820; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liovic M, 2008, EXP CELL RES, V314, P2066, DOI 10.1016/j.yexcr.2008.02.020; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PROBY CM, 1993, AM J PATHOL, V143, P1667; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; SMEDTS F, 1992, AM J PATHOL, V140, P601; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; STRICKLAND JE, 1988, CANCER RES, V48, P165; Strnad P, 2001, CELL TISSUE RES, V306, P277, DOI 10.1007/s004410100455; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Wallis S, 2000, MOL BIOL CELL, V11, P1077, DOI 10.1091/mbc.11.3.1077; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YATSUNAMI J, 1993, CANCER RES, V53, P992; Zhou Q, 2006, J BIOL CHEM, V281, P16453, DOI 10.1074/jbc.M512284200	73	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42403	42413		10.1074/jbc.M111.302042	http://dx.doi.org/10.1074/jbc.M111.302042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006917	hybrid, Green Published			2022-12-25	WOS:000298180900049
J	Fernandez-Fernandez, C; Gonzalez, D; Collier, J				Fernandez-Fernandez, Carmen; Gonzalez, Diego; Collier, Justine			Regulation of the Activity of the Dual-Function DnaA Protein in Caulobacter crescentus	PLOS ONE			English	Article							BACTERIAL-CELL CYCLE; ESCHERICHIA-COLI; REPLICATION INITIATION; CHROMOSOMAL REPLICATION; MOLECULAR SWITCH; HDA; EXPRESSION; ATP; INACTIVATION; GENE	DnaA is a conserved essential bacterial protein that acts as the initiator of chromosomal replication as well as a master transcriptional regulator in Caulobacter crescentus. Thus, the intracellular levels of active DnaA need to be tightly regulated during the cell cycle. Our previous work suggested that DnaA may be regulated at the level of its activity by the replisome-associated protein HdaA. Here, we describe the construction of a mutant DnaA protein [DnaA(R357A)]. The R357 residue in the AAA+ domain of the C. crescentus DnaA protein is equivalent to the R334 residue of the E. coli DnaA protein, which is required for the Regulatory Inactivation of DnaA (RIDA). We found that the expression of the DnaA(R357A) mutant protein in C. crescentus, but not the expression of the wild-type DnaA protein at similar levels, causes a severe phenotype of over-initiation of chromosomal replication and that it blocks cell division. Thus, the mutant DnaA(R357A) protein is hyper-active to promote the initiation of DNA replication, compared to the wild-type DnaA protein. DnaA(R357A) could not replace DnaA in vivo, indicating that the switch in DnaA activity once chromosomal replication has started may be an essential process in C. crescentus. We propose that the inactivation of DnaA is the main mechanism ensuring that chromosomal replication starts only once per cell cycle. We further observed that the R357A substitution in DnaA does not promote the activity of DnaA as a direct transcriptional activator of four important genes, encoding HdaA, the GcrA master cell cycle regulator, the FtsZ cell division protein and the MipZ spatial regulator of cell division. Thus, the AAA+ domain of DnaA may play a role in temporally regulating the bifunctionality of DnaA by reallocating DnaA molecules from initiating DNA replication to transcribing genes within the unique DnaA regulon of C. crescentus.	[Fernandez-Fernandez, Carmen; Gonzalez, Diego; Collier, Justine] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	Fernandez-Fernandez, C (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland.	Justine.collier@unil.ch		Collier, Justine/0000-0003-4213-9687; Gonzalez, Diego/0000-0003-3414-1461	Swiss National Science Foundation (SNSF) [31003A_122541, 316030_121391]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF) fellowship 31003A_122541 and the SNSF R'Equip grant 316030_121391 (SNSF: http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Camara JE, 2003, J BACTERIOL, V185, P3244, DOI 10.1128/JB.185.10.3244-3248.2003; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; Cheng L, 2009, J BACTERIOL, V191, P4268, DOI 10.1128/JB.00362-09; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Collier J, 2007, CURR OPIN BIOTECH, V18, P333, DOI 10.1016/j.copbio.2007.07.007; Collier J, 2009, J BACTERIOL, V191, P5706, DOI 10.1128/JB.00525-09; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; GOBER JW, 1992, MOL BIOL CELL, V3, P913, DOI 10.1091/mbc.3.8.913; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x; Gorbatyuk B, 2001, MOL MICROBIOL, V40, P485, DOI 10.1046/j.1365-2958.2001.02404.x; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Jonas K, 2011, CURR BIOL, V21, P1092, DOI 10.1016/j.cub.2011.05.040; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lesley JA, 2008, J BACTERIOL, V190, P6867, DOI 10.1128/JB.00700-08; Marczynski GT, 2002, ANNU REV MICROBIOL, V56, P625, DOI 10.1146/annurev.micro.56.012302.161103; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; MILLER JH, 1972, EXPRERIMENTS MOL GEN; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Olliver A, 2010, MOL MICROBIOL, V76, P1555, DOI 10.1111/j.1365-2958.2010.07185.x; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Riber L, 2006, GENE DEV, V20, P2121, DOI 10.1101/gad.379506; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scholefield G, 2011, TRENDS CELL BIOL, V21, P188, DOI 10.1016/j.tcb.2010.10.006; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; ZWEIGER G, 1994, J BACTERIOL, V176, P401, DOI 10.1128/JB.176.2.401-408.1994	46	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26028	10.1371/journal.pone.0026028	http://dx.doi.org/10.1371/journal.pone.0026028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022497	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600027
J	Nakao, R; Hasegawa, H; Ochiai, K; Takashiba, S; Ainai, A; Ohnishi, M; Watanabe, H; Senpuku, H				Nakao, Ryoma; Hasegawa, Hideki; Ochiai, Kuniyasu; Takashiba, Shogo; Ainai, Akira; Ohnishi, Makoto; Watanabe, Haruo; Senpuku, Hidenobu			Outer Membrane Vesicles of Porphyromonas gingivalis Elicit a Mucosal Immune Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTEROIDES-GINGIVALIS; EXTRACELLULAR VESICLES; PROTECTIVE IMMUNITY; BIOFILM FORMATION; VACCINE PROTECTS; MICE; PERIODONTITIS; CELLS; LIPOPOLYSACCHARIDE	We previously reported that mutation of galE in Porphyromonas gingivalis has pleiotropic effects, including a truncated lipopolysaccharide (LPS) O-antigen and deglycosylation of the outer membrane protein OMP85 homolog. In the present study, further analysis of the galE mutant revealed that it produced little or no outer membrane vesicles (OMVs). Using three mouse antisera raised against whole cells of the P. gingivalis wild type strain, we performed ELISAs to examine the reactivity of these antisera with whole cells of the wild type or the galE mutant. All three antisera had significantly lower reactivity against the galE mutant compared to wild type. OMVs, but not LPS, retained the immunodominant determinant of P. gingivalis, as determined by ELISAs (with wild type LPS or OMVs as antigen) and absorption assays. In addition, we assessed the capacity of OMVs as a vaccine antigen by intranasal immunization to BALB/c mice. Synthetic double-stranded RNA polyriboinosinic polyribocytidylic acid [Poly (I: C)], an agonist of Toll-like receptor 3 (TLR3), was used as the mucosal adjuvant. Vaccination with OMV elicited dramatically high levels of P. gingivalis-specific IgA in nasal washes and saliva, as well as serum IgG and IgA. In conclusion, the OMVs of P. gingivalis have an important role in mucosal immunogenicity as well as in antigenicity. We propose that P. gingivalis OMV is an intriguing immunogen for development of a periodontal disease vaccine.	[Nakao, Ryoma; Ohnishi, Makoto; Watanabe, Haruo; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Hasegawa, Hideki; Ainai, Akira] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Ochiai, Kuniyasu] Nihon Univ, Dept Microbiol, Tokyo, Japan; [Takashiba, Shogo] Okayama Univ, Grad Sch Med, Dept Pathophysiol Periodontal Sci, Okayama 7008530, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nihon University; Okayama University	Nakao, R (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan.	hsenpuku@nih.go.jp	Takashiba, Shogo/C-9830-2010; SENPUKU, HIDENOBU/ABC-6160-2021; Hasegawa, Hideki/C-7978-2014	Takashiba, Shogo/0000-0002-4712-6829; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19791360, 22791822, 21390506, S1001024]; Ministry of Health, Labor and Welfare [H19 Iryo-Ippan-007]; Japan Health Science Foundation [KHC3308]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation	This study was supported in part by Grants-in-Aid from the Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (19791360, 22791822, and 21390506); the Ministry of Health, Labor and Welfare (H19 Iryo-Ippan-007); and the Japan Health Science Foundation (No. KHC3308). This study was also supported in part by a grant of the "Strategic Research Base Development" Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clinical trials.gov, SERV US NAT I HLTH; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; DESLAURIERS M, 1990, ORAL MICROBIOL IMMUN, V5, P1, DOI 10.1111/j.1399-302X.1990.tb00217.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; IMAMURA T, 1995, INFECT IMMUN, V63, P4877, DOI 10.1128/IAI.63.12.4877-4882.1995; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; KESAVALU L, 1992, INFECT IMMUN, V60, P1455, DOI 10.1128/IAI.60.4.1455-1464.1992; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Matsumoto N, 2004, ORAL MICROBIOL IMMUN, V19, P270, DOI 10.1111/j.1399-302X.2004.00151.x; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Ojima M, 2005, DIABETES CARE, V28, P433, DOI 10.2337/diacare.28.2.433; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; SMALLEY JW, 1991, ORAL MICROBIOL IMMUN, V6, P202, DOI 10.1111/j.1399-302X.1991.tb00478.x; Tsuha Y, 2004, CLIN EXP IMMUNOL, V137, P393, DOI 10.1111/j.1365-2249.2004.02548.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203	34	70	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26163	10.1371/journal.pone.0026163	http://dx.doi.org/10.1371/journal.pone.0026163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022548	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600033
J	Shorter, J				Shorter, James			The Mammalian Disaggregase Machinery: Hsp110 Synergizes with Hsp70 and Hsp40 to Catalyze Protein Disaggregation and Reactivation in a Cell-Free System	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; NUCLEOTIDE EXCHANGE FACTORS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; AGGREGATED PROTEINS; HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; IN-VITRO; YEAST	Bacteria, fungi, protozoa, chromista and plants all harbor homologues of Hsp104, a AAA+ ATPase that collaborates with Hsp70 and Hsp40 to promote protein disaggregation and reactivation. Curiously, however, metazoa do not possess an Hsp104 homologue. Thus, whether animal cells renature large protein aggregates has long remained unclear. Here, it is established that mammalian cytosol prepared from different sources possesses a potent, ATP-dependent protein disaggregase and reactivation activity, which can be accelerated and stimulated by Hsp104. This activity did not require the AAA+ ATPase, p97. Rather, mammalian Hsp110 (Apg-2), Hsp70 (Hsc70 or Hsp70) and Hsp40 (Hdj1) were necessary and sufficient to slowly dissolve large disordered aggregates and recover natively folded protein. This slow disaggregase activity was conserved to yeast Hsp110 (Sse1), Hsp70 (Ssa1) and Hsp40 (Sis1 or Ydj1). Hsp110 must engage substrate, engage Hsp70, promote nucleotide exchange on Hsp70, and hydrolyze ATP to promote disaggregation of disordered aggregates. Similarly, Hsp70 must engage substrate and Hsp110, and hydrolyze ATP for protein disaggregation. Hsp40 must harbor a functional J domain to promote protein disaggregation, but the J domain alone is insufficient. Optimal disaggregase activity is achieved when the Hsp40 can stimulate the ATPase activity of Hsp110 and Hsp70. Finally, Hsp110, Hsp70 and Hsp40 fail to rapidly remodel amyloid forms of the yeast prion protein, Sup35, or the Parkinson's disease protein, alpha-synuclein. However, Hsp110, Hsp70 and Hsp40 enhanced the activity of Hsp104 against these amyloid substrates. Taken together, these findings suggest that Hsp110 fulfils a subset of Hsp104 activities in mammals. Moreover, they suggest that Hsp104 can collaborate with the mammalian disaggregase machinery to rapidly remodel amyloid conformers.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Shorter, J (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533	NIH [1DP2OD002177-01, R21 NS067354-0110]; Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following: an NIH Director's New Innovator Award 1DP2OD002177-01, an NIH R21 NS067354-0110, and an Ellison Medical Foundation New Scholar in Aging Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McClellan AJ, 2000, GENETICS, V156, P501; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Needham PG, 2008, ARCH BIOCHEM BIOPHYS, V478, P167, DOI 10.1016/j.abb.2008.07.023; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Okui M, 2000, NEUROCHEM INT, V36, P35, DOI 10.1016/S0197-0186(99)00095-9; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; STUART RA, 1993, J BIOL CHEM, V268, P4050; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wakatsuki T, 1998, BIOL PHARM BULL, V21, P905; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wong E, 2011, COLD SPRING HARB PER, V2; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200	81	209	210	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26319	10.1371/journal.pone.0026319	http://dx.doi.org/10.1371/journal.pone.0026319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022600	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600055
J	Kumagai, A; Horike, N; Satoh, Y; Uebi, T; Sasaki, T; Itoh, Y; Hirata, Y; Uchio-Yamada, K; Kitagawa, K; Uesato, S; Kawahara, H; Takemori, H; Nagaoka, Y				Kumagai, Ayako; Horike, Nanao; Satoh, Yudai; Uebi, Tatsuya; Sasaki, Tsutomu; Itoh, Yumi; Hirata, Yoshiyuki; Uchio-Yamada, Kozue; Kitagawa, Kazuo; Uesato, Shinichi; Kawahara, Hidehisa; Takemori, Hiroshi; Nagaoka, Yasuo			A Potent Inhibitor of SIK2, 3, 3 ', 7-Trihydroxy-4 '-Methoxyflavon (4 '-O-Methylfisetin), Promotes Melanogenesis in B16F10 Melanoma Cells	PLOS ONE			English	Article							BINDING PROTEIN-ACTIVITY; SALT-INDUCIBLE KINASE-1; LONG-TERM POTENTIATION; SKIN PIGMENTATION; TRANSCRIPTION FACTOR; COACTIVATOR TORC2; SIGNALING CASCADE; CAMP; ACTIVATION; FLAVONOIDS	Flavonoids, which are plant polyphenols, are now widely used in supplements and cosmetics. Here, we report that 4'-methylflavonoids are potent inducers of melanogenesis in B16F10 melanoma cells and in mice. We recently identified salt inducible kinase 2 (SIK2) as an inhibitor of melanogenesis via the suppression of the cAMP-response element binding protein (CREB)-specific coactivator 1 (TORC1). Using an in vitro kinase assay targeting SIK2, we identified fisetin as a candidate inhibitor, possibly being capable of promoting melanogenesis. However, fisetin neither inhibited the CREB-inhibitory activity of SIK2 nor promoted melanogenesis in B16F10 melanoma cells. Conversely, mono-methyl-flavonoids, such as diosmetin (4'-O-metlylluteolin), efficiently inhibited SIK2 and promoted melanogenesis in this cell line. The cAMP-CREB system is impaired in A(y)/a mice and these mice have yellow hair as a result of pheomelanogenesis, while Sik2(+/-); A(y)/a mice also have yellow hair, but activate eumelanogenesis when they are exposed to CREB stimulators. Feeding Sik(2+/-); A(y)/a mice with diets supplemented with fisetin resulted in their hair color changing to brown, and metabolite analysis suggested the presence of mono-methylfisetin in their feces. Thus, we decided to synthesize 4'-O-methylfisetin (4'MF) and found that 4'MF strongly induced melanogenesis in B16F10 melanoma cells, which was accompanied by the nuclear translocation of TORC1, and the 4'-O-methylfisetin-induced melanogenic programs were inhibited by the overexpression of dominant negative TORC1. In conclusion, compounds that modulate SIK2 cascades are helpful to regulate melanogenesis via TORC1 without affecting cAMP levels, and the combined analysis of Sik2(+/-) mice and metabolites from these mice is an effective strategy to identify beneficial compounds to regulate CREB activity in vivo.	[Kumagai, Ayako; Horike, Nanao; Satoh, Yudai; Hirata, Yoshiyuki; Uesato, Shinichi; Kawahara, Hidehisa; Nagaoka, Yasuo] Kansai Univ, Dept Life Sci & Biotechnol, Fac Chem Mat & Bioengn, Osaka, Japan; [Kumagai, Ayako; Horike, Nanao; Uebi, Tatsuya; Itoh, Yumi; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan; [Sasaki, Tsutomu; Kitagawa, Kazuo] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan; [Uchio-Yamada, Kozue] Natl Inst Biomed Innovat, Lab Anim Models Human Dis, Osaka, Japan	Kansai University; National Institute of Health Sciences - Japan; Osaka University; National Institute of Health Sciences - Japan	Kumagai, A (corresponding author), Kansai Univ, Dept Life Sci & Biotechnol, Fac Chem Mat & Bioengn, Osaka, Japan.	takemori@nibio.go.jp		sasaki, tsutomu/0000-0001-8726-978X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Sumitomo Foundation; Natural Scientists and the Strategic Project	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Natural Scientists and the Strategic Project	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project to Support the Formation of Research Bases at Private Universities; and a grant from the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; BLASKO G, 1989, J NAT PROD, V52, P1363, DOI 10.1021/np50066a035; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Bouktaib M, 2002, TETRAHEDRON, V58, P10001, DOI 10.1016/S0040-4020(02)01306-6; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chan ALF, 2008, INVEST NEW DRUG, V26, P417, DOI 10.1007/s10637-008-9114-7; Cho M, 2009, BIOCHEM BIOPH RES CO, V390, P500, DOI 10.1016/j.bbrc.2009.09.124; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Fujii T, 2009, BIOSCI BIOTECH BIOCH, V73, P1989, DOI 10.1271/bbb.90181; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; JIMBOW K, 1992, PIGM CELL RES, P36; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P265, DOI 10.3109/10799893.2011.586353; Lee J, 2005, J INVEST DERMATOL, V124, P405, DOI 10.1111/j.0022-202X.2004.23606.x; Lee J, 2007, LIFE SCI, V81, P249, DOI 10.1016/j.lfs.2007.05.009; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu Y, 2010, ENDOCRINOLOGY, V151, P1109, DOI 10.1210/en.2009-0963; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; NAKAYAMA T, 1994, CANCER RES, V54, pS1991; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Peluso MR, 2006, EXP BIOL MED, V231, P1287, DOI 10.1177/153537020623100802; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shoji T, 2005, J AGR FOOD CHEM, V53, P6105, DOI 10.1021/jf050418m; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu M, 2000, GENE DEV, V14, P301; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yoon HS, 2007, BIOSCI BIOTECH BIOCH, V71, P1781, DOI 10.1271/bbb.70088; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	43	30	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26148	10.1371/journal.pone.0026148	http://dx.doi.org/10.1371/journal.pone.0026148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022544	gold, Green Submitted, Green Published			2022-12-25	WOS:000295978600041
J	Belhouchet, M; Jaafar, FM; Firth, AE; Grimes, JM; Mertens, PPC; Attoui, H				Belhouchet, Mourad; Jaafar, Fauziah Mohd; Firth, Andrew E.; Grimes, Jonathan M.; Mertens, Peter P. C.; Attoui, Houssam			Detection of a Fourth Orbivirus Non-Structural Protein	PLOS ONE			English	Article							OUTER-CAPSID PROTEINS; S1 MESSENGER-RNA; REOVIRUS-SPECIFIED POLYPEPTIDES; BLUETONGUE VIRUS SEROTYPE-1; CRYOELECTRON MICROSCOPY; FAMILY REOVIRIDAE; COMPLETE SEQUENCE; MAMMALIAN-CELLS; GENOME SEGMENTS; AVIAN REOVIRUS	The genus Orbivirus includes both insect and tick-borne viruses. The orbivirus genome, composed of 10 segments of dsRNA, encodes 7 structural proteins (VP1-VP7) and 3 non-structural proteins (NS1-NS3). An open reading frame (ORF) that spans almost the entire length of genome segment-9 (Seg-9) encodes VP6 (the viral helicase). However, bioinformatic analysis recently identified an overlapping ORF (ORFX) in Seg-9. We show that ORFX encodes a new non-structural protein, identified here as NS4. Western blotting and confocal fluorescence microscopy, using antibodies raised against recombinant NS4 from Bluetongue virus (BTV, which is insect-borne), or Great Island virus (GIV, which is tick-borne), demonstrate that these proteins are synthesised in BTV or GIV infected mammalian cells, respectively. BTV NS4 is also expressed in Culicoides insect cells. NS4 forms aggregates throughout the cytoplasm as well as in the nucleus, consistent with identification of nuclear localisation signals within the NS4 sequence. Bioinformatic analyses indicate that NS4 contains coiled-coils, is related to proteins that bind nucleic acids, or are associated with membranes and shows similarities to nucleolar protein UTP20 (a processome subunit). Recombinant NS4 of GIV protects dsRNA from degradation by endoribonucleases of the RNAse III family, indicating that it interacts with dsRNA. However, BTV NS4, which is only half the putative size of the GIV NS4, did not protect dsRNA from RNAse III cleavage. NS4 of both GIV and BTV protect DNA from degradation by DNAse. NS4 was found to associate with lipid droplets in cells infected with BTV or GIV or transfected with a plasmid expressing NS4.	[Belhouchet, Mourad; Jaafar, Fauziah Mohd; Mertens, Peter P. C.; Attoui, Houssam] Inst Anim Hlth, Vector Borne Viral Dis Programme, Pirbright, England; [Firth, Andrew E.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Belhouchet, Mourad; Grimes, Jonathan M.] Div Struct Biol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Cambridge; University of Oxford	Belhouchet, M (corresponding author), Inst Anim Hlth, Vector Borne Viral Dis Programme, Pirbright, England.	houssam.attoui@iah.ac.uk		Grimes, Jonathan Mark/0000-0001-9698-0389; Attoui, Houssam/0000-0001-9639-9981; Firth, Andrew/0000-0002-7986-9520; Mertens, Peter/0000-0002-3438-3738	Defra; Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; European Union [OrbiVac 245266, WildTech 222633-2, OrbiNet K1303206]; BBSRC/Pfizer; Wellcome Trust [088789]	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); European Union(European Commission); BBSRC/Pfizer(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission)	Work within the Vector-borne disease programme at the Institute for Animal Health is supported by Defra, the Biotechnology and Biological Sciences Research Council (BBSRC) and Pfizer and by European Union contracts OrbiVac 245266, WildTech 222633-2, and OrbiNet K1303206. M. B. is supported by a BBSRC/Pfizer funded Ph.D. studentship. AEF is supported by the Wellcome Trust (grant number 088789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AP, 2007, RNA, V13, P422, DOI 10.1261/rna.348307; Anantharaman V, 2002, GENOME BIOL, V3; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BERNARDI A, 1975, EUR J BIOCHEM, V52, P451, DOI 10.1111/j.1432-1033.1975.tb04013.x; Camproux AC, 1999, PROTEIN ENG, V12, P1063, DOI 10.1093/protein/12.12.1063; Chen HY, 2002, J VIROL, V76, P5233, DOI 10.1128/JVI.76.10.5233-5250.2002; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; DOOHAN JP, 1993, J BIOL CHEM, V268, P18313; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GRUBMAN MJ, 1983, VIROLOGY, V131, P355, DOI 10.1016/0042-6822(83)90503-2; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HEWAT EA, 1992, J STRUCT BIOL, V109, P61, DOI 10.1016/1047-8477(92)90068-L; Hiscox JA, 2002, ARCH VIROL, V147, P1077, DOI 10.1007/s00705-001-0792-0; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; Jaafar FM, 2005, J GEN VIROL, V86, P1147, DOI 10.1099/vir.0.80578-0; Jaafar FM, 2005, STRUCTURE, V13, P17, DOI 10.1016/j.str.2004.10.017; Jaafar FM, 2003, J CLIN MICROBIOL, V41, P2102, DOI [10.1128/JCM.41.5.2102-2105.2003, 10.1128/JCM.41.5.2102.2105.2003]; JACOBS BL, 1985, VIROLOGY, V147, P9, DOI 10.1016/0042-6822(85)90222-3; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Mortola E, 2004, J VIROL, V78, P2875, DOI 10.1128/JVI.78.6.2875-2883.2004; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nagaleekar VK, 2007, ARCH VIROL, V152, P1751, DOI 10.1007/s00705-007-0988-z; O'Hara RS, 1998, ARCH VIROL, P259; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Racine T, 2007, J BIOL CHEM, V282, P25613, DOI 10.1074/jbc.M703708200; Racine T, 2010, NUCLEIC ACIDS RES, V38, P7260, DOI 10.1093/nar/gkq611; Rainsford EW, 2007, VIRUS RES, V130, P193, DOI 10.1016/j.virusres.2007.06.011; Ren B, 2010, J VIROL, V84, P12914, DOI 10.1128/JVI.00864-10; Sangar D. V., 1983, Double-stranded RNA viruses. Proceedings of the First International Symposium, October 5-10, 1982, U.S. Virgin Islands, P183; Schoehn G, 1997, VIROLOGY, V235, P191, DOI 10.1006/viro.1997.8685; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Stuart DI, 1998, ARCH VIROL, P235; Suzuki N, 1996, J VIROL, V70, P8155, DOI 10.1128/JVI.70.11.8155-8159.1996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WADEEVANS AM, 1992, J GEN VIROL, V73, P3023, DOI 10.1099/0022-1317-73-11-3023; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Yue ZY, 1996, J VIROL, V70, P3497, DOI 10.1128/JVI.70.6.3497-3501.1996	57	161	173	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25697	10.1371/journal.pone.0025697	http://dx.doi.org/10.1371/journal.pone.0025697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022432	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000031
J	Xue, C; Fu, YX; Zhao, YH; Gong, Y; Liu, XM				Xue, Cheng; Fu, Yun-Xin; Zhao, Yuhai; Gong, Yun; Liu, Xiaoming			Smaller Genetic Risk in Catabolic Process Explains Lower Energy Expenditure, More Athletic Capability and Higher Prevalence of Obesity in Africans	PLOS ONE			English	Article							BATON-ROUGE CHILDRENS; RACIAL-DIFFERENCES; WHITE BOYS; DUPLICATION; AMERICAN; WOMEN; BLACK; GIRLS	Lower energy expenditure (EE) for physical activity was observed in Africans than in Europeans, which might contribute to the higher prevalence of obesity and more athletic capability in Africans. But it is still unclear why EE is lower among African populations. In this study we tried to explore the genetic mechanism underlying lower EE in Africans. We screened 231 common variants with possibly harmful impact on 182 genes in the catabolic process. The genetic risk, including the total number of mutations and the sum of harmful probabilities, was calculated and analyzed for the screened variants at a population level. Results of the genetic risk among human groups showed that most Africans (3 out of 4 groups) had a significantly smaller genetic risk in the catabolic process than Europeans and Asians, which might result in higher efficiency of generating energy among Africans. In sport competitions, athletes need massive amounts of energy expenditure in a short period of time, so higher efficiency of energy generation might help make African-descendent athletes more powerful. On the other hand, higher efficiency of generating energy might also result in consuming smaller volumes of body mass. As a result, Africans might be more vulnerable to obesity compared to the other races when under the same or similar conditions. Therefore, the smaller genetic risk in the catabolic process might be at the core of understanding lower EE, more athletic capability and higher prevalence of obesity in Africans.	[Xue, Cheng; Fu, Yun-Xin; Gong, Yun; Liu, Xiaoming] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Xue, Cheng] GuangDong Inst Monitoring Lab Anim, Guangzhou, Guangdong, Peoples R China; [Fu, Yun-Xin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan, Peoples R China; [Zhao, Yuhai] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Yunnan University; University of Texas System; University of Texas Health Science Center Houston	Xue, C (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA.	lflf27@yahoo.com.cn	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528	Yunnan University	Yunnan University	This work is supported by funds from Yunnan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; DeLany JP, 2004, AM J CLIN NUTR, V79, P268; DeLany JP, 2002, AM J CLIN NUTR, V75, P705, DOI 10.1093/ajcn/75.4.705; Gannon B, 2000, INT J OBESITY, V24, P4, DOI 10.1038/sj.ijo.0801115; GEISSLER CA, 1985, ANN NUTR METAB, V29, P40, DOI 10.1159/000176952; Hunter GR, 2000, AM J CLIN NUTR, V71, P500; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lomax ME, 2008, SPORTS AND THE RACIAL DIVIDE: AFRICAN AMERICAN AND LATINO EXPERIENCE IN AN ERA OF CHANGE, P1; Luke Amy, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P370, DOI 10.1097/MED.0b013e3282c48a7c; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Xue C, 2010, GENETICS, V186, P287, DOI 10.1534/genetics.110.118646; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26027	10.1371/journal.pone.0026027	http://dx.doi.org/10.1371/journal.pone.0026027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016803	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700033
J	Caronia, D; Patino-Garcia, A; Perez-Martinez, A; Pita, G; Moreno, LT; Zalacain-Diez, M; Molina, B; Colmenero, I; Sierrasesumaga, L; Benitez, J; Gonzalez-Neira, A				Caronia, Daniela; Patino-Garcia, Ana; Perez-Martinez, Antonio; Pita, Guillermo; Tais Moreno, Leticia; Zalacain-Diez, Marta; Molina, Blanca; Colmenero, Isabel; Sierrasesumaga, Luis; Benitez, Javier; Gonzalez-Neira, Anna			Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-3; DRUG TRANSPORTERS; P-GLYCOPROTEIN; MESSENGER-RNA; GENE; EXPRESSION; MRP3; CANCER; PHARMACOKINETICS; GENOTYPE	Background: Standard treatment for osteosarcoma patients consists of a combination of cisplatin, adriamycin, and methotrexate before surgical resection of the primary tumour, followed by postoperative chemotherapy including vincristine and cyclophosphamide. Unfortunately, many patients still relapse or suffer adverse events. We examined whether common germline polymorphisms in chemotherapeutic transporter and metabolic pathway genes of the drugs used in standard osteosarcoma treatment may predict treatment response. Methodology/Principal Findings: In this study we screened 102 osteosarcoma patients for 346 Single Nucleotide Polymorphisms (SNPs) and 2 Copy Number Variants (CNVs) in 24 genes involved in the metabolism or transport of cisplatin, adriamycin, methotrexate, vincristine, and cyclophosphamide. We studied the association of the genotypes with tumour response and overall survival. We found that four SNPs in two ATP-binding cassette genes were significantly associated with overall survival: rs4148416 in ABCC3 (per-allele HR = 8.14, 95% CI = 2.73-20.2, p-value = 5.1x10(-5)), and three SNPs in ABCB1, rs4148737 (per-allele HR = 3.66, 95% CI = 1.85-6.11, p-value = 6.9x10(-5)), rs1128503 and rs10276036 (r(2) = 1, per-allele HR = 0.24, 95% CI = 0.11-0.47 p-value = 7.9x10(-5)). Associations with these SNPs remained statistically significant after correction for multiple testing (all corrected p-values [permutation test] <= 0.03). Conclusions: Our findings suggest that these polymorphisms may affect osteosarcoma treatment efficacy. If these associations are independently validated, these variants could be used as genetic predictors of clinical outcome in the treatment of osteosarcoma, helping in the design of individualized therapy.	[Caronia, Daniela; Pita, Guillermo; Tais Moreno, Leticia; Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Madrid, Spain; [Patino-Garcia, Ana; Zalacain-Diez, Marta; Sierrasesumaga, Luis] Univ Navarra, Dept Pediat, E-31080 Pamplona, Spain; [Perez-Martinez, Antonio; Zalacain-Diez, Marta; Sierrasesumaga, Luis] Univ Clin, Pamplona, Spain; [Perez-Martinez, Antonio; Molina, Blanca; Colmenero, Isabel] Univ Childrens Hosp Nino Jesus, Dept Pediat Oncol, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; Centro Nacional de Investigaciones Oncologicas (CNIO)	Caronia, D (corresponding author), Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Madrid, Spain.	agonzalez@cnio.es	Gonzalez-Neira, Anna/C-5791-2015; Pérez-Martínez, Antonio/AAF-5797-2019; Colmenero, Isabel/AAM-1316-2020; Perez, Antonio/I-6032-2012; Patiño-Garcia, Ana/I-4299-2012	Gonzalez-Neira, Anna/0000-0002-5421-2020; Patiño-Garcia, Ana/0000-0002-4066-8203; Perez Martinez, Antonio/0000-0002-6436-9195; colmenero, isabel/0000-0001-6859-187X	AECC (Asociacion Espanola contra el Cancer); "Inocente Inocente'' Foundation; FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III)	AECC (Asociacion Espanola contra el Cancer); "Inocente Inocente'' Foundation; FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III)(Instituto de Salud Carlos III)	This work was supported by the AECC (Asociacion Espanola contra el Cancer), FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III) and the "Inocente Inocente'' Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; BALCERCZAK E, INT J COLORECTAL DIS, V25, P1167; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Caronia D, 2009, PHARMACOGENOMICS J, V9, P347, DOI 10.1038/tpj.2009.19; CASCORBI I, METHODS MOL BIOL, V596, P95; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang R, 2006, BIOCHEM PHARMACOL, V71, P1695, DOI 10.1016/j.bcp.2006.03.009; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jamroziak K, 2009, LEUKEMIA RES, V33, P332, DOI 10.1016/j.leukres.2008.06.008; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]; Kobayashi K, 2008, PHARMACOGENET GENOM, V18, P823, DOI 10.1097/FPC.0b013e328306e9ae; Lal S, 2008, CANCER SCI, V99, P816, DOI 10.1111/j.1349-7006.2008.00744.x; Lang T, 2004, PHARMACOGENETICS, V14, P155, DOI 10.1097/00008571-200403000-00003; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Mathijssen RHJ, 2003, CLIN CANCER RES, V9, P3246; Morita N, 2003, BIOCHEM PHARMACOL, V65, P1843, DOI 10.1016/S0006-2952(03)00178-3; Redlich G, 2008, J PROTEOME RES, V7, P4678, DOI 10.1021/pr800231w; Rost D, 2001, GASTROENTEROLOGY, V121, P1203, DOI 10.1053/gast.2001.28648; Sakaeda Toshiyuki, 2005, Drug Metab Pharmacokinet, V20, P391, DOI 10.2133/dmpk.20.391; Schaich M, 2009, ANN ONCOL, V20, P175, DOI 10.1093/annonc/mdn548; Sissung Tristan M., 2008, V448, P41, DOI 10.1007/978-1-59745-205-2_4; Young LC, 2001, CLIN CANCER RES, V7, P1798; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zeng H, 2000, CANCER RES, V60, P4779; Zhang YT, 2008, BRIT J CLIN PHARMACO, V66, P240, DOI 10.1111/j.1365-2125.2008.03180.x; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	34	66	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26091	10.1371/journal.pone.0026091	http://dx.doi.org/10.1371/journal.pone.0026091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016816	Green Submitted, Green Published, gold			2022-12-25	WOS:000295970300059
J	Gelmedin, V; Brodigan, T; Gao, X; Krause, M; Wang, Z; Hawdon, JM				Gelmedin, Verena; Brodigan, Thomas; Gao, Xin; Krause, Michael; Wang, Zhu; Hawdon, John M.			Transgenic C. elegans Dauer Larvae Expressing Hookworm Phospho Null DAF-16/FoxO Exit Dauer	PLOS ONE			English	Article							3RD-STAGE INFECTIVE LARVAE; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ANCYLOSTOMA-CANINUM; FEEDING INVITRO; LIFE-SPAN; PHOSPHORYLATION SITES; SIGNALING PATHWAY; FAMILY-MEMBER	Parasitic hookworms and the free-living model nematode Caenorhabtidis elegans share a developmental arrested stage, called the dauer stage in C. elegans and the infective third-stage larva (L3) in hookworms. One of the key transcription factors that regulate entrance to and exit from developmental arrest is the forkhead transcription factor DAF-16/FoxO. During the dauer stage, DAF-16 is activated and localized in the nucleus. DAF-16 is negatively regulated by phosphorylation by the upstream kinase AKT, which causes DAF-16 to localize out of the nucleus and the worm to exit from dauer. DAF-16 is conserved in hookworms, and hypothesized to control recovery from L3 arrest during infection. Lacking reverse genetic techniques for use in hookworms, we used C. elegans complementation assays to investigate the function of Ancylostoma caninum DAF-16 during entrance and exit from L3 developmental arrest. We performed dauer switching assays and observed the restoration of the dauer phenotype when Ac-DAF-16 was expressed in temperature-sensitive dauer defective C. elegans daf-2(e1370);daf-16(mu86) mutants. AKT phosphorylation site mutants of Ac-DAF-16 were also able to restore the dauer phenotype, but surprisingly allowed dauer exit when temperatures were lowered. We used fluorescence microscopy to localize DAF-16 during dauer and exit from dauer in C. elegans DAF-16 mutant worms expressing Ac-DAF-16, and found that Ac-DAF-16 exited the nucleus during dauer exit. Surprisingly, Ac-DAF-16 with mutated AKT phosphorylation sites also exited the nucleus during dauer exit. Our results suggest that another mechanism may be involved in the regulation DAF-16 nuclear localization during recovery from developmental arrest.	[Gelmedin, Verena; Gao, Xin; Hawdon, John M.] Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Brodigan, Thomas; Krause, Michael] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Wang, Zhu] UT SW Med Sch, Dept Pharmacol, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Southwestern Medical Center Dallas	Gelmedin, V (corresponding author), Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	mtmvxg@gwumc.edu	Hawdon, John/I-1201-2019; Gao, Cyan/O-9316-2014	Hawdon, John/0000-0002-6164-1413; Krause, Michael/0000-0001-6127-3940	NIH from the National Institute of Allergy and Infectious Diseases [R01AI069293]; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH; NIH [SIG S10RR025565]; NIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069293] Funding Source: NIH RePORTER	NIH from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH Grant R01AI069293 from the National Institute of Allergy and Infectious Diseases and, in part, by the National Institute of Diabetes and Digestive and Kidney Diseases of the Intramural Research Program of the NIH. The confocal microscope Zeiss 710 was funded by NIH SIG S10RR025565. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM H, CELL METAB, V12, P30; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Benito M, 1996, INT J BIOCHEM CELL B, V28, P499, DOI 10.1016/1357-2725(95)00168-9; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; CHUNG H, FEBS LETT, V584, P3609; GAO X, 2008, INT J PARASITOL; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOTTLIEB S, 1994, GENETICS, V137, P107; HAWDON JM, 1990, J PARASITOL, V76, P394, DOI 10.2307/3282673; HAWDON JM, 1993, PARASITOLOGY, V106, P163, DOI 10.1017/S0031182000074953; HAWDON JM, 1992, EXP PARASITOL, V75, P40, DOI 10.1016/0014-4894(92)90120-Y; HAWDON JM, 1991, J PARASITOL, V77, P587, DOI 10.2307/3283164; HAWDON JM, 1993, EXP PARASITOL, V77, P489, DOI 10.1006/expr.1993.1110; HAWDON JM, 1992, J PARASITOL, V78, P1036, DOI 10.2307/3283226; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; HOTEZ P, 1990, INFECT IMMUN, V58, P3883, DOI 10.1128/IAI.58.12.3883-3892.1990; HUANG H, BIOCH BIOPHYS ACTA; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiss JE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-21; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; QIANG L, J BIOL CHEM, V285, P27396; ROGERS WP, 1963, ADV PARASIT, V1, P109, DOI 10.1016/S0065-308X(08)60503-5; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Tissenbaum HA, 1998, GENETICS, V148, P703; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013	46	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25996	10.1371/journal.pone.0025996	http://dx.doi.org/10.1371/journal.pone.0025996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016799	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300047
J	Wiskerke, J; Stoop, N; Schetters, D; Schoffelmeer, ANM; Pattij, T				Wiskerke, Joost; Stoop, Nicky; Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy			Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice	PLOS ONE			English	Article							REACTION-TIME-TASK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MU-OPIOID RECEPTORS; INDUCED BEHAVIORAL SENSITIZATION; NUCLEUS-ACCUMBENS CORE; ENDOCANNABINOID SYSTEM; DOPAMINE NEURONS; GENE CNR1; PREFRONTAL CORTEX; RAT-BRAIN	It is well known that acute challenges with psychostimulants such as amphetamine affect impulsive behavior. We here studied the pharmacology underlying the effects of amphetamine in two rat models of impulsivity, the 5-choice serial reaction time task (5-CSRTT) and the delayed reward task (DRT), providing measures of inhibitory control, an aspect of impulsive action, and impulsive choice, respectively. We focused on the role of cannabinoid CB1 receptor activation in amphetamine-induced impulsivity as there is evidence that acute challenges with psychostimulants activate the endogenous cannabinoid system, and CB1 receptor activity modulates impulsivity in both rodents and humans. Results showed that pretreatment with either the CB1 receptor antagonist/inverse agonist SR141716A or the neutral CB1 receptor antagonist O-2050 dose-dependently improved baseline inhibitory control in the 5-CSRTT. Moreover, both compounds similarly attenuated amphetamine-induced inhibitory control deficits, suggesting that CB1 receptor activation by endogenously released cannabinoids mediates this aspect of impulsive action. Direct CB1 receptor activation by Delta 9-Tetrahydrocannabinol (Delta 9-THC) did, however, not affect inhibitory control. Although neither SR141716A nor O-2050 affected baseline impulsive choice in the DRT, both ligands completely prevented amphetamine-induced reductions in impulsive decision making, indicating that CB1 receptor activity may decrease this form of impulsivity. Indeed, acute Delta 9-THC was found to reduce impulsive choice in a CB1 receptor-dependent way. Together, these results indicate an important, though complex role for cannabinoid CB1 receptor activity in the regulation of impulsive action and impulsive choice as well as the opposite effects amphetamine has on both forms of impulsive behavior.	[Wiskerke, Joost; Stoop, Nicky; Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wiskerke, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands.	t.pattij@vumc.nl	Wiskerke, Joost/L-5271-2017; Stoop, Nicky/GPG-0589-2022	Wiskerke, Joost/0000-0001-5029-341X; Pattij, Tommy/0000-0002-0079-7385	Dutch Top Institute Pharma [T5-107-1]	Dutch Top Institute Pharma	This research was supported by a grant from the Dutch Top Institute Pharma (T5-107-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arguello PA, 2004, PSYCHOPHARMACOLOGY, V177, P141, DOI 10.1007/s00213-004-1953-0; Bizarro L, 2004, BEHAV PHARMACOL, V15, P195, DOI 10.1097/01.fbp.0000131574.61491.50; Bizarro L, 2003, PSYCHOPHARMACOLOGY, V170, P271, DOI 10.1007/s00213-003-1543-6; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Centonze D, 2009, NEUROLOGY, V72, P1526, DOI 10.1212/WNL.0b013e3181a2e8f6; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Clark L, 2009, J PSYCHOPHARMACOL, V23, P14, DOI 10.1177/0269881108089587; COLE BJ, 1987, PSYCHOPHARMACOLOGY, V91, P458, DOI 10.1007/BF00216011; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalley JW, 2005, NEUROPSYCHOPHARMACOL, V30, P525, DOI 10.1038/sj.npp.1300590; de Bruin NMWJ, 2011, BEHAV BRAIN RES, V217, P408, DOI 10.1016/j.bbr.2010.11.013; De Vries TJ, 2001, NAT MED, V7, P1151, DOI 10.1038/nm1001-1151; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; Ehlers CL, 2007, TWIN RES HUM GENET, V10, P805, DOI 10.1375/twin.10.6.805; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Fillmore MT, 2003, DRUG ALCOHOL DEPEN, V71, P143, DOI 10.1016/S0376-8716(03)00089-9; Gardner A, 2006, EUR J PHARMACOL, V530, P103, DOI 10.1016/j.ejphar.2005.11.032; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Grottick AJ, 2000, BEHAV BRAIN RES, V117, P197, DOI 10.1016/S0166-4328(00)00305-3; Haj-Dahmane S, 2011, NEUROPHARMACOLOGY, V61, P414, DOI 10.1016/j.neuropharm.2011.02.016; Han CJ, 2001, BEHAV NEUROSCI, V115, P243, DOI 10.1037/0735-7044.115.1.243; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Kutcher S, 2004, EUR NEUROPSYCHOPHARM, V14, P11, DOI 10.1016/S0924-977X(03)00045-2; Lu AT, 2008, AM J MED GENET B, V147B, P1488, DOI 10.1002/ajmg.b.30693; Lupica CR, 2005, NEUROPHARMACOLOGY, V48, P1105, DOI 10.1016/j.neuropharm.2005.03.016; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Mendiguren A, 2007, NEUROPHARMACOLOGY, V52, P617, DOI 10.1016/j.neuropharm.2006.09.004; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Patel S, 2003, J PHARMACOL EXP THER, V306, P880, DOI 10.1124/jpet.103.054270; Paterson NE, 2011, NEUROSCI RES, V69, P41, DOI 10.1016/j.neures.2010.10.001; Pattij T, 2008, EUR J PHARMACOL, V585, P458, DOI 10.1016/j.ejphar.2008.02.099; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Ponce G, 2003, MOL PSYCHIATR, V8, P466, DOI 10.1038/sj.mp.4001278; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; Ramaekers JG, 2009, J PSYCHOPHARMACOL, V23, P266, DOI 10.1177/0269881108092393; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robledo P, 2008, ADDICT BIOL, V13, P213, DOI 10.1111/j.1369-1600.2008.00107.x; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Schoffelmeer ANM, 2006, NEUROPHARMACOLOGY, V51, P773, DOI 10.1016/j.neuropharm.2006.05.019; Skelly MJ, 2010, PHARMACOL BIOCHEM BE, V97, P144, DOI 10.1016/j.pbb.2010.05.024; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2007, J PHARMACOL EXP THER, V321, P370, DOI 10.1124/jpet.106.114124; Solowij N, 2007, J PSYCHIATR NEUROSCI, V32, P30; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Taylor KM, 2007, BEHAV PROCESS, V74, P168, DOI 10.1016/j.beproc.2006.11.005; Thiemann G, 2008, PHARMACOL BIOCHEM BE, V89, P384, DOI 10.1016/j.pbb.2008.01.010; Thiemann G, 2008, BEHAV BRAIN RES, V187, P289, DOI 10.1016/j.bbr.2007.09.022; Tzavara ET, 2009, EUR NEUROPSYCHOPHARM, V19, P196, DOI 10.1016/j.euroneuro.2008.11.003; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; van Gaalen MM, 2009, BEHAV PHARMACOL, V20, P484, DOI 10.1097/FBP.0b013e3283305e3b; van Gaalen MM, 2006, BIOL PSYCHIAT, V60, P66, DOI 10.1016/j.biopsych.2005.06.005; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Wiley JL, 2011, EUR J PHARMACOL, V651, P96, DOI 10.1016/j.ejphar.2010.10.085; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V170, P320, DOI 10.1007/s00213-003-1546-3; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Winstanley CA, 2011, BRIT J PHARMACOL, V164, P1301, DOI 10.1111/j.1476-5381.2011.01323.x; Winstanley CA, 2010, ALCOHOL CLIN EXP RES, V34, P1306, DOI 10.1111/j.1530-0277.2010.01215.x; Wiskerke J, 2008, ADDICT BIOL, V13, P225, DOI 10.1111/j.1369-1600.2008.00109.x; Wiskerke J, 2011, J NEUROSCI, V31, P262, DOI 10.1523/JNEUROSCI.4794-10.2011; Zacny JP, 2009, PHARMACOL BIOCHEM BE, V94, P108, DOI 10.1016/j.pbb.2009.07.010	89	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25856	10.1371/journal.pone.0025856	http://dx.doi.org/10.1371/journal.pone.0025856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016780	Green Published, gold			2022-12-25	WOS:000295970300033
J	Jiang, YL; Yu, WL; Zhang, JW; Frolet, C; Di Guilmi, AM; Zhou, CZ; Vernet, T; Chen, YX				Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Frolet, Cecile; Di Guilmi, Anne-Marie; Zhou, Cong-Zhao; Vernet, Thierry; Chen, Yuxing			Structural Basis for the Substrate Specificity of a Novel beta-N-Acetylhexosaminidase StrH Protein from Streptococcus pneumoniae R6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED CATALYSIS; CRYSTAL-STRUCTURE; SEQUENCE; CLASSIFICATION; CHITOBIASE; RECOGNITION; MECHANISM; INSIGHTS; PROVIDES; CLONING	The beta-N-acetylhexosaminidase (EC 3.2.1.52) from glycoside hydrolase family 20 (GH20) catalyzes the hydrolysis of the beta-N-acetylglucosamine (NAG) group from the nonreducing end of various glycoconjugates. The putative surface-exposed N-acetylhexosaminidase StrH/Spr0057 from Streptococcus pneumoniae R6 was proved to contribute to the virulence by removal of beta(1,2)-linked NAG on host defense molecules following the cleavage of sialic acid and galactose by neuraminidase and beta-galactosidase, respectively. StrH is the only reported GH20 enzyme that contains a tandem repeat of two 53% sequence-identical catalytic domains (designated as GH20-1 and GH20-2, respectively). Here, we present the 2.1 angstrom crystal structure of the N-terminal domain of StrH (residues Glu-175 to Lys-642) complexed with NAG. It adopts an overall structure similar to other GH20 enzymes: a (beta/alpha)(8) TIM barrel with the active site residing at the center of the beta-barrel convex side. The kinetic investigation using 4-nitrophenyl N-acetyl-beta-D-glucosaminide as the substrate demonstrated that GH20-1 had an enzymatic activity (k(cat)/K-m) of one-fourth compared with GH20-2. The lower activity of GH20-1 could be attributed to the substitution of active site Cys-469 of GH20-1 to the counterpart Tyr-903 of GH20-2. A complex model of NAG beta(1,2) Man at the active site of GH20-1 combined with activity assays of the corresponding site-directed mutants characterized two key residues Trp-443 and Tyr-482 at subsite +1 of GH20-1 (Trp-876 and Tyr-914 of GH20-2) that might determine the beta(1,2) substrate specificity. Taken together, these findings shed light on the mechanism of catalytic specificity toward the beta(1,2)-inked beta-N-acetylglucosides.	[Vernet, Thierry] Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, F-38027 Grenoble, France; [Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Vernet, T (corresponding author), Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	thierry.vernet@ibs.fr; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Vernet, Thierry/G-1118-2012; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936; Di Guilmi, Anne Marie/0000-0001-7335-3470	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China 30870488.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Intra J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-214; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177	41	28	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43004	43012		10.1074/jbc.M111.256578	http://dx.doi.org/10.1074/jbc.M111.256578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013074	Green Published, hybrid			2022-12-25	WOS:000298351300021
J	Singh, RK; Larson, JD; Zhu, WD; Rambo, RP; Hura, GL; Becker, DF; Tanner, JJ				Singh, Ranjan K.; Larson, John D.; Zhu, Weidong; Rambo, Robert P.; Hura, Greg L.; Becker, Donald F.; Tanner, John J.			Small-angle X-ray Scattering Studies of the Oligomeric State and Quaternary Structure of the Trifunctional Proline Utilization A (PutA) Flavoprotein from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; SALMONELLA-TYPHIMURIUM; MULTIFUNCTIONAL PUTA; CONFORMATIONAL-CHANGES; MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; DNA-BINDING; PROTEIN; DOMAIN	The trifunctional flavoprotein proline utilization A (PutA) links metabolism and gene regulation in Gram-negative bacteria by catalyzing the two-step oxidation of proline to glutamate and repressing transcription of the proline utilization regulon. Small-angle x-ray scattering (SAXS) and domain deletion analysis were used to obtain solution structural information for the 1320-residue PutA from Escherichia coli. Shape reconstructions show that PutA is a symmetric V-shaped dimer having dimensions of 205 x 85 x 55 angstrom. The particle consists of two large lobes connected by a 30-angstrom diameter cylinder. Domain deletion analysis shows that the N-terminal DNA-binding domain mediates dimerization. Rigid body modeling was performed using the crystal structure of the DNA-binding domain and a hybrid x-ray/homology model of residues 87-1113. The calculations suggest that the DNA-binding domain is located in the connecting cylinder, whereas residues 87-1113, which contain the two catalytic active sites, reside in the large lobes. The SAXS data and amino acid sequence analysis suggest that the Delta(1)-pyrroline-5-carboxylate dehydrogenase domains lack the conventional oligomerization flap, which is unprecedented for the aldehyde dehydrogenase superfamily. The data also provide insight into the function of the 200-residue C-terminal domain. It is proposed that this domain serves as a lid that covers the internal substrate channeling cavity, thus preventing escape of the catalytic intermediate into the bulk medium. Finally, the SAXS model is consistent with a cloaking mechanism of gene regulation whereby interaction of PutA with the membrane hides the DNA-binding surface from the put regulon thereby activating transcription.	[Singh, Ranjan K.; Larson, John D.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Zhu, Weidong; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Rambo, Robert P.; Hura, Greg L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	tannerjj@missouri.edu	SINGH, RANJAN/Q-2752-2017	SINGH, RANJAN/0000-0002-6929-0670; Hura, Greg/0000-0003-0501-8464; Tanner, John/0000-0001-8314-113X	National Institutes of Health [GM065546, GM061068]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061068, R01GM065546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065546 and GM061068.; We thank Kevin Dyer of the SIBYLS Mail In SAXS Program for collecting some of the SAXS data. We also thank Prof. Krishna K. Sharma for use of his SEC-MALS instrument, and Dr. Santhoshkumar Puttur for helping with SEC-MALS data collection and analysis. Part of this research was performed at the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BROWN ED, 1992, J BIOL CHEM, V267, P13086; BROWN ED, 1993, J BIOL CHEM, V268, P8972; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; DESPICER PO, 1993, P NATL ACAD SCI USA, V90, P4295, DOI 10.1073/pnas.90.9.4295; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MALOY SR, 1983, J BACTERIOL, V154, P561, DOI 10.1128/JB.154.2.561-568.1983; MENZEL R, 1981, J MOL BIOL, V148, P21, DOI 10.1016/0022-2836(81)90233-3; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; MUROPASTOR AM, 1995, J BIOL CHEM, V270, P9819, DOI 10.1074/jbc.270.17.9819; MuroPastor AM, 1997, J BACTERIOL, V179, P2788, DOI 10.1128/jb.179.8.2788-2791.1997; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RATZKIN B, 1978, J BACTERIOL, V133, P744, DOI 10.1128/JB.133.2.744-754.1978; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Srivastava D, 2010, BIOCHEMISTRY-US, V49, P560, DOI 10.1021/bi901717s; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Surber MW, 1998, ARCH BIOCHEM BIOPHYS, V354, P281, DOI 10.1006/abbi.1998.0697; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Vilchez S, 2000, APPL ENVIRON MICROB, V66, P5221, DOI 10.1128/AEM.66.12.5221-5225.2000; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; WOOD JM, 1987, P NATL ACAD SCI USA, V84, P373, DOI 10.1073/pnas.84.2.373; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhang WM, 2007, BIOCHEMISTRY-US, V46, P483, DOI 10.1021/bi061935g; Zhang WM, 2004, BIOCHEMISTRY-US, V43, P13165, DOI 10.1021/bi048596g; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084; Zhu WD, 2005, BIOCHEMISTRY-US, V44, P12297, DOI 10.1021/bi051026b; Zhu WD, 2003, BIOCHEMISTRY-US, V42, P5469, DOI 10.1021/bi0272196	48	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43144	43153		10.1074/jbc.M111.292474	http://dx.doi.org/10.1074/jbc.M111.292474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013066	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000298351300035
J	Nemecz, A; Taylor, P				Nemecz, Akos; Taylor, Palmer			Creating an alpha 7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein CRYSTALLOGRAPHIC AND LIGAND SELECTIVITY ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4 BETA 2; CONFORMATIONAL-CHANGES; IN-VITRO; PHARMACOLOGICAL-PROPERTIES; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; RECEPTOR; SITE; AGONISTS; SUBUNIT	Determining the structure of the ligand-binding domain of the nicotinic acetylcholine receptor (nAChR) has been a long standing goal in the design of selective drugs useful in implicated diseases for this prevalent receptor family. Acetylcholine-binding proteins have proven to be valuable surrogates with structural similarity and sequence identity to the extracellular domain of the nicotinic receptor, yet these soluble proteins have their unique features and do not serve as exact replicates of the nAChRs of interest. Here we systematically modify the sequence of these proteins toward the homomeric human alpha 7 nAChR. These chimeric proteins exhibit a shift in affinities to reflect alpha 7 binding characteristics yet maintain expression levels and stability conducive for crystallization. We also present a pentameric humanoid nAChR extracellular domain with the structural determination of the alpha 7 nAChR glycosylation site.	[Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Pharmaceut Sci Bldg 0657,9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu			National Institutes of Health [T32 GM-007752, R01 GM 18360, U01 DA 019372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA019372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM-007752 (to A.N.) and R01 GM 18360 and U01 DA 019372 (to P.T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Astles PC, 2002, CNS NEUROL DISORD-DR, V1, P337, DOI 10.2174/1568007023339256; Avramopoulou V, 2004, J BIOL CHEM, V279, P38287, DOI 10.1074/jbc.M402533200; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Briggs CA, 1999, EUR J PHARMACOL, V366, P301, DOI 10.1016/S0014-2999(98)00909-1; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; BRIGGS CA, 1995, NEUROPHARMACOLOGY, V34, P583, DOI 10.1016/0028-3908(95)00028-5; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; de Kloe GE, 2010, J MED CHEM, V53, P7192, DOI 10.1021/jm100834y; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer M, 2001, P NATL ACAD SCI USA, V98, P3567, DOI 10.1073/pnas.041594798; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kem WR, 2004, MOL PHARMACOL, V65, P56, DOI 10.1124/mol.65.1.56; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marinou M, 2003, BIOCHEM J, V372, P543, DOI 10.1042/BJ20021537; Mazurov A, 2006, CURR MED CHEM, V13, P1567, DOI 10.2174/092986706777442011; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Nguyen QT, 2010, NAT NEUROSCI, V13, P127, DOI 10.1038/nn.2469; Papke RL, 2005, NEUROSCI LETT, V378, P140, DOI 10.1016/j.neulet.2004.12.025; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; PENG X, 1994, MOL PHARMACOL, V45, P546; Pereira EFR, 1996, J PHARMACOL EXP THER, V278, P1472; Person AM, 2005, J BIOL CHEM, V280, P39990, DOI 10.1074/jbc.M505087200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Schrodinger L., 2020, PYMOL; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1994, J BIOL CHEM, V269, P8808; Stokes C, 2004, MOL PHARMACOL, V66, P14, DOI 10.1124/mol.66.1.14; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; TAYLOR P, 1990, P1; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Tierney ML, 2000, J MOL BIOL, V303, P185, DOI 10.1006/jmbi.2000.4137; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Zouridakis M, 2007, INT J BIOL MACROMOL, V41, P423, DOI 10.1016/j.ijbiomac.2007.05.012; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	70	56	56	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42555	42565		10.1074/jbc.M111.286583	http://dx.doi.org/10.1074/jbc.M111.286583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009746	Green Published, hybrid			2022-12-25	WOS:000298180900063
J	Chang, TC; Klabnik, JL; Liu, WS				Chang, Ti-Cheng; Klabnik, Jessica L.; Liu, Wan-Sheng			Regional Selection Acting on the OFD1 Gene Family	PLOS ONE			English	Article							FACIAL-DIGITAL SYNDROME; SYNDROME TYPE-1; I SYNDROME; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; SEX-CHROMOSOMES; Y-CHROMOSOME; PROTEIN; DISEASE; PSEUDOGENES	The OFD1 (oral-facial-digital, type 1) gene is implicated in several developmental disorders in humans. The X-linked OFD1 (OFD1X) is conserved in Eutheria. Knowledge about the Y-linked paralog (OFD1Y) is limited. In this study, we identified an OFD1Y on the bovine Y chromosome, which is expressed differentially from the bovine OFD1X. Phylogenetic analysis indicated that: a) the eutherian OFD1X and OFD1Y were derived from the pair of ancestral autosomes during sex chromosome evolution; b) the autosomal OFD1 pseudogenes, present in Catarrhini and Murinae, were derived from retropositions of OFD1X after the divergence of primates and rodents; and c) the presence of OFD1Y in the ampliconic region of the primate Y chromosome is an indication that the expansion of the ampliconic region may initiate from the X-degenerated sequence. In addition, we found that different regions of OFD1/OFD1X/OFD1Y are under differential selection pressures. The C-terminal half of OFD1 is under relaxed selection with an elevated Ka/Ks ratio and clustered positively selected sites, whereas the N-terminal half is under stronger constraints. This study provides some insights into why the OFD1X gene causes OFD1 (male-lethal X-linked dominant) and SGBS2 & JSRDs (X-linked recessive) syndromes in humans, and reveals the origin and evolution of the OFD1 family, which will facilitate further clinical investigation of the OFD1-related syndromes.	[Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA; [Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Huck Inst Life Sci, Integrat Biosci Program, University Pk, PA 16802 USA; [Klabnik, Jessica L.] Penn State Univ, Coll Agr Sci, Vet & Biomed Dept, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chang, TC (corresponding author), Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA.	wul12@psu.edu	Chang, Ti-Cheng/HHS-7370-2022; Chang, Ti-Cheng/N-3252-2018; Klabnik, Jessica/V-6221-2017	Klabnik, Jessica/0000-0003-4843-6498	USDA-NIFA [2005-35205-18653, 2010-65205-20362]; Pennsylvania State University	USDA-NIFA(United States Department of Agriculture (USDA)); Pennsylvania State University	This work was supported by grants from USDA-NIFA (No. 2005-35205-18653 and No. 2010-65205-20362) and start-up funds from the Pennsylvania State University to Liu, W-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; de Conciliis L, 1998, GENOMICS, V51, P243, DOI 10.1006/geno.1998.5348; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; FELSENSTEIN J, 1985, EVOLUTION, V39, P791; Ferrante MI, 2009, HUM MOL GENET, V18, P289, DOI 10.1093/hmg/ddn356; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Morisawa T, 2004, HUM GENET, V115, P97, DOI 10.1007/s00439-004-1139-1; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prattichizzo C, 2008, HUM MUTAT, V29, P1237, DOI 10.1002/humu.20792; Rakkolainen A, 2002, J MED GENET, V39, P292, DOI 10.1136/jmg.39.4.292; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thauvin-Robinet C, 2006, J MED GENET, V43, P54, DOI 10.1136/jmg.2004.027672; Thauvin-Robinet C, 2009, HUM MUTAT, V30, pE320, DOI 10.1002/humu.20888; Van Laere AS, 2008, GENOME RES, V18, P1884, DOI 10.1101/gr.082487.108; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003	57	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26195	10.1371/journal.pone.0026195	http://dx.doi.org/10.1371/journal.pone.0026195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022562	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600037
J	Sanabani, SS; Pastena, ERD; da Costa, AC; Martinez, VP; Kleine-Neto, W; de Oliveira, ACS; Sauer, MM; Bassichetto, KC; Oliveira, SMS; Tomiyama, HTI; Sabino, EC; Kallas, EG				Sanabani, Sabri Saeed; de Souza Pastena, Evelyn Regina; da Costa, Antonio Charlys; Martinez, Vanessa Pouza; Kleine-Neto, Walter; Soares de Oliveira, Ana Carolina; Sauer, Mariana Melillo; Bassichetto, Katia Cristina; Santos Oliveira, Solange Maria; Iwashita Tomiyama, Helena Tomoko; Sabino, Ester Cerdeira; Kallas, Esper Georges			Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL DRUG-RESISTANCE; SUBTYPE-B; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; TYPE-1; PREVALENCE; TROPISM; RECOMBINATION; TRANSMISSION	Background: Genetic variability is a major feature of human immunodeficiency virus type 1 (HIV-1) and is considered the key factor frustrating efforts to halt the HIV epidemic. A proper understanding of HIV-1 genomic diversity is a fundamental prerequisite for proper epidemiology, genetic diagnosis, and successful drugs and vaccines design. Here, we report on the partial and near full-length genomic (NFLG) variability of HIV-1 isolates from a well-characterized cohort of recently infected patients in Sao Paul, Brazil. Methodology: HIV-1 proviral DNA was extracted from the peripheral blood mononuclear cells of 113 participants. The NFLG and partial fragments were determined by overlapping nested PCR and direct sequencing. The data were phylogenetically analyzed. Results: Of the 113 samples (90.3% male; median age 31 years; 79.6% homosexual men) studied, 77 (68.1%) NFLGs and 32 (29.3%) partial fragments were successfully subtyped. Of the successfully subtyped sequences, 88 (80.7%) were subtype B sequences, 12 (11%) BF1 recombinants, 3 (2.8%) subtype C sequences, 2 (1.8%) BC recombinants and subclade F1 each, 1 (0.9%) CRF02 AG, and 1 (0.9%) CRF31 BC. Primary drug resistance mutations were observed in 14/101 (13.9%) of samples, with 5.9% being resistant to protease inhibitors and nucleoside reverse transcriptase inhibitors (NRTI) and 4.9% resistant to non-NRTIs. Predictions of viral tropism were determined for 86 individuals. X4 or X4 dual or mixed-tropic viruses (X4/DM) were seen in 26 (30.2%) of subjects. The proportion of X4 viruses in homosexuals was detected in 19/69 (27.5%). Conclusions: Our results confirm the existence of various HIV-1 subtypes circulating in Sao Paulo, and indicate that subtype B account for the majority of infections. Antiretroviral (ARV) drug resistance is relatively common among recently infected patients. The proportion of X4 viruses in homosexuals was significantly higher than the proportion seen in other study populations.	[Sanabani, Sabri Saeed; Sauer, Mariana Melillo; Iwashita Tomiyama, Helena Tomoko; Kallas, Esper Georges] Univ Sao Paulo, Fac Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; da Costa, Antonio Charlys; Kleine-Neto, Walter; Soares de Oliveira, Ana Carolina] Univ Fed Sao Paulo, Dept Translat Med, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; Kleine-Neto, Walter; Sabino, Ester Cerdeira] Fundacao Pro Sangue, Blood Ctr Sau Paulo, Sao Paulo, Brazil; [de Souza Pastena, Evelyn Regina; da Costa, Antonio Charlys; Martinez, Vanessa Pouza; Soares de Oliveira, Ana Carolina; Sabino, Ester Cerdeira] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Bassichetto, Katia Cristina; Santos Oliveira, Solange Maria] Publ Hlth Dept Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Fac Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.	sabyem_63@yahoo.com	da-Costa, Antonio Charlys/G-1548-2010; Sabino, Ester C/F-7750-2010; Sanabani, Sabri Saeed/F-5600-2012; Kallas, Esper G/C-9539-2012	da-Costa, Antonio Charlys/0000-0001-5516-5177; Sabino, Ester C/0000-0003-2623-5126; Sanabani, Sabri Saeed/0000-0002-8876-8262; Kallas, Esper/0000-0003-2026-6925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15856-9, 2006/50096-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by grants 04/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Batista MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005613; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Cohen OJ, 1998, NEW ENGL J MED, V339, P341, DOI 10.1056/NEJM199807303390511; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lehmann C, 2006, J CLIN VIROL, V37, P300, DOI 10.1016/j.jcv.2006.08.008; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; de Souza ACMF, 2008, AIDS RES HUM RETROV, V24, P1521, DOI 10.1089/aid.2008.0089; Mansky LM, 1996, VIROLOGY, V222, P391, DOI 10.1006/viro.1996.0436; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Nicastri E, 2003, J MED VIROL, V69, P1, DOI 10.1002/jmv.10269; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; Sa-Ferreira JA, 2007, TRANSFUSION, V47, P97, DOI 10.1111/j.1537-2995.2007.01069.x; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Worobey M, 2001, MOL BIOL EVOL, V18, P254, DOI 10.1093/oxfordjournals.molbev.a003799; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	55	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25869	10.1371/journal.pone.0025869	http://dx.doi.org/10.1371/journal.pone.0025869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022460	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600017
J	Tseng, AS; Carneiro, K; Lemire, JM; Levin, M				Tseng, Ai-Sun; Carneiro, Katia; Lemire, Joan M.; Levin, Michael			HDAC Activity Is Required during Xenopus Tail Regeneration	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; ACETYLATION; MORPHOGENESIS; CHROMATIN; PROTEIN; GROWTH; POTENT; ROLES; MSIN3; MODEL	The ability to fully restore damaged or lost organs is present in only a subset of animals. The Xenopus tadpole tail is a complex appendage, containing epidermis, muscle, nerves, spinal cord, and vasculature, which regenerates after amputation. Understanding the mechanisms of tail regeneration may lead to new insights to promote biomedical regeneration in non-regenerative tissues. Although chromatin remodeling is known to be critical for stem cell pluripotency, its role in complex organ regeneration in vivo remains largely uncharacterized. Here we show that histone deacetylase (HDAC) activity is required for the early stages of tail regeneration. HDAC1 is expressed during the 1(st) two days of regeneration. Pharmacological blockade of HDACs using Trichostatin A (TSA) increased histone acetylation levels in the amputated tail. Furthermore, treatment with TSA or another HDAC inhibitor, valproic acid, specifically inhibited regeneration. Over-expression of wild-type Mad3, a transcriptional repressor known to associate in a complex with HDACs via Sin3, inhibited regeneration. Similarly, expression of a Mad3 mutant lacking the Sin3-interacting domain that is required for HDAC binding also blocks regeneration, suggesting that HDAC and Mad3 may act together to regulate regeneration. Inhibition of HDAC function resulted in aberrant expression of Notch1 and BMP2, two genes known to be required for tail regeneration. Our results identify a novel early role for HDAC in appendage regeneration and suggest that modulation of histone acetylation is important in regenerative repair of complex appendages.	[Tseng, Ai-Sun; Lemire, Joan M.; Levin, Michael] Tufts Univ, Dept Dev Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA; [Carneiro, Katia] Univ Fed Rio de Janeiro, Dept Histol & Embryol, Inst Biomed Sci, Rio De Janeiro, Brazil	Tufts University; Universidade Federal do Rio de Janeiro	Tseng, AS (corresponding author), Tufts Univ, Dept Dev Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Carneiro, Katia/AAQ-3415-2020; Levin, Michael/A-5918-2011; Carneiro, Katia/I-6014-2015	Carneiro, Katia/0000-0001-5915-5486; Levin, Michael/0000-0001-7292-8084; 	NIH [GM078484]; G. Harold and Leila Y. Mathers Charitable Foundation; Telemedicine and Advanced Technology Research Center (TATRC); U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH-10-2-0058]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Telemedicine and Advanced Technology Research Center (TATRC); U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML gratefully acknowledges funding support of NIH grant GM078484, the G. Harold and Leila Y. Mathers Charitable Foundation, and the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) through award W81XWH-10-2-0058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Adler JT, 2008, SURGERY, V144, P956, DOI 10.1016/j.surg.2008.08.027; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Beck CW, 2009, DEV DYNAM, V238, P1226, DOI 10.1002/dvdy.21890; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Beck CW, 1999, DEVELOPMENT, V126, P1611; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Carneiro K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-29; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Damjanovski S, 2000, INT J DEV BIOL, V44, P769; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Li X, 2008, Mol Biol (Mosk), V42, P990; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nieukoop P, 1967, NORMAL TABLE XENOPUS; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; Riau AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014687; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slack JMW, 2004, PHILOS T R SOC B, V359, P745, DOI 10.1098/rstb.2004.1463; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Sugiura T, 2009, MECH DEVELOP, V126, P56, DOI 10.1016/j.mod.2008.10.002; Tseng AS, 2008, J DENT RES, V87, P806, DOI 10.1177/154405910808700909; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Xiao XM, 2009, MOL CANCER THER, V8, P350, DOI 10.1158/1535-7163.MCT-08-0585; Xiong L, 2011, J BIOL CHEM, V286, P13657, DOI 10.1074/jbc.M110.204800; Yakushiji N, 2007, DEV BIOL, V312, P171, DOI 10.1016/j.ydbio.2007.09.022; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	52	46	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26382	10.1371/journal.pone.0026382	http://dx.doi.org/10.1371/journal.pone.0026382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022609	gold, Green Submitted, Green Published			2022-12-25	WOS:000295981600057
J	Chang, CJ; Mitra, K; Koya, M; Velho, M; Desprat, R; Lenz, J; Bouhassira, EE				Chang, Chan-Jung; Mitra, Koyel; Koya, Mariko; Velho, Michelle; Desprat, Romain; Lenz, Jack; Bouhassira, Eric E.			Production of Embryonic and Fetal-Like Red Blood Cells from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; DIRECTED DIFFERENTIATION; EPIGENETIC MEMORY; IPS CELLS; FIBROBLASTS; METHYLATION; PROGENITORS; INTEGRATION; GENERATION; EXPRESSION	We have previously shown that human embryonic stem cells can be differentiated into embryonic and fetal type of red blood cells that sequentially express three types of hemoglobins recapitulating early human erythropoiesis. We report here that we have produced iPS from three somatic cell types: adult skin fibroblasts as well as embryonic and fetal mesenchymal stem cells. We show that regardless of the age of the donor cells, the iPS produced are fully reprogrammed into a pluripotent state that is undistinguishable from that of hESCs by low and high-throughput expression and detailed analysis of globin expression patterns by HPLC. This suggests that reprogramming with the four original Yamanaka pluripotency factors leads to complete erasure of all functionally important epigenetic marks associated with erythroid differentiation regardless of the age or the tissue type of the donor cells, at least as detected in these assays. The ability to produce large number of erythroid cells with embryonic and fetal-like characteristics is likely to have many translational applications.	[Chang, Chan-Jung; Koya, Mariko; Velho, Michelle; Desprat, Romain; Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Dept Cell Biol, Bronx, NY 10467 USA; [Mitra, Koyel; Lenz, Jack] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chang, CJ (corresponding author), Albert Einstein Coll Med, Dept Med, Dept Cell Biol, Bronx, NY 10467 USA.	eric.bouhassira@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NYSTEM, the funding agency of New York State Empire Stem Cell Board [HL08846, N08T-006 (C024405), N08S-001 (C024172)]	NYSTEM, the funding agency of New York State Empire Stem Cell Board	Dr. Chang, Dr. Desprat, Dr. Velho, and Dr. Bouhassira are supported in part by grants HL08846 and by Grants N08T-006 (C024405) and N08S-001 (C024172) from NYSTEM, the funding agency of New York State Empire Stem Cell Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Chang KH, 2010, BLOOD, V115, P2553, DOI 10.1182/blood-2009-11-252650; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Desprat R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005956; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; FINA L, 1990, BLOOD, V75, P2417; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P191, DOI 10.1111/j.1749-6632.2009.04962.x; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P523, DOI 10.1001/archderm.127.4.523; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; POBLET E, 1994, J CUTAN PATHOL, V21, P224, DOI 10.1111/j.1600-0560.1994.tb00264.x; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yen BL, 2009, STEM CELLS, V27, P451, DOI 10.1634/stemcells.2008-0390; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	52	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25761	10.1371/journal.pone.0025761	http://dx.doi.org/10.1371/journal.pone.0025761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022444	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600029
J	Kaddurah-Daouk, R; Baillie, RA; Zhu, HJ; Zeng, ZB; Wiest, MM; Nguyen, UT; Wojnoonski, K; Watkins, SM; Trupp, M; Krauss, RM				Kaddurah-Daouk, Rima; Baillie, Rebecca A.; Zhu, Hongjie; Zeng, Zhao-Bang; Wiest, Michelle M.; Uyen Thao Nguyen; Wojnoonski, Katie; Watkins, Steven M.; Trupp, Miles; Krauss, Ronald M.			Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment	PLOS ONE			English	Article							GLOBAL BIOCHEMICAL APPROACH; TANDEM MASS-SPECTROMETRY; BILE-ACIDS; LIQUID-CHROMATOGRAPHY; REDUCTASE INHIBITORS; LACTONE FORMS; CARDIOVASCULAR-DISEASE; SLCO1B1 POLYMORPHISM; RANDOMIZED-TRIALS; DRUG-INTERACTIONS	Although statins are widely prescribed medications, there remains considerable variability in therapeutic response. Genetics can explain only part of this variability. Metabolomics is a global biochemical approach that provides powerful tools for mapping pathways implicated in disease and in response to treatment. Metabolomics captures net interactions between genome, microbiome and the environment. In this study, we used a targeted GC-MS metabolomics platform to measure a panel of metabolites within cholesterol synthesis, dietary sterol absorption, and bile acid formation to determine metabolite signatures that may predict variation in statin LDL-C lowering efficacy. Measurements were performed in two subsets of the total study population in the Cholesterol and Pharmacogenetics (CAP) study: Full Range of Response (FR), and Good and Poor Responders (GPR) were 100 individuals randomly selected from across the entire range of LDL-C responses in CAP. GPR were 48 individuals, 24 each from the top and bottom 10% of the LDL-C response distribution matched for body mass index, race, and gender. We identified three secondary, bacterial-derived bile acids that contribute to predicting the magnitude of statin-induced LDL-C lowering in good responders. Bile acids and statins share transporters in the liver and intestine; we observed that increased plasma concentration of simvastatin positively correlates with higher levels of several secondary bile acids. Genetic analysis of these subjects identified associations between levels of seven bile acids and a single nucleotide polymorphism (SNP), rs4149056, in the gene encoding the organic anion transporter SLCO1B1. These findings, along with recently published results that the gut microbiome plays an important role in cardiovascular disease, indicate that interactions between genome, gut microbiome and environmental influences should be considered in the study and management of cardiovascular disease. Metabolic profiles could provide valuable information about treatment outcomes and could contribute to a more personalized approach to therapy.	[Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Baillie, Rebecca A.] Rosa & Co, Cupertino, CA USA; [Zhu, Hongjie; Zeng, Zhao-Bang] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Zhu, Hongjie; Zeng, Zhao-Bang] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Wiest, Michelle M.] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Uyen Thao Nguyen; Watkins, Steven M.] Lipom Technol Tethys Biosci, W Sacramento, CA USA; [Trupp, Miles] SRI Int, AI Ctr, Bioinformat Res Grp, Menlo Pk, CA 94025 USA; [Wojnoonski, Katie; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Duke University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Idaho; University of Idaho; SRI International; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Kaddurah-Daouk, R (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	kaddu001@mc.duke.edu; rkrauss@chori.org	baillie, rebecca/AAQ-3400-2020	baillie, rebecca/0000-0003-3966-6320; Kaddurah-Daouk, Rima/0000-0003-1858-5732	National Institute of General Medical Sciences [R24, GM078233, U01 HL069757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institute of General Medical Sciences grants R24, GM078233, "The Metabolomics Research Network for Drug Response Phenotype'' (RKD, RMK); and U01 HL069757, "Pharmacogenomics and Risk of Cardiovascular Disease'' (RMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM HEART ASS, 2004, HEART DIS STROK STAT; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Burkard I, 2005, J CHROMATOGR B, V826, P147, DOI 10.1016/j.jchromb.2005.08.016; Chen CP, 2005, DRUG METAB DISPOS, V33, P537, DOI 10.1124/dmd.104.002477; Chen C, 2007, DRUG METAB DISPOS, V35, P1725, DOI 10.1124/dmd.107.015677; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Deo AK, 2008, DRUG METAB DISPOS, V36, P1983, DOI 10.1124/dmd.108.022194; Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001; Holtzman CW, 2006, PHARMACOTHERAPY, V26, P1601, DOI 10.1592/phco.26.11.1601; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2010, METABOLOMICS, V6, P191, DOI 10.1007/s11306-010-0207-x; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Keskitalo JE, 2008, CLIN PHARMACOL THER, V84, P457, DOI 10.1038/clpt.2008.25; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lye HS, 2010, J DAIRY SCI, V93, P1383, DOI 10.3168/jds.2009-2574; Mangravite LM, 2008, CURR OPIN MOL THER, V10, P555; Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90; Phillips KM, 1999, J CHROMATOGR B, V732, P17, DOI 10.1016/S0378-4347(99)00257-1; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rodrigues AC, 2009, ACTA PHARMACOL SIN, V30, P956, DOI 10.1038/aps.2009.85; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Tazuma S, 1998, J CLIN GASTROENTEROL, V26, P287, DOI 10.1097/00004836-199806000-00015; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xiang XQ, 2009, PHARMACOGENET GENOM, V19, P447, DOI 10.1097/FPC.0b013e32832bcf7b; Yamasaki D, 2009, EUR J PHARM SCI, V37, P126, DOI 10.1016/j.ejps.2009.01.009; Zhao JJ, 2000, J MASS SPECTROM, V35, P1133, DOI 10.1002/1096-9888(200009)35:9<1133::AID-JMS42>3.0.CO;2-X; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	42	130	139	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25482	10.1371/journal.pone.0025482	http://dx.doi.org/10.1371/journal.pone.0025482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022402	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600017
J	Beurel, E				Beurel, Eleonore			HDAC6 Regulates LPS-Tolerance in Astrocytes	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-KAPPA-B; GROWTH-FACTOR-BETA; HISTONE DEACETYLASE; ENDOTOXIN TOLERANCE; MOLECULAR-MECHANISM; VALPROIC ACID; LIPOPOLYSACCHARIDE; INFLAMMATION; INHIBITORS	Inflammatory tolerance is a crucial mechanism that limits inflammatory responses in order to avoid prolonged inflammation that may damage the host. Evidence that chronic inflammation contributes to the neuropathology of prevalent neurodegenerative and psychiatric diseases suggests that inflammatory tolerance mechanisms are often inadequate to control detrimental inflammation in the central nervous system. Thus, identifying mechanisms that regulate neuroinflammatory tolerance may reveal opportunities for bolstering tolerance to reduce chronic inflammation in these diseases. Examination of tolerance after repeated lipopolysaccharide (LPS) treatment of mouse primary astrocytes demonstrated that histone deacetylase (HDAC) activity promoted tolerance, opposite to the action of glycogen synthase kinase-3 (GSK3), which counteracts tolerance. HDAC6 in particular was found to be critical for tolerance induction, as its deacetylation of acetyl-tubulin was increased during LPS tolerance, this was enhanced by inhibition of GSK3, and the HDAC6 inhibitor tubacin completely blocked tolerance and the promotion of tolerance by inhibition of GSK3. These results reveal opposing interactions between HDAC6 and GSK3 in regulating tolerance, and indicate that shifting the balance between these two opposing forces on inflammatory tolerance can obliterate or enhance tolerance to LPS in astrocytes.	Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA	University of Miami	Beurel, E (corresponding author), Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA.	eleonore_beurel@hotmail.fr			National Instute of Mental Health (NIMH), National Institutes of Health (NIH) [MH090236, MH038752]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH090236, R01MH038752, K99MH090236, R56MH038752] Funding Source: NIH RePORTER	National Instute of Mental Health (NIMH), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the National Instute of Mental Health (NIMH), National Institutes of Health (NIH)(MH090236 and MH038752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89; Ayala A., 1993, ARCH SURG-CHICAGO, V128, P94; Beurel E, 2010, NEUROSCIENCE, V169, P1063, DOI 10.1016/j.neuroscience.2010.05.044; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Blackwell TS, 1997, J LEUKOCYTE BIOL, V62, P885, DOI 10.1002/jlb.62.6.885; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Marie C, 2000, CYTOKINE, V12, P55, DOI 10.1006/cyto.1999.0517; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; MILLERGRAZIANO CL, 1991, J CLIN IMMUNOL, V11, P95, DOI 10.1007/BF00917745; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	30	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25804	10.1371/journal.pone.0025804	http://dx.doi.org/10.1371/journal.pone.0025804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022450	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000040
J	Liu, YN; Wang, W; Li, X; Wang, H; Luo, YX; Wu, LJ; Guo, XH				Liu, Yunning; Wang, Wei; Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua			Geographic Distribution and Risk Factors of the Initial Adult Hospitalized Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in Mainland China	PLOS ONE			English	Article								Background: As of 31(st) March 2010, more than 127,000 confirmed cases of 2009 pandemic influenza A (H1N1), including 800 deaths, were reported in mainland China. The distribution and characteristics of the confirmed cases in the initial phase of this pandemic in this country are largely unknown. The present study aimed to characterize the geographic distribution and patient characteristics of H1N1 infection in the 2009 pandemic as well as to identify potential risk factors associated with adverse patient outcome in China, through retrospective analyses of 885 hospitalized cases with confirmed H1N1 infection. Methodology/Principal Findings: The proportional hazards model was employed to detect risk factors for adverse outcome; the geo-statistical maps were used to characterize the distribution of all 2668 confirmed H1N1 patients throughout mainland China. The number of new cases increased slowly in May, 2009, but rapidly between June and August of the year. Confirmed cases were reported in 26 provinces; Beijing, Guangdong, Shanghai, Zhejiang and Fujian were the top five regions of the incidence of the virus infection. After being adjusted for gender, age, chronic pulmonary disease and other general symptoms, delay for more than two days before hospital admission (HR: 0.6; 95% CI: 0.5-0.7) and delayed onset of the H1N1-specific respiratory symptoms (HR: 0.3; 95% CI: 0.2-0.4) were associated with adverse patient outcome. Conclusions/Significance: The 2009 pandemic influenza A affected east and southeast coastal provinces and most populous cities more severely than other regions in mainland China due to higher risk of high level traffic-, high population density-, and high population mobility-associated H1N1 transmission. The clinical symptoms were mild in the initial phase of infection. Delayed hospital admission and delayed appearance of respiratory symptoms were among the major risk factors for poor patient outcome. These findings may have significant implications in the future pandemic preparedness and response.	[Liu, Yunning; Wang, Wei; Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University	Liu, YN (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022	wang, wei/0000-0002-1430-1360	Jurisdiction of Beijing Municipality [PHR201007112]; National ST Major Project [2010ZX09401]	Jurisdiction of Beijing Municipality; National ST Major Project	This work was supported by Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); National S&T Major Project (2010ZX09401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulos Maged N Kamel, 2004, Int J Health Geogr, V3, P2, DOI 10.1186/1476-072X-3-2; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chowell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021287; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jeong I, 2010, AM J INFECT CONTROL, V38, P482, DOI 10.1016/j.ajic.2010.02.006; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; *MIN HLTH PEOPL RE, 3 VERS CLIN GUID PAN; *MIN HLTH PEOPL RE, 2010, NAT INFL H1N1 PREV C; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; WENGER JD, 2011, J INFECT DIS, V203, P828; WHO, CURR WHO PHAS PAND A; *WHO, PAND H1N1 2009 UPD 9	16	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25934	10.1371/journal.pone.0025934	http://dx.doi.org/10.1371/journal.pone.0025934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022474	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000048
J	Nakayama, S; Sawamura, K; Mohri, K; Uchiyama, T				Nakayama, Shinsuke; Sawamura, Kenta; Mohri, Kaneo; Uchiyama, Tsuyoshi			Pulse-Driven Magnetoimpedance Sensor Detection of Cardiac Magnetic Activity	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MAGNETOCARDIOGRAPHY; SEGMENT; WIRE	This study sought to establish a convenient method for detecting biomagnetic activity in the heart. Electrical activity of the heart simultaneously induces a magnetic field. Detection of this magnetic activity will enable non-contact, noninvasive evaluation to be made. We improved the sensitivity of a pulse-driven magnetoimpedance (PMI) sensor, which is used as an electric compass in mobile phones and as a motion sensor of the operation handle in computer games, toward a pico-Tesla (pT) level, and measured magnetic fields on the surface of the thoracic wall in humans. The changes in magnetic field detected by this sensor synchronized with the electric activity of the electrocardiogram (ECG). The shape of the magnetic wave was largely altered by shifting the sensor position within 20 mm in parallel and/or perpendicular to the thoracic wall. The magnetic activity was maximal in the 4th intercostals near the center of the sterna. Furthermore, averaging the magnetic activity at 15 mm in the distance between the thoracic wall and the sensor demonstrated magnetic waves mimicking the P wave and QRS complex. The present study shows the application of PMI sensor in detecting cardiac magnetic activity in several healthy subjects, and suggests future applications of this technology in medicine and biology.	[Nakayama, Shinsuke; Sawamura, Kenta] Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Mohri, Kaneo; Uchiyama, Tsuyoshi] Nagoya Univ, Dept Elect, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Nakayama, S (corresponding author), Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	tutiyama@nuee.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency (JST) [b120058]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partly supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, and Japan Science and Technology Agency (JST, b120058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN D, 1971, SCIENCE, V172, P1329, DOI 10.1126/science.172.3990.1329; Fenici R, 2005, EXPERT REV MOL DIAGN, V5, P291, DOI 10.1586/14737159.5.3.291; Ikefuji Hiroyuki, 2007, J Med Invest, V54, P116, DOI 10.2152/jmi.54.116; INADA K, 1994, IEEE T MAGN, V30, P4263; Ishikawa T, 2004, AM J PHYSIOL-CELL PH, V286, pC1344, DOI 10.1152/ajpcell.00392.2003; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Katritsis D, 2010, J AM COLL CARDIOL, V55, P2293, DOI 10.1016/j.jacc.2010.03.016; Koch H, 2004, J ELECTROCARDIOL, V37, P117, DOI 10.1016/j.jelectrocard.2004.08.035; Mallinson JC, 1993, FDN MAGNETIC RECORDI; Melo LGC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2837106; Mohri K, 2007, SENS LETT, V5, P267, DOI 10.1166/sl.2007.082; NAKAYA Y, 1992, CLIN PHYS PHYSIOL M, V13, P191, DOI 10.1088/0143-0815/13/3/001; Nakayama S, 2011, BIOSENS BIOELECTRON, V27, P34, DOI 10.1016/j.bios.2011.05.041; Nelson TJ, 2010, NAT REV CARDIOL, V7, P700, DOI 10.1038/nrcardio.2010.159; Sanacci S., 2004, IEEE T MAGN, V40, P3505; Srinivasan S, 2008, CURR OPIN PEDIATR, V20, P522, DOI 10.1097/MOP.0b013e32830f93ec; STROINK G, 1985, MED BIOL ENG COMPUT, V23, P61; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; Uchiyama T, 2009, PHYS STATUS SOLIDI A, V206, P639, DOI 10.1002/pssa.200881251; Uetani T, 2009, JACC-CARDIOVASC INTE, V2, P127, DOI 10.1016/j.jcin.2008.07.010	22	21	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25834	10.1371/journal.pone.0025834	http://dx.doi.org/10.1371/journal.pone.0025834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022453	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000043
J	Ni, MJ; Hu, ZH; Liu, Q; Liu, MF; Lu, MH; Zhang, JS; Zhang, L; Zhang, YL				Ni, Min-Jie; Hu, Zhi-Hong; Liu, Qiang; Liu, Mo-Fang; Lu, Min-hua; Zhang, Jin-Song; Zhang, Li; Zhang, Yong-Lian			Identification and Characterization of a Novel Non-Coding RNA Involved in Sperm Maturation	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; POSTTRANSCRIPTIONAL REGULATION; EPIDIDYMAL DEVELOPMENT; PRIMARY MICRORNAS; MESSENGER-RNA; DICER; GENE; CAPACITATION; EXPRESSION; BIOGENESIS	A long and ever-expanding roster of small (similar to 20-30 nucleotides) RNAs has emerged during the last decade, and most can be subsumed under the three main headings of microRNAs(miRNAs), Piwi-interacting RNAs(piRNAs), and short interferingRNAs(siRNAs). Among the three categories, miRNAs is the most quickly expanded group. The most recent number of identified miRNAs is 16,772 (Sanger miRbase, April 2011). However, there are insufficient publications on their primary forms, and no tissue-specific small RNAs precursors have been reported in the epididymis. Here, we report the identification in rats of an epididymis-specific, chimeric, noncoding RNA that is spliced from two different chromosomes (chromosomes 5 and 19), which we named HongrES2. HongrES2 is a 1.6 kb mRNA-like precursor that gives rise to a new microRNA-like small RNA (mil-HongrES2) in rat epididymis. The generation of mil-HongrES2 is stimulated during epididymitis. An epididymis-specific carboxylesterase named CES7 had 100% cDNA sequence homology at the 3' end with HongrES2 and its protein product could be downregulated by HongrES2 via mil-HongrES2. This was confirmed in vivo by initiating mil-HongrES2 over-expression in rats and observing an effect on sperm capacitation.	[Ni, Min-Jie; Hu, Zhi-Hong; Liu, Qiang; Zhang, Jin-Song; Zhang, Li; Zhang, Yong-Lian] State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China; [Liu, Mo-Fang; Lu, Min-hua] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Core Facil Noncoding RNA, Shanghai, Peoples R China; [Zhang, Yong-Lian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ni, MJ (corresponding author), State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China.	ylzhang@sibs.ac.cn	Liu, Qiang/HHZ-3181-2022	Zhang, Jinsong/0000-0002-6457-0235	National Basic Science Research and Development Project of China [2006CB504002]; Chinese Academy of Sciences [2006CB944002]	National Basic Science Research and Development Project of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Science Research and Development Project of China [2006CB504002] and the Chinese Academy of Sciences Knowledge Innovation Program [2006CB944002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Araki Y, 2002, J ANDROL, V23, P854; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HOU J, CANC CELL, V19, P232; Hu ZH, 2002, CELL RES, V12, P407, DOI 10.1038/sj.cr.7290143; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Kappler-Hanno K, 2003, ASIAN J ANDROL, V5, P277; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Luconi M, 1998, BIOL REPROD, V58, P1476, DOI 10.1095/biolreprod58.6.1476; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Robaire B., 1988, P999; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Stefani G, 2007, EXPERT OPIN BIOL TH, V7, P1833, DOI 10.1517/14712598.7.12.1833; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; TURNER TT, 1991, ANN NY ACAD SCI, V637, P364, DOI 10.1111/j.1749-6632.1991.tb27323.x; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang JF, 2010, ACTA BIOCH BIOPH SIN, V42, P628, DOI 10.1093/abbs/gmq073; Yang JS, 2010, CELL CYCLE, V9, P4455, DOI 10.4161/cc.9.22.13958; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yang L, 2004, J BIOL CHEM, V279, P46253, DOI 10.1074/jbc.M408155200; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang L, 2010, BIOCHEM BIOPH RES CO, V400, P696, DOI 10.1016/j.bbrc.2010.08.130; Zhang L, 2009, ACTA BIOCH BIOPH SIN, V41, P809, DOI 10.1093/abbs/gmp075; Zhang L, 2009, ACTA BIOCH BIOPH SIN, V41, P731, DOI 10.1093/abbs/gmp061; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	66	47	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26053	10.1371/journal.pone.0026053	http://dx.doi.org/10.1371/journal.pone.0026053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022505	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000061
J	Zembe, L; Burgers, WA; Jaspan, HB; Bekker, LG; Bredell, H; Stevens, G; Gilmour, J; Cox, JH; Fast, P; Hayes, P; Vardas, E; Williamson, C; Gray, CM				Zembe, Lycias; Burgers, Wendy A.; Jaspan, Heather B.; Bekker, Linda-Gail; Bredell, Helba; Stevens, Gwynneth; Gilmour, Jill; Cox, Josephine H.; Fast, Patricia; Hayes, Peter; Vardas, Eftyhia; Williamson, Carolyn; Gray, Clive M.			Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HLA-CLASS-I; COMPREHENSIVE EPITOPE ANALYSIS; IMMUNE-RESPONSES; VIRAL LOAD; IMMUNOGENICITY EVALUATION; CANDIDATE VACCINE; PHASE-1 SAFETY; TAP TRANSPORT; DOUBLE-BLIND	The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. To facilitate immunogen design, it is important to characterize clusters of commonly targeted T-cell epitopes across different HIV clades. To address this, we examined 39 HIV-1 clade C infected individuals for IFN-gamma Gag-specific T-cell responses using five sets of overlapping peptides, two sets matching clade C vaccine candidates derived from strains from South Africa and China, and three peptide sets corresponding to consensus clades A, B, and D sequences. The magnitude and breadth of T-cell responses against the two clade C peptide sets did not differ, however clade C peptides were preferentially recognized compared to the other peptide sets. A total of 84 peptides were recognized, of which 19 were exclusively from clade C, 8 exclusively from clade B, one peptide each from A and D and 17 were commonly recognized by clade A, B, C and D. The entropy of the exclusively recognized peptides was significantly higher than that of commonly recognized peptides (p = 0.0128) and the median peptide processing scores were significantly higher for the peptide variants recognized versus those not recognized (p = 0.0001). Consistent with these results, the predicted Major Histocompatibility Complex Class I IC(50) values were significantly lower for the recognized peptide variants compared to those not recognized in the ELISPOT assay (p<0.0001), suggesting that peptide variation between clades, resulting in lack of cross-clade recognition, has been shaped by host immune selection pressure. Overall, our study shows that clade C infected individuals recognize clade C peptides with greater frequency and higher magnitude than other clades, and that a selection of highly conserved epitope regions within Gag are commonly recognized and give rise to cross-clade reactivities.	[Zembe, Lycias; Burgers, Wendy A.; Bredell, Helba; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7925 Cape Town, South Africa; [Jaspan, Heather B.; Gray, Clive M.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa; [Jaspan, Heather B.; Bekker, Linda-Gail] Desmond Tutu HIV Ctr, Cape Town, South Africa; [Stevens, Gwynneth; Gilmour, Jill; Cox, Josephine H.; Fast, Patricia; Hayes, Peter] Int AIDS Vaccine Initiat, New York, NY USA; [Vardas, Eftyhia] Univ Stellenbosch, Dept Med Virol, ZA-7600 Stellenbosch, South Africa; [Gray, Clive M.] Natl Inst Communicable Dis, Johannesburg, South Africa	University of Cape Town; University of Cape Town; International AIDS Vaccine Initiative; Stellenbosch University; National Institute for Communicable Diseases (NICD)	Zembe, L (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7925 Cape Town, South Africa.	wendy.burgers@uct.ac.za	Bekker, Linda-Gail/AAZ-8929-2020	, Carolyn/0000-0003-0125-1226; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Vardas, Eftyhia/0000-0002-7804-878X; Gray, Clive/0000-0002-9293-901X; Cox, Josephine/0000-0003-1301-7373; Burgers, Wendy/0000-0003-3396-9398	South African AIDS vaccine initiative; National Research Foundation; Poliomyelitis Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519, U01AI069519] Funding Source: NIH RePORTER	South African AIDS vaccine initiative; National Research Foundation; Poliomyelitis Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the International AIDS Vaccine Initiative (IAVI) and its donors. IAVI is a not-for-profit organization whose mission is to ensure the development of safe, effective, preventive HIV vaccines for use throughout the world. For more information, go to www.iavi.org.IAVI played a direct role in study design and preparation of the manuscript. The study was also supported by South African AIDS vaccine initiative, the National Research Foundation and the Poliomyelitis Research Foundation.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Aidoo M, 2008, VACCINE, V26, P4830, DOI 10.1016/j.vaccine.2008.06.097; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Bansal A, 2003, AIDS RES HUM RETROV, V19, P1017, DOI 10.1089/088922203322588378; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Cao HY, 2000, J INFECT DIS, V182, P1350, DOI 10.1086/315868; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Currier JR, 2003, AIDS, V17, P2149, DOI 10.1097/00002030-200310170-00002; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Gupta SB, 2006, JAIDS-J ACQ IMM DEF, V42, P135, DOI 10.1097/01.qai.0000223017.01568.e7; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Horig H, 1999, J IMMUNOL, V163, P4434; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kresge Kristen Jill, 2009, IAVI Rep, V13, P19; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Malhotra U, 2007, VACCINE, V25, P381, DOI 10.1016/j.vaccine.2006.07.045; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McKinney DM, 2004, J IMMUNOL, V173, P1941, DOI 10.4049/jimmunol.173.3.1941; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Woo J, 2010, J VIROL, V84, P12995, DOI 10.1128/JVI.00702-10; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26096	10.1371/journal.pone.0026096	http://dx.doi.org/10.1371/journal.pone.0026096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022524	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000067
J	Lee, SA; Leitao, R; Zheng, GA; Yang, S; Rodriguez, A; Yang, CH				Lee, Seung Ah; Leitao, Ricardo; Zheng, Guoan; Yang, Samuel; Rodriguez, Ana; Yang, Changhuei			Color Capable Sub-Pixel Resolving Optofluidic Microscope and Its Application to Blood Cell Imaging for Malaria Diagnosis	PLOS ONE			English	Article								Miniaturization of imaging systems can significantly benefit clinical diagnosis in challenging environments, where access to physicians and good equipment can be limited. Sub-pixel resolving optofluidic microscope (SROFM) offers high-resolution imaging in the form of an on-chip device, with the combination of microfluidics and inexpensive CMOS image sensors. In this work, we report on the implementation of color SROFM prototypes with a demonstrated optical resolution of 0.66 mu m at their highest acuity. We applied the prototypes to perform color imaging of red blood cells (RBCs) infected with Plasmodium falciparum, a particularly harmful type of malaria parasites and one of the major causes of death in the developing world.	[Lee, Seung Ah; Zheng, Guoan; Yang, Samuel; Yang, Changhuei] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Leitao, Ricardo; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Yang, Changhuei] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; New York University; California Institute of Technology	Lee, SA (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	salee30@caltech.edu		Rodriguez, Ana/0000-0002-0060-3405; Zheng, Guoan/0000-0002-4268-2690; Yang, Samuel/0000-0003-2460-6456	Gates Foundation [OPP1007336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096226] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Gates Foundation (OPP1007336 GCE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Bishara W, 2010, OPT EXPRESS, V18, P11181, DOI 10.1364/OE.18.011181; Breslauer D, 2009, MOBILE PHONE BASED C; Cui XQ, 2008, P NATL ACAD SCI USA, V105, P10670, DOI 10.1073/pnas.0804612105; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; Gascoyne P, 2004, ACTA TROP, V89, P357, DOI 10.1016/j.actatropica.2003.11.009; Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Oheim M, 2007, BRIT J PHARMACOL, V152, P1, DOI 10.1038/sj.bjp.0707348; Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Xuan XC, 2010, MICROFLUID NANOFLUID, V9, P1, DOI 10.1007/s10404-010-0602-7; Zheng GA, 2010, LAB CHIP, V10, P3125, DOI [10.1039/c01c00213e, 10.1039/c0lc00213e]	14	12	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26127	10.1371/journal.pone.0026127	http://dx.doi.org/10.1371/journal.pone.0026127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022535	gold, Green Accepted, Green Published			2022-12-25	WOS:000295973200041
J	Maharjan, AS; Pilling, D; Gomer, RH				Maharjan, Anu S.; Pilling, Darrell; Gomer, Richard H.			High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM-AMYLOID-P; PERIPHERAL-BLOOD FIBROCYTES; TOLL-LIKE RECEPTOR-4; INDUCED PULMONARY-FIBROSIS; CIRCULATING FIBROCYTES; BONE-MARROW; LUNG INJURY; DENDRITIC CELLS; HUMAN-MONOCYTES; TISSUE-REPAIR	Background: Following tissue injury, monocytes can enter the tissue and differentiate into fibroblast-like cells called fibrocytes, but little is known about what regulates this differentiation. Extracellular matrix contains high molecular weight hyaluronic acid (HMWHA; similar to 2x10(6) Da). During injury, HMWHA breaks down to low molecular weight hyaluronic acid (LMWHA;, similar to 0.8-8x10(5) Da). Methods and Findings: In this report, we show that HMWHA potentiates the differentiation of human monocytes into fibrocytes, while LMWHA inhibits fibrocyte differentiation. Digestion of HMWHA with hyaluronidase produces small hyaluronic acid fragments, and these fragments inhibit fibrocyte differentiation. Monocytes internalize HMWHA and LMWHA equally well, suggesting that the opposing effects on fibrocyte differentiation are not due to differential internalization of HMWHA or LMWHA. Adding HMWHA to PBMC does not appear to affect the levels of the hyaluronic acid receptor CD44, whereas adding LMWHA decreases CD44 levels. The addition of anti-CD44 antibodies potentiates fibrocyte differentiation, suggesting that CD44 mediates at least some of the effect of hyaluronic acid on fibrocyte differentiation. The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition. Conversely, LMWHA inhibits the ability of HMWHA, interleukin-4 (IL-4), or interleukin-13 (IL-13) to promote fibrocyte differentiation. Conclusions: We hypothesize that hyaluronic acid signals at least in part through CD44 to regulate fibrocyte differentiation, with a dominance hierarchy of SAP>LMWHA>HMWHA>IL-4 or IL-13.	[Maharjan, Anu S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Maharjan, Anu S.; Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Rice University; Texas A&M University System; Texas A&M University College Station	Maharjan, AS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, MS-140, Houston, TX 77251 USA.	rgomer@bio.tamu.edu		Gomer, Richard/0000-0003-2361-4307; Pilling, Darrell/0000-0002-7413-2773	National Institutes of Health [HL083029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL083029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; BIANCHETTI L, 2011, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; ENGSTROMLAURENT A, 1985, HEPATOLOGY, V5, P638, DOI 10.1002/hep.1840050420; Filion MC, 2001, J PHARM PHARMACOL, V53, P555, DOI 10.1211/0022357011775677; FORRESTER JV, 1980, IMMUNOLOGY, V40, P435; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Grenier J, 2002, EXP HEMATOL, V30, P1029, DOI 10.1016/S0301-472X(02)00874-3; Grishko V, 2009, J BIOL CHEM, V284, P9132, DOI 10.1074/jbc.M804178200; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; KANSAS GS, 1989, J IMMUNOL, V142, P3050; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; KUO JW, 2005, PRACTICAL ASPECTS HY, P1; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Maharjan AS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-23; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mattoli S, 2009, CURR STEM CELL RES T, V4, P266, DOI 10.2174/157488809789649232; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; NONG YH, 1989, J EXP MED, V170, P259, DOI 10.1084/jem.170.1.259; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Weiss JM, 1998, J INVEST DERMATOL, V111, P227, DOI 10.1046/j.1523-1747.1998.00286.x; Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC	74	115	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26078	10.1371/journal.pone.0026078	http://dx.doi.org/10.1371/journal.pone.0026078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022512	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200030
J	Boreddy, SR; Sahu, RP; Srivastava, SK				Boreddy, Srinivas Reddy; Sahu, Ravi P.; Srivastava, Sanjay K.			Benzyl Isothiocyanate Suppresses Pancreatic Tumor Angiogenesis and Invasion by Inhibiting HIF-alpha/VEGF/Rho-GTPases: Pivotal Role of STAT-3	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE ARREST; VEGF EXPRESSION; RHO-GTPASES; CANCER CELLS; HYPOXIA; APOPTOSIS; MIGRATION; ORGANIZATION; METASTASIS	Our previous studies have shown that benzyl isothiocyanate (BITC) suppresses pancreatic tumor growth by inhibiting STAT-3; however, the exact mechanism of tumor growth suppression was not clear. Here we evaluated the effects and mechanism of BITC on pancreatic tumor angiogenesis. Our results reveal that BITC significantly inhibits neovasularization on rat aorta and Chicken-Chorioallantoic membrane. Furthermore, BITC blocks the migration and invasion of BxPC-3 and PanC-1 pancreatic cancer cells in a dose dependant manner. Moreover, secretion of VEGF and MMP-2 in normoxic and hypoxic BxPC-3 and PanC-1 cells was significantly suppressed by BITC. Both VEGF and MMP-2 play a critical role in angiogenesis and metastasis. Our results reveal that BITC significantly suppresses the phosphorylation of VEGFR-2 (Tyr-1175), and expression of HIF-alpha. Rho-GTPases, which are regulated by VEGF play a crucial role in pancreatic cancer progression. BITC treatment reduced the expression of RhoC whereas up-regulated the expression of tumor suppressor RhoB. STAT-3 over-expression or IL-6 treatment significantly induced HIF-1 alpha and VEGF expression; however, BITC substantially suppressed STAT-3 as well as STAT-3-induced HIF-1 alpha and VEGF expression. Finally, in vivo tumor growth and matrigel-plug assay show reduced tumor growth and substantial reduction of hemoglobin content in the matrigel plugs and tumors of mice treated orally with 12 mu mol BITC, indicating reduced tumor angiogenesis. Immunoblotting of BITC treated tumors show reduced expression of STAT-3 phosphorylation (Tyr-705), HIF-alpha, VEGFR-2, VEGF, MMP-2, CD31 and RhoC. Taken together, our results suggest that BITC suppresses pancreatic tumor growth by inhibiting tumor angiogenesis through STAT-3-dependant pathway.	[Boreddy, Srinivas Reddy] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Boreddy, SR (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA.	Sanjay.Srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020; Sahu, Ravi Prakash/AFQ-3359-2022	Sahu, Ravi Prakash/0000-0003-3857-9073	National Cancer Institute (NCI); National Institutes of Health (NIH) [R01 CA106953, R01 CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH) (R01 CA106953 and R01 CA129038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavani MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2689; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Batra S, 2010, MOL CANCER THER, V9, P1596, DOI 10.1158/1535-7163.MCT-09-1146; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Boyd PJ, 2005, AM J PHYSIOL-CELL PH, V288, pC659, DOI 10.1152/ajpcell.00211.2004; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JEMAL A, 2010, CA CANC J CLIN; JI BT, 1995, CANCER EPIDEM BIOMAR, V4, P885; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kruger EA, 2001, SEMIN ONCOL, V28, P570, DOI 10.1053/sonc.2001.28600; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Milkiewicz M, 2006, INT J BIOCHEM CELL B, V38, P333, DOI 10.1016/j.biocel.2005.10.006; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Philip PA, 2008, LANCET, V371, P2062, DOI 10.1016/S0140-6736(08)60770-9; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Slomiany MG, 2006, J PHARMACOL EXP THER, V318, P666, DOI 10.1124/jpet.106.104158; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tournaire R, 2004, EMBO REP, V5, P262, DOI 10.1038/sj.embor.7400100; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120; Zhang RF, 2006, J NUTR, V136, P2728, DOI 10.1093/jn/136.11.2728; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	46	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25799	10.1371/journal.pone.0025799	http://dx.doi.org/10.1371/journal.pone.0025799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016776	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700018
J	Mercer, N; Ramakrishnan, B; Boeggeman, E; Qasba, PK				Mercer, Natalia; Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.			Applications of Site-Specific Labeling to Study HAMLET, a Tumoricidal Complex of alpha-Lactalbumin and Oleic Acid	PLOS ONE			English	Article							TUMOR-CELL DEATH; MOLTEN GLOBULE STATE; BREAST CARCINOMAS; PROGNOSTIC-SIGNIFICANCE; N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; MAMMARY-GLAND; APOPTOSIS; PROTEIN; LETHAL	Background: Alpha-lactalbumin (a-LA) is a calcium-bound mammary gland-specific protein that is found in milk. This protein is a modulator of beta 1,4-galactosyltransferase enzyme, changing its acceptor specificity from N-acetyl-glucosamine to glucose, to produce lactose, milk's main carbohydrate. When calcium is removed from alpha-LA, it adopts a molten globule form, and this form, interestingly, when complexed with oleic acid (OA) acquires tumoricidal activity. Such a complex made from human alpha-LA (hLA) is known as HAMLET (Human A-lactalbumin Made Lethal to Tumor cells), and its tumoricidal activity has been well established. Methodology/Principal Findings: In the present work, we have used site-specific labeling, a technique previously developed in our laboratory, to label HAMLET with biotin, or a fluoroprobe for confocal microscopy studies. In addition to full length hLA, the alpha-domain of hLA (alpha D-hLA) alone is also included in the present study. We have engineered these proteins with a 17-amino acid C-terminal extension (hLA-ext and alpha D-hLA-ext). A single Thr residue in this extension is glycosylated with 2-acetonyl-galactose (C2-keto-galactose) using polypeptide-alpha-N-acetylgalactosaminyltransferase II (ppGalNAc-T2) and further conjugated with aminooxy-derivatives of fluoroprobe or biotin molecules. Conclusions/Significance: We found that the molten globule form of hLA and alpha D-hLA proteins, with or without C-terminal extension, and with and without the conjugated fluoroprobe or biotin molecule, readily form a complex with OA and exhibits tumoricidal activity similar to HAMLET made with full-length hLA protein. The confocal microscopy studies with fluoroprobe-labeled samples show that these proteins are internalized into the cells and found even in the nucleus only when they are complexed with OA. The HAMLET conjugated with a single biotin molecule will be a useful tool to identify the cellular components that are involved with it in the tumoricidal activity.	[Mercer, Natalia; Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.] NCI Frederick, Struct Glycobiol Sect, CCR Nanobiol Program, Ctr Canc Res, Frederick, MD USA; [Ramakrishnan, Boopathy; Boeggeman, Elizabeth] NCI Frederick, Basic Sci Program, SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Mercer, N (corresponding author), NCI Frederick, Struct Glycobiol Sect, CCR Nanobiol Program, Ctr Canc Res, Frederick, MD USA.	qasba@helix.nih.gov			NCI, NIH [HHSN261200800001E]; National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010804, ZIABC011385] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with Federal funds from NCI, NIH under contract HHSN261200800001E. This research was supported ( in part) by the Intramural Research Program at the National Institutes of Health, National Cancer Institute, Center for Cancer Research. No external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; Brest P, 2007, CANCER RES, V67, P11327, DOI 10.1158/0008-5472.CAN-07-1153; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; COHEN C, 1987, CANCER, V60, P1294, DOI 10.1002/1097-0142(19870915)60:6<1294::AID-CNCR2820600622>3.0.CO;2-2; DANDEKAR AM, 1981, P NATL ACAD SCI-BIOL, V78, P4853, DOI 10.1073/pnas.78.8.4853; de Laureto PP, 2001, EUR J BIOCHEM, V268, P4324, DOI 10.1046/j.1432-1327.2001.02352.x; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Hao G, 2007, J AM SOC MASS SPECTR, V18, P1579, DOI 10.1016/j.jasms.2007.05.019; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; LALA AK, 1992, J BIOL CHEM, V267, P19914; LEE AK, 1985, AM J CLIN PATHOL, V84, P687, DOI 10.1093/ajcp/84.6.687; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; NAKHASI HL, 1979, J BIOL CHEM, V254, P6016; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; PENG ZY, 1994, BIOCHEMISTRY-US, V33, P2136, DOI 10.1021/bi00174a021; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; QASBA PK, 1984, NATURE, V308, P377, DOI 10.1038/308377a0; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; RAMAKRISHNAN B, 2011, METHODS MOL BIOL BIO, P281; Ramakrishnan B, 2007, BIOCONJUGATE CHEM, V18, P1912, DOI 10.1021/bc7002346; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Sharp JA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-48; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; THOMPSON MP, 1992, PROTOPLASMA, V167, P134, DOI 10.1007/BF01403376; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; WRBA F, 1988, PATHOL RES PRACT, V183, P277, DOI 10.1016/S0344-0338(88)80122-5	41	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26093	10.1371/journal.pone.0026093	http://dx.doi.org/10.1371/journal.pone.0026093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016817	Green Published, Green Submitted, gold			2022-12-25	WOS:000295971700038
J	Alvarez-Suarez, JM; Dekanski, D; Ristic, S; Radonjic, NV; Petronijevic, ND; Giampieri, F; Astolfi, P; Gonzalez-Paramas, AM; Santos-Buelga, C; Tulipani, S; Quiles, JL; Mezzetti, B; Battino, M				Alvarez-Suarez, Jose M.; Dekanski, Dragana; Ristic, Slavica; Radonjic, Nevena V.; Petronijevic, Natasa D.; Giampieri, Francesca; Astolfi, Paola; Gonzalez-Paramas, Ana M.; Santos-Buelga, Celestino; Tulipani, Sara; Quiles, Jose L.; Mezzetti, Bruno; Battino, Maurizio			Strawberry Polyphenols Attenuate Ethanol-Induced Gastric Lesions in Rats by Activation of Antioxidant Enzymes and Attenuation of MDA Increase	PLOS ONE			English	Article							ANTIULCER ACTIVITY; PHENOLIC-COMPOUNDS; VITAMIN-C; IN-VITRO; CAPACITY; FLAVONOIDS; DAMAGE; GASTROPROTECTION; IDENTIFICATION; ANTHOCYANINS	Background and Aim: Free radicals are implicated in the aetiology of gastrointestinal disorders such as gastric ulcer, colorectal cancer and inflammatory bowel disease. Strawberries are common and important fruit due to their high content of essential nutrient and beneficial phytochemicals which seem to have relevant biological activity on human health. In the present study we investigated the antioxidant and protective effects of three strawberry extracts against ethanol-induced gastric mucosa damage in an experimental in vivo model and to test whether strawberry extracts affect antioxidant enzyme activities in gastric mucosa. Methods/Principal Findings: Strawberry extracts were obtained from Adria, Sveva and Alba cultivars. Total antioxidant capacity and radical scavenging capacity were performed by TEAC, ORAC and electron paramagnetic resonance assays. Identification and quantification of anthocyanins was carried out by HPLC-DAD-MS analyses. Different groups of animals received 40 mg/day/kg body weight of strawberry crude extracts for 10 days. Gastric damage was induced by ethanol. The ulcer index was calculated together with the determination of catalase and SOD activities and MDA contents. Strawberry extracts are rich in anthocyanins and present important antioxidant capacity. Ethanol caused severe gastric damage and strawberry consumption protected against its deleterious role. Antioxidant enzyme activities increased significantly after strawberry extract intake and a concomitantly decrease in gastric lipid peroxidation was found. A significant correlation between total anthocyanin content and percent of inhibition of ulcer index was also found. Conclusions: Strawberry extracts prevented exogenous ethanol-induced damage to rats' gastric mucosa. These effects seem to be associated with the antioxidant activity and phenolic content in the extract as well as with the capacity of promoting the action of antioxidant enzymes. A diet rich in strawberries might exert a beneficial effect in the prevention of gastric diseases related to generation of reactive oxygen species.	[Alvarez-Suarez, Jose M.; Giampieri, Francesca; Battino, Maurizio] Univ Politecn Marche, Fac Med, Sez Biochim, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Dekanski, Dragana; Ristic, Slavica] Galenika Ad, R&D Inst, Biomed Res, Belgrade, Serbia; [Radonjic, Nevena V.; Petronijevic, Natasa D.] Univ Belgrade, Inst Med & Clin Biochem, Sch Med, Belgrade, Serbia; [Astolfi, Paola] Marche Polytech Univ, ISAC Chem Div, Ancona, Italy; [Gonzalez-Paramas, Ana M.; Santos-Buelga, Celestino] Univ Salamanca, Grp Invest Polifenoles GIP USAL, Fac Pharm, E-37008 Salamanca, Spain; [Tulipani, Sara] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci CeRTA, Barcelona, Spain; [Quiles, Jose L.] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Dept Physiol, Granada, Spain; [Mezzetti, Bruno] Marche Polytech Univ, Fac Agr, Dept Environm & Crop Sci SAPROV, Ancona, Italy	Marche Polytechnic University; University of Belgrade; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Marche Polytechnic University; University of Salamanca; University of Barcelona; University of Granada; Marche Polytechnic University	Alvarez-Suarez, JM (corresponding author), Univ Politecn Marche, Fac Med, Sez Biochim, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.	m.a.battino@univpm.it	Astolfi, Paola/C-5953-2008; Quiles, José L./C-6911-2013; Santos-Buelga, Celestino/U-1358-2019; González-Paramás, Ana María/O-3771-2019; Mezzetti, Bruno/AAE-7696-2019; Alvarez-Suarez, José M./M-7160-2014; Lin, KuanYu/L-9195-2016; Battino, Maurizio/E-6103-2012; Tulipani, Sara/K-8285-2019; Mezzetti, Bruno/AAB-8500-2019; Giampieri, Francesca/I-1911-2015; González-Paramás, Ana M/D-2229-2011; Dekanski, Dragana/H-4584-2019; Santos-Buelga, Celestino/A-1071-2008	Astolfi, Paola/0000-0003-3226-082X; Quiles, José L./0000-0002-9048-9086; González-Paramás, Ana María/0000-0001-5477-0703; Alvarez-Suarez, José M./0000-0001-8509-1498; Lin, KuanYu/0000-0002-5291-0909; Battino, Maurizio/0000-0002-7250-1782; Tulipani, Sara/0000-0001-5658-8462; Giampieri, Francesca/0000-0002-8151-9132; González-Paramás, Ana M/0000-0001-5477-0703; Dekanski, Dragana/0000-0001-8467-4165; Santos-Buelga, Celestino/0000-0001-6592-5299; Petronijevic, Natasa/0000-0002-4338-1953; Mezzetti, Bruno/0000-0001-9307-812X; Radonjic, Nevena/0000-0002-1272-2284	EU [KBBE-2010-4, 265942]; Consolider-Ingenio [FUN-C-FOOD, CSD2007-00063]; Junta de Castilla y Leon (Grupo de Investigacion de Excelencia) [GR133]	EU(European Commission); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon (Grupo de Investigacion de Excelencia)(Junta de Castilla y Leon)	The research was partially granted by EUBerry Project: EU FP7 KBBE-2010-4 Grant Agreement No. 265942. The GIP-USAL is financially supported by the Consolider-Ingenio 2010 Programme (FUN-C-FOOD, CSD2007-00063) and Junta de Castilla y Leon (Grupo de Investigacion de Excelencia GR133). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCARAZ MJ, 1985, BIOCHEM PHARMACOL, V34, P2477, DOI 10.1016/0006-2952(85)90529-5; Azzi A, 2004, FEBS LETT, V558, P3, DOI 10.1016/S0014-5793(03)01526-6; Battino M, 2000, J BIOENERG BIOMEMBR, V32, P163, DOI 10.1023/A:1005559930210; BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T; Battino M, 2009, NUTR REV, V67, pS145, DOI 10.1111/j.1753-4887.2009.00178.x; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Bompadre S, 2004, FREE RADICAL RES, V38, P831, DOI 10.1080/10715760410001715158; BRONNER C, 1985, AGENTS ACTIONS, V16, P147, DOI 10.1007/BF01983124; Brzozowski T, 1998, J PHYSIOL PHARMACOL, V49, P83; Buege J A, 1978, Methods Enzymol, V52, P302; Cao GH, 1998, J NUTR, V128, P2383, DOI 10.1093/jn/128.12.2383; Capocasa F, 2008, FOOD CHEM, V111, P872, DOI 10.1016/j.foodchem.2008.04.068; Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1118::AID-JSFA570&gt;3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9]; Dekanski D, 2009, MEDITERR J NUTR META, V2, P205, DOI 10.1007/s12349-009-0068-x; Dekanski D, 2009, GEN PHYSIOL BIOPHYS, V28, P135; DELALASTRA CA, 1992, J PHARM PHARMACOL, V44, P929; DICARLO G, 1994, PHYTOTHER RES, V8, P42, DOI 10.1002/ptr.2650080110; El-Abhar HS, 2010, EUR J PHARMACOL, V649, P314, DOI 10.1016/j.ejphar.2010.09.012; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Graziani G, 2005, GUT, V54, P193, DOI 10.1136/gut.2004.046292; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Henriques A, 2006, J ANTIMICROB CHEMOTH, V58, P773, DOI 10.1093/jac/dkl336; HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P93, DOI 10.1016/j.fct.2010.10.002; IZZO AA, 1994, PHYTOTHER RES, V8, P179, DOI 10.1002/ptr.2650080313; Kim SJ, 2011, BRIT J NUTR, V106, P1792, DOI 10.1017/S000711451100242X; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Li GG, 2011, BRIT J NUTR, V106, P1632, DOI 10.1017/S0007114511003813; da Silva FL, 2007, LWT-FOOD SCI TECHNOL, V40, P374, DOI 10.1016/j.lwt.2005.09.018; Lopes-da-Silva F, 2002, EUR FOOD RES TECHNOL, V214, P248, DOI 10.1007/s00217-001-0434-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIBONMATI E, 1980, EUR J PHARMACOL, V68, P49, DOI 10.1016/0014-2999(80)90059-X; Matsumoto M, 2004, J AGR FOOD CHEM, V52, P2226, DOI 10.1021/jf034818q; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyazawa T, 1998, BIOSCI BIOTECH BIOCH, V62, P829, DOI 10.1271/bbb.62.829; Olaleye SB, 2006, PHYTOTHER RES, V20, P14, DOI 10.1002/ptr.1793; Oliveira CPMS, 2003, WORLD J GASTROENTERO, V9, P446; Osakabe N, 1998, BIOSCI BIOTECH BIOCH, V62, P1535, DOI 10.1271/bbb.62.1535; Pinto MD, 2010, J MED FOOD, V13, P1027, DOI 10.1089/jmf.2009.0257; Pohle T, 2001, ALIMENT PHARM THER, V15, P677, DOI 10.1046/j.1365-2036.2001.00975.x; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Saito M, 1998, J AGR FOOD CHEM, V46, P1460, DOI 10.1021/jf9709156; Sannomiya M, 2005, J ETHNOPHARMACOL, V97, P1, DOI 10.1016/j.jep.2004.09.053; Scalzo J, 2005, NUTRITION, V21, P207, DOI 10.1016/j.nut.2004.03.025; Seeram NP, 2006, FOOD CHEM, V97, P1, DOI 10.1016/j.foodchem.2005.02.047; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Talavera S, 2004, J NUTR, V134, P2275, DOI 10.1093/jn/134.9.2275; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Tulipani S, 2011, FOOD CHEM, V128, P180, DOI 10.1016/j.foodchem.2011.03.025; Tulipani S, 2011, FOOD CHEM, V124, P906, DOI 10.1016/j.foodchem.2010.07.018; Tulipani S, 2008, BIOFACTORS, V34, P47, DOI 10.1002/biof.5520340106; Tulipani S, 2009, FOOD CHEM, V117, P181, DOI 10.1016/j.foodchem.2009.03.096; Ustun O, 2006, J ETHNOPHARMACOL, V108, P457, DOI 10.1016/j.jep.2006.06.001; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; Wang SY, 2009, J AGR FOOD CHEM, V57, P9651, DOI 10.1021/jf9020575; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345	59	150	153	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25878	10.1371/journal.pone.0025878	http://dx.doi.org/10.1371/journal.pone.0025878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016781	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300036
J	Zhang, XH; Seftel, A; DiSanto, ME				Zhang, Xinhua; Seftel, Allen; DiSanto, Michael E.			Blebbistain, a Myosin II Inhibitor, as a Novel Strategy to Regulate Detrusor Contractility in a Rat Model of Partial Bladder Outlet Obstruction	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; PARTIAL URETHRAL OBSTRUCTION; CHAIN ISOFORM EXPRESSION; ESSENTIAL LIGHT-CHAIN; IN-VIVO RELAXATION; URINARY-BLADDER; HEAVY-CHAIN; SHORTENING VELOCITY; NONMUSCLE MYOSIN; SINGLE-GENE	Partial bladder outlet obstruction (PBOO), a common urologic pathology mostly caused by benign prostatic hyperplasia, can coexist in 40-45% of patients with overactive bladder (OAB) and is associated with detrusor overactivity (DO). PBOO that induces DO results in alteration in bladder myosin II type and isoform composition. Blebbistatin (BLEB) is a myosin II inhibitor we recently demonstrated potently relaxed normal detrusor smooth muscle (SM) and reports suggest varied BLEB efficacy for different SM myosin (SMM) isoforms and/or SMM vs nonmuscle myosin (NMM). We hypothesize BLEB inhibition of myosin II as a novel contraction protein targeted strategy to regulate DO. Using a surgically-induced male rat PBOO model, organ bath contractility, competitive and Real-Time-RT-PCR were performed. It was found that obstructed-bladder weight significantly increased 2.74-fold while in vitro contractility of detrusor to various stimuli was impaired similar to 50% along with decreased shortening velocity. Obstruction also altered detrusor spontaneous activities with significantly increased amplitude but depressed frequency. PBOO switched bladder from a phasic-type to a more tonic-type SM. Expression of 5' myosin heavy chain (MHC) alternatively spliced isoform SM-A (associated with tonic-type SM) increased 3-fold while 3' MHC SM1 and essential light chain isoform MLC17b also exhibited increased relative expression. Total SMMHC expression was decreased by 25% while the expression of NMM IIB (SMemb) was greatly increased by 4.5-fold. BLEB was found to completely relax detrusor strips from both sham-operated and PBOO rats pre-contracted with KCl, carbachol or electrical field stimulation although sensitivity was slightly decreased (20%) only at lower doses for PBOO. Thus we provide the first thorough characterization of the response of rat bladder myosin to PBOO and demonstrate complete BLEB-induced PBOO bladder SM relaxation. Furthermore, the present study provides valuable evidence that BLEB may be a novel type of potential therapeutic agent for regulation of myogenic and nerve-evoked DO in OAB.	[Zhang, Xinhua; DiSanto, Michael E.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Zhang, Xinhua; Seftel, Allen; DiSanto, Michael E.] Rowan Univ, Cooper Med Sch, Div Urol, Dept Surg, Camden, NJ USA	Yeshiva University; Albert Einstein College of Medicine; Rowan University; Cooper Medical School of Rowan University	Zhang, XH (corresponding author), Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA.	disanto-michael@cooperhealth.edu			United States National Institutes of Health [5R01DK077116]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077116] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by United States National Institutes of Health Grant 5R01DK077116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PH, 1979, J UROLOGY, V121, P640, DOI 10.1016/S0022-5347(17)56918-9; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Austin JC, 2004, J UROLOGY, V172, P1524, DOI 10.1097/01.ju.0000138045.61378.96; Aydin M, 2010, BJU INT, V106, P562, DOI 10.1111/j.1464-410X.2009.09156.x; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Bing W, 2003, AM J PHYSIOL-RENAL, V285, pF990, DOI 10.1152/ajprenal.00378.2002; Braverman AS, 2006, NEUROUROL URODYNAM, V25, P55, DOI 10.1002/nau.20180; CAI S, 1995, AM J PHYSIOL-CELL PH, V269, pC1126, DOI 10.1152/ajpcell.1995.269.5.C1126; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Cher ML, 1996, WORLD J UROL, V14, P295; Chi M, 2008, P NATL ACAD SCI USA, V105, P18614, DOI 10.1073/pnas.0808162105; Chua RG, 2009, MOL CELL ENDOCRINOL, V303, P67, DOI 10.1016/j.mce.2009.02.001; DiSanto ME, 1998, AM J PHYSIOL-CELL PH, V275, pC976, DOI 10.1152/ajpcell.1998.275.4.C976; DiSanto ME, 2003, AM J PHYSIOL-CELL PH, V285, pC1397, DOI 10.1152/ajpcell.00513.2002; DiSanto ME, 1997, AM J PHYSIOL-CELL PH, V272, pC1532, DOI 10.1152/ajpcell.1997.272.5.C1532; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Ekman M, 2005, J GEN PHYSIOL, V125, P187, DOI 10.1085/jgp.200409212; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Gomes CM, 2000, J UROLOGY, V163, P2008, DOI 10.1016/S0022-5347(05)67619-7; HASEGAWA Y, 1992, J BIOCHEM-TOKYO, V111, P798, DOI 10.1093/oxfordjournals.jbchem.a123839; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hypolite JA, 2001, AM J PHYSIOL-CELL PH, V280, pC254, DOI 10.1152/ajpcell.2001.280.2.C254; Karagiannis P, 2004, J MUSCLE RES CELL M, V25, P149, DOI 10.1023/B:JURE.0000035879.87045.4b; KELLEY CA, 1993, J BIOL CHEM, V268, P12848; Koi PT, 2007, INT J IMPOT RES, V19, P62, DOI 10.1038/sj.ijir.3901503; Lavelle JP, 2000, AM J PHYSIOL-RENAL, V278, pF540, DOI 10.1152/ajprenal.2000.278.4.F540; LENZ S, 1989, J BIOL CHEM, V264, P9009; LEVIN RM, 1995, ADV EXP MED BIOL, V385, P7; Levin RM, 2000, NEUROUROL URODYNAM, V19, P609, DOI 10.1002/1520-6777(2000)19:5<609::AID-NAU7>3.0.CO;2-H; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; MALMQVIST U, 1991, AM J PHYSIOL, V260, pC1085, DOI 10.1152/ajpcell.1991.260.5.C1085; MALMQVIST U, 1991, PFLUG ARCH EUR J PHY, V418, P523, DOI 10.1007/BF00370566; Martin AF, 1997, COMP BIOCHEM PHYS B, V117, P3, DOI 10.1016/S0305-0491(96)00308-2; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Matthew JD, 1998, J BIOL CHEM, V273, P31289, DOI 10.1074/jbc.273.47.31289; Melman A, 2005, UROLOGY, V66, P1127, DOI 10.1016/j.urology.2005.06.070; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morano I, 2003, J MOL MED-JMM, V81, P481, DOI 10.1007/s00109-003-0451-x; NABESHIMA Y, 1987, J BIOL CHEM, V262, P10608; Oelke M, 2008, EUR UROL, V54, P419, DOI 10.1016/j.eururo.2008.02.017; Ren J, 2002, PHARMACOL RES, V45, P195, DOI 10.1006/phrs.2002.0947; Rhee AY, 2006, PFLUG ARCH EUR J PHY, V452, P766, DOI 10.1007/s00424-006-0091-4; Ruggieri M. R. Sr., 2006, Autonomic & Autacoid Pharmacology, V26, P311, DOI 10.1111/j.1474-8673.2006.00377.x; SAITO M, 1993, NEUROUROL URODYNAM, V12, P573, DOI 10.1002/nau.1930120610; SAITO M, 1994, NEUROUROL URODYNAM, V13, P297, DOI 10.1002/1520-6777(1994)13:3<297::AID-NAU1930130311>3.0.CO;2-Y; Sandhu KS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.007; Sjuve R, 1996, J CELL BIOCHEM, V63, P86; Somlyo AV, 1998, ACTA PHYSIOL SCAND, V164, P381, DOI 10.1111/j.1365-201X.1998.tb10695.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Takahashi N, 2009, NEUROUROL URODYNAM, V28, P257, DOI 10.1002/nau.20625; WANG Z, 1995, LAB INVEST, V73, P244; YAMAMOTO M, 1992, P NATL ACAD SCI USA, V89, P5326, DOI 10.1073/pnas.89.12.5326; Yuan X, 2011, UROLOGY, V77, P1008; Zhang XH, 2009, J SEX MED, V6, P2661, DOI 10.1111/j.1743-6109.2009.01424.x; Zhang XH, 2011, BJU INT, V107, P310, DOI 10.1111/j.1464-410X.2010.09366.x	57	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25958	10.1371/journal.pone.0025958	http://dx.doi.org/10.1371/journal.pone.0025958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016792	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300042
J	Bakker, PR; de Groot, IW; van Os, J; van Harten, PN				Bakker, P. Roberto; de Groot, Izaak W.; van Os, Jim; van Harten, Peter N.			Long-Stay Psychiatric Patients: A Prospective Study Revealing Persistent Antipsychotic-Induced Movement Disorder	PLOS ONE			English	Article							INDUCED EXTRAPYRAMIDAL SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; TARDIVE-DYSKINESIA; CHRONIC-SCHIZOPHRENIA; 1ST-EPISODE SCHIZOPHRENIA; BOTULINUM TOXIN; RATING-SCALE; PREVALENCE; AKATHISIA; PARKINSONISM	Objective: The purpose of this study was to assess the frequency of persistent drug-induced movement disorders namely, tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia in a representative sample of long-stay patients with chronic severe mental illness. Method: Naturalistic study of 209, mainly white, antipsychotic-treated patients, mostly diagnosed with psychotic disorder. Of this group, the same rater examined 194 patients at least two times over a 4-year period, with a mean follow-up time of 1.1 years, with validated scales for TD, parkinsonism, akathisia, and tardive dystonia. Results: The frequencies of persistent movement disorders in the sample were 28.4% for TD, 56.2% for parkinsonism, 4.6% for akathisia and 5.7% for tardive dystonia. Two-thirds of the participants displayed at least one type of persistent movement disorder. Conclusions: Persistent movement disorder continues to be the norm for long-stay patients with chronic mental illness and long-term antipsychotic treatment. Measures are required to remedy this situation.	[Bakker, P. Roberto; van Harten, Peter N.] Psychiat Ctr GGZ Cent, Amersfoort, Netherlands; [de Groot, Izaak W.] Ctr Mental Hlth Care, Deventer, Netherlands; [van Os, Jim; van Harten, Peter N.] Maastricht Univ, EURON, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; University of London; King's College London	Bakker, PR (corresponding author), Psychiat Ctr GGZ Cent, Amersfoort, Netherlands.	robertobakker@gmail.com	van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Bakker, P. Roberto/0000-0002-9964-9939	Foundation, 'The Open Ankh', The Netherlands [SG 21.02]; Eli Lilly company; BMS company; Lundbeck company; Organon company; Janssen-Cilag company; GSK company; AstraZeneca company; Pfizer company; Servier company	Foundation, 'The Open Ankh', The Netherlands; Eli Lilly company(Eli Lilly); BMS company; Lundbeck company(Lundbeck Corporation); Organon company; Janssen-Cilag company; GSK company; AstraZeneca company(AstraZeneca); Pfizer company; Servier company	This work was supported by grant from the Foundation, 'The Open Ankh', The Netherlands [grant number SG 21.02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Bakker and Dr. de Groot have declared that no competing interests exist. Dr. van Os has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Dr. van Harten has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Janssen-Cilag, GSK, and AstraZeneca, companies that have an interest in the treatment of psychosis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Psychiatry Association, 1992, TARD DYSK TASK FORC; Arango C, 1999, AM J PSYCHIAT, V156, P1097; Ballesteros J, 2000, J CLIN PSYCHOPHARM, V20, P188, DOI 10.1097/00004714-200004000-00011; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; BARNES TRE, 1985, ARCH GEN PSYCHIAT, V42, P874; Broekema WJ, 2007, PHARM WORLD SCI, V29, P126, DOI 10.1007/s11096-006-9063-1; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; Burke RE, 1992, DRUG INDUCED MOVEMEN, P167; Casey DE, 2006, CNS SPECTRUMS, V11, P25, DOI 10.1017/S1092852900026651; Chakos MH, 1996, ARCH GEN PSYCHIAT, V53, P313; Chong SA, 2009, J CLIN PSYCHOPHARM, V29, P5, DOI 10.1097/JCP.0b013e3181929f94; Correll CU, 2008, CURR OPIN PSYCHIATR, V21, P151, DOI 10.1097/YCO.0b013e3282f53132; Correll CU, 2004, AM J PSYCHIAT, V161, P414, DOI 10.1176/appi.ajp.161.3.414; Dean CE, 2009, BRIT J PSYCHIAT, V194, P360, DOI 10.1192/bjp.bp.108.049395; EMSLEY R, 2010, EUR PSYCHIAT; Esper CD, 2008, MOVEMENT DISORD, V23, P401, DOI 10.1002/mds.21854; FACTOR SA, 2009, DRUG INDUCED MOVEMEN; Factor SA., 2005, DRUG INDUCED MOVEMEN, V2nd; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Fisher WH, 2001, PSYCHIATR SERV, V52, P1051, DOI 10.1176/appi.ps.52.8.1051; Fisher WH, 2009, HEALTH AFFAIR, V28, P676, DOI 10.1377/hlthaff.28.3.676; Friedman JH, 2004, J GERIATR PSYCH NEUR, V17, P39, DOI 10.1177/0891988703262001; Guy W, 1975, ECDEU ASSESSMENT MAN, P534; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HALSTEAD SM, 1994, BRIT J PSYCHIAT, V164, P177, DOI 10.1192/bjp.164.2.177; HOFFMAN WF, 1994, NEUROPSYCHOPHARMAC S, V135; Janno S, 2004, AM J PSYCHIAT, V161, P160, DOI 10.1176/appi.ajp.161.1.160; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KEEPERS GA, 1983, ARCH GEN PSYCHIAT, V40, P1113; Kefalopoulou Z, 2009, ACTA NEUROL SCAND, V119, P269, DOI 10.1111/j.1600-0404.2008.01115.x; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Laugharne J, 2004, INT J LAW PSYCHIAT, V27, P101, DOI 10.1016/j.ijlp.2003.12.004; Lerner V, 2007, ISR J PSYCHIATR REL, V44, P20; Leucht S, 2009, PSYCHOL MED, V39, P1591, DOI 10.1017/S0033291709005455; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Leung JG, 2011, ANN PHARMACOTHER, V45, P525, DOI 10.1345/aph.1P312; Lewis S, 2008, BRIT J PSYCHIAT, V192, P161, DOI 10.1192/bjp.bp.107.037218; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MACPHERSON R, 1992, BRIT J PSYCHIAT, V160, P110, DOI 10.1192/bjp.160.1.110; Miller DD, 2008, BRIT J PSYCHIAT, V193, P279, DOI 10.1192/bjp.bp.108.050088; Mittal V, 2010, POLYM SCI TECHNOL SE, P1, DOI 10.1039/9781849732192-00001; Modestin J, 2008, SCHIZOPHR RES, V100, P97, DOI 10.1016/j.schres.2007.10.018; OWENS DC, 1999, GUIDE EXTRAPYRAMIDAL; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Procyshyn RM, 2001, CAN J PSYCHIAT, V46, P334, DOI 10.1177/070674370104600404; RICHARDSON MA, 1991, AM J PSYCHIAT, V148, P1322; Richardson MA, 2003, AM J PSYCHIAT, V160, P1117, DOI 10.1176/appi.ajp.160.6.1117; Rijcken CAW, 2003, J CLIN PSYCHOPHARM, V23, P657, DOI 10.1097/01.jcp.0000096247.29231.3a; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Sachdev PS, 2005, PSYCHIAT CLIN N AM, V28, P255, DOI 10.1016/j.psc.2004.10.004; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; SETHI KD, 1990, MOVEMENT DISORD, V5, P319, DOI 10.1002/mds.870050411; Slotema CW, 2008, PROG NEURO-PSYCHOPH, V32, P507, DOI 10.1016/j.pnpbp.2007.10.004; Soares-Weiser K, 2007, SEMIN NEUROL, V27, P159, DOI 10.1055/s-2007-971169; Tamminga CA, 2006, AM J PSYCHIAT, V163, P563, DOI 10.1176/appi.ajp.163.4.563; Taylor D, 2010, PSYCHIATR BULL, V34, P41, DOI 10.1192/pb.bp.109.027086; Tenback DE, 2005, J CLIN PSYCHIAT, V66, P1130, DOI 10.4088/JCP.v66n0907; Tenback DE, 2009, MOVEMENT DISORD, V24, P2309, DOI 10.1002/mds.22707; van Harten PN, 2009, PSYCHOL MED, V39, P1754, DOI 10.1017/S0033291709990456; Van Harten P. N., 1996, Schizophrenia Research, V19, P195; van Harten PN, 2006, MOVEMENT DISORD, V21, P1276, DOI 10.1002/mds.20904; van Harten PN, 1999, SCHIZOPHRENIA BULL, V25, P741, DOI 10.1093/oxfordjournals.schbul.a033415; VANHARTEN PN, 1998, MOVEMENT DISORDERS A; Weiden Peter J, 2007, J Psychiatr Pract, V13, P13, DOI 10.1097/00131746-200701000-00003; WOODS SW, 2010, J CLIN PSYCHIAT; YASSA R, 1992, SCHIZOPHRENIA BULL, V18, P701, DOI 10.1093/schbul/18.4.701	69	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25588	10.1371/journal.pone.0025588	http://dx.doi.org/10.1371/journal.pone.0025588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	22022416	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000044
J	Franks, SE; Campbell, CI; Barnett, EF; Siwicky, MD; Livingstone, J; Cory, S; Moorehead, RA				Franks, S. E.; Campbell, C. I.; Barnett, E. F.; Siwicky, M. D.; Livingstone, J.; Cory, S.; Moorehead, R. A.			Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature	ONCOGENE			English	Article						IGF-IR; mammary tumor; DNA microarray; EMT; claudin	ESTROGEN-RECEPTOR-ALPHA; HUMAN-BREAST-CANCER; PROGESTERONE-RECEPTORS; MOLECULAR PORTRAITS; PROFILES; CARCINOMAS; PATTERNS	Molecular profiling has allowed a more precise classification of human cancers. With respect to breast cancer, this approach has been used to identify five subtypes; luminal A, luminal B, HER2-enriched, basal-like and claudin-low. In addition, this approach can be used to determine the type of tumor represented by particular cell lines or transgenic animal models. Therefore, this approach was utilized to classify the mammary tumors that develop in MTB-IGFIR transgenic mice. It was determined that the primary mammary tumors, which develop due to elevated expression of the type I insulin-like growth factor receptor (IGF-IR) in mammary epithelial cells, most closely resemble murine tumors with basal-like or mixed gene expression profiles and with human basal-like breast cancers. Downregulation of IGF-IR transgene in MTB-IGFIR tumor-bearing mice leads to the regression of most of the tumors, followed by tumor reappearance in some of the mice. These tumors that reappear following IGF-IR transgene downregulation do not express the IGF-IR transgene and cluster with murine mammary tumors that express a mesenchymal gene expression profile and with human claudin-low breast cancers. Therefore, IGF-IR overexpression in murine mammary epithelial cells induces mammary tumors with primarily basal-like characteristics, whereas tumors that develop following IGF-IR downregulation express a gene signature that most closely resembles human claudin-low breast tumors. Oncogene (2012) 31, 3298-3309; doi:10.1038/onc.2011.486; published online 24 October 2011	[Franks, S. E.; Campbell, C. I.; Barnett, E. F.; Siwicky, M. D.; Moorehead, R. A.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N5A 7Z1, Canada; [Livingstone, J.; Cory, S.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Biochem Oncol, Montreal, PQ, Canada; [Livingstone, J.; Cory, S.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Med, Montreal, PQ, Canada	University of Guelph; McGill University; McGill University	Moorehead, RA (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, 50 Stone Rd E, Guelph, ON N5A 7Z1, Canada.	rmoorehe@uoguelph.ca		, Roger/0000-0001-9539-6295; Livingstone, Julie/0000-0002-8424-3768	Cancer Research Society; Canadian Institutes of Health Research	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Cancer Research Society and the Canadian Institutes of Health Research awarded to RAM.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gruvberger S, 2001, CANCER RES, V61, P5979; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Jones RA, 2009, ONCOGENE, V13, P407; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Koda M, 2003, HORM METAB RES, V35, P794; Koda M, 2005, ONCOL REP, V14, P93; Lanzino M, 2008, CURR CANCER DRUG TAR, V8, P597, DOI 10.2174/156800908786241104; Lerma E, 2007, MODERN PATHOL, V20, P1200, DOI 10.1038/modpathol.3800961; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PEYRAT JP, 1988, CANCER RES, V48, P6429; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sarfstein R, 2006, MOL CELL ENDOCRINOL, V252, P241, DOI 10.1016/j.mce.2006.03.018; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	29	17	17	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	27					3298	3309		10.1038/onc.2011.486	http://dx.doi.org/10.1038/onc.2011.486			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22020329	Green Published, hybrid			2022-12-25	WOS:000306113400009
J	Fransson, S; Uv, A; Eriksson, H; Andersson, MK; Wettergren, Y; Bergo, M; Ejeskar, K				Fransson, S.; Uv, A.; Eriksson, H.; Andersson, M. K.; Wettergren, Y.; Bergo, M.; Ejeskar, K.			p37 delta is a new isoform of PI3K p110 delta that increases cell proliferation and is overexpressed in tumors	ONCOGENE			English	Article						p110 delta; p37 delta; p85; RAS; ovarian cancer; colorectal cancer	P85 REGULATORY SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3'-KINASE; NEUROBLASTOMA TUMORS; COLORECTAL-CANCER; CLASS IPI3K; KEY ROLE; MUCOSA; METABOLISM	The phosphatidylinositol 3-kinases (PI3Ks) regulate cell growth, proliferation and survival, and are frequently affected in human cancer. PI3K is composed of a catalytic subunit, p110, and a regulatory subunit, p85. The PI3K catalytic subunit p110 delta is encoded by PIK3CD and contains p85- and RAS-binding domains, and a kinase domain. Here we present an alternatively spliced PIK3CD transcript encoding a previously unknown protein, p37 delta, and demonstrate that this protein is expressed in human ovarian and colorectal tumors. p37 delta retains the p85-binding domain and a fraction of the RAS-binding domain, lacks the catalytic domain, and has a unique carboxyl-terminal region. In contrast to p110 delta, which stabilizes p85, p37 delta promoted p85 sequestering. Despite the truncated RAS-binding domain, p37 delta bound to RAS and we found a strong positive correlation between the protein levels of p37 delta and RAS. Overexpressing p37 delta, but not p110 delta, increased the proliferation and invasive properties of HEK-293 cells and mouse embryonic fibroblasts. Cells overexpressing p37 delta showed a quicker phosphorylation response of AKT and ERK1/2 following serum stimulation. Ubiquitous expression of human p37 delta in the fruit fly increased body size, DNA content and phosphorylated ERK1/2 levels. Thus, p37 delta appears to be a new tumor-specific isoform of p110 delta with growth-promoting properties. Oncogene (2012) 31, 3277-3286; doi: 10.1038/onc.2011.492; published online 24 October 2011	[Fransson, S.; Uv, A.; Eriksson, H.; Ejeskar, K.] Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Med & Clin Genet, SE-40530 Gothenburg, Sweden; [Andersson, M. K.] Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Pathol, SE-40530 Gothenburg, Sweden; [Wettergren, Y.] Univ Gothenburg, Dept Gen Surg, SE-40530 Gothenburg, Sweden; [Bergo, M.] Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Med, SE-40530 Gothenburg, Sweden; [Ejeskar, K.] Univ Skovde, Sch Life Sci, Skovde, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde	Ejeskar, K (corresponding author), Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Med & Clin Genet, Box 425, SE-40530 Gothenburg, Sweden.	katarina.ejeskar@gu.se		Fransson, Susanne/0000-0002-9713-3074; Ejeskar, Katarina/0000-0001-8962-0860	Swedish Cancer Society [100405]; Swedish Children's Cancer Fund; Gunvor and Ivan Svensson's Foundation; Ake Wiberg's Foundation; Sahlgrenska University Hospital Foundation; Assar Gabrielsson Foundation; Mary Beves Stiftelse for Barncancerforskning; Frimurare Barnhusdirektionen; ALF Grants, County of Vastergotland	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Fund; Gunvor and Ivan Svensson's Foundation; Ake Wiberg's Foundation; Sahlgrenska University Hospital Foundation; Assar Gabrielsson Foundation; Mary Beves Stiftelse for Barncancerforskning; Frimurare Barnhusdirektionen; ALF Grants, County of Vastergotland	We thank the Genomics Core Facility for access to the ABI PRISM7900HT System, Magnus Pettersson, Maria Yhr and Grissel Faura for technical assistance. This work was supported by grants from the Swedish Cancer Society (K Ejeskar and 100405), the Swedish Children's Cancer Fund, Gunvor and Ivan Svensson's Foundation, Ake Wiberg's Foundation, the Sahlgrenska University Hospital Foundation, the Assar Gabrielsson Foundation, Mary Beves Stiftelse for Barncancerforskning, Frimurare Barnhusdirektionen and ALF Grants, County of Vastergotland.	Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Fransson S, 2007, GENE CHROMOSOME CANC, V46, P45, DOI 10.1002/gcc.20387; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Odin E, 2003, CLIN CANCER RES, V9, P6012; Patton DT, 2007, BIOCHEM SOC T, V35, P167, DOI 10.1042/BST0350167; Philp AJ, 2001, CANCER RES, V61, P7426; Polley ACJ, 2006, CANCER RES, V66, P6553, DOI 10.1158/0008-5472.CAN-06-0534; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Sawyer C, 2003, CANCER RES, V63, P1667; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wettergren Y, 2008, MOL MED, V14, P412, DOI 10.2119/2007-00096.Wettergren; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	29	13	17	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	27					3277	3286		10.1038/onc.2011.492	http://dx.doi.org/10.1038/onc.2011.492			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22020336				2022-12-25	WOS:000306113400007
J	Chen, HZ; Li, L; Wang, WJ; Du, XD; Wen, Q; He, JP; Zhao, BX; Li, GD; Zhou, W; Xia, Y; Yang, QY; Hew, CL; Liou, YC; Wu, Q				Chen, H-Z; Li, L.; Wang, W-J; Du, X-D; Wen, Q.; He, J-P; Zhao, B-X; Li, G-D; Zhou, W.; Xia, Y.; Yang, Q-Y; Hew, C-L; Liou, Y-C; Wu, Q.			Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis	ONCOGENE			English	Article						prolyl isomerase pin1; orphan receptor TR3; phosphorylation; cell proliferation	N-TERMINAL KINASE; CANCER CELL; NEGATIVE REGULATION; GROWTH-FACTORS; NGFI-B; APOPTOSIS; PHOSPHORYLATION; SUBSTRATE; TRANSLOCATION; DOMAINS	Pin1 regulates a subset of phosphoproteins by isomerizing phospho-Ser/Thr-Pro motifs via a 'post-phosphorylation' mechanism. Here, we characterize TR3 as a novel Pin1 substrate, and the mitogenic function of TR3 depends on Pin1-induced isomerization. There are at least three phospho-Ser-Pro motifs on TR3 that bind to Pin1. The Ser95-Pro motif of TR3 is the key site through which Pin1 enhances TR3 stability by retarding its degradation. Pin1 can also catalyze TR3 through phospho-Ser431-Pro motif, which is phosphorylated by extracellular signal-regulated kinase 2 (ERK2), resulting in enhanced TR3 transactivation. Furthermore, Pin1 not only facilitates TR3 targeting to the promoter of cyclin D2, a novel downstream target of TR3, but also promotes TR3 to recruit p300, thereby inducing cell proliferation. Importantly, we found that Pin1 is indispensable for TR3 to promote tumor growth both in vitro and in vivo. Our study thus suggests that Pin1 has an important role in cell proliferation by isomerizing TR3. Oncogene (2012) 31, 2876-2887; doi:10.1038/onc.2011.463; published online 17 October 2011	[Chen, H-Z; Li, L.; Wang, W-J; Du, X-D; Wen, Q.; He, J-P; Zhao, B-X; Li, G-D; Wu, Q.] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Zhou, W.; Xia, Y.; Yang, Q-Y; Hew, C-L; Liou, Y-C] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Xiamen University; National University of Singapore	Wu, Q (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	dbslyc@nus.edu.sg; qiaow@xmu.edu.cn	Wu, Q/G-4646-2010; Hew, Choy Leong/I-1501-2012; Xia, Yun/K-4128-2015	Hew, Choy Leong/0000-0002-9441-0064; Xia, Yun/0000-0003-2184-4870; Li, Li/0000-0002-7720-6731	Ministry of Education, China [B06016]; Ministry of Science and Technology, China [2007CB914402]; National Natural Science Foundation of China [30810103905, 30871281, 31000620]; National Key New Drug Creation Program of China [2009ZX09103-083]; Fundamental Research Funds for the Central Universities, China [2010121096]; Science Planning program grant of Fujian Province, China [2009J1010]; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore [09/1/21/19/604]	Ministry of Education, China(Ministry of Education, China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Program of China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Science Planning program grant of Fujian Province, China; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from Ministry of Education, China (Project 111, B06016) to WQ and YCL; grants from the Ministry of Science and Technology, China (2007CB914402) to WQ; the National Natural Science Foundation of China (30810103905 and 30871281 to WQ, 31000620 to CHZ); grants from the National Key New Drug Creation Program of China (2009ZX09103-083) to WQ; grants from the Fundamental Research Funds for the Central Universities, China (2010121096) to CHZ; Science Planning program grant of Fujian Province, China (2009J1010); and the grant (09/1/21/19/604) from the Biomedical Research Council, the Agency for Science, Research and Technology, Singapore to YCL.	CHANG C, 1989, J STEROID BIOCHEM, V34, P391; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Jacobs CM, 2004, J BIOL CHEM, V279, P50097, DOI 10.1074/jbc.M409145200; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li GD, 2007, NUCLEIC ACIDS RES, V35, P7348, DOI 10.1093/nar/gkm870; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu B, 2007, ENDOCRINOLOGY, V148, P34, DOI 10.1210/en.2006-0800; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Liu S, 2002, WORLD J GASTROENTERO, V8, P446, DOI 10.3748/wjg.v8.i3.446; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Mu XM, 2003, J BIOL CHEM, V278, P42840, DOI 10.1074/jbc.M305594200; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	42	30	32	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	23					2876	2887		10.1038/onc.2011.463	http://dx.doi.org/10.1038/onc.2011.463			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	22002310				2022-12-25	WOS:000305277900007
J	Hone, AJ; Meyer, EL; McIntyre, M; McIntosh, JM				Hone, Arik J.; Meyer, Erin L.; McIntyre, Melissa; McIntosh, J. Michael			Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the alpha 6 beta 4*subtype	FASEB JOURNAL			English	Article						alpha-conotoxin; real-time RT-PCR; patch-clamp electrophysiology	VENTRAL TEGMENTAL AREA; INHIBITORY SYNAPTIC-TRANSMISSION; ALPHA-CONOTOXIN; CHOLINERGIC-RECEPTORS; DOPAMINE RELEASE; RAT RETINA; SUBUNIT; MODULATION; ACTIVATION; EXPRESSION	The alpha 6-containing nicotinic acetylcholine receptors (nAChRs) have recently been implicated in diseases of the central nervous system (CNS), including Parkinson's disease and substance abuse. In contrast, little is known about the role of alpha 6* nAChRs in the peripheral nervous system (where the asterisk denotes the possible presence of additional subunits). Dorsal root ganglia (DRG) neurons are known to express nAChRs with a pharmacology consistent with an alpha 7, alpha 3 beta 4*, and alpha 4 beta 2* composition. Here we present evidence that DRG neurons also express alpha 6* nAChRs. We used RT-PCR to show the presence of alpha 6 subunit transcripts and patch-clamp electrophysiology together with subtype-selective alpha-conotoxins to pharmacologically characterize the nAChRs in rat DRG neurons. alpha-Conotoxin BuIA (500 nM) blocked acetylcholine-gated currents (I-ACh) by 90.3 +/- 3.0%; the recovery from blockade was very slow, indicating a predominance of alpha(x)beta 4* nAChRs. Perfusion with either 300 nM BuIA[T5A;P6O] or 200 nM MII[E11A], alpha-conotoxins that target the alpha 6 beta 4* subtype, blocked I-ACh by 49.3 +/- 5 and 46.7 +/- 8%, respectively. In these neurons, I-ACh was relatively insensitive to 200 nM ArIB[V11L;V16D] (9.4 +/- 2.0% blockade) or 500 nM PnIA (23.0 +/- 4% blockade), alpha-conotoxins that target alpha 7 and alpha 3 beta 2*/alpha 6 beta 2* nAChRs, respectively. We conclude that alpha 6 beta 4* nAChRs are among the subtypes expressed by DRG, and to our knowledge, this is the first demonstration of alpha 6 beta 4* in neurons outside the CNS.-Hone, A.J., Meyer, E. L., McIntyre, M., McIntosh, J. M. Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the alpha 6 beta 4* subtype. FASEB J. 26, 917-926 (2012). www.fasebj.org	[Meyer, Erin L.; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [Hone, Arik J.; McIntosh, J. Michael] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84132 USA; [Meyer, Erin L.; McIntyre, Melissa; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McIntosh, JM (corresponding author), Univ Utah, Dept Psychiat, 50 North 1900 East, Salt Lake City, UT 84132 USA.	mcintosh.mike@gmail.com		Meyer, Erin/0000-0003-0704-5861	U.S. National Institutes of Health [MH-53631, GM-48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053631, R01MH053631] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Daniel McGehee (University of Chicago, Chicago, IL, USA) and Dr. Doju Yoshikami (University of Utah) for critical consultation regarding DRG patch-clamp experiments, and the University of Utah Genomics Core facility for assistance with the RT-PCR experiments. This work was supported by U.S. National Institutes of Health grants MH-53631 and GM-48677 (to J.M.M). The authors declare no conflicts of interest.	Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2006, MOL PHARMACOL, V70, P967, DOI 10.1124/mol.106.024513; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Carroll FI, 2010, J NAT PROD, V73, P306, DOI 10.1021/np9006124; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Cheng LZ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-56; Cucchiaro G, 2008, ANESTHESIOLOGY, V109, P512, DOI 10.1097/ALN.0b013e3181834490; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Dube GR, 2005, NEUROSCI LETT, V376, P29, DOI 10.1016/j.neulet.2004.11.020; Everhart D, 2003, J PHARMACOL EXP THER, V306, P664, DOI 10.1124/jpet.103.051656; Exley R, 2011, P NATL ACAD SCI USA, V108, P7577, DOI 10.1073/pnas.1103000108; Fucile S, 2005, J PHYSIOL-LONDON, V565, P219, DOI 10.1113/jphysiol.2005.084871; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grinevich VP, 2005, J PHARMACOL EXP THER, V312, P619, DOI 10.1124/jpet.104.075069; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; LAMAR E, 1990, Society for Neuroscience Abstracts, V16, P681; LANGE KW, 1993, J NEUROCHEM, V60, P197, DOI 10.1111/j.1471-4159.1993.tb05838.x; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; Mao D, 2006, MOL PHARMACOL, V70, P1693, DOI 10.1124/mol.106.027458; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Parker SL, 2004, MOL PHARMACOL, V65, P611, DOI 10.1124/mol.65.3.611; Perez XA, 2010, MOL PHARMACOL, V78, P971, DOI 10.1124/mol.110.067561; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2006, J NEUROCHEM, V98, P1866, DOI 10.1111/j.1471-4159.2006.04078.x; Rau KK, 2005, J NEUROPHYSIOL, V93, P1358, DOI 10.1152/jn.00591.2004; Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279; Simopoulos TT, 2008, PAIN PHYSICIAN, V11, P137; Takeda D, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-26; Van Boxem K, 2011, PAIN MED, V12, P1322, DOI 10.1111/j.1526-4637.2011.01202.x; Van Zundert J, 2007, PAIN, V127, P173, DOI 10.1016/j.pain.2006.09.002; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; WHITEHOUSE PJ, 1988, NEUROLOGY, V38, P720, DOI 10.1212/WNL.38.5.720; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zheng GR, 2011, BIOORG MED CHEM LETT, V21, P2476, DOI 10.1016/j.bmcl.2011.02.043	51	51	52	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					917	926		10.1096/fj.11-195883	http://dx.doi.org/10.1096/fj.11-195883			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22024738	Green Published			2022-12-25	WOS:000300485700041
J	Gadd, MS; Bhati, M; Jeffries, CM; Langley, DB; Trewhella, J; Guss, JM; Matthews, JM				Gadd, Morgan S.; Bhati, Mugdha; Jeffries, Cy M.; Langley, David B.; Trewhella, Jill; Guss, J. Mitchell; Matthews, Jacqueline M.			Structural Basis for Partial Redundancy in a Class of Transcription Factors, the LIM Homeodomain Proteins, in Neural Cell Type Specification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; MOTOR-NEURON; MACROMOLECULAR STRUCTURES; INTERNEURON IDENTITY; LMO4-LDB1 COMPLEX; LHX3; CRYSTALLIZATION; PROGRAM; DOMAINS; BINDING	Background: Lhx and Isl proteins contribute to genetic control in developing neurons. Results: The Lhx3/4-binding motif in Isl2 was identified, and the structures of Lhx-Isl complexes were characterized and compared. Conclusion: There are minor differences in the structures of Lhx3/4 binding Isl1/2 reflected by mutational and biophysical analyses. Significance: Redundant sets of interactions conserve function in developing neurons while allowing divergence in other contexts.	[Gadd, Morgan S.; Bhati, Mugdha; Jeffries, Cy M.; Langley, David B.; Trewhella, Jill; Guss, J. Mitchell; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Matthews, JM (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	jacqui.matthews@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019; Matthews, Jacqueline/A-7322-2013; Langley, David B/B-1861-2009	Guss, Jules Mitchell/0000-0003-4259-6079; Langley, David B/0000-0003-2752-0041; Trewhella, Jill/0000-0002-8555-6766; Gadd, Morgan/0000-0001-6124-0858; /0000-0002-8718-7343; Matthews, Jacqueline/0000-0001-8518-3472	Australian Research Council; Australian Government; Viertel Foundation; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Viertel Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council.; Supported by Australian Postgraduate Awards from the Australian Government.; Supported by senior research fellowships from the Viertel Foundation and National Health and Medical Research Council. To whom correspondence should be addressed: Bldg. G08, School of Molecular Bioscience, The University of Sydney, New South Wales 2006, Australia. E-mail: jacqui.matthews@sydney.edu.au.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Bachy I, 2002, NEUROREPORT, V13, pA23, DOI 10.1097/00001756-200202110-00002; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Failli V, 2000, GENOMICS, V64, P307, DOI 10.1006/geno.2000.6123; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; LI H, 1994, EMBO J, V13, P2876, DOI 10.1002/j.1460-2075.1994.tb06582.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ryan DP, 2006, J MOL BIOL, V359, P66, DOI 10.1016/j.jmb.2006.02.074; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	47	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42971	42980		10.1074/jbc.M111.248559	http://dx.doi.org/10.1074/jbc.M111.248559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025611	Green Published, hybrid			2022-12-25	WOS:000298351300018
J	Hanfrey, CC; Pearson, BM; Hazeldine, S; Lee, J; Gaskin, DJ; Woster, PM; Phillips, MA; Michael, AJ				Hanfrey, Colin C.; Pearson, Bruce M.; Hazeldine, Stuart; Lee, Jeongmi; Gaskin, Duncan J.; Woster, Patrick M.; Phillips, Margaret A.; Michael, Anthony J.			Alternative Spermidine Biosynthetic Route Is Critical for Growth of Campylobacter jejuni and Is the Dominant Polyamine Pathway in Human Gut Microbiota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; AMINO-ACID DECARBOXYLASES; ALKYLPOLYAMINE ANALOGS; SUBSTRATE-SPECIFICITY; VIBRIO-ALGINOLYTICUS; SYM-HOMOSPERMIDINE; BACILLUS-SUBTILIS; BIOFILM FORMATION; GENOME SEQUENCE; PUTRESCINE	The availability of fully sequenced bacterial genomes has revealed that many species known to synthesize the polyamine spermidine lack the spermidine biosynthetic enzymes S-adenosylmethionine decarboxylase and spermidine synthase. We found that such species possess orthologues of the sym-norspermidine biosynthetic enzymes carboxynorspermidine dehydrogenase and carboxynorspermidine decarboxylase. By deleting these genes in the food-borne pathogen Campylobacter jejuni, we found that the carboxynorspermidine decarboxylase orthologue is responsible for synthesizing spermidine and not symnorspermidine in vivo. In polyamine auxotrophic gene deletion strains of C. jejuni, growth is highly compromised but can be restored by exogenous sym-homospermidine and to a lesser extent by sym-norspermidine. The alternative spermidine biosynthetic pathway is present in many bacterial phyla and is the dominant spermidine route in the human gut, stomach, and oral microbiomes, and it appears to have supplanted the S-adenosylmethionine decarboxylase/spermidine synthase pathway in the gut microbiota. Approximately half of the gut Firmicutes species appear to be polyamine auxotrophs, but all encode the pot-ABCD spermidine/putrescine transporter. Orthologues encoding carboxyspermidine dehydrogenase and carboxyspermidine decarboxylase are found clustered with an array of diverse putrescine biosynthetic genes in different bacterial genomes, consistent with a role in spermidine, rather than sym-norspermidine biosynthesis. Due to the pervasiveness of epsilon-proteobacteria in deep sea hydrothermal vents and to the ubiquity of the alternative spermidine biosynthetic pathway in that phylum, the carboxyspermidine route is also dominant in deep sea hydrothermal vents. The carboxyspermidine pathway for polyamine biosynthesis is found in diverse human pathogens, and this alternative spermidine biosynthetic route presents an attractive target for developing novel antimicrobial compounds.	[Phillips, Margaret A.; Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hanfrey, Colin C.; Pearson, Bruce M.; Gaskin, Duncan J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hazeldine, Stuart] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA; [Lee, Jeongmi] Sungkyunkwan Univ, Sch Pharm, Suwon 440747, South Korea; [Woster, Patrick M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Wayne State University; Sungkyunkwan University (SKKU); Medical University of South Carolina	Michael, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu	Woster, Patrick M/A-5604-2010; Lee, Jeongmi/AAJ-7720-2020	Woster, Patrick M/0000-0002-9471-1916; Lee, Jeongmi/0000-0002-9948-7554; Pearson, Bruce/0000-0002-9223-7712	National Institutes of Health [7RO1 CA149095, R01 AI034432]; Biotechnology and Biological Sciences Research Council (United Kingdom) CSG [BB/E024467/1]; University of Texas Southwestern Medical Center; Welch Foundation [I-1257]; BBSRC [BB/E024467/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024467/1, BBS/E/F/00042254] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA149095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432, R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (United Kingdom) CSG; University of Texas Southwestern Medical Center; Welch Foundation(The Welch Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 7RO1 CA149095 (to P. M. W.) and R01 AI034432 (to M. A. P.). This work was also supported by a Biotechnology and Biological Sciences Research Council (United Kingdom) CSG Grant, Institute Development Fellowship BB/E024467/1, University of Texas Southwestern Medical Center grant (to A. J. M.), and the Welch Foundation Grant I-1257 (to M. A. P.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bellevue FH, 1996, BIOORG MED CHEM LETT, V6, P2765, DOI 10.1016/S0960-894X(96)00510-0; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Chou HT, 2008, J BACTERIOL, V190, P1966, DOI 10.1128/JB.01804-07; Covassin L, 2003, BIOORG MED CHEM LETT, V13, P3267, DOI 10.1016/S0960-894X(03)00668-1; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; HAMANA K, 1994, J GEN APPL MICROBIOL, V40, P181, DOI 10.2323/jgam.40.181; HAMANA K, 2004, MICROBIOL CULTURE CO, V20, P3; Hamana K., 1998, MICROBIOL CULT COLL, V14, P1; HAMANA K, 1999, MICROBIOL CULT COLL, V15, P9; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P255, DOI 10.2323/jgam.50.255; Hosoya R., 2006, MICROBIOL CULT; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li Y, 2006, SYNTHETIC COMMUN, V36, P925, DOI 10.1080/00397910500466199; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Takaki Y, 2010, DNA RES, V17, P123, DOI 10.1093/dnares/dsq005; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; WANG WLL, 1980, J CLIN MICROBIOL, V12, P479, DOI 10.1128/JCM.12.3.479-480.1980; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; YAMAMOTO S, 1994, MICROBIOL-UK, V140, P3117, DOI 10.1099/13500872-140-11-3117; Zou Y, 2001, BIOORG MED CHEM LETT, V11, P1613, DOI 10.1016/S0960-894X(01)00315-8	37	65	67	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43301	43312		10.1074/jbc.M111.307835	http://dx.doi.org/10.1074/jbc.M111.307835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025614	Green Published, hybrid			2022-12-25	WOS:000298351300050
J	Dvorkin-Gheva, A; Hassell, JA				Dvorkin-Gheva, Anna; Hassell, John A.			Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples	PLOS ONE			English	Article							ESTROGEN-REGULATED GENES; MOLECULAR PORTRAITS; CANCER; PROGESTERONE; ALPHA; SENSITIVITY; TAMOXIFEN; SUBTYPES; IDENTIFICATION; ACTIVATION	The occurrence of large publically available repositories of human breast tumor gene expression profiles provides an important resource to discover new breast cancer biomarkers and therapeutic targets. For example, knowledge of the expression of the estrogen and progesterone hormone receptors (ER and PR), and that of the ERBB2 in breast tumor samples enables choice of therapies for the breast cancer patients that express these proteins. Identifying new biomarkers and therapeutic agents affecting the activity of signaling pathways regulated by the hormone receptors or ERBB2 might be accelerated by knowledge of their expression levels in large gene expression profiling data sets. Unfortunately, the status of these receptors is not invariably reported in public databases of breast tumor gene expression profiles. Attempts have been made to employ a single probe set to identify ER, PR and ERBB2 status, but the specificity or sensitivity of their prediction is low. We enquired whether estimation of ER, PR and ERBB2 status of profiled tumor samples could be improved by using multiple probe sets representing these three genes and others with related expression. We used 8 independent datasets of human breast tumor samples to define gene expression signatures comprising 24, 51 and 14 genes predictive of ER, PR and ERBB2 status respectively. These signatures, as demonstrated by sensitivity and specificity measures, reliably identified hormone receptor and ERBB2 expression in breast tumors that had been previously determined using protein and DNA based assays. Our findings demonstrate that gene signatures can be identified which reliably predict the expression status of the estrogen and progesterone hormone receptors and that of ERBB2 in publically available gene expression profiles of breast tumor samples. Using these signatures to query transcript profiles of breast tumor specimens may enable discovery of new biomarkers and therapeutic targets for particular subtypes of breast cancer.	[Dvorkin-Gheva, Anna; Hassell, John A.] McMaster Univ, Ctr Funct Genom, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Dvorkin-Gheva, A (corresponding author), McMaster Univ, Ctr Funct Genom, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	hassell@mcmaster.ca		Dvorkin-Gheva, Anna/0000-0001-7295-7440	The Canadian Breast Cancer Foundation; Stem Cell Network; Terry Fox Research Institute; Ontario Institute for Cancer Research	The Canadian Breast Cancer Foundation; Stem Cell Network; Terry Fox Research Institute; Ontario Institute for Cancer Research	The Canadian Breast Cancer Foundation, the Stem Cell Network, the Terry Fox Research Institute, and the Ontario Institute for Cancer Research provided operating grants to JAH to support the research described herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Campone M, 2008, BREAST CANCER RES TR, V109, P491, DOI 10.1007/s10549-007-9673-x; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Daidone MG, 2004, EUR J NUCL MED MOL I, V31, pS3, DOI 10.1007/s00259-004-1522-0; Demir H, 2010, J BUON, V15, P774; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Everitt B. S., 1981, FINITE MIXTURE DISTR; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; FOEKENS JA, 1989, CANCER RES, V49, P5823; Gandhi S, 2011, ONCOLOGIST, V16, P479, DOI 10.1634/theoncologist.2010-0279; Ghosh MG, 2000, CANCER RES, V60, P6367; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Han JS, 2011, AM J CLIN PATHOL, V135, P230, DOI 10.1309/AJCP9DV3EVZUATFV; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang HJ, 2005, BREAST CANCER RES TR, V91, P81, DOI 10.1007/s10549-004-8235-8; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Karn A, 2010, J NEPAL MED ASSOC, V49, P62; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Lacroix M, 2001, BREAST CANCER RES TR, V67, P263, DOI 10.1023/A:1017946810277; Layfield Lester J, 2003, Breast J, V9, P257, DOI 10.1046/j.1524-4741.2003.09325.x; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; Lo R, 2010, BBA-GENE REGUL MECH, V1799, P469, DOI 10.1016/j.bbagrm.2010.01.005; Maller JL, 2002, MOL CELL ENDOCRINOL, V187, P173, DOI 10.1016/S0303-7207(01)00695-5; MANNING DL, 1995, ACTA ONCOL, V34, P641, DOI 10.3109/02841869509094041; Mannocci A, 2010, TUMORI J, V96, P385, DOI 10.1177/030089161009600302; MARTIN M, 2011, BREAST CANC RES TREA; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pusztai L, 2003, CLIN CANCER RES, V9, P2406; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; Rody A, 2009, EUR J CANCER, V45, P405, DOI 10.1016/j.ejca.2008.10.016; Rudiger T, 2002, AM J SURG PATHOL, V26, P873, DOI 10.1097/00000478-200207000-00005; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Song G, 2006, BIOL REPROD, V74, P913, DOI 10.1095/biolreprod.106.050807; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Telli ML, 2010, CLIN BREAST CANCER, V10, pE16, DOI 10.3816/CBC.2010.s.003; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Tung JJ, 2005, CELL CYCLE, V4, P478, DOI 10.4161/cc.4.3.1532; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413	64	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26023	10.1371/journal.pone.0026023	http://dx.doi.org/10.1371/journal.pone.0026023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022496	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600036
J	Wolz, R; Julkunen, V; Koikkalainen, J; Niskanen, E; Zhang, DP; Rueckert, D; Soininen, H; Lotjonen, J				Wolz, Robin; Julkunen, Valtteri; Koikkalainen, Juha; Niskanen, Eini; Zhang, Dong Ping; Rueckert, Daniel; Soininen, Hilkka; Lotjonen, Jyrki		Alzheimers Dis Neuroimaging	Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROIMAGING INITIATIVE ADNI; BRAIN; BIOMARKERS; HIPPOCAMPAL; VOLUME; CLASSIFICATION; SEGMENTATION; ACCUMULATION; PARAMETER	The role of structural brain magnetic resonance imaging (MRI) is becoming more and more emphasized in the early diagnostics of Alzheimer's disease (AD). This study aimed to assess the improvement in classification accuracy that can be achieved by combining features from different structural MRI analysis techniques. Automatically estimated MR features used are hippocampal volume, tensor-based morphometry, cortical thickness and a novel technique based on manifold learning. Baseline MRIs acquired from all 834 subjects (231 healthy controls (HC), 238 stable mild cognitive impairment (S-MCI), 167 MCI to AD progressors (P-MCI), 198 AD) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were used for evaluation. We compared the classification accuracy achieved with linear discriminant analysis (LDA) and support vector machines (SVM). The best results achieved with individual features are 90% sensitivity and 84% specificity (HC/AD classification), 64%/66% (S-MCI/P-MCI) and 82%/76% (HC/P-MCI) with the LDA classifier. The combination of all features improved these results to 93% sensitivity and 85% specificity (HC/AD), 67%/69% (S-MCI/P-MCI) and 86%/82% (HC/P-MCI). Compared with previously published results in the ADNI database using individual MR-based features, the presented results show that a comprehensive analysis of MRI images combining multiple features improves classification accuracy and predictive power in detecting early AD. The most stable and reliable classification was achieved when combining all available features.	[Wolz, Robin; Zhang, Dong Ping; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England; [Julkunen, Valtteri; Niskanen, Eini; Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Tampere, Finland; [Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	Imperial College London; Kuopio University Hospital; University of Eastern Finland; VTT Technical Research Center Finland; University of Eastern Finland; University of Eastern Finland	Wolz, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England.	jyrki.lotjonen@vtt.fi	Rueckert, Daniel/C-4393-2008; Levey, Allan/F-2104-2011; Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013	Levey, Allan/0000-0002-3153-502X; Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Julkunen, Valtteri/0000-0002-8727-8536; Rueckert, Daniel/0000-0002-5683-5889	European Commission; Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering (NIBIB); Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING [R01AG012101, P30AG013846, U01AG024904, R01AG022374, U19AG010483, P30AG019610] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project is partially funded under the 7th Framework Programme by the European Commission (http://cordis.europa.eu/ist/). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI; Principal Investigator: Michael Weiner; NIH grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and through generous contributions from the following: Pzer Inc., Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co. Inc., AstraZeneca AB, Novartis Pharmaceuticals Corporation, Alzheimer's Association, Eisai Global Clinical Development, Elan Corporation, plc, Forest Laboratories, and the Institute for the Study of Aging, with participation from the U.S. Food and Drug Administration. Industry partnerships are coordinated through the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California Los Angeles. Data used in the preparation of this article were obtained from the ADNI database (www.loni.ucla.edu/ADNI). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI investigators include (complete listing available at http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Authorship_List.pdf).	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Chung MK, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P432; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuingnet R, 2010, NEUROIMAGE IN PRESS; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Davatzikos C, 2010, NEUROBIOLOG IN PRESS; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Draper N. R., 1998, WILEY SERIES PROBABI, V3rd, DOI DOI 10.1111/ecog.01134; Eckerstrom C, 2010, DEMENT GERIATR COGN, V29, P294, DOI 10.1159/000289814; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hinrichs C, 2009, LECT NOTES COMPUT SC, V5762, P786, DOI 10.1007/978-3-642-04271-3_95; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack Jr C, 2010, LANCET NEUROL, V27, P685; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu Y, 2009, NEUROBIOLOG IN PRESS; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wenk G, 2003, J CLIN PSYCHIAT S9, V64; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Wolz R, 2011, IEEE INT S BIOM IM, P960; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	55	211	212	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25446	10.1371/journal.pone.0025446	http://dx.doi.org/10.1371/journal.pone.0025446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022397	gold, Green Published			2022-12-25	WOS:000295978600014
J	Da Silva-Ferrada, E; Torres-Ramos, M; Aillet, F; Campagna, M; Matute, C; Rivas, C; Rodriguez, MS; Lang, V				Da Silva-Ferrada, Elisa; Torres-Ramos, Monica; Aillet, Fabienne; Campagna, Michela; Matute, Carlos; Rivas, Carmen; Rodriguez, Manuel S.; Lang, Valerie			Role of Monoubiquitylation on the Control of I kappa B alpha Degradation and NF-kappa B Activity	PLOS ONE			English	Article							SIGNAL-INDUCED DEGRADATION; GENE-EXPRESSION; ACTIVATION; UBIQUITINATION; BINDING; MONOUBIQUITINATION; PHOSPHORYLATION; PROTEINS	The NF-kappa B pathway is regulated by multiple post-translational modifications including phosphorylation, ubiquitylation and SUMOylation. Many of these modifications act on the natural inhibitor I kappa B alpha modulating its capacity to control signalmediated NF-kappa B activity. While the canonical pathway involving the phosphorylation and polyubiquitylation of I kappa B alpha has been well characterized, the role of these post-translational modifications in the control of basal NF-kappa B activity has not been deeply explored. Using the recently developed Tandem-repeated Ubiquitin Binding Entities (also known as ubiquitin traps) to capture ubiquitylated proteins, we identified monoubiquitylated forms of I kappa B alpha from multiple rat organs and cell types. The identification of these forms was demonstrated through different procedures such as immunoprecipitations with specific ubiquitin antibodies or His6-Ubiquitin pull downs. Monoubiquitylated forms of I kappa B alpha are resistant to TNF alpha-mediated degradation and can be captured using TUBEs, even after proteasome inhibitors treatment. As it occurs for monoSUMOylation, monoubiquitylation is not dependent of the phosphorylation of I kappa B alpha on the serines 32/36 and is not optimally degraded after TNF alpha stimulation. A ubiquitin-I kappa B alpha fusion exhibits phosphorylation defects and resistance to TNF alpha mediated degradation similar to the ones observed for endogenous monoubiquitylated I kappa B alpha. The N-terminal attachment of a single ubiquitin moiety on the I kappa B alpha fusion results in a deficient binding to the IKK beta kinase and recruitment of the SCF ligase component beta TrCP, promoting a negative impact on the NF-kappa B activity. Altogether, our results suggest the existence of a reservoir of monoubiquitylated I kappa B alpha resistant to TNF alpha-induced proteolysis, which is able to interact and repress DNA binding and NF-kappa B transcriptional activity. Such pool of I kappa B alpha may play an important role in the control of basal and signal-mediated NF-kappa B activity.	[Da Silva-Ferrada, Elisa; Torres-Ramos, Monica; Aillet, Fabienne; Rodriguez, Manuel S.; Lang, Valerie] CIBERehd, CIC BioGUNE, Prote Unit, Derio, Spain; [Campagna, Michela; Rivas, Carmen] Campus Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Matute, Carlos] Dept Neurosci Univ Basque Country UPV EHU, CIBERNED, Leioa, Bizkaia, Spain; [Rodriguez, Manuel S.] Dept Biochem Univ Basque Country UPV EHU, Leioa, Bizkaia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBERNED; University of Basque Country	Da Silva-Ferrada, E (corresponding author), CIBERehd, CIC BioGUNE, Prote Unit, Bizkaia Technol Pk, Derio, Spain.	mrodriguez@cicbiogune.es	RODRIGUEZ, Manuel S./D-5439-2018; Rivas, Carmen/AAB-6278-2019; Matute, Carlos/N-5559-2014; Rivas, Carmen/L-3162-2017; Torres-Ramos, Mónica/AAU-7618-2020	Rivas, Carmen/0000-0002-0518-7199; Matute, Carlos/0000-0001-8672-711X; Rivas, Carmen/0000-0002-0518-7199; Torres-Ramos, Mónica/0000-0002-8900-4037; Da Silva-Ferrada, Elisa Aida/0000-0003-0282-3855	Ministerio de Educacion y Ciencia [BFU2006-12991, BFU2008-01108/BMC]; Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country [PI09-05]; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country(Instituto de Salud Carlos III); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country	This work was funded by the Ramon y Cajal Program, Ministerio de Educacion y Ciencia grant BFU2006-12991 and BFU2008-01108/BMC, Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country grant PI09-05, Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2008/2009) and from the Innovation Technology Department of the Bizkaia Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lang V, 2008, BIOCHEM SOC T, V36, P853, DOI 10.1042/BST0360853; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; LIU S, 2010, CELL RES; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mathes E, 2010, J BIOL CHEM, V285, P32927, DOI 10.1074/jbc.M110.107326; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137	24	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25397	10.1371/journal.pone.0025397	http://dx.doi.org/10.1371/journal.pone.0025397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022389	Green Published, gold			2022-12-25	WOS:000295976000013
J	McMahon, CR; Buscot, MJ; Wiggins, NL; Collier, N; Maindonald, JH; McCallum, HI; Bowman, DMJS				McMahon, Clive R.; Buscot, Marie-Jeanne; Wiggins, Natasha L.; Collier, Neil; Maindonald, John H.; McCallum, Hamish I.; Bowman, David M. J. S.			A Two-Phase Model for Smoothly Joining Disparate Growth Phases in the Macropodid Thylogale billardierii	PLOS ONE			English	Article							POPULATION-DYNAMICS; AGE-DETERMINATION; ELEPHANT SEAL; MAMMALS; DENSITY	Generally, sigmoid curves are used to describe the growth of animals over their lifetime. However, because growth rates often differ over an animal's lifetime a single curve may not accurately capture the growth. Broken-stick models constrained to pass through a common point have been proposed to describe the different growth phases, but these are often unsatisfactory because essentially there are still two functions that describe the lifetime growth. To provide a single, converged model to age animals with disparate growth phases we developed a smoothly joining two-phase nonlinear function (SJ2P), tailored to provide a more accurate description of lifetime growth of the macropod, the Tasmanian pademelon Thylogale billardierii. The model consists of the Verhulst logistic function, which describes pouch-phase growth - joining smoothly to the Brody function, which describes post-pouch growth. Results from the model demonstrate that male pademelons grew faster and bigger than females. Our approach provides a practical means of ageing wild pademelons for life history studies but given the high variability of the data used to parametrise the second growth phase of the model, the accuracy of ageing of post-weaned animals is low: accuracy might be improved with collection of longitudinal growth data. This study provides a unique, first robust method that can be used to characterise growth over the lifespan of pademelons. The development of this method is relevant to collecting age-specific vital rates from commonly used wildlife management practices to provide crucial insights into the demographic behaviour of animal populations.	[McMahon, Clive R.; Buscot, Marie-Jeanne; Collier, Neil] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Wiggins, Natasha L.; Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Maindonald, John H.] Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia; [McCallum, Hamish I.] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Charles Darwin University; University of Tasmania; Australian National University; Griffith University	McMahon, CR (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	wigginsn@utas.edu.au	Collier, Neil/F-4729-2010; McMahon, Clive R/D-5713-2013; Bowman, David M.J.S./A-2930-2011; McCallum, Hamish/E-1638-2013	McMahon, Clive R/0000-0001-5241-8917; Bowman, David M.J.S./0000-0001-8075-124X; McCallum, Hamish/0000-0002-3493-0412; Collier, Neil/0000-0003-0115-0564; BUSCOT, Marie-jeanne/0000-0002-9055-5928	Tasmanian Community Forest Agreement; University of Tasmania; Tasmanian Community Forest Agreement: [1080]	Tasmanian Community Forest Agreement; University of Tasmania; Tasmanian Community Forest Agreement:	Financial support was provided by the Tasmanian Community Forest Agreement: Alternatives to 1080 Programme. In-kind support was provided by the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1983, J ANIM ECOL, V52, P969, DOI 10.2307/4467; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Brody S., 1945, BIOENERGETICS GROWTH; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Caughley G., 1996, CONSERVATION BIOL TH; Caughley G., 1977, ANAL VERTEBRATE POPU; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chiu G, 2006, J AM STAT ASSOC, V101, P542, DOI 10.1198/016214505000001177; Coleman JD, 2006, LC0506144 DEP PRIM I; Driessen M. M, 1992, EFFECTS HUNTING RAIN; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Garel M, 2009, J MAMMAL, V90, P954, DOI 10.1644/08-MAMM-A-287.1; Johnson K.A., 2008, MAMMALS AUSTR, P395; KIRKPATRICK T. H., 1965, QUEENSLAND J AGR ANIM SCI, V22, P301; Kirkpatrick T. H., 1964, Queensland Journal of Agricultural Science, V21, P163; LAWS RM, 1956, NATURE, V178, P193, DOI 10.1038/178193a0; Maindonald J, 2010, DATA ANAL GRAPHICS U; McMahon CR, 2010, METHODS ECOL EVOL, V1, P53, DOI 10.1111/j.2041-210X.2009.00002.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; Otway NM, 2004, BIOL CONSERV, V119, P341, DOI 10.1016/j.biocon.2003.11.017; POOLE WE, 1982, AUST WILDLIFE RES, V9, P9; POOLE WE, 1985, AUST WILDLIFE RES, V12, P127; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; ROSE RW, 1982, AUST WILDLIFE RES, V9, P33; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Sharman G. B., 1964, Wildlife Res, V9, P20; Topal M, 2004, SMALL RUMINANT RES, V55, P229, DOI 10.1016/j.smallrumres.2004.01.007; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wiggins NL, 2010, WILDLIFE RES, V37, P379, DOI 10.1071/WR09144; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24934	10.1371/journal.pone.0024934	http://dx.doi.org/10.1371/journal.pone.0024934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022369	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000006
J	Teichroeb, JH; Betts, DH; Vaziri, H				Teichroeb, Jonathan H.; Betts, Dean H.; Vaziri, Homayoun			Suppression of the Imprinted Gene NNAT and X-Chromosome Gene Activation in Isogenic Human iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; METHYLATION STATUS; NUCLEAR TRANSFER; NEURONATIN GENE; EXPRESSION; INACTIVATION; RTL1	Genetic comparison between human embryonic stem cells and induced pluripotent stem cells has been hampered by genetic variation. To solve this problem, we have developed an isogenic system that allows direct comparison of induced pluripotent stem cells (hiPSCs) to their genetically matched human embryonic stem cells (hESCs). We show that hiPSCs have a highly similar transcriptome to hESCs. Global transcriptional profiling identified 102-154 genes (>2 fold) that showed a difference between isogenic hiPSCs and hESCs. A stringent analysis identified NNAT as a key imprinted gene that was dysregulated in hiPSCs. Furthermore, a disproportionate number of X-chromosome localized genes were over-expressed in female hiPSCs. Our results indicate that despite a remarkably close transcriptome to hESCs, isogenic hiPSCs have alterations in imprinting and regulation of X-chromosome genes.	[Teichroeb, Jonathan H.; Vaziri, Homayoun] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada; [Teichroeb, Jonathan H.; Betts, Dean H.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario)	Teichroeb, JH (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada.	h.vaziri@utoronto.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142	Natural Sciences and Engineering Research Coucil	Natural Sciences and Engineering Research Coucil	Postdoctoral funding was provided by Natural Sciences and Engineering Research Coucil. Otherwise there are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CARREL L, 1999, HETEROGENEOUS GENE E, P7364; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Edwards RG, 2001, NATURE, V413, P349, DOI 10.1038/35096649; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; JIN SG, 2010, EXAMINATION SPECIFIC; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; LENGNER CJ, 2010, CELL; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIU L, 2010, J BIOL CHEM; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; SATO S, 2011, GENOMICS IN PRESS; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SILVA SS, 2008, X CHROMOSOME INACTIV, P4820; Simerly C, 2004, DEV BIOL, V276, P237, DOI 10.1016/j.ydbio.2004.10.006; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; West MD, 2008, REGEN MED, V3, P287, DOI 10.2217/17460751.3.3.287; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; WRIGHT K, 2011, HUMAN REPROD, P1; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e23436	10.1371/journal.pone.0023436	http://dx.doi.org/10.1371/journal.pone.0023436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022350	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000001
J	Yang, SW; Chanda, D; Cody, JJ; Rivera, AA; Waehler, R; Siegal, GP; Douglas, JT; Ponnazhagan, S				Yang, Sherry W.; Chanda, Diptiman; Cody, James J.; Rivera, Angel A.; Waehler, Reinhard; Siegal, Gene P.; Douglas, Joanne T.; Ponnazhagan, Selvarangan			Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; TUMOR-GROWTH; SELECTIVE VIRUSES; CELL-MIGRATION; GENE DELIVERY; CARCINOMA; METALLOPROTEINASE-2; ANGIOGENESIS; THERAPY	Ovarian cancer remains difficult to treat mainly due to presentation of the disease at an advanced stage. Conditionally-replicating adenoviruses (CRAds) are promising anti-cancer agents that selectively kill the tumor cells. The present study evaluated the efficacy of a novel CRAd (Ad5/3-CXCR4-TIMP2) containing the CXCR4 promoter for selective viral replication in cancer cells together with TIMP2 as a therapeutic transgene, targeting the matrix metalloproteases (MMPs) in a murine orthotopic model of disseminated ovarian cancer. An orthotopic model of ovarian cancer was established in athymic nude mice by intraperitonal injection of the human ovarian cancer cell line, SKOV3-Luc, expressing luciferase. Upon confirmation of peritoneal dissemination of the cells by non-invasive imaging, mice were randomly divided into four treatment groups: PBS, Ad-Delta E1-TIMP2, Ad5/3-CXCR4, and Ad5/3-CXCR4-TIMP2. All mice were imaged weekly to monitor tumor growth and were sacrificed upon reaching any of the predefined endpoints, including high tumor burden and significant weight loss along with clinical evidence of pain and distress. Survival analysis was performed using the Log-rank test. The median survival for the PBS cohort was 33 days; for Ad-Delta E1-TIMP2, 39 days; for Ad5/3-CXCR4, 52.5 days; and for Ad5/3-CXCR4-TIMP2, 63 days. The TIMP2-armed CRAd delayed tumor growth and significantly increased survival when compared to the unarmed CRAd. This therapeutic effect was confirmed to be mediated through inhibition of MMP9. Results of the in vivo study support the translational potential of Ad5/3-CXCR4-TIMP2 for treatment of human patients with advanced ovarian cancer.	[Yang, Sherry W.; Chanda, Diptiman; Cody, James J.; Siegal, Gene P.; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Rivera, Angel A.; Waehler, Reinhard; Douglas, Joanne T.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rivera, Angel A.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yang, SW (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	pons@uab.edu	Rivera, Ángel/GRJ-2093-2022		National Institutes of Health [R01CA108585, T32 CA075930]; University of Alabama at Birmingham, Department of Pathology; NATIONAL CANCER INSTITUTE [T32CA075930, R01CA108585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham, Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R01CA108585, T32 CA075930, and the University of Alabama at Birmingham, Department of Pathology Research Fund is appreciated. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker AH, 1996, MATRIX BIOL, V15, P383, DOI 10.1016/S0945-053X(96)90158-4; Biederer C, 2002, J MOL MED-JMM, V80, P163, DOI 10.1007/s00109-001-0295-1; Brand K, 2000, CANCER RES, V60, P5723; Brand Karsten, 2002, Current Gene Therapy, V2, P255, DOI 10.2174/1566523024605564; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Davidson B, 2001, EUR J CANCER, V37, P2040, DOI 10.1016/S0959-8049(01)00235-0; Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Feldman AL, 2004, CANCER RES, V64, P4481, DOI 10.1158/0008-5472.CAN-03-2929; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Fidler IJ, 2007, J CELL BIOCHEM, V101, P927, DOI 10.1002/jcb.21148; Hakkarainen T, 2006, INT J MOL MED, V18, P751; Heideman DAM, 2005, MOL THER, V12, P1083, DOI 10.1016/j.ymthe.2005.06.443; Hemminki O, 2011, CANCER GENE THER, V18, P288, DOI 10.1038/cgt.2010.79; Hermiston T, 2000, J CLIN INVEST, V105, P1169, DOI 10.1172/JCI9973; Huang SY, 2002, J NATL CANCER I, V94, P1134; JEMAL A, 2010, CA CANC J CLIN; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Kanerva A, 2004, GENE THER, V11, P552, DOI 10.1038/sj.gt.3302181; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kim TJ, 2006, HUM PATHOL, V37, P906, DOI 10.1016/j.humpath.2006.02.017; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Lam JT, 2004, J GENE MED, V6, P1333, DOI 10.1002/jgm.635; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; McNally LR, 2009, CANCER GENE THER, V16, P246, DOI 10.1038/cgt.2008.76; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Oh J, 2004, CANCER RES, V64, P9062, DOI 10.1158/0008-5472.CAN-04-1981; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; PAGET S, 1989, CANCER METAST REV, V8, P98; Partridge EE, 1999, CA-CANCER J CLIN, V49, P297, DOI 10.3322/canjclin.49.5.297; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; Raki M, 2008, GYNECOL ONCOL, V108, P166, DOI 10.1016/j.ygyno.2007.09.013; Rein DT, 2005, CLIN CANCER RES, V11, P1327; Rigg AS, 2001, CANCER GENE THER, V8, P869, DOI 10.1038/sj.cgt.7700387; Rocconi RP, 2007, GYNECOL ONCOL, V105, P113, DOI 10.1016/j.ygyno.2006.10.057; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Scotton CJ, 2001, CANCER RES, V61, P4961; Scotton CJ, 2002, CANCER RES, V62, P5930; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Torng PL, 2004, GYNECOL ONCOL, V92, P559, DOI 10.1016/j.ygyno.2003.11.011; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; van Beusechem VW, 2005, MOL CANCER THER, V4, P1013, DOI 10.1158/1535-7163.MCT-05-0010; Vasey PA, 2002, J CLIN ONCOL, V20, P1562, DOI 10.1200/JCO.20.6.1562; Vincent L, 2003, INT J CANCER, V105, P419, DOI 10.1002/ijc.11105; Yang SW, 2011, CLIN CANCER RES, V17, P538, DOI 10.1158/1078-0432.CCR-10-1628; Zeamari S, 2004, BRIT J CANCER, V90, P1259, DOI 10.1038/sj.bjc.6601637; Zhu ZB, 2004, CANCER GENE THER, V11, P256, DOI 10.1038/sj.cgt.7700679; Zhu ZB, 2008, INT J ONCOL, V32, P1179; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	56	38	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25131	10.1371/journal.pone.0025131	http://dx.doi.org/10.1371/journal.pone.0025131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022379	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000010
J	Yuan, Q; Hong, SJ; Han, S; Zeng, L; Liu, F; Ding, GS; Kang, YD; Mao, JY; Cai, M; Zhu, YH; Wang, QX				Yuan, Qing; Hong, Shanjuan; Han, Shu; Zeng, Li; Liu, Fang; Ding, Guoshan; Kang, Yindong; Mao, Jingyan; Cai, Ming; Zhu, Youhua; Wang, Quan-xing			Preconditioning with Physiological Levels of Ethanol Protect Kidney against Ischemia/Reperfusion Injury by Modulating Oxidative Stress	PLOS ONE			English	Article							RENAL TUBULAR CELLS; ALCOHOL-CONSUMPTION; LIPID-PEROXIDATION; REPERFUSION INJURY; IN-VIVO; ISCHEMIA; MORTALITY; ACTIVATION; QUERCETIN; DISEASE	Background: Oxidative stress due to excessive production of reactive oxygen species (ROS) and subsequent lipid peroxidation plays a critical role in renal ischemia/reperfusion (IR) injury. The purpose of current study is to demonstrate the effect of antecedent ethanol exposure on IR-induced renal injury by modulation of oxidative stress. Materials and Methods: Bilateral renal warm IR was induced in male C57BL/6 mice after ethanol or saline administration. Blood ethanol concentration, kidney function, histological damage, inflammatory infiltration, cytokine production, oxidative stress, antioxidant capacity and Aldehyde dehydrogenase (ALDH) enzymatic activity were assessed to evaluate the impact of antecedent ethanol exposure on IR-induced renal injury. Results: After bilateral kidney ischemia, mice preconditioned with physiological levels of ethanol displayed significantly preserved renal function along with less histological tubular damage as manifested by the reduced inflammatory infiltration and cytokine production. Mechanistic studies revealed that precondition of mice with physiological levels of ethanol 3 h before IR induction enhanced antioxidant capacity characterized by significantly higher superoxidase dismutase (SOD) activities. Our studies further demonstrated that ethanol pretreatment specifically increased ALDH2 activity, which then suppressed lipid peroxidation by promoting the detoxification of Malondialdehyde (MDA) and 4-hydroxynonenal (HNE). Conclusions: Our results provide first line of evidence indicating that antecedent ethanol exposure can provide protection for kidneys against IR-induced injury by enhancing antioxidant capacity and preventing lipid peroxidation. Therefore, ethanol precondition and ectopic ALDH2 activation could be potential therapeutic approaches to prevent renal IR injury relevant to various clinical conditions.	[Yuan, Qing; Han, Shu; Zeng, Li; Liu, Fang; Ding, Guoshan; Kang, Yindong; Zhu, Youhua] Second Mil Med Univ, Changzheng Hosp, Organ Transplantat Inst PLA, Shanghai, Peoples R China; [Hong, Shanjuan; Mao, Jingyan; Wang, Quan-xing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Yuan, Qing; Cai, Ming] 309th Hosp PLA, Organ Transplant Ctr, Beijing, Peoples R China	Naval Medical University; Naval Medical University	Yuan, Q (corresponding author), Second Mil Med Univ, Changzheng Hosp, Organ Transplantat Inst PLA, Shanghai, Peoples R China.	zhuyouhua@126.com; wangqx64@hotmail.com			National Key Basic Research Program of China [2009CB522402]; National Natural Science Foundation of China [U0832009, 30872581]; Science and Technology Foundation of Shanghai, China [09JC1405500]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shanghai, China	This work was supported by grants from the National Key Basic Research Program of China (2009CB522402) and the National Natural Science Foundation of China (U0832009, 30872581) and the Science and Technology Foundation of Shanghai, China (09JC1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Aragno M, 2003, KIDNEY INT, V64, P836, DOI 10.1046/j.1523-1755.2003.00152.x; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Castilla R, 2004, ALCOHOL ALCOHOLISM, V39, P290, DOI 10.1093/alcalc/agh065; Cecchin E, 1996, ADDICT BIOL, V1, P7, DOI 10.1080/1355621961000124656; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Dayton C, 2004, MICROCIRCULATION, V11, P709, DOI 10.1080/10739680490521014; DELABRY LO, 1992, J STUD ALCOHOL, V53, P25, DOI 10.15288/jsa.1992.53.25; Eschwege P, 1999, J UROLOGY, V162, P553, DOI 10.1016/S0022-5347(05)68626-0; ESTERBAUER H, 1986, BIOCHEM J, V239, P405, DOI 10.1042/bj2390405; Facchini FS, 2003, DIABETES, V52, P1204, DOI 10.2337/diabetes.52.5.1204; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; HAYAMA T, 2007, TRANSPL P, V123, P7; Ishikawa Y, 2000, BIOCHEM BIOPH RES CO, V279, P629, DOI 10.1006/bbrc.2000.4016; Kahraman A, 2003, J NEPHROL, V16, P219; Kim JI, 2010, BMB REP, V43, P629, DOI 10.3858/BMBRep.2010.43.9.629; Kim J, 2010, AM J PHYSIOL-RENAL, V298, pF158, DOI 10.1152/ajprenal.00474.2009; Kim KH, 2009, SURGERY, V146, P181, DOI 10.1016/j.surg.2009.06.011; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Krajka-Kuzniak V, 2003, TOXICOL LETT, V143, P209, DOI 10.1016/S0378-4274(03)00177-2; Li X, 2005, KIDNEY INT, V68, P569, DOI 10.1111/j.1523-1755.2005.00435.x; Lloberas NR, 2002, FASEB J, V16, P908, DOI 10.1096/fj.01-0880fje; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Pearson TA, 1996, CIRCULATION, V94, P3023, DOI 10.1161/01.CIR.94.11.3023; Pomfret EA, 2008, AM J TRANSPLANT, V8, P745, DOI 10.1111/j.1600-6143.2007.02146.x; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Satyanarayana PSV, 2001, METHOD FIND EXP CLIN, V23, P175, DOI 10.1358/mf.2001.23.4.634641; Sheridan AM, 2000, CURR OPIN NEPHROL HY, V9, P427, DOI 10.1097/00041552-200007000-00015; Shigematsu S, 2003, FREE RADICAL BIO MED, V34, P810, DOI 10.1016/S0891-5849(02)01430-2; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Walker LM, 2001, TOXICOL SCI, V63, P143, DOI 10.1093/toxsci/63.1.143; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yamaguchi T, 2003, FREE RADICAL BIO MED, V34, P365, DOI 10.1016/S0891-5849(02)01292-3; Yamaguchi T, 2002, AM J PHYSIOL-HEART C, V283, pH1019, DOI 10.1152/ajpheart.00173.2002	46	38	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25811	10.1371/journal.pone.0025811	http://dx.doi.org/10.1371/journal.pone.0025811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022451	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000041
J	Herbert, C; Kubler, A				Herbert, Cornelia; Kuebler, Andrea			Dogs Cannot Bark: Event-Related Brain Responses to True and False Negated Statements as Indicators of Higher-Order Conscious Processing	PLOS ONE			English	Article							LOCKED-IN SYNDROME; VEGETATIVE STATE; OWN-NAME; LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; TEXT INFORMATION; TIME-COURSE; VERIFICATION; POTENTIALS; ACTIVATION	The present study investigated event-related brain potentials elicited by true and false negated statements to evaluate if discrimination of the truth value of negated information relies on conscious processing and requires higher-order cognitive processing in healthy subjects across different levels of stimulus complexity. The stimulus material consisted of true and false negated sentences (sentence level) and prime-target expressions (word level). Stimuli were presented acoustically and no overt behavioral response of the participants was required. Event-related brain potentials to target words preceded by true and false negated expressions were analyzed both within group and at the single subject level. Across the different processing conditions (word pairs and sentences), target words elicited a frontal negativity and a late positivity in the time window from 600-1000 msec post target word onset. Amplitudes of both brain potentials varied as a function of the truth value of the negated expressions. Results were confirmed at the single-subject level. In sum, our results support recent suggestions according to which evaluation of the truth value of a negated expression is a time-and cognitively demanding process that cannot be solved automatically, and thus requires conscious processing. Our paradigm provides insight into higher-order processing related to language comprehension and reasoning in healthy subjects. Future studies are needed to evaluate if our paradigm also proves sensitive for the detection of consciousness in non-responsive patients.	[Herbert, Cornelia; Kuebler, Andrea] Univ Wurzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Herbert, C (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	cornelia.herbert@psychologie.uni-wuerzburg.de		Kubler, Andrea/0000-0003-4876-0415	German Research Foundation [DFG/HE5880]; European ICT Programme Project [FP7-247919]	German Research Foundation(German Research Foundation (DFG)); European ICT Programme Project	This research was supported by the German Research Foundation (DFG/HE5880) and the European ICT Programme Project FP7-247919 (http://cordis.europa.eu/fetch?CALLER = PROJ_ICT&ACTION = D&CAT = PROJ&RCN = 93827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Carpenter PA, 1999, NEUROIMAGE, V10, P216, DOI 10.1006/nimg.1999.0465; CARPENTER PA, 1975, PSYCHOL REV, V82, P45, DOI 10.1037/h0076248; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Deutsch R, 2006, J PERS SOC PSYCHOL, V91, P385, DOI 10.1037/0022-3514.91.3.385; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Ferguson HJ, 2008, BRAIN RES, V1236, P113, DOI 10.1016/j.brainres.2008.07.099; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; FISCHLER I, 1983, PSYCHOPHYSIOLOGY, V20, P400, DOI 10.1111/j.1469-8986.1983.tb00920.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Kaup B, 2003, J EXP PSYCHOL LEARN, V29, P439, DOI 10.1037/0278-7393.29.3.439; Kaup B, 2001, MEM COGNITION, V29, P960, DOI 10.3758/BF03195758; Kaup B., 2007, HIGHER LEVEL LANGUAG, P255, DOI [10.4324/9780203936443, DOI 10.4324/9780203936443]; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2004, BRAINWAVES MIND RECE, P75; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Ludtke J, 2008, J COGNITIVE NEUROSCI, V20, P1355, DOI 10.1162/jocn.2008.20093; MACDONALD MC, 1989, J EXP PSYCHOL LEARN, V15, P633, DOI 10.1037/0278-7393.15.4.633; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; NACHEV P, 2007, SCIENCE, V1221, P315; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Paivio A., 2006, MIND ITS EVOLUTION D; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Ropper AH, 2010, NEW ENGL J MED, V362, P648, DOI 10.1056/NEJMe0909667; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002	49	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25574	10.1371/journal.pone.0025574	http://dx.doi.org/10.1371/journal.pone.0025574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022414	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200011
J	Vatolina, TY; Boldyreva, LV; Demakova, OV; Demakov, SA; Kokoza, EB; Semeshin, VF; Babenko, VN; Goncharov, FP; Belyaeva, ES; Zhimulev, IF				Vatolina, Tatyana Yu.; Boldyreva, Lidiya V.; Demakova, Olga V.; Demakov, Sergey A.; Kokoza, Elena B.; Semeshin, Valeriy F.; Babenko, Vladimir N.; Goncharov, Fedor P.; Belyaeva, Elena S.; Zhimulev, Igor F.			Identical Functional Organization of Nonpolytene and Polytene Chromosomes in Drosophila melanogaster	PLOS ONE			English	Article							RNA-POLYMERASE-II; X-CHROMOSOME; IN-VIVO; INTERCALARY HETEROCHROMATIN; GENETIC ORGANIZATION; BINDING-SITES; NOTCH LOCUS; BAND 10A1-2; HISTONE H3; CHROMATIN	Salivary gland polytene chromosomes demonstrate banding pattern, genetic meaning of which is an enigma for decades. Till now it is not known how to mark the band/interband borders on physical map of DNA and structures of polytene chromosomes are not characterized in molecular and genetic terms. It is not known either similar banding pattern exists in chromosomes of regular diploid mitotically dividing nonpolytene cells. Using the newly developed approach permitting to identify the interband material and localization data of interband-specific proteins from modENCODE and other genome-wide projects, we identify physical limits of bands and interbands in small cytological region 9F13-10B3 of the X chromosome in D. melanogaster, as well as characterize their general molecular features. Our results suggests that the polytene and interphase cell line chromosomes have practically the same patterns of bands and interbands reflecting, probably, the basic principle of interphase chromosome organization. Two types of bands have been described in chromosomes, early and late-replicating, which differ in many aspects of their protein and genetic content. As appeared, origin recognition complexes are located almost totally in the interbands of chromosomes.	[Vatolina, Tatyana Yu.; Boldyreva, Lidiya V.; Demakova, Olga V.; Demakov, Sergey A.; Kokoza, Elena B.; Semeshin, Valeriy F.; Babenko, Vladimir N.; Goncharov, Fedor P.; Belyaeva, Elena S.; Zhimulev, Igor F.] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia	Russian Academy of Sciences	Vatolina, TY (corresponding author), Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Goncharov, Fedor/C-8891-2018; Kokoza, E l e n a/N-8507-2015; Zhimulev, Igor F/N-7978-2015; Babenko, Vladimir/K-5609-2014; Demakova, Olga/N-7478-2015; Belyaeva, Elena S/N-8066-2015; Demakov, Sergey A/N-6543-2015; Boldyreva, Lidiya/N-6978-2015; Zykova (Vatolina), Tatyana/I-3897-2014	Goncharov, Fedor/0000-0001-9728-2670; Boldyreva, Lidiya/0000-0003-0716-4545; Babenko, Vladimir/0000-0002-3077-9559; Demakov, Sergey/0000-0002-5526-6784; Demakova, Olga/0000-0002-8538-7384; Zhimulev, Igor/0000-0002-6220-3028	Ministry of Education and Science of Russian Federation (ROSNAUKA) [02.740.11.0099]; RAS "Molecular and Cellular Biology" [6.4]; SB RAS [37]; Russian Foundation for Basic Research [09-04-00409]	Ministry of Education and Science of Russian Federation (ROSNAUKA)(Ministry of Education and Science, Russian Federation); RAS "Molecular and Cellular Biology"; SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by grant of Ministry of Education and Science of Russian Federation (ROSNAUKA), governmental contract 02.740.11.0099; Programm of RAS "Molecular and Cellular Biology" 6.4; Integration project of SB RAS #37, and the Russian Foundation for Basic Research (#09-04-00409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkov OV, 2010, DOKL BIOCHEM BIOPHYS, V431, P57, DOI 10.1134/S1607672910020018; Andreyenkova NG, 2009, CHROMOSOMA, V118, P747, DOI 10.1007/s00412-009-0232-6; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Ashburner M., 2004, DROSOPHILA LAB HDB; Babenko VN, 2009, DOKL BIOCHEM BIOPHYS, V424, P27, DOI 10.1134/S1607672909010086; Beermann W, 1972, Results Probl Cell Differ, V4, P1; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Carre C, 2008, EMBO REP, V9, P187, DOI 10.1038/sj.embor.7401141; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DEMAKOV SA, 1993, MOL GEN GENET, V238, P437, DOI 10.1007/BF00292003; Demakov SA, 2011, RUSSIAN J GENETICS, P15; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; DONAHUE PR, 1986, P NATL ACAD SCI USA, V83, P4744, DOI 10.1073/pnas.83.13.4744; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; ELGIN SCR, 1988, CHROMOSOME STRUCTURE, P145; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; Gerber M, 2001, EMBO J, V20, P6104, DOI 10.1093/emboj/20.21.6104; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Hollmann M, 2002, MOL GENET GENOMICS, V268, P425, DOI 10.1007/s00438-002-0768-0; JAMRICH M, 1977, P NATL ACAD SCI USA, V74, P2079, DOI 10.1073/pnas.74.5.2079; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; KEPPY DO, 1977, GENETICS, V85, P497; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; KOZLOVA TY, 1994, GENETICS, V136, P1063; Lavrov S, 2004, METH MOL B, V247, P289; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; LEFEVRE G, 1971, GENETICS, V67, P497; LEFEVRE G, 1969, GENETICS, V63, P589; Li YP, 2011, MOL BIOL REP, V38, P3795, DOI 10.1007/s11033-010-0495-2; Lis JT, 2000, GENE DEV, V14, P792; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Markov A. V., 2003, Genetika, V39, P1203; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; RAMOS RGP, 1989, GENETICS, V123, P337; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; SASS H, 1982, CHROMOSOMA, V86, P77, DOI 10.1007/BF00330731; SASS H, 1982, CELL, V28, P269, DOI 10.1016/0092-8674(82)90345-2; SASS H, 1982, CHROMOSOMA, V85, P633, DOI 10.1007/BF00330777; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Semeshin VF, 2004, METH MOL B, V247, P305; Sorsa V, 1988, CHROMOSOME MAPS DROS, V2, P147; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Vazquez J, 2000, GENETICS, V155, P1297; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zhimolev IF, 1996, ADV GENET, V34, P1; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; ZHIMULEV IF, 1981, CHROMOSOMA, V82, P25, DOI 10.1007/BF00285747	71	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25960	10.1371/journal.pone.0025960	http://dx.doi.org/10.1371/journal.pone.0025960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022482	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200024
J	Sommer, G; Rossa, C; Chi, AC; Neville, BW; Heise, T				Sommer, Gunhild; Rossa, Carlos; Chi, Angela C.; Neville, Brad W.; Heise, Tilman			Implication of RNA-Binding Protein La in Proliferation, Migration and Invasion of Lymph Node-Metastasized Hypopharyngeal SCC Cells	PLOS ONE			English	Article							AUTOANTIGEN LA/SS-B; BETA-CATENIN; MATRIX METALLOPROTEINASES; CANCER STATISTICS; HEAD; PHOSPHORYLATION; CARCINOMA; TRANSLATION; IDENTIFICATION; EXPRESSION	The 5-year survival rate for oral cavity cancer is poorer than for breast, colon or prostate cancer, and has improved only slightly in the last three decades. Hence, new therapeutic strategies are urgently needed. Here we demonstrate by tissue micro array analysis for the first time that RNA-binding protein La is significantly overexpressed in oral squamous cell carcinoma (SCC). Within this study we therefore addressed the question whether siRNA-mediated depletion of the La protein may interfere with known tumor-promoting characteristics of head and neck SCC cells. Our studies demonstrate that the La protein promotes cell proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. We also reveal that La is required for the expression of beta-catenin as well as matrix metalloproteinase type 2 (MMP-2) within these cells. Taken together these data suggest a so far unknown function of the RNA-binding protein La in promoting tumor progression of head and neck SCC.	[Sommer, Gunhild; Heise, Tilman] Med Univ S Carolina, Coll Dent Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sommer, Gunhild] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Rossa, Carlos] Univ Estadual Paulista UNESP, Dept Diag & Surg, Araraquara, Brazil; [Chi, Angela C.; Neville, Brad W.] Med Univ S Carolina, Div Oral Pathol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Universidade Estadual Paulista; Medical University of South Carolina	Sommer, G (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	sommerg@musc.edu	Rossa, Carlos/D-8328-2012	Rossa, Carlos/0000-0003-1705-5481	Department of Biochemistry & Molecular Biology (MUSC); SC COBRE for Oral Health Research [P20RR017696-09]; NIH/NCRR [1R03DE021729-01]; Cancer Center [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021729] Funding Source: NIH RePORTER	Department of Biochemistry & Molecular Biology (MUSC); SC COBRE for Oral Health Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Department of Biochemistry & Molecular Biology (MUSC), by SC COBRE for Oral Health Research P20RR017696-09 and NIH/NCRR 1R03DE021729-01. FACS analysis was performed at the Flow Cytometry Shared Resource as part of the Hollings Cancer Center at MUSC, which is funded by a Cancer Center Support Grant P30 CA138313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; BEENKEN SW, 2003, CURRENT SURG DIAGNOS, P282; Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Broekhuis CHD, 2000, BIOCHEMISTRY-US, V39, P3023, DOI 10.1021/bi992308c; CAREY TE, 1983, OTOLARYNG HEAD NECK, V91, P482, DOI 10.1177/019459988309100503; Carter MS, 2000, J BIOL CHEM, V275, P28301; CHAMBERS JC, 1988, J BIOL CHEM, V263, P18043; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Gao ZB, 2005, INT J MOL MED, V16, P599; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Inge LJ, 2008, MOL CANCER THER, V7, P1386, DOI 10.1158/1535-7163.MCT-07-2029; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Kenan DJ, 2004, NAT STRUCT MOL BIOL, V11, P303, DOI 10.1038/nsmb0404-303; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kremerskothen J, 1998, DNA CELL BIOL, V17, P751, DOI 10.1089/dna.1998.17.751; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lo Muzio L, 2001, CRIT REV ORAL BIOL M, V12, P152, DOI 10.1177/10454411010120020501; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Rodriguez Luis G., 2004, V294, P23; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; Ruokolainen H, 2006, MODERN PATHOL, V19, P208, DOI 10.1038/modpathol.3800506; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; TROSTER H, 1994, J EXP MED, V180, P2059, DOI 10.1084/jem.180.6.2059; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Ueda G, 2006, INT J ORAL MAX SURG, V35, P356, DOI 10.1016/j.ijom.2005.07.023; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Yu ZW, 2005, CLIN CANCER RES, V11, P2471, DOI 10.1158/1078-0432.CCR-04-2199; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	56	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25402	10.1371/journal.pone.0025402	http://dx.doi.org/10.1371/journal.pone.0025402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016766	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700008
J	Putila, JJ; Guo, NL				Putila, Joseph J.; Guo, Nancy Lan			Association of Arsenic Exposure with Lung Cancer Incidence Rates in the United States	PLOS ONE			English	Article							DRINKING-WATER; US POPULATION; EPIDEMIOLOGY; PREVALENCE; MORTALITY; SMOKING; RISK	Background: Although strong exposure to arsenic has been shown to be carcinogenic, its contribution to lung cancer incidence in the United States is not well characterized. We sought to determine if the low-level exposures to arsenic seen in the U.S. are associated with lung cancer incidence after controlling for possible confounders, and to assess the interaction with smoking behavior. Methodology: Measurements of arsenic stream sediment and soil concentration obtained from the USGS National Geochemical Survey were combined, respectively, with 2008 BRFSS estimates on smoking prevalence and 2000 U.S. Census county level income to determine the effects of these factors on lung cancer incidence, as estimated from respective state-wide cancer registries and the SEER database. Poisson regression was used to determine the association between each variable and age-adjusted county-level lung cancer incidence. ANOVA was used to assess interaction effects between covariates. Principal Findings: Sediment levels of arsenic were significantly associated with an increase in incident cases of lung cancer (P>0.0001). These effects persisted after controlling for smoking and income (P>0.0001). Across the U.S., exposure to arsenic may contribute to up to 5,297 lung cancer cases per year. There was also a significant interaction between arsenic exposure levels and smoking prevalence (P>0.05). Conclusions/Significance: Arsenic was significantly associated with lung cancer incidence rates in the U.S. after controlling for smoking and income, indicating that low-level exposure to arsenic is responsible for excess cancer cases in many parts of the U.S. Elevated county smoking prevalence strengthened the association between arsenic exposure and lung cancer incidence rate, an effect previously unseen on a population level.	[Putila, Joseph J.; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Putila, Joseph J.; Guo, Nancy Lan] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Putila, JJ (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			National Institutes of Health (NIH)/National Library of Medicine (NLM) [R01LM009500]; NIH/National Center for Research Resources (NCRR) [P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study is supported by National Institutes of Health (NIH)/National Library of Medicine (NLM) R01LM009500 (PI: Dr. Guo) and NIH/National Center for Research Resources (NCRR) P20RR16440 and Supplement (PD: Dr. Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloise-Young PA, 2002, SUBST USE MISUSE, V37, P613, DOI 10.1081/JA-120004276; Beeson WL, 1998, ENVIRON HEALTH PERSP, V106, P813, DOI 10.2307/3434125; BRIGGS PH, 2002, 02223G1G18 US GEOL S; BUDAHN JR, 2002, 02223Y1Y9 US GEOL SU; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; COLSHER P, 2009, CANC INCIDENCE W VIR; CRONBACH LJ, 1987, PSYCHOL BULL, V102, P414, DOI 10.1037/0033-2909.102.3.414; *DHHS, 2006, 11 US DHHS; HAGEMAN PL, 2002, 02223L1L7 US GEOL SU; HERTZPICCIOTTO I, 1992, EPIDEMIOLOGY, V3, P23, DOI 10.1097/00001648-199201000-00006; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Liu J, 2008, TOXICOL SCI, V105, P24, DOI 10.1093/toxsci/kfn120; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; *MO DEP HLTH SEN S, 2010, MISS INF COMM ASS; MUSHAK P, 1995, ENVIRON HEALTH PERSP, V103, P684, DOI 10.2307/3432859; National Cancer Institute Surveillance, 2010, SEER STAT DAT INC SE; NHANES III. National Health and Nutrition Examination Survey, 2009, NAT HLTH NUTR EX SUR; *OH DEP HLTH, 2010, ODH INF WAR; *PA DEP HLTH, 2010, EP QUER MAPP SYST; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; U.S. Geological Survey, 2004, NAT GEOCH SURV DAT D	24	73	75	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25886	10.1371/journal.pone.0025886	http://dx.doi.org/10.1371/journal.pone.0025886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003413	Green Published, Green Submitted, gold			2022-12-25	WOS:000295970300037
J	Kelly, KR; Espitia, CM; Mahalingam, D; Oyajobi, BO; Coffey, M; Giles, FJ; Carew, JS; Nawrocki, ST				Kelly, K. R.; Espitia, C. M.; Mahalingam, D.; Oyajobi, B. O.; Coffey, M.; Giles, F. J.; Carew, J. S.; Nawrocki, S. T.			Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma	ONCOGENE			English	Article						bortezomib; NOXA; ER stress; Reolysin; reovirus	PROTEASOME INHIBITOR BORTEZOMIB; PANCREATIC-CANCER CELLS; ONCOLYTIC VIRUS THERAPY; ER STRESS; MELANOMA-CELLS; VIRAL THERAPY; IFN-BETA; IN-VITRO; KAPPA-B; PHASE-I	Oncolytic virotherapy with reovirus has demonstrated anti-cancer activity and minimal toxicity in clinical trials, but the mechanisms underlying these effects have not been fully elucidated. Reolysin, a proprietary formulation of reovirus for cancer therapy, stimulated selective viral replication and apoptosis in multiple myeloma (MM) cells. Reolysin-mediated apoptosis was associated with an induction of endoplasmic reticular (ER) stress-related gene expression, swelling of the endoplasmic reticulum, increases in intracellular calcium levels and a strong induction of the Bcl-2 homology 3 (BH3)-only pro-apoptotic protein NOXA. Knockdown of NOXA expression by short hairpin RNA significantly reduced the pro-apoptotic effects of Reolysin. We next showed that co-administration of Reolysin and bortezomib resulted in the dual accumulation of viral and ubiquitinated proteins, which led to enhanced ER stress, NOXA induction and apoptosis. Importantly, the combination of reovirus infection and proteasomal inhibition significantly decreased tumor burden in a xenograft and syngeneic bone disease model of MM without exhibiting adverse side effects. Our study establishes ER stress stimulation and NOXA induction as novel mediators of reovirus-induced apoptosis. Furthermore, reovirus infection can be used as a promising approach to augment the anti-myeloma activity of bortezomib by promoting additional stress to the endoplasmic reticulum of MM cells. Oncogene (2012) 31, 3023-3038; doi: 10.1038/onc.2011.478; published online 17 October 2011	[Kelly, K. R.; Espitia, C. M.; Mahalingam, D.; Giles, F. J.; Carew, J. S.; Nawrocki, S. T.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Inst Drug Dev, Dept Med, San Antonio, TX 78229 USA; [Oyajobi, B. O.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Struct Biol, San Antonio, TX 78229 USA; [Coffey, M.] Oncolyt Biotech Inc, Calgary, AB, Canada	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Oncolytics Biotech	Nawrocki, ST (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Inst Drug Dev, Dept Med, 7979 Wurzbach Rd, San Antonio, TX 78229 USA.	Nawrocki@uthscsa.edu		Oyajobi, Babatunde/0000-0002-1064-3072	Leukemia and Lymphoma Society of America [6319-11]; International Myeloma Foundation; William and Ella Owens Foundation; National Cancer Institute P30 Cancer Center Support Grant [CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); International Myeloma Foundation; William and Ella Owens Foundation; National Cancer Institute P30 Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Leukemia and Lymphoma Society of America (6319-11), The International Myeloma Foundation, The William and Ella Owens Foundation and the National Cancer Institute P30 Cancer Center Support Grant # CA054174.	Alain T, 2007, MOL THER, V15, P1512, DOI 10.1038/sj.mt.6300207; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; Carew JS, 2006, BLOOD, V107, P222, DOI 10.1182/blood-2005-05-1923; Clarke P, 2004, J VIROL, V78, P13132, DOI 10.1128/JVI.78.23.13132-13138.2004; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Etoh T, 2003, CLIN CANCER RES, V9, P1218; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Hamamdzic D, 2001, AM J PHYSIOL-LUNG C, V280, pL18, DOI 10.1152/ajplung.2001.280.1.L18; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Homicsko K, 2005, CANCER RES, V65, P6882, DOI 10.1158/0008-5472.CAN-05-0309; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kelly K, 2009, EXPERT OPIN BIOL TH, V9, P817, DOI 10.1517/14712590903002039; Kottke T, 2010, J CLIN INVEST, V120, P1551, DOI 10.1172/JCI41431; Kumar SK, 2004, MAYO CLIN PROC, V79, P867, DOI 10.4065/79.7.867; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Libertini S, 2008, CLIN CANCER RES, V14, P6505, DOI 10.1158/1078-0432.CCR-08-0200; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nawrocki ST, 2002, MOL CANCER THER, V1, P1243; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Nencioni A, 2006, BLOOD, V108, P551, DOI 10.1182/blood-2005-08-3494; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Oyajobi BO, 2007, MOL CANCER THER, V6, P1701, DOI 10.1158/1535-7163.MCT-07-0121; Pandha HS, 2009, CLIN CANCER RES, V15, P6158, DOI 10.1158/1078-0432.CCR-09-0796; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qiao J, 2008, CLIN CANCER RES, V14, P259, DOI 10.1158/1078-0432.CCR-07-1510; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Rhim JH, 2007, J NATL CANCER I, V99, P1739, DOI 10.1093/jnci/djm234; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Rudd P, 2005, J GEN VIROL, V86, P1489, DOI 10.1099/vir.0.80628-0; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; SIDKY YA, 1987, CANCER RES, V47, P5155; Smakman N, 2006, CANCER GENE THER, V13, P815, DOI 10.1038/sj.cgt.7700949; Steele L, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-20; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Sun K, 2004, P NATL ACAD SCI USA, V101, P8120, DOI 10.1073/pnas.0401563101; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Taylor KL, 2008, J INTERF CYTOK RES, V28, P733, DOI 10.1089/jir.2008.0030; Thirukkumaran Chandini, 2009, V542, P607, DOI 10.1007/978-1-59745-561-9_31; Thirukkumaran CM, 2003, BLOOD, V102, P377, DOI 10.1182/blood-2002-08-2508; Twigger K, 2008, CLIN CANCER RES, V14, P912, DOI 10.1158/1078-0432.CCR-07-1400; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2; Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	59	54	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	25					3023	3038		10.1038/onc.2011.478	http://dx.doi.org/10.1038/onc.2011.478			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22002308				2022-12-25	WOS:000305705900002
J	Das, A; Ghosh, J; Bhattacharya, A; Samanta, D; Das, D; Das Gupta, C				Das, Anindita; Ghosh, Jaydip; Bhattacharya, Arpita; Samanta, Dibyendu; Das, Debasis; Das Gupta, Chanchal			Involvement of Mitochondrial Ribosomal Proteins in Ribosomal RNA-mediated Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; DOMAIN-V; IN-VITRO; DENATURED PROTEINS; LARGE SUBUNIT; REACTIVATION; WORLD; EXTRACTION; EVOLUTION; PEPTIDE	The peptidyl transferase center of the domain V of large ribosomal RNA in the prokaryotic and eukaryotic cytosolic ribosomes acts as general protein folding modulator. We showed earlier that one part of the domain V (RNA1 containing the peptidyl transferase loop) binds unfolded protein and directs it to a folding competent state (FCS) that is released by the other part (RNA2) to attain the folded native state by itself. Here we show that the peptidyl transferase loop of the mitochondrial ribosome releases unfolded proteins in FCS extremely slowly despite its lack of the rRNA segment analogous to RNA2. The release of FCS can be hastened by the equivalent activity of RNA2 or the large subunit proteins of the mitochondrial ribosome. The RNA2 or large subunit proteins probably introduce some allosteric change in the peptidyl transferase loop to enable it to release proteins in FCS.	[Das, Anindita; Ghosh, Jaydip; Bhattacharya, Arpita; Samanta, Dibyendu; Das, Debasis; Das Gupta, Chanchal] Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, India; [Das, Anindita; Das Gupta, Chanchal] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohanpur 741252, Nadia, India; [Ghosh, Jaydip] St Xaviers Coll, Dept Microbiol, Kolkata 700016, India	University of Calcutta; Indian Institute of Science Education & Research (IISER) - Kolkata; St. Xavier's College Kolkata	Das Gupta, C (corresponding author), Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, India.	chanchaldg2000@yahoo.com		Bhattacharya, Arpita/0000-0002-0252-1550	Department of Science and Technology; Department of Biotechnology; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Science and Technology, Department of Biotechnology, and Council for Scientific and Industrial Research, Government of India.	Altman S, 2007, BIOL CHEM, V388, P663, DOI 10.1515/BC.2007.085; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, BIOCHEM MOL BIOL INT, V32, P315; Cech TR, 2009, COLD SH Q B, V74, P11, DOI 10.1101/sqb.2009.74.024; Cech TR, 2009, CELL, V136, P599, DOI 10.1016/j.cell.2009.02.002; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Ghosh J, 2003, MOL MICROBIOL, V48, P1679, DOI 10.1046/j.1365-2958.2003.03538.x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P2095, DOI 10.1093/nar/20.suppl.2095; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Margulis L, 1970, ORIGIN EUKARYOTIC CE; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; SCHIEBER GL, 1982, J BIOL CHEM, V257, P8781; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Woese CR, 2001, RNA, V7, P1055, DOI 10.1017/S1355838201010615	38	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43771	43781		10.1074/jbc.M111.263574	http://dx.doi.org/10.1074/jbc.M111.263574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020935	Green Published, hybrid			2022-12-25	WOS:000298402300020
J	Jain, S; Kahnt, J; van der Does, C				Jain, Samta; Kahnt, Joerg; van der Does, Chris			Processing and Maturation of the Pilin of the Type IV Secretion System Encoded within the Gonococcal Genetic Island	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; T-PILUS BIOGENESIS; AGROBACTERIUM-TUMEFACIENS; NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; F-PILIN; DNA TRANSFER; MUTATIONAL ANALYSIS; MEMBRANE INSERTION; SIGNAL PEPTIDASES	The type IV secretion system (T4SS) encoded within the gonococcal genetic island (GGI) of Neisseria gonorrhoeae has homology to the T4SS encoded on the F plasmid. The GGI encodes the putative pilin protein TraA and a serine protease TrbI, which is homologous to the TraF protein of the RP4 plasmid involved in circularization of pilin subunits of P-type pili. TraA was processed to a 68-amino acid long circular peptide by leader peptidase and TrbI. Processing occurred after co-translational membrane insertion and was independent of other proteins. Circularization occurred after removal of three C-terminal amino acids. Mutational analysis of TraA revealed limited flexibility at the cleavage and joining sites. Mutagenesis of TrbI showed that the conserved Lys-93 and Asp-155 are essential, whereas mutagenesis of Ser-52, the putative catalytic serine did not influence circularization. Further mutagenesis of other serine residues did not identify a catalytic serine, indicating that TrbI either contains redundant catalytic serine residues or does not function via a serine-lysine dyad mechanism. In vitro studies revealed that circularization occurs via a covalent intermediate between the C terminus of TraA and TrbI. The intermediate is processed to the circular form after cleavage of the N-terminal signal sequence. This is the first demonstration of a covalent intermediate in the circularization mechanism of conjugative pili.	[Jain, Samta; Kahnt, Joerg; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Jain, Samta; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Jain, Samta; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	Max Planck Society; University of Groningen; University of Groningen	van der Does, C (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, Karl von Frisch Str, D-35043 Marburg, Germany.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019					Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; BARKOCYGALLAGHER GA, 1992, J BIOL CHEM, V267, P1231; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; BRADLEY DE, 1980, PLASMID, V4, P155, DOI 10.1016/0147-619X(80)90005-0; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Keyzer Jeanine, 2007, V390, P17; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Felnagle EA, 2008, MOL PHARMACEUT, V5, P191, DOI 10.1021/mp700137g; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; Haase J, 1997, J BACTERIOL, V179, P5728, DOI 10.1128/jb.179.18.5728-5735.1997; HAASE J, 1995, J BACTERIOL, V177, P4779, DOI 10.1128/jb.177.16.4779-4791.1995; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Harris RL, 1999, MOL MICROBIOL, V34, P780, DOI 10.1046/j.1365-2958.1999.01640.x; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jones AL, 1996, J BACTERIOL, V178, P5706, DOI 10.1128/jb.178.19.5706-5711.1996; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Kalkum M, 2002, TRENDS MICROBIOL, V10, P382, DOI 10.1016/S0966-842X(02)02399-5; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, FEMS MICROBIOL LETT, V210, P111, DOI 10.1111/j.1574-6968.2002.tb11168.x; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lawley TD, 2003, J BACTERIOL, V185, P581, DOI 10.1128/JB.185.2.581-591.2003; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Majdalani N, 1996, J BACTERIOL, V178, P3742, DOI 10.1128/jb.178.13.3742-3747.1996; Manchak J, 2002, MOL MICROBIOL, V43, P195, DOI 10.1046/j.1365-2958.2002.02731.x; MANEEWANNAKUL K, 1995, J BACTERIOL, V177, P2957, DOI 10.1128/jb.177.11.2957-2964.1995; MOORE D, 1993, J BACTERIOL, V175, P1375, DOI 10.1128/JB.175.5.1375-1383.1993; Pachulec E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009962; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; Waksman G, 2010, TRENDS BIOCHEM SCI, V35, P691, DOI 10.1016/j.tibs.2010.06.002; Williams NK, 2005, J MOL BIOL, V346, P1095, DOI 10.1016/j.jmb.2004.12.037	68	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43601	43610		10.1074/jbc.M111.264028	http://dx.doi.org/10.1074/jbc.M111.264028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22006923	Green Published, hybrid			2022-12-25	WOS:000298402300003
J	Westergard, L; Turnbaugh, JA; Harris, DA				Westergard, Laura; Turnbaugh, Jessie A.; Harris, David A.			A Naturally Occurring C-terminal Fragment of the Prion Protein (PrP) Delays Disease and Acts as a Dominant-negative Inhibitor of PrPSc Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE AMINO-ACID; CELLULAR PRION; TRANSGENIC MICE; NEUROBLASTOMA-CELLS; CULTURED-CELLS; SCRAPIE ISOFORM; INCUBATION-TIME; KNOCKOUT MICE; N-TERMINUS; IN-VIVO	The cellular prion protein (PrPC) undergoes constitutive proteolytic cleavage between residues 111/112 to yield a soluble N-terminal fragment (N1) and a membrane-anchored C-terminal fragment (C1). The C1 fragment represents the major proteolytic fragment of PrPC in brain and several cell types. To explore the role of C1 in prion disease, we generated Tg(C1) transgenic mice expressing this fragment (PrP(Delta 23-111)) in the presence and absence of endogenous PrP. In contrast to several other N-terminally deleted forms of PrP, the C1 fragment does not cause a spontaneous neurological disease in the absence of endogenous PrP. Tg(C1) mice inoculated with scrapie prions remain healthy and do not accumulate protease-resistant PrP, demonstrating that C1 is not a substrate for conversion to PrPSc (the disease-associated isoform). Interestingly, Tg(C1) mice co-expressing C1 along with wild-type PrP (either endogenous or encoded by a second transgene) become ill after scrapie inoculation, but with a dramatically delayed time course compared with mice lacking C1. In addition, accumulation of PrPSc was markedly slowed in these animals. Similar effects were produced by a shorter C-terminal fragment of PrP(Delta 23-134). These results demonstrate that C1 acts as dominant-negative inhibitor of PrPSc formation and accumulation of neurotoxic forms of PrP. Thus, C1, a naturally occurring fragment of PrPC, might play a modulatory role during the course of prion diseases. In addition, enhancing production of C1, or exogenously administering this fragment, represents a potential therapeutic strategy for the treatment of prion diseases.	[Turnbaugh, Jessie A.; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Westergard, Laura] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu		Harris, David/0000-0002-6985-5790	National Institutes of Health [NS40975, NS052526, NS056376, NS065244]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, R01NS052526, R01NS040975, R01NS056376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40975, NS052526, NS056376, and NS065244 (to D. A. H.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Holscher C, 1998, J VIROL, V72, P1153; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Horiuchi M, 2001, J BIOL CHEM, V276, P15489, DOI 10.1074/jbc.M100288200; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lee CI, 2007, PROTEIN SCI, V16, P2166, DOI 10.1110/ps.072954607; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rigter Alan, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-6; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Toupet K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002773; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115	73	71	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44234	44242		10.1074/jbc.M111.286195	http://dx.doi.org/10.1074/jbc.M111.286195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22025612	hybrid, Green Published			2022-12-25	WOS:000298402300063
J	Ramirez-Aguilar, SJ; Keuthe, M; Rocha, M; Fedyaev, VV; Kramp, K; Gupta, KJ; Rasmusson, AG; Schulze, WX; van Dongen, JT				Ramirez-Aguilar, Santiago J.; Keuthe, Mandy; Rocha, Marcio; Fedyaev, Vadim V.; Kramp, Katharina; Gupta, Kapuganti J.; Rasmusson, Allan G.; Schulze, Waltraud X.; van Dongen, Joost T.			The Composition of Plant Mitochondrial Supercomplexes Changes with Oxygen Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; OXIDATIVE-PHOSPHORYLATION SYSTEM; CYTOCHROME-C-OXIDASE; COMPLEX-I; NICOTIANA-SYLVESTRIS; MAMMALIAN MITOCHONDRIA; PH; MEMBRANE; ASSEMBLY/STABILITY; DEHYDROGENASES	Background: Respiratory supercomplexes are known to exist, but their function remains to be revealed. Results: Plant supercomplexes are affected by hypoxia and a concomitant drop in pH. Conclusion: Respiratory supercomplexes are dynamic structures that are affected by the intracellular environment. Significance: Supercomplexes could have a regulatory function in guiding electrons through alternative respiratory pathways.	[Ramirez-Aguilar, Santiago J.; Keuthe, Mandy; Rocha, Marcio; Fedyaev, Vadim V.; Kramp, Katharina; Gupta, Kapuganti J.; Schulze, Waltraud X.; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, Energy Metab Res Grp, D-14476 Potsdam, Germany; [Fedyaev, Vadim V.] Bashkir State Univ, Dept Biol, Chair Plant Physiol, Ufa 450074, Russia; [Rasmusson, Allan G.] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	Max Planck Society; Bashkir State University; Lund University	van Dongen, JT (corresponding author), Max Planck Inst Mol Plant Physiol, Energy Metab Res Grp, Muhlenberg 1, D-14476 Potsdam, Germany.	dongen@mpimp-golm.mpg.de	van Dongen, Joost T/F-5372-2016; Schulze, Waltraud X/E-9800-2011; Fedyaev, Vadim/G-3019-2017; Kapuganti, Jagadis Gupta/D-3429-2014	van Dongen, Joost T/0000-0001-7944-9289; Schulze, Waltraud X/0000-0001-9957-7245; Fedyaev, Vadim/0000-0003-3373-9445; Kapuganti, Jagadis Gupta/0000-0002-7090-5097	Max Planck Society; German Research Foundation [SFB429]; Swedish Research Council	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Max Planck Society, the German Research Foundation (SFB429), and the Swedish Research Council.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Chien LF, 2011, PLANT PHYSIOL BIOCH, V49, P449, DOI 10.1016/j.plaphy.2011.01.024; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Couldwell DL, 2009, ANN BOT-LONDON, V103, P249, DOI 10.1093/aob/mcn174; DEPAEPE R, 1990, MOL GEN GENET, V222, P206, DOI 10.1007/BF00633819; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Douce R., 1985, MITOCHONDRIA HIGHER; Dudkina NV, 2006, TRENDS PLANT SCI, V11, P232, DOI 10.1016/j.tplants.2006.03.007; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; Gupta KJ, 2009, PHYSIOL PLANTARUM, V137, P383, DOI 10.1111/j.1399-3054.2009.01253.x; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; JENSEN BD, 1986, ARCH BIOCHEM BIOPHYS, V248, P305, DOI 10.1016/0003-9861(86)90427-3; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kierszniowska S, 2009, PROTEOMICS, V9, P1916, DOI 10.1002/pmic.200800443; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Maas MFPM, 2009, J MOL BIOL, V387, P259, DOI 10.1016/j.jmb.2008.12.025; MANDOLINO G, 1983, BIOCHIM BIOPHYS ACTA, V723, P428, DOI 10.1016/0005-2728(83)90050-6; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Narsai R, 2011, NEW PHYTOL, V190, P472, DOI 10.1111/j.1469-8137.2010.03589.x; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200; RASMUSSON AG, 1991, PHYSIOL PLANTARUM, V83, P357, DOI 10.1111/j.1399-3054.1991.tb00106.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; van Dongen JT, 2011, J PLANT PHYSIOL, V168, P1434, DOI 10.1016/j.jplph.2010.11.004; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Wessa P, 2008, PEARSON CORRELATION; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	51	76	76	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43045	43053		10.1074/jbc.M111.252544	http://dx.doi.org/10.1074/jbc.M111.252544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009743	hybrid, Green Published			2022-12-25	WOS:000298351300025
J	Shchedrina, VA; Everley, RA; Zhang, Y; Gygi, SP; Hatfield, DL; Gladyshev, VN				Shchedrina, Valentina A.; Everley, Robert A.; Zhang, Yan; Gygi, Steven P.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Selenoprotein K Binds Multiprotein Complexes and Is Involved in the Regulation of Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; ER PROTEIN; HUMAN HRD1; STRESS; RETROTRANSLOCATION; DEGRADATION	Background: Selenoprotein K (SelK) is an endoplasmic reticulum (ER) protein of unknown function. Results: SelK associates with proteins involved in elimination of misfolded proteins from the ER. Conclusion: SelK is a functional component of ER homeostasis. Significance: This study defines a new family of selenoproteins and links it to an ER-associated degradation.	[Shchedrina, Valentina A.; Zhang, Yan; Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Div Genet, Dept Med, New Res Bldg,77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	shchedrina, valentina a/B-8398-2015; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	shchedrina, valentina a/0000-0003-1627-982X; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603]; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061603 (to V. N. G.). This work was also supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Crawshaw SG, 2007, MOL MEMBR BIOL, V24, P113, DOI 10.1080/09687860600988727; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Huang Z, 2011, J BIOL CHEM, V286, P34830, DOI 10.1074/jbc.M111.265520; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P496, DOI 10.1093/nar/gkj450; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Turanov AA, 2009, SCIENCE, V323, P259, DOI 10.1126/science.1164748; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	54	91	107	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42937	42948		10.1074/jbc.M111.310920	http://dx.doi.org/10.1074/jbc.M111.310920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016385	Green Published, hybrid			2022-12-25	WOS:000298351300015
J	Cai, J; Chen, ZJ; Ruan, Q; Han, S; Liu, L; Qi, XP; Boye, SL; Hauswirth, WW; Grant, MB; Boulton, ME				Cai, Jun; Chen, Zhijuan; Ruan, Qing; Han, Song; Liu, Li; Qi, Xiaoping; Boye, Sanford L.; Hauswirth, William W.; Grant, Maria B.; Boulton, Michael E.			gamma-Secretase and Presenilin Mediate Cleavage and Phosphorylation of Vascular Endothelial Growth Factor Receptor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; PROTEIN-TYROSINE PHOSPHATASES; VE-PTP; ANGIOGENESIS; COMPLEX; CANCER; CELL; IDENTIFICATION; ASSOCIATION; EXPRESSION	We have reported previously that pigment epithelium-derived factor (PEDF) can, via gamma-secretase-mediated events, inhibit VEGF-induced angiogenesis in microvascular endothelial cells by both (a) cleavage and intracellular translocation of a C-terminal fragment of VEGF receptor-1 (VEGFR1) and (b) inhibition of VEGF-induced phosphorylation of VEGFR1. Using site-direct mutagenesis and transfection of wild type and mutated receptors into endothelial cells, we showed that transmembrane cleavage of VEGFR1 occurs at valine 767 and that a switch from valine to alanine at this position prevented cleavage and formation of a VEGFR1 intracellular fragment. Using siRNA to selectively knock down protein-tyrosine phosphatases (PTPs) in endothelial cells, we demonstrated that vascular endothelial PTP is responsible for dephosphorylation of activated VEGFR1. PEDF up-regulation of full-length presenilin 1 (Fl.PS1) facilitated the association of vascular endothelial PTP and VEGFR1. Knockdown of Fl.PS1 prevented dephosphorylation of VEGFR1, whereas up-regulation of Fl.PS1 stimulated VEGFR1 dephosphorylation. Fl.PS1 associated with VEGFR1 within 15 min after PEDF treatment. In conclusion, we determined the PEDF-mediated events responsible for VEGFR1 signaling and identified full-length presenilin as a critical adaptor molecule in the dephosphorylation of VEGFR1. This greater understanding of the regulation of VEGFR1 signaling will help identify novel anti-VEGF therapeutic strategies.	[Cai, Jun; Chen, Zhijuan; Ruan, Qing; Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Han, Song] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Liu, Li; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Boulton, ME (corresponding author), Univ Florida, Dept Anat & Cell Biol, 1600 SW Archer Rd,POB 100235, Gainesville, FL 32610 USA.	meboulton@ufl.edu		hauswirth, william/0000-0002-3244-4947; Han, Song/0000-0002-6542-335X	National Institutes of Health [R01EY018358, R01EY018358-04S1, EY012601, DK090730, R01EY11123, P30EY021721]; Macular Vision Research Foundation; Foundation Fighting Blindness; Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY018358, P30EY021721, R01EY011123, R01EY012601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY018358 and R01EY018358-04S1 (to M. B.), EY012601 and DK090730 (to M. B. G.), and R01EY11123 and P30EY021721 (to W. W. H.). W. W. H. and the University of Florida have a financial interest in the use of AAV therapies and own equity in a company (AGTC Inc.) that might, in the future, commercialize some aspects of this work.; Supported by grants from the Macular Vision Research Foundation, Foundation Fighting Blindness, Eldon Family Foundation, Vision for Children, and Research to Prevent Blindness, Inc.	Adachi M, 1996, CELL, V85, P15; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Chen AC, 2010, J BIOL CHEM, V285, P11378, DOI 10.1074/jbc.M109.088815; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kametani F, 2004, NEUROCHEM INT, V44, P313, DOI 10.1016/S0197-0186(03)00176-1; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pinto CA, 2003, CLIN CANCER RES, V9, P3098; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Scheper W, 2004, MOL BRAIN RES, V122, P17, DOI 10.1016/j.molbrainres.2003.11.013; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Shiraishi H, 2006, GENES CELLS, V11, P83, DOI 10.1111/j.1365-2443.2005.00914.x; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Zhao B, 2004, MICROVASC RES, V68, P239, DOI 10.1016/j.mvr.2004.07.004; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	39	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42514	42523		10.1074/jbc.M111.296590	http://dx.doi.org/10.1074/jbc.M111.296590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22016384	Green Published, hybrid			2022-12-25	WOS:000298180900059
J	Ma, CW; Xiu, ZL; Zeng, AP				Ma, Cheng-Wei; Xiu, Zhi-Long; Zeng, An-Ping			A New Concept to Reveal Protein Dynamics Based on Energy Dissipation	PLOS ONE			English	Article							LYSINE-SENSITIVE ASPARTOKINASE; MOLECULAR-DYNAMICS; STRUCTURAL DYNAMICS; ESCHERICHIA-COLI; ENZYME CATALYSIS; BINDING-SITES; PERSPECTIVE; NMR; SIMULATIONS; CONSTRAINTS	Protein dynamics is essential for its function, especially for intramolecular signal transduction. In this work we propose a new concept, energy dissipation model, to systematically reveal protein dynamics upon effector binding and energy perturbation. The concept is applied to better understand the intramolecular signal transduction during allostery of enzymes. The E. coli allosteric enzyme, aspartokinase III, is used as a model system and special molecular dynamics simulations are designed and carried out. Computational results indicate that the number of residues affected by external energy perturbation (i.e. caused by a ligand binding) during the energy dissipation process shows a sigmoid pattern. Using the two-state Boltzmann equation, we define two parameters, the half response time and the dissipation rate constant, which can be used to well characterize the energy dissipation process. For the allostery of aspartokinase III, the residue response time indicates that besides the ACT2 signal transduction pathway, there is another pathway between the regulatory site and the catalytic site, which is suggested to be the beta 15-alpha K loop of ACT1. We further introduce the term "protein dynamical modules" based on the residue response time. Different from the protein structural modules which merely provide information about the structural stability of proteins, protein dynamical modules could reveal protein characteristics from the perspective of dynamics. Finally, the energy dissipation model is applied to investigate E. coli aspartokinase III mutations to better understand the desensitization of product feedback inhibition via allostery. In conclusion, the new concept proposed in this paper gives a novel holistic view of protein dynamics, a key question in biology with high impacts for both biotechnology and biomedicine.	[Ma, Cheng-Wei; Zeng, An-Ping] Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany; [Ma, Cheng-Wei; Xiu, Zhi-Long] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Hamburg University of Technology; Dalian University of Technology	Ma, CW (corresponding author), Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany.	aze@tu-harburg.de		Zeng, An-Ping/0000-0001-9768-7096	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Financial support for this work was provided by the China Scholarship Council (to CWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunori M, 2000, BIOPHYS CHEM, V86, P221, DOI 10.1016/S0301-4622(00)00142-3; CASSAN M, 1986, J BIOL CHEM, V261, P1052; Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129; Chen Z, 2011, J BIOTECHNOL, V154, P248, DOI 10.1016/j.jbiotec.2011.05.005; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Dubois JM, 2009, PROG BIOPHYS MOL BIO, V99, P87, DOI 10.1016/j.pbiomolbio.2009.07.001; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; HAYWARD S, 1995, PROTEINS, V23, P177, DOI 10.1002/prot.340230207; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; Martinez KL, 2002, FEBS LETT, V528, P251, DOI 10.1016/S0014-5793(02)03306-9; Matoba Y, 2003, PROTEINS, V51, P453, DOI 10.1002/prot.10360; Miyata YO, 2001, BIOSCI BIOTECH BIOCH, V65, P1149; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Rousseau F, 2005, CURR OPIN STRUC BIOL, V15, P23, DOI 10.1016/j.sbi.2005.01.007; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Whitten ST, 2005, P NATL ACAD SCI USA, V102, P4282, DOI 10.1073/pnas.0407499102; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26453	10.1371/journal.pone.0026453	http://dx.doi.org/10.1371/journal.pone.0026453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022616	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400060
J	Chen, GF; Zhang, CY; Zhang, BY; Wang, GC; Lu, DD; Xu, Z; Yan, PS				Chen, Guofu; Zhang, Chunyu; Zhang, Baoyu; Wang, Guangce; Lu, Douding; Xu, Zhong; Yan, Peishen			Development of a PNA Probe for Fluorescence In Situ Hybridization Detection of Prorocentrum donghaiense	PLOS ONE			English	Article							RNA-TARGETED PROBES; DINOFLAGELLATES ALEXANDRIUM-TAMARENSE; PSEUDO-NITZSCHIA-AUSTRALIS; NUCLEIC-ACID PNA; RIBOSOMAL-RNA; SANDWICH HYBRIDIZATION; WHOLE-CELL; RAPID IDENTIFICATION; HETEROSIGMA-AKASHIWO; SEQUENCE-ANALYSIS	Prorocentrum donghaiense is a common but dominant harmful algal bloom (HAB) species, which is widely distributed along the China Sea coast. Development of methods for rapid and precise identification and quantification is prerequisite for early-stage warning and monitoring of blooms due to P. donghaiense. In this study, sequences representing the partial large subunit rDNA (D1-D2), small subunit rDNA and internal transcribed spacer region (ITS-1, 5.8S rDNA and ITS-2) of P. donghaiense were firstly obtained, and then seven candidate DNA probes were designed for performing fluorescence in situ hybridization (FISH) tests on P. donghaiense. Based on the fluorescent intensity of P. donghaiense cells labeled by the DNA probes, the probe DP0443A displayed the best hybridization performance. Therefore, a PNA probe (PP0443A) analogous to DP0443A was used in the further study. The cells labeled with the PNA probe displayed more intensive green fluorescence than that labeled with its DNA analog. The PNA probe was used to hybridize with thirteen microalgae belonging to five families, i.e., Dinophyceae, Prymnesiophyceae, Raphidophyceae, Chlorophyceae and Bacillariophyceae, and showed no visible cross-reaction. Finally, FISH with the probes PP0443A and DP0443A and light microscopy (LM) analysis aiming at enumerating P. donghaiense cells were performed on the field samples. Statistical comparisons of the cell densities (cells/L) of P. donghaiense in the natural samples determined by FISH and LM were performed using one-way ANOVA and Duncan's multiple comparisons of the means. The P. donghaiense cell densities determined by LM and the PNA probe are remarkably higher than (p < 0.05) that determined by the DNA probe, while no significant difference is observed between LM and the PNA probe. All results suggest that the PNA probe is more sensitive that its DNA analog, and therefore is promising for the monitoring of harmful algal blooms of P. donghaiense in the future.	[Chen, Guofu; Zhang, Chunyu; Xu, Zhong; Yan, Peishen] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Chen, Guofu; Zhang, Baoyu; Wang, Guangce] Tianjin Univ Sci & Technol, Tianjin Key Lab Marine Resources & Chem, Tianjin, Peoples R China; [Wang, Guangce] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Chen, Guofu] SOA, Inst Oceanog 1, Qingdao, Peoples R China; [Lu, Douding] SOA, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China	Harbin Institute of Technology; Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; State Oceanic Administration; State Oceanic Administration	Chen, GF (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	linmeng23@sohu.com; byzhang@163.com; gcwang@ms.qdio.ac.cn	Zhang, Chun-yu/HDP-5776-2022		Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [2010BSA10004]; Foundation of Tianjin Key Laboratory of Marine Resources and Chemistry [200904]; Tianjin University of Science Technology [2010-027]; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology [ES200802]; National Scientific foundation of China [41106082, 41176141]; Key Laboratory of Marine Ecology and Environmental Science and Engineering [MESE-2011-06]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.200808]; Harbin Institute of Techonology	Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; Foundation of Tianjin Key Laboratory of Marine Resources and Chemistry; Tianjin University of Science Technology; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology(Harbin Institute of Technology); National Scientific foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Marine Ecology and Environmental Science and Engineering; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology); Harbin Institute of Techonology	This work was supported by Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (2010BSA10004); the Foundation (No. 200904) of Tianjin Key Laboratory of Marine Resources and Chemistry; Tianjin University of Science & Technology, Technology and Development Program of Weihai (2010-027); Open Project of State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology (ES200802); National Scientific foundation of China (No. 41106082, 41176141); Key Laboratory of Marine Ecology and Environmental Science and Engineering (MESE-2011-06); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (HIT.NSRIF.200808); and Program of Excellent Team in Harbin Institute of Techonology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P1049, DOI 10.1111/j.0022-3646.1996.01049.x; Alm EW, 1996, APPL ENVIRON MICROB, V62, P3557, DOI 10.1128/AEM.62.10.3557-3559.1996; Anderson DM, 1999, J PHYCOL, V35, P870, DOI 10.1046/j.1529-8817.1999.3540870.x; Chen GF, 2011, CAHIERS BIO IN PRESS; Chen GF, 2008, J EXP MAR BIOL ECOL, V355, P66, DOI 10.1016/j.jembe.2007.12.012; Chen GF, 2007, CAH BIOL MAR, V48, P55; Chen J, 2009, ACTA OCEANOL SIN, V28, P121; Congestri R, 2008, PLANT BIOSYST, V142, P337, DOI 10.1080/11263500802150746; Connell L, 2006, AFR J MAR SCI, V28, P237, DOI 10.2989/18142320609504154; Connell LB, 2000, MAR BIOL, V136, P953, DOI 10.1007/s002270000314; Diercks S, 2008, HARMFUL ALGAE, V7, P137, DOI 10.1016/j.hal.2007.06.005; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EMBLEY TM, 1992, J GEN MICROBIOL, V138, P1479, DOI 10.1099/00221287-138-7-1479; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Hosoi-Tanabe S, 2006, FISHERIES SCI, V72, P77, DOI 10.1111/j.1444-2906.2006.01119.x; Hosoi-Tanabe S, 2005, HARMFUL ALGAE, V4, P319, DOI 10.1016/j.hal.2004.04.002; Huang BQ, 2008, HARMFUL ALGAE, V7, P495, DOI 10.1016/j.hal.2007.11.006; KIM SK, 1993, J AM CHEM SOC, V115, P6477, DOI 10.1021/ja00068a001; Litaker RW, 2002, J PHYCOL, V38, P442, DOI 10.1046/j.1529-8817.2002.t01-1-01242.x; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; LU DD, 2003, CHINESE J APPL ECOLO, V14, P1060; Lu Dou-ding, 2001, Chinese Journal of Oceanology and Limnology, V19, P337; Mikulski CM, 2008, HARMFUL ALGAE, V7, P347, DOI 10.1016/j.hal.2007.12.015; Miller PE, 1998, J PHYCOL, V34, P371, DOI 10.1046/j.1529-8817.1998.340371.x; NIELSEN PE, 1994, BIOCONJUGATE CHEM, V5, P3, DOI 10.1021/bc00025a001; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Park TG, 2010, HARMFUL ALGAE, V9, P59, DOI 10.1016/j.hal.2009.08.002; QI Y, 2003, CHIN J APPL ECOL, V14, P1188; Sako Y, 2004, J PHYCOL, V40, P598, DOI 10.1111/j.1529-8817.2004.03035.x; SCHLOTTERER C, 1994, MOL BIOL EVOL, V11, P513; Scholin C, 1997, LIMNOL OCEANOGR, V42, P1265, DOI 10.4319/lo.1997.42.5_part_2.1265; Scholin CA, 1996, PHYCOLOGIA, V35, P190, DOI 10.2216/i0031-8884-35-3-190.1; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sen S, 1998, J AM CHEM SOC, V120, P619, DOI 10.1021/ja972234x; [石彦红 SHI Yanhong], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P267; STEANE DA, 1991, J PHYCOL, V27, P758, DOI 10.1111/j.0022-3646.1991.00758.x; Tyrrell John V., 2002, Harmful Algae, V1, P205, DOI 10.1016/S1568-9883(02)00012-4; Tyrrell JV, 2001, PHYCOLOGIA, V40, P457, DOI 10.2216/i0031-8884-40-5-457.1; Ulrich RM, 2010, HARMFUL ALGAE, V9, P116, DOI 10.1016/j.hal.2009.08.010; Wang DZ, 2007, J APPL PHYCOL, V19, P325, DOI 10.1007/s10811-006-9139-2; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Worden AZ, 2003, J PHYCOL, V39, P527, DOI 10.1046/j.1529-8817.2003.01248.x; Worden AZ, 2000, APPL ENVIRON MICROB, V66, P284, DOI 10.1128/AEM.66.1.284-289.2000; [张宝玉 Zhang bao yu], 2005, [高技术通讯, High Technology Letters], V15, P101; Zhang FY, 2009, HARMFUL ALGAE, V8, P839, DOI 10.1016/j.hal.2009.03.004; Zhen Y, 2009, HARMFUL ALGAE, V8, P651, DOI 10.1016/j.hal.2008.12.001; Zhou M., 2007, CHIN J NAT, V29, P72, DOI DOI 10.3969/j.issn.0253-9608.2007.02.003	51	21	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25527	10.1371/journal.pone.0025527	http://dx.doi.org/10.1371/journal.pone.0025527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022408	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600009
J	Tan, G; Pan, SH; Li, J; Dong, XS; Kang, K; Zhao, MY; Jiang, X; Kanwar, JR; Qiao, HQ; Jiang, HC; Sun, XY				Tan, Gang; Pan, Shangha; Li, Jie; Dong, Xuesong; Kang, Kai; Zhao, Mingyan; Jiang, Xian; Kanwar, Jagat R.; Qiao, Haiquan; Jiang, Hongchi; Sun, Xueying			Hydrogen Sulfide Attenuates Carbon Tetrachloride-Induced Hepatotoxicity, Liver Cirrhosis and Portal Hypertension in Rats	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; 3RD GAS; H2S; VASORELAXATION; PATHOGENESIS; CONTRIBUTES; FIBROSIS; STRESS	Background: Hydrogen sulfide (H2S) displays vasodilative, anti-oxidative, anti-inflammatory and cytoprotective activities. Impaired production of H2S contributes to the increased intrahepatic resistance in cirrhotic livers. The study aimed to investigate the roles of H2S in carbon tetrachloride (CCl4)-induced hepatotoxicity, cirrhosis and portal hypertension. Methods and Findings: Sodium hydrosulfide (NaHS), a donor of H2S, and DL-propargylglycine (PAG), an irreversible inhibitor of cystathionine gamma-lyase (CSE), were applied to the rats to investigate the effects of H2S on CCl4-induced acute hepatotoxicity, cirrhosis and portal hypertension by measuring serum levels of H2S, hepatic H2S producing activity and CSE expression, liver function, activity of cytochrome P450 (CYP) 2E1, oxidative and inflammatory parameters, liver fibrosis and portal pressure. CCl4 significantly reduced serum levels of H2S, hepatic H2S production and CSE expression. NaHS attenuated CCl4-induced acute hepatotoxicity by supplementing exogenous H2S, which displayed anti-oxidative activities and inhibited the CYP2E1 activity. NaHS protected liver function, attenuated liver fibrosis, inhibited inflammation, and reduced the portal pressure, evidenced by the alterations of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hyaluronic acid (HA), albumin, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and soluble intercellular adhesion molecule (ICAM)-1, liver histology, hepatic hydroxyproline content and a-smooth muscle actin (SMA) expression. PAG showed opposing effects to NaHS on most of the above parameters. Conclusions: Exogenous H2S attenuates CCl4-induced hepatotoxicity, liver cirrhosis and portal hypertension by its multiple functions including anti-oxidation, anti-inflammation, cytoprotection and anti-fibrosis, indicating that targeting H2S may present a promising approach, particularly for its prophylactic effects, against liver cirrhosis and portal hypertension.	[Tan, Gang; Pan, Shangha; Dong, Xuesong; Jiang, Xian; Qiao, Haiquan; Jiang, Hongchi; Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hepatosplen Surg Ctr, Harbin, Peoples R China; [Kang, Kai; Zhao, Mingyan] Harbin Med Univ, Affiliated Hosp 1, Dept ICU, Harbin, Peoples R China; [Li, Jie] Shandong Univ, Affiliated Qianfoshan Hosp, Dept Hepatobiliary Surg, Jinan 250100, Peoples R China; [Kanwar, Jagat R.] Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol & Res Innovat, Geelong, Vic 3217, Australia; [Sun, Xueying] Univ Auckland, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1, New Zealand	Harbin Medical University; Harbin Medical University; Shandong University; Deakin University; University of Auckland	Tan, G (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hepatosplen Surg Ctr, Harbin, Peoples R China.	jianghc@vip.163.com; k.sun@auckland.ac.nz	Jiang, HongChi/M-5031-2018; wang, jianqi/G-6194-2013	Jiang, HongChi/0000-0001-8215-8984; Sun, Xueying/0000-0002-8065-8747	National Natural Scientific Foundation of China [30872987, 30973474]; Heilongjiang Provincial Scientific and Technology Bureau, China [QC06C075]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Scientific and Technology Bureau, China	Grants from the National Natural Scientific Foundation of China (30872987 and 30973474)(www.nsfc.gov.cn), and Heilongjiang Provincial Scientific and Technology Bureau, China (QC06C075)(http://www.hljkjt.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang T K, 1998, Methods Mol Biol, V107, P147; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fang LP, 2009, CAN J PHYSIOL PHARM, V87, P531, DOI [10.1139/Y09-039, 10.1139/y09-039]; Fiorucci S, 2007, DIGEST LIVER DIS, V39, P1043, DOI 10.1016/j.dld.2007.09.001; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fujii K, 2005, ANTIOXID REDOX SIGN, V7, P788, DOI 10.1089/ars.2005.7.788; Fukao T, 2004, BIOFACTORS, V21, P171, DOI 10.1002/biof.552210135; Gao Y, 2011, INT J CARDIOL, V152, P177, DOI 10.1016/j.ijcard.2010.07.012; Guidotti TL, 1996, OCCUP MED-OXFORD, V46, P367, DOI 10.1093/occmed/46.5.367; Hosono-Fukao T, 2009, J NUTR, V139, P2252, DOI 10.3945/jn.109.109611; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lou LX, 2008, CLIN EXP PHARMACOL P, V35, P223, DOI 10.1111/j.1440-1681.2007.04812.x; Lowicka E, 2007, PHARMACOL REP, V59, P4; Morsy MA, 2010, LIFE SCI, V87, P692, DOI 10.1016/j.lfs.2010.10.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PREDMORE BL, 2010, J AM COLL CARDIOL, V55, pA116; Siebert N, 2008, AM J PHYSIOL-GASTR L, V295, pG1266, DOI 10.1152/ajpgi.90484.2008; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Steib CJ, 2010, GUT, V59, P827, DOI 10.1136/gut.2009.197756; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang CY, 2003, BIOCHEM BIOPH RES CO, V302, P810, DOI 10.1016/S0006-291X(03)00256-0; Zhang LM, 2009, NEUROCHEM RES, V34, P1984, DOI 10.1007/s11064-009-0006-9; Zhang QY, 2004, BIOCHEM BIOPH RES CO, V317, P30, DOI 10.1016/j.bbrc.2004.02.176; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhong GZ, 2010, CARDIOLOGY, V115, P120, DOI 10.1159/000260073; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015	37	93	100	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25943	10.1371/journal.pone.0025943	http://dx.doi.org/10.1371/journal.pone.0025943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022478	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600023
J	Ong, YC; Boyle, JP; Boothroyd, JC				Ong, Yi-Ching; Boyle, Jon P.; Boothroyd, John C.			Strain-Dependent Host Transcriptional Responses to Toxoplasma Infection Are Largely Conserved in Mammalian and Avian Hosts	PLOS ONE			English	Article							NF-KAPPA-B; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; GONDII; EXPRESSION; CELLS; STAT5; RESISTANCE; DIVERSITY; ZEBRAFISH	Toxoplasma gondii has a remarkable ability to infect an enormous variety of mammalian and avian species. Given this, it is surprising that three strains (Types I/II/III) account for the majority of isolates from Europe/North America. The selective pressures that have driven the emergence of these particular strains, however, remain enigmatic. We hypothesized that strain selection might be partially driven by adaptation of strains for mammalian versus avian hosts. To test this, we examine in vitro, strain-dependent host responses in fibroblasts of a representative avian host, the chicken (Gallus gallus). Using gene expression profiling of infected chicken embryonic fibroblasts and pathway analysis to assess host response, we show here that chicken cells respond with distinct transcriptional profiles upon infection with Type II versus III strains that are reminiscent of profiles observed in mammalian cells. To identify the parasite drivers of these differences, chicken fibroblasts were infected with individual F1 progeny of a Type II x III cross and host gene expression was assessed for each by microarray. QTL mapping of transcriptional differences suggested, and deletion strains confirmed, that, as in mammalian cells, the polymorphic rhoptry kinase ROP16 is the major driver of strain-specific responses. We originally hypothesized that comparing avian versus mammalian host response might reveal an inversion in parasite strain-dependent phenotypes; specifically, for polymorphic effectors like ROP16, we hypothesized that the allele with most activity in mammalian cells might be less active in avian cells. Instead, we found that activity of ROP16 alleles appears to be conserved across host species; moreover, additional parasite loci that were previously mapped for strain-specific effects on mammalian response showed similar strain-specific effects in chicken cells. These results indicate that if different hosts select for different parasite genotypes, the selection operates downstream of the signaling occurring during the beginning of the host's immune response.	[Ong, Yi-Ching; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Boyle, Jon P.] Univ Pittsburgh, Dept Mol Biol, Pittsburgh, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ong, YC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jboothr@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Boyle, Jon/0000-0003-0000-9243	National Science Foundation; Pew Scholarship in the Biomedical Sciences; NIH [K22AI080977, AI73756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756, K22AI080977] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Pew Scholarship in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Y-CO was supported by a National Science Foundation Graduate Research Fellowship and Smith Stanford Graduate Fellowship. JPB was supported by a Pew Scholarship in the Biomedical Sciences and an NIH Research Scholar Award K22AI080977. JCB was supported by the NIH AI73756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Angeloni MB, 2009, PLACENTA, V30, P785, DOI 10.1016/j.placenta.2009.07.002; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2009, MEM I OSWALDO CRUZ, V104, P179, DOI 10.1590/S0074-02762009000200009; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Dubey JP, 2007, VET PARASITOL, V148, P207, DOI 10.1016/j.vetpar.2007.06.033; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; DUBEY JP, 1993, AM J VET RES, V54, P1668; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Friedrich K, 1999, INT IMMUNOL, V11, P1283, DOI 10.1093/intimm/11.8.1283; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hemmers S, 2009, NAT IMMUNOL, V10, P806, DOI 10.1038/ni0809-806; HERNANDEZ R, 2010, CURRENT PROTOCOLS MI, V17, P2046; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IKEDA T, 1993, GENE, V133, P237, DOI 10.1016/0378-1119(93)90645-J; IRIZARRY R, 2003, NUCL ACIDS RES, P2046; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kaiser P, 2007, CYTOGENET GENOME RES, V117, P221, DOI 10.1159/000103183; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kaneto CN, 1997, VET PARASITOL, V69, P203, DOI 10.1016/S0304-4017(96)01126-0; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Kieslinger M, 2000, GENE DEV, V14, P232; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Lewis RS, 2004, GENE, V338, P65, DOI 10.1016/j.gene.2004.05.012; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YAMAMOTO M, 2009, J EXP MED; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031	56	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26369	10.1371/journal.pone.0026369	http://dx.doi.org/10.1371/journal.pone.0026369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022607	Green Published, gold			2022-12-25	WOS:000295978600051
J	Ho, DWH; Yiu, WC; Yap, MKH; Fung, WY; Ng, PW; Yip, SP				Ho, Daniel W. H.; Yiu, Wai Chi; Yap, Maurice K. H.; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping			Genotyping Performance Assessment of Whole Genome Amplified DNA with Respect to Multiplexing Level of Assay and Its Period of Storage	PLOS ONE			English	Article							AMPLIFICATION; SEQUENCE; FIDELITY	Whole genome amplification can faithfully amplify genomic DNA (gDNA) with minimal bias and substantial genome coverage. Whole genome amplified DNA (wgaDNA) has been tested to be workable for high-throughput genotyping arrays. However, issues about whether wgaDNA would decrease genotyping performance at increasing multiplexing levels and whether the storage period of wgaDNA would reduce genotyping performance have not been examined. Using the Sequenom MassARRAY iPLEX Gold assays, we investigated 174 single nucleotide polymorphisms for 3 groups of matched samples: group 1 of 20 gDNA samples, group 2 of 20 freshly prepared wgaDNA samples, and group 3 of 20 stored wgaDNA samples that had been kept frozen at -70 degrees C for 18 months. MassARRAY is a medium-throughput genotyping platform with reaction chemistry different from those of high-throughput genotyping arrays. The results showed that genotyping performance (efficiency and accuracy) of freshly prepared wgaDNA was similar to that of gDNA at various multiplexing levels (17-plex, 21-plex, 28-plex and 36-plex) of the MassARRAY assays. However, compared with gDNA or freshly prepared wgaDNA, stored wgaDNA was found to give diminished genotyping performance (efficiency and accuracy) due to potentially inferior quality. Consequently, no matter whether gDNA or wgaDNA was used, better genotyping efficiency would tend to have better genotyping accuracy.	[Ho, Daniel W. H.; Yiu, Wai Chi; Yap, Maurice K. H.; Ng, Po Wah] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China; [Ho, Daniel W. H.; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ho, DWH (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China.	shea.ping.yip@inet.polyu.edu.hk	Yip, Shea Ping/A-1185-2016; Ho, Daniel Wai Hung WH/O-1194-2016; Yap, Maurice KH/K-4927-2016	Yip, Shea Ping/0000-0002-2170-8185; Ho, Daniel Wai Hung WH/0000-0003-3884-296X; Yap, Maurice KH/0000-0003-4687-4101	Hong Kong Polytechnic University [G-YX2V, 87TP, J-BB7P]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work is a contribution from the Centre for Myopia Research, The Hong Kong Polytechnic University, and was supported by grants (G-YX2V, 87TP and J-BB7P) from the Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Bergen AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/humu.20213; Bergen AW, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-24; Berthier-Schaad Y, 2007, ELECTROPHORESIS, V28, P2812, DOI 10.1002/elps.200600674; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2009, ELECTROPHORESIS, V30, P2532, DOI 10.1002/elps.200800655; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Magee DA, 2010, J ANIM SCI, V88, P3183, DOI 10.2527/jas.2009-2723; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Park JW, 2005, CLIN CHEM, V51, P1520, DOI 10.1373/clinchem.2004.047076; Pask R, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-15; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	22	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26119	10.1371/journal.pone.0026119	http://dx.doi.org/10.1371/journal.pone.0026119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022531	Green Submitted, Green Published, gold			2022-12-25	WOS:000295973200038
J	Wu, JM; Richards, MH; Huang, JH; Al-Harthi, L; Xu, XL; Lin, R; Xie, FL; Gibson, AW; Edberg, JC; Kimberly, RP				Wu, Jianming; Richards, Maureen H.; Huang, Jinhai; Al-Harthi, Lena; Xu, Xiulong; Lin, Rui; Xie, Fenglong; Gibson, Andrew W.; Edberg, Jeffrey C.; Kimberly, Robert P.			Human FasL Gene Is a Target of beta-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; APO-1/FAS LIGAND PROMOTER; COLON-CANCER; CD95 LIGAND; TRANSCRIPTION FACTOR; LYMPHOPROLIFERATIVE SYNDROME; INDUCED APOPTOSIS; IMMUNE PRIVILEGE; HMG DOMAIN; T-CELLS	FasL expression on human immune cells and cancer cells plays important roles in immune homeostasis and in cancer development. Our previous study suggests that polymorphisms in the FasL promoter can significantly affect the gene expression in human cells. In addition to the functional FasL SNP -844C>T (rs763110), three other SNPs (SNP -756A>G or rs2021837, SNP -478A>T or rs41309790, and SNP -205 C>G or rs74124371) exist in the proximal FasL promoter. In the current study, we established three major FasL hyplotypes in humans. Interestingly, a transcription motif search revealed that the FasL promoter possessed two consensus T-cell factor (TCF/LEF1) binding elements (TBEs), which is either polymorphic (SNP -205C>G) or close to the functional SNP -844C>T. Subsequently, we demonstrate that both FasL TBEs formed complexes with the TCF-4 and beta-catenin transcription factors in vitro and in vivo. Co-transfection of LEF-1 and beta-catenin transcription factors significantly increased FasL promoter activities, suggesting that FasL is a target gene of the beta-catenin/T-cell factor pathway. More importantly, we found that the rare allele (-205G) of the polymorphic FasL TBE (SNP -205C>G) failed to bind the TCF-4 transcription factor and that SNP -205 C>G significantly affected the promoter activity. Furthermore, promoter reporter assays revealed that FasL SNP haplotypes influenced promoter activities in human colon cancer cells and in human T cells. Finally, beta-catenin knockdown significantly decreased the FasL expression in human SW480 colon cancer cells. Collectively, our data suggest that beta-catenin may be involved in FasL gene regulation and that FasL expression is influenced by FasL SNP haplotypes, which may have significant implications in immune response and tumorigenesis.	[Wu, Jianming; Huang, Jinhai; Lin, Rui] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Richards, Maureen H.; Al-Harthi, Lena] Rush Presbyterian St Lukes Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Xu, Xiulong] Rush Presbyterian St Lukes Med Ctr, Dept Gen Surg, Chicago, IL 60612 USA; [Xie, Fenglong; Gibson, Andrew W.; Edberg, Jeffrey C.; Kimberly, Robert P.] Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, IL USA	University of Minnesota System; University of Minnesota Twin Cities; Rush University; Rush University; University of Alabama System; University of Alabama Birmingham	Wu, JM (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jmwu@umn.edu	huang, jinhai/B-1334-2016	huang, jinhai/0000-0002-1073-533X; Kimberly, Robert/0000-0002-5330-3086	Lupus Research Institute; National Institutes of Health [R01-AR33062, P01-AR49084]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033062, P01AR049084] Funding Source: NIH RePORTER	Lupus Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Lupus Research Institute grant (J.W.) and National Institutes of Health grants R01-AR33062 (RPK), and P01-AR49084 (RPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDERBRIDGES M, 1992, J CELL BIOCHEM, V48, P129, DOI 10.1002/jcb.240480204; ASHANY D, 1995, P NATL ACAD SCI USA, V92, P11225, DOI 10.1073/pnas.92.24.11225; Barker N, 2000, ADV CANCER RES, V77, P1; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bennett MW, 1999, GUT, V44, P156, DOI 10.1136/gut.44.2.156; Bennett MW, 2001, J CLIN PATHOL, V54, P598, DOI 10.1136/jcp.54.8.598; Bennett MW, 1998, J IMMUNOL, V160, P5669; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; DosReis GA, 2004, J CELL MOL MED, V8, P285, DOI 10.1111/j.1582-4934.2004.tb00318.x; Duran S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1332, DOI 10.1002/art.24020; Elkon KB, 1996, CURR OPIN IMMUNOL, V8, P852, DOI 10.1016/S0952-7915(96)80015-X; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Houston A, 2004, CURR OPIN PHARMACOL, V4, P321, DOI 10.1016/j.coph.2004.03.008; Houston A, 2003, BRIT J CANCER, V89, P1345, DOI 10.1038/sj.bjc.6601240; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li HC, 2009, GASTROENTEROLOGY, V137, P934, DOI 10.1053/j.gastro.2009.06.004; Li-Weber M, 1998, EUR J IMMUNOL, V28, P2373, DOI 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Liu Y, 2009, EUR J CANCER, V45, P2574, DOI 10.1016/j.ejca.2009.04.001; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Maeda A, 1998, BRIT J DERMATOL, V139, P198; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Niehans GA, 1997, CANCER RES, V57, P1007; Norian LA, 1998, J IMMUNOL, V161, P1078; O'Connell J, 1998, J PATHOL, V186, P240; O'Connell J, 1999, IMMUNOL TODAY, V20, P46, DOI 10.1016/S0167-5699(98)01382-6; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; OOSTERWEGEL MA, 1991, INT IMMUNOL, V3, P1189, DOI 10.1093/intimm/3.11.1189; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; Shiraki K, 1997, P NATL ACAD SCI USA, V94, P6420, DOI 10.1073/pnas.94.12.6420; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sparks AB, 1998, CANCER RES, V58, P1130; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yokomizo H, 2003, ANTICANCER RES, V23, P5221; Zhang H, 1999, J IMMUNOL, V162, P1423; Zhang W, 2005, WORLD J GASTROENTERO, V11, P3632, DOI 10.3748/wjg.v11.i23.3632	72	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26143	10.1371/journal.pone.0026143	http://dx.doi.org/10.1371/journal.pone.0026143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022540	Green Submitted, Green Published, gold			2022-12-25	WOS:000295973200044
J	Palazzo, AL; Evensen, E; Huang, YW; Cesano, A; Nolan, GP; Fantl, WJ				Palazzo, Adam L.; Evensen, Erik; Huang, Ying-Wen; Cesano, Alessandra; Nolan, Garry P.; Fantl, Wendy J.			Association of Reactive Oxygen Species-Mediated Signal Transduction with In Vitro Apoptosis Sensitivity in Chronic Lymphocytic Leukemia B Cells	PLOS ONE			English	Article							GENE MUTATION STATUS; RECEPTOR-TYPE-O; NF-KAPPA-B; TYROSINE KINASE; DISEASE PROGRESSION; ANTIGEN RECEPTOR; THERAPEUTIC TARGET; CD38 EXPRESSION; FLOW-CYTOMETRY; GROWTH-FACTORS	Background: Chronic lymphocytic leukemia (CLL) is a B cell malignancy with a variable clinical course and unpredictable response to therapeutic agents. Single cell network profiling (SCNP) utilizing flow cytometry measures alterations in signaling biology in the context of molecular changes occurring in malignancies. In this study SCNP was used to identify proteomic profiles associated with in vitro apoptotic responsiveness of CLL B cells to fludarabine, as a basis for ultimately linking these with clinical outcome. Methodology/Principal Finding: SCNP was used to quantify modulated-signaling of B cell receptor (BCR) network proteins and in vitro F-ara-A mediated apoptosis in 23 CLL samples. Of the modulators studied the reactive oxygen species, hydrogen peroxide (H(2)O(2)), a known intracellular second messenger and a general tyrosine phosphatase inhibitor stratified CLL samples into two sub-groups based on the percentage of B cells in a CLL sample with increased phosphorylation of BCR network proteins. Separately, in the same patient samples, in vitro exposure to F-ara-A also identified two sub-groups with B cells showing competence or refractoriness to apoptotic induction. Statistical analysis showed that in vitro F-ara-A apoptotic proficiency was highly associated with the proficiency of CLL B cells to undergo H(2)O(2)-augmented signaling. Conclusions/Significance: This linkage in CLL B cells among the mechanisms governing chemotherapy-induced apoptosis increased signaling of BCR network proteins and a likely role of phosphatase activity suggests a means of stratifying patients for their response to F-ara-A based regimens. Future studies will examine the clinical applicability of these findings and also the utility of this approach in relating mechanism to function of therapeutic agents.	[Palazzo, Adam L.; Evensen, Erik; Huang, Ying-Wen; Cesano, Alessandra; Fantl, Wendy J.] Nodality Inc, San Francisco, CA USA; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Baxter Lab Stem Cell Biol, Palo Alto, CA 94304 USA; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Palazzo, AL (corresponding author), Nodality Inc, San Francisco, CA USA.	wjfantl@stanford.edu	Nolan, Garry/AAE-7903-2019	Huang, Ying-Wen/0000-0003-3727-7903; Nolan, Garry/0000-0002-8862-9043	Nodality, Inc.	Nodality, Inc.	This work was supported by research funding from Nodality, Inc. to WJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; BREZSKI RJ, 2008, MULTICHAIN IMMUNE RE; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Du J., 2002, COMBINED ALGORITHMS; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fuentes-Panana EM, 2006, J IMMUNOL, V177, P7913, DOI 10.4049/jimmunol.177.11.7913; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghia P, 2003, BLOOD, V101, P1262, DOI 10.1182/blood-2002-06-1801; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 2007, BEST PRACT RES CL HA, V20, P455, DOI 10.1016/j.beha.2007.02.001; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hertlein E, 2008, BLOOD, V111, P4427, DOI 10.1182/blood-2008-02-137802; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kaplan D, 2010, CYTOM PART B-CLIN CY, V78B, P115, DOI 10.1002/cyto.b.20506; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kay NE, 2007, LEUKEMIA, V21, P1885, DOI 10.1038/sj.leu.2404802; Kolb Jean-Pierre, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P261, DOI 10.2174/1568006033481384; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Motiwala T, 2007, CLIN CANCER RES, V13, P3174, DOI 10.1158/1078-0432.CCR-06-1720; Rao GN, 1997, CELL SIGNAL, V9, P181, DOI 10.1016/S0898-6568(96)00139-8; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Sattler M, 1999, BLOOD, V93, P2928; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Smith SH, 2004, MOL CELL, V14, P696, DOI 10.1016/j.molcel.2004.06.015; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tam CS, 2009, BLOOD, V114, P957, DOI 10.1182/blood-2009-03-210591; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24592	10.1371/journal.pone.0024592	http://dx.doi.org/10.1371/journal.pone.0024592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016760	Green Submitted, gold, Green Published			2022-12-25	WOS:000295971700001
J	Chen, LN; Liu, JN; Xu, CS; Keblesh, J; Zang, WJ; Xiong, HG				Chen, Lina; Liu, Jianuo; Xu, Changshui; Keblesh, James; Zang, Weijin; Xiong, Huangui			HIV-1gp120 Induces Neuronal Apoptosis through Enhancement of 4-Aminopyridine-Senstive Outward K+ Currents	PLOS ONE			English	Article							PROTEIN-KINASE-C; PROSTATE-CANCER CELLS; CHEMOKINE RECEPTOR CXCR4; CEREBELLAR GRANULE CELL; ESTER-INDUCED APOPTOSIS; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; NEUROCOGNITIVE DISORDERS; GP120 NEUROTOXICITY; HIPPOCAMPAL-NEURONS	Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) usually occurs late in the course of HIV-1 infection and the mechanisms underlying HAD pathogenesis are not well understood. Accumulating evidence indicates that neuronal voltage-gated potassium (Kv) channels play an important role in memory processes and acquired neuronal channelopathies in HAD. To examine whether Kv channels are involved in HIV-1-associated neuronal injury, we studied the effects of HIV-1 glycoprotein 120 (gp120) on outward K+ currents in rat cortical neuronal cultures using whole-cell patch techniques. Exposure of cortical neurons to gp120 produced a dose-dependent enhancement of A-type transient outward K+ currents (IA). The gp120-induced increase of IA was attenuated by T140, a specific antagonist for chemokine receptor CXCR4, suggesting gp120 enhancement of neuronal IA via CXCR4. Pretreatment of neuronal cultures with a protein kinase C (PKC) inhibitor, GF109203X, inhibited the gp120-induced increase of IA. Biological significance of gp120 enhancement of IA was demonstrated by experimental results showing that gp120-induced neuronal apoptosis, as detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and caspase-3 staining, was attenuated by either an IA blocker 4-aminopyridine or a specific CXCR4 antagonist T140. Taken together, these results suggest that gp120 may induce caspase-3 dependent neuronal apoptosis by enhancing IA via CXCR4-PKC signaling.	[Chen, Lina; Liu, Jianuo; Xu, Changshui; Keblesh, James; Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurophysiol Lab, Omaha, NE 68198 USA; [Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Chen, Lina; Zang, Weijin] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Xi'an Jiaotong University	Chen, LN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurophysiol Lab, Omaha, NE 68198 USA.	hxiong@unmc.edu			National Institutes of Health [2R01NS041862]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA028555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants by the National Institutes of Health: 2R01NS041862 to HX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2004, NEUROTOX RES, V5, P605; AggounZouaoui D, 1996, NEUROREPORT, V7, P433, DOI 10.1097/00001756-199601310-00014; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Anderson P, 1997, MICROBIOL MOL BIOL R, V61, P33, DOI 10.1128/.61.1.33-46.1997; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bachis A, 2004, J NEUROSCI RES, V75, P75, DOI 10.1002/jnr.10826; Bachis A, 2003, J NEUROSCI, V23, P5715; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; Bonini JS, 2007, NEUROSCIENCE, V147, P37, DOI 10.1016/j.neuroscience.2007.04.013; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Ekhterae D, 2001, AM J PHYSIOL-CELL PH, V281, pC157, DOI 10.1152/ajpcell.2001.281.1.C157; Everall IP, 1999, BRAIN PATHOL, V9, P209; FELIPO V, 1993, BRAIN RES, V604, P192, DOI 10.1016/0006-8993(93)90368-W; Ferrando S, 1998, AIDS, V12, pF65, DOI 10.1097/00002030-199808000-00002; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gelman BB, 2004, J NEUROIMMUNOL, V157, P111, DOI 10.1016/j.jneuroim.2004.08.044; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Hu DH, 2010, EUR J NEUROSCI, V31, P214, DOI 10.1111/j.1460-9568.2009.07063.x; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Keblesh J, 2009, J NEUROIMMUNE PHARM, V4, P60, DOI 10.1007/s11481-008-9106-6; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; LAURIE DJ, 1995, MOL BRAIN RES, V32, P94, DOI 10.1016/0169-328X(95)00067-3; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McCutchan JA, 2007, AIDS, V21, P1109, DOI 10.1097/QAD.0b013e3280ef6acd; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; Parsons TD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-11; PETITO CK, 1995, AM J PATHOL, V146, P1121; Redman PT, 2006, NEUROSCIENCE, V143, P1, DOI 10.1016/j.neuroscience.2006.08.039; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sa MJ, 2000, ACTA NEUROPATHOL, V99, P643, DOI 10.1007/s004010051175; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SEILHEAN D, 1993, NEUROLOGY, V43, P1492, DOI 10.1212/WNL.43.8.1492; Shen QJ, 2009, J NEUROSCI RES, V87, P3153, DOI 10.1002/jnr.22136; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhu DM, 2004, NEUROTOX RES, V6, P281, DOI 10.1007/BF03033438	69	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25994	10.1371/journal.pone.0025994	http://dx.doi.org/10.1371/journal.pone.0025994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016798	Green Submitted, gold, Green Published			2022-12-25	WOS:000295970300046
J	Gao, JB; Hu, J; Mao, X; Zhou, M; Gurbaxani, B; Lin, J				Gao, Jianbo; Hu, Jing; Mao, Xiang; Zhou, Mi; Gurbaxani, Brian; Lin, Johnny			Entropies of Negative Incomes, Pareto-Distributed Loss, and Financial Crises	PLOS ONE			English	Article							SOCIAL PHASE-TRANSITIONS; LAW; ECONOMICS; MARKETS	Health monitoring of world economy is an important issue, especially in a time of profound economic difficulty world-wide. The most important aspect of health monitoring is to accurately predict economic downturns. To gain insights into how economic crises develop, we present two metrics, positive and negative income entropy and distribution analysis, to analyze the collective "spatial'' and temporal dynamics of companies in nine sectors of the world economy over a 19 year period from 1990-2008. These metrics provide accurate predictive skill with a very low false-positive rate in predicting downturns. The new metrics also provide evidence of phase transition-like behavior prior to the onset of recessions. Such a transition occurs when negative pretax incomes prior to or during economic recessions transition from a thin-tailed exponential distribution to the higher entropy Pareto distribution, and develop even heavier tails than those of the positive pretax incomes. These features propagate from the crisis initiating sector of the economy to other sectors.	[Gao, Jianbo] PMB Intelligence LLC, W Lafayette, IN 47996 USA; [Gao, Jianbo] Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China; [Gao, Jianbo] Wright State Univ, Dayton, OH 45435 USA; [Hu, Jing] Affymetrix Inc, Santa Clara, CA USA; [Mao, Xiang] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL USA; [Zhou, Mi] Univ Florida, Fredric G Levin Coll Law, Gainesville, FL USA; [Gurbaxani, Brian] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Lin, Johnny] N Pk Univ, Dept Phys, Chicago, IL USA	Chinese Academy of Sciences; Institute of Mechanics, CAS; University System of Ohio; Wright State University Dayton; Affymetrix; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology	Gao, JB (corresponding author), PMB Intelligence LLC, W Lafayette, IN 47996 USA.	jbgao@pmbintelligence.com			State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China; Directorate For Engineering [1031958] Funding Source: National Science Foundation	State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is partially supported by the State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; AZIZ J, 2000, 67 IMF; Cover TM, 1991, ELEMENTS INFORM THEO; Feynman Richard Phillips, 1969, FEYNMAN LECT PHYS; Furceri D, 2008, APPL ECON LETT, V15, P921, DOI 10.1080/13504850600972261; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gao J., 2007, MULTISCALE ANAL COMP; Hors I, 1997, J EVOL ECON, V7, P355, DOI 10.1007/s001910050048; *INT MON FUND, 1998, FIN CRIS CHAR IND VU, P74; JORGE CL, 2002, REV INT ECON, V10, P53; Kindleberger Charles, 1996, MANIAS PANICS CRASHE; Levy M, 2005, J ECON BEHAV ORGAN, V57, P71, DOI 10.1016/j.jebo.2003.11.013; Levy M, 2008, J ECON DYN CONTROL, V32, P137, DOI 10.1016/j.jedc.2007.01.023; McCauley JL, 2003, PHYSICA A, V329, P199, DOI 10.1016/S0378-4371(03)00591-0; *NAT BUR EC RES, BUS CYCL EXP CONTR; Niemira MP, 2004, INT J FORECASTING, V20, P573, DOI 10.1016/j.ijforecast.2003.09.013; Ozkan-Gunay EN, 2007, J RISK FINANC, V8, P465, DOI 10.1108/15265940710834753; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Plerou V, 2003, NATURE, V421, P130, DOI 10.1038/421130a; Rachev S. T., 2005, FAT TAILED SKEWED AS; Roll R., 1988, FINANC ANAL J, V44, P19; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; UTSU T, 1995, J PHYS EARTH, V43, P1, DOI 10.4294/jpe1952.43.1; Yeh YH, 2005, J BANK FINANC, V29, P1857, DOI 10.1016/j.jbankfin.2004.07.004	24	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25053	10.1371/journal.pone.0025053	http://dx.doi.org/10.1371/journal.pone.0025053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	22007270	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000009
J	Rygiel, TP; Karnam, G; Goverse, G; van der Marel, APJ; Greuter, MJ; van Schaarenburg, RA; Visser, WF; Brenkman, AB; Molenaar, R; Hoek, RM; Mebius, RE; Meyaard, L				Rygiel, T. P.; Karnam, G.; Goverse, G.; van der Marel, A. P. J.; Greuter, M. J.; van Schaarenburg, R. A.; Visser, W. F.; Brenkman, A. B.; Molenaar, R.; Hoek, R. M.; Mebius, R. E.; Meyaard, L.			CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor	ONCOGENE			English	Article						CD200R; immune regulation; anti-tumor responses; skin carcinogenesis; inhibitory receptors	REGULATORY T-CELLS; PROGNOSTIC-FACTOR; DENDRITIC CELLS; MOUSE SKIN; TH17 CELLS; TGF-BETA; HA-RAS; TOLERANCE; ANTIGEN; CANCER	Expression of CD200, the gene encoding the ligand for the inhibitory immune receptor CD200R, is an independent prognostic factor for various forms of leukemia predicting worse overall survival of the patients. The enhanced expression of CD200 on the tumors implies that anti-tumor responses can be enhanced by blockage of the CD200-CD200R interaction. Indeed, antibody-mediated blockade of the CD200-CD200R inhibitory axis is currently evaluated in clinical tests to boost immune responses against CD200-expressing tumors. Here, we show that mice lacking CD200, the exclusive ligand for CD200R, are resistant to chemical skin carcinogenesis. Importantly, CD200R controls tumor outgrowth independently of CD200 expression by the tumor cells themselves. Furthermore, Cd200(-/-) mice do not become tolerant to intranasally administered antigens, suggesting that tumor rejection is normally suppressed through CD200-induced immune tolerance. Decreased tumor outgrowth is accompanied by increased expression of the proinflammatory cytokines interleukin (IL)-1 beta and IL-6 by the lymph node (LN) dendritic cells. During carcinogenesis, skin-draining LNs of Cd200(-/-) mice contain increased numbers of IL-17-producing FoxP3(+) cells, which preferentially home to the tumors. Thus, the CD200-CD200R axis induces tolerance to external and tumor antigens and influences the T-regulatory/Th17 cell ratio. We demonstrate for the first time that the absence of CD200R signaling inhibits outgrowth of an endogenous tumor irrespective of CD200 expression by the tumor cells. This important paradigm shift leads to a much broader applicability of CD200-blockade in the treatment of tumors.	[Rygiel, T. P.; Karnam, G.; van Schaarenburg, R. A.; Meyaard, L.] Univ Med Ctr Utrecht, Dept Immunol, NL-3584 EA Utrecht, Netherlands; [Goverse, G.; van der Marel, A. P. J.; Greuter, M. J.; Molenaar, R.; Mebius, R. E.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Visser, W. F.; Brenkman, A. B.] Netherlands Metabol Ctr, Utrecht, Netherlands; [Visser, W. F.; Brenkman, A. B.] Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Hoek, R. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Meyaard, L (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lundlaan 6,Room KC02-085-2, NL-3584 EA Utrecht, Netherlands.	l.meyaard@umcutrecht.nl		Rygiel, Tomasz/0000-0003-4746-6505; Meyaard, Linde/0000-0003-0707-4793; Mebius, Reina/0000-0003-0451-7464	Association for International Cancer Research [AICR 07-0086]; VICI [918.56.612]; Netherlands Organization for Scientific Research	Association for International Cancer Research; VICI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank Gerrit Spierenburg for cell sorting, Serge van de Pavert for assistance with the confocal microscope and Lewis Lanier, Frank Miedema, Berent Prakken and Erik Hack for critical review of versions of this manuscript. This research was supported by the Association for International Cancer Research (AICR 07-0086) to LM and TPR and by a VICI grant (918.56.612) (from the Netherlands Organization for Scientific Research) to REM, MJG and RM.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Finch JS, 1996, CARCINOGENESIS, V17, P2551, DOI 10.1093/carcin/17.12.2551; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gorczynski RM, 1999, J IMMUNOL, V163, P1654; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Min WP, 2003, J IMMUNOL, V170, P1304, DOI 10.4049/jimmunol.170.3.1304; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Pallasch CP, 2009, LEUKEMIA RES, V33, P460, DOI 10.1016/j.leukres.2008.08.021; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Ralph C, 2010, CLIN CANCER RES, V16, P1662, DOI 10.1158/1078-0432.CCR-09-2870; Rijkers ESK, 2008, MOL IMMUNOL, V45, P1126, DOI 10.1016/j.molimm.2007.07.013; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Siva A, 2008, CANCER IMMUNOL IMMUN, V57, P987, DOI 10.1007/s00262-007-0429-6; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Taylor N, 2005, J IMMUNOL, V174, P143, DOI 10.4049/jimmunol.174.1.143; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Unger WWJ, 2003, J IMMUNOL, V171, P4592, DOI 10.4049/jimmunol.171.9.4592; Unger WWJ, 2003, INT IMMUNOL, V15, P731, DOI 10.1093/intimm/dxg069; van der Marel APJ, 2007, J IMMUNOL, V179, P894, DOI 10.4049/jimmunol.179.2.894; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wilke CM, 2011, CARCINOGENESIS, V32, P643, DOI 10.1093/carcin/bgr019; Wolvers DAW, 1997, IMMUNOLOGY, V92, P328, DOI 10.1046/j.1365-2567.1997.00356.x; Wong KK, 2010, J LEUKOCYTE BIOL, V88, P361, DOI 10.1189/jlb.1009686; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	44	53	53	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					2979	2988		10.1038/onc.2011.477	http://dx.doi.org/10.1038/onc.2011.477			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22020332				2022-12-25	WOS:000305388400007
J	Zhou, AD; Diao, LT; Xu, H; Xiao, ZD; Li, JH; Zhou, H; Qu, LH				Zhou, A-D; Diao, L-T; Xu, H.; Xiao, Z-D; Li, J-H; Zhou, H.; Qu, L-H			beta-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/beta-catenin-signaling pathway	ONCOGENE			English	Article						miR-372&373; Wnt/beta-catenin; LEF1; DKK1; feedback loop	EMBRYONIC STEM-CELLS; COLORECTAL-CANCER; BETA-CATENIN; EPIGENETIC INACTIVATION; NEGATIVE REGULATOR; COLON-CANCER; C-MYC; GENE; MICRORNAS; TARGET	The microRNA-371-373 (miR-371-373) cluster is specifically expressed in human embryonic stem cells (ESCs) and is thought to be involved in stem cell maintenance. Recently, microRNAs (miRNAs) of this cluster were shown to be frequently upregulated in several human tumors. However, the regulatory mechanism for the involvement of the miR-371-373 cluster in human ESCs or cancer cells remains unclear. In this study, we explored the relationship between this miRNA cluster and the Wnt/beta-catenin-signaling pathway, which has been shown to be involved in both stem cell maintenance and tumorigenesis. We show that miR-371-373 expression is induced by lithium chloride and is positively correlated with Wnt/beta-catenin-signaling activity in several human cancer cell lines. Mechanistically, three TCF/LEF1-binding elements (TBEs) were identified in the promoter region and shown to be required for Wnt-dependent activation of miR-371-373. Interestingly, we also found that miR-372&373, in turn, activate Wnt/beta-catenin signaling. In addition, four protein genes related to the Wnt/beta-catenin-signaling pathway were identified as direct targets of miR-372&373, including Dickkopf-1 (DKK1), a well-known inhibitor of Wnt/beta-catenin signaling. Using a lentiviral system, we showed that overexpression of miR-372 or miR-373 promotes cell growth and the invasive activity of tumor cells as knockdown of DKK1. Taken together, our study demonstrates a novel beta-catenin/LEF1-miR-372&373-DKK1 regulatory feedback loop, which may have a critical role in regulating the activity of Wnt/beta-catenin signaling in human cancer cells.	[Zhou, A-D; Diao, L-T; Xu, H.; Xiao, Z-D; Li, J-H; Zhou, H.; Qu, L-H] Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Qu, LH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ, 135 Xingangxi Rd, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	Li, Junhao/AAI-2570-2019	Li, Junhao/0000-0001-6784-3780; Zhou, Hui/0000-0001-9157-3792; Zhou, Aidong/0000-0001-8389-9522; Xu, Hui/0000-0003-3424-1219	National Natural Science Foundation of China [30830066, 81070589, 30870530]; Ministry of Science and Technology of China [2011CB811300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank Professor Mitsuyasu Kato at the University of Tsukuba for providing the pCAGGS-HA-LEF1 plasmid and Professor Mengfeng Li at the Second Affiliated Hospital of Sun Yat-Sen University for providing the Topflash/Fopflash plasmids. This work was supported by grants from the National Natural Science Foundation of China (30830066, 81070589 and 30870530) and the National Basic Research Program from the Ministry of Science and Technology of China (2011CB811300).	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818	39	113	124	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					2968	2978		10.1038/onc.2011.461	http://dx.doi.org/10.1038/onc.2011.461			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	22020335				2022-12-25	WOS:000305388400006
J	Chang, CL; Wang, HS; Soong, YK; Huang, SY; Pai, SY; Hsu, SYT				Chang, Chia Lin; Wang, Hsin-Shih; Soong, Yung-Kuei; Huang, Shang Yu; Pai, Shun Yuan; Hsu, Sheau Yu Teddy			Regulation of Oocyte and Cumulus Cell Interactions by Intermedin/Adrenomedullin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; OVARIAN FOLLICULAR DEVELOPMENT; EXPANSION-ENABLING FACTOR; PREANTRAL GRANULOSA-CELL; RECEPTOR-LIKE-RECEPTOR; GENE-EXPRESSION; MOUSE OOCYTES; IN-VITRO; MICE LACKING; INTERCELLULAR COMMUNICATION	Ovarian folliculogenesis has been studied as a model of hormonal regulation of development and differentiation, cell death, and cell-cell communication. In addition to gonadotropins from the pituitary and follicular paracrine factors, oocyte secreted factors have been shown to play critical roles in the regulation of follicular cell functions. Except for the well characterized BMP family proteins, including GDF9 and BMP15, oocytes are known to secrete oocyte secreted factors that are important for the regulation of cumulus cell survival and the maintenance of tertiary structure of cumulus cell-enclosed oocyte complexes (COCs). Based on genomic screening and studies of COCs cultured in vitro, we showed that intermedin (IMD)/adrenomedullin 2 (ADM2) is a novel oocyte-derived ligand important for the regulation of cell interactions in COCs that functions, in part, by suppressing cumulus cell apoptosis. Consistently, we showed that suppression of IMD/ADM2 signaling in growing rat ovaries in vivo leads to oocyte atresia and aberrant cell cycle progression in follicular cells. Together, our studies indicated that mammalian oocytes deploy a G protein-coupled receptor ligand to coordinate normal interactions of oocytes and cumulus cells and provided a better understanding of how the tertiary structure of a COC is maintained as follicles undergo exponential growth during the late stages of folliculogenesis.	[Chang, Chia Lin; Wang, Hsin-Shih; Soong, Yung-Kuei; Huang, Shang Yu; Pai, Shun Yuan] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Sch Med,Dept Obstet & Gynecol, Tao Yuan 333, Taiwan; [Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA	Chang Gung Memorial Hospital; Chang Gung University; Stanford University	Chang, CL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Sch Med,Dept Obstet & Gynecol, 5 Fu Shin St, Tao Yuan 333, Taiwan.	amego@cgmh.org.tw; relaxinangel@gmail.com			National Institutes of Health [DK70652]; Avon Foundation [02-2009-054]; New Century Health Care Promotion Foundation, Taiwan [NCHCPF-94001]; Chang Gung Memorial Hospital [CMRPG34002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; New Century Health Care Promotion Foundation, Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK70652 (to S. Y. T. H.). This work was also supported by Avon Foundation Research Award 02-2009-054 (to S. Y. T. H.), New Century Health Care Promotion Foundation, Taiwan, Grant NCHCPF-94001 (to C. L. C.), and Chang Gung Memorial Hospital Grant CMRPG34002 (to C. L. C.).	ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; BACHVAROVA R, 1980, J EXP ZOOL, V211, P159, DOI 10.1002/jez.1402110206; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Byskov AG, 1997, MOL REPROD DEV, V46, P296, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;296::AID-MRD8&gt;3.0.CO;2-K; Canipari R, 2000, HUM REPROD UPDATE, V6, P279, DOI 10.1093/humupd/6.3.279; Chang CL, 2005, MOL ENDOCRINOL, V19, P2824, DOI 10.1210/me.2004-0191; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; De A, 2006, MOL ENDOCRINOL, V20, P2528, DOI 10.1210/me.2006-0028; Diaz FJ, 2007, DEV BIOL, V305, P300, DOI 10.1016/j.ydbio.2007.02.019; Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; GWATKIN RBL, 1976, LIFE SCI, V19, P527, DOI 10.1016/0024-3205(76)90232-0; HERLANDS RL, 1984, J EXP ZOOL, V229, P317, DOI 10.1002/jez.1402290217; HERNANDEZ ER, 1990, ENDOCRINOLOGY, V127, P2804, DOI 10.1210/endo-127-6-2804; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; HILLENSJO T, 1976, ACTA PHYSIOL SCAND, V96, P558, DOI 10.1111/j.1748-1716.1976.tb10226.x; Hsueh AJW, 1996, RECENT PROG HORM RES, V51, P433; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee E, 1997, ENDOCRINOLOGY, V138, P2417, DOI 10.1210/en.138.6.2417; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MILLER WA, 1973, FERTIL STERIL, V24, P609; MOOR RM, 1977, J REPROD FERTIL, V49, P101, DOI 10.1530/jrf.0.0490101; Neulen J, 1998, MOL HUM REPROD, V4, P203, DOI 10.1093/molehr/4.3.203; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pangas SA, 2005, BIOL REPROD, V73, P582, DOI 10.1095/biolreprod.105.042127; Pangas SA, 2007, MOL ENDOCRINOL, V21, P2458, DOI 10.1210/me.2007-0146; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Roberts AE, 2007, BIOL REPROD, V76, P218, DOI 10.1095/biolreprod.106.050880; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Smith RS, 2009, AM J PHYSIOL-HEART C, V297, pH1040, DOI 10.1152/ajpheart.00404.2009; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Thibault C., 1973, The regulation of mammalian reproduction., P231; THIBAULT C, 1975, J REPROD FERTIL, V45, P605, DOI 10.1530/jrf.0.0450605; THIBAULT C, 1977, J REPROD FERTIL, V51, P1; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; TSAFRIRI A, 1972, J REPROD FERTIL, V31, P39, DOI 10.1530/jrf.0.0310039; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; WIESEN JF, 1993, ENDOCRINOLOGY, V133, P741, DOI 10.1210/en.133.2.741; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103; ZACHOW RJ, 1993, ENDOCRINOLOGY, V133, P2269, DOI 10.1210/en.133.5.2269; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	81	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43193	43203		10.1074/jbc.M111.297358	http://dx.doi.org/10.1074/jbc.M111.297358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009752	Green Published, hybrid			2022-12-25	WOS:000298351300040
J	Dong, CM; Li, CM; Wu, GY				Dong, Chunmin; Li, Chunman; Wu, Guangyu			Regulation of alpha(2B)-Adrenergic Receptor-mediated Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Activation by ADP-ribosylation Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPASE-D; ENDOPLASMIC-RETICULUM; ALPHA(2)-ADRENERGIC RECEPTORS; ANGIOTENSIN-II; 7-TRANSMEMBRANE RECEPTORS; ANTEROGRADE TRANSPORT; ADRENERGIC-RECEPTORS; GOLGI-COMPLEX; CELL-SURFACE	A number of signaling molecules are involved in the activation of the mitogen-activated protein kinase (MAPK) pathway by G protein-coupled receptors. In this study, we have demonstrated that alpha(2B)-adrenergic receptor (alpha(2B)-AR) interacts with ADP-ribosylation factor 1 (ARF1), a small GTPase involved in vesicle-mediated trafficking, in an agonist activation-dependent manner and that the interaction is mediated through a unique double Trp motif in the third intracellular loop of the receptor. Interestingly, mutation of the double Trp motif and siRNA-mediated depletion of ARF1 attenuate alpha(2B)-AR-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) without altering receptor intracellular trafficking, whereas expression of the constitutively active mutant ARF1Q71L and ARNO, a GDP-GTP exchange factor of ARF1, markedly enhances the activation of Raf1, MEK1, and ERK1/2. These data strongly demonstrate that the small GTPase ARF1 modulates ERK1/2 activation by alpha(2B)-AR and provide the first evidence indicating a novel function for ARF1 in regulating the MAPK signaling pathway.	[Li, Chunman; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Dong, Chunmin; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	guwu@georgiahealth.edu			National Institutes of Health [R01GM076167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM076167 (to G. W.).	BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Cussac D, 2002, J BIOL CHEM, V277, P19882, DOI 10.1074/jbc.M110142200; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Robertson DN, 2003, MOL PHARMACOL, V64, P1239, DOI 10.1124/mol.64.5.1239; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wade SM, 1996, MOL PHARMACOL, V50, P351; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21	52	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43361	43369		10.1074/jbc.M111.267286	http://dx.doi.org/10.1074/jbc.M111.267286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025613	Green Published, hybrid			2022-12-25	WOS:000298351300056
J	Shirakabe, K; Hattori, S; Seiki, M; Koyasu, S; Okada, Y				Shirakabe, Kyoko; Hattori, Seisuke; Seiki, Motoharu; Koyasu, Shigeo; Okada, Yasunori			VIP36 Protein Is a Target of Ectodomain Shedding and Regulates Phagocytosis in Macrophage Raw 264.7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; SUGAR-BINDING-ACTIVITY; MEMBRANE-PROTEIN; MDCK CELLS; ERGIC-53; RECEPTOR; LECTINS; GLYCOPROTEINS; TRANSPORT; GLYCANS	Ectodomain shedding is a posttranslational modification mechanism, which liberates extracellular domains of membrane proteins through juxtamembrane processing executed mainly by the ADAM (a disintegrin and metalloprotease) family of metalloproteases. Shedding is a unique and effective mechanism for inducing multifaceted effects through the soluble extracellular domains released and/or the remaining membrane-bound portions; however, the physiological functions of shedding are not yet fully understood. In this study, we performed unbiased proteomic screening for shedding targets in a lipopolysaccharide (LPS)-stimulated macrophage cell line to elucidate a new immunological function of shedding. We identified VIP36 (36-kDa vesicular integral membrane protein), a lectin domain-containing transmembrane protein postulated as a cargo receptor for Golgi-to-endoplasmic reticulum transport, as a new target for shedding and found that the shedding of VIP36 occurs mainly on the cell surface. In addition, we demonstrate that the amount of VIP36 precisely regulates phagocytosis in macrophages and that the shedding of VIP36 is required for this regulation. These results substantially expand our knowledge of the immunological and cell biological functions of both the shedding process and VIP36 itself.	[Shirakabe, Kyoko] Keio Univ Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Koyasu, Shigeo] Keio Univ Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yasunori] Keio Univ Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Shirakabe, Kyoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, Tokyo 1088641, Japan; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST); Kitasato University; University of Tokyo	Shirakabe, K (corresponding author), Keio Univ Sch Med, Ctr Integrated Med Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kshira@z8.keio.jp	Okada, Yasunori/B-5550-2014; Koyasu, Shigeo/J-5583-2015; Seiki, Motoharu/K-9443-2015	Okada, Yasunori/0000-0001-9208-4755; Koyasu, Shigeo/0000-0001-9585-3038; 	Japan Society for the Promotion of Science [21790328, 19109004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Young Scientists (B) 21790328 (to K. S.) and Grant-in-aid for Scientific Research (S) 19109004 (to Y. O.) from the Japan Society for the Promotion of Science. S. K. is a consultant for Medical and Biological Laboratories, Co. Ltd.	Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Hood BL, 2005, J PROTEOME RES, V4, P1561, DOI 10.1021/pr050107r; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kawasaki N, 2007, J BIOCHEM, V141, P221, DOI 10.1093/jh/mvm024; LEEUWENBERG JFM, 1994, J IMMUNOL, V152, P5070; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Yamaguchi D, 2007, GLYCOBIOLOGY, V17, P1061, DOI 10.1093/glycob/cwm074	27	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43154	43163		10.1074/jbc.M111.275586	http://dx.doi.org/10.1074/jbc.M111.275586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016386	Green Published, hybrid			2022-12-25	WOS:000298351300036
J	Beckmann, S; Hahnel, S; Cailliau, K; Vanderstraete, M; Browaeys, E; Dissous, C; Grevelding, CG				Beckmann, Svenja; Hahnel, Steffen; Cailliau, Katia; Vanderstraete, Mathieu; Browaeys, Edith; Dissous, Colette; Grevelding, Christoph G.			Characterization of the Src/Abl Hybrid Kinase SmTK6 of Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MALE-FEMALE INTERACTION; GROWTH-FACTOR RECEPTOR; REPRODUCTIVE-ORGANS; SIGNAL-TRANSDUCTION; C-ABL; FAMILY; IMATINIB; DOMAINS; IDENTIFICATION	Cellular protein-tyrosine kinases play key roles in signal transduction processes in eukaryotes. SmTK4 was the first Syk kinase identified in a parasite and found to be tissue-specifically transcribed in the gonads of adult Schistosoma mansoni. Functional analyses confirmed its role in oogenesis and spermatogenesis. As an SmTK4 upstream binding partner, the cellular protein-tyrosine kinase SmTK6 was isolated from a yeast two-hybrid library. Phylogenetic analyses performed in this study confirmed the first suggestions of a hybrid character of SmTK6. Biochemical studies made in Xenopus oocytes using inhibitors against Src (herbimycin A) and Abl (imatinib) kinases exhibited a biochemical inhibition profile of SmTK6, which was intermediate of Src and Abl kinases. As SmTK6 upstream interaction partners, we identified among others the known Src kinase SmTK3 and the Venus kinase receptor SmVKR1 of S. mansoni by yeast two-hybrid analyses, all of which co-localized in the gonads. Co-immunoprecipitation experiments confirmed interactions between SmTK6 and SmTK3 or SmVKR1. In Xenopus oocytes, it was finally shown that SmVKR1 but also SmTK3 were able to activate SmTK6 enzymatic activity indicating its functions in a receptor tyrosine kinase signal transduction cascade. These results not only demonstrate an intermediate but Src-biased profile of the unusual kinase SmTK6. They also strongly substantiate previous indications for a kinase complex, consisting of a receptor tyrosine kinase, Syk and Src kinases, which has been hypothesized to be involved in proliferation and differentiation processes in the gonads of schistosomes.	[Beckmann, Svenja; Hahnel, Steffen; Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, D-35392 Giessen, Germany; [Vanderstraete, Mathieu; Dissous, Colette] Inst Pasteur, CNRS UMR 8204, Inserm U1019, Ctr Infect & Immun Lille, F-59019 Lille, France; [Cailliau, Katia; Browaeys, Edith] Univ Lille 1 Sci & Technol, EA 4479, IFR 147, F-59655 Villeneuve Dascq, France	Justus Liebig University Giessen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Grevelding, CG (corresponding author), Univ Giessen, Inst Parasitol, Rudolf Buchheimstr 2, D-35392 Giessen, Germany.	Christoph.Grevelding@vetmed.uni-giessen.de		Dissous, Colette/0000-0002-5003-8205; Cailliau, Katia/0000-0001-7993-8437; cailliau, katia/0000-0003-1772-1034	Deutsche Forschungsgemeinschaft [GR1549/8-2]; Bill and Melinda Gates Foundation through the Grand Challenges Exploration Initiative [OPP1024324]; INSERM; CNRS; Universite de Lille 1-Lille 2; H.-J. and G. Engemann Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bill and Melinda Gates Foundation through the Grand Challenges Exploration Initiative; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lille 1-Lille 2; H.-J. and G. Engemann Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant GR1549/8-2, Bill and Melinda Gates Foundation Grant OPP1024324 through the Grand Challenges Exploration Initiative, by INSERM, CNRS, Universite de Lille 1-Lille 2, and by the H.-J. and G. Engemann Foundation (to S. H.).	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Baumgartner M, 2009, EXP CELL RES, V315, P2888, DOI 10.1016/j.yexcr.2009.07.028; Beckmann S, 2010, INT J PARASITOL, V40, P521, DOI 10.1016/j.ijpara.2010.01.007; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Dissous C, 2011, TRENDS PARASITOL, V27, P59, DOI 10.1016/j.pt.2010.09.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; GOUIGNARD N, 2011, EXP PARASIT IN PRESS; Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006; GREVELDING CG, 1995, MOL BIOCHEM PARASIT, V71, P269, DOI 10.1016/0166-6851(94)00058-U; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kapp K, 2001, PARASITOLOGY, V122, P317, DOI 10.1017/S0031182001007430; Knobloch J, 2002, GENE, V294, P87, DOI 10.1016/S0378-1119(02)00760-6; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Knobloch J, 2006, INT J PARASITOL, V36, P1261, DOI 10.1016/j.ijpara.2006.06.004; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Q, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-60; Long T, 2010, INT J PARASITOL, V40, P1075, DOI 10.1016/j.ijpara.2010.03.002; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Nagar B, 2002, CANCER RES, V62, P4236; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; OVERDUIN M, 1992, P NATL ACAD SCI USA, V89, P11673, DOI 10.1073/pnas.89.24.11673; Quack T, 2006, BERL MUNCH TIERARZTL, V119, P365; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Stothard JR, 2009, PARASITOLOGY, V136, P1665, DOI 10.1017/S0031182009991272; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Yan Y, 2007, INT J PARASITOL, V37, P1539, DOI 10.1016/j.ijpara.2007.06.001	53	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42325	42336		10.1074/jbc.M110.210336	http://dx.doi.org/10.1074/jbc.M110.210336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013071	hybrid, Green Published			2022-12-25	WOS:000298180900042
J	Blahna, MT; Jones, MR; Quinton, LJ; Matsuura, KY; Mizgerd, JP				Blahna, Matthew T.; Jones, Matthew R.; Quinton, Lee J.; Matsuura, Kori Y.; Mizgerd, Joseph P.			Terminal Uridyltransferase Enzyme Zcchc11 Promotes Cell Proliferation Independent of Its Uridyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; PROTEIN; RNA; TUMORIGENESIS; CARCINOMA; FAMILY; GROWTH; CID1	Zcchc11 is a uridyltransferase protein with enzymatic activity directed against diverse RNA species. On the basis of its known uridylation targets, we hypothesized that Zcchc11 might regulate cell proliferation. Confirming this, loss-of-function and complementary gain-of-function experiments consistently revealed that Zcchc11 promotes the transition from G(1) to S phase of the cell cycle. This activity takes place through both Rb-dependent and Rb-independent mechanisms by promoting the expression of multiple G(1)-associated proteins, including cyclins D-1 and A and CDK4. Surprisingly, a Zcchc11 construct with point mutations inactivating the uridyltransferase domain enhanced cell proliferation as effectively as wild-type Zcchc11. Furthermore, truncated mutant constructs revealed that the cell cycle effects of Zcchc11 were driven by the N-terminal region of the protein that lacks the RNA-binding domains and uridyltransferase activity of the full protein. Therefore, the N-terminal portion of Zcchc11, which lacks nucleotidyltransferase capabilities, is biologically active and mediates a previously unrecognized role for Zcchc11 in facilitating cell proliferation.	[Blahna, Matthew T.; Jones, Matthew R.; Quinton, Lee J.; Matsuura, Kori Y.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Blahna, Matthew T.] Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Mizgerd, JP (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St, Boston, MA 02118 USA.	jmizgerd@bu.edu	Blahna, Matthew T/F-3172-2013; Mizgerd, Joseph/GRY-6369-2022	Jones, Matthew/0000-0003-4647-2962; Mizgerd, Joseph/0000-0002-4042-3169; Quinton, Lee/0000-0003-1938-2507	National Institutes of Health [R01 HL079392, R01 HL068153, R01 HL104053, R00 HL092956, T32 HL007035, T90 DK070078]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092956, T32HL007035, R01HL079392, R01HL068153, R01HL104053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079392 and R01 HL068153 (to J. P. M.), R01 HL104053 (to M. R. J.), R00 HL092956 (to L. J. Q.), and T32 HL007035 and T90 DK070078 (to M. T. B.).	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; CARNEY DN, 1981, P NATL ACAD SCI-BIOL, V78, P3185, DOI 10.1073/pnas.78.5.3185; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129	29	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42381	42389		10.1074/jbc.M111.259689	http://dx.doi.org/10.1074/jbc.M111.259689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006926	Green Published, hybrid			2022-12-25	WOS:000298180900047
J	Ghosh, S; Sulistyoningrum, DC; Glier, MB; Verchere, CB; Devlin, AM				Ghosh, Sanjoy; Sulistyoningrum, Dian C.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.			Altered Glutathione Homeostasis in Heart Augments Cardiac Lipotoxicity Associated with Diet-induced Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; KAPPA-B ACTIVITY; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; HOMOCYSTEINE METABOLISM; MITOCHONDRIAL DAMAGE; LIPID-METABOLISM; FATTY-ACIDS; CYSTEINE; DISEASE	Obesity-related cardiac lipid accumulation is associated with increased myocardial oxidative stress. The role of the antioxidant glutathione in cardiac lipotoxicity is unclear. Cystathionine beta-synthase (Cbs) catalyzes the first step in the trans-sulfuration of homocysteine to cysteine, which is estimated to provide similar to 50% of cysteine for hepatic glutathione biosynthesis. As cardiac glutathione is a reflection of the liver glutathione pool, we hypothesize that mice heterozygous for targeted disruption of Cbs (Cbs(+/-)) are more susceptible to obesity-related cardiolipotoxicity because of impaired liver glutathione synthesis. Cbs(+/+) and Cbs(+/-) mice were fed a high fat diet (60% energy) from weaning for 13 weeks to induce obesity and had similar increases in body weight and body fat. This was accompanied by increased hepatic triglyceride but no differences in hepatic glutathione levels compared with mice fed chow. However, Cbs(+/-) mice with diet-induced obesity had greater glucose intolerance and lower total and reduced glutathione levels in the heart, accompanied by lower plasma cysteine levels compared with Cbs(+/+) mice. Higher triglyceride concentrations, increased oxidative stress, and increased markers of apoptosis were also observed in heart from Cbs(+/-) mice with diet-induced obesity compared with Cbs(+/+) mice. This study suggests a novel role for Cbs in maintaining the cardiac glutathione pool and protecting against cardiac lipid accumulation and oxidative stress during diet-induced obesity in mice.	[Devlin, Angela M.] Univ British Columbia, Dept Paediat, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Ghosh, Sanjoy; Sulistyoningrum, Dian C.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pathol & Lab Med, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Devlin, AM (corresponding author), Univ British Columbia, Dept Paediat, Child & Family Res Inst, 272-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	adevlin@cfri.ubc.ca		Verchere, Cameron Bruce/0000-0002-9262-0586; Glier, Melissa/0000-0003-3723-3177; Devlin, Angela/0000-0002-1390-6587	Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to A. M. D.) and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to A. M. D.).; Supported by postdoctoral fellowships from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.; Supported by a New Investigator award from the Heart and Stroke Foundation of Canada.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Antunes F, 2002, FREE RADICAL BIO MED, V33, P1260, DOI 10.1016/S0891-5849(02)01016-X; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Aronis A, 2005, FREE RADICAL BIO MED, V38, P1221, DOI 10.1016/j.freeradbiomed.2005.01.015; Baron V, 1999, BBA-GEN SUBJECTS, V1472, P173, DOI 10.1016/S0304-4165(99)00118-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cabrero A, 2003, J LIPID RES, V44, P388, DOI 10.1194/jlr.M200294-JLR200; CECONI C, 1988, J MOL CELL CARDIOL, V20, P5, DOI 10.1016/S0022-2828(88)80174-3; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; De Mattia G, 1998, DIABETOLOGIA, V41, P1392, DOI 10.1007/s001250051082; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friesen RW, 2007, J NUTR, V137, P2641; Ghosh S, 2005, AM J PHYSIOL-HEART C, V289, pH768, DOI 10.1152/ajpheart.00038.2005; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Innis SM, 2002, J LIPID RES, V43, P1529, DOI 10.1194/jlr.M200120-JLR200; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; Lin CC, 2004, LIPIDS, V39, P843, DOI 10.1007/s11745-004-1305-4; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Lu SC, 1999, HEPATOLOGY, V30, P209, DOI 10.1002/hep.510300134; Malmezat T, 2000, J NUTR, V130, P1239, DOI 10.1093/jn/130.5.1239; Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Pechanova O, 2010, J HYPERTENS, V28, pS39, DOI 10.1097/01.hjh.0000388493.81578.b1; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900; *SUBC LAB AN NUTR, 1995, NUTR REQ LAB AN, P80; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Vincent BRD, 1999, EUR J BIOCHEM, V262, P873, DOI 10.1046/j.1432-1327.1999.00449.x; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; WANG J, 1992, ATHEROSCLEROSIS, V97, P97, DOI 10.1016/0021-9150(92)90055-L; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	47	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42483	42493		10.1074/jbc.M111.304592	http://dx.doi.org/10.1074/jbc.M111.304592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22021075	hybrid, Green Published			2022-12-25	WOS:000298180900056
J	Boehler, CN; Appelbaum, LG; Krebs, RM; Chen, LC; Woldorff, MG				Boehler, Carsten N.; Appelbaum, Lawrence G.; Krebs, Ruth M.; Chen, Ling-Chia; Woldorff, Marty G.			The Role of Stimulus Salience and Attentional Capture Across the Neural Hierarchy in a Stop-Signal Task	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; EVENT-RELATED FMRI; RESPONSE-INHIBITION; COGNITIVE CONTROL; DEFICIT/HYPERACTIVITY DISORDER; FRONTOPARIETAL NETWORK; ANTERIOR INSULA; FUNCTIONAL MRI; PERFORMANCE; CORTEX	Inhibitory motor control is a core function of cognitive control. Evidence from diverse experimental approaches has linked this function to a mostly right-lateralized network of cortical and subcortical areas, wherein a signal from the frontal cortex to the basal ganglia is believed to trigger motor-response cancellation. Recently, however, it has been recognized that in the context of typical motor-control paradigms those processes related to actual response inhibition and those related to the attentional processing of the relevant stimuli are highly interrelated and thus difficult to distinguish. Here, we used fMRI and a modified Stop-signal task to specifically examine the role of perceptual and attentional processes triggered by the different stimuli in such tasks, thus seeking to further distinguish other cognitive processes that may precede or otherwise accompany the implementation of response inhibition. In order to establish which brain areas respond to sensory stimulation differences by rare Stop-stimuli, as well as to the associated attentional capture that these may trigger irrespective of their task-relevance, we compared brain activity evoked by Stop-trials to that evoked by Go-trials in task blocks where Stop-stimuli were to be ignored. In addition, region-of-interest analyses comparing the responses to these task-irrelevant Stop-trials, with those to typical relevant Stop-trials, identified separable activity profiles as a function of the task-relevance of the Stop-signal. While occipital areas were mostly blind to the task-relevance of Stop-stimuli, activity in temporo-parietal areas dissociated between task-irrelevant and task-relevant ones. Activity profiles in frontal areas, in turn, were activated mainly by task-relevant Stop-trials, presumably reflecting a combination of triggered top-down attentional influences and inhibitory motor-control processes.	[Boehler, Carsten N.; Appelbaum, Lawrence G.; Krebs, Ruth M.; Chen, Ling-Chia; Woldorff, Marty G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Boehler, Carsten N.; Krebs, Ruth M.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Woldorff, Marty G.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA	Duke University; Ghent University; Duke University	Boehler, CN (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	c.n.boehler@gmail.com	Chen, Ling-Chia/K-3686-2019; Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Appelbaum, Lawrence/0000-0002-3184-6725; Woldorff, Marty/0000-0002-2683-4551; Chen, Ling-Chia/0000-0001-5782-6047	NIH [R01-MH060415, R01-NS051048]; Deutsche Forschungsgemeinschaft [BO 3345/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants R01-MH060415 and R01-NS051048 to M. G. W. and funds from the Deutsche Forschungsgemeinschaft (BO 3345/1-1) to C.N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2009, NEUROSCI BIOBEHAV R, V33, P611, DOI 10.1016/j.neubiorev.2008.10.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; ARON AR, 2011, BIOL PSYCHI IN PRESS; Bekker EM, 2005, ARCH GEN PSYCHIAT, V62, P1129, DOI 10.1001/archpsyc.62.10.1129; Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Boehler CN, 2009, CEREB CORTEX, V19, P134, DOI 10.1093/cercor/bhn063; Boehler CN, 2011, J COGNITIVE NEUROSCI, V23, P362, DOI 10.1162/jocn.2010.21473; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Burnham BR, 2010, J EXP PSYCHOL HUMAN, V36, P317, DOI 10.1037/a0015871; Cai WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020840; Cai WD, 2009, BRAIN RES, V1261, P20, DOI 10.1016/j.brainres.2008.12.073; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Fenker DB, 2010, J COGNITIVE NEUROSCI, V22, P2926, DOI 10.1162/jocn.2009.21340; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Knyazev GG, 2008, CLIN NEUROPHYSIOL, V119, P556, DOI 10.1016/j.clinph.2007.11.041; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Nakata H, 2008, NEUROIMAGE, V39, P1858, DOI 10.1016/j.neuroimage.2007.10.041; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Overtoom CCE, 2009, BIOL PSYCHIAT, V65, P614, DOI 10.1016/j.biopsych.2008.10.048; Padmala S, 2010, COGN AFFECT BEHAV NE, V10, P279, DOI 10.3758/CABN.10.2.279; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220	57	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26386	10.1371/journal.pone.0026386	http://dx.doi.org/10.1371/journal.pone.0026386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022611	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400053
J	Ehlken, H; Kondylis, V; Heinrichsdorff, J; Ochoa-Callejero, L; Roskams, T; Pasparakis, M				Ehlken, Hanno; Kondylis, Vangelis; Heinrichsdorff, Jan; Ochoa-Callejero, Laura; Roskams, Tania; Pasparakis, Manolis			Hepatocyte IKK2 Protects Mdr2(-/-) Mice from Chronic Liver Failure	PLOS ONE			English	Article							NF-KAPPA-B; MDR2-KNOCKOUT MICE; INDUCED APOPTOSIS; ACTIVATION; FIBROSIS; INFLAMMATION; DISEASE; HEPATOCARCINOGENESIS; CARCINOGENESIS; MECHANISMS	Mice lacking the Abc4 protein encoded by the multidrug resistance-2 gene (Mdr2(-/-)) develop chronic periductular inflammation and cholestatic liver disease resulting in the development of hepatocellular carcinoma (HCC). Inhibition of NF-kappa B by expression of an I kappa B alpha super-repressor (I kappa B alpha SR) transgene in hepatocytes was shown to prevent HCC development in Mdr2(-/-) mice, suggesting that NF-kappa B acts as a tumour promoter in this model of inflammation-associated carcinogenesis. On the other hand, inhibition of NF-kappa B by hepatocyte specific ablation of IKK2 resulted in increased liver tumour development induced by the chemical carcinogen DEN. To address the role of IKK2-mediated NF-kappa B activation in hepatocytes in the pathogenesis of liver disease and HCC in Mdr2(-/-) mice, we generated Mdr2-deficient animals lacking IKK2 specifically in hepatocytes using the Cre-loxP system. Mdr2(-/-) mice lacking IKK2 in hepatocytes developed spontaneously a severe liver disease characterized by cholestasis, major hyperbilirubinemia and severe to end-stage fibrosis, which caused muscle wasting, loss of body weight, lethargy and early spontaneous death. Cell culture experiments showed that primary hepatocytes lacking IKK2 were more sensitive to bile acid induced death, suggesting that hepatocyte-specific IKK2 deficiency sensitized hepatocytes to the toxicity of bile acids under conditions of cholestasis resulting in greatly exacerbated liver damage. Mdr2(-/-) IKK2(Hep-KO) mice remarkably recapitulate chronic liver failure in humans and might be of special importance for the study of the mechanisms contributing to the pathogenesis of end-stage chronic liver disease or its implications on other organs. Conclusion: IKK2-mediated signaling in hepatocytes protects the liver from damage under conditions of chronic inflammatory cholestasis and prevents the development of severe fibrosis and liver failure.	[Ehlken, Hanno; Kondylis, Vangelis; Heinrichsdorff, Jan; Ochoa-Callejero, Laura; Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, Cologne Excellence Cluster Cellular Stress Respon, D-5000 Cologne, Germany; [Roskams, Tania] Catholic Univ Louvain, Dept Pathol, B-3000 Louvain, Belgium	University of Cologne; Universite Catholique Louvain	Ehlken, H (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, Cologne Excellence Cluster Cellular Stress Respon, Weyertal 121, D-5000 Cologne, Germany.	pasparakis@uni-koeln.de	Kondylis, Vangelis/S-6276-2019; Pasparakis, Manolis/H-9292-2017; Ochoa-Callejero, Laura/K-2560-2012; Pasparakis, Manolis/N-4350-2019	Kondylis, Vangelis/0000-0002-6970-8731; Pasparakis, Manolis/0000-0002-9870-0966; Ochoa-Callejero, Laura/0000-0001-5366-6613; Pasparakis, Manolis/0000-0002-9870-0966; Roskams, Tania/0000-0002-2816-1530	European Commission (EC) [223151]	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was funded by European Commission FP7 program grant "INFLA-CARE" (EC contract number 223151) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker S, 2007, CELL PHYSIOL BIOCHEM, V19, P89, DOI 10.1159/000099197; BLAAS L, HEPATOLOGY BALTIMORE, V51, P1319; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kamath PS, 1996, MAYO CLIN PROC, V71, P1089, DOI 10.4065/71.11.1089; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Keasler VV, 2006, VIROLOGY, V347, P466, DOI 10.1016/j.virol.2005.11.050; Klopstock N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005025; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; MAIR M, GASTROENTEROLOGY, V138, P2499; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Miyoshi H, 2001, AM J PATHOL, V158, P967, DOI 10.1016/S0002-9440(10)64043-6; Najimi Mustapha, 2009, V481, P59, DOI 10.1007/978-1-59745-201-4_6; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25942	10.1371/journal.pone.0025942	http://dx.doi.org/10.1371/journal.pone.0025942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022477	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600022
J	Ma, LF; Jiang, Y; Bai, JE; Gong, QY; Liu, HC; Chen, HC; He, S; Weng, XC				Ma, Lifei; Jiang, Yi; Bai, Jian'e; Gong, Qiyong; Liu, Haicheng; Chen, Hsuan-Chih; He, Sheng; Weng, Xuchu			Robust and Task-Independent Spatial Profile of the Visual Word Form Activation in Fusiform Cortex	PLOS ONE			English	Article							AREA; FMRI; SYSTEM; GYRUS; FACE	Written language represents a special category of visual information. There is strong evidence for the existence of a cortical region in ventral occipitotemporal cortex for processing the visual form of written words. However, due to inconsistent findings obtained with different tasks, the level of specialization and selectivity of this so called visual word form area (VWFA) remains debated. In this study, we examined category selectivity for Chinese characters, a non-alphabetic script, in native Chinese readers. In contrast to traditional approaches of examining response levels in a restricted predefined region of interest (ROI), a detailed distribution of the BOLD signal across the mid-fusiform cortical surface and the spatial patterns of responses to Chinese characters were obtained. Results show that a region tuned for Chinese characters could be consistently found in the lateral part of the left fusiform gyrus in Chinese readers, and this spatial pattern of selectivity for written words was not influenced by top-down tasks such as phonological or semantic modulations. These results provide strong support for the robust spatial coding of category selective response in the mid-fusiform cortex, and demonstrate the utility of the spatial distribution analysis as a more meaningful approach to examine functional magnetic resonance imaging (fMRI) data.	[Ma, Lifei; Jiang, Yi; Bai, Jian'e; Liu, Haicheng; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Jiang, Yi; He, Sheng] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Gong, Qiyong] Sichuan Univ, HMRRC, Dept Radiol, W China Hosp, Chengdu 610064, Peoples R China; [Chen, Hsuan-Chih] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Weng, Xuchu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Minnesota System; University of Minnesota Twin Cities; Sichuan University; Chinese University of Hong Kong; Hangzhou Normal University	Ma, LF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	sheng@umn.edu; wengxc@psych.ac.cn	Jiang, Yi/I-1688-2018; Gong, Qiyong/W-3052-2019	Jiang, Yi/0000-0002-5746-7301; Gong, Qiyong/0000-0002-5912-4871	National Natural Science Foundation of China [31070903, 31070905]; National Science Foundation of US [BCS-0818588]; Chinese Ministry of Science and Technology [2007CB512300]; Chinese University of Hong Kong; United States NIH [R01-EY002934, BTRR P41 RR008079, P30 NS057091]; MIND foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY002934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of US(National Science Foundation (NSF)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese University of Hong Kong(Chinese University of Hong Kong); United States NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIND foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Natural Science Foundation of China (31070903 and 31070905); National Science Foundation of US (BCS-0818588); Chinese Ministry of Science and Technology (2007CB512300); a departmental grant from the Chinese University of Hong Kong; United States NIH (R01-EY002934, BTRR P41 RR008079, and P30 NS057091); the MIND foundation. http://www.nsfc.gov.cn/Portal0/default124.htm. http://www.nsf.gov/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Cai Q, 2008, J COGNITIVE NEUROSCI, V20, P672, DOI 10.1162/jocn.2008.20043; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fox CJ, 2008, HUM BRAIN MAPP; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Joseph JE, 2006, NEUROIMAGE, V32, P806, DOI 10.1016/j.neuroimage.2006.04.175; Joseph JE, 2003, COGNITIVE BRAIN RES, V17, P56, DOI 10.1016/S0926-6410(03)00080-6; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Liu JG, 2009, NEUROREPORT, V20, P273, DOI 10.1097/WNR.0b013e32832000f8; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Puce A, 1996, J NEUROSCI, V16, P5205; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Song YY, 2010, BRAIN RES, V1316, P83, DOI 10.1016/j.brainres.2009.11.086; Szwed M, 2011, NEUROIMAGE, V56, P330, DOI 10.1016/j.neuroimage.2011.01.073; Tan LH, 2001, NEUROREPORT, V12, P83, DOI 10.1097/00001756-200101220-00024; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Twomey T, 2011, NEUROIMAGE, V55, P1242, DOI 10.1016/j.neuroimage.2011.01.001; Woodhead ZVJ, 2011, J NEUROSCI, V31, P193, DOI 10.1523/JNEUROSCI.2705-10.2011; Wright ND, 2008, HUM BRAIN MAPP, V29, P986, DOI 10.1002/hbm.20443; Xue G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013204; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129	32	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26310	10.1371/journal.pone.0026310	http://dx.doi.org/10.1371/journal.pone.0026310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022597	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600053
J	Biesmans, L; Macquaide, N; Heinzel, FR; Bito, V; Smith, GL; Sipido, KR				Biesmans, Liesbeth; Macquaide, Niall; Heinzel, Frank R.; Bito, Virginie; Smith, Godfrey L.; Sipido, Karin R.			Subcellular Heterogeneity of Ryanodine Receptor Properties in Ventricular Myocytes with Low T- Tubule Density	PLOS ONE			English	Article							CARDIAC CA2+ SPARKS; SARCOPLASMIC-RETICULUM; SR CA2+; TRANSVERSE TUBULES; CALCIUM-RELEASE; SPATIOTEMPORAL CHARACTERISTICS; REDUCED SYNCHRONY; CONFOCAL IMAGES; NA/CA EXCHANGE; LOCAL CA2+	Rationale: In ventricular myocytes of large mammals, not all ryanodine receptor (RyR) clusters are associated with T-tubules (TTs); this fraction increases with cellular remodeling after myocardial infarction (MI). Objective: To characterize RyR functional properties in relation to TT proximity, at baseline and after MI. Methods: Myocytes were isolated from left ventricle of healthy pigs (CTRL) or from the area adjacent to a myocardial infarction (MI). Ca2+ transients were measured under whole-cell voltage clamp during confocal linescan imaging (fluo-3) and segmented according to proximity of TTs (sites of early Ca2+ release, F > F-50 within 20 ms) or their absence (delayed areas). Spontaneous Ca2+ release events during diastole, Ca2+ sparks, reflecting RyR activity and properties, were subsequently assigned to either category. Results: In CTRL, spark frequency was higher in proximity of TTs, but spark duration was significantly shorter. Block of Na+/Ca2+ exchanger (NCX) prolonged spark duration selectively near TTs, while block of Ca2+ influx via Ca2+ channels did not affect sparks properties. In MI, total spark mass was increased in line with higher SR Ca2+ content. Extremely long sparks (> 47.6 ms) occurred more frequently. The fraction of near-TT sparks was reduced; frequency increased mainly in delayed sites. Increased duration was seen in near-TT sparks only; Ca2+ removal by NCX at the membrane was significantly lower in MI. Conclusion: TT proximity modulates RyR cluster properties resulting in intracellular heterogeneity of diastolic spark activity. Remodeling in the area adjacent to MI differentially affects these RyR subpopulations. Reduction of the number of sparks near TTs and reduced local NCX removal limit cellular Ca2+ loss and raise SR Ca2+ content, but may promote Ca2+ waves.	[Biesmans, Liesbeth; Macquaide, Niall; Heinzel, Frank R.; Bito, Virginie; Sipido, Karin R.] Univ Leuven, Lab Expt Cardiol, Louvain, Belgium; [Macquaide, Niall; Smith, Godfrey L.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Heinzel, Frank R.] Med Univ Graz, Div Cardiol, Graz, Austria	KU Leuven; University of Glasgow; Medical University of Graz	Biesmans, L (corresponding author), Univ Leuven, Lab Expt Cardiol, Louvain, Belgium.	Karin.Sipido@med.kuleuven.be		Bito, Virginie/0000-0003-0986-7906; Macquaide, Niall/0000-0001-9026-0073; Heinzel, Frank R./0000-0002-4529-5282	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Belgian Science Policy program (IUAP) [P6/31]; European Union [LSHM-CT-2005-018833, EUGeneHeart]; EC [FP7/2007-2013, HEALTH-F2-2009-241526]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy program (IUAP); European Union(European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a fellowship to LB by the "Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen),'' and by grants from the Belgian Science Policy program (IUAP, P6/31) and the European Union (LSHM-CT-2005-018833, EUGeneHeart) and from the EC FP7/2007-2013 under grant agreement no HEALTH-F2-2009-241526, EUTrigTreat (to K.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Brette F, 2005, J MOL CELL CARDIOL, V39, P804, DOI 10.1016/j.yjmcc.2005.08.005; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cleemann L, 1998, P NATL ACAD SCI USA, V95, P10984, DOI 10.1073/pnas.95.18.10984; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Despa S, 2003, BIOPHYS J, V85, P3388, DOI 10.1016/S0006-3495(03)74758-4; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Goldhaber JI, 1999, J PHYSIOL-LONDON, V520, P431, DOI 10.1111/j.1469-7793.1999.00431.x; Gomez AM, 1996, J PHYSIOL-LONDON, V496, P575, DOI 10.1113/jphysiol.1996.sp021708; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Katoh H, 2000, CIRC RES, V87, P106, DOI 10.1161/01.RES.87.2.106; Lipp P, 1996, J PHYSIOL-LONDON, V497, P589, DOI 10.1113/jphysiol.1996.sp021792; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Neco P, 2010, BIOPHYS J, V99, P755, DOI 10.1016/j.bpj.2010.04.071; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Satoh H, 1997, AM J PHYSIOL-HEART C, V272, pH657, DOI 10.1152/ajpheart.1997.272.2.H657; Saucerman JJ, 2008, BIOPHYS J, V95, P4597, DOI 10.1529/biophysj.108.128728; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Seki S, 2003, CARDIOVASC RES, V58, P535, DOI 10.1016/S0008-6363(03)00255-4; SHACKLOCK PS, 1995, J PHYSIOL-LONDON, V487, P601, DOI 10.1113/jphysiol.1995.sp020903; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Sobie EA, 2008, BIOPHYS J, V94, pL54, DOI 10.1529/biophysj.107.127878; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Toischer K, 2010, CIRCULATION, V122, P993, DOI 10.1161/CIRCULATIONAHA.110.943431; TRAFFORD AW, 1995, J PHYSIOL-LONDON, V488, P577, DOI 10.1113/jphysiol.1995.sp020991; Volkers M, 2007, CELL CALCIUM, V41, P135, DOI 10.1016/j.ceca.2006.06.001; Woo SH, 2003, CIRC RES, V92, pE1, DOI 10.1161/01.RES.0000051887.97625.07; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236; Zima AV, 2008, BIOPHYS J, V94, P1867, DOI 10.1529/biophysj.107.114694; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	48	43	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25100	10.1371/journal.pone.0025100	http://dx.doi.org/10.1371/journal.pone.0025100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022376	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295978600010
J	Arslan, SC; Scheidereit, C				Arslan, Seda Coel; Scheidereit, Claus			The Prevalence of TNF alpha-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CELL-DEATH; RIP1 KINASE; TAK1; IDENTIFICATION; INFLAMMATION; REGULATOR; PATHWAYS; FAMILY	Death receptor-induced programmed necrosis is regarded as a secondary death mechanism dominating only in cells that cannot properly induce caspase-dependent apoptosis. Here, we show that in cells lacking TGF beta-activated Kinase-1 (TAK1) expression, catalytically active Receptor Interacting Protein 1 (RIP1)-dependent programmed necrosis overrides apoptotic processes following Tumor Necrosis Factor-alpha (TNF alpha) stimulation and results in rapid cell death. Importantly, the activation of the caspase cascade and caspase-8-mediated RIP1 cleavage in TNF alpha-stimulated TAK1 deficient cells is not sufficient to prevent RIP1-dependent necrosome formation and subsequent programmed necrosis. Our results demonstrate that TAK1 acts independently of its kinase activity to prevent the premature dissociation of ubiquitinated-RIP1 from TNF alpha-stimulated TNF-receptor I and also to inhibit the formation of TNF alpha-induced necrosome complex consisting of RIP1, RIP3, FADD, caspase-8 and cFLIPL. The surprising prevalence of catalytically active RIP1-dependent programmed necrosis over apoptosis despite ongoing caspase activity implicates a complex regulatory mechanism governing the decision between both cell death pathways following death receptor stimulation.	[Arslan, Seda Coel; Scheidereit, Claus] Max Delbruck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Arslan, SC (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	scheidereit@mdc-berlin.de			Deutsche Forschungsgemeinschaft [TRR54]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (TRR54) to C.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	27	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26069	10.1371/journal.pone.0026069	http://dx.doi.org/10.1371/journal.pone.0026069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016814	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700037
J	Zhang, T; Zhang, XX; Ye, L				Zhang, Tong; Zhang, Xu-Xiang; Ye, Lin			Plasmid Metagenome Reveals High Levels of Antibiotic Resistance Genes and Mobile Genetic Elements in Activated Sludge	PLOS ONE			English	Article							WATER TREATMENT-PLANT; SEWAGE-TREATMENT PLANTS; WASTE-WATER; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITY; PROVIDES EVIDENCE; INCP-1-BETA GROUP; TRANSPORT-SYSTEM; VIRULENCE FACTOR; INTEGRONS	The overuse or misuse of antibiotics has accelerated antibiotic resistance, creating a major challenge for the public health in the world. Sewage treatment plants (STPs) are considered as important reservoirs for antibiotic resistance genes (ARGs) and activated sludge characterized with high microbial density and diversity facilitates ARG horizontal gene transfer (HGT) via mobile genetic elements (MGEs). However, little is known regarding the pool of ARGs and MGEs in sludge microbiome. In this study, the transposon aided capture (TRACA) system was employed to isolate novel plasmids from activated sludge of one STP in Hong Kong, China. We also used Illumina Hiseq 2000 high-throughput sequencing and metagenomics analysis to investigate the plasmid metagenome. Two novel plasmids were acquired from the sludge microbiome by using TRACA system and one novel plasmid was identified through metagenomics analysis. Our results revealed high levels of various ARGs as well as MGEs for HGT, including integrons, transposons and plasmids. The application of the TRACA system to isolate novel plasmids from the environmental metagenome, coupled with subsequent high-throughput sequencing and metagenomic analysis, highlighted the prevalence of ARGs and MGEs in microbial community of STPs.	[Zhang, Tong; Zhang, Xu-Xiang; Ye, Lin] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hkucc.hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008; Ye, Lin/F-9709-2013	Ye, Lin/0000-0002-4682-8917; Zhang, Tong/0000-0003-1148-4322	Research Grants Council of Hong Kong [HKU 7201/11E, HKU7202/09E]; University of Hong Kong [201007176069]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This study was financially supported by the Research Grants Council of Hong Kong (HKU 7201/11E) and (HKU7202/09E), Small Project Fund (201007176069) and SPACE Research Fund of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Bonemann G, 2006, ANTIMICROB AGENTS CH, V50, P3075, DOI 10.1128/AAC.00378-06; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; da Silva MF, 2007, FEMS MICROBIOL ECOL, V60, P166, DOI 10.1111/j.1574-6941.2006.00268.x; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Hooper SD, 2010, BIOINFORMATICS, V26, P295, DOI 10.1093/bioinformatics/btp687; Jencova V, 2008, RES MICROBIOL, V159, P118, DOI 10.1016/j.resmic.2007.11.018; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Jones BV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-46; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu YF, 2007, J ANTIMICROB CHEMOTH, V59, P1167, DOI 10.1093/jac/dkm106; Luck SN, 2001, INFECT IMMUN, V69, P6012, DOI 10.1128/IAI.69.10.6012-6021.2001; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Okitsu N, 2005, J CLIN MICROBIOL, V43, P168, DOI 10.1128/JCM.43.1.168-173.2005; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RATHER PN, 1992, ANTIMICROB AGENTS CH, V36, P2222, DOI 10.1128/AAC.36.10.2222; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schluter A, 2008, J BIOTECHNOL, V136, P65, DOI 10.1016/j.jbiotec.2008.03.017; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Szczepanowski R, 2004, MICROBIOL-SGM, V150, P3613, DOI 10.1099/mic.0.27317-0; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; Taviani E, 2008, FEMS MICROBIOL ECOL, V64, P45, DOI 10.1111/j.1574-6941.2008.00455.x; Tennstedt T, 2005, PLASMID, V53, P218, DOI 10.1016/j.plasmid.2004.09.004; Tennstedt T, 2003, FEMS MICROBIOL ECOL, V45, P239, DOI 10.1016/S0168-6496(03)00164-8; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VANDERPLOEG J, 1995, J BACTERIOL, V177, P1348, DOI 10.1128/jb.177.5.1348-1356.1995; Walsh F, 2010, INT J ANTIMICROB AG, V35, P593, DOI 10.1016/j.ijantimicag.2010.02.011; Yan QM, 2011, FRONT ENVIRON SCI EN, V5, P40, DOI 10.1007/s11783-011-0304-8; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	50	254	271	18	317	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26041	10.1371/journal.pone.0026041	http://dx.doi.org/10.1371/journal.pone.0026041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016806	gold, Green Published			2022-12-25	WOS:000295971700034
J	Natsume, A; Kato, T; Kinjo, S; Enomoto, A; Toda, H; Shimato, S; Ohka, F; Motomura, K; Kondo, Y; Miyata, T; Takahashi, M; Wakabayashi, T				Natsume, A.; Kato, T.; Kinjo, S.; Enomoto, A.; Toda, H.; Shimato, S.; Ohka, F.; Motomura, K.; Kondo, Y.; Miyata, T.; Takahashi, M.; Wakabayashi, T.			Girdin maintains the stemness of glioblastoma stem cells	ONCOGENE			English	Article						Girdin; glioblastoma; cancer stem cells; migration; stemness	INITIATING CELLS; PROTEIN GIRDIN; HUMAN CANCER; AKT; PATHWAY; GLIOMA; BRAIN; ACTIVATION; ANGIOGENESIS; SURVIVAL	Glioblastomas (GBMs) are the most common and aggressive type of brain tumor. GBMs usually show hyperactivation of the PI3K-Akt pathway, a pro-tumorigenic signaling cascade that contributes to pathogenesis. Girdin, an actin-binding protein identified as a novel substrate of Akt, regulates the sprouting of axons and the migration of neural progenitor cells during early postnatal-stage neurogenesis in the hippocampus. Here, we show that Girdin is highly expressed in human glioblastoma (GBM). Stable Girdin knockdown in isolated GBM stem cells resulted in decreased expression of stem cell markers, including CD133, induced multilineage neural differentiation, and inhibited in vitro cell motility, ex vivo invasion, sphere-forming capacity and in vivo tumor formation. Furthermore, exogenous expression of the Akt-binding domain of Girdin, which competitively inhibits its Akt-mediated phosphorylation, diminished the expression of stem cell markers, SOX2 and nestin, and migration on the brain slice and induced the expression of neural differentiation markers glial fibrillary acidic protein/beta III Tubulin. Our results reveal that Girdin is required for GBM-initiating stem cells to sustain the stemness and invasive properties. Oncogene (2012) 31, 2715-2724; doi: 10.1038/onc.2011.466; published online 24 October 2011	[Natsume, A.; Kato, T.; Kinjo, S.; Toda, H.; Shimato, S.; Ohka, F.; Motomura, K.; Wakabayashi, T.] Nagoya Univ, Dept Neurosurg, Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, A.; Takahashi, M.] Nagoya Univ, Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kondo, Y.] Aichi Canc Ctr Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi, Japan; [Miyata, T.] Nagoya Univ, Dept Anat & Cell Biol, Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Aichi Cancer Center; Nagoya University	Natsume, A (corresponding author), Nagoya Univ, Dept Neurosurg, Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	anatsume@med.nagoya-u.ac.jp	TAKAHASHI, Masahide/I-7244-2014; Ohka, Fumiharu/A-3420-2016; MIYATA, TAKAKI/I-7066-2014; Motomura, Kazuya/AAF-8776-2021; Enomoto, Atsushi/I-7272-2014; Natsume, Atsushi/I-7364-2014; Wakabayashi, Toshihiko/I-3526-2012; Takahashi, Masahide/AAN-4770-2020	Motomura, Kazuya/0000-0002-4376-1104; Enomoto, Atsushi/0000-0002-9206-6116; Natsume, Atsushi/0000-0002-9113-0470; Wakabayashi, Toshihiko/0000-0001-5254-2088; Takahashi, Masahide/0000-0002-2803-2683; Ohka, Fumiharu/0000-0002-5569-5626	Grants-in-Aid for Scientific Research [22117005] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kato H, 2008, LAB INVEST, V88, P731, DOI 10.1038/labinvest.2008.42; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sonoda Y, 2001, CANCER RES, V61, P6674; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314	28	62	66	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	22					2715	2724		10.1038/onc.2011.466	http://dx.doi.org/10.1038/onc.2011.466			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	952DB	22020337				2022-12-25	WOS:000304769000002
J	Jones, EM; Wu, B; Surewicz, K; Nadaud, PS; Helmus, JJ; Chen, SG; Jaroniec, CP; Surewicz, WK				Jones, Eric M.; Wu, Bo; Surewicz, Krystyna; Nadaud, Philippe S.; Helmus, Jonathan J.; Chen, Shugui; Jaroniec, Christopher P.; Surewicz, Witold K.			Structural Polymorphism in Amyloids NEW INSIGHTS FROM STUDIES WITH Y145Stop PRION PROTEIN FIBRILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; STATE NMR-SPECTROSCOPY; BETA-SHEET STRUCTURE; SECONDARY STRUCTURE; Y145STOP VARIANT; STRAIN VARIANTS; IN-VITRO; FIBRILS; PROPAGATION	The C-terminally-truncated human prion protein variant Y145Stop (or PrP23-144), associated with a familial prion disease, provides a valuable model for studying the fundamental properties of protein amyloids. In previous solid-state NMR experiments, we established that the beta-sheet core of the PrP23-144 amyloid is composed of two beta-strand regions encompassing residues similar to 113-125 and similar to 130-140. The former segment contains a highly conserved hydrophobic palindrome sequence, (113)AGAAAAGA(120), which has been considered essential to PrP conformational conversion. Here, we examine the role of this segment in fibrillization of PrP23-144 using a deletion variant, Delta 113-120 PrP23-144, in which the palindrome sequence is missing. Surprisingly, we find that deletion of the palindrome sequence affects neither the amyloidogenicity nor the polymerization kinetics of PrP23-144, although it does alter amyloid conformation and morphology. Using two-dimensional and three-dimensional solid-state NMR methods, we find that Delta 113-120 PrP23-144 fibrils contain an altered beta-core extended N-terminally to residue similar to 106, encompassing residues not present in the core of wild-type PrP23-144 fibrils. The C-terminal beta-strand of the core, however, is similar in both fibril types. Collectively, these data indicate that amyloid cores of PrP23-144 variants contain "essential" (i.e. nucleation-determining) and "nonessential" regions, with the latter being "movable" in amino acid sequence space. These findings reveal an intriguing new mechanism for structural polymorphism in amyloids and suggest a potential means for modulating the physicochemical properties of amyloid fibrils without compromising their polymerization characteristics.	[Wu, Bo; Nadaud, Philippe S.; Helmus, Jonathan J.; Jaroniec, Christopher P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Jones, Eric M.; Surewicz, Krystyna; Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Ohio State University; Case Western Reserve University	Jaroniec, CP (corresponding author), Ohio State Univ, Dept Chem, Columbus, OH 43210 USA.	jaroniec@chemistry.ohio-state.edu; witold.surewicz@case.edu	Jaroniec, Christopher/A-4948-2008	Jaroniec, Christopher/0000-0003-0364-2888	National Institutes of Health [R01NS038604, R01NS044158, R01GM094357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038604, R01NS044158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS038604 and R01NS044158 (to W.K.S.) and R01GM094357 (to C.P.J.).	Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Goddard T. D., 2006, SPARKY 3; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hiramatsu H, 2010, B CHEM SOC JPN, V83, P495, DOI 10.1246/bcsj.20090317; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lee SW, 2008, J MOL BIOL, V378, P1142, DOI 10.1016/j.jmb.2008.03.035; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nadaud PS, 2007, BIOMOL NMR ASSIGN, V1, P117, DOI 10.1007/s12104-007-9041-0; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	52	29	29	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42777	42784		10.1074/jbc.M111.302539	http://dx.doi.org/10.1074/jbc.M111.302539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002245	hybrid, Green Published			2022-12-25	WOS:000298180900084
J	Bezuidt, O; Pierneef, R; Mncube, K; Lima-Mendez, G; Reva, ON				Bezuidt, Oliver; Pierneef, Rian; Mncube, Kingdom; Lima-Mendez, Gipsi; Reva, Oleg N.			Mainstreams of Horizontal Gene Exchange in Enterobacteria: Consideration of the Outbreak of Enterohemorrhagic E. coli O104:H4 in Germany in 2011	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; BACTERIAL GENOMES; MOLECULAR EPIDEMIOLOGY; PROKARYOTIC GENOMES; TRANSFERRED GENES; RHS ELEMENTS; VIRULENCE; EVOLUTION; SIGNATURE	Background: Escherichia coli O104:H4 caused a severe outbreak in Europe in 2011. The strain TY-2482 sequenced from this outbreak allowed the discovery of its closest relatives but failed to resolve ways in which it originated and evolved. On account of the previous statement, may we expect similar upcoming outbreaks to occur recurrently or spontaneously in the future? The inability to answer these questions shows limitations of the current comparative and evolutionary genomics methods. Principal Findings: The study revealed oscillations of gene exchange in enterobacteria, which originated from marine gamma-Proteobacteria. These mobile genetic elements have become recombination hotspots and effective 'vehicles' ensuring a wide distribution of successful combinations of fitness and virulence genes among enterobacteria. Two remarkable peculiarities of the strain TY-2482 and its relatives were observed: i) retaining the genetic primitiveness by these strains as they somehow avoided the main fluxes of horizontal gene transfer which effectively penetrated other enetrobacteria; ii) acquisition of antibiotic resistance genes in a plasmid genomic island of beta-Proteobacteria origin which ontologically is unrelated to the predominant genomic islands of enterobacteria. Conclusions: Oscillations of horizontal gene exchange activity were reported which result from a counterbalance between the acquired resistance of bacteria towards existing mobile vectors and the generation of new vectors in the environmental microflora. We hypothesized that TY-2482 may originate from a genetically primitive lineage of E. coli that has evolved in confined geographical areas and brought by human migration or cattle trade onto an intersection of several independent streams of horizontal gene exchange. Development of a system for monitoring the new and most active gene exchange events was proposed.	[Bezuidt, Oliver; Pierneef, Rian; Mncube, Kingdom; Reva, Oleg N.] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa; [Lima-Mendez, Gipsi] Univ Libre Bruxelles, Lab Bioinformat Genomes & Reseaux BiGRe, Brussels, Belgium	University of Pretoria; Universite Libre de Bruxelles	Bezuidt, O (corresponding author), Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa.	oleg.reva@up.ac.za	Lima-Mendez, Gipsi/AAV-4158-2021; Reva, Oleg N/A-7316-2009; Lima-Mendez, Gipsi/AAX-6291-2021	Lima-Mendez, Gipsi/0000-0002-5309-1845; Reva, Oleg N/0000-0002-5459-2772; Lima-Mendez, Gipsi/0000-0002-5309-1845; Pierneef, Rian/0000-0002-0619-0058; bezuidt, keoagile oliver/0000-0002-1690-9716	National Research Foundation (South Africa) [71261]	National Research Foundation (South Africa)(National Research Foundation - South Africa)	This work was funded by the National Research Foundation (South Africa) grant #71261 for National Bioinformatics and Functional Genomics Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bhowmick PP, 2011, MICROBIOL-SGM, V157, P160, DOI 10.1099/mic.0.043596-0; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coenye T, 2004, SYST APPL MICROBIOL, V27, P175, DOI 10.1078/072320204322881790; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Davenport CF, 2009, ENVIRON MICROBIOL, V11, P1092, DOI 10.1111/j.1462-2920.2008.01839.x; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Ejrnaes K, 2011, DAN MED BULL, V58; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; FLEISS JL, 1973, STAT METHODS RATES P, V13, P223; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; Ganesan H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-333; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jernigan RW, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-23; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kiewitz C, 2000, MICROBIOL-UK, V146, P2365, DOI 10.1099/00221287-146-10-2365; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kuo CH, 2009, FEMS MICROBIOL REV, V33, P38, DOI 10.1111/j.1574-6976.2008.00140.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Levings RS, 2007, ANTIMICROB AGENTS CH, V51, P317, DOI 10.1128/AAC.01229-06; Lewin A, 1998, J BASIC MICROB, V38, P17, DOI 10.1002/(SICI)1521-4028(199803)38:1<17::AID-JOBM17>3.0.CO;2-D; Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Lukacova M, 2008, CLIN MICROBIOL INFEC, V14, P200, DOI 10.1111/j.1469-0691.2007.01876.x; Mainil JG, 2005, J APPL MICROBIOL, V98, P1332, DOI 10.1111/j.1365-2672.2005.02653.x; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; MARKLEIN G, 1981, KLIN PADIATR, V193, P394, DOI 10.1055/s-2008-1034507; Marri PR, 2008, GENOME, V51, P164, DOI [10.1139/G07-105, 10.1139/g07-105]; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nogueira T, 2009, CURR BIOL, V19, P1683, DOI 10.1016/j.cub.2009.08.056; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oelschlaeger TA, 2002, INT J ANTIMICROB AG, V19, P517, DOI 10.1016/S0924-8579(02)00092-4; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Pal C, 2005, BIOINFORMATICS, V21, P222, DOI 10.1093/bioinformatics/bti1136; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Pride DT, 2002, GENOME LETT, V1, P2, DOI [doi.org/10.1166/gl.2002.003, DOI 10.1166/GL.2002.003]; Ramaiah N, 2003, MICROB ECOL, V45, P444, DOI 10.1007/s00248-001-1068-7; Ray JL, 2005, METHOD ENZYMOL, V395, P491, DOI 10.1016/S0076-6879(05)95026-X; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Reva ON, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-251; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; RITTER A, 1995, MOL MICROBIOL, V17, P109, DOI 10.1111/j.1365-2958.1995.mmi_17010109.x; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Rowley G, 2011, MICROBIOL-SGM, V157, P848, DOI 10.1099/mic.0.046011-0; Sasaki Y, 2011, VET MICROBIOL, V150, P140, DOI 10.1016/j.vetmic.2010.12.024; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tobes R., 2011, NAT PRECEDI IN PRESS, DOI [10.1038/npre.2011.6001.1, DOI 10.1038/NPRE.2011.6001.1]; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; van Passel MWJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-84; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; WEINER M, 1973, NEW YORK STATE J MED, V73, P2256; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790	96	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25702	10.1371/journal.pone.0025702	http://dx.doi.org/10.1371/journal.pone.0025702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022434	Green Submitted, gold, Green Published			2022-12-25	WOS:000295981600013
J	Lu, ZJ; Yuan, ZB; Miyoshi, T; Wang, Q; Su, ZG; Chang, CC; Shi, WB				Lu, Zongji; Yuan, Zuobiao; Miyoshi, Toru; Wang, Qian; Su, Zhiguang; Chang, Catherine C.; Shi, Weibin			Identification of Soat1 as a Quantitative Trait Locus Gene on Mouse Chromosome 1 Contributing to Hyperlipidemia	PLOS ONE			English	Article							APOLIPOPROTEIN-A-II; ATHEROSCLEROTIC LESIONS; ACAT INHIBITION; HDL CHOLESTEROL; ACYL-COA; MICE; INTERCROSS; C57BL/6; C3H; HYPERCHOLESTEROLEMIA	We previously identified two closely linked quantitative trait loci (QTL) on distal chromosome 1 contributing to major variations in plasma cholesterol and triglyceride levels in an intercross derived from C57BL/6 (B6) and C3H/HeJ (C3H) apolipoprotein E-deficient (apoE(-/-)) mice. Soat1, encoding sterol o-acyltransferase 1, is a functional candidate gene located underneath the proximal linkage peak. We sequenced the coding region of Soat1 and identified four single nucleotide polymorphisms (SNPs) between B6 and C3H mice. Two of the SNPs resulted in amino-acid substitutions (Ile147Val and His205Tyr). Functional assay revealed an increased enzyme activity of Soat1 in peritoneal macrophages of C3H mice relative to those of B6 mice despite comparable protein expression levels. Allelic variants of Soat1 were associated with variations in plasma cholesterol and triglyceride levels in an intercross between B6.apoE(-/-) and C3H.apoE(-/-) mice. Inheritance of the C3H allele resulted in significantly higher plasma lipid levels than inheritance of the B6 allele. Soat1 variants were also significantly linked to major variations in plasma esterified cholesterol levels but not with free cholesterol levels. Trangenic expression of C3H Soat1 in B6.apoE(-/-) mice resulted in elevations of plasma cholesterol and triglyceride levels. These results indicate that Soat1 is a QTL gene contributing to hyperlipidemia.	[Lu, Zongji; Yuan, Zuobiao; Miyoshi, Toru; Wang, Qian; Su, Zhiguang; Shi, Weibin] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA; [Shi, Weibin] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Chang, Catherine C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA	University of Virginia; University of Virginia; Dartmouth College	Lu, ZJ (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA.	ws4v@virginia.edu	, ws4v/L-4372-2019; Su, Zhiguang/AFS-0022-2022	Su, Zhiguang/0000-0001-8635-9310; shi, weibin/0000-0002-9155-613X	NIH [HL82881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL82881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Bocan TMA, 2001, ATHEROSCLEROSIS, V157, P97, DOI 10.1016/S0021-9150(00)00713-9; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Dansky HM, 2002, GENETICS, V160, P1599; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; LEBOEUF RC, 1990, J LIPID RES, V31, P91; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Ohta T, 2004, BBA-MOL CELL BIOL L, V1682, P56, DOI 10.1016/S1388-1981(04)00025-3; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Shi WB, 2003, ARTERIOSCL THROM VAS, V23, P1901, DOI 10.1161/01.ATV.0000091249.34404.B7; Shi WB, 2002, CIRCULATION, V105, P2078, DOI 10.1161/01.CIR.0000015853.59427.32; Su YR, 2005, CIRCULATION, V111, P2373, DOI 10.1161/01.CIR.0000164236.19860.13; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Suto J, 1999, BBA-MOL BASIS DIS, V1453, P385, DOI 10.1016/S0925-4439(99)00013-7; Tardif JC, 2006, NAT CLIN PRACT CARD, V3, P366, DOI 10.1038/ncpcardio0599; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2005, BIOCHEM BIOPH RES CO, V329, P1102, DOI 10.1016/j.bbrc.2005.02.090; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wang XS, 2003, GENOME RES, V13, P1654, DOI 10.1101/gr.1185803; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Wierzbicki AS, 2008, CURR VASC PHARMACOL, V6, P13, DOI 10.2174/157016108783331268; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25344	10.1371/journal.pone.0025344	http://dx.doi.org/10.1371/journal.pone.0025344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022387	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600006
J	Domenichini, A; Dadda, M; Facchin, L; Bisazza, A; Argenton, F				Domenichini, Alice; Dadda, Marco; Facchin, Lucilla; Bisazza, Angelo; Argenton, Francesco			Isolation and Genetic Characterization of Mother-of-Snow-White, a Maternal Effect Allele Affecting Laterality and Lateralized Behaviors in Zebrafish	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HAIR-WHORL DIRECTION; KUPFFERS VESICLE; EMBRYONIC-DEVELOPMENT; BRAIN LATERALIZATION; CEREBRAL ASYMMETRY; LEFTWARD FLOW; NODAL FLOW; EXPRESSION; HANDEDNESS	In the present work we report evidence compatible with a maternal effect allele affecting left-right development and functional lateralization in vertebrates. Our study demonstrates that the increased frequency of reversed brain asymmetries in a zebrafish line isolated through a behavioral assay is due to selection of mother-of-snow-white (msw), a maternal effect allele involved in early stages of left-right development in zebrafish. msw homozygous females could be identified by screening of their progeny for the position of the parapineal organ because in about 50% of their offspring we found an altered, either bilateral or right-sided, expression of lefty1 and spaw. Deeper investigations at earlier stages of development revealed that msw is involved in the specification and differentiation of precursors of the Kupffer's vesicle, a structure homologous to the mammalian node. To test the hypothesis that msw, by controlling Kupffer's vesicle morphogenesis, controls lateralized behaviors related to diencephalic asymmetries, we analyzed left-and right-parapineal offspring in a "viewing test''. As a result, left-and right-parapineal individuals showed opposite and complementary eye preference when scrutinizing a model predator, and a different degree of lateralization when scrutinizing a virtual companion. As maternal effect genes are expected to evolve more rapidly when compared to zygotic ones, our results highlight the driving force of maternal effect alleles in the evolution of vertebrates behaviors.	[Domenichini, Alice; Facchin, Lucilla; Argenton, Francesco] Univ Padua, Dipartimento Biol, Padua, Italy; [Dadda, Marco; Bisazza, Angelo] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua; University of Padua	Domenichini, A (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	francesco.argenton@unipd.it	Dadda, Marco/D-2417-2014; DADDA, Marco/ABI-7266-2020; Argenton, Francesco/AAS-8494-2021	DADDA, Marco/0000-0001-7944-4058; Argenton, Francesco/0000-0002-0803-8236; Bisazza, Angelo/0000-0003-0209-7638				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; ANNETT M, 1995, RIGHT SHIFT THEORY G; BARKER MS, 2005, PLOS GENETICS, V1; Barth KA, 2005, CURR BIOL, V15, P844, DOI 10.1016/j.cub.2005.03.047; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Blum M, 2009, SEMIN CELL DEV BIOL, V20, P464, DOI 10.1016/j.semcdb.2008.11.005; Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; Bryden M. P., 1982, LATERALITY FUNCTIONA; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; COLLINS RL, 1985, CEREBRAL LATERALIZAT, P41; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Corballis MC, 1998, TRENDS COGN SCI, V2, P152, DOI 10.1016/S1364-6613(98)01156-5; Coutellier L, 2009, BEHAV BRAIN RES, V196, P192, DOI 10.1016/j.bbr.2008.08.042; Dadda M, 2010, BEHAV BRAIN RES, V206, P208, DOI 10.1016/j.bbr.2009.09.019; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; Demuth JP, 2007, GENETICA, V129, P37, DOI 10.1007/s10709-006-0031-4; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Facchin L, 1999, BEHAV BRAIN RES, V103, P229, DOI 10.1016/S0166-4328(99)00043-1; Facchin L, 2009, BEHAV BRAIN RES, V197, P157, DOI 10.1016/j.bbr.2008.08.033; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hopkins WD, 2001, PSYCHOL SCI, V12, P299, DOI 10.1111/1467-9280.00355; Hosoiri Y, 2003, DEV GENES EVOL, V213, P193, DOI 10.1007/s00427-003-0315-y; Jansen A, 2007, NEUROIMAGE, V35, P853, DOI 10.1016/j.neuroimage.2006.12.025; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klar AJS, 1996, COLD SPRING HARB SYM, V61, P59; Klar AJS, 2003, GENETICS, V165, P269; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kreiling JA, 2007, DEV DYNAM, V236, P1963, DOI 10.1002/dvdy.21191; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Maynard Smith J., 1982, pi; McManus IC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P37, DOI 10.1017/CBO9780511576744.004; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; MCMANUS IC, 2002, LEFT HAND RIGHT HAND; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Miklosi A, 1997, PHYSIOL BEHAV, V63, P127, DOI 10.1016/S0031-9384(97)00418-6; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; NEUGEBAUER JM, 2009, NATURE; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rife DC, 1940, GENETICS, V25, P0178; Rogers LJ., 2002, COMP VERTEBRATE LATE; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sicotte N L, 1999, Laterality, V4, P265, DOI 10.1080/135765099396980; Sovrano VA, 2006, BEHAV BRAIN RES, V167, P226, DOI 10.1016/j.bbr.2005.09.021; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P615, DOI 10.1017/S0140525X05480103; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	80	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25972	10.1371/journal.pone.0025972	http://dx.doi.org/10.1371/journal.pone.0025972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022484	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600033
J	Ligr, M; Patwa, RR; Daniels, G; Pan, L; Wu, XY; Li, YR; Tian, LT; Wang, ZX; Xu, RL; Wu, JJ; Chen, F; Liu, JS; Wei, JJ; Lee, P				Ligr, Martin; Patwa, Ruzeen Rohintan; Daniels, Garrett; Pan, Lorraine; Wu, Xinyu; Li, Yirong; Tian, Liantian; Wang, Zhenxing; Xu, Ruliang; Wu, Jingjing; Chen, Fan; Liu, Jinsong; Wei, Jian-Jun; Lee, Peng			Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; CARCINOMA; ALPHA; CELLS; POLYMORPHISMS; ASSOCIATION; BIOMARKER; SURVIVAL; HORMONES	Hormones, including estrogen and progesterone, and their receptors play an important role in the development and progression of ovarian carcinoma. Androgen, its receptor and coactivators have also been implicated in these processes. p44/Mep50/WDR77 was identified as a subunit of the methylosome complex and lately characterized as a steroid receptor coactivator that enhances androgen receptor as well as estrogen receptor-mediated transcriptional activity in a ligand-dependent manner. We previously described distinct expression and function of p44 in prostate, testis, and breast cancers. In this report, we examined the expression and function of p44 in ovarian cancer. In contrast to findings in prostate and testicular cancer and similar to breast cancer, p44 shows strong cytoplasmic localization in morphologically normal ovarian surface and fallopian tube epithelia, while nuclear p44 is observed in invasive ovarian carcinoma. We observed that p44 can serve as a coactivator of both androgen receptor (AR) and estrogen receptor (ER) in ovarian cells. Further, overexpression of nuclear-localized p44 stimulates proliferation and invasion in ovarian cancer cells in the presence of estrogen or androgen. These findings strongly suggest that p44 plays a role in mediating the effects of hormones during ovarian tumorigenesis.	[Ligr, Martin; Patwa, Ruzeen Rohintan; Daniels, Garrett; Pan, Lorraine; Wu, Xinyu; Li, Yirong; Tian, Liantian; Xu, Ruliang; Chen, Fan; Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Lee, Peng] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Lee, Peng] NYU, Sch Med, NYU Canc Inst, New York, NY USA; [Lee, Peng] New York Harbor Healthcare Syst, New York, NY USA; [Wu, Jingjing; Wei, Jian-Jun] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Zhenxing] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	New York University; New York University; New York University; Northwestern University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ligr, M (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	jianjun-wei@northwestern.edu; peng.lee@nyumc.org	WEI, JJ/AAN-2638-2020	xu, ruliang/0000-0002-9165-4610	Northwestern Memorial Hospital; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893, UL1RR025741] Funding Source: NIH RePORTER	Northwestern Memorial Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Northwestern Memorial Hospital Dixon Translational Research Fund grant to JJW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E; Cardillo MR, 1998, J EXP CLIN CANC RES, V17, P231; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fujimura M, 2001, AM J SURG PATHOL, V25, P667, DOI 10.1097/00000478-200105000-00016; Geisler JP, 2008, EUR J GYNAECOL ONCOL, V29, P126; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Halperin R, 2001, EUR J GYNAECOL ONCOL, V22, P122; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Howlader NNA, 2010, SEER CANC STAT REV 1; Hua WH, 1995, J STEROID BIOCHEM, V55, P279, DOI 10.1016/0960-0760(95)00187-5; Ilekis JV, 1997, GYNECOL ONCOL, V66, P250, DOI 10.1006/gyno.1997.4764; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Lee P, 2005, GYNECOL ONCOL, V96, P671, DOI 10.1016/j.ygyno.2004.11.010; Levine DA, 2001, CANCER RES, V61, P908; Li AJ, 2005, CANCER EPIDEM BIOMAR, V14, P2919, DOI 10.1158/1055-9965.EPI-05-0540; Liang JJ, 2007, J UROLOGY, V177, P1918, DOI 10.1016/j.juro.2007.01.017; LIPSETT MB, 1979, CANCER-AM CANCER SOC, V43, P1967, DOI 10.1002/1097-0142(197905)43:5+<1967::AID-CNCR2820430704>3.0.CO;2-7; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Menin C, 2001, CANCER LETT, V168, P31, DOI 10.1016/S0304-3835(01)00473-6; Modugno F, 2004, AM J EPIDEMIOL, V159, P319, DOI 10.1093/aje/kwh046; Munstedt K, 2000, CANCER, V89, P1783, DOI 10.1002/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; OZOLS RF, 1987, CURR PROB CANCER, V11, P57; PENG Y, 2009, J CELL MOL MED; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; SLOTMAN BJ, 1989, GYNECOL ONCOL, V33, P76, DOI 10.1016/0090-8258(89)90607-0; TALERMAN A, 1992, CURR OPIN OBSTET GYN, V4, P608; Wang PH, 2004, EUR J GYNAECOL ONCOL, V25, P157	36	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26250	10.1371/journal.pone.0026250	http://dx.doi.org/10.1371/journal.pone.0026250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022581	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600047
J	Sheldon, KL; Maldonado, EN; Lemasters, JJ; Rostovtseva, TK; Bezrukov, SM				Sheldon, Kely L.; Maldonado, Eduardo N.; Lemasters, John J.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.			Phosphorylation of Voltage-Dependent Anion Channel by Serine/Threonine Kinases Governs Its Interaction with Tubulin	PLOS ONE			English	Article							PROTEIN-KINASE; PERMEABILITY TRANSITION; MITOCHONDRIA; VDAC; CAMP; INHIBITION; APOPTOSIS; BINDING; DRP1; PH	Tubulin was recently found to be a uniquely potent regulator of the voltage-dependent anion channel (VDAC), the most abundant channel of the mitochondrial outer membrane, which constitutes a major pathway for ATP/ADP and other metabolites across this membrane. Dimeric tubulin induces reversible blockage of VDAC reconstituted into a planar lipid membrane and dramatically reduces respiration of isolated mitochondria. Here we show that VDAC phosphorylation is an important determinant of its interaction with dimeric tubulin. We demonstrate that in vitro phosphorylation of VDAC by either glycogen synthase kinase-3 beta (GSK3 beta) or cAMP-dependent protein kinase A (PKA), increases the on-rate of tubulin binding to the reconstituted channel by orders of magnitude, but only for tubulin at the cis side of the membrane. This and the fact the basic properties of VDAC, such as single-channel conductance and selectivity, remained unaltered by phosphorylation allowed us to suggest the phosphorylation regions positioned on the cytosolic loops of VDAC and establish channel orientation in our reconstitution experiments. Experiments on human hepatoma cells HepG2 support our conjecture that VDAC permeability for the mitochondrial respiratory substrates is regulated by dimeric tubulin and channel phosphorylation. Treatment of HepG2 cells with colchicine prevents microtubule polymerization, thus increasing dimeric tubulin availability in the cytosol. Accordingly, this leads to a decrease of mitochondrial potential measured by assessing mitochondrial tetramethylrhodamine methyester uptake with confocal microscopy. Inhibition of PKA activity blocks and reverses mitochondrial depolarization induced by colchicine. Our findings suggest a novel functional link between serine/threonine kinase signaling pathways, mitochondrial respiration, and the highly dynamic microtubule network which is characteristic of cancerogenesis and cell proliferation.	[Sheldon, Kely L.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Phys & Struct Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Sheldon, Kely L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Maldonado, Eduardo N.; Lemasters, John J.] Med Univ S Carolina, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of South Carolina	Sheldon, KL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Phys & Struct Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Maldonado, Eduardo/AAN-3907-2020	Maldonado, Eduardo/0000-0002-5285-3027	NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336] Funding Source: NIH RePORTER	NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the Intramural Research Program of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (for K.L.S., T.K.R., and S.M.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre N, 2000, CANCER RES, V60, P5349; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; APELL HJ, 1977, J MEMBRANE BIOL, V31, P171, DOI 10.1007/BF01869403; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BERA AK, 1995, BIOCHEM BIOPH RES CO, V209, P213, DOI 10.1006/bbrc.1995.1491; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Capone RF, 2007, BIOPHYS J, p609A; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Esteve MA, 2007, CURR CANCER DRUG TAR, V7, P713; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; GLASS DB, 1986, J BIOL CHEM, V261, P2166; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Guzun R, 2011, BBA-BIOENERGETICS, V1807, P458, DOI 10.1016/j.bbabio.2011.01.010; Karbowski M, 2001, J CELL SCI, V114, P281; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Liberatori S, 2004, PROTEOMICS, V4, P1335, DOI 10.1002/pmic.200300734; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Monge C., 2008, MOL CELL BIOCHEM, V318, P94; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Okamoto K, 2011, EMBO J, V30, P2095, DOI 10.1038/emboj.2011.149; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pediaditakis P, 2010, BIOCHEM J, V431, P411, DOI 10.1042/BJ20091741; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Priel A., 2005, EUR BIOPHYS J, V35; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rovini A, 2011, BBA-BIOENERGETICS, V1807, P679, DOI 10.1016/j.bbabio.2011.01.001; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schwertz H, 2007, PROTEOMICS, V7, P4579, DOI 10.1002/pmic.200700734; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wolff J, 1996, PROTEIN SCI, V5, P2020, DOI 10.1002/pro.5560051008; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417	51	77	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25539	10.1371/journal.pone.0025539	http://dx.doi.org/10.1371/journal.pone.0025539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022409	Green Published, gold, Green Submitted			2022-12-25	WOS:000295978600021
J	Siddiqui, MSM; Bhaumik, B				Siddiqui, Mohammed Sultan Mohiuddin; Bhaumik, Basabi			A Reaction-Diffusion Model to Capture Disparity Selectivity in Primary Visual Cortex	PLOS ONE			English	Article							SPATIAL-FREQUENCY SELECTIVITY; CELL RECEPTIVE-FIELDS; SELF-ORGANIZING MODEL; OCULAR DOMINANCE; BINOCULAR DISPARITY; ORIENTATION SELECTIVITY; COMPLEX CELLS; HORIZONTAL DISPARITY; FUNCTIONAL ARCHITECTURE; DEPTH DISCRIMINATION	Decades of experimental studies are available on disparity selective cells in visual cortex of macaque and cat. Recently, local disparity map for iso-orientation sites for near-vertical edge preference is reported in area 18 of cat visual cortex. No experiment is yet reported on complete disparity map in V1. Disparity map for layer IV in V1 can provide insight into how disparity selective complex cell receptive field is organized from simple cell subunits. Though substantial amounts of experimental data on disparity selective cells is available, no model on receptive field development of such cells or disparity map development exists in literature. We model disparity selectivity in layer IV of cat V1 using a reaction-diffusion two-eye paradigm. In this model, the wiring between LGN and cortical layer IV is determined by resource an LGN cell has for supporting connections to cortical cells and competition for target space in layer IV. While competing for target space, the same type of LGN cells, irrespective of whether it belongs to left-eye-specific or right-eye-specific LGN layer, cooperate with each other while trying to push off the other type. Our model captures realistic 2D disparity selective simple cell receptive fields, their response properties and disparity map along with orientation and ocular dominance maps. There is lack of correlation between ocular dominance and disparity selectivity at the cell population level. At the map level, disparity selectivity topography is not random but weakly clustered for similar preferred disparities. This is similar to the experimental result reported for macaque. The details of weakly clustered disparity selectivity map in V1 indicate two types of complex cell receptive field organization.	[Siddiqui, Mohammed Sultan Mohiuddin; Bhaumik, Basabi] Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Siddiqui, MSM (corresponding author), Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India.	bhaumik@ee.iitd.ac.in			IIT Delhi	IIT Delhi	IIT Delhi provides the PhD scholarship of MSMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ANDREWS BW, 1979, J PHYSIOL-LONDON, V287, P163, DOI 10.1113/jphysiol.1979.sp012652; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Bednar JA, 2006, NEUROCOMPUTING, V69, P1272, DOI 10.1016/j.neucom.2005.12.090; BERNS GS, 1993, P NATL ACAD SCI USA, V90, P8277, DOI 10.1073/pnas.90.17.8277; BETZ WJ, 1989, J PHYSIOL-LONDON, V418, P25, DOI 10.1113/jphysiol.1989.sp017827; Bhaumik B, 2003, J COMPUT NEUROSCI, V14, P211, DOI 10.1023/A:1021911019241; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; BLAKEMORE C, 1970, VISION RES, V10, P1181, DOI 10.1016/0042-6989(70)90036-2; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cheng H, 1995, J NEUROPHYSIOL, V74, P2548, DOI 10.1152/jn.1995.74.6.2548; CHINO YM, 1994, J NEUROSCI, V14, P5050; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Durand JB, 2007, CEREB CORTEX, V17, P1260, DOI 10.1093/cercor/bhl050; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Erwin E, 1998, J NEUROSCI, V18, P9870; Erwin E., 1995, Society for Neuroscience Abstracts, V21, P2025; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FIORENTINI A, 1971, VISION RES, V11, P1299, DOI 10.1016/0042-6989(71)90012-5; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; FREEMAN RD, 1992, J NEUROSCI, V12, P4721; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; Gerstner W, 1998, PULSED NEURAL NETWORKS, P3; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; HAMMOND P, 1991, EXP BRAIN RES, V85, P631; HAYES WP, 1989, J NEUROSCI, V9, P1414; HEYDT RVD, 1978, EXP BRAIN RES, V31, P523; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Jegelka S, 2006, NEUROCOMPUTING, V69, P1291, DOI 10.1016/j.neucom.2005.12.094; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; Mathur M, 2005, NEUROCOMPUTING, V65, P85, DOI 10.1016/j.neucom.2004.10.059; MILLER KD, 1994, J NEUROSCI, V14, P409; Mitchell D, 2004, VISUAL NEUROSCIENCES, P189; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Olson SJ, 1998, NEURAL NETWORKS, V11, P189, DOI 10.1016/S0893-6080(98)00003-3; Orban GA, 1991, VISION VISUAL DYSFUN, P173; PACKWOOD J, 1975, J NEUROPHYSIOL, V38, P1485, DOI 10.1152/jn.1975.38.6.1485; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Piepenbrock C, 1997, NEURAL COMPUT, V9, P959, DOI 10.1162/neco.1997.9.5.959; Piepenbrock C, 1996, NEURAL P LETT, V3, P1; POGGIO GF, 1990, COLD SPRING HARB SYM, V55, P749; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Pollen DA, 1989, MODELS BRAIN FUNCTIO, P115; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Sanada TM, 2006, J NEUROPHYSIOL, V95, P2768, DOI 10.1152/jn.00955.2005; Sasaki KS, 2007, J NEUROPHYSIOL, V98, P1194, DOI 10.1152/jn.00429.2007; Sasaki KS, 2010, J NEUROSCI, V30, P13826, DOI 10.1523/JNEUROSCI.1135-10.2010; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Shouval H, 1996, NEURAL COMPUT, V8, P1021, DOI 10.1162/neco.1996.8.5.1021; Shouval H, 1997, VISION RES, V37, P3339, DOI 10.1016/S0042-6989(97)00087-4; Smith EL, 1997, J NEUROPHYSIOL, V78, P351, DOI 10.1152/jn.1997.78.1.351; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Ts'o DY, 2009, J PHYSIOL-LONDON, V587, P2791, DOI 10.1113/jphysiol.2009.171082; Tsao DY, 2003, NEURON, V38, P103, DOI 10.1016/S0896-6273(03)00150-8; TYLER CW, 1979, VISION RES, V19, P859, DOI 10.1016/0042-6989(79)90019-1; Wehmeier U., 1989, METHODS NEURONAL MOD, P335; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WILSON HR, 1976, VISION RES, V16, P983, DOI 10.1016/0042-6989(76)90230-3; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; WORGOTTER F, 1991, J NEUROSCI, V11, P1959; XIONG MJ, 1994, J COMP NEUROL, V344, P581, DOI 10.1002/cne.903440407	99	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24997	10.1371/journal.pone.0024997	http://dx.doi.org/10.1371/journal.pone.0024997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022370	Green Submitted, Green Published, gold			2022-12-25	WOS:000295978600007
J	Jankovic, J; Yeeles, K; Katsakou, C; Amos, T; Morriss, R; Rose, D; Nichol, P; McCabe, R; Priebe, S				Jankovic, Jelena; Yeeles, Ksenija; Katsakou, Christina; Amos, Tim; Morriss, Richard; Rose, Diana; Nichol, Peter; McCabe, Rosemarie; Priebe, Stefan			Family Caregivers' Experiences of Involuntary Psychiatric Hospital Admissions of Their Relatives - a Qualitative Study	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; CARE; BURDEN; USERS; SCHIZOPHRENIA; INFORMATION; ILLNESS; PEOPLE	Background: Family caregivers of people with mental disorders are frequently involved in involuntary hospital admissions of their relatives. Objective: To explore family caregivers' experience of involuntary admission of their relative. Method: 30 in-depth interviews were conducted with family caregivers of 29 patients who had been involuntarily admitted to 12 hospitals across England. Interviews were analysed using thematic analysis. Results: Four major themes of experiences were identified: relief and conflicting emotions in response to the relative's admission; frustration with a delay in getting help; being given the burden of care by services; and difficulties with confidentiality. Relief was a predominant emotion as a response to the relative's admission and it was accompanied by feelings of guilt and worry. Family caregivers frequently experienced difficulties in obtaining help from services prior to involuntary admission and some thought that services responded to crises rather than prevented them. Family caregivers experienced increased burden when services shifted the responsibility of caring for their mentally unwell relatives to them. Confidentiality was a delicate issue with family caregivers wanting more information and a say in decisions when they were responsible for aftercare, and being concerned about confidentiality of information they provided to services. Conclusion: Compulsory admission of a close relative can be a complex and stressful experience for family caregivers. In order for caregivers to be effective partners in care, a balance needs to be struck between valuing their involvement in providing care for a patient and not overburdening them.	[Jankovic, Jelena; Yeeles, Ksenija; Katsakou, Christina; Nichol, Peter; McCabe, Rosemarie; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Amos, Tim] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [Morriss, Richard] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [Rose, Diana] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; Queen Mary University London; University of Bristol; University of Nottingham; University of London; King's College London	Jankovic, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	j.jankovic@qmul.ac.uk	Rose, Diana/HGE-8574-2022; Rose, Diana S/D-1387-2010; McCabe, Rose/A-9802-2013	Rose, Diana S/0000-0002-6393-6389; McCabe, Rose/0000-0003-2041-7383; Morriss, Richard/0000-0003-2910-4121; Yeeles, Ksenija/0000-0002-7757-0154; Priebe, Stefan/0000-0001-9864-3394	Department of Health, United Kingdom [0230072]; National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network; NIHR Specialist Biomedical Research Centre; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London	Department of Health, United Kingdom; National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network(National Institute for Health Research (NIHR)); NIHR Specialist Biomedical Research Centre; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London	The study was funded by a grant from the Policy Research Programme of the Department of Health, United Kingdom (Commission no 0230072). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. This study was supported by the National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network. DR acknowledges financial support from the NIHR Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley National Health Service Foundation Trust and the Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AG, 2008, PHARMACOECONOMICS, V26, P149, DOI 10.2165/00019053-200826020-00005; Cormac I, 2006, ADV PSYCHIAT TREAT, V12, P162, DOI DOI 10.1192/APT.12.3.162; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2008, MENT HLTH ACT 1983 C; FRANCELL CG, 1988, HOSP COMMUNITY PSYCH, V39, P1296; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; HERVEY N, 2004, ADV PSYCHIAT TREATME, V10, P81; Jones IR, 2009, SOC SCI MED, V69, P632, DOI 10.1016/j.socscimed.2009.06.015; Jungbauer J, 2004, SCHIZOPHRENIA BULL, V30, P665, DOI 10.1093/oxfordjournals.schbul.a007114; Katsakou C, 2010, PSYCHIAT SERV, V61, P286, DOI 10.1176/ps.2010.61.3.286; Kersten P, 2001, HEALTH SOC CARE COMM, V9, P235, DOI 10.1046/j.1365-2524.2001.00297.x; Lakeman R, 2008, J PSYCHIATR MENT HLT, V15, P203, DOI 10.1111/j.1365-2850.2007.01213.x; Lammers J, 2003, J Psychiatr Ment Health Nurs, V10, P385, DOI 10.1046/j.1365-2850.2003.00598.x; Noble LM, 2004, CURR OPIN PSYCHIATR, V17, P289, DOI 10.1097/01.yco.0000133832.42167.76; Ohaeri JU, 2003, CURR OPIN PSYCHIATR, V16, P457, DOI 10.1097/01.yco.0000079212.36371.c0; Pescosolido BA, 2004, SOC SCI MED, V58, P1795, DOI 10.1016/S0277-9536(03)00398-8; PINFOLD V, 2003, UNDER PRESSURE IMPAC; Pinfold V, 2007, MENT HEALTH REV J, V12, P7, DOI 10.1108/13619322200700015; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; Simpson EL, 2002, BRIT MED J, V325, P1265, DOI 10.1136/bmj.325.7375.1265; Slade M, 2007, BRIT J PSYCHIAT, V190, P148, DOI 10.1192/bjp.bp.106.024935; Szmukler GI, 1997, BRIT J PSYCHIAT, V171, P401, DOI 10.1192/bjp.171.5.401; Zahid MA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-71	24	54	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25425	10.1371/journal.pone.0025425	http://dx.doi.org/10.1371/journal.pone.0025425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022393	Green Published, gold			2022-12-25	WOS:000295976000015
J	Kim, HJ; Song, DE; Lim, SY; Lee, SH; Kang, JL; Lee, SJ; Benveniste, EN; Choi, YH				Kim, Hee Ja; Song, Dong Eun; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee; Lee, Sun Jung; Benveniste, Etty N.; Choi, Youn-Hee			Loss of the Promyelocytic Leukemia Protein in Gastric Cancer: Implications for IP-10 Expression and Tumor-Infiltrating Lymphocytes	PLOS ONE			English	Article							PML-RAR-ALPHA; SUPPRESSOR PML; T-CELLS; KAPPA-B; STAT3 ACTIVATION; POOR-PROGNOSIS; INFLAMMATION; TRANSCRIPTION; GENE; MICROENVIRONMENT	Gastric cancer is one of the most common causes of cancer-related mortality worldwide. Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis. Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma. We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML. The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN-gamma-stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro. Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels. Moreover, both Pml knockout and knockdown cells displayed enhanced IP-10 mRNA and protein expression in the presence of IFN-gamma. PML knockdown increased IFN-gamma-mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene. Conversely, PML IV protein expression suppressed IP-10 promoter activation. Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.	[Kim, Hee Ja; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee; Choi, Youn-Hee] Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Kim, Hee Ja; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Sun Jung] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Benveniste, Etty N.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Ewha Womans University; Ewha Womans University; University of Ulsan; Asan Medical Center; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham	Kim, HJ (corresponding author), Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea.	yc@ewha.ac.kr	LEE, Sunghee/HCH-4510-2022		National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2010-0015506]; Korea government (MEST) [2010-0029353, RO1 NS50665]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050665] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0015506) to Y-HC, by the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (2010-0029353) to JLK, and by RO1 NS50665 to ENB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Choi YH, 2006, P NATL ACAD SCI USA, V103, P18715, DOI 10.1073/pnas.0604800103; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Hsu MC, 2010, MODERN PATHOL, V23, P1393, DOI 10.1038/modpathol.2010.130; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawasaki A, 2003, BLOOD, V101, P3668, DOI 10.1182/blood-2002-08-2474; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kyrlagkitsis I, 2004, HEPATO-GASTROENTEROL, V51, P320; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Lee HE, 2007, CANCER LETT, V247, P103, DOI 10.1016/j.canlet.2006.03.034; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Nakano O, 2001, CANCER RES, V61, P5132; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Olsnes AM, 2006, CANCER IMMUNOL IMMUN, V55, P830, DOI 10.1007/s00262-005-0080-z; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Stadler M, 1995, ONCOGENE, V11, P2565; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192; Vallian S, 1998, ONCOGENE, V16, P2843, DOI 10.1038/sj.onc.1201837; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Wang ZG, 1998, SCIENCE, V279, P1547; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Wu WS, 2002, ONCOGENE, V21, P3925, DOI 10.1038/sj.onc.1205491; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Zhang P, 2000, INT J CANCER, V85, P599, DOI 10.1002/(SICI)1097-0215(20000301)85:5<599::AID-IJC1>3.0.CO;2-#	55	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26264	10.1371/journal.pone.0026264	http://dx.doi.org/10.1371/journal.pone.0026264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022583	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000094
J	Menezes, AM; Torelly, J; Real, L; Bay, M; Poeta, J; Sprinz, E				Menezes, Andreia M.; Torelly, Jorge, Jr.; Real, Lucia; Bay, Monica; Poeta, Julia; Sprinz, Eduardo			Prevalence and Risk Factors Associated to Chronic Kidney Disease in HIV-Infected Patients on HAART and Undetectable Viral Load in Brazil	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; SERUM CREATININE; DYSFUNCTION; PREDICTION; MORTALITY; COHORT; DIET; ERA	Background: To determine the prevalence and associated factors with chronic kidney disease (CKD) in a cohort of HIV-positive individuals with undetectable viral load on HAART. Methods: From March, 2009 to September 2009, 213 individuals between 18-70 years, period on HAART >= 12 months, viral load < 50 copies/mm(3), and CD4 >= 200 cells/mm(3), were consecutively enrolled at the outpatient clinic of Hospital de Clinicas, Porto Alegre, Brazil. Exclusion criteria were obesity, malnourishment, amputee, paraplegic, previous history of renal disease, pregnancy and hepatic insufficiency. Renal function was determined by estimated glomerular filtration rate (eGFR) assessed by the modification of diet in renal disease. CKD was defined as an eGFR less or equal than 60 ml/min/1.73 m(2), for a period of at least 3 months. Poisson regression was used to determine factors associated with CKD. Results: CKD was diagnosed in 8.4% of the population, and after adjustment, the risk factors were hypertension (RR = 3.88, 95%CI, 1.84 - 8.16), time on HAART (RR = 1.15, 95%CI, 1.03-1.27) and tenofovir exposure (RR = 2.25, 95%CI, 1.04-4.95). Higher weight (RR = ,0.88 95%CI, 0.82-0.96) was associated to normal function. Conclusions: CKD was a common finding in this cohort of patients and was related to hypertension, time on HAART and tenofovir exposure. We suggest a more frequent monitoring of renal function, especially for those with risk factors to early identify renal impairment.	[Menezes, Andreia M.; Torelly, Jorge, Jr.; Real, Lucia; Poeta, Julia; Sprinz, Eduardo] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Bay, Monica; Sprinz, Eduardo] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Menezes, AM (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.	eduardo.sprinz@gmail.com.br	sprinz, eduardo/V-7961-2019	sprinz, eduardo/0000-0003-4343-8304	Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE); Center for Reseach Support (CAPES/REUNI); National Research Council (CNPq) of Brazil	Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE); Center for Reseach Support (CAPES/REUNI)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Research Council (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Center for Reseach Support (CAPES/REUNI) and National Research Council (CNPq) of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM DIAB ASS, 2010, DIABETES CARE, V33, P57; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1995, WHO TECH REP SER, V854, P1; Barrios A, 2004, AIDS, V18, P960, DOI 10.1097/00002030-200404090-00019; Cheung CY, 2007, NEPHROL DIAL TRANSPL, V22, P3186, DOI 10.1093/ndt/gfm350; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V34, P320, DOI 10.1097/00126334-200311010-00011; Gupta SK, 2004, CLIN NEPHROL, V61, P1; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; LUGON JR, 2009, JORNAL BRASILEIRO S1, V31, P2; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Romao JE, 2004, J BRAS NEPHROL, V26, P1; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Soares A, 2010, AM J KIDNEY DIS, V55, P1162, DOI 10.1053/j.ajkd.2010.03.008; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Stohr W, 2008, ANTIVIR THER, V13, P761; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; World Health Organization (WHO), 2008, GLOB DAT BOD MASS IN; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	30	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26042	10.1371/journal.pone.0026042	http://dx.doi.org/10.1371/journal.pone.0026042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022501	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000059
J	Tai, AW; Salloum, S				Tai, Andrew W.; Salloum, Shadi			The Role of the Phosphatidylinositol 4-Kinase PI4KA in Hepatitis C Virus-Induced Host Membrane Rearrangement	PLOS ONE			English	Article							CELL-CULTURE; EFFICIENT REPLICATION; RNA; PROTEIN; EXPRESSION; SYSTEM; ALPHA; RECRUITMENT; SCREEN; GENOME	Background: Hepatitis C virus (HCV), like other positive-sense RNA viruses, replicates on an altered host membrane compartment that has been called the "membranous web." The mechanisms by which the membranous web are formed from cellular membranes are poorly understood. Several recent RNA interference screens have demonstrated a critical role for the host phosphatidylinositol 4-kinase PI4KA in HCV replication. We have sought to define the function of PI4KA in viral replication. Methodology/Principal Findings: Using a nonreplicative model of membranous web formation, we show that PI4KA silencing leads to aberrant web morphology. Furthermore, we find that PI4KA and its product, phosphatidylinositol 4-phosphate, are enriched on membranous webs and that PI4KA is found in association with NS5A in HCV-infected cells. While the related lipid kinase PI4KB also appears to support HCV replication, it does not interact with NS5A. Silencing of PI4KB does not overtly impair membranous web morphology or phosphatidylinositol 4-phosphate enrichment at webs, suggesting that it acts at a different point in viral replication. Finally, we demonstrate that the aberrant webs induced by PI4KA silencing require the activity of the viral NS3-4A serine protease but not integrity of the host secretory pathway. Conclusions/Significance: PI4KA is necessary for the local enrichment of PI 4-phosphate at the HCV membranous web and for the generation of morphologically normal webs. We also show that nonreplicative systems of web formation can be used to order molecular events that drive web assembly.	[Tai, Andrew W.; Salloum, Shadi] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Tai, Andrew W.] Ann Arbor Vet Adm Hlth Syst, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Tai, AW (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	andrewwt@med.umich.edu	Tai, Andrew W./M-8380-2017	Tai, Andrew W./0000-0002-6877-450X	National Institute of Allergy and Infectious Diseases [AI083785]; Foundation of the American Gastroenterological Association; University of Michigan GI Peptide Center; Greenview Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI083785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation of the American Gastroenterological Association; University of Michigan GI Peptide Center(University of Michigan System); Greenview Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grant AI083785 from the National Institute of Allergy and Infectious Diseases, the Foundation of the American Gastroenterological Association (http://www.gastro.org/aga-foundation), the University of Michigan GI Peptide Center (http://www.med.umich.edu/mgpc/), and the Greenview Foundation (http://www.hepcfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BERGER KL, 2011, J VIROLOGY; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Chung RT, 2001, P NATL ACAD SCI USA, V98, P9847, DOI 10.1073/pnas.171319698; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gonzalez G, 2007, J VIROL METHODS, V145, P14, DOI 10.1016/j.jviromet.2007.04.013; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; PFEIFER U, 1980, VIRCHOWS ARCH B, V33, P233, DOI 10.1007/BF02899184; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Tai AW, 2011, ANAL BIOCHEM, V417, P97, DOI 10.1016/j.ab.2011.05.046; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	40	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26300	10.1371/journal.pone.0026300	http://dx.doi.org/10.1371/journal.pone.0026300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022594	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000096
J	Mui, UN; Lubczyk, CM; Nam, SC				Uyen Ngoc Mui; Lubczyk, Christina M.; Nam, Sang-Chul			Role of Spectraplakin in Drosophila Photoreceptor Morphogenesis	PLOS ONE			English	Article							ESSENTIAL STRUCTURAL ROLE; MICROTUBULE PLUS END; RETINITIS-PIGMENTOSA; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; AXON EXTENSION; SHORT-STOP; CRUMBS; EYE; PROTEIN	Background: Crumbs (Crb), a cell polarity gene, has been shown to provide a positional cue for the apical membrane domain and adherens junction during Drosophila photoreceptor morphogenesis. It has recently been found that stable microtubules in developing Drosophila photoreceptors were linked to Crb localization. Coordinated interactions between microtubule and actin cytoskeletons are involved in many polarized cellular processes. Since Spectraplakin is able to bind both microtubule and actin cytoskeletons, the role of Spectraplakin was analyzed in the regulations of apical Crb domain in developing Drosophila photoreceptors. Methodology/Principal Findings: The localization pattern of Spectraplakin in developing pupal photoreceptors showed a unique intracellular distribution. Spectraplakin localized at rhabdomere terminal web which is at the basal side of the apical Crb or rhabdomere, and in between the adherens junctions. The spectraplakin mutant photoreceptors showed dramatic mislocalizations of Crb, adherens junctions, and the stable microtubules. This role of Spectraplakin in Crb and adherens junction regulation was further supported by spectraplakin's gain-of-function phenotype. Spectraplakin overexpression in photoreceptors caused a cell polarity defect including dramatic mislocalization of Crb, adherens junctions and the stable microtubules in the developing photoreceptors. Furthermore, a strong genetic interaction between spectraplakin and crb was found using a genetic modifier test. Conclusions/Significance: In summary, we found a unique localization of Spectraplakin in photoreceptors, and identified the role of spectraplakin in the regulation of the apical Crb domain and adherens junctions through genetic mutational analysis. Our data suggest that Spectraplakin, an actin-microtubule cross-linker, is essential in the apical and adherens junction controls during the photoreceptors morphogenesis.	[Uyen Ngoc Mui; Lubczyk, Christina M.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X	Knights Templar Eye Foundation; University Research Committee of Baylor University	Knights Templar Eye Foundation; University Research Committee of Baylor University	This study was supported by Ophthalmology Research Grant of Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef/), and University Research Committee Grant of Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016127; Chen G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009480; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Fan SS, 1997, DEVELOPMENT, V124, P1497; Fischer JA, 2004, GENETICS, V168, P1385, DOI 10.1534/genetics.104.028662; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; League GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021218; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee M, 2003, DEVELOPMENT, V130, P5989, DOI 10.1242/dev.00806; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Mukhopadhyay B, 2010, GENESIS, V48, P522, DOI 10.1002/dvg.20642; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Newsome TP, 2000, DEVELOPMENT, V127, P851; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; Roper K, 2003, J CELL BIOL, V162, P1305, DOI 10.1083/jcb.200307089; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; XU T, 1993, DEVELOPMENT, V117, P1223	46	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25965	10.1371/journal.pone.0025965	http://dx.doi.org/10.1371/journal.pone.0025965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022483	Green Published, Green Submitted, gold			2022-12-25	WOS:000295976000051
J	Reguero, L; Puente, N; Elezgarai, I; Mendizabal-Zubiaga, J; Canduela, MJ; Buceta, I; Ramos, A; Suarez, J; de Fonseca, FR; Marsicano, G; Grandes, P				Reguero, Leire; Puente, Nagore; Elezgarai, Izaskun; Mendizabal-Zubiaga, Juan; Josune Canduela, Miren; Buceta, Ianire; Ramos, Almudena; Suarez, Juan; Rodriguez de Fonseca, Fernando; Marsicano, Giovanni; Grandes, Pedro			GABAergic and Cortical and Subcortical Glutamatergic Axon Terminals Contain CB1 Cannabinoid Receptors in the Ventromedial Nucleus of the Hypothalamus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ENDOCANNABINOID SYSTEM; FOOD-INTAKE; RAT-BRAIN; NEURONS; EXPRESSION; PROTEIN; APPETITE; BEHAVIOR; ENHANCER	Background: Type-1 cannabinoid receptors (CB1R) are enriched in the hypothalamus, particularly in the ventromedial hypothalamic nucleus (VMH) that participates in homeostatic and behavioral functions including food intake. Although CB1R activation modulates excitatory and inhibitory synaptic transmission in the brain, CB1R contribution to the molecular architecture of the excitatory and inhibitory synaptic terminals in the VMH is not known. Therefore, the aim of this study was to investigate the precise subcellular distribution of CB1R in the VMH to better understand the modulation exerted by the endocannabinoid system on the complex brain circuitries converging into this nucleus. Methodology/Principal Findings: Light and electron microscopy techniques were used to analyze CB1R distribution in the VMH of CB1R-WT, CB1R-KO and conditional mutant mice bearing a selective deletion of CB1R in cortical glutamatergic (Glu-CB1R-KO) or GABAergic neurons (GABA-CB1R-KO). At light microscopy, CB1R immunolabeling was observed in the VMH of CB1R-WT and Glu-CB1R-KO animals, being remarkably reduced in GABA-CB1R-KO mice. In the electron microscope, CB1R appeared in membranes of both glutamatergic and GABAergic terminals/preterminals. There was no significant difference in the percentage of CB1R immunopositive profiles and CB1R density in terminals making asymmetric or symmetric synapses in CB1R-WT mice. Furthermore, the proportion of CB1R immunopositive terminals/preterminals in CB1R-WT and Glu-CB1R-KO mice was reduced in GABA-CB1R-KO mutants. CB1R density was similar in all animal conditions. Finally, the percentage of CB1R labeled boutons making asymmetric synapses slightly decreased in Glu-CB1R-KO mutants relative to CB1R-WT mice, indicating that CB1R was distributed in cortical and subcortical excitatory synaptic terminals. Conclusions/Significance: Our anatomical results support the idea that the VMH is a relevant hub candidate in the endocannabinoid-mediated modulation of the excitatory and inhibitory neurotransmission of cortical and subcortical pathways regulating essential hypothalamic functions for the individual's survival such as the feeding behavior.	[Reguero, Leire; Puente, Nagore; Elezgarai, Izaskun; Mendizabal-Zubiaga, Juan; Josune Canduela, Miren; Buceta, Ianire; Ramos, Almudena; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Suarez, Juan; Rodriguez de Fonseca, Fernando] Fdn IMABIS, Malaga, Spain; [Marsicano, Giovanni] Univ Bordeaux 2, INSERM, U862, NeuroCtr Magendie, F-33076 Bordeaux, France	University of Basque Country; FIMABIS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Reguero, L (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain.	pedro.grandes@ehu.es	Ramos-Uriarte, Almudena/H-3179-2015; Ramos, Almudena/AAS-1563-2020; Puente, Nagore/H-7054-2015; Grandes, Pedro/AAA-1627-2019; Grandes, Pedro/H-7494-2015; Suarez, Juan/I-5188-2015; Marsicano, Giovanni/I-9603-2016; Mendizabal, Juan Luis/H-6874-2015; Elezgarai, Izaskun/H-7076-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Reguero, Leire/H-6865-2015	Ramos-Uriarte, Almudena/0000-0002-2632-1625; Ramos, Almudena/0000-0002-2632-1625; Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Suarez, Juan/0000-0001-5254-9802; Mendizabal, Juan Luis/0000-0002-4750-4797; Elezgarai, Izaskun/0000-0003-0880-8058; Alonso-Alconada, Daniel/0000-0002-9874-2947; Reguero, Leire/0000-0002-0267-5568; Marsicano, Giovanni/0000-0003-3804-1951	Basque Country Government [BFI 07.286, GIC07/70-IT-432-07]; Basque Country University; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN [RD07/0001/2001]; AVENIR/INSERM; Fondation Bettencourt-Schueller; ANR [ANR-06-NEURO-043-01]; European Foundation for the Study of Diabetes (EFSD); EU [HEALTH-F2-2008-223713]; European Commission Coordination Action ENINET [LSHM-CT-2005-19063]	Basque Country Government(Basque Government); Basque Country University; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation Bettencourt-Schueller; ANR(French National Research Agency (ANR)); European Foundation for the Study of Diabetes (EFSD); EU(European Commission); European Commission Coordination Action ENINET(European CommissionEuropean Commission Joint Research Centre)	L. Reguero is in receipt of a Predoctoral Fellowship from the Basque Country Government (BFI 07.286); I. Buceta is in receipt of a Predoctoral Fellowship from the Basque Country University. Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovacion (SAF2009-07065) and by Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632; Chee MJS, 2010, J NEUROSCI, V30, P3380, DOI 10.1523/JNEUROSCI.4031-09.2010; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jelsing J, 2008, NEUROSCIENCE, V154, P641, DOI 10.1016/j.neuroscience.2008.03.051; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kim KW, 2008, MOL ENDOCRINOL, V22, P1950, DOI 10.1210/me.2008-0127; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kiss J, 2011, NEUROSCIENCE, V176, P210, DOI 10.1016/j.neuroscience.2010.12.047; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puente N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008869; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	42	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26167	10.1371/journal.pone.0026167	http://dx.doi.org/10.1371/journal.pone.0026167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022550	Green Published, gold, Green Submitted			2022-12-25	WOS:000295973200045
J	Paini, DR; Bianchi, FJJA; Northfield, TD; De Barro, PJ				Paini, Dean R.; Bianchi, Felix J. J. A.; Northfield, Tobin D.; De Barro, Paul J.			Predicting Invasive Fungal Pathogens Using Invasive Pest Assemblages: Testing Model Predictions in a Virtual World	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; ECONOMIC-IMPACT; PATTERNS; DIVERSITY; RISK	Predicting future species invasions presents significant challenges to researchers and government agencies. Simply considering the vast number of potential species that could invade an area can be insurmountable. One method, recently suggested, which can analyse large datasets of invasive species simultaneously is that of a self organising map (SOM), a form of artificial neural network which can rank species by establishment likelihood. We used this method to analyse the worldwide distribution of 486 fungal pathogens and then validated the method by creating a virtual world of invasive species in which to test the SOM. This novel validation method allowed us to test SOM's ability to rank those species that can establish above those that can't. Overall, we found the SOM highly effective, having on average, a 96-98% success rate (depending on the virtual world parameters). We also found that regions with fewer species present (i.e. 1-10 species) were more difficult for the SOM to generate an accurately ranked list, with success rates varying from 100% correct down to 0% correct. However, we were able to combine the numbers of species present in a region with clustering patterns in the SOM, to further refine confidence in lists generated from these sparsely populated regions. We then used the results from the virtual world to determine confidences for lists generated from the fungal pathogen dataset. Specifically, for lists generated for Australia and its states and territories, the reliability scores were between 84-98%. We conclude that a SOM analysis is a reliable method for analysing a large dataset of potential invasive species and could be used by biosecurity agencies around the world resulting in a better overall assessment of invasion risk.	[Paini, Dean R.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Paini, Dean R.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia; [Bianchi, Felix J. J. A.; De Barro, Paul J.] Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia; [Northfield, Tobin D.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Washington State University	Paini, DR (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	Dean.Paini@csiro.au	Bianchi, Felix JJA/B-6044-2011; De Barro, Paul J/C-1724-2008; Northfield, Tobin/I-2323-2013; Paini, Dean R/C-2341-2009	Northfield, Tobin/0000-0002-0563-485X; 	Cooperative Research Corporation for National Plant Biosecurity [CRC 10001]	Cooperative Research Corporation for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Corporation for National Plant Biosecurity (http://www.crcplantbiosecurity.com.au/), CRC 10001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Brown KA, 2008, J APPL ECOL, V45, P1639, DOI 10.1111/j.1365-2664.2008.01550.x; Burgman M., 2005, RISKS DECISIONS CONS; CABI, 2003, CROP PROT COMP; Cereghino R, 2005, BIOL CONSERV, V125, P459, DOI 10.1016/j.biocon.2005.04.018; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Davis M. A., 2009, INVASION BIOL; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jacobs MJ, 2009, FRESHWATER BIOL, V54, P296, DOI 10.1111/j.1365-2427.2008.02108.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; KRITICOS D, 2001, WEED RISK ASSESSMENT; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mathworks, 2007, MATL VERS 7 4; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; R Core Development Team, 2010, R LANG ENV STAT COMP; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Underwood EC, 2004, DIVERS DISTRIB, V10, P447, DOI 10.1111/j.1366-9516.2004.00093.x; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	29	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25695	10.1371/journal.pone.0025695	http://dx.doi.org/10.1371/journal.pone.0025695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016773	Green Published, Green Accepted, gold			2022-12-25	WOS:000295971700015
J	Ward-Paige, CA; Lotze, HK				Ward-Paige, Christine A.; Lotze, Heike K.			Assessing the Value of Recreational Divers for Censusing Elasmobranchs	PLOS ONE			English	Article							PRESENCE-ABSENCE DATA; REEF FISHES; SHARK; ABUNDANCE; BEHAVIOR; TRENDS; CONSEQUENCES; TELEOSTEI; DENSITY; DECLINE	Background: Around the world, researchers are using the observations and experiences of citizens to describe patterns in animal populations. This data is often collected via ongoing sampling or by synthesizing past experiences. Since elasmobranchs are relatively rare, obtaining data for broad-scale trend analysis requires high sampling effort. Elasmobranchs are also relatively large and conspicuous and therefore it may be possible to enlist recreational divers to collect data on their occurrence and relative abundance from daily dive activities. For this, however, a good understanding of the value of data collected by recreational divers is essential. Methodology/Principal Findings: Here, we explore the value of recreational divers for censusing elasmobranchs using a diverse set of data sources. First, we use a simulation experiment to explore detection rates of the roving diver technique, used by recreational divers, across a range of fish densities and speeds. Next, using a field survey, we show that inexperienced recreational divers detect and count elasmobranchs as well as experienced recreational divers. Finally, we use semi-structured interviews of recreational dive instructors to demonstrate the value of their recollections in terms of effort and their descriptions of spatial and temporal distributions of sharks in Thailand. Conclusions/Significance: Overall, this study provides initial ground-work for using recreational divers for monitoring elasmobranch populations. If used appropriately, citizen-collected data may provide additional information that can be used to complement more standardized surveys and to describe population trends across a range of spatial and temporal scales. Due to the non-extractive nature of this data, recreational divers may also provide important insight into the success of conservation initiatives, such as shark sanctuaries and no-take zones.	[Ward-Paige, Christine A.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Ward-Paige, CA (corresponding author), Natl Marine Fisheries Serv, SEFSC, Panama City Lab, Panama City, FL USA.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada with grants to Dr. Lotze, and by the NSERC: http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack JA, 1986, STATIONARY VISUAL CE; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Bunce M, 2008, OCEAN COAST MANAGE, V51, P285, DOI 10.1016/j.ocecoaman.2007.09.006; C?lix M., 2018, EUROPEAN RED LIST SA; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; Cooper CB, 2007, ECOL SOC, V12; Darwall WRT, 1996, BIOL CONSERV, V78, P223, DOI 10.1016/0006-3207(95)00147-6; Davis D, 1997, TOURISM MANAGE, V18, P259, DOI 10.1016/S0261-5177(97)00015-0; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2008, AQUATIC CONSERVATION; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holt BG, 2010, GLOBAL ECOL BIOGEOGR, V19, P432, DOI 10.1111/j.1466-8238.2010.00539.x; Huveneers C, 2009, AQUAT LIVING RESOUR, V22, P255, DOI 10.1051/alr/2009046; JONES R S, 1975, Micronesica, V11, P127; KIMMEL JJ, 1985, ENVIRON BIOL FISH, V12, P23, DOI 10.1007/BF00007707; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Martin RA, 2007, MAR FRESHW BEHAV PHY, V40, P3, DOI 10.1080/10236240601154872; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Quiros AL, 2007, FISH RES, V84, P102, DOI 10.1016/j.fishres.2006.11.017; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Saenz-Arroyo A, 2005, FISH FISH, V6, P280; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Schmitt EF, 1996, B MAR SCI, V59, P404; Schmitt EF, 1993, RES APPL VOLUNTEER G; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Strayer DL, 1999, CONSERV BIOL, V13, P1034, DOI 10.1046/j.1523-1739.1999.98143.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Theberge MM, 2006, ORYX, V40, P337, DOI 10.1017/S0030605306000998; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Topelko Karen N., 2005, Journal of Ecotourism, V4, P108, DOI 10.1080/14724040409480343; Vidthayanon, 1997, ELASMOBRANCH BIODIVE; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Ward-Paige CA, 2011, ENVIRON BIOL FISH, V90, P263, DOI 10.1007/s10641-010-9739-1; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Weaver DC, 2007, COPEIA, P798, DOI 10.1643/0045-8511(2007)7[798:ANSOHT]2.0.CO;2; WEBB PW, 1982, FISH B-NOAA, V80, P803; Williams ID, 2000, ENVIRON CONSERV, V27, P382, DOI 10.1017/S0376892900000436; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551	52	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25609	10.1371/journal.pone.0025609	http://dx.doi.org/10.1371/journal.pone.0025609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016771	Green Submitted, Green Published, gold			2022-12-25	WOS:000295971700013
J	Afify, AMR; El-Beltagi, HS; Abd El-Salam, SM; Omran, AA				Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.; Abd El-Salam, Samiha M.; Omran, Azza A.			Bioavailability of Iron, Zinc, Phytate and Phytase Activity during Soaking and Germination of White Sorghum Varieties	PLOS ONE			English	Article							VITRO PROTEIN DIGESTIBILITY; PHYTIC ACID; PHENOLIC-COMPOUNDS; ALKALINE PHYTASE; LEGUME SEEDS; ABSORPTION; FERMENTATION; CEREALS; FOODS; PURIFICATION	The changes in phytate, phytase activity and in vitro bioavailability of iron and zinc during soaking and germination of three white sorghum varieties (Sorghum bicolor L. Moench), named Dorado, Shandweel-6, and Giza-15 were investigated. Sorghum varieties were soaked for 20 h and germinated for 72 h after soaking for 20 h to reduce phytate content and increase iron and zinc in vitro bioavailability. The results revealed that iron and zinc content was significantly reduced from 28.16 to 32.16% and 13.78 to 26.69% for soaking treatment and 38.43 to 39.18% and 21.80 to 31.27% for germination treatments, respectively. Phytate content was significantly reduced from 23.59 to 32.40% for soaking treatment and 24.92 to 35.27% for germination treatments, respectively. Phytase enzymes will be activated during drying in equal form in all varieties. The results proved that the main distinct point is the change of phytase activity as well as specific activity during different treatment which showed no significant differences between the varieties used. The in vitro bioavailability of iron and zinc were significantly improved as a result of soaking and germination treatments.	[Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.] Cairo Univ, Dept Biochem, Fac Agr, Cairo, Egypt; [Abd El-Salam, Samiha M.; Omran, Azza A.] Agr Res Ctr, Dept Crops Technol, Food Technol Res Inst, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Afify, AMR (corresponding author), Cairo Univ, Dept Biochem, Fac Agr, Cairo, Egypt.	lbltg@yahoo.com	Omran, Azza A./AAY-3922-2020; El-Beltagi, Hossam/T-2547-2018; El-Beltagi, Hossam S./L-8546-2019; Omran, Azza A. A./ABF-3888-2021	Omran, Azza A./0000-0002-9328-8087; El-Beltagi, Hossam/0000-0003-4433-2034; Omran, Azza A. A./0000-0002-9328-8087	Department of Biochemistry, Faculty of Agriculture, Cairo University	Department of Biochemistry, Faculty of Agriculture, Cairo University(Cairo University)	This work was supported by the Department of Biochemistry, Faculty of Agriculture, Cairo University. The Department of Crops Technology, the Food Technology Research Institute, and the Agricultural Research Center cooperated in study design, data collection and analysis, and decision to publish.	Abdel-Rahim E. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1117; Adeyeye EI, 2000, FOOD CHEM, V71, P435, DOI 10.1016/S0308-8146(00)00159-X; Agte V. V., 1999, Journal of Food Composition and Analysis, V12, P161, DOI 10.1006/jfca.1999.0826; Agte VV, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P261; ALLEN LH, 1997, IMPROVING IRON STATU, P1; [Anonymous], 1939, INDIAN ENG CHEM ANN; [Anonymous], 2000, OFF METH AN ASS OFF; BARRIENTOS L, 1994, PLANT PHYSIOL, V106, P1489, DOI 10.1104/pp.106.4.1489; BARRIER GB, 1996, J SCI FOOD AGR, V70, P69; BRUNE M, 1989, AM J CLIN NUTR, V49, P542, DOI 10.1093/ajcn/49.3.542; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; El-Beltagi HES, 2011, INT J FOOD SCI NUTR, V62, P453, DOI 10.3109/09637486.2010.544642; Elkhalifa AEO, 2005, FOOD CHEM, V92, P1, DOI 10.1016/j.foodchem.2004.05.058; Elkhalil EAI, 2001, FOOD CHEM, V72, P29, DOI 10.1016/S0308-8146(00)00195-3; Elsheikh EAE, 2000, FOOD CHEM, V68, P211, DOI 10.1016/S0308-8146(99)00153-3; FERGUSON E L, 1988, Journal of Food Composition and Analysis, V1, P316, DOI 10.1016/0889-1575(88)90031-2; FROLICH W, 1995, EUR J CLIN NUTR, V49, pS116; Gibson Rosalind S., 1994, Nutrition Research Reviews, V7, P151, DOI 10.1079/NRR19940010; Godoy S, 2005, INTERCIENCIA, V30, P24; Greiner R, 2002, J AGR FOOD CHEM, V50, P6858, DOI 10.1021/jf025619u; Greiner R, 2001, J AGR FOOD CHEM, V49, P2234, DOI 10.1021/jf0100806; Greiner R, 1999, J FOOD PROCESS PRES, V23, P249, DOI 10.1111/j.1745-4549.1999.tb00383.x; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; HENRIKSEN LK, 1985, J AM DIET ASSOC, V85, P563; Hulse JH, 1980, SORGHUM MILLETS THEI; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Jambunathan R., 1980, Food and Nutrition Bulletin, V2, P11; Jog SP, 2005, ARCH BIOCHEM BIOPHYS, V440, P133, DOI 10.1016/j.abb.2005.05.029; Kayode APP, 2007, LWT-FOOD SCI TECHNOL, V40, P834, DOI 10.1016/j.lwt.2006.04.001; Kayode APP, 2006, J SCI FOOD AGR, V86, P1032, DOI 10.1002/jsfa.2451; Kayode APP, 2006, THESIS WAGENINGEN U, P1; Kiers JL, 2000, J SCI FOOD AGR, V80, P1325, DOI 10.1002/1097-0010(200007)80:9&lt;1325::AID-JSFA648&gt;3.0.CO;2-K; Konietzny U, 2002, INT J FOOD SCI TECH, V37, P791, DOI 10.1046/j.1365-2621.2002.00617.x; Lestienne I, 2005, FOOD CHEM, V89, P421, DOI 10.1016/j.foodchem.2004.03.040; Lind T, 2003, AM J CLIN NUTR, V78, P168, DOI 10.1093/ajcn/78.1.168; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahgoub SEO, 1998, FOOD CHEM, V61, P77, DOI 10.1016/S0308-8146(97)00109-X; MARERO LM, 1991, FOOD SCI TECHNOL-LEB, V24, P177; MOHAMED AI, 1986, CEREAL CHEM, V63, P475; MOSHA MC, 1990, FOOD NUTR BULL, V12, P69; MULIMANI VH, 1994, PLANT FOOD HUM NUTR, V46, P27, DOI 10.1007/BF01088458; RABOY V, 1990, PLANT BIOL, V9, P55; RADHAKRISHNAN MR, 1980, J AGR FOOD CHEM, V28, P55, DOI 10.1021/jf60227a038; Reddy NR, 2002, FOOD PHYTATES, P25; Saharan K., 2001, Innovative Food Science & Emerging Technologies, V2, P323, DOI 10.1016/S1466-8564(01)00044-3; SANDBERG AS, 1991, J FOOD SCI, V56, P1330, DOI 10.1111/j.1365-2621.1991.tb04765.x; SANDSTROM B, 1992, P NUTR SOC, V51, P211, DOI 10.1079/PNS19920031; Serna-Saldivar S., 1995, SORGHUM MILLETS CHEM, P69; Shallan M. A., 2010, Australian Journal of Basic and Applied Sciences, V4, P114; Shallan M. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P958; Shehab GG, 2010, NOT BOT HORTI AGROBO, V38, P139; Steiner T, 2007, ANIM FEED SCI TECH, V133, P320, DOI 10.1016/j.anifeedsci.2006.04.007; Svanberg U, 1997, FOOD CONTROL, V8, P319, DOI 10.1016/S0956-7135(97)00018-2; SVANBERG U, 1987, IMPROVING YOUNG CHIL; Towo E, 2006, FOOD CHEM, V94, P369, DOI 10.1016/j.foodchem.2004.11.027; Troost FJ, 2003, AM J CLIN NUTR, V78, P1018, DOI 10.1093/ajcn/78.5.1018	58	94	98	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25512	10.1371/journal.pone.0025512	http://dx.doi.org/10.1371/journal.pone.0025512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003395	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300016
J	Gaballah, A; Kloeckner, A; Otten, C; Sahl, HG; Henrichfreise, B				Gaballah, Ahmed; Kloeckner, Anna; Otten, Christian; Sahl, Hans-Georg; Henrichfreise, Beate			Functional Analysis of the Cytoskeleton Protein MreB from Chlamydophila pneumoniae	PLOS ONE			English	Article							CELL-WALL; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; CHLAMYDIA-TRACHOMATIS; DIVISION MACHINE; ACTIN MREB; PEPTIDOGLYCAN; MEMBRANE; BACTERIA	In rod-shaped bacteria, the bacterial actin ortholog MreB is considered to organize the incorporation of cell wall precursors into the side-wall, whereas the tubulin homologue FtsZ is known to tether incorporation of cell wall building blocks at the developing septum. For intracellular bacteria, there is no need to compensate osmotic pressure by means of a cell wall, and peptidoglycan has not been reliably detected in Chlamydiaceae. Surprisingly, a nearly complete pathway for the biosynthesis of the cell wall building block lipid II has been found in the genomes of Chlamydiaceae. In a previous study, we discussed the hypothesis that conservation of lipid II biosynthesis in cell wall-lacking bacteria may reflect the intimate molecular linkage of cell wall biosynthesis and cell division and thus an essential role of the precursor in cell division. Here, we investigate why spherical-shaped chlamydiae harbor MreB which is almost exclusively found in elongated bacteria (i.e. rods, vibrios, spirilla) whereas they lack the otherwise essential division protein FtsZ. We demonstrate that chlamydial MreB polymerizes in vitro and that polymerization is not inhibited by the blocking agent A22. As observed for MreB from Bacillus subtilis, chlamydial MreB does not require ATP for polymerization but is capable of ATP hydrolysis in phosphate release assays. Co-pelleting and bacterial two-hybrid experiments indicate that MreB from Chlamydophila (Chlamydia) pneumoniae interacts with MurF, MraY and MurG, three key components in lipid II biosynthesis. In addition, MreB polymerization is improved in the presence of MurF. Our findings suggest that MreB is involved in tethering biosynthesis of lipid II and as such may be necessary for maintaining a functional divisome machinery in Chlamydiaceae.	[Gaballah, Ahmed; Kloeckner, Anna; Otten, Christian; Sahl, Hans-Georg; Henrichfreise, Beate] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-5300 Bonn, Germany	University of Bonn	Gaballah, A (corresponding author), Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-5300 Bonn, Germany.	bhenrich@uni-bonn.de	Gaballah, Ahmed/AFL-6554-2022	Gaballah, Ahmed/0000-0002-9038-6597	European Union; Medical Faculty of Bonn; DAAD	European Union(European Commission); Medical Faculty of Bonn; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	BH was supported by the European Union ("New Antimicrobials" project, people programme, FP7) (http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&QUERY=01321ea9dcd3:5038:207a143f&RCN=86714). Support for this study was received by the intramural funding scheme of the Medical Faculty of Bonn (http://www.meb.uni-bonn.de/bonfor/). A. Gaballah received a PhD fellowship from the DAAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ghuysen JM, 1999, ANTIMICROB AGENTS CH, V43, P2339, DOI 10.1128/AAC.43.10.2339; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Iwai N, 2007, BIOSCI BIOTECH BIOCH, V71, P246, DOI 10.1271/bbb.60443; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Patin D, 2009, J BACTERIOL, V191, P7430, DOI 10.1128/JB.01029-09; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Takacs CN, 2010, J BACTERIOL, V192, P1671, DOI 10.1128/JB.01311-09; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Vats P, 2009, MOL MICROBIOL, V72, P170, DOI 10.1111/j.1365-2958.2009.06632.x; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Wu X, 2011, RES MICROBIOL, V162, P375, DOI 10.1016/j.resmic.2011.02.001	41	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25129	10.1371/journal.pone.0025129	http://dx.doi.org/10.1371/journal.pone.0025129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	22022378	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900008
J	Lolicato, M; Nardini, M; Gazzarrini, S; Moller, S; Bertinetti, D; Herberg, FW; Bolognesi, M; Martin, H; Fasolini, M; Bertrand, JA; Arrigoni, C; Thiel, G; Moroni, A				Lolicato, Marco; Nardini, Marco; Gazzarrini, Sabrina; Moeller, Stefan; Bertinetti, Daniela; Herberg, Friedrich W.; Bolognesi, Martino; Martin, Holger; Fasolini, Marina; Bertrand, Jay A.; Arrigoni, Cristina; Thiel, Gerhard; Moroni, Anna			Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HCN PACEMAKER CHANNELS; STRUCTURAL BASIS; LIGAND-BINDING; PROTEINS; MODULATION; MODEL; IDENTIFICATION; MECHANISMS; AMP	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are dually activated by hyperpolarization and binding of cAMP to their cyclic nucleotide binding domain (CNBD). HCN isoforms respond differently to cAMP; binding of cAMP shifts activation of HCN2 and HCN4 by 17 mV but shifts that of HCN1 by only 2-4 mV. To explain the peculiarity of HCN1, we solved the crystal structures and performed a biochemical-biophysical characterization of the C-terminal domain (C-linker plus CNBD) of the three isoforms. Our main finding is that tetramerization of the C-terminal domain of HCN1 occurs at basal cAMP concentrations, whereas those of HCN2 and HCN4 require cAMP saturating levels. Therefore, HCN1 responds less markedly than HCN2 and HCN4 to cAMP increase because its CNBD is already partly tetrameric. This is confirmed by voltage clamp experiments showing that the right-shifted position of V-1/2 in HCN1 is correlated with its propensity to tetramerize in vitro. These data underscore that ligand-induced CNBD tetramerization removes tonic inhibition from the pore of HCN channels.	[Moroni, Anna] Univ Milan, Dept Biol, CNR IBF, I-20133 Milan, Italy; [Lolicato, Marco; Gazzarrini, Sabrina; Martin, Holger; Arrigoni, Cristina; Moroni, Anna] Univ Milan, Consiglio Nazl Ric, Ist Biofis, I-20133 Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Moeller, Stefan; Bertinetti, Daniela; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Fasolini, Marina; Bertrand, Jay A.] Nerviano Med Sci Srl, Oncol, I-20014 Nerviano, MI, Italy; [Thiel, Gerhard] Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Universitat Kassel; Nerviano Medical Sciences S.r.l; Technical University of Darmstadt	Moroni, A (corresponding author), Univ Milan, Dept Biol, CNR IBF, Via Celoria 26, I-20133 Milan, Italy.	anna.moroni@unimi.it	Bolognesi, Martino/B-7924-2017; Bertinetti, Daniela/B-5655-2015; Nardini, Marco/B-7842-2017; Lolicato, Marco/AAL-3614-2020; moroni, anna/H-2097-2014; Lolicato, Marco/ABC-6878-2020; Herberg, Friedrich W/B-5572-2015; Arrigoni, Cristina/AAG-8176-2020	Bolognesi, Martino/0000-0002-9253-5170; Bertinetti, Daniela/0000-0003-1150-3765; Nardini, Marco/0000-0002-3718-2165; Lolicato, Marco/0000-0002-2022-7961; moroni, anna/0000-0002-1860-406X; Lolicato, Marco/0000-0002-2022-7961; Herberg, Friedrich W/0000-0001-7117-7653; gazzarrini, sabrina/0000-0003-3062-7536; Thiel, Gerhard/0000-0002-2335-1351; Arrigoni, Cristina/0000-0003-1917-1750	European Union; Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia	European Union(European Commission); Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia	This work was supported in part by European Union Grant EDICT (European Drug Initiative on Channels and Transporters) and Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia (to A. M.) and European Union grant Affinity Proteome and Affinomics (to F. W. H.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Moll D, 2006, J NEURAL TRANSM, V113, P1015, DOI 10.1007/s00702-006-0515-5; Moll D, 2007, BIOL CHEM, V388, P163, DOI 10.1515/BC.2007.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Scott SP, 2007, BIOCHEMISTRY-US, V46, P9417, DOI 10.1021/bi6026049; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wicks NL, 2011, P NATL ACAD SCI USA, V108, P609, DOI 10.1073/pnas.1012750108; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	36	95	99	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44811	44820		10.1074/jbc.M111.297606	http://dx.doi.org/10.1074/jbc.M111.297606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22006928	Green Published, hybrid			2022-12-25	WOS:000298645500050
J	Abuhatzira, L; Shamir, A; Schones, DE; Schaffer, AA; Bustin, M				Abuhatzira, Liron; Shamir, Alon; Schones, Dustin E.; Schaeffer, Alejandro A.; Bustin, Michael			The Chromatin-binding Protein HMGN1 Regulates the Expression of Methyl CpG-binding Protein 2 (MECP2) and Affects the Behavior of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-SYNDROME; CHROMOSOMAL-PROTEINS; HISTONE DEACETYLASE; NEURONAL MECP2; RETT-SYNDROME; MOUSE; DISEASE; GENE; PHENOTYPE; ELEMENTS	High mobility group N1 protein (HMGN1), a nucleosomal-binding protein that affects the structure and function of chromatin, is encoded by a gene located on chromosome 21 and is overexpressed in Down syndrome, one of the most prevalent genomic disorders. Misexpression of HMGN1 affects the cellular transcription profile; however, the biological function of this protein is still not fully understood. We report that HMGN1 modulates the expression of methyl CpG-binding protein 2 (MeCP2), a DNA-binding protein known to affect neurological functions including autism spectrum disorders, and whose alterations in HMGN1 levels affect the behavior of mice. Quantitative PCR and Western analyses of cell lines and brain tissues from mice that either overexpress or lack HMGN1 indicate that HMGN1 is a negative regulator of MeCP2 expression. Alterations in HMGN1 levels lead to changes in chromatin structure and histone modifications in the MeCP2 promoter. Behavior analyses by open field test, elevated plus maze, Reciprocal Social Interaction, and automated sociability test link changes in HMGN1 levels to abnormalities in activity and anxiety and to social deficits in mice. Targeted analysis of the Autism Genetic Resource Exchange genotype collection reveals a non-random distribution of genotypes within 500 kbp of HMGN1 in a region affecting its expression in families predisposed to autism spectrum disorders. Our results reveal that HMGN1 affects the behavior of mice and suggest that epigenetic changes resulting from altered HMGN1 levels could play a role in the etiology of neurodevelopmental disorders.	[Abuhatzira, Liron; Bustin, Michael] NCI, Prot Sect, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Shamir, Alon] NICHD, Bethesda, MD 20892 USA; [Schones, Dustin E.] City Hope Natl Med Ctr, Duarte, CA 91010 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); City of Hope	Bustin, M (corresponding author), Bldg 37,Rm 3122, Bethesda, MD 20892 USA.	Bustin@helix.nih.gov	Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242; Abuhatzira, Liron/0000-0002-2742-0908	National Institutes of Health Center for Cancer Research; NCI; National Library of Medicine; NIMH, National Institutes of Health [1U24MH081810]; NATIONAL CANCER INSTITUTE [ZIABC011154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health Center for Cancer Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Center for Cancer Research, the intramural program of the NCI, and by the Intramural Research Program of the National Library of Medicine.; Human brain tissue was obtained from the NICHD, National Institutes of Health Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD. We acknowledge the resources provided by the AGRE Consortium and the participating AGRE families. AGRE is a program of Autism Speaks and is supported, in part, by NIMH, National Institutes of Health Grant 1U24MH081810 (to Dr. Clara M. Lajonchere). We thank Dr. Vlad Kustanovich at AGRE for answering numerous questions, Dr. Stefan Wuchty for extracting the FHS data from dbGa-Pand, and Dr. Mu Yang, NIMH, National Institutes of Health for critical review of the mouse behavior test results.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Abuhatzira L, 2009, HUM MOL GENET, V18, P1415, DOI 10.1093/hmg/ddp048; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Bird A, 2008, BIOCHEM SOC T, V36, P575, DOI 10.1042/BST0360575; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; BUSTIN M, 1995, SEMIN CELL BIOL, V6, P247, DOI 10.1006/scel.1995.0033; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; BUSTIN M, 1990, J BIOL CHEM, V265, P20077; Bustin M, 1995, DNA CELL BIOL, V14, P997, DOI 10.1089/dna.1995.14.997; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Catez F, 2010, BBA-GENE REGUL MECH, V1799, P15, DOI 10.1016/j.bbagrm.2009.11.001; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; CoussonsRead ME, 1996, BEHAV GENET, V26, P7, DOI 10.1007/BF02361154; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dimas C, 2008, J AM PSYCHOANAL ASS, V56, P1342, DOI 10.1177/00030651080560042203; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; Dubinsky MC, 2010, INFLAMM BOWEL DIS, V16, P1357, DOI 10.1002/ibd.21174; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Gardiner K, 2010, J NEUROSCI, V30, P14943, DOI 10.1523/JNEUROSCI.3728-10.2010; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Grafodatskaya D, 2010, J AM ACAD CHILD PSY, V49, P794, DOI 10.1016/j.jaac.2010.05.005; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kamens HM, 2007, NAT PROTOC, V2, P277, DOI 10.1038/nprot.2007.19; KOOY RF, 2010, F1000 BIOL REP, V2; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Murata K, 2009, DEV GROWTH DIFFER, V51, P95, DOI 10.1111/j.1440-169X.2008.01084.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; PASH JM, 1990, J BIOL CHEM, V265, P4197; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Scherr R, 2009, DIGEST DIS, V27, P236, DOI 10.1159/000228555; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SINET PM, 1994, BIOMED PHARMACOTHER, V48, P247, DOI 10.1016/0753-3322(94)90140-6; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; van Bokhoven H, 2010, NEUROBIOL DIS, V39, P3, DOI 10.1016/j.nbd.2010.03.010; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104	68	34	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42051	42062		10.1074/jbc.M111.300541	http://dx.doi.org/10.1074/jbc.M111.300541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009741	Green Published, hybrid			2022-12-25	WOS:000298180900015
J	Chen, Y; Shi, HY; Stock, SR; Stern, PH; Zhang, M				Chen, Yan; Shi, Heidi Y.; Stock, Stuart R.; Stern, Paula H.; Zhang, Ming			Regulation of Breast Cancer-induced Bone Lesions by beta-Catenin Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; HUMAN OSTEOSARCOMA; WNT PATHWAY; CYCLIN D1; CELLS; EXPRESSION; METASTASIS	Breast cancer patients have an extremely high rate of bone metastases. Morphological analyses of the bones in most of the patients have revealed the mixed bone lesions, comprising both osteolytic and osteoblastic elements. beta-Catenin plays a key role in both embryonic skeletogenesis and postnatal bone regeneration. Although this pathway is also involved in many bone malignancy, such as osteosarcoma and prostate cancer-induced bone metastases, its regulation of breast cancer bone metastases remains unknown. Here, we provide evidence that the beta-catenin signaling pathway has a significant impact on the bone lesion phenotype. In this study, we established a novel mouse model of mixed bone lesions using intratibial injection of TM40D-MB cells, a breast cancer cell line that is highly metastatic to bone. We found that both upstream and downstream molecules of the beta-catenin pathway are up-regulated in TM40D-MB cells compared with non-bone metastatic TM40D cells. TM40D-MB cells also have a higher T cell factor (TCF) reporter activity than TM40D cells. Inactivation of beta-catenin in TM40D-MB cells through expression of a dominant negative TCF4 not only increases osteoclast differentiation in a tumor-bone co-culture system and enhances osteolytic bone destruction in mice, but also inhibits osteoblast differentiation. Surprisingly, although tumor cells overexpressing beta-catenin did induce a slight increase of osteoblast differentiation in vitro, these cells display a minimal effect on osteoblastic bone formation in mice. These data collectively demonstrate that beta-catenin acts as an important determinant in mixed bone lesions, especially in controlling osteoblastic effect within tumor-harboring bone environment.	[Chen, Yan; Shi, Heidi Y.; Stock, Stuart R.; Stern, Paula H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Robert H Lurie Comprehens Canc Ctr, Lurie 6-250,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Stock, Stuart R./0000-0002-8886-4035	National Institutes of Health [R01 CA79736]; Susan G. Komen Breast Cancer Foundation [KG080231]; NATIONAL CANCER INSTITUTE [R01CA079736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA79736 (to M. Z.). This work was also supported by Susan G. Komen Breast Cancer Foundation Grant KG080231 (to M. Z.).	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Barnes GL, 2003, CANCER RES, V63, P2631; Behrens J, 2000, J CELL SCI, V113, P911; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Howe LR, 1999, CANCER RES, V59, P1572; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; KITTRELL FS, 1992, CANCER RES, V52, P1924; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Miki T, 2004, INT J CANCER, V108, P511, DOI 10.1002/ijc.11586; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yang Yingzi, 2003, Birth Defects Research, V69, P305, DOI 10.1002/bdrc.10026; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	46	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42575	42584		10.1074/jbc.M111.294595	http://dx.doi.org/10.1074/jbc.M111.294595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009747	Green Published, hybrid			2022-12-25	WOS:000298180900065
J	Miranda, DA; Koves, TR; Gross, DA; Chadt, A; Al-Hasani, H; Cline, GW; Schwartz, GJ; Muoio, DM; Silver, DL				Miranda, Diego A.; Koves, Timothy R.; Gross, David A.; Chadt, Alexandra; Al-Hasani, Hadi; Cline, Gary W.; Schwartz, Gary J.; Muoio, Deborah M.; Silver, David L.			Re-patterning of Skeletal Muscle Energy Metabolism by Fat Storage-inducing Transmembrane Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; LIPID DROPLET PROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; INTRAMUSCULAR TRIACYLGLYCEROL; GLUCOSE-TRANSPORT; RAT; EXERCISE; FAMILY; ALPHA	Triacylglyceride stored in cytosolic lipid droplets (LDs) constitutes a major energy reservoir in most eukaryotes. The regulated turnover of triacylglyceride in LDs provides fatty acids for mitochondrial beta-oxidation and ATP generation in physiological states of high demand for energy. The mechanisms for the formation of LDs in conditions of energy excess are not entirely understood. Fat storage-inducing transmembrane protein 2 (FIT2/FITM2) is the anciently conserved member of the fat storage-inducing transmembrane family of proteins implicated to be important in the formation of LDs, but its role in energy metabolism has not been tested. Here, we report that expression of FIT2 in mouse skeletal muscle had profound effects on muscle energy metabolism. Mice with skeletal muscle-specific overexpression of FIT2 (CKF2) had significantly increased intramyocellular triacylglyceride and complete protection from high fat diet-induced weight gain due to increased energy expenditure. Mass spectrometry-based metabolite profiling suggested that CKF2 skeletal muscle had increased oxidation of branched chain amino acids but decreased oxidation of fatty acids. Glucose was primarily utilized in CKF2 muscle for synthesis of the glycerol backbone of triacylglyceride and not for glycogen production. CKF2 muscle was ATP-deficient and had activated AMP kinase. Together, these studies indicate that FIT2 expression in skeletal muscle plays an unexpected function in regulating muscle energy metabolism and indicates an important role for lipid droplet formation in this process.	[Miranda, Diego A.; Gross, David A.; Schwartz, Gary J.; Silver, David L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Chadt, Alexandra; Al-Hasani, Hadi] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany; [Cline, Gary W.] Yale Univ, Sch Med, Diabet Endocrinol Res Ctr, New Haven, CT 06520 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Duke University; Deutsches Diabetes-Zentrum (DDZ); Yale University	Silver, DL (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.silver@einstein.yu.edu	Koves, Tim/I-4806-2012; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Muoio, Deborah/0000-0003-3760-9277; Silver, David/0000-0002-7289-9890	National Institutes of Health [HL082697, 5F31DK083919, NIHDK020541, R01-AG028930]; American Diabetes Association; The Ellison Medical Foundation [AG-NS-0548-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, F31DK083919, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); The Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082697 (to D. L. S.), 5F31DK083919 (to D. A. M.), NIHDK020541 (to G. J. S.), and R01-AG028930 (to D. M.). This work was also supported by a grant from the American Diabetes Association (to D. M.) and Grant AG-NS-0548-09 from The Ellison Medical Foundation (to T. K.).	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Buse MG, 1996, J BIOL CHEM, V271, P23197, DOI 10.1074/jbc.271.38.23197; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kornberg H L, 1970, Biochem Soc Symp, V30, P155; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; PALFREYMAN RW, 1992, BIOCHEM J, V284, P275, DOI 10.1042/bj2840275; REN JM, 1993, J BIOL CHEM, V268, P16113; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Streeper RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE388, DOI 10.1152/ajpendo.00621.2005; Thyfault JP, 2010, AM J PHYSIOL-REG I, V299, pR926, DOI 10.1152/ajpregu.00093.2010; Vaitheesvaran B, 2010, DIABETOLOGIA, V53, P2224, DOI 10.1007/s00125-010-1827-4; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	48	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42188	42199		10.1074/jbc.M111.297127	http://dx.doi.org/10.1074/jbc.M111.297127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002063	Green Published, hybrid			2022-12-25	WOS:000298180900029
J	Sen, GS; Mohanty, S; Hossain, DMS; Bhattacharyya, S; Banerjee, S; Chakraborty, J; Saha, S; Ray, P; Bhattacharjee, P; Mandal, D; Bhattacharya, A; Chattopadhyay, S; Das, T; Sa, G				Sen, Gouri Sankar; Mohanty, Suchismita; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Banerjee, Shuvomoy; Chakraborty, Juni; Saha, Shilpi; Ray, Pallab; Bhattacharjee, Pushpak; Mandal, Debaprasad; Bhattacharya, Arindam; Chattopadhyay, Samit; Das, Tanya; Sa, Gaurisankar			Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NF kappa B-p300 Cross-talk in Favor of p53-p300 in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL APOPTOSIS; NECROSIS-FACTOR-ALPHA; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; CHEMOPREVENTIVE AGENT; DNA-DAMAGE; P53; ACTIVATION; CARCINOMA	Breast cancer cells often develop multiple mechanisms of drug resistance during tumor progression, which is the major reason for the failure of breast cancer therapy. High constitutive activation of NF kappa B has been found in different cancers, creating an environment conducive for chemotherapeutic resistance. Here we report that doxorubicin-induced SMAR1-dependent transcriptional repression and SMAR1-independent degradation of IkB alpha resulted in nuclear translocation of p65NF kappa B and its association with p300 histone acetylase and subsequent transcription of Bcl-2 to impart protective response in drug-resistant cells. Consistently SMAR1-silenced drug-resistant cells exhibited IkB alpha-mediated inhibition of p65NF kappa B and induction of p53-dependent apoptosis. Interestingly, curcumin pretreatment of drug-resistant cells alleviated SMAR1-mediated p65NF kappa B activation and hence restored doxorubicin sensitivity. Under such anti-survival condition, induction of p53-p300 cross-talk enhanced the transcriptional activity of p53 and intrinsic death cascade. Importantly, promyelocyte leukemia-mediated SMAR1 sequestration that relieved the repression of apoptosis-inducing genes was indispensable for such chemosensitizing ability of curcumin. A simultaneous decrease in drug-induced systemic toxicity by curcumin might also have enhanced the efficacy of doxorubicin by improving the intrinsic defense machineries of the tumor-bearer. Overall, the findings of this preclinical study clearly demonstrate the effectiveness of curcumin to combat doxorubicin-resistance. We, therefore, suggest curcumin as a potent chemo-sensitizer to improve the therapeutic index of this widely used anti-cancer drug. Taken together, these results suggest that curcumin can be developed into an adjuvant chemotherapeutic drug.	[Sen, Gouri Sankar; Mohanty, Suchismita; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Banerjee, Shuvomoy; Chakraborty, Juni; Saha, Shilpi; Ray, Pallab; Bhattacharjee, Pushpak; Mandal, Debaprasad; Bhattacharya, Arindam; Chattopadhyay, Samit; Das, Tanya; Sa, Gaurisankar] Bose Inst, Div Mol Med, Kolkata 700054, India; [Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sa, G (corresponding author), Bose Inst, Div Mol Med, P-1-12,Calcutta Improvement Trust Scheme 7 M, Kolkata 700054, India.	gauri@bic.boseinst.ernet.in	Bhattacharyya, Sankar/GZH-3091-2022; Banerjee, Shuvomoy/AAZ-2479-2021; Bhattacharjee, Pushpak/AFV-4590-2022; Bhattacharyya, Sankar/AAK-2204-2020	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950; Mandal, Deba Prasad/0000-0002-8052-6576	Department of Science and Technology, Government of India; Grants-in-Aid for Scientific Research [22659246] Funding Source: KAKEN	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from Department of Science and Technology, Government of India.	Angelini A, 2008, ONCOL REP, V20, P731, DOI 10.3892/or_0000067; Arafa ESA, 2011, MUTAT RES-FUND MOL M, V706, P28, DOI 10.1016/j.mrfmmm.2010.10.007; Auvinen PK, 2010, TUMORI J, V96, P271, DOI 10.1177/030089161009600214; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Chanvorachote P, 2009, CANCER INVEST, V27, P624, DOI 10.1080/07357900802653472; Chattopadhyay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007382; Chearwae W, 2006, MOL CANCER THER, V5, P1995, DOI 10.1158/1535-7163.MCT-06-0087; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chintamani, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-19; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Choudhuri SK, 1998, ANTI-CANCER DRUG, V9, P825, DOI 10.1097/00001813-199810000-00013; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Chuang SE, 2000, CARCINOGENESIS, V21, P331, DOI 10.1093/carcin/21.2.331; Constantinidou A, 2011, ACTA ONCOL, V50, P455, DOI 10.3109/0284186X.2010.509105; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lahiry L, 2010, CARCINOGENESIS, V31, P259, DOI 10.1093/carcin/bgp240; LEHMANN W, 1980, ACTA BIOL MED GER, V39, P93; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu XG, 2009, JPN J CLIN ONCOL, V39, P418, DOI 10.1093/jjco/hyp037; Matsuda H, 1998, BIOORG MED CHEM LETT, V8, P339, DOI 10.1016/S0960-894X(98)00021-3; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002; Pal S, 2005, CANCER DETECT PREV, V29, P470, DOI 10.1016/j.cdp.2005.05.003; Pal S, 2001, BIOCHEM BIOPH RES CO, V288, P658, DOI 10.1006/bbrc.2001.5823; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Roy SG, 2007, MATRIX BIOL, V26, P269, DOI 10.1016/j.matbio.2006.12.005; Ryan KM, 2011, EUR J CANCER, V47, P44, DOI 10.1016/j.ejca.2010.10.020; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shankar S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-16; Singh K, 2009, J BIOL CHEM, V284, P1267, DOI 10.1074/jbc.M801088200; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Tao ZM, 2008, ANAL BIOCHEM, V381, P43, DOI 10.1016/j.ab.2008.06.020; Venkatesan N, 1998, BRIT J PHARMACOL, V124, P425, DOI 10.1038/sj.bjp.0701877; Wang QE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-24; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	61	83	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42232	42247		10.1074/jbc.M111.262295	http://dx.doi.org/10.1074/jbc.M111.262295			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013068	Green Published, hybrid			2022-12-25	WOS:000298180900033
J	Emmerson, CD; van der Vlist, EJ; Braam, MR; Vanlandschoot, P; Merchiers, P; de Haard, HJW; Verrips, CT; Henegouwen, PMPVE; Dolk, E				Emmerson, Chris D.; van der Vlist, Els J.; Braam, Myrthe R.; Vanlandschoot, Peter; Merchiers, Pascal; de Haard, Hans J. W.; Verrips, C. Theo; Henegouwen, Paul M. P. van Bergen En; Dolk, Edward			Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH	PLOS ONE			English	Article							EPITHELIAL-CELLS; SECRETORY COMPONENT; IG RECEPTOR; DIMERIC IGA; MDCK CELLS; TRANSPORT; BINDING; NANOBODIES; SIGNAL	The polymeric immunoglobulin receptor (pIgR) ensures the transport of dimeric immunoglobulin A (dIgA) and pentameric immunoglobulin M (pIgM) across epithelia to the mucosal layer of for example the intestines and the lungs via transcytosis. Per day the human pIgR mediates the excretion of 2 to 5 grams of dIgA into the mucosa of luminal organs. This system could prove useful for therapies aiming at excretion of compounds into the mucosa. Here we investigated the use of the variable domain of camelid derived heavy chain only antibodies, also known as VHHs or Nanobodies (R), targeting the human pIgR, as a transport system across epithelial cells. We show that VHHs directed against the human pIgR are able to bind the receptor with high affinity (similar to 1 nM) and that they compete with the natural ligand, dIgA. In a transcytosis assay both native and phage-bound VHH were only able to get across polarized MDCK cells that express the human pIgR gene in a basolateral to apical fashion. Indicating that the VHHs are able to translocate across epithelia and to take along large particles of cargo. Furthermore, by making multivalent VHHs we were able to enhance the transport of the compounds both in a MDCK-hpIgR and Caco-2 cell system, probably by inducing receptor clustering. These results show that VHHs can be used as a carrier system to exploit the human pIgR transcytotic system and that multivalent compounds are able to significantly enhance the transport across epithelial monolayers.	[Emmerson, Chris D.; van der Vlist, Els J.; Braam, Myrthe R.; Verrips, C. Theo; Henegouwen, Paul M. P. van Bergen En; Dolk, Edward] Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands; [Vanlandschoot, Peter; Merchiers, Pascal; de Haard, Hans J. W.] Ablynx NV, Zwijnaarde, Belgium	Utrecht University	Emmerson, CD (corresponding author), Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands.	peter.vanlandschoot@ablynx.com; e.dolk@qvquality.com	van Bergen en Henegouwen, Paul/B-8870-2011	van Bergen en Henegouwen, Paul/0000-0001-6050-9042	Ablynx	Ablynx(Ablynx)	This study was funded by Ablynx, who had a say in study design, data collection and analysis. To be specific, the selection of anti-human pIgR VHHs.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; Brock SC, 2002, INFECT IMMUN, V70, P5091, DOI 10.1128/IAI.70.9.5091-5095.2002; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Giffroy D, 2001, SCAND J IMMUNOL, V53, P56, DOI 10.1046/j.1365-3083.2001.00843.x; HOFMAN EG, 2010, J BIOL CHEM; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jerdeva GV, 2010, TRAFFIC, V11, P1205, DOI 10.1111/j.1600-0854.2010.01083.x; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; LINDH E, 1975, J IMMUNOL, V114, P284; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Luton F, 1999, MOL BIOL CELL, V10, P1409, DOI 10.1091/mbc.10.5.1409; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Mostov K, 1991, Semin Cell Biol, V2, P411; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; Muyldermans S, 2001, J Biotechnol, V74, P277; Reich V, 1996, J CELL SCI, V109, P2133; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Singer KL, 1998, MOL BIOL CELL, V9, P901, DOI 10.1091/mbc.9.4.901; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	28	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26299	10.1371/journal.pone.0026299	http://dx.doi.org/10.1371/journal.pone.0026299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022593	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600051
J	Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CWG; Sargent, IL				Gardiner, Chris; Tannetta, Dionne S.; Simms, Carol A.; Harrison, Paul; Redman, Christopher W. G.; Sargent, Ian L.			Syncytiotrophoblast Microvesicles Released from Pre-Eclampsia Placentae Exhibit Increased Tissue Factor Activity	PLOS ONE			English	Article							AUTOMATED THROMBIN GENERATION; FACTOR PATHWAY INHIBITOR; HORMONE MESSENGER-RNA; NORMAL-PREGNANCY; TROPHOBLAST CELLS; FIBRINOPEPTIDE-A; MATERNAL PLASMA; PRE-ECLAMPSIA; WHOLE-BLOOD; MICROPARTICLES	Background: Pre-eclampsia is a complication of pregnancy associated with activation of coagulation. It is caused by the placenta, which sheds increased amounts of syncytiotrophoblast microvesicles (STBM) into the maternal circulation. We hypothesized that STBM could contribute to the haemostatic activation observed in pre-eclampsia. Methodology/Principal Findings: STBM were collected by perfusion of the maternal side of placentae from healthy pregnant women and women with pre-eclampsia at caesarean section. Calibrated automated thrombography was used to assess thrombin generation triggered by STBM-borne tissue factor in platelet poor plasma (PPP). No thrombin was detected in PPP alone but the addition of STBM initiated thrombin generation in 14/16 cases. Pre-eclampsia STBM significantly shortened the lag time (LagT, P = 0.01) and time to peak thrombin generation (TTP, P = 0.005) when compared to normal STBM. Blockade of tissue factor eliminated thrombin generation, while inhibition of tissue factor pathway inhibitor significantly shortened LagT (p = 0.01) and TTP (P < 0.0001), with a concomitant increase in endogenous thrombin potential. Conclusions/Significance: STBM triggered thrombin generation in normal plasma in a tissue factor dependent manner, indicating that TF activity is expressed by STBM. This is more pronounced in STBM shed from pre-eclampsia placentae. As more STBM are shed in pre-eclampsia these observations give insight into the disordered haemostasis observed in this condition.	[Gardiner, Chris; Tannetta, Dionne S.; Simms, Carol A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Harrison, Paul] Churchill Hosp, Oxford Haemophilia & Thrombosis Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Gardiner, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Level 3, Oxford OX3 9DU, England.	chris.gardiner@obs-gyn.ox.ac.uk	Harrison, Paul/AAN-1916-2021; Gardiner, Chris/F-1178-2011	Harrison, Paul/0000-0003-4610-8909; Gardiner, Chris/0000-0002-2318-0062	Wellcome Trust [GR079862, GR0877930]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust grants GR079862 and GR0877930, and the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. http://www.wellcome.ac.uk. http://www.oxfordbrc.org. http://www.nihr.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2004, THROMB HAEMOSTASIS, V92, P776, DOI 10.1160/TH04-01-0033; Aharon A, 2009, J THROMB HAEMOST, V7, P1047, DOI 10.1111/j.1538-7836.2009.03342.x; Bellart J, 1999, BRIT J OBSTET GYNAEC, V106, P594, DOI 10.1111/j.1471-0528.1999.tb08330.x; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Bonnar J, 1976, Perspect Nephrol Hypertens, V5, P85; BONNAR J, 1971, BRIT MED J, V2, P12, DOI 10.1136/bmj.2.5752.12; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Butenas S, 2009, ARTERIOSCL THROM VAS, V29, P1989, DOI 10.1161/ATVBAHA.108.177402; CADROY Y, 1993, BRIT J OBSTET GYNAEC, V100, P416, DOI 10.1111/j.1471-0528.1993.tb15264.x; DOUGLAS JT, 1982, THROMB HAEMOSTASIS, V47, P54; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Estelles A, 1998, THROMB HAEMOSTASIS, V79, P500; FAULK WP, 1990, BLOOD, V76, P86; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Freeman DJ, 2008, J THROMB HAEMOST, V6, P421, DOI 10.1111/j.1538-7836.2007.02882.x; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Girardi G, 2011, J THROMB HAEMOST, V9, P250, DOI 10.1111/j.1538-7836.2010.04135.x; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011; HALLIGAN A, 1994, BRIT J OBSTET GYNAEC, V101, P488, DOI 10.1111/j.1471-0528.1994.tb13147.x; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Krudysz-Amblo J, 2010, J BIOL CHEM, V285, P3371, DOI 10.1074/jbc.M109.055178; Kumpel B, 2008, ANN NY ACAD SCI, V1137, P144, DOI 10.1196/annals.1448.017; Lakasing L, 1999, AM J OBSTET GYNECOL, V181, P180, DOI 10.1016/S0002-9378(99)70457-6; Lanir N, 2003, SEMIN THROMB HEMOST, V29, P175, DOI 10.1055/s-2003-38833; Lok CAR, 2008, REPROD SCI, V15, P1002, DOI 10.1177/1933719108324133; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ollivier V, 2010, THROMB RES, V125, P90, DOI 10.1016/j.thromres.2009.03.003; Osterud B, 2010, THROMB RES, V125, pS31, DOI 10.1016/j.thromres.2010.01.032; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REVERDIAU P, 1995, THROMB HAEMOSTASIS, V73, P49; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Rousseau A, 2009, EUR J OBSTET GYN R B, V146, P46, DOI 10.1016/j.ejogrb.2009.06.001; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; So AK, 2003, J THROMB HAEMOST, V1, P2510, DOI 10.1111/j.1538-7836.2003.00462.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; ten Cate JW, 1989, AM J OBSTET GYNECOL, V160, P95; Teng YC, 2009, J PERINAT MED, V37, P343, DOI 10.1515/JPM.2009.060; Teng YC, 2010, THROMB RES, V126, pE41, DOI 10.1016/j.thromres.2010.02.012; VanWijk MJ, 2002, THROMB HAEMOSTASIS, V88, P415	51	62	69	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26313	10.1371/journal.pone.0026313	http://dx.doi.org/10.1371/journal.pone.0026313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022598	gold, Green Published, Green Submitted			2022-12-25	WOS:000295981600054
J	Segev, E; Shefer, G; Adar, R; Chapal-Ilani, N; Itzkovitz, S; Horovitz, I; Reizel, Y; Benayahu, D; Shapiro, E				Segev, Elad; Shefer, Gabi; Adar, Rivka; Chapal-Ilani, Noa; Itzkovitz, Shalev; Horovitz, Inna; Reizel, Yitzhak; Benayahu, Dafna; Shapiro, Ehud			Muscle-Bound Primordial Stem Cells Give Rise to Myofiber-Associated Myogenic and Non-Myogenic Progenitors	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; BONE-MARROW; SOMITIC ORIGIN; DISTINCT; FATE; PROLIFERATION; HETEROGENEITY; REGENERATION; POPULATION	Myofiber cultures give rise to myogenic as well as to non-myogenic cells. Whether these myofiber-associated non-myogenic cells develop from resident stem cells that possess mesenchymal plasticity or from other stem cells such as mesenchymal stem cells (MSCs) remain unsolved. To address this question, we applied a method for reconstructing cell lineage trees from somatic mutations to MSCs and myogenic and non-myogenic cells from individual myofibers that were cultured at clonal density. Our analyses show that (i) in addition to myogenic progenitors, myofibers also harbor non-myogenic progenitors of a distinct, yet close, lineage; (ii) myofiber-associated non-myogenic and myogenic cells share the same muscle-bound primordial stem cells of a lineage distinct from bone marrow MSCs; (iii) these muscle-bound primordial stem-cells first part to individual muscles and then differentiate into myogenic and non-myogenic stem cells.	[Segev, Elad; Chapal-Ilani, Noa; Itzkovitz, Shalev; Horovitz, Inna; Shapiro, Ehud] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shefer, Gabi; Benayahu, Dafna] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Adar, Rivka; Shapiro, Ehud] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Reizel, Yitzhak] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Weizmann Institute of Science	Segev, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il		Segev, Elad/0000-0002-2786-324X	Israel Science Foundation [1694/07]; European Union; Miel de Botton Aynsley Foundation; Paul Sparr Foundation	Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Miel de Botton Aynsley Foundation; Paul Sparr Foundation	This research was supported by The Converging Technologies Program (Grant No 1694/07) of The Israel Science Foundation, The European Union FP7-ERC-AdG, Miel de Botton Aynsley and Paul Sparr Foundations, Excell project 214706 to Dr. Benayahu. Dr. Shapiro is the Incumbent of The Harry Weinrebe Professorial Chair of Computer Science and Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JJ, 2010, J ORTHOP RES; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Brent AE, 2002, CURR OPIN GENET DEV, V12, P548, DOI 10.1016/S0959-437X(02)00339-8; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Frumkin D, 2008, CANCER RES, V68, P5924, DOI 10.1158/0008-5472.CAN-07-6216; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kumar G, 2008, BIOTECHNIQUES, V44, P879, DOI 10.2144/000112755; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Liu ZD, 2000, J CELL BIOCHEM, V76, P509, DOI 10.1002/(SICI)1097-4644(20000301)76:3<509::AID-JCB17>3.0.CO;2-R; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; OWEN M, 1988, J CELL SCI, P63; Pouget C, 2008, DEV BIOL, V315, P437, DOI 10.1016/j.ydbio.2007.12.045; Reizel Y, 2011, PLOS GENETICS; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Salipante SJ, 2010, EVOL DEV, V12, P84, DOI 10.1111/j.1525-142X.2009.00393.x; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Shefer G, 2008, J CELL PHYSIOL, V215, P265, DOI 10.1002/jcp.21306; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shefer G, 2007, CRIT REV EUKAR GENE, V17, P13, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.20; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Shefer G, 2010, STEM CELL REV REP, V6, P42, DOI 10.1007/s12015-009-9106-9; Shepard JL, 2000, CURR OPIN HEMATOL, V7, P3, DOI 10.1097/00062752-200001000-00002; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wagner KR, 2008, NEUROTHERAPEUTICS, V5, P583, DOI 10.1016/j.nurt.2008.08.013; Wasserstrom A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000058; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Young HE, 2004, ANAT REC PART A, V276A, P75, DOI 10.1002/ar.a.10134	65	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25605	10.1371/journal.pone.0025605	http://dx.doi.org/10.1371/journal.pone.0025605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022423	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600011
J	Shih, YY; Lee, H; Nakagawara, A; Juan, HF; Jeng, YM; Tsay, YG; Lin, DT; Hsieh, FJ; Pan, CY; Hsu, WM; Liao, YF				Shih, Yu-Yin; Lee, Hsinyu; Nakagawara, Akira; Juan, Hseuh-Fen; Jeng, Yung-Ming; Tsay, Yeou-Guang; Lin, Dong-Tsamn; Hsieh, Fon-Jou; Pan, Chien-Yuan; Hsu, Wen-Ming; Liao, Yung-Feng			Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; CHILDRENS ONCOLOGY GROUP; GENE-EXPRESSION; 13-CIS-RETINOIC ACID; MYELOABLATIVE THERAPY; MOLECULAR CHAPERONES; SIGNALING PATHWAY; STEROID-RECEPTORS; NERVOUS-SYSTEM; RAR-ALPHA	Retinoic acid (RA) has been approved for the differentiation therapy of neuroblastoma (NB). Previous work revealed a correlation between glucose-regulated protein 75 (GRP75) and the RA-elicited neuronal differentiation of NB cells. The present study further demonstrated that GRP75 translocates into the nucleus and physically interacts with retinoid receptors (RAR alpha and RXR alpha) to augment RA-elicited neuronal differentiation. GRP75 was required for RAR alpha/RXR alpha-mediated transcriptional regulation and was shown to reduce the proteasome-mediated degradation of RAR alpha/RXR alpha in a RA-dependent manner. More intriguingly, the level of GRP75/RAR alpha/RXR alpha tripartite complexes was tightly associated with the RA-induced suppression of tumor growth in animals and the histological grade of differentiation in human NB tumors. The formation of GRP75/RAR alpha/RXR alpha complexes was intimately correlated with a normal MYCN copy number of NB tumors, possibly implicating a favorable prognosis of NB tumors. The present findings reveal a novel function of nucleus-localized GRP75 in actively promoting neuronal differentiation, delineating the mode of action for the differentiation therapy of NB by RA.	[Shih, Yu-Yin; Liao, Yung-Feng] Acad Sinica, Mol Neurobiol Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Shih, Yu-Yin; Lee, Hsinyu; Pan, Chien-Yuan] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lee, Hsinyu; Juan, Hseuh-Fen; Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Nakagawara, Akira] Chiba Univ, Grad Sch Med, Chiba Canc Ctr Res Inst, Dept Mol Biol & Oncol, Chiba, Japan; [Juan, Hseuh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Hsieh, Fon-Jou] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Lin, Dong-Tsamn] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lin, Dong-Tsamn; Hsu, Wen-Ming] Childhood Canc Fdn, Taipei, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Chiba Cancer Center; Chiba University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Shih, YY (corresponding author), Acad Sinica, Mol Neurobiol Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	cypan@ccms.ntu.edu.tw; billwmhsu@gmail.com; yliao@sinica.edu.tw	Tsay, Yeou-Guang/HGE-2076-2022; Liao, Yung-Feng/A-9761-2011	LIN, DONG-TSAMN/0000-0002-5773-3200; HSU, WEN-MING/0000-0002-5145-9538; JUAN, HSUEH-FEN/0000-0003-4876-3309; Lee, Hsinyu/0000-0002-1477-0183; Tsay, Yeou-Guang/0000-0001-6511-9158; JENG, YUNG-MING/0000-0002-3878-4491; PAN, CHIEN-YUAN/0000-0002-6654-9309	National Health Research Institutes [NHRI-EX96-9620NI]; National Science Council, Taiwan [NSC 95-2314-B-002-155-MY2]; Academia Sinica; NSC [NSC 100-2319-B-001-002]; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); NSC(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National Health Research Institutes (NHRI-EX96-9620NI to W.-M. H.), National Science Council, Taiwan (NSC 95-2314-B-002-155-MY2 to W.-M. H.), and Academia Sinica (to Y.-F.L.). The National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, is supported by the National Core Facility Program for Biotechnology Grants of NSC (NSC 100-2319-B-001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren MAE, 2004, MOL CANCER RES, V2, P387; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Boudjelal M, 2000, CANCER RES, V60, P2247; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Deocaris CC, 2007, ANN NY ACAD SCI, V1119, P165, DOI 10.1196/annals.1404.007; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Gabriele N, 2010, SYNAPSE, V64, P808, DOI 10.1002/syn.20794; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Heinlein CA, 2001, ENDOCRINE, V14, P143, DOI 10.1385/ENDO:14:2:143; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Kawai A, 2001, J CELL SCI, V114, P3565; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Knutson DC, 2008, ARCH BIOCHEM BIOPHYS, V477, P163, DOI 10.1016/j.abb.2008.06.005; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Liao YF, 2007, MOL PHARMACOL, V71, P588, DOI 10.1124/mol.106.024299; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; Merrill RA, 2004, BIOL CHEM, V385, P605, DOI 10.1515/BC.2004.075; Merrill RA, 2002, P NATL ACAD SCI USA, V99, P3422, DOI 10.1073/pnas.052017399; Michalak M, 1996, J BIOL CHEM, V271, P29436, DOI 10.1074/jbc.271.46.29436; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Park JR, 2009, PEDIATR BLOOD CANCER, V52, P44, DOI 10.1002/pbc.21784; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Peverali FA, 1996, ONCOGENE, V12, P457; Reynolds C P, 1994, Prog Clin Biol Res, V385, P237; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Shimada H, 2003, Pathologica, V95, P240; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Srinivas H, 2006, BIOCHEM J, V395, P653, DOI 10.1042/BJ20051794; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; WADHWA R, 1995, EXP CELL RES, V216, P101, DOI 10.1006/excr.1995.1013; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wadhwa R, 2000, CANCER RES, V60, P6818; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Zhao HL, 2009, BIOCHEM BIOPH RES CO, V383, P119, DOI 10.1016/j.bbrc.2009.03.141; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	53	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26236	10.1371/journal.pone.0026236	http://dx.doi.org/10.1371/journal.pone.0026236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022577	Green Published, Green Submitted, gold			2022-12-25	WOS:000295981600042
J	Zhang, EJ; Zhang, XY; Liu, J; Wang, BJ; Tian, YJ; Kosinska, AD; Ma, ZY; Xu, Y; Dittmer, U; Roggendorf, M; Yang, DL; Lu, MJ				Zhang, Ejuan; Zhang, Xiaoyong; Liu, Jia; Wang, Baoju; Tian, Yongjun; Kosinska, Anna D.; Ma, Zhiyong; Xu, Yang; Dittmer, Ulf; Roggendorf, Michael; Yang, Dongliang; Lu, Mengji			The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; DENDRITIC CELLS; B PATIENTS; DYSFUNCTION; ACTIVATION; LIVER; MODEL; IMMUNOMODULATION	Background: The programmed cell death 1 (PD-1)/programmed death-1 ligand 1 (PD-L1) system may play a role in the negative regulation of T cell functions in hepatitis B virus (HBV) infection. Thus, it is important to study its role in the widely used animal model for HBV infection of woodchucks with woodchuck hepatitis virus (WHV). Methods: Woodchuck PD-L1 (wPD-L1) and -L2 (wPD-L2) were cloned and characterized. The levels of wPD-L1 expression in primary woodchuck hepatocytes (PWH), peripheral blood mononuclear cells (PBMCs), and liver tissue of naive and WHV-infected woodchucks were examined by real time reverse transcription (RT)-PCR and flow cytometry. Using antibodies against wPD-L1 and -L2, the effect of blocking PD-1/PD-L1/PD-L2 interaction on the proliferation and degranulation of woodchuck PBMCs was examined. Principal Findings: Both wPD-L1 and -L2 showed a high homology to their counterparts of other mammalian species and humans. WPD-L1 expression in PWH and PBMCs of naive animals was low but could be stimulated by Toll-like receptor (TLR) ligands and interferons (IFN). WPD-L1 expression in liver tissue was significantly higher than that measured in PWHs and was slightly elevated during acute and chronic WHV infection. However, wPD-1 and wPD-L1 expression on PBMCs was strongly up-regulated during acute and chronic infection. In vitro blockade with antibodies against wPD-L1 and -L2 partially enhanced proliferation and degranulation of PBMCs from WHV-infected woodchucks. Conclusions: Our results demonstrated that wPD-1/wPD-L1 expression in hepatocytes and PBMCs can be induced by different inflammatory stimuli and is up-regulated mainly on PBMCs during WHV infection. A blockade of the woodchuck PD-1/PD-L pathway could partially enhance T cell functions in WHV infection.	[Zhang, Ejuan; Zhang, Xiaoyong; Xu, Yang; Lu, Mengji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China; [Zhang, Ejuan; Zhang, Xiaoyong; Liu, Jia; Kosinska, Anna D.; Ma, Zhiyong; Dittmer, Ulf; Roggendorf, Michael; Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany; [Wang, Baoju; Tian, Yongjun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Clin Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; University of Duisburg Essen; Huazhong University of Science & Technology	Zhang, EJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China.	dlyang@tjh.tjmu.edu.cn; mengji.lu@uni-due.de	Tian, Yongjun/F-8007-2011; Lu, Mengji/ABF-9410-2020	Kosinska, Anna D./0000-0002-6352-1415	Deutsche Forschungsgemeinschaft [Transregio TRR60]; International Science & Technology Cooperation Program of China [2011DFA31030]; National Natural Science Foundation of China [30271170]; National Key Basic Research Program of China [2005CB522901, 2007CB512804, 2009CB522506]; National Major Science and Technology Special Project for Infectious Diseases of China [2008ZX10002-011]; China Scholarship Council [2008102014]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Major Science and Technology Special Project for Infectious Diseases of China; China Scholarship Council(China Scholarship Council)	This work is partially supported by grants from the Deutsche Forschungsgemeinschaft (Transregio TRR60), the International Science & Technology Cooperation Program of China (2011DFA31030), the National Natural Science Foundation of China (30271170), the National Key Basic Research Program of China (2005CB522901, 2007CB512804, 2009CB522506), and National Major Science and Technology Special Project for Infectious Diseases of China (2008ZX10002-011). EZ was supported by the China Scholarship Council (2008102014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Groschel S, 2008, J MOL MED, V86, P443, DOI 10.1007/s00109-008-0310-x; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Knolle Percy A., 2006, V43, P151, DOI 10.1007/018; Lu M, 2005, J VIROL, V79, P6368, DOI 10.1128/JVI.79.10.6368-6376.2005; Lu MJ, 2008, J VIROL, V82, P2598, DOI 10.1128/JVI.01613-07; Lu MJ, 2007, EXPERT OPIN INV DRUG, V16, P787, DOI 10.1517/13543784.16.6.787; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Overstreet MG, 2010, EUR J IMMUNOL, V40, P124, DOI 10.1002/eji.200939493; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Roggendorf M, 2007, J VIRAL HEPATITIS, V14, P51, DOI 10.1111/j.1365-2893.2007.00914.x; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x; Zhang Z, 2009, J HEPATOL, V50, P1163, DOI 10.1016/j.jhep.2009.01.026	36	34	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26196	10.1371/journal.pone.0026196	http://dx.doi.org/10.1371/journal.pone.0026196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022563	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600038
J	Eleswarapu, SV; Responte, DJ; Athanasiou, KA				Eleswarapu, Sriram V.; Responte, Donald J.; Athanasiou, Kyriacos A.			Tensile Properties, Collagen Content, and Crosslinks in Connective Tissues of the Immature Knee Joint	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE; IN-VITRO; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLD; STEM-CELLS; INJURIES; GROWTH; REPAIR	Background: The major connective tissues of the knee joint act in concert during locomotion to provide joint stability, smooth articulation, shock absorption, and distribution of mechanical stresses. These functions are largely conferred by the intrinsic material properties of the tissues, which are in turn determined by biochemical composition. A thorough understanding of the structure-function relationships of the connective tissues of the knee joint is needed to provide design parameters for efforts in tissue engineering. Methodology/Principal Findings: The objective of this study was to perform a comprehensive characterization of the tensile properties, collagen content, and pyridinoline crosslink abundance of condylar cartilage, patellar cartilage, medial and lateral menisci, cranial and caudal cruciate ligaments (analogous to anterior and posterior cruciate ligaments in humans, respectively), medial and lateral collateral ligaments, and patellar ligament from immature bovine calves. Tensile stiffness and strength were greatest in the menisci and patellar ligament, and lowest in the hyaline cartilages and cruciate ligaments; these tensile results reflected trends in collagen content. Pyridinoline crosslinks were found in every tissue despite the relative immaturity of the joints, and significant differences were observed among tissues. Notably, for the cruciate ligaments and patellar ligament, crosslink density appeared more important in determining tensile stiffness than collagen content. Conclusions/Significance: To our knowledge, this study is the first to examine tensile properties, collagen content, and pyridinoline crosslink abundance in a direct head-to-head comparison among all of the major connective tissues of the knee. This is also the first study to report results for pyridinoline crosslink density that suggest its preferential role over collagen in determining tensile stiffness for certain tissues.	[Eleswarapu, Sriram V.; Responte, Donald J.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Eleswarapu, Sriram V.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Rice University; Baylor College of Medicine; University of California System; University of California Davis	Eleswarapu, SV (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	athanasiou@ucdavis.edu			National Institutes of Health [R01 AR053286, R01 AR047839]; UC Davis; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047839, R01AR053286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was performed with funding from grants R01 AR053286 and R01 AR047839 by the National Institutes of Health, as well as UC Davis institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; American Academy Of Orthopaedic Surgeons, 2008, US BON JOINT DEC BUR; Aufderheide AC, 2006, ANN BIOMED ENG, V34, P1463, DOI 10.1007/s10439-006-9157-x; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; BROOM ND, 1984, J ANAT, V139, P275; Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464; Chan BP, 1998, J ORTHOP RES, V16, P597, DOI 10.1002/jor.1100160512; CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517; Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472; Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; HUEY DJ, BIOMATERIALS, V32, P2052; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lim JJ, 2011, BIOTECHNOL BIOENG, V108, P151, DOI 10.1002/bit.22909; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Louw QA, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.035360; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; MeridaVelasco JA, 1997, ANAT REC, V248, P259, DOI 10.1002/(SICI)1097-0185(199706)248:2<259::AID-AR13>3.0.CO;2-O; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI 10.1089/ten.TEA.2008.0478; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; RALPHS JR, 1994, J ANAT, V184, P503; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363, DOI 10.1615/CritRevBiomedEng.v35.i5.20; Sah RL, 1996, J ORTHOPAED RES, V14, P44, DOI 10.1002/jor.1100140109; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Smith KD, 2011, J ANAT, V218, P600, DOI 10.1111/j.1469-7580.2011.01374.x; Tanimori S, 2000, BIOSCI BIOTECH BIOCH, V64, P1758, DOI 10.1271/bbb.64.1758; Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428; Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83	41	79	81	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26178	10.1371/journal.pone.0026178	http://dx.doi.org/10.1371/journal.pone.0026178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022553	Green Published, gold			2022-12-25	WOS:000295978600042
J	Campo, JJ; Dobano, C; Sacarlal, J; Guinovart, C; Mayor, A; Angov, E; Dutta, S; Chitnis, C; Macete, E; Aponte, JJ; Alonso, PL				Campo, Joseph J.; Dobano, Carlota; Sacarlal, Jahit; Guinovart, Caterina; Mayor, Alfredo; Angov, Evelina; Dutta, Sheetij; Chitnis, Chetan; Macete, Eusebio; Aponte, John J.; Alonso, Pedro L.			Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; ERYTHROCYTE-MEMBRANE PROTEIN-1; MOZAMBICAN CHILDREN; MEROZOITE ANTIGENS; DOUBLE-BLIND; FOLLOW-UP; PROTECTION; EFFICACY; RTS,S/AS02A	Background: Partial protective efficacy lasting up to 43 months after vaccination with the RTS, S malaria vaccine has been reported in one cohort (C1) of a Phase IIb trial in Mozambique, but waning efficacy was observed in a smaller contemporaneous cohort (C2). We hypothesized that low dose exposure to asexual stage parasites resulting from partial pre-erythrocytic protection afforded by RTS, S may contribute to long-term vaccine efficacy to clinical disease, which was not observed in C2 due to intense active detection of infection and treatment. Methodology/Principal Findings: Serum collected 6 months post-vaccination was screened for antibodies to asexual blood stage antigens AMA-1, MSP-1(42), EBA-175, DBL-alpha and variant surface antigens of the R29 laboratory strain (VSA(R29)). Effect of IgG on the prospective hazard of clinical malaria was estimated. No difference was observed in antibody levels between RTS, S and control vaccine when all children aged 1-4 years at enrollment in both C1 and C2 were analyzed together, and no effects were observed between cohort and vaccine group. RTS, S-vaccinated children <2 years of age at enrollment had lower levels of IgG for AMA-1 and MSP-1(42) (p<0.01, all antigens), while no differences were observed in children >= 2 years. Lower risk of clinical malaria was associated with high IgG to EBA-175 and VSA(R29) in C2 only (Hazard Ratio [HR]: 0.76, 95% CI 0.66-0.88; HR: 0.75, 95% CI 0.62-0.92, respectively). Conclusions: Vaccination with RTS, S modestly reduces anti-AMA-1 and anti-MSP-1 antibodies in very young children. However, for antigens associated with lower risk of clinical malaria, there were no vaccine group or cohort-specific effects, and age did not influence antibody levels between treatment groups for these antigens. The antigens tested do not explain the difference in protective efficacy in C1 and C2. Other less-characterized antigens or VSA may be important to protection.	[Campo, Joseph J.; Dobano, Carlota; Guinovart, Caterina; Mayor, Alfredo; Aponte, John J.; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona, Barcelona, Spain; [Campo, Joseph J.; Dobano, Carlota; Sacarlal, Jahit; Guinovart, Caterina; Mayor, Alfredo; Macete, Eusebio; Aponte, John J.; Alonso, Pedro L.] Ctr Invest Saude Manhica, Manhica, Mozambique; [Angov, Evelina; Dutta, Sheetij] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Chitnis, Chetan] Int Ctr Genet Engn & Biotechnol, New Delhi, India	University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Campo, JJ (corresponding author), Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona, Barcelona, Spain.	cdobano@clinic.ub.es	Guinovart, Caterina/ABH-2981-2020; Alonso, Pedro L/AAZ-3645-2020; Mayor, Alfredo/H-7488-2017; Sacarlal, Jahit/R-3172-2016; Dobaño, Carlota/N-4119-2014	Alonso, Pedro L/0000-0003-3292-3443; Mayor, Alfredo/0000-0003-3890-2897; Sacarlal, Jahit/0000-0003-1059-217X; Dobaño, Carlota/0000-0002-6751-4060; Chitnis, Chetan/0000-0002-8773-9865	Program for Appropriate Technology in Health-Malaria Vaccine Initiative; Fundacion Ramon Areces; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010FI_B 00168]; Spanish Ministry of Science and Innovation [RYC-2008-02631]	Program for Appropriate Technology in Health-Malaria Vaccine Initiative; Fundacion Ramon Areces; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Program for Appropriate Technology in Health-Malaria Vaccine Initiative, the Fundacion Ramon Areces, the Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010FI_B 00168 to JC] and the Spanish Ministry of Science and Innovation [RYC-2008-02631 to CD]. The Centro de Investigacao em Saude da Manhica receives core support from the Spanish Agency for International Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE P, 2011, VACCINE; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Ferreira MU, 1996, AM J TROP MED HYG, V55, P315, DOI 10.4269/ajtmh.1996.55.315; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Little JA, 2004, CHROMATOGRAPHIA, V59, pS177, DOI 10.1365/s10337-003-0182-8; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Okenu DMN, 2000, INFECT IMMUN, V68, P5559, DOI 10.1128/IAI.68.10.5559-5566.2000; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Quelhas D, 2008, CLIN VACCINE IMMUNOL, V15, P1282, DOI 10.1128/CVI.00044-08; REED GF, 1995, PEDIATRICS, V96, P600; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Sacarlal J, 2008, VACCINE, V26, P174, DOI 10.1016/j.vaccine.2007.11.003; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06	49	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25779	10.1371/journal.pone.0025779	http://dx.doi.org/10.1371/journal.pone.0025779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022448	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000038
J	De Stefani, E; Pinello, L; Campana, G; Mazzarolo, M; Lo Giudice, G; Casco, C				De Stefani, Elisa; Pinello, Luisa; Campana, Gianluca; Mazzarolo, Monica; Lo Giudice, Giuseppe; Casco, Clara			Illusory Contours over Pathological Retinal Scotomas	PLOS ONE			English	Article							PERCEPTUAL FILLING-IN; PRIMARY VISUAL-CORTEX; BLIND-SPOT; MACULAR DEGENERATION; NEURAL RESPONSES; CORTICAL MAPS; ARTIFICIAL SCOTOMAS; STRIATE CORTEX; DYNAMIC NOISE; HUMAN VISION	Our visual percepts are not fully determined by physical stimulus inputs. Thus, in visual illusions such as the Kanizsa figure, inducers presented at the corners allow one to perceive the bounding contours of the figure in the absence of luminance-defined borders. We examined the discrimination of the curvature of these illusory contours that pass across retinal scotomas caused by macular degeneration. In contrast with previous studies with normal-sighted subjects that showed no perception of these illusory contours in the region of physiological scotomas at the optic nerve head, we demonstrated perfect discrimination of the curvature of the illusory contours over the pathological retinal scotoma. The illusion occurred despite the large scar around the macular lesion, strongly reducing discrimination of whether the inducer openings were acute or obtuse and suggesting that the coarse information in the inducers (low spatial frequency) sufficed. The result that subjective contours can pass through the pathological retinal scotoma suggests that the visual cortex, despite the loss of bottom-up input, can use low-spatial frequency information from the inducers to form a neural representation of new complex geometrical shapes inside the scotoma.	[De Stefani, Elisa] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Pinello, Luisa; Mazzarolo, Monica] Univ Padua, Dept Paediat, Paediat Low Vis Ctr, Padua, Italy; [Campana, Gianluca; Casco, Clara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Lo Giudice, Giuseppe] San Antonio Hosp, San Paolo Ophthalm Ctr, Padua, Italy	University of Parma; University of Padua; University of Padua; ULSS 6 Euganea; Ospedale Sant'antonio Padova	De Stefani, E (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	elidestefani@gmail.com	Campana, Gianluca/AAC-5909-2022; Campana, Gianluca/F-8981-2010; LO GIUDICE, GIUSEPPE/GQB-0418-2022; De Stefani, Elisa/C-3154-2018	Campana, Gianluca/0000-0003-4019-085X; De Stefani, Elisa/0000-0003-4492-3926				Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; BROWN RJ, 1993, PERCEPT PSYCHOPHYS, V53, P200, DOI 10.3758/BF03211730; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Casco C, 2003, VISUAL NEUROSCI, V20, P501, DOI 10.1017/S0952523803205046; Cheong AMY, 2007, VISION RES, V47, P2943, DOI 10.1016/j.visres.2007.07.010; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Crossland MD, 2009, INVEST OPHTH VIS SCI, V50, P1464, DOI 10.1167/iovs.08-2690; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Dennett D. C., 1992, COGNITION CONCEPTUAL; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Finney D.J., 1971, PROBIT ANAL; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GERRITS HJM, 1969, VISION RES, V9, P439, DOI 10.1016/0042-6989(69)90092-3; GILBERT TN, 1992, NATURE, V356, P150; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Howell D., 2009, STAT METHODS PSYCHOL, V7th; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KANIZSA K, 1976, SCI AM, V234, P48; KAPADIA MK, 1994, J NEUROSCI, V14, P451; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Komatsu H, 2002, NEUROSCI RES, V44, P231, DOI 10.1016/S0168-0102(02)00149-9; Komatsu H, 2000, J NEUROSCI, V20, P9310; Maertens M, 2005, J COGNITIVE NEUROSCI, V17, P1553, DOI 10.1162/089892905774597209; Maertens M, 2007, J COGNITIVE NEUROSCI, V19, P91, DOI 10.1162/jocn.2007.19.1.91; Maertens M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.002.2008; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Matsumoto M, 2005, J NEUROPHYSIOL, V93, P2374, DOI 10.1152/jn.00811.2004; Meng M, 2005, NAT NEUROSCI, V8, P1248, DOI 10.1038/nn1518; Mihaylov P, 2007, VISION RES, V47, P1479, DOI 10.1016/j.visres.2007.01.028; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, NATURE, V356, P115, DOI 10.1038/356115a0; Reich LN, 2000, VISION RES, V40, P805, DOI 10.1016/S0042-6989(99)00215-1; Safran AB, 1999, BRIT J OPHTHALMOL, V83, P137, DOI 10.1136/bjo.83.2.137; SAFRAN AB, 1996, VISION RES, V36, pS214; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; Spillmann L, 2006, VISION RES, V46, P4252, DOI 10.1016/j.visres.2006.08.033; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Tailby C, 2004, VISUAL NEUROSCI, V21, P79, DOI 10.1017/S0952523804041082; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; TRIPATHY SP, 1994, VISION RES, V34, P1127, DOI 10.1016/0042-6989(94)90295-X; Tripathy SP, 1999, VISION RES, V39, P1917, DOI 10.1016/S0042-6989(98)00230-2; Tyler CW, 1998, PERCEPTION, V27, P203, DOI 10.1068/p270203; Wittich W, 2006, VISION RES, V46, P4064, DOI 10.1016/j.visres.2006.07.005; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	55	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26154	10.1371/journal.pone.0026154	http://dx.doi.org/10.1371/journal.pone.0026154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022546	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000076
J	Menuet, C; Cazals, Y; Gestreau, C; Borghgraef, P; Gielis, L; Dutschmann, M; Van Leuven, F; Hilaire, G				Menuet, Clement; Cazals, Yves; Gestreau, Christian; Borghgraef, Peter; Gielis, Lies; Dutschmann, Mathias; Van Leuven, Fred; Hilaire, Gerard			Age-Related Impairment of Ultrasonic Vocalization in Tau.P301L Mice: Possible Implication for Progressive Language Disorders	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; FINAL COMMON PATHWAY; BRAIN-STEM NUCLEI; PERIAQUEDUCTAL GRAY; ALZHEIMERS-DISEASE; RETROAMBIGUUS PROJECTIONS; MONOSYNAPTIC PROJECTIONS; LARYNGEAL MOTONEURONS; COGNITIVE IMPAIRMENT; NONFLUENT APHASIA	Background: Tauopathies, including Alzheimer's Disease, are the most frequent neurodegenerative diseases in elderly people and cause various cognitive, behavioural and motor defects, but also progressive language disorders. For communication and social interactions, mice produce ultrasonic vocalization (USV) via expiratory airflow through the larynx. We examined USV of Tau.P301L mice, a mouse model for tauopathy expressing human mutant tau protein and developing cognitive, motor and upper airway defects. Methodology/Principal Findings: At age 4-5 months, Tau.P301L mice had normal USV, normal expiratory airflow and no brainstem tauopathy. At age 8-10 months, Tau.P301L mice presented impaired USV, reduced expiratory airflow and severe tauopathy in the periaqueductal gray, Kolliker-Fuse and retroambiguus nuclei. Tauopathy in these nuclei that control upper airway function and vocalization correlates well with the USV impairment of old Tau.P301L mice. Conclusions: In a mouse model for tauopathy, we report for the first time an age-related impairment of USV that correlates with tauopathy in midbrain and brainstem areas controlling vocalization. The vocalization disorder of old Tau.P301L mice could be, at least in part, reminiscent of language disorders of elderly suffering tauopathy.	[Menuet, Clement; Cazals, Yves] Univ Paul Cezanne, Univ Mediterranee, CNRS, Neurovegetat Physiol Lab,Unite Mixte Rech 6231, Marseille, France; [Borghgraef, Peter; Gielis, Lies; Van Leuven, Fred] Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, Louvain, Belgium; [Dutschmann, Mathias] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; KU Leuven; University of Leeds	Menuet, C (corresponding author), Univ Paul Cezanne, Univ Mediterranee, CNRS, Neurovegetat Physiol Lab,Unite Mixte Rech 6231, Marseille, France.	gerard.hilaire@univ-cezanne.fr	Gestreau, Christian/K-5161-2017	Gestreau, Christian/0000-0001-5069-482X; Dutschmann, Mathias/0000-0002-0692-746X; Menuet, Clement/0000-0002-7419-6427	Centre National de la Recherche Scientifique; Universite Paul Cezanne; Universite de la Mediterranee (Unite Mixte de Recherche) [6231]; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut voor Wetenschap en Techniek (IWT); KULeuven-Research Fund (BOF); KULeuven-Research Development; NHLBI [R33HL087377]; EEC Framework program FP6; EEC Framework program FP7; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087377] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Cezanne; Universite de la Mediterranee (Unite Mixte de Recherche); Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut voor Wetenschap en Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KULeuven-Research Fund (BOF)(KU Leuven); KULeuven-Research Development; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EEC Framework program FP6; EEC Framework program FP7; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the support of the Centre National de la Recherche Scientifique, the Universite Paul Cezanne and the Universite de la Mediterranee (Unite Mixte de Recherche 6231). Dr. Borghgraef, Dr. Gielis, Dr. Van Leuven acknowledge support by Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen), Instituut voor Wetenschap en Techniek (IWT), KULeuven-Research Fund (BOF), KULeuven-Research & Development and EEC Framework programs FP6 & FP7. Dr. Dutschmann was supported by NHLBI (Cluster Grant R33HL087377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Attems J, 2005, J ALZHEIMERS DIS, V8, P57; Baekey DM, 2001, J PHYSIOL-LONDON, V534, P565, DOI 10.1111/j.1469-7793.2001.t01-1-00565.x; Bajic D, 2000, J COMP NEUROL, V427, P649, DOI 10.1002/1096-9861(20001127)427:4<649::AID-CNE11>3.0.CO;2-M; Bajic D, 1999, J COMP NEUROL, V405, P359; Bianchi AL, 2009, RESP PHYSIOL NEUROBI, V168, P4, DOI 10.1016/j.resp.2009.04.019; Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019; Boers J, 2006, BRAIN RES BULL, V68, P249, DOI 10.1016/j.brainresbull.2005.08.011; Boers J, 2002, NEUROSCI LETT, V319, P5, DOI 10.1016/S0304-3940(01)02395-3; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Braz JM, 2009, J COMP NEUROL, V514, P145, DOI 10.1002/cne.22003; Chapman SB, 1997, NEUROLOGY, V49, P1298, DOI 10.1212/WNL.49.5.1298; Chong MS, 2006, J AM GERIATR SOC, V54, P777, DOI 10.1111/j.1532-5415.2006.00694.x; Cooke Jana R, 2006, Behav Sleep Med, V4, P219, DOI 10.1207/s15402010bsm0404_2; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Dutschmann M, 2009, J PHYSIOL-LONDON, V587, P4931, DOI 10.1113/jphysiol.2009.174599; Duyckaerts C, 2011, ACTA NEUROPATHOL, V121, P145, DOI 10.1007/s00401-010-0794-7; Esposito A, 1999, NEUROREPORT, V10, P681, DOI 10.1097/00001756-199903170-00004; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; FUH JL, 1994, CORTEX, V30, P701, DOI 10.1016/S0010-9452(13)80246-8; Gerrits PO, 1996, J COMP NEUROL, V373, P173, DOI 10.1002/(SICI)1096-9861(19960916)373:2<173::AID-CNE2>3.0.CO;2-0; Gerstner E, 2007, COGN BEHAV NEUROL, V20, P15, DOI 10.1097/WNN.0b013e31802b6c45; Gestreau C, 2005, RESP PHYSIOL NEUROBI, V147, P159, DOI 10.1016/j.resp.2005.03.015; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Grossman M, 2010, NAT REV NEUROL, V6, P88, DOI 10.1038/nrneurol.2009.216; Gunawardena D, 2010, NEUROLOGY, V75, P588, DOI 10.1212/WNL.0b013e3181ed9c7d; HOFER MA, 1993, BEHAV NEUROSCI, V107, P354, DOI 10.1037/0735-7044.107.2.354; HOIT JD, 1987, J SPEECH HEAR RES, V30, P351, DOI 10.1044/jshr.3003.351; HOLSTEGE G, 1989, J COMP NEUROL, V284, P242, DOI 10.1002/cne.902840208; Holstege G, 1997, NEUROSCIENCE, V80, P587, DOI 10.1016/S0306-4522(97)00061-4; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hu WT, 2010, NEUROLOGY, V75, P595, DOI 10.1212/WNL.0b013e3181ed9c52; Huber JE, 2008, J SPEECH LANG HEAR R, V51, P651, DOI 10.1044/1092-4388(2008/047); Huber JE, 2008, RESP PHYSIOL NEUROBI, V164, P323, DOI 10.1016/j.resp.2008.08.007; Humbert IA, 2010, J ALZHEIMERS DIS, V19, P1185, DOI 10.3233/JAD-2010-1316; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Johnson AM, 2010, J ACOUST SOC AM, V128, pEL75, DOI 10.1121/1.3462234; Jourdan D, 1997, J PHARMACOL TOXICOL, V38, P109, DOI 10.1016/S1056-8719(97)00067-1; Klop EM, 2002, J COMP NEUROL, V445, P47, DOI 10.1002/cne.10151; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lee Eiyai, 2007, Brain and Nerve (Tokyo), V59, P629; LI YQ, 1993, BRAIN RES, V608, P138, DOI 10.1016/0006-8993(93)90784-K; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; Morgan MM, 2008, PAIN, V140, P376, DOI 10.1016/j.pain.2008.09.009; Munoz David G, 2007, Am J Alzheimers Dis Other Demen, V22, P294, DOI 10.1177/1533317507302320; NASTITI K, 1991, NEUROSCI BIOBEHAV R, V15, P483, DOI 10.1016/S0149-7634(05)80136-8; NUNEZ AA, 1985, PHYSIOL BEHAV, V34, P901, DOI 10.1016/0031-9384(85)90011-3; Ogar JM, 2007, ALZ DIS ASSOC DIS, V21, pS23, DOI 10.1097/WAD.0b013e31815d19fe; Oka T, 2008, NEUROSCI RES, V62, P286, DOI 10.1016/j.neures.2008.10.004; Onen F, 2010, PSYCHOL NEUROPSYCHIA, V8, P163, DOI 10.1684/pnv.2010.0219; Parvizi J, 2000, ANN NEUROL, V48, P344, DOI 10.1002/1531-8249(200009)48:3<344::AID-ANA9>3.3.CO;2-J; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; ROHRER JD, 2011, CURR ALZHEIMER RES; Rohrer JD, 2010, NEUROLOGY, V75, P603, DOI 10.1212/WNL.0b013e3181ed9c6b; Rohrer JD, 2010, J NEUROL, V257, P569, DOI 10.1007/s00415-009-5371-4; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shiba K, 2007, J NEUROSCI, V27, P5156, DOI 10.1523/JNEUROSCI.0001-07.2007; SPERRY EE, 1992, J SPEECH HEAR RES, V35, P1246, DOI 10.1044/jshr.3506.1246; Subramanian HH, 2009, J NEUROSCI, V29, P3824, DOI 10.1523/JNEUROSCI.0607-09.2009; Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008; Sugiyama Y, 2010, NEUROSCI RES, V66, P359, DOI 10.1016/j.neures.2009.12.006; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tsuchiya K, 2000, ACTA NEUROPATHOL, V99, P81, DOI 10.1007/PL00007411; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P251, DOI 10.1002/1096-9861(20000821)424:2<251::AID-CNE5>3.0.CO;2-D; VanderHorst VGJM, 2005, J COMP NEUROL, V488, P180, DOI 10.1002/cne.20574; VANDERHORST VGJM, 1995, J COMP NEUROL, V359, P457, DOI 10.1002/cne.903590308; Vanderhorst VGJM, 2001, NEUROSCIENCE, V107, P117, DOI 10.1016/S0306-4522(01)00343-8; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; YAJIMA Y, 1983, EXP BRAIN RES, V50, P359; Zhang SP, 1995, J NEUROPHYSIOL, V74, P2500, DOI 10.1152/jn.1995.74.6.2500	81	24	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25770	10.1371/journal.pone.0025770	http://dx.doi.org/10.1371/journal.pone.0025770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022446	Green Published, gold			2022-12-25	WOS:000295976000037
J	Yager, JE; Kadiyala, S; Weiser, SD				Yager, Jessica E.; Kadiyala, Suneetha; Weiser, Sheri D.			HIV/AIDS, Food Supplementation and Livelihood Programs in Uganda: A Way Forward?	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; ANTIRETROVIRAL TREATMENT; ADHERENCE; INSECURITY; NUTRITION; HEALTH; CARE; INTERVENTION; ASSOCIATION; SERVICES	Background: Over the last decade, health, nutrition and policy experts have become increasingly aware of the many ways in which food insecurity and HIV infection negatively impact and reinforce one another. In response, many organizations providing HIV care began supplying food aid to clients in need. Food supplementation, however, was quickly recognized as an unsustainable and incomplete intervention. Many HIV care organizations therefore developed integrated HIV and livelihood programs (IHLPs) to target the root causes of food insecurity. Methods and Findings: We conducted a qualitative study using in-depth interviews with 21 key informants who worked at seven organizations providing HIV care, food aid, or IHLPs in Kampala, Uganda in 2007-2008 to better understand the impact of IHLPs on the well-being of people living with HIV and AIDS (PLWHAs) and the challenges in transitioning clients from food aid to IHLPs. There was strong consensus among those interviewed that IHLPs are an important intervention in addressing food insecurity and its adverse health consequences among PLWHAs. Key informants identified three main challenges in transitioning PLWHAs from food supplementation programs to IHLPs: (1) lack of resources (2) timing of the transition and (3) logistical considerations including geography and weather. Factors seen as contributing to the success of programs included: (1) close involvement of community leaders (2) close ties with local and national government (3) diversification of IHLP activities and (4) close integration with food supplementation programs, all linked through a central program of HIV care. Conclusion: Health, policy and development experts should continue to strengthen IHLPs for participants in need. Further research is needed to determine when and how participants should be transitioned from food supplementation to IHLPs, and to determine how to better correlate measures of food insecurity with objective clinical outcomes so as to better evaluate program results.	[Yager, Jessica E.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA; [Yager, Jessica E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Kadiyala, Suneetha] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India; [Weiser, Sheri D.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; CGIAR; International Food Policy Research Institute (IFPRI); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Yager, JE (corresponding author), Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA.	jeyager@fhcrc.org		Kadiyala, Suneetha/0000-0002-9101-1471	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative; Irish Aid; Swedish International Development Cooperation Agency (SIDA); NIMH [5K23MH079713-01]; California HIV/AIDS Research Program [ID08-SF-054]; Burke Global Health Faculty Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713] Funding Source: NIH RePORTER	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative; Irish Aid(CGIAR); Swedish International Development Cooperation Agency (SIDA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California HIV/AIDS Research Program; Burke Global Health Faculty Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Kadiyala's time was funded by the Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative, and facilitated by the International Food Policy Research Institute (IFPRI). RENEWAL is grateful for support from Irish Aid and from the Swedish International Development Cooperation Agency (SIDA). Dr. Weiser receives funding from NIMH: 5K23MH079713-01, California HIV/AIDS Research Program grant number ID08-SF-054 and the Burke Global Health Faculty Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; Fields-Gardner C, 2010, J AM DIET ASSOC, V110, P1105, DOI 10.1016/j.jada.2010.05.020; Gillespie S, 2005, INT FOOD POLICY RES; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Kadiyala S, 2009, J DEV EFFECT, V1, P470, DOI 10.1080/19439340903370469; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Pandit JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-245; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; SEUMEFOSSO E, 2004, FOOD NUTR TECHNICAL; *UN, 2006, UN GEN ASS; *UN ADM COMM COORD, 2001, NUTR HIV AIDS; *UN WORLD FOOD PRO, 2008, HIV AIDS AN INT HIV; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; van Oosterhout JJ, 2010, AIDS CARE, V22, P737, DOI 10.1080/09540120903373581; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; World Food Programme, 2003, PROGR ER AIDS WPFS R	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26117	10.1371/journal.pone.0026117	http://dx.doi.org/10.1371/journal.pone.0026117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022530	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000295976000070
J	Adarkwah, CC; Gandjour, A; Akkerman, M; Evers, SM				Adarkwah, Charles Christian; Gandjour, Afschin; Akkerman, Maren; Evers, Silvia M.			Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands - A Markov Model	PLOS ONE			English	Article							II RECEPTOR BLOCKERS; STAGE RENAL-DISEASE; QUALITY-OF-LIFE; TIME TRADE-OFF; HEALTH STATES; RISK-FACTORS; ALBUMINURIA; MELLITUS; MICROALBUMINURIA; PREVALENCE	Objective: Type 2 diabetes is the main cause of end-stage renal disease (ESRD) in Europe and the USA. Angiotensin-converting enzyme (ACE) inhibitors have a potential to slow down the progression of renal disease and therefore provide a renal-protective effect. The aim of our study was to assess the most cost-effective time to start an ACE inhibitor (or an angiotensin II receptor blocker [ARB] if coughing as a side effect occurs) in patients with newly diagnosed type 2 diabetes in The Netherlands. Methods: A lifetime Markov decision model with simulated 50-year-old patients with newly diagnosed diabetes mellitus was developed using published data on costs and health outcomes and simulating the progression of renal disease. A health insurance perspective was adopted. Three strategies were compared: treating all patients at the time of diagnosing type 2 diabetes, screening for microalbuminuria, and screening for macroalbuminuria. Results: In the base-case analysis, the treat-all strategy is associated with the lowest costs and highest benefit and therefore dominates screening both for macroalbuminuria and microalbuminuria. A multivariate sensitivity analysis shows that the probability of savings is 70%. Conclusions: In The Netherlands for patients with type 2 diabetes prescription of an ACE inhibitor immediately after diagnosis should be considered if they do not have contraindications. An ARB should be considered for those patients developing a dry cough under ACE inhibitor therapy. The potential for cost savings would be even larger if the prevention of cardiovascular events were considered.	[Adarkwah, Charles Christian; Evers, Silvia M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Adarkwah, Charles Christian] RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Gandjour, Afschin] Frankfurt Sch Finance & Management, Frankfurt, Germany; [Akkerman, Maren] Rhein Westfal TH Aachen, Fac Med, Aachen, Germany	Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; Frankfurt School Finance & Management; RWTH Aachen University	Adarkwah, CC (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands.	s.evers@maastrichtuniversity.nl	Evers, Silvia MAA/K-9720-2015; Gandjour, Afschin/I-8963-2019; Evers, Silvia/ABG-2128-2020	Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; Adarkwah, Charles Christian/0000-0002-1073-5866				Adarkwah CC, 2011, EXPERT REV PHARM OUT, V11, P215, DOI [10.1586/erp.11.18, 10.1586/ERP.11.8]; Adarkwah CC, 2010, INT J TECHNOL ASSESS, V26, P62, DOI 10.1017/S0266462309990584; Ahmad J, 1997, DIABETES CARE, V20, P1576, DOI 10.2337/diacare.20.10.1576; [Anonymous], 2011, CONS PRIC PRIC 2009; [Anonymous], 2009, OV; [Anonymous], 2003, VA DOD CLIN PRACT GU; Arnesen Trude, 2004, J Health Serv Res Policy, V9, P43, DOI 10.1258/135581904322716111; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Bakker A J, 2004, Ned Tijdschr Geneeskd, V148, P2012; Bakker AJ, 1998, NED TIJDSCHR KLIN CH, V23, P129; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Bleichrodt H, 1997, J HEALTH ECON, V16, P155, DOI 10.1016/S0167-6296(96)00509-7; Boersma C, 2010, CLIN THER, V32, P1103, DOI 10.1016/j.clinthera.2010.06.013; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; CHURCHILL DN, 1987, CLIN INVEST MED, V10, P14; College voor Zorgverzekeringen (CVZ), 2009, DUTCH GUID PHARM RES; College Voor Zorgverzekeringen (CVZ), 2009, GIPCILINGEN; Comper WD, 2003, AM J KIDNEY DIS, V41, P336, DOI 10.1053/ajkd.2003.50041; Dale PL, 2008, CURR MED RES OPIN, V24, P193, DOI 10.1185/030079908X253410; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; Dolan P, 1996, J HEALTH ECON, V15, P209, DOI 10.1016/0167-6296(95)00038-0; Dutch End-Stage Renal Disease Registry, 2011, DUTCH END STAGE RENA; Farmacotherapeutisch kompas, 2010, FARM KOMP; Farmacotherapeutisch kompas, 2002, FARM KOMP; Frei U, 2006, NIERENERSATZTHERAPIE; Gandjour A, 2002, DIABETIC MED, V19, P594, DOI 10.1046/j.1464-5491.2002.00763.x; Gansevoort RT, 2005, KIDNEY INT, V67, pS28, DOI 10.1111/j.1523-1755.2005.09408.x; Gerstein HC, 2000, LANCET, V355, P253; Giani G, 2004, EVIDENZBASIERTE DIAB; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Hasslacher C, 2000, EVIDENZBASIERTE DIAB; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; John JA, 2006, STAT THINKING BUSINE; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Kuntz KM, 2005, EC EVALUATION HLTH C, P141; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; McIntosh AHA, 2002, CLIN GUIDELINES EVID; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MOLITCH ME, 2004, DIABETES CARE S1, V27, pS79, DOI DOI 10.2337/DIACARE.27.5.1240-A; Nederlandse internisten vereniging (NIV), 2006, RICHTL DIAB NEFR MON, P16; Nederlandse internisten vereniging (NIV), 2006, RICHTL DIAB NEFR SAM, P3; Nederlandse Zorgautoriteit, 2010, RAPP INK PRAKT AP, p[Nov, 52]; Niskanen LK, 1996, DIABETES CARE, V19, P486, DOI 10.2337/diacare.19.5.486; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Peeters P, 2000, HEALTH POLICY, V54, P209, DOI 10.1016/S0168-8510(00)00112-3; Renine Statistic Report, 2007, DEV RENAL REPLACEMEN; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Scheid DC, 2001, J FAM PRACTICE, V50, P661; Schroeder A, 2005, GMS HLTH TECHNOL ASS, V2; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006257; Strippoli GFM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004136.pub2; Third National Health and Nutrition Examination Survey 1988-1994, 1996, 76200 US DEP HHS NAT; *US REN DAT SYST, 2001, USRDS 2001 ANN DAT R; van Os N, 2000, HEALTH POLICY, V51, P135, DOI 10.1016/S0168-8510(00)00063-4; Vegter S, 2009, PHARMACOGENET GENOM, V19, P695, DOI 10.1097/FPC.0b013e3283307ca0	63	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26139	10.1371/journal.pone.0026139	http://dx.doi.org/10.1371/journal.pone.0026139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022539	gold, Green Published, Green Submitted			2022-12-25	WOS:000295973200043
J	Miao, XY; Wu, X; Li, R; Chen, KW; Yao, L				Miao, Xiaoyan; Wu, Xia; Li, Rui; Chen, Kewei; Yao, Li			Altered Connectivity Pattern of Hubs in Default-Mode Network with Alzheimer's Disease: An Granger Causality Modeling Approach	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; WANDERING MINDS; BRAIN ACTIVITY; BASE-LINE; FMRI; ATTENTION; DEMENTIA	Background: Evidences from normal subjects suggest that the default-mode network (DMN) has posterior cingulate cortex (PCC), medial prefrontal cortex (MPFC) and inferior parietal cortex (IPC) as its hubs; meanwhile, these DMN nodes are often found to be abnormally recruited in Alzheimer's disease (AD) patients. The issues on how these hubs interact to each other, with the rest nodes of the DMN and the altered pattern of hubs with respect to AD, are still on going discussion for eventual final clarification. Principal Findings: To address these issues, we investigated the causal influences between any pair of nodes within the DMN using Granger causality analysis and graph-theoretic methods on resting-state fMRI data of 12 young subjects, 16 old normal controls and 15 AD patients respectively. We found that: (1) PCC/MPFC/IPC, especially the PCC, showed the widest and distinctive causal effects on the DMN dynamics in young group; (2) the pattern of DMN hubs was abnormal in AD patients compared to old control: MPFC and IPC had obvious causal interaction disruption with other nodes; the PCC showed outstanding performance for it was the only region having causal relation with all other nodes significantly; (3) the altered relation between hubs and other DMN nodes held potential as a noninvasive biomarker of AD. Conclusions: Our study, to the best of our knowledge, is the first to support the hub configuration of the DMN from the perspective of causal relationship, and reveal abnormal pattern of the DMN hubs in AD. Findings from young subjects provide additional evidence for the role of PCC/MPFC/IPC acting as hubs in the DMN. Compared to old control, MPFC and IPC lost their roles as hubs owing to the obvious causal interaction disruption, and PCC was preserved as the only hub showing significant causal relations with all other nodes.	[Miao, Xiaoyan; Li, Rui; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wu, Xia; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Chen, Kewei] BAI, Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Miao, Xiaoyan] Beijing Inst Informat & Control, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Banner Research; Banner Health	Miao, XY (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yaoli@bnu.edu.cn	Chen, kewei/P-6304-2015	Chen, kewei/0000-0001-8497-3069	National Natural Science Foundation of China [60931003, 60905063, 81000603, 60805040]; National Institute of Mental Health, United States of America [RO1 MH57899]; National Institute on Aging, United States of America [R01AG031581-10, P30 AG19610, k23 AG24062]; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG024062, P30AG019610, R01AG031581] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Mental Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the National Natural Science Foundation of China (60931003, 60905063, 81000603, and 60805040). It is also supported by the National Institute of Mental Health, United States of America (RO1 MH57899), the National Institute on Aging, United States of America (R01AG031581-10 and P30 AG19610, k23 AG24062) and the State of Arizona. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bagarinao E, 2002, ANN BIOMED ENG, V30, P260, DOI 10.1114/1.1454134; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; BAKARDJIAN H, 2006, CLIN NEUROPHYSIOL, V117, P149; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Collette F, 1999, COGNITIVE BRAIN RES, V7, P411, DOI 10.1016/S0926-6410(98)00045-7; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Durston S, 2006, BIOL PSYCHIAT, V60, P1062, DOI 10.1016/j.biopsych.2005.12.020; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gao Q, 2008, NEUROSCI LETT, V443, P1, DOI 10.1016/j.neulet.2008.07.036; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Goldberg S, 2004, NEUROBIOL AGING, V25, P167, DOI 10.1016/S0197-4580(03)00088-5; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LI R, 2011, NEUROIMAGE; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mulas F, 2006, BIOL PSYCHIAT, V59, P373, DOI 10.1016/j.biopsych.2005.06.031; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; SHANNON BJ, FUNCTIONAL ANATOMIC; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; WU X, 2011, HUMAN BRAIN MAPPING; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; ZWEIG MH, 1993, CLIN CHEM, V39, P561	78	58	59	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25546	10.1371/journal.pone.0025546	http://dx.doi.org/10.1371/journal.pone.0025546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022410	Green Published, Green Submitted, gold			2022-12-25	WOS:000295973200010
J	Moores, B; Drolle, E; Attwood, SJ; Simons, J; Leonenko, Z				Moores, Bradley; Drolle, Elizabeth; Attwood, Simon J.; Simons, Janet; Leonenko, Zoya			Effect of Surfaces on Amyloid Fibril Formation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BETA-PROTEIN; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; LIPID-BILAYERS; PHASE DOMAINS; LIGHT-CHAIN; IN-VITRO; PEPTIDE; AGGREGATION	Using atomic force microscopy (AFM) we investigated the interaction of amyloid beta (A beta) (1-42) peptide with chemically modified surfaces in order to better understand the mechanism of amyloid toxicity, which involves interaction of amyloid with cell membrane surfaces. We compared the structure and density of A beta fibrils on positively and negatively charged as well as hydrophobic chemically-modified surfaces at physiologically relevant conditions. We report that due to the complex distribution of charge and hydrophobicity amyloid oligomers bind to all types of surfaces investigated (CH3, COOH, and NH2) although the charge and hydrophobicity of surfaces affected the structure and size of amyloid deposits as well as surface coverage. Hydrophobic surfaces promote formation of spherical amorphous clusters, while charged surfaces promote protofibril formation. We used the nonlinear Poisson-Boltzmann equation (PBE) approach to analyze the electrostatic interactions of amyloid monomers and oligomers with modified surfaces to complement our AFM data.	[Moores, Bradley; Attwood, Simon J.; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Drolle, Elizabeth; Simons, Janet; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Moores, B (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca	attwood, simon J/N-7237-2014	attwood, simon J/0000-0002-2973-2059; MOORES, BRADLEY/0000-0002-4745-606X	Natural Science and Engineering Council of Canada (NSERC); Canada Foundation for Innovation; Ontario Ministry of Research and Innovation; Ontario Research Fund (ORF); Waterloo Institute for Nanotechnology (WIN)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Research Fund (ORF); Waterloo Institute for Nanotechnology (WIN)	This work was supported by the Natural Science and Engineering Council of Canada (NSERC), http://www.nserc-crsng.gc.ca, Canada Foundation for Innovation, www.innovation.ca, and Ontario Ministry of Research and Innovation, www.mri.gov.on.ca: Ontario Research Fund (ORF), and Waterloo Institute for Nanotechnology (WIN), www.nano.uwaterloo.ca. JS is an undergraduate student supported by NSERC USRA award, BM is a MS student supported by NSERC Discovery grant (ZL) and WIN Graduate Fellowship (BM), ED is a PhD student supported by NSERC Graduate Scholarship (ED), Simon Attwood is a Postdoctoral Fellow supported by NSERC Discovery grant (ZL). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Buxbaum J, 1999, HEMATOL ONCOL CLIN N, V13, P1235, DOI 10.1016/S0889-8588(05)70123-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DYRKS T, 1993, FEBS LETT, V324, P231, DOI 10.1016/0014-5793(93)81399-K; Ege C, 2005, CHEMPHYSCHEM, V6, P226, DOI 10.1002/cphc.200400468; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Guo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008900; Hammarstrom P, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052039; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johansson J, 2003, SWISS MED WKLY, V133, P275; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McMasters MJ, 2005, LANGMUIR, V21, P4464, DOI 10.1021/la047044w; Melquiond A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2435358; Nayak A, 2008, BIOCHEM BIOPH RES CO, V369, P303, DOI 10.1016/j.bbrc.2008.01.159; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Powers ET, 2001, J AM CHEM SOC, V123, P775, DOI 10.1021/ja005528i; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Rocha S, 2005, CHEMPHYSCHEM, V6, P2527, DOI 10.1002/cphc.200500158; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797; Sharp JS, 2002, BIOCHEMISTRY-US, V41, P15810, DOI 10.1021/bi020525z; SHARP KA, 1994, CURR OPIN STRUC BIOL, V4, P234, DOI 10.1016/S0959-440X(94)90314-X; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Wang QM, 2010, LANGMUIR, V26, P12722, DOI 10.1021/la1017906; Wang QM, 2010, LANGMUIR, V26, P3308, DOI 10.1021/la903070y; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yokoyama K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105101; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	65	123	124	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25954	10.1371/journal.pone.0025954	http://dx.doi.org/10.1371/journal.pone.0025954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016789	Green Submitted, gold, Green Published			2022-12-25	WOS:000295971700028
J	Wood, R; Lawn, SD; Caldwell, J; Kaplan, R; Middelkoop, K; Bekker, LG				Wood, Robin; Lawn, Stephen D.; Caldwell, Judy; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail			Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status	PLOS ONE			English	Article							HIGH PREVALENCE; ANNUAL RISK; INFECTION; REINFECTION; COMMUNITY; TRANSMISSION; CHILDREN	Aim: To describe the burden of tuberculosis (TB) in Cape Town by calculating TB incidence rates stratified by age and HIV-status, assessing the contribution of retreatment disease and estimating the cumulative lifetime TB risk in HIV-negative individuals. Methods: Details of TB cases were abstracted from the 2009 electronic TB register. Population denominators were estimated from census data and actuarial estimates of HIV prevalence, allowing calculation of age-specific and HIV-stratified TB notification rates. Results: The 2009 mid-year population was 3,443,010 (3,241,508 HIV-negative and 201,502 HIV-positive individuals). There were 29,478 newly notified TB cases of which 56% were laboratory confirmed. HIV status was recorded for 87% of cases and of those with known HIV-status 49% were HIV-negative and 51% were positive. Discrete peaks in the incidence of non-HIV-associated TB occurred at three ages: 511/100,000 at 0-4 years of age, 553/100,000 at 20-24 years and 628/100,000 at 45-49 years with 1.5%, 19% and 45% being due to retreatment TB, respectively. Only 15.5% of recurrent cases had a history of TB treatment failure or default. The cumulative lifetime risks in the HIV-negative population of all new TB episodes and new smear-positive TB episodes were 24% and 12%, respectively; the lifetime risk of retreatment disease was 9%. The HIV-positive notification rate was 6,567/100,000 (HIV-associated TB rate ratio = 17). Although retreatment cases comprised 30% of the HIV-associated TB burden, 88% of these patients had no history of prior treatment failure or default. Conclusions: The annual burden of TB in this city is huge. TB in the HIV-negative population contributed almost half of the overall disease burden and cumulative lifetime risks were similar to those reported in the pre-chemotherapy era. Retreatment TB contributed significantly to both HIV-associated and non-HIV-associated TB but infrequently followed prior inadequate treatment. This likely reflects ongoing TB transmission to both HIV-negative and positive individuals.	[Wood, Robin; Lawn, Stephen D.; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wood, Robin; Lawn, Stephen D.; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Wood, Robin] Univ Stellenbosch, Ctr Excellence Epidemiol Modeling & Anal, Natl Res Fdn, Dept Sci & Technol, Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Caldwell, Judy] City Cape Town Dept Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine	Wood, R (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	Linda-Gail.Bekker@hiv-research.org.za	Wood, Robin/G-8509-2011; Bekker, Linda-Gail/AAZ-8929-2020	Kaplan, Richard/0000-0003-1565-4704; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Middelkoop, Keren/0000-0001-9922-4263	National Institutes of Health (NIH) [1U19AI53217-01, A1058736-02, IeDEA 5U01A1069924-02]; USAID [CA 674A00080000700]; Wellcome Trust, London, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, U01AI069924, R01AI058736] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID(United States Agency for International Development (USAID)); Wellcome Trust, London, UK(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RW, LGB and KM were funded in part by the National Institutes of Health (NIH) through CIPRA grant 1U19AI53217-01, RO1 grant A1058736-02, and IeDEA 5U01A1069924-02 and USAID grant CA 674A00080000700. SDL was funded by the Wellcome Trust, London, UK. No additional funding was obtained for this study. The funding sources played no part in the decision to publish this data or any role in the design, analysis or writing of this manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; *ACT SOC S AFR, ASSA 2003 AIDS DEM M; [Anonymous], MIDYEAR POPULATION E; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; CLAYTON D, 1993, CONSECUTIVE FOLLOW I; Department of Health (South Africa), 2009, NAT ANT SENT HIV SYP; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; LAWN SD, 2010, SAMJ, V100, P1; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Middelkoop K, 2009, SAMJ S AFR MED J, V99, P738; REIDER HI, 1999, EPIDEMIOLOGICAL BASI; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Sutherland I., 10 YEAR INC CLIN TUB; Uys PW, 2009, J R SOC INTERFACE, V6, P11, DOI 10.1098/rsif.2008.0184; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; *WHO, WHO TUB REP 2011 ANN; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, WHOHTMTB2009411; Wiker HG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-37; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization, 2006, WHOHTMTB2006368; World Health Organization (WHO), TUB PROF; DEV DISTRICT HLTH IN; CITY CAPE TOWN HIV A; S AFRICAN TUBERCULOS; CAPE TOWN TB CONTROL	33	78	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25098	10.1371/journal.pone.0025098	http://dx.doi.org/10.1371/journal.pone.0025098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016763	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295971700004
J	Grosse, J; Wehland, M; Pietsch, J; Ma, X; Ulbrich, C; Schulz, H; Saar, K; Hubner, N; Hauslage, J; Hemmersbach, R; Braun, M; van Loon, J; Vagt, N; Infanger, M; Eilles, C; Egli, M; Richter, P; Baltz, T; Einspanier, R; Sharbati, S; Grimm, D				Grosse, Jirka; Wehland, Markus; Pietsch, Jessica; Ma, Xiao; Ulbrich, Claudia; Schulz, Herbert; Saar, Katrin; Huebner, Norbert; Hauslage, Jens; Hemmersbach, Ruth; Braun, Markus; van Loon, Jack; Vagt, Nicole; Infanger, Manfred; Eilles, Christoph; Egli, Marcel; Richter, Peter; Baltz, Theo; Einspanier, Ralf; Sharbati, Soroush; Grimm, Daniela			Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; cytoskeleton; integrins; microgravity	LEFT-VENTRICULAR HYPERTROPHY; FIBROBLAST-GROWTH-FACTOR; NF-KAPPA-B; SIMULATED MICROGRAVITY; F-ACTIN; ADHESION MOLECULE-1; MAMMALIAN-CELLS; GELSOLIN; APOPTOSIS; GRAVITY	This study focused on the effects of short-term microgravity (22 s) on the gene expression and morphology of endothelial cells (ECs) and evaluated gravisensitive signaling elements. ECs were investigated during four German Space Agency (Deutsches Zentrum fur Luft-und Raumfahrt) parabolic flight campaigns. Hoechst 33342 and acridine orange/ethidium bromide staining showed no signs of cell death in ECs after 31 parabolas (P31). Gene array analysis revealed 320 significantly regulated genes after the first parabola (P1) and P31. COL4A5, COL8A1, ITGA6, ITGA10, and ITGB3 mRNAs were down-regulated after P1. EDN1 and TNFRSF12A mRNAs were up-regulated. ADAM19, CARD8, CD40, GSN, PRKCA (all down-regulated after P1), and PRKAA1 (AMPK alpha 1) mRNAs (up-regulated) provide a very early protective mechanism of cell survival induced by 22 s microgravity. The ABL2 gene was significantly up-regulated after P1 and P31, TUBB was slightly induced, but ACTA2 and VIM mRNAs were not changed. beta-Tubulin immunofluorescence revealed a cytoplasmic rearrangement. Vibration had no effect. Hypergravity reduced CARD8, NOS3, VASH1, SERPINH1 (all P1), CAV2, ADAM19, TNFRSF12A, CD40, and ITGA6 (P31) mRNAs. These data suggest that microgravity alters the gene expression patterns and the cytoskeleton of ECs very early. Several gravisensitive signaling elements, such as AMPK alpha 1 and integrins, are involved in the reaction of ECs to altered gravity.-Grosse, J., Wehland, M., Pietsch, J., Ma, X., Ulbrich, C., Schulz, H., Saar, K., Hubner, N., Hauslage, J., Hemmersbach, R., Braun, M., van Loon, J., Vagt, N., Infanger, M., Eilles, C., Egli, M., Richter, P., Baltz, T., Einspanier, R., Sharbati, S., Grimm, D. Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells. FASEB J. 26, 639-655 (2012). www.fasebj.org	[Ma, Xiao; Grimm, Daniela] Aarhus Univ, Inst Biomed, DK-8000 Aarhus C, Denmark; [Grosse, Jirka; Eilles, Christoph] Univ Regensburg, Dept Nucl Med, Regensburg, Germany; [Wehland, Markus; Pietsch, Jessica; Infanger, Manfred; Grimm, Daniela] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Ulbrich, Claudia] Univ Hohenheim, Inst Zool, D-7000 Stuttgart, Germany; [Schulz, Herbert; Saar, Katrin; Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hauslage, Jens; Hemmersbach, Ruth] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany; [Braun, Markus; Vagt, Nicole] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, Bonn, Germany; [van Loon, Jack] ACTA Free Univ, Dept Oral Cell Biol, Dutch Expt Support Ctr, Amsterdam, Netherlands; [Egli, Marcel] ETH, Space Biol Grp, Zurich, Switzerland; [Richter, Peter] Univ Erlangen Nurnberg, Erlangen, Germany; [Baltz, Theo] Univ Bordeaux 2, Dept Mol Parasitol & Mycol, F-33076 Bordeaux, France; [Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany	Aarhus University; University of Regensburg; Otto von Guericke University; University Hohenheim; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; German Aerospace Centre (DLR); University of Bonn; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Erlangen Nuremberg; UDICE-French Research Universities; Universite de Bordeaux; Free University of Berlin	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	daniela.grimm@farm.au.dk	van Loon, Jack JJWA/A-4250-2013; Koch, Claudia/AAH-1421-2019; Koch, Claudia/D-6350-2017; Sharbati, Soroush/D-2548-2014	Koch, Claudia/0000-0001-8630-9700; Saar, Kathrin/0000-0002-4483-1557; van Loon, Jack/0000-0001-9051-6016; Sharbati, Soroush/0000-0003-3338-7654; Grimm, Daniela/0000-0002-4991-3105; Hauslage, Jens/0000-0003-2184-7000; Wehland, Markus/0000-0002-8160-859X	Deutsches Zentrum fur Luft- und Raumfahrt (BMWi) [50WB0824]; Eidgenossische Technische Hochschule Zurich (Zurich, Switzerland); Aarhus University (Aarhus, Denmark); Freie Universitat Berlin (Berlin, Germany); University of Regensburg (Regensburg, Germany); Netherlands Organisation for Scientific Research Earth and Life Sciences via the Netherlands Space Office [MG-057]	Deutsches Zentrum fur Luft- und Raumfahrt (BMWi); Eidgenossische Technische Hochschule Zurich (Zurich, Switzerland); Aarhus University (Aarhus, Denmark); Freie Universitat Berlin (Berlin, Germany); University of Regensburg (Regensburg, Germany); Netherlands Organisation for Scientific Research Earth and Life Sciences via the Netherlands Space Office	The authors thank the team of Proof-Reading-Service.com (Letchworth Garden City, UK; http://www.proof-reading-service.com) for academic proofreading of the article. This study was supported by the Deutsches Zentrum fur Luft- und Raumfahrt (BMWi grant 50WB0824 to D.G.), Eidgenossische Technische Hochschule Zurich (Zurich, Switzerland; M. E.), Aarhus University (Aarhus, Denmark; D. G.), Freie Universitat Berlin (Berlin, Germany; R. E.), and University of Regensburg (Regensburg, Germany; J.G.). J.V.L. is supported by grant MG-057 from the Netherlands Organisation for Scientific Research Earth and Life Sciences via the Netherlands Space Office.	Alliegro MC, 2001, CELL BIOL INT, V220, P2077; Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Buravkova L, 2005, ACTA ASTRONAUT, V57, P67, DOI 10.1016/j.actaastro.2005.03.012; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Chhabra D, 2005, PROTEOMICS, V5, P3131, DOI 10.1002/pmic.200401127; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Cotrupi S, 2005, BBA-MOL CELL RES, V1746, P163, DOI 10.1016/j.bbamcr.2005.10.002; Dosaka-Akita H, 1998, CANCER RES, V58, P322; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grimm D, 2002, CARDIOVASC PATHOL, V11, P229, DOI 10.1016/S1054-8807(01)00116-8; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2007, CARDIOVASC PATHOL, V16, P291, DOI 10.1016/j.carpath.2007.04.001; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kang CY, 2011, EUR J APPL PHYSIOL, V111, P2131, DOI 10.1007/s00421-011-1844-0; Kossmehl P, 2005, J MOL MED, V83, P626, DOI 10.1007/s00109-005-0642-8; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Krajewska WM, 2004, CELL MOL BIOL LETT, V9, P195; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Liu GH, 2010, PROTEINS, V78, P1326, DOI 10.1002/prot.22656; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Malik N, 1996, J IMMUNOL, V156, P3952; Mantovani A, 1997, IMMUNOL TODAY, V18, P231, DOI 10.1016/S0167-5699(97)81662-3; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; MORTON LF, 1983, THROMB RES, V32, P545, DOI 10.1016/0049-3848(83)90056-7; Pearson JD, 2000, LUPUS, V9, P183, DOI 10.1191/096120300678828299; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; Romanov Y, 2000, J Gravit Physiol, V7, pP77; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Russell FD, 1999, BRIT J PHARMACOL, V126, P391, DOI 10.1038/sj.bjp.0702315; Sangha DS, 2001, J APPL PHYSIOL, V91, P789, DOI 10.1152/jappl.2001.91.2.789; SCHIFFRIN EL, 1994, CLIN INVEST MED, V17, P602; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sowa G, 2008, BIOCHEMISTRY-US, V47, P101, DOI 10.1021/bi701709s; Spisni E, 2003, J CELL PHYSIOL, V197, P198, DOI 10.1002/jcp.10344; Sun RJ, 2002, EUR BIOPHYS J BIOPHY, V30, P605, DOI 10.1007/s00249-001-0195-x; TANAKA M, 1995, CANCER RES, V55, P3228; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; Younes A, 1999, INT J BIOL MARKER, V14, P135, DOI 10.1177/172460089901400303; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	75	64	65	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					639	655		10.1096/fj.11-194886	http://dx.doi.org/10.1096/fj.11-194886			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22024737				2022-12-25	WOS:000300485700017
J	Schmidt, S; Mo, M; Heidrich, FM; Celic, A; Ehrlich, BE				Schmidt, Stefan; Mo, Michelle; Heidrich, Felix M.; Celic, Andjelka; Ehrlich, Barbara E.			C-terminal Domain of Chromogranin B Regulates Intracellular Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SECRETORY GRANULES; CA2+ MOBILIZATION; ENTRY; PARVALBUMIN; ACTIVATION; TRANSIENTS; NEURONS; CHANNEL; BINDING	The versatility of intracellular calcium as a second messenger is seen in its ability to mediate opposing events such as neuronal cell growth and apoptosis. A leading hypothesis used to explain how calcium regulates such divergent signaling pathways is that molecules responsible for maintaining calcium homeostasis have multiple roles. For example, chromogranin B (CGB), a calcium binding protein found in secretory granules and in the lumen of the endoplasmic reticulum, buffers calcium and also binds to and amplifies the activity of the inositol 1,4,5-trisphosphate receptor (InsP(3)R). Previous studies have identified two conserved domains of CGB, an N-terminal domain (N-CGB) and a C-terminal domain (C-CGB). N-CGB binds to the third intraluminal loop of the InsP(3)R and inhibits binding of full-length CGB. This displacement of CGB decreases InsP(3)R-dependent calcium release and alters normal signaling patterns. In the present study, we further characterized the role of N-CGB and identified roles for C-CGB. The effect of N-CGB on calcium release depended upon endogenous levels of cellular CGB, whereas the regulatory effect of C-CGB was apparent regardless of endogenous levels of CGB. When either full-length CGB or C-CGB was expressed in cells, calcium transients were increased. Additionally, the calcium signal initiation site was altered upon C-CGB expression in neuronally differentiated PC12 and SHSY5Y cells. These results show that CGB has numerous regulatory roles and that CGB is a critical component in modulating InsP(3)R-dependent calcium signaling.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	Celic, Andjeka S/AAC-1865-2022; /AAX-8408-2021	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Heidrich, M.D., Felix M./0000-0002-1972-8216; Schmidt, Stefan/0000-0001-8590-6319	National Institutes of Health [DK57751, DK61747]; German National Merit Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Merit Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by scholarships from the German National Merit Foundation (to S. S.) and the Howard Hughes Medical Institute (to M. M.).	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huh YH, 2006, BIOCHEMISTRY-US, V45, P1212, DOI 10.1021/bi051594r; Huh YH, 2005, BIOCHEMISTRY-US, V44, P6122, DOI 10.1021/bi048070w; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; Johenning FW, 2002, J NEUROSCI, V22, P5344; Putney JW, 2001, J CELL SCI, V114, P2223; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	22	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44888	44896		10.1074/jbc.M111.251330	http://dx.doi.org/10.1074/jbc.M111.251330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22016391	hybrid, Green Published			2022-12-25	WOS:000298645500057
J	Sen, T; Sen, N; Huang, YP; Sinha, D; Luo, ZG; Ratovitski, EA; Sidransky, D				Sen, Tanusree; Sen, Nilkantha; Huang, Yiping; Sinha, Debasish; Luo, Zhen-Ge; Ratovitski, Edward A.; Sidransky, David			Tumor Protein p63/Nuclear Factor kappa B Feedback Loop in Regulation of Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; P53 FAMILY; TRANSCRIPTIONAL REGULATION; INDUCED APOPTOSIS; CARCINOMA-CELLS; CROSS-TALK; IN-VIVO; CANCER; AUTOPHAGY; DELTA-NP63-ALPHA	Tumor protein (TP)-p53 family members often play proapoptotic roles, whereas nuclear factor kappa B (NF-kappa B) functions as a proapoptotic and antiapoptotic regulator depending on the cellular environment. We previously showed that the NF-kappa B activation leads to the reduction of the TP63 isoform, Delta Np63 alpha, thereby rendering the cells susceptible to cell death upon DNA damage. However, the functional relationship between TP63 isotypes and NF-kappa B is poorly understood. Here, we report that the TAp63 regulates NF-kappa B transcription and protein stability subsequently leading to the cell death phenotype. We found that TAp63 beta induced the expression of the p65 subunit of NF-kappa B (RELA) and target genes involved in cell cycle arrest or apoptosis, thereby triggering cell death pathways in MCF10A cells. RELA was shown to concomitantly modulate specific cell survival pathways, making it indispensable for the TAp63 beta-dependent regulation of cell death. We showed that TAp63 beta and RELA formed protein complexes resulted in their mutual stabilization and inhibition of the RELA ubiquitination. Finally, we showed that TAp63 beta directly induced RelA transcription by binding to and activating of its promoter and, in turn, leading to activation of the NF-kappa B-dependent cell death genes. Overall, our data defined the regulatory feedback loop between TAp63 beta and NF-kappa B involved in the activation of cell death process of cancer cells.	[Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Canc Res, Baltimore, MD 21231 USA; [Sen, Nilkantha] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21231 USA; [Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA; [Sinha, Debasish; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA; [Luo, Zhen-Ge] Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ratovitski, EA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Canc Res, Canc Res Bldg 2,Rm 2M05,1550 Orleans St, Baltimore, MD 21231 USA.	eratovi1@jhmi.edu	Sen, Nilkantha/AAW-9788-2020		National Institute of Health through the NIDCR [R01-DE13561]; National Institute of Health through the NEI [R01-EY018636-01]; NATIONAL EYE INSTITUTE [R01EY018636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013561] Funding Source: NIH RePORTER	National Institute of Health through the NIDCR; National Institute of Health through the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part by National Institutes of Health Grants R01-DE13561 through the NIDCR (to D. Sidransky and E. A. R.) and R01-EY018636-01 through the NEI (to D. Sinha and E. A. R.).	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Borrelli S, 2009, CELL DEATH DIFFER, V16, P253, DOI 10.1038/cdd.2008.147; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Fomenkov A, 2003, J BIOL CHEM, V278, P23906, DOI 10.1074/jbc.M300746200; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Fujioka S, 2004, J BIOL CHEM, V279, P27549, DOI 10.1074/jbc.M313435200; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Huang YP, 2008, CELL CYCLE, V7, P2846, DOI 10.4161/cc.7.18.6627; Huang YP, 2010, AGING-US, V2, P959, DOI 10.18632/aging.100249; Huang YP, 2010, CELL CYCLE, V9, P328, DOI 10.4161/cc.9.2.10432; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Karin M, 1991, CURR OPIN CELL BIOL, V3, P467, DOI 10.1016/0955-0674(91)90075-A; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; Kuribayashi K, 2011, CELL CYCLE, V10, P2380, DOI 10.4161/cc.10.14.16588; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martin AG, 2009, AGING-US, V1, P335, DOI 10.18632/aging.100026; Mauro C, 2009, METHODS MOL BIOL, V512, P169, DOI 10.1007/978-1-60327-530-9_10; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Schilling T, 2009, BIOCHEM BIOPH RES CO, V387, P399, DOI 10.1016/j.bbrc.2009.07.063; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Schuster A, 2010, CELL CYCLE, V9, P2629, DOI 10.4161/cc.9.13.12110; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Sen T, 2010, CELL CYCLE, V9, P4841, DOI 10.4161/cc.9.24.14093; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Vousden KH, 2009, AGING-US, V1, P275, DOI 10.18632/aging.100033; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang J, 2010, J NEUROSCI, V30, P11104, DOI 10.1523/JNEUROSCI.2118-10.2010; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wu J, 2010, J CELL BIOCHEM, V109, P702, DOI 10.1002/jcb.22449; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	67	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43204	43213		10.1074/jbc.M111.257105	http://dx.doi.org/10.1074/jbc.M111.257105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020940	Green Published, hybrid			2022-12-25	WOS:000298351300041
J	Senkal, CE; Ponnusamy, S; Manevich, Y; Meyers-Needham, M; Saddoughi, SA; Mukhopadyay, A; Dent, P; Bielawski, J; Ogretmen, B				Senkal, Can E.; Ponnusamy, Suriyan; Manevich, Yefim; Meyers-Needham, Marisa; Saddoughi, Sahar A.; Mukhopadyay, Archana; Dent, Paul; Bielawski, Jacek; Ogretmen, Besim			Alteration of Ceramide Synthase 6/C-16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; LONGEVITY ASSURANCE GENE-1; BREFELDIN-A; HUMAN HEAD; GOLGI PROTEINS; DISTINCT ROLES; HELA-CELLS; ATF6; DEATH; SPHINGOLIPIDS	Mechanisms that regulate endoplasmic reticulum (ER) stress-induced apoptosis in cancer cells remain enigmatic. Recent data suggest that ceramide synthase1-6 (CerS1-6)-generated ceramides, containing different fatty acid chain lengths, might exhibit distinct and opposing functions, such as apoptosis versus survival in a context-dependent manner. Here, we investigated the mechanisms involved in the activation of one of the major ER stress response proteins, ATF-6, and subsequent apoptosis by alterations of CerS6/C-16-ceramide. Induction of wild type (WT), but not the catalytically inactive mutant CerS6, increased tumor growth in SCID mice, whereas siRNA-mediated knockdown of CerS6 induced ATF-6 activation and apoptosis in multiple human cancer cells. Down-regulation of CerS6/C-16-ceramide, and not its further metabolism to glucosylceramide or sphingomyelin, activated ATF-6 upon treatment with ER stress inducers tunicamycin or SAHA (suberoylanilide hydroxamic acid). Induction of WT-CerS6 expression, but not its mutant, or ectopic expression of the dominant-negative mutant form of ATF-6 protected cells from apoptosis in response to CerS6 knockdown and tunicamycin or SAHA treatment. Mechanistically, ATF-6 activation was regulated by a concerted two-step process involving the release of Ca2+ from the ER stores ([Ca2+](ER)), which resulted in the fragmentation of Golgi membranes in response to CerS6/C16-ceramide alteration. This resulted in the accumulation of pro-ATF-6 in the disrupted ER/Golgi membrane network, where pro-ATF6 is activated. Accordingly, ectopic expression of a Ca2+ chelator calbindin prevented the Golgi fragmentation, ATF-6 activation, and apoptosis in response to CerS6/C16-ceramide down-regulation. Overall, these data suggest a novel mechanism of how CerS6/C-16-ceramide alteration activates ATF6 and induces ER-stress-mediated apoptosis in squamous cell carcinomas.	[Senkal, Can E.; Ponnusamy, Suriyan; Meyers-Needham, Marisa; Saddoughi, Sahar A.; Mukhopadyay, Archana; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Manevich, Yefim] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Dent, Paul] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA	Medical University of South Carolina; Medical University of South Carolina; Virginia Commonwealth University	Ogretmen, B (corresponding author), 86 Jonathan Lucas St,HO512, Charleston, SC 29425 USA.	ogretmen@musc.edu			National Institutes of Health [CA088932, DE016572, CA097132]; National Institutes of Health at National Center for Research Resources [C06 RR015455]; NATIONAL CANCER INSTITUTE [R01CA088932, R01CA141703, P01CA097132, R01CA150214] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES019464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health at National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA088932, DE016572, and CA097132.; Human HNSCC cell lines UM-SCC-1, UM-SCC-14A, and UM-SCC-22A cells were kindly provided by Dr. Thomas Carey (University of Michigan). The dominant-negative-ATF6 cDNA was kindly provided by Dr. Christopher Glembotski (University of California, San Diego). Lung cancer cell lines were obtained from Dr. Harry Drabkin (Medical University of South Carolina). The core facilities utilized for animal studies and Lipidomics were constructed using support from the National Institutes of Health (Grant C06 RR015455) at the Extramural Research Facilities Program of the National Center for Research Resources.	Balla T, 2009, CELL CALCIUM, V45, P527, DOI 10.1016/j.ceca.2009.03.013; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Erez-Roman R, 2010, BIOCHEM BIOPH RES CO, V391, P219, DOI 10.1016/j.bbrc.2009.11.035; Ginzburg L, 2008, J NEUROCHEM, V104, P140, DOI 10.1111/j.1471-4159.2007.04983.x; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hisatsune C, 2005, J BIOL CHEM, V280, P11723, DOI 10.1074/jbc.M409535200; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Manevich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014151; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	87	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42446	42458		10.1074/jbc.M111.287383	http://dx.doi.org/10.1074/jbc.M111.287383			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013072	hybrid, Green Published			2022-12-25	WOS:000298180900053
J	Zhang, Y; Yang, XH; Gui, B; Xie, GJ; Zhang, D; Shang, YF; Liang, J				Zhang, Yu; Yang, Xiaohan; Gui, Bin; Xie, Guojia; Zhang, Di; Shang, Yongfeng; Liang, Jing			Corepressor Protein CDYL Functions as a Molecular Bridge between Polycomb Repressor Complex 2 and Repressive Chromatin Mark Trimethylated Histone Lysine 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; METHYLTRANSFERASE ACTIVITY; GENE REPRESSION; BINDING; METHYLATION; ESTROGEN; ELEMENT; CORE; PRC2; EZH2	Polycomb group proteins play essential roles in transcriptional regulation of multiple gene families involved in various pathophysiological processes. It is believed that Polycomb Repressive Complex 2 (PRC2) is targeted to chromatin by the EED subunit to methylate histone H3 lysine 27 (H3K27), leading to a repressive chromatin state that inhibits gene expression. Here we report that the chromodomain-containing protein CDYL specifically recognizes di- and tri-methylated H3K27 (H3K27me2 and H3K27me3) and directly interacts with EZH2, the catalytic subunit of PRC2. We show that CDYL dramatically enhances the methyltransferase activity of PRC2 toward oligonucleosome substrates in vitro. Genome-wide analysis of CDYL targets by ChIP sequencing revealed that CDYL and PRC2 share a number of genomic targets. CDYL is required for chromatin targeting and maximal enzymatic activity of PRC2 at their common target sites. Our experiments indicate that CDYL functions as a molecular bridge between PRC2 and the repressive chromatin mark H3K27me3, forming a positive feedback loop to facilitate the establishment and propagation of H3K27me3 modifications along the chromatin.	[Zhang, Yu; Yang, Xiaohan; Gui, Bin; Xie, Guojia; Zhang, Di; Shang, Yongfeng; Liang, Jing] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minst Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Liang, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minst Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	liang_jing@bjmu.edu.cn	Zhang, Di/AAE-2027-2021; Zhang, Di/AAD-6936-2021	Xie, Guojia/0000-0002-8250-6157	National Natural Science Foundation of China [30971637, 90919045, 30830032, 30921062]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30971637 and 90919045 (to J. L.) and 30830032 and 30921062 (to Y. S.) from the National Natural Science Foundation of China and Grants 973 Program: 2011CB504204 (to J. L. and Y. S.) from the Ministry of Science and Technology of China.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Li X, 2007, TRENDS GENET, V23, P427, DOI 10.1016/j.tig.2007.06.001; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sims RJ, 2006, METHODS, V40, P331, DOI 10.1016/j.ymeth.2006.07.031; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2004, COLD SPRING HARB SYM, V69, P309, DOI 10.1101/sqb.2004.69.309; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	55	59	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42414	42425		10.1074/jbc.M111.271064	http://dx.doi.org/10.1074/jbc.M111.271064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009739	Green Published, hybrid			2022-12-25	WOS:000298180900050
J	Brewer, TF; Choi, HW; Seas, C; Krapp, F; Zamudio, C; Shah, L; Ciampi, A; Heymann, SJ; Gotuzzo, E				Brewer, Timothy F.; Choi, Howard W.; Seas, Carlos; Krapp, Fiorella; Zamudio, Carlos; Shah, Lena; Ciampi, Antonio; Heymann, S. Jody; Gotuzzo, Eduardo			Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; DIAGNOSIS; ASSAY; PROGRAM; COST	Background: Multiple drug-resistance in new tuberculosis (TB) cases accounts for the majority of all multiple drug-resistant TB (MDR-TB) worldwide. Effective control requires determining which new TB patients should be tested for MDR disease, yet the effectiveness of global screening recommendations of high-risk groups is unknown. Methods: Sixty MDR-TB cases with no history of previous TB treatment, 80 drug-sensitive TB and 80 community-based controls were recruited in Lima, Peru between August and December, 2008 to investigate whether recommended screening practices identify individuals presenting with MDR-TB. Odd ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression to study the association of potential risk factors with case/control variables. Results: MDR-TB cases did not differ from drug-sensitive TB and community controls in rates of human immunodeficiency virus infection, reported hospital or prison visits in the 3 years prior to diagnosis. MDR-TB cases were more likely than drug-sensitive TB controls to have had a recent MDR-TB household contact (OR 4.66, (95% CI 1.56-13.87)); however, only 15 cases (28.3%) reported this exposure. In multivariate modeling, recent TB household contact, but not contact with an MDR-TB case, remained predictive of MDR-TB, OR 7.47, (95% CI 1.91-29.3). Living with a partner rather than parents was associated with a lower risk of MDR-TB, OR 0.15, (95% CI 0.04-0.51). Conclusion: Targeted drug susceptibility testing (DST) linked to reported MDR-TB contact or other high-risk exposures does not identify the majority of new TB cases with MDR disease in Lima where it is endemic. All new TB cases should be screened with DST to identify MDR patients. These findings are likely applicable to other regions with endemic MDR-TB.	[Brewer, Timothy F.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Brewer, Timothy F.; Shah, Lena; Ciampi, Antonio; Heymann, S. Jody] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Heymann, S. Jody] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Choi, Howard W.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Seas, Carlos; Krapp, Fiorella; Zamudio, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru	McGill University; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Brewer, TF (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	timothy.brewer@mcgill.ca	Krapp, Fiorella/ABG-7436-2021	Krapp, Fiorella/0000-0002-8404-2827; Seas, Carlos/0000-0001-7067-9141; Zamudio, Carlos/0000-0001-7479-127X	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec; National Institutes of Health	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Royal Victoria Hospital Foundation and Fonds de la Recherche en Sante, Quebec. Dr. Krapp was supported in part by a National Institutes of Health International Clinical, Operational, and Health Services Research and Training Award to the Universidad Peruana Cayetano Heredia. The authors had full access to all data and final responsibility for the decision to submit this study for publication. The funder had no role in the study design, implementation, data collection, analyses, interpretation or the writing of this report.	Banerjee R, 2010, J CLIN MICROBIOL, V48, P3779, DOI 10.1128/JCM.01236-10; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; BLONDAL K, 2007, ORGAN, V85, P391; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Borgdorff MW, 2009, LANCET, V373, P1822, DOI 10.1016/S0140-6736(09)60557-2; Breslow N E, 1987, IARC Sci Publ, P1; BUSKIN SE, 1994, AM J PUBLIC HEALTH, V84, P1750, DOI 10.2105/AJPH.84.11.1750; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Heymann SJ, 1997, PUBLIC HEALTH REP, V112, P513; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Martinez D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082; Moore DAJ, 2007, FUTURE MICROBIOL, V2, P97, DOI 10.2217/17460913.2.2.97; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; *TUB PER INF, 2006, EV ESTR SAN NAC PREV; *USAID, 2009, HLTH INF DIS; Uys PW, 2009, J CLIN MICROBIOL, V47, P1484, DOI 10.1128/JCM.02289-08; Vazquez-Gallardo R, 2007, INT J TUBERC LUNG D, V11, P429; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; *WHO, 2008, ANT DRUG RES WORLD; World Health Organization, 2011, WHOHTMTB20113; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25861	10.1371/journal.pone.0025861	http://dx.doi.org/10.1371/journal.pone.0025861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022459	Green Published, gold, Green Submitted			2022-12-25	WOS:000295981600016
J	Gathercole, LL; Morgan, SA; Bujalska, IJ; Hauton, D; Stewart, PM; Tomlinson, JW				Gathercole, Laura L.; Morgan, Stuart A.; Bujalska, Iwona J.; Hauton, David; Stewart, Paul M.; Tomlinson, Jeremy W.			Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE-1; DE-NOVO LIPOGENESIS; VISCERAL OBESITY; HORMONAL-REGULATION; GLUCOSE-TOLERANCE; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; KNOCKOUT MICE	Patients with glucocorticoid (GC) excess, Cushing's syndrome, develop a classic phenotype characterized by central obesity and insulin resistance. GCs are known to increase the release of fatty acids from adipose, by stimulating lipolysis, however, the impact of GCs on the processes that regulate lipid accumulation has not been explored. Intracellular levels of active GC are dependent upon the activity of 11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and we have hypothesized that 11 beta-HSD1 activity can regulate lipid homeostasis in human adipose tissue (Chub-S7 cell line and primary cultures of human subcutaneous (sc) and omental (om) adipocytes. Across adipocyte differentiation, lipogenesis increased whilst beta-oxidation decreased. GC treatment decreased lipogenesis but did not alter rates of beta-oxidation in Chub-S7 cells, whilst insulin increased lipogenesis in all adipocyte cell models. Low dose Dexamethasone pre-treatment (5 nM) of Chub-S7 cells augmented the ability of insulin to stimulate lipogenesis and there was no evidence of adipose tissue insulin resistance in primary sc cells. Both cortisol and cortisone decreased lipogenesis; selective 11 beta-HSD1 inhibition completely abolished cortisone-mediated repression of lipogenesis. GCs have potent actions upon lipid homeostasis and these effects are dependent upon interactions with insulin. These in vitro data suggest that manipulation of GC availability through selective 11 beta-HSD1 inhibition modifies lipid homeostasis in human adipocytes.	[Gathercole, Laura L.; Morgan, Stuart A.; Bujalska, Iwona J.; Hauton, David; Stewart, Paul M.; Tomlinson, Jeremy W.] Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England	University of Birmingham	Gathercole, LL (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England.	J.W.Tomlinson@bham.ac.uk		gathercole, laura/0000-0001-5983-0306; Tomlinson, Jeremy/0000-0002-3170-8533	Medical Research Council; Wellcome Trust [066357]; Medical Research Council [G0802765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Medical Research Council senior clinical fellowship (JWT), Wellcome Trust programme grant 066357 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Berthiaume M, 2007, ENDOCRINOLOGY, V148, P2391, DOI 10.1210/en.2006-1199; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; DIAMANT S, 1975, EUR J BIOCHEM, V53, P541, DOI 10.1111/j.1432-1033.1975.tb04097.x; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; FONTBONNE A, 1992, DIABETOLOGIA, V35, P464, DOI 10.1007/BF02342445; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gathercole LL, 2007, J CLIN ENDOCR METAB, V92, P4332, DOI 10.1210/jc.2007-1399; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; JAMDAR SC, 1978, BIOCHEM J, V170, P153, DOI 10.1042/bj1700153; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kola B, 2008, J CLIN ENDOCR METAB, V93, P4969, DOI 10.1210/jc.2008-1297; Lammert O, 2000, BRIT J NUTR, V84, P233; Laviola L, 2006, DIABETES, V55, P952, DOI 10.2337/diabetes.55.04.06.db05-1414; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; SIMACOPOULOSJEA.F, 1995, METABOLISM, V44, P228; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Tomlinson JJ, 2010, MOL ENDOCRINOL, V24, P104, DOI 10.1210/me.2009-0091; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Viana AYI, 2006, DIABETES RES CLIN PR, V73, P135, DOI 10.1016/j.diabres.2005.12.011; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; VOLPE JJ, 1975, BIOCHIM BIOPHYS ACTA, V380, P454, DOI 10.1016/0005-2760(75)90113-7; Wang YX, 2004, J NUTR, V134, P1032; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zierath JR, 1998, DIABETOLOGIA, V41, P1343, DOI 10.1007/s001250051075	43	99	101	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26223	10.1371/journal.pone.0026223	http://dx.doi.org/10.1371/journal.pone.0026223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022575	Green Published, gold			2022-12-25	WOS:000295981600041
J	de Jong, PA; Gondrie, MJA; Buckens, CFM; Jacobs, PC; Mali, WPTHM; van der Graaf, Y				de Jong, Pim A.; Gondrie, Martijn J. A.; Buckens, Constantinus F. M.; Jacobs, Peter C.; Mali, Willem P. T. H. M.; van der Graaf, Yolanda		PROVIDI Study Grp	Prediction of Cardiovascular Events by Using Non-Vascular Findings on Routine Chest CT	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK REDUCTION; MORTALITY; BRONCHIECTASIS	Background: Routine computed tomography (CT) examinations contain an abundance of findings unrelated to the diagnostic question. Those with prognostic significance may contribute to early detection and treatment of disease, irrelevant findings can be ignored. We aimed to assess the association between unrequested chest CT findings in lungs, mediastinum and pleura and future cardiovascular events. Methods: Multi-center case-cohort study in 5 tertiary and 3 secondary care hospitals involving 10410 subjects who underwent routine chest CT for non-cardiovascular reasons. 493 cardiovascular hospitalizations or deaths were recorded during an average follow-up time of 17.8 months. 1191 patients were randomly sampled to serve as a control subcohort. Hazard ratios and annualized event rates were calculated. Results: Abnormalities in the lung (26-44%), pleura (14-15%) and mediastinum (20%) were common. Hazard ratios after adjustment for age and sex were for airway wall thickening 2.26 (1.59-3.22), ground glass opacities 2.50 (1.72-3.62), consolidations 1.97 (1.12-3.47), pleural effusions 2.77 (1.81-4.25) and lymph-nodes 2.04 (1.40-2.96). Corresponding annual event rates were 5.5%, 6.0%, 3.8%, 10.2% and 4.4%. Conclusions: We have identified several common chest CT findings that are predictive for future risk of cardiovascular events and found that other findings have little utility for this. The added value of the non-vascular predictors to established vascular calcifications on CT remains to be determined.	[de Jong, Pim A.; Jacobs, Peter C.; Mali, Willem P. T. H. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Gondrie, Martijn J. A.; Buckens, Constantinus F. M.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Mali, Willem PThM/I-1123-2014; Prokop, W.M./H-8081-2014	de Jong, Pim A/0000-0003-4840-6854; Mali, Willem PThM/0000-0003-4391-0904; Prokop, Mathias/0000-0001-8157-8055; Buckens, Constantinus F/0000-0002-3190-258X	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW) [40-00812-98-07-005]	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a program grant from the Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW, www.nwo.nl) grant 40-00812-98-07-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2008, AM J MED SCI, V335, P484, DOI 10.1097/MAJ.0b013e318160ede9; Akalin F, 2003, PEDIATR INT, V45, P169, DOI 10.1046/j.1442-200X.2003.01692.x; BADUI E, 1985, ANGIOLOGY, V36, P431, DOI 10.1177/000331978503600705; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DEBRUIN A, 2004, STAT J UN EC COMM EU, V21, P23; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Gondrie MJA, 2010, EUR J EPIDEMIOL, V25, P751, DOI 10.1007/s10654-010-9514-9; Gondrie MJA, 2011, EUR RADIOL, V21, P963, DOI 10.1007/s00330-010-1995-0; Gondrie MJA, 2010, RADIOLOGY, V257, P549, DOI 10.1148/radiol.10100054; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Jacobs PCA, 2008, J COMPUT ASSIST TOMO, V32, P214, DOI 10.1097/RCT.0b013e3181585ff2; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee CI, 2010, RADIOLOGY, V257, P313, DOI 10.1148/radiol.10101437; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Liu SF, 2005, INT J TUBERC LUNG D, V9, P111; Macnee William, 2008, Proc Am Thorac Soc, V5, P824, DOI 10.1513/pats.200807-071TH; Man SFP, 2008, EUR RESPIR J, V32, P1451, DOI 10.1183/09031936.00153207; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayne TJ, 2006, J CLIN EPIDEMIOL, V59, P217, DOI 10.1016/j.jclinepi.2005.07.006; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Ngom A, 2001, CHEST, V119, P653, DOI 10.1378/chest.119.2.653; Paas G, 2002, RES VALIDITY LMR; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; PENTICE RL, 1986, BIOMETRIKA, V73, P1; Sin DD, 2009, CHEST, V136, P329, DOI 10.1378/chest.09-0808; TIDDENS H, AM J RESP CRIT CAR 2, V162, pS7; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Vehmas T, 2008, EUR J CARDIOV PREV R, V15, P599, DOI 10.1097/HJR.0b013e328309a224; Wells DK, 2010, CLIN EXP RHEUMATOL, V28, P223; WILLIAMS FLR, 1989, COMMUNITY MED, V11, P306	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26036	10.1371/journal.pone.0026036	http://dx.doi.org/10.1371/journal.pone.0026036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022499	Green Published, gold, Green Submitted			2022-12-25	WOS:000295976000057
J	Polini, A; Pisignano, D; Parodi, M; Quarto, R; Scaglione, S				Polini, Alessandro; Pisignano, Dario; Parodi, Manuela; Quarto, Rodolfo; Scaglione, Silvia			Osteoinduction of Human Mesenchymal Stem Cells by Bioactive Composite Scaffolds without Supplemental Osteogenic Growth Factors	PLOS ONE			English	Article							MARROW STROMAL CELLS; ALKALINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; NANOFIBROUS SCAFFOLD; TISSUE REGENERATION; BONE REGENERATION; IN-VITRO; DIFFERENTIATION; EXPRESSION; NANOTECHNOLOGY	The development of a new family of implantable bioinspired materials is a focal point of bone tissue engineering. Implant surfaces that better mimic the natural bone extracellular matrix, a naturally nano-composite tissue, can stimulate stem cell differentiation towards osteogenic lineages in the absence of specific chemical treatments. Herein we describe a bioactive composite nanofibrous scaffold, composed of poly-caprolactone (PCL) and nano-sized hydroxyapatite (HA) or beta-tricalcium phosphate (TCP), which was able to support the growth of human bone marrow mesenchymal stem cells (hMSCs) and guide their osteogenic differentiation at the same time. Morphological and physical/chemical investigations were carried out by scanning, transmission electron microscopy, Fourier-transform infrared (FTIR) spectroscopy, mechanical and wettability analysis. Upon culturing hMSCs on composite nanofibers, we found that the incorporation of either HA or TCP into the PCL nanofibers did not affect cell viability, meanwhile the presence of the mineral phase increases the activity of alkaline phosphatase (ALP), an early marker of bone formation, and mRNA expression levels of osteoblast-related genes, such as the Runt-related transcription factor 2 (Runx-2) and bone sialoprotein (BSP), in total absence of osteogenic supplements. These results suggest that both the nanofibrous structure and the chemical composition of the scaffolds play a role in regulating the osteogenic differentiation of hMSCs.	[Polini, Alessandro; Pisignano, Dario] CNR Natl Res Council Italy, NNL Natl Nanotechnol Lab, Inst Nanosci, Lecce, Italy; [Pisignano, Dario] Univ Salento, Dipartimento Ingn Innovaz, Lecce, Italy; [Parodi, Manuela; Quarto, Rodolfo] Univ Genoa, Dipartimento Med Sperimentale DIMES, Genoa, Italy; [Scaglione, Silvia] CNR Natl Res Council Italy, IEIIT Inst, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Salento; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Polini, A (corresponding author), CNR Natl Res Council Italy, NNL Natl Nanotechnol Lab, Inst Nanosci, Lecce, Italy.	alessandro.polini@nano.cnr.it; dario.pisignano@unisalento.it	scaglione, silvia/K-5378-2019; Quarto, Rodolfo/AAB-2182-2019; Polini, Alessandro/A-2077-2012; Pisignano, Dario/M-8309-2015; Scaglione, Silvia/B-7124-2014	scaglione, silvia/0000-0002-9464-3554; Polini, Alessandro/0000-0002-3188-983X; Pisignano, Dario/0000-0003-3758-5199; Scaglione, Silvia/0000-0002-9464-3554; Quarto, Rodolfo/0000-0002-1146-894X	Italian Minister of University and Research [RBIP068JL9, RBNE08BNL7]	Italian Minister of University and Research(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by the Italian Minister of University and Research through the FIRB Contracts RBIP068JL9 and RBNE08BNL7 (MERIT Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]; Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Deng M, 2010, BIOMATERIALS, V31, P4898, DOI 10.1016/j.biomaterials.2010.02.058; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; Hild N, 2011, NANOSCALE, V3, P401, DOI 10.1039/c0nr00615g; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013; Hubbell JA, 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041; Kim HW, 2007, J BIOMED MATER RES A, V83A, P169, DOI 10.1002/jbm.a.31247; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kolambkar YM, 2010, TISSUE ENG PT A, V16, P3219, DOI [10.1089/ten.tea.2010.0004, 10.1089/ten.TEA.2010.0004]; Kon E, 2000, J BIOMED MATER RES, V49, P328; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65; MATSUMOTO H, 1990, GASTROENTEROLOGY, V98, P1199, DOI 10.1016/0016-5085(90)90334-W; Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X; Nandakumar A, 2010, MACROMOL BIOSCI, V10, P1365, DOI 10.1002/mabi.201000145; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Parekh SH, 2011, BIOMATERIALS, V32, P2256, DOI 10.1016/j.biomaterials.2010.11.065; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c; Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006; Sanchez-Salcedo S, 2009, ACTA BIOMATER, V5, P2738, DOI 10.1016/j.actbio.2009.03.025; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098; Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038	54	154	156	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26211	10.1371/journal.pone.0026211	http://dx.doi.org/10.1371/journal.pone.0026211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022571	Green Submitted, Green Published, gold			2022-12-25	WOS:000295976000088
J	Verspoor, RL; Haddrill, PR				Verspoor, Rudi L.; Haddrill, Penelope R.			Genetic Diversity, Population Structure and Wolbachia Infection Status in a Worldwide Sample of Drosophila melanogaster and D. simulans Populations	PLOS ONE			English	Article							NON-AFRICAN POPULATIONS; AUTOSOMAL NUCLEOTIDE VARIATION; MULTILOCUS GENOTYPE DATA; CYTOPLASMIC INCOMPATIBILITY; NATURAL-POPULATIONS; ENDOSYMBIONT WOLBACHIA; NONEQUILIBRIUM MODELS; CONTRASTING PATTERNS; MOLECULAR EVOLUTION; POSITIVE SELECTION	Drosophila melanogaster and its close relatives have been extremely important model species in the development of population genetic models that serve to explain patterns of diversity in natural populations, a major goal of evolutionary biology. A detailed picture of the evolutionary history of these species is beginning to emerge, as the relative importance of forces including demographic changes and natural selection is established. A continuing aim is to characterise levels of genetic diversity in a large number of populations of these species, covering a wide geographic area. We have used collections from five previously un-sampled wild populations of D. melanogaster and two of D. simulans, across three continents. We estimated levels of genetic diversity within, and divergence between, these populations, and looked for evidence of genetic structure both between ancestral and derived populations, and amongst derived populations. We also investigated the prevalence of infection with the bacterial endosymbiont Wolbachia. We found that D. melanogaster populations from Sub-Saharan Africa are the most diverse, and that divergence is highest between these and non-Sub-Saharan populations. There is strong evidence for structuring of populations between Sub-Saharan Africa and the rest of the world, and some evidence for weak structure amongst derived populations. Populations from Sub-Saharan Africa also differ in the prevalence of Wolbachia infection, with very low levels of infection compared to populations from the rest of the world.	[Verspoor, Rudi L.; Haddrill, Penelope R.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Verspoor, RL (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	p.haddrill@ed.ac.uk	Haddrill, Penelope R/H-4439-2011	Haddrill, Penelope/0000-0001-6805-0694; Verspoor, Rudi/0000-0002-4328-7721	Natural Environment Research Council [NE/G013195/1]; NERC [NE/G013195/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council (http://www.nerc.ac.uk/) Fellowship, reference NE/G013195/1, to PRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1995, GENETICS, V139, P1067; Akashi H, 1996, GENETICS, V144, P1297; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Andolfatto P, 2000, GENETICS, V156, P257; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baudry E, 2004, MOL BIOL EVOL, V21, P1482, DOI 10.1093/molbev/msh089; Begun DJ, 1996, MOL BIOL EVOL, V13, P1405, DOI 10.1093/oxfordjournals.molbev.a025587; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; CABALLERO A, 1995, GENETICS, V139, P1007; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Dieringer D, 2005, MOL ECOL, V14, P563, DOI 10.1111/j.1365-294X.2004.02422.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Falush D, 2003, GENETICS, V164, P1567; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Galtier N, 2000, GENETICS, V155, P981; Glinka S, 2003, GENETICS, V165, P1269; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hamblin MT, 1999, GENETICS, V153, P305; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; HOFFMANN AA, 1994, GENETICS, V136, P993; Hoffmann AA, 1998, GENETICS, V148, P221; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Kauer M, 2003, MOL BIOL EVOL, V20, P1329, DOI 10.1093/molbev/msg148; Kauer M, 2002, GENETICS, V160, P247; Kauer MO, 2003, GENETICS, V165, P1137; Kliman RM, 2000, GENETICS, V156, P1913; Krebs C. J., 2014, ECOLOGICAL METHODOLO; LACHAISE D, 1988, EVOL BIOL, V22, P159; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; MARUYAMA T, 1985, GENETICS, V111, P691; MARUYAMA T, 1985, GENETICS, V111, P675; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Mousset S, 2003, GENETICS, V163, P599; Nolte V, 2008, GENETICS, V178, P405, DOI 10.1534/genetics.107.080200; Nunes MDS, 2008, MOL ECOL, V17, P4470, DOI 10.1111/j.1365-294X.2008.03944.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Orozco-terWengel P, 2011, MOL ECOL, V20, P1108, DOI 10.1111/j.1365-294X.2010.04990.x; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Pool JE, 2008, MOL BIOL EVOL, V25, P1728, DOI 10.1093/molbev/msn124; Pool JE, 2006, GENETICS, V174, P915, DOI 10.1534/genetics.106.058693; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2001, MOL BIOL EVOL, V18, P291, DOI 10.1093/oxfordjournals.molbev.a003805; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Singh ND, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-202; Sokal RR, 1995, BIOMETRY; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Wall JD, 2002, GENETICS, V162, P203; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WIEHE THE, 1993, MOL BIOL EVOL, V10, P842, DOI 10.1093/oxfordjournals.molbev.a040046; Yukilevich R, 2008, EVOLUTION, V62, P2112, DOI 10.1111/j.1558-5646.2008.00427.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	73	32	35	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26318	10.1371/journal.pone.0026318	http://dx.doi.org/10.1371/journal.pone.0026318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022599	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000295976000097
J	Wakabayashi-Ito, N; Doherty, OM; Moriyama, H; Breakefield, XO; Gusella, JF; O'Donnell, JM; Ito, N				Wakabayashi-Ito, Noriko; Doherty, Olugbenga M.; Moriyama, Hideaki; Breakefield, Xandra O.; Gusella, James F.; O'Donnell, Janis M.; Ito, Naoto			dtorsin, the Drosophila Ortholog of the Early-Onset Dystonia TOR1A (DYT1), Plays a Novel Role in Dopamine Metabolism	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE; TORSION DYSTONIA; PHENOTYPIC ANALYSIS; PROTEIN TORSINA; PUNCH LOCUS; MOUSE MODEL; GENE; IDENTIFICATION; LOCOMOTION; BIOSYNTHESIS	Dystonia represents the third most common movement disorder in humans. At least 15 genetic loci (DYT1-15) have been identified and some of these genes have been cloned. TOR1A (formally DYT1), the gene responsible for the most common primary hereditary dystonia, encodes torsinA, an AAA ATPase family protein. However, the function of torsinA has yet to be fully understood. Here, we have generated and characterized a complete loss-of-function mutant for dtorsin, the only Drosophila ortholog of TOR1A. Null mutation of the X-linked dtorsin was semi-lethal with most male flies dying by the pre-pupal stage and the few surviving adults being sterile and slow moving, with reduced cuticle pigmentation and thin, short bristles. Third instar male larvae exhibited locomotion defects that were rescued by feeding dopamine. Moreover, biochemical analysis revealed that the brains of third instar larvae and adults heterozygous for the loss-of-function dtorsin mutation had significantly reduced dopamine levels. The dtorsin mutant showed a very strong genetic interaction with Pu (Punch: GTP cyclohydrolase), the ortholog of the human gene underlying DYT14 dystonia. Biochemical analyses revealed a severe reduction of GTP cyclohydrolase protein and activity, suggesting that dtorsin plays a novel role in dopamine metabolism as a positive-regulator of GTP cyclohydrolase protein. This dtorsin mutant line will be valuable for understanding this relationship and potentially other novel torsin functions that could play a role in human dystonia.	[Wakabayashi-Ito, Noriko; Gusella, James F.; Ito, Naoto] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Doherty, Olugbenga M.; O'Donnell, Janis M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Moriyama, Hideaki] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Wakabayashi-Ito, Noriko; Breakefield, Xandra O.; Ito, Naoto] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol & Radiol, Boston, MA USA; [Wakabayashi-Ito, Noriko; Breakefield, Xandra O.; Ito, Naoto] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Tuscaloosa; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wakabayashi-Ito, N (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	iton@chgr.mgh.harvard.edu			NIH/NIDS [NS037409]; Nebraska Tobacco Settlement Biomedical Research Development Funds; Dystonia Medical Research Foundation; University of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS087997, P50NS037409, P01NS037409] Funding Source: NIH RePORTER	NIH/NIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Development Funds; Dystonia Medical Research Foundation; University of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NIDS Grant NS037409 (JFG) (http://www.ninds.nih.gov/), Nebraska Tobacco Settlement Biomedical Research Development Funds (HM), Dystonia Medical Research Foundation (NI and JFG) (http://www.dystonia-foundation.org/) and The University of Alabama (JMO and OMD)(http://www.ua.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bhidayasiri R, 2011, POSTGRAD MED J, V87, P132, DOI 10.1136/pgmj.2010.103234; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Carbon M, 2010, EUR J NEUROL, V17, P58, DOI 10.1111/j.1468-1331.2010.03054.x; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; CHEN XY, 1994, J CELL SCI, V107, P3501; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Dasari S, 2004, NEUROSCI RES, V48, P221, DOI 10.1016/j.neures.2003.10.005; DAVIS MD, 1991, FEBS LETT, V285, P17, DOI 10.1016/0014-5793(91)80714-E; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiMonte DA, 1996, BRAIN RES, V738, P53, DOI 10.1016/0006-8993(96)00761-5; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gibson S, 2003, COMPUT GRAPH-UK, V27, P293, DOI 10.1016/S0097-8493(02)00285-6; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hirsh J, 2000, EXPOSING DROSOPHILA; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Kamm C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-48; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Krishnakumar S, 2000, J NEUROGENET, V14, P1, DOI 10.3109/01677060009083474; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee DW, 2009, MOL CELLS, V27, P89, DOI 10.1007/s10059-009-0009-z; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Muraro NI, 2006, J NEUROBIOL, V66, P1338, DOI 10.1002/neu.20313; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; ODONNELL JM, 1989, DEV GENET, V10, P273, DOI 10.1002/dvg.1020100316; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; REYNOLDS ER, 1987, DEV BIOL, V123, P430, DOI 10.1016/0012-1606(87)90401-5; REYNOLDS ER, 1988, GENETICS, V119, P609; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Sciamanna G, 2009, NEUROBIOL DIS, V34, P133, DOI 10.1016/j.nbd.2009.01.001; Segawa Masaya, 2009, Chang Gung Med J, V32, P1; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Wang JW, 2002, J NEUROGENET, V16, P45, DOI 10.1080/01677060213106; Watschinger K, 2010, P NATL ACAD SCI USA, V107, P13672, DOI 10.1073/pnas.1002404107; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027	57	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26183	10.1371/journal.pone.0026183	http://dx.doi.org/10.1371/journal.pone.0026183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022556	gold, Green Published			2022-12-25	WOS:000295976000082
J	Zhou, M; Kindt, M; Joels, M; Krugers, HJ				Zhou, Ming; Kindt, Merel; Joels, Marian; Krugers, Harm J.			Blocking Mineralocorticoid Receptors prior to Retrieval Reduces Contextual Fear Memory in Mice	PLOS ONE			English	Article							DAY-OLD CHICKS; GLUCOCORTICOID-RECEPTORS; PROTEIN-SYNTHESIS; RECONSOLIDATION; CORTICOSTERONE; EXTINCTION; STRESS; CONSOLIDATION; ANTAGONISTS; AMYGDALA	Background: Corticosteroid hormones regulate appraisal and consolidation of information via mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) respectively. How activation of these receptors modulates retrieval of fearful information and the subsequent expression of fear is largely unknown. We tested here whether blockade of MRs or GRs during retrieval also affects subsequent expression of fear memory. Methodology/Principal Findings: Mice were trained in contextual or tone cue fear conditioning paradigms, by pairing mild foot shocks with a particular context or tone respectively. Twenty-four hours after training, context-conditioned animals were re-exposed to the context for 3 or 30 minutes (day 2); tone-conditioned animals were placed in a different context and re-exposed to one or six tones. Twenty-four hours (day 3) and one month later, freezing behavior to the aversive context/tone was scored again. MR or GR blockade was achieved by giving spironolactone or RU486 subcutaneously one hour before retrieval on day 2. Spironolactone administered prior to brief context re-exposure reduced freezing behavior during retrieval and 24 hours later, but not one month later. Administration of spironolactone without retrieval of the context or immediately after retrieval on day 2 did not reduce freezing on day 3. Re-exposure to the context for 30 minutes on day 2 significantly reduced freezing on day 3 and one month later, but freezing was not further reduced by spironolactone. Administration of spironolactone prior to tone-cue re-exposure on day 2 did not affect freezing behavior. Treatment with RU486 prior to re-exposure did not affect context or tone-cue fear memories at any time point. Conclusions/Significance: We conclude that MR blockade prior to retrieval strongly reduces the expression of contextual fear, implying that MRs, rather than GRs, play an important role in retrieval of emotional information and subsequent fear expression.	[Zhou, Ming; Joels, Marian; Krugers, Harm J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Joels, Marian] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center	Zhou, M (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	h.krugers@uva.nl	Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209	Cognitive Science Center Amsterdam; Royal Dutch Academy of Arts and Sciences [05CDP013, 08CDP004]; Dutch Brain Foundation [2008 (1).07]	Cognitive Science Center Amsterdam; Royal Dutch Academy of Arts and Sciences; Dutch Brain Foundation	This project is supported by a special grant from the Cognitive Science Center Amsterdam, the Royal Dutch Academy of Arts and Sciences (05CDP013 and 08CDP004) and grant 2008 (1).07 from the Dutch Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Atkinson HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1011, DOI 10.1152/ajpendo.00721.2007; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Bitran D, 1998, PHARMACOL BIOCHEM BE, V60, P879, DOI 10.1016/S0091-3057(98)00071-9; Blundell J, 2011, NEUROBIOL LEARN MEM, V95, P453, DOI 10.1016/j.nlm.2011.02.006; Brinks V, 2009, EXP NEUROL, V216, P375, DOI 10.1016/j.expneurol.2008.12.011; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Herman JP, 1998, J NEUROSCI, V18, P7462; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Koenig HN, 2004, PSYCHONEUROENDOCRINO, V29, P999, DOI 10.1016/j.psyneuen.2003.09.004; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nikzad S, 2011, STRESS, V14, P459, DOI 10.3109/10253890.2010.548171; OITZL MS, 1992, BEHAV NEUROSCI, V106, P62, DOI 10.1037/0735-7044.106.1.62; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pugh CR, 1997, NEUROBIOL LEARN MEM, V67, P75, DOI 10.1006/nlme.1996.3741; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; SANDI C, 1994, EUR J NEUROSCI, V6, P1292, DOI 10.1111/j.1460-9568.1994.tb00319.x; SANDI C, 1994, BRAIN RES, V647, P106, DOI 10.1016/0006-8993(94)91404-4; Sangha S, 2003, J NEUROSCI, V23, P8034; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Yang YL, 2006, NEUROPSYCHOPHARMACOL, V31, P912, DOI 10.1038/sj.npp.1300899; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	42	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26220	10.1371/journal.pone.0026220	http://dx.doi.org/10.1371/journal.pone.0026220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022574	gold, Green Published, Green Submitted			2022-12-25	WOS:000295976000090
J	Flower, K; Thomas, D; Heather, J; Ramasubramanyan, S; Jones, S; Sinclair, AJ				Flower, Kirsty; Thomas, David; Heather, James; Ramasubramanyan, Sharada; Jones, Susan; Sinclair, Alison J.			Epigenetic Control of Viral Life-Cycle by a DNA-Methylation Dependent Transcription Factor	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYTIC TRANSACTIVATOR ZTA; INDUCTION; ACTIVATION; PROTEIN; BZLF1; GENE; EXPRESSION; PROMOTER; SITES	Epstein-Barr virus (EBV) encoded transcription factor Zta (BZLF1, ZEBRA, EB1) is the prototype of a class of transcription factor (including C/EBPalpha) that interact with CpG-containing DNA response elements in a methylation-dependent manner. The EBV genome undergoes a biphasic methylation cycle; it is extensively methylated during viral latency but is reset to an unmethylated state following viral lytic replication. Zta is expressed transiently following infection and again during the switch between latency and lytic replication. The requirement for CpG-methylation at critical Zta response elements (ZREs) has been proposed to regulate EBV replication, specifically it could aid the activation of viral lytic gene expression from silenced promoters on the methylated genome during latency in addition to preventing full lytic reactivation from the non-methylated EBV genome immediately following infection. We developed a computational approach to predict the location of ZREs which we experimentally assessed using in vitro and in vivo DNA association assays. A remarkably different binding motif is apparent for the CpG and non-CpG ZREs. Computational prediction of the location of these binding motifs in EBV revealed that the majority of lytic cycle genes have at least one and many have multiple copies of methylation-dependent CpG ZREs within their promoters. This suggests that the abundance of Zta protein coupled with the methylation status of the EBV genome act together to co-ordinate the expression of lytic cycle genes at the majority of EBV promoters.	[Flower, Kirsty; Thomas, David; Heather, James; Ramasubramanyan, Sharada; Jones, Susan; Sinclair, Alison J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Flower, Kirsty] Univ London Imperial Coll Sci Technol & Med, Epigenet Unit, Dept Surg & Canc, London, England; [Heather, James] UCL, Infect & Immun Div, London, England; [Jones, Susan] James Hutton Inst, Dundee, Scotland	University of Sussex; Imperial College London; University of London; University College London; James Hutton Institute	Flower, K (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.j.sinclair@sussex.ac.uk	Heather, James/I-1123-2019	Heather, James/0000-0002-1783-5181; Sinclair, Alison/0000-0001-8510-8691; Flower, Kirsty/0000-0002-5473-1197	Wellcome Trust, United Kingdom; University of Sussex	Wellcome Trust, United Kingdom(Wellcome Trust); University of Sussex	This research was supported by grants from the Wellcome Trust, United Kingdom, and University of Sussex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bergbauer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001114; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Broderick P, 2009, CHINESE J C IN PRESS; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Countryman J, 1985, P NATL ACAD SCI USA, V81, P7632; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Farrell PJ, 2005, EPSTEIN-BARR VIRUS, P263; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Flower K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009443; Fu Yutao, 2005, Genome Inform, V16, P68; Heather J, 2009, J GEN VIROL, V90, P1450, DOI 10.1099/vir.0.007922-0; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Jones RJ, 2007, J BIOL CHEM, V282, P8317, DOI 10.1074/jbc.M608667200; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Karlsson QH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000005; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; TAKADA K, 1989, J VIROL, V63, P445, DOI 10.1128/JVI.63.1.445-449.1989; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006	43	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25922	10.1371/journal.pone.0025922	http://dx.doi.org/10.1371/journal.pone.0025922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022468	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295973200021
J	Rupf, S; Idlibi, AN; Al Marrawi, F; Hannig, M; Schubert, A; von Mueller, L; Spitzer, W; Holtmann, H; Lehmann, A; Rueppell, A; Schindler, A				Rupf, Stefan; Idlibi, Ahmad Nour; Al Marrawi, Fuad; Hannig, Matthias; Schubert, Andreas; von Mueller, Lutz; Spitzer, Wolfgang; Holtmann, Henrik; Lehmann, Antje; Rueppell, Andre; Schindler, Axel			Removing Biofilms from Microstructured Titanium Ex Vivo: A Novel Approach Using Atmospheric Plasma Technology	PLOS ONE			English	Article							ARGON PLASMA; IN-VITRO; DENTAL IMPLANTS; DISCHARGE; INACTIVATION; VIABILITY; EFFICACY; ADHERENT; CELLS	The removal of biofilms from microstructured titanium used for dental implants is a still unresolved challenge. This experimental study investigated disinfection and removal of in situ formed biofilms from microstructured titanium using cold atmospheric plasma in combination with air/water spray. Titanium discs (roughness (Ra): 1.96 mu m) were exposed to human oral cavities for 24 and 72 hours (n = 149 each) to produce biofilms. Biofilm thickness was determined using confocal laser scanning microscopy (n = 5 each). Plasma treatment of biofilms was carried out ex vivo using a microwave-driven pulsed plasma source working at temperatures from 39 to 43 degrees C. Following plasma treatment, one group was air/water spray treated before re-treatment by second plasma pulses. Vital microorganisms on the titanium surfaces were identified by contact culture (Rodac agar plates). Biofilm presence and bacterial viability were quantified by fluorescence microscopy. Morphology of titanium surfaces and attached biofilms was visualized by scanning electron microscopy (SEM). Total protein amounts of biofilms were colorimetrically quantified. Untreated and air/water treated biofilms served as controls. Cold plasma treatment of native biofilms with a mean thickness of 19 mu m (24 h) to 91 mm (72 h) covering the microstructure of the titanium surface caused inactivation of biofilm bacteria and significant reduction of protein amounts. Total removal of biofilms, however, required additional application of air/water spray, and a second series of plasma treatment. Importantly, the microstructure of the titanium discs was not altered by plasma treatment. The combination of atmospheric plasma and non-abrasive air/water spray is applicable for complete elimination of oral biofilms from microstructured titanium used for dental implants and may enable new routes for the therapy of periimplant disease.	[Rupf, Stefan; Idlibi, Ahmad Nour; Al Marrawi, Fuad; Hannig, Matthias; Rueppell, Andre] Saarland Univ Hosp, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Schubert, Andreas] Fraunhofer Inst, Vasc Biol Grp, Leipzig, Germany; [von Mueller, Lutz] Saarland Univ Hosp, Dept Med Microbiol, Homburg, Germany; [Spitzer, Wolfgang; Holtmann, Henrik] Univ Clin Saarland, Clin Oral & Maxillofacial Surg, Homburg, Germany; [Lehmann, Antje; Rueppell, Andre; Schindler, Axel] Leibniz Inst Surface Modificat IOM, Leipzig, Germany; [Idlibi, Ahmad Nour] Univ Aleppo, Fac Dent, Dept Periodontol, Aleppo, Syria	Universitatsklinikum des Saarlandes; Fraunhofer Gesellschaft; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Leibniz Institut fur Oberflachenmodifizierung (IOM)	Rupf, S (corresponding author), Saarland Univ Hosp, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany.	Stefan.rupf@uks.eu			Federal Ministry of Education and Research Germany (BMBF) [FKZ 01 EZ 0730, 01 EZ 0731]; Freunde des Universitatsklinikums des Saarlandes e.V.	Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Freunde des Universitatsklinikums des Saarlandes e.V.	This study was supported by grants from the Federal Ministry of Education and Research Germany (BMBF; FKZ 01 EZ 0730 and 01 EZ 0731) and of the "Freunde des Universitatsklinikums des Saarlandes e.V.''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augthun M, 1998, J PERIODONTOL, V69, P857, DOI 10.1902/jop.1998.69.8.857; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; Coulombe S, 2006, PURE APPL CHEM, V78, P1147, DOI 10.1351/pac200678061147; do Nascimento C, 2011, INT J ORAL MAX IMPL, V26, P782; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Duan YX, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2409624; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Goncalves F, 2010, PHOTOMED LASER SURG, V28, P273, DOI 10.1089/pho.2009.2496; Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x; Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Kamgang JO, 2007, J APPL MICROBIOL, V103, P621, DOI 10.1111/j.1365-2672.2007.03286.x; Kieft I.E., 2005, PLASMA PROCESS POLYM, P295; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lopez-Heredia MA, 2008, ACTA BIOMATER, V4, P1953, DOI 10.1016/j.actbio.2008.04.024; Manner H, 2008, CURR OPIN GASTROEN, V24, P612, DOI 10.1097/MOG.0b013e32830bf825; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Masaoka Satoshi, 2007, Biocontrol Science, V12, P59; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; RUHLING A, 1994, CLIN ORAL IMPLAN RES, V5, P19, DOI 10.1034/j.1600-0501.1994.050103.x; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; Schwarz F, 2005, CLIN ORAL INVEST, V9, P111, DOI 10.1007/s00784-005-0305-8; Schwarz F, 2006, J BIOMED MATER RES A, V77A, P437, DOI 10.1002/jbm.a.30628; Schwarz F, 2009, J BIOMED MATER RES B, V88B, P83, DOI 10.1002/jbm.b.31154; Sladek REJ, 2007, LETT APPL MICROBIOL, V45, P318, DOI 10.1111/j.1472-765X.2007.02194.x; Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616; Vleugels M, 2005, IEEE T PLASMA SCI, V33, P824, DOI 10.1109/TPS.2005.844524; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Yoshinari M., 2009, WORLD ACAD SCI ENG T, V58, P171	35	63	66	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25893	10.1371/journal.pone.0025893	http://dx.doi.org/10.1371/journal.pone.0025893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016784	gold, Green Published, Green Submitted			2022-12-25	WOS:000295971700022
J	Sztriha, LK; Manawadu, D; Jarosz, J; Keep, J; Kalra, L				Sztriha, Laszlo K.; Manawadu, Dulka; Jarosz, Jozef; Keep, Jeff; Kalra, Lalit			Safety and Clinical Outcome of Thrombolysis in Ischaemic Stroke Using a Perfusion CT Mismatch between 3 and 6 Hours	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; TIME; ALTEPLASE; THERAPY; DIFFUSION; TRIALS; MRI	Objective: It may be possible to thrombolyse ischaemic stroke (IS) patients up to 6 h by using penumbral imaging. We investigated whether a perfusion CT (CTP) mismatch can help to select patients for thrombolysis up to 6 h. Methods: A cohort of 254 thrombolysed IS patients was studied. 174 (69%) were thrombolysed at 0-3 h by using non-contrast CT (NCCT), and 80 (31%) at 3-6 h (35 at 3-4.5 h and 45 at 4.5-6 h) by using CTP mismatch criteria. Symptomatic intracerebral haemorrhage (SICH), the mortality and the modified Rankin Score (mRS) were assessed at 3 months. Independent determinants of outcome in patients thrombolysed between 3 and 6 h were identified. Results: The baseline characteristics were comparable in the two groups. There were no differences in SICH (3% v 4%, p = 0.71), any ICH (7% v 9%, p = 0.61), or mortality (16% v 9%, p = 0.15) or mRS 0-2 at 3 months (55% v 54%, p = 0.96) between patients thrombolysed at 0-3 h (NCCT only) or at 3-6 h (CTP mismatch). There were no significant differences in outcome between patients thrombolysed at 3-4.5 h or 4.5-6 h. The NIHSS score was the only independent determinant of a mRS of 0-2 at 3 months (OR 0.89, 95% CI 0.82-0.97, p = 0.007) in patients treated using CTP mismatch criteria beyond 3 h. Conclusions: The use of a CTP mismatch model may help to guide thrombolysis decisions up to 6 h after IS onset.	[Sztriha, Laszlo K.; Manawadu, Dulka; Kalra, Lalit] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [Jarosz, Jozef] Kings Coll Hosp London, Dept Neuroradiol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Sztriha, LK (corresponding author), Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England.	laszlo.sztriha@kcl.ac.uk		Sztriha, Laszlo/0000-0003-4639-3180				Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; [Anonymous], EXTENDING TIME THROM; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Johnson SC, 2005, NEUROLOGY, V64, P654; Kohrmann M, 2006, LANCET NEUROL, V5, P661, DOI 10.1016/S1474-4422(06)70499-9; Kohrmann M, 2009, RADIOLOGY, V251, P627, DOI 10.1148/radiol.2513081074; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Mishra NK, 2010, STROKE, V41, pE25, DOI 10.1161/STROKEAHA.109.566869; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; RANKIN J, 1957, Scott Med J, V2, P200; Schellinger PD, 2007, STROKE, V38, P2640, DOI 10.1161/STROKEAHA.107.483255; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	20	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25796	10.1371/journal.pone.0025796	http://dx.doi.org/10.1371/journal.pone.0025796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016775	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700017
J	Kemp, K; Mallam, E; Hares, K; Witherick, J; Scolding, N; Wilkins, A				Kemp, Kevin; Mallam, Elizabeth; Hares, Kelly; Witherick, Jonathan; Scolding, Neil; Wilkins, Alastair			Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; IRON ACCUMULATION; OXIDATIVE STRESS; MESSENGER-RNA; INHIBITORS; BLOOD; MOUSE; DEFICIENCY; LYMPHOBLASTS; SENSITIVITY	Dramatic advances in recent decades in understanding the genetics of Friedreich ataxia (FRDA)-a GAA triplet expansion causing greatly reduced expression of the mitochondrial protein frataxin-have thus far yielded no therapeutic dividend, since there remain no effective treatments that prevent or even slow the inevitable progressive disability in affected individuals. Clinical interventions that restore frataxin expression are attractive therapeutic approaches, as, in theory, it may be possible to re-establish normal function in frataxin deficient cells if frataxin levels are increased above a specific threshold. With this in mind several drugs and cytokines have been tested for their ability to increase frataxin levels. Cell transplantation strategies may provide an alternative approach to this therapeutic aim, and may also offer more widespread cellular protective roles in FRDA. Here we show a direct link between frataxin expression in fibroblasts derived from FRDA patients with both decreased expression of hydrogen peroxide scavenging enzymes and increased sensitivity to hydrogen peroxide-mediated toxicity. We demonstrate that normal human mesenchymal stem cells (MSCs) induce both an increase in frataxin gene and protein expression in FRDA fibroblasts via secretion of soluble factors. Finally, we show that exposure to factors produced by human MSCs increases resistance to hydrogen peroxide-mediated toxicity in FRDA fibroblasts through, at least in part, restoring the expression of the hydrogen peroxide scavenging enzymes catalase and glutathione peroxidase 1. These findings suggest, for the first time, that stem cells may increase frataxin levels in FRDA and transplantation of MSCs may offer an effective treatment for these patients.	[Kemp, Kevin; Mallam, Elizabeth; Hares, Kelly; Witherick, Jonathan; Scolding, Neil; Wilkins, Alastair] Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Multiple Sclerosis & Stem Cell Grp, Bristol, Avon, England	University of Bristol	Kemp, K (corresponding author), Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Multiple Sclerosis & Stem Cell Grp, Bristol, Avon, England.	kevin.kemp@bristol.ac.uk	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Kemp, Kevin/B-9755-2017	Scolding, Neil/0000-0001-9177-1043; Kemp, Kevin/0000-0003-1465-1309	Ataxia UK; Ataxia UK [7160] Funding Source: researchfish	Ataxia UK; Ataxia UK	The study was funded by Ataxia UK research grant. www.ataxia.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2008, CEREBELLUM, V7, P360, DOI 10.1007/s12311-008-0036-x; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babady NE, 2007, MOL GENET METAB, V92, P23, DOI 10.1016/j.ymgme.2007.05.009; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Boesch S, 2007, ANN NEUROL, V62, P521, DOI 10.1002/ana.21177; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goncalves S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-20; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kemp K, 2010, STEM CELL REV REP, V6, P548, DOI 10.1007/s12015-010-9178-6; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lim CK, 2008, MOL PHARMACOL, V74, P225, DOI 10.1124/mol.108.046847; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mallam E, 2010, MULT SCLER J, V16, P909, DOI 10.1177/1352458510371959; Mancuso M, 2010, NEUROPSYCH DIS TREAT, V6, P491; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Marmolino D, 2009, CEREBELLUM, V8, P245, DOI 10.1007/s12311-008-0084-2; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; NACHBAUER W, 2011, CEREBELLUM IN PRESS; Pandolfo M, 2008, NAT CLIN PRACT NEURO, V4, P86, DOI 10.1038/ncpneuro0704; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Sturm B, 2005, EUR J CLIN INVEST, V35, P711, DOI 10.1111/j.1365-2362.2005.01568.x; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Tozzi G, 2002, ARCH DIS CHILD, V86, P376, DOI 10.1136/adc.86.5.376; Voncken M, 2004, NEUROGENETICS, V5, P1, DOI 10.1007/s10048-003-0170-z; Wang T, 2007, CRIT CARE MED, V35, P2587, DOI 10.1097/01.CCM.0000285992.99391.7E; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wong A, 2000, ANTIOXID REDOX SIGN, V2, P461, DOI 10.1089/15230860050192233; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	59	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26098	10.1371/journal.pone.0026098	http://dx.doi.org/10.1371/journal.pone.0026098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016819	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300060
J	Proft, J; Faraji, J; Robbins, JC; Zucchi, FCR; Zhao, XX; Metz, GA; Braun, JEA				Proft, Juliane; Faraji, Jamshid; Robbins, Jerrah C.; Zucchi, Fabiola C. R.; Zhao, Xiaoxi; Metz, Gerlinde A.; Braun, Janice E. A.			Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease	PLOS ONE			English	Article							PRION PROTEIN PRPC; HUMAN DNAJ PROTEIN; ALPHA-SYNUCLEIN; CSP-ALPHA; MOLECULAR CHAPERONES; HOMOLOG; HSP70; GENE; SUPPRESSION; APOPTOSIS	Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra and the aggregation of alpha-synuclein into Lewy bodies. Existing therapies address motor dysfunction but do not halt progression of the disease. A still unresolved question is the biochemical pathway that modulates the outcome of protein misfolding and aggregation processes in PD. The molecular chaperone network plays an important defensive role against cellular protein misfolding and has been identified as protective in experimental models of protein misfolding diseases like PD. Molecular mechanisms underlying chaperone-neuroprotection are actively under investigation. Current evidence implicates a number of molecular chaperones in PD including Hsp25, Hsp70 and Hsp90, however their precise involvement in the neurodegenerative cascade is unresolved. The J protein family (DnaJ or Hsp40 protein family) has long been known to be important in protein conformational processes. We assessed sensory and motor function of control and PD rats and then evaluated the brain region-specific expression levels of select J proteins by Western analysis. Surprisingly, we observed a widespread 26 kDa breakdown product of the J protein, TID1, (tumorous imaginal discs, mtHsp40 or DnaJ3) in a 6-hydroxydopamine (6-OHDA) rat model of PD in which food handling, gait symmetry and sensory performance were impaired. Greater behavioral deficits were associated with lower TID1 expression. Furthermore, direct application of either 6-OHDA or MPP+ (1-methyl-4-phenylpyridinum) to CAD (CNS-derived catecholinaminergic neuronal cell line) cell cultures, reduced TID1 expression levels. Our results suggest that changes in cellular TID1 are a factor in the pathogenesis of PD by impeding functional and structural compensation and exaggerating neurodegenerative processes. In contrast, no changes were observed in CSP alpha, Hsp40, Hsp70, Hsc70 and PrPC levels and no activation of caspase3 was observed. This study links TID1 to PD and provides a new target for therapeutics that halts the PD progression.	[Proft, Juliane; Zhao, Xiaoxi; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Faraji, Jamshid; Robbins, Jerrah C.; Zucchi, Fabiola C. R.; Metz, Gerlinde A.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Faraji, Jamshid] Golestan Univ Med Sci, Neurosci Res Ctr, Gorgan, Iran	University of Calgary; University of Lethbridge; Golestan University of Medical Sciences	Proft, J (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014; Zucchi, Fabiola/K-1296-2017	Proft, Juliane/0000-0003-0980-8930; Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Canadian Institute of Health Research [MOP74713]; Alberta Prion Research Institute; National Institutes of Neurological Disorders and Stroke, National Institutes of Health [NS043588]; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS043588] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute; National Institutes of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the Canadian Institute of Health Research #MOP74713, the Alberta Prion Research Institute, the National Institutes of Neurological Disorders and Stroke, National Institutes of Health Grant #NS043588, the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada (GM). JEAB and GM are Senior Scholars of Alberta Innovates-Health Solutions. Dr. Jamshid Faraji is a CCBN visiting scholar from Golestan University of Medical Sciences, Gorgan, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bandopadhyay R, 2010, TRENDS MOL MED, V16, P27, DOI 10.1016/j.molmed.2009.11.004; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brundin P, 2011, EXPERT REV NEUROTHER, V11, P917, DOI [10.1586/ERN.11.73, 10.1586/ern.11.73]; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Fornaguera J, 1999, PROG NEURO-PSYCHOPH, V23, P1353, DOI 10.1016/S0278-5846(99)00071-8; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JOHNSON JN, 2009, BIOCH CELL IN PRESS; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klein A, 2011, BEHAV BRAIN RES, V222, P33, DOI 10.1016/j.bbr.2011.03.018; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee KJ, 2007, J CELL SCI, V120, P2663, DOI 10.1242/jcs.004598; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martins AR, 2011, J NEUROSCI METH, V198, P16, DOI 10.1016/j.jneumeth.2011.02.024; Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Metz GA, 2002, NEUROSCIENCE, V111, P325, DOI 10.1016/S0306-4522(02)00013-1; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Nishida N, 1999, LAB INVEST, V79, P689; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; RUIPEREZ V, 2010, ALPHA SYNUCLEIN LIPI; Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; SCHALLERT T, 1988, BEHAV BRAIN RES, V30, P15, DOI 10.1016/0166-4328(88)90003-4; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheng JZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1531, DOI 10.1152/ajpcell.00561.2007; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; STEELE AD, 2008, P NATL ACAD SCI US; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weise J, 2008, RESTOR NEUROL NEUROS, V26, P57; Whishaw IQ, 1997, BEHAV BRAIN RES, V84, P167, DOI 10.1016/S0166-4328(96)00148-9; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Yakunin E, 2010, J NEUROSCI RES, V88, P866, DOI 10.1002/jnr.22246; Yin X, 2001, GENE, V278, P201, DOI 10.1016/S0378-1119(01)00720-X; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x; Zucchi Fabiola Cr, 2010, Exp Transl Stroke Med, V2, P18, DOI 10.1186/2040-7378-2-18	69	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26045	10.1371/journal.pone.0026045	http://dx.doi.org/10.1371/journal.pone.0026045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016808	Green Published, gold, Green Submitted			2022-12-25	WOS:000295970300052
J	Stanton, MC; Taylor-Robinson, D; Harris, D; Paize, F; Makwana, N; Hackett, SJ; Baines, PB; Riordan, FAI; Marzouk, O; Thomson, APJ; Diggle, PJ; Hart, CA; Carrol, ED				Stanton, Michelle C.; Taylor-Robinson, David; Harris, David; Paize, Fauzia; Makwana, Nick; Hackett, Scott J.; Baines, Paul B.; Riordan, F. Andrew I.; Marzouk, Omnia; Thomson, Alistair P. J.; Diggle, Peter J.; Hart, C. Anthony; Carrol, Enitan D.			Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study	PLOS ONE			English	Article							MORTALITY; DEPRIVATION; CONFIRMATION; EPIDEMIOLOGY	Meningococcal disease (MCD) is the leading infectious cause of death in early childhood in the United Kingdom, making it a public health priority. MCD most commonly presents as meningococcal meningitis (MM), septicaemia (MS), or as a combination of the two syndromes (MM/MS). We describe the changing epidemiology and clinical presentation of MCD, and explore associations with socioeconomic status and other risk factors. A hospital-based study of children admitted to a tertiary children's centre, Alder Hey Children's Foundation Trust, with MCD, was undertaken between 1977 to 2007 (n = 1157). Demographics, clinical presentations, microbiological confirmation and measures of deprivation were described. The majority of cases occurred in the 1-4 year age group and there was a dramatic fall in serogroup C cases observed with the introduction of the meningococcal C conjugate (MCC) vaccine. The proportion of MS cases increased over the study period, from 11% in the first quarter to 35% in the final quarter. Presentation with MS (compared to MM) and serogroup C disease (compared to serogroup B) were demonstrated to be independent risk factors for mortality, with odds ratios of 3.5 (95% CI 1.18 to 10.08) and 2.18 (95% CI 1.26 to 3.80) respectively. Cases admitted to Alder Hey were from a relatively more deprived population (mean Townsend score 1.25, 95% CI 1.09 to 1.41) than the Merseyside reference population. Our findings represent one of the largest single-centre studies of MCD. The presentation of MS is confirmed to be a risk factor of mortality from MCD. Our study supports the association between social deprivation and MCD.	[Stanton, Michelle C.; Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, Fac Hlth & Med, Lancaster, England; [Taylor-Robinson, David] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Hlth Inequal & Social Determinants Hlth, Liverpool L69 3BX, Merseyside, England; [Harris, David; Paize, Fauzia; Carrol, Enitan D.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Makwana, Nick] Sandwell & W Birmingham NHS Trust, Dept Child Hlth, W Bromwich, W Midlands, England; [Hackett, Scott J.] Birmingham Heartlands Hosp, Dept Paediat Infect Dis & Immunol, Birmingham B9 5ST, W Midlands, England; [Baines, Paul B.] Keele Univ, Dept Profess Eth, Keele, Staffs, England; [Baines, Paul B.; Riordan, F. Andrew I.; Marzouk, Omnia; Carrol, Enitan D.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Thomson, Alistair P. J.] Leighton Hosp, Crewe, Cheshire, England; [Diggle, Peter J.; Carrol, Enitan D.] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Lancaster University; University of Liverpool; University of Liverpool; Heart of England NHS Foundation Trust; University of Birmingham; Keele University; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Stanton, MC (corresponding author), Univ Lancaster, Lancaster Med Sch, Fac Hlth & Med, Lancaster, England.	m.stanton@lancaster.ac.uk	Stanton, Michelle/AAB-5291-2021	Stanton, Michelle/0000-0002-1754-4894; Carrol, Enitan/0000-0001-8357-7726; Diggle, Peter/0000-0003-3521-5020	Alder Hey Children's NHS Foundation Trust; Meningitis Merseyside; The Meningitis Research Foundation [MRF] [0605.1]; Medical Research Council [G0802448]; Engineering and Physical Sciences Research Council; MRC [G0802448] Funding Source: UKRI	Alder Hey Children's NHS Foundation Trust; Meningitis Merseyside; The Meningitis Research Foundation [MRF]; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Johanne Holly Fund, Alder Hey Children's NHS Foundation Trust Charitable Funds; Meningitis Merseyside; The Meningitis Research Foundation [MRF project 0605.1]; Medical Research Council Population Health Scientist Fellowship [G0802448 to D.T.R.]; and Engineering and Physical Sciences Research Council Doctoral Training Account [to M.C.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENCY HP, 2010, MEN REF UN IS NEISS; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Carrol ED, 2000, ARCH DIS CHILD, V83, P271, DOI 10.1136/adc.83.3.271; Carrol ED, 2000, CLIN MICROBIOL INFEC, V6, P259, DOI 10.1046/j.1469-0691.2000.00078.x; DEWALS P, 1984, J INFECTION, V8, P264, DOI 10.1016/S0163-4453(84)94123-9; Fone DL, 2003, EPIDEMIOL INFECT, V130, P53, DOI 10.1017/S095026880200794X; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hackett SJ, 2002, ARCH DIS CHILD, V86, P449, DOI 10.1136/adc.86.6.449; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Howitz M, 2009, EPIDEMIOL INFECT, V137, P1631, DOI 10.1017/S0950268809002428; JACOBSSON S, 2008, SCAND J INFECT DIS, P1; Jones D M, 1995, Commun Dis Rep CDR Rev, V5, pR125; Lloyd, 2004, ENGLISH INDICES DEPR; Martinez AI, 2009, VACCINE, V27, P3496, DOI 10.1016/j.vaccine.2009.01.045; Olowokure B, 2006, J INFECTION, V52, P61, DOI 10.1016/j.jinf.2005.01.013; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Pollard AJ, 2007, ARCH DIS CHILD, V92, P283, DOI 10.1136/adc.2006.102384; Ramsay M, 1997, COMMUN DIS REP CDR R, V7, pR49; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Rolleston H, 1919, LANCET, V1, P541; Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; Townsend PP., 1988, HLTH DEPRIVATION INE; Williams CJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-30	24	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25957	10.1371/journal.pone.0025957	http://dx.doi.org/10.1371/journal.pone.0025957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016791	Green Published, gold, Green Accepted			2022-12-25	WOS:000295970300041
J	Zhao, K; Blacker, K; Luo, YH; Bryant, B; Jiang, JB				Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo			Perceiving Nasal Patency through Mucosal Cooling Rather than Air Temperature or Nasal Resistance	PLOS ONE			English	Article							TOPOGRAPHICAL DIFFERENCES; TRIGEMINAL SENSITIVITY; SUBJECTIVE MEASURES; FLOW	Adequate perception of nasal airflow (i.e., nasal patency) is an important consideration for patients with nasal sinus diseases. The perception of a lack of nasal patency becomes the primary symptom that drives these patients to seek medical treatment. However, clinical assessment of nasal patency remains a challenge because we lack objective measurements that correlate well with what patients perceive. The current study examined factors that may influence perceived patency, including air temperature, humidity, mucosal cooling, nasal resistance, and trigeminal sensitivity. Forty-four healthy subjects rated nasal patency while sampling air from three facial exposure boxes that were ventilated with untreated room air, cold air, and dry air, respectively. In all conditions, air temperature and relative humidity inside each box were recorded with sensors connected to a computer. Nasal resistance and minimum airway cross-sectional area (MCA) were measured using rhinomanometry and acoustic rhinometry, respectively. General trigeminal sensitivity was assessed through lateralization thresholds to butanol. No significant correlation was found between perceived patency and nasal resistance or MCA. In contrast, air temperature, humidity, and butanol threshold combined significantly contributed to the ratings of patency, with mucosal cooling (heat loss) being the most heavily weighted predictor. Air humidity significantly influences perceived patency, suggesting that mucosal cooling rather than air temperature alone provides the trigeminal sensation that results in perception of patency. The dynamic cooling between the airstream and the mucosal wall may be quantified experimentally or computationally and could potentially lead to a new clinical evaluation tool.	[Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Zhao, K (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	kzhao@monell.org	Bianconi, Ginestra/I-5742-2018	Bianconi, Ginestra/0000-0002-3380-887X; Karsai, Marton/0000-0001-5382-8950	 [NIH P50 DC00006760];  [NIH 5R03DC008187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008187, P50DC006760] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study is supported in part by a grant to PD (NIH P50 DC00006760) and a grant to KZ (NIH 5R03DC008187). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre RF, 2009, CLIN OTOLARYNGOL, V34, P518, DOI 10.1111/j.1749-4486.2009.02042.x; Cahusac PMB, 2007, NEUROSCIENCE, V148, P489, DOI 10.1016/j.neuroscience.2007.06.018; Clarke JD, 2005, CLIN OTOLARYNGOL, V30, P35, DOI 10.1111/j.1365-2273.2004.00915.x; CLARKE RW, 1994, J LARYNGOL OTOL, V108, P1045, DOI 10.1017/S0022215100128853; CLARKE RW, 1992, CLIN OTOLARYNGOL, V17, P388, DOI 10.1111/j.1365-2273.1992.tb01680.x; Clement P A, 1984, Rhinology, V22, P151; ECCLES R, 1983, J LARYNGOL OTOL, V97, P705, DOI 10.1017/S002221510009486X; Fontanari P, 1996, J APPL PHYSIOL, V81, P1739, DOI 10.1152/jappl.1996.81.4.1739; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; JONES AS, 1987, CLIN OTOLARYNGOL, V12, P461, DOI 10.1111/j.1365-2273.1987.tb00233.x; Lam DJ, 2006, AM J RHINOL, V20, P463, DOI 10.2500/ajr.2006.20.2940; Lindemann J, 2002, CLIN OTOLARYNGOL, V27, P135, DOI 10.1046/j.1365-2273.2002.00544.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meusel T, 2010, PAIN, V151, P516, DOI 10.1016/j.pain.2010.08.013; Naftali S, 2005, ANN BIOMED ENG, V33, P545, DOI 10.1007/s10439-005-2513-4; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; Scheibe M, 2006, NEUROREPORT, V17, P1417, DOI 10.1097/01.wnr.0000224764.61959.e8; Voets T., 2007, V179, P329; Wrobel BB, 2006, AM J RHINOL, V20, P364, DOI 10.2500/ajr.2006.20.2862; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; Yogeetha R., 2007, SMJ Singapore Medical Journal, V48, P304; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033	24	86	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24618	10.1371/journal.pone.0024618	http://dx.doi.org/10.1371/journal.pone.0024618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194809	Green Submitted, gold, Green Published			2022-12-25	WOS:000295978600005
J	Li, YH; Romeis, J; Wang, P; Peng, YF; Shelton, AM				Li, Yunhe; Romeis, Joerg; Wang, Ping; Peng, Yufa; Shelton, Anthony M.			A Comprehensive Assessment of the Effects of Bt Cotton on Coleomegilla maculata Demonstrates No Detrimental Effects by Cry1Ac and Cry2Ab	PLOS ONE			English	Article							RESISTANT TRANSGENIC PLANTS; BACILLUS-THURINGIENSIS; CORN POLLEN; LEPIDOPTERA; NONTARGET; SURVIVAL; TOXIN; COLEOPTERA; PREDATORS; PROTEINS	The ladybird beetle, Coleomegilla maculata (DeGeer), is a common and abundant predator in many cropping systems. Its larvae and adults are predaceous, feeding on aphids, thrips, lepidopteran larvae and plant tissues, such as pollen. Therefore, this species is exposed to insecticidal proteins expressed in insect-resistant, genetically engineered cotton expressing Cry proteins derived from Bacillus thuringiensis (Bt). A tritrophic bioassay was conduced to evaluate the potential impact of Cry2Ab- and Cry1Ac-expressing cotton on fitness parameters of C. maculata using Bt-susceptible and -resistant larvae of Trichoplusia ni as prey. Coleomegilla maculata survival, development time, adult weight and fecundity were not different when they were fed with resistant T. ni larvae reared on either Bt or control cotton. To ensure that C. maculata were not sensitive to the tested Cry toxins independent from the plant background and to add certainty to the hazard assessment, C. maculata larvae were fed artificial diet incorporated with Cry2Ab, Cry1Ac or both at > 10 times higher concentrations than in cotton tissue. Artificial diet containing E-64 was included as a positive control. No differences were detected in any life-table parameters between Cry protein-containing diet treatments and the control diet. In contrast, larvae of C. maculata fed the E-64 could not develop to the pupal stage and the 7-d larval weight was significantly negatively affected. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources were confirmed by ELISA and sensitive-insect bioassays. Our results show that C. maculata is not affected by Bt cotton and is not sensitive to Cry2Ab and Cry1Ac at concentrations exceeding the levels in Bt cotton, thus demonstrating that Bt cotton will pose a negligible risk to C. maculata. More importantly, this study demonstrates a comprehensive system for assessing the risk of genetically modified plants on non-target organisms.	[Li, Yunhe; Wang, Ping; Shelton, Anthony M.] Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA; [Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Cornell University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Shelton, AM (corresponding author), Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA.	ams5@cornell.edu	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Key Basic Research and Development (973) Program in China [2007CB109204]; Swiss National Science Foundation [PBBEP3-125563]	National Key Basic Research and Development (973) Program in China(National Basic Research Program of China); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the National Key Basic Research and Development (973) Program (2007CB109204) in China and funded by a postdoctoral grant from the Swiss National Science Foundation (PBBEP3-125563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; BOODLEY JW, 1977, CORNELL U COOPERATIO, V43; BROOKES G, 2010, GM CROPS GLOBAL SOCI; CAB International, 2007, CROP PROT COMP; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Ferry N, 2007, TRANSGENIC RES, V16, P795, DOI 10.1007/s11248-007-9088-9; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Kennedy George G., 2008, V5, P1; Knox O. G. G., 2008, The Open Agriculture Journal, V2, P105, DOI 10.2174/1874331500802010105; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li YX, 2006, CROP PROT, V25, P940, DOI 10.1016/j.cropro.2005.12.007; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; LIU CX, 2010, SCIENCE CHINA C, V8, P934; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Naranjo S., 2009, CAB REV PERSPECTIVES, V4; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; NAS (National Academy of Sciences), 2002, ENV EFF TRANSG PLANT; Organisation for Economic Co-operation and Development (OECD), 2007, SER HARM REG OV BIOT; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Raybould A, 2010, TRANSGENIC RES, V20, P599, DOI DOI 10.1007/S11248-010-9442-1; ROGER C, 1999, THESIS MCGILI U MONT; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; USEPA, 2002, 006487 EPA AMENDED	36	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22185	10.1371/journal.pone.0022185	http://dx.doi.org/10.1371/journal.pone.0022185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22022595	Green Submitted, gold, Green Published			2022-12-25	WOS:000292699000028
J	Hume, JCC; Hamilton, H; Lee, KL; Lehmann, T				Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi			Susceptibility of Anopheles stephensi to Plasmodium gallinaceum: A Trait of the Mosquito, the Parasite, and the Environment	PLOS ONE			English	Article							COEVOLUTIONARY INTERACTIONS; CULICOIDES-VARIIPENNIS; MALARIA TRANSMISSION; WUCHERERIA-BANCROFTI; VECTOR COMPETENCE; LOCAL ADAPTATION; HOST; GAMBIAE; INFECTION; EPIDEMIOLOGY	Background: Vector susceptibility to Plasmodium infection is treated primarily as a vector trait, although it is a composite trait expressing the joint occurrence of the parasite and the vector with genetic contributions of both. A comprehensive approach to assess the specific contribution of genetic and environmental variation on "vector susceptibility" is lacking. Here we developed and implemented a simple scheme to assess the specific contributions of the vector, the parasite, and the environment to "vector susceptibility." To the best of our knowledge this is the first study that employs such an approach. Methodology/Principal Findings: We conducted selection experiments on the vector (while holding the parasite "constant") and on the parasite (while holding the vector "constant") to estimate the genetic contributions of the mosquito and the parasite to the susceptibility of Anopheles stephensi to Plasmodium gallinaceum. We separately estimated the realized heritability of (i) susceptibility to parasite infection by the mosquito vector and (ii) parasite compatibility (transmissibility) with the vector while controlling the other. The heritabilities of vector and the parasite were higher for the prevalence, i. e., fraction of infected mosquitoes, than the corresponding heritabilities of parasite load, i. e., the number of oocysts per mosquito. Conclusions: The vector's genetics (heritability) comprised 67% of "vector susceptibility" measured by the prevalence of mosquitoes infected with P. gallinaceum oocysts, whereas the specific contribution of parasite genetics (heritability) to this trait was only 5%. Our parasite source might possess minimal genetic diversity, which could explain its low heritability (and the high value of the vector). Notably, the environment contributed 28%. These estimates are relevant only to the particular system under study, but this experimental design could be useful for other parasite-host systems. The prospects and limitations of the genetic manipulation of vector populations to render the vector resistant to the parasite are better considered on the basis of this framework.	[Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hume, JCC (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	tlehmann@niaid.nih.gov	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	NIH, NIAID; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Intramural Research Program in NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Brumpt E, 1936, CR HEBD ACAD SCI, V203, P750; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; COLLINS RC, 1995, AM J TROP MED HYG, V52, P213, DOI 10.4269/ajtmh.1995.52.213; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; DIMOPOULOS G, 2007, J VIS EXP; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; FALCONER DS, 1996, INTRO QANTITATIVE GE; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; FONTENILLE D, 1992, J MED ENTOMOL, V29, P197, DOI 10.1093/jmedent/29.2.197; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; HUFF CLAY G., 1929, ANN TROP MED & PARASIT [LIVERPOOL], V23, P427; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; HUNT RH, 1990, ANN TROP MED PARASIT, V84, P381, DOI 10.1080/00034983.1990.11812483; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; JAMES AA, 2007, J VIS EXP; JONES JS, 1987, NATURE, V325, P298, DOI 10.1038/325298a0; Koella JC, 1998, PARASITOLOGY, V116, pS47, DOI 10.1017/S0031182000084936; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2006, P ROY SOC B-BIOL SCI, V273, P1501, DOI 10.1098/rspb.2006.3483; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Laurence B. R., 1967, Journal of Helminthology, V41, P365, DOI 10.1017/S0022149X00021908; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ljungstr?m I., 2004, METHODS MALARIA RES; LYNCH M, 2008, EVOLUTION SELECTION, V2; Nace D, 2004, J AM MOSQUITO CONTR, V20, P272; NILES WJ, 1965, NATURE, V205, P411, DOI 10.1038/205411a0; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Price P W, 1980, Monogr Popul Biol, V15, P1; RAMSDALE C D, 1975, Parassitologia (Rome), V17, P39; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; *SAS I INC, 2002, SAS WIND VERS 9 0; Shahabuddin M, 1995, EXP PARASITOL, V81, P386, DOI 10.1006/expr.1995.1129; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TABACHNICK WJ, 1991, AM J TROP MED HYG, V45, P666, DOI 10.4269/ajtmh.1991.45.666; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110	52	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20156	10.1371/journal.pone.0020156	http://dx.doi.org/10.1371/journal.pone.0020156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	22022570	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900006
J	Tseng, YC; Chen, RD; Lucassen, M; Schmidt, MM; Dringen, R; Abele, D; Hwang, PP				Tseng, Yung-Che; Chen, Ruo-Dong; Lucassen, Magnus; Schmidt, Maike M.; Dringen, Ralf; Abele, Doris; Hwang, Pung-Pung			Exploring Uncoupling Proteins and Antioxidant Mechanisms under Acute Cold Exposure in Brains of Fish	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NONSHIVERING THERMOGENESIS; SUPEROXIDE-DISMUTASE; ENERGY-METABOLISM; SKELETAL-MUSCLE; UP-REGULATION; HYPOXIA; ZEBRAFISH	Exposure to fluctuating temperatures accelerates the mitochondrial respiration and increases the formation of mitochondrial reactive oxygen species (ROS) in ectothermic vertebrates including fish. To date, little is known on potential oxidative damage and on protective antioxidative defense mechanisms in the brain of fish under cold shock. In this study, the concentration of cellular protein carbonyls in brain was significantly increased by 38% within 1 h after cold exposure (from 28 degrees C to 18 degrees C) of zebrafish (Danio rerio). In addition, the specific activity of superoxide dismutase (SOD) and the mRNA level of catalase (CAT) were increased after cold exposure by about 60% (6 h) and by 60%-90% (1 and 24 h), respectively, while the specific glutathione content as well as the ratio of glutathione disulfide to glutathione remained constant and at a very low level. In addition, cold exposure increased the protein level of hypoxia-inducible factor (HIF) by about 50% and the mRNA level of the glucose transporter zglut3 in brain by 50%-100%. To test for an involvement of uncoupling proteins (UCPs) in the cold adaptation of zebrafish, five UCP members were annotated and identified (zucp1-5). With the exception of zucp1, the mRNA levels of the other four zucps were significantly increased after cold exposure. In addition, the mRNA levels of four of the fish homologs (zppar) of the peroxisome proliferator-activated receptor (PPAR) were increased after cold exposure. These data suggest that PPARs and UCPs are involved in the alterations observed in zebrafish brain after exposure to 18 degrees C. The observed stimulation of the PPAR-UCP axis may help to prevent oxidative damage and to maintain metabolic balance and cellular homeostasis in the brains of ectothermic zebrafish upon cold exposure.	[Tseng, Yung-Che; Chen, Ruo-Dong; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Tseng, Yung-Che] Leibniz Inst Marine Sci, IFM GEOMAR, D-24105 Kiel, Germany; [Chen, Ruo-Dong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lucassen, Magnus; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schmidt, Maike M.; Dringen, Ralf] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Academia Sinica - Taiwan; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Academia Sinica - Taiwan; National Taiwan University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Tseng, YC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Tseng, Yung-Che/AAE-7509-2022; Lucassen, Magnus/E-8433-2011; Lucassen, Magnus/ABA-8396-2021; Hwang, Pung-Pung/AAH-1538-2022	Tseng, Yung-Che/0000-0001-7489-0403; Lucassen, Magnus/0000-0003-4276-4781; Lucassen, Magnus/0000-0003-4276-4781; Dringen, Ralf/0000-0001-7869-1305; Abele, Doris/0000-0002-5766-5017	Academia Sinica; Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan; International Bureau of the Germany Federal Ministry of Education and Research	Academia Sinica(Academia Sinica - Taiwan); Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan(Ministry of Science and Technology, Taiwan); International Bureau of the Germany Federal Ministry of Education and Research	This study was financially supported by Academia Sinica (P. P. Hwang) and Alfred-Wegener Institute for Polar and Marine Research (D. Abele). Y. C. Tseng was awarded the Postdoc Scholarship supported by both the National Science of Council of Taiwan and the Bilateral Cooperation in Science and Technology grant from International Bureau of the Germany Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Benarroch EE, 2009, NEUROLOGY, V73, P560, DOI 10.1212/WNL.0b013e3181b2a719; Bermejo-Nogales A, 2010, J COMP PHYSIOL B, V180, P685, DOI 10.1007/s00360-009-0441-6; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chavez A, 2008, ANN NY ACAD SCI, V1147, P312, DOI 10.1196/annals.1427.021; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; CRAWSHAW L, 1985, PHARMACOL THERAPEUT, V30, P19, DOI 10.1016/0163-7258(85)90045-2; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; FRIEDLANDER MJ, 1976, J COMP PHYSIOL, V112, P19, DOI 10.1007/BF00612674; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heise K, 2007, J COMP PHYSIOL B, V177, P765, DOI 10.1007/s00360-007-0173-4; Heise K, 2006, J EXP BIOL, V209, P353, DOI 10.1242/jeb.01977; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Kern B, 2009, COMP BIOCHEM PHYS D, V4, P121, DOI 10.1016/j.cbd.2008.12.006; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Rial Eduardo, 2009, Journal of Biology (London), V8, P58, DOI 10.1186/jbiol155; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Schwartz TS, 2008, P ROY SOC B-BIOL SCI, V275, P979, DOI 10.1098/rspb.2007.1761; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHAKLEE JB, 1977, J EXP ZOOL, V201, P1, DOI 10.1002/jez.1402010102; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van den Burg EH, 2005, J NEUROPHYSIOL, V93, P2849, DOI 10.1152/jn.01113.2004; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang PY, 2010, CIRC RES, V106, P911, DOI 10.1161/CIRCRESAHA.109.206185; WULLIMANN M, 1997, PHYSL FISHES, V2007, P245; Yoo HY, 1999, GENE, V234, P87, DOI 10.1016/S0378-1119(99)00176-6; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002	69	76	83	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18180	10.1371/journal.pone.0018180	http://dx.doi.org/10.1371/journal.pone.0018180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464954	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000288813900047
J	Li, YC; Li, YM; Zhang, H; Chen, Y				Li, Yichen; Li, Yumin; Zhang, Hui; Chen, Yong			MicroRNA-Mediated Positive Feedback Loop and Optimized Bistable Switch in a Cancer Network Involving miR-17-92	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; GENE-REGULATION; NOISE; HETEROGENEITY; BIOGENESIS; MOTIFS; MEMORY	MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in many key biological processes, including development, cell differentiation, the cell cycle and apoptosis, as central post-transcriptional regulators of gene expression. Recent studies have shown that miRNAs can act as oncogenes and tumor suppressors depending on the context. The present work focuses on the physiological significance of miRNAs and their role in regulating the switching behavior. We illustrate an abstract model of the Myc/E2F/miR-17-92 network presented by Aguda et al. (2008), which is composed of coupling between the E2F/Myc positive feedback loops and the E2F/Myc/miR-17-92 negative feedback loop. By systematically analyzing the network in close association with plausible experimental parameters, we show that, in the presence of miRNAs, the system bistability emerges from the system, with a bistable switch and a one-way switch presented by Aguda et al. instead of a single one-way switch. Moreover, the miRNAs can optimize the switching process. The model produces a diverse array of response-signal behaviors in response to various potential regulating scenarios. The model predicts that this transition exists, one from cell death or the cancerous phenotype directly to cell quiescence, due to the existence of miRNAs. It was also found that the network involving miR-17-92 exhibits high noise sensitivity due to a positive feedback loop and also maintains resistance to noise from a negative feedback loop.	[Li, Yichen; Li, Yumin] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Li, Yichen; Li, Yumin; Chen, Yong] Key Lab Digest Syst Tumors, Lanzhou, Peoples R China; [Zhang, Hui; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Li, YC (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	liym@lzu.edu.cn; ychen@lzu.edu.cn	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Natural Science Foundation of China [10975063, 30870364]; High Technology Research and Development Program of China (863 program) [2007AA021807]; Key Technology R&D Program of Gansu Province [0708NKCA129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Key Technology R&D Program of Gansu Province	This work was supported by the National Natural Science Foundation of China (Grant No. 10975063, 30870364), the High Technology Research and Development Program of China (863 program, Grant No. 2007AA021807), and The Key Technology R&D Program of Gansu Province (Grant No. 0708NKCA129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Khanin R, 2008, J COMPUT BIOL, V15, P305, DOI 10.1089/cmb.2007.0184; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031902; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van der Pol B, 1926, PHILOS MAG, V2, P978; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang XP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031924; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	53	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26302	10.1371/journal.pone.0026302	http://dx.doi.org/10.1371/journal.pone.0026302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022595	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600052
J	Hamilton, CA; Formanowicz, DR; Bond, JE				Hamilton, Chris A.; Formanowicz, Daniel R.; Bond, Jason E.			Species Delimitation and Phylogeography of Aphonopelma hentzi (Araneae, Mygalomorphae, Theraphosidae): Cryptic Diversity in North American Tarantulas	PLOS ONE			English	Article							MULTIPLE PLEISTOCENE REFUGIA; GENETIC DIFFERENTIATION; CONSERVATION GENETICS; POPULATION HISTORY; STATISTICAL TESTS; TRAPDOOR SPIDERS; COMPUTER-PROGRAM; TIGER SALAMANDER; DNA BARCODES; SPECIATION	Background: The primary objective of this study is to reconstruct the phylogeny of the hentzi species group and sister species in the North American tarantula genus, Aphonopelma, using a set of mitochondrial DNA markers that include the animal "barcoding gene". An mtDNA genealogy is used to consider questions regarding species boundary delimitation and to evaluate timing of divergence to infer historical biogeographic events that played a role in shaping the present-day diversity and distribution. We aimed to identify potential refugial locations, directionality of range expansion, and test whether A. hentzi post-glacial expansion fit a predicted time frame. Methods and Findings: A Bayesian phylogenetic approach was used to analyze a 2051 base pair (bp) mtDNA data matrix comprising aligned fragments of the gene regions CO1 (1165 bp) and ND1-16S (886 bp). Multiple species delimitation techniques (DNA tree-based methods, a "barcode gap" using percent of pairwise sequence divergence (uncorrected p-distances), and the GMYC method) consistently recognized a number of divergent and genealogically exclusive groups. Conclusions: The use of numerous species delimitation methods, in concert, provide an effective approach to dissecting species boundaries in this spider group; as well they seem to provide strong evidence for a number of nominal, previously undiscovered, and cryptic species. Our data also indicate that Pleistocene habitat fragmentation and subsequent range expansion events may have shaped contemporary phylogeographic patterns of Aphonopelma diversity in the southwestern United States, particularly for the A. hentzi species group. These findings indicate that future species delimitation approaches need to be analyzed in context of a number of factors, such as the sampling distribution, loci used, biogeographic history, breadth of morphological variation, ecological factors, and behavioral data, to make truly integrative decisions about what constitutes an evolutionary lineage recognized as a "species".	[Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA; [Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Formanowicz, Daniel R.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Texas System; University of Texas Arlington	Hamilton, CA (corresponding author), Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA.	chamilton@auburn.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	American Arachnological Society (AAS); NSF REVSYS [DEB0841610]; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	American Arachnological Society (AAS); NSF REVSYS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the American Arachnological Society (AAS) (2009) Vincent Roth Fund for Systematic Research (http://www.americanarachnology.org) to C. Hamilton; NSF REVSYS #DEB0841610 "Systematics and taxonomy of the tarantula spider genus Aphonopelma (Araneae, Mygalomorphae, Theraphosidae)" (http://www.nsf.gov) to J. Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Avise John C., 1994, pi; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Baerg WJ, 1958, TARANTULA; Bailey AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012744; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2004, INVERTEBR SYST, V18, P361, DOI 10.1071/IS04008; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Boulton AM, 1998, BIOL J LINN SOC, V64, P69, DOI 10.1111/j.1095-8312.1998.tb01534.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Chamberlin R. V., 1939, Bulletin of the University of Utah Biological Series, V5, P1; Chamberlin R. V., 1940, Bulletin of the University of Utah Biological Series, V5, P1; Church SA, 2003, EVOLUTION, V57, P372; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Costa FG, 2002, J ARACHNOL, V30, P571, DOI 10.1636/0161-8202(2002)030[0571:RBOUTA]2.0.CO;2; COYNE JA, 1994, EVOLUTION, V48, P19, DOI 10.1111/j.1558-5646.1994.tb01290.x; Croucher PJP, 2004, BIOL J LINN SOC, V81, P79, DOI 10.1111/j.1095-8312.2004.00280.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Drummond AJ, 2010, BEAST V1 5 4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELIAS SA, 1992, SOUTHWEST NAT, V37, P101, DOI 10.2307/3671658; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T. H. G., 2009, SPLITS SPECIES LIMIT; Foelix RF, 1996, BIOL SPIDERS; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gantenbein BI, 2003, J ARACHNOL, V31, P412, DOI 10.1636/H01-23; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Girard C, 1854, EXPLORATION RED RIVE, P262; Goloboff P.A., 1993, American Museum Novitates, P1; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Hamilton CA, 2009, THESIS U TEXAS ARLIN; Hamilton DE, 2008, THESIS TEXAS TU; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2009, MOL PHYLOGENET EVOL, V53, P300, DOI 10.1016/j.ympev.2009.06.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hull JM, 2010, MOL PHYLOGENET EVOL, V56, P212, DOI 10.1016/j.ympev.2010.02.027; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Janowski-Bell ME, 2001, THESIS U MISSOURI CO; Jennings CE, 2007, ENCY QUATERNARY SCI, P1044; Knowles LL, 2008, EVOLUTION, V62, P2713, DOI 10.1111/j.1558-5646.2008.00481.x; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kozak KH, 2006, MOL ECOL, V15, P191, DOI 10.1111/j.1365-294X.2005.02757.x; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1; Maddison WP, 2010, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Masta SE, 2000, EVOLUTION, V54, P1699; McGaughran A, 2008, MOL PHYLOGENET EVOL, V46, P606, DOI 10.1016/j.ympev.2007.10.003; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murray EA, 2006, THESIS KANSAS STATE; Musgrove M, 2001, GEOL SOC AM BULL, V113, P1532, DOI 10.1130/0016-7606(2001)113<1532:GOLPTH>2.0.CO;2; Okello JBA, 2005, HEREDITY, V95, P206, DOI 10.1038/sj.hdy.6800711; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pedersen AA, 2001, MOL ECOL, V10, P1133, DOI 10.1046/j.1365-294X.2001.01266.x; Perez-Miles Fernando, 1996, Mygalomorph, V1, P33; Petersen SD, 2007, CONSERV GENET, V8, P497, DOI 10.1007/s10592-006-9173-2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prentice TR, 1997, J ARACHNOL, V25, P137; Prentice TR, 2005, SPIDERS N AM IDENTIF, P54; Punzo F., 1989, Bulletin of the British Arachnological Society, V8, P72; Punzo F., 1991, Bulletin of the British Arachnological Society, V8, P277; Punzo F, 2007, J HYMENOPT RES, V16, P297; Punzo Fred, 1999, Bulletin of the British Arachnological Society, V11, P121; Rambaut A, 2010, TRACER V1 6 1; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Ramirez MG, 2004, BIOL J LINN SOC, V82, P27, DOI 10.1111/j.1095-8312.2004.00312.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raven R.J., 1990, Bulletin of Zoological Nomenclature, V47, P126; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Reichling SB, 2000, SW NATURALIST, V44, P518; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Roy M, 2004, EARTH PLANET SC LETT, V227, P281, DOI 10.1016/j.epsl.2004.09.001; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Smith A. M., 1994, TARANTULA SPIDERS TA; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; TEMPLETON AR, 1995, GENETICS, V140, P767; Turgeon J, 2002, MOL ECOL, V11, P1989, DOI 10.1046/j.1365-294X.2002.01580.x; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velasco JD, 2009, BIOL PHILOS, V24, P473, DOI 10.1007/s10539-009-9151-4; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Warriner W., 2008, Journal of the Arkansas Academy of Science, V62, P107; WELLS PV, 1966, SCIENCE, V153, P970, DOI 10.1126/science.153.3739.970; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	133	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26207	10.1371/journal.pone.0026207	http://dx.doi.org/10.1371/journal.pone.0026207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022570	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000087
J	Du, J; Xu, R; Hu, ZZ; Tian, YH; Zhu, YC; Gu, L; Zhou, L				Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Zhu, Yichao; Gu, Luo; Zhou, Lei			PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1 alpha Expression in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROXIMAL TUBULE CELLS; ANGIOGENESIS IN-VITRO; INDUCIBLE FACTOR-1-ALPHA; GENE-TRANSCRIPTION; EPITHELIAL-CELLS; NADPH OXIDASE; UP-REGULATION; TUMOR-GROWTH; ROS	Background: Hypoxia-inducible factor 1 (HIF-1 alpha) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1 alpha in tumor cells remain unknown. Methodology/Principal Findings: In this study, we reported that hypoxia could induce HIF-1 alpha and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1 alpha and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1 alpha expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1 alpha expression. Conclusions/Significance: Taken together, our study demonstrated that hypoxia-induced HIF-1 alpha expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.	[Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Xu, Rui; Hu, Zhenzhen; Tian, Yinhui] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zhou, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.	lgu@njmu.edu.cn; zhoulei7005@hotmail.com			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]; Postdoctoral Science Foundation of Jiangsu Province; Science Development Foundation of Nanjing Medical University [2010NJMUZ35]; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province; Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Science Development Foundation of Nanjing Medical University; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province, the Science Development Foundation of Nanjing Medical University (2010NJMUZ35) and the Research Program funded by the School of Basic Medical Sciences, Nanjing Medical University to Dr. Jun Du. This work was also partially supported by a research grant from State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chen MJ, 2007, J CELL BIOCHEM, V101, P1316, DOI 10.1002/jcb.21254; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Chung BH, 2010, PHYTOTHER RES, V24, P934, DOI 10.1002/ptr.3063; Colley NJ, 2000, SCIENCE, V290, P1902, DOI 10.1126/science.290.5498.1902; Criss AK, 2001, J CELL SCI, V114, P1331; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Desireddi JR, 2010, ANTIOXID REDOX SIGN, V12, P595, DOI 10.1089/ars.2009.2862; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hess AR, 2003, CANCER RES, V63, P4757; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kim J, 2008, MOL BIOL CELL, V19, P433, DOI 10.1091/mbc.E07-02-0182; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Lee TK, 2006, CLIN CANCER RES, V12, P5082, DOI 10.1158/1078-0432.CCR-05-2794; Li SM, 2010, ENDOCRINOLOGY, V151, P5315, DOI 10.1210/en.2010-0178; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; PARK JH, 2011, ONCOGENE; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ribatti D, 2010, STEM CELLS DEV, V19, P1, DOI 10.1089/scd.2009.0402; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xue Y, 2006, INT J CANCER, V118, P2965, DOI 10.1002/ijc.21763; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yuan LP, 2010, CLIN EXP METASTAS, V27, P481, DOI 10.1007/s10585-010-9337-9; Yuan YG, 2011, AM J PHYSIOL-RENAL, V300, pF393, DOI 10.1152/ajprenal.00418.2010; Zhang Jun, 2007, Cancer Ther, V5, P273; ZHANG L, 2011, J PHARM EXP THER; Zhang L, 2011, PHARMACOLOGY, V87, P265, DOI 10.1159/000326082	61	128	136	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25213	10.1371/journal.pone.0025213	http://dx.doi.org/10.1371/journal.pone.0025213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980400	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700021
J	Li, JS; Bi, YT; Dong, C; Yang, JF; Liang, WD				Li, Jin-song; Bi, Yun-tian; Dong, Cheng; Yang, Ji-feng; Liang, Wan-dong			Transcriptome Analysis of Adaptive Heat Shock Response of Streptococcus thermophilus	PLOS ONE			English	Article							GROWTH TEMPERATURE; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; CLPL; METABOLISM; BULGARICUS; REGULATORS; TOLERANCE; BACTERIA; SYSTEMS	Streptococcus thermophilus, a gram-positive facultative anaerobe, is one of the most important lactic acid bacteria widely used in the dairy fermentation industry. In this study, we have analyzed the global transcriptional profiling of S. thermophilus upon temperature change. During a temperature shift from 42 degrees C to 50 degrees C, it is found that 196 (10.4%) genes show differential expression with 102 up-regulated and 94 down-regulated at 50 degrees C. In particular, 1) Heat shock genes, such as DnaK, GroESL and clpL, are identified to be elevated at 50 degrees C; 2) Transcriptional regulators, such as HrcA, CtsR, Fur, MarR and MerR family, are differentially expressed, indicating the complex molecular mechanisms of S. thermophilus adapting to heat shock; 3) Genes associated with signal transduction, cell wall genes, iron homeostasis, ABC transporters and restriction-modification system were induced; 4) A large number of the differentially expressed genes are hypothetical genes of unknown function, indicating that much remains to be investigated about the heat shock response of S. thermophilus. Experimental investigation of selected heat shock gene ClpL shows that it plays an important role in the physiology of S. thermophilus at high temperature and meanwhile we confirmed ClpL as a member of the CtsR regulon. Overall, this study has contributed to the underlying adaptive molecular mechanisms of S. thermophilus upon temperature change and provides a basis for future in-depth functional studies.	[Li, Jin-song; Yang, Ji-feng; Liang, Wan-dong] Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Bi, Yun-tian] Wenzhou Med Coll, Sch Basic Med Sci, Wenzhou, Peoples R China; [Dong, Cheng] Harbin Med Univ, Hosp 4, Harbin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Harbin Medical University	Li, JS (corresponding author), Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	liliang2011@yahoo.com	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	Natural Science Foundation of Zhejiang Province [Y2090642]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2090642), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Herve-Jimenez L, 2009, APPL ENVIRON MICROB, V75, P2062, DOI 10.1128/AEM.01984-08; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suokko A, 2008, PROTEOMICS, V8, P1029, DOI 10.1002/pmic.200700925; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Varcamonti M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-6; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	28	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25777	10.1371/journal.pone.0025777	http://dx.doi.org/10.1371/journal.pone.0025777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600030
J	Li, J; Ding, ZY; Wang, ZX; Lu, JF; Maity, SN; Navone, NM; Logothetis, CJ; Mills, GB; Kim, J				Li, Jin; Ding, Zhiyong; Wang, Zhengxin; Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Mills, Gordon B.; Kim, Jeri			Androgen Regulation of 5 alpha-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; DEPENDENT INHIBITION; SERUM TESTOSTERONE; GENE-EXPRESSION; MESSENGER-RNA; ADULT-RAT; FINASTERIDE; RECEPTOR; DUTASTERIDE; TYPE-1	The enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5 alpha-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5 alpha-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5 alpha-reductase isoenzymes in a cell type-specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5 alpha-reductase isoenzymes may confer response or resistance to 5 alpha-reductase inhibitors and thus may have importance in prostate cancer prevention.	[Li, Jin; Ding, Zhiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, J (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	jekim@mdanderson.org	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Prostate Cancer Research Program at MD Anderson Cancer Center and supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Fitzpatrick JM, 2009, BJU INT, V103, P864, DOI 10.1111/j.1464-410X.2008.08206.x; George FW, 1997, ENDOCRINOLOGY, V138, P871, DOI 10.1210/en.138.3.871; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Makridakis N, 2005, J MOL ENDOCRINOL, V34, P617, DOI 10.1677/jme.1.01725; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Reddy G Kesava, 2004, Clin Prostate Cancer, V2, P209; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Schatzl G, 2001, PROSTATE, V47, P52; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Steiner JF, 1996, CLIN PHARMACOKINET, V30, P16, DOI 10.2165/00003088-199630010-00002; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024; TITUS MA, 2009, 5ALPHA REDUCTASE I 2, P175; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; WILBERT DM, 1983, J CLIN ENDOCR METAB, V56, P113, DOI 10.1210/jcem-56-1-113; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wilson JD, 1996, PROSTATE, P88; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Yamana K, 2010, HORM MOL BIOL CLIN I, V2, P293, DOI 10.1515/HMBCI.2010.035; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhou ZF, 1999, MOL GENET METAB, V68, P410, DOI 10.1006/mgme.1999.2898; Zhu YS, 2009, ANN NY ACAD SCI, V1155, P43, DOI 10.1111/j.1749-6632.2009.04115.x	49	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28840	10.1371/journal.pone.0028840	http://dx.doi.org/10.1371/journal.pone.0028840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100109
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Lin, Jinxing/0000-0001-9338-1356; Speicher, Andreas/0000-0001-6608-3994; Li, Ping/0000-0002-3314-943X	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22022536	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300033
